Citrus Sinensis ID: 015352

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------41
Protein Sequence
MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSVLAT
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccEEEcccccccccccEEEcccccccccccEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHcccccccEEEEEEEEEEcccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHcccccccEEHHHHHHHHHHccccccHHHHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEccHHccccccEEEEEEEccccccEEEEHHHHHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccccccEEEccccEEEEccccEEEcccccHHHHcHHHHHHHEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHcccccccEEEHHHHHHHHHHHcccccHHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
mgnccrspaavaredvksnysshdharkeagankkqpitvlagvpkeniedrylvdrelgrgefgvtylCIDRDTRELLACKSISkrklrtavdidDVRREVAIMKhlpknssivSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKhgvihrdlkpenflfankkensplkaidfglsiffkpgerfseivgspyymapevlkrnygpeidiwSAGVILYILLCgvppfwaesEQGVAQAILRGLidfkrdpwpnvsESAKSLVRQmlepdpklrlTAKQVlehpwlqnakkapnvplgdvVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKidsdndgvvstDELKAGLRNFGSQLAESEVQMLIEASSSVLAT
Flexible Loop (DISEMBL)
mgnccrspaavaredvksnySSHDharkeagankkqpitvlagvpkeniedrylvdrelgrgefgvtylcidrdtRELLAcksiskrklrtavdiddvRREVAImkhlpknssivslKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEhpwlqnakkapnvplgdVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMfkkidsdndgvVSTDELKAGLRNFGSQLAESEVQMLIEASSSVLAT
Low Complexity Region (SEG)
MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSVLAT
Disordered region (IsUnstruct)
*************************************ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP*********************LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKI******************************************
Disordered Region (DISOPRED)
*******************************************VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK****PLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSVL**
Disordered Region (DISEMBL)
*********AVAR*******************NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE********
Disordered Region (DISPRO)
***************************************VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSVLAT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	408	2.2.26 [Sep-21-2011]
Q8W4I7	528	Calcium-dependent protein	yes	no	0.982	0.759	0.895	0.0
Q9SSF8	541	Calcium-dependent protein	no	no	0.911	0.687	0.739	1e-167
Q9M9V8	545	Calcium-dependent protein	no	no	0.970	0.726	0.696	1e-166
Q38873	535	Calcium-dependent protein	no	no	0.980	0.747	0.670	1e-164
Q42438	533	Calcium-dependent protein	no	no	0.980	0.750	0.682	1e-164
Q6NLQ6	538	Calcium-dependent protein	no	no	0.985	0.747	0.652	1e-161
P93759	530	Calcium-dependent protein	no	no	0.985	0.758	0.630	1e-154
Q9SIQ7	582	Calcium-dependent protein	no	no	0.990	0.694	0.582	1e-143
Q9FMP5	528	Calcium-dependent protein	no	no	0.990	0.765	0.568	1e-138
Q3E9C0	523	Calcium-dependent protein	no	no	0.914	0.713	0.611	1e-135

>sp|Q8W4I7|CDPKD_ARATH Calcium-dependent protein kinase 13 OS=Arabidopsis thaliana GN=CPK13 PE=1 SV=2

 Score =  757 bits (1954), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/402 (89%), Positives = 386/402 (96%), Gaps = 1/402 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEA-GANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+A G  K  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRVIAEFLS EEVEDI
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLSTEEVEDI 360

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           K MF K+D+DNDG+VS +ELKAGLR+F +QLAESEVQMLIEA
Sbjct: 361 KVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEA 402

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1

 Score =  588 bits (1515), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 275/372 (73%), Positives = 319/372 (85%)

Query: 31  GANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
           G     P+ V+    +  I D+Y++ RELGRGEFG+TYLC DR+TRE LACKSISKRKLR
Sbjct: 37  GLRTHAPLRVIPMSHQSQISDKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLR 96

Query: 91  TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT 150
           TAVD++DVRREV IM  LP++ ++V LK   ED+  VHLVMELCEGGELFDRIVARGHYT
Sbjct: 97  TAVDVEDVRREVTIMSTLPEHPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYT 156

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           ERAAA V RTI EVV++CH +GV+HRDLKPENFLFANKKENS LKAIDFGLS+ FKPGER
Sbjct: 157 ERAAATVARTIAEVVRMCHVNGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGER 216

Query: 211 FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
           F+EIVGSPYYMAPEVLKRNYGPE+D+WSAGVILYILLCGVPPFWAE+EQGVA AILRG++
Sbjct: 217 FTEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVL 276

Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           DFKRDPW  +SESAKSLV+QMLEPD   RLTA+QVL+HPW+QNAKKAPNVPLGD+VRSRL
Sbjct: 277 DFKRDPWSQISESAKSLVKQMLEPDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRL 336

Query: 331 KQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
           KQFSMMNR K+KALRVIAE LS++EVE I+ MF  +D DNDG +S  EL+AGLR  GSQL
Sbjct: 337 KQFSMMNRLKKKALRVIAEHLSIQEVEVIRNMFTLMDDDNDGKISYLELRAGLRKVGSQL 396

Query: 391 AESEVQMLIEAS 402
            E E+++L+E +
Sbjct: 397 GEPEIKLLMEVA 408

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1

 Score =  583 bits (1503), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 291/418 (69%), Positives = 335/418 (80%), Gaps = 22/418 (5%)

Query: 1   MGNC--CRSP----------AAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGV-PKE 47
           MGNC  C  P                D K N  + D  R  A      PI VL  V P  
Sbjct: 1   MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGDFTRSPA------PIRVLKDVIPMS 54

Query: 48  N---IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           N   I D+Y++ RELGRGEFG+TYLC DR+T E LACKSISKRKLRTAVDI+DVRREVAI
Sbjct: 55  NQTQISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAI 114

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  LP++ ++V LK + ED+  VHLVMELCEGGELFDRIVARGHYTERAAAAV RTI EV
Sbjct: 115 MSTLPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEV 174

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           V +CH +GV+HRDLKPENFLFANKKENSPLKAIDFGLS+FFKPG++F+EIVGSPYYMAPE
Sbjct: 175 VMMCHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPE 234

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           VLKR+YGP +D+WSAGVI+YILLCGVPPFWAE+EQGVA AILRG++DFKRDPWP +SESA
Sbjct: 235 VLKRDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESA 294

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           KSLV+QML+PDP  RLTA+QVL HPW+QNAKKAPNVPLGD+VRSRLKQFSMMNRFK+K L
Sbjct: 295 KSLVKQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVL 354

Query: 345 RVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           RVIAE LS++EVE IK MF  +D D DG ++  ELKAGL+  GSQL E E++ML+E +
Sbjct: 355 RVIAEHLSIQEVEVIKNMFSLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLMEVA 412

May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1

 Score =  579 bits (1493), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 275/410 (67%), Positives = 337/410 (82%), Gaps = 10/410 (2%)

Query: 1   MGNCCRSPAAVAREDVKSN--------YSSHDHARKEAGANKKQPITVLAGVPKENIEDR 52
           MGNCC +P++   +  +          YS+       +GA  K  ++VL      +I  +
Sbjct: 1   MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFK--LSVLKDPTGHDISLQ 58

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + RE+GRGEFG+TYLC D++T E  ACKSISK+KLRTAVDI+DVRREV IMKH+PK+ 
Sbjct: 59  YDLGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHP 118

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           ++VSLK++ EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TIVEVVQ+CHK G
Sbjct: 119 NVVSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQG 178

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGP 232
           V+HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE+F+EIVGSPYYMAPEVL+RNYGP
Sbjct: 179 VMHRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGP 238

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
           EID+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VS+SAK LVR+ML
Sbjct: 239 EIDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKML 298

Query: 293 EPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLS 352
           EPDPK RLTA QVLEH W+ NAKKAPNV LG+ V++RLKQFS+MN+ K++ALRVIAE LS
Sbjct: 299 EPDPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLS 358

Query: 353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           VEE   IKE F+ +D +  G ++ +ELK GL+  G Q+A++++Q+L+EA+
Sbjct: 359 VEEAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEAT 408

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42438|CDPK8_ARATH Calcium-dependent protein kinase 8 OS=Arabidopsis thaliana GN=CPK8 PE=1 SV=1

 Score =  577 bits (1486), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 279/409 (68%), Positives = 335/409 (81%), Gaps = 9/409 (2%)

Query: 1   MGNCCRSPAA-----VAREDVKSN-YSSHDHARKEAGANKKQPITVLAGVPKENIEDRYL 54
           MGNCC SP +       +  +KSN + S  +    +G   K  ++VL      +I   Y 
Sbjct: 1   MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTGFK--LSVLKDPTGHDISLMYD 58

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           + RE+GRGEFG+TYLC D  T E  ACKSISK+KLRTAVDI+DVRREV IMKH+P++ +I
Sbjct: 59  LGREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNI 118

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           VSLK+A EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TI+EVVQ+CHKHGV+
Sbjct: 119 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVM 178

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI 234
           HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 179 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEV 238

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VSE+AK LVR+MLEP
Sbjct: 239 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEP 298

Query: 295 DPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVE 354
           DPK RL+A QVLEH W+QNAKKAPNV LG+ V++RLKQFS+MN+ K++ALRVIAE LSVE
Sbjct: 299 DPKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 358

Query: 355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-SQLAESEVQMLIEAS 402
           EV  IKE F+ +DS   G ++ +ELK GL   G  Q+ ++++Q+L+EA+
Sbjct: 359 EVAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAA 407

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6NLQ6|CDPKW_ARATH Calcium-dependent protein kinase 32 OS=Arabidopsis thaliana GN=CPK32 PE=1 SV=1

 Score =  568 bits (1463), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 269/412 (65%), Positives = 333/412 (80%), Gaps = 10/412 (2%)

Query: 1   MGNCCRSPAAVARED-------VKSNYSSHDHARKEAGANKKQ---PITVLAGVPKENIE 50
           MGNCC +  ++A+ D        K N  S D+     G +       + VL       IE
Sbjct: 1   MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +Y + RELGRGEFGVTYLC D++T ++ ACKSI K+KLRTAVDI+DVRREV IM+H+P+
Sbjct: 61  SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V+LKE  ED++AVHLVMELCEGGELFDRIVARGHYTERAAAAVT+TI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           HGV+HRDLKPENFLF NKKE +PLKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R ++DF+RDPWP VSE+AK L+R+
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300

Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEF 350
           ML+PD K RLTA+QVL+HPWLQNAK APNV LG+ VR+RLKQF++MN+ K++ALRVIAE 
Sbjct: 301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAEH 360

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           LS EE   I+E F+ +D+   G ++ DELK GL+  G  + + ++Q+L++A 
Sbjct: 361 LSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDAG 412

May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factor ABF4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93759|CDPKE_ARATH Calcium-dependent protein kinase 14 OS=Arabidopsis thaliana GN=CPK14 PE=2 SV=1

 Score =  546 bits (1407), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 254/403 (63%), Positives = 323/403 (80%), Gaps = 1/403 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
           MGNCC +  ++ ++  K  +   +    E G +     + VL       I+ +Y + REL
Sbjct: 1   MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDGLKLIVLKEPTGHEIKQKYKLGREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLC + +T E+ ACKSI K+KL+T++DI+DV+REV IM+ +P++ +IV+LKE
Sbjct: 61  GRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
             EDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V +TI+EVVQ+CHKHGV+HRDLK
Sbjct: 121 TYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKE + LKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVL+R+YG EIDIWSA
Sbjct: 181 PENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAE+E GVA+AIL+ +IDFKRDPWP VS++AK L+++ML PDP+ R
Sbjct: 241 GVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDPRRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTA+QVL+HPW+QN K A NV LG+ VR+RLKQFS+MN+ K++ALRVIAE LSVEE   I
Sbjct: 301 LTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLSVEETSCI 360

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           KE F+ +D+ N G ++  EL  GL+  G  + + ++Q+L++A 
Sbjct: 361 KERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDAG 403

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SIQ7|CDPKO_ARATH Calcium-dependent protein kinase 24 OS=Arabidopsis thaliana GN=CPK24 PE=2 SV=1

 Score =  508 bits (1307), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 243/417 (58%), Positives = 322/417 (77%), Gaps = 13/417 (3%)

Query: 1   MGNCCRSP---AAVAREDVKSNYSSHDHA----RKEAGANKKQ------PITVLAGVPKE 47
           MG+C  SP   +   +  V+  +SS+       R ++  N  +      P  VL     +
Sbjct: 1   MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            I  +Y + +ELGRGEFGVT+ CI+  TRE  ACK ISK KLRT +D++DVRREV IM+ 
Sbjct: 61  GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           LPK+ +IVS KEA ED +AV+LVME+CEGGELFDRIV+RGHYTERAAA+V +TI+EVV++
Sbjct: 121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
           CH+HGVIHRDLKPENFLF+N  E + LKAIDFGLSIFFKP +RF+EIVGSPYYMAPEVL+
Sbjct: 181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           RNYGPEID+WSAGVILYILLCGVPPFWAE+E+G+A AI+RG IDF+RDPWP VS  AK L
Sbjct: 241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300

Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
           V+ ML+ +P  RLT ++VLEHPW++NA++APNV LGD VR++++QF +MNRFK+K LR++
Sbjct: 301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIV 360

Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS 404
           A+ L  EE+  I +MF+ +D+D +G ++ +EL+ GL+  G  + + +V+ML++A+ +
Sbjct: 361 ADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLMDAADT 417

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1

 Score =  491 bits (1263), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 241/424 (56%), Positives = 298/424 (70%), Gaps = 20/424 (4%)

Query: 1   MGNCCRSPAAVARE-DVKSNYSSHDHARKEAG-------------------ANKKQPITV 40
           MGNCC      A   D   N +S  +A    G                   A K+ PI  
Sbjct: 1   MGNCCSHGRDSADNGDALENGASASNAANSTGPTAEASVPQSKHAPPSPPPATKQGPIGP 60

Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL    DI+DVRR
Sbjct: 61  VLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRR 120

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           EV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+ERAAA++ RT
Sbjct: 121 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 180

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           IV++V  CH  GVIHRDLKPENFL  NK ENSPLKA DFGLS+F+KPGE F +IVGS YY
Sbjct: 181 IVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 240

Query: 221 MAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +APEVLKR YGPE DIWS GV+LYILLCGVPPFWAESE G+  AILRG +DF  DPWP++
Sbjct: 241 IAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSI 300

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFK 340
           S  AK LV++ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLKQF  MN FK
Sbjct: 301 SPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 360

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           + ALRVIA  LS EE+  +KEMFK +D+D+ G ++ +EL+ GL   G++L+E EVQ L+E
Sbjct: 361 KVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLME 420

Query: 401 ASSS 404
           A+ +
Sbjct: 421 AADA 424

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1

 Score =  483 bits (1242), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 228/373 (61%), Positives = 283/373 (75%)

Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT 91
           A K+ PI  + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL  
Sbjct: 47  ATKQGPIGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVN 106

Query: 92  AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
             DI+DVRREV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+E
Sbjct: 107 KEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSE 166

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           RAAA++ RTIV+++  CH  GVIHRDLKPENFL  +K ENSPLKA DFGLS+F+KPGE F
Sbjct: 167 RAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVF 226

Query: 212 SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
            +IVGS YY+APEVL+R YGPE DIWS GV+LYILLCGVPPFWAESE G+  AIL G +D
Sbjct: 227 KDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVD 286

Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK 331
           F  DPWP +S  AK LVR+ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLK
Sbjct: 287 FSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLK 346

Query: 332 QFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLA 391
           QF  MN FK+ ALRVIA  LS EE+  +KEMFK +D+DN G ++ +EL+ GL   G++L+
Sbjct: 347 QFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLS 406

Query: 392 ESEVQMLIEASSS 404
           E EVQ L+EA+ +
Sbjct: 407 EYEVQQLMEAADA 419

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
255585928	525	calcium-dependent protein kinase, putati	0.982	0.763	0.927	0.0
224140425	528	calcium dependent protein kinase 13 [Pop	0.982	0.759	0.917	0.0
224091012	528	calcium dependent protein kinase 23 [Pop	0.982	0.759	0.915	0.0
225439418	527	PREDICTED: calcium-dependent protein kin	0.980	0.759	0.915	0.0
297816446	528	calcium-dependent protein kinase 13 [Ara	0.982	0.759	0.900	0.0
307135929	527	calcium-dependent protein kinase [Cucumi	0.982	0.760	0.895	0.0
449525946	527	PREDICTED: calcium-dependent protein kin	0.990	0.766	0.888	0.0
449439886	527	PREDICTED: calcium-dependent protein kin	0.990	0.766	0.886	0.0
22331739	528	calcium-dependent protein kinase 13 [Ara	0.982	0.759	0.895	0.0
1314711	503	calcium-dependent protein kinase [Arabid	0.982	0.797	0.895	0.0

>gi|255585928|ref|XP_002533636.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223526474|gb|EEF28747.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  786 bits (2030), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/401 (92%), Positives = 391/401 (97%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKSNYSSHDH++K+  A KKQPITVL GV KENIE++YLVDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSSHDHSKKDNAATKKQPITVLTGVAKENIEEKYLVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDRD RELLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRDNRELLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKA DFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAFDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAESEQGVAQAILRG+IDFKRDPWPN+SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAESEQGVAQAILRGIIDFKRDPWPNISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIK 360
           TAKQVLEHPWLQNAKKAPNVPLGDVV+SRLKQFSMMNRFKRKALRVIAEFLS EE+EDIK
Sbjct: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRVIAEFLSTEEIEDIK 360

Query: 361 EMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +MF+K+D+DNDG+VS +ELK+GL+NF SQLAESEVQMLIEA
Sbjct: 361 DMFRKMDTDNDGIVSIEELKSGLQNFNSQLAESEVQMLIEA 401

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224140425|ref|XP_002323583.1| calcium dependent protein kinase 13 [Populus trichocarpa] gi|222868213|gb|EEF05344.1| calcium dependent protein kinase 13 [Populus trichocarpa]

 Score =  773 bits (1995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/402 (91%), Positives = 388/402 (96%), Gaps = 1/402 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKK-QPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKS++S  DH +K + A K  QPI VL GVPKENIE+RYLVDREL
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHGKKNSTAKKTPQPIRVLTGVPKENIEERYLVDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+RD+RELLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKE
Sbjct: 61  GRGEFGVTYLCIERDSRELLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKRDPWPN+SESAKSLVRQMLEPDPKLR
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGIIDFKRDPWPNISESAKSLVRQMLEPDPKLR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTA+QV+EHPWLQNAKKAPNVPLGDVV+SRLKQFSMMNRFKRKALRVIA+FLS+EEVEDI
Sbjct: 301 LTARQVIEHPWLQNAKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRVIADFLSIEEVEDI 360

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           KEMF K+D+D DG+VS +ELK GLRNFGSQLAESEVQMLIEA
Sbjct: 361 KEMFMKMDTDGDGIVSVEELKTGLRNFGSQLAESEVQMLIEA 402

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224091012|ref|XP_002309145.1| calcium dependent protein kinase 23 [Populus trichocarpa] gi|222855121|gb|EEE92668.1| calcium dependent protein kinase 23 [Populus trichocarpa]

 Score =  769 bits (1985), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/402 (91%), Positives = 389/402 (96%), Gaps = 1/402 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKK-QPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKS++S HDH +K+  A K  QPITVL G PKENIE+RYLVDREL
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGHDHGKKDNTAKKTPQPITVLTGFPKENIEERYLVDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+RD+RELLACKSISKRKLRTAVDI+DVRREVAIMKHLPK+SSIVSLKE
Sbjct: 61  GRGEFGVTYLCIERDSRELLACKSISKRKLRTAVDIEDVRREVAIMKHLPKSSSIVSLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFA+KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFASKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKRDPWPN+SE+AKSLVRQMLEPDPKLR
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGIIDFKRDPWPNISENAKSLVRQMLEPDPKLR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTAKQVLEHPWL NAKKAPNVPLGDVV+SRLKQFSMMNRFKRKALRVIA+FLS+EEVEDI
Sbjct: 301 LTAKQVLEHPWLLNAKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRVIADFLSIEEVEDI 360

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           KEMFKK+D+DNDG+VS +ELK GLR+FGSQL ESEVQMLIEA
Sbjct: 361 KEMFKKMDTDNDGIVSIEELKTGLRSFGSQLGESEVQMLIEA 402

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439418|ref|XP_002264564.1| PREDICTED: calcium-dependent protein kinase 13 [Vitis vinifera]

 Score =  765 bits (1975), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/402 (91%), Positives = 386/402 (96%), Gaps = 2/402 (0%)

Query: 1   MGNCCRSPAAVAREDVKS-NYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKS NYS HDH RK+AGA KK  ITVL GV K+ IE++Y+VDREL
Sbjct: 1   MGNCCRSPAAVAREDVKSANYSGHDHGRKDAGAGKK-TITVLNGVSKDGIEEKYMVDREL 59

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD++DVRREVAIMKHLPKNSSIVSLKE
Sbjct: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDVEDVRREVAIMKHLPKNSSIVSLKE 119

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK
Sbjct: 120 ACEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN+SESAKSLVRQMLEPDPKLR
Sbjct: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNISESAKSLVRQMLEPDPKLR 299

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTAKQVLEH WLQNAKKAPNVPLGDVV++RLKQFSMMNRFKRKALRVIA+ LS EEVEDI
Sbjct: 300 LTAKQVLEHSWLQNAKKAPNVPLGDVVKARLKQFSMMNRFKRKALRVIADHLSTEEVEDI 359

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           KE FKK+D+DNDG+VS +ELK+GLR FGSQLAE+EVQMLIE 
Sbjct: 360 KESFKKMDTDNDGIVSIEELKSGLRKFGSQLAEAEVQMLIET 401

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297816446|ref|XP_002876106.1| calcium-dependent protein kinase 13 [Arabidopsis lyrata subsp. lyrata] gi|297321944|gb|EFH52365.1| calcium-dependent protein kinase 13 [Arabidopsis lyrata subsp. lyrata]

 Score =  761 bits (1966), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/402 (90%), Positives = 388/402 (96%), Gaps = 1/402 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+AG  KK  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAGGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRVIAEFLS EEVEDI
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLSTEEVEDI 360

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           K MF K+D+DNDG+VS +ELKAGLR+FG+QLAESEVQMLIEA
Sbjct: 361 KVMFNKMDTDNDGIVSIEELKAGLRDFGTQLAESEVQMLIEA 402

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|307135929|gb|ADN33791.1| calcium-dependent protein kinase [Cucumis melo subsp. melo]

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/401 (89%), Positives = 387/401 (96%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKS++S  DH+R+++ A KK P+TVL GVPKENIE++Y+VDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHSRRDSNAGKKVPVTVLNGVPKENIEEKYMVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDR TR+LLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRQTRDLLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAV RTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAE+EQGVAQAILRGLIDFKRDPWP++SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAETEQGVAQAILRGLIDFKRDPWPSISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIK 360
           TAKQVL+HPWLQN KKAPNVPLGDVV+SRLKQFSMMNRFKRKALRVIA+FLS EEVEDIK
Sbjct: 301 TAKQVLDHPWLQNIKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRVIADFLSTEEVEDIK 360

Query: 361 EMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           EMFKKID+DNDG+V+ ++LKAG+ NF SQLAE E+QMLIEA
Sbjct: 361 EMFKKIDTDNDGIVNIEDLKAGIHNFSSQLAEPEIQMLIEA 401

Source: Cucumis melo subsp. melo

Species: Cucumis melo

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449525946|ref|XP_004169977.1| PREDICTED: calcium-dependent protein kinase 13-like [Cucumis sativus]

 Score =  759 bits (1959), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/404 (88%), Positives = 387/404 (95%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKS++S  DH+R+++ A KK P+TVL GVPKENIE++Y+VDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHSRRDSNAGKKVPVTVLNGVPKENIEEKYMVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDR TR+LLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRQTRDLLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAV RTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAE+EQGVAQAILRGLIDFKRDPWP++SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAETEQGVAQAILRGLIDFKRDPWPSISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIK 360
           TAKQVL+HPWLQN KKAPNVPLGDVV+SRLKQFSMMNRFKRKALRVIA+FLS EEVEDIK
Sbjct: 301 TAKQVLDHPWLQNIKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRVIADFLSTEEVEDIK 360

Query: 361 EMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS 404
           EMFKKID+DNDG+V+ ++LKAG+  F SQLAE E+QMLIEA  S
Sbjct: 361 EMFKKIDTDNDGIVNIEDLKAGIHYFSSQLAEPEIQMLIEAVDS 404

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439886|ref|XP_004137716.1| PREDICTED: calcium-dependent protein kinase 13-like [Cucumis sativus]

 Score =  757 bits (1955), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/404 (88%), Positives = 387/404 (95%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
           MGNCCRSPAAVAREDVKS++S  DH+R+++ A KK P+TVL GVPKENIE++Y+VDRELG
Sbjct: 1   MGNCCRSPAAVAREDVKSSFSGQDHSRRDSNAGKKVPVTVLNGVPKENIEEKYMVDRELG 60

Query: 61  RGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA 120
           RGEFGVTYLCIDR TR+LLACKSISKRKLRTAVDI+DVRREVAIMKHLPKNSSIVSLKEA
Sbjct: 61  RGEFGVTYLCIDRQTRDLLACKSISKRKLRTAVDIEDVRREVAIMKHLPKNSSIVSLKEA 120

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
           CED+NAVHLVMELCEGGELFDRIVARGHYTERAAAAV RTIVEVVQLCHKHGVIHRDLKP
Sbjct: 121 CEDENAVHLVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQLCHKHGVIHRDLKP 180

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240
           ENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSAG
Sbjct: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSAG 240

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           VILYILLCGVPPFWAE+EQGVAQAILRGLIDFKRDPWP++SESAKSLV+QMLEPDPKLRL
Sbjct: 241 VILYILLCGVPPFWAETEQGVAQAILRGLIDFKRDPWPSISESAKSLVKQMLEPDPKLRL 300

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIK 360
           +AKQVL+HPWLQN KKAPNVPLGDVV+SRLKQFSMMNRFKRKALRVIA+FLS EEVEDIK
Sbjct: 301 SAKQVLDHPWLQNIKKAPNVPLGDVVKSRLKQFSMMNRFKRKALRVIADFLSTEEVEDIK 360

Query: 361 EMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS 404
           EMFKKID+DNDG+V+ ++LKAG+  F SQLAE E+QMLIEA  S
Sbjct: 361 EMFKKIDTDNDGIVNIEDLKAGIHYFSSQLAEPEIQMLIEAVDS 404

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|22331739|ref|NP_190753.2| calcium-dependent protein kinase 13 [Arabidopsis thaliana] gi|223635148|sp|Q8W4I7.2|CDPKD_ARATH RecName: Full=Calcium-dependent protein kinase 13 gi|332645331|gb|AEE78852.1| calcium-dependent protein kinase 13 [Arabidopsis thaliana]

 Score =  757 bits (1954), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/402 (89%), Positives = 386/402 (96%), Gaps = 1/402 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEA-GANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+A G  K  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRVIAEFLS EEVEDI
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLSTEEVEDI 360

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           K MF K+D+DNDG+VS +ELKAGLR+F +QLAESEVQMLIEA
Sbjct: 361 KVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEA 402

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1314711|gb|AAA99794.1| calcium-dependent protein kinase [Arabidopsis thaliana] gi|3068712|gb|AAC14412.1| calcium dependent protein kinase [Arabidopsis thaliana]

 Score =  757 bits (1954), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/402 (89%), Positives = 386/402 (96%), Gaps = 1/402 (0%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEA-GANKKQPITVLAGVPKENIEDRYLVDREL 59
           MGNCCRSPAAVAREDVKSNYS HDHARK+A G  K  PI VL+ VPKENIEDRYL+DREL
Sbjct: 1   MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query: 60  GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
           GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct: 61  GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query: 120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
           ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct: 121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
           PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct: 181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query: 240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct: 241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
           LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRVIAEFLS EEVEDI
Sbjct: 301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLSTEEVEDI 360

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           K MF K+D+DNDG+VS +ELKAGLR+F +QLAESEVQMLIEA
Sbjct: 361 KVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEA 402

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
TAIR|locus:2074338	528	CPK13 "calcium-dependent prote	0.982	0.759	0.895	2.4e-195
TAIR|locus:2011201	545	CDPK1 "calcium-dependent prote	0.985	0.737	0.701	4.1e-152
TAIR|locus:2027227	541	CPK30 "calcium-dependent prote	0.911	0.687	0.739	6.9e-150
TAIR|locus:505006616	535	CPK7 "calmodulin-domain protei	0.980	0.747	0.675	9e-148
TAIR|locus:2150230	533	CDPK19 "calcium-dependent prot	0.980	0.750	0.682	3.9e-147
TAIR|locus:2103498	538	CPK32 "calcium-dependent prote	0.982	0.745	0.654	9.3e-146
TAIR|locus:2054386	530	CPK14 "calcium-dependent prote	0.982	0.756	0.631	5.6e-139
TAIR|locus:2061290	582	CPK24 "AT2G31500" [Arabidopsis	0.990	0.694	0.582	3.2e-129
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.914	0.706	0.616	2.4e-125
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.914	0.713	0.611	6.5e-122

TAIR|locus:2074338 CPK13 "calcium-dependent protein kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1892 (671.1 bits), Expect = 2.4e-195, P = 2.4e-195
 Identities = 360/402 (89%), Positives = 386/402 (96%)

Query:     1 MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
             MGNCCRSPAAVAREDVKSNYS HDHARK+A   KK  PI VL+ VPKENIEDRYL+DREL
Sbjct:     1 MGNCCRSPAAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRYLLDREL 60

Query:    60 GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
             GRGEFGVTYLCI+R +R+LLACKSISKRKLRTAVDI+DV+REVAIMKHLPK+SSIV+LKE
Sbjct:    61 GRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIVTLKE 120

Query:   120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
             ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA VT+TIVEVVQLCHKHGVIHRDLK
Sbjct:   121 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIHRDLK 180

Query:   180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
             PENFLFANKKENSPLKAIDFGLSIFFKPGE+FSEIVGSPYYMAPEVLKRNYGPEIDIWSA
Sbjct:   181 PENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 240

Query:   240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
             GVILYILLCGVPPFWAESEQGVAQAILRG+IDFKR+PWPN+SE+AK+LVRQMLEPDPK R
Sbjct:   241 GVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPDPKRR 300

Query:   300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
             LTAKQVLEHPW+QNAKKAPNVPLGDVV+SRLKQFS+MNRFKRKALRVIAEFLS EEVEDI
Sbjct:   301 LTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLSTEEVEDI 360

Query:   360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             K MF K+D+DNDG+VS +ELKAGLR+F +QLAESEVQMLIEA
Sbjct:   361 KVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEA 402

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1484 (527.5 bits), Expect = 4.1e-152, P = 4.1e-152
 Identities = 289/412 (70%), Positives = 336/412 (81%)

Query:     1 MGNC--CRSP-AAVAREDVKSNYSSHDHARKE-AG--ANKKQPITVLAGV-PKEN---IE 50
             MGNC  C  P +  ++   K    + D      AG       PI VL  V P  N   I 
Sbjct:     1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGDFTRSPAPIRVLKDVIPMSNQTQIS 60

Query:    51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             D+Y++ RELGRGEFG+TYLC DR+T E LACKSISKRKLRTAVDI+DVRREVAIM  LP+
Sbjct:    61 DKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMSTLPE 120

Query:   111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
             + ++V LK + ED+  VHLVMELCEGGELFDRIVARGHYTERAAAAV RTI EVV +CH 
Sbjct:   121 HPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMMCHS 180

Query:   171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
             +GV+HRDLKPENFLFANKKENSPLKAIDFGLS+FFKPG++F+EIVGSPYYMAPEVLKR+Y
Sbjct:   181 NGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKRDY 240

Query:   231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             GP +D+WSAGVI+YILLCGVPPFWAE+EQGVA AILRG++DFKRDPWP +SESAKSLV+Q
Sbjct:   241 GPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSLVKQ 300

Query:   291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEF 350
             ML+PDP  RLTA+QVL HPW+QNAKKAPNVPLGD+VRSRLKQFSMMNRFK+K LRVIAE 
Sbjct:   301 MLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRVIAEH 360

Query:   351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
             LS++EVE IK MF  +D D DG ++  ELKAGL+  GSQL E E++ML+E +
Sbjct:   361 LSIQEVEVIKNMFSLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLMEVA 412

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;TAS

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)]

 Score = 1463 (520.1 bits), Expect = 6.9e-150, P = 6.9e-150
 Identities = 275/372 (73%), Positives = 319/372 (85%)

Query:    31 GANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
             G     P+ V+    +  I D+Y++ RELGRGEFG+TYLC DR+TRE LACKSISKRKLR
Sbjct:    37 GLRTHAPLRVIPMSHQSQISDKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLR 96

Query:    91 TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT 150
             TAVD++DVRREV IM  LP++ ++V LK   ED+  VHLVMELCEGGELFDRIVARGHYT
Sbjct:    97 TAVDVEDVRREVTIMSTLPEHPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYT 156

Query:   151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
             ERAAA V RTI EVV++CH +GV+HRDLKPENFLFANKKENS LKAIDFGLS+ FKPGER
Sbjct:   157 ERAAATVARTIAEVVRMCHVNGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGER 216

Query:   211 FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
             F+EIVGSPYYMAPEVLKRNYGPE+D+WSAGVILYILLCGVPPFWAE+EQGVA AILRG++
Sbjct:   217 FTEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVL 276

Query:   271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
             DFKRDPW  +SESAKSLV+QMLEPD   RLTA+QVL+HPW+QNAKKAPNVPLGD+VRSRL
Sbjct:   277 DFKRDPWSQISESAKSLVKQMLEPDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRL 336

Query:   331 KQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
             KQFSMMNR K+KALRVIAE LS++EVE I+ MF  +D DNDG +S  EL+AGLR  GSQL
Sbjct:   337 KQFSMMNRLKKKALRVIAEHLSIQEVEVIRNMFTLMDDDNDGKISYLELRAGLRKVGSQL 396

Query:   391 AESEVQMLIEAS 402
              E E+++L+E +
Sbjct:   397 GEPEIKLLMEVA 408

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1443 (513.0 bits), Expect = 9.0e-148, P = 9.0e-148
 Identities = 277/410 (67%), Positives = 343/410 (83%)

Query:     1 MGNCCRSPAAVAREDV------KSN-YSSHDHARKE-AGANKKQPITVLAGVPKENIEDR 52
             MGNCC +P++   +        K+N + S+++A  + +GA  K  ++VL      +I  +
Sbjct:     1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFK--LSVLKDPTGHDISLQ 58

Query:    53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
             Y + RE+GRGEFG+TYLC D++T E  ACKSISK+KLRTAVDI+DVRREV IMKH+PK+ 
Sbjct:    59 YDLGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHP 118

Query:   113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
             ++VSLK++ EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TIVEVVQ+CHK G
Sbjct:   119 NVVSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQG 178

Query:   173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGP 232
             V+HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE+F+EIVGSPYYMAPEVL+RNYGP
Sbjct:   179 VMHRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGP 238

Query:   233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
             EID+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VS+SAK LVR+ML
Sbjct:   239 EIDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKML 298

Query:   293 EPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLS 352
             EPDPK RLTA QVLEH W+ NAKKAPNV LG+ V++RLKQFS+MN+ K++ALRVIAE LS
Sbjct:   299 EPDPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLS 358

Query:   353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
             VEE   IKE F+ +D +  G ++ +ELK GL+  G Q+A++++Q+L+EA+
Sbjct:   359 VEEAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEAT 408

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150230 CDPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 1437 (510.9 bits), Expect = 3.9e-147, P = 3.9e-147
 Identities = 279/409 (68%), Positives = 335/409 (81%)

Query:     1 MGNCCRSPAAVA-----REDVKSN-YSSHDHARKEAGANKKQPITVLAGVPKENIEDRYL 54
             MGNCC SP +       +  +KSN + S  +    +G   K  ++VL      +I   Y 
Sbjct:     1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTGFK--LSVLKDPTGHDISLMYD 58

Query:    55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
             + RE+GRGEFG+TYLC D  T E  ACKSISK+KLRTAVDI+DVRREV IMKH+P++ +I
Sbjct:    59 LGREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNI 118

Query:   115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             VSLK+A EDD+AVH+VMELCEGGELFDRIVARGHYTERAAAAV +TI+EVVQ+CHKHGV+
Sbjct:   119 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVM 178

Query:   175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI 234
             HRDLKPENFLFANKKE S LKAIDFGLS+FFKPGE F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct:   179 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEV 238

Query:   235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
             DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R +IDFKRDPWP VSE+AK LVR+MLEP
Sbjct:   239 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEP 298

Query:   295 DPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVE 354
             DPK RL+A QVLEH W+QNAKKAPNV LG+ V++RLKQFS+MN+ K++ALRVIAE LSVE
Sbjct:   299 DPKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 358

Query:   355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEAS 402
             EV  IKE F+ +DS   G ++ +ELK GL   G Q + ++++Q+L+EA+
Sbjct:   359 EVAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAA 407

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2103498 CPK32 "calcium-dependent protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1424 (506.3 bits), Expect = 9.3e-146, P = 9.3e-146
 Identities = 269/411 (65%), Positives = 334/411 (81%)

Query:     1 MGNCCRSPAAVARED-------VKSNYSSHDHARKEAGAN---KKQPITVLAGVPKENIE 50
             MGNCC +  ++A+ D        K N  S D+     G +   +   + VL       IE
Sbjct:     1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60

Query:    51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
              +Y + RELGRGEFGVTYLC D++T ++ ACKSI K+KLRTAVDI+DVRREV IM+H+P+
Sbjct:    61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120

Query:   111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
             + ++V+LKE  ED++AVHLVMELCEGGELFDRIVARGHYTERAAAAVT+TI+EVVQ+CHK
Sbjct:   121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180

Query:   171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
             HGV+HRDLKPENFLF NKKE +PLKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVLKRNY
Sbjct:   181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240

Query:   231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             GPE+DIWSAGVILYILLCGVPPFWAE+EQGVAQAI+R ++DF+RDPWP VSE+AK L+R+
Sbjct:   241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300

Query:   291 MLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEF 350
             ML+PD K RLTA+QVL+HPWLQNAK APNV LG+ VR+RLKQF++MN+ K++ALRVIAE 
Sbjct:   301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAEH 360

Query:   351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             LS EE   I+E F+ +D+   G ++ DELK GL+  G  + + ++Q+L++A
Sbjct:   361 LSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDA 411

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004698 "calcium-dependent protein kinase C activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009651 "response to salt stress" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
 Identities = 254/402 (63%), Positives = 323/402 (80%)

Query:     1 MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQ-PITVLAGVPKENIEDRYLVDREL 59
             MGNCC +  ++ ++  K  +   +    E G +     + VL       I+ +Y + REL
Sbjct:     1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDGLKLIVLKEPTGHEIKQKYKLGREL 60

Query:    60 GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE 119
             GRGEFGVTYLC + +T E+ ACKSI K+KL+T++DI+DV+REV IM+ +P++ +IV+LKE
Sbjct:    61 GRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVTLKE 120

Query:   120 ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK 179
               EDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V +TI+EVVQ+CHKHGV+HRDLK
Sbjct:   121 TYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHRDLK 180

Query:   180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSA 239
             PENFLFANKKE + LKAIDFGLS+FFKPGERF+EIVGSPYYMAPEVL+R+YG EIDIWSA
Sbjct:   181 PENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDIWSA 240

Query:   240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
             GVILYILLCGVPPFWAE+E GVA+AIL+ +IDFKRDPWP VS++AK L+++ML PDP+ R
Sbjct:   241 GVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDPRRR 300

Query:   300 LTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDI 359
             LTA+QVL+HPW+QN K A NV LG+ VR+RLKQFS+MN+ K++ALRVIAE LSVEE   I
Sbjct:   301 LTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLSVEETSCI 360

Query:   360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             KE F+ +D+ N G ++  EL  GL+  G  + + ++Q+L++A
Sbjct:   361 KERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDA 402

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)]

 Score = 1268 (451.4 bits), Expect = 3.2e-129, P = 3.2e-129
 Identities = 243/417 (58%), Positives = 322/417 (77%)

Query:     1 MGNCCRSP---AAVAREDVKSNYSSHDHA----RKEAGANKKQ------PITVLAGVPKE 47
             MG+C  SP   +   +  V+  +SS+       R ++  N  +      P  VL     +
Sbjct:     1 MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60

Query:    48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
              I  +Y + +ELGRGEFGVT+ CI+  TRE  ACK ISK KLRT +D++DVRREV IM+ 
Sbjct:    61 GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120

Query:   108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
             LPK+ +IVS KEA ED +AV+LVME+CEGGELFDRIV+RGHYTERAAA+V +TI+EVV++
Sbjct:   121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180

Query:   168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
             CH+HGVIHRDLKPENFLF+N  E + LKAIDFGLSIFFKP +RF+EIVGSPYYMAPEVL+
Sbjct:   181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240

Query:   228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             RNYGPEID+WSAGVILYILLCGVPPFWAE+E+G+A AI+RG IDF+RDPWP VS  AK L
Sbjct:   241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300

Query:   288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
             V+ ML+ +P  RLT ++VLEHPW++NA++APNV LGD VR++++QF +MNRFK+K LR++
Sbjct:   301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIV 360

Query:   348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS 404
             A+ L  EE+  I +MF+ +D+D +G ++ +EL+ GL+  G  + + +V+ML++A+ +
Sbjct:   361 ADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLMDAADT 417

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:1901979 "regulation of inward rectifier potassium channel activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1209 (430.6 bits), Expect = 2.4e-125, Sum P(2) = 2.4e-125
 Identities = 230/373 (61%), Positives = 285/373 (76%)

Query:    32 ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT 91
             A K+ PI  + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL  
Sbjct:    52 ATKQGPIGPVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVN 111

Query:    92 AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
               DI+DVRREV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+E
Sbjct:   112 KEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSE 171

Query:   152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             RAAA++ RTIV++V  CH  GVIHRDLKPENFL  NK ENSPLKA DFGLS+F+KPGE F
Sbjct:   172 RAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVF 231

Query:   212 SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
              +IVGS YY+APEVLKR YGPE DIWS GV+LYILLCGVPPFWAESE G+  AILRG +D
Sbjct:   232 KDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVD 291

Query:   272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK 331
             F  DPWP++S  AK LV++ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLK
Sbjct:   292 FSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLK 351

Query:   332 QFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLA 391
             QF  MN FK+ ALRVIA  LS EE+  +KEMFK +D+D+ G ++ +EL+ GL   G++L+
Sbjct:   352 QFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLS 411

Query:   392 ESEVQMLIEASSS 404
             E EVQ L+EA+ +
Sbjct:   412 EYEVQQLMEAADA 424

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
 Identities = 228/373 (61%), Positives = 283/373 (75%)

Query:    32 ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT 91
             A K+ PI  + G P E+++  Y + +ELGRG+FGVT+LC  + T    ACK+I+KRKL  
Sbjct:    47 ATKQGPIGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVN 106

Query:    92 AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
               DI+DVRREV IM HL    +IV LK A ED ++VHLVMELC GGELFDRI+A+GHY+E
Sbjct:   107 KEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSE 166

Query:   152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             RAAA++ RTIV+++  CH  GVIHRDLKPENFL  +K ENSPLKA DFGLS+F+KPGE F
Sbjct:   167 RAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVF 226

Query:   212 SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
              +IVGS YY+APEVL+R YGPE DIWS GV+LYILLCGVPPFWAESE G+  AIL G +D
Sbjct:   227 KDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVD 286

Query:   272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK 331
             F  DPWP +S  AK LVR+ML  DPK RLTA QVL HPW++   +AP+VPL + V SRLK
Sbjct:   287 FSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLK 346

Query:   332 QFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLA 391
             QF  MN FK+ ALRVIA  LS EE+  +KEMFK +D+DN G ++ +EL+ GL   G++L+
Sbjct:   347 QFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLS 406

Query:   392 ESEVQMLIEASSS 404
             E EVQ L+EA+ +
Sbjct:   407 EYEVQQLMEAADA 419

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8W4I7	CDPKD_ARATH	2, ., 7, ., 1, 1, ., 1	0.8955	0.9828	0.7594	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	CPK13	calcium dependent protein kinase 13 (528 aa)
		(Populus trichocarpa)
Predicted Functional Partners:
	eugene3.01330027	hypothetical protein (876 aa)						•			0.800
	eugene3.00121046	hypothetical protein (907 aa)						•			0.800
	eugene3.00010578	hypothetical protein (927 aa)						•			0.800
	gw1.V.650.1	hypothetical protein (490 aa)			•						0.408
	gw1.40.842.1	hypothetical protein (445 aa)			•						0.406

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	408
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-101
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-90
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-67
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-61
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-60
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-49
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-48
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-48
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-44
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-44
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-44
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-44
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-43
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-42
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-42
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-42
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-41
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-41
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-39
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-39
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-39
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-38
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-38
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-37
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-35
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-35
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-35
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-33
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-33
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-33
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-33
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-33
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-32
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-32
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-32
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-32
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-32
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-31
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-31
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-31
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-31
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-31
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-30
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-30
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-29
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-29
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-29
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-29
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-29
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-29
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-29
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-28
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-28
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-28
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-28
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-28
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-28
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-27
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-27
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-27
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-27
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-27
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-26
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-26
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-26
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-26
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-26
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-26
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-25
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-25
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-25
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-25
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-25
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-25
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-25
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-25
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-24
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-24
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-24
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-24
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-24
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-23
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-23
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-23
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-23
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-23
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-23
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-22
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-21
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-21
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-21
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-21
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-20
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-20
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-19
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-19
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-18
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-17
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-08
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	7e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-06
pfam13405	30	pfam13405, EF_hand_4, EF-hand domain	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
COG5126	160	COG5126, FRQ1, Ca2+-binding protein (EF-Hand super	1e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-05
pfam00036	29	pfam00036, efhand, EF hand	3e-05
smart00054	29	smart00054, EFh, EF-hand, calcium binding motif	5e-05
PTZ00184	149	PTZ00184, PTZ00184, calmodulin; Provisional	5e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-05
COG5126	160	COG5126, FRQ1, Ca2+-binding protein (EF-Hand super	8e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-04
PTZ00184	149	PTZ00184, PTZ00184, calmodulin; Provisional	4e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-04
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	5e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	8e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-04
pfam13499	60	pfam13499, EF_hand_5, EF-hand domain pair	0.002
pfam13202	25	pfam13202, EF_hand_3, EF hand	0.002
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
pfam13499	60	pfam13499, EF_hand_5, EF-hand domain pair	0.004
pfam13833	53	pfam13833, EF_hand_6, EF-hand domain pair	0.004
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  299 bits (768), Expect = e-101
 Identities = 108/260 (41%), Positives = 155/260 (59%), Gaps = 7/260 (2%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y +  +LG G FG  YL  D+ T +L+A K I K+K++   D + + RE+ I+K L K+ 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKL-KHP 57

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L +  ED++ ++LVME CEGG+LFD +  RG  +E  A    R I+  ++  H  G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YG 231
           ++HRDLKPEN L     E+  +K  DFGL+    PGE+ +  VG+P YMAPEVL    YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
             +DIWS GVILY LL G PPF  + +       +         P  ++S  AK L+R++
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 292 LEPDPKLRLTAKQVLEHPWL 311
           L  DP+ RLTA++ L+HP+ 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  273 bits (701), Expect = 1e-90
 Identities = 107/265 (40%), Positives = 155/265 (58%), Gaps = 11/265 (4%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + R+LG G FG  Y    + T +++A K + KR  ++  D    RRE+ I++ L  + 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L +A ED + ++LVME CEGG+LFD +   G  +E  A  +   I+  ++  H +G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLK--RN 229
           +IHRDLKPEN L     EN  +K  DFGL+    K     +  VG+P+YMAPEVL     
Sbjct: 119 IIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQG---VAQAILRGLIDFKRDPWPNVSESAKS 286
           YGP++D+WS GVILY LL G PPF  E+      + + IL   ++F    W + SE AK 
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+++ L  DP  R TA+++L+HPW 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  213 bits (545), Expect = 3e-67
 Identities = 88/257 (34%), Positives = 136/257 (52%), Gaps = 13/257 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   +DT +L A K + K+K+    +++    E  I+  +  +  IV L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A + +  ++LV+E   GGELF  +   G ++E  A      IV  ++  H  G+I+RDL
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           KPEN L      +  +K  DFGL+      G R +   G+P Y+APEVL    YG  +D 
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G PPF+AE  + + + IL+  + F       +S  A+ L+  +L+ DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232

Query: 297 KLRLT---AKQVLEHPW 310
             RL    A+++  HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  197 bits (503), Expect = 8e-61
 Identities = 88/268 (32%), Positives = 134/268 (50%), Gaps = 19/268 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           + +G +G  +L   + T ++ A K I K  +     +D V  E  I+    ++  +V L 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLY 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++LVME   GG+L   +   G   E  A      IV  ++  H +G+IHRDL
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGLSIF---------FKPGERFSEIVGSPYYMAPEV-LKR 228
           KP+N L  +   N  LK  DFGLS               +    IVG+P Y+APEV L +
Sbjct: 120 KPDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +   +D WS G ILY  L G+PPF  E+ + + Q IL G I++  D    VS+ A  L+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234

Query: 289 RQMLEPDPKLRLTAK---QVLEHPWLQN 313
            ++L PDP+ RL AK   ++  HP+ + 
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  193 bits (492), Expect = 7e-60
 Identities = 91/255 (35%), Positives = 126/255 (49%), Gaps = 44/255 (17%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG  YL  D+ T + +A K I K    + ++  ++ RE+ I+K L  + +IV L 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE--ELLREIEILKKL-NHPNIVKLY 57

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
              ED+N ++LVME CEGG L D +    G  +E     +   I+E ++  H +G+IHRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVLKRN--YGPEI 234
           LKPEN L  +      +K  DFGLS      +     IVG+P YMAPEVL     Y  + 
Sbjct: 118 LKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           DIWS GVILY L                                      K L+R+ML+ 
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 295 DPKLRLTAKQVLEHP 309
           DP+ R +AK++LEH 
Sbjct: 201 DPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  185 bits (473), Expect = 2e-56
 Identities = 76/265 (28%), Positives = 132/265 (49%), Gaps = 16/265 (6%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y + +++G+G FG  YL   +   +L   K I    +    + +D   EV I+K L  +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL-NH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQL 167
            +I+   E+ E+   + +VME  +GG+L  +I  +      + E         +   ++ 
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 168 CHKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEV 225
            H   ++HRD+KP+N FL +N      +K  DFG+S         ++ +VG+PYY++PE+
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            +   Y  + DIWS G +LY L     PF  E+   +A  IL+G   +   P    S   
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--QYPPIP-SQYSSEL 231

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHP 309
           ++LV  +L+ DP+ R +  Q+L+ P
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  176 bits (450), Expect = 6e-53
 Identities = 86/262 (32%), Positives = 136/262 (51%), Gaps = 14/262 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
             LGRG FG  YL +D+DT EL+A KS+ +    +  +++ + RE+ I+  L ++ +IV 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL-QHPNIVR 63

Query: 117 LKEAC--EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
              +   E+ N +++ +E   GG L   +   G   E      TR I+E +   H +G++
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK---PGERFSEIVGSPYYMAPEVLKRN-Y 230
           HRD+K  N L  +      +K  DFG +        GE    + G+PY+MAPEV++   Y
Sbjct: 124 HRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVR 289
           G   DIWS G  +  +  G PP W+E       A+ +     +    P ++SE AK  +R
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP-WSELGN-PMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 290 QMLEPDPKLRLTAKQVLEHPWL 311
           + L  DPK R TA ++L+HP+L
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  173 bits (438), Expect = 4e-50
 Identities = 91/293 (31%), Positives = 140/293 (47%), Gaps = 28/293 (9%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + R+LG G FG  YL  DR   +L+A K ++K+    + +++   RE+ I+  L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCH 169
           +IV L +  +D+ +++LVME  +GG L D +   G     +E  A  +   I+  ++  H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-------ERFSEIVGSPYYMA 222
             G+IHRD+KPEN L    ++   +K IDFGL+                S  VG+P YMA
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 223 PEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--------- 269
           PEVL            DIWS G+ LY LL G+PPF  E         L+ +         
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                     +S++A  L++++L  DPK RL++   L H  L + K   +   
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  168 bits (427), Expect = 1e-49
 Identities = 80/258 (31%), Positives = 133/258 (51%), Gaps = 14/258 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
            ++G+G FG  Y    + T + +A K I   KL +    + +  E+ I+K   K+ +IV 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKC-KHPNIVK 61

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIH 175
              +    + + +VME C GG L D + +     TE   A V + +++ ++  H +G+IH
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEI 234
           RD+K  N L  +  E   +K IDFGLS      +  + +VG+PY+MAPEV+    Y  + 
Sbjct: 122 RDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILR-GLIDFKRDPWP-NVSESAKSLVRQML 292
           DIWS G+    L  G PP+   SE    +A+ +           P   S+  K  +++ L
Sbjct: 179 DIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235

Query: 293 EPDPKLRLTAKQVLEHPW 310
           + +P+ R TA+Q+L+HP+
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  165 bits (420), Expect = 1e-48
 Identities = 83/264 (31%), Positives = 131/264 (49%), Gaps = 16/264 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +      A K + KR +      + +  E  I++    +  IV L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +D   ++++ME C GGEL+  +  RG + E  A      +V   +  H  G+I+RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIW 237
           KPEN L  +   N  +K +DFG +   K G++     G+P Y+APE+ L + Y   +D W
Sbjct: 120 KPENLLLDS---NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 238 SAGVILYILLCGVPPFWAESE--QGVAQAILRGLIDFKRDPWPN-VSESAKSLVRQMLEP 294
           S G++LY LL G PPF  + E    +   IL+G    +   +PN + ++AK L++Q+L  
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLRR 233

Query: 295 DPKLRL-----TAKQVLEHPWLQN 313
           +P+ RL       K + +H W   
Sbjct: 234 NPEERLGNLKGGIKDIKKHKWFNG 257

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  165 bits (419), Expect = 4e-48
 Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 33/280 (11%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G G F    L  +++T +  A K + KR+L     +  V+ E  ++  L  +  I+ 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    +D+  ++ V+E    GEL   I   G   E+        I+  ++  H  G+IHR
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR 126

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---------------------RFSEIV 215
           DLKPEN L         +K  DFG +    P                       RF+  V
Sbjct: 127 DLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183

Query: 216 GSPYYMAPEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
           G+  Y++PE+L     G   D+W+ G I+Y +L G PPF   +E    Q IL+    F  
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF-- 241

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAK----QVLEHPW 310
            P PN    AK L+ ++L  DP+ RL       ++  HP+
Sbjct: 242 -P-PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 2e-44
 Identities = 84/264 (31%), Positives = 139/264 (52%), Gaps = 14/264 (5%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y +   +GRG FGV Y  ++ +T + +A K IS  K++    +  + +E+ ++K+L K+
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +IV    + E  +++++++E  E G L   I   G + E   A     +++ +   H+ 
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           GVIHRD+K  N L    K+   +K  DFG++       +  + +VG+PY+MAPEV+    
Sbjct: 119 GVIHRDIKAANILTT--KDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMS 174

Query: 231 GPEI--DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSL 287
           G     DIWS G  +  LL G PP++   +     A+ R + D    P P  +S   K  
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY---DLNPMAALFRIVQD-DHPPLPEGISPELKDF 230

Query: 288 VRQMLEPDPKLRLTAKQVLEHPWL 311
           + Q  + DP LR TAKQ+L+HPW+
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  154 bits (391), Expect = 4e-44
 Identities = 84/288 (29%), Positives = 123/288 (42%), Gaps = 42/288 (14%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR--REVAIMKHLPKNSSI 114
            ++G G +GV Y   D+ T E++A K I   KLR   +       RE+ ++K L  + +I
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKEL-NHPNI 60

Query: 115 VSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           + L +       ++LV E  +    +L      +    E    +    +++ +  CH HG
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRN 229
           ++HRDLKPEN L         LK  DFGL+  F  P   ++  V + +Y APE+L   + 
Sbjct: 119 ILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVAQAILRGLI 270
           Y   +DIWS G I   LL   P F  +SE                               
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 271 DFK---RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            F      P     PN S  A  L+ QML  DP  R+TA+Q L HP+ 
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  155 bits (394), Expect = 6e-44
 Identities = 89/278 (32%), Positives = 133/278 (47%), Gaps = 20/278 (7%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G +G  +L   +DT E++A K + K  L    ++  V  E  I+    K+  +V L
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             A +DD  ++L ME   GG+    +   G  +E  A      + E V   H+ G IHRD
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           LKPENFL         +K  DFGLS         + +VGSP YMAPEVL+ + Y   +D 
Sbjct: 127 LKPENFLIDASGH---IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR----DPWPNVSESAKSLVRQML 292
           WS G +LY  LCG PPF   +     + +       +R    DP  N+S+ A  L+ +++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 293 EPDPKLRLTA-KQVLEHPWLQN-------AKKAPNVPL 322
             DP  R  + + +  HP+ +          K P VP 
Sbjct: 242 N-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPE 278

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (395), Expect = 6e-44
 Identities = 95/310 (30%), Positives = 142/310 (45%), Gaps = 44/310 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + V + +GRG FG  +L  D+DT ++ A K + K  +     I  VR E  I+     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  IV L  + +D+  ++LVME   GG+L + ++ +  + E  A      +V  +   HK
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSE---------------- 213
            G IHRD+KP+N L         +K  DFGL     K  +R                   
Sbjct: 120 LGFIHRDIKPDNILIDADGH---IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 214 -------------IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ 259
                         VG+P Y+APEVL+   YG E D WS GVILY +L G PPF++++ Q
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT-AKQVLEHPWLQN----- 313
                I+      +  P P VS  A  L+ ++L  DP+ RL   +++  HP+ +      
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN 295

Query: 314 --AKKAPNVP 321
               K P VP
Sbjct: 296 LRETKPPFVP 305

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 6e-43
 Identities = 80/293 (27%), Positives = 138/293 (47%), Gaps = 45/293 (15%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHL 108
           Y    +LG G +GV Y   D+ T E++A K     K+R   + + +     RE++++K L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            K+ +IV L +    +  ++LV E C+    +  D+    G  +     ++   ++  + 
Sbjct: 56  -KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLA 112

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEV 225
            CH H ++HRDLKP+N +  N+     LK  DFGL+  F  P   ++  V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQN-ILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 226 L--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI--------------LRGL 269
           L   ++Y   +DIWS G I   ++ G P F  +SE      I              +  L
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 270 IDFKRDP--W---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            D+K     +         P +      L+ +ML+ +P  R++AK+ L+HP+ 
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  149 bits (379), Expect = 3e-42
 Identities = 87/287 (30%), Positives = 143/287 (49%), Gaps = 30/287 (10%)

Query: 38  ITVLAGVPKENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID 96
             V  G P+E        + E +G G  G  Y   DR T + +A K +  RK       +
Sbjct: 10  DIVSEGDPRE-----LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN----KE 60

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY---TERA 153
            +  E+ IMK   K+ +IV   ++    + + +VME  +GG L D  +   ++    E  
Sbjct: 61  LIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQ 117

Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFS 212
            A V R +++ ++  H   VIHRD+K +N L +       +K  DFG +    K   + +
Sbjct: 118 IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRN 174

Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---- 267
            +VG+PY+MAPEV+KR  YGP++DIWS G++   +  G PP+  E      +A+      
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTK 231

Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           G+   K +P    S   K  + + L  DP+ R +A+++L+HP+L+ A
Sbjct: 232 GIPPLK-NP-EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  147 bits (374), Expect = 6e-42
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 8/262 (3%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + + R +G+G FG   +   RDT+++ A K ++K+K      + +V  E  I++ L  + 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V+L  + +D+  ++LV++L  GG+L   +  +  ++E         IV  ++  H  G
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYG 231
           +IHRD+KP+N L     E   +   DF ++    P    +   G+P YMAPEVL R  Y 
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
             +D WS GV  Y  L G  P+   S     Q I               S  A   + ++
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQETADVLYPATWSTEAIDAINKL 236

Query: 292 LEPDPKLRL--TAKQVLEHPWL 311
           LE DP+ RL    K +  HP+ 
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  148 bits (377), Expect = 7e-42
 Identities = 86/286 (30%), Positives = 142/286 (49%), Gaps = 25/286 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D +   + LG G FG   L   + + +  A K +SK K+     ++ V  E  I++ + +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-R 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +V+L  + +DD+ ++LVME   GGELF  +   G + E  A      +V  ++  H 
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LKRN 229
             +++RDLKPEN L  +   +  +K  DFG +   K   R   + G+P Y+APE+ L + 
Sbjct: 120 LDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVK--GRTYTLCGTPEYLAPEIILSKG 174

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           YG  +D W+ G+++Y +L G PPF+ ++   + + IL G + F        S  AK L+R
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR 230

Query: 290 QMLEPDPKLRL-----TAKQVLEHPW---------LQNAKKAPNVP 321
            +L+ D   RL         +  HPW         LQ   +AP +P
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIP 276

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  147 bits (374), Expect = 1e-41
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 37/291 (12%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY +   +G G  G+ +   DR+T E +A K ++ R+L   +  +   RE+  ++   ++
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHK 170
             +V L +     +   LVME     +L + +        E    +  R +++ V   H 
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVL-- 226
           +G++HRDLKP N L +    +  LK  DFGL+  F   E   +S  V + +Y APE+L  
Sbjct: 118 NGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAES--EQ-----------------GVAQAILR 267
            R Y P +D+W+ G I   LL G P F  E+  EQ                 G+      
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234

Query: 268 GLIDF---KRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             I F   K  P     P+ S  A  L++ +L  DP  RL+A + L HP+ 
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 5e-41
 Identities = 81/263 (30%), Positives = 125/263 (47%), Gaps = 10/263 (3%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + + +G FG  YL   R T +  A K + K  +     + +V+ E AIM    ++  +  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +  + ++LVME   GG+    I   G   E  A      +V  V+  H+ G+IHR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI-D 235
           D+KPEN L     +   LK  DFGLS   + G    + VG+P Y+APE +      ++ D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            WS G +++  L G PPF AE+   V   IL   I++  +     S  A  L+ ++L  D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 296 PKLRLTAKQVLE---HPWLQNAK 315
           P  RL A    E   HP+ ++  
Sbjct: 236 PAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  144 bits (367), Expect = 2e-40
 Identities = 92/294 (31%), Positives = 141/294 (47%), Gaps = 46/294 (15%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR--REV-AIMKHLP 109
           Y V ++LG G FG  YL  +++T EL+A K + K+K  +    ++    REV ++ K L 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS---WEECMNLREVKSLRK-LN 55

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQL 167
           ++ +IV LKE   +++ ++ V E  EG  L+  +  R    ++E    ++   I++ +  
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEV 225
            HKHG  HRDLKPEN L +       +K  DFGL+  I  +P   +++ V + +Y APE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRP--PYTDYVSTRWYRAPEI 169

Query: 226 LKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW------ 277
           L R  +Y   +DIW+ G I+  L    P F   SE      I   L    +  W      
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Query: 278 --------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                               PN S  A  L++ ML  DPK R TA Q L+HP+ 
Sbjct: 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  141 bits (357), Expect = 2e-39
 Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 18/267 (6%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-MKHLPKNSS--I 114
            LG+G  GV Y    + T ++ A K I           ++ R+++   +K L    S  +
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ-LCHKHGV 173
           V    A   +  + +V+E  +GG L D +   G   E   A + R I++ +  L  K  +
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGSPYYMAPEVLK-RNYG 231
           IHRD+KP N L  +K E   +K  DFG+S   +   ++ +  VG+  YM+PE ++  +Y 
Sbjct: 122 IHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--NVSESAKSLVR 289
              DIWS G+ L     G  PF     Q     +++ + D      P    S   +  + 
Sbjct: 179 YAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             L+ DPK R +A ++L+HP+++ A  
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  140 bits (356), Expect = 4e-39
 Identities = 79/270 (29%), Positives = 124/270 (45%), Gaps = 30/270 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G FG  Y  ++ DT EL+A K I  +       I ++  E+ +++ L K+ ++V   
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KHPNLVKYY 65

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
                   V++ ME C GG L + +       E      T  ++E +   H HG++HRD+
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP-----GERFSEIVGSPYYMAPEVLKRN---- 229
           KP N        N  +K  DFG ++  K      GE    + G+P YMAPEV+       
Sbjct: 126 KPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-----RDPWP---NVS 281
           +G   DIWS G ++  +  G  P W+E +           I F      + P P    +S
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRP-WSELDNEFQ-------IMFHVGAGHKPPIPDSLQLS 234

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              K  + + LE DPK R TA ++L+HP++
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  140 bits (355), Expect = 5e-39
 Identities = 81/272 (29%), Positives = 124/272 (45%), Gaps = 25/272 (9%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V   +G+G FG       +   ++L  K I    + T  +   +  EV I++ L K+ 
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHP 59

Query: 113 SIVSL--KEACEDDNAVHLVMELCEGGELFDRI----VARGHYTERAAAAVTRTIVEVVQ 166
           +IV    +     +  +++VME CEGG+L   I      R +  E     +   ++  + 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 167 LCH-----KHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERF-SEIVGSPY 219
            CH      + V+HRDLKP N FL AN      +K  DFGL+        F    VG+PY
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTPY 175

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           YM+PE L    Y  + DIWS G ++Y L    PPF A ++  +A  I  G         P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----RRIP 231

Query: 279 NV-SESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
              S     +++ ML  DP  R + +++L+ P
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  139 bits (352), Expect = 2e-38
 Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 17/269 (6%)

Query: 57  RELGRGEFGVTYLCIDR---DTRELLACKSISK-RKLRTAVDIDDVRREVAIMKHLPKNS 112
           R LG G +G  +L       D  +L A K + K   ++ A   +  R E  +++ + +  
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V+L  A + D  +HL+++   GGELF  +  R H+TE         IV  +   H+ G
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKR-- 228
           +I+RD+K EN L         +   DFGLS  F   E  R     G+  YMAPEV++   
Sbjct: 126 IIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182

Query: 229 -NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
             +   +D WS GV+ + LL G  PF  + EQ  +Q+ +   I   + P+P  +S  A+ 
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPKTMSAEARD 241

Query: 287 LVRQMLEPDPKLRL---TAKQVLEHPWLQ 312
            ++++LE DPK RL    A ++  HP+ Q
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 4e-38
 Identities = 91/305 (29%), Positives = 140/305 (45%), Gaps = 61/305 (20%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y V   +G G +GV   C ++ T E++A K     K + + D +DV+    REV +++
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLR 55

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER-----AAAAVTRTI 161
            L ++ +IV+LKEA      ++LV E  E   L           E         AV   I
Sbjct: 56  QL-RHENIVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYI 106

Query: 162 VEVVQ---LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVG 216
            +++Q    CH H +IHRD+KPEN L     E+  LK  DFG +     +P    ++ V 
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVA 163

Query: 217 SPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----- 269
           + +Y APE+L    NYG  +D+W+ G I+  LL G P F  +S+      I + L     
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223

Query: 270 ---IDFKRDP-------------------WPN-VSESAKSLVRQMLEPDPKLRLTAKQVL 306
                F  +P                   +P  VS  A   ++  L  DPK RLT  ++L
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283

Query: 307 EHPWL 311
           +HP+ 
Sbjct: 284 QHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  135 bits (343), Expect = 7e-37
 Identities = 85/298 (28%), Positives = 140/298 (46%), Gaps = 45/298 (15%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-ID-DVRREVAIMKHLP 109
           RY   ++LG G + V Y   D++T  ++A K I   + + A D I+    RE+ +++ L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59

Query: 110 KNSSIVSLKEA-CEDDNAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K+ +I+ L +      N ++LV E  E      + D+ +     T     +     +  +
Sbjct: 60  KHPNIIGLLDVFGHKSN-INLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPE 224
           +  H + ++HRDLKP N L A+      LK  DFGL+  F  P  + +  V + +Y APE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVAQ 263
           +L   R+YG  +D+WS G I   LL  VP    +S+                    GV  
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 264 AILRGLIDFK-------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             L   ++FK       +  +P  S+ A  L++++L  +P  R+TA+Q LEHP+  N 
Sbjct: 233 --LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  132 bits (333), Expect = 1e-35
 Identities = 88/282 (31%), Positives = 139/282 (49%), Gaps = 25/282 (8%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G P+  + D ++   ++G G  G+  +  D+ T   +A K +  RK +        R
Sbjct: 12  VDPGDPRSYL-DNFV---KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--------R 59

Query: 100 RE-----VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           RE     V IM+    + +IV +  +    + + +VME  EGG L D IV      E   
Sbjct: 60  RELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQI 117

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSE 213
           A V   +++ +   H  GVIHRD+K ++ L      +  +K  DFG  +   K   R   
Sbjct: 118 ATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKS 174

Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           +VG+PY+MAPEV+ R  YG E+DIWS G+++  ++ G PP++ E      + I   L   
Sbjct: 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK 234

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
            ++    VS   +S + +ML  DP  R TA ++L HP+L  A
Sbjct: 235 LKNL-HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 1e-35
 Identities = 75/260 (28%), Positives = 128/260 (49%), Gaps = 16/260 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G FG  +L  DR +    A K ++  ++        V  E  ++K +  +  I+ L 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLF 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
               D   ++++ME   GGELF  +   G ++          IV  ++  H   +++RDL
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIW 237
           KPEN L    KE   +K  DFG +   K  +R   + G+P Y+APEV++   +   +D W
Sbjct: 128 KPENILL--DKEGH-IKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182

Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK 297
           + G+++Y +L G PPF+ ++  G+ + IL G ++F R    ++   AK L++++L  D  
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRT 238

Query: 298 LRL-----TAKQVLEHPWLQ 312
            RL      A  V  H W +
Sbjct: 239 RRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 2e-35
 Identities = 83/284 (29%), Positives = 138/284 (48%), Gaps = 31/284 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHLP 109
           + + +   +G+G FG  Y  ID+ T +++A K I    L  A D I+D+++E+  +    
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQC- 56

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           ++  I     +    + + ++ME C GG   D ++  G   E   A + R ++  ++  H
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE------RFSEIVGSPYYMAP 223
           + G IHRD+K  N L +   E   +K  DFG+S     G+      + +  VG+P++MAP
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAP 167

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP----WP 278
           EV+K++ Y  + DIWS G+    L  G PP        V   I       K +P      
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KNNPPSLEGN 221

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             S+  K  V   L  DPK R +AK++L+H +++ AKK   + L
Sbjct: 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (330), Expect = 8e-35
 Identities = 79/267 (29%), Positives = 138/267 (51%), Gaps = 21/267 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV--RREVAIMKHLPKNSSIVS 116
           +G+G FG  Y    +DTR + A K +SK+++    ++      R + +   L ++  IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           LK + + D+ ++LV +   GGELF  +   G ++E  A      +V  ++  HK+ +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKP----GERFSEIVGSPYYMAPEVL--KRNY 230
           DLKPEN L         +   DFGLS   K      +  +   G+  Y+APEVL  ++ Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
              +D WS GV+++ + CG  PF+AE  Q + + I  G + F ++    +S+  +  V+ 
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKG 231

Query: 291 MLEPDPKLRL----TAKQVLEHPWLQN 313
           +L  +P+ RL     A ++ EHP+  +
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 1e-34
 Identities = 81/260 (31%), Positives = 128/260 (49%), Gaps = 17/260 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG  YLC D DT   LA K +        T  +++ +  E+ ++K+L ++  IV 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQ 68

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
                 DD  + + ME   GG + D++ A G  TE      TR I+E V+  H + ++HR
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128

Query: 177 DLKPENFLFANKKENSPLKAIDFG----LSIFFKPGERFSEIVGSPYYMAPEVLK-RNYG 231
           D+K  N L   +     +K  DFG    L      G     + G+PY+M+PEV+    YG
Sbjct: 129 DIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSLVR 289
            + D+WS G  +  +L   PP WAE E   A A +  +     +P    +VS  A++ +R
Sbjct: 186 RKADVWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPQLPSHVSPDARNFLR 241

Query: 290 QMLEPDPKLRLTAKQVLEHP 309
           +    + K R +A+++L H 
Sbjct: 242 RTFVENAKKRPSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  125 bits (317), Expect = 1e-33
 Identities = 73/270 (27%), Positives = 132/270 (48%), Gaps = 23/270 (8%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           E+ + +  +LG G +G  Y  I ++T +++A K +         D+ ++ +E++I+K   
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQC- 55

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLC 168
            +  IV    +   +  + +VME C  G + D +       TE   AA+    ++ ++  
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK 227
           H +  IHRD+K  N L   + +    K  DFG+S        + + ++G+P++MAPEV++
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172

Query: 228 R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-----RDPWPNVS 281
              Y  + DIWS G+    +  G PP+   S+    +AI   +I  K      DP    S
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIF--MIPNKPPPTLSDP-EKWS 226

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                 V++ L  DP+ R +A Q+L+HP++
Sbjct: 227 PEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  126 bits (318), Expect = 1e-33
 Identities = 86/282 (30%), Positives = 141/282 (50%), Gaps = 26/282 (9%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       D+ +L A K + K  + + A   +  R E  +++H+ ++  +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + D  +HL+++   GGELF  +  R  + E+     +  IV  ++  HK G+I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYYMAPEVLK---RN 229
           +RD+K EN L      N  +   DFGLS  F     ER     G+  YMAP++++     
Sbjct: 128 YRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLV 288
           +   +D WS GV++Y LL G  PF  + E+     I R ++     P+P  +S  AK ++
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDII 243

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN-------AKKAP 318
           +++L  DPK RL      A ++ +HP+ Q        AKK P
Sbjct: 244 QRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 1e-33
 Identities = 79/297 (26%), Positives = 130/297 (43%), Gaps = 50/297 (16%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y    ++G G +G  Y   ++ T EL+A K I     +    I  +R E+ +++ L ++ 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKL-RHP 58

Query: 113 SIVSLKEAC--EDDNAVHLVMELCEGGELFD--RIVARG--HYTERAAAAVTRTIVEVVQ 166
           +IV LKE    +   ++++V E  +     D   ++      +TE       + ++E +Q
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP--GERFSEIVGSPYYMAPE 224
             H +G++HRD+K  N L  N      LK  DFGL+  +       ++  V + +Y  PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--GLIDFKRDPWPNV 280
           +L     YGPE+D+WS G IL  L  G P F   +E    + I    G      + WP V
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT--DENWPGV 229

Query: 281 ---------------------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                                        SA  L+ ++L  DPK R++A Q L+H +
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  127 bits (321), Expect = 2e-33
 Identities = 94/310 (30%), Positives = 135/310 (43%), Gaps = 66/310 (21%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKHL 108
           RY + + +G G +GV    +D+ T   +A K IS        D+ D +   RE+ +++HL
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHL 56

Query: 109 PKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
            ++ +I+ L       + ED N V++V EL E  +L   I +    T+            
Sbjct: 57  -RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL----- 109

Query: 164 VVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSE 213
             Q+       H   VIHRDLKP N +  N   N  LK  DFGL+    P E      +E
Sbjct: 110 -YQILRGLKYLHSANVIHRDLKPSN-ILVN--SNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 214 IVGSPYYMAPEVL--KRNYGPEIDIWSAGVIL--------------YI----LLC---GV 250
            V + +Y APE+L     Y   IDIWS G I               YI    L+    G 
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225

Query: 251 PP----FWAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTA 302
           P      +  SE+  A+  L+ L    + P     P  S  A  L+ +ML  DPK R+TA
Sbjct: 226 PSEEDLKFITSEK--ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283

Query: 303 KQVLEHPWLQ 312
            + L HP+L 
Sbjct: 284 DEALAHPYLA 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  126 bits (319), Expect = 3e-33
 Identities = 77/243 (31%), Positives = 125/243 (51%), Gaps = 11/243 (4%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   +   + T E  A K + KR++     +  V +E +I+  L  +  IV++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMM 84

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D+N V+ ++E   GGELF  +   G +    A      +V   +  H   +I+RDL
Sbjct: 85  CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDL 144

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIW 237
           KPEN L  NK     +K  DFG +   K  +R   + G+P Y+APEV++ + +G  +D W
Sbjct: 145 KPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWW 199

Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK 297
           + GV+LY  + G PPF+ ++   + + IL G + F    W      A+ LV+ +L+ D  
Sbjct: 200 TMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQTDHT 255

Query: 298 LRL 300
            RL
Sbjct: 256 KRL 258

Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  124 bits (313), Expect = 2e-32
 Identities = 86/267 (32%), Positives = 133/267 (49%), Gaps = 31/267 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA---IMKHLPKNSS-- 113
           LG+G FG   L  ++ T +  A K I K+++  A D      EVA       + +N+   
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKD------EVAHTLTESRVLQNTRHP 55

Query: 114 -IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            + +LK + +  + +  VME   GGELF  +     ++E  A      IV  +   H   
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           V++RDLK EN +     ++  +K  DFGL    I    G       G+P Y+APEVL+ N
Sbjct: 116 VVYRDLKLENLML---DKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDN 170

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            YG  +D W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLL 226

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPW 310
             +L+ DPK RL      AK+++EH +
Sbjct: 227 AGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  122 bits (309), Expect = 2e-32
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 24/274 (8%)

Query: 51  DRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           D Y +   +G G   V Y  +C+     E +A K I   K +T   +D++R+EV  M   
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQT--SVDELRKEVQAMS-Q 55

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD---RIVARGHYTERAAAAVTRTIVEVV 165
             + ++V    +    + + LVM    GG L D       RG   E   A V + +++ +
Sbjct: 56  CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE----IVGSPYY 220
           +  H +G IHRD+K  N L     E+  +K  DFG+S      G+R  +     VG+P +
Sbjct: 116 EYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 221 MAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG---LIDFKRD 275
           MAPEV++    Y  + DIWS G+    L  G  P+       V    L+     ++   D
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                S+S + ++   L+ DP  R TA+++L+H 
Sbjct: 233 YKK-YSKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  121 bits (306), Expect = 5e-32
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 18/261 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG G FG  Y  ++ D  +  A K  S++         +  + +E+A++  L ++ +IV 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQ 66

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
                 +++ +++ +EL  GG L   +   G + E      TR I+  ++  H    +HR
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVLKR--NYG 231
           D+K  N L      N  +K  DFG++   K    FS      GSPY+MAPEV+ +   YG
Sbjct: 127 DIKGANILVDT---NGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLVRQ 290
              DIWS G  +  +  G PP W++ E     A+ +     +  P P+ +S+ AK  + +
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L+ DP LR TA ++LEHP++
Sbjct: 238 CLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  123 bits (310), Expect = 5e-32
 Identities = 84/302 (27%), Positives = 146/302 (48%), Gaps = 22/302 (7%)

Query: 59  LGRGEFGVTYL---CIDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       DT +L A K + K  L + A  ++  R E  +++H+ ++  +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + +  +HL+++   GGE+F  +  R +++E      +  I+  ++  HK G++
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYYMAPEVL--KRNY 230
           +RD+K EN L  ++     +   DFGLS  F  +  ER     G+  YMAPE++  K  +
Sbjct: 128 YRDIKLENILLDSEGH---VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           G  +D WS G++++ LL G  PF  E E+     + R ++         +   A+ L+ +
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHK 244

Query: 291 MLEPDPKLRL-----TAKQVLEHP------WLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
           +L  DPK RL      A ++ EHP      W   A +  N P    +R+ L   +    F
Sbjct: 245 LLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEF 304

Query: 340 KR 341
             
Sbjct: 305 TN 306

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  123 bits (311), Expect = 7e-32
 Identities = 95/279 (34%), Positives = 139/279 (49%), Gaps = 23/279 (8%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
             ED + V + +GRG FG   L   + ++++ A K +SK ++    D      E  IM H
Sbjct: 41  KAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 108 LPKNSS-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
              NS  IV L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  + 
Sbjct: 100 --ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALD 156

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGE-RFSEIVGSPYYMAPE 224
             H  G IHRD+KP+N L     ++  LK  DFG  +     G  R    VG+P Y++PE
Sbjct: 157 AIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213

Query: 225 VLKRN-----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPW 277
           VLK       YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D  
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD-- 271

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE---HPWLQN 313
             +S+ AK L+   L  D ++RL    V E   HP+ +N
Sbjct: 272 IEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 1e-31
 Identities = 85/280 (30%), Positives = 142/280 (50%), Gaps = 27/280 (9%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHL----PKNSS 113
           +GRG +G  Y      T  ++A K I+   L T  D + D++REVA++  L    P N  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPN-- 63

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHG 172
           I     +      + ++ME  EGG +  R + + G   E+  + + R ++  ++  HK G
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVG 121

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK--RN 229
           VIHRD+K  N L  N      +K  DFG++        + S  VG+PY+MAPEV+   + 
Sbjct: 122 VIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL-- 287
           Y  + DIWS G+ +Y +  G PP+   S+    +A++  LI   + P    +  +K L  
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMM--LIPKSKPPRLEDNGYSKLLRE 233

Query: 288 -VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVV 326
            V   L+ +PK RL+A+++L+  W++   K P   L +++
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELI 273

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  120 bits (303), Expect = 2e-31
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 46/288 (15%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           +LG G +   Y   +R T E++A K I     +    TA+      RE+++MK L K+ +
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI------REISLMKEL-KHEN 59

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV---TRTIVEVVQLCHK 170
           IV L +    +N + LV E  +  +L   +   G         V   T  +++ +  CH+
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL--K 227
           + V+HRDLKP+N L   + E   LK  DFGL+  F  P   FS  V + +Y AP+VL   
Sbjct: 119 NRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-- 285
           R Y   IDIWS G I+  ++ G P F   + +     I R +       WP +S+  +  
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 286 -----------------------SLVRQMLEPDPKLRLTAKQVLEHPW 310
                                   L+ ++L+ +P+LR++A   L+HPW
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  119 bits (300), Expect = 3e-31
 Identities = 83/266 (31%), Positives = 128/266 (48%), Gaps = 16/266 (6%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y+  R LG+G FG   L    +   L+  K ++  +L       D   E+ I+  L ++
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLL-QH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCH 169
            +I++      DDN + + ME   GG L+D+IV +    + E         IV  V   H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS---EIVGSPYYMAPEVL 226
           K G++HRD+K  N +F  K     +K  DFG+S     G  +S    +VG+PYYM+PE+ 
Sbjct: 119 KAGILHRDIKTLN-IFLTKA--GLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELC 173

Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           +   Y  + DIW+ G +LY LL     F A +   +   I++G        +   S    
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           SLV  +L+ DP+ R TA +VL+ P L
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  119 bits (300), Expect = 3e-31
 Identities = 82/264 (31%), Positives = 126/264 (47%), Gaps = 16/264 (6%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            + V ++LG+G +G  Y        +  A K +    +      D V  E+ I+  +  +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASV-NH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVVQL 167
            +I+S KEA  D N + +VME    G+L   I  R        E+    +   ++  +Q 
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
            H+  ++HRDLK  N L      N  +K  D G+S   K     ++I G+P+YMAPEV K
Sbjct: 119 LHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK 174

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-SESAK 285
            R Y  + DIWS G +LY +    PPF A S Q +   + RG    K  P P + S+  +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQDLQ 230

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHP 309
           + +R ML+  PKLR    ++L  P
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 6e-31
 Identities = 85/287 (29%), Positives = 134/287 (46%), Gaps = 34/287 (11%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y    ++T    A K I   ++ +  +++D   E+ I+    K+ +IV L
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSEC-KHPNIVGL 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            EA   +N + +++E C+GG L   ++      TE     V R ++E +   H H VIHR
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGSPYYMAPEVL------KRN 229
           DLK  N L     +   +K  DFG+S   K   ++    +G+PY+MAPEV+         
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP--------WPNVS 281
           Y  + DIWS G+ L  L    PP     E    + +L+ L   K +P        W   S
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLKIL---KSEPPTLDQPSKW---S 235

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS 328
            S    ++  L  DP  R TA ++L+HP++ +     N  + D++  
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD--NKAIKDLLAE 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 6e-31
 Identities = 87/318 (27%), Positives = 139/318 (43%), Gaps = 62/318 (19%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG+G+ G  +L   + T +L A K + K+++     +  V  E  I+  L  +  + +
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFD-RIVARGHY-TERAA---AAVTRTIVEVV---QLC 168
           L  + + +  + LVM+ C GGELF       G   +E  A   AA      EV+   +  
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA------EVLLALEYL 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI------------------------- 203
           H  G+++RDLKPEN L     E+  +   DF LS                          
Sbjct: 120 HLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 204 ---FFK--PGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAES 257
               F   P  R +  VG+  Y+APEV+  + +G  +D W+ G++LY +L G  PF   +
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL----TAKQVLEHPWLQN 313
                  IL+  + F     P VS SA+ L+R++L  DP  RL     A ++ +HP+ + 
Sbjct: 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294

Query: 314 AK-------KAPNVPLGD 324
                      P +P  D
Sbjct: 295 VNWALIRHTTPPIIPRPD 312

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  118 bits (296), Expect = 2e-30
 Identities = 87/275 (31%), Positives = 145/275 (52%), Gaps = 12/275 (4%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   + + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 82

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  K      VS S K  + ++L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   +  VPL    R R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPSCIVPLMRQNRMR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  117 bits (294), Expect = 7e-30
 Identities = 83/269 (30%), Positives = 135/269 (50%), Gaps = 23/269 (8%)

Query: 57  RELGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNS 112
           + LG+G +G  +        DT ++ A K + K  + R   D    + E  I++ + K+ 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHP 60

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV L  A +    ++L++E   GGELF  +   G + E  A      I   ++  H+ G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           +I+RDLKPEN L   +     +K  DFGL   SI    G       G+  YMAPE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +G  +D WS G ++Y +L G PPF AE+ +     IL+G ++      P ++  A+ L+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQ 312
           +++L+ +P  RL      A +V  HP+ +
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  115 bits (289), Expect = 9e-30
 Identities = 82/260 (31%), Positives = 135/260 (51%), Gaps = 15/260 (5%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y V R +G G FG   L    ++ +  A K I  R  +++  ++D R+E  ++  + K+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKM-KH 57

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGH-YTERAAAAVTRTIVEVVQLCH 169
            +IV+ KE+ E D  +++VME C+GG+L  +I + RG  + E         +   VQ  H
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKR 228
           +  V+HRD+K +N       +N  +K  DFG + +   PG      VG+PYY+ PE+ + 
Sbjct: 118 EKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 229 -NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKS 286
             Y  + DIWS G ILY L     PF A S + +   + +G       P P + S   +S
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY----KPLPSHYSYELRS 230

Query: 287 LVRQMLEPDPKLRLTAKQVL 306
           L++QM + +P+ R +A  +L
Sbjct: 231 LIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  115 bits (289), Expect = 1e-29
 Identities = 78/267 (29%), Positives = 131/267 (49%), Gaps = 21/267 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI------SKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +G G FG  YL ++  + EL+A K +      +  K R    +D + RE+A++K L ++ 
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV    +  D + +++ +E   GG +   +   G + E       R I++ +   H  G
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSEIVGSPYYMAPEV 225
           +IHRD+K  N L  NK     +K  DFG+S       +  K       + GS ++MAPEV
Sbjct: 127 IIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           +K+  Y  + DIWS G ++  +L G  P + +  Q   QAI +   +   +   N+S  A
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEIPSNISSEA 240

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              + +  E D   R TA ++L+HP+L
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  115 bits (291), Expect = 2e-29
 Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 40/287 (13%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G +G+ Y   D  + E++A K +     R  + I  +R E+ ++ +L ++ +IV LK
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNL-RHPNIVELK 72

Query: 119 EACEDD--NAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           E       +++ LVME CE     L D +     ++E     +   ++  +Q  H++ +I
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFII 130

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLK  N L  +K     LK  DFGL+  +  P +  +  V + +Y APE+L     Y 
Sbjct: 131 HRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVAQAILRGLIDF 272
             ID+W+ G IL  LL   P    +SE                    G +   L G    
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL 247

Query: 273 KRDPWPN-------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            + P+ N       +SE+   L+  +L  DPK R TA++ LE  + +
Sbjct: 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  115 bits (291), Expect = 2e-29
 Identities = 80/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG+G FG   L   + T EL A K + K  +    D++    E  ++    K+  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    +  + +  VME   GG+L   I   G + E  A      IV  +Q  H+ G+I+R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFK----PGERFSEIVGSPYYMAPEVLK-RNYG 231
           DLK +N L  ++     +K  DFG+    K     G   S   G+P Y+APE+L  + YG
Sbjct: 121 DLKLDNVLLDSEGH---IKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
           P +D W+ GV+LY +L G  PF  + E  + Q+IL   + + R     +S+ AKS+++  
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSF 230

Query: 292 LEPDPKLRLTA-----KQVLEHPWLQN 313
           L  +P+ RL       + +  HP+ + 
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  114 bits (288), Expect = 4e-29
 Identities = 84/285 (29%), Positives = 132/285 (46%), Gaps = 53/285 (18%)

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G +G  YL   ++TR+  A K I+K+ L     I  V  E  I+    +N  +VS+  + 
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSF 70

Query: 122 EDDNAVHLVMELCEGGE---LFDRI------VARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           E    + +VME  EGG+   L   I      +AR ++ E   A         ++  H +G
Sbjct: 71  ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA---------LEYLHNYG 121

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFF--------------KPGERFS--EIVG 216
           ++HRDLKP+N L  +      +K  DFGLS                 K    F   ++ G
Sbjct: 122 IVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178

Query: 217 SPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKR 274
           +P Y+APEV L++ YG  +D W+ G+ILY  L G  PF+ ++ E+   Q I   +     
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---- 234

Query: 275 DPWPNVSES----AKSLVRQMLEPDPKLRL---TAKQVLEHPWLQ 312
             WP   E+    A+ L+ ++L  +P  RL    A +V +H +  
Sbjct: 235 --WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  114 bits (286), Expect = 6e-29
 Identities = 83/295 (28%), Positives = 142/295 (48%), Gaps = 45/295 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y    ++G G +GV + C +R+T +++A K     K   + D   ++    RE+ ++K
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVV 165
            L K+ ++V+L E       +HLV E C+   + + +        E     +    ++ V
Sbjct: 56  QL-KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPE 224
             CHKH  IHRD+KPEN L     +   +K  DFG + I   PG+ +++ V + +Y APE
Sbjct: 114 NFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPE 170

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------- 272
           +L     YGP +D+W+ G +   LL G P +  +S+      I + L D           
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230

Query: 273 -------------KRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                         R+P    +PN+S  A S ++  L+ DP  RL+ +++LEHP+
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  113 bits (285), Expect = 8e-29
 Identities = 87/284 (30%), Positives = 144/284 (50%), Gaps = 27/284 (9%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  ID  T + +A K ++   L+     + + 
Sbjct: 12  VSVGDPKK----KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELII 64

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   K+ +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 65  NEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 122

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P +   S +VG+P
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGT 232

Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + LE D + R +AK++L+HP+L+ AK
Sbjct: 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  114 bits (287), Expect = 8e-29
 Identities = 81/262 (30%), Positives = 130/262 (49%), Gaps = 15/262 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +      +  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 122 KLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234

Query: 297 KLRL-----TAKQVLEHPWLQN 313
           K RL      AK+V+EH +  +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLS 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  114 bits (286), Expect = 8e-29
 Identities = 77/258 (29%), Positives = 127/258 (49%), Gaps = 13/258 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG       RDT+ + A K+I K  + +  ++     E  ++  +     IV LK
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++LV+    GGELF  +   G +    A   T  ++  ++  HK  VI+RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           KPEN L   +     +   DFGL  +  K  ++ +   G+P Y+APE+L    Y   +D 
Sbjct: 120 KPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV+LY +L G+PPF+ E+   + + IL+  + F           AK L+  +L  DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232

Query: 297 KLRL---TAKQVLEHPWL 311
             RL    A+++  HP+ 
Sbjct: 233 TRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (284), Expect = 8e-29
 Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 33/272 (12%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
            ELG G  GV    + R T +++A K+I       ++  +      RE+ I+     +  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKC-NSPY 60

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTRTIVE-VVQLCHK 170
           IV    A  ++  + + ME  +GG L D+I    +G   ER    +   +++ +  L  K
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVL 226
           H +IHRD+KP N L  ++ +   +K  DFG+S     G+  + +    VG+  YMAPE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-----NV 280
           + N Y  + DIWS G+ L  L  G  P+    E      I   L     +P P       
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP--PENDPPDGIFELLQYIVNEPPPRLPSGKF 229

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           S   +  V   L  DP+ R + K++LEHP+++
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  113 bits (285), Expect = 9e-29
 Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 45/286 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR--REVAIMKHLPKNSSIVS 116
           +G G F        R T +  A K + K        ++ V   RE+  ++ L  + +I+ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKH----FKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGV 173
           L E   D     + LV EL +   L++ I  R     E+   +    +++ +   H++G+
Sbjct: 63  LIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVLKRN-- 229
            HRD+KPEN L   K +   LK  DFG    I+ KP   ++E + + +Y APE L  +  
Sbjct: 122 FHRDIKPENILI--KDDI--LKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTDGY 175

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL------IDFKRDPW------ 277
           YGP++DIW+ G + + +L   P F   +E      I   L      +  K          
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235

Query: 278 -------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                        PN S     L++++L  DP  R+TAKQ L HP+
Sbjct: 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  112 bits (282), Expect = 9e-29
 Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 10/256 (3%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG FG+ +LC  +  ++L+  K I   ++ T  +    + E  ++K L  + +I+ 
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLL-SHPNIIE 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVI 174
             E   +D A+ +VME   GG L + I  R +    E         I+  +   H   ++
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPE 233
           HRDLK +N L  +K +   +K  DFG+S       +   +VG+P Y++PE+ + + Y  +
Sbjct: 124 HRDLKTQNILL-DKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
            DIW+ G +LY L      F A +   +   I+ G      D     S   + L+  ML 
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLILSMLN 238

Query: 294 PDPKLRLTAKQVLEHP 309
            DP  R    Q++  P
Sbjct: 239 LDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  113 bits (285), Expect = 1e-28
 Identities = 88/304 (28%), Positives = 134/304 (44%), Gaps = 51/304 (16%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++ +  ++G G +G  Y   D+DT EL+A K +     +    I  +R E+ I++ L  
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL-N 64

Query: 111 NSSIVSLKEACEDDN----------AVHLVMELCEG---GELFDRIVARGHYTERAAAAV 157
           + +IV+LKE   D            A +LV E  +    G L   +V   H++E    + 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHIKSF 121

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIV 215
            + ++E +  CHK   +HRD+K  N L  NK +   +K  DFGL+  +   E   ++  V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKV 178

Query: 216 GSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
            + +Y  PE+L  +  YGP ID+WS G IL  L    P F A  E    + I R      
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 274 RDPWPNVSE--------------------------SAKSLVRQMLEPDPKLRLTAKQVLE 307
              WP+V +                           A  L+  ML  DP  R TA++ L 
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 308 HPWL 311
            PWL
Sbjct: 299 SPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  112 bits (283), Expect = 1e-28
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 16/261 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG    C  + T ++ ACK + K++L  R    +    +++           IVS
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR---FIVS 57

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVI 174
           L  A E  + + LVM L  GG+L   I   G   + E  A      I+  ++  H+  ++
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPE 233
           +RDLKPEN L     ++  ++  D GL++  K G++     G+P YMAPEVL+   Y   
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           +D ++ G  LY ++ G  PF    E+   + + R  ++   +     S  AK L   +L+
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234

Query: 294 PDPKLRL-----TAKQVLEHP 309
            DP+ RL     +A +V EHP
Sbjct: 235 KDPEKRLGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (281), Expect = 2e-28
 Identities = 77/270 (28%), Positives = 136/270 (50%), Gaps = 24/270 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             + +++++G+G+F V Y  I      ++A K +   ++  A    D  +E+ ++K L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC- 168
           + +++    +  ++N +++V+EL + G+L   I    H+ ++      RTI +  VQLC 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCS 117

Query: 169 -----HKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYY 220
                H   ++HRD+KP N F+ A       +K  D GL  FF  K     S +VG+PYY
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHS-LVGTPYY 172

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAE--SEQGVAQAILRGLIDFKRDPW 277
           M+PE +  N Y  + DIWS G +LY +     PF+ +  +   + + I +   D+   P 
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPA 230

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
            + SE  + LV + + PDP+ R     VL+
Sbjct: 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  112 bits (281), Expect = 2e-28
 Identities = 90/284 (31%), Positives = 145/284 (51%), Gaps = 27/284 (9%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  +  ID  T + +A K I+   L+     + + 
Sbjct: 12  VSIGDPKK----KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELII 64

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +MK L KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 65  NEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCR 122

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L         +K  DFG      P + + S +VG+P
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTP 179

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGT 232

Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + LE D + R +AK++L+HP+L+ AK
Sbjct: 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  112 bits (282), Expect = 5e-28
 Identities = 80/281 (28%), Positives = 124/281 (44%), Gaps = 37/281 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             + V   +GRG FG   +  ++ T ++ A K + K  L     +     E  I+  +  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISN 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGEL----------FDRIVARGHYTERAAAAVTRT 160
           +  I  L+ A +D + ++LVME   GG+L          FD  +A+ +  E         
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE--------- 110

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEI-VGSP 218
           +V  +   H+ G +HRD+KPEN L         +K  DFG +          S++ VG+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 219 YYMAPEVL-------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGL 269
            Y+APEVL       K  YG E D WS GVI Y ++ G  PF   +       I+  +  
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
           + F  D  P VS     L++ +L    K RL  + +  HP+
Sbjct: 228 LKFPED--PKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  111 bits (278), Expect = 6e-28
 Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 12/265 (4%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  +  +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVN 64

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVI 174
           L  A E  +A+ LV+ +  GG+L   I   G+  + E  A      I+  ++  H+   +
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPE 233
           +RDLKPEN L     +   ++  D GL++    GE     VG+  YMAPEVL  + Y   
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
            D W  G ++Y ++ G  PF    E+   + + R +++ +       SE AKS+ + +L 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 294 PDPKLRLTAK-----QVLEHPWLQN 313
            DPK RL  +     +V  HP+ +N
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 6e-28
 Identities = 74/288 (25%), Positives = 120/288 (41%), Gaps = 40/288 (13%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIV 115
           E+G G +G  Y   D +T   +A K +        + +  +R E+A++K L    + +IV
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIV 64

Query: 116 SLKEAC---EDDNA--VHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            L + C     D    + LV E  +        +    G         + R ++  V   
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFL 123

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H H ++HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEVL +
Sbjct: 124 HSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ 180

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--GL---------------- 269
           + Y   +D+WS G I   L    P F   SE      I    GL                
Sbjct: 181 SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS 240

Query: 270 ------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                   FK    P + E    L+++ML  +P  R++A + L+HP+ 
Sbjct: 241 FPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 7e-28
 Identities = 85/273 (31%), Positives = 136/273 (49%), Gaps = 26/273 (9%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ++ Y + + +G G +G  Y   D  T EL+A K I   KL    D + +++E++++K   
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKEC- 57

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLC 168
           ++ +IV+   +    + + +VME C GG L D   V RG  +E   A V R  ++ +   
Sbjct: 58  RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVL 226
           H+ G IHRD+K  N L     E+  +K  DFG+S  +     +R S I G+PY+MAPEV 
Sbjct: 118 HETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVA 173

Query: 227 ----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
               K  Y  + DIW+ G+    L    PP +   +    +A+   LI     P P + +
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALF--LISKSNFPPPKLKD 228

Query: 283 SAK------SLVRQMLEPDPKLRLTAKQVLEHP 309
             K        +++ L  DPK R TA ++L+HP
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 7e-28
 Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 46/294 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   +DT  + A K + K ++     +  VR E  I+     N  +V L 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D+N ++L+ME   GG++   ++ +  +TE          +  +   HK G IHRD+
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK---------------PGERFSEI--------- 214
           KP+N L   K     +K  DFGL    K               P      I         
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 215 ---------------VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
                          VG+P Y+APEV L+  Y  E D WS GVI+Y +L G PPF +++ 
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML-EPDPKL-RLTAKQVLEHPW 310
           Q   + I+      +      +S  AK L++++  E + +L      ++  HP+
Sbjct: 245 QETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  110 bits (277), Expect = 9e-28
 Identities = 86/278 (30%), Positives = 143/278 (51%), Gaps = 15/278 (5%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  ID  T + +A K ++   L+     + + 
Sbjct: 12  VSVGDPKK----KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELII 64

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 65  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 122

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ +   H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+       I        ++P 
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP- 238

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
             +S   +  + + LE D   R +AK++L+HP+L+ AK
Sbjct: 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  110 bits (275), Expect = 1e-27
 Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 25/268 (9%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           LG+G +G  Y  +  +  +L+A K +   +   L    + + ++ EV ++K L K+ +IV
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIV 65

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
                C DDN + + ME   GG +   +   G   E      T+ I++ V   H + V+H
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125

Query: 176 RDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           RD+K  N +      N  +K IDFG       + +          + G+PY+MAPEV+  
Sbjct: 126 RDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SES 283
           + YG + DIWS G  ++ +  G PP  A  ++  A       I   R   P +    S +
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMF----YIGAHRGLMPRLPDSFSAA 237

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           A   V   L  D   R +A Q+L H +L
Sbjct: 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  109 bits (274), Expect = 2e-27
 Identities = 85/284 (29%), Positives = 143/284 (50%), Gaps = 27/284 (9%)

Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233

Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + L+ D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  111 bits (278), Expect = 2e-27
 Identities = 92/273 (33%), Positives = 137/273 (50%), Gaps = 20/273 (7%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 277

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQN 313
           AK+L+   L  D ++RL    V E   H + +N
Sbjct: 278 AKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  110 bits (275), Expect = 4e-27
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 17/264 (6%)

Query: 57  RELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           R LG G FG   L   ++     +A K   K K+     +D V  E  I+ ++  +   V
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCV 94

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
           +L  + +D++ ++LV+E   GGE F  +     +           IV + +      +++
Sbjct: 95  NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEI 234
           RDLKPEN L     ++  +K  DFG +       R   + G+P Y+APE+L    +G   
Sbjct: 155 RDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHGKAA 209

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ G+ +Y +L G PPF+A     + Q IL G+I F +     +  + K L++++L  
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSH 265

Query: 295 D-----PKLRLTAKQVLEHPWLQN 313
           D       L+  A+ V EHPW  N
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPWFGN 289

Length = 340

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  108 bits (271), Expect = 5e-27
 Identities = 67/267 (25%), Positives = 113/267 (42%), Gaps = 30/267 (11%)

Query: 56  DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ++LG G FG  Y           +  +A K++ +    +   I++  RE  IM+ L  +
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKL-DH 60

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC-- 168
            ++V L   C ++  +++VME  EGG+L   +                 ++   +Q+   
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS------LSDLLSFALQIARG 114

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG-SPY-YMA 222
                    IHRDL   N L         +K  DFGLS      + + +  G  P  +MA
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171

Query: 223 PEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE LK   +  + D+WS GV+L+ I   G  P+   S + V + +  G   ++    PN 
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQPPNC 228

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 L+ Q    DP+ R T  +++E
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  108 bits (272), Expect = 6e-27
 Identities = 84/290 (28%), Positives = 131/290 (45%), Gaps = 50/290 (17%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKN 111
           ++G G +G  +   +R+T E++A K       R  +D DD        RE+ ++K L K+
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALK-------RVRLDDDDEGVPSSALREICLLKEL-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +IV L +    D  + LV E C+    + FD     G        +    +++ +  CH
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-- 226
            H V+HRDLKP+N L  NK  N  LK  DFGL+  F  P   +S  V + +Y  P+VL  
Sbjct: 117 SHNVLHRDLKPQNLLI-NK--NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 227 KRNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE--- 282
            + Y   ID+WSAG I   L   G P F         + I R L     + WP VS+   
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233

Query: 283 ----------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                                 + + L++ +L  +P  R++A++ L+HP+
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  107 bits (269), Expect = 6e-27
 Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 18/264 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSIS--KRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG  YLC D DT   LA K +        T+ ++  +  E+ ++K+L ++  IV 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQ 68

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                 D  +  + + ME   GG + D++ A G  TE      TR I+E +   H + ++
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128

Query: 175 HRDLKPENFLFANKKENSPLKAIDFG----LSIFFKPGERFSEIVGSPYYMAPEVLK-RN 229
           HRD+K  N L   +     +K  DFG    L      G     + G+PY+M+PEV+    
Sbjct: 129 HRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLV 288
           YG + D+WS G  +  +L   PP WAE E     AI +          P+ +SE A+  +
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQ 312
             +   + + R +A+++L HP+ Q
Sbjct: 243 GCIF-VEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  108 bits (271), Expect = 7e-27
 Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 36/277 (12%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IM 105
           E ++   L+D     G+FG   +   + T++L   K I K K   A++       V  +M
Sbjct: 17  EIVKKLKLID-----GKFGKVSVLKHKPTQKLFVQKII-KAKNFNAIEPM-----VHQLM 65

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K    N + + L  +        L+M+  + G+LFD +   G  +E     + R +VE +
Sbjct: 66  KD---NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY------ 219
              HKH +IH D+K EN L+   K+   +   D+GL           +I+G+P       
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDR--IYLCDYGL----------CKIIGTPSCYDGTL 170

Query: 220 -YMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y +PE +   NY    D W+ GV+ Y LL G  PF  + ++ +    L      K    
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTA-KQVLEHPWLQN 313
            NVS++A   V+ ML+ +   RLT   ++++HP+L+ 
Sbjct: 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  108 bits (271), Expect = 1e-26
 Identities = 79/258 (30%), Positives = 130/258 (50%), Gaps = 16/258 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 122 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLKKD 234

Query: 296 PKLRL-----TAKQVLEH 308
           PK RL      AK++++H
Sbjct: 235 PKQRLGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 82/283 (28%), Positives = 129/283 (45%), Gaps = 32/283 (11%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKHLPKNSSIV 115
             LG G  G    C  ++T  + A K+I+        D+   + RE+ I K   K+  IV
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQILRELEINKSC-KSPYIV 62

Query: 116 SLKEAC--EDDNAVHLVMELCEGGEL---FDRIVARGHYT-ERAAAAVTRTIVEVVQLCH 169
               A   E  +++ + ME CEGG L   + ++  RG    E+    +  ++++ +   H
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEV 225
              +IHRD+KP N L   K +   +K  DFG+S     GE  + +     G+ +YMAPE 
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174

Query: 226 LK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI------DFKRDPWP 278
           ++ + Y    D+WS G+ L  +     PF  E E  +    L   I      + K +P  
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 279 NV--SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
            +  SE  K  ++Q LE DP  R T   +LEHPW++   K   
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  106 bits (266), Expect = 2e-26
 Identities = 80/261 (30%), Positives = 129/261 (49%), Gaps = 20/261 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LG+G FG  YLC D DT   LA K +        T+ +++ +  E+ ++K+L  +  IV 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQ 68

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                 D  +  + + ME   GG + D++ + G  TE      TR I+E V   H + ++
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK----PGERFSEIVGSPYYMAPEVLK-RN 229
           HRD+K  N L   +     +K  DFG S   +     G     + G+PY+M+PEV+    
Sbjct: 129 HRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSL 287
           YG + DIWS G  +  +L   PP WAE E   A A +  +     +P   P+VS+  +  
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPVLPPHVSDHCRDF 241

Query: 288 VRQMLEPDPKLRLTAKQVLEH 308
           ++++   + KLR +A ++L H
Sbjct: 242 LKRIF-VEAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (266), Expect = 3e-26
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 30/268 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D  T+  +A K I +R  R    +  +  E+A+  +L K+ +IV   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYL-KHRNIVQYL 71

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  ++    + ME   GG L   + ++       E+     T+ I+E ++  H + ++H
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-------VGSPYYMAPEVLK- 227
           RD+K +N L      +  +K  DFG S      +R + I        G+  YMAPEV+  
Sbjct: 132 RDIKGDNVLV--NTYSGVVKISDFGTS------KRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 228 --RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSES 283
             R YG   DIWS G  +  +  G PPF    E G  QA +  +  FK  P    ++S  
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFI---ELGEPQAAMFKVGMFKIHPEIPESLSAE 240

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           AK+ + +  EPDP  R +A  +L+ P+L
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  106 bits (267), Expect = 3e-26
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 43/288 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSS 113
           ++G G +GV Y   ++ T +++A K     K+R   + + V     RE++++K L ++ +
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKEL-QHPN 60

Query: 114 IVSLKEACEDDNAVHLVMEL--CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
           IV L++    ++ ++L+ E    +  +  D +    +       +    I++ +  CH  
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL--KR 228
            V+HRDLKP+N L  NK     +K  DFGL+  F  P   ++  V + +Y APEVL    
Sbjct: 121 RVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---------- 278
            Y   +DIWS G I   +    P F  +SE      I R L     D WP          
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237

Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                          N+ E    L+ +ML  DP  R++AK+ L HP+ 
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  107 bits (267), Expect = 3e-26
 Identities = 81/281 (28%), Positives = 146/281 (51%), Gaps = 24/281 (8%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +  ++ +   +A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDY-QHQNVVEM 83

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
            ++      + ++ME  +GG L D IV++    E   A V  ++++ +   H  GVIHRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K ++ L      +  +K  DFG  +   K   +   +VG+PY+MAPEV+ R  YG E+D
Sbjct: 143 IKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK------SLVR 289
           IWS G+++  ++ G PP++++S     QA+ R     +  P P +  + K        + 
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNAHKISPVLRDFLE 252

Query: 290 QMLEPDPKLRLTAKQVLEHPW-LQNAKKAPNVPLGDVVRSR 329
           +ML  +P+ R TA+++L+HP+ LQ       VPL    R R
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKR 293

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  106 bits (267), Expect = 3e-26
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 46/286 (16%)

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G +GV Y   D+ T E++A K +   K +    I  + RE+ I+  L ++ +IV++KE  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKL-QHPNIVTVKEVV 73

Query: 122 --EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV----EVVQLCHKHGVIH 175
              + + +++VME  E  +L   +       +    +  + ++      V   H + ++H
Sbjct: 74  VGSNLDKIYMVMEYVE-HDLKSLM---ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVL--KRNYGP 232
           RDLK  N L  N+     LK  DFGL+  +  P + ++++V + +Y APE+L   + Y  
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------------------GLIDFK 273
            ID+WS G I   LL   P F  +SE      I +                       F 
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246

Query: 274 RDPW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
           + P+          ++S++   L+ ++L  DP  R++A+  L+HP+
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  106 bits (265), Expect = 4e-26
 Identities = 86/286 (30%), Positives = 146/286 (51%), Gaps = 29/286 (10%)

Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           + V  G P+E + D ++   ++G G  G+  +  ++ T + +A K +  RK +     + 
Sbjct: 13  LVVSPGDPREYL-DSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---EL 65

Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +  EV IM+    + ++V +  +    + + +VME  EGG L D IV      E   A V
Sbjct: 66  LFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 123

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVG 216
             +++  +   H  GVIHRD+K ++ L  +   +  +K  DFG  +   K   +   +VG
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVG 180

Query: 217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +PY+MAPEV+ R  YG E+DIWS G+++  ++ G PP++ E      QA+ R      RD
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRR-----IRD 232

Query: 276 PWP-------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             P        VS   +  +  ML  +P  R TA+++L+HP+L+ A
Sbjct: 233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  106 bits (267), Expect = 5e-26
 Identities = 89/296 (30%), Positives = 136/296 (45%), Gaps = 45/296 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I +RY+  + +G G FG+     D+ T + +A K I K    T V      RE+ ++KHL
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHL 66

Query: 109 PKNSSIVSLKE----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
            ++ +I+SL +      ED   ++ V EL   G    R++      ++        I+  
Sbjct: 67  -RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           ++  H  GV+HRDLKP N L     EN  LK  DFGL+    P  + +  V + YY APE
Sbjct: 121 LKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPE 175

Query: 225 VLK--RNYGPEIDIWSAGVILYILLCGVPPFWAE----------------SEQGVAQAIL 266
           ++   + Y  E+DIWSAG I   +L G P F  +                 +  +     
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235

Query: 267 RGLIDF-----KRDPWP------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              + F     KR+P P      N   SA  L+ +ML  DP+ R++A + L HP+L
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  107 bits (269), Expect = 6e-26
 Identities = 85/321 (26%), Positives = 130/321 (40%), Gaps = 61/321 (19%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G G FG   L    DT  L A K++ K  +        V+ E  I+     N  +V 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +D + ++ VM+   GG++   ++  G + E  A      +   ++  HK G IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFK--------------------PGERFSEI-- 214
           D+KP+N L      +  +K  DFGL   F+                    P E +SEI  
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 215 ----------------------VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVP 251
                                 VG+P Y+APEVL R  Y    D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEH 308
           PF A++       ++             +S  A  L+ + L    + RL    A ++  H
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAH 301

Query: 309 PWLQNA--------KKAPNVP 321
           P+ +          +KAP +P
Sbjct: 302 PFFKGIDFASLIRRQKAPYIP 322

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 6e-26
 Identities = 84/301 (27%), Positives = 132/301 (43%), Gaps = 72/301 (23%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSSI 114
           +G G +GV Y   D+ T E++A K     K+R   + + V     RE++++K L  + +I
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL-NHPNI 60

Query: 115 VSLKEACEDDNAVHLV-----------MELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           V L +    +N ++LV           M+      L   ++    Y           +++
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ----------LLQ 110

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMA 222
            +  CH H V+HRDLKP+N L  +++    LK  DFGL+  F  P   ++  V + +Y A
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLI-DREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGV 261
           PE+L   R Y   +DIWS G I   ++   P F  +SE                    GV
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 262 AQAILRGLIDFK-------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                  L D+K       R       PN+ E    L+ +ML  DP  R++AK  L+HP+
Sbjct: 228 TS-----LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Query: 311 L 311
            
Sbjct: 283 F 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  104 bits (261), Expect = 9e-26
 Identities = 74/273 (27%), Positives = 144/273 (52%), Gaps = 30/273 (10%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y+  +++G G FG   L   ++  +    K I+  K+    + ++ R+EVA++ ++ K+
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNM-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC-- 168
            +IV  +E+ E++  +++VM+ CEGG+L+ +I A+     R        I++  VQ+C  
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLA 113

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
               H   ++HRD+K +N +F  K  +  +K  DFG++ +     E     +G+PYY++P
Sbjct: 114 LKHVHDRKILHRDIKSQN-IFLTK--DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170

Query: 224 EVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-- 280
           E+ + R Y  + DIW+ G +LY +      F A + + +   I+RG        +P V  
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------SYPPVSS 223

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S   ++LV Q+ + +P+ R +   +LE  ++
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  105 bits (264), Expect = 1e-25
 Identities = 84/299 (28%), Positives = 138/299 (46%), Gaps = 29/299 (9%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R LG+G FG   L   +++  L A K + K  +    D++    E  I+     +  +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    +  + +  VME   GG+L   I     + E  A      I   +   H  G+I+R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGP 232
           DLK +N L  ++      K  DFG+    IF   G+  S   G+P Y+APE+L+   YGP
Sbjct: 121 DLKLDNVLLDHEGH---CKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
            +D W+ GV+LY +LCG  PF AE+E  + +AIL   + +    W  +S+ A  +++  +
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TW--LSQDAVDILKAFM 231

Query: 293 EPDPKLRLTA------KQVLEHP------WLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
             +P +RL +      + +L HP      W +  ++    P     R R+K    ++ F
Sbjct: 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPF----RPRIKSREDVSNF 286

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  104 bits (261), Expect = 1e-25
 Identities = 68/267 (25%), Positives = 110/267 (41%), Gaps = 29/267 (10%)

Query: 56  DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ++LG G FG  Y              +A K++ +    +   I++  RE  IM+ L  +
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKL-DH 60

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC-- 168
            +IV L   C ++  + +VME   GG+L D +                 ++   +Q+   
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS-----LSDLLSFALQIARG 115

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG-SPY-YMA 222
                    IHRDL   N L         +K  DFGLS      + +    G  P  +MA
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172

Query: 223 PEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE LK   +  + D+WS GV+L+ I   G  P+   S   V + + +G   ++    PN 
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPKPPNC 229

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 L+ Q    DP+ R T  +++E
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  105 bits (262), Expect = 1e-25
 Identities = 81/262 (30%), Positives = 130/262 (49%), Gaps = 14/262 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IV 115
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  NS  +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV--NSRFVV 63

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGV 173
           SL  A E  +A+ LV+ L  GG+L   I   G   + E  A      I   ++  H+  +
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGP 232
           ++RDLKPEN L     ++  ++  D GL++    G+     VG+  YMAPEV+K   Y  
Sbjct: 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
             D W+ G +LY ++ G  PF    ++   + + R + + + +     S  A+SL + +L
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240

Query: 293 EPDPKLRL-----TAKQVLEHP 309
             DPK RL      A++V EHP
Sbjct: 241 CKDPKERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  105 bits (264), Expect = 1e-25
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 21/263 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ + +  A K + K  +    ++     E  ++K+  ++  + SLK
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + +  VME   GGELF  +     ++E         IV  +   H   +++RDL
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPG----ERFSEIVGSPYYMAPEVLKRN-YGPE 233
           K EN +     ++  +K  DFGL    K G           G+P Y+APEVL+ N YG  
Sbjct: 122 KLENLML---DKDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           +D W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L 
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLI 231

Query: 294 PDPKLRL-----TAKQVLEHPWL 311
            DP  RL      AK+++ H + 
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  105 bits (263), Expect = 2e-25
 Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 18/263 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +   H  G+I+RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEI 234
           K +N +         +K  DFG+   +IF   G+      G+P Y+APE +  + YG  +
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G PPF  E E  + Q+I+   + + +    ++S+ A S+ + +L  
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLLTK 238

Query: 295 DPKLRLTA-----KQVLEHPWLQ 312
            P  RL       + + EH + +
Sbjct: 239 HPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 79/261 (30%), Positives = 126/261 (48%), Gaps = 18/261 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           LGRG FG  YLC D DT   LA K +        T+ +++ +  E+ ++K+L ++  IV 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQ 68

Query: 117 LKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                 D  +  + + +E   GG + D++ A G  TE      TR I++ V   H + ++
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS----IFFKPGERFSEIVGSPYYMAPEVLK-RN 229
           HRD+K  N L   +     +K  DFG S         G     + G+PY+M+PEV+    
Sbjct: 129 HRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLV 288
           YG + D+WS    +  +L   PP WAE E     AI +      +   P  VS++ +  +
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPDGVSDACRDFL 242

Query: 289 RQMLEPDPKLRLTAKQVLEHP 309
           +Q+   + K R TA+ +L HP
Sbjct: 243 KQIFVEE-KRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  104 bits (262), Expect = 2e-25
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 16/263 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T E+ A K + K  +    D+D    E  I+    K+  + +L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + +  VME   GG+L  +I     + E  +      +   +   H+HGVI+RDL
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDI 236
           K +N L          K  DFG+       G   +   G+P Y+APE+L+   YGP +D 
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV++Y ++ G PPF A++E  + ++IL    D     W  +S+ A S+++  +  +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNP 235

Query: 297 KLRL-------TAKQVLEHPWLQ 312
             RL           + +HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  105 bits (264), Expect = 2e-25
 Identities = 86/273 (31%), Positives = 139/273 (50%), Gaps = 20/273 (7%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + ++++ A K +SK ++    D      E  IM     + 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKRN- 229
           +IHRD+KP+N L     ++  LK  DFG  +        R    VG+P Y++PEVLK   
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV L+ +L G  PF+A+S  G    I+  +  ++F  D    +S+ 
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISKH 277

Query: 284 AKSLVRQMLEPDPKLRL---TAKQVLEHPWLQN 313
           AK+L+   L  D ++RL     +++ +HP+ +N
Sbjct: 278 AKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 309

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 5e-25
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 14/267 (5%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IV 115
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  NS  +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV--NSRFVV 63

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGV 173
           SL  A E  +A+ LV+ L  GG+L   I   G+  + E  A      I   ++  H+  +
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGP 232
           ++RDLKPEN L  +      ++  D GL++    GE     VG+  YMAPEV+K   Y  
Sbjct: 124 VYRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML 292
             D W  G ++Y ++ G  PF    E+   + + R + + + +     SE+A+S+ RQ+L
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240

Query: 293 EPDPKLRL-----TAKQVLEHPWLQNA 314
             DP  RL      A++V  HP+ + A
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 5e-25
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 37/284 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             + +   +G G +G  Y    + T +L+A K +   +       ++++ E  I++    
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSN 61

Query: 111 NSSIVS------LKEACEDDNAVHLVMELCEGG---ELFDRIVARGH-YTERAAAAVTRT 160
           + +I +       K    +D+ + LVMELC GG   +L   +  +G    E   A + R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPY 219
            +  +   H++ VIHRD+K +N L     +N+ +K +DFG+S        R +  +G+PY
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 220 YMAPEVLKRNYGPE------IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
           +MAPEV+  +  P+       D+WS G+    L  G PP             +R L    
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------CDMHPMRALFKIP 231

Query: 274 RDPWPNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           R+P P +             + + L  + + R   +++LEHP++
Sbjct: 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  103 bits (258), Expect = 5e-25
 Identities = 87/301 (28%), Positives = 136/301 (45%), Gaps = 49/301 (16%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           D Y    ++G G +G  Y   D++T +L+A K     K R  +D + +     RE+++++
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQ 55

Query: 107 HLPKNSSIVSL--KEACEDDNA---VHLVME-LCEGGELFDRIVARGHYTERAAAAVTRT 160
            L ++  IV L   E  E+ N    ++LV E L    + F     RG      A  +   
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 161 IVEVVQ---LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVG 216
           + ++++    CHKHGV+HRDLKP+N L    K+   LK  D GL   F  P + ++  + 
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 217 SPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----- 269
           + +Y APEVL    +Y   +DIWS G I   +    P F  +SE      I + L     
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233

Query: 270 --------------------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                                D  R   P++S     L+++ML  DP  R++AK  L HP
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292

Query: 310 W 310
           +
Sbjct: 293 Y 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  103 bits (257), Expect = 6e-25
 Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R LG+G FG    C  R T ++ ACK + K++++          E  I++ +  +  +VS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLC------ 168
           L  A E  +A+ LV+ +  GG+L   I   G+  + E+      R I    +LC      
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ------RAIFYAAELCCGLEDL 118

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
            +  +++RDLKPEN L  ++     ++  D GL++    GE     VG+  YMAPEV+  
Sbjct: 119 QRERIVYRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             Y    D W  G ++Y ++ G  PF    E+   + + R + + + +     SE AKS+
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235

Query: 288 VRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
            R +L  +PK RL      A  V +HP  +N
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  102 bits (256), Expect = 7e-25
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 42/286 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSS 113
           ++G G +GV Y   ++ T E++A K     K+R   + + V     RE++++K L  + +
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 60

Query: 114 IVSLKEACEDDNAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           IV L +    +N ++LV E L +  + F               +    +++ +  CH H 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRN 229
           V+HRDLKP+N L         +K  DFGL+  F  P   ++  V + +Y APE+L   + 
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--------------GLIDFKRD 275
           Y   +DIWS G I   ++     F  +SE      I R               L D+K  
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 276 --PW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
              W         P + E  + L+ QML  DP  R++AK  L HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  102 bits (256), Expect = 1e-24
 Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 47/304 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D+Y    ++G G +GV Y   DR T E +A K I   +    V    +R E++++K + +
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEM-Q 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV------ 164
           + +IV L++    +  ++LV E  +       +  + H       A    +++       
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 165 --VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYM 221
             +  CH H V+HRDLKP+N L  +++ N+ LK  DFGL+  F  P   F+  V + +Y 
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLI-DRRTNA-LKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE+L   R+Y   +DIWS G I   ++   P F  +SE      I R L     + WP 
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 280 VSE-------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           V+                          +   L+ +ML  DP  R+TA+  LEH + ++ 
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Query: 315 KKAP 318
             AP
Sbjct: 291 GDAP 294

Length = 294

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  102 bits (257), Expect = 1e-24
 Identities = 79/269 (29%), Positives = 133/269 (49%), Gaps = 27/269 (10%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS----I 114
           LGRG FG   L   + T EL A K++ K  +    +++ +  E  I      NS     +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF--ETANSERHPFL 64

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L    + ++ V  VME   GG+L   I     ++E  A      +V  +Q  H++ ++
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK----PGERFSEIVGSPYYMAPEVL-KRN 229
           +RDLK +N L   +     +K  DFGL    K     G+R S   G+P ++APEVL + +
Sbjct: 124 YRDLKLDNLLLDTEGF---VKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETS 177

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W  GV++Y +L G  PF  + E+ V  +I+   + + R     +S  A S++R
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMR 233

Query: 290 QMLEPDPKLRL-----TAKQVLEHPWLQN 313
           ++L  +P+ RL      A+ V + P+ ++
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRD 262

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (253), Expect = 1e-24
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 12/263 (4%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + +  ++G+G FGV +  + +  + + A K I   K+    + ++   E  ++  L  +S
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKL-DSS 59

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGH-YTERAAAAVTRTIVEVVQLCHK 170
            I+   E+  D   +++VME  E G+L   +   RG    E         I+  +   H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK-R 228
             ++HRD+K  N LF +  +N  +K  D G++        F+  IVG+PYY++PE+ + +
Sbjct: 120 KKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y  + D+W+ GV+LY    G  PF A ++  +   I+RG+  F        S+    L+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FPPVSQM-YSQQLAQLI 233

Query: 289 RQMLEPDPKLRLTAKQVLEHPWL 311
            Q L  D + R    Q+L +P L
Sbjct: 234 DQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  100 bits (251), Expect = 2e-24
 Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 26/273 (9%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           RY++ + LG+G FG  YL  D+       L   K I   +L     +    +E  ++  L
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKL 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTRTIVEV--- 164
             + +IV    +  + +A  ++ E CEG +L  ++    H  +  +   V    +++   
Sbjct: 60  -DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGSPYYMAP 223
           V   H+  ++HRDLK +N       +N+ LK  DFG+S       +  +   G+PYYM+P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 224 EVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-- 280
           E LK + Y  + DIWS G ILY + C    F  ++   V   I+ G       P P++  
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-------PTPSLPE 227

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S    S+++ ML  DP LR +A ++L +P++
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  101 bits (253), Expect = 3e-24
 Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 9/247 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +   +  A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           KPEN L  ++     +   DFGL     +     S   G+P Y+APEVL K+ Y   +D 
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++ +   +   IL   +  K    PN++ SA+ L+  +L+ D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235

Query: 297 KLRLTAK 303
             RL AK
Sbjct: 236 TKRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  101 bits (253), Expect = 3e-24
 Identities = 80/257 (31%), Positives = 125/257 (48%), Gaps = 10/257 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T E  A K++ K  +    D++    E  ++    ++  +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I + G + E  A      I+  +Q  HK G+I+RDL
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           K +N L     ++  +K  DFG+      GE + S   G+P Y+APE+LK + Y   +D 
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF  E E  +  +IL     F R  W  +S+ AK  + ++ E DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235

Query: 297 KLRLTAK-QVLEHPWLQ 312
             RL     + +HP+ +
Sbjct: 236 TKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =   99 bits (249), Expect = 6e-24
 Identities = 88/298 (29%), Positives = 132/298 (44%), Gaps = 43/298 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK----HLPKNSS 113
           ELG+G +G  Y  + R T   +A K I        +++D+ +    IM+    H   +  
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIR-------LELDESKFNQIIMELDILHKAVSPY 60

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV-----QLC 168
           IV    A   + AV++ ME  + G L D++ A G  TE     V R I   V      L 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPE 224
            +H +IHRD+KP N L     +   +K  DFG+S     G   + +    +G   YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171

Query: 225 VLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGV---AQAILRGLIDFKR 274
            +K         Y  + D+WS G+ +  +  G  P+  E+   +     AI+ G  D   
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPT 229

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQ 332
            P    S+ A+  V + L   P  R T  Q+LEHPWL    K  +V + + V   LK+
Sbjct: 230 LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNADVDMAEWVTGALKR 285

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  101 bits (253), Expect = 7e-24
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 44/296 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY     +G G +G      D  T   +A K +S R  ++A+      RE+ ++KH+  
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHM-D 72

Query: 111 NSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           + +++ L        + ED   V+LV  L  G +L + IV     ++     +   I+  
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRG 130

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           ++  H  G+IHRDLKP N +  N  E+  LK +DFGL+      +  +  V + +Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSN-IAVN--EDCELKILDFGLA--RHTDDEMTGYVATRWYRAPE 185

Query: 225 VL--KRNYGPEIDIWSAGVILYILL---------------------CGVPP--FWAESEQ 259
           ++    +Y   +DIWS G I+  LL                      G P      +   
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 260 GVAQAILRGLIDFKR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             A+  ++ L    +    + +   +  A  L+ +ML  DP  R+TA + L HP+L
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  100 bits (250), Expect = 9e-24
 Identities = 79/311 (25%), Positives = 145/311 (46%), Gaps = 28/311 (9%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E  +   RE+G G FG  Y   D  T E++A K +S    ++     D+ +EV  +
Sbjct: 10  KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVE 163
           + L ++ + +  K     ++   LVME C G   ++ +  V +    E   AA+    ++
Sbjct: 70  QQL-RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQ 126

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H H  IHRD+K  N L     E   +K  DFG +    P   F   VG+PY+MAP
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAP 180

Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG----VAQAILRGLIDFKRD 275
           EV+    +  Y  ++D+WS G+    L    PP +  +       +AQ     L     +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---SSN 237

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR--LKQF 333
            W   S+  ++ V   L+  P+ R +++++L+H ++   ++ P V +  + R++  +++ 
Sbjct: 238 DW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR-ERPPTVIIDLIQRTKDAVREL 293

Query: 334 SMMNRFKRKAL 344
             +   K K +
Sbjct: 294 DNLQYRKMKKI 304

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 98.5 bits (245), Expect = 1e-23
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 13/265 (4%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY + +++G G FG  YL   +   E    K I   K+    + +  ++EV ++  + K+
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKM-KH 58

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARG-HYTERAAAAVTRTIVEVVQLCH 169
            +IV+   + +++  + +VME C+GG+L  RI   RG  ++E    +    I   ++  H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 170 KHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSEI-VGSPYYMAPEVLK 227
              ++HRD+K +N FL  N       K  DFG++         +   VG+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGM---VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
            R Y  + DIWS G +LY L     PF   +   +   I +G         PN S   +S
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---APISPNFSRDLRS 232

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ Q+ +  P+ R +   +L+ P+L
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 99.9 bits (249), Expect = 1e-23
 Identities = 71/247 (28%), Positives = 117/247 (47%), Gaps = 9/247 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +   +  A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +I+RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           KPEN L  ++     +   DFGL     +  +  S   G+P Y+APEVL K+ Y   +D 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++     +   IL   +  K    PN+S SA+ L+  +L+ D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235

Query: 297 KLRLTAK 303
             RL AK
Sbjct: 236 TKRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 81/309 (26%), Positives = 130/309 (42%), Gaps = 56/309 (18%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRRE 101
            ++  RY     +G G +G+      + T   +A K IS  +      RT        RE
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-------RE 53

Query: 102 VAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           + I++   K+ +I+ +       + E  N V++V EL E  +L+ +++   H +      
Sbjct: 54  IKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQY 110

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS---- 212
               I+  ++  H   V+HRDLKP N L      N  LK  DFGL+    P    +    
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLT 167

Query: 213 EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----------------- 253
           E V + +Y APE++   + Y   IDIWS G IL  +L   P F                 
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227

Query: 254 --WAESEQGV----AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAK 303
               E    +    A+  ++ L    + PW    PN    A  L+ +ML  +P  R+T +
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287

Query: 304 QVLEHPWLQ 312
           + L HP+L+
Sbjct: 288 EALAHPYLE 296

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 76/268 (28%), Positives = 127/268 (47%), Gaps = 27/268 (10%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG    C  R T +L ACK ++K++L+     +    E  I+  +  +  IVSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGH----------YTERAAAAVTRTIVEVVQLC 168
            A +    + LVM +  GG+L      R H          + E  A   T  I+  ++  
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDL------RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK 227
           H+  +I+RDLKPEN L  N   +  ++  D GL++  K G+  ++   G+P +MAPE+L+
Sbjct: 114 HQRRIIYRDLKPENVLLDN---DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              Y   +D ++ GV LY ++    PF A  E+   + + + +++         S ++KS
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKS 230

Query: 287 LVRQMLEPDPKLRL-----TAKQVLEHP 309
               +L  DP+ RL         +  HP
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHP 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 97.6 bits (243), Expect = 3e-23
 Identities = 73/262 (27%), Positives = 126/262 (48%), Gaps = 21/262 (8%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDT-RELLACKSIS-------KRKLRTAVDIDDVRREVAI 104
           Y V   LG G FG  Y    ++  + LLA K I+       K K      I D+  EV I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEG---GELFDRIVARG-HYTERAAAAVTRT 160
           +K   ++ +IV   +   +++ +++VM+L EG   GE F+ +  +   +TE     +   
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 161 IVEVVQLCHKHG-VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           +V  ++  HK   ++HRDL P N +     E+  +   DFGL+   +P  + + +VG+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-FKRDPW 277
           Y  PE++K   YG + D+W+ G ILY +    PPF++ +   +A  I+  + +      +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 278 PNVSESAKSLVRQMLEPDPKLR 299
              SE    ++   L PD + R
Sbjct: 239 ---SEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 86/280 (30%), Positives = 133/280 (47%), Gaps = 33/280 (11%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+E+ E   L+ R +G G +G  Y   + +T EL A K I   KL    D   V++E+ +
Sbjct: 7   PQEDFE---LIQR-IGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIM 59

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           MK   K+S+IV+   +    + + + ME C GG L D     G  +E   A V+R  ++ 
Sbjct: 60  MKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMA 222
           +   H  G +HRD+K  N L     +N  +K  DFG+S  I     +R S  +G+PY+MA
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMA 174

Query: 223 PEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW- 277
           PEV     K  Y    DIW+ G+    L    PP +           +R L    +  + 
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-------MRALFLMTKSNFQ 227

Query: 278 -PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPW 310
            P + +  K        V+  L  +PK R TA+++L+HP+
Sbjct: 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.2 bits (242), Expect = 5e-23
 Identities = 68/277 (24%), Positives = 122/277 (44%), Gaps = 39/277 (14%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACK-------SISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +G+G +G  YL ++  T E++A K          +   R    +  +R E+  +K L  +
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +IV        +  + + +E   GG +   +   G + E+     T  ++E +   H  
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV----------GSPYYM 221
           G++HRDLK +N L      +   K  DFG+S       + S+ +          GS ++M
Sbjct: 128 GILHRDLKADNLLV---DADGICKISDFGIS-------KKSDDIYDNDQNMSMQGSVFWM 177

Query: 222 APEVL---KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APEV+    + Y  ++DIWS G ++  +  G  P W++ E     A+ +        P P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--IAAMFKLGNKRSAPPIP 234

Query: 279 -----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                N+S  A   +      +P  R TA+++L+HP+
Sbjct: 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 97.1 bits (241), Expect = 7e-23
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 19/273 (6%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHL 108
           E+ +    ++G+G FG  +  ID  T++++A K I    L  A D I+D+++E+ ++   
Sbjct: 3   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             +  +     +   D  + ++ME   GG   D ++  G   E   A + R I++ +   
Sbjct: 60  -DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYL 117

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK 227
           H    IHRD+K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K
Sbjct: 118 HSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174

Query: 228 RN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESA 284
           ++ Y  + DIWS G+    L  G PP    SE    + +   LI     P    N S+  
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPL 229

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKK 316
           K  V   L  +P  R TAK++L+H + ++ AKK
Sbjct: 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.9 bits (241), Expect = 7e-23
 Identities = 69/265 (26%), Positives = 123/265 (46%), Gaps = 21/265 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV----RREVAIMKHLPKNSSI 114
           LG G F   Y   D  T  L+A K ++  +  T+ + ++V    R+E+ +M  L  +  I
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARL-NHPHI 65

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           + +  A  +D+  +L +E   GG +   +   G + E      T  ++  +   H++ +I
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-----FFKPGERFSEIVGSPYYMAPEVLK-R 228
           HRD+K  N L  +  +   L+  DFG +          GE   +++G+  +MAPEVL+  
Sbjct: 126 HRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            YG   D+WS G ++  +    PP+ AE        I +  I       P++ E     +
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK--IASATTA-PSIPEHLSPGL 240

Query: 289 RQM----LEPDPKLRLTAKQVLEHP 309
           R +    LE  P+ R  ++++L+HP
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 97.8 bits (243), Expect = 8e-23
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 24/274 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 121 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233

Query: 286 SLVRQMLEPDPKLRLTA------KQVLEHPWLQN 313
           S+++  L  DPK RL          +  HP+ +N
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 96.6 bits (240), Expect = 9e-23
 Identities = 72/258 (27%), Positives = 126/258 (48%), Gaps = 20/258 (7%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + +++++GRG+F   Y       R+ +A K +   ++  A    D  +E+ ++K L  + 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC--- 168
           +++   ++  +DN +++V+EL + G+L   I    ++ ++      RT+ +  VQLC   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 169 ---HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
              H   V+HRD+KP N           +K  D GL  FF      +  +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQ--GVAQAILRGLIDFKRDPWPNVS 281
            +  N Y  + DIWS G +LY +     PF+ +      + Q I +   D+   P  + S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ--CDYPPLPTEHYS 234

Query: 282 ESAKSLVRQMLEPDPKLR 299
           E  + LV   + PDP  R
Sbjct: 235 EKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 97.8 bits (243), Expect = 9e-23
 Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 16/253 (6%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   +   ++ A K + K  +    DID V+ E  + +    N  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    +  + + LV+E   GG+L   +  +    E  A      I   +   H+ G+I+R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L      +  +K  D+G+      PG+  S   G+P Y+APE+L+   YG  +
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177

Query: 235 DIWSAGVILYILLCGVPPF-------WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           D W+ GV+++ ++ G  PF          +E  + Q IL   I   R     +S  A  +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233

Query: 288 VRQMLEPDPKLRL 300
           ++  L  DPK RL
Sbjct: 234 LKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 82/308 (26%), Positives = 129/308 (41%), Gaps = 55/308 (17%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG G FG   L    DT+ L A K++ K+ +     +  V+ E  I+     N  +V 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +D + ++ VM+   GG++   ++  G + E  A      +   V+  HK G IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFF------------------------------- 205
           D+KP+N L      +  +K  DFGL   F                               
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 206 -------KPGERFS----------EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
                  KP ER +           +VG+P Y+APEVL R  Y    D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE-PDPKL-RLTAKQV 305
            G PPF A++       ++         P   +S  A  L+ ++   P+ +L +  A ++
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302

Query: 306 LEHPWLQN 313
             HP+ + 
Sbjct: 303 KAHPFFKT 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 36/274 (13%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   +   ++T ++ A K ++K ++    +    R E  ++ +      I +L 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GDRRWITNLH 67

Query: 119 EACEDDNAVHLVMELCEGGELF-------DRI---VARGHYTERAAAAVTRTIVEVVQLC 168
            A +D+N ++LVM+   GG+L        DR+   +AR +  E         +V  +   
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE---------MVLAIDSV 118

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVL 226
           H+ G +HRD+KP+N L     +N  ++  DFG  L +      + +  VG+P Y++PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 227 ------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWP 278
                 K  YGPE D WS GV +Y +L G  PF+AES       I+  +    F  D   
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-T 234

Query: 279 NVSESAKSLVRQML-EPDPKL-RLTAKQVLEHPW 310
           +VSE AK L+R+++  P+ +L R   +   +HP+
Sbjct: 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 93/319 (29%), Positives = 138/319 (43%), Gaps = 75/319 (23%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++I  +Y + ++LG+G +G+ +  IDR T+E++A K I     R A D     RE+  ++
Sbjct: 3   KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-AFRNATDAQRTFREIMFLQ 61

Query: 107 HLPKNSSIVSLKEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT-IVE 163
            L  + +IV L      E+D  ++LV E                Y E    AV R  I+E
Sbjct: 62  ELGDHPNIVKLLNVIKAENDKDIYLVFE----------------YMETDLHAVIRANILE 105

Query: 164 VV-------QL------CHKHGVIHRDLKPENFLFANKKENSP--LKAIDFGLSIFFKPG 208
            V       QL       H   VIHRDLKP N L      NS   +K  DFGL+      
Sbjct: 106 DVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL-----NSDCRVKLADFGLARSLSEL 160

Query: 209 ER------FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------- 253
           E        ++ V + +Y APE+L     Y   +D+WS G IL  +L G P F       
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220

Query: 254 ---------WAESEQGVAQ-------AILRGLIDFKRDP----WPNVSESAKSLVRQMLE 293
                       S + +          +L  L    R P     P  S+ A  L++++L 
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV 280

Query: 294 PDPKLRLTAKQVLEHPWLQ 312
            +P  RLTA++ LEHP++ 
Sbjct: 281 FNPNKRLTAEEALEHPYVA 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 97.0 bits (241), Expect = 1e-22
 Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 15/277 (5%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E+ ++   E+G G FG  Y   +  T E++A K +S    +T     D+ +EV  +
Sbjct: 16  KDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFL 75

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L K+ + +  K     ++   LVME C G       V +    E   AA+T   ++ +
Sbjct: 76  QQL-KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 134

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L     E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 135 AYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEV 188

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNV 280
           +    +  Y  ++D+WS G+    L    PP +  +       I +      + + W   
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW--- 245

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
           ++S +  V   L+  P+ R  + ++L H +++  + A
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 95.2 bits (237), Expect = 4e-22
 Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 43/286 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNSSI 114
           +G G +G+   C  ++T +++A K     K   + D   V+    RE+ ++K L ++ ++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQL-RHENL 62

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L E       ++LV E  +   L D         E         I+  ++ CH H +I
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVLKRN--YG 231
           HRD+KPEN L +   ++  +K  DFG +     PGE +++ V + +Y APE+L  +  YG
Sbjct: 123 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------FKRDP------- 276
             +DIW+ G ++  +L G P F  +S+      I++ L +        F+++P       
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 277 ------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                       +P +S     L +Q L  DP  R ++ Q+L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 94.7 bits (235), Expect = 5e-22
 Identities = 75/266 (28%), Positives = 131/266 (49%), Gaps = 23/266 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHLPKNSSIVSL 117
           +G+G FG  +  ID  T++++A K I    L  A D I+D+++E+ ++     +  +   
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYVTKY 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +      + ++ME   GG   D + A G + E   A + + I++ +   H    IHRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K  N L +   E   +K  DFG++      + + +  VG+P++MAPEV++++ Y  + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SESAKSLVRQM 291
           IWS G+    L  G PP             +R L    ++  P +    S+  K  +   
Sbjct: 184 IWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236

Query: 292 LEPDPKLRLTAKQVLEHPWL-QNAKK 316
           L  DP  R TAK++L+H ++ +NAKK
Sbjct: 237 LNKDPSFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 95.5 bits (237), Expect = 5e-22
 Identities = 74/250 (29%), Positives = 124/250 (49%), Gaps = 26/250 (10%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   +   ++  ++ A K ++K ++    +    R E  ++ +   N  I +L 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITTLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQLCHKHGVI 174
            A +D+N ++LVM+   GG+L   +     + +R    + R     +V  +   H+   +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 175 HRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVL------ 226
           HRD+KP+N L      N  ++  DFG  L +      + S  VG+P Y++PE+L      
Sbjct: 125 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP----NVSE 282
           K  YGPE D WS GV +Y +L G  PF+AES       I+     F+   +P    +VSE
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVTDVSE 238

Query: 283 SAKSLVRQML 292
            AK L+R+++
Sbjct: 239 DAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 95.1 bits (236), Expect = 6e-22
 Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 35/285 (12%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E  +   RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  +
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L ++ + +  +     ++   LVME C G       V +    E   AAVT   ++ +
Sbjct: 70  QKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 129 AYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEV 182

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFW-----------AESEQGVAQAILRGLI 270
           +    +  Y  ++D+WS G+    L    PP +           A++E    Q+      
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS------ 236

Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                 W   SE  ++ V   L+  P+ R T++ +L+H ++   +
Sbjct: 237 ----GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 89/317 (28%), Positives = 135/317 (42%), Gaps = 74/317 (23%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS---------KRKLRTAVDIDDVR 99
           +  RY     +G G +GV    ID  + + +A K I          KR LR         
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR--------- 53

Query: 100 REVAIMKHLPKNSSIVSLKE----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            E+ I++H  K+ +I+++++       D   V++VM+L E  +L   I +    TE    
Sbjct: 54  -ELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIR 110

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL--SIFFKPGE--RF 211
                ++  ++  H   VIHRDLKP N L     E+  L+  DFG+   +   P E   F
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYF 167

Query: 212 -SEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVI---------------------LYILL 247
            +E V + +Y APE+L     Y   ID+WS G I                     L + +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227

Query: 248 CGVPPFWAESEQGVAQAI----LRGLI-DFKRD---PW----PNVSESAKSLVRQMLEPD 295
            G P       + V   I    +R  I +  R    PW    P  S  A  L+ QML+ D
Sbjct: 228 LGSPS------EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281

Query: 296 PKLRLTAKQVLEHPWLQ 312
           P+ R+T +Q L+HP+L 
Sbjct: 282 PEERITVEQALQHPFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 95.7 bits (238), Expect = 7e-22
 Identities = 85/311 (27%), Positives = 139/311 (44%), Gaps = 71/311 (22%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--IVS 116
           +G+G FG   L   +DT ++ A K++ K ++     +  V+ E  +   L ++ S  +VS
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV---LAESDSPWVVS 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQLCHKHG 172
           L  + +D   ++L+ME   GG+L   ++    ++E     VTR      V  ++  HK G
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED----VTRFYMAECVLAIEAVHKLG 121

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFF------------------KPG--ERFS 212
            IHRD+KP+N L         +K  DFGLS  F                  K     R S
Sbjct: 122 FIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 213 EIV----------------------------GSPYYMAPEV-LKRNYGPEIDIWSAGVIL 243
             V                            G+P Y+APE+ L++ YG E D WS G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 244 YILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSESAKSLVRQML-EPDPKL-R 299
           +  L G PPF +E+     + I+  R  + F  D   ++S  A+ L+R+++   + +L R
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLITNAENRLGR 296

Query: 300 LTAKQVLEHPW 310
             A ++  HP+
Sbjct: 297 GGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 34/285 (11%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
            +LG G  G         T  ++A K +   +K  +R       + RE+ IM H  ++  
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-----QILRELQIM-HECRSPY 64

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE-VVQLCHKH 171
           IVS   A  ++N + + ME  + G L DRI  + G         +   +VE +  L + H
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK 227
            ++HRD+KP N L  ++ +   +K  DFG+S     GE  + I    VG+  YM+PE ++
Sbjct: 124 RIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQ 175

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------KRDPW 277
              Y  + D+WS G+ +  L  G  PF   +     Q    G++D           R P 
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            +  E  +  V   L  DP  R T +Q+   P    A +A NV L
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 12/205 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G +GV   C  ++T+E++A K     +    V  +   RE+ +++ L K  +IV LK
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL-KQENIVELK 66

Query: 119 EACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           EA      ++LV E  E    EL + +   G   E+  + + + +++ +  CHK+ ++HR
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHR 124

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPE-VLKRNYGPE 233
           D+KPEN L ++   N  LK  DFG +     G    ++E V + +Y +PE +L   YG  
Sbjct: 125 DIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESE 258
           +D+WS G IL  L  G P F  ESE
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 19/264 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +   +  A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV----GSPYYMAPEVLKRN-YGPE 233
           KPEN L  ++     +   DFGL    K G   S+      G+P Y+APEV+++  Y   
Sbjct: 123 KPENILLDSQGH---VVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           +D W  G +LY +L G+PPF+      +   IL   +  +    P  S +A S++ ++LE
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232

Query: 294 PDPKLRLTAK----QVLEHPWLQN 313
            D + RL AK    ++ EHP+ ++
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPFFES 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 17/287 (5%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           KE+ E  +   RE+G G FG  Y   D  T E++A K +S    ++     D+ +EV  +
Sbjct: 20  KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + +   +SI   K     ++   LVME C G       V +    E   AA+T   ++ +
Sbjct: 80  QRIKHPNSI-EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L     E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 139 AYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEV 192

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNV 280
           +    +  Y  ++D+WS G+    L    PP +  +       I +      + + W   
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW--- 249

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
           S+  ++ V   L+  P+ R T++++L+H ++   ++ P   L D+++
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFV--LRERPETVLIDLIQ 294

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 83/303 (27%), Positives = 138/303 (45%), Gaps = 49/303 (16%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD--IDDVR--REVAI 104
           ++ +Y+  + +GRG +G+     + +T E +A K I+      A D  ID  R  RE+ +
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-----AFDNRIDAKRTLREIKL 57

Query: 105 MKHLPKNSSIVSLKEAC-----EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           ++HL  + +++++K+       E  N V++V EL +  +L   I +    ++        
Sbjct: 58  LRHL-DHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSP 218
            ++  ++  H   V+HRDLKP N L      N  LK  DFGL+    + G+  +E V + 
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTR 172

Query: 219 YYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA------------------ESE 258
           +Y APE+L     Y   ID+WS G I   LL   P F                    E +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232

Query: 259 QGV-----AQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
            G      A+  +R L    R      +P+ +  A  L+ +ML  DP  R+T ++ L HP
Sbjct: 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292

Query: 310 WLQ 312
           +L 
Sbjct: 293 YLA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 76/251 (30%), Positives = 120/251 (47%), Gaps = 18/251 (7%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR--REVAIMKHLPKNSS 113
           LG+G FG  +L       D  +L A K + K  L+     D VR   E  I+  +  +  
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR---DRVRTKMERDILAEV-NHPF 59

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  G+
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRNYG 231
           I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R + 
Sbjct: 120 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
              D WS GV+++ +L G  PF  +  +     IL+  +   +     +S  A+SL+R +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232

Query: 292 LEPDPKLRLTA 302
            + +P  RL A
Sbjct: 233 FKRNPANRLGA 243

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 45/294 (15%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   +DT  + A K + K  +     +  +R E  I+      + +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-ADGAWVVKMF 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D   ++L+ME   GG++   ++ +   +E A        V  +   H+ G IHRD+
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGER--------------FS------------ 212
           KP+N L   K     +K  DFGL    K   R              FS            
Sbjct: 128 KPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 213 ----------EIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
                       VG+P Y+APEV ++  Y    D WS GVI+Y +L G PPF +E+ Q  
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE---HPWLQ 312
            + ++         P   +SE AK L+ +    D + R+ +  V E   HP+ +
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 9/244 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +   H+ G+I+RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           K +N +  ++     +K  DFG+       G       G+P Y+APE++  + YG  +D 
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV+LY +L G PPF  E E  + Q+I+   + + +    ++S+ A S+ + ++   P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHP 240

Query: 297 KLRL 300
             RL
Sbjct: 241 SKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.0 bits (228), Expect = 4e-21
 Identities = 77/265 (29%), Positives = 127/265 (47%), Gaps = 22/265 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHLPKNSSIVSL 117
           +G+G FG  Y  ID  T+E++A K I    L  A D I+D+++E+ ++     +  I   
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYITRY 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +      + ++ME   GG   D ++  G   E   A + R I++ +   H    IHRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRD 126

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K  N L +   E   +K  DFG++      + + +  VG+P++MAPEV+K++ Y  + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SESAKSLVRQM 291
           IWS G+    L  G PP             +R L    ++  P +    S+  K  V   
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHP-------MRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236

Query: 292 LEPDPKLRLTAKQVLEHPWLQNAKK 316
           L  DP+ R TAK++L+H ++    K
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYTK 261

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 93.6 bits (232), Expect = 4e-21
 Identities = 73/268 (27%), Positives = 112/268 (41%), Gaps = 43/268 (16%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   +DT  + A K + K  +     +  +R E  I+     +  +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D   ++L+ME   GG++   ++ +   TE          V  +   H+ G IHRD+
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGER---------------------------- 210
           KP+N L  +K     +K  DFGL    K   R                            
Sbjct: 128 KPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 211 ---------FSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
                    FS  VG+P Y+APEV  +  Y    D WS GVI+Y +L G PPF +E+ Q 
Sbjct: 185 WKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243

Query: 261 VAQAILRGLIDFKRDPWPNVSESAKSLV 288
             + ++         P   +SE AK L+
Sbjct: 244 TYKKVMNWKETLIFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 82/310 (26%), Positives = 131/310 (42%), Gaps = 52/310 (16%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  RY+  R LG G  G+ +  +D D  + +A K I    L     +    RE+ I++ 
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIRR 58

Query: 108 L-------------PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           L             P  S +     +  + N+V++V E  E       ++ +G  +E  A
Sbjct: 59  LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHA 116

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---- 210
                 ++  ++  H   V+HRDLKP N +F N  E+  LK  DFGL+    P       
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 211 FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG 268
            SE + + +Y +P +L    NY   ID+W+AG I   +L G P F    E    Q IL  
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234

Query: 269 --LIDFK------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTA 302
             ++  +                        RD  P V+  A   + Q+L  +P  RLTA
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294

Query: 303 KQVLEHPWLQ 312
           ++ L HP++ 
Sbjct: 295 EEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 91.2 bits (226), Expect = 6e-21
 Identities = 70/256 (27%), Positives = 120/256 (46%), Gaps = 16/256 (6%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + +++++GRG+F   Y          +A K +    L  A    D  +E+ ++K L  + 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC--- 168
           +++    +  +DN +++V+EL + G+L   I    H+ ++      +T+ +  VQLC   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 169 ---HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPE 224
              H   V+HRD+KP N           +K  D GL  FF      +  +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
            +  N Y  + DIWS G +LY +     PF+ +     +        D+   P  + SE 
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236

Query: 284 AKSLVRQMLEPDPKLR 299
            + LV   + PDP+ R
Sbjct: 237 LRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 91.6 bits (227), Expect = 8e-21
 Identities = 86/285 (30%), Positives = 136/285 (47%), Gaps = 34/285 (11%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y   +++T  L A K I   + ++  +++D   E+ I+     +  IV L
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATC-NHPYIVKL 74

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             A   D  + +++E C GG + D I+    RG  TE     + R ++E +Q  H   +I
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKII 132

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVL------K 227
           HRDLK  N L     +   +K  DFG+S    K  +R    +G+PY+MAPEV+       
Sbjct: 133 HRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-- 285
             Y  + DIWS G+ L  +    PP    +   V   I       K +P P +S+ +K  
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------KSEP-PTLSQPSKWS 242

Query: 286 ----SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVV 326
                 ++  L+  P+ R +A Q+LEHP++  +    N PL ++V
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPLRELV 285

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 91.7 bits (228), Expect = 8e-21
 Identities = 78/317 (24%), Positives = 134/317 (42%), Gaps = 58/317 (18%)

Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
              P  +   +Y    ++G+G FG  +    + T++++A K +     +    I  +R E
Sbjct: 3   YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-E 61

Query: 102 VAIMKHLPKNSSIVSLKEAC--------EDDNAVHLVMELCE---GGELFDRIVARGHYT 150
           + I++ L K+ ++V+L E C            + +LV E CE    G L ++ V    +T
Sbjct: 62  IKILQLL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFT 117

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE- 209
                 V + ++  +   H++ ++HRD+K  N L     ++  LK  DFGL+  F   + 
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKN 174

Query: 210 ----RFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
               R++  V + +Y  PE+L  +R+YGP ID+W AG I+  +    P     +EQ    
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234

Query: 264 AI--LRGLIDFKRDPWPNV----------------------------SESAKSLVRQMLE 293
            I  L G I    + WP V                               A  L+ ++L 
Sbjct: 235 LISQLCGSIT--PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLV 292

Query: 294 PDPKLRLTAKQVLEHPW 310
            DP  R+ A   L H +
Sbjct: 293 LDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 72/257 (28%), Positives = 120/257 (46%), Gaps = 10/257 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   +   E  A K++ K  +    D++    E  ++    +N  +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I  +G +    A      IV  +Q  H  G+I+RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK-RNYGPEIDI 236
           K +N +      +  +K  DFG+      G+ R S   G+P Y+APE+L+   Y   +D 
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF  + E  + ++I      + R  W  +++ +K ++ ++ E DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235

Query: 297 KLRL-TAKQVLEHPWLQ 312
             RL     +  HP+ +
Sbjct: 236 TRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 24/274 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + TR + A K I K  +    DID V+ E  + +    +  +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 177 DLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L         +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 121 DLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233

Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQN 313
           S+++  L  DPK RL          +  HP+ +N
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 66/247 (26%), Positives = 112/247 (45%), Gaps = 9/247 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +      A K + K+ +    + + +  E  ++    K+  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +    ++ V++   GGELF  +     + E  A      +   +   H   +I+RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           KPEN L  ++     +   DFGL     +P E  S   G+P Y+APEVL++  Y   +D 
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++     +   IL   +          + +A  L+  +L  D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235

Query: 297 KLRLTAK 303
           + RL AK
Sbjct: 236 RRRLGAK 242

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 80/317 (25%), Positives = 128/317 (40%), Gaps = 76/317 (23%)

Query: 60  GRGEFGVTYLCI--DRDTRELLACKSISKRKLR------TAVDIDDVRREVAIMKHLPKN 111
           GRG +G  Y     +    +  A K     K +      +A       RE+A+++ L K+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC------REIALLREL-KH 61

Query: 112 SSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRT-------IV 162
            ++VSL E   +     V+L+ +  E  +L+  I  + H   +  +            I+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII--KFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 163 EVVQLCHKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGS 217
             V   H + V+HRDLKP N  +     E   +K  D GL+ +F  P +  ++   +V +
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA---------QAIL 266
            +Y APE+L   R+Y   IDIW+ G I   LL   P F     +            + I 
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238

Query: 267 RGL---------------------IDFKRDPWPNVS------------ESAKSLVRQMLE 293
             L                      DFK   +P+ S                 L+R++LE
Sbjct: 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298

Query: 294 PDPKLRLTAKQVLEHPW 310
            DP  R+TA++ LEHP+
Sbjct: 299 YDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 81/323 (25%), Positives = 134/323 (41%), Gaps = 62/323 (19%)

Query: 46  KENIEDRYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-----IDDV- 98
             +I +RY+     LG G +G      D  T +++A K +   ++   V      +    
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 99  -----RREVAIMKHLPKNSSIVSLKEA-CEDDNAVHLVMELCEGGELFDRIVARGHYTER 152
                 RE+ IM  + K+ +I+ L +   E D  ++LVM++    +L   +  +   TE 
Sbjct: 63  IHFTTLRELKIMNEI-KHENIMGLVDVYVEGD-FINLVMDIMAS-DLKKVVDRKIRLTES 119

Query: 153 AAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---------- 202
               +   I+  + + HK   +HRDL P N +F N K     K  DFGL+          
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPAN-IFINSK--GICKIADFGLARRYGYPPYSD 176

Query: 203 -----IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA 255
                   +  E  +  V + +Y APE+L     Y   +D+WS G I   LL G P F  
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236

Query: 256 ESEQGVAQAI--LRGL-----------------------IDFKRDPWPNVSESAKSLVRQ 290
           E+E      I  L G                         D K   +PN S+ A  L++ 
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQS 295

Query: 291 MLEPDPKLRLTAKQVLEHPWLQN 313
           +L+ +P  R++AK+ L+H + ++
Sbjct: 296 LLKLNPLERISAKEALKHEYFKS 318

Length = 335

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 89.8 bits (222), Expect = 2e-20
 Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 34/273 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G  Y      T +L A K +      T  + +++++E+ ++K    + +I +  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQEINMLKKYSHHRNIATYY 69

Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIVARGHYT--ERAAAAVTRTIVEVVQLCHK 170
                K     D+ + LVME C  G + D I      T  E   A + R I+  +   H+
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKRN 229
           H VIHRD+K +N L     EN+ +K +DFG+S    +   R +  +G+PY+MAPEV+  +
Sbjct: 130 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 230 YGPEI------DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV--- 280
             P+       D+WS G+    +  G PP             +R L    R+P P +   
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPAPRLKSK 239

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S+  +S +   L  +   R T +Q+++HP++
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 30/286 (10%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N E+ + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILAS 58

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  +E +
Sbjct: 59  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEAL 116

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H++ +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 117 NYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173

Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           V+       R Y  + D+WS G+ L  +    PP    +        +R L+   +   P
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPP 226

Query: 279 NVSESA------KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            +++ +      K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 73/258 (28%), Positives = 127/258 (49%), Gaps = 26/258 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + + +GRG FG   +   + T  + A K ++K ++    +    R E  ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQ 166
              I +L  A +D+N ++LVM+   GG+L   +     + +R    + R     +V  + 
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIH 116

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEI-VGSPYYMAPE 224
             H+   +HRD+KP+N L      N  ++  DFG  +   + G   S + VG+P Y++PE
Sbjct: 117 SIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 225 VLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           +L+        YGPE D WS GV +Y +L G  PF+AES       I+     F+   +P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FP 230

Query: 279 ----NVSESAKSLVRQML 292
               +VSE AK L+++++
Sbjct: 231 SHITDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 24/275 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSL 117
           LG+G FG       ++T ++ ACK + K++L+          E  I++ +  NS  IV+L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV--NSPFIVNL 58

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIV---ARGHYTERA---AAAVTRTIVEVVQLCHKH 171
             A E    + LVM L  GG+L   I     RG   ER    +A +T  I+ +    H  
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL----HSM 114

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-Y 230
            +++RD+KPEN L     +    +  D GL++  K G+  ++  G+  YMAPE+LK   Y
Sbjct: 115 DIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRDPWPNVSESAKS 286
              +D ++ G  +Y ++ G  PF    E    + + +  L   + F+     N +E +K 
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKD 228

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           + R  L   P+ RL +++  + P      K  N P
Sbjct: 229 ICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 91.6 bits (227), Expect = 5e-20
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVVQLCH 169
           IV   +  + D+ + L+ME   GG+L  +I  R      + E     +   IV  +   H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVL 226
              ++HRDLK  N           +K  DFG S  +         S   G+PYY+APE+ 
Sbjct: 187 SRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW 243

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
           +R  Y  + D+WS GVILY LL    PF   S++ + Q +L G    K DP+P  VS   
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG----KYDPFPCPVSSGM 299

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           K+L+  +L  +P LR T +Q+L   +L+
Sbjct: 300 KALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 89.4 bits (222), Expect = 8e-20
 Identities = 93/362 (25%), Positives = 151/362 (41%), Gaps = 86/362 (23%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSIS---------KRKLRTAVDIDDV 98
           RY + +ELG+G +G+  +C  R+      E +A K I+         KR LR        
Sbjct: 1   RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRALR-------- 50

Query: 99  RREVAIMKHLPKNSSIVSL--KEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAA 154
             E+ +++H   + +I  L   +       N ++L  EL E  +L   I +    T+   
Sbjct: 51  --ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHF 107

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-----E 209
            +    I+  ++  H   V+HRDLKP N L      +  LK  DFGL+  F         
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAG 164

Query: 210 RFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE----------- 256
             +E V + +Y APE++   ++Y   ID+WS G IL  LL   P F  +           
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224

Query: 257 ----------SEQGV--AQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRL 300
                     S  G   AQ  +R L +  + P    +PN +  A  L+ ++L  DP  R+
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284

Query: 301 TAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIK 360
           + ++ LEHP+L       + P+        K F     F          F S + +E+++
Sbjct: 285 SVEEALEHPYLAIWHDPDDEPVCQ------KPF----DF---------SFESEDSMEELR 325

Query: 361 EM 362
           +M
Sbjct: 326 DM 327

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 13/246 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L  +I   G + E  A      I   +   H  G+I+RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           K +N +  ++     +K  DFG+   +++   G       G+P Y+APE++  + YG  +
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G  PF  E E  + Q+I+   + + +    ++S+ A ++ + ++  
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTK 238

Query: 295 DPKLRL 300
            P  RL
Sbjct: 239 HPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 90.6 bits (224), Expect = 2e-19
 Identities = 87/299 (29%), Positives = 137/299 (45%), Gaps = 47/299 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + Y V +++G G FG  +L   + T+E    K+IS R L+   +   +  EV +M+ L K
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIEVNVMREL-K 70

Query: 111 NSSIVS-----LKEACEDDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTI 161
           + +IV      L +A   +  ++++ME C+ G+L   I       G   E A   +TR +
Sbjct: 71  HKNIVRYIDRFLNKA---NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 162 VEVVQLCH--KHG-----VIHRDLKPENFLF-------------ANKKENSPLKAI-DFG 200
           +  +  CH  K G     V+HRDLKP+N                AN     P+  I DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 201 LSIFFKPGERFSEIVGSPYYMAPEVL---KRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           LS            VG+PYY +PE+L    ++Y  + D+W+ G I+Y L  G  PF    
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HK 245

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKS---LVRQMLEPDPKLRLTAKQVLEHPWLQN 313
               +Q I     + KR P   +   +K    L++ +L    K R +A Q L +  ++N
Sbjct: 246 ANNFSQLI----SELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300

Length = 1021

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 68/250 (27%), Positives = 105/250 (42%), Gaps = 53/250 (21%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + LG G FG   L    DT  L A K++ K+ +     +  V+ E  I+     N  +V 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L  + +D + ++ VM+   GG++   ++    + E  A      +   ++  HK G IHR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFK--------------------P--------- 207
           D+KP+N L      +  +K  DFGL   F+                    P         
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 208 ---GERFS----------------EIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILL 247
              G+R                   +VG+P Y+APEV L++ Y    D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 248 CGVPPFWAES 257
            G PPF A +
Sbjct: 243 VGQPPFLAPT 252

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 68/257 (26%), Positives = 121/257 (47%), Gaps = 10/257 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG  +L   + T +  A K++ K  +    D++    E  ++    ++  +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I +   +    A      I+  +Q  H  G+++RDL
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K +N L      +  +K  DFG+      G+ +     G+P Y+APE+L  + Y   +D 
Sbjct: 123 KLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF    E+ + Q+I      + R  W  ++  AK ++ ++   +P
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLFVREP 235

Query: 297 KLRLTAK-QVLEHPWLQ 312
           + RL  K  + +HP+ +
Sbjct: 236 ERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 89/323 (27%), Positives = 137/323 (42%), Gaps = 49/323 (15%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY +   +G+G +GV    ID  T E +A K I+        D   + RE+ +++ L ++
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLL-RH 58

Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
             IV +K      +  +   +++V EL E  +L   I A    T          ++  ++
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFK--PGERF-SEIVGSPYYMA 222
             H   V HRDLKP+N L AN   +  LK  DFGL+ + F   P   F ++ V + +Y A
Sbjct: 118 YIHTANVFHRDLKPKNIL-ANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 223 PEV---LKRNYGPEIDIWSAGVILYILLCGVPPF-------------------WAESEQG 260
           PE+       Y P IDIWS G I   +L G P F                     E+   
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 261 V----AQAILRGLIDFKRDP------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
           V    A+  L  +   K+ P      +PN    A  L+ ++L  DPK R TA++ L  P+
Sbjct: 235 VRNEKARRYLSSM--RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 311 LQNAKKAPNVPLGDVVRSRLKQF 333
            +   K    P    +     +F
Sbjct: 293 FKGLAKVEREPSAQPITKLEFEF 315

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 85.4 bits (211), Expect = 6e-19
 Identities = 69/270 (25%), Positives = 127/270 (47%), Gaps = 25/270 (9%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKH 107
           Y   R +G+G +G   L   R   +    K +     S+R+ + A       +E  ++  
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA------EQEAQLLSQ 55

Query: 108 LPKNSSIVSLKEACE-DDNAVHLVMELCEGGELFDRIV-ARGHY-TERAAAAVTRTIVEV 164
           L K+ +IV+ +E+ E +D  +++VM  CEGG+L+ ++   +G    E         I   
Sbjct: 56  L-KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA 114

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           +Q  H+  ++HRDLK +N         + +K  D G++ +     +  S ++G+PYYM+P
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171

Query: 224 EVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNVS 281
           E+   + Y  + D+W+ G  +Y +      F A+    +   I+ G L    +D  P + 
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           E    L+  ML   P+ R + K +L  P++
Sbjct: 232 E----LIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 38/287 (13%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIV 115
           E+G G +G  Y   D  +   +A KS+  +     + +  VR EVA++K L    + +IV
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65

Query: 116 SLKEAC-----EDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            L + C     + +  V LV E  +       D++   G   E     + R  +  +   
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFLRGLDFL 124

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LK 227
           H + ++HRDLKPEN L  +  +   +K  DFGL+  +      + +V + +Y APEV L+
Sbjct: 125 HANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---------- 277
             Y   +D+WS G I   +    P F   SE      I   +     D W          
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241

Query: 278 -------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                        P + ES   L+ +ML  +P  R++A + L+HP+ 
Sbjct: 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 51/279 (18%)

Query: 56  DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ++LG G FG  Y          T   +A K++  ++  +  + ++   E +IMK L  +
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL-SH 60

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV-VQLC-- 168
            +IV L   C     +++V E   GG+L D +   G           + ++++ +Q+   
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE------KLTLKDLLQMALQIAKG 114

Query: 169 ----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY---- 220
                    +HRDL   N L         +K  DFGLS          +I    YY    
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLSR---------DIYEDDYYRKRG 162

Query: 221 --------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
                   MAPE LK   +  + D+WS GV+L+ I   G  P+   S + V + +  G  
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-- 220

Query: 271 DFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
              R P P N  +    L+ Q    DP+ R T  +++E 
Sbjct: 221 --YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 74/314 (23%), Positives = 123/314 (39%), Gaps = 65/314 (20%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             Y +  +LG G FG  Y      T  ++A K I     +    I  +R E+ I+K L K
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL-K 65

Query: 111 NSSIVSL--------KEACEDDNAVHLVM-----ELCEGGELFDRIVARGHYTERAAAAV 157
           + ++V L         ++     +V++V      +L   G L +  V     TE      
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCY 120

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-----KPG---- 208
              ++E +   H++ ++HRD+K  N L  N+     LK  DFGL+  +      P     
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLARPYDGPPPNPKGGGG 177

Query: 209 ---ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
               +++ +V + +Y  PE+L  +R Y   +DIW  G +   +    P    +S+     
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237

Query: 264 AILR--------------------GLIDFKRDPWPNVSESAK-------SLVRQMLEPDP 296
            I +                    G+  F   P   + E           L+ ++L  DP
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 297 KLRLTAKQVLEHPW 310
             RLTA   LEHP+
Sbjct: 297 YKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 78/302 (25%), Positives = 125/302 (41%), Gaps = 72/302 (23%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +   Y    + T +L+A K I          TA+      RE +++K L K+++I
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLKDL-KHANI 65

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV--QL----- 167
           V+L +       + LV E        D  + +  Y +     ++   V +   QL     
Sbjct: 66  VTLHDIIHTKKTLTLVFEYL------DTDLKQ--YMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 168 -CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEIVGSPYYMA 222
            CH+  V+HRDLKP+N L + + E   LK  DFGL    S+   P + +S  V + +Y  
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PSKTYSNEVVTLWYRP 171

Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPW 277
           P+VL     Y   +D+W  G I Y +  G P F   +   +Q     I R L     + W
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETW 229

Query: 278 PNVSE----------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           P VS                               + L  + L+ +PK R++A + ++HP
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289

Query: 310 WL 311
           + 
Sbjct: 290 YF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 34/273 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G  Y      T +L A K +      T  + ++++ E+ ++K    + +I +  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEEIKLEINMLKKYSHHRNIATYY 79

Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIV-ARGH-YTERAAAAVTRTIVEVVQLCHK 170
                K     D+ + LVME C  G + D +   +G+   E   A + R I+  +   H 
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKRN 229
           H VIHRD+K +N L     EN+ +K +DFG+S    +   R +  +G+PY+MAPEV+  +
Sbjct: 140 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 230 YGPEI------DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV--- 280
             P+       DIWS G+    +  G PP             +R L    R+P P +   
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPPPKLKSK 249

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             S+     +   L  +   R + +Q+L+HP++
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 74/268 (27%), Positives = 119/268 (44%), Gaps = 29/268 (10%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
             +G G  G  Y  I R T  L A K I           D VR    RE+ I++ +  + 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDV-NHP 132

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           ++V   +  + +  + +++E  +GG L    +A     E+  A V R I+  +   H+  
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLHRRH 188

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRNY- 230
           ++HRD+KP N L  + K    +K  DFG+S I  +  +  +  VG+  YM+PE +  +  
Sbjct: 189 IVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245

Query: 231 -----GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--NVSES 283
                G   DIWS GV +     G  PF     QG   A L   I   + P      S  
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQG-DWASLMCAICMSQPPEAPATASRE 303

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            +  +   L+ +P  R +A Q+L+HP++
Sbjct: 304 FRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 73/301 (24%), Positives = 131/301 (43%), Gaps = 53/301 (17%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV    + R +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIR-NQIIRELKVL-HECNSPYIVGF 64

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE-VVQLCHKHGVIH 175
             A   D  + + ME  +GG L D+++ + G   E     ++  ++  +  L  KH ++H
Sbjct: 65  YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLKRN-Y 230
           RD+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+   Y
Sbjct: 124 RDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175

Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-----GLIDFKRDPWPNVSESAK 285
             + DIWS G+ L  +  G  P      + +     R        +  R    +  +S +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235

Query: 286 SL-VRQML-----EPDPKL-----------------------RLTAKQVLEHPWLQNAKK 316
            + + ++L     EP PKL                       R   K++ +HP+++ A+ 
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295

Query: 317 A 317
            
Sbjct: 296 E 296

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 18/266 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS---IV 115
           +GRG FG  Y C   DT ++ A K + K++++          E  IM  L        IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H   V++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGPE 233
           RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++   Y   
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSS 176

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLVRQML 292
            D +S G +L+ LL G  PF     +     I R  +    +  P+  S   +SL+  +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVE-LPDSFSPELRSLLEGLL 234

Query: 293 EPDPKLRL-----TAKQVLEHPWLQN 313
           + D   RL      A++V EHP+ ++
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 81.0 bits (201), Expect = 2e-17
 Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 32/272 (11%)

Query: 57  RELGRGEFGVTYLCI--DRDTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNS 112
           ++LG G FG  Y      +D +    A K++ +    +  +  D  +E  +MK L   N 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPN- 57

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC---- 168
            +V L   C ++  ++LV+E  EGG+L D +            +   ++ +++       
Sbjct: 58  -VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIA 115

Query: 169 ------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSP-Y 219
                      +HRDL   N L         +K  DFGLS  ++     R       P  
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 220 YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           +MAPE LK   +  + D+WS GV+L+ I   G  P+   S + V + + +G     R P 
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG----YRLPK 228

Query: 278 P-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           P    +    L+    + DP+ R T  +++E 
Sbjct: 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.7 bits (196), Expect = 7e-17
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 29/279 (10%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + + N +  Y + + +G G +G  Y   +  T EL A K I   KL    D   +++E+ 
Sbjct: 2   ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIF 58

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           ++K   K+ +IV+   +      + + ME C GG L D     G  +E   A V R  ++
Sbjct: 59  MVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYM 221
            +   H  G +HRD+K  N L     +N  +K  DFG++  I     +R S  +G+PY+M
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKS-FIGTPYWM 173

Query: 222 APEV--LKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           APEV  +++N  Y    DIW+ G+    L    PP +           +R L    +  +
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP-------MRALFLMSKSNF 226

Query: 278 --PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEH 308
             P + +  K      + V+  L  +PK R TA+++L H
Sbjct: 227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 82/309 (26%), Positives = 140/309 (45%), Gaps = 47/309 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY   +++G G +G     ID+ T E +A K +S R  ++ +      RE+ ++KH+
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHM 71

Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTI 161
            ++ +++ L +      + ++    +LVM   +     D     GH  +E     +   +
Sbjct: 72  -QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQM 126

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  ++  H  G+IHRDLKP N L  N  E+  LK +DFGL+         +  V + +Y 
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGN-LAVN--EDCELKILDFGLA--RHADAEMTGYVVTRWYR 181

Query: 222 APEVLKR--NYGPEIDIWSAGVILYILLCGV-----------------------PPFWAE 256
           APEV+    +Y   +DIWS G I+  +L G                        P F  +
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241

Query: 257 SEQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            E   A++ ++ L  + R      +P  S  A  L+ +MLE D   RLTA + LEHP+  
Sbjct: 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301

Query: 313 NAKKAPNVP 321
           + + A    
Sbjct: 302 SFRDADEET 310

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 79.7 bits (196), Expect = 9e-17
 Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 38/285 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-VRREVAIMKHLP 109
           D + +   +G+G +G  Y   ++    L A K      L    D+D+ +  E  I++ LP
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDPISDVDEEIEAEYNILQSLP 76

Query: 110 KNSSIVSL-----KEACEDDNAVHLVMELCEGG---ELFDRIVARGHYTERAAAA-VTRT 160
            + ++V       K        + LV+ELC GG   EL   ++  G   + A  + +   
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPY 219
            +  +Q  H + +IHRD+K  N L   +     +K +DFG+S        R +  VG+P+
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193

Query: 220 YMAPEVL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
           +MAPEV+        +Y    D+WS G+    L  G PP +           ++ L    
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VKTLFKIP 246

Query: 274 RDPWPNV------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           R+P P +        S    + Q L  D + R +   +LEHP+++
Sbjct: 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 76/278 (27%), Positives = 114/278 (41%), Gaps = 45/278 (16%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI--------SKRKLRTAVDIDDVRREVAIMKHLP 109
           E+G G  G  Y    + T  ++A K +        +KR L    D+D     V +  H  
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM---DLD-----VVLKSHDC 73

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQ- 166
               IV        D+ V + MEL       D+++ R  G   E     +T  IV+ +  
Sbjct: 74  PY--IVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
           L  KHGVIHRD+KP N L      +  +K  DFG+S      +  +   G   YMAPE +
Sbjct: 130 LKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI 186

Query: 227 -----KRNYGPEIDIWSAGVILYILLCGVPPF-WAESEQGVAQAILRGLIDFKRDPWP-- 278
                   Y    D+WS G+ L  L  G  P+   ++E  V   IL       ++  P  
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-------QEEPPSL 239

Query: 279 ----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                 S    S V   L  D + R   +++L+HP+++
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 59/295 (20%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHLPKNSS 113
           +LG G +   +    + T  L+A K I          TA+      REV+++K+L K+++
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------REVSLLKNL-KHAN 64

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV--------V 165
           IV+L +    +  + LV E  +             Y +     ++   V++        +
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDSD--------LKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPE 224
             CHK  ++HRDLKP+N L   K E   LK  DFGL+     P + +S  V + +Y  P+
Sbjct: 117 SYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           VL     Y   ID+W  G ILY +  G P F   + +     I R L     + WP ++ 
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 283 SAK--------------------------SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + +                           L+  +L  + K R++A+  L H + 
Sbjct: 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 67/246 (27%), Positives = 112/246 (45%), Gaps = 33/246 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           + Y+   +LG G +   +    + T  L+A K I          TA+      REV+++K
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------REVSLLK 59

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV-- 164
            L K+++IV+L +    D ++ LV E        D+ + +  Y +     ++   V++  
Sbjct: 60  DL-KHANIVTLHDIVHTDKSLTLVFEY------LDKDLKQ--YMDDCGNIMSMHNVKIFL 110

Query: 165 ------VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGS 217
                 +  CH+  V+HRDLKP+N L   + E   LK  DFGL+     P + +S  V +
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVT 167

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
            +Y  P+VL     Y  +ID+W  G I + +  G P F   + +     I R L     +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227

Query: 276 PWPNVS 281
            WP +S
Sbjct: 228 TWPGIS 233

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 74/302 (24%), Positives = 138/302 (45%), Gaps = 50/302 (16%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + DRY   +++G G +G     +DR T   +A K +  R  ++ +      RE+ ++KH+
Sbjct: 13  VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHM 71

Query: 109 PKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L        + +  +  +LVM     G    +++     +E     +   ++
Sbjct: 72  -KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG---SPY 219
           + ++  H  G+IHRDLKP N       E+  LK +DFGL+      +  SE+ G   + +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA-----RQTDSEMTGYVVTRW 180

Query: 220 YMAPEVLKR--NYGPEIDIWSAGVILYILLCGVP-----------------------PFW 254
           Y APEV+    +Y   +DIWS G I+  +L G P                        F 
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240

Query: 255 AESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
            + +   A+  ++ L  F++  +    PN +  A +++ +ML  D + R+TA + L HP+
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Query: 311 LQ 312
            +
Sbjct: 301 FE 302

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 88/312 (28%), Positives = 140/312 (44%), Gaps = 44/312 (14%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +Y + R LG G  G T LC  R +  E  A K +    + +  D +  + EV  + +   
Sbjct: 33  KYWISRVLGSGATG-TVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-D 89

Query: 111 NSSIVSLKE--ACEDDN------AVHLVMELCEGGELFDRIVARGH----YTERAAAAVT 158
             SIV   E  A +D         + LV++    G+L   I +R      + E  A  + 
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP------GERFS 212
             ++  V   H   +IHRD+K  N L  +   N  +K  DFG S  +        G  F 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTF- 205

Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
              G+PYY+APE+ +R  Y  + D++S GV+LY LL    PF  E+ + V    L G   
Sbjct: 206 --CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--- 260

Query: 272 FKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHP--------WLQNAKKAP--NV 320
            + DP P ++S   + +V  +L  DPK R ++ ++L  P         L+  +  P  + 
Sbjct: 261 -RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSG 319

Query: 321 PLGDVVRSRLKQ 332
           PL D +  +++Q
Sbjct: 320 PLRDTISRQIQQ 331

Length = 496

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 80/315 (25%), Positives = 129/315 (40%), Gaps = 52/315 (16%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 15  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 73

Query: 109 PKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L        + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 74  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 130

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 185

Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE++    +Y   +DIWS G I+  LL G   F         + ILR        P   +
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTPGAEL 241

Query: 281 -----SESAKS--------------------------LVRQMLEPDPKLRLTAKQVLEHP 309
                SESA++                          L+ +ML  D   R+TA Q L H 
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301

Query: 310 WLQNAKKAPNVPLGD 324
           +        + P+ D
Sbjct: 302 YFAQYHDPDDEPVAD 316

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 38/284 (13%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-VRREVAIMKHLP 109
           D + +   +G+G +G  +  +++      A K      L    DID+ +  E  I+K L 
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALS 72

Query: 110 KNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRI---VARG-HYTERAAAAVTRT 160
            + ++V       K+  ++ + + LV+ELC GG + D +   + RG    E   A +   
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPY 219
            +  +Q  H +  IHRD+K  N L   +     +K +DFG+S        R +  VG+P+
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 220 YMAPEV------LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
           +MAPEV      L   Y    D+WS G+    L  G PP  A+         +R L    
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRALFKIP 242

Query: 274 RDPWPNV------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           R+P P +      S      +R+ L  D + R T   +L+H ++
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 85/300 (28%), Positives = 121/300 (40%), Gaps = 56/300 (18%)

Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHL 108
           YL   +LG G +   Y  I R   +L+A K IS +       TA+      RE +++K L
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI------REASLLKGL 60

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            K+++IV L +       +  V E          I   G             ++  +   
Sbjct: 61  -KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEIVGSPYYMAPE 224
           H   ++HRDLKP+N L +   E   LK  DFGL    SI   P + +S  V + +Y  P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSI---PSQTYSSEVVTLWYRPPD 173

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPWPN 279
           VL    +Y   +DIW AG I   +L G P F   S   EQ   + I   L     D WP 
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPG 231

Query: 280 VSE----------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           VS+                             A+ L  QML   PK R++A+  L HP+ 
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 77/306 (25%), Positives = 136/306 (44%), Gaps = 65/306 (21%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           + Y+   +LG G +   Y    + T  L+A K I          TA+      REV+++K
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI------REVSLLK 59

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV-- 164
            L K+++IV+L +    + ++ LV E        D+ + +  Y +    ++    V++  
Sbjct: 60  DL-KHANIVTLHDIIHTEKSLTLVFEY------LDKDLKQ--YLDDCGNSINMHNVKLFL 110

Query: 165 ------VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEI 214
                 +  CH+  V+HRDLKP+N L   + E   LK  DFGL    SI   P + +S  
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSI---PTKTYSNE 164

Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           V + +Y  P++L    +Y  +ID+W  G I Y +  G P F   + +     I R L   
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224

Query: 273 KRDPWPNV--SESAKS------------------------LVRQMLEPDPKLRLTAKQVL 306
             + WP +  +E  KS                        L+ ++L+ + + R++A++ +
Sbjct: 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 307 EHPWLQ 312
           +HP+  
Sbjct: 285 KHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 16/264 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS---IV 115
           +GRG FG  Y C   DT ++ A K + K++++     + +     IM  L        IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  A    + +  +++L  GG+L   +   G ++E+        I+  ++  H   V++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGPE 233
           RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++   Y   
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
            D +S G +L+ LL G  PF     +     I R  +    +   + S   KSL+  +L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235

Query: 294 PDPKLRL-----TAKQVLEHPWLQ 312
            D   RL      A++V EH + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 86/298 (28%), Positives = 128/298 (42%), Gaps = 51/298 (17%)

Query: 56  DRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIM---KHLPKN 111
           DR +G G FGV +   D RD + + A K +     +  V    V RE+ ++   KH    
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRV-ALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 112 SSIVSLKEACEDD-NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           S++  L+    D    +++V EL +  +L   IV+    +          I+  ++  H 
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVL- 226
            G++HRD+KP N L  +   N  LK  DFGL+   +P E      E+V + YY APE+L 
Sbjct: 122 AGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILM 177

Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-----------------------QGVA 262
             R+Y   +DIWS G I   LL     F A+S                        +G  
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237

Query: 263 QAILRGLIDFKRDPWPNV--------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             ILRG     + P   V        +  A  L+ +ML  DP  R++A   L HP+L 
Sbjct: 238 AHILRGP---HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 17/209 (8%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KH+
Sbjct: 13  VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHM 71

Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     ++     +   ++
Sbjct: 72  -KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H  G+IHRDLKP N       E+  L+ +DFGL+   +  +  +  V + +Y A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLA--RQADDEMTGYVATRWYRA 183

Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCG 249
           PE++    +Y   +DIWS G I+  LL G
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 83/289 (28%), Positives = 123/289 (42%), Gaps = 49/289 (16%)

Query: 52  RYL-VDRELGRGEFG-VTYLCID---RDTRELLACKSISK---RKLRTAVDIDDVRREVA 103
           RYL   R LG G FG V+  C D     T E++A K++ +   ++  +       ++E+ 
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW-----KKEIN 58

Query: 104 IMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I+K L  + +IV  K  C +     + L+ME    G L D       Y  +    + + +
Sbjct: 59  ILKTL-YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLL 110

Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFS 212
           +   Q+C      H    IHRDL   N L  N +    +K  DFGL+     G    R  
Sbjct: 111 LFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVR 167

Query: 213 EIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILL--CG---VPPFWAESEQGVAQAI 265
           E   SP ++ A E LK N +    D+WS GV LY LL  C     PP   E   G  Q  
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227

Query: 266 LR--GLIDF----KRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +    LI+      R P P N  +    L++   E + K R T + ++ 
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 43/108 (39%), Positives = 63/108 (58%), Gaps = 15/108 (13%)

Query: 208 GERFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           GER   I+G+P Y+APE+L  + +GP +D W+ GV L+  L G+PPF  E+ Q V Q IL
Sbjct: 537 GER---ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL 593

Query: 267 RGLIDFKRD-PWPN----VSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                  RD PWP     +S +A++ +  +L  DP  R   K++ +HP
Sbjct: 594 ------NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 69/272 (25%), Positives = 108/272 (39%), Gaps = 44/272 (16%)

Query: 59  LGRGEFGVTY----LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G FG  Y      I       +     + RK  T  +  +  +E  +M +   + +I
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQLC-- 168
           V L   C  +   +++MEL EGG+L         Y   A          T+ E++ +C  
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDICLD 114

Query: 169 --------HKHGVIHRDLKPENFLFANKKENSP--LKAIDFGLS-------IFFKPGERF 211
                    +   IHRDL   N L + K  ++   +K  DFGL+        + K GE  
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 212 SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
             +     +MAPE L    +  + D+WS GV+++ IL  G  P+ A + Q V Q +  G 
Sbjct: 175 LPV----RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG- 229

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT 301
              +     N  +    L+      DP  R T
Sbjct: 230 --GRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 5/154 (3%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           IE+  +V + + RG FG  YL   ++  +L A K + K  +     +  V+ E   +  L
Sbjct: 3   IEEFVIV-KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-L 60

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            K+  IV L  + +  N V+LVME   GG++   +   G++ E  A      +   +   
Sbjct: 61  SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           H+HG+IHRDLKP+N L +N+     +K  DFGLS
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGH---IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 29/216 (13%)

Query: 50  EDRYLVD-RELGRGEFGVTYLC---IDRD-TRELLACKSISKRKLRTAVDIDDVRREVAI 104
           E R+L   ++LG G FG   LC      D T E +A KS+            D  RE+ I
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEI 59

Query: 105 MKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++ L  + +IV  K  CE     ++ L+ME    G L  R   + H   R    + R ++
Sbjct: 60  LRTL-DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRH---RDQINLKRLLL 113

Query: 163 EVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSE 213
              Q+C           IHRDL   N L  ++     +K  DFGL+      +      E
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAKVLPEDKDYYYVKE 170

Query: 214 IVGSP-YYMAPEVLK-RNYGPEIDIWSAGVILYILL 247
              SP ++ APE L+   +    D+WS GV LY L 
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 101/401 (25%), Positives = 164/401 (40%), Gaps = 71/401 (17%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
           SH++   E    +K     +   P ++    Y +   +G G FGV Y  I  DT E +A 
Sbjct: 41  SHNNNAGEDEDEEKMIDNDINRSPNKS----YKLGNIIGNGSFGVVYEAICIDTSEKVAI 96

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE----ACEDDNAVHLVMELCEGG 137
           K + +       D     RE+ IMK+L  + +I+ LK+     C   N  ++ + +    
Sbjct: 97  KKVLQ-------DPQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM-- 146

Query: 138 ELFDRIVAR--GHYTERAAAAVTRTIVEVV--QLC------HKHGVIHRDLKPENFLFAN 187
           E   + V +   HY  R   A+   +V++   QLC      H   + HRDLKP+N L   
Sbjct: 147 EFIPQTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP 205

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
                 LK  DFG +     G+R    + S +Y APE++    NY   ID+WS G I+  
Sbjct: 206 NTHT--LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263

Query: 246 LLCGVPPFWAESEQGVAQAILRGL------------IDFKRDPWPNVS------------ 281
           ++ G P F  +S       I++ L             ++    +P+V             
Sbjct: 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323

Query: 282 -ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK----KAP----NVP-LGDVVRSRLK 331
            + A + + Q L+ +P  RL   + L  P+  + +    K P     +P L +   + +K
Sbjct: 324 PDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK 383

Query: 332 QFSMMNRFK---RKALRVIAEFLSVEEVEDIKEMFKKIDSD 369
           + S   R K   +       EFL  +E  D   +  KI  D
Sbjct: 384 EMSDACRRKIIPKCTYEAYKEFLMSDE-NDANIIADKISKD 423

Length = 440

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 16/220 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV +L   R   + +A K I +     A+  DD   E  +M  L  + ++V 
Sbjct: 10  KELGSGQFGVVHLGKWRGKID-VAIKMIRE----GAMSEDDFIEEAKVMMKL-SHPNLVQ 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRTIVEVVQLCHKHGVIH 175
           L   C     + +V E    G L + +  R           +   + E ++    +G IH
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN-YG 231
           RDL   N L     E++ +K  DFGL+ +    +  S   G+ +   +  PEV   + + 
Sbjct: 124 RDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFS 179

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
            + D+WS GV+++ +   G  P+   S   V +++  G  
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 15/192 (7%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           E+G G+FG+ +L    + R+ +A K+I +     A+  +D   E  +M  L     +V L
Sbjct: 11  EIGSGQFGLVWLGYWLEKRK-VAIKTIRE----GAMSEEDFIEEAQVMMKLSHP-KLVQL 64

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
              C + + + LV E  E G L D + A RG +++     +   + E +       VIHR
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLK-RNYGP 232
           DL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV     Y  
Sbjct: 125 DLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 233 EIDIWSAGVILY 244
           + D+WS GV+++
Sbjct: 181 KSDVWSFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 82/296 (27%), Positives = 129/296 (43%), Gaps = 57/296 (19%)

Query: 50  EDRYLVD-RELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           E R+L   R+LG G FG   LC      D  T E +A KS+          I D+++E+ 
Sbjct: 2   EKRFLKRIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPES--GGNHIADLKKEIE 58

Query: 104 IMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVT--R 159
           I+++L  + +IV  K  C +D  N + L+ME    G L +       Y  R    +   +
Sbjct: 59  ILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQ 110

Query: 160 TIVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +   VQ+C           +HRDL   N L  ++ +   +K  DFGL+   +  + +  
Sbjct: 111 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYT 167

Query: 214 I---VGSP-YYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESE---------- 258
           +   + SP ++ APE L +  +    D+WS GV LY LL      + +SE          
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKM 222

Query: 259 ------QGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 Q     ++R L + KR P P N  E    L+R+  E  P  R T + ++E
Sbjct: 223 IGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 39/287 (13%)

Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 66

Query: 115 VSLKEAC-----EDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN------- 279
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 242

Query: 280 ----------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                           + E  K L+ + L  +P  R++A   L HP+
Sbjct: 243 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 69.0 bits (168), Expect = 8e-13
 Identities = 82/305 (26%), Positives = 130/305 (42%), Gaps = 53/305 (17%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 75

Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      +++ E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 133

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 134 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189

Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++  + L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309

Query: 307 EHPWL 311
           +HP++
Sbjct: 310 QHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 8e-13
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 20/223 (8%)

Query: 99  RREVAIMKHLPKNSSIVSLKEACE-DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           RRE A+   L  + +IV+L ++ E     +  V E   G  L + + A G         +
Sbjct: 26  RRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG--------- 208
              +++ +   H  G++HRDLKP+N + +        K +DFG+     PG         
Sbjct: 85  MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143

Query: 209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            R +E++G+P Y APE L+     P  D+++ G+I    L G       S   VA+ + +
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ 200

Query: 268 GL--IDFKRDPWPNVSESAKSLVRQMLEPDPKLR-LTAKQVLE 307
            L  +D    PW         ++R+ L  DP+ R  +A  + E
Sbjct: 201 QLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPALAE 242

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 60/298 (20%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSI----------SKRKLRTAVDIDDVRRE 101
           RY + R +G+G  G  YL  D      +A K I           KR LR A       + 
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREA-------KI 55

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--------RIVARGHYTERA 153
            A + H      IV +   C D + V+  M   EG  L            +++    + +
Sbjct: 56  AADLIH----PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTS 111

Query: 154 AAAVTR---TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK---- 206
             A       I   ++  H  GV+HRDLKP+N L     E   +  +D+G +IF K    
Sbjct: 112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDWGAAIFKKLEEE 168

Query: 207 ---------PGERFSE------IVGSPYYMAPEVLKRNYGPE-IDIWSAGVILYILLCGV 250
                        +S       IVG+P YMAPE L      E  DI++ GVILY +L   
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Query: 251 PPFWAESEQGVAQAILRGLIDFKRD--PWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            P+  +  + ++    R +I    +  P+  +      +  + L  DP  R ++ Q L
Sbjct: 229 FPYRRKKGRKIS---YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 67/326 (20%), Positives = 127/326 (38%), Gaps = 65/326 (19%)

Query: 54  LVDRELGRGEFGVT--YLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHL 108
            +   +G+    +   +L   + T  L+A K I+   L +    +D++    E+   + L
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSK-EDLKLLQQEIITSRQL 56

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT----ERAAAAVTRTIVEV 164
            ++ +I+    +   D+ +++V  L   G   D +  + H+     E A A + + ++  
Sbjct: 57  -QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI---FFKPGERFSEIVGSP--- 218
           +   H  G IHR +K  + L +        K +  GL       K G+R   +   P   
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDG-----KVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168

Query: 219 ----YYMAPEVLKRN---YGPEIDIWSAGVILYILLCGVPPF------------------ 253
                +++PEVL++N   Y  + DI+S G+    L  G  PF                  
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228

Query: 254 -------WAESEQGVAQAILRGLIDFKRDPWPNV-----SESAKSLVRQMLEPDPKLRLT 301
                  +   E  ++Q+         RD   +      SE     V   L+ DP+ R +
Sbjct: 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288

Query: 302 AKQVLEHPWLQNAKKAPNVPLGDVVR 327
           A Q+L H + +  K+     L D+++
Sbjct: 289 ASQLLNHSFFKQCKRRNTS-LLDLLK 313

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 55/306 (17%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ ++K +  +
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCV-NH 79

Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      +++ E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIK 137

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 138 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPF--------WAESEQGVA----------QAIL 266
            L   Y   +DIWS G I+  L+ G   F        W +  + +           Q  +
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 267 RGLIDFKRDPWPNVS---------------------ESAKSLVRQMLEPDPKLRLTAKQV 305
           R  ++  R  +P +S                       A+ L+ +ML  DP  R++  + 
Sbjct: 254 RNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 306 LEHPWL 311
           L HP++
Sbjct: 313 LRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 21/231 (9%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 68

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+  +Y 
Sbjct: 129 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 232 PEIDIWSAGVILYILLCG----VPPFWAESEQGVAQAILRGLIDFKRDPWP 278
            + DIWS G+ L  +  G     PP   E E      +     + +  P P
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82

Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS G I+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 16/218 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV +L   R   + +A K+I++     A+  +D   E  +M  L  +  +V 
Sbjct: 10  KELGSGQFGVVHLGKWRAQIK-VAIKAINE----GAMSEEDFIEEAKVMMKL-SHPKLVQ 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
           L   C     +++V E  E G L + +  R G  ++    ++ + + E ++   ++  IH
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN-YG 231
           RDL   N L +       +K  DFG++ +    E  S   G+ +   +  PEV   + Y 
Sbjct: 124 RDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKYS 179

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + D+WS GV+++ +   G  PF  +S   V + I RG
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 84/313 (26%), Positives = 132/313 (42%), Gaps = 68/313 (21%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D  T + +A K +S R  +         RE+ +MK L  +
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKRAYRELVLMK-LVNH 74

Query: 112 SSIVSL------KEACEDDNAVHLVME-----LCEGGELFDRIVARGHYTERAAAAVTRT 160
            +I+ L      +++ E+   V+LVME     LC+       ++      ER +  + + 
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDLDHERMSYLLYQM 127

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGSP 218
           +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+     G  F  +  V + 
Sbjct: 128 LCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA--RTAGTSFMMTPYVVTR 181

Query: 219 YYMAPEV-LKRNYGPEIDIWSAGVIL---------------------YILLCGVPP--FW 254
           YY APEV L   Y   +DIWS G I+                      I   G P   F 
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241

Query: 255 AESEQGVAQAIL-----RGL-ID--FKRDPWPNVSES--------AKSLVRQMLEPDPKL 298
           +  +  V   +       G   +  F    +P  SES        A+ L+ +ML  DP+ 
Sbjct: 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 299 RLTAKQVLEHPWL 311
           R++    L+HP++
Sbjct: 302 RISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 60/260 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY-----LCIDRDTRELLACKSISKR---KLRTAVDI 95
           +P   +  R+L   ELG G FG  Y        +R +   +A K++ +    K++     
Sbjct: 2   IPLSAV--RFL--EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ----- 52

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            + R+E  +M  L ++ +IV L   C  +    ++ E    G+L + +V    +++  A 
Sbjct: 53  QEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111

Query: 156 AVTRT----------------IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
           +   T                I   ++    H  +HRDL   N L         +K  DF
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDF 168

Query: 200 GLSIFFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-I 245
           GLS          +I  + YY            M PE +L   +  E DIWS GV+L+ I
Sbjct: 169 GLS---------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Query: 246 LLCGVPPFWAESEQGVAQAI 265
              G+ P++  S Q V + I
Sbjct: 220 FSYGLQPYYGFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 39/280 (13%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
            ELGRG +GV        T  ++A K I     S+ + R  +D+D   R V      P  
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV----DCPY- 61

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARG-HYTERAAAAVTRTIVEVVQLC 168
              V+   A   +  V + ME+ +    + + ++  +G    E     +  +IV+ ++  
Sbjct: 62  --TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 169 H-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           H K  VIHRD+KP N L  N+     +K  DFG+S +       +   G   YMAPE + 
Sbjct: 120 HSKLSVIHRDVKPSNVL-INRNGQ--VKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN 176

Query: 227 ----KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV 280
               ++ Y  + D+WS G+ +  L  G  P+  W    Q + Q +         +P P +
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPSPQL 228

Query: 281 SESAKSL-----VRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                S      V + L+ + K R    ++L+HP+ +   
Sbjct: 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 33/267 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--IVS 116
           LG G  G  Y      TR +LA K I    L   V++   ++ ++ ++ L K  S  I+ 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP---LDITVELQ--KQIMSELEILYKCDSPYIIG 63

Query: 117 LKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
              A   +N + +  E  +GG L  + +I    H   R A AV + +  +  L     ++
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYLWSL----KIL 117

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPE-VLKRN 229
           HRD+KP N L   + +   +K  DFG+S      +  + I    VG+  YMAPE +    
Sbjct: 118 HRDVKPSNMLVNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQ 169

Query: 230 YGPEIDIWSAGVILYILLCGVPPF-WAESEQG--VAQAILRGLIDFK--RDPWPNVSESA 284
           YG   D+WS G+    L  G  P+   +  QG  +   +L+ ++D      P    SE  
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              + Q +   PK R   + +++HP++
Sbjct: 230 VHFITQCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 72/317 (22%), Positives = 131/317 (41%), Gaps = 70/317 (22%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVS 116
           ++GRG +G  Y    +D ++    +  + +++  T + +   R E+A+++ L K+ +++S
Sbjct: 8   KVGRGTYGHVYKAKRKDGKD---DRDYALKQIEGTGISMSACR-EIALLREL-KHPNVIS 62

Query: 117 LKEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR--------TIVEVVQ 166
           L++      D  V L+ +  E          R     +    + R         I++ + 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 167 LCHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFF----KPGERFSEIVGSPYYM 221
             H + V+HRDLKP N L   +  E   +K  D G +  F    KP      +V + +Y 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPF-------------------------- 253
           APE+L   R+Y   IDIW+ G I   LL   P F                          
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242

Query: 254 ------WAESEQGVAQAILRGLIDFKRDPWPNVS-------------ESAKSLVRQMLEP 294
                 W + ++    + L  + DF+R+ + N S               A  L++++L  
Sbjct: 243 FPADKDWEDIKKMPEHSTL--MKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 300

Query: 295 DPKLRLTAKQVLEHPWL 311
           DP  R+T++Q ++ P+ 
Sbjct: 301 DPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 21/188 (11%)

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G  G  + CID  T E +  K+  +    T         E  I++ +  + SI+ LK   
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQRGGTAT---------EAHILRAI-NHPSIIQLKGTF 152

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE 181
             +    L++   +  +L+  + A+ +       A+ R+++  +Q  H++ +IHRD+K E
Sbjct: 153 TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAE 211

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKP----GERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           N +F N   +  L   DFG + F  P      ++    G+    APE+L R+ YGP +DI
Sbjct: 212 N-IFINHPGDVCLG--DFGAACF--PVDINANKYYGWAGTIATNAPELLARDPYGPAVDI 266

Query: 237 WSAGVILY 244
           WSAG++L+
Sbjct: 267 WSAGIVLF 274

Length = 391

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 58/255 (22%), Positives = 112/255 (43%), Gaps = 19/255 (7%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           +LG G++G  Y  + +     +A K++ +  +     +++  +E A+MK + K+ ++V L
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEI-KHPNLVQL 67

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVIH 175
              C  +   +++ E    G L D +         A   +     I   ++   K   IH
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN-YG 231
           RDL   N L     EN  +K  DFGLS     G+ ++   G+ +   + APE L  N + 
Sbjct: 128 RDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
            + D+W+ GV+L+ I   G+ P+       V + + +G   ++ +           L+R 
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCPPKVYELMRA 240

Query: 291 MLEPDPKLRLTAKQV 305
             + +P  R +  ++
Sbjct: 241 CWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 32/274 (11%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSSI 114
           E+GRG FG     + + +  ++A K I     R+ VD  + +R   ++ ++        I
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 115 VSLKEACEDDNAVHLVMELCEGG-ELFDRIV---ARGHYTERAAAAVTRTIVEVVQ-LCH 169
           V    A   +    + MEL +   + F + V    +    E     +    V+ +  L  
Sbjct: 66  VKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPE 224
           +  +IHRD+KP N L  ++  N  +K  DFG+S     G+    I      G   YMAPE
Sbjct: 126 ELKIIHRDVKPSNILL-DRNGN--IKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPE 177

Query: 225 VLKRN----YGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWP 278
            +  +    Y    D+WS G+ LY +  G  P+  W      + Q +             
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             S S  + +   L  D   R   K++LEHP+++
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 81/305 (26%), Positives = 132/305 (43%), Gaps = 61/305 (20%)

Query: 54  LVDRELGRGEFGVTYL------CIDRDTRELLACKSISKRKLRTAVD--IDDVRREVAIM 105
           ++ RELG G FG  +L      C ++D + L+A K+     L+ A D    D  RE  ++
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLCPEQD-KILVAVKT-----LKDASDNARKDFHREAELL 61

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-------------HYTER 152
            +L ++  IV     C + + + +V E  + G+L   + A G               T+ 
Sbjct: 62  TNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 153 AAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
               + + I   +V L  +H  +HRDL   N L     EN  +K  DFG+S         
Sbjct: 121 QMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVG---ENLLVKIGDFGMS--------- 167

Query: 212 SEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
            ++  + YY            M PE ++ R +  E D+WS GV+L+ I   G  P++  S
Sbjct: 168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
              V + I +G +  +    P   +    L+    + +P +RL  K++  H  LQN  KA
Sbjct: 228 NNEVIECITQGRVLQRPRTCP---KEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKA 282

Query: 318 PNVPL 322
             V L
Sbjct: 283 SPVYL 287

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV      + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 68

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +       E     V+  ++  +  L  KH ++HR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 128

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+  +Y 
Sbjct: 129 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180

Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  L  G   +PP
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 56/304 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           D Y    +LG G +   Y    +   +L+A K I  ++      TA+      RE +++K
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI------REASLLK 58

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVME-----LCEGGELFDRIVARGHYTERAAAAVTRTI 161
            L K+++IV L +       + LV E     LC+     D+    G             +
Sbjct: 59  GL-KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDK--HPGGLHPENVKLFLFQL 112

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYY 220
           +  +   H+  ++HRDLKP+N L ++  E   LK  DFGL+     P   +S  V + +Y
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWY 169

Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPW 277
             P+VL     Y   +D+W  G I   ++ GV  F    + Q   + I   L     D W
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229

Query: 278 PNVSE----------------------------SAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           P V                               A+ L  ++L+  PK RL+A+  L H 
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289

Query: 310 WLQN 313
           +  +
Sbjct: 290 YFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 77/299 (25%), Positives = 117/299 (39%), Gaps = 66/299 (22%)

Query: 51  DRYLVDRELGRGEFG----VTYLCIDRDTREL-LACKSISKRKLRTAVDIDDVRREVAIM 105
           DR  + + LG G FG       + +D       +A K +      T  D+ D+  E+ +M
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMM 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K + K+ +I++L   C  +  +++V+E    G L D + AR    E A+    R   E  
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE-- 127

Query: 166 QLCHKHGV------------------IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
            L  K  V                  IHRDL   N L     E+  +K  DFGL+     
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA----- 179

Query: 208 GERFSEIVGSPYY------------MAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                +I    YY            MAPE L  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 180 ----RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Query: 254 WAESEQGVAQAILRGLIDFKR-----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                 G+    +  L    +     +   N ++    L+R      P  R T KQ++E
Sbjct: 236 -----PGIP---VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 68/290 (23%), Positives = 112/290 (38%), Gaps = 43/290 (14%)

Query: 44  VPKENIEDRYLVDRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           VP+++I    L+ R LG G FG      Y   D D  EL      +  +  +  D  D  
Sbjct: 3   VPRDSIT---LL-RALGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFL 57

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E  IM     + +IV L     +     +++EL  GG+L   +       ER ++   +
Sbjct: 58  MEALIMSKF-NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116

Query: 160 TIV----EVVQLCH---KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
            ++    +V + C    ++  IHRD+   N L   K      K  DFG++          
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------R 167

Query: 213 EIVGSPYY------------MAPEV-LKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M PE  L   +  + D+WS GV+L+ I   G  P+   + 
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           Q V + +  G    + DP          ++    +  P+ R     +LE 
Sbjct: 228 QEVMEFVTGG---GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 64/261 (24%), Positives = 105/261 (40%), Gaps = 37/261 (14%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+E       ++R+LG G FG  +  + ++   + A K +   K    +   D ++EV  
Sbjct: 4   PREEFT----LERKLGSGYFGEVWEGLWKNRVRV-AIKIL---KSDDLLKQQDFQKEVQA 55

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT---- 160
           +K L ++  ++SL   C     V+++ EL E G L         +       V       
Sbjct: 56  LKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASLI 107

Query: 161 -----IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
                + E +    +   IHRDL   N L     E+   K  DFGL+   K     S   
Sbjct: 108 DMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLSSDK 164

Query: 216 GSPY-YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDF 272
             PY + APE      +  + D+WS G++LY +   G  P+   +   V   I  G    
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--- 221

Query: 273 KRDPWPNVSESAKSLVRQMLE 293
            R P P  ++  + + + MLE
Sbjct: 222 -RMPCP--AKCPQEIYKIMLE 239

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 63/301 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYL--C---IDRDTRELLACKSISKRKLRTAVDIDDV 98
           V ++ I    ++ RELG G FG  +L  C      + +EL+A K++ +     A    D 
Sbjct: 2   VQRDTI----VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK--DF 55

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
            RE  ++ +  ++ +IV     C + +   +V E  E G+L      R H  + A     
Sbjct: 56  EREAELLTNF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK--FLRSHGPDAAFLKSP 112

Query: 159 R------TIVEVVQ-----------LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
                  T+ +++Q           L  +H V HRDL   N L      +  +K  DFG+
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG---YDLVVKIGDFGM 168

Query: 202 SIFFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILL 247
           S          ++  + YY            M PE ++ R +  E D+WS GV+L+ I  
Sbjct: 169 S---------RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Query: 248 CGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G  P++  S + V + I +G L+   R     V +    ++    + DP+ R+  K + 
Sbjct: 220 YGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYD----IMLGCWKRDPQQRINIKDIH 275

Query: 307 E 307
           E
Sbjct: 276 E 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNID 191

Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251

Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 252 LKEG---HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 73/316 (23%), Positives = 127/316 (40%), Gaps = 68/316 (21%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++GRG +G  Y    +D ++    K  + +++          RE+A+++ L K+ ++++L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMSACREIALLREL-KHPNVIAL 63

Query: 118 KEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV--------VQL 167
           ++      D  V L+ +  E          R     +    + R++V+         +  
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 168 CHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFF----KPGERFSEIVGSPYYMA 222
            H + V+HRDLKP N L   +  E   +K  D G +  F    KP      +V + +Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF--------------------------- 253
           PE+L   R+Y   IDIW+ G I   LL   P F                           
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Query: 254 -----WAESEQGVAQAILRGLIDFKRDPWPNVS-----ESAKS--------LVRQMLEPD 295
                W +  +      L+   DF+R  + N S     E  K         L++++L  D
Sbjct: 244 PADKDWEDIRKMPEYPTLQK--DFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301

Query: 296 PKLRLTAKQVLEHPWL 311
           P  R+T++Q L+ P+ 
Sbjct: 302 PTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 44/222 (19%)

Query: 50  EDRYLVD-RELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           E+R+L   ++LG+G FG   LC    +  +T E++A K   K +  TA  + D  RE+ I
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEI 58

Query: 105 MKHLPKNSSIVSLKEAC--EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +K L ++ +IV  K  C       + LVME    G L D +       +       + ++
Sbjct: 59  LKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH-----RKLLL 112

Query: 163 EVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF----------K 206
              Q+C           +HRDL   N L  ++   + +K  DFGL+             +
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVRE 169

Query: 207 PGERFSEIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYIL 246
           PGE       SP ++ APE L  + +    D+WS GV+LY L
Sbjct: 170 PGE-------SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 76/259 (29%), Positives = 108/259 (41%), Gaps = 37/259 (14%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
            +GRG FG  +    R     +A KS   R+           +E  I+K    + +IV L
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQY-SHPNIVRL 58

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARG---------HYTERAAAAVTRTIVEVVQLC 168
              C     +++VMEL +GG+    +   G            E AAA +         L 
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME-------YLE 111

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPY-YMAPEV 225
            KH  IHRDL   N L     E + LK  DFG+S   + G   S   +   P  + APE 
Sbjct: 112 SKH-CIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167

Query: 226 LKRNYG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NV 280
           L  NYG    E D+WS G++L+     G  P+   S Q   +AI +G+    R P P   
Sbjct: 168 L--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----RLPCPELC 221

Query: 281 SESAKSLVRQMLEPDPKLR 299
            ++   L+ +  E DP  R
Sbjct: 222 PDAVYRLMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE- 213
            AV R ++  +   H  G+IHRD+K EN +  N  E+  L   DFG + F + G   +  
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFAR-GSWSTPF 318

Query: 214 ---IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY 244
              I G+    APEVL  + Y P +DIWSAG++++
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 56/201 (27%), Positives = 82/201 (40%), Gaps = 25/201 (12%)

Query: 58  ELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +LG G FGV    + R            +A K +   KL     +DD  +E AIM  L  
Sbjct: 2   KLGDGSFGV----VRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSL-D 54

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTRTIVEVVQLC 168
           + +++ L         + +V EL   G L DR+   A GH+           I   ++  
Sbjct: 55  HENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPY-YMAPE 224
                IHRDL   N L A+  +   +K  DFGL       E      E +  P+ + APE
Sbjct: 114 ESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 225 VLK-RNYGPEIDIWSAGVILY 244
            L+ R +    D+W  GV L+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLW 191

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 71/280 (25%), Positives = 106/280 (37%), Gaps = 52/280 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----DIDDVRR----- 100
           +   + R +G G+FG  Y  +           S    K+  AV           R     
Sbjct: 6   EDITLGRCIGEGQFGDVYQGV---------YMSPENEKIAVAVKTCKNCTSPSVREKFLQ 56

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY--TERAAAAVT 158
           E  IM+    +  IV L     ++  V +VMEL   GEL         Y    + +  + 
Sbjct: 57  EAYIMRQF-DHPHIVKLIGVITEN-PVWIVMELAPLGEL-------RSYLQVNKYSLDLA 107

Query: 159 RTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSP--LKAIDFGLSIFFKPGER 210
             I+   QL            +HRD+   N L +     SP  +K  DFGLS + +    
Sbjct: 108 SLILYSYQLSTALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESY 162

Query: 211 FSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
           +    G  P  +MAPE +  R +    D+W  GV ++ IL+ GV PF       V   I 
Sbjct: 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE 222

Query: 267 RGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQV 305
            G    +R P P N   +  SL+ +    DP  R    ++
Sbjct: 223 NG----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 69/261 (26%), Positives = 107/261 (40%), Gaps = 38/261 (14%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R+LG G+FG  +  +  +T  +    ++   K  T  D  D   E  IMK L ++  ++ 
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPV----AVKTLKPGTM-DPKDFLAEAQIMKKL-RHPKLIQ 65

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARG-------HYTERAA-AAVTRTIVEVVQLC 168
           L   C  +  +++V EL + G L + +              + AA  A     +E     
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----- 120

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEV 225
                IHRDL   N L     EN+  K  DFGL+   K    +    G+ +   + APE 
Sbjct: 121 -AQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEA 175

Query: 226 LKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
              N +  + D+WS G++L  I+  G  P+   +   V Q + +G     R P P     
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY----RMPCP--PGC 229

Query: 284 AKSLVRQMLE---PDPKLRLT 301
            K L   ML+    DP  R T
Sbjct: 230 PKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 36/285 (12%)

Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIM 105
           DR ++ + LG G FG         ID+   +     ++   K   T  D+ D+  E+ +M
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K + K+ +I++L   C  +  +++++E    G L + + AR          +T+   E  
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-- 129

Query: 166 QLCHKHGV------------------IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
           QL  K  V                  IHRDL   N L     E++ +K  DFGL+     
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHD 186

Query: 208 GERFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
            + + +         +MAPE L  R Y  + D+WS G++++ I   G  P+     + + 
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           + +  G    + D   N +     L+R+     P  R T KQ++E
Sbjct: 247 KLLREG---HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLC--IDRDTRELLACKSISKRKLR---TAVDIDDVRREVAIM 105
           DR ++ + LG G FG   +   I  D  +      ++ + L+   T  D+ D+  E+ +M
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG------HYTERAAAAVTR 159
           K + K+ +I++L  AC  D  +++++E    G L + + AR        Y          
Sbjct: 78  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 160 TIVEVVQLCHK----------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           +  ++V   ++             IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 194

Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254

Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 255 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 31/204 (15%)

Query: 57  RELGRGEFGVTYLCI--DRDTREL-LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           +ELG G FG     +   +  +E+ +A K++ +  +       +  RE ++M  L  +  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQL-DHPC 57

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           IV L   C+ +  + LVMEL   G L   +  R          +   +   +        
Sbjct: 58  IVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK---RNY 230
           +HRDL   N L  N+ +    K  DFG+S             GS YY A    +   + Y
Sbjct: 117 VHRDLAARNVLLVNRHQ---AKISDFGMSRALGA--------GSDYYRATTAGRWPLKWY 165

Query: 231 GPEI----------DIWSAGVILY 244
            PE           D+WS GV L+
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLW 189

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 44/199 (22%)

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             A  + + I+E ++  H   +IHRD+K EN +F N  +   +   D G + F      F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTEN-IFINDVDQVCIG--DLGAAQFPVVAPAF 213

Query: 212 SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC------GVPPFWAESEQGVAQA 264
             + G+    APEVL R+ Y  + DIWSAG++L+ +L         PP   E       +
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273

Query: 265 ILRGLI--------DFKRDP---------------------WP-----NVSESAKSLVRQ 290
            L  +I        +F RDP                     +P     N+    + LV +
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333

Query: 291 MLEPDPKLRLTAKQVLEHP 309
           ML  D  +R +A+++L +P
Sbjct: 334 MLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 21/254 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+GEFG   L   R  +  +A K + K     A        E ++M  L ++ ++V L 
Sbjct: 14  IGKGEFGDVMLGDYRGQK--VAVKCL-KDDSTAA---QAFLAEASVMTTL-RHPNLVQLL 66

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
                 N +++V E    G L D + +RG    T          + E ++   +   +HR
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEI 234
           DL   N L +   E+   K  DFGL+   K   +  +    P  + APE L+   +  + 
Sbjct: 127 DLAARNVLVS---EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 235 DIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
           D+WS G++L+ I   G  P+     + V   + +G   ++ +           +++   E
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEGCPPEVYKVMKDCWE 237

Query: 294 PDPKLRLTAKQVLE 307
            DP  R T KQ+ E
Sbjct: 238 LDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 26/228 (11%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +Y +   L  G  G  ++C       R+ +  K+++  K           RE+ I+K + 
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTI- 143

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            + +I++L  A    + V +VM   +  +LF  +   G      A  + R ++E +   H
Sbjct: 144 SHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLH 202

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-----IVGSPYYMAPE 224
             G+IHRD+K EN +F ++ EN+ L   DFG +   K              G+    +PE
Sbjct: 203 GRGIIHRDVKTEN-IFLDEPENAVLG--DFGAAC--KLDAHPDTPQCYGWSGTLETNSPE 257

Query: 225 VLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
           +L  + Y  + DIWSAG++L+ + +  V  F  + +   +Q  LR +I
Sbjct: 258 LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ--LRSII 303

Length = 392

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 36/284 (12%)

Query: 52  RYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLR---TAVDIDDVRREVAI 104
           R  + + LG G FG   +     ID+D        +++ + L+   T  D+ D+  E+ +
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPN--KPVTVAVKMLKDDATDKDLSDLVSEMEM 70

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GH 148
           MK + K+ +I++L  AC  D  +++++E    G L + + AR                  
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 149 YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            T +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNI 187

Query: 209 ERFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           + + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + +
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
            +  G    + D   N +     ++R+     P  R T KQ++E
Sbjct: 248 LLKEG---HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 36/234 (15%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD------IDDVRR----EVAI 104
           +++ +G GEFG   +C  R        K   KR++  A+        +  RR    E +I
Sbjct: 8   IEKVIGAGEFG--EVCSGR-------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI 58

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +  G +T      + R I 
Sbjct: 59  MGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFK--PGERFSEIVGS- 217
             ++     G +HRDL   N L      NS L  K  DFGLS   +  P   ++   G  
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILV-----NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171

Query: 218 PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
           P  + APE +  R +    D+WS G++++ ++  G  P+W  S Q V +AI  G
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 53/253 (20%)

Query: 54  LVDRELGRGEFGVTYL--CID---RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           ++ RELG G FG  +L  C +      + L+A K++    L       D +RE  ++ +L
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNL 64

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT-----------------E 151
            ++  IV     C D + + +V E  + G+L   + A G                     
Sbjct: 65  -QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           +     ++    +V L  +H  +HRDL   N L      N  +K  DFG+S         
Sbjct: 124 QMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGA---NLLVKIGDFGMS--------- 170

Query: 212 SEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
            ++  + YY            M PE ++ R +  E D+WS GVIL+ I   G  P++  S
Sbjct: 171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230

Query: 258 EQGVAQAILRGLI 270
              V + I +G +
Sbjct: 231 NTEVIECITQGRV 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 14/219 (6%)

Query: 58  ELGRGEFGVTYLCI--DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           ELG G FG     +   + + + +A K I K         D++ RE  +M+ L  N  IV
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQL-DNPYIV 59

Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +   CE ++ + LVMEL E G L   +    H TE+    +   +   ++   +   +H
Sbjct: 60  RMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS---PY-YMAPEVLK-RNY 230
           RDL   N L   +      K  DFGLS      E + +       P  + APE +    +
Sbjct: 119 RDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 231 GPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
             + D+WS GV+++     G  P+       V Q I  G
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 22/192 (11%)

Query: 125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH------KHGVIHRDL 178
           N +++VMEL   G L + +  RG    RA  +V + +   + +           ++HRDL
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDI 236
              N L +   E+   K  DFGL+   + G    +    P  + APE LK   +  + D+
Sbjct: 127 AARNILVS---EDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180

Query: 237 WSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           WS GV+L+ +   G  P+   S + V + + +G   ++ +P          L+    E +
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETE 237

Query: 296 PKLRLTAKQVLE 307
           PK R +  ++ E
Sbjct: 238 PKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 75/307 (24%), Positives = 124/307 (40%), Gaps = 63/307 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKR-KLRTAVDI 95
           V +E I     + RELG+G FG+ Y    RD       TR  +A K++++   LR  ++ 
Sbjct: 3   VSREKIT----LLRELGQGSFGMVYEGNARDIIKGEAETR--VAVKTVNESASLRERIEF 56

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            +   E ++MK    +  +V L           +VMEL   G+L   + +     E    
Sbjct: 57  LN---EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 156 AVTRTIVEVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
               T+ E++Q+           +    +HRDL   N + A    +  +K  DFG++   
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT--- 166

Query: 206 KPGERFSEIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVP 251
                  +I  + YY            MAPE LK   +    D+WS GV+L+ I      
Sbjct: 167 ------RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 220

Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE---- 307
           P+   S + V + ++ G      D   N  E    L+R   + +PK+R T  +++     
Sbjct: 221 PYQGLSNEQVLKFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Query: 308 --HPWLQ 312
             HP   
Sbjct: 278 DLHPSFP 284

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 50/278 (17%)

Query: 59  LGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           LGRGEFG  +L       +     L+  K++ K K        + RRE+ + + L  + +
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKL-SHKN 69

Query: 114 IVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTRTIVEVV-QLCH- 169
           +V L   C +    ++++E  + G+L  F R         +     T+  V +  Q+   
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 170 -----KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY---- 220
                    +HRDL   N L ++++E   +K     LS          ++  S YY    
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLS---------KDVYNSEYYKLRN 177

Query: 221 -------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
                  +APE V + ++  + D+WS GV+++ +   G  PF+  S++ V   +  G ++
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237

Query: 272 FKRDPWPNVSESAKSLVRQMLE---PDPKLRLTAKQVL 306
                 P        L + M      +PK R +  +++
Sbjct: 238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 64/242 (26%), Positives = 94/242 (38%), Gaps = 61/242 (25%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------DIDDVRR----EVAIMK 106
            ++G+G FG  Y             K + K     AV         D++R    E  I+K
Sbjct: 1   EKIGKGNFGDVY-------------KGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILK 47

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
               + +IV L   C     +++VMEL  GG L         +  +    +  T+ +++Q
Sbjct: 48  QY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRL--TVKKLLQ 97

Query: 167 LC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           +                IHRDL   N L     EN+ LK  DFG+S   +  E     V 
Sbjct: 98  MSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVS 151

Query: 217 S-----PY-YMAPEVLKRNYG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAIL 266
                 P  + APE L  NYG    E D+WS G++L+     G  P+   S Q   + I 
Sbjct: 152 DGLKQIPIKWTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE 209

Query: 267 RG 268
            G
Sbjct: 210 SG 211

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 48.7 bits (117), Expect = 7e-08
 Identities = 18/43 (41%), Positives = 28/43 (65%)

Query: 358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +++E F+  D D DG +S DELKA L++ G  L+E E+  +I 
Sbjct: 1   ELREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIR 43

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 35/233 (15%)

Query: 55  VDRELGRGEFGVTY---LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +++ +G GEFG      L +       +A K++  +   +     D   E +IM     +
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQF-DH 64

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +I+ L+        V ++ E  E G L  F R    G +T      + R I   ++   
Sbjct: 65  PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 170 KHGVIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPY-------- 219
           +   +HRDL   N L      NS L  K  DFGLS       R  E   + Y        
Sbjct: 124 EMNYVHRDLAARNILV-----NSNLVCKVSDFGLS-------RRLEDSEATYTTKGGKIP 171

Query: 220 --YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
             + APE +  R +    D+WS G++++ ++  G  P+W  S Q V +A+  G
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 47/229 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYL-----CIDRDTRELLACKSISKRKLRTAVDIDDV 98
           +P+E I     + RELG+G FG+ Y       +  +    +A K++++    +  +  + 
Sbjct: 3   LPREKIT----LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEF 56

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E ++MK    +  +V L           +VMEL   G+L   + +R    E       
Sbjct: 57  LNEASVMKEFNCHH-VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 159 RTIVEVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            T+ + +Q+                +HRDL   N + A   E+  +K  DFG++      
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT------ 166

Query: 209 ERFSEIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY 244
               +I  + YY            MAPE LK   +  + D+WS GV+L+
Sbjct: 167 ---RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 28/223 (12%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG  +    +D +  +A K+  K  L   + I  +  E  I+K    + +IV L 
Sbjct: 3   LGKGNFGEVFKGTLKD-KTPVAVKT-CKEDLPQELKIKFLS-EARILKQY-DHPNIVKLI 58

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLCHKHGVIH 175
             C     +++VMEL  GG+    +  R    E     + +  ++    +        IH
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLS------IFFKPGERFSEIVGSPYYMAPEVLKRN 229
           RDL   N L     EN+ LK  DFG+S      I+   G +   I     + APE L  N
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPI----KWTAPEAL--N 167

Query: 230 YG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
           YG    E D+WS G++L+     GV P+   + Q   + + +G
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 16/219 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV      R   + +A K I +  +      D+   E  +M  L  +  +V 
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMKL-SHEKLVQ 63

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA-AAVTRTIVEVVQLCHKHGVIH 175
           L   C     +++V E    G L + +   G   + +    + + + E +        IH
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKR-NYG 231
           RDL   N L     +   +K  DFGLS +    E  S  VGS +   +  PEVL    + 
Sbjct: 124 RDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFS 179

Query: 232 PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
            + D+W+ GV+++ +   G  P+   +     + + +GL
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL 218

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 18/164 (10%)

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVT 158
           E+ IM HL  + +IV+L  AC     + ++ E C  G+L +  R       T     + +
Sbjct: 88  ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-------SIFFKPGERF 211
             + + +        IHRDL   N L  + K    +K  DFGL       S +   G   
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNYVVKGNAR 204

Query: 212 SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
             +     +MAPE +    Y  E D+WS G++L+ I   G  P+
Sbjct: 205 LPV----KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 36/244 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKS---------ISKRKLRTAVDI---DDV 98
            +  +  +LG G+FG  +LC      E L   +         ++ + LR  V     +D 
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA--- 155
            +E+ IM  L KN +I+ L   C  D+ + ++ E  E G+L   +  R   +    A   
Sbjct: 65  LKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 156 -AVTRT--------IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
            +V+          I   ++       +HRDL   N L  N   +  +K  DFG+S    
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLY 180

Query: 207 PGERFSEIVGSPY----YMAPE-VLKRNYGPEIDIWSAGVILY--ILLCGVPPFWAESEQ 259
            G+ +  I G       +MA E +L   +    D+W+ GV L+    LC   P+   S++
Sbjct: 181 SGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239

Query: 260 GVAQ 263
            V +
Sbjct: 240 QVIE 243

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 59/271 (21%), Positives = 114/271 (42%), Gaps = 24/271 (8%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N+++  L+ + +G+GEFG   L   R  +  + C       ++          E ++M  
Sbjct: 4   NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 55

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVV 165
           L  ++ +  L    E+   +++V E    G L D + +RG         +  +  + E +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPE 224
           +    +  +HRDL   N L +   E++  K  DFGL+   K      +    P  + APE
Sbjct: 116 EYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPE 169

Query: 225 VLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
            L+ + +  + D+WS G++L+ I   G  P+     + V   + +G   +K D       
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPP 226

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
               +++Q    D   R +  Q+ E   L++
Sbjct: 227 VVYDVMKQCWHLDAATRPSFLQLRE--QLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 57/234 (24%), Positives = 108/234 (46%), Gaps = 25/234 (10%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+I+    + ++LG G+FG  ++    ++ ++ A K++        + +     E  
Sbjct: 3   IPRESIK----LVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKP----GTMSVQAFLEEAN 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTI 161
           +MK L ++  +V L      +  ++++ E    G L D + +   G          +  I
Sbjct: 54  LMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI 112

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L +   E+   K  DFGL+   +  E ++   G+ +  
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPI 168

Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + APE +  N+G    + D+WS G++LY I+  G  P+   S   V  A+ RG
Sbjct: 169 KWTAPEAI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 45/250 (18%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACK---SISK-RKLRTAVDI----------DD 97
             L   +LG G+FG  +LC   + ++L   +   ++ K R L  AV I          +D
Sbjct: 6   HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65

Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA- 156
             +EV I+  L K+ +I+ L   C D++ + ++ E  E G+L ++ ++  H  ++     
Sbjct: 66  FLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGN 123

Query: 157 -------------------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                              V   I   ++       +HRDL   N L     EN  +K  
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIA 180

Query: 198 DFGLSIFFKPGERF---SEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILY--ILLCGVP 251
           DFG+S     G+ +      V    +MA E +L   +    D+W+ GV L+  ++LC   
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240

Query: 252 PFWAESEQGV 261
           P+   +++ V
Sbjct: 241 PYGELTDEQV 250

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 50/244 (20%)

Query: 96  DDVRREVAIMKHLPKNS---------------SIVSLKEACEDDNAVHLVMELCEGGELF 140
           D   ++  I+K L K+S               ++V L +    +++V LV++  EGG+L+
Sbjct: 14  DTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73

Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
             I    +  E         +V  +   H+ G++ RDL P N L  ++            
Sbjct: 74  SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--------IQ 125

Query: 201 LSIFFKPGERFSEIVGS-------PYYMAPEVLKRNYGPE-IDIWSAGVILYILLCGVPP 252
           L+ F     R+SE+  S         Y APEV   +   E  D WS G IL+ LL G   
Sbjct: 126 LTYF----SRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKT- 180

Query: 253 FWAESE-QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTA-----KQVL 306
              E    G+       + ++       VSE A+SL++Q+L+ +P  RL A     + + 
Sbjct: 181 -LVECHPSGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232

Query: 307 EHPW 310
            HP+
Sbjct: 233 SHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 49/212 (23%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAIMKH 107
           ELG G FG    C+ +   ++       K+++  A+ +          D++ RE  IM  
Sbjct: 2   ELGSGNFG----CVKKGVYKM------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ 51

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  N  IV +   CE + A+ LVME+  GG L   +  +             T+  VV+L
Sbjct: 52  L-DNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGKKD---------EITVSNVVEL 100

Query: 168 CHK----------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIV 215
            H+             +HRDL   N L  N+      K  DFGLS      + +  +   
Sbjct: 101 MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY---AKISDFGLSKALGADDSYYKARSA 157

Query: 216 GS-PY-YMAPE-VLKRNYGPEIDIWSAGVILY 244
           G  P  + APE +  R +    D+WS G+ ++
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 72/285 (25%), Positives = 127/285 (44%), Gaps = 39/285 (13%)

Query: 59  LGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           +G G FG V    I +D  ++ A   + K +  +  D  D   E+ ++  L  + +I++L
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 118 KEACEDDNAVHLVMELCEGGELFD-----RIV------ARGHYTERAAAAVTRTIVEV-- 164
             ACE+   +++ +E    G L D     R++      A+ H T  A+   ++ +++   
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT--ASTLTSQQLLQFAS 126

Query: 165 -----VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGS 217
                +Q   +   IHRDL   N L     EN   K  DFGLS     GE     + +G 
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS----RGEEVYVKKTMGR 179

Query: 218 -PY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFK 273
            P  +MA E L  + Y  + D+WS GV+L+ I+  G  P+   +   + + + +G   ++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YR 236

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV-LEHPWLQNAKKA 317
            +   N  +    L+RQ     P  R    Q+ ++   +  A+KA
Sbjct: 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 30/268 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+++    ++R+LG G+FG  ++     T ++ A K++        +  +   +E  
Sbjct: 3   IPRESLK----LERKLGAGQFGEVWMGTWNGTTKV-AVKTLKP----GTMSPEAFLQEAQ 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTI 161
           IMK L ++  +V L   C ++  +++V E    G L D + +      R    V     I
Sbjct: 54  IMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +        IHRDL   N L     EN   K  DFGL+   +  E ++   G+ +  
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPI 168

Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE    NYG    + D+WS G++L  I+  G  P+   + + V + + RG     R
Sbjct: 169 KWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----R 222

Query: 275 DPWP-NVSESAKSLVRQMLEPDPKLRLT 301
            P P N  E    L+ Q  + DP+ R T
Sbjct: 223 MPRPPNCPEELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 46/252 (18%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY------LCIDRDTRELLACKSISKRKLRTAVDID- 96
            P+ NIE  Y+  R++G+G FG  +      L        ++A K +   K   + D+  
Sbjct: 2   YPRNNIE--YV--RDIGQGAFGRVFQARAPGLLPYEP-FTMVAVKML---KEEASADMQA 53

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D +RE A+M     + +IV L   C     + L+ E    G+L + +  R    + + + 
Sbjct: 54  DFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112

Query: 157 VTRT----------IVEVVQLCHKHGV------------IHRDLKPENFLFANKKENSPL 194
            T +          +    QLC    V            +HRDL   N L     EN  +
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVV 169

Query: 195 KAIDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCG 249
           K  DFGLS  I+     + SE    P  +M PE +    Y  E D+W+ GV+L+ I   G
Sbjct: 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229

Query: 250 VPPFWAESEQGV 261
           + P++  + + V
Sbjct: 230 MQPYYGMAHEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 47/283 (16%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKR-KLRTAVDI 95
           V +E I     + RELG+G FG+ Y  I +       +TR  +A K++++   +R  ++ 
Sbjct: 3   VAREKIT----MSRELGQGSFGMVYEGIAKGVVKDEPETR--VAIKTVNEAASMRERIEF 56

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            +   E ++MK       +V L           ++MEL   G+L   + +     E    
Sbjct: 57  LN---EASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 112

Query: 156 AVTRTIVEVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--- 202
               ++ +++Q+           + +  +HRDL   N + A   E+  +K  DFG++   
Sbjct: 113 QAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDI 169

Query: 203 ----IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAE 256
                + K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   
Sbjct: 170 YETDYYRKGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225

Query: 257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
           S + V + ++ G +  K D  P++      L+R   + +PK+R
Sbjct: 226 SNEQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 27/266 (10%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E++     +D +LG+G FG  ++     T ++ A K++    +     +     E  
Sbjct: 3   IPRESLR----LDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQ 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAA-VTRTI 161
           IMK L ++  +V L  A   +  +++V E    G L D +    G Y +      +   I
Sbjct: 54  IMKKL-RHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI 111

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            + +    +   IHRDL+  N L     +N   K  DFGL+   +  E ++   G+ +  
Sbjct: 112 ADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPI 167

Query: 220 -YMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP 276
            + APE  L   +  + D+WS G++L  L+  G  P+     + V + + RG     R P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY----RMP 223

Query: 277 WPN-VSESAKSLVRQMLEPDPKLRLT 301
            P    ES   L++   + DP  R T
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 65/246 (26%), Positives = 97/246 (39%), Gaps = 52/246 (21%)

Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++ +       D    +RE  ++  L ++ 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELLTVL-QHQ 67

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGEL--FDR-------------IVARGHYTERAAAAV 157
            IV     C +   + +V E    G+L  F R              VA G  T     A+
Sbjct: 68  HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 158 TRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
              I   +V L   H  +HRDL   N L     +   +K  DFG+S          +I  
Sbjct: 128 ASQIASGMVYLASLH-FVHRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYS 174

Query: 217 SPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
           + YY            M PE +L R +  E DIWS GV+L+ I   G  P++  S     
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234

Query: 263 QAILRG 268
           + I +G
Sbjct: 235 ECITQG 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 59/305 (19%)

Query: 51  DRYLVDRELGRGEFGVTYLC--------IDRDTRELLACKS---ISKRKLRTAVDID--- 96
            R     +LG G+FG  +LC        +D+D    ++      ++ + LR   + +   
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D  +E+ IM  L K+ +I+ L   C   + + ++ E  E G+L ++ ++R H  + AA  
Sbjct: 65  DFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEK 121

Query: 157 VTRTIVEVVQLCHKHGVI-------------HRDLKPENFLFANKKENSPLKAIDFGLSI 203
                +    L      I             HRDL   N L     +N  +K  DFG+S 
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSR 178

Query: 204 FFKPGERFSEIVGSPY----YMAPE-VLKRNYGPEIDIWSAGVILY--ILLCGVPPFWAE 256
               G+ +  I G       +M+ E +L   +    D+W+ GV L+  + LC   P+   
Sbjct: 179 NLYSGD-YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237

Query: 257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA 314
           S++ V +               N  E  +   RQ+  P P L      K +L   W +NA
Sbjct: 238 SDEQVIE---------------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLS-CWRRNA 281

Query: 315 KKAPN 319
           K+ P+
Sbjct: 282 KERPS 286

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 46/241 (19%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI---DDVRREVAIMKHLPKNSSI 114
           ELG   FG  Y      T      ++++ + L+   +    ++ + E A+M+   ++ +I
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE-AMMRSRLQHPNI 70

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI---VEVVQLCH-- 169
           V L      +  + ++   C   +L + +V R  +++  +    +T+   +E     H  
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 170 -----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
                       H V+H+DL   N L  +K     +K  D GL         F E+  + 
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL---------FREVYAAD 178

Query: 219 YY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
           YY            M+PE ++   +  + DIWS GV+L+ +   G+ P+   S Q V + 
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238

Query: 265 I 265
           I
Sbjct: 239 I 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 50/243 (20%)

Query: 58  ELGRGEFGVTY----LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ELG   FG  Y         D  +L+A K++  + +       + ++E ++M  L  + +
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAEL-HHPN 68

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA----------------- 156
           IV L      +  V ++ E    G+L + ++ R  +++   ++                 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           +   I   ++    H  +H+DL   N L     E   +K  D GLS          EI  
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLS---------REIYS 176

Query: 217 SPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
           + YY            M PE ++   +  + DIWS GV+L+ I   G+ P++  S Q V 
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236

Query: 263 QAI 265
           + +
Sbjct: 237 EMV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 55/235 (23%), Positives = 110/235 (46%), Gaps = 28/235 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++    +     +     E 
Sbjct: 3   IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLA----EA 52

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 53  NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY- 219
           I E +    +   IHRDL+  N L +    +   K  DFGL+   +  E ++   G+ + 
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFP 166

Query: 220 --YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
             + APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG
Sbjct: 167 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 46.8 bits (111), Expect = 9e-06
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 35/279 (12%)

Query: 57  RELGRGEFGV---TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK--HLPKN 111
           R LG+GEFG      L  +  + + +A K + K  + ++ DI++  RE A MK    P  
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNV 63

Query: 112 SSI--VSLKEACEDDNAVHLV-MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             +  VSL+   +    + +V +   + G+L   ++      E     +   +  ++ + 
Sbjct: 64  IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 169 ------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY--- 219
                      IHRDL   N +     EN  +   DFGLS     G+ + +   S     
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA-ILRGLIDFKR-- 274
           ++A E L  N Y    D+W+ GV ++ I+  G  P+      GV  + I   LI   R  
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLIKGNRLK 235

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPW 310
            P P+  E    L+ Q   P+PK R +    +  LE  W
Sbjct: 236 QP-PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 38/272 (13%)

Query: 59  LGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           +G G FG V    I +D   + A     K +  +  D  D   E+ ++  L  + +I++L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 118 KEACEDDNAVHLVMELCEGGELFD-----RIV------ARGHYTERAAAAVTRTIVEV-- 164
             ACE    ++L +E    G L D     R++      A  + T  A+   ++ ++    
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST--ASTLSSQQLLHFAA 119

Query: 165 -----VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGS 217
                +    +   IHRDL   N L     EN   K  DFGLS     G+     + +G 
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYVKKTMGR 172

Query: 218 --PYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFK 273
               +MA E L  + Y    D+WS GV+L+ I+  G  P+   +   + + + +G   ++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YR 229

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
            +   N  +    L+RQ     P  R +  Q+
Sbjct: 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain

 Score = 41.8 bits (99), Expect = 1e-05
 Identities = 13/30 (43%), Positives = 20/30 (66%)

Query: 358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFG 387
           +++E FK  D D DG +S +EL+  LR+ G
Sbjct: 1   ELREAFKLFDKDGDGYISAEELRKALRSLG 30

Length = 30

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 46/277 (16%)

Query: 59  LGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSSI 114
           +G G FG V    I +D   + A    + ++++     DD R    E+ ++  L  + +I
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDA----AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRT--IVEVVQLCH-- 169
           ++L  ACE    ++L +E    G L D +  +R   T+ A A    T   +   QL H  
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 170 -----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
                      +   IHRDL   N L     EN   K  DFGLS       R  E+    
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RGQEVYVKK 180

Query: 219 Y-------YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
                   +MA E L  + Y    D+WS GV+L+ I+  G  P+   +   + + + +G 
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 239

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
             ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 240 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

 Score = 44.6 bits (106), Expect = 1e-05
 Identities = 18/50 (36%), Positives = 33/50 (66%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           L+ E+++++KE F+  D D+DG++  +EL   LR+ G   +E+E+  L E
Sbjct: 14  LTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFE 63

Length = 160

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 19/118 (16%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
           R+ RT       RRE  I+    +    V +    + DN + +VME  EG  L D     
Sbjct: 42  RRERT-------RREARILAKAREAGVPVPIVYDVDPDNGL-IVMEYIEGELLKD----- 88

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
               E A   + R +  +V   HK G++H DL   N + +  +    +  IDFGL  F
Sbjct: 89  --ALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEF 140

Length = 204

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)

Query: 59  LGRGEFGVTYLCI---DRDTREL-LACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSS 113
           LG G FG  +  I   + D+ ++ +A K+I  R  R T  +I D    +  + H    + 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDH----AY 70

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC----- 168
           IV L   C    ++ LV +L   G L D +  R H   R +    R +   VQ+      
Sbjct: 71  IVRLLGICPG-ASLQLVTQLSPLGSLLDHV--RQH---RDSLDPQRLLNWCVQIAKGMYY 124

Query: 169 -HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
             +H ++HR+L   N L    K +S ++  DFG++    P ++   +SE      +MA E
Sbjct: 125 LEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 225 -VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
            +L   Y  + D+WS GV ++ ++  G  P+       V   + +G    +R   P +
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG----ERLAQPQI 235

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 40.1 bits (95), Expect = 3e-05
 Identities = 12/29 (41%), Positives = 18/29 (62%)

Query: 358 DIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
           ++KE FK+ D D DG +S +E K  L+  
Sbjct: 1   ELKEAFKEFDKDGDGKISFEEFKELLKKL 29

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif

 Score = 39.7 bits (94), Expect = 5e-05
 Identities = 10/29 (34%), Positives = 16/29 (55%)

Query: 358 DIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
           ++KE F+  D D DG +  +E K  L+  
Sbjct: 1   ELKEAFRLFDKDGDGKIDFEEFKDLLKAL 29

EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29

>gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 20/46 (43%), Positives = 29/46 (63%), Gaps = 1/46 (2%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV-QMLIEA 401
           E+IKE FK  D D +G +S  EL+  + N G +L + EV +M+ EA
Sbjct: 84  EEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREA 129

Length = 149

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 31/268 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV + LG G+FG  ++       ++ A KS+ +     ++  +    E  
Sbjct: 3   VPRETLK---LVKK-LGAGQFGEVWMGYYNGHTKV-AIKSLKQ----GSMSPEAFLAEAN 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGH-YTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +    G   T      +   I
Sbjct: 54  LMKQL-QHPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI 111

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L +   E    K  DFGL+   +  E ++   G+ +  
Sbjct: 112 AEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPI 167

Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG     R
Sbjct: 168 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----R 221

Query: 275 DPWP-NVSESAKSLVRQMLEPDPKLRLT 301
            P P N  E    L+R   +  P+ R T
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 7e-05
 Identities = 29/122 (23%), Positives = 49/122 (40%), Gaps = 14/122 (11%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIV-SLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           +   +     D  REVAI++ L +    V  +  + E D   +L+ME  EG  L      
Sbjct: 27  KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------ 80

Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKH---GVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
               +E     +   + E++   H+     + H DL P N L  + K    L  ID+  +
Sbjct: 81  -DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI---LGIIDWEYA 136

Query: 203 IF 204
            +
Sbjct: 137 GY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.7 bits (105), Expect = 7e-05
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 5/73 (6%)

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
            V R ++  ++  H+ G++HRD+KPEN L      +  +K IDFG ++    G  F+ + 
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLY 369

Query: 216 G--SPYYMAPEVL 226
           G   P Y  PE L
Sbjct: 370 GMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

 Score = 42.3 bits (100), Expect = 8e-05
 Identities = 20/58 (34%), Positives = 38/58 (65%), Gaps = 1/58 (1%)

Query: 344 LRVIAEFLS-VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           L V++  L   ++ E+++E FK  D D+DG +S  EL+  L++ G +L++ EV+ L++
Sbjct: 78  LTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLK 135

Length = 160

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 62/285 (21%), Positives = 118/285 (41%), Gaps = 43/285 (15%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRREVAIMKHLPKN 111
           + + LG GEFG          +      +++ + L+   ++ ++ D+  E  ++K +  +
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVAR------GHYTERAAAAVTRTIVE 163
             ++ L  AC  D  + L++E  + G L  F R   +      G    R ++ +      
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 164 VV----------QLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
            +          Q+        +  ++HRDL   N L A  ++   +K  DFGLS     
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLSRDVYE 179

Query: 208 GERF---SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
            + +   S+      +MA E L  + Y  + D+WS GV+L+ I+  G  P+      G+A
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIA 234

Query: 263 QAILRGLID--FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              L  L+   ++ +   N SE   +L+    + +P  R T   +
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 16/143 (11%)

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGE-RFSEIVGSPYYMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P   R  +      +MAPE +  R 
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 230 YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
           Y  + D+WS GV+L+ I   G  P+       + +   R L +  R   P+ +     + 
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVK---IDEEFCRRLKEGTRMRAPDYTTP--EMY 312

Query: 289 RQMLE---PDPKLRLTAKQVLEH 308
           + ML+    +P  R T  +++EH
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 39/266 (14%)

Query: 57  RELGRGEFGVTY--LCIDRDTREL-LACKSISKRKLRTAVDIDDVR---REVAIMKHLPK 110
           R +G+G FG  Y    ID D +++  A KS+++       D+++V    +E  IMK    
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-----ITDLEEVEQFLKEGIIMKDF-S 54

Query: 111 NSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           + +++SL   C   + +  +V+   + G+L + I      +E     V   I   +Q+  
Sbjct: 55  HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAK 109

Query: 170 ------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY-- 219
                     +HRDL   N +     E+  +K  DFGL+  I+ K         G+    
Sbjct: 110 GMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166

Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP 276
            +MA E L+ + +  + D+WS GV+L+ L+  G PP+       +   +L+G    +R  
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG----RRLL 222

Query: 277 WPN-VSESAKSLVRQMLEPDPKLRLT 301
            P    +    ++     P P++R T
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 13/102 (12%)

Query: 218 PYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---- 272
           PY+MAPEV++  +Y  + DI+S G+ LY  L    P    +E+    AIL  L++     
Sbjct: 68  PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP---YNEERELSAILEILLNGMPAD 124

Query: 273 ---KRDPWPNVSE--SAKSLVRQMLEPDPKLRLTAKQVLEHP 309
               R     VS   S +  +R      P+ R  A   L H 
Sbjct: 125 DPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 62/298 (20%), Positives = 118/298 (39%), Gaps = 72/298 (24%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSS 113
           +E+G G FG   L    +         +  ++LR +  + +  +   E    + L ++S+
Sbjct: 1   KEIGNGWFGKVIL---GEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSN 56

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLC---- 168
           ++     C +     LVME C  G+L      +G+  + R A  +T     + ++     
Sbjct: 57  LLQCLGQCTEVTPYLLVMEFCPLGDL------KGYLRSCRKAELMTPDPTTLQRMACEIA 110

Query: 169 ------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSEIV 215
                 HK+  IH DL   N L      +  +K  D+GLS        +  P + +  + 
Sbjct: 111 LGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL- 166

Query: 216 GSPYYMAPEVLKRNYG--------PEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAIL 266
               ++APE++   +G         E ++WS GV ++ L   G  P+   S++ V    +
Sbjct: 167 ---RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV 223

Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK----QVLEHPWLQNAKKAPNV 320
           R                     +Q+  P P+L+L       +V++  WLQ  ++ P+ 
Sbjct: 224 RE--------------------QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQR-PSA 260

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 19/53 (35%), Positives = 32/53 (60%)

Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           +A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 53

Length = 149

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 64/271 (23%), Positives = 118/271 (43%), Gaps = 37/271 (13%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+++    + ++LG G+FG  ++       ++ A K++    +     ++    E  
Sbjct: 3   IPRESLQ----LIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQ 53

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-------RIVARGHYTERAAAA 156
           IMK L ++  +V L  A   +  +++V E    G L D       R +   +  + AA  
Sbjct: 54  IMKKL-RHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA-- 109

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
               +   +    +   IHRDL+  N L  +       K  DFGL+   +  E ++   G
Sbjct: 110 ---QVAAGMAYIERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIEDNE-YTARQG 162

Query: 217 SPY---YMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLID 271
           + +   + APE  L   +  + D+WS G++L  L+  G  P+   + + V + + RG   
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-- 220

Query: 272 FKRDPWPNVSE-SAKSLVRQMLEPDPKLRLT 301
             R P P     S   L+ Q  + DP+ R T
Sbjct: 221 --RMPCPQDCPISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 8/85 (9%)

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P          P  +MAPE +  + 
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 230 YGPEIDIWSAGVILY-ILLCGVPPF 253
           Y  + D+WS GV+L+ I   G  P+
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 37.9 bits (89), Expect = 5e-04
 Identities = 15/44 (34%), Positives = 24/44 (54%), Gaps = 3/44 (6%)

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
           + AL+ + E LS EE   I EM +++D D DG +  +E    + 
Sbjct: 23  KAALKSLGEGLSEEE---IDEMIREVDKDGDGKIDFEEFLELMA 63

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 8/85 (9%)

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P          P  +MAPE +  + 
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251

Query: 230 YGPEIDIWSAGVILY-ILLCGVPPF 253
           Y  + D+WS GV+L+ I   G  P+
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 61/246 (24%), Positives = 100/246 (40%), Gaps = 46/246 (18%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI------DDVRR----EVAI 104
           ++R LG G FG   LC     R  L  K  SKR+L  A+        D  RR    E   
Sbjct: 9   IERILGTGRFG--ELC-----RGCL--KLPSKRELPVAIHTLRAGCSDKQRRGFLAEALT 59

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           +     +S+IV L+      N + +V E    G L D  + +  G         +   + 
Sbjct: 60  LGQF-DHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLA 117

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER------FSEIVG 216
             ++   + G +H+ L     L      NS L     G    F+  +       ++ + G
Sbjct: 118 SGMKYLSEMGYVHKGLAAHKVLV-----NSDLVCKISG----FRRLQEDKSEAIYTTMSG 168

Query: 217 -SP-YYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDF 272
            SP  + APE ++  ++    D+WS G++++ ++  G  P+W  S Q V +A+  G    
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--- 225

Query: 273 KRDPWP 278
            R P P
Sbjct: 226 -RLPAP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 37/118 (31%), Positives = 51/118 (43%), Gaps = 16/118 (13%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
           R+ RT       RRE  IM    K    V      + +N + +VME  EG  L D I + 
Sbjct: 42  RRERT-------RREARIMSRARKAGVNVPAVYFVDPENFI-IVMEYIEGEPLKDLINSN 93

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
           G         ++R I  +V   H  G+IH DL   N + +  K    +  IDFGL+ F
Sbjct: 94  G----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGK----IYLIDFGLAEF 143

Length = 211

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSE- 213
           A+ + ++  V+  H   +IHRD+K EN +F N      L   DFG ++ F K  E F   
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327

Query: 214 IVGSPYYMAPEVLKRNYGPEI-DIWSAGVIL 243
            VG+    +PE+L  +   EI DIWS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Length = 501

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 47/213 (22%), Positives = 79/213 (37%), Gaps = 37/213 (17%)

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPE-VLKR 228
           ++HRDL   N L    +    +K  DFGL+      E+     G      +MA E +L R
Sbjct: 130 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186

Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
            Y  + D+WS GV ++ L+  G  P+       ++  + +G    +R P P         
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----ERLPQP--------- 233

Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
                   P   +    ++   W+ +A   P        R  + +FS M R  ++ L + 
Sbjct: 234 --------PICTIDVYMIMVKCWMIDADSRPK------FRELIIEFSKMARDPQRYLVIQ 279

Query: 348 AE--FLSVEEVEDIKEMFKKIDSDNDGVVSTDE 378
            +         +         + D D VV  DE
Sbjct: 280 GDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 312

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.8 bits (96), Expect = 9e-04
 Identities = 69/311 (22%), Positives = 111/311 (35%), Gaps = 73/311 (23%)

Query: 54  LVDRELGRGEFGVTYLC-----------IDRDTRELLACKSISKRKLRTAVDI---DDVR 99
               +LG G+FG  +LC              +     A   ++ + LR        +D  
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           +EV I+  L  + +I  L   C  D  + ++ME  E G+L         + ++  A  + 
Sbjct: 68  KEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDL-------NQFLQKHVAETSG 119

Query: 160 TIVEVVQL---CHKH---------------GVIHRDLKPENFLFANKKENSPLKAIDFGL 201
                  L      +                 +HRDL   N L      N  +K  DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGM 176

Query: 202 SIFFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-IL- 246
           S           +  S YY            MA E VL   +  + D+W+ GV L+ IL 
Sbjct: 177 S---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Query: 247 LCGVPPFWAESEQGVAQAILRGLIDFKR----DPWPNVSESAKSLVRQMLEPDPKLRLTA 302
           LC   P+   ++Q V +       D  R       PN  +    L+ +    D + R T 
Sbjct: 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287

Query: 303 KQVLEHPWLQN 313
           +++  H +LQ 
Sbjct: 288 REI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.9 bits (96), Expect = 9e-04
 Identities = 31/112 (27%), Positives = 48/112 (42%), Gaps = 27/112 (24%)

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EI 214
           + R I+  +   H  G++HRD+KP+N +F+    +   K ID G +   + G  +   E 
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIIDLGAAADLRVGINYIPKEF 317

Query: 215 VGSPYYMAPE----------------------VL-KRNYGPEIDIWSAGVIL 243
           +  P Y APE                      VL + N     DI+SAG+I 
Sbjct: 318 LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369

Length = 566

>gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair

 Score = 36.2 bits (84), Expect = 0.002
 Identities = 16/38 (42%), Positives = 24/38 (63%)

Query: 364 KKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           K +D D DG +  +EL+  L+  G +L + EV+ LIEA
Sbjct: 1   KLLDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEA 38

Length = 60

>gnl|CDD|205383 pfam13202, EF_hand_3, EF hand

 Score = 34.9 bits (82), Expect = 0.002
 Identities = 9/23 (39%), Positives = 18/23 (78%)

Query: 359 IKEMFKKIDSDNDGVVSTDELKA 381
           +K++F++ D++ DG +S +ELK 
Sbjct: 1   LKDLFRQFDTNGDGKISKEELKR 23

Length = 25

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 33/116 (28%), Positives = 45/116 (38%), Gaps = 19/116 (16%)

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
           R+ RT       R E  ++    K      +    + DN   +VME  EG  L D     
Sbjct: 40  RRERT-------RNEARLLSRARKAGVNTPVVYDVDPDNKT-IVMEYIEGKPLKD----- 86

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
               E     + R I  +V   HK G++H DL   N +  + K    L  IDFGL 
Sbjct: 87  --VIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDK----LYLIDFGLG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair

 Score = 35.4 bits (82), Expect = 0.004
 Identities = 17/44 (38%), Positives = 26/44 (59%), Gaps = 1/44 (2%)

Query: 341 RKALRVIAEFLSVEEVED-IKEMFKKIDSDNDGVVSTDELKAGL 383
           RK L+ +   L+ EEVE+ I+  F +ID D DG +S +E    +
Sbjct: 17  RKLLKALGLKLTDEEVEELIEADFNEIDKDGDGRISFEEFLEAM 60

Length = 60

>gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair

 Score = 35.2 bits (82), Expect = 0.004
 Identities = 15/44 (34%), Positives = 27/44 (61%), Gaps = 3/44 (6%)

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
           ++AL ++   LS EEV+    +F++ D+D DG +S +E    L+
Sbjct: 11  KRALALLGISLSEEEVDI---LFREFDTDGDGKISFEEFCVLLQ 51

Length = 53

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 7/81 (8%)

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPE-VL 226
             ++HRDL   N L    K    +K  DFGL+      E+     G      +MA E +L
Sbjct: 128 KRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 227 KRNYGPEIDIWSAGVILYILL 247
            R Y  + D+WS GV ++ L+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	408
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK10345	210	hypothetical protein; Provisional	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
smart00090	237	RIO RIO-like kinase.	99.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.48
KOG3087	229	consensus Serine/threonine protein kinase [General	99.47
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.42
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.41
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.26
COG4248	637	Uncharacterized protein with protein kinase and he	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
PRK09902	216	hypothetical protein; Provisional	98.86
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.81
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.74
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.62
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.59
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.47
PLN02876	822	acyl-CoA dehydrogenase	98.46
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.32
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	98.28
KOG0031	171	consensus Myosin regulatory light chain, EF-Hand p	98.22
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
PF00036	29	EF-hand_1: EF hand; InterPro: IPR018248 Many calci	98.14
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.11
cd05022	89	S-100A13 S-100A13: S-100A13 domain found in protei	98.11
cd05027	88	S-100B S-100B: S-100B domain found in proteins sim	98.1
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.09
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	98.08
KOG0028	172	consensus Ca2+-binding protein (centrin/caltractin	98.05
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	98.03
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	97.97
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.95
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.95
PF13405	31	EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J	97.91
PF13499	66	EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A	97.91
smart00027	96	EH Eps15 homology domain. Pair of EF hand motifs t	97.89
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.82
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.82
cd05029	88	S-100A6 S-100A6: S-100A6 domain found in proteins	97.78
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.75
KOG2270	520	consensus Serine/threonine protein kinase involved	97.7
cd05031	94	S-100A10_like S-100A10_like: S-100A10 domain found	97.7
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.7
cd00213	88	S-100 S-100: S-100 domain, which represents the la	97.61
KOG0031	171	consensus Myosin regulatory light chain, EF-Hand p	97.6
cd05025	92	S-100A1 S-100A1: S-100A1 domain found in proteins	97.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.58
KOG0030	152	consensus Myosin essential light chain, EF-Hand pr	97.55
cd05026	93	S-100Z S-100Z: S-100Z domain found in proteins sim	97.53
PLN02236	344	choline kinase	97.52
cd00052	67	EH Eps15 homology domain; found in proteins implic	97.52
PF13202	25	EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ	97.49

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-67  Score=469.48  Aligned_cols=270  Identities=37%  Similarity=0.676  Sum_probs=250.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh----hcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA----VDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      +...+.+.|.+.+.||+|+||.|.+|..+.||+.||||++.++.....    .....+.+|++||++| +|||||+++++
T Consensus       166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~  244 (475)
T KOG0615|consen  166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDF  244 (475)
T ss_pred             ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeee
Confidence            455688899999999999999999999999999999999998776542    2334568999999999 99999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      |+..+..|+||||++||+|++.+..++.+.+...+.+++||+.|+.|||++||+||||||+|||+..+.+...+||+|||
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999988788999999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc---c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCcccCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR---N-YGPEIDIWSAGVILYILLCGVPPFWAESEQG-VAQAILRGLIDFKRD  275 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  275 (408)
                      +|+.......+.+.+|||.|.|||++.+   . +..++|+||+||+||-+++|.+||.+..... +.++|.++.+.+.+.
T Consensus       325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~  404 (475)
T KOG0615|consen  325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL  404 (475)
T ss_pred             hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence            9999888888899999999999999964   2 4458999999999999999999998876655 899999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .|..+|+++.+||.+||..||++|||++++|+||||+...
T Consensus       405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            9999999999999999999999999999999999998765

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-65  Score=423.64  Aligned_cols=302  Identities=38%  Similarity=0.718  Sum_probs=278.0

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ...+.+.|++.+.||+|.|+.||++.+..||+.+|+|++...++... +.+.+.+|+.|.+.| +||||+++++.+.++.
T Consensus         6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~   83 (355)
T KOG0033|consen    6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEES   83 (355)
T ss_pred             ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhc-CCCcEeehhhhhcccc
Confidence            34578899999999999999999999999999999999988777544 678999999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ..|+|+|++.|++|..-+..+..++|..+..+++||+.||.|+|.+||||||+||+|+|+.+++....+||+|||+|...
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999999999998888778999999999999999999999999999999999999999888999999999999998


Q ss_pred             CCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ..+......+|||.|||||+++. +|+..+|||+.|+|||.|+.|.+||++.+...+.++|..+.++++.+.|+.+++++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            87777788899999999999985 79999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhhh
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAE  349 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~  349 (408)
                      ++||++||..||.+|+|+.|+|+|||+.+........-.+...+.+++|....++|-.++..+..
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s  308 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA  308 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999987653322222345668899999999999998887754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-61  Score=451.66  Aligned_cols=257  Identities=37%  Similarity=0.596  Sum_probs=243.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .+|...+.||+|||+.||.+++..+|..||+|++++..+......+.+.+||+|.+.| +|||||+++++|++.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence            6899999999999999999999999999999999998888888899999999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      .|+|..++|.+++++++.++|.+++.+++||+.||.|||+++|+|||||..|+++   +++.+|||+|||+|...... +
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence            9999999999999999999999999999999999999999999999999999999   67778999999999998744 6


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ...+.+|||.|.|||++.. .++..+||||+||+||.|++|++||...+-.+.++.|....+.++.    .+|.++++||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            7788999999999999875 6999999999999999999999999999999999999999887765    7899999999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||++||.+|||++++|.|+||....
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            999999999999999999999996543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-60  Score=443.92  Aligned_cols=323  Identities=57%  Similarity=0.973  Sum_probs=298.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.+.|.+.+.||+|.||.||+|+++.+|+.+|+|++.+...........+.+|+.+|+++..||||+.++++|++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            55778899999999999999999999999999999999999988877767789999999999996699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC-CCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~-~~~vkl~Dfg~~~  203 (408)
                      ..+++|||+|.||.|++.+... .++|..+..+++|++.|++|||+.||+||||||+|+|+..... ++.+|++|||++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999887 4999999999999999999999999999999999999987654 4689999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ....+......+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||++.+.......+..+.+.+..+.|+.++.
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            988877889999999999999998 5899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhhhhhchhhhHHHHHH
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEM  362 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~ls~~~~~~l~~~  362 (408)
                      .+++||++||..||.+|+|+.++|+|||++......+.+.......+++++...+++++.+++......+   ...++.+
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  344 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEM  344 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHH
Confidence            9999999999999999999999999999998876677777777777888888888888887777766655   7777888


Q ss_pred             HhhcCCCCC
Q 015352          363 FKKIDSDND  371 (408)
Q Consensus       363 F~~~D~~~d  371 (408)
                      |...|.+++
T Consensus       345 ~~~~~~~~~  353 (382)
T KOG0032|consen  345 FKLMDTDNN  353 (382)
T ss_pred             HHhhccccc
Confidence            999988777

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-59  Score=410.77  Aligned_cols=259  Identities=33%  Similarity=0.608  Sum_probs=240.3

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.|++.+.||+|+||.||.++.++|++.||+|++.+..+....+.+....|..||..+ +||.||+++-.|++...+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence            57899999999999999999999999999999999999887777788999999999998 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc-CCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~-~~~  208 (408)
                      |+||+.||.|+.+|++.+.++|..++.++..|+.||.|||++|||||||||+|||+   +..++|+|+|||+++.. ..+
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999   77889999999999854 445


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ....+.+||+.|||||++.+ .|+..+|.||||+++|+|++|.+||.+.+...+.++|.++......   .-++.+++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence            56677899999999999875 7999999999999999999999999999999999999998744333   2489999999


Q ss_pred             HHHhcCCCcCCCC----CHHHHhcCccccCCc
Q 015352          288 VRQMLEPDPKLRL----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       288 i~~~l~~dp~~R~----s~~~~l~h~~~~~~~  315 (408)
                      |+++|..||++|.    ++.++-+||||....
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            9999999999995    789999999998754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-58  Score=406.68  Aligned_cols=257  Identities=27%  Similarity=0.391  Sum_probs=227.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-eEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-AVHL  129 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~~~l  129 (408)
                      ++.+.++.||+|+.|+||+|+|+.|++.+|+|+|...  ......+++.+|+++++.. +||+||.+|++|.+++ .++|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence            3566788999999999999999999999999999433  2344568899999999998 9999999999999999 5999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||+||+|.+.++..+.++|.....++.++++||.|||+ ++||||||||+|||+   +..+.|||||||.+......
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence            99999999999999988999999999999999999999995 999999999999999   45677999999999887655


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE-----SEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                       ...+++||..|||||.+.+ .|+.++||||||+.++|+.+|+.||...     ...+++..|..+..+-.+.  ...|+
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence             5678899999999999987 6999999999999999999999999874     5567777777754332221  14899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ++++||..||++||.+|||+.|+++|||+++...
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            9999999999999999999999999999987653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-58  Score=410.48  Aligned_cols=266  Identities=35%  Similarity=0.606  Sum_probs=240.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|.+.+.||+|+||+||+|+++.++..||||.+.+.++ .....+.+..|+.+|+.+ +|||||.+++++++++.
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCe
Confidence            3456789999999999999999999999999999999998776 344567889999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC---CCEEEeeccccc
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN---SPLKAIDFGLSI  203 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~---~~vkl~Dfg~~~  203 (408)
                      +|+|||||+||+|.+++.+.+.++|..++.++.||+.||++||+++||||||||+|||++.....   ..+||+|||+|+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999865233   679999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ...++....+.+|+|.|||||++. ++|+.|+|+||+|+|+|++++|+.||...+..++...+.++.-..+.. ...++.
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-~~~~s~  242 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-PAELSN  242 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-hhhccC
Confidence            999988889999999999999995 689999999999999999999999999999999988777665433322 235677


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ...+|+...|..+|.+|.+..+-+.|+++....
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            788999999999999999999999999997654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-58  Score=422.57  Aligned_cols=258  Identities=31%  Similarity=0.570  Sum_probs=240.3

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      ..+|.+++.||.|+|++|++|+++.+++.||||++.++-+......+.+.+|-.+|.+|.+||.|++++-.|+|+..+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            35799999999999999999999999999999999998887777788899999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |+||+++|+|.++|.+.|.+++..++.++.+|+.||+|||++|||||||||+|||+   ++++++||+|||.|+.+.+..
T Consensus       152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999   788899999999998764322


Q ss_pred             c--------------eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          210 R--------------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       210 ~--------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      .              ..+++||..|.+||++.. ..++.+|||+||||+|+|+.|.+||.+.+...+.+.|+...+.|+.
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence            1              145899999999999985 5889999999999999999999999999999999999998888775


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                          ..++.+++||+++|..||.+|+|+.+|.+||||...
T Consensus       309 ----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  309 ----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             ----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence                678999999999999999999999999999999874

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-57  Score=422.57  Aligned_cols=261  Identities=35%  Similarity=0.621  Sum_probs=243.5

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      +--+-|++++.||.|+.|.|.+|+|..||+.+|||+|.+..-........+.+||-||+.+ .|||+++++++|++..++
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHL   87 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceE
Confidence            3446799999999999999999999999999999999987544555567899999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+|.||++||.|++++..+|++++.+++++++||+.|+.|||..+|+||||||+|+|+   +....|||+|||+|..-.+
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccC
Confidence            9999999999999999999999999999999999999999999999999999999999   4555599999999999888


Q ss_pred             CCceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      +.-+.+.||+|.|.|||++.| . .+.++||||+|||||.|+||++||.+.+...++.++.+|.+..+    .++|++++
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQ  240 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQ  240 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHH
Confidence            888999999999999999987 3 46899999999999999999999999999999999999998877    48999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      +||++||..||.+|+|.+||++|||+.....
T Consensus       241 dLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  241 DLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence            9999999999999999999999999988654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-57  Score=386.55  Aligned_cols=258  Identities=29%  Similarity=0.555  Sum_probs=241.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .-.++|++.+.||.|+||.|.+++++.+|..+|+|++.+..+-...+.+...+|..+|+.+ .||+++++++.|.+.+++
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeE
Confidence            4557899999999999999999999999999999999998877777788899999999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++||.|+.++.+.+++++..++.++.||+.||+|||+++|++|||||+|||+   +.+|.+||+|||+|+....
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecC
Confidence            9999999999999999999999999999999999999999999999999999999999   7788999999999998754


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      .  ..+.||||.|+|||++.. +|+.++|.|||||++|||+.|.+||.+.+...+.++|..+.+.++.    ..++++++
T Consensus       197 r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kd  270 (355)
T KOG0616|consen  197 R--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKD  270 (355)
T ss_pred             c--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHH
Confidence            3  677899999999999875 7999999999999999999999999999999999999999998875    67999999


Q ss_pred             HHHHhcCCCcCCCC-----CHHHHhcCccccCCc
Q 015352          287 LVRQMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       287 li~~~l~~dp~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      ||.++|+.|-.+|.     ...++.+||||+...
T Consensus       271 Ll~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  271 LLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             HHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence            99999999999993     578999999998643

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-58  Score=389.70  Aligned_cols=266  Identities=34%  Similarity=0.655  Sum_probs=245.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC-----hhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      ...+..+|.-.+.||+|..++|.++.++.+|..+|+|++.......     ..-.+.-.+|+.||+++.+||+|+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            3456678888999999999999999999999999999997543221     11234567899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      |+++..+++|+|.|+.|.|++++...-.++|...+.|++||+.|+.|||.++||||||||+|||+   +++.++||+|||
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFG  168 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFG  168 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccc
Confidence            99999999999999999999999998889999999999999999999999999999999999999   677889999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhh-------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      +|....+++.+...+|||+|+|||.+.       .+|+..+|+||+|+|||.|+.|.+|||....--+++.|+.|.+.|.
T Consensus       169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            999999999999999999999999874       2488999999999999999999999999988889999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .+.|.++|...++||.+||+.||.+|+|++|+|.||||...
T Consensus       249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            99999999999999999999999999999999999999653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-56  Score=416.10  Aligned_cols=260  Identities=39%  Similarity=0.682  Sum_probs=236.1

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh--hcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....++|.+.+.||+|+||+|+.|.+..+|..||+|++.++.....  ...+.+.+|+.+++.+..||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            3466799999999999999999999999999999998877533311  23456778999999995599999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC-CCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~-~~vkl~Dfg~~~  203 (408)
                      ..+|+|||||.||+|++++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++   .+ +.+||+|||++.
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSA  169 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999995   44 789999999999


Q ss_pred             cc-CCCCceecccCCCCCcchhhhhc-c-C-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          204 FF-KPGERFSEIVGSPYYMAPEVLKR-N-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       204 ~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      .. .......+.+||+.|+|||++.+ . | +.++||||+||+||.|++|..||.+.+...+...|.++.+.++.    .
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~  245 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----Y  245 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----C
Confidence            88 46677889999999999999986 4 5 47899999999999999999999999999999999998887764    3


Q ss_pred             C-CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          280 V-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       280 ~-~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      + |+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus       246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            4 999999999999999999999999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-56  Score=410.99  Aligned_cols=262  Identities=32%  Similarity=0.525  Sum_probs=238.2

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|.++..||+|+||.||+|+.+.||..+|+|++.+..+....+++.++.|-.+|... +.|.||+++-.|++.+++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeE
Confidence            446899999999999999999999999999999999999888778889999999999996 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-  207 (408)
                      +||||++||++..+|.+.+.+++..++.++.+++.|++.||++|+|||||||+|+||   +..|++||+|||++..... 
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence            999999999999999999999999999999999999999999999999999999999   7889999999999853210 


Q ss_pred             ---------------------CC-c-------------------------eecccCCCCCcchhhhhc-cCCCchhHHHH
Q 015352          208 ---------------------GE-R-------------------------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSA  239 (408)
Q Consensus       208 ---------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  239 (408)
                                           .+ .                         ....+|||.|+|||++.+ +|+..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 00 0                         013579999999999986 69999999999


Q ss_pred             HHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCccccCCc
Q 015352          240 GVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNAK  315 (408)
Q Consensus       240 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~~~  315 (408)
                      |||+||||.|.+||.+.++.++.++|.+....+..+.-..++++++|||.+||. ||++|..   +.||.+||||+...
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            999999999999999999999999999988655555556789999999999999 9999985   89999999998754

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.7e-57  Score=385.72  Aligned_cols=257  Identities=29%  Similarity=0.566  Sum_probs=222.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|+.+..+|+|+||+||+|+++.||+.||||.+-.+.- ...-.+-.+|||.+|++| +|||+|.++++|.....+++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEE
Confidence            578889999999999999999999999999999864432 222334568999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~  208 (408)
                      +|||+. ++.+.+... ..+++..+..++.|++.|+.|+|++++|||||||+|||+   ..++.+||||||+|+... ++
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence            999987 555556554 559999999999999999999999999999999999999   567889999999999887 78


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc--------------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF--------------  272 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------------  272 (408)
                      +.++.++.|.+|+|||.+.+  +|++.+||||+||++.||++|.+.|.+.++-+.+-.|.....++              
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            88899999999999999876  69999999999999999999999999988877666654432111              


Q ss_pred             -----CC--------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          273 -----KR--------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       273 -----~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                           +.        ..++.++..+.+|+++||..||.+|++.+|+|.||||.+
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence                 11        123567888999999999999999999999999999954

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-55  Score=388.80  Aligned_cols=263  Identities=37%  Similarity=0.647  Sum_probs=248.1

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      .+..++.-+|++.+.||+|.||.|-+|++...|+.||||.|.+.++....+.-.+++||+||+.| +||||+.+|++|++
T Consensus        46 hhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFEN  124 (668)
T KOG0611|consen   46 HHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFEN  124 (668)
T ss_pred             CcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcC
Confidence            45677888999999999999999999999999999999999999999999999999999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      .+.+.|||||..||.|++|+.+.+.++|.+++.+++||..|+.|||.++++|||||.+|||+   +.++++||+|||++.
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSN  201 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999   677889999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cC-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .+.....+.+++|+|.|.+||++.+ .| ++.+|-||||++||.|+.|.+||.+.+...+.++|.++.+.-+     .-|
T Consensus       202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~P  276 (668)
T KOG0611|consen  202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETP  276 (668)
T ss_pred             hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CCC
Confidence            9988888999999999999999987 34 7899999999999999999999999999999999999987644     346


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..+.-||+.||..||++|.|+.++..|-|++-..
T Consensus       277 SdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  277 SDASGLIRWMLMVNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             chHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence            7899999999999999999999999999997543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-55  Score=397.36  Aligned_cols=264  Identities=34%  Similarity=0.523  Sum_probs=230.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ...+.++|.+++.||.|.||.||+|+.+.+|..||||.+.+.-. ... .-.-+||+..|++|..||||+++.+++.+.+
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            34567899999999999999999999999999999999865433 222 2334689999999955999999999998887


Q ss_pred             -eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          126 -AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       126 -~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                       .+|+|||||+. +|+++++.+ ..+++..++.|+.||++||+|+|.+|+.|||+||+|||+.   ....|||+|||+|+
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAR  158 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEeccccccc
Confidence             99999999976 999999876 4599999999999999999999999999999999999995   35679999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC-----
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-----  276 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----  276 (408)
                      .......++.++.|.+|+|||++..  -|+.+.||||+|||++|+++-++.|.|.+..+.+.+|..-........     
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            9998899999999999999998864  599999999999999999999999999988877777765443222221     


Q ss_pred             ---------------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          277 ---------------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       277 ---------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                           .++.++++.++|.+||..||.+||||.|+|+||||+...
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                                 245789999999999999999999999999999998754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.2e-54  Score=363.05  Aligned_cols=260  Identities=31%  Similarity=0.516  Sum_probs=230.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|...+.||+|.||.||+|++..||+.||||.|.........+ ....|||+.|+.+ +|+||+.++++|.+.+.+.+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence            57889999999999999999999999999999998876655544 4567899999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      +||++. +|...++.+ ..++..+++.++.+++.||+|||++.|+||||||+|+|+   +.++.+||+|||+|+.+.+..
T Consensus        80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence            999976 898888775 458999999999999999999999999999999999999   667889999999999876443


Q ss_pred             -ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC--------
Q 015352          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--------  278 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--------  278 (408)
                       .....+-|.+|+|||.+-|  .|+...||||+|||+.||+-|.+-|.|.++-+.+..|.+.......+.|+        
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence             3444478999999999875  69999999999999999999999999999999999888876655555543        


Q ss_pred             ----------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          279 ----------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       279 ----------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                      ..++++.+|+.+||..||.+|+|+.|+|+|+||.....
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence                            34677899999999999999999999999999997543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-55  Score=373.49  Aligned_cols=272  Identities=38%  Similarity=0.692  Sum_probs=246.2

Q ss_pred             cccccccceEec-ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....+.++|.+. +.||-|-.|.|-.|.++.||+.+|+|++.-        ....++|+++.-..+.|||||.++++|++
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            455688889885 569999999999999999999999999852        24567888888777799999999999874


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          124 ----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       124 ----~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                          ...+.+|||.++||.|+..++.++.  ++|+++..|++||..|+.|||+.+|.||||||+|+|++....+..+||+
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence                4678899999999999999998876  9999999999999999999999999999999999999998899999999


Q ss_pred             ecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCccc
Q 015352          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDF  272 (408)
Q Consensus       198 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~  272 (408)
                      |||+|+.......+.+.+-||+|.|||++.. .|+..+|+||+||++|.|++|.+||+...    ...+...|..+.+.|
T Consensus       207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9999998876777788899999999999974 69999999999999999999999998753    457889999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCch
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD  324 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~  324 (408)
                      +.+.|..+|+.++++|+.+|..+|.+|.|+.++++|||+......+..++..
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t  338 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST  338 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence            9999999999999999999999999999999999999999988777766654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-54  Score=400.29  Aligned_cols=254  Identities=32%  Similarity=0.568  Sum_probs=234.4

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|-+.+.||+|+||+||+|+.+.+.+.||+|.+.+... ...++..+.+|++|++.| +||||+.++++|+...++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence            578899999999999999999999999999999998654 344678899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      +|||.| +|+.++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+   +.++.+|+||||+|+....+. 
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence            999988 999999999999999999999999999999999999999999999999   778899999999999876554 


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ..+.+.|||.|||||+..+ .|+..+|+||||||+||+++|++||...+..++.+.|......++    ...+..+..|+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHHHH
Confidence            3466789999999999986 699999999999999999999999999999999998888765544    37899999999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +.+|.+||.+|.|..+++.|||.+..
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhh
Confidence            99999999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-53  Score=388.62  Aligned_cols=259  Identities=29%  Similarity=0.512  Sum_probs=227.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--CeE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAV  127 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~  127 (408)
                      .+.|+.++.||+|.||.||+|++..+|+.||+|.+........ ...-..|||.||++| +||||+++.+...+.  +.+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhc-CCCcccceeeEEEecCCceE
Confidence            3568889999999999999999999999999999998765443 345667899999999 999999999988766  789


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+|+|||+. +|.-++...+ .|++.+++.+|+||+.||+|||++||+|||||.+|||+   +..+.+||+|||+|+++.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence            999999987 8877776643 59999999999999999999999999999999999999   677889999999999776


Q ss_pred             CCC--ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC----
Q 015352          207 PGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP----  278 (408)
Q Consensus       207 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----  278 (408)
                      ...  .++..+-|.+|+|||++.|  .|+.+.|+||+||||.||++|++.|.+.+.-+.+..|.+.........|+    
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            544  5677888999999999986  69999999999999999999999999999999999998766554444343    


Q ss_pred             ---------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          279 ---------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       279 ---------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                           .+++.+.+|+..||..||.+|.||.++|+|+||...
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence                                 457889999999999999999999999999999443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-55  Score=371.23  Aligned_cols=249  Identities=29%  Similarity=0.496  Sum_probs=218.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEee-EEEeCC
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE-ACEDDN  125 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~-~~~~~~  125 (408)
                      ..-...|++.+.||+|+||+||++.+..+|..+|.|.+....+ +....+.+..|+.+|++| +||||+++++ .|..++
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccc
Confidence            3445679999999999999999999999999999999985544 444577899999999999 9999999998 454444


Q ss_pred             -eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeccCCCCceEeecCCCCCCEEE
Q 015352          126 -AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHK--HG--VIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       126 -~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~--~~--ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                       .++||||||++|+|...++.    +..++|..+|.++.|++.||..+|+  ..  |+||||||.||++   +.++.|||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKL  169 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKL  169 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceee
Confidence             49999999999999998864    3569999999999999999999999  44  9999999999999   57788999


Q ss_pred             eecccccccCCCCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          197 IDFGLSIFFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      +|||+++....... ..+.+|||+||+||.+.+ +|+.++||||+||++|||+.-.+||.+.+-.++..+|.++..+  +
T Consensus       170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--~  247 (375)
T KOG0591|consen  170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--P  247 (375)
T ss_pred             ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--C
Confidence            99999998876554 356899999999999986 7999999999999999999999999999999999999998543  2


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCH
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTA  302 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~  302 (408)
                      -+-..+|.++..+|.-|+..||++||+.
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            2224689999999999999999999986

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-53  Score=374.15  Aligned_cols=271  Identities=33%  Similarity=0.497  Sum_probs=231.9

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-  123 (408)
                      ....+..+|...+.||+|+||.|+.|.++.+|+.||||.+.. .+......++..||+.+|+++ +|+||+.+.+++.. 
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPP   93 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccc
Confidence            344567788888999999999999999999999999999863 355666778999999999999 89999999999865 


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          124 ----DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       124 ----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                          -+.+|+|+|++ +.+|...++.+..+++..+..++.||+.||+|+|+.||+||||||.|+|+   +.+..+||+||
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DF  169 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDF  169 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccc
Confidence                45799999999 55898888888779999999999999999999999999999999999999   56677999999


Q ss_pred             ccccccCC---CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc--
Q 015352          200 GLSIFFKP---GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF--  272 (408)
Q Consensus       200 g~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--  272 (408)
                      |+|+...+   ....+.++.|.+|+|||++..  .|+.+.||||+|||+.||++|++.|.|.+.-+.++.|..-....  
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            99998764   445678899999999998763  69999999999999999999999999987766666554433211  


Q ss_pred             ---------------------CCC----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCC
Q 015352          273 ---------------------KRD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP  321 (408)
Q Consensus       273 ---------------------~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~  321 (408)
                                           +..    .+++.++.+.+|+.+||..||.+|+|++|+|.|||+.....+...+
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                                 111    2467899999999999999999999999999999998876555444

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-53  Score=383.13  Aligned_cols=263  Identities=34%  Similarity=0.619  Sum_probs=228.7

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC-----------hhcHHHHHHHHHHHHhCCCCCCe
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----------AVDIDDVRREVAIMKHLPKNSSI  114 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~h~~i  114 (408)
                      +.....+|++.+.||+|.||.|.+|++..+++.||||++.+.....           ...++.+.+||.||+++ +||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nV  170 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNV  170 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCe
Confidence            3345568999999999999999999999999999999998765432           12356899999999999 99999


Q ss_pred             eEEeeEEEe--CCeEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          115 VSLKEACED--DNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       115 ~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      |+++++..+  .+.+|||+|||..|.+.+ ....+. +++.+++.|++.++.||+|||.+|||||||||+|+|+   +.+
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~  246 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSD  246 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCC
Confidence            999999976  468999999999998754 333344 9999999999999999999999999999999999999   566


Q ss_pred             CCEEEeecccccccCCC------CceecccCCCCCcchhhhhcc-----CCCchhHHHHHHHHHHHhhCCCCCCCCCHHH
Q 015352          192 SPLKAIDFGLSIFFKPG------ERFSEIVGSPYYMAPEVLKRN-----YGPEIDIWSAGVILYILLCGVPPFWAESEQG  260 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  260 (408)
                      ++|||+|||.+.....+      ..+...+|||.|+|||.+.+.     -+.+.||||+||+||.|+.|..||.+....+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            89999999998866322      234557899999999998652     3578999999999999999999999999999


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +..+|.+..+.|+..  +.+.+++++||.+||.+||++|+++.++..|||....-
T Consensus       327 l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  327 LFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            999999998888765  36889999999999999999999999999999997753

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-54  Score=356.15  Aligned_cols=259  Identities=29%  Similarity=0.555  Sum_probs=239.4

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..-.++|++++.||+|-||.||.|+.++++-.||+|++-++.+........+.+|++|.+.| +||||+++|++|.++..
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKR   96 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccce
Confidence            44557899999999999999999999999999999999998877666678899999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIV--ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +|+++||..+|+|+..+.  ....+++..++.++.|++.||.|+|..+++||||||+|+|+   +..+.+|++|||.+..
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVH  173 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceee
Confidence            999999999999999998  55679999999999999999999999999999999999999   5566799999999988


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .. ...-.+.+||..|.+||...+ .++..+|+|++|++.||++.|.+||...+..+..+.|.+..+.++    ..++..
T Consensus       174 ~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~  248 (281)
T KOG0580|consen  174 AP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGG  248 (281)
T ss_pred             cC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChh
Confidence            65 455577899999999999986 699999999999999999999999999999999999998887776    589999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ++|+|.+||.++|.+|.+..|++.|||+...
T Consensus       249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  249 AADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999999998653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-53  Score=379.32  Aligned_cols=258  Identities=32%  Similarity=0.512  Sum_probs=216.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC--eE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--AV  127 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~  127 (408)
                      ..+|...+.||+|+||+||++.+.++|...|+|.+.....   ...+.+.+|+.+|++| +|||||++++......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeee
Confidence            4568889999999999999999999999999999986522   1267799999999999 6999999999855444  69


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +++|||++||+|.+++.+.+ .+++..++.+.+||+.||.|||++||+||||||+|||++..  ++.+||+|||++....
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLE  169 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCccccccc
Confidence            99999999999999999877 79999999999999999999999999999999999999531  5779999999988765


Q ss_pred             C----CCceecccCCCCCcchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCcccCCCCCCC
Q 015352          207 P----GERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       207 ~----~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      .    ........||+.|||||++...  ..+++|||||||++.||+||..||.. .......-.+.....  .+.....
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~--~P~ip~~  247 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS--LPEIPDS  247 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC--CCCCCcc
Confidence            3    2223457899999999999843  23499999999999999999999987 333333333333331  1233456


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +|+++++||.+||..||++||||.++|+|||+....
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            999999999999999999999999999999998754

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-52  Score=396.65  Aligned_cols=258  Identities=29%  Similarity=0.515  Sum_probs=238.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|+||+|++|..+.+++.+|||++.|..+-...+++....|..|+....+||.++.++..|+..+++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            46899999999999999999999999999999999999988888899999999999999789999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~  208 (408)
                      ||||+.||++. .+...+.+++..++.|+..|+.||.|||++||||||||.+|||+   +..|++||+|||+++... .+
T Consensus       447 vmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  447 VMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCC
Confidence            99999999953 44455789999999999999999999999999999999999999   778899999999998765 56


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ...++++|||.|+|||++.+ .|+.++|.|||||+||+|+.|..||.+.+..++...|+.....++.    .+|.++.++
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~i  598 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAI  598 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHH
Confidence            67889999999999999986 6999999999999999999999999999999999999988776654    789999999


Q ss_pred             HHHhcCCCcCCCCC-----HHHHhcCccccCCc
Q 015352          288 VRQMLEPDPKLRLT-----AKQVLEHPWLQNAK  315 (408)
Q Consensus       288 i~~~l~~dp~~R~s-----~~~~l~h~~~~~~~  315 (408)
                      ++++|.++|++|..     +.+|..||||+...
T Consensus       599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             HHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            99999999999986     47899999998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-52  Score=373.30  Aligned_cols=262  Identities=31%  Similarity=0.476  Sum_probs=230.2

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .-.+.|++.+.||.|..++||+|+...++..||||++..++....  .+.+.+|++.++.+ +||||++++..|..+..+
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLI-DHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhc-CCCCcceEEEEEEeccee
Confidence            345789999999999999999999999999999999998876554  78999999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |+||.|+.+|++.+.++..  ..++|..++.|++++++||.|||++|.||||||+.|||+   +.+|.|||+|||.+...
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASL  176 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeee
Confidence            9999999999999999875  349999999999999999999999999999999999999   67788999999987654


Q ss_pred             C-CCC----ceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc------
Q 015352          206 K-PGE----RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID------  271 (408)
Q Consensus       206 ~-~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~------  271 (408)
                      . .+.    .+.+.+|||+|||||++..   +|+.|+||||||++..||.+|..||....+..++-.-+++..+      
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            3 222    2256689999999999643   6999999999999999999999999988877766666666553      


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++.+.....+..++.+|..||++||.+|||++++|+|+||+...
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            22233346778899999999999999999999999999999865

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-53  Score=390.20  Aligned_cols=260  Identities=32%  Similarity=0.539  Sum_probs=227.1

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ..+....|.....||+|+.|.||.|+...+++.||||.+.....   ...+.+.+|+.+|+.+ +|+|||.+++.|-.++
T Consensus       268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDL-HHPNIVNFLDSYLVGD  343 (550)
T ss_pred             CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhc-cchHHHHHHHHhcccc
Confidence            35566789999999999999999999999999999999987653   3457789999999998 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|+||||++||+|.+.+... .++|.+++.|++.++.||+|||.+||+|||||.+|||+   +.++.+||+|||++..+
T Consensus       344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecc
Confidence            999999999999998877554 59999999999999999999999999999999999999   55667999999999887


Q ss_pred             CCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH-HcCCcccCCCCCCCCCH
Q 015352          206 KPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI-LRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       206 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~  282 (408)
                      .... .-.+.+|||+|||||+... .|+++.||||||+++.||+-|.+||...++...+..| .++.  .....+..+|+
T Consensus       420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~--P~lk~~~klS~  497 (550)
T KOG0578|consen  420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT--PKLKNPEKLSP  497 (550)
T ss_pred             ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC--CCcCCccccCH
Confidence            6554 5677899999999999875 7999999999999999999999999876554443333 3333  33444568999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+++|+.+||+.|+++|+++.++|+||||+.+.
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            999999999999999999999999999996654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.8e-52  Score=360.47  Aligned_cols=264  Identities=27%  Similarity=0.430  Sum_probs=226.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--C
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--D  124 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~  124 (408)
                      ..-.+.|+.+..|++|+||.||+|+++.|++.||+|.+..++-.....+. -+|||.+|.++ +|||||.+-++...  -
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~-~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKA-RHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhc-CCCCeeeeEEEEecccc
Confidence            34456799999999999999999999999999999999876644444443 46799999998 89999999998763  4


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+|||||+. +|...+..-+ ++...+++.++.|++.|++|||.+.|+||||||+|+|+   ...+.+||+|||+|+
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhh
Confidence            579999999977 8888887754 79999999999999999999999999999999999999   556779999999999


Q ss_pred             ccCCC-CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC--
Q 015352          204 FFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--  278 (408)
Q Consensus       204 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--  278 (408)
                      .+... ..++..+-|.+|+|||++.+  .|+.+.|+||+|||+.||+++.+.|.+.+..+....|.+.........|+  
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            87543 45777888999999999886  59999999999999999999999999999988888887654333332222  


Q ss_pred             --------------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          279 --------------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       279 --------------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                                .+++...+|++.+|..||.+|.||.|+|+|+||.....
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence                                      14588899999999999999999999999999988543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-52  Score=369.30  Aligned_cols=261  Identities=31%  Similarity=0.534  Sum_probs=236.0

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.|++++.||+|.-|+||+|..+.++..+|+|++.+..+.......+...|.+||+.+ +||.++.+|..|+.+...|+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEE
Confidence            35788999999999999999999999999999999998887777778888999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-
Q 015352          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-  206 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-  206 (408)
                      +||||+||+|....+++  +.+++..++.++..++.||+|||-.|||+|||||+|||+   .++|+|.|+||.++.... 
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCC
Confidence            99999999999988775  459999999999999999999999999999999999999   678899999998864221 


Q ss_pred             ---------------------------------C-C----------------------CceecccCCCCCcchhhhhc-c
Q 015352          207 ---------------------------------P-G----------------------ERFSEIVGSPYYMAPEVLKR-N  229 (408)
Q Consensus       207 ---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~-~  229 (408)
                                                       . .                      .....++||-.|.|||++.+ .
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                      01124579999999999997 5


Q ss_pred             CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCC----HHHH
Q 015352          230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT----AKQV  305 (408)
Q Consensus       230 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~~~  305 (408)
                      .+.++|.|+|||++|||+.|..||.+.+..+...+|+.....|+...  .++..++|||+++|.+||.+|..    +.||
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            99999999999999999999999999999999999999998888764  88999999999999999999998    9999


Q ss_pred             hcCccccCCcC
Q 015352          306 LEHPWLQNAKK  316 (408)
Q Consensus       306 l~h~~~~~~~~  316 (408)
                      .+||||+....
T Consensus       390 K~HpFF~gVnW  400 (459)
T KOG0610|consen  390 KRHPFFEGVNW  400 (459)
T ss_pred             hcCccccCCCh
Confidence            99999998653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-51  Score=379.81  Aligned_cols=254  Identities=28%  Similarity=0.515  Sum_probs=226.5

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEE
Confidence            4789999999999999999999999999999999765443334456788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence            9999999999999988889999999999999999999999999999999999999   45678999999998865432  


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++    ..+++.+++||+
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  230 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIK  230 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHH
Confidence            234579999999999875 589999999999999999999999999888888888887765543    356899999999


Q ss_pred             HhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          290 QMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      +||+.||.+||+     +.++++||||...
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            999999999995     9999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-51  Score=384.44  Aligned_cols=256  Identities=30%  Similarity=0.548  Sum_probs=228.5

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEE
Confidence            347899999999999999999999999999999999866544444567789999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC
Confidence            999999999999999988889999999999999999999999999999999999999   55678999999999865432


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+..+...++    ..+++.+++|
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  245 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDL  245 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHH
Confidence              234579999999999875 589999999999999999999999999888888888887765443    3478999999


Q ss_pred             HHHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          288 VRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       288 i~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      |.+||+.||.+||+     +.++++||||...
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999999997     7999999999864

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-52  Score=377.52  Aligned_cols=266  Identities=36%  Similarity=0.612  Sum_probs=244.6

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....|.+-|.+.+.||+|.|+.|.+|+|.-||..||||+|.+.++... ....+.+|+..|+.+ .|||||++|++....
T Consensus        12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLV-QHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLV-QHPNIVRLYEVIDTQ   89 (864)
T ss_pred             cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHh-cCcCeeeeeehhccc
Confidence            345677889999999999999999999999999999999999887554 356788999999998 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ..+|+|+|+-+||+|++||.++ ..+.|..+..++.||+.|+.|+|+..+|||||||+||.+.  .+-+.|||+|||++.
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSN  167 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccc
Confidence            9999999999999999999776 4599999999999999999999999999999999999886  467889999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCC-CchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYG-PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .+.++..+.+.+|+..|.|||++.+ .|+ +++||||||||||.|++|++||...++.+.+-.|+...+..+    ..++
T Consensus       168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS  243 (864)
T KOG4717|consen  168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVS  243 (864)
T ss_pred             cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhh
Confidence            9999999999999999999999987 464 789999999999999999999999999999999999887765    3789


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCC
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  318 (408)
                      .++++||..||..||++|.|.++|..|+|++......
T Consensus       244 ~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  244 KECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             HHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence            9999999999999999999999999999999876443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.2e-51  Score=386.19  Aligned_cols=259  Identities=27%  Similarity=0.443  Sum_probs=223.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++.+.+.+.+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999865444444456788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence            9999999999999988899999999999999999999999999999999999999   456789999999987542110 


Q ss_pred             -----------------------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCC
Q 015352          210 -----------------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPF  253 (408)
Q Consensus       210 -----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf  253 (408)
                                                         .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                               0123579999999999875 6999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcC---CCCCHHHHhcCccccCC
Q 015352          254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK---LRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~R~s~~~~l~h~~~~~~  314 (408)
                      .+.+..+....+.........+....++++++++|.+|+. +|.   .||++.|+++||||+..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            9988888888887654333333334689999999999875 444   46899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.6e-51  Score=381.83  Aligned_cols=250  Identities=31%  Similarity=0.553  Sum_probs=221.5

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999865444444456788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~~  215 (408)
                      ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   456779999999987532 223344567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+......++    ..+++++.+||.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999875 689999999999999999999999999888887777776655443    46899999999999999


Q ss_pred             CcCCCC-----CHHHHhcCccccCC
Q 015352          295 DPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      ||++||     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     89999999999774

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-50  Score=372.86  Aligned_cols=259  Identities=29%  Similarity=0.475  Sum_probs=219.2

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.+ +|++|+++++++.+++.+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence            78889999999999999999999999999999866544333445678899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          133 LCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       133 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |++||+|..++...  ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998887653  358999999999999999999999999999999999999   4567799999999987655555


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+..............+++++.+||+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            556689999999999875 6999999999999999999999999876543322223222222222333568999999999


Q ss_pred             HhcCCCcCCCCC-----HHHHhcCccccCCc
Q 015352          290 QMLEPDPKLRLT-----AKQVLEHPWLQNAK  315 (408)
Q Consensus       290 ~~l~~dp~~R~s-----~~~~l~h~~~~~~~  315 (408)
                      +||+.||.+||+     ++++++||||....
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999997     89999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-50  Score=381.27  Aligned_cols=258  Identities=31%  Similarity=0.506  Sum_probs=226.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+++..|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999999876544444466788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....  .
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--c
Confidence            9999999999999888889999999999999999999999999999999999999   5567899999999976543  3


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC----CCCCHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW----PNVSESAK  285 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~~~~  285 (408)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........+.+    ..+++++.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            345679999999999875 6899999999999999999999999998887777776654433222222    25789999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +||.+||..+|.+||++.++++||||...
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=385.97  Aligned_cols=259  Identities=30%  Similarity=0.511  Sum_probs=225.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence            4799999999999999999999999999999999865443444456788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence            9999999999999888889999999999999999999999999999999999999   566789999999986542211 


Q ss_pred             --------------------------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCC
Q 015352          210 --------------------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGV  250 (408)
Q Consensus       210 --------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~  250 (408)
                                                            .....+||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                  0112469999999999865 6899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCccccCC
Q 015352          251 PPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNA  314 (408)
Q Consensus       251 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~~  314 (408)
                      .||.+.+..+....+......+..+....+++++++||.+||. +|.+|++   +.++++||||+..
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999988888777777655444444444689999999999996 9999998   9999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-52  Score=358.28  Aligned_cols=268  Identities=37%  Similarity=0.603  Sum_probs=238.2

Q ss_pred             ccccceEe-cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           48 NIEDRYLV-DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        48 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .+.+-|.+ .+.||+|+|+.|-.|+...+|..||||+|.+.   ....+.++.+|++++.+.++|+||+.++++|+++..
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            35556766 46799999999999999999999999999876   344578899999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+|||-+.||+|..+|.++..++|.++..+++.|+.||.+||.+||.|||+||+|||....+.-..||||||.+.....
T Consensus       151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999877777789999998865443


Q ss_pred             CC--------CceecccCCCCCcchhhhh---c---cCCCchhHHHHHHHHHHHhhCCCCCCCCC---------------
Q 015352          207 PG--------ERFSEIVGSPYYMAPEVLK---R---NYGPEIDIWSAGVILYILLCGVPPFWAES---------------  257 (408)
Q Consensus       207 ~~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~DiwslG~il~~l~~g~~pf~~~~---------------  257 (408)
                      -.        ..+.+.+|+..|||||+..   +   -|+.++|.||||+|+|.|++|.+||.+.-               
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C  310 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC  310 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence            21        1344568899999999753   3   48999999999999999999999996641               


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCC
Q 015352          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  318 (408)
                      .+.+...|..|.+.|+...|..+|.+++++|..+|..|+.+|.++.++++|||++......
T Consensus       311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence            3467889999999999999999999999999999999999999999999999999865443

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-50  Score=379.72  Aligned_cols=257  Identities=29%  Similarity=0.515  Sum_probs=227.7

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCC-cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .-.++|.+.+.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESY  105 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCE
Confidence            34568999999999999999999877655 68999999766544444567788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecC
Confidence            99999999999999999988889999999999999999999999999999999999999   556789999999998654


Q ss_pred             CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ..  .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+..+...++    ..+++.++
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  256 (340)
T PTZ00426        183 TR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCK  256 (340)
T ss_pred             CC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            32  245679999999999875 589999999999999999999999999888888888887765543    35789999


Q ss_pred             HHHHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      ++|++||+.||.+|+     |++++++||||.+.
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999995     89999999999864

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4e-50  Score=383.80  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=221.9

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|.+++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence            688999999999999999999999999999999876554455567889999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC--
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~--  209 (408)
                      ||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   456789999999875321000  


Q ss_pred             ----------------------------------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHH
Q 015352          210 ----------------------------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVI  242 (408)
Q Consensus       210 ----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i  242 (408)
                                                                    .....+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          0123579999999999875 68999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC--CCcCCCCCHHHHhcCccccCC
Q 015352          243 LYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE--PDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       243 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~--~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +|+|++|..||...+..+....+.........+....+++++++||.+|+.  .+|..|+++.++++||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999999887776666666544334444445789999999999654  455569999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-50  Score=374.46  Aligned_cols=248  Identities=31%  Similarity=0.556  Sum_probs=219.8

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++++ +||||+++++++.+.+..|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            79999999999999999999999999765444444567788999999999 99999999999999999999999999999


Q ss_pred             hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceecccCC
Q 015352          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIVGS  217 (408)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~~gt  217 (408)
                      |.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999   5567899999999875432 2233456799


Q ss_pred             CCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCc
Q 015352          218 PYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP  296 (408)
Q Consensus       218 ~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  296 (408)
                      +.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......++    ..+++.+++||.+||..||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence            99999999875 589999999999999999999999999888888888777655443    4688999999999999999


Q ss_pred             CCCC---CHHHHhcCccccCC
Q 015352          297 KLRL---TAKQVLEHPWLQNA  314 (408)
Q Consensus       297 ~~R~---s~~~~l~h~~~~~~  314 (408)
                      .+||   ++.++++||||...
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-50  Score=384.04  Aligned_cols=259  Identities=28%  Similarity=0.484  Sum_probs=221.4

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+++++.+ +||||+++++++.+.+++|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence            4789999999999999999999999999999999765443344456788999999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   456789999999986321100 


Q ss_pred             -----------------------------------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHH
Q 015352          210 -----------------------------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGV  241 (408)
Q Consensus       210 -----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~  241 (408)
                                                                     .....+||+.|+|||++.+ .++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                           0012469999999999875 6999999999999


Q ss_pred             HHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCC---CCHHHHhcCccccCC
Q 015352          242 ILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR---LTAKQVLEHPWLQNA  314 (408)
Q Consensus       242 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---~s~~~~l~h~~~~~~  314 (408)
                      ++|+|++|..||.+.+..+....+.........+....++.++++||.+||. +|.+|   +|+.+++.||||...
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999999888777777776544333333334689999999999998 67765   599999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.4e-50  Score=383.94  Aligned_cols=258  Identities=31%  Similarity=0.520  Sum_probs=223.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.+++.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence            689999999999999999999999999999999865444444567788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC---
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG---  208 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~---  208 (408)
                      |||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   56678999999987532100   


Q ss_pred             ---------------------------------------------CceecccCCCCCcchhhhhc-cCCCchhHHHHHHH
Q 015352          209 ---------------------------------------------ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVI  242 (408)
Q Consensus       209 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i  242 (408)
                                                                   ......+||+.|+|||++.+ .++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         00123479999999999875 69999999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCccccCC
Q 015352          243 LYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNA  314 (408)
Q Consensus       243 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~~  314 (408)
                      +|+|++|..||.+.+..+....+.........+....+++++.++|.+|+ .+|.+|++   +.++++||||+..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999999988877777777665544444555678999999999987 59999997   9999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-52  Score=374.76  Aligned_cols=258  Identities=28%  Similarity=0.481  Sum_probs=224.8

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ....|...+.||+|+||.||+|.+..+++.||||++.....  ..+++.+.+|+.+|.++ +++||.++|+.|-.+..++
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHH
Confidence            34567788999999999999999999999999999987654  34578899999999998 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ++||||.||++.+.++..+.+.|..+..++++++.||.|||.++.+|||||+.|||+.   ..+.+||+|||.+.+....
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeech
Confidence            9999999999999998888889999999999999999999999999999999999995   4478999999999887654


Q ss_pred             Cce-ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          209 ERF-SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       209 ~~~-~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      ... .+++|||.|||||++.+ .|+.++||||||++.+||.+|.+|+....+..++-.|-+..   ++..-...|+.+++
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~---PP~L~~~~S~~~kE  241 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA---PPRLDGDFSPPFKE  241 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC---CCccccccCHHHHH
Confidence            432 67899999999999986 79999999999999999999999998776633322222221   11222367899999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ||..||.+||+.||||.++|+|+|++...
T Consensus       242 FV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  242 FVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            99999999999999999999999999844

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.2e-50  Score=384.20  Aligned_cols=259  Identities=29%  Similarity=0.484  Sum_probs=223.4

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEE
Confidence            3699999999999999999999999999999999765443334456788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC--
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG--  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~--  208 (408)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   55678999999997422100  


Q ss_pred             ------------------------------------------CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHH
Q 015352          209 ------------------------------------------ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYI  245 (408)
Q Consensus       209 ------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~  245 (408)
                                                                ......+||+.|+|||++.+ .++.++|||||||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      00123579999999999875 68999999999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCccccCC
Q 015352          246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNA  314 (408)
Q Consensus       246 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~~  314 (408)
                      |++|..||.+.+..+....+.........+....+++++.++|.+|+ .+|.+|+   |+.++++||||+..
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            99999999988877776666655444444445678999999999977 5999999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.9e-50  Score=380.20  Aligned_cols=261  Identities=32%  Similarity=0.491  Sum_probs=227.3

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|.+.+.||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEE
Confidence            346899999999999999999999999999999999765444444456678899999998 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence            99999999999998865 468999999999999999999999999999999999999   56778999999998765433


Q ss_pred             C--ceecccCCCCCcchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          209 E--RFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       209 ~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .  ......||+.|+|||++.+     .++.++|||||||++|+|++|..||.+.+.......+.........+....+|
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            2  2234679999999998853     37899999999999999999999999988888888887765444444445789


Q ss_pred             HHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCC
Q 015352          282 ESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~  314 (408)
                      .++++||.+||+.+|.+  |+|+.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            99999999999999998  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7e-50  Score=373.28  Aligned_cols=251  Identities=30%  Similarity=0.537  Sum_probs=221.1

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998654433444567788999998876899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~~  215 (408)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   556779999999987542 223334567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......++    ..+++++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence            9999999999875 689999999999999999999999999988888888877655433    35789999999999999


Q ss_pred             CcCCCCCH------HHHhcCccccCC
Q 015352          295 DPKLRLTA------KQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~s~------~~~l~h~~~~~~  314 (408)
                      ||.+||++      .++++||||...
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999998      999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-50  Score=380.89  Aligned_cols=259  Identities=35%  Similarity=0.586  Sum_probs=227.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.++..+ +||||+++++++.+++++|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence            4799999999999999999999999999999999876544444567788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence            9999999999999888889999999999999999999999999999999999999   556789999999987654332 


Q ss_pred             -----------------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH
Q 015352          210 -----------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ  259 (408)
Q Consensus       210 -----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  259 (408)
                                                   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         2234579999999999875 6899999999999999999999999998887


Q ss_pred             HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCC-HHHHhcCccccCC
Q 015352          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT-AKQVLEHPWLQNA  314 (408)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s-~~~~l~h~~~~~~  314 (408)
                      .....+.........+....+++++.+||.+||. ||.+||+ +.++++||||+..
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            7777777733333333344589999999999997 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7e-50  Score=374.45  Aligned_cols=250  Identities=29%  Similarity=0.536  Sum_probs=220.4

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++..++.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999999865544444567788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~~  215 (408)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence            9999999888889999999999999999999999999999999999999   4567799999999875322 22334567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++    ..+++++.+||.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence            9999999999875 689999999999999999999999998888777777766555443    36899999999999999


Q ss_pred             CcCCCC-----CHHHHhcCccccCC
Q 015352          295 DPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      ||.+|+     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999997     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-49  Score=371.84  Aligned_cols=256  Identities=28%  Similarity=0.476  Sum_probs=225.0

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            48899999999999999999999999999999987554444456778889999999855677999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCc
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGER  210 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~  210 (408)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   456789999999987532 2233


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......++    ..+++++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            445679999999999875 589999999999999999999999999888888888877655443    368999999999


Q ss_pred             HhcCCCcCCCCCH-----HHHhcCccccCC
Q 015352          290 QMLEPDPKLRLTA-----KQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~s~-----~~~l~h~~~~~~  314 (408)
                      +||.+||.+|+++     .++++||||...
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999986     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.4e-50  Score=373.24  Aligned_cols=250  Identities=32%  Similarity=0.559  Sum_probs=220.6

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|++..+|..||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            4699999999999999999999999999865443444456778899999999 999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~~  215 (408)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   456779999999987532 223334567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+......++    ..+++++.+||.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999865 689999999999999999999999998888887777776655443    36799999999999999


Q ss_pred             CcCCCC-----CHHHHhcCccccCC
Q 015352          295 DPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      ||.+|+     ++.++++||||...
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999998     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-49  Score=364.73  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=212.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||.|+||.||+|++..++..||+|++......  .....+.+|+.+++.+ +||||+++++++.+++..|+|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEE
Confidence            5799999999999999999999999999999999754322  2235677899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      |||++| +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence            999976 8988887654 47999999999999999999999999999999999999   45677999999998764322 


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC------------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------------  274 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------  274 (408)
                      .......|++.|+|||++.+  .++.++||||+||++|+|++|..||.+.+..+....+.+.......            
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            22344578999999998864  5899999999999999999999999888776665555432211110            


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          275 --------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       275 --------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                    ...+.+++++++||.+||+.||.+|||+.|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                          0113568899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-49  Score=377.35  Aligned_cols=262  Identities=31%  Similarity=0.478  Sum_probs=225.5

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|++.+.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++.+++.+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEE
Confidence            3457899999999999999999999999999999999765444444456688999999998 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++.....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence            9999999999999988654 68999999999999999999999999999999999999   5567899999999987543


Q ss_pred             CC--ceecccCCCCCcchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          208 GE--RFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       208 ~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ..  ......||+.|+|||++.+     .++.++||||+||++|+|++|..||.+.+.......+......+..+....+
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  274 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI  274 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence            32  2245679999999999864     2788999999999999999999999998888888888765544444444568


Q ss_pred             CHHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~  314 (408)
                      +..++++|.+||..++.+  |+|+.++++||||+..
T Consensus       275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999999866554  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-50  Score=355.50  Aligned_cols=259  Identities=31%  Similarity=0.464  Sum_probs=223.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      ...-.|.-.+.+|+|+||.||+|....+++.||||.+-.++--       -.+|+++|+.+ +|||||++.-+|...   
T Consensus        21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l-~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKL-DHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhc-CCcCeeeEEEEEEecCCC
Confidence            3555788899999999999999999999999999998654322       23699999998 999999999888632   


Q ss_pred             --CeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          125 --NAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       125 --~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                        -+..+||||++. +|.+.++.    +..++.-.++-++.||++||.|||+.||+||||||.|+|++  .+.+.+||||
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicD  169 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICD  169 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEecc
Confidence              245699999976 99998874    46799999999999999999999999999999999999996  4568899999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc----
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF----  272 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----  272 (408)
                      ||.|+....++...++.-|..|+|||.+.+  .|+.+.||||.||++.||+-|.+.|.|.+...++..|.+....+    
T Consensus       170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999999998888888999999999999876  69999999999999999999999999998888777775533111    


Q ss_pred             ----------------CCCC-----CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          273 ----------------KRDP-----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       273 ----------------~~~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                                      ....     ....++++.+|+.++|..+|.+|.++.|++.||||.....+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                            1111     23578999999999999999999999999999999987654

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-49  Score=351.28  Aligned_cols=261  Identities=30%  Similarity=0.484  Sum_probs=225.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC-eeEEeeEEEeCC---
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDN---  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-i~~~~~~~~~~~---  125 (408)
                      ...|..++.||+|+||+||+|+++.+|+.||+|.+....-... ......+|+.+++.| +|+| |+++++++...+   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccc
Confidence            4567788899999999999999999999999999986643222 234567899999999 8888 999999998877   


Q ss_pred             ---eEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          126 ---AVHLVMELCEGGELFDRIVARG----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       126 ---~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                         .+++|+||++- +|..++....    .++...++.+++||+.||+|||+++|+||||||+|||+   ++.+.+||+|
T Consensus        88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence               89999999965 9999998755    57888999999999999999999999999999999999   4578899999


Q ss_pred             cccccccC-CCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC
Q 015352          199 FGLSIFFK-PGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       199 fg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (408)
                      ||+|+... +...++..++|.+|+|||++.+  .|+...||||+|||++||+++++.|.+.+..+....|.+........
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99999766 5556778899999999999876  59999999999999999999999999999888888886655443333


Q ss_pred             CCC--------------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          276 PWP--------------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       276 ~~~--------------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      .|+                          ..+++..+++.+||+.+|.+|.|+..+|.||||.....
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            332                          23458899999999999999999999999999988753

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-49  Score=377.65  Aligned_cols=259  Identities=29%  Similarity=0.494  Sum_probs=223.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +.|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..+ +||+|+++++.+.+++.+|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            4689999999999999999999999999999999865444444567788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   556789999999986432110 


Q ss_pred             -----------------------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCC
Q 015352          210 -----------------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPF  253 (408)
Q Consensus       210 -----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf  253 (408)
                                                         .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               0123579999999999875 6999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCccccCC
Q 015352          254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNA  314 (408)
Q Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~~  314 (408)
                      .+.+.......+.........+....+++++++||.+|+. ||.+|+   ++.++++||||...
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            9988888877777644333223334578999999999874 999998   48999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-49  Score=370.13  Aligned_cols=251  Identities=29%  Similarity=0.518  Sum_probs=221.3

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999998755444445567788999998776899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~~  215 (408)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999   5567899999999875432 22334567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence            9999999999875 689999999999999999999999999998888888887665433    35789999999999999


Q ss_pred             CcCCCC-------CHHHHhcCccccCC
Q 015352          295 DPKLRL-------TAKQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~-------s~~~~l~h~~~~~~  314 (408)
                      ||++||       ++.++++||||...
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999       99999999999663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.6e-49  Score=369.12  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=225.5

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48889999999999999999999999999999987654444445667788899888867999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCc
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GER  210 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~  210 (408)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   5567899999999875432 223


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence            345679999999999875 699999999999999999999999999988888888887665443    368999999999


Q ss_pred             HhcCCCcCCCCCH-----HHHhcCccccCC
Q 015352          290 QMLEPDPKLRLTA-----KQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~s~-----~~~l~h~~~~~~  314 (408)
                      +||+.||.+|+++     .++++||||+..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999984     899999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-49  Score=373.37  Aligned_cols=259  Identities=29%  Similarity=0.436  Sum_probs=224.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence            4789999999999999999999999999999999866543344456788999999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||++||+|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence            9999999999999876 679999999999999999999999999999999999999   566789999999998765433


Q ss_pred             ce--ecccCCCCCcchhhhh-------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          210 RF--SEIVGSPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       210 ~~--~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ..  ....||+.|+|||++.       ..++.++|||||||++|+|++|..||...+.......+.........+....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            22  2347899999999885       24788999999999999999999999988887777777765433333333568


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ++.+.+||.+||. +|.+|||+.++++||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.7e-49  Score=369.86  Aligned_cols=251  Identities=29%  Similarity=0.527  Sum_probs=214.9

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999998765544455667889999999987899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc-CCCCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~-~~~~~~~~~~  215 (408)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++... ..........
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888899999999999999999999999999999999999999   45677999999998753 2333445568


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC---------CHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---------SEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ||+.|+|||++.+ .++.++|+||+||++|+|++|..||...         ......+.+.......+    ..++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            9999999999875 5899999999999999999999999531         11223444444443332    36789999


Q ss_pred             HHHHHhcCCCcCCCCC------HHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s------~~~~l~h~~~~~~  314 (408)
                      ++|.+||+.||.+|+|      +.++++||||...
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999997      7899999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-49  Score=361.94  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=212.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.+++.+ +||||+++++++..++.+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEE
Confidence            4799999999999999999999999999999999765332 23356788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++++.+..+....+.+++..++.++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence            9999998776555445679999999999999999999999999999999999999   456679999999998754322 


Q ss_pred             -ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc----------------
Q 015352          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID----------------  271 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------  271 (408)
                       ......|++.|+|||++.+ .++.++||||+||++|+|++|++||.+.+..+....+......                
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             2334578999999999875 6899999999999999999999999887655443333221100                


Q ss_pred             ---cCC---------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 ---FKR---------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 ---~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                         ++.         .....+|+.+.+||.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               000         0112368889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-49  Score=371.62  Aligned_cols=250  Identities=30%  Similarity=0.553  Sum_probs=220.1

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|.+..+|..||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876544444556778899999998 999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceecc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEI  214 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~  214 (408)
                      |+|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999   556789999999987533 23333456


Q ss_pred             cCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       215 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+||.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            79999999999875 689999999999999999999999998888777777766655443    3578999999999999


Q ss_pred             CCcCCCC-----CHHHHhcCccccCC
Q 015352          294 PDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       294 ~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      .||++|+     ++.++++||||...
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.5e-49  Score=366.57  Aligned_cols=251  Identities=27%  Similarity=0.469  Sum_probs=217.5

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|+++.+|..||+|++.+...........+..|..++..+.+||||+++++++.+++++|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999998654333334566778888887665899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~~  215 (408)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999   4566899999999875322 22344567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......++    ..++.++++||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999875 689999999999999999999999999888887777766543332    35789999999999999


Q ss_pred             CcCCCCCH-HHHhcCccccCC
Q 015352          295 DPKLRLTA-KQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~s~-~~~l~h~~~~~~  314 (408)
                      ||++||++ .++++||||...
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCC
Confidence            99999998 589999999774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.1e-49  Score=367.22  Aligned_cols=251  Identities=31%  Similarity=0.533  Sum_probs=221.0

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765444445667788999999887899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~~  215 (408)
                      ++|..++.+.+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   556789999999987532 222334457


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+......++    ..+++.+.+||++||..
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence            9999999999875 689999999999999999999999998888888777776655433    35789999999999999


Q ss_pred             CcCCCCCH-----HHHhcCccccCC
Q 015352          295 DPKLRLTA-----KQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~s~-----~~~l~h~~~~~~  314 (408)
                      ||.+|||+     .++++||||+..
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999     999999999774

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.5e-49  Score=365.66  Aligned_cols=251  Identities=31%  Similarity=0.510  Sum_probs=217.0

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+.+||||+++++++..++.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998654433344556677888887666899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-Cceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~~~~~~~  215 (408)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... .......
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   45678999999998764322 2334567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++    ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999875 589999999999999999999999999888887777765543322    35789999999999999


Q ss_pred             CcCCCCCH-HHHhcCccccCC
Q 015352          295 DPKLRLTA-KQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~s~-~~~l~h~~~~~~  314 (408)
                      ||.+||++ .++++||||...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCC
Confidence            99999986 488899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-48  Score=362.12  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=209.4

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|+||.||+|+++.+++.||+|++......  .....+.+|+.+++.+ +||||+++++++.++...|+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEE
Confidence            47899999999999999999999999999999998754322  2234577899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-
Q 015352          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-  207 (408)
                      ||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... 
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCC
Confidence            999996 4777777654 568999999999999999999999999999999999999   4567799999999875432 


Q ss_pred             CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCcc-------------
Q 015352          208 GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLID-------------  271 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~-------------  271 (408)
                      ........||+.|+|||++.+  .++.++||||+||++|+|++|..||.+... ......+......             
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            223344578999999998864  488999999999999999999999987533 2333322211000             


Q ss_pred             -cCCCC------------C--CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          272 -FKRDP------------W--PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       272 -~~~~~------------~--~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                       +....            +  ...++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence             00000            0  1245789999999999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.4e-49  Score=372.73  Aligned_cols=261  Identities=32%  Similarity=0.479  Sum_probs=224.8

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|.+.+.||+|+||.||+|+++.+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence            347999999999999999999999999999999999765443344456678899999998 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence            999999999999988654 58999999999999999999999999999999999999   45678999999999865433


Q ss_pred             C--ceecccCCCCCcchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          209 E--RFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       209 ~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .  ......||+.|+|||++.+     .++.++|||||||++|+|++|..||.+.+.......+......+..+....++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            2  2235679999999999864     27899999999999999999999999998888888887765444444456789


Q ss_pred             HHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCC
Q 015352          282 ESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~  314 (408)
                      ..++++|.+||..++.+  |+++.++++||||++.
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999999854443  7899999999999774

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.9e-49  Score=369.79  Aligned_cols=256  Identities=30%  Similarity=0.538  Sum_probs=215.3

Q ss_pred             ceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++.+.... .....+.+.+|+.+++.+.+||+|+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999999864   47899999999764332 2233456788999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   4566899999999876433


Q ss_pred             CC--ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCcccCCCCCCC
Q 015352          208 GE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       208 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||....    .......+.....    .....
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP----PFPSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC----CCCCC
Confidence            22  2234579999999999875  47889999999999999999999996532    2333344443322    22346


Q ss_pred             CCHHHHHHHHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +++.++++|.+||+.||++||     ++.++++||||+..
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            899999999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=362.17  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=212.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcE-EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-eEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTREL-LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-AVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~~~l  129 (408)
                      ...+.+.||+|+||+||+|.++  |.. ||+|++......... .+.+.+|+.+|.++ +||||+++++++.+.. .+++
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEE
Confidence            3445666999999999999986  455 999999866554433 77999999999999 9999999999999887 7999


Q ss_pred             EEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCceEeecCCCCC-CEEEeeccccccc
Q 015352          130 VMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHG-VIHRDLKPENFLFANKKENS-PLKAIDFGLSIFF  205 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~-ivH~dikp~NIl~~~~~~~~-~vkl~Dfg~~~~~  205 (408)
                      ||||+++|+|.+++..  .+.++...+..++.+|+.||+|||+++ ||||||||+|||++   ... ++||+|||+++..
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccceee
Confidence            9999999999999988  578999999999999999999999999 99999999999994   454 8999999999876


Q ss_pred             CCC-CceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPG-ERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ... ...+...||+.|||||++.+   .|+.++||||||+++|||+||..||.+.........+.........+  ...+
T Consensus       195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~  272 (362)
T KOG0192|consen  195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECP  272 (362)
T ss_pred             ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCC
Confidence            544 33444789999999999984   49999999999999999999999999988766666555444332222  2489


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+..|+.+||..||.+||+..+++.
T Consensus       273 ~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  273 PHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999999999875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-48  Score=366.01  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=218.8

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHH---hCCCCCCeeEEeeEEEeCCeEEE
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK---HLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      |++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.++.   .+ +||||+++++++.+.+.+|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence            678999999999999999999999999999998654433344567777777664   44 79999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-C
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-G  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~  208 (408)
                      ||||++|++|..++.. +.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..... .
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence            9999999999887754 579999999999999999999999999999999999999   4567899999999875332 2


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      .......|++.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..+....+......++    ..+++.+.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  231 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI  231 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            23345679999999999875 589999999999999999999999999888888888877655433    3679999999


Q ss_pred             HHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          288 VRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       288 i~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      |.+||+.||.+||     ++.++++||||...
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999999999999     79999999999764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-49  Score=367.39  Aligned_cols=256  Identities=33%  Similarity=0.537  Sum_probs=233.4

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe-EE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA-VH  128 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~-~~  128 (408)
                      .++|..++.+|+|+||.+++++++..+..+|+|.+........ ..+...+|+.+++++ .||||+.+.+.|..++. .+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEE
Confidence            4689999999999999999999999999999999988776443 345788999999998 99999999999998888 99


Q ss_pred             EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          129 LVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |||+||+||+|.+.+.+.+  .++|+.+..|+.|++.|+.|||+++|+|||||+.||+++   .+..|||+|||+|+...
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcC
Confidence            9999999999999997754  599999999999999999999999999999999999995   55568999999999988


Q ss_pred             CCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 PGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      +.. ...+++|||.|++||++.+ +|+.|+|||||||++|||++-+++|.+.+...+..+|.++......   ..++.++
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el  234 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSEL  234 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHH
Confidence            776 6678899999999999987 7999999999999999999999999999999999999998844332   4789999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      +.+|+.||.++|..||++.++|.+|.++.
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            99999999999999999999999998874

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-48  Score=365.95  Aligned_cols=259  Identities=30%  Similarity=0.451  Sum_probs=211.9

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC-----Ce
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-----NA  126 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~  126 (408)
                      +|++.+.||+|+||.||+|++..+|..||+|.+.... ........+.+|+.+++.+ +||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCce
Confidence            6999999999999999999999999999999986432 2223345788999999999 999999999988543     35


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence            899999995 6899999888889999999999999999999999999999999999999   566789999999987543


Q ss_pred             CCC----ceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Q 015352          207 PGE----RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-----------  268 (408)
Q Consensus       207 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~-----------  268 (408)
                      ...    ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.+.+.......+...           
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            211    1234579999999999864   5899999999999999999999999876543332221110           


Q ss_pred             ----------------CcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          269 ----------------LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       269 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                      ........++.+++.+.++|.+||+.||++|||+.++++||||+....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                            000011223467889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-48  Score=364.41  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=224.0

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|+.++..+.+||+|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            36788999999999999999999999999999986544344445677889999998867788999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-Cc
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ER  210 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~~  210 (408)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence            999999999999888889999999999999999999999999999999999999   45678999999998754322 22


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+......++    ..++.++.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            344579999999999875 589999999999999999999999999888888888877665433    367899999999


Q ss_pred             HhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          290 QMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      +||+++|.+|++     ..++++||||...
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            999999999997     5789999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-48  Score=358.14  Aligned_cols=259  Identities=31%  Similarity=0.501  Sum_probs=219.6

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.+ +||||+++++.+.+++.+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence            488899999999999999999999999999999765444333345678899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||++||+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence            999999999887654  458999999999999999999999999999999999999   556789999999998765444


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+..............+++.+.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            4445678999999999875 689999999999999999999999988765444333333222222233346899999999


Q ss_pred             HHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          289 RQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       289 ~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      .+||..||.+||     ++.++++||||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999     89999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-48  Score=362.53  Aligned_cols=251  Identities=26%  Similarity=0.449  Sum_probs=216.8

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|++..+++.||+|++.+..............|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998654333334556777888888755999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~~  215 (408)
                      |+|..++.....+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999888889999999999999999999999999999999999999   4566799999999875322 22334567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......++    ..++.+++++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            9999999999875 689999999999999999999999998888777777765543322    35789999999999999


Q ss_pred             CcCCCCCHH-HHhcCccccCC
Q 015352          295 DPKLRLTAK-QVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~s~~-~~l~h~~~~~~  314 (408)
                      ||++||++. ++++||||...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCC
Confidence            999999996 89999999774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-48  Score=365.39  Aligned_cols=251  Identities=29%  Similarity=0.509  Sum_probs=214.0

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765545555667888999998876899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~~  215 (408)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   556789999999987532 233344567


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC---------CHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---------SEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...         ......+.+......++    ..++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            9999999999875 5899999999999999999999999521         11223344444443332    46789999


Q ss_pred             HHHHHhcCCCcCCCCC------HHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s------~~~~l~h~~~~~~  314 (408)
                      +||.+||+.||.+|||      +.++++||||...
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.5e-48  Score=375.79  Aligned_cols=256  Identities=27%  Similarity=0.408  Sum_probs=210.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----  124 (408)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....       ....+|+.+++.+ +||||++++++|...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhc-CCCCCcceeeeEeeccccc
Confidence            4568999999999999999999999999999999885432       2345799999999 999999999887432    


Q ss_pred             ----CeEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          125 ----NAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       125 ----~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                          ..+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.  ....+||
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~vkL  212 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKL  212 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCceee
Confidence                257799999976 6766654    3456999999999999999999999999999999999999952  3346999


Q ss_pred             eecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc----
Q 015352          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----  270 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----  270 (408)
                      +|||++.............||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+....+.+...    
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987765555556789999999998764  589999999999999999999999998877665555543211    


Q ss_pred             -------------ccCCC--------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          271 -------------DFKRD--------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       271 -------------~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                   .++..        .....|+++++||.+||+.||.+|||+.|+|+||||....
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                         11100        0124678999999999999999999999999999998754

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-48  Score=356.39  Aligned_cols=252  Identities=29%  Similarity=0.494  Sum_probs=209.8

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||+|+||+||+|.++.+|+.||+|.+.+.........+.+..|+.+++.+ +||||+++.+++..++.+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            79999999999999999999999999866544444456778899999999 99999999999999999999999999999


Q ss_pred             hHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-ceec
Q 015352          139 LFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSE  213 (408)
Q Consensus       139 L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-~~~~  213 (408)
                      |..++..    ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....... ....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence            9887743    3468999999999999999999999999999999999999   456779999999987654332 2334


Q ss_pred             ccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhc
Q 015352          214 IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQML  292 (408)
Q Consensus       214 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l  292 (408)
                      ..||+.|+|||++.+ .++.++||||+||++|+|++|..||...........+.......+......+++.+.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            578999999999875 6899999999999999999999999765432222222222222222223468999999999999


Q ss_pred             CCCcCCCC-----CHHHHhcCccccCC
Q 015352          293 EPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       293 ~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +.||++||     +++++++||||+..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-48  Score=365.29  Aligned_cols=250  Identities=28%  Similarity=0.521  Sum_probs=216.0

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHH-HHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-MKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+..|..+ ++.+ +||||+++++.+.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            469999999999999999999999999986544333334555666554 5677 99999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceecc
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEI  214 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~  214 (408)
                      ||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   4567899999999875422 2233456


Q ss_pred             cCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       215 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......+    +.+++.+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            79999999999875 689999999999999999999999999888888888877654432    4679999999999999


Q ss_pred             CCcCCCCCH----HHHhcCccccCC
Q 015352          294 PDPKLRLTA----KQVLEHPWLQNA  314 (408)
Q Consensus       294 ~dp~~R~s~----~~~l~h~~~~~~  314 (408)
                      .||.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999999998    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.8e-48  Score=361.28  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=218.0

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|++..+|..+|+|++....  .......+.+|+++++.+ +||||+++++++.+++.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence            578999999999999999999999999999999987542  223356789999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||||++|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999   45667999999998765332


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc----------------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID----------------  271 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------  271 (408)
                       ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+......                
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             2344579999999999875 5899999999999999999999999776655443322111000                


Q ss_pred             ----------------------------cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 ----------------------------FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                                  .+......+++++++||.+||+.||++|||+.++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                        00111124688999999999999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-48  Score=363.17  Aligned_cols=251  Identities=32%  Similarity=0.555  Sum_probs=217.9

Q ss_pred             cceecccCCeEEEEEEEC---CCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           56 DRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      ++.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+++.+ +||||+++++++..++.+|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEE
Confidence            367999999999999864   47889999999765432 223345678899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCc
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GER  210 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~  210 (408)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ...
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCc
Confidence            999999999999988889999999999999999999999999999999999999   5567899999999875432 223


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+..+...++    +.+++.+.+||.
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  232 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLK  232 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            344579999999999875 588999999999999999999999999888888888877655433    467899999999


Q ss_pred             HhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          290 QMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +||++||++||     ++.++++||||...
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-50  Score=365.81  Aligned_cols=260  Identities=32%  Similarity=0.589  Sum_probs=236.3

Q ss_pred             cceEe--cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           51 DRYLV--DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        51 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      .-|++  .+.||+|.||+||-|+++.+|+.||||+|.+-++.... ...+++|+.||+++ +||.||.+.-.|+..+.++
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l-~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNL-HHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEE
Confidence            34555  47899999999999999999999999999998886654 47899999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          129 LVMELCEGGELFDRIV--ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|||-+.| +..+.+.  +.+.++++....++.||+.||.|||.+||+|.||||+|||+.+.+.-.++||||||+|++..
T Consensus       640 VVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg  718 (888)
T KOG4236|consen  640 VVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG  718 (888)
T ss_pred             EEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence            99999977 5545543  35789999999999999999999999999999999999999887777899999999999988


Q ss_pred             CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ......+++|||.|+|||+++. .|+..-|+||+|+|+|--++|..||..  .+++-.+|.+..+-++..+|..+++++.
T Consensus       719 EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~Ai  796 (888)
T KOG4236|consen  719 EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAI  796 (888)
T ss_pred             hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHH
Confidence            7777778899999999999985 699999999999999999999999954  4567788999999999999999999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +||..+|+..-.+|.|..+.|.|||+++..
T Consensus       797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  797 DLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            999999999999999999999999998764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-48  Score=362.16  Aligned_cols=260  Identities=29%  Similarity=0.491  Sum_probs=219.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+.+++++.+++++|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence            4799999999999999999999999999999999864443444456788999999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||++||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            999999999999976 4569999999999999999999999999999999999999   556789999999987654332


Q ss_pred             c--eecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-CCCCCC
Q 015352          210 R--FSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-DPWPNV  280 (408)
Q Consensus       210 ~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  280 (408)
                      .  .....||+.|+|||++.      +.++.++||||+||++|+|++|..||.+.+..+....+......+.. .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            2  22346999999999986      24788999999999999999999999988877777777654322221 223458


Q ss_pred             CHHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~  314 (408)
                      ++.+++||++||..++++  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            999999999999765444  8899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-49  Score=367.56  Aligned_cols=250  Identities=31%  Similarity=0.556  Sum_probs=216.9

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      ||+|+||+||+|++..+|+.||+|++.+..............|..++..+.  +||||+++++++.+.+.+|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997654433334455666777777654  799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~~  215 (408)
                      |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999   4567799999999875422 22334567


Q ss_pred             CCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          216 GSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       216 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+..+...++.   ..+++.+++||.+||.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence            9999999999864  4899999999999999999999999998888888888777655443   2578999999999999


Q ss_pred             CCcCCCC----CHHHHhcCccccCC
Q 015352          294 PDPKLRL----TAKQVLEHPWLQNA  314 (408)
Q Consensus       294 ~dp~~R~----s~~~~l~h~~~~~~  314 (408)
                      .||.+||    ++.++++||||...
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCC
Confidence            9999998    79999999999764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.8e-48  Score=361.46  Aligned_cols=251  Identities=28%  Similarity=0.481  Sum_probs=214.4

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++.+||+|+.+++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765544455677889999999987899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceeccc
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~~  215 (408)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999999888889999999999999999999999999999999999999   456779999999987532 333445678


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC-------CHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE-------SEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...       ........+......+    ...++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----PRFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC----CCCCCHHHHHH
Confidence            9999999999875 6899999999999999999999999532       1223334444433322    23578999999


Q ss_pred             HHHhcCCCcCCCCC------HHHHhcCccccCC
Q 015352          288 VRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (408)
Q Consensus       288 i~~~l~~dp~~R~s------~~~~l~h~~~~~~  314 (408)
                      |.+||+.||.+|++      +.++++||||...
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999999998      5799999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-47  Score=353.88  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             cceEecceecccCCeEEEEEEECC-CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEE-----
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACE-----  122 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~-----  122 (408)
                      .+|++.+.||+|+||.||+|++.. +|..||+|.+....... .....+.+|+.+++.+.  +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 46889999987544322 22345667888877763  5999999999885     


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      ....+++||||+. ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcccc
Confidence            3457899999996 4898888764  348999999999999999999999999999999999999   456779999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC----
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD----  275 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  275 (408)
                      ++.............||+.|+|||.+.+ .++.++||||+||++|+|++|.+||.+.+..+....+..........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9987655444455679999999999864 68999999999999999999999999888777766665432111110    


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          276 -------------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       276 -------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                         ..+.+++.+++|+.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                               113577889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-47  Score=366.21  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=208.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|...         ...+.+|+++++++ +||||++++++|..+...+
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeE
Confidence            3468999999999999999999999999999999753         23467899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-  207 (408)
                      +|+|++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++..... 
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccc
Confidence            9999995 6899999888889999999999999999999999999999999999999   4567799999999865322 


Q ss_pred             -CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCcc-------
Q 015352          208 -GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES-------EQGVAQAILRGLID-------  271 (408)
Q Consensus       208 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~-------  271 (408)
                       ........||+.|+|||++.+ .++.++|||||||++|+|++|..||....       .......+......       
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence             123345679999999999875 69999999999999999999998875432       11111112111000       


Q ss_pred             ---------------------cCCCCC---CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          272 ---------------------FKRDPW---PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       272 ---------------------~~~~~~---~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                                           ...+.|   ..++.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                                 000111   1356789999999999999999999999999999876543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-48  Score=367.67  Aligned_cols=261  Identities=31%  Similarity=0.444  Sum_probs=218.7

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC-----CCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-----NSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~i~~~~~~  120 (408)
                      .+.+.-+|.+.+.||+|+||.|-+|.+..|++.||||++...+    .-......|+.+|..|+.     .-|+|+++++
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            4455568999999999999999999999999999999997543    224556779999999952     3479999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      |...++.|||+|++ +.+|+++++.++  .++...++.++.||+.||.+||+.||||+||||+|||+...+. ..|||+|
T Consensus       257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVID  334 (586)
T KOG0667|consen  257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVID  334 (586)
T ss_pred             cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEEe
Confidence            99999999999999 459999999864  4899999999999999999999999999999999999986443 4899999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC----
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK----  273 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----  273 (408)
                      ||.|.+....-  -+++-+..|+|||++.| +|+.+.||||||||++||++|.+.|.+.+..+.+..|..-...++    
T Consensus       335 FGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  335 FGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99998864332  37888999999999887 799999999999999999999999999998888777744321100    


Q ss_pred             -----------C-CC-------------------------------CC------------CCCHHHHHHHHHhcCCCcCC
Q 015352          274 -----------R-DP-------------------------------WP------------NVSESAKSLVRQMLEPDPKL  298 (408)
Q Consensus       274 -----------~-~~-------------------------------~~------------~~~~~~~~li~~~l~~dp~~  298 (408)
                                 . ..                               .+            .....+.+||.+||..||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                       0 00                               00            11234689999999999999


Q ss_pred             CCCHHHHhcCccccCC
Q 015352          299 RLTAKQVLEHPWLQNA  314 (408)
Q Consensus       299 R~s~~~~l~h~~~~~~  314 (408)
                      |+|+.++|+||||...
T Consensus       493 R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  493 RITPAQALNHPFLTGT  508 (586)
T ss_pred             cCCHHHHhcCcccccc
Confidence            9999999999999854

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.2e-48  Score=361.63  Aligned_cols=250  Identities=27%  Similarity=0.509  Sum_probs=215.5

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHH-HHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-MKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      +.||+|+||.||+|++..+|+.+|+|++.+...........+.+|..+ ++.+ +||||+++++++..++.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999986544333334556666654 5666 99999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceecc
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEI  214 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~  214 (408)
                      ||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   5567899999999875322 2233456


Q ss_pred             cCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       215 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+........    +..+..+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            79999999999875 589999999999999999999999999888888888777654332    3678999999999999


Q ss_pred             CCcCCCCCH----HHHhcCccccCC
Q 015352          294 PDPKLRLTA----KQVLEHPWLQNA  314 (408)
Q Consensus       294 ~dp~~R~s~----~~~l~h~~~~~~  314 (408)
                      .+|.+||++    .++++||||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            999999977    589999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-47  Score=358.82  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=221.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+++++.+++.+|+|++.+...........+.+|+.++..+ +||+|+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence            4789999999999999999999999999999999764433333455688899999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence            999999999999977 4678999999999999999999999999999999999999   456789999999987643322


Q ss_pred             c--eecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-CCCCCC
Q 015352          210 R--FSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-DPWPNV  280 (408)
Q Consensus       210 ~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  280 (408)
                      .  .....||+.|+|||++.      +.++.++|||||||++|+|++|..||.+.+..+....+......+.. .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            2  23357999999999885      24889999999999999999999999998888888887765433322 223468


Q ss_pred             CHHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~  314 (408)
                      ++++++||++||..++.+  |+++.++++||||...
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            999999999999765554  7899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-48  Score=362.88  Aligned_cols=263  Identities=36%  Similarity=0.588  Sum_probs=242.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ...+....|.+.+.||+|.|+.|.+|++..|+..||||+|++...... ..+.+.+|+++|+.| +||||++++.+.+..
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETE  127 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Confidence            344566789999999999999999999999999999999998876544 345689999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..+|+||||+.||.+++++.+.+...+..++.++.|+..|++|||+++|+|||||++|||+   +.+..+||+|||++..
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTF  204 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeecccccee
Confidence            9999999999999999999999999999999999999999999999999999999999999   6667799999999999


Q ss_pred             cCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      +..+....+.+|++.|.|||++.+  ..++++|+||+|+++|.|+.|.+||.+.+..+.....+.+.+..+.    .++.
T Consensus       205 ~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~  280 (596)
T KOG0586|consen  205 FDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSC  280 (596)
T ss_pred             ecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeec
Confidence            998888999999999999999987  3578999999999999999999999999988888888888776654    5789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ++.++|+++|.++|.+|++++++.+|.|+.....
T Consensus       281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             hhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence            9999999999999999999999999999976543

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-47  Score=359.02  Aligned_cols=260  Identities=28%  Similarity=0.465  Sum_probs=221.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..+ +||+|+++++++++++..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999999764433334456678899999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||++||+|.+++.+ .+.+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            999999999999987 4679999999999999999999999999999999999999   456779999999987654333


Q ss_pred             ce--ecccCCCCCcchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-CCCCCC
Q 015352          210 RF--SEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-DPWPNV  280 (408)
Q Consensus       210 ~~--~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  280 (408)
                      ..  ....||+.|+|||++.+      .++.++||||+||++|+|++|+.||.+.+..+....+......++. ..+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            22  23579999999998863      4788999999999999999999999988887777777665433322 223467


Q ss_pred             CHHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~  314 (408)
                      +++++++|.+||..++.+  |++++++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            999999999999876655  5799999999999764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.4e-48  Score=359.35  Aligned_cols=250  Identities=27%  Similarity=0.493  Sum_probs=214.2

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHH-HHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.+ +||||+++++++.+.+..|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999999999999999998654433333445556655 56777 99999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceecc
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEI  214 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~  214 (408)
                      |++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.... ........
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   456789999999987532 22233456


Q ss_pred             cCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       215 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    +..+..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence            79999999999875 689999999999999999999999999888787777776654333    3578899999999999


Q ss_pred             CCcCCCCCH----HHHhcCccccCC
Q 015352          294 PDPKLRLTA----KQVLEHPWLQNA  314 (408)
Q Consensus       294 ~dp~~R~s~----~~~l~h~~~~~~  314 (408)
                      .||.+||++    .++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            999999975    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.4e-47  Score=350.57  Aligned_cols=259  Identities=30%  Similarity=0.490  Sum_probs=215.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.+ +|++++.+++.+.+++..|+||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence            377888999999999999999999999999999765544433345678899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||++|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   +..+.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence            999999999988654  358999999999999999999999999999999999999   456679999999987665444


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......|++.|+|||++.+ .++.++||||+||++|+|++|..||..........................+++++++|+
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            4445679999999999875 689999999999999999999999986543211111111111111222346889999999


Q ss_pred             HHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          289 RQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       289 ~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      .+||+.||++|||     +.++++||||+..
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999     9999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.6e-48  Score=360.41  Aligned_cols=249  Identities=30%  Similarity=0.505  Sum_probs=217.4

Q ss_pred             ceecccCCeEEEEEEE---CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           57 RELGRGEFGVTYLCID---RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +.||+|+||.||++++   ..+|+.||+|++.+.... ......+.+|+++++++ +||||+++++++.+++.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence            6799999999999986   357899999999865432 22345677899999999 999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-Ccee
Q 015352          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFS  212 (408)
Q Consensus       134 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~~~~  212 (408)
                      ++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... ....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence            9999999999888889999999999999999999999999999999999999   45667999999998765433 2334


Q ss_pred             cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHh
Q 015352          213 EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM  291 (408)
Q Consensus       213 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  291 (408)
                      ...||+.|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+......++    ..+++.+.+||++|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence            5679999999999875 588999999999999999999999999888888888877655433    35789999999999


Q ss_pred             cCCCcCCCCC-----HHHHhcCccccCC
Q 015352          292 LEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       292 l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      |+.||.+|||     +.+++.||||...
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-47  Score=359.30  Aligned_cols=250  Identities=28%  Similarity=0.513  Sum_probs=214.0

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHH-HHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      +.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+.+|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999998654333333344555554 45677 99999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CCCceecc
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEI  214 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~~~~~~~  214 (408)
                      |++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   456679999999987542 22234456


Q ss_pred             cCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       215 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......+    .+.+++.+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcc
Confidence            79999999999875 58999999999999999999999999988888877777654433    24789999999999999


Q ss_pred             CCcCCCCCHH----HHhcCccccCC
Q 015352          294 PDPKLRLTAK----QVLEHPWLQNA  314 (408)
Q Consensus       294 ~dp~~R~s~~----~~l~h~~~~~~  314 (408)
                      .||.+|+++.    ++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCC
Confidence            9999999876    89999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.7e-47  Score=347.94  Aligned_cols=249  Identities=27%  Similarity=0.466  Sum_probs=209.2

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||+|+||.||++.++.+|+.||+|.+.............+..|+++++.+ +||||++++++++++.++|+||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            79999999999999999999999999765544333345567799999999 99999999999999999999999999999


Q ss_pred             hHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccC
Q 015352          139 LFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG  216 (408)
Q Consensus       139 L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~g  216 (408)
                      |..++...+  .+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence            998886543  48899999999999999999999999999999999999   4567799999999887655544455679


Q ss_pred             CCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHh
Q 015352          217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLIDFKRDPWPNVSESAKSLVRQM  291 (408)
Q Consensus       217 t~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  291 (408)
                      ++.|+|||++.+ .++.++||||+||++|+|++|..||.+....    .+..........+   ....+++++++||.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHHHHH
Confidence            999999999865 5899999999999999999999999764332    2333333332222   2246899999999999


Q ss_pred             cCCCcCCCCCH----HHHhcCccccCC
Q 015352          292 LEPDPKLRLTA----KQVLEHPWLQNA  314 (408)
Q Consensus       292 l~~dp~~R~s~----~~~l~h~~~~~~  314 (408)
                      |+.||++||++    .+++.||||+..
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCC
Confidence            99999999999    678899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4e-47  Score=349.70  Aligned_cols=255  Identities=28%  Similarity=0.448  Sum_probs=208.3

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEEe-----C
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACED-----D  124 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~-----~  124 (408)
                      +|++.+.||+|+||+||+|+++.+|+.||+|.+....... .....+.+|+.+++.+.  +||||+++++++.+     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999987543222 12234566777777653  69999999998864     3


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      ..+++||||+.+ +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence            468999999975 888888764  348999999999999999999999999999999999999   45677999999999


Q ss_pred             cccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC--------
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK--------  273 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------  273 (408)
                      .............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.........+........        
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            87655444455678999999998865 689999999999999999999999988776655555443211000        


Q ss_pred             ---------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          274 ---------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       274 ---------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                     ....+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                           01123578889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-47  Score=362.58  Aligned_cols=259  Identities=26%  Similarity=0.399  Sum_probs=211.0

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-  125 (408)
                      ..+.++|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.+ +||||+++++++...+ 
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~   94 (359)
T cd07876          17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCC
Confidence            3577899999999999999999999999999999999865432 233456788999999999 9999999999986543 


Q ss_pred             -----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          126 -----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       126 -----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                           .+|+||||+++ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg  168 (359)
T cd07876          95 LEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  168 (359)
T ss_pred             ccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCC
Confidence                 57999999976 5666653  348899999999999999999999999999999999999   456789999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----------  269 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~----------  269 (408)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+....          
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            9976544444455678999999999875 69999999999999999999999998776544333222111          


Q ss_pred             ------------cccCC----------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          270 ------------IDFKR----------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       270 ------------~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                                  ...+.                ......++.+++||.+||..||++|||+.|+|+||||..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                        00000                001124678999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.7e-47  Score=346.90  Aligned_cols=260  Identities=30%  Similarity=0.494  Sum_probs=220.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|+..+.||.|+||+||+|.+..+++.+|+|.+.............+.+|+++++.+ +|+||+.+++.+.+++..++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEE
Confidence            377788999999999999999999999999999766554444455678899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence            999999999888654  359999999999999999999999999999999999999   455679999999987654444


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......|++.|+|||.+.+ .++.++|+||+||++|+|++|..||.+.........+..............+++.+.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            4455679999999999864 689999999999999999999999988766544444433333323333456889999999


Q ss_pred             HHhcCCCcCCCCC-----HHHHhcCccccCCc
Q 015352          289 RQMLEPDPKLRLT-----AKQVLEHPWLQNAK  315 (408)
Q Consensus       289 ~~~l~~dp~~R~s-----~~~~l~h~~~~~~~  315 (408)
                      .+||+.||++||+     +.++++|+||....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            9999999999999     89999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.7e-47  Score=358.11  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=209.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.|...+.||+|+||.||+|++..+|+.||+|++....  .......+.+|+++++.+ +|+||+++++++.+++.+|+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEE
Confidence            467888999999999999999999999999999986432  223346788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||++|++|...    ...++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence            9999999998542    346788889999999999999999999999999999999   456789999999988654322


Q ss_pred             -ceecccCCCCCcchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                       ......||..|+|||++..      ..+.++|||||||++|+|++|+.||...........+..............++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence             2345679999999998742      245689999999999999999999974332222221211111222233356889


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++++||.+||..||++|||+.|+++||||....
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            999999999999999999999999999998864

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.9e-47  Score=351.33  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=214.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|+++.++..||+|.+......  .....+.+|+.+++.+ +||||+++++++..++..|+|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEE
Confidence            6799999999999999999999999999999998754322  2234577899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      |||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence            999976 888887665 348999999999999999999999999999999999999   45677999999998754322 


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc---------------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID---------------  271 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------------  271 (408)
                      .......+++.|+|||.+.+  .++.++||||+||++|+|++|..||.+.+..+....+.+....               
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            22334568899999998864  5889999999999999999999999887765554444332110               


Q ss_pred             ----cCC-------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 ----FKR-------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ----~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                          ++.       ...+.+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                000       11235788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-46  Score=368.52  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=205.5

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC-----CCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-----KNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~  124 (408)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....    ........|+.+++.+.     +|++++.++++|..+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            578999999999999999999999999999999986421    12334566777777661     345689999998765


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCC------------
Q 015352          125 -NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKE------------  190 (408)
Q Consensus       125 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~------------  190 (408)
                       +++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.            
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 77999999888889999999999999999999998 59999999999999965331            


Q ss_pred             -CCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Q 015352          191 -NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       191 -~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  268 (408)
                       ...+||+|||.+....  ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus       283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT  360 (467)
T ss_pred             CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence             2359999999876432  22345689999999999876 6999999999999999999999999887765544443322


Q ss_pred             CcccCCC------------------------------------CCC--CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          269 LIDFKRD------------------------------------PWP--NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       269 ~~~~~~~------------------------------------~~~--~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      ...++..                                    .+.  ..++.+.+||.+||+.||.+|||+.|+|+|||
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            1111000                                    000  11456789999999999999999999999999


Q ss_pred             ccCCc
Q 015352          311 LQNAK  315 (408)
Q Consensus       311 ~~~~~  315 (408)
                      |....
T Consensus       441 ~~~~~  445 (467)
T PTZ00284        441 VLKYY  445 (467)
T ss_pred             ccccC
Confidence            98743

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-47  Score=346.24  Aligned_cols=254  Identities=35%  Similarity=0.662  Sum_probs=214.9

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |++++.||+|+||+||+|++..+++.+|+|++........ ......+|+.+++++ +||||+++++++.+....++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence            8899999999999999999999999999999987643222 122345699999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc-CCCCce
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERF  211 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~-~~~~~~  211 (408)
                      |+.+++|.+++...+.+++..+..++.||+.||.+||++|++|+||||+||++   +.++.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999877889999999999999999999999999999999999999   46677999999998763 334455


Q ss_pred             ecccCCCCCcchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          212 SEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       212 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      ....+++.|+|||++.  ..++.++|+||||+++|+|++|..||....   .......................+..+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5678899999999987  468999999999999999999999998873   33333333333332222222233589999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +|.+||+.||++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.8e-46  Score=356.68  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=213.4

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--  124 (408)
                      ..+.++|.+.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhc-CCCCccccceeeccccc
Confidence            4567899999999999999999999999999999999875432 233456788999999999 999999999987543  


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          125 ----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       125 ----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                          ..+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG  171 (364)
T cd07875          98 LEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  171 (364)
T ss_pred             ccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCC
Confidence                467999999976 67777643  48899999999999999999999999999999999999   456789999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc-------
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-------  272 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------  272 (408)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......       
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9987654444455679999999999875 68999999999999999999999998887766555554321110       


Q ss_pred             -------------------------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          273 -------------------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       273 -------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                                                     ........+..+++||.+||+.||.+|||+.++|+||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                                           00011123567899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-46  Score=352.88  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=214.8

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||.|+||.||+|.+..++..+|+|++....  .......+.+|+++++.+ +||||+++++++.+++.+|
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEE
Confidence            3578999999999999999999999999999999987542  223346788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||++|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++   .++.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchhhhh
Confidence            9999999999999998888899999999999999999999985 799999999999994   556799999999876532


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-------------------
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------------------  267 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~-------------------  267 (408)
                      . ......|++.|+|||++.+ .++.++|+|||||++|+|++|..||...........+..                   
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence            2 2234578999999999875 589999999999999999999999976554333211100                   


Q ss_pred             ---------------------CCcccCCC--CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          268 ---------------------GLIDFKRD--PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       268 ---------------------~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                           .......+  .....+.++++||.+||+.||++|||+.|++.||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                 00000000  0113578899999999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-46  Score=356.56  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=212.2

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC-
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-  124 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-  124 (408)
                      ...+.++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++... 
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~   89 (355)
T cd07874          12 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccc
Confidence            34577899999999999999999999999999999999865432 233456778899999999 999999999998644 


Q ss_pred             -----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          125 -----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       125 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                           ...|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Df  163 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDF  163 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeC
Confidence                 357999999976 66666643  48899999999999999999999999999999999999   45678999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc--------
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI--------  270 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--------  270 (408)
                      |++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.....        
T Consensus       164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99987654444455689999999999875 689999999999999999999999988765444333222110        


Q ss_pred             --------------cc----------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          271 --------------DF----------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       271 --------------~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                    ..                ........+..+++||.+||..||++|||+.|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                          00                001112245778999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4e-46  Score=365.44  Aligned_cols=254  Identities=28%  Similarity=0.432  Sum_probs=219.6

Q ss_pred             ccceEecceecccCCeEEEEEEECCC-CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ...|.+.+.||+|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+++.+ +||||+++++++..++.+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEE
Confidence            44599999999999999999998887 788999977533   233345678899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          129 LVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +||||++||+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCcee
Confidence            99999999999987754    3468999999999999999999999999999999999999   4567899999999987


Q ss_pred             cCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          205 FKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       205 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .....   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+....   ....+
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~  295 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPV  295 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccC
Confidence            54332   2345579999999999875 59999999999999999999999999888888888777665432   12467


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ++.++++|.+||..||++||++.+++.|+|++.
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            899999999999999999999999999999864

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=337.02  Aligned_cols=259  Identities=30%  Similarity=0.565  Sum_probs=239.3

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      --++|..++.||+|.||.|-+|+.+.+|+.||+|++.+.-+-.......-..|-.+|+.. +||.+..+--.|+..+++|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEE
Confidence            346788999999999999999999999999999999988776666677788899999997 9999999988999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc-cCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF-FKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~-~~~  207 (408)
                      +||||+.||.|+-++.+...+++..++.+...|+.||.|||+++||.||||.+|.|+   +.++++||+|||+++. ...
T Consensus       245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccc
Confidence            999999999999999998899999999999999999999999999999999999999   7888999999999975 355


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      +....+++|||.|+|||++.. .|+.++|.|.+||++|||++|++||+..+...+..-|+-..+.|+.    .++++++.
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAkt  397 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKT  397 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHH
Confidence            667889999999999999985 6999999999999999999999999999999999999999888875    78999999


Q ss_pred             HHHHhcCCCcCCCC-----CHHHHhcCccccCCc
Q 015352          287 LVRQMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       287 li~~~l~~dp~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      |+..+|.+||.+|.     .+.++.+|+||....
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            99999999999997     589999999998753

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-46  Score=367.04  Aligned_cols=259  Identities=28%  Similarity=0.444  Sum_probs=222.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC--
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--  125 (408)
                      ...++|.+.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.++..+ +|+||+++++.+...+  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcC-CCCcEEEeecceeccccc
Confidence            3457999999999999999999999999999999999765442 34456788999999998 9999999988775432  


Q ss_pred             ------eEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEE
Q 015352          126 ------AVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (408)
Q Consensus       126 ------~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vk  195 (408)
                            .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEE
Confidence                  478999999999999988653    468999999999999999999999999999999999999   4567799


Q ss_pred             EeecccccccCCC---CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc
Q 015352          196 AIDFGLSIFFKPG---ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (408)
Q Consensus       196 l~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  271 (408)
                      |+|||++......   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999998765322   22345679999999999875 6999999999999999999999999998888887777766543


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .   ..+.+++++.+++.+||+.||.+||++.++++|||++..
T Consensus       264 ~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 P---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            2   234689999999999999999999999999999998753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.6e-46  Score=343.72  Aligned_cols=255  Identities=31%  Similarity=0.589  Sum_probs=225.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|.+..+++.+|+|++.+.........+.+.+|+++++++ +||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence            4799999999999999999999999999999999765544444567789999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|.||++   +.++.+||+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence            9999999999999888889999999999999999999999999999999999999   45677999999998876543  


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.........+.+..+...++    ..+++.++++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  230 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHH
Confidence            334578999999998864 588899999999999999999999988877667777766554433    356899999999


Q ss_pred             HhcCCCcCCCC-----CHHHHhcCccccCCc
Q 015352          290 QMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       290 ~~l~~dp~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      +||..||.+|+     +++++++||||....
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999999     999999999997643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-46  Score=358.28  Aligned_cols=258  Identities=29%  Similarity=0.427  Sum_probs=214.2

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-----e
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----A  126 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~  126 (408)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+ +||||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccce
Confidence            4778999999999999999999999999999986432 2223456788999999999 9999999999998876     8


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      .|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence            999999996 5888888887889999999999999999999999999999999999999   556789999999997653


Q ss_pred             CCC--ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------------
Q 015352          207 PGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL-------------  269 (408)
Q Consensus       207 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  269 (408)
                      ...  ......+++.|+|||++.+  .++.++||||+||++|+|++|+.||.+.+.......+....             
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  2334568899999999875  48899999999999999999999998877665554443211             


Q ss_pred             ----------cccCC-----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          270 ----------IDFKR-----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       270 ----------~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                ...+.     ......++++.+||.+||+.||.+|||+.++++||||....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                      00000     11234688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-46  Score=378.30  Aligned_cols=265  Identities=29%  Similarity=0.488  Sum_probs=220.1

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-  123 (408)
                      ++....++|.+++.||.|+||+||+|.+..++..+|+|++...... ......+.+|+.+++.| +||||++++++|.+ 
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMREL-KHKNIVRYIDRFLNK   84 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEec
Confidence            5667778999999999999999999999999999999999765443 23456788999999999 99999999998854 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeccCCCCceEeecC---
Q 015352          124 -DNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKH-------GVIHRDLKPENFLFANK---  188 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~-------~ivH~dikp~NIl~~~~---  188 (408)
                       ...+||||||+++++|.+++..    .+.+++..++.|+.||+.||.|||+.       +|+||||||+|||++..   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             4679999999999999998865    35699999999999999999999985       49999999999999642   


Q ss_pred             -----------CCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCC
Q 015352          189 -----------KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFW  254 (408)
Q Consensus       189 -----------~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~  254 (408)
                                 +....+||+|||++.............||+.|+|||++.+   .++.++||||||||+|+|++|..||.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       1234589999999987654444455679999999999853   48899999999999999999999997


Q ss_pred             CCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ................   ..+....+.++.+||..||..+|.+|||+.|+|.|||++..
T Consensus       245 ~~~~~~qli~~lk~~p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        245 KANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             cCCcHHHHHHHHhcCC---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            6554433333332222   22234678999999999999999999999999999999754

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-48  Score=382.55  Aligned_cols=260  Identities=31%  Similarity=0.503  Sum_probs=233.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|.+++.||+|+||.|..++++.|++.||+|++.+-......+..-|..|-.+|..- +.+-|+.++-.|+++.++|
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceE
Confidence            446899999999999999999999999999999999886655555667899999999886 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||++||+|..++.+.+++|+..++.|+..|+.||..||+.|+|||||||+|||+   +..|+|||+|||.+......
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCC
Confidence            999999999999999998899999999999999999999999999999999999999   78899999999998877633


Q ss_pred             C--ceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CcccCCCCCC
Q 015352          209 E--RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG--LIDFKRDPWP  278 (408)
Q Consensus       209 ~--~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~  278 (408)
                      .  .....+|||.|.|||+++      +.|++.+|.||+||++|||+.|..||+..+-.+.+-+|++-  .+.||  .-.
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~  306 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DET  306 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--ccc
Confidence            3  334568999999999984      35999999999999999999999999999999999999987  45555  334


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCccccCCc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNAK  315 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~~~  315 (408)
                      .+|+++++||.+++.. |+.|..   +.++.+||||.+..
T Consensus       307 ~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  307 DVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             ccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCC
Confidence            6999999999999865 888888   99999999998753

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.9e-46  Score=344.16  Aligned_cols=260  Identities=25%  Similarity=0.437  Sum_probs=215.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||.|+||.||+|+++.++..||+|.+......  .....+.+|+.+++.+ +||||+++++++..++.+|+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEE
Confidence            46799999999999999999999999999999998754322  2234677899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIP  157 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCC
Confidence            9999975 888888764 468999999999999999999999999999999999999   45667999999998764322


Q ss_pred             -CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-----------
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----------  274 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  274 (408)
                       .......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||...+..+....+.+.......           
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence             22334467899999998864  4788999999999999999999999887766555444332111000           


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          275 ---------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       275 ---------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                     ...+.+++.+++||.+||+.||.+|||+.++++||||+...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                           011357889999999999999999999999999999987653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-46  Score=336.45  Aligned_cols=255  Identities=29%  Similarity=0.468  Sum_probs=217.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC--hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT--AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      +.|.+.+.||+|++|.||.|.+..+++.+|+|.+.......  ......+.+|+.+++++ +||||+++++++++++..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence            46899999999999999999999999999999987543321  22346788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +|+||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++......
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence            999999999999999888889999999999999999999999999999999999999   45667999999998765332


Q ss_pred             Cce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          209 ERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       209 ~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ...    ....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+......  ......++..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSHVSPD  235 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCccCCHH
Confidence            211    23467889999999875 5889999999999999999999999876655544444433222  2223468899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +.++|.+||..+|++|||+.++++||||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=343.88  Aligned_cols=259  Identities=30%  Similarity=0.525  Sum_probs=223.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|++|.||+|.+..+++.+|+|.+.+...........+.+|+++++.+ +||||+++++.+.+++..|+|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEE
Confidence            4799999999999999999999999999999999876554434567789999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      |||+.|++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++   .++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhccccc
Confidence            9999999999998764  4689999999999999999999999999999999999994   5677999999988754321


Q ss_pred             C------------------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC
Q 015352          209 E------------------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES  257 (408)
Q Consensus       209 ~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~  257 (408)
                      .                              ......|+..|+|||++.+ .++.++||||||+++|+|++|..||.+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1                              1123468889999999875 58899999999999999999999999888


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCC----HHHHhcCccccCCc
Q 015352          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT----AKQVLEHPWLQNAK  315 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~~~l~h~~~~~~~  315 (408)
                      .......+......++..  ..+++.++++|.+||..||++|||    +.++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            777777666554443322  347899999999999999999999    99999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-46  Score=352.52  Aligned_cols=260  Identities=25%  Similarity=0.446  Sum_probs=212.3

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      .+.++|.+.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccc
Confidence            466899999999999999999999999999999999875422 222345677899999999 999999999988543   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       125 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                         ..+|++++++ |++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence               4579999998 778877664 4579999999999999999999999999999999999999   4567799999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc--------
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------  271 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------  271 (408)
                      +.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+......        
T Consensus       165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            986543  2345678999999999865  5889999999999999999999999876655444443321100        


Q ss_pred             ---------------cCC----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          272 ---------------FKR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       272 ---------------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                     .+.    ..+...++.+.+||.+||..||.+|||+.++++||||.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                           000    012345778899999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=336.21  Aligned_cols=256  Identities=29%  Similarity=0.489  Sum_probs=218.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||.|++|.||+|.+..++..+|+|.+....  .......+.+|+.+++.+ +||||+++++++.++..+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEE
Confidence            47899999999999999999999999999999987543  223356788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      +||+++++|.+++... .+++..++.++.|++.||.|||+.+++||||+|+||++   +.++.++|+|||++...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence            9999999999998765 78999999999999999999999999999999999999   45677999999998776543 2


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+........  ....+++.+.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL--EGNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC--cccccCHHHHHHH
Confidence            3344578889999998875 589999999999999999999999987665555544444322111  1112789999999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||..+|++|||+.++++||||+...
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            999999999999999999999998865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-45  Score=353.21  Aligned_cols=258  Identities=24%  Similarity=0.417  Sum_probs=208.5

Q ss_pred             cccccccceEecceecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      +...+..+|.+.+.||.|+||.||+|...  .++..||+|.+...        ....+|+.+++.+ +||||+++++++.
T Consensus        86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l-~h~~iv~~~~~~~  156 (392)
T PHA03207         86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTI-SHRAIINLIHAYR  156 (392)
T ss_pred             cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhc-CCCCccceeeeEe
Confidence            34456678999999999999999999764  35678999987543        2345799999999 9999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      .....|+|||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++
T Consensus       157 ~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a  232 (392)
T PHA03207        157 WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAA  232 (392)
T ss_pred             eCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccc
Confidence            9999999999995 5888998777889999999999999999999999999999999999999   55678999999998


Q ss_pred             cccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCC----cc
Q 015352          203 IFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---GVAQAILRGL----ID  271 (408)
Q Consensus       203 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~----~~  271 (408)
                      .......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....   .....+.+..    ..
T Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence            7654322   1234579999999999875 6999999999999999999999999775321   1122221110    00


Q ss_pred             cCC------------------CC--------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 FKR------------------DP--------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ~~~------------------~~--------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++.                  +.        ...++.++.++|.+||..||++|||+.++|.||||....
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            000                  00        013467889999999999999999999999999997753

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.6e-45  Score=336.28  Aligned_cols=256  Identities=30%  Similarity=0.570  Sum_probs=213.5

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|++|.||+|+++.+|+.||+|++...... ....+.+.+|+.+++.+ +|||++++++++..+..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEE
Confidence            4799999999999999999999999999999998754322 22235678899999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||+++++|..++.....+++..+..++.||+.||.|||++|++||||||+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            9999998888777666779999999999999999999999999999999999999   455679999999998765433 


Q ss_pred             ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc----------------
Q 015352          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID----------------  271 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------  271 (408)
                      ......++..|+|||.+.+  .++.++|+||+|+++|+|++|..||.+.+..+....+......                
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            3334568889999998864  4789999999999999999999999887665444333221100                


Q ss_pred             ---cCC--------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 ---FKR--------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 ---~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                         .+.        ..++.++..+.+||.+||+.+|++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence               000        0124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.3e-46  Score=345.42  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=194.4

Q ss_pred             cceecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--CCeEEEEE
Q 015352           56 DRELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAVHLVM  131 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~  131 (408)
                      .+.||+|+||+||+|+++  .+++.+|+|.+.....     ...+.+|+.+++++ +||||+++++++..  +..+|++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEE
Confidence            457999999999999976  4678899999864422     24567899999999 99999999999854  56789999


Q ss_pred             eccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC-CCCCCEEEeeccc
Q 015352          132 ELCEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGL  201 (408)
Q Consensus       132 e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~-~~~~~vkl~Dfg~  201 (408)
                      ||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            99965 887777532         248999999999999999999999999999999999999643 3456899999999


Q ss_pred             ccccCCC----CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCH---------HHHHHHHH
Q 015352          202 SIFFKPG----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESE---------QGVAQAIL  266 (408)
Q Consensus       202 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~~i~  266 (408)
                      +......    .......||+.|+|||++.+  .++.++||||+||++|+|++|.+||.....         ......+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            9765422    12345678999999998865  489999999999999999999999965332         11111121


Q ss_pred             cCCccc---------------------C-------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          267 RGLIDF---------------------K-------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       267 ~~~~~~---------------------~-------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ......                     .             .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            110000                     0             00011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.7e-45  Score=338.75  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=222.4

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +.|.+.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.+ +||||+++++.+..++.+|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEE
Confidence            3688999999999999999999999999999998765443334456788999999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||++   +..+.+||+|||++....... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCcc
Confidence            9999999999999888889999999999999999999999999999999999999   456789999999886321000 


Q ss_pred             ---------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          210 ---------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       210 ---------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                                     ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.+....+....+..+....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                           0112457888999998764 689999999999999999999999998888887777776655444


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCccccCC
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNA  314 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~~  314 (408)
                      ... ..+++++.++|.+||+.||++||+   +.++++||||...
T Consensus       237 ~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         237 EGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             Ccc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            433 267899999999999999999998   7999999999663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-45  Score=332.16  Aligned_cols=253  Identities=31%  Similarity=0.482  Sum_probs=215.7

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++....+|||++++++++..++.+|+|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999987654333333344556666555444899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccC
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG  216 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~g  216 (408)
                      ++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++   +..+.+||+|||++.....   .....|
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999   4566799999998876432   234468


Q ss_pred             CCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCC
Q 015352          217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (408)
Q Consensus       217 t~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (408)
                      ++.|+|||.+.+ .++.++||||+|+++|+|++|..||...+.......+..+...++......+++.+.++|.+||+.+
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            899999999875 4789999999999999999999999988887777777776666555555578999999999999999


Q ss_pred             cCCCCC---HHHHhcCccccCCc
Q 015352          296 PKLRLT---AKQVLEHPWLQNAK  315 (408)
Q Consensus       296 p~~R~s---~~~~l~h~~~~~~~  315 (408)
                      |++||+   +.|+++||||.+..
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcCC
Confidence            999994   57999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-45  Score=334.22  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=213.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+ +||||+++++.+...+.+
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEE
Confidence            34568999999999999999999999999999999986542   22345678899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||++   +..+.+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccC
Confidence            9999999999999999888899999999999999999999999999999999999999   4566799999999875432


Q ss_pred             CC-ceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC-CCCCCCCC
Q 015352          208 GE-RFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-RDPWPNVS  281 (408)
Q Consensus       208 ~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~  281 (408)
                      .. ......|++.|+|||++.    +.++.++|+||+||++|+|++|..||...................+ ......++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS  238 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence            21 223457899999999873    3588899999999999999999999976554433333332222211 11122578


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      ..+.++|.+||..+|++|||+.++++|||
T Consensus       239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.2e-45  Score=339.46  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=213.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+++++++ +||||+++++++.+++.+|+|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999986432  222345688999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++   .++.+||+|||++...... 
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccccc-
Confidence            9999999999999888889999999999999999999997 5999999999999994   4567999999998754322 


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc----------------
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF----------------  272 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----------------  272 (408)
                      ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+.......+.......                
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            2244578999999999875 58899999999999999999999997655433322221111000                


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          273 ------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       273 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                        +..+...++.++++|+.+||..+|++|||+.++++||||.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                              000112367889999999999999999999999999999774

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-47  Score=352.27  Aligned_cols=261  Identities=27%  Similarity=0.449  Sum_probs=228.5

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      -.++....|.-++.||.|+||.||-|++..+.+.||||.+.............+.+|+..|++| .|||++.+-++|-.+
T Consensus        20 ~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre   98 (948)
T KOG0577|consen   20 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE   98 (948)
T ss_pred             ccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc
Confidence            3455667788889999999999999999999999999999887777777788999999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ...|+|||||-| +-.+.+.- +.++.+.+++.|..+.+.||.|||+++.||||||..|||+   .+.+.|||+|||.|.
T Consensus        99 ~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAs  174 (948)
T KOG0577|consen   99 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSAS  174 (948)
T ss_pred             chHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchh
Confidence            999999999976 77777643 4679999999999999999999999999999999999999   677889999999998


Q ss_pred             ccCCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ...+.   .+++|||+|||||++.    |+|+-++||||||++..+|.-.++|+..++.-..+-.|-++..+.  -.-+.
T Consensus       175 i~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--Lqs~e  249 (948)
T KOG0577|consen  175 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNE  249 (948)
T ss_pred             hcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--CCCch
Confidence            86554   5679999999999874    579999999999999999999999998887766666665544321  12245


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .|..++.||..||++-|.+|||++++|+|+|+....
T Consensus       250 WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  250 WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            689999999999999999999999999999998765

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.9e-45  Score=335.27  Aligned_cols=254  Identities=29%  Similarity=0.456  Sum_probs=208.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||+|++|.||+|++..++..||+|.+...... ......+.+|+.+++.+ +||||+++++++.+++.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEE
Confidence            488999999999999999999999999999998654322 22346778899999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          132 ELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       132 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||+. ++|.+++...   +.+++..++.++.||+.||.|||++|++||||+|+||++   +.++.+||+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence            9997 4888887543   468999999999999999999999999999999999999   45677999999998754322


Q ss_pred             -CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc--------------
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------------  271 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------------  271 (408)
                       .......+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.........+......              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             22233467889999998864  4789999999999999999999999876654333322211100              


Q ss_pred             -----------cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 -----------FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                 ........++++++++|++||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                       0011124578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-45  Score=335.58  Aligned_cols=253  Identities=31%  Similarity=0.522  Sum_probs=213.0

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.+ +||||+++++.+...+.+|+||||++|++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            69999999999999999999999999865544444455677899999999 89999999999999999999999999999


Q ss_pred             hHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccC
Q 015352          139 LFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG  216 (408)
Q Consensus       139 L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~g  216 (408)
                      |.+++.+.+  .+++..+..++.|++.||.|||++|++||||+|+||++   +.++.++|+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence            999997765  69999999999999999999999999999999999999   4566799999999876654444445568


Q ss_pred             CCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCC
Q 015352          217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (408)
Q Consensus       217 t~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (408)
                      +..|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+..............+++.+.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            889999999864 5889999999999999999999999776542222233333333333334567999999999999999


Q ss_pred             cCCCC-----CHHHHhcCccccCCc
Q 015352          296 PKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       296 p~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      |.+||     ++.++++||||....
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCC
Confidence            99999     899999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.6e-45  Score=328.23  Aligned_cols=252  Identities=25%  Similarity=0.442  Sum_probs=218.8

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|.+.+.||+|++|.||+|.+..++..|++|.+...... ......+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEE
Confidence            478889999999999999999999999999998765443 33467788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||++|++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCcc
Confidence            999999999998774  5689999999999999999999999999999999999994   55679999999988654432


Q ss_pred             -ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......|++.|+|||++.+ .++.++|+||||+++++|++|..||...+.......+..+......   ..++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence             2234568899999998875 5889999999999999999999999888877777777665433211   2678999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-47  Score=341.24  Aligned_cols=261  Identities=32%  Similarity=0.511  Sum_probs=230.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ..|+.-+.||+|+||.||.+..+.||+.||+|.+.+..++........++|-.||.++ +.+.||.+--.|++.+.+++|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEE
Confidence            3467788999999999999999999999999999988777666667788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +..|.||+|.-+|.+.+  .+++..+..++.+|+.||.+||+.+||+||+||+|||+   ++.++|+|+|+|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence            99999999988888776  69999999999999999999999999999999999999   77889999999999999988


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ......+||.+|||||++.+ .|+...|.|||||++|+|+.|+.||.......-.+.+-+.....+.+.....|++++++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            88888899999999999985 59999999999999999999999997654433233333333333444446889999999


Q ss_pred             HHHhcCCCcCCCC-----CHHHHhcCccccCCc
Q 015352          288 VRQMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       288 i~~~l~~dp~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      .+.+|++||.+|.     +++++.+||||+...
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            9999999999997     467999999998754

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-45  Score=334.60  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=218.9

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||.|+||.||+|.+..++..||+|++.+.........+.+.+|+++++++ +||||+++++.+..+...|+|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence            588999999999999999999999999999999876554444567899999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~  211 (408)
                      ||+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence            999999999999887789999999999999999999999999999999999999   45667999999998876554444


Q ss_pred             ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          212 SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       212 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ....|+..|+|||.+.+ .++.++|+||+|+++|+|++|..||...+.   .........    .........+..+.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----ADVLYPATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----ccccCcccCcHHHHHH
Confidence            55678899999999875 589999999999999999999999987763   333322222    1222334678999999


Q ss_pred             HHHhcCCCcCCCCCH--HHHhcCccc
Q 015352          288 VRQMLEPDPKLRLTA--KQVLEHPWL  311 (408)
Q Consensus       288 i~~~l~~dp~~R~s~--~~~l~h~~~  311 (408)
                      |.+||..||.+||++  .|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=356.26  Aligned_cols=261  Identities=29%  Similarity=0.461  Sum_probs=225.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .+..+-|.|+..||.|+||.||+|..+.++...|.|+|...   .....+.+.-||+||... +||+|+++++.|-.++.
T Consensus        28 lnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   28 LNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENK  103 (1187)
T ss_pred             CCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCc
Confidence            45567799999999999999999999999999999998643   455678899999999998 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ++|+.|||.||-....+..- ..+++.++..+++|++.||+|||+++|||||||..|||++   -+|.|+|+|||.+...
T Consensus       104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKN  180 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccc
Confidence            99999999999988877664 4699999999999999999999999999999999999995   4566999999987654


Q ss_pred             CC-CCceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          206 KP-GERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       206 ~~-~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      .. -..-.+++|||+|||||+..      .+|+.++||||||++|.+|..+.+|....++..++-.|-....+- .-...
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT-LlqPS  259 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LLQPS  259 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc-ccCcc
Confidence            32 23446789999999999752      369999999999999999999999998888877777776554332 12234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..+..+.||+.+||.+||..||+++++|+|||+++..
T Consensus       260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            6788999999999999999999999999999998764

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-44  Score=334.77  Aligned_cols=262  Identities=29%  Similarity=0.487  Sum_probs=220.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .-.+...+|.+.+.||+|+||.||+|++..++..+|+|.+......   ..+.+.+|+.+++.+ +|||++++++.+..+
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~   89 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVG   89 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeC
Confidence            3355667999999999999999999999999999999998764432   346788999999998 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ...|+||||++|++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++..
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~  165 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ  165 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchh
Confidence            999999999999999998864 468999999999999999999999999999999999999   4566799999999876


Q ss_pred             cCCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ..... ......|++.|+|||.+.+ .++.++||||+||++|+|++|..||...........+..... ........+++
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  244 (296)
T cd06654         166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSA  244 (296)
T ss_pred             ccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCH
Confidence            54332 2234578899999998875 588999999999999999999999988765443333332211 11222346889


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+.++|.+||..+|++|||+.++++||||....
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.4e-45  Score=330.50  Aligned_cols=253  Identities=28%  Similarity=0.496  Sum_probs=214.3

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh------hcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA------VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      +|.+.+.||.|++|.||+|.+..++..+|+|.+........      ...+.+.+|+.+++++ +||||+++++++...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence            57888999999999999999999999999999875433221      1235688999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++   +.++.++|+|||.+...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence            999999999999999999888889999999999999999999999999999999999999   45677999999998765


Q ss_pred             CCCC-------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          206 KPGE-------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       206 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      ....       ......|+..|+|||.+.+ .++.++|+||+||++|+|++|..||...+.......+....   .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPEIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCcCC
Confidence            4211       1123457889999998875 58899999999999999999999998766554444443322   12222


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ..++..+.++|++||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            4678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-45  Score=337.82  Aligned_cols=254  Identities=28%  Similarity=0.514  Sum_probs=207.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||+|+||.||+|++..+|..+|+|.+...... ......+.+|+.+++.+ +||||+++++++.+.+.+|+|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEE
Confidence            588999999999999999999999999999999754322 22235677899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          132 ELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      ||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... .
T Consensus        79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence            99975 78787765 4679999999999999999999999999999999999999   45667999999998765332 2


Q ss_pred             ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCCcc--------------c
Q 015352          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGLID--------------F  272 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~~--------------~  272 (408)
                      ......+++.|+|||.+.+  .++.++|||||||++|+|++|..||. +.+..+....+.+....              +
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2334567899999998865  37899999999999999999988854 44444443333221100              0


Q ss_pred             ---C--------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          273 ---K--------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       273 ---~--------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                         +        ....+.+++++++||.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence               0        01123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.9e-45  Score=330.15  Aligned_cols=255  Identities=29%  Similarity=0.469  Sum_probs=217.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||.|+||+||+|.+..++..+|+|++.......  ....+.+|+.+++.+ +||||+++++.+..++.+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEE
Confidence            47999999999999999999999899999999987544322  467889999999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          131 MELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|+++|++|.+++...   ..+++..++.++.|++.||.|||+.|++||||+|+||+++   +++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHhcc
Confidence            9999999999999764   4589999999999999999999999999999999999994   456799999999876543


Q ss_pred             CCce-----ecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC--CCC
Q 015352          208 GERF-----SEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD--PWP  278 (408)
Q Consensus       208 ~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~  278 (408)
                      ....     ....|+..|+|||.+..  .++.++|+|||||++|+|++|..||...+.......+..........  .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3221     33468899999998864  58899999999999999999999998776665555555443221111  124


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      .+++.+.+++.+||..||++|||+.++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-47  Score=354.81  Aligned_cols=251  Identities=29%  Similarity=0.483  Sum_probs=217.2

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCC
Q 015352           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG  137 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~  137 (408)
                      .||+|.||+||.|++..|...+|||.|....   ....+-+..||.+.++| .|.|||++++.+..++++-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            5999999999999999999999999997543   33456788899999999 9999999999999999999999999999


Q ss_pred             chHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-ceec
Q 015352          138 ELFDRIVAR-GHY--TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSE  213 (408)
Q Consensus       138 ~L~~~l~~~-~~~--~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-~~~~  213 (408)
                      +|.+++... |++  .|..+..+.+||++||+|||++.|||||||-+|||++  .-.|.+||+|||-++....-. ...+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence            999999765 777  8899999999999999999999999999999999996  567889999999988765433 3456


Q ss_pred             ccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 015352          214 IVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ  290 (408)
Q Consensus       214 ~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  290 (408)
                      +.||..|||||++..   +|+.++|||||||++.||.||++||....... .....-|.+...++....+|.+++.||.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-HhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            789999999999963   59999999999999999999999997654322 22333455555555556789999999999


Q ss_pred             hcCCCcCCCCCHHHHhcCccccCCc
Q 015352          291 MLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       291 ~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      |+.+||.+||++.++|..||++..+
T Consensus       815 cFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             HcCCCcccCccHHHhccCcccccCC
Confidence            9999999999999999999998763

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.6e-45  Score=329.89  Aligned_cols=250  Identities=32%  Similarity=0.565  Sum_probs=216.2

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||.|++|.||+|++..+++.+|+|++.+.........+.+.+|+.+++.+ +||||+++++.+.++..+|+++||++|++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            69999999999999999999999999876554444557899999999999 99999999999999999999999999999


Q ss_pred             hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCC
Q 015352          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP  218 (408)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~  218 (408)
                      |.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++   .++.++|+|||++.............|++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccccccccCCc
Confidence            999998887899999999999999999999999999999999999994   56679999999998765543334457899


Q ss_pred             CCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCC
Q 015352          219 YYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES--EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (408)
Q Consensus       219 ~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (408)
                      .|+|||.+.+ .++.++|+||+|+++|+|++|..||....  .......+..+......+  ...++++.++|.+||..+
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence            9999998864 58999999999999999999999998776  555666665332222222  245899999999999999


Q ss_pred             cCCCCC-----HHHHhcCccccCC
Q 015352          296 PKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       296 p~~R~s-----~~~~l~h~~~~~~  314 (408)
                      |++||+     +.|+++||||+..
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCC
Confidence            999999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-46  Score=350.32  Aligned_cols=261  Identities=22%  Similarity=0.426  Sum_probs=226.5

Q ss_pred             cccccce-EecceecccCCeEEEEEEECCCCcEEEEEEeecccc-CChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           47 ENIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        47 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ..-.++| +....||+|+|-+||+|.|..+|..||.-.+....+ +.....+++..|+.+|+.| .||||+++++.|.+.
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDT  113 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecC
Confidence            3344565 456789999999999999999999999766654443 3455578999999999999 999999999999876


Q ss_pred             Ce--EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          125 NA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       125 ~~--~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      ..  +.+|+|++.+|+|..|+++.+.++...++.|++||+.||.|||++.  |+|||||.+||+|+  +..|.|||+|+|
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLG  191 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLG  191 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchh
Confidence            55  8899999999999999999999999999999999999999999995  99999999999996  677899999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCcccCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      +|....... ...++|||.|||||+....|+..+||||||++|.||+|+..||.. .+..++++++..|..+-.....  
T Consensus       192 LAtl~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--  268 (632)
T KOG0584|consen  192 LATLLRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--  268 (632)
T ss_pred             HHHHhhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--
Confidence            999865443 334899999999999999999999999999999999999999976 5667888888888754332221  


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      -.+++++||.+||.. ...|+|+.|+|+||||...
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            268999999999999 9999999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-45  Score=344.47  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=201.4

Q ss_pred             ccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            468999999999999999999752     346789999986432  2233567889999999987899999999988754


Q ss_pred             -CeEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 015352          125 -NAVHLVMELCEGGELFDRIVAR---------------------------------------------------------  146 (408)
Q Consensus       125 -~~~~lv~e~~~g~~L~~~l~~~---------------------------------------------------------  146 (408)
                       +.+++||||++||+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999998653                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc---eecccCCC
Q 015352          147 -----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSP  218 (408)
Q Consensus       147 -----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~  218 (408)
                           ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........   .....+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 236778889999999999999999999999999999999   4567799999999976532221   12334567


Q ss_pred             CCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHH-HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCC
Q 015352          219 YYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQG-VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD  295 (408)
Q Consensus       219 ~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  295 (408)
                      .|+|||++.+ .++.++|||||||++|+|++ |..||.+....+ ....+..+.. .  .....+++.+.+++.+||+.|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-M--RAPENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-C--CCCCCCCHHHHHHHHHHccCC
Confidence            8999998865 68999999999999999997 999998755433 3333333322 1  122467899999999999999


Q ss_pred             cCCCCCHHHHhc
Q 015352          296 PKLRLTAKQVLE  307 (408)
Q Consensus       296 p~~R~s~~~~l~  307 (408)
                      |.+|||+.++++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-48  Score=332.49  Aligned_cols=252  Identities=27%  Similarity=0.459  Sum_probs=216.4

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +-|.+++.||+|+||.||+|.|+.+|+.+|||.++..     .+.+.+.+|+.|+++. +.|++|++|+.|-....+|||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEee
Confidence            4577899999999999999999999999999998753     4688999999999998 999999999998888889999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      ||||..|+..+.+.- +.++++.++..+++..+.||.|||...-+|||||..|||+   +.++..||+|||.+...... 
T Consensus       107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhH
Confidence            999999999998865 4679999999999999999999999999999999999999   56778999999999876532 


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC---CCCCCHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP---WPNVSESA  284 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~  284 (408)
                      ....+++|||.|||||++.. .|+.++||||||++..||..|++||.+--+-   +.|.--. ..+++.   ....|.++
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIP-T~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIP-TKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEecc-CCCCCCCCChHhhhhHH
Confidence            23467899999999999986 7999999999999999999999999764332   1221111 111111   13468899


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||+.||.++|++|-|+.++++|||++++.
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            9999999999999999999999999998865

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=340.73  Aligned_cols=244  Identities=27%  Similarity=0.384  Sum_probs=210.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .+.+++.||+|.||.||.|.++.+ ..||+|.+.....    ..+.+.+|+++|++| +|++||++++++..++.+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEEE
Confidence            345678899999999999998743 3699999875433    346788999999999 9999999999999988999999


Q ss_pred             eccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||++.|+|.++|+.  .+.+...+...++.||++|++||+++++|||||-..|||+   +++..+||+|||+|+......
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCc
Confidence            99999999999987  4569999999999999999999999999999999999999   677789999999999544333


Q ss_pred             ceecc--cCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          210 RFSEI--VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       210 ~~~~~--~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .....  .-...|+|||++. +.++.++|||||||+|+||+| |+.||.+.+..++.+.+.+|..-.   ....+|+++.
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp---~P~~CP~~vY  434 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP---RPEGCPDEVY  434 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC---CCCCCCHHHH
Confidence            22211  1234599999987 579999999999999999999 999999999999999999986432   3357999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +++..||..+|++|||.+.+..
T Consensus       435 ~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  435 ELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHhhCCcccCCCHHHHHH
Confidence            9999999999999999996643

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.4e-45  Score=331.10  Aligned_cols=254  Identities=27%  Similarity=0.444  Sum_probs=211.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----  124 (408)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+||||+++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4568999999999999999999999999999999987542    23457888999999987799999999998753    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          125 --NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       125 --~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                        ..+|++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+++|+||||+|+||++   +.++.++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg  156 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFG  156 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCC
Confidence              4689999999999999998764  458999999999999999999999999999999999999   456679999999


Q ss_pred             cccccCCC-CceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          201 LSIFFKPG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       201 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      ++...... .......|++.|+|||++.      ..++.++|+||+||++|+|++|..||...........+....  ..
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~  234 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP  234 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CC
Confidence            98765332 2233457899999999874      247889999999999999999999997766554444333322  12


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ......++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            22234678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-45  Score=333.55  Aligned_cols=259  Identities=32%  Similarity=0.483  Sum_probs=219.8

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|.+.+.||.|+||.||+|.+..++..+|+|++...   .....+.+.+|+.+++.+ +||||+++++.+..+...|
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEE
Confidence            456799999999999999999999989999999998643   333456788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+|+||+|+||++   +.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhcc
Confidence            999999999999998764 569999999999999999999999999999999999999   4567799999998865432


Q ss_pred             C-CceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          208 G-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       208 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      . .......|++.|+|||.+.      ..++.++|+||||+++|+|++|..||...........+..+.... ......+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  234 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT-LDQPSKW  234 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-cCCcccC
Confidence            2 2223456899999999874      236789999999999999999999998887766666665543221 1122467


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +.++.++|.+||+.+|.+||++.++++||||....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            89999999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-44  Score=335.02  Aligned_cols=264  Identities=30%  Similarity=0.487  Sum_probs=220.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ...+...+|.+.+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+ +||||+++++++..+
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~   88 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVG   88 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            345667899999999999999999999999999999999875432   2346688999999998 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceE
Confidence            999999999999999998865 468999999999999999999999999999999999999   4567799999999876


Q ss_pred             cCCCCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ...... .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||.+.+.......+.... .........+++
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  243 (297)
T cd06656         165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSA  243 (297)
T ss_pred             ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCH
Confidence            543322 234568899999998875 58899999999999999999999998765433322222211 111122346788


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                      .+++|+.+||..+|++|||+.++++||||+.....
T Consensus       244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            99999999999999999999999999999887643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.3e-45  Score=331.37  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=212.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.+ +||||+++++++..++.+|
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEE
Confidence            4568999999999999999999999999999999986442   22345678999999998 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||++   +.++.+||+|||++......
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence            999999999999999888889999999999999999999999999999999999999   45667999999998765422


Q ss_pred             C-ceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-CCCCCCCH
Q 015352          209 E-RFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-DPWPNVSE  282 (408)
Q Consensus       209 ~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~  282 (408)
                      . ......|++.|+|||.+.    ..++.++|+||+||++|+|++|..||...........+.......+. .....++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 223456889999999874    24788999999999999999999999765443322222222221111 11235688


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      .+.+||++||..+|++|||++++++|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-44  Score=326.00  Aligned_cols=252  Identities=25%  Similarity=0.477  Sum_probs=214.9

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-CCeEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DNAVHLV  130 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv  130 (408)
                      .|++.+.||.|++|.||++.++.+++.+|+|.+...... ....+.+.+|+.+++.+ +|||++++++.+.. +..+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEE
Confidence            489999999999999999999999999999999754332 23356788999999999 89999999998864 4568999


Q ss_pred             EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      |||+++++|.+++...  ..+++.++..++.|++.||.+||+.|++||||+|+||++   +.++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence            9999999999998763  458999999999999999999999999999999999999   45677999999998765432


Q ss_pred             -CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                       .......|++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.......+..+...   .....+++.+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence             22334568899999998875 5889999999999999999999999887776666666655432   122468899999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ++.+||+.||++|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-44  Score=332.96  Aligned_cols=259  Identities=32%  Similarity=0.517  Sum_probs=219.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ....+|++.+.||.|++|.||+|++..+|+.||+|.+.....   ...+.+.+|+.+++.+ +||||+++++++..++.+
T Consensus        16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKEL-KNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhc-CCCceeeeeeeEecCceE
Confidence            345689999999999999999999999999999999875432   2356788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+|+||++|++|..++... .+++.++..++.|++.||.|||++|++||||+|+||++   +.++.+||+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccc
Confidence            9999999999999888654 68999999999999999999999999999999999999   4567799999999876543


Q ss_pred             CCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ... .....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.+.......+..... ........+++.+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  246 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFR  246 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHH
Confidence            322 234568899999998875 588999999999999999999999988776554444433221 12223356889999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++|.+||..||++|||+.+++.||||+...
T Consensus       247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            999999999999999999999999998755

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.3e-45  Score=335.31  Aligned_cols=259  Identities=28%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|.+..+|..||+|.+....  .......+.+|+.+++++ +||||+++++.+..++.+|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence            47899999999999999999999999999999986432  233356788999999998 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          131 MELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |||++|++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++   .++.+||+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCccccc
Confidence            9999999998888763   368999999999999999999997 5999999999999994   46779999999987653


Q ss_pred             CCCceecccCCCCCcchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      .. ......+++.|+|||.+.+       .++.++|+||+||++|+|++|..||...........+..............
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            22 2234568889999998743       257899999999999999999999976655444433322211122223346


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      +++++.+||.+||+.+|++||++.++++||||.....
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            8999999999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-44  Score=333.09  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=218.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      -...+.|++.+.||.|+||.||+|.+..++..+++|.+...   .......+.+|+.+++.+ +||||+++++.+..++.
T Consensus         8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   83 (292)
T cd06644           8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGK   83 (292)
T ss_pred             cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCe
Confidence            34567899999999999999999999999999999998653   233466788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      +|+||||++|++|..++.+ ...+++..+..++.|++.+|.|||++|++||||||+||++   +.++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKN  160 (292)
T ss_pred             EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceec
Confidence            9999999999999887755 4568999999999999999999999999999999999999   45667999999988654


Q ss_pred             CCC-CceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          206 KPG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       206 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ... .......+++.|+|||.+.      ..++.++|+|||||++|+|++|..||...+......++...... ......
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  239 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPS  239 (292)
T ss_pred             cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCc
Confidence            322 2233456889999999874      23688999999999999999999999887766555555443321 112224


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .++.++.++|.+||..+|++||++.++++||||....
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            6788999999999999999999999999999997654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.4e-45  Score=341.09  Aligned_cols=256  Identities=20%  Similarity=0.284  Sum_probs=205.5

Q ss_pred             ecceeccc--CCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           55 VDRELGRG--EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        55 ~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      +++.||+|  +|++||++.++.+|+.||+|.+...... ......+.+|+.+++.+ +||||+++++++..++..|+|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  7889999999999999999999755432 23345778899999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          133 LCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       133 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      |+++|+|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++   .++.++++||+.+...... .
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhccccccc
Confidence            99999999998653  4589999999999999999999999999999999999994   4567999999865432211 1


Q ss_pred             -------ceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC------
Q 015352          210 -------RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------  273 (408)
Q Consensus       210 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~------  273 (408)
                             ......++..|+|||++.+   .++.++||||+||++|+|++|..||..............+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0112346778999999864   488999999999999999999999987655443333332221100      


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          274 ------------------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       274 ------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                                          .+....+++.+.+||.+||+.||++|||++++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                001123567899999999999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-45  Score=346.21  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=199.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ..|.+.+.||+|+||.||+|++..++..||+|+..+.         ....|+.+++.+ +||||+++++++...+..++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEE
Confidence            4699999999999999999999999999999985432         234699999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      +|++.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++.......
T Consensus       136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence            999964 88888765 4569999999999999999999999999999999999999   556679999999987644333


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH----------HHHHHHHcCCc----ccC-
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ----------GVAQAILRGLI----DFK-  273 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------~~~~~i~~~~~----~~~-  273 (408)
                      ......||+.|+|||++.+ .++.++|||||||++|+|+++..|+......          .....+.....    .++ 
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            4445679999999999875 6999999999999999999865554322110          11111111100    000 


Q ss_pred             -------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          274 -------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       274 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                                               ......++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                     0001245778889999999999999999999999999975

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-44  Score=331.41  Aligned_cols=241  Identities=19%  Similarity=0.215  Sum_probs=206.9

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe----CCeEEEEEe
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----DNAVHLVME  132 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~~lv~e  132 (408)
                      ..||+|++|.||+|..  +|+.||+|.+...........+.+.+|+.+++++ +||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence            4689999999999987  6889999999765433333356788999999999 99999999999877    457899999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~  211 (408)
                      |++||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+||++   +.++.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence            999999999998888899999999999999999999984 99999999999999   556789999999987654322  


Q ss_pred             ecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          212 SEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       212 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ....|++.|+|||++.+   .++.++|||||||++|+|++|..||.+.+..+....+......++.+  ...++.+++|+
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            23568899999999864   68999999999999999999999999988888777776554443322  36789999999


Q ss_pred             HHhcCCCcCCCCCHHHHhc
Q 015352          289 RQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+||+.||++|||+.++++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999986

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-44  Score=335.18  Aligned_cols=261  Identities=29%  Similarity=0.471  Sum_probs=216.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC--hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT--AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+.......  ......+.+|+++++.+ +||||+++++++.+.+..|+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence            5888999999999999999999999999999997654331  12234567899999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++||||+|+||+++   .++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeeccCC
Confidence            99999 889999998766 799999999999999999999999999999999999994   5677999999999876433


Q ss_pred             -CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-----------
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----------  274 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  274 (408)
                       .......+++.|+|||.+.+  .++.++|+||+||++|+|++|.+||.+....+....+.........           
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence             23334457888999998854  4789999999999999999998888877665554444332111000           


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          275 -------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       275 -------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                                   ..+...+..+.++|.+||..||++|||+.++++||||.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence                         0123457889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.1e-44  Score=330.70  Aligned_cols=257  Identities=28%  Similarity=0.461  Sum_probs=217.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +-|++.+.||.|+||.||+|.+..++..+++|.+....   ......+.+|+++++.+ +||||+++++++..++..|+|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEE
Confidence            34788899999999999999999999999999986432   33456788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      +||+++++|..++.+ .+.+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence            999999999888765 4569999999999999999999999999999999999999   45667999999998654322 


Q ss_pred             CceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          209 ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .......+++.|+|||++.      ..++.++|+||+||++|+|++|..||...+..+....+....... ......++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCH
Confidence            2233456899999999873      247789999999999999999999998877766666665543221 112245789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+++||.+||+.||.+|||+.++++||||....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            999999999999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-44  Score=331.42  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=209.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+....  .......+.+|+.+++++ +||||+++++.+..++..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEE
Confidence            36788999999999999999999999999999987542  222345788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++...... .
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~  149 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-I  149 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-c
Confidence            999999998654    357899999999999999999999999999999999999   45678999999998765432 2


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCcccCCCCCCCCCH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-------GVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||......       .....+....  .+.......++
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  227 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSE  227 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCH
Confidence            334578999999998875 6899999999999999999999999653211       1222222211  11112345788


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++.++|.+||+.+|.+||++.++++||||....
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.7e-44  Score=324.21  Aligned_cols=252  Identities=31%  Similarity=0.503  Sum_probs=220.4

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|++.+.||.|+||.||.+++..++..+++|.+...... ......+.+|+.+++++ +|+||+++++++.+.+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence            589999999999999999999999999999998765433 23456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||++|++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++   .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEccccc
Confidence            999999999999765  4589999999999999999999999999999999999994   45679999999987654333


Q ss_pred             -ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||......+....+..+.....   ...++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence             2344578999999998875 588899999999999999999999998888787777776554322   25678999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      |.+||..+|.+|||+.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=331.32  Aligned_cols=269  Identities=27%  Similarity=0.430  Sum_probs=217.5

Q ss_pred             eeccccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC-CCC----e
Q 015352           40 VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-NSS----I  114 (408)
Q Consensus        40 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~----i  114 (408)
                      ++....++.+..+|.+...+|+|.||.|-.+.+..++..||+|++..-    ..-.+..+-|+++|.++.. .|+    +
T Consensus        78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             eEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            344457788899999999999999999999999999999999998632    1123455679999999832 233    8


Q ss_pred             eEEeeEEEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC---
Q 015352          115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK---  189 (408)
Q Consensus       115 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~---  189 (408)
                      +.+.+||+..++.|||+|.+ |.++++++.+++  +++...++.+..||+.++++||+.+++|.||||+|||+.+..   
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence            89999999999999999999 779999998864  488999999999999999999999999999999999986421   


Q ss_pred             --------------CCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCC
Q 015352          190 --------------ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFW  254 (408)
Q Consensus       190 --------------~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~  254 (408)
                                    .+..|+|+|||.|+.....  .++.+.|..|+|||++.+ +|+.++||||+||||+|+++|...|+
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                          2456999999999875433  367789999999999887 89999999999999999999999998


Q ss_pred             CCCHHH---HHHHHHcCC------------------cccCCCCCC---------------------CCCHHHHHHHHHhc
Q 015352          255 AESEQG---VAQAILRGL------------------IDFKRDPWP---------------------NVSESAKSLVRQML  292 (408)
Q Consensus       255 ~~~~~~---~~~~i~~~~------------------~~~~~~~~~---------------------~~~~~~~~li~~~l  292 (408)
                      ..++.+   +++.|+...                  ++++.....                     ..-.++.||+++||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            877665   333332211                  111100000                     01134779999999


Q ss_pred             CCCcCCCCCHHHHhcCccccCCc
Q 015352          293 EPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       293 ~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..||.+|+|+.|+|.||||....
T Consensus       391 ~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  391 EFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             ccCccccccHHHHhcCHHhhcCC
Confidence            99999999999999999998754

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-44  Score=327.64  Aligned_cols=254  Identities=28%  Similarity=0.459  Sum_probs=212.2

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC---ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      +|.+.+.||.|+||.||+|.+ .+|..+|+|.+......   .......+.+|+++++.+ +|+||+++++++.+.+.++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence            478899999999999999986 47889999998754321   122345688999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-  207 (408)
                      +++||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||++..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence            999999999999999888889999999999999999999999999999999999999   4567799999999875421 


Q ss_pred             ------CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          208 ------GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       208 ------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                            ........|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+....... ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCCCC
Confidence                  112234568899999999875 58899999999999999999999998766554443333322111 1223468


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +..+.++|++||..+|.+|||+.++++||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.2e-44  Score=325.60  Aligned_cols=253  Identities=27%  Similarity=0.447  Sum_probs=219.6

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.+ +|||++++++.+..++..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEE
Confidence            5899999999999999999999999999999998654433 3467889999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||++|++|.+++...  ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.  .+..+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence            999999999999764  34899999999999999999999999999999999999953  34468999999998765544


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+.......+......   .....++..+++++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHH
Confidence            4445678999999999875 5789999999999999999999999888777766666554332   12235789999999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccc
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      .+||..+|++|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-44  Score=326.00  Aligned_cols=254  Identities=29%  Similarity=0.460  Sum_probs=216.4

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||.|+||.||+|.+..++..+++|++.....   ...+.+.+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEE
Confidence            4689999999999999999999999999999999975432   2467889999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.+||+|||++......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence            99999999999998776 789999999999999999999999999999999999999   45667999999998765432


Q ss_pred             C-ceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-CCCCCCCH
Q 015352          209 E-RFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-DPWPNVSE  282 (408)
Q Consensus       209 ~-~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~  282 (408)
                      . ......++..|+|||.+.+    .++.++|+||+|+++|+|++|..||.+.+.......+......... .....++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 2334578889999998753    5888999999999999999999999887765555544444222111 11235678


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      ++.+++.+||..+|.+|||+.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-44  Score=330.77  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=203.9

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhC--CCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      .||+|+||.||++.+..+++.+|+|.+.+.............+|..+++.+  .+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999999866543333233344555444332  279999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceeccc
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV  215 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  215 (408)
                      |++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999   456679999999987543322 23346


Q ss_pred             CCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          216 GSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       216 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      |++.|+|||.+.+  .++.++|+||+||++|+|++|..||........ ..+..............+++++.++|.+||.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            8999999998853  488999999999999999999999975432111 1111111222223335689999999999999


Q ss_pred             CCcCCCC-----CHHHHhcCccccCCc
Q 015352          294 PDPKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       294 ~dp~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      .||.+||     |+.++++||||+...
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            9999999     699999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-44  Score=330.40  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=217.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      ...|+..+.||.|+||.||+|.+..++..+|+|++.....  ......+.+|+.+++.+ +||||+++++++.+++.+|+
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence            4568888999999999999999999999999999875432  23456788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||++|++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++   .++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCCc
Confidence            9999999999998864 5789999999999999999999999999999999999994   56679999999987654333


Q ss_pred             -ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.....   ......++..+.++
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  232 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEF  232 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHH
Confidence             2233467889999998865 588999999999999999999999988776655544433221   22233578889999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +.+||..+|++||++.++++||||....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         233 IDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            9999999999999999999999997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-44  Score=328.65  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=203.3

Q ss_pred             ccceEeccee--cccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           50 EDRYLVDREL--GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        50 ~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.|.+.+.+  |.|+||.||++.++.++..+|+|++.......        .|+.....+.+||||+++++.+...+.+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3566776666  99999999999999999999999987543221        1333333334799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++  ..++|+|||++.....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecCC
Confidence            99999999999999998888899999999999999999999999999999999999995322  2799999999876543


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      .   ....|+..|+|||++.+ .++.++|+||+|+++|+|++|..||.......................++.+++.+.+
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND  239 (267)
T ss_pred             C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence            2   23468899999999875 6899999999999999999999999765443321111111112223334578999999


Q ss_pred             HHHHhcCCCcCCCCC-HHHHhcCccccC
Q 015352          287 LVRQMLEPDPKLRLT-AKQVLEHPWLQN  313 (408)
Q Consensus       287 li~~~l~~dp~~R~s-~~~~l~h~~~~~  313 (408)
                      ||.+||+.+|.+||+ ++++|+||||++
T Consensus       240 li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        240 FVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHhccChhhCCchHHHHhcCCcccC
Confidence            999999999999996 599999999964

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.6e-44  Score=332.07  Aligned_cols=255  Identities=31%  Similarity=0.532  Sum_probs=213.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||.|++|.||+|.+..+|..||+|++....... .....+.+|+.+++.+ +||||+++++++..+..+|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEe
Confidence            5899999999999999999999999999999997654322 2346788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          132 ELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      ||+ |++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCCC
Confidence            999 99999998653 5689999999999999999999999999999999999994   46779999999988664332 


Q ss_pred             -ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc---------------
Q 015352          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID---------------  271 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------------  271 (408)
                       ......|+..|+|||.+.+  .++.++||||+|+++|+|++|.+||.+.........+......               
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             2344578999999998754  4789999999999999999999888877665555444332110               


Q ss_pred             ----cCC-------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          272 ----FKR-------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       272 ----~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                          ++.       ..++..+..+.++|.+||..+|++|||+.++++||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                000       11235678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.7e-44  Score=325.00  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=214.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|+||.||+|.+..++..+++|.+....     ..+.+.+|+++++.+ +||||+++++.+.++..+|+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEE
Confidence            368999999999999999999999989999999986432     157889999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++   .++.+||+|||++......
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcccC
Confidence            9999999999999876 45689999999999999999999999999999999999994   5667999999998876543


Q ss_pred             C-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          209 E-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       209 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      . ......|+..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+...... .......++..+.+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFND  231 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHH
Confidence            3 2334568899999999875 5889999999999999999999999876655443333222111 11112357789999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +|.+||+.||++|||+.+++.||||
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4e-44  Score=325.98  Aligned_cols=255  Identities=28%  Similarity=0.473  Sum_probs=210.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--CCe
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~  126 (408)
                      ..|...+.||+|+||.||+|.+..++..||+|.+......  .......+.+|+.+++.+ +||||+++++++.+  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence            3688899999999999999999999999999998754322  122346788999999999 89999999999875  467


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +++++||+++++|.+++...+.+++..+..++.|++.||.|||+++|+||||+|+||++   +.++.+||+|||++....
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence            89999999999999999888889999999999999999999999999999999999999   456679999999987543


Q ss_pred             CC----CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          207 PG----ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       207 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..    .......++..|+|||.+.+ .++.++|+||+||++|+|++|..||...........+......  ......++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~  235 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHIS  235 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcC
Confidence            21    12233468889999999875 5889999999999999999999999876554444433322211  11123568


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      +.+++++ +||..+|++||+++|+++||||+
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8899999 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.2e-44  Score=331.59  Aligned_cols=258  Identities=29%  Similarity=0.446  Sum_probs=209.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe----
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA----  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~----  126 (408)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+.+||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999865432 222345678899999999678999999999987665    


Q ss_pred             -EEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          127 -VHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       127 -~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                       .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||+|+||+++.  .++.+||+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence             8999999986 788887643     34799999999999999999999999999999999999953  25679999999


Q ss_pred             cccccCCC-CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC---
Q 015352          201 LSIFFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR---  274 (408)
Q Consensus       201 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---  274 (408)
                      ++...... .......+++.|+|||.+.+  .++.++|+||+|+++|+|++|..||.+.+.......+.........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98754322 22233457889999998764  4789999999999999999999999887665554444332111000   


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          275 ---------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       275 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                                           ...+.+++.+.+||.+||..||.+|||+.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                 11135789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-44  Score=348.45  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=203.8

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ....|.+.+.||+|+||.||+|.+..+++.||+|...         ...+.+|++++++| +||||+++++++..++..+
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRL-SHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEE
Confidence            3457999999999999999999999999999999642         12356899999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||++. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++.....
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccc
Confidence            9999995 5888888664 469999999999999999999999999999999999999   4566799999999976543


Q ss_pred             CC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCcc---c
Q 015352          208 GE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES--------EQGVAQAILRGLID---F  272 (408)
Q Consensus       208 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~---~  272 (408)
                      ..   ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+....        ...+.+.+......   +
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            22   1224569999999999875 59999999999999999999876653321        22333333222211   0


Q ss_pred             ------------------------CCCCC---CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          273 ------------------------KRDPW---PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       273 ------------------------~~~~~---~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                                              ....|   ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    11112   245678999999999999999999999999999975

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-44  Score=333.06  Aligned_cols=256  Identities=27%  Similarity=0.478  Sum_probs=213.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+.+..... ...+.+.+|+++++.+ +||||+++++++..++..|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence            47999999999999999999999999999999987543322 2345678899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      +||+++++|..+....+.+++..+..++.||+.||.|||+.|++||||+|+||++   +.++.++|+|||++...... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence            9999999888877666679999999999999999999999999999999999999   45678999999998765433 2


Q ss_pred             ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc---------------
Q 015352          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF---------------  272 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------------  272 (408)
                      ......++..|+|||.+.+  .++.++||||+|+++|+|++|.+||......+....+......+               
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            3344568889999998864  47889999999999999999999998766544333332211000               


Q ss_pred             ----C--------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          273 ----K--------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       273 ----~--------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                          +        ...++.++..+.+|+.+||..+|++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                0        01134678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-44  Score=328.19  Aligned_cols=258  Identities=24%  Similarity=0.437  Sum_probs=212.4

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      +|+..+.||+|++|.||+|.+..+++.+|+|++.......   ......+.+|+.+++.+ +||||+++++++.+.+.++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence            4788899999999999999999999999999997543221   11246788999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +|+||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.  .+..+||+|||.+......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence            99999999999999988888999999999999999999999999999999999999943  2345999999998765432


Q ss_pred             C-----ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-cccCCCCCCCCC
Q 015352          209 E-----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL-IDFKRDPWPNVS  281 (408)
Q Consensus       209 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  281 (408)
                      .     ......|+..|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+.+.. ..........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1     1123467889999998865 58899999999999999999999996544322222222111 111122224678


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      +++.+++.+||..+|.+|||+.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.7e-44  Score=326.53  Aligned_cols=256  Identities=25%  Similarity=0.431  Sum_probs=213.0

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC-------hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-------AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+.......       ....+.+.+|+.+++.+ +|||++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence            6889999999999999999999999999999986432211       11235678899999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..++||||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++   +.++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   4567899999999876


Q ss_pred             cCCCC---ceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--cccCCCC
Q 015352          205 FKPGE---RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--IDFKRDP  276 (408)
Q Consensus       205 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~  276 (408)
                      .....   ......|+..|+|||.+..   .++.++|+||||+++|++++|..||...........+....  ..++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43211   1233468889999998864   37889999999999999999999997655544333332221  2223333


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ...++..+.++|.+||.++|++|||+.++++|||+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            45678999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.2e-44  Score=324.12  Aligned_cols=254  Identities=28%  Similarity=0.481  Sum_probs=214.6

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+...... ....+.+.+|+.+++.+ +|+||+++++.+.+.+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEE
Confidence            689999999999999999999999999999999765433 34567899999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc-
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~-  210 (408)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.+||+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            999999999999887779999999999999999999999999999999999999   4567799999999877543322 


Q ss_pred             ----eecccCCCCCcchhhhhc-c---CCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCCCCCCCCC
Q 015352          211 ----FSEIVGSPYYMAPEVLKR-N---YGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       211 ----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                          .....+++.|+|||.+.+ .   ++.++||||+|+++|++++|..||...... .....+.. ......+.+..++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence                123467889999999864 3   788999999999999999999999765332 22222222 2222233334568


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +.+.++|.+||+.+|++|||+.+++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.5e-44  Score=323.60  Aligned_cols=255  Identities=29%  Similarity=0.492  Sum_probs=211.4

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--Ce
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~  126 (408)
                      ..|.+.+.||+|+||.||.|.+..+|..||+|.+......  .....+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence            5789999999999999999999999999999998643221  223356788999999999 999999999998763  57


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++++|||++|++|.+++...+.+++..+..++.|++.||.|||+++++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence            88999999999999999887789999999999999999999999999999999999999   456679999999987543


Q ss_pred             CC----CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          207 PG----ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       207 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..    .......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+......  ......++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  235 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVS  235 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhC
Confidence            21    12233568899999998865 5889999999999999999999999876555444443322211  11224577


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      ..+.++|.+||. +|++||+++++++|||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            889999999995 899999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.4e-44  Score=322.66  Aligned_cols=252  Identities=26%  Similarity=0.521  Sum_probs=218.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++.+ +||||+++++++...+..|+|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEE
Confidence            589999999999999999999999999999998764432 23356789999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||+.+++|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence            9999999999987643  57899999999999999999999999999999999999   455679999999987654332


Q ss_pred             c-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      . .....|++.|+|||.+.+ .++.++|+||+||++|+|++|..||......+....+..+....   .....+.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence            1 223468889999999875 58889999999999999999999998888777777776665432   224678999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      |.+||+.+|.+||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-45  Score=337.57  Aligned_cols=255  Identities=25%  Similarity=0.433  Sum_probs=202.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ..|++.+.||+||.+.||++..-.. +.||+|.+.... .....+..+.+|+..|.+|.+|.+|++++++-..++.+|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            4699999999999999999986544 446666554322 23445788999999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||=+. +|..+|.+... .+.-.++.+..|++.|++++|++||||-||||.|+|+.    .|.+||+|||+|....+..
T Consensus       439 mE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCccc
Confidence            998744 99999988755 44468899999999999999999999999999999995    5679999999998876544


Q ss_pred             c---eecccCCCCCcchhhhhc------------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          210 R---FSEIVGSPYYMAPEVLKR------------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       210 ~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      .   ..+.+||+.|||||.+..            ..++++||||||||||+|+.|++||..-.  ....++..-.-+-..
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHE  591 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCcc
Confidence            2   245689999999998831            15678999999999999999999995432  222222221111111


Q ss_pred             CCCCCCC--HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          275 DPWPNVS--ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       275 ~~~~~~~--~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      -.++.+|  .++.++++.||..||++|||+.++|+|||++..
T Consensus       592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            1222222  348999999999999999999999999999764

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6e-44  Score=331.98  Aligned_cols=261  Identities=29%  Similarity=0.450  Sum_probs=214.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--Ce
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~  126 (408)
                      -.++|++.+.||.|+||.||+|.+..+|..||+|.+........ ....+.+|+.+++++ +|+||+++++++...  +.
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNL-RHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCe
Confidence            34689999999999999999999999999999999875433221 123456799999999 999999999998755  57


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      +|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||++   +..+.+||+|||++...
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeec
Confidence            8999999975 788887653 568999999999999999999999999999999999999   45677999999998876


Q ss_pred             CCCC-ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc-----------
Q 015352          206 KPGE-RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-----------  271 (408)
Q Consensus       206 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------  271 (408)
                      .... ......+++.|+|||.+.+  .++.++||||+||++|+|++|..||.+.+..+....+......           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            4332 2233356788999998864  4789999999999999999999999988877776666542211           


Q ss_pred             --------cCCCC-------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 --------FKRDP-------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 --------~~~~~-------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                              .....       +...++.+.+||.+||+.||++|||+.+++.||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                    00000       123588899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-43  Score=326.95  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=212.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--  124 (408)
                      ....++|.+.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+|||++++++++...  
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            345788999999999999999999999999999999986432    12356778999999987899999999998653  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          125 ---NAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       125 ---~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                         +.+|+||||++|++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||++   +.++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEe
Confidence               468999999999999988753    3568999999999999999999999999999999999999   455679999


Q ss_pred             ecccccccCCCC-ceecccCCCCCcchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc
Q 015352          198 DFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       198 Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      |||++....... ......|+..|+|||.+..      .++.++||||+||++|+|++|+.||...........+.+...
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            999987654322 2234568899999998753      268899999999999999999999988766555555544432


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      .. .......+..+.++|.+||+.+|++||++.++++||||+
T Consensus       251 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            11 111235678899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.6e-44  Score=321.67  Aligned_cols=254  Identities=29%  Similarity=0.469  Sum_probs=216.0

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      +|+..+.||+|++|.||+|.+..++..|++|.+......  .....+.+.+|+.+++.+ +||||+++++++.++..+|+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence            578889999999999999999989999999998754321  223456789999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ++||++|++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.+||+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence            99999999999999888889999999999999999999999999999999999999   456789999999987755444


Q ss_pred             ceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ......|++.|+|||.+.. . ++.++|+||+|+++|+|++|..||...........+.....  .......+++.+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE--LPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--CCCcCCCcCHHHHHH
Confidence            3455678999999998764 4 88999999999999999999999977665444444333111  112234678999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +.+||+.+|.+|||+.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4e-44  Score=334.38  Aligned_cols=249  Identities=26%  Similarity=0.433  Sum_probs=192.7

Q ss_pred             cceecccCCeEEEEEEECC--CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE--eCCeEEEEE
Q 015352           56 DRELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--DDNAVHLVM  131 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~~~lv~  131 (408)
                      ...||+|+||.||+|+++.  ++..||+|.+.....     ...+.+|+.+++.+ +||||+++++++.  .+..+|+||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEE
Confidence            3579999999999999764  568899998864322     34577899999999 9999999999885  456889999


Q ss_pred             eccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC-CCCCCEEEeeccc
Q 015352          132 ELCEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-KENSPLKAIDFGL  201 (408)
Q Consensus       132 e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~-~~~~~vkl~Dfg~  201 (408)
                      ||+.+ +|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+|||+..+ +..+.+||+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99965 777776421         248899999999999999999999999999999999999643 3456899999999


Q ss_pred             ccccCCCC----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH---------HHHHHHH
Q 015352          202 SIFFKPGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---------GVAQAIL  266 (408)
Q Consensus       202 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~i~  266 (408)
                      +.......    ......||+.|+|||++.+  .++.++||||+||++|+|+||.+||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            98654321    2334578999999998864  4899999999999999999999999654321         1111111


Q ss_pred             cCCccc----------------------------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          267 RGLIDF----------------------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       267 ~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ......                                  ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            100000                                  000011245678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-44  Score=327.80  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=210.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE------
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE------  122 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~------  122 (408)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++.+||||+++++++.      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4578999999999999999999999999999999986532    234567889999999878999999999985      


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      ....+|++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.||+|+||+|+||++   +.++.++|+|||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg  166 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG  166 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence            356889999999999999988763  458899999999999999999999999999999999999   456679999999


Q ss_pred             cccccCCC-CceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          201 LSIFFKPG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       201 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      ++...... .......|++.|+|||.+.      ..++.++|+|||||++|+|++|..||...........+.+...  .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~  244 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P  244 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence            98754321 2233456899999999874      2478899999999999999999999977655444333332211  1


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ......++..+.+||.+||..||.+|||+.++++||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1e-43  Score=330.09  Aligned_cols=260  Identities=27%  Similarity=0.456  Sum_probs=217.9

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ......+|.+.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.+ +||||+++++++.+++
T Consensus        10 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~   88 (307)
T cd06607          10 KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREH   88 (307)
T ss_pred             CCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCC
Confidence            355667899999999999999999999999999999998755444444456788999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..|+|+||+.| +|.+.+.. .+.+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~  164 (307)
T cd06607          89 TAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASL  164 (307)
T ss_pred             eEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCccee
Confidence            99999999975 67676654 4569999999999999999999999999999999999999   4567799999999876


Q ss_pred             cCCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ....   ....+++.|+|||++.    +.++.++||||+|+++|+|++|..||.+.+.......+.....  +.......
T Consensus       165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~  239 (307)
T cd06607         165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDW  239 (307)
T ss_pred             cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhh
Confidence            5433   3456888999999873    3588999999999999999999999988776655444433221  11112346


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +..+.++|.+||..+|++||++.+++.||||....
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            78999999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.1e-44  Score=339.19  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=210.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.+ +||||++++++|...   
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCc
Confidence            567899999999999999999999999999999999864322 233345678899999999 999999999988643   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       125 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                         ...|+||||+.+ +|.+.+...  +++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~  164 (353)
T cd07850          91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  164 (353)
T ss_pred             cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence               357999999965 888877654  8999999999999999999999999999999999999   4567799999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc--------
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF--------  272 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  272 (408)
                      +.............+++.|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+.......        
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            987654444445578899999998875 68999999999999999999999998776554444432211000        


Q ss_pred             --------------CC-----------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          273 --------------KR-----------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       273 --------------~~-----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                                    ..                 ......++.++++|.+||+.||++|||+.|+|.||||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                          00                 001134667899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.3e-44  Score=327.31  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=209.8

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE----
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC----  121 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----  121 (408)
                      .....++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+||||+++++++    
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3456789999999999999999999999999999999875422    11356778999999986799999999987    


Q ss_pred             -EeCCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          122 -EDDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       122 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                       ..++.+|+||||++|++|.+++..    ...+++..++.++.|++.||.|||+++++||||||+||+++   ..+.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEE
Confidence             345679999999999999988753    34688999999999999999999999999999999999994   4566999


Q ss_pred             eecccccccCCCC-ceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Q 015352          197 IDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       197 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      +|||++....... ......|++.|+|||++.      ..++.++||||+||++|+|++|..||...........+....
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~  245 (286)
T cd06638         166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP  245 (286)
T ss_pred             ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence            9999987654322 223456899999999874      247889999999999999999999998766544333332221


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      . .........+..+.+||.+||+.||++|||+.++++|+||
T Consensus       246 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 P-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             C-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            1 1111112457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-44  Score=325.34  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=211.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC---
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN---  125 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---  125 (408)
                      ..++|++.+.||+|++|.||+|.++.+++.+++|++.....    ..+.+.+|+.+++++.+||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            35799999999999999999999999999999999875432    34678899999999877999999999997644   


Q ss_pred             ---eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          126 ---AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       126 ---~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                         .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||++   +.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence               58999999999999998865    3578999999999999999999999999999999999999   4567799999


Q ss_pred             cccccccCCCC-ceecccCCCCCcchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc
Q 015352          199 FGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (408)
Q Consensus       199 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  271 (408)
                      ||++....... ......|++.|+|||.+..      .++.++||||||+++|+|++|..||...........+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            99987643322 2234568899999998742      3678999999999999999999999876655555555444321


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      . .......+..+++||.+||..||++|||+.++++|||+
T Consensus       237 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 T-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             C-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            1 11112467899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=342.58  Aligned_cols=247  Identities=34%  Similarity=0.521  Sum_probs=215.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.+.|.+...+|.|+|+.|..+.+..+++..++|++.++..       ...+|+.++....+||||+++.+++.+..+.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence            467889999999999999999999999999999999987632       2235777777777999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+|||++.|+.|.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+|||+.  +..++++|+|||.+.....
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence            99999999999999888776555 88889999999999999999999999999999996  4567899999999988765


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .  ..+.+-|..|.|||++.. .|++++|+||||++||+|++|+.||...... ++...+..+...      ..+|+.++
T Consensus       469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK  540 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK  540 (612)
T ss_pred             h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence            4  344466888999999985 6999999999999999999999999876665 555555544333      57999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      +||++||+.||.+|+++.+++.||||-
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcchh
Confidence            999999999999999999999999993

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.1e-44  Score=326.99  Aligned_cols=252  Identities=29%  Similarity=0.496  Sum_probs=207.2

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--CeEEEE
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHLV  130 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv  130 (408)
                      |.+.+.||+|+||.||+|.+..++..+|+|.+..... .. ......+|+.+++++.+|||++++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6788999999999999999999999999999865422 21 2234457999999986699999999999987  899999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||+.| +|.+.+... +.+++..++.++.|++.||.|||+.|++||||+|+||+++   . +.+||+|||++.......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCC
Confidence            999975 788887664 5689999999999999999999999999999999999995   3 789999999998765444


Q ss_pred             ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc-----------------
Q 015352          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI-----------------  270 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----------------  270 (408)
                      ......+++.|+|||.+..  .++.++||||+||++|+|++|..||.+.+..+....+.....                 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            4455678999999997643  478899999999999999999999988776554444432110                 


Q ss_pred             -ccCCC-------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          271 -DFKRD-------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       271 -~~~~~-------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                       .++..       ..+.++..+.++|.+||.++|++|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence             01000       013568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-43  Score=322.00  Aligned_cols=252  Identities=30%  Similarity=0.509  Sum_probs=216.8

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE--eCCeEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--DDNAVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~~~l  129 (408)
                      +|.+.+.||.|+||.||+|.+..+|..+|+|.+..... .....+.+.+|+++++.+ +||||+++++++.  .....|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEE
Confidence            58899999999999999999999999999999876543 233456788999999999 9999999999775  3457899


Q ss_pred             EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          130 VMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCH-----KHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH-----~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      +|||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+++|+||+|+||+++   .++.+||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccc
Confidence            9999999999999865    357899999999999999999999     89999999999999994   56789999999


Q ss_pred             cccccCCCCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          201 LSIFFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       201 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ++........ .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+..+....   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Ccc
Confidence            9987654443 345578999999999875 58899999999999999999999999887777766666654321   224


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ..+..+.+++.+||..+|++|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.7e-44  Score=326.71  Aligned_cols=255  Identities=29%  Similarity=0.425  Sum_probs=213.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||.|++|.||+|.++.+++.+|+|.+.....  ......+.+|+++++.+ +||||+++++.+..++.++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEE
Confidence            368889999999999999999999999999999876532  23456788999999999 799999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||++|++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++   .++.++|+|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHH
Confidence            9999999999999876 779999999999999999999999 9999999999999994   5677999999998765322


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES-----EQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .. ....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||....     ..+..+.+......  ......+++
T Consensus       155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (265)
T cd06605         155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSP  231 (265)
T ss_pred             Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCH
Confidence            22 12678899999999875 58999999999999999999999997642     22333333332211  111112789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ++.++|.+||..||++|||+.+++.||||+..
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=327.02  Aligned_cols=255  Identities=27%  Similarity=0.446  Sum_probs=205.5

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|++|.||+|.++.+++.||+|.+.......  ....+.+|+.+++.+ +||||+++++++.+++..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEE
Confidence            468999999999999999999999999999999987543221  223467899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-
Q 015352          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-  207 (408)
                      ||||+.+ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++..... 
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVP  156 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCC
Confidence            9999975 898888764 468999999999999999999999999999999999999   4566799999999865432 


Q ss_pred             CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCccc------------
Q 015352          208 GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDF------------  272 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~------------  272 (408)
                      ........++..|+|||++.+  .++.++||||+|+++|+|++|..||.+.. ..+....+.+.....            
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            112223356888999998864  48899999999999999999999997655 222222222111000            


Q ss_pred             -------C-------CCCCCCCC--HHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          273 -------K-------RDPWPNVS--ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       273 -------~-------~~~~~~~~--~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                             .       ......++  ..+.+++.+||+.+|++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                   0       00112334  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-45  Score=353.29  Aligned_cols=246  Identities=34%  Similarity=0.493  Sum_probs=207.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEee-EEEe------
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE-ACED------  123 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~-~~~~------  123 (408)
                      -++++.+.|.+|||+.||+|.+...|..||+|++...   +....+.+.+||++|++|.+|+|||.+++ ....      
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            4678999999999999999999988899999998654   45667889999999999988999999999 3321      


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeec
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      .-.++|+||||.||.|.+++..+  ..|+|.++..|+.++++|+.+||..+  |||||||-+|||+   ..++..|||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcc
Confidence            13578999999999999999753  45999999999999999999999998  9999999999999   55668999999


Q ss_pred             ccccccCCCC-ce---------ecccCCCCCcchhhhh---c-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH
Q 015352          200 GLSIFFKPGE-RF---------SEIVGSPYYMAPEVLK---R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI  265 (408)
Q Consensus       200 g~~~~~~~~~-~~---------~~~~gt~~y~aPE~~~---~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  265 (408)
                      |.+....... ..         -....|+.|+|||++.   + ..+.|+|||||||+||-|+....||.+...    ..|
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence            9986432211 10         1124789999999985   2 589999999999999999999999976532    357


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +.+.+.++.  +++++..+++||+.||+.||++||++-|++.+
T Consensus       267 lng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  267 LNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             EeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            777776654  46899999999999999999999999999875

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-43  Score=327.16  Aligned_cols=260  Identities=30%  Similarity=0.474  Sum_probs=212.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||.|++|.||+|.++.+|+.||+|.+...... ......+.+|+++++.+ +||||+++++++.+++.+|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence            5799999999999999999999999999999998654332 22345678899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      |||+++ +|.+++.....  +++..++.++.||+.||.|||++|++||||+|+||+++.  .+..+||+|||++......
T Consensus        80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence            999964 78888765443  578889999999999999999999999999999999953  3456999999998754322


Q ss_pred             -CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-----------
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----------  274 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  274 (408)
                       .......+++.|+|||.+.+  .++.++||||+|+++|+|++|..||...+..+...++.........           
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22234467889999998864  4789999999999999999999999887665555444321111000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          275 --------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       275 --------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                    ...+.+++.+.++|.+||+.+|++||++.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                          01245788999999999999999999999999999998654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-44  Score=335.90  Aligned_cols=265  Identities=29%  Similarity=0.470  Sum_probs=211.5

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      ++.++|.+.+.||+|+||.||+|++..+|+.||+|.+....  .......+.+|+.+++.+ +||||+++++++...   
T Consensus         2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFE   78 (336)
T ss_pred             ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCcCchhheeeccccc
Confidence            35689999999999999999999999999999999986322  222345678899999999 899999999987644   


Q ss_pred             --CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          125 --NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       125 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                        ...|+|+||+.+ +|.+.+. .+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~  153 (336)
T cd07849          79 SFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLA  153 (336)
T ss_pred             ccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccce
Confidence              358999999965 8877764 4579999999999999999999999999999999999999   55677999999998


Q ss_pred             cccCCCC----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc-----
Q 015352          203 IFFKPGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-----  271 (408)
Q Consensus       203 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----  271 (408)
                      .......    ......|++.|+|||.+.+  .++.++||||+||++|+|++|+.||.+.+.......+......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            7654322    1233568999999998653  5889999999999999999999999876544333222111000     


Q ss_pred             -----------------c-CC----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCC
Q 015352          272 -----------------F-KR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV  320 (408)
Q Consensus       272 -----------------~-~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~  320 (408)
                                       . ..    ...+.+++++.++|.+||+.+|++|||+.++++||||+........
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~  304 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDE  304 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCc
Confidence                             0 00    0123568889999999999999999999999999999887654333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.8e-44  Score=330.07  Aligned_cols=255  Identities=29%  Similarity=0.460  Sum_probs=210.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--CeEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVH  128 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~  128 (408)
                      +.|.+.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.+ +||||+++++++...  +..|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence            5799999999999999999999999999999999755432 22234567899999999 899999999999877  8999


Q ss_pred             EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||+.+ +|.+++.... .+++..++.++.||+.||.|||++|++||||||+||++   +.++.+||+|||++.....
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence            99999975 8988887643 58999999999999999999999999999999999999   4567799999999886654


Q ss_pred             C-CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc------------
Q 015352          208 G-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF------------  272 (408)
Q Consensus       208 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------  272 (408)
                      . .......+++.|+|||.+.+  .++.++|+||+|+++|+|++|..||...........+.......            
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 33344567889999998864  36889999999999999999999998877665554443221100            


Q ss_pred             --------------CCCCCCC--CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          273 --------------KRDPWPN--VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       273 --------------~~~~~~~--~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                    ....++.  +++.+.++|++||+.+|++|||+.|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          0011222  48889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=308.70  Aligned_cols=256  Identities=25%  Similarity=0.352  Sum_probs=219.3

Q ss_pred             EecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      .++..||.|+.|.|++++.+.+|...|||.+.+..  +..+.++++..+.++..-.++|+||+.+++|..+..++|.||.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            45678999999999999999999999999998654  3445678888888887764699999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce
Q 015352          134 CEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF  211 (408)
Q Consensus       134 ~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~  211 (408)
                      +.. .+..+++. .++++|..+-.+...++.||.||.+ +||+|||+||+|||+   ++.+.|||||||++.........
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccccc
Confidence            843 45444443 4679999999999999999999986 589999999999999   77889999999999988777777


Q ss_pred             ecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          212 SEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       212 ~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      +...|.+.|||||.+.-    .|+.++||||||++++||.||..||.+. ...+++-.+.+...+ ..+.-...|+.+.+
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F~~  327 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDFQS  327 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHHHH
Confidence            77889999999999852    5999999999999999999999999883 556777788775542 22333458999999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      |+..||++|+.+||...++|+|||+.....
T Consensus       328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  328 FVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            999999999999999999999999988654

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.8e-44  Score=330.46  Aligned_cols=264  Identities=28%  Similarity=0.499  Sum_probs=220.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +.....+.|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.+ +||||+++++.+...
T Consensus        16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~   91 (292)
T cd06658          16 SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVG   91 (292)
T ss_pred             ccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecC
Confidence            44555566776788999999999999999999999999986432   23356788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        92 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~  167 (292)
T cd06658          92 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhh
Confidence            999999999999999888754 568999999999999999999999999999999999999   4556799999999875


Q ss_pred             cCCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ..... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+.......+.... .........++.
T Consensus       168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (292)
T cd06658         168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSS  246 (292)
T ss_pred             cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCH
Confidence            43222 2234568899999999865 68999999999999999999999998877666555544332 122222235788


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                      .+.+++.+||..||.+|||+.++++||||.....+
T Consensus       247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.9e-44  Score=327.96  Aligned_cols=254  Identities=30%  Similarity=0.460  Sum_probs=208.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|++.+.||.|++|.||+|++..+|+.||+|.+..... .......+.+|+++++++ +||||+++++++.+++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEe
Confidence            48889999999999999999999999999999865432 222345788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          132 ELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       132 e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      ||+. ++|..++..  .+.+++..+..++.|++.||+|||+.|++||||+|+||++   +.++.+||+|||++...... 
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence            9996 588888865  3568999999999999999999999999999999999999   45667999999998765332 


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC-------------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-------------  273 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  273 (408)
                      .......+++.|+|||.+.+  .++.++||||||+++|+|+||..||.+.+.......+.+......             
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            22333457889999998764  368899999999999999999999987765544443332111100             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          274 ------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       274 ------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                  ....+.++++++++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        00123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.9e-43  Score=323.50  Aligned_cols=260  Identities=30%  Similarity=0.511  Sum_probs=219.2

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      +....|...+.||.|++|.||++.+..++..+++|.+....   ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             cchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeE
Confidence            34455666789999999999999999999999999886432   22345688999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ++++||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||++   +.++.++|+|||.+.....
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhcc
Confidence            999999999999998877 678999999999999999999999999999999999999   4567899999998765432


Q ss_pred             CC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .. ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+.......+....... ......++..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  246 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-LKNLHKVSPRLR  246 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC-CcccccCCHHHH
Confidence            22 2233568999999999875 58999999999999999999999998877766666665553222 122234789999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      +++.+||+.+|++|||+.++++||||.....
T Consensus       247 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         247 SFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=324.22  Aligned_cols=256  Identities=29%  Similarity=0.505  Sum_probs=214.0

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEEeCCeEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .|++.+.||.|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++.+.  .|||++++++++..+..+|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5788899999999999999999999999999986542  2234567889999999983  39999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++   ..+.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCc
Confidence            9999999999998865 4799999999999999999999999999999999999994   46779999999987764433


Q ss_pred             -ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                       ......|+..|+|||.+.+  .++.++|+||+|+++|+|++|..||.+.........+....  .+.......+.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCHHHHH
Confidence             2334568899999998864  47889999999999999999999998776554433332221  111112237889999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++.+||+.||++||++.++++|+||+...
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999999997765

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-44  Score=327.57  Aligned_cols=256  Identities=32%  Similarity=0.512  Sum_probs=212.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+++++.+ +||||+++++++..++..++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEE
Confidence            479999999999999999999999999999999865432 223356789999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||++++.+..+..+...+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence            9999987776666666679999999999999999999999999999999999999   457789999999988765443 


Q ss_pred             -ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc---------------
Q 015352          210 -RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID---------------  271 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------------  271 (408)
                       ......++..|+|||++.+  .++.++|+||+|+++|+|++|..||.+....+....+......               
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             3345678899999998864  5789999999999999999999999876654433332221100               


Q ss_pred             ----cCC---------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 ----FKR---------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 ----~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                          +..         .....++.++++||++||..+|++|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                000         0111248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-44  Score=335.53  Aligned_cols=262  Identities=28%  Similarity=0.460  Sum_probs=214.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----  124 (408)
                      +..+|.+.+.||+|+||+||+|++..++..||+|.+..... .......+.+|+.+++.+ +||||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence            56789999999999999999999999999999999875422 222345677899999999 999999999988644    


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 -NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                       ...|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++   +.++.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence             35899999996 5899999888889999999999999999999999999999999999999   456679999999988


Q ss_pred             ccCCC-CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----------
Q 015352          204 FFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL-----------  269 (408)
Q Consensus       204 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-----------  269 (408)
                      ..... .......++..|+|||.+.+  .++.++|||||||++|+|++|..||.+.+.......+....           
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            65433 22344568899999998763  58899999999999999999999997765433322221100           


Q ss_pred             ------------cccC----CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          270 ------------IDFK----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       270 ------------~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                  ....    ...++.+++.+.++|++||+.+|++|||+.++++||||.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                        0000    0113468899999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-43  Score=323.85  Aligned_cols=249  Identities=28%  Similarity=0.451  Sum_probs=203.3

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHH---HHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA---IMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~---~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      .||+|+||.||+|.+..+++.||+|.+.+..............|..   +++.. +||+|+.+++++.+.+.+|+||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence            4899999999999999999999999998765433222222333433   44444 7999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecc
Q 015352          135 EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI  214 (408)
Q Consensus       135 ~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~  214 (408)
                      .|++|..++...+.+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.+||+|||++...... .....
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~-~~~~~  155 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KPHAS  155 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc-CCcCc
Confidence            999999999888889999999999999999999999999999999999999   45667999999998755332 22345


Q ss_pred             cCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          215 VGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       215 ~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .|+..|+|||.+.+  .++.++||||+|+++|+|++|..||.+..   ............    ......++..+.+++.
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~  231 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----VELPDSFSPELRSLLE  231 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC----CCCCCcCCHHHHHHHH
Confidence            78999999999863  48999999999999999999999997762   222222222221    2222357899999999


Q ss_pred             HhcCCCcCCCC-----CHHHHhcCccccCCc
Q 015352          290 QMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       290 ~~l~~dp~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      +||..+|.+||     ++.++++||||+...
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999999     999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-44  Score=351.88  Aligned_cols=266  Identities=21%  Similarity=0.305  Sum_probs=197.7

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCC-cEEEEEE--------------eeccccCChhcHHHHHHHHHHHHhCC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTR-ELLACKS--------------ISKRKLRTAVDIDDVRREVAIMKHLP  109 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~  109 (408)
                      .+..+.++|++++.||+|+||+||+|..+... ...+.|.              +.+...........+.+|+.+++++ 
T Consensus       142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-  220 (501)
T PHA03210        142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-  220 (501)
T ss_pred             cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-
Confidence            34556789999999999999999999765432 2222221              1111111222345678999999999 


Q ss_pred             CCCCeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceE
Q 015352          110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL  184 (408)
Q Consensus       110 ~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl  184 (408)
                      +||||+++++++.+.+..|+|+|++.+ +|.+++...     .......++.++.||+.||.|||++||+||||||+|||
T Consensus       221 ~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL  299 (501)
T PHA03210        221 NHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF  299 (501)
T ss_pred             CCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            999999999999999999999999954 777776543     22346778899999999999999999999999999999


Q ss_pred             eecCCCCCCEEEeecccccccCCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC---CH
Q 015352          185 FANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---SE  258 (408)
Q Consensus       185 ~~~~~~~~~vkl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~---~~  258 (408)
                      +   +.++.+||+|||++........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..++...   ..
T Consensus       300 l---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        300 L---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             E---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            9   4567799999999987643322  234579999999999875 6999999999999999999987654332   12


Q ss_pred             HHHHHHHHcCCc----ccCC------------------C------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          259 QGVAQAILRGLI----DFKR------------------D------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       259 ~~~~~~i~~~~~----~~~~------------------~------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      ......+.....    .++.                  .      ....++.++.++|.+||+.||.+|||+.|+|.|||
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            222222221110    0000                  0      00135677888999999999999999999999999


Q ss_pred             ccCCc
Q 015352          311 LQNAK  315 (408)
Q Consensus       311 ~~~~~  315 (408)
                      |....
T Consensus       457 f~~~~  461 (501)
T PHA03210        457 FSAEE  461 (501)
T ss_pred             hhcCC
Confidence            97643

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-43  Score=321.61  Aligned_cols=255  Identities=28%  Similarity=0.415  Sum_probs=219.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||.|++|.||+|.+..+++.|++|++......  .....+.+|+.++..+ +|||++++++++..++.+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEE
Confidence            3688999999999999999999999999999998765322  3457789999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      +||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCC
Confidence            9999999999999888889999999999999999999999 999999999999999   456789999999988765433


Q ss_pred             ce-ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHHcCCcccCCCCCCC-CCHH
Q 015352          210 RF-SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---SEQGVAQAILRGLIDFKRDPWPN-VSES  283 (408)
Q Consensus       210 ~~-~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~~~~  283 (408)
                      .. ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...   ...+....+.......   .... ++..
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---LPAEEFSPE  231 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC---CCcccCCHH
Confidence            22 24568899999998875 5889999999999999999999999776   4445555555332211   1123 7899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +.++|.+||..+|++|||+.++++|||++..
T Consensus       232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         232 FRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            9999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-43  Score=321.58  Aligned_cols=248  Identities=18%  Similarity=0.261  Sum_probs=208.2

Q ss_pred             cceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+....  .......+.+|+.+++++ +||||+++++++..++..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCc
Confidence            46999999999999999999865   346789999987542  223346788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++||||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||++   +.++.+|++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence            9999999999999998774 568999999999999999999999999999999999999   456789999999876543


Q ss_pred             CCCcee--cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGERFS--EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ......  ...++..|+|||.+.+ .++.++||||+||++|++++ |..||++.+..+....+..+...   +....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  235 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCPN  235 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCH
Confidence            222111  2235678999998864 68999999999999999775 99999998888877777655322   22356889


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.+++.+||+.+|.+|||+.++++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-43  Score=321.42  Aligned_cols=251  Identities=27%  Similarity=0.473  Sum_probs=210.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.+ +||||+++++++.+.+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence            5799999999999999999999999999999998765444444456788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          131 MELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999888753    3458999999999999999999999999999999999999   456679999999987654


Q ss_pred             CCCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .... .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.....  ......+....  ++......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            3221 234568899999998865 588999999999999999999999976532  33444443322  22222345788


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHH
Confidence            9999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-43  Score=325.69  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=214.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|.+..+|..||+|++....  .......+.+|+++++.+ +||||+++++.+...+.+|+|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEE
Confidence            57889999999999999999999999999999986542  223356788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||+++++|.+++.+.+.+++..+..++.+++.||.|||+ .+++||||+|+||++   +.++.++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-
Confidence            9999999999999888889999999999999999999997 699999999999999   45677999999988654322 


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-----------HHHHHHHcCCcccCCCCC
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-----------GVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~  277 (408)
                      ......|+..|+|||++.+ .++.++|+||+||++|+|++|..||......           +....+.....  +....
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPS  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCc
Confidence            1234578999999998864 6889999999999999999999999765432           22222222211  11111


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ..++..+.+|+.+||++||++|||+.++++|+||.....
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            237889999999999999999999999999999977543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7e-44  Score=326.56  Aligned_cols=254  Identities=31%  Similarity=0.569  Sum_probs=220.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++++.+||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998755544444577889999999993399999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccc
Confidence            9999999999999988889999999999999999999999999999999999999   456679999999987654322 


Q ss_pred             --------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Q 015352          210 --------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       210 --------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  268 (408)
                                          ......++..|+|||.+.. .++.++|+||||++++++++|..||...+.......+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  237 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL  237 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence                                1223467889999998764 5888999999999999999999999888766666666654


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCH----HHHhcCccc
Q 015352          269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTA----KQVLEHPWL  311 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~----~~~l~h~~~  311 (408)
                      ...++    ..+++.+.+||.+||+.+|.+|||+    .++++||||
T Consensus       238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44333    3668999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-43  Score=324.31  Aligned_cols=257  Identities=24%  Similarity=0.313  Sum_probs=206.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|++..+|+.||+|.+......  .....+..|+.++.+..+||||+++++++..++..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            4689999999999999999999999999999998754322  12345566777644444999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          131 MELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |||++ ++|.+++..    ...+++..++.++.||+.||.|||++ +++||||||+||++   +.++.+||+|||++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence            99997 478777654    24589999999999999999999997 99999999999999   45678999999998865


Q ss_pred             CCCCceecccCCCCCcchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCcccCCCCCCC
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ..........|+..|+|||.+.+     .++.++|+||+||++|+|++|..||.... ..+....+..+...  ..+...
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~  232 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP--QLPAEK  232 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC--CCCccc
Confidence            43333333568899999998753     46889999999999999999999996532 22323333332111  111235


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +|.++.++|.+||..+|++|||+.++++||||....
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            789999999999999999999999999999998864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.4e-44  Score=322.84  Aligned_cols=250  Identities=34%  Similarity=0.584  Sum_probs=217.0

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||.|+||.||+|++..+|+.+++|++.............+.+|+++++.+ +||||+++++.+..++..|+++||++|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            68999999999999999999999999766544444567889999999999 89999999999999999999999999999


Q ss_pred             hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC---------
Q 015352          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---------  209 (408)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~---------  209 (408)
                      |.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||++   +.++.++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence            99999887889999999999999999999999999999999999999   456679999999987643321         


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......++..|+|||.+.+ .++.++|+||||+++|++++|..||......+....+..+...++..  ..+++.+.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence            2234567889999998865 58889999999999999999999999888888777777655443322  23589999999


Q ss_pred             HHhcCCCcCCCCCH---HHHhcCccccCC
Q 015352          289 RQMLEPDPKLRLTA---KQVLEHPWLQNA  314 (408)
Q Consensus       289 ~~~l~~dp~~R~s~---~~~l~h~~~~~~  314 (408)
                      .+||+.+|.+|||+   .++++||||+..
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.2e-44  Score=338.85  Aligned_cols=253  Identities=20%  Similarity=0.300  Sum_probs=204.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCC-----CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      -..++|.+.+.||+|+||.||+|++..+     +..||+|.+.....  ......+.+|+.+++.+.+||||+++++++.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            3456899999999999999999986544     35799999975432  2235678899999999878999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC--------------------------------------------------------
Q 015352          123 DDNAVHLVMELCEGGELFDRIVAR--------------------------------------------------------  146 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~--------------------------------------------------------  146 (408)
                      ..+..|+||||+++|+|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999988542                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce-
Q 015352          147 --------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF-  211 (408)
Q Consensus       147 --------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~-  211 (408)
                                    ..+++..++.++.||+.||.|||++||+||||||+|||++   ++..+||+|||++......... 
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCccee
Confidence                          1367888999999999999999999999999999999994   5667999999998765433221 


Q ss_pred             --ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          212 --SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       212 --~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                        ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.....................  ...+++++.++
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l  347 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSI  347 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHH
Confidence              12234567999998864 69999999999999999997 99999876554444344433322222  23568999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhc
Q 015352          288 VRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+||+.||.+|||+.++++
T Consensus       348 i~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         348 MKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-43  Score=338.21  Aligned_cols=252  Identities=20%  Similarity=0.329  Sum_probs=203.3

Q ss_pred             ccceEecceecccCCeEEEEEEE-----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++.....  ....+.+.+|+.+++.+.+||||+++++++.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            45799999999999999999974     34677899999864332  223567889999999987899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC---------------------------------------------------------
Q 015352          125 NAVHLVMELCEGGELFDRIVARG---------------------------------------------------------  147 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~---------------------------------------------------------  147 (408)
                      +..++||||++||+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999986532                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          148 ------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       148 ------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                                        .+++..+..++.||+.||.|||++||+||||||+|||++   .+..+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcc
Confidence                              367788999999999999999999999999999999994   45679999999987654332


Q ss_pred             ce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          210 RF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       210 ~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ..   ....++..|+|||++.+ .++.++|||||||++|+|++ |..||....................  .....+.++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  346 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM  346 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence            21   12234567999999875 69999999999999999998 8999977654433333333222211  223568899


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+|+.+||+.||++|||+.++++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-43  Score=324.23  Aligned_cols=253  Identities=30%  Similarity=0.528  Sum_probs=209.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|++.+.||.|++|.||+|++..+|..||+|.+......  .....+.+|+.+++.+ +||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEE
Confidence            588999999999999999999999999999999765322  2345677899999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          132 ELCEGGELFDRIVAR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       132 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence            99986 888887654   358999999999999999999999999999999999999   45667999999998754322


Q ss_pred             -CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-----------
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----------  274 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  274 (408)
                       .......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+..+....+.+.......           
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             22234467889999998864  4788999999999999999999999887766555544332110000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          275 --------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       275 --------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                    ...+.+++.++++|.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                          0012457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-43  Score=327.82  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=207.1

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .....++|.+.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.+ +||||+++++++....
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   84 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKA   84 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhC-CCCCccceEEEEeccc
Confidence            3455678999999999999999999999999999999987543222 2234567899999999 9999999999987553


Q ss_pred             --------eEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          126 --------AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       126 --------~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                              ..|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||++   +.++.+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl  160 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKL  160 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEE
Confidence                    45999999965 7877776543 68999999999999999999999999999999999999   55678999


Q ss_pred             eecccccccCCCC-----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Q 015352          197 IDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       197 ~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      +|||++.......     ......++..|+|||.+.+  .++.++||||+|+++|+|++|..||.+.+.......+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999987653221     1223457888999998765  37889999999999999999999998876654444333311


Q ss_pred             cccCCCC----------------------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          270 IDFKRDP----------------------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       270 ~~~~~~~----------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ..++.+.                            ....+..+.+||.+||..||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            1111100                            01135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-43  Score=326.94  Aligned_cols=258  Identities=22%  Similarity=0.321  Sum_probs=207.6

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|...+.||+|+||.||++.+..+|..+|+|.+......  .....+.+|+.++.++.+||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            566778999999999999999999999999998754432  335678899999999855999999999999999999999


Q ss_pred             eccCCCchHHH---HH--hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          132 ELCEGGELFDR---IV--ARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       132 e~~~g~~L~~~---l~--~~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ||+.+ ++.++   +.  ..+.+++..+..++.|++.||+|||+. +++||||||+||+++   ..+.+||+|||++...
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHh
Confidence            99865 54443   22  235699999999999999999999975 999999999999994   4567999999998765


Q ss_pred             CCCCceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCC-cccCCCCCCC
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGL-IDFKRDPWPN  279 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~  279 (408)
                      ..........|++.|+|||.+.+    .++.++||||+||++|+|++|..||..... .+....+..+. ..........
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            44433344568899999999864    488999999999999999999999976542 12222222222 1222222345


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++.++.+||.+||+.+|++|||+.++++||||+...
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            889999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.5e-43  Score=326.06  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=202.7

Q ss_pred             ccceEecceecccCCeEEEEEEECC----------------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRD----------------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~  113 (408)
                      .++|.+.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++..+ +|||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRL-KDPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhc-CCCC
Confidence            4689999999999999999998642                34579999986532  233456789999999999 9999


Q ss_pred             eeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 015352          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-------------------HYTERAAAAVTRTIVEVVQLCHKHGVI  174 (408)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~i~~ql~~~l~~lH~~~iv  174 (408)
                      |+++++++.+.+..++||||+++++|.+++....                   .++...+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   357788899999999999999999999


Q ss_pred             eccCCCCceEeecCCCCCCEEEeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh--
Q 015352          175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC--  248 (408)
Q Consensus       175 H~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~--  248 (408)
                      ||||||+|||+   +.++.+||+|||++.........   ....++..|+|||++.+ .++.++||||||+++|+|++  
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999   45677999999999765433321   22345778999998764 69999999999999999986  


Q ss_pred             CCCCCCCCCHHHHHHHHHcCC----cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          249 GVPPFWAESEQGVAQAILRGL----IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       249 g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +..||...+..+....+....    ........+.++..+.+|+.+||+.||++|||+.++.+
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            668888776665554432211    11111122467899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-43  Score=328.00  Aligned_cols=250  Identities=23%  Similarity=0.303  Sum_probs=204.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcE--EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ++|++.+.||+|+||.||+|.++.++..  +|+|.+..  .........+.+|+.++.++.+||||+++++++.+++.+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            4789999999999999999999887765  46665542  2233345678899999999878999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          129 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      +||||+++++|.+++...+                .+++..+..++.||+.||+|||++|++||||||+|||+   +.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence            9999999999999997543                47899999999999999999999999999999999999   4566


Q ss_pred             CEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCc
Q 015352          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      .+||+|||++.............++..|+|||.+.+ .++.++|||||||++|+|+| |..||.+.+..+....+..+. 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-  240 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  240 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence            799999999864321111111234567999998865 58899999999999999998 999998877776666554432 


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                        ........++.+.+|+.+||+.+|++||++.+++.+
T Consensus       241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              122234578999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.5e-43  Score=317.64  Aligned_cols=248  Identities=31%  Similarity=0.504  Sum_probs=213.6

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+.....  ....+.+.+|+.+++.+ +||||+++++.+.+++.+|++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence            58899999999999999999999999999999875432  23456788999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||+++++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence            999999999988653  458999999999999999999999999999999999999   456779999999987654322


Q ss_pred             -ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......|++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.......+..+.....   ...++..+.+|
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHH
Confidence             2234578999999999875 589999999999999999999999998887777666665544321   23578899999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcC
Q 015352          288 VRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h  308 (408)
                      |.+||+.||++|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-43  Score=356.59  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=205.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+++..|+|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence            5899999999999999999999999999999999765433334456789999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          131 MELCEGGELFDRIVAR-----------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-----------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      |||++|++|.+++...           ...+...+..++.||+.||.|||++||+||||||+||++   +..+.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999988642           234566788999999999999999999999999999999   45677999999


Q ss_pred             ccccccCCCC-------------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH
Q 015352          200 GLSIFFKPGE-------------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ  259 (408)
Q Consensus       200 g~~~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  259 (408)
                      |++.......                   .....+||+.|+|||.+.+ .++.++||||+||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                   1123469999999999875 6899999999999999999999999875544


Q ss_pred             HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ......... .......+..+|+.+.+++.+||..||++||+..+.+.+
T Consensus       238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            332221111 111112335788999999999999999999887766654

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.3e-43  Score=323.89  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=210.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCC-----cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ++|++.+.||+|+||.||+|.+...+     ..+|+|.+....  .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCC
Confidence            47889999999999999999876555     679999886432  223356788999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC
Q 015352          126 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~  189 (408)
                      ..|++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||++   +
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence            999999999999999999764                457889999999999999999999999999999999999   4


Q ss_pred             CCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 015352          190 ENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  264 (408)
                      +++.+||+|||++.......   ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            56679999999987653322   123345678899999876 468999999999999999998 9999999888888777


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +..+....   ....+|+++.+|+.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76654332   224689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.9e-44  Score=334.35  Aligned_cols=263  Identities=30%  Similarity=0.444  Sum_probs=214.2

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE----eC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE----DD  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----~~  124 (408)
                      +.++|.+.+.||+|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.+ +||||+++++++.    ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCC
Confidence            45789999999999999999999999999999999875432 223356778899999999 8999999999876    34


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~  156 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG  156 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence            57899999995 5899998877789999999999999999999999999999999999999   5567899999999876


Q ss_pred             cCCCC-----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------
Q 015352          205 FKPGE-----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--------  269 (408)
Q Consensus       205 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--------  269 (408)
                      .....     ......|+..|+|||.+.+  .++.++||||+||++|+|++|+.||.+.+.......+....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            53221     1234578899999998754  48899999999999999999999998765443332222110        


Q ss_pred             ---------------cccCCC----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          270 ---------------IDFKRD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       270 ---------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                                     ......    .++..++.+.++|.+||+.+|.+|||+.+++.||||.....+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                           000000    124578999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-44  Score=327.60  Aligned_cols=256  Identities=29%  Similarity=0.464  Sum_probs=214.5

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.|...+.||+|+||.||+|.+..++..||+|.+.....  ....+.+.+|+.+++.+ +||||+++++++..++.+|+
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEE
Confidence            4567888999999999999999999999999999875432  22356789999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcc
Confidence            9999999999988754 5789999999999999999999999999999999999994   56679999999987654332


Q ss_pred             -ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.....   .......+..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  232 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKEF  232 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHHH
Confidence             1223468889999999875 588999999999999999999999976655554444333221   11123578899999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      |.+||..+|++|||+.++++||||....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999999999997643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.7e-43  Score=320.83  Aligned_cols=256  Identities=28%  Similarity=0.469  Sum_probs=215.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+-|.+.+.||.|+||.||+|.+..++..+|+|++.....  ......+.+|+.+++.+ +||||+++++++..++..|+
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEE
Confidence            3457788999999999999999999999999999865432  22346788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||+++++|.+++.. +.+++..+..++.|++.|+.|||+.|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        80 v~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          80 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccch
Confidence            9999999999988864 468999999999999999999999999999999999999   455679999999987654322


Q ss_pred             -ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......++..|+|||.+.+ .++.++|+||+||++|+|++|..||...........+......   .....++.++.++
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  232 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEF  232 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHHH
Confidence             2233468889999998865 5888999999999999999999999877665555554433221   1223578899999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      |.+||..+|.+||++.++++||||.+..
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         233 VEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            9999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=324.32  Aligned_cols=259  Identities=29%  Similarity=0.490  Sum_probs=235.6

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      ...|.++..||+|+||.|.+|..+.+.+.||||++.+.-+-...+.+--..|-++|....+.|.++.++.+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            35788899999999999999999999999999999988776666677777788888877778999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc-CCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~-~~~  208 (408)
                      ||||+.||+|.-.+++-+.+.|..+..++..|+.||-+||++||+.||||.+||++   +..++|||+|||+++.. -.+
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCC
Confidence            99999999999999999999999999999999999999999999999999999999   67788999999999754 345


Q ss_pred             CceecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ....+++|||.|+|||++. .+|+.++|.||+|++||||+.|.+||.+.+..++.+.|......++.    .+|.++.++
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~i  580 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAI  580 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHH
Confidence            5667899999999999887 57999999999999999999999999999999999999998877664    789999999


Q ss_pred             HHHhcCCCcCCCCCH-----HHHhcCccccCCc
Q 015352          288 VRQMLEPDPKLRLTA-----KQVLEHPWLQNAK  315 (408)
Q Consensus       288 i~~~l~~dp~~R~s~-----~~~l~h~~~~~~~  315 (408)
                      +..+|.+.|.+|..+     .++-.||||....
T Consensus       581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            999999999999854     6899999998753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=286.16  Aligned_cols=258  Identities=29%  Similarity=0.541  Sum_probs=221.5

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .+|.-.+.||+|.||+||+|+++.+++.||+|.++...-... ......+||-+++.| .|.||++++++...++.+-+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkel-khknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEe
Confidence            356677899999999999999999999999999987654333 235678999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-C
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-G  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~  208 (408)
                      +|||+. +|..+... ++.+..+.++.++.|++.||.++|++++.|||+||.|.|+   +.++.+||+|||+++...- -
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce
Confidence            999965 78777765 5679999999999999999999999999999999999999   5678899999999987643 2


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC-------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP-------  278 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------  278 (408)
                      ..++..+-|.+|++|.++-+  -|+...|+||.|||+.|+.. |++.|.+.+-.+....|.+.......+.|+       
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            34555677999999999876  39999999999999999986 888899998888888887766555444443       


Q ss_pred             ------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          279 ------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       279 ------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                        +++..-+++++++|.-+|.+|++++++++||||...
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                              334567899999999999999999999999999764

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-42  Score=320.09  Aligned_cols=258  Identities=29%  Similarity=0.427  Sum_probs=209.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--CCeEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAVH  128 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~  128 (408)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++.+ +||||+++++++.+  .+.+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEE
Confidence            468899999999999999999999999999999875432  23356789999999999 89999999998864  44789


Q ss_pred             EEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          129 LVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeecccccc
Confidence            99999999999887653    34589999999999999999999999999999999999994   456799999999875


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCccc-CCCCC
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE-----SEQGVAQAILRGLIDF-KRDPW  277 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~-~~~~~  277 (408)
                      ..... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||...     ...+....+....... .....
T Consensus       155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            43222 123457889999998875 6899999999999999999999999765     2233444443322111 11111


Q ss_pred             --CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          278 --PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       278 --~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                        ...++.+.+||.+||..+|.+|||+.|++.||||+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence              23567899999999999999999999999999996654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.2e-43  Score=331.49  Aligned_cols=259  Identities=31%  Similarity=0.478  Sum_probs=210.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD----  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----  124 (408)
                      +..+|.+.+.||.|+||.||+|.++.+|..||+|.+.....   ...+.+.+|+++++.+ +||||+++++++...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence            56899999999999999999999999999999999865432   3456788999999999 999999999876654    


Q ss_pred             ----------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          125 ----------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       125 ----------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                                ...|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.  .+..+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVL  154 (342)
T ss_pred             ccccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCceE
Confidence                      368999999974 88887754 57899999999999999999999999999999999999953  34568


Q ss_pred             EEeecccccccCCCC----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Q 015352          195 KAIDFGLSIFFKPGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       195 kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  268 (408)
                      ||+|||.+.......    ......++..|+|||.+.+  .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999987653221    1123457889999998753  5888999999999999999999999877665554444332


Q ss_pred             Cccc----------------------C----CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          269 LIDF----------------------K----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       269 ~~~~----------------------~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ....                      .    ....+.++.++.+||.+||+.||.+|||+.+++.||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence            1100                      0    001235788999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=336.15  Aligned_cols=254  Identities=23%  Similarity=0.404  Sum_probs=214.1

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ..+...+...+.+.||+|+||+||+|++-.+   ||||++..... +....+.|++|+.++++- +|-||+-+.+++..+
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~p-t~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDP-TPEQLQAFKNEVAVLKKT-RHENILLFMGACMNP  460 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCC-CHHHHHHHHHHHHHHhhc-chhhheeeehhhcCC
Confidence            3444555667889999999999999998654   99999987655 344789999999999997 999999999999998


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      .. .||+.+|+|.+|+.++.-. ..+.....+.|++|+++|+.|||.++|||||||..||++   .+++.|||+|||++.
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLAT  536 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEeccccee
Confidence            87 8999999999999998654 458889999999999999999999999999999999999   555889999999986


Q ss_pred             cc---CCCCceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-C
Q 015352          204 FF---KPGERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-D  275 (408)
Q Consensus       204 ~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~  275 (408)
                      .-   .....+....|...|||||+++.    +|++.+|||||||++|||+||..||.......++-.+-+|...... .
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence            53   23334445568888999999862    5999999999999999999999999977776666666666443322 2


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...+.+.++++|+..||..++++||...+||.
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            23467789999999999999999999999987

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=323.51  Aligned_cols=253  Identities=30%  Similarity=0.475  Sum_probs=208.8

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |++.+.||.|++|.||+|.++.+|..||+|++....... .....+.+|+++++.+ +|||++++++++.+++..|++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEe
Confidence            677899999999999999999999999999997654322 2235678899999999 89999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          133 LCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      |++ ++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||+++   .++.++|+|||++...... .
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc
Confidence            995 58999887765  689999999999999999999999999999999999994   4678999999998754322 2


Q ss_pred             ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc----------------
Q 015352          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID----------------  271 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------------  271 (408)
                      ......+++.|+|||++.+  .++.++|+||+|+++|+|++|..||...+.......+.+....                
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            2233456889999998754  4788999999999999999999999877665443333321110                


Q ss_pred             ---------cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 ---------FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                               ......+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     0011234678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.2e-43  Score=330.00  Aligned_cols=265  Identities=28%  Similarity=0.431  Sum_probs=215.8

Q ss_pred             cccccceEe-cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh-----------cHHHHHHHHHHHHhCCCCCCe
Q 015352           47 ENIEDRYLV-DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----------DIDDVRREVAIMKHLPKNSSI  114 (408)
Q Consensus        47 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~~i  114 (408)
                      ..+.++|.. .+.||.|+||+||+|.+..+++.||+|++.........           ....+.+|+.+++.+ +||||
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i   82 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENI   82 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcce
Confidence            346778875 57799999999999999999999999998754332100           012467899999999 99999


Q ss_pred             eEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       115 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                      +++++++..++..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||++   +..+.+
T Consensus        83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~  158 (335)
T PTZ00024         83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGIC  158 (335)
T ss_pred             eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCE
Confidence            999999999999999999997 5899999887889999999999999999999999999999999999999   456679


Q ss_pred             EEeecccccccCC---------------CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCC
Q 015352          195 KAIDFGLSIFFKP---------------GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAES  257 (408)
Q Consensus       195 kl~Dfg~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~  257 (408)
                      +|+|||++.....               ........+++.|+|||.+.+  .++.++|+|||||++|+|++|..||.+.+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999875541               111223356888999998865  37899999999999999999999998887


Q ss_pred             HHHHHHHHHcCCcccCCC------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          258 EQGVAQAILRGLIDFKRD------------------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ..+....+..........                        .....++.+.++|.+||+.+|++|||+.+++.||||+.
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            766655544321111100                        11345788999999999999999999999999999987


Q ss_pred             CcC
Q 015352          314 AKK  316 (408)
Q Consensus       314 ~~~  316 (408)
                      ...
T Consensus       319 ~~~  321 (335)
T PTZ00024        319 DPL  321 (335)
T ss_pred             CCC
Confidence            643

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.5e-43  Score=317.19  Aligned_cols=253  Identities=27%  Similarity=0.517  Sum_probs=215.5

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||.|+||.||+|.++.+|..+|+|.+....... ...+.+.+|+.+++.+ +||||+++++.+.+++.+|+|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEE
Confidence            5889999999999999999999999999999997654322 2356788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.  ....+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence            9999999999987643  4799999999999999999999999999999999999953  22457999999987654332


Q ss_pred             c-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          210 R-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       210 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      . .....|++.|+|||.+.+ .++.++|+||+|+++++|++|..||...+.......+......   ...+.++..+.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence            2 233468899999998864 5889999999999999999999999887766666655554332   2224678899999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccc
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      |.+||..+|++|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.8e-43  Score=322.11  Aligned_cols=255  Identities=29%  Similarity=0.443  Sum_probs=203.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|++.......  ....+.+|+.+++.+ +|+||+++++++.+++..|+
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEE
Confidence            368999999999999999999999999999999987543221  234567899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      |+||+. ++|.+++.. .+.+++..+..++.|++.||.|||++||+|+||||+||++   +.++.+||+|||++......
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCC
Confidence            999996 577676654 3568889999999999999999999999999999999999   45667999999998754322


Q ss_pred             -CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCC--------------c
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGL--------------I  270 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~--------------~  270 (408)
                       .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.... +....+....              .
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             22234467899999998864  4788999999999999999999999765432 2222211100              0


Q ss_pred             ccCCC------------CCC--CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          271 DFKRD------------PWP--NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       271 ~~~~~------------~~~--~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      .+...            .+.  ..++.+.+++.+||..||.+|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00000            011  125788999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.4e-43  Score=324.91  Aligned_cols=259  Identities=26%  Similarity=0.483  Sum_probs=217.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ...-|.....||+|+||.||+|.+..++..||+|.+.....   ...+.+.+|+.+++.+ +||||+++++++..++..|
T Consensus        19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~   94 (297)
T cd06659          19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELW   94 (297)
T ss_pred             chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEE
Confidence            33445556689999999999999999999999999865432   2346788999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +|+||+++++|..++.. ..+++..++.++.|++.||.|||++|++||||+|+||++   +.++.+||+|||++......
T Consensus        95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccc
Confidence            99999999999887654 568999999999999999999999999999999999999   45678999999998754332


Q ss_pred             C-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          209 E-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       209 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      . ......|++.|+|||.+.+ .++.++||||+||++|+|++|..||......+....+..... .....+..+++.+.+
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~  249 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLRD  249 (297)
T ss_pred             cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCccccCCCCHHHHH
Confidence            2 2234578999999999875 689999999999999999999999988776666555543322 222334567899999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      +|.+||+.+|++||++.++++||||.....
T Consensus       250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         250 FLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.5e-43  Score=319.51  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=210.6

Q ss_pred             ccceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .++|.+.+.||+|++|.||+|.+..     ++..||+|.+....  .......+.+|+.+++.+ +||||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC
Confidence            3578999999999999999999987     77889999876432  222345688999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          125 NAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      +..++||||++|++|.+++...+       .+++..+..++.||+.||.|||+++++||||||+||+++.++....+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999987653       48899999999999999999999999999999999999765555679999


Q ss_pred             ecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCccc
Q 015352          198 DFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (408)
Q Consensus       198 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (408)
                      |||++.........   .....+..|+|||++.+ .++.++|||||||++|+|++ |..||.+.+.......+.....  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--  239 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR--  239 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--
Confidence            99998865322211   12233567999999864 69999999999999999997 9999998887776665554321  


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                       ......++..+.+++.+||+.+|++|||+.++++|
T Consensus       240 -~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 -LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             12234678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-42  Score=322.80  Aligned_cols=262  Identities=28%  Similarity=0.448  Sum_probs=220.0

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      .....+...|...+.||+|+||.||+|++..++..+|+|.+.............+.+|+++++.+ +|||++++++++.+
T Consensus        18 ~~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   96 (317)
T cd06635          18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLR   96 (317)
T ss_pred             hcCCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee
Confidence            34456666788999999999999999999999999999999765444444456788999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      ++..|+||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||++   +.++.+||+|||++
T Consensus        97 ~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~  172 (317)
T cd06635          97 EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSA  172 (317)
T ss_pred             CCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCc
Confidence            9999999999976 77776654 4568999999999999999999999999999999999999   45677999999988


Q ss_pred             cccCCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ......   ....|++.|+|||.+.    +.++.++|+||+||++|+|++|..||...........+.......  ....
T Consensus       173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  247 (317)
T cd06635         173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSN  247 (317)
T ss_pred             cccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCc
Confidence            754332   3456889999999873    358899999999999999999999998877666655555543221  2224


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..++.+++++.+||+.+|.+||++.++++|+|+....
T Consensus       248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            5788999999999999999999999999999996654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-43  Score=328.53  Aligned_cols=261  Identities=28%  Similarity=0.457  Sum_probs=214.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-  125 (408)
                      ..+.++|.+.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+ +||||+++++++..+. 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   88 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcc
Confidence            457889999999999999999999999999999999986432 2222345678999999999 9999999999987654 


Q ss_pred             -----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          126 -----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       126 -----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                           .+++||||+ |++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++   .++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg  163 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFG  163 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecc
Confidence                 468999999 778887775 45799999999999999999999999999999999999994   56679999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc------
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF------  272 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------  272 (408)
                      ++......  .....+++.|+|||.+.+  .++.++|+||+|+++|+|++|..||.+.+.......+.......      
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         164 LARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98765332  234467899999998864  48899999999999999999999998776654444433321110      


Q ss_pred             -----------------C----CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          273 -----------------K----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       273 -----------------~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                       .    ...++.+++.+.++|.+||+.||.+|||+.+++.||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                             0    0112467888999999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=315.10  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=212.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeecccc--CChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--Ce
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~  126 (408)
                      .+|++.+.||+|+||.||+|.+..++..+|+|.+.....  ........+.+|+.+++++ +||||+++++++.+.  +.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence            579999999999999999999999999999999864321  1233456788999999999 999999999998764  56


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +++++||++|++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence            89999999999999999887889999999999999999999999999999999999999   456679999999987653


Q ss_pred             CC----CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          207 PG----ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       207 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..    .......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||..........++.....  .......++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~  235 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS  235 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence            21    12234568899999999875 588999999999999999999999987765554444433221  122335788


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +.+.++|.+||. +|..|||+.+++.|||.
T Consensus       236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-42  Score=313.46  Aligned_cols=253  Identities=32%  Similarity=0.541  Sum_probs=215.3

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--CeEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~l  129 (408)
                      +|.+.+.||+|++|.||+|.+..++..+++|++...... ....+.+.+|+.+++++ +||||+++++.+.+.  +.+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEE
Confidence            478889999999999999999999999999998765432 33467889999999999 899999999999988  89999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ++||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence            999999999999998887899999999999999999999999999999999999994   46779999999988765544


Q ss_pred             c---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          210 R---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       210 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      .   .....++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+...  .........++..+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHH
Confidence            3   345678899999999875 48999999999999999999999997765 22222222211  11112224568999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      .++|.+||+.+|++||++.++++||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-42  Score=323.51  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=218.5

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.+.|...+.||+|+||+||+|++..+|..|++|.+.............+.+|+.+++.+ +|||++++++++.+.
T Consensus        15 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   93 (313)
T cd06633          15 YKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE   93 (313)
T ss_pred             ccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC
Confidence            3455666788888999999999999999999999999999765544444556788999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ...|+||||+.| +|.+.+.. ...+++..+..++.||+.||.|||++|++||||+|+||++   +.++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~  169 (313)
T cd06633          94 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSAS  169 (313)
T ss_pred             CEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCc
Confidence            999999999965 77777655 4568999999999999999999999999999999999999   456679999999886


Q ss_pred             ccCCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ....   .....|+..|+|||.+.    +.++.++||||+||++|+|++|..||...+.......+.....  +......
T Consensus       170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  244 (313)
T cd06633         170 KSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNE  244 (313)
T ss_pred             ccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccc
Confidence            5332   23457889999999873    3588899999999999999999999988776655555544322  2222345


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++..+++|+.+||+.+|.+||++.+++.||||....
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            678899999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.5e-43  Score=323.15  Aligned_cols=257  Identities=31%  Similarity=0.551  Sum_probs=213.3

Q ss_pred             ceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++...... .....+.+.+|+.+++.+.+||||+.++++++.+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999875   47899999998754322 2223466788999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   4567899999999876543


Q ss_pred             CC--ceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCcccCCCCCC
Q 015352          208 GE--RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       208 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ..  ......|+..|+|||.+.+   .++.++||||+|+++|+|++|..||.....    ......+......    ...
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~  233 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----YPQ  233 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC----CCc
Confidence            22  2234568899999998863   477899999999999999999999964322    3333333333222    224


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCC-----CHHHHhcCccccCCc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNAK  315 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~~  315 (408)
                      .+++.+.+++.+||+.||++||     ++.+++.||||+...
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            5789999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=304.49  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=206.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-----C
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----D  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~  124 (408)
                      .+||++.+.||+|||+.||++.+..++..||+|.+....   ..+++...+|++..+++ +|||+++++++...     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence            368999999999999999999999999999999998764   44578899999999999 99999999887643     3


Q ss_pred             CeEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEee
Q 015352          125 NAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      ...|+++.|+..|+|.+.+...    ..++|.++..|+.+|++||++||+..  +.||||||.|||++   +.+.++|+|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEe
Confidence            3589999999999999988652    36999999999999999999999998  99999999999994   467799999


Q ss_pred             cccccccCCCC----------ceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH--HHH
Q 015352          199 FGLSIFFKPGE----------RFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQ--GVA  262 (408)
Q Consensus       199 fg~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~  262 (408)
                      ||.+....-.-          .......|..|+|||.+.-    ..+.++|||||||++|.|+.|..||...-.+  .+.
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            99987543111          1122346788999999862    3788999999999999999999999432111  122


Q ss_pred             HHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      -.+..+.+.++...  .+|+.+.++|+.||+.||.+||++.+++.+
T Consensus       253 LAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            23444555665553  489999999999999999999999999874

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4e-43  Score=319.47  Aligned_cols=251  Identities=26%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|++|.||+|.+..++..+|+|.+.............+.+|+.+++.+ +||||+++++++..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence            4788999999999999999999999999999988765444444556888999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          131 MELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |||++|++|.+++..    ...+++..++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            999999999998864    3458999999999999999999999999999999999999   456679999999987654


Q ss_pred             CCCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .... .....|+..|+|||.+.+ .++.++|+||+|+++|+|++|..||.+...  ......+....  ++.......++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence            3322 234568899999999865 588999999999999999999999976543  23333333322  22223346789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+++++.+||..||++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-43  Score=332.11  Aligned_cols=261  Identities=33%  Similarity=0.485  Sum_probs=219.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-----e
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----A  126 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~  126 (408)
                      +|.+.+.||.|++|.||+|++..+|..+|+|.+.... ......+.+.+|+.+++.+ +||||+++++++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccc
Confidence            6899999999999999999999999999999987532 2233456788999999999 8999999999998775     8


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|++|||+.+ +|.+++.+...+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence            9999999974 899998887789999999999999999999999999999999999999   455789999999998765


Q ss_pred             CCC----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC-----
Q 015352          207 PGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-----  275 (408)
Q Consensus       207 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----  275 (408)
                      ...    ......+++.|+|||.+.+  .++.++|+||+|+++|+|++|.+||.+.+..+....+..........     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    2344568899999998864  58899999999999999999999998887766666555432211110     


Q ss_pred             ----------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCC
Q 015352          276 ----------------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (408)
Q Consensus       276 ----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  318 (408)
                                            ..+.+++.+.++|.+||+.+|.+|||+.+++.||||+.....+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence                                  1234688999999999999999999999999999998866543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-45  Score=334.79  Aligned_cols=238  Identities=25%  Similarity=0.411  Sum_probs=205.1

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      ++.||+|+.|.||+|+..  ++.||||.+..          .-..+|+-|++| +||||+.+.++|.....+|||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccc
Confidence            467999999999999764  77899998752          123588899999 99999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceeccc
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV  215 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  215 (408)
                      .|.|.+.|+....++......|..+|+.|+.|||.++|||||||.-||||+.   +..|||+|||-++..........++
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~---~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY---DDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec---cceEEeccccchHhhhhhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999954   4469999999998876665666789


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ||..|||||++++ ..+.|+|||||||+||||+||..||.+-+...++--+-...+.  .+....+|+.++-||+.||+-
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~--LpvPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLH--LPVPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccc--ccCcccCchHHHHHHHHHHhc
Confidence            9999999999986 6899999999999999999999999776654433322222222  233357899999999999999


Q ss_pred             CcCCCCCHHHHhcCccc
Q 015352          295 DPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       295 dp~~R~s~~~~l~h~~~  311 (408)
                      .|..||++.++|.|-=+
T Consensus       351 KpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CCCCCccHHHHHHHHhh
Confidence            99999999999998433

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-43  Score=321.19  Aligned_cols=253  Identities=29%  Similarity=0.487  Sum_probs=210.9

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--CeEEEE
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHLV  130 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv  130 (408)
                      |.+.+.||.|++|.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.+ +|||++++++++.+.  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEE
Confidence            678899999999999999999999999999998654 2223345688899999999 899999999999988  899999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      +||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||++   ++++.+||+|||++.......
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence            999975 888888665 579999999999999999999999999999999999999   456789999999988765433


Q ss_pred             --ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC---------
Q 015352          210 --RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP---------  276 (408)
Q Consensus       210 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------  276 (408)
                        ......++..|+|||.+.+  .++.++||||||+++|+|++|..||...+.......+...........         
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              2334467888999997654  478999999999999999999999988776665555544221111111         


Q ss_pred             -----------------CCC-CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          277 -----------------WPN-VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       277 -----------------~~~-~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                       +.. .++.+.+++++||..+|.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                             112 28889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-43  Score=330.98  Aligned_cols=263  Identities=27%  Similarity=0.459  Sum_probs=216.8

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..+.++|.+.+.||+|++|.||+|++..++..||+|++..... .......+.+|+.+++.+ +|||++++++++...+.
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASS   88 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcccc
Confidence            3467899999999999999999999999999999999865322 222345678899999999 99999999998876654


Q ss_pred             ------EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          127 ------VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       127 ------~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                            .|+|+||+ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||++   +.++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg  163 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFG  163 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccc
Confidence                  89999999 6699888765 579999999999999999999999999999999999999   456779999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC-----
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-----  273 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----  273 (408)
                      ++......  .....+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.........+.......+     
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         164 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             cccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            98865432  344578889999998864  578899999999999999999999988776665555443221100     


Q ss_pred             ------------------C----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCC
Q 015352          274 ------------------R----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (408)
Q Consensus       274 ------------------~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  318 (408)
                                        .    ..+...++.+.++|.+||+.||++|||+.++++||||+......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                              0    01234688999999999999999999999999999998865443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-43  Score=326.88  Aligned_cols=258  Identities=29%  Similarity=0.462  Sum_probs=204.5

Q ss_pred             ceEecceecccCCeEEEEEEECC--CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--CeE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAV  127 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~  127 (408)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+.............+.+|+.+++.+ +||||+++++++.+.  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence            58899999999999999999988  8999999999864422233346678899999999 999999999999988  889


Q ss_pred             EEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec-CCCCCCEEEeeccc
Q 015352          128 HLVMELCEGGELFDRIVAR-----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN-KKENSPLKAIDFGL  201 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~-~~~~~~vkl~Dfg~  201 (408)
                      |+||||+.+ +|.+.+...     ..+++..++.++.||+.||.|||+.+|+||||||+||+++. ++..+.+||+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999975 676666432     36899999999999999999999999999999999999954 22267899999999


Q ss_pred             ccccCCCCc----eecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHH---------HHHHHH
Q 015352          202 SIFFKPGER----FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQG---------VAQAIL  266 (408)
Q Consensus       202 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~~~i~  266 (408)
                      +........    .....+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+.....         ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            886532221    233467889999998764  48899999999999999999999997654321         111111


Q ss_pred             cCCc---------------------ccCCCCC------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          267 RGLI---------------------DFKRDPW------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       267 ~~~~---------------------~~~~~~~------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ....                     ......+            ...+..+.+++.+||+.||++|||+.++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            1000                     0000111            1567789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.3e-43  Score=323.04  Aligned_cols=259  Identities=30%  Similarity=0.507  Sum_probs=215.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|.+.+.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.+ +||||+++++.+...+..
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcE
Confidence            34579999999999999999999998899999999986432   22346788999999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccc
Confidence            9999999999999988654 58899999999999999999999999999999999999   4566799999998876543


Q ss_pred             CC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .. ......|++.|+|||.+.+ .++.++|+||||+++|++++|..||...+.......+.... .........++..++
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  246 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR  246 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHH
Confidence            32 2233468889999998764 58899999999999999999999998765543322222211 111122345788999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++|++||..+|++||++.+++.|+||+...
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-42  Score=313.07  Aligned_cols=252  Identities=29%  Similarity=0.519  Sum_probs=218.8

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||.|+||.||++.+..++..+|+|++...... ......+.+|+++++.+ +|||++++.+.+..+...++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEE
Confidence            588999999999999999999999999999999765432 33456788999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          132 ELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       132 e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||++|++|.+++...    ..+++..+..++.+++.||.|||++|++|+||+|+||+++   .++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceeeccc
Confidence            999999999998764    6799999999999999999999999999999999999994   467799999999877544


Q ss_pred             CC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .. ......|++.|+|||.+.+ .++.++|+||+|+++++|++|..||...................   ....++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence            33 2334578899999998765 58899999999999999999999998887777777666554322   1236789999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +++.+||..+|++|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.4e-43  Score=320.40  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=210.3

Q ss_pred             cceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ++|.+.+.||+|+||.||+|.+..     ++..||+|.+.....  ....+.+.+|+++++.+ +||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNF-QHENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhc-CCCCchheeeEEecCC
Confidence            568899999999999999998753     367899999864322  22356889999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          126 AVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      ..++||||++|++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||++   +.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence            9999999999999999997643              37888999999999999999999999999999999999   456


Q ss_pred             CCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 015352          192 SPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~  266 (408)
                      +.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            7899999999875432221   123345778999998875 68999999999999999998 999999888888878777


Q ss_pred             cCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.....   ...++..+.+++.+||..||++|||+.|+++
T Consensus       239 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6654332   2468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-43  Score=314.15  Aligned_cols=245  Identities=35%  Similarity=0.640  Sum_probs=215.2

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||.|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++.+++++.+|+||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            69999999999999989999999999877655555567889999999999 89999999999999999999999999999


Q ss_pred             hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-CceecccCC
Q 015352          139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERFSEIVGS  217 (408)
Q Consensus       139 L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~~~~~~~gt  217 (408)
                      |.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++   ..+.++|+|||.+...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccCCcCC
Confidence            999998888899999999999999999999999999999999999994   5567999999998776443 233455788


Q ss_pred             CCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCc
Q 015352          218 PYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP  296 (408)
Q Consensus       218 ~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  296 (408)
                      ..|+|||.+.+ .++.++|+||||+++|++++|..||...+.......+......++    ...+..+.+++++||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence            89999998875 578899999999999999999999988777666666665433322    3568999999999999999


Q ss_pred             CCCCCH---HHHhcCccc
Q 015352          297 KLRLTA---KQVLEHPWL  311 (408)
Q Consensus       297 ~~R~s~---~~~l~h~~~  311 (408)
                      ++|||+   .++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-42  Score=310.71  Aligned_cols=251  Identities=29%  Similarity=0.485  Sum_probs=213.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      .|.+.+.||+|++|.||++.+..+++.+++|++.....   .....+.+|+.+++.+ +||+++++++++..+...++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence            47888999999999999999999999999999975432   2457889999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          132 ELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       132 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      ||++|++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++   .++.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc
Confidence            999999999998776 5799999999999999999999999999999999999994   467799999999887665443


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+...... .......++..+.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP-GLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC-CcCcccccCHHHHHHHH
Confidence            345578899999998875 5788999999999999999999999877555444444332211 11111234889999999


Q ss_pred             HhcCCCcCCCCCHHHHhcCcc
Q 015352          290 QMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      +||+.||++|||+.++++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-42  Score=319.08  Aligned_cols=247  Identities=24%  Similarity=0.409  Sum_probs=208.5

Q ss_pred             cceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+|.+.+.||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+.+++++ +||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence            47899999999999999999863     34567899988643   223456789999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          126 AVHLVMELCEGGELFDRIVARG-------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      .+++||||+++++|.+++...+             .+++..+..++.||+.||+|||++|++||||||+||++   +.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence            9999999999999999997543             38999999999999999999999999999999999999   4567


Q ss_pred             CEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHc
Q 015352          193 PLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILR  267 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~  267 (408)
                      .+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||...........+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            799999999876533221   122345678999998875 58999999999999999998 9999988888777777777


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.....   ....+..+.+|+.+||+.||.+|||+.+++.
T Consensus       238 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            653221   2357899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-42  Score=321.21  Aligned_cols=250  Identities=23%  Similarity=0.299  Sum_probs=205.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCc--EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ++|++.+.||+|+||.||+|..+.++.  .+++|.+..  .......+.+.+|+.++.++.+||||+++++++...+.+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            579999999999999999999887765  467877652  2223335678899999999877999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          129 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      +++||+++++|.+++....                .+++..+..++.|++.||+|||++||+||||||+|||+   +.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence            9999999999999997542                47889999999999999999999999999999999999   4566


Q ss_pred             CEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCc
Q 015352          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      .+||+|||++..............+..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            799999999864322111111223456999998865 68999999999999999997 9999998888777777665432


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                         ......++..+.+|+.+||..+|.+|||+.++++.
T Consensus       237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               12224688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-42  Score=315.25  Aligned_cols=248  Identities=29%  Similarity=0.483  Sum_probs=202.6

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      ..||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.+ +||||+++++++..++..++|+||++|
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            47999999999999999999999999886442   23456788999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-cee
Q 015352          137 GELFDRIVAR-GHY--TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFS  212 (408)
Q Consensus       137 ~~L~~~l~~~-~~~--~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-~~~  212 (408)
                      ++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.  ..+.++|+|||.+....... ...
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCCCccc
Confidence            9999998764 445  88889999999999999999999999999999999953  24579999999987653322 223


Q ss_pred             cccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          213 EIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       213 ~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ...|++.|+|||.+.+   .++.++|+||+|+++|+|++|..||............ .............+++++++++.
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHHH
Confidence            3468899999998854   3789999999999999999999999764332211111 11111111222467899999999


Q ss_pred             HhcCCCcCCCCCHHHHhcCccc
Q 015352          290 QMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +||+.+|.+|||+.+++.||||
T Consensus       247 ~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=310.79  Aligned_cols=252  Identities=31%  Similarity=0.551  Sum_probs=217.3

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+++++++ +|||++++++++.+++.++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Confidence            588999999999999999999999999999999766432 23467899999999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc-
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~-  210 (408)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||+++   .++.++|+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence            9999999999998888899999999999999999999999999999999999994   467899999999987654332 


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.................   ......+++.+.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHHHHHH
Confidence            234568889999998864 578899999999999999999999987665444444432221   2223467899999999


Q ss_pred             HhcCCCcCCCCCHHHHhcCccc
Q 015352          290 QMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-42  Score=316.67  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=207.6

Q ss_pred             ccccceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      ...++|++.+.||+|+||.||+|.++.     ++..||+|.+....  .......+.+|+.+++.+ +||||+++++++.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~   79 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVS   79 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEc
Confidence            356789999999999999999998652     35679999885432  222345688999999998 9999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      .....++||||+++++|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+||++   +.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~  156 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF  156 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCC
Confidence            9999999999999999999987532          25678889999999999999999999999999999999   4567


Q ss_pred             CEEEeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHc
Q 015352          193 PLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILR  267 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~  267 (408)
                      .++|+|||++.........   ....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+.........+..
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            7999999998754332211   12345678999999875 68999999999999999999 7899988887777766665


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .....   .....++.+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 GGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            54321   124678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.2e-42  Score=317.92  Aligned_cols=260  Identities=31%  Similarity=0.506  Sum_probs=221.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....+.|.+.+.||+|++|.||+|.+..++..+++|++.....    ....+.+|+++++.+ +|+|++++++.+...+.
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDC-KHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCE
Confidence            4566789999999999999999999998999999999975432    356788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .|+|+||++|++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhh
Confidence            999999999999999998876 79999999999999999999999999999999999999   45667999999988765


Q ss_pred             CCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          206 KPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       206 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+...... .......++..
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPE  245 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHH
Confidence            4322 2233457889999998865 5899999999999999999999999887665555554433222 12222347899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +.++|.+||+.+|.+|||+.++++|+||...-
T Consensus       246 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            99999999999999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.6e-42  Score=313.47  Aligned_cols=247  Identities=21%  Similarity=0.355  Sum_probs=210.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      ...|.+.+.||+|+||.||+|.++.++..+|+|++...    ......+.+|+++++.+ +||||+++++++..++.+++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEE
Confidence            34688999999999999999999999999999998643    22356788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCcccccccc
Confidence            99999999999998764  358999999999999999999999999999999999999   4567799999999887643


Q ss_pred             CCcee--cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GERFS--EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .....  ...+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+..   ......++..
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPK  233 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHH
Confidence            32211  1234567999998874 68999999999999999998 9999988887777666665421   2223568899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.++|.+||..||++|||+.++++
T Consensus       234 ~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         234 VYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-45  Score=333.62  Aligned_cols=259  Identities=28%  Similarity=0.506  Sum_probs=238.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .+..++..||-|+||.|=+++.......+|+|++.+..+-...+.+.+..|-+||... +.|.||++|..|.++.++|++
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhh
Confidence            3556778899999999999988766667999999988777777788999999999998 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      ||-|-||.|...+.+++.+.+..++.++..+++|++|||++|||+|||||+|.++   +..+.+||+|||+|+....+..
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   6788899999999999999999


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ..+++|||.|.|||++.+ ..+.++|.||||+++|||++|.+||.+.++-..++.|+++.-.+..+  ..++..+.+||+
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik  653 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK  653 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence            999999999999998764 68999999999999999999999999999999999999987544333  478999999999


Q ss_pred             HhcCCCcCCCCC-----HHHHhcCccccCCc
Q 015352          290 QMLEPDPKLRLT-----AKQVLEHPWLQNAK  315 (408)
Q Consensus       290 ~~l~~dp~~R~s-----~~~~l~h~~~~~~~  315 (408)
                      ++...+|.+|..     +.+|.+|.||....
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            999999999986     89999999998754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.7e-42  Score=351.15  Aligned_cols=150  Identities=30%  Similarity=0.489  Sum_probs=137.6

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+++|+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999876554455567788999999998 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCc
Confidence            999999999999998888899999999999999999999999999999999999994   56789999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.5e-42  Score=313.14  Aligned_cols=251  Identities=26%  Similarity=0.479  Sum_probs=210.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++++ +|+|++++++++..++..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence            5899999999999999999999999999999998765444444467889999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          131 MELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |||++|++|.+++..    ...+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            999999999998864    2458999999999999999999999999999999999999   456679999999987654


Q ss_pred             CCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES--EQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ... ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||....  .......+..+...  ..+...++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence            322 2233468899999998865 58999999999999999999999996543  23344444443322  122236788


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.6e-42  Score=311.26  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=207.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||.||+|.++. +..+|+|.+.....    ....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEE
Confidence            468899999999999999998764 56799998764322    246788899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||+|+||++   +.++.+||+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence            9999999999998754 568999999999999999999999999999999999999   456679999999987654332


Q ss_pred             cee--cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          210 RFS--EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       210 ~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ...  ...++..|+|||.+.+ .++.++|+||+|+++|+|++ |+.||...+..+....+..+.....   ....+..+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHH
Confidence            221  2234567999999874 68999999999999999999 9999998888888888776543221   134678899


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=317.45  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=209.0

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEEeCCe----
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNA----  126 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~----  126 (408)
                      |++.+.||.|+||.||+|.++.++..||+|.+...... ......+.+|+.+++++.  +|||++++++++.+.+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            67889999999999999999989999999999754332 222345667888887763  59999999999988776    


Q ss_pred             -EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          127 -VHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       127 -~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                       ++++|||+.+ +|.+++....  .+++..++.++.|++.||.|||+.+++|+||+|+||+++   .++.+||+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCcce
Confidence             9999999975 8888887643  489999999999999999999999999999999999994   45789999999988


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc-----cC----
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-----FK----  273 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----~~----  273 (408)
                      ............++..|+|||.+.+ .++.++|+||+||++|+|++|.+||.+.+..+....+......     ++    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            7654444445568889999998875 5889999999999999999999999888777666655442110     00    


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          274 --------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       274 --------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                    ....+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                          00112456788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-42  Score=311.79  Aligned_cols=251  Identities=31%  Similarity=0.473  Sum_probs=217.3

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.+ +||||+++++++.+....|+|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEe
Confidence            588999999999999999999999999999998765432 23456778899999999 8999999999999999999999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          132 ELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       132 e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++   ..+.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence            99999999998866    35689999999999999999999999999999999999995   456799999999887654


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      . ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||...+..+....+..+.....   ....+.++++
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHHHHH
Confidence            4 3334568899999999875 588899999999999999999999998887777666665543322   1367899999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ++.+||..+|++|||+.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-42  Score=312.40  Aligned_cols=243  Identities=25%  Similarity=0.388  Sum_probs=209.9

Q ss_pred             ceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           57 RELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +.||+|+||.||+|.+...   +..+++|++.......  ..+.+.+|+.+++.+ +|+||+++++++.++..+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEe
Confidence            4699999999999999866   8899999987553322  467889999999999 799999999999999999999999


Q ss_pred             cCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          134 CEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       134 ~~g~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +++++|.+++...         ..+++..++.++.|++.||.|||++|++||||+|+||++   +.++.+||+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence            9999999999875         679999999999999999999999999999999999999   4557899999999987


Q ss_pred             cCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          205 FKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       205 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      .....   ......+++.|+|||.+.+ .++.++||||+|+++|+|++ |..||......+....+..+..   ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence            65432   2234457889999998875 68999999999999999999 6999998888777777776432   222346


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +|+++.+++.+||..+|++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            78999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.7e-44  Score=307.81  Aligned_cols=265  Identities=29%  Similarity=0.459  Sum_probs=212.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCc----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-  123 (408)
                      ....|++++.||+|.||.||+|..++++.    .+|||.+..++-.+... ....||+.+++.| +|||++.+..+|-. 
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl-~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLREL-KHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHh-cCCcchhHHHHHhcc
Confidence            44679999999999999999997665533    68999987664433332 4667899999999 99999999999877 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEe
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAI  197 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~  197 (408)
                      +..+++++||++. +|.+.++-+     ..++...++.|+.||+.|+.|||++-|+||||||.|||+..++ +.+.|||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            8899999999977 888887543     3589999999999999999999999999999999999997542 34889999


Q ss_pred             ecccccccCCC----CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCH---------HHHH
Q 015352          198 DFGLSIFFKPG----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESE---------QGVA  262 (408)
Q Consensus       198 Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~  262 (408)
                      |||+++.+...    .....++-|.+|+|||++.|  .|+++.||||+|||+.||+|-.+.|.+...         ...+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999976432    23345677899999999886  699999999999999999999888865421         1334


Q ss_pred             HHHHcCCcccCCCCCC---------------------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 015352          263 QAILRGLIDFKRDPWP---------------------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHP  309 (408)
Q Consensus       263 ~~i~~~~~~~~~~~~~---------------------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  309 (408)
                      ..|..-........|+                                 .-++.+.+|+.+||+.||.+|+|+.++|+|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            4444333222222221                                 1245588999999999999999999999999


Q ss_pred             cccCCcC
Q 015352          310 WLQNAKK  316 (408)
Q Consensus       310 ~~~~~~~  316 (408)
                      ||....-
T Consensus       339 yF~~d~l  345 (438)
T KOG0666|consen  339 YFTEDPL  345 (438)
T ss_pred             ccccCCC
Confidence            9987653

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-42  Score=320.86  Aligned_cols=259  Identities=31%  Similarity=0.522  Sum_probs=211.5

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-  125 (408)
                      ....++|.+.+.||.|+||.||+|.++.+|+.||+|.+...... ......+.+|+.+++.+ +||||+++++++.+.. 
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhC-CCCCeeeeeheecCcch
Confidence            44567899999999999999999999999999999998754322 22335677899999999 9999999999987654 


Q ss_pred             ---------eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEE
Q 015352          126 ---------AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (408)
Q Consensus       126 ---------~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vk  195 (408)
                               .+|+|+||+++ ++...+... ..+++..+..++.|++.||.|||+.||+||||+|+||++   +.++.+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~k  156 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIK  156 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEE
Confidence                     89999999987 676766654 468999999999999999999999999999999999999   5567899


Q ss_pred             EeecccccccCCCC--ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc
Q 015352          196 AIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (408)
Q Consensus       196 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  271 (408)
                      |+|||.+.......  ......++..|+|||.+.+  .++.++||||+||++|+|++|++||...+..+....+......
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999987654332  2223356788999998754  4789999999999999999999999877766555554442111


Q ss_pred             cC--------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 FK--------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 ~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ..                          ...+..+|..+.++|.+||..||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            10                          01233578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=306.90  Aligned_cols=259  Identities=27%  Similarity=0.494  Sum_probs=233.7

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -...|.+++.||+|+|+.|.++++++|.+.||+|++.++-+....+++-+..|-.+..+.++||.+|.++.+|+.+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            34679999999999999999999999999999999999988888889999999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc-cCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF-FKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~-~~~  207 (408)
                      +|.||++||+|.-+++++.+++|+.++.+...|+.||.|||++||+.||||.+|||+   +..+++||+|+|+++. ..+
T Consensus       328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence            999999999999999999999999999999999999999999999999999999999   6778899999999975 456


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCC--------CCHHHHHHHHHcCCcccCCCCCC
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWA--------ESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~--------~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      +...++++|||.|.|||++++ .|+..+|.|+||++++||+.|+.||.-        ++..-+.+.|+...+..+.    
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----  480 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----  480 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----
Confidence            778889999999999999997 699999999999999999999999942        2233456666766666554    


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCC------HHHHhcCccccCC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLT------AKQVLEHPWLQNA  314 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s------~~~~l~h~~~~~~  314 (408)
                      .+|-.+..+++..|++||.+|..      ..++..|+||...
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence            56788889999999999999974      6899999999854

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-42  Score=330.51  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=202.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCC-----CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      -.++|.+.+.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+++++++..||||+++++++.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            456899999999999999999987533     3469999986432  223356789999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC---------------------------------------------------------
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR---------------------------------------------------------  146 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~---------------------------------------------------------  146 (408)
                      .+..|+|||||++|+|.+++...                                                         
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            99999999999999999988642                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec
Q 015352          147 ---------------------------------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN  187 (408)
Q Consensus       147 ---------------------------------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~  187 (408)
                                                             ..+++..+..++.||+.||.|||+.+|+||||||+|||++ 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~-  271 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA-  271 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe-
Confidence                                                   1367788899999999999999999999999999999994 


Q ss_pred             CCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHH-
Q 015352          188 KKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGV-  261 (408)
Q Consensus       188 ~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~-  261 (408)
                        .+..+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||........ 
T Consensus       272 --~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         272 --QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             --CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence              456799999999876533221   123356788999998865 68999999999999999997 9999977544333 


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...+..+ ...  .....++..+.+++.+||+.||++|||+.++.+
T Consensus       350 ~~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         350 YNKIKSG-YRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHhcC-CCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3333333 222  222467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.9e-42  Score=322.14  Aligned_cols=260  Identities=24%  Similarity=0.389  Sum_probs=208.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC-
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-  124 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-  124 (408)
                      +....++|.+.+.||.|+||.||+|.++.+++.+|+|.+........ ....+.+|+++++.+ +||||+++++++... 
T Consensus         3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (311)
T cd07866           3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKL-KHPNVVPLIDMAVERP   80 (311)
T ss_pred             CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhc-CCCCccchhhheeccc
Confidence            33446899999999999999999999999999999999875433221 234567899999999 999999999987543 


Q ss_pred             -------CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          125 -------NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       125 -------~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                             ..+|+|+||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEE
Confidence                   357999999976 67666654 3469999999999999999999999999999999999999   55678999


Q ss_pred             eecccccccCCCC------------ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHH
Q 015352          197 IDFGLSIFFKPGE------------RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA  262 (408)
Q Consensus       197 ~Dfg~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  262 (408)
                      +|||++.......            ......+++.|+|||.+.+  .++.++||||+||++|+|++|.+||.+.+.....
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999987543221            1123457888999998764  4889999999999999999999999887776555


Q ss_pred             HHHHcCCcccCC--------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          263 QAILRGLIDFKR--------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       263 ~~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ..+.........                          ..+...++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            554432111000                          0123455788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.2e-43  Score=326.64  Aligned_cols=256  Identities=18%  Similarity=0.264  Sum_probs=204.0

Q ss_pred             cceeccc--CCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           56 DRELGRG--EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        56 ~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      ...||+|  +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.+ +||||+++++++..++..++|+||
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEec
Confidence            3456766  9999999999999999999998755332 23457889999999998 999999999999999999999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc-
Q 015352          134 CEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (408)
Q Consensus       134 ~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~-  210 (408)
                      +.+++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||++.   .++.++++||+.+........ 
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCcc
Confidence            9999999988764  3489999999999999999999999999999999999994   456799999986543221110 


Q ss_pred             e-------ecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC-------
Q 015352          211 F-------SEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-------  273 (408)
Q Consensus       211 ~-------~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------  273 (408)
                      .       ....++..|+|||++.+   .++.++||||+||++|+|++|..||.+.................+       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence            0       11234567999999864   378999999999999999999999987665554444333211100       


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          274 ------------------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       274 ------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                                          .+.....++.+.+|+++||+.||++|||+.++++||||....+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                                0111235678999999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.9e-42  Score=315.34  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=209.4

Q ss_pred             cccceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ..++|.+.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.+ +||||+++++++.+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence            45789999999999999999997653     35579999876432  222334678899999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCC
Q 015352          124 DNAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP  193 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~  193 (408)
                      .+..|+||||+++|+|.+++...+          ..+...+..++.||+.||.|||++||+||||||+||++   +.++.
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCc
Confidence            999999999999999999997532          24567888999999999999999999999999999999   45677


Q ss_pred             EEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcC
Q 015352          194 LKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       194 vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~  268 (408)
                      ++|+|||++........   .....++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+....+..+
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999875432221   122345678999998864 68999999999999999998 78999888877776666554


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc------CccccCC
Q 015352          269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE------HPWLQNA  314 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~------h~~~~~~  314 (408)
                      ....   .....++.+.+++.+||+.||++|||+.++++      ||||...
T Consensus       238 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         238 GYLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            3221   12356889999999999999999999999987      8888653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.8e-42  Score=320.50  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=215.8

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ......|...+.||.|+||.||+|++..++..+|+|.+.............+.+|+++++.+ +|||++++++++.....
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   89 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHT   89 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCe
Confidence            34556688889999999999999999999999999998754443444456788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .++||||+.| +|.+.+.. ...+++..+..++.|++.||.|||+++++||||+|+||++   +.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          90 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIM  165 (308)
T ss_pred             eEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceee
Confidence            9999999974 77777654 4568999999999999999999999999999999999999   45677999999998765


Q ss_pred             CCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ...   ....|++.|+|||.+.    +.++.++|||||||++|+|++|..||...+.......+..+....  ......+
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  240 (308)
T cd06634         166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWS  240 (308)
T ss_pred             cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC--cCccccc
Confidence            432   2346889999999874    357889999999999999999999998776555444444433221  1123578


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..+.+||.+||..+|++||++.++++|||+....
T Consensus       241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            8999999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.5e-42  Score=310.57  Aligned_cols=242  Identities=26%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|.++.+++.+|+|.+....  .......+.+|+++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            46999999999999999999999999876432  223346789999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCcee---
Q 015352          137 GELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS---  212 (408)
Q Consensus       137 ~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~---  212 (408)
                      ++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||++   +.++.+||+|||++..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence            99999987654 58999999999999999999999999999999999999   455679999999987544321111   


Q ss_pred             cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 015352          213 EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ  290 (408)
Q Consensus       213 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  290 (408)
                      ...++..|+|||.+.+ .++.++|+||||+++|+|++ |..||...........+.....   .......+..+.+|+.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---LPCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCcccCCHHHHHHHHH
Confidence            1122456999998864 68999999999999999997 9999987776665555554322   12234678999999999


Q ss_pred             hcCCCcCCCCCHHHHhc
Q 015352          291 MLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       291 ~l~~dp~~R~s~~~~l~  307 (408)
                      ||+.+|++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.7e-42  Score=323.07  Aligned_cols=259  Identities=30%  Similarity=0.443  Sum_probs=209.2

Q ss_pred             ceEecceecccCCeEEEEEEECCC--CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe----CC
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDT--RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----DN  125 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~  125 (408)
                      +|.+.+.||+|+||.||+|.+..+  +..||+|.+.... ........+.+|+.+++++.+||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            588999999999999999999988  8999999986432 2222345678899999998679999999987532    35


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|+++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence            6889999985 5899999888889999999999999999999999999999999999999   45677999999998765


Q ss_pred             CCCC-----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc-------
Q 015352          206 KPGE-----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-------  271 (408)
Q Consensus       206 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------  271 (408)
                      ....     ......|++.|+|||.+.+  .++.++|+||+|+++|+|++|.+||.+.+.......+......       
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4221     1234578999999998764  5899999999999999999999999876654444333321100       


Q ss_pred             ----------------cC----CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 ----------------FK----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ----------------~~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                      .+    ...++..+..+.+|+.+||+.||.+|||+.+++.|||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                            00    112245688999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.9e-42  Score=309.46  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||.|.+.. +..+|+|.+.....    ..+.+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEE
Confidence            468999999999999999998754 44699998864322    246788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||++   +.++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence            9999999999998764 468999999999999999999999999999999999999   456679999999987654332


Q ss_pred             cee--cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          210 RFS--EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       210 ~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ...  ...++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+.++......   ...+..++
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            211  1234567999999874 68999999999999999998 99999888777777777766443222   34689999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +++.+||..+|.+|||+.+++++
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-42  Score=324.81  Aligned_cols=261  Identities=27%  Similarity=0.451  Sum_probs=211.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++++ +||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence            466899999999999999999999999999999999865322 222345678899999999 999999999988643   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       125 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                         ...|++++++ |++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~  166 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGL  166 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccc
Confidence               3578888887 7799877654 469999999999999999999999999999999999999   4566799999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc---------
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI---------  270 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------  270 (408)
                      +.....  ......+++.|+|||.+.+  .++.++||||+||++|+|++|..||...+.......+.....         
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         167 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             cccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            876432  2334578899999998765  578899999999999999999999987665544443322111         


Q ss_pred             --------------ccCC----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          271 --------------DFKR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       271 --------------~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                                    ..+.    ..+...++.+.+||.+||+.||.+|||+.+++.||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                          0000    1112467889999999999999999999999999999875543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4e-42  Score=316.90  Aligned_cols=257  Identities=31%  Similarity=0.529  Sum_probs=214.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ..|.....||+|+||.||++.+..+|..||+|.+....   ......+.+|+.+++.+ +||||+++++.+...+..|+|
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEE
Confidence            34444578999999999999999999999999885432   23356788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||+++++|.+++. .+.+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++....... 
T Consensus        96 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~  171 (292)
T cd06657          96 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP  171 (292)
T ss_pred             EecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc
Confidence            99999999988764 4568999999999999999999999999999999999999   456679999999887553322 


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+..... ........+++.+.+++
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li  250 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFL  250 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHH
Confidence            2233568899999998864 688999999999999999999999988776655555443322 12222356789999999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      .+||..+|.+||++.++++||||.....
T Consensus       251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         251 DRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            9999999999999999999999988763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-42  Score=326.32  Aligned_cols=264  Identities=30%  Similarity=0.499  Sum_probs=214.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--  124 (408)
                      ..+.++|.+.+.||+|+||.||+|.+..+|..+|+|.+.... ........+.+|+.+++++.+||||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            457789999999999999999999999999999999886432 22233456778999999987899999999998653  


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..+|+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~  156 (337)
T cd07852          82 KDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARS  156 (337)
T ss_pred             ceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence            468999999975 998888765 78899999999999999999999999999999999999   5667899999999876


Q ss_pred             cCCCC------ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc------
Q 015352          205 FKPGE------RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI------  270 (408)
Q Consensus       205 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------  270 (408)
                      .....      ......|++.|+|||.+.+  .++.++|+||+|+++|+|++|+.||.+.........+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            54322      2234568999999998753  578899999999999999999999987665444333222110      


Q ss_pred             ---------------------ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          271 ---------------------DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       271 ---------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                           .......+.++.++.++|.+||+.||++|||+.++++|||++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                                 0111123457899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.2e-42  Score=316.94  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=208.0

Q ss_pred             ccceEecceecccCCeEEEEEEECCCC----------------cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTR----------------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~  113 (408)
                      .++|++.+.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|+++++.+ +|||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRL-SDPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhc-CCCC
Confidence            468999999999999999999876544                5579999875432  23456788999999999 9999


Q ss_pred             eeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 015352          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (408)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~N  182 (408)
                      |+++++++..++..+++|||+++++|.+++....           .+++..++.++.|++.||.|||++|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999997765           68999999999999999999999999999999999


Q ss_pred             eEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh--CCCCCCCC
Q 015352          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC--GVPPFWAE  256 (408)
Q Consensus       183 Il~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~--g~~pf~~~  256 (408)
                      |+++   ..+.++|+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++  |..||...
T Consensus       161 ili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eeec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9994   557899999999876543321   123346778999998875 68999999999999999998  78898877


Q ss_pred             CHHHHHHHHHcCC----cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          257 SEQGVAQAILRGL----IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       257 ~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.......+....    .....+....+|.++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            7666666554431    11111222456789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.8e-42  Score=325.24  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=202.0

Q ss_pred             cccceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ..++|++.+.||+|+||.||+|.+..     +++.||+|++....  .......+.+|+.+++++.+||||+++++++..
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            34689999999999999999997543     45789999986432  223346778899999998789999999998764


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhC--------------------------------------------------------
Q 015352          124 -DNAVHLVMELCEGGELFDRIVAR--------------------------------------------------------  146 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~l~~~--------------------------------------------------------  146 (408)
                       +..++++|||+++++|.+++...                                                        
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             56789999999999999988542                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc---eecccCCC
Q 015352          147 -----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSP  218 (408)
Q Consensus       147 -----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~  218 (408)
                           ..+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++........   .....++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                 2578899999999999999999999999999999999994   456799999999986533221   12334567


Q ss_pred             CCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCc
Q 015352          219 YYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP  296 (408)
Q Consensus       219 ~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  296 (408)
                      .|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.............  .....++++.+++.+||+.+|
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p  317 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNP  317 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCCh
Confidence            8999998765 69999999999999999998 9999987554333333322222111  123578899999999999999


Q ss_pred             CCCCCHHHHhcC
Q 015352          297 KLRLTAKQVLEH  308 (408)
Q Consensus       297 ~~R~s~~~~l~h  308 (408)
                      ++||++.++++|
T Consensus       318 ~~RPs~~ell~~  329 (337)
T cd05054         318 EDRPTFSELVEI  329 (337)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999884

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6e-42  Score=314.49  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=207.0

Q ss_pred             cceEecceecccCCeEEEEEEEC----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDR----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      +.|++.+.||+|+||.||+|.+.    .++..+|+|.+....  .......+.+|+.+++.+ +||||+++++++..++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence            56889999999999999999853    456789999986432  233456788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC
Q 015352          127 VHLVMELCEGGELFDRIVAR-----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~  189 (408)
                      .|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||++|++||||||+||+++   
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~---  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---
Confidence            99999999999999998532                 2378889999999999999999999999999999999994   


Q ss_pred             CCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 015352          190 ENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  264 (408)
                      ....+||+|||++.......   ......++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+.........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            55679999999997654322   1223345677999998864 68999999999999999998 9999988877666666


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +......   +....+++.+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6554422   2234678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.2e-42  Score=310.19  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=207.8

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+....    ...+.+.+|+.+++.+ +||||+++++.+.+.+..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEE
Confidence            468999999999999999999865 56679999876432    2356788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||+++++|.+++...  ..++...+..++.|++.||.|||+.+++||||||+||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCC
Confidence            99999999999998653  458889999999999999999999999999999999999   4567799999999986543


Q ss_pred             CCce--ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ....  ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+..+..   .+....++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENCPDE  232 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHH
Confidence            2211  22345667999998864 68899999999999999998 9999988877777777665432   2233568899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+++.+||..+|++|||++++.+
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         233 LYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-45  Score=362.83  Aligned_cols=261  Identities=29%  Similarity=0.481  Sum_probs=222.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .++.-+|.-...||.|.||.||.|.+..+|...|+|.+...... ......+.+|..++..+ +|||+|+++++-.+.+.
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHH
Confidence            45666788888999999999999999999999999998755433 33356788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      .+|.||||+||+|.+.+...+..+|.....+..|++.|+.|||++|||||||||+||++   +.++.+|++|||.|....
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEec
Confidence            99999999999999999888888999999999999999999999999999999999999   566789999999998776


Q ss_pred             CCC-----ceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCCCC
Q 015352          207 PGE-----RFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDP  276 (408)
Q Consensus       207 ~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  276 (408)
                      +..     .....+|||.|||||++.+    +...+.|||||||++.||+||+.||...+.. .++-.+-.+..+   ..
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P---q~ 1462 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP---QI 1462 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC---CC
Confidence            543     3345789999999999965    3567999999999999999999999765443 333333333322   12


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ...+|++.++||.+||+.||++|+++.|+++|.|-+...
T Consensus      1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            235999999999999999999999999999999976654

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=310.03  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=209.1

Q ss_pred             cceEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ++|.+.+.||+|+||.||+|.++.+   ...||+|.+....  .......+.+|+.+++.+ +||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCce
Confidence            5789999999999999999998754   4579999886443  223356788899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +++|||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence            9999999999999998764 468999999999999999999999999999999999999   456779999999998764


Q ss_pred             C-CCcee--cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          207 P-GERFS--EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       207 ~-~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      . .....  ...+++.|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+..+...   +.....+
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---PPPMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            2 11112  1234578999998874 68999999999999999998 99999888877777777654322   2224678


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +.+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-42  Score=324.01  Aligned_cols=259  Identities=29%  Similarity=0.486  Sum_probs=209.8

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      .+.++|.+.+.||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.+ +||||+++++++...   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhc-CCCCccchhheecccccC
Confidence            356799999999999999999999999999999999875432 222345678999999999 999999999998754   


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          125 ---NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       125 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                         ..+|+|+||+.+ +|..+.  ...+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~  163 (342)
T cd07879          90 DEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGL  163 (342)
T ss_pred             CCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCC
Confidence               356999999964 676654  3468999999999999999999999999999999999999   4567899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc---------
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI---------  270 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------  270 (408)
                      +.....  ......+++.|+|||.+.+  .++.++|+|||||++|+|++|+.||.+.+.......+.....         
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            876432  2234567889999998864  488999999999999999999999988765544443332110         


Q ss_pred             --------------ccCCC----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          271 --------------DFKRD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       271 --------------~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                    ..+..    .++..++.+.+||.+||+.||.+||++.+++.||||.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                          00111    12357788999999999999999999999999999987653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3e-42  Score=317.36  Aligned_cols=257  Identities=31%  Similarity=0.528  Sum_probs=210.6

Q ss_pred             ceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      +|.+.+.||+|++|.||+|.+.   .++..||+|++.+.... .......+.+|+.+++++.+||||+++++.+..+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788999999999999999864   46788999998754322 2223456788999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence            9999999999999999887789999999999999999999999999999999999999   4567799999999876543


Q ss_pred             CCc--eecccCCCCCcchhhhhcc---CCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCcccCCCCCC
Q 015352          208 GER--FSEIVGSPYYMAPEVLKRN---YGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       208 ~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ...  .....|+..|+|||.+.+.   .+.++|+||+|+++|+|++|..||....    ..+....+.....    +...
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~  233 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP----PFPK  233 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC----CCCc
Confidence            322  1234688999999988642   6889999999999999999999996432    2233333333322    2234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCC---HHHHhcCccccCCc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPWLQNAK  315 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~~~  315 (408)
                      .++..+.++|.+||+.||++|||   +.++|+||||+...
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            57899999999999999999998   56779999997753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.6e-42  Score=317.15  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=207.9

Q ss_pred             cccceEecceecccCCeEEEEEEECC-------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ..++|.+.+.||+|+||.||+|++..       ++..+|+|.+....  .......+.+|+.+++.+.+||||+++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34789999999999999999998643       23569999987542  2233567888999999987799999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEe
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~  185 (408)
                      ...+..|+||||+++|+|.+++...+                .++...+..++.|++.||.|||++|++||||||+||++
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            99999999999999999999997642                37888999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHH
Q 015352          186 ANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQG  260 (408)
Q Consensus       186 ~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  260 (408)
                         +.++.+||+|||.+........   .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+
T Consensus       174 ---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         174 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             ---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence               4556899999999876532221   111234568999998875 58999999999999999998 899998877766


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ....+.....   .+.....+.++.+|+.+||..+|++|||+.+++++
T Consensus       251 ~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            6666654432   12234678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=316.01  Aligned_cols=253  Identities=34%  Similarity=0.539  Sum_probs=210.3

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |.+.+.||.|++|.||+|.+..+|+.+++|.+...... ......+.+|+.+++.+ +||||+++++++.+++..++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEe
Confidence            56788999999999999999999999999998754432 23356788899999999 89999999999999999999999


Q ss_pred             ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-c
Q 015352          133 LCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-R  210 (408)
Q Consensus       133 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-~  210 (408)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||++   +.++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence            9976 888877664 579999999999999999999999999999999999999   456779999999987765443 3


Q ss_pred             eecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc-----------------
Q 015352          211 FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-----------------  271 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------  271 (408)
                      .....++..|+|||.+.+  .++.++|+||+|+++|+|++|+.||.+.+..+....+......                 
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            334568889999998864  5889999999999999999999999887765544443322111                 


Q ss_pred             --cC-------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 --FK-------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 --~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                        ++       ...++.++..++++|.+||.+||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence              00       01123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=315.85  Aligned_cols=253  Identities=34%  Similarity=0.529  Sum_probs=209.3

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |.+.+.||+|++|+||+|....+++.|++|.+......  .......+|+..++.+.+|||++++++++.+++..|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999999999999998654321  1233456799999999339999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          133 LCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |+ +++|.+++....  .+++..+..++.|++.+|.|||++|++|+||+|+||++   +.++.++|+|||.+........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence            99 779999887764  68999999999999999999999999999999999999   5567899999999987665545


Q ss_pred             eecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC---------------
Q 015352          211 FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---------------  273 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---------------  273 (408)
                      .....++..|+|||++.+  .++.++|+||||+++++|++|.+||...........+........               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            555678999999998753  478999999999999999999999987765554443332111100               


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          274 -----------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       274 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                 ....+..+..+.++|++||+.+|++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       01112346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-41  Score=308.13  Aligned_cols=241  Identities=24%  Similarity=0.340  Sum_probs=201.1

Q ss_pred             eecccCCeEEEEEEE--CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           58 ELGRGEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      .||+|+||.||+|.+  ..++..+|+|++.... ......+.+.+|+.+++.+ +||||++++++++. +..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence            589999999999965  4567889999986443 2233456788999999999 99999999998864 46789999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce----
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----  211 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~----  211 (408)
                      +++|.+++...+.+++..+..++.|++.||.|||++||+||||||.||+++   .++.+||+|||++.........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCeeeec
Confidence            999999998888899999999999999999999999999999999999994   5667999999998765433221    


Q ss_pred             ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          212 SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       212 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ....+++.|+|||.+.. .++.++|+|||||++|+|++ |..||.+....+....+..+..   .+....+++++.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---MECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHHH
Confidence            12234578999998864 58889999999999999998 9999988877777777765542   1222468999999999


Q ss_pred             HhcCCCcCCCCCHHHHhc
Q 015352          290 QMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~  307 (408)
                      +||+.||++||+++++..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.7e-42  Score=315.18  Aligned_cols=262  Identities=25%  Similarity=0.322  Sum_probs=211.5

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..-.+.|.+.+.||+|+||.||+|.+..+++.||+|.+.+...  ......+.+|+.++....+||||+++++++.++..
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            3345789999999999999999999999999999999975432  22245667788877777569999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .|++|||+.+ +|...+.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||++   +.++.+||+|||++..
T Consensus        89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~  164 (296)
T cd06618          89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGR  164 (296)
T ss_pred             EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchh
Confidence            9999999854 77666655 4578999999999999999999997 599999999999999   4567899999999876


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCcccCCCCCC
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ...........+++.|+|||.+.+     .++.++|+||||+++|+|++|..||..... .+....+....... .+...
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~  243 (296)
T cd06618         165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPPNE  243 (296)
T ss_pred             ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCCCC
Confidence            544333344467889999998863     278899999999999999999999976332 33444444432211 11122


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .++.++.+|+.+||..||++|||+.+++.||||....
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            5789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=311.60  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=208.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCC-----CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ..++|.+.+.||+|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVST   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC
Confidence            356899999999999999999988654     4789999986432  223345788999999998 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCC
Q 015352          124 DNAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP  193 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~  193 (408)
                      ....|+||||+++++|.+++....          .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCC
Confidence            999999999999999999986532          36778899999999999999999999999999999999   45677


Q ss_pred             EEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcC
Q 015352          194 LKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       194 vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~  268 (408)
                      +||+|||++........   .....++..|+|||.+.+ .++.++|||||||++|++++ |..||.+.+..+..+.+..+
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            99999999876543221   223456788999998864 68999999999999999998 99999888887777766644


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...   ......+..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 GHL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            321   122356899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=315.55  Aligned_cols=253  Identities=31%  Similarity=0.526  Sum_probs=211.1

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |++.+.||+|++|.||+|++..+++.+|+|++..... .....+.+.+|+.+++.+ +|||++++++++.+.+.+++|+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEec
Confidence            6678899999999999999999999999999976542 222346678899999999 89999999999999999999999


Q ss_pred             ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-c
Q 015352          133 LCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-R  210 (408)
Q Consensus       133 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-~  210 (408)
                      |+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++   +.++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence            9975 899999876 579999999999999999999999999999999999999   456789999999987654332 3


Q ss_pred             eecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc-----------------
Q 015352          211 FSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-----------------  271 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------  271 (408)
                      .....++..|+|||.+.+  .++.++|+|||||++|++++|..||.+.+.......+......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            334456788999998754  5889999999999999999999999887765555444331100                 


Q ss_pred             -c-------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          272 -F-------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       272 -~-------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                       +       ....++.++..+.++|.+||..||++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             0       001223567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-43  Score=327.96  Aligned_cols=258  Identities=31%  Similarity=0.523  Sum_probs=222.6

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |..++.||-|+||.|.+++..+|...||+|.+.+..+........+..|..||... +.+-||++|-.|++++.+|+||+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEe
Confidence            67788999999999999999999999999999988777777778889999999997 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC------
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------  206 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~------  206 (408)
                      |++||++..+|.+.+.|+|..++.++..|..|+++.|..|+|||||||+||||   +.+++|||+|||+++-+.      
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccccc
Confidence            99999999999999999999999999999999999999999999999999999   678899999999986321      


Q ss_pred             ---CCCc----------------------------------eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh
Q 015352          207 ---PGER----------------------------------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC  248 (408)
Q Consensus       207 ---~~~~----------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~  248 (408)
                         .+..                                  ....+||+.|+|||++.. .|+.-+|.||.|||||+|+.
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence               1100                                  113579999999999875 79999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCccccCCc
Q 015352          249 GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNAK  315 (408)
Q Consensus       249 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~~~  315 (408)
                      |++||...+..+....+.+-.-.+......++|.++.++|.+++. +++.|.   .++|+..||||+...
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence            999998887766655554443333344456899999999998764 477776   467899999998753

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.1e-42  Score=319.01  Aligned_cols=249  Identities=20%  Similarity=0.296  Sum_probs=204.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcE----EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTREL----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ..+|++.+.||+|+||.||+|++..++..    ||+|.+....  .....+.+.+|+.+++.+ +||||+++++++..+ 
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-
Confidence            35799999999999999999998766654    8999886432  223356788999999999 999999999998875 


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..++++||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~  158 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  158 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence            577999999999999999875 458899999999999999999999999999999999999   4566799999999987


Q ss_pred             cCCCCcee---cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          205 FKPGERFS---EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       205 ~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ........   ...++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+ ..++.  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~  235 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ--PPI  235 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCCCC--CCC
Confidence            65433221   2234567999998865 68999999999999999997 99999887766654444333 22222  245


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+..+.+++.+||..+|.+|||+.+++.+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-44  Score=303.89  Aligned_cols=265  Identities=28%  Similarity=0.492  Sum_probs=221.8

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-  123 (408)
                      |.-...+.|.-...||+|.||.||+|+++.+|+.||+|++-.+.-+.... ....+|+.+|..| .|+|++.+++++.. 
T Consensus        11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~l-kHenv~nliEic~tk   88 (376)
T KOG0669|consen   11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLL-KHENVVNLIEICRTK   88 (376)
T ss_pred             CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHh-cchhHHHHHHHHhhc
Confidence            55566678888899999999999999999999999998775543333333 3456799999999 99999999988743 


Q ss_pred             -------CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEE
Q 015352          124 -------DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (408)
Q Consensus       124 -------~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vk  195 (408)
                             ...+|+|+.+|+. +|.-.+... -.++...+..++++++.||.|+|+..|+|||+|++|+|+   +.++.+|
T Consensus        89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilk  164 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILK  164 (376)
T ss_pred             cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEE
Confidence                   3468999999976 888887665 569999999999999999999999999999999999999   6678899


Q ss_pred             EeecccccccCCC-----CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Q 015352          196 AIDFGLSIFFKPG-----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       196 l~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  268 (408)
                      |+|||+++.+...     ..++..+-|.+|++||.+.+  +|+++.|||..|||+.+|+||.+.|.+.+.+..+..|..-
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            9999999654322     23455567999999999876  6999999999999999999999999999998888887766


Q ss_pred             CcccCCCCCCCC-------------------------------CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          269 LIDFKRDPWPNV-------------------------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       269 ~~~~~~~~~~~~-------------------------------~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ...+..+.|+++                               ++++.+|+.++|..||.+|++++++++|.||....
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            655555555432                               34688999999999999999999999999998754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-41  Score=318.06  Aligned_cols=261  Identities=32%  Similarity=0.487  Sum_probs=211.1

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-CCe
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DNA  126 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~  126 (408)
                      .+.++|.+.+.||.|+||.||+|.+..+|..||+|.+.+... .......+.+|+.+++.+ +||||+++++++.. ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCc
Confidence            367899999999999999999999999999999999865432 223346788999999999 99999999999875 567


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      .|+++||+ +++|.+++.. +.+++..+..++.||+.||.|||+.||+||||+|+||++   +.++.++|+|||.+....
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccC
Confidence            89999999 5688777654 468899999999999999999999999999999999999   456789999999987543


Q ss_pred             CCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------------
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL---------------  269 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------------  269 (408)
                      .  ......+++.|+|||.+.+  .++.++|+||+|+++|+|++|..||...........+.+..               
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            2  2234567889999998754  58999999999999999999999998765433222111100               


Q ss_pred             -------c----c-cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          270 -------I----D-FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       270 -------~----~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                             .    . ......+.+++.+.++|.+||+.+|++|||+.+++.||||.....+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                   0    0 0001124578899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-41  Score=313.89  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=207.2

Q ss_pred             cceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+|.+.+.||+|+||.||+|.+..     ++..+++|.+....   ......+.+|+.+++.+ +||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNL-QHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCC
Confidence            468899999999999999998643     45668888875432   23346788999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC
Q 015352          126 AVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~  189 (408)
                      ..++||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+||++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence            9999999999999999997543                37899999999999999999999999999999999999   4


Q ss_pred             CCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 015352          190 ENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  264 (408)
                      .++.++|+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+..+.
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            567899999999876533221   123456788999998875 68899999999999999998 9999988887777777


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +..+....   .....|..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            66654432   22357889999999999999999999999977

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.4e-42  Score=315.48  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=209.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCC-----cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .++|++.+.||+|+||.||++.+...+     ..+|+|.+....  .......+.+|+.+++.+.+||||+++++++..+
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            368999999999999999999886443     679999987542  2233567889999999987799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC
Q 015352          125 NAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK  188 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~  188 (408)
                      +.++++|||+++|+|..++...                +.+++..+..++.|++.||.|||++||+||||||+||++   
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence            9999999999999999998642                358899999999999999999999999999999999999   


Q ss_pred             CCCCCEEEeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHH
Q 015352          189 KENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQ  263 (408)
Q Consensus       189 ~~~~~vkl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  263 (408)
                      +.++.+||+|||++.........   ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            45677999999999875433221   12234567999998764 68999999999999999997 999998888777776


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+..+...   ......+..+.+|+.+||..||++|||+.+++++
T Consensus       246 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66654321   2224678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=307.38  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=205.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++.....    ....+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEE
Confidence            35889999999999999999886 466799999864322    235678899999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||++|++|.+++... +.+++..+..++.||+.||.|||+.|++||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence            9999999999998764 468999999999999999999999999999999999999   456779999999987654322


Q ss_pred             cee--cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          210 RFS--EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       210 ~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ...  ...++..|+|||.+.+ .++.++|+||||+++|+|++ |..||...+..+....+..+..   .......+..+.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  231 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPTEVY  231 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHH
Confidence            111  1123457999998874 68999999999999999999 8999988777777766655432   122245799999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +++.+||..+|++|||+.++++.
T Consensus       232 ~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         232 TIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=309.91  Aligned_cols=243  Identities=23%  Similarity=0.309  Sum_probs=198.8

Q ss_pred             ceecccCCeEEEEEEECCCCcE--EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           57 RELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      +.||+|+||.||+|.+..++..  +++|.+...  ......+.+.+|+.++.++.+||||+++++++...+.+|++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            4689999999999999887764  577777532  122335678899999999978999999999999999999999999


Q ss_pred             CCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          135 EGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       135 ~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      ++++|.+++....                .+++..+..++.|++.||+|||++|++||||||+||++   +.++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence            9999999987543                37889999999999999999999999999999999999   4567799999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCC
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP  276 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (408)
                      ||++..............+..|+|||++.. .++.++|||||||++|+|++ |..||.+.+..+....+..+.   ..+.
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence            999864321111111223567999998864 68999999999999999997 999998887777766665432   1122


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...++.++.+++.+||..+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=314.51  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=207.1

Q ss_pred             cccccceEecceecccCCeEEEEEEE-----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....++|.+.+.||+|+||.||+|.+     ..++..+|+|.+.....  ....+.+.+|+.+++++.+||||+++++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            34456899999999999999999975     23456799998865422  233567889999999996799999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      ...+..|+||||+.+|+|.+++....  .+++.++..++.|++.||.|||+++|+|+||||+||++   +.+..++|+||
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~df  185 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDF  185 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCC
Confidence            99999999999999999999997643  38999999999999999999999999999999999999   45667999999


Q ss_pred             ccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          200 GLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       200 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      |++........   .....+++.|+|||.+.+ .++.++||||+||++|+|++ |..||.+.................  
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--  263 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--  263 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--
Confidence            99876543321   112345678999998864 68999999999999999998 999998766554443433332222  


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ......++.+.+++.+||.++|++|||+.++++
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            222457899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.3e-42  Score=310.65  Aligned_cols=245  Identities=28%  Similarity=0.468  Sum_probs=201.1

Q ss_pred             EecceecccCCeEEEEEEEC----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           54 LVDRELGRGEFGVTYLCIDR----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.+.||.|+||.||+|.+.    ..+..|+||.+...  ......+.+.+|+++++++ +||||+++++++...+.+++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            45788999999999999988    45678999999432  2333468899999999999 99999999999998888999


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|++|+++||+++   .++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc
Confidence            99999999999999887  6799999999999999999999999999999999999995   466899999999987632


Q ss_pred             CCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          208 GERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       208 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ....   ....+...|+|||.+.. .++.++||||||+++||+++ |..||...+..+....+..+....   ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence            2221   22345678999999875 58999999999999999999 789999988888888886654422   2246799


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.++|.+||..||++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.1e-42  Score=313.28  Aligned_cols=248  Identities=20%  Similarity=0.312  Sum_probs=207.9

Q ss_pred             cceEecceecccCCeEEEEEEECCC-----CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+|++.+.||.|+||.||+|.+..+     +..||+|++....  .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCC
Confidence            3578899999999999999987543     5789999987432  222346788999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC
Q 015352          126 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~  189 (408)
                      ..++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||++.   
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---
Confidence            999999999999999998532                2478888999999999999999999999999999999994   


Q ss_pred             CCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 015352          190 ENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  264 (408)
                      +++.+||+|||++........   .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            556799999999876533221   22334678899999876 468999999999999999998 8899988888888887


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +........   ...++..+.+|+.+||+.+|.+||++.+++.
T Consensus       239 i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         239 IRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            777654321   2468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=306.41  Aligned_cols=245  Identities=22%  Similarity=0.321  Sum_probs=206.6

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|++|.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++++ +||||+++++++...+..|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeee
Confidence            467999999999999999999875 456799999865432    246788999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||||++|++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccC
Confidence            999999999999997654  68999999999999999999999999999999999999   4566799999999887642


Q ss_pred             CCceeccc---CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          208 GERFSEIV---GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       208 ~~~~~~~~---gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ... ....   .+..|+|||.+.+ .++.++|+||||+++|+|++ |..||.+.........+..... .  ......+.
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~  231 (261)
T cd05068         156 DIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGCPK  231 (261)
T ss_pred             Ccc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCCH
Confidence            221 1122   2357999998875 68999999999999999999 9999988887777776655432 1  22246789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         232 ELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-41  Score=305.92  Aligned_cols=241  Identities=22%  Similarity=0.329  Sum_probs=201.7

Q ss_pred             ceecccCCeEEEEEEECCCC---cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           57 RELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +.||+|+||.||+|++..++   ..+|+|.+......  ...+.+.+|+.+++.+ +||||+++++++.. +.+++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEe
Confidence            46999999999999876554   78999998765433  3356788999999999 99999999998764 468999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce-e
Q 015352          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF-S  212 (408)
Q Consensus       134 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~-~  212 (408)
                      +++++|.+++...+.+++..+..++.|++.||.|||+.+++||||||+||++   +.++.+||+|||++......... .
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence            9999999999888889999999999999999999999999999999999999   45667999999998866433321 1


Q ss_pred             ---cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          213 ---EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       213 ---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                         ...++..|+|||.+.+ .++.++||||||+++|++++ |..||...+..+....+.....   .+....++..++++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---LPRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHHH
Confidence               1123467999998864 68999999999999999998 9999988877777666655432   22334678999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhc
Q 015352          288 VRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~  307 (408)
                      |.+||..+|++|||+.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-41  Score=307.01  Aligned_cols=245  Identities=23%  Similarity=0.327  Sum_probs=203.7

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|.+..++ .||+|.+.....    ..+.+.+|+++++.+ +||||+++++.+.. +..|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhC-CCCCcceEEEEECC-CCcEE
Confidence            468999999999999999999887654 599999875332    245788999999999 89999999998754 56899


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.+++||||||+||++   +.++.+||+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence            99999999999999763  358899999999999999999999999999999999999   4566799999999976543


Q ss_pred             CCce--ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ....  ....++..|+|||...+ .++.++|||||||++|+|++ |..||.+....+....+..+..   ......++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---CCCccccCHH
Confidence            3221  12345678999998764 68999999999999999999 8999988877777666654421   1122467899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+++.+||+++|++|||+.++++
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.1e-42  Score=309.47  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=209.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      ..+|.+.+.||.|+||.||+|.+.. +..+|+|++.....   .....+.+|+.+++.+ +||||+++++++.+.+.+++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEE
Confidence            4578999999999999999999987 88899999875432   2356788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||||+++++|.+++...  ..+++..+..++.||+.||.|||++|++||||+|+||++   +.++.+||+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCC
Confidence            99999999999999763  458999999999999999999999999999999999999   4566799999999876543


Q ss_pred             CCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          208 GER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       208 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ... .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+.+..+....+..+..   .+.....++.+
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---MPCPAKCPQEI  233 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---CCCCCCCCHHH
Confidence            221 122345678999998864 68899999999999999998 8999988887777777765422   22235788999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+++.+||+.||.+|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-41  Score=310.43  Aligned_cols=247  Identities=22%  Similarity=0.369  Sum_probs=205.9

Q ss_pred             cceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+|.+.+.||+|+||.||+|...     .++..+|+|.+...   .......+.+|+++++.+ +||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence            46788999999999999999743     34667899987643   233456889999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC
Q 015352          126 AVHLVMELCEGGELFDRIVARG---------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE  190 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~  190 (408)
                      ..+++|||+++++|.+++...+               .+++..+..++.||+.||.|||++|++||||||+||+++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence            9999999999999999987643               478899999999999999999999999999999999994   5


Q ss_pred             CCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 015352          191 NSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAI  265 (408)
Q Consensus       191 ~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i  265 (408)
                      ++.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            67799999999875433221   122335678999998875 68999999999999999998 99999887777776666


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+...   .....+++.+.++|.+||+.||.+||++.++++
T Consensus       238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            655322   222468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.1e-41  Score=309.10  Aligned_cols=248  Identities=20%  Similarity=0.272  Sum_probs=204.3

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCc----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ..+|.+.+.||+|+||+||+|.+..+|.    .||+|++....  .......+.+|+.+++.+ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGV-GSPYVCRLLGICLTS-   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCC-
Confidence            4578999999999999999999877776    47999886432  233356788999999998 999999999998764 


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..++++||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~  158 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARL  158 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceee
Confidence            477999999999999999764 5689999999999999999999999999999999999994   456799999999987


Q ss_pred             cCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          205 FKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       205 ~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      .......   ....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||...........+..+...   +....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL---PQPPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC---CCCcc
Confidence            6433221   12234678999998864 68999999999999999998 99999877766665555443321   22346


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+..+.+++.+||..||++||++.++++
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-41  Score=310.67  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=196.5

Q ss_pred             ccce-EecceecccCCeEEEEEE----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-
Q 015352           50 EDRY-LVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-  123 (408)
Q Consensus        50 ~~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-  123 (408)
                      .++| .+.+.||+|+||+||++.    ...++..||+|.+....  .......+.+|+++++.+ +||||+++++++.. 
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   78 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQ   78 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            4567 899999999999998865    33568889999986542  122356788999999999 99999999998765 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 -DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                       ...+|+||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~  154 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLA  154 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccc
Confidence             34689999999999999998764 59999999999999999999999999999999999999   45577999999998


Q ss_pred             cccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH--HHH------------H
Q 015352          203 IFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ--GVA------------Q  263 (408)
Q Consensus       203 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~------------~  263 (408)
                      ........    .....++..|+|||.+.+ .++.++||||||+++|+|++|..||......  +..            .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            86543221    112245667999998864 6899999999999999999999998543211  000            0


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .......  ..+.....+..+.+++.+||+.+|++|||++++++
T Consensus       235 ~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         235 ELLERGM--RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhcCC--CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000001  11112457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-41  Score=308.14  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=207.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+....  .......+.+|+.+++.+ +||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence            578999999999999999999865443   69999886432  223356789999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence            9999999999999999765 458999999999999999999999999999999999999   456679999999988654


Q ss_pred             CCCce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          207 PGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       207 ~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .....    ....++..|+|||.+.+ .++.++|+||||+++|++++ |..||......+....+..+. ..  +....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RL--PAPMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cC--CCCCCC
Confidence            32211    11223567999999875 68999999999999999886 999998887777766666542 22  223467


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++.+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.5e-41  Score=314.03  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=206.9

Q ss_pred             cccceEecceecccCCeEEEEEEECC-------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ..++|.+.+.||+|+||.||+|.+..       .+..+|+|.+....  .......+.+|+.+++.+.+||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34689999999999999999998642       34569999886432  2334567889999999986799999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEe
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~  185 (408)
                      .+.+.+|++|||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999999763                247888999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHH
Q 015352          186 ANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQG  260 (408)
Q Consensus       186 ~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  260 (408)
                      +   .++.+||+|||++........   .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+
T Consensus       168 ~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 T---EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             c---CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            4   566799999999976543221   112234467999998865 58999999999999999999 899998887777


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ....+..+..   ......++.++++++.+||..+|++|||+.++++
T Consensus       245 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            7776655432   1223467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-41  Score=308.70  Aligned_cols=248  Identities=20%  Similarity=0.293  Sum_probs=204.3

Q ss_pred             eEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe---
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA---  126 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---  126 (408)
                      |.+.+.||+|+||.||+|.+..+   +..||+|.+..... .......+.+|+.+++.+ +||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence            56789999999999999987653   47899999875433 233456789999999999 99999999998765543   


Q ss_pred             ---EEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          127 ---VHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       127 ---~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                         .++++||+++++|..++...      ..+++..+..++.|++.||.|||++|++||||||+||++   ++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence               79999999999999888542      358999999999999999999999999999999999999   456779999


Q ss_pred             ecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCccc
Q 015352          198 DFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (408)
Q Consensus       198 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (408)
                      |||++.........   ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-  234 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99998865433221   11234568999998864 58999999999999999999 99999888877777766655322 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                        .....+++.+.+++.+||+.||++|||+.+++++
T Consensus       235 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         235 --KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              1234678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-41  Score=312.89  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=210.3

Q ss_pred             cccccceEecceecccCCeEEEEEEEC-------CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEee
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~  119 (408)
                      ....++|.+.+.||+|+||.||+|++.       ..+..+|+|.+....  .......+.+|+.+++.+.+||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            345678999999999999999999753       234579999886432  23345678999999999878999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          120 ACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       120 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                      ++...+..|+||||+++++|.+++....                .++...+..++.||+.||.|||++|++||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            9999999999999999999999997642                367788999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCH
Q 015352          184 LFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESE  258 (408)
Q Consensus       184 l~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  258 (408)
                      ++   +.++.+||+|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.
T Consensus       169 li---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         169 LV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            99   4567799999999886543221   122345678999998865 58999999999999999998 8899988888


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+....+......   .....++..+++|+.+||..+|++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            8877777655322   1224678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.7e-41  Score=308.32  Aligned_cols=247  Identities=20%  Similarity=0.292  Sum_probs=202.3

Q ss_pred             EecceecccCCeEEEEEEECCCCc--EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe------CC
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED------DN  125 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~------~~  125 (408)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.+.... ......+.+.+|+.+++.+ +||||+++++++..      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCC
Confidence            467899999999999999887765  58999886542 2334467888999999999 99999999987642      23


Q ss_pred             eEEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          126 AVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      ..+++|||+.+|+|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCC
Confidence            578999999999999887431      347899999999999999999999999999999999999   45677999999


Q ss_pred             ccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          200 GLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       200 g~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      |++.........   ....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---  233 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL---  233 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            999876433221   12245678999998875 58999999999999999999 89999888777777776665432   


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .....++..+.++|.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1224678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=304.54  Aligned_cols=243  Identities=24%  Similarity=0.356  Sum_probs=207.4

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.|.+.+.||.|+||.||+|...  |+.||+|.+.....    ..+.+.+|+.+++.+ +|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEE
Confidence            357889999999999999999864  78899999865432    457789999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccc
Confidence            999999999999998765  68999999999999999999999999999999999999   4567799999999887632


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ...  ...++..|+|||.+.. .++.++|+||||+++|++++ |..||...+.......+.....   ......+++.+.
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVY  229 (256)
T ss_pred             ccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHH
Confidence            222  2344567999998764 68899999999999999997 9999988877776666654421   222346789999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++|.+||..+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         230 KVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-41  Score=308.77  Aligned_cols=252  Identities=28%  Similarity=0.497  Sum_probs=209.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      +|.+.+.||+|+||.||++++..++..+++|++......  .......+.+|+.+++.+ +||||+++++++.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence            689999999999999999999888777777776543221  122234567899999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          130 VMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |+||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.    +.++|+|||.+...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence            9999999999988753    356899999999999999999999999999999999999952    45999999998765


Q ss_pred             CCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          206 KPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       206 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+..+....   ....++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---CcchhcHH
Confidence            4332 2334568899999998864 58889999999999999999999998777666666665543221   12467889


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +.++|.+||..+|++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=324.13  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=215.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCc---E-EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---L-LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      ..-.++-.+.+.||+|+||.||+|..+..+.   . ||+|....+.......+..+.+|+++++++ +||||++++|+..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAV  231 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEc
Confidence            3344555667899999999999998775432   3 899988754444566788999999999999 9999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ....+++|||+|+||+|.++|++.+. ++..+...++.+.+.||+|||+++++||||-..|+|++   .+..+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCcccc
Confidence            99999999999999999999999874 99999999999999999999999999999999999994   455689999999


Q ss_pred             ccccCCCCcee-cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          202 SIFFKPGERFS-EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       202 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ++......... ...-...|+|||.+.. -|+.++||||+||++||+++ |..||.+....++...+....+..+.+  .
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~  386 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--S  386 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--C
Confidence            88654111111 1123467999999975 69999999999999999999 899999999999999996655444433  3


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..|.++..++.+|+..+|++|||+.++.+
T Consensus       387 ~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  387 KTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            77889999999999999999999999876

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-41  Score=317.17  Aligned_cols=248  Identities=22%  Similarity=0.311  Sum_probs=198.1

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCchHHH
Q 015352           63 EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR  142 (408)
Q Consensus        63 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~  142 (408)
                      ++|.||.+++..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+.+..|++|||+++++|.++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            456677777777999999999976532 334567899999999999 899999999999999999999999999999999


Q ss_pred             HHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC--------cee
Q 015352          143 IVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--------RFS  212 (408)
Q Consensus       143 l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~--------~~~  212 (408)
                      +...  ..+++..+..++.|++.||+|||+++|+||||||+||+++   .++.+||+|||.+.......        ...
T Consensus        90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeeccccccccccccccc
Confidence            8764  4589999999999999999999999999999999999994   45679999999886543211        112


Q ss_pred             cccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC----------------
Q 015352          213 EIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK----------------  273 (408)
Q Consensus       213 ~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------------  273 (408)
                      ...++..|+|||++..   .++.++|+||+||++|+|++|..||..............+.....                
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence            3457788999999864   488999999999999999999999987655443322222111000                


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          274 --------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       274 --------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                    ......++.++.+|+.+||..||++|||+.++|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                          000012346788999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.5e-41  Score=304.84  Aligned_cols=246  Identities=22%  Similarity=0.311  Sum_probs=204.8

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ..+.+.+|+.+++.+ +|||++++++++.. ...|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEECC-CCcE
Confidence            4568999999999999999999876 566799999875432    245788999999999 99999999998864 5688


Q ss_pred             EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          129 LVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++   .++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeecc
Confidence            999999999999998763  3589999999999999999999999999999999999994   56679999999997654


Q ss_pred             CCCce--ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .....  ....++..|+|||.+.+ .++.++|+||||+++|+|++ |..||.+.+..+....+..+..   .+.....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR---MPCPQDCPI  230 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCH
Confidence            33211  12235567999998764 68899999999999999999 9999988887777777665421   222346789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.+|+.+||.++|++|||+.++.+
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.4e-41  Score=307.16  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=207.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ..|++.+.||+|+||.||+|.++.++.   .||+|.+....  .......+..|+.+++.+ +||||+++++++.++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCce
Confidence            468899999999999999999887665   59999986432  233456889999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||++   +.+..+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence            9999999999999998764 568999999999999999999999999999999999999   456789999999987654


Q ss_pred             CCCce---eccc---CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          207 PGERF---SEIV---GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       207 ~~~~~---~~~~---gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      .....   ....   .+..|+|||.+.+ .++.++||||+||++|++++ |..||+..+.......+... .  ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~--~~~~~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-Y--RLPPPM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-C--cCCCcc
Confidence            32211   1111   2347999999874 68999999999999999886 99999988877777766543 2  222234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .++..+.+++.+||..+|.+||++.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.5e-41  Score=304.78  Aligned_cols=245  Identities=28%  Similarity=0.411  Sum_probs=209.4

Q ss_pred             EecceecccCCeEEEEEEECCCC----cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.+.||.|+||.||+|.+..++    ..+|+|.+.....  ......+.+|+.+++.+ +||||+++++++.+.+..|+
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEE
Confidence            56789999999999999998766    8899999864432  22467889999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||+++++|.+++.....  +++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceeccc
Confidence            9999999999999976544  8999999999999999999999999999999999999   4556799999999887654


Q ss_pred             CCceec--ccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GERFSE--IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~~~~~--~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ......  ..+++.|+|||.+.+ .++.++|+||+|+++|+|++ |..||...+.....+.+........   ...++.+
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPE  232 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence            422221  236788999998864 58999999999999999998 8999988887777777766553322   2358999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+++.+||..||++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4e-41  Score=310.17  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=203.7

Q ss_pred             ceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....  .......+.+|+.+++.+ +||||+++++.+..++.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC
Confidence            47889999999999999998753     23568888876433  223356788999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 015352          127 VHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~N  182 (408)
                      .++++||+.+++|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999988642                        247788999999999999999999999999999999


Q ss_pred             eEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCC
Q 015352          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (408)
Q Consensus       183 Il~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~  257 (408)
                      |+++   +++.+||+|||++........   .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+..
T Consensus       158 ill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9994   566799999999876533221   122345678999998765 58999999999999999998 999998888


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...+.+.+.... .  ......++.++.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~-~--~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGY-R--MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCC-C--CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            777666655442 2  2223468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.2e-41  Score=304.83  Aligned_cols=248  Identities=22%  Similarity=0.359  Sum_probs=207.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+|...+.||+|+||.||+|+++.++.   .+|+|.+....  .....+.+.+|+.+++.+ +||||+++.+++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCc
Confidence            478889999999999999999876654   69999886432  223356788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence            9999999999999998764 568999999999999999999999999999999999999   456679999999987654


Q ss_pred             CCCc--eec--ccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          207 PGER--FSE--IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       207 ~~~~--~~~--~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ....  ...  ...++.|+|||.+.+ .++.++|||||||++|+|++ |..||+..+..+....+..+.   ..+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CCCCCCCC
Confidence            3221  111  123457999998874 68999999999999999997 999999888777777776542   22223457


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +..+.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-41  Score=319.43  Aligned_cols=252  Identities=22%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             cccceEecceecccCCeEEEEEEE-----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      -.++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ......+.+|+.++.++.+||||+++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            346899999999999999999984     34678899999865432  22356788999999999778999999998764


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhCC-------------------------------------------------------
Q 015352          124 -DNAVHLVMELCEGGELFDRIVARG-------------------------------------------------------  147 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~l~~~~-------------------------------------------------------  147 (408)
                       +..++++|||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             456899999999999999886431                                                       


Q ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc---ee
Q 015352          148 ------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FS  212 (408)
Q Consensus       148 ------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~  212 (408)
                                  .++...+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++........   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcC
Confidence                        35777888999999999999999999999999999999   4567899999999876432211   11


Q ss_pred             cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHH-HHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          213 EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQG-VAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       213 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ...+++.|+|||.+.+ .++.++||||||+++|+|++ |..||....... ....+..+. ....  ....++.+.+++.
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~  316 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRA--PDYTTPEMYQTML  316 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-CCCC--CCCCCHHHHHHHH
Confidence            2345677999998764 68999999999999999997 999997754332 333333332 1111  1246789999999


Q ss_pred             HhcCCCcCCCCCHHHHhcC
Q 015352          290 QMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~h  308 (408)
                      +||+.||++|||+.++++|
T Consensus       317 ~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.9e-41  Score=303.32  Aligned_cols=241  Identities=23%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE-EeCCeEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC-EDDNAVHL  129 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~~~~~~l  129 (408)
                      .+|.+.+.||+|+||.||++...  |..+|+|.+...     ...+.+.+|+.+++.+ +|||++++++++ ..++..|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence            47889999999999999999764  778999988533     2346788999999999 999999999875 55678999


Q ss_pred             EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||+++++|.+++.+.+  .+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999987654  37899999999999999999999999999999999999   4567799999999876433


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ..  ....++..|+|||++.+ .++.++|||||||++|+|++ |..||......+....+..+..   ....+.+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  22344567999998875 58899999999999999997 9999988877777666655422   223356889999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +++.+||..+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.6e-41  Score=302.97  Aligned_cols=245  Identities=23%  Similarity=0.327  Sum_probs=203.6

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.+++.+ +|||++++++++.. +..|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKL-RHDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhC-CCCCeeeEEEEEcC-CCcEE
Confidence            46799999999999999999987655 4599998764322    246788999999999 99999999998864 56889


Q ss_pred             EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||+.+++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||++   ++++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccC
Confidence            999999999999997643  47899999999999999999999999999999999999   5567799999999976543


Q ss_pred             CCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ...  .....++..|+|||...+ .++.++||||||+++|+|++ |..||.+....+....+..+..   .......+..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPES  231 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHH
Confidence            221  112345677999998864 68999999999999999999 9999998887777776655422   2223467899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+++.+||.+||++||+++++++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         232 LHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.3e-41  Score=309.60  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=207.1

Q ss_pred             ccceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .++|++.+.||+|+||.||+|.+..     ++..+|+|++....  .......+.+|+.+++.+ +||||+++++++.++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence            3579999999999999999998753     67889999986432  222346788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 015352          125 NAVHLVMELCEGGELFDRIVARG----------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~----------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~N  182 (408)
                      +..++||||+++++|.+++....                      .+++..+..++.|++.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997532                      36788899999999999999999999999999999


Q ss_pred             eEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCC
Q 015352          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (408)
Q Consensus       183 Il~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~  257 (408)
                      |++   +.++.++|+|||++........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+..
T Consensus       161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999   4567799999999875432221   122234567999998764 68999999999999999997 889998888


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+....+..+....   .....+.++.+|+.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            777777766554321   12357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.1e-41  Score=302.28  Aligned_cols=240  Identities=24%  Similarity=0.331  Sum_probs=197.8

Q ss_pred             eecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           58 ELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      .||+|+||.||+|.+.  ..+..||+|++....  .....+.+.+|+.+++++ +||||++++++++. ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            4899999999999775  445679999986442  233356788999999999 99999999999864 47899999999


Q ss_pred             CCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce---
Q 015352          136 GGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---  211 (408)
Q Consensus       136 g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~---  211 (408)
                      +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.........   
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence            9999999875 4568999999999999999999999999999999999999   45667999999998755433211   


Q ss_pred             -ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          212 -SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       212 -~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                       ....+++.|+|||.+.+ .++.++|||||||++|++++ |..||.+....+....+..+...   ......++++.+++
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHH
Confidence             11223568999998864 68999999999999999996 99999988877777666655421   22246789999999


Q ss_pred             HHhcCCCcCCCCCHHHHhc
Q 015352          289 RQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+||..+|++||++.++.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.6e-41  Score=302.98  Aligned_cols=246  Identities=23%  Similarity=0.332  Sum_probs=206.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..+.|++.+.||+|+||.||+|... ++..||+|.+.....    ....+.+|+.+++.+ +||||+++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcE
Confidence            4578999999999999999999865 567899999875432    346788999999999 8999999999875 45689


Q ss_pred             EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          129 LVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecC
Confidence            999999999999998653  358999999999999999999999999999999999999   456779999999987654


Q ss_pred             CCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ....  .....++..|+|||.+.. .++.++||||||+++|++++ |..||.+.+..+....+.....   .+.....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCH
Confidence            2221  122345678999998864 68899999999999999999 9999998887777766655432   223346789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++.+++.+||..+|++|||++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=310.39  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=202.0

Q ss_pred             ccceEecceecccCCeEEEEEEECCCC--------------cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCee
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTR--------------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV  115 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~  115 (408)
                      ..+|++.+.||+|+||.||+|++..++              ..||+|.+....  .......+.+|+++++++ +|||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~   80 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRL-KNPNII   80 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCcC
Confidence            358999999999999999999875432              358999986432  223356788999999999 999999


Q ss_pred             EEeeEEEeCCeEEEEEeccCCCchHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          116 SLKEACEDDNAVHLVMELCEGGELFDRIVARG------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       116 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                      ++++++...+..++||||+++++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999886532            367888999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh--CCCCCCCCC
Q 015352          184 LFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC--GVPPFWAES  257 (408)
Q Consensus       184 l~~~~~~~~~vkl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~--g~~pf~~~~  257 (408)
                      +++   .++.+||+|||++.........   ....+++.|+|||.+.+ .++.++|+|||||++|+|++  |..||...+
T Consensus       161 ll~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         161 LVG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             EEc---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            994   4567999999998765332211   22344678999998764 68999999999999999988  678888776


Q ss_pred             HHHHHHHHHcCC----cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          258 EQGVAQAILRGL----IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       258 ~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+....+....    ........+..++.+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            665554442211    11111223457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-41  Score=314.85  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=208.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCC-------CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEee
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDT-------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~  119 (408)
                      +....+|.+.+.||+|+||.||+|.+...       +..+|+|.+....  .......+.+|+.+++++.+||||+++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            33446899999999999999999986432       2368999876432  22345678899999999877999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          120 ACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       120 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                      ++..++..|+++||+++|+|.+++....                .++...+..++.|++.||.|||++|++||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            9999999999999999999999987532                367788899999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCH
Q 015352          184 LFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESE  258 (408)
Q Consensus       184 l~~~~~~~~~vkl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  258 (408)
                      ++   +.++.+||+|||++.........   ....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.
T Consensus       166 ll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         166 LV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99   45567999999998765432211   12234567999998865 68999999999999999998 8999998887


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+....+......   +.....+.++.+++.+||+.+|.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7777776654321   2224678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=301.70  Aligned_cols=248  Identities=24%  Similarity=0.362  Sum_probs=208.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|.+.+.||+|+||.||+|.+. .+..+|+|.+.....    ....+.+|+.+++.+ +||||+++++++......
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCce
Confidence            34678999999999999999999976 457799999875432    346788999999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ++||||+++++|.+++....  .++...+..++.|++.||.|||++|++|+||||+||++   +.++.+||+|||.+...
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLI  153 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceec
Confidence            99999999999999997653  58999999999999999999999999999999999999   45678999999998765


Q ss_pred             CCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .....  .....++..|+|||.+.+ .++.++|+||+|+++|+|++ |+.||.+.........+..+..   .......+
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPNCP  230 (261)
T ss_pred             cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            43211  112234567999998875 58999999999999999998 9999988887777777765432   12224568


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+.+++.+||..+|++||++.++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.3e-41  Score=305.94  Aligned_cols=247  Identities=22%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcE----EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTREL----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ++|++.+.||+|+||+||+|.+..+|..    +++|.+....  .......+..|+.+++.+ +||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence            5788999999999999999999877764    6666654221  122345677888899998 99999999998764 45


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||++   +.++.+||+|||++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            78999999999999999764 568999999999999999999999999999999999999   45678999999999765


Q ss_pred             CCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          206 KPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       206 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ....   ......++..|+|||.+.+ .++.++|||||||++|++++ |..||.+.........+..+....   .....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA---QPQIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC---CCCCC
Confidence            4322   1223456778999998864 69999999999999999998 999998887766655554443221   12346


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +..+.+++.+||..||.+|||+.++++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8e-41  Score=302.56  Aligned_cols=242  Identities=24%  Similarity=0.325  Sum_probs=202.8

Q ss_pred             ceecccCCeEEEEEEECC-CC--cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           57 RELGRGEFGVTYLCIDRD-TR--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +.||+|++|.||+|.+.. .+  ..+|+|.+......  ...+.+.+|+.+++++ +||||+++++.+.. ..+++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999999865 33  36999999765543  4467889999999999 99999999999988 899999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc-
Q 015352          134 CEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (408)
Q Consensus       134 ~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~-  210 (408)
                      +++++|.+++.+..  .+++..++.++.|++.||.|||++|++||||+|+||+++   .++.+||+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc
Confidence            99999999998764  689999999999999999999999999999999999994   457899999999887643221 


Q ss_pred             ---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          211 ---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       211 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                         .....++..|+|||.+.. .++.++|||||||++|+|++ |..||...+..+....+........  .....|..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence               112356778999998875 68999999999999999998 9999988777777666654322222  2235789999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.8e-41  Score=337.34  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=207.2

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE------
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE------  122 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~------  122 (408)
                      ...+|+..+.||+||||.||+++++-+|+.||||.|....  .......+.+|+..|.+| +|||||+++..|.      
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcc
Confidence            4456778899999999999999999999999999998654  333456789999999999 9999999985420      


Q ss_pred             ---------------e---------------------------------------------------------C------
Q 015352          123 ---------------D---------------------------------------------------------D------  124 (408)
Q Consensus       123 ---------------~---------------------------------------------------------~------  124 (408)
                                     .                                                         .      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                           0                                                         0      


Q ss_pred             -----------------------------------CeEEEEEeccCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHH
Q 015352          125 -----------------------------------NAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLC  168 (408)
Q Consensus       125 -----------------------------------~~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~i~~ql~~~l~~l  168 (408)
                                                         -.+||-||||+..+|.+++..+... ....+|.++++|+.||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                               1368999999987777666665444 4788999999999999999


Q ss_pred             HHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-------------------CCCceecccCCCCCcchhhhhc-
Q 015352          169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-------------------PGERFSEIVGSPYYMAPEVLKR-  228 (408)
Q Consensus       169 H~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-  228 (408)
                      |+.|||||||||.||++   +....|||+|||+|....                   +....+..+||.-|+|||++.+ 
T Consensus       714 H~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99999999999999999   466779999999998621                   1113456789999999999864 


Q ss_pred             ---cCCCchhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHH
Q 015352          229 ---NYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQ  304 (408)
Q Consensus       229 ---~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~  304 (408)
                         .|+.|+||||||+++|||+.   ||.. +....++.++..+.++.+...+.+--+.-..+|++||+.||.+||||.|
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence               49999999999999999995   5644 3344566777777776664444444566789999999999999999999


Q ss_pred             HhcCccccC
Q 015352          305 VLEHPWLQN  313 (408)
Q Consensus       305 ~l~h~~~~~  313 (408)
                      +|++.||..
T Consensus       868 LL~s~llpp  876 (1351)
T KOG1035|consen  868 LLNSELLPP  876 (1351)
T ss_pred             HhhccCCCc
Confidence            999999965

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.1e-41  Score=319.92  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=203.9

Q ss_pred             ccccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      .-.++|.+.+.||+|+||.||+|++.     .++..||+|++.....  ....+.+.+|+.++.++..||||+++++++.
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34467889999999999999999864     3456899999975422  2234578899999999944999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC-------------------------------------------------------
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARG-------------------------------------------------------  147 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~-------------------------------------------------------  147 (408)
                      ..+..++||||+++|+|.+++...+                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999986532                                                       


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceE
Q 015352          148 -------------------------------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL  184 (408)
Q Consensus       148 -------------------------------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl  184 (408)
                                                                 .++...+..++.||+.||.|||+.+++||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       2566678889999999999999999999999999999


Q ss_pred             eecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHH
Q 015352          185 FANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQ  259 (408)
Q Consensus       185 ~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~  259 (408)
                      ++   ....+||+|||++........   .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||......
T Consensus       272 l~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         272 IC---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             Ee---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            94   466799999999876432211   123356788999998875 58999999999999999998 89999775554


Q ss_pred             HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +............  .....++.++.+|+.+||..+|.+||++.++++.
T Consensus       349 ~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4443333332222  2234678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.1e-41  Score=306.04  Aligned_cols=250  Identities=21%  Similarity=0.366  Sum_probs=209.4

Q ss_pred             cceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ++|++.+.||+|+||.||+|+.+.     +.+.+++|.+....  .......+.+|+.+++++ +||||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence            678899999999999999999764     34679999876432  222356789999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          126 AVHLVMELCEGGELFDRIVARG---------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      ..|+||||+++++|.+++....         .+++..+..++.||+.||.|||++||+||||||+||+++   ..+.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEE
Confidence            9999999999999999998765         689999999999999999999999999999999999994   4567999


Q ss_pred             eecccccccCCCC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCccc
Q 015352          197 IDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (408)
Q Consensus       197 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (408)
                      +|||++.......  ......++..|+|||.+.+ .++.++||||||+++|+|++ |..||...........+..+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986543221  2233456778999998764 58899999999999999998 889998777777777766555443


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..  ...++..+.+++.+||..+|.+|||+.+++..
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            32  24688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-41  Score=330.16  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=214.3

Q ss_pred             ceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      +-.+.+.||+|+||.||+|+-..     ....||||.+....  ......+|+||++++..| +|||||++++++..++.
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCe
Confidence            44678899999999999997543     34579999986443  334578999999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          127 VHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      +|+|+||+..|+|.++|...+              +++..+...|+.||+.|+.||-++.+|||||-..|+||   +++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccce
Confidence            999999999999999997532              27888999999999999999999999999999999999   7788


Q ss_pred             CEEEeecccccccCCCCcee---cccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHc
Q 015352          193 PLKAIDFGLSIFFKPGERFS---EIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILR  267 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~  267 (408)
                      .|||+|||+++.....+.+.   ...-..+|||||.+. ++|+.++||||+||+|||+++ |..||.+.+.+++++.+.+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            89999999998765544332   123356899999775 689999999999999999998 9999999999999999999


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.. ++.  ..+.|.++.+|+..||+.+|.+||++.||-.
T Consensus       721 g~l-L~~--Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  721 GQL-LSC--PENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             CCc-ccC--CCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            987 333  3689999999999999999999999999843

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=304.07  Aligned_cols=248  Identities=21%  Similarity=0.279  Sum_probs=207.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCc----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .++|++.+.||+|+||.||+|.++.+|.    .+|+|.+.....  ......+.+|+.+++.+ +||||+++++++.. .
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~   81 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASV-DHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-C
Confidence            4688999999999999999999877665    588898765432  33456788999999999 99999999999987 7


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++   +..+.+||+|||.+..
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~  158 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  158 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence            899999999999999998774 468999999999999999999999999999999999999   4556799999999987


Q ss_pred             cCCCCcee---cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          205 FKPGERFS---EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       205 ~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ........   ...++..|+|||.+.. .++.++|+||+|+++|++++ |..||.+....+....+..+...   .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  235 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL---PQPPI  235 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC---CCCCC
Confidence            65333211   1223567999998864 68999999999999999998 99999988877777777654321   11235


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+..+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-40  Score=308.20  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=201.1

Q ss_pred             ccceEecceecccCCeEEEEEEECC----------------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRD----------------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~  113 (408)
                      .++|++.+.||+|+||.||+|.+..                ++..+|+|.+....  .......+.+|+.+++.+ +|||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l-~~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRL-KDPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCC
Confidence            4579999999999999999986543                34568999986442  223356788999999999 9999


Q ss_pred             eeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 015352          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (408)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~N  182 (408)
                      |+++++++..++..++||||+++++|.+++....           .+++..+..++.|++.||.|||++|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987642           36677899999999999999999999999999999


Q ss_pred             eEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh--CCCCCCCC
Q 015352          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC--GVPPFWAE  256 (408)
Q Consensus       183 Il~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~--g~~pf~~~  256 (408)
                      |+++   .++.++|+|||++........   .....+++.|+|||... +.++.++|+|||||++|+|++  |..||...
T Consensus       161 ili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9994   567799999999876533221   12233467899999765 469999999999999999998  78999776


Q ss_pred             CHHHHHHHHHc----CCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          257 SEQGVAQAILR----GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       257 ~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +..+.......    .......+....+++.+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66554443321    0011111222457899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-40  Score=304.38  Aligned_cols=249  Identities=21%  Similarity=0.299  Sum_probs=206.3

Q ss_pred             ccceEecceecccCCeEEEEEEECC----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-C
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRD----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-D  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~  124 (408)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.+...  ........+.+|+.+++.+ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence            4689999999999999999999876    3577999987532  2334467788999999999 99999999998765 5


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          125 NAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      ...++++||+++++|.+++...        ..+++..+..++.|++.||.|||+++++||||||+||++   +.++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence            7789999999999999998663        358899999999999999999999999999999999999   45578999


Q ss_pred             eecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcc
Q 015352          197 IDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLID  271 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~  271 (408)
                      +|||+++...+....   ....++..|+|||.+.+ .++.++|||||||++|++++ |..||...+..+....+..+. .
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence            999999765433211   12345667999998875 58999999999999999999 999998877777666555442 2


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +  .....+++.+.+++.+||..||++|||+.++++
T Consensus       238 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2  223457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.7e-40  Score=297.85  Aligned_cols=241  Identities=22%  Similarity=0.335  Sum_probs=200.2

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||+|+||.||+|... ++..+|+|.+....  .......+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence            46899999999999865 67889999886432  222345688999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce--ec
Q 015352          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SE  213 (408)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~--~~  213 (408)
                      ++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||++   +.++.+||+|||++.........  ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence            9999988764 458899999999999999999999999999999999999   45667999999998754332211  11


Q ss_pred             ccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHh
Q 015352          214 IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM  291 (408)
Q Consensus       214 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  291 (408)
                      ..+++.|+|||++.+ .++.++||||||+++|++++ |..||.+.........+..+..   ......++..+.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---MSCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHH
Confidence            234567999998874 68899999999999999998 9999988877776666654432   122346889999999999


Q ss_pred             cCCCcCCCCCHHHHhc
Q 015352          292 LEPDPKLRLTAKQVLE  307 (408)
Q Consensus       292 l~~dp~~R~s~~~~l~  307 (408)
                      |..+|++|||+.++++
T Consensus       231 l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         231 WDYKPENRPKFSELQK  246 (250)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-40  Score=298.63  Aligned_cols=246  Identities=26%  Similarity=0.420  Sum_probs=206.5

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .+|++.+.||.|+||.||+|.+. .+..+|+|.+.....    ....+.+|+++++++ +|||++++++++......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEE
Confidence            47889999999999999999875 467899998864432    245688999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||+++++||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence            9999999999998764 568999999999999999999999999999999999999   456679999999987653322


Q ss_pred             c--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          210 R--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       210 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .  .....++..|+|||.+.+ .++.++|+||+|+++|+|++ |..||...........+..+...+.   ....+..+.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHH
Confidence            1  112234568999998874 68899999999999999998 9999988887777777765532222   134689999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +|+.+||+.+|++|||+.+++++
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHHh
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=298.25  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      +.||.|+||.||+|.+.. ++.||+|.+......  .....+.+|+++++++ +||||+++++++.+....++||||++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999887 999999998754332  3456789999999999 999999999999999999999999999


Q ss_pred             CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce---e
Q 015352          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---S  212 (408)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~---~  212 (408)
                      ++|.+++... ..+++..+..++.+++.||.|||+++++||||+|+||++   +.++.+||+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence            9999998664 468999999999999999999999999999999999999   45667999999998765422211   1


Q ss_pred             cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 015352          213 EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ  290 (408)
Q Consensus       213 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  290 (408)
                      ...++..|+|||.+.+ .++.++|+||||+++|+|++ |..||...........+.... .  .......+..+.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-R--MPAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-C--CCCCccCCHHHHHHHHH
Confidence            1223556999998764 68999999999999999999 899998877666655554432 1  12234678999999999


Q ss_pred             hcCCCcCCCCCHHHHhc
Q 015352          291 MLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       291 ~l~~dp~~R~s~~~~l~  307 (408)
                      ||..+|++|||+.++++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.6e-40  Score=301.31  Aligned_cols=252  Identities=29%  Similarity=0.500  Sum_probs=210.3

Q ss_pred             ceEecceecccCCeEEEEEEECC-CCcEEEEEEeecccc-------CChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKL-------RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      .|.+.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++....+||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37888999999999999999987 688899998864321       1223345677899988764499999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          124 DNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      ++..+++|||++|++|.+++..    ...+++..++.++.|++.||.|||+ .+++|+||+|+||++   +..+.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence            9999999999999999888743    3468999999999999999999996 689999999999999   4566799999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      ||.+.............|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+........  ..
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Cc
Confidence            999987655444455678999999998875 589999999999999999999999988777766666665544321  12


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..+++.+.++|.+||+.||++||++.|+..+
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3578999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-41  Score=305.13  Aligned_cols=240  Identities=18%  Similarity=0.280  Sum_probs=193.1

Q ss_pred             ceecccCCeEEEEEEECCCCcE-------EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           57 RELGRGEFGVTYLCIDRDTREL-------LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~-------~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      +.||+|+||.||+|.++..+..       +|+|.+....   ....+.+.+|+.+++.+ +||||+++++++..++..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence            4699999999999998765443       8888775432   22346788899999998 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC-----CCCEEEeeccccc
Q 015352          130 VMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-----NSPLKAIDFGLSI  203 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~-----~~~vkl~Dfg~~~  203 (408)
                      ||||+++|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.     ...++++|||.+.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997654 5899999999999999999999999999999999999975432     1247999999987


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCC-CCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGV-PPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ...+.   ....+++.|+|||++.+  .++.++||||||+++|+|++|. .||......... .+......++    ...
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~----~~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLP----APK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCC----CCC
Confidence            65432   23467889999999875  4789999999999999999984 666555444332 2333222222    245


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +.++.+++.+||+.||++|||+.++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            6889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.5e-41  Score=299.97  Aligned_cols=228  Identities=25%  Similarity=0.348  Sum_probs=188.4

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCchHH
Q 015352           62 GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD  141 (408)
Q Consensus        62 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~  141 (408)
                      |.+|.||+|+++.+++.||+|.+.+..        ...+|...+... .||||+++++++.+.+.+|+||||++||+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999997542        122344444454 79999999999999999999999999999999


Q ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCc
Q 015352          142 RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM  221 (408)
Q Consensus       142 ~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~  221 (408)
                      ++.+...+++..+..++.|++.||.|||++||+||||||+||++   +.++.++++|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999   45667999999987654432  23345677899


Q ss_pred             chhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCC
Q 015352          222 APEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL  300 (408)
Q Consensus       222 aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  300 (408)
                      |||.+.+ .++.++|+||+|+++|+|++|..||.......      .....+  .....+++.++++|.+||+.||++||
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTL--NIPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------cccccc--CCcccCCHHHHHHHHHHccCCHHHhc
Confidence            9998864 58999999999999999999998875432210      011111  11235789999999999999999999


Q ss_pred             CH-----HHHhcCccc
Q 015352          301 TA-----KQVLEHPWL  311 (408)
Q Consensus       301 s~-----~~~l~h~~~  311 (408)
                      ++     .++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            86     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-40  Score=300.88  Aligned_cols=248  Identities=23%  Similarity=0.322  Sum_probs=204.5

Q ss_pred             ccceEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .++|.+.+.||+|+||.||+|.+...   ...+|+|.+....  .....+.+.+|+.+++.+ +||||+++++++.+. .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~-~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITEN-P   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcCC-C
Confidence            35688999999999999999987654   3468999876432  123456788999999999 899999999998764 5


Q ss_pred             EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++   ..+.+||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence            789999999999999997754 589999999999999999999999999999999999994   4567999999998765


Q ss_pred             CCCCcee--cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGERFS--EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .......  ...+++.|+|||.+.. .++.++||||||+++|++++ |..||.+.+..+....+..+...   .....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence            4332221  2234467999998864 58999999999999999986 99999888877776666654322   2235678


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+.++|.+||..+|.+|||+.+++.
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.1e-40  Score=297.91  Aligned_cols=247  Identities=21%  Similarity=0.339  Sum_probs=205.2

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|++.+.||+|+||.||+|.+. .+..+|+|.+....    .....+.+|+.+++.+ +|+||+++++.+.+ ...
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCe
Confidence            35678999999999999999999865 45569999876432    2346788999999999 89999999999988 778


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      +++|||+++++|.+++.+.  ..++...+..++.|++.||.|||+.|++|+||+|+||++   +..+.+||+|||.+...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVI  152 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeec
Confidence            9999999999999999763  347888999999999999999999999999999999999   45678999999998765


Q ss_pred             CCCCce--ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ......  ....++..|+|||.+.. .++.++|+|||||++|++++ |..||.+.+.......+..+..   .+.....+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCP  229 (260)
T ss_pred             cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCcccCC
Confidence            432211  12235567999998875 58889999999999999998 9999998877777666655432   22335688


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHH
Confidence            99999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-40  Score=298.77  Aligned_cols=240  Identities=25%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||.||++.  .+++.+|+|.+....     ....+.+|+.+++.+ +|||++++++++..+. .+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~-~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKL-HHKNLVRLLGVILHNG-LYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCCC-cEEE
Confidence            579999999999999999996  468889999986432     245788999999999 9999999999987654 7899


Q ss_pred             EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      |||++|++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence            99999999999997653  47899999999999999999999999999999999999   45667999999998764322


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                        ......+..|+|||.+.+ .++.++|+||||+++|+|++ |..||...+..+....+.++..   ......+++.+.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---MEPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---CCCCCcCCHHHHH
Confidence              122334567999998864 68999999999999999997 9999988887777776665432   2223568899999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++.+||+.+|++||++++++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-40  Score=304.63  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=197.4

Q ss_pred             eEecceecccCCeEEEEEEE----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--Ce
Q 015352           53 YLVDRELGRGEFGVTYLCID----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~  126 (408)
                      |.+.+.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence            57889999999999999974    4568899999986432  233356789999999999 999999999998875  67


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .++||||++|++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++   .++.++|+|||++...
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCcccccc
Confidence            89999999999999998765 3589999999999999999999999999999999999994   4667999999998865


Q ss_pred             CCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH---------------HHHHHHH
Q 015352          206 KPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---------------QGVAQAI  265 (408)
Q Consensus       206 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------------~~~~~~i  265 (408)
                      .....    .....++..|+|||.+.+ .++.++|||||||++|+|+++..|+.....               ......+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            43321    123456778999998765 689999999999999999998776532111               1111111


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..+.   ..+.+..++..+.+|+.+||+.+|++|||+.+++++
T Consensus       240 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         240 EEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1111   122235688999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=324.28  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=199.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-----
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----  125 (408)
                      .-|...+.||+|+||.||+++++.+|+.||||.+.+...  ....+..-+|+++|++| +|||||+++++-++..     
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccc
Confidence            456678899999999999999999999999999976542  33467888999999999 7999999998876544     


Q ss_pred             -eEEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecc
Q 015352          126 -AVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFG  200 (408)
Q Consensus       126 -~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg  200 (408)
                       ...+|||||.||+|...+.+   ...+++.+...++..+..||.|||++||+||||||.||++.... .....||+|||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence             56899999999999999965   34699999999999999999999999999999999999987643 33446999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhh--ccCCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCC-----
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGL-----  269 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~-----  269 (408)
                      .|+....+..+.+.+||+.|.+||+..  +.|+..+|.||+||++|++.||..||-...    ..++...+....     
T Consensus       170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            999999999999999999999999997  468999999999999999999999995432    222333332221     


Q ss_pred             ----------cccC--CCCCCCCCH----HHHHHHHHhcCCCcCCCC
Q 015352          270 ----------IDFK--RDPWPNVSE----SAKSLVRQMLEPDPKLRL  300 (408)
Q Consensus       270 ----------~~~~--~~~~~~~~~----~~~~li~~~l~~dp~~R~  300 (408)
                                +.+.  .+....+++    .+...+..+|..+|.+|.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                      1111  111112333    345677888999999998

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.8e-40  Score=301.05  Aligned_cols=245  Identities=26%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             ceecccCCeEEEEEEECCCC------cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           57 RELGRGEFGVTYLCIDRDTR------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +.||+|+||.||+|.+...+      ..+|+|.+.+...  ......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEE
Confidence            36899999999999886543      6799998864321  23356788999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC--CCCCEEEeeccc
Q 015352          131 MELCEGGELFDRIVAR-------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGL  201 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~--~~~~vkl~Dfg~  201 (408)
                      |||++|++|.+++...       ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++  ....++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999998652       2378899999999999999999999999999999999997543  233799999999


Q ss_pred             ccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCC
Q 015352          202 SIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP  276 (408)
Q Consensus       202 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (408)
                      +........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+..+..   ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR---LQK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc---cCC
Confidence            876533221   122345678999998874 68999999999999999998 9999988777666665544321   122


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...+|..+.++|.+||..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3467899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=310.02  Aligned_cols=264  Identities=31%  Similarity=0.470  Sum_probs=220.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeecccc-C---ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-R---TAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-  122 (408)
                      .+.++|.++.+||+|||+.||+|.+....+.||+|+-...+- +   ...-.+...+|..|.+.| +||.||++|++|. 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSL  538 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeee
Confidence            466899999999999999999999999999999998765432 1   122234567899999999 9999999999996 


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      +.+.+|-|+|||+|.+|.-|++.+..++|.+++.|+-||+.||.||....  |||-||||.|||+.+....+.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            55678999999999999999999999999999999999999999999874  9999999999999988888999999999


Q ss_pred             cccccCCCC--------ceecccCCCCCcchhhhh-c----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHH--H
Q 015352          201 LSIFFKPGE--------RFSEIVGSPYYMAPEVLK-R----NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQ--A  264 (408)
Q Consensus       201 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~-~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~--~  264 (408)
                      +++.+....        ..+...||.+|++||.+. +    ..+.++||||+|||+|..+.|+.||.....+ .+++  .
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            999875432        224568999999999874 2    3778999999999999999999999765333 2221  1


Q ss_pred             HH-cCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          265 IL-RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       265 i~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      |+ ...+.|+..  +.+++++++||++||+.--+.|.+..++..||+|...
T Consensus       699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            22 222444443  5789999999999999999999999999999999753

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.7e-40  Score=298.65  Aligned_cols=244  Identities=21%  Similarity=0.276  Sum_probs=192.3

Q ss_pred             ceecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           57 RELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ......+.+|+.+++.+ +||||+++++++.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999864  3556799998865432  22345788899999999 9999999999999999999999999


Q ss_pred             CCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          135 EGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       135 ~g~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ++|+|.+++....     ..++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence            9999999986532     35677888999999999999999999999999999999   456779999999986543222


Q ss_pred             c---eecccCCCCCcchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH-cCCcccCCCC
Q 015352          210 R---FSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL-RGLIDFKRDP  276 (408)
Q Consensus       210 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~-~~~~~~~~~~  276 (408)
                      .   .....+++.|+|||++.+        .++.++|+||+|+++|+|++ |..||......+...... ......+.+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   123456788999998853        25789999999999999996 999998766555443322 2222222222


Q ss_pred             C-CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          277 W-PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       277 ~-~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      . ...++.+.+++.+|+ .+|++|||+++++.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            2 246788999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.1e-41  Score=282.01  Aligned_cols=256  Identities=28%  Similarity=0.538  Sum_probs=213.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--Ce
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NA  126 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~  126 (408)
                      -.++|++.+.+|+|.|+.||.|++..+++.++||++..      ...+.+.+|+.||+.|.++|||++++++..+.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            45789999999999999999999999999999999853      23578899999999998899999999998764  56


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ..+|+||+.+.+.....   ..++.-.++.++.+|+.||.|||+.||+|||+||.|++++  .....++|+|||+|.+.-
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcC
Confidence            78999999887665443   3478889999999999999999999999999999999996  345679999999999999


Q ss_pred             CCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCC-------------c
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-------------I  270 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~-------------~  270 (408)
                      ++......+.+..|-.||++..  .|+..-|+|||||++..|+..+.||. +.+..+.+..|-.-.             +
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            9998888889999999999864  59999999999999999999998874 444444443331110             0


Q ss_pred             -----------ccCCCCCC---------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          271 -----------DFKRDPWP---------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       271 -----------~~~~~~~~---------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                 ......|.         -.++++.||+.++|..|.++|+|+.|++.||||....
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                       11112221         2579999999999999999999999999999997644

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-40  Score=301.09  Aligned_cols=239  Identities=17%  Similarity=0.205  Sum_probs=191.2

Q ss_pred             eecccCCeEEEEEEECCC------------------------CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC
Q 015352           58 ELGRGEFGVTYLCIDRDT------------------------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS  113 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~------------------------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~  113 (408)
                      .||+|+||.||+|....+                        ...|++|++....   ......+.+|+.+++.+ +|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l-~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQV-SHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcC-CCCC
Confidence            699999999999975322                        2358888875432   22245678899999998 9999


Q ss_pred             eeEEeeEEEeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC---
Q 015352          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK---  189 (408)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~---  189 (408)
                      |+++++++.+++..++||||+++|+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999988865 46689999999999999999999999999999999999996432   


Q ss_pred             -CCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHH-hhCCCCCCCCCHHHHHHHH
Q 015352          190 -ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYIL-LCGVPPFWAESEQGVAQAI  265 (408)
Q Consensus       190 -~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l-~~g~~pf~~~~~~~~~~~i  265 (408)
                       ....+|++|||.+......   ....++..|+|||.+.+  .++.++|||||||++|++ ++|..||......+.... 
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-  233 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-  233 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence             2335899999987654322   22357888999998864  589999999999999998 479999987765544332 


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .......+    ...++.+.++|.+||+.+|++|||+.+++++
T Consensus       234 ~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22222222    2346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=308.85  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=198.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-e
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-A  126 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~  126 (408)
                      ...+.|.-...||+|+||.||+|.... |..||||.+.......   ..+|.+|+.++.++ +|||+++++++|.+.+ +
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRL-RHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcC-CCcCcccEEEEEecCCce
Confidence            344678778899999999999998765 4889999776443221   35599999999999 7999999999999988 5


Q ss_pred             EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          127 VHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHG---VIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      .++|+||+++|+|.+++....  .+++.....|+.+++.||.|||...   |+||||||+|||+   +++...||+|||+
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGL  223 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGL  223 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccC
Confidence            999999999999999998765  8999999999999999999999864   9999999999999   6788899999999


Q ss_pred             ccccCC-CCceecc-cCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCC---HHHHHH----HHHcCCcc
Q 015352          202 SIFFKP-GERFSEI-VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQ----AILRGLID  271 (408)
Q Consensus       202 ~~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~----~i~~~~~~  271 (408)
                      |..... .....+. .||.+|+|||... +..+.++||||||++|.||+||+.|.....   ......    .+..+...
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~  303 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR  303 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh
Confidence            976654 4333333 8999999999986 579999999999999999999998876432   111111    22221111


Q ss_pred             -cCCCCC--CCCC-----HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          272 -FKRDPW--PNVS-----ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       272 -~~~~~~--~~~~-----~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                       +..+..  ...+     ..+..+..+|++.+|..||++.|+++
T Consensus       304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence             111111  1223     22557788999999999999999755

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.6e-40  Score=300.70  Aligned_cols=248  Identities=24%  Similarity=0.381  Sum_probs=196.1

Q ss_pred             cceEecceecccCCeEEEEEEE----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--C
Q 015352           51 DRYLVDRELGRGEFGVTYLCID----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--D  124 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~  124 (408)
                      .+|++.+.||+|+||.||+|..    ..++..||+|.+...   .....+.+.+|+++++.+ +||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC
Confidence            4789999999999999999973    457889999998643   233456788999999999 99999999997643  4


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ..+++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence            5789999999999999998764 468999999999999999999999999999999999999   456679999999998


Q ss_pred             ccCCCCce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHH---------------HHH
Q 015352          204 FFKPGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG---------------VAQ  263 (408)
Q Consensus       204 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------------~~~  263 (408)
                      ........    ....++..|+|||.+.+ .++.++||||||+++|+|++|..|+......-               ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            76433221    11123446999998875 58999999999999999999877764332110               001


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+......+  +....++.++.+|+.+||..+|++|||+.++++
T Consensus       237 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         237 ELLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            111111111  222467899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.9e-40  Score=297.52  Aligned_cols=244  Identities=21%  Similarity=0.294  Sum_probs=192.5

Q ss_pred             ceecccCCeEEEEEEECC--CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           57 RELGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.+ +||||+++++.+.....+|+||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence            368999999999996433  34568888775432  222345678899999998 9999999999999999999999999


Q ss_pred             CCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          135 EGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       135 ~g~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ++|+|.+++....     ..++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence            9999999987643     24677889999999999999999999999999999999   456779999999986543222


Q ss_pred             c---eecccCCCCCcchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcC-CcccCCCC
Q 015352          210 R---FSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG-LIDFKRDP  276 (408)
Q Consensus       210 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  276 (408)
                      .   .....+++.|+|||++..        .++.++||||+||++|+|++ |..||......+....+... ...++.+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            1   122345677999998742        46789999999999999999 88899877766655554433 22333222


Q ss_pred             -CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          277 -WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       277 -~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                       ...+++.+.+++..|+ .||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence             2357888999999998 59999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.5e-40  Score=297.90  Aligned_cols=237  Identities=19%  Similarity=0.214  Sum_probs=190.8

Q ss_pred             ceecccCCeEEEEEEECCCC----------cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           57 RELGRGEFGVTYLCIDRDTR----------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      +.||+|+||.||+|.+..++          ..+++|++....    .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcC-CCcchhheeeEEec-CC
Confidence            46899999999999998776          347777765332    1156788999999999 99999999999888 77


Q ss_pred             EEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC----CCCCEEEeeccc
Q 015352          127 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----ENSPLKAIDFGL  201 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~----~~~~vkl~Dfg~  201 (408)
                      .++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++    ....+||+|||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998765 689999999999999999999999999999999999996533    223699999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      +.....   .....++..|+|||.+.+   .++.++||||||+++|+|++ |..||...+..+....... ....+    
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~----  226 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLP----  226 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCC----
Confidence            886543   223456778999999864   48899999999999999999 6888876654333322221 11111    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ......+.++|.+||..+|.+|||+.++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            122378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-39  Score=295.76  Aligned_cols=242  Identities=22%  Similarity=0.352  Sum_probs=194.2

Q ss_pred             ceecccCCeEEEEEEECC---CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-eCCeEEEEEe
Q 015352           57 RELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-DDNAVHLVME  132 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~~~~~~lv~e  132 (408)
                      +.||+|+||.||+|.+..   .+..+|+|.+...  ......+.+.+|+.+++.+ +||||+++++++. .++..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence            468999999999998653   3457999987532  2233456788999999998 9999999999765 5667899999


Q ss_pred             ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC--
Q 015352          133 LCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--  209 (408)
Q Consensus       133 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~--  209 (408)
                      |+.+++|.+++.+. ...++..+..++.|++.||.|||+.+++||||||+|||+   +.++.+||+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence            99999999998764 346778888999999999999999999999999999999   456679999999987543221  


Q ss_pred             ---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          210 ---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       210 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                         ......+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||...+..+....+..+...   .....+++.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL---LQPEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCCCcCCHHH
Confidence               1122345678999998864 68999999999999999999 56778777766666666554321   1123568899


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+++.+||..+|++||++.++++
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-40  Score=296.43  Aligned_cols=240  Identities=19%  Similarity=0.227  Sum_probs=191.2

Q ss_pred             ceecccCCeEEEEEEECCC------------CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           57 RELGRGEFGVTYLCIDRDT------------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~------------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +.||+|+||.||+|+....            ...+++|.+....   ......+.+|+.+++.+ +||||+++++++..+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQV-SHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            4689999999999985422            2358888865432   22345778899999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC----CCCEEEeec
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE----NSPLKAIDF  199 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~----~~~vkl~Df  199 (408)
                      ...++||||+++++|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.    ...++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999998888654 56899999999999999999999999999999999999964321    123899999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhh--ccCCCchhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHHHcCCcccCCCC
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (408)
                      |++......   ....++..|+|||.+.  ..++.++|||||||++|+|+ +|..||......+.. .........    
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~----  228 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCML----  228 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccC----
Confidence            988654322   2346788899999886  35899999999999999997 588998776544432 233322221    


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ....++++.+||.+||+.||.+||++.+++++
T Consensus       229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            22346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-39  Score=302.70  Aligned_cols=249  Identities=21%  Similarity=0.282  Sum_probs=201.7

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCc----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .++|+..+.||+|+||.||+|.+..+|.    .+|+|.+.....  ......+.+|+.+++.+ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-
Confidence            3568889999999999999999887776    468887754322  22234678999999999 999999999998765 


Q ss_pred             eEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~  158 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARL  158 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEcccccccc
Confidence            4679999999999999987654 589999999999999999999999999999999999994   456799999999986


Q ss_pred             cCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          205 FKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       205 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ......   .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+.........+..+. .++  ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~  235 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLP--QPPI  235 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCC--CCCC
Confidence            543322   122345678999998875 68999999999999999997 999998776655544444332 222  2245


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+..+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=292.48  Aligned_cols=256  Identities=21%  Similarity=0.264  Sum_probs=211.9

Q ss_pred             EecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +-++.||.|+||+|++..|+.+|+..|||.|+....  ..+..+++.|.+...+-.+.||||++++..-.++..||.||+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            446789999999999999999999999999986654  334577888998887777899999999999999999999999


Q ss_pred             cCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          134 CEGGELFDRIV-----ARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       134 ~~g~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ++- +|..+.+     ++..++|..+..|....+.||.||.. .+|||||+||+|||+   +..+.|||||||.+.....
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHH
Confidence            954 6544332     34579999999999999999999985 589999999999999   6678899999999987655


Q ss_pred             CCceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCcccCCCC--CCCCC
Q 015352          208 GERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDP--WPNVS  281 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~--~~~~~  281 (408)
                      .-..+.-.|...|||||.+..   .|+.++|+||||++|||+.||+.||..-+ ..+.+.++..+..+.-...  .-.++
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence            444455578899999999863   49999999999999999999999996643 3455566666654432221  12578


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..+..+|.-||.+|-..||...+++++||+....
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            9999999999999999999999999999998754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-39  Score=301.28  Aligned_cols=251  Identities=14%  Similarity=0.154  Sum_probs=189.4

Q ss_pred             cccccceEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcH--------HHHHHHHHHHHhCCCCCCee
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDI--------DDVRREVAIMKHLPKNSSIV  115 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~  115 (408)
                      +...++|.+.+.||+|+||.||+|.+..+   +..+|+|+............        .....+...+..+ +|++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~   86 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP   86 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence            34557999999999999999999998877   66778876543321110000        1112233445566 899999


Q ss_pred             EEeeEEEeCC----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          116 SLKEACEDDN----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       116 ~~~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      ++++++....    ..++++|++.. ++.+.+......++..+..++.|++.||.|||+++|+||||||+|||+   +..
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~  162 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGN  162 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCC
Confidence            9998765543    45788888744 666666665567889999999999999999999999999999999999   456


Q ss_pred             CCEEEeecccccccCCCC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHH
Q 015352          192 SPLKAIDFGLSIFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGV  261 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~  261 (408)
                      +.++|+|||+|.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            679999999987653211        1123469999999999875 599999999999999999999999987632 221


Q ss_pred             --------HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          262 --------AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       262 --------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                              ...+..+..     ..+..++.+.+++..|+..+|++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                    122222221     23466899999999999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3e-39  Score=319.84  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=178.1

Q ss_pred             cccceEecceecccCCeEEEEEEECCC----CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA----  120 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~----  120 (408)
                      -.++|.+.+.||+|+||.||+|++..+    +..||+|.+.....     .+....|  .++.. .+.++..+...    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~-~~~~~~~~~~~~~~~  201 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRA-CPNSCADFVYGFLEP  201 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhh-chhhHHHHHHhhhcc
Confidence            456899999999999999999999988    99999998753211     1111111  11221 22222222211    


Q ss_pred             --EEeCCeEEEEEeccCCCchHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 015352          121 --CEDDNAVHLVMELCEGGELFDRIVARGH--------------------YTERAAAAVTRTIVEVVQLCHKHGVIHRDL  178 (408)
Q Consensus       121 --~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------------------~~~~~~~~i~~ql~~~l~~lH~~~ivH~di  178 (408)
                        ...+..+++|+||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              2456789999999999999998865421                    123456789999999999999999999999


Q ss_pred             CCCceEeecCCCCCCEEEeecccccccCCCC--ceecccCCCCCcchhhhhc-----------------------cCCCc
Q 015352          179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLKR-----------------------NYGPE  233 (408)
Q Consensus       179 kp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------------------~~~~~  233 (408)
                      ||+|||++.  ..+.+||+|||+|.......  ......+++.|+|||.+..                       .++.+
T Consensus       282 KP~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        282 KPQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CHHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            999999953  34679999999997653322  2345678999999996531                       13446


Q ss_pred             hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc-------CC----------CCCCCCCHHHHHHHHHhcCCCc
Q 015352          234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-------KR----------DPWPNVSESAKSLVRQMLEPDP  296 (408)
Q Consensus       234 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~~~~~~~li~~~l~~dp  296 (408)
                      +||||+||++|+|+++..|+... .......+......+       ..          +.+...+...++||.+||++||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            69999999999999987664322 111111111111100       00          0011223446699999999999


Q ss_pred             CCCCCHHHHhcCccccCCcC
Q 015352          297 KLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       297 ~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ++|||+.++|+||||+....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999987543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-39  Score=298.24  Aligned_cols=249  Identities=24%  Similarity=0.380  Sum_probs=200.5

Q ss_pred             cceEecceecccCCeEEEEEEEC----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--C
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDR----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--D  124 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~  124 (408)
                      +.|.+.+.||+|+||.||+|.+.    .++..+|+|++......  .....+.+|+++++.+ .||||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC
Confidence            46788899999999999999865    34889999998754332  3457889999999999 99999999999887  6


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ...+++|||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++   .++.++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEccccccc
Confidence            68999999999999999997754 589999999999999999999999999999999999994   55789999999998


Q ss_pred             ccCCCCce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHH--------------HHHH
Q 015352          204 FFKPGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG--------------VAQA  264 (408)
Q Consensus       204 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------------~~~~  264 (408)
                      ........    ....++..|+|||.+.+ .++.++||||||+++|+|++|..||.......              ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76532221    11234566999998864 68899999999999999999999986543221              1112


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ........+  ....++.++.+++.+||..+|++|||+.++++
T Consensus       238 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLKEGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHcCCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222222221  22456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=327.69  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=212.2

Q ss_pred             cceEecceecccCCeEEEEEEECCC-Cc----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDT-RE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      +.-.+.+.||+|+||.||.|....- |.    .||+|.+.+  ..+..+...|.+|..+|+.+ +||||+++++++-+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence            3456788999999999999986543 32    377787753  44566788999999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          126 AVHLVMELCEGGELFDRIVAR-------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      ..+|++|||.||+|..+|++.       ..++......++.+|++|++||+++++|||||...|+|+   +....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcc
Confidence            999999999999999999876       348899999999999999999999999999999999999   4558899999


Q ss_pred             cccccccCCCCceecc---cCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          199 FGLSIFFKPGERFSEI---VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      ||+|+.....+.+...   .-...|||||.+. +.++.++|||||||++||++| |..||.+.+..++..-+.++-   .
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R  922 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R  922 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c
Confidence            9999955433332211   2235799999987 579999999999999999999 999999999999988666665   3


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .++...+|+.+.+++..||+.+|++||++..+++
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            3444689999999999999999999999999987

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.9e-41  Score=309.92  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=218.1

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC-----CCCeeEEee
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-----NSSIVSLKE  119 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~i~~~~~  119 (408)
                      .++.+.++|.+....|+|-|++|.+|.+...|..||||+|....+    ..+.=++|++||++|..     .-|+++++.
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            466777899999999999999999999999999999999986542    22344679999999932     347999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          120 ACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       120 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      .|...+++|+|+|.+ ..+|.+.+++.|.   +....++.++.||+.||..|-..||+|.||||+|||++  .....+||
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKL  578 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKL  578 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeee
Confidence            999999999999998 4599999988654   88899999999999999999999999999999999996  44567999


Q ss_pred             eecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC
Q 015352          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (408)
                      ||||.|.....++ .+.+.-+..|+|||++.| .|+...|+||+||+||||+||+..|.+.+...++.-.+.....|+..
T Consensus       579 CDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  579 CDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             ccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            9999998876544 344455667999999887 79999999999999999999999999999888877766554433321


Q ss_pred             CC-------------------------------------------------CCCC-------HHHHHHHHHhcCCCcCCC
Q 015352          276 PW-------------------------------------------------PNVS-------ESAKSLVRQMLEPDPKLR  299 (408)
Q Consensus       276 ~~-------------------------------------------------~~~~-------~~~~~li~~~l~~dp~~R  299 (408)
                      ..                                                 +.++       ..+++|+.+||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            00                                                 0112       347899999999999999


Q ss_pred             CCHHHHhcCccccC
Q 015352          300 LTAKQVLEHPWLQN  313 (408)
Q Consensus       300 ~s~~~~l~h~~~~~  313 (408)
                      .|+.|+|.||||..
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999964

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.4e-39  Score=293.09  Aligned_cols=243  Identities=19%  Similarity=0.273  Sum_probs=191.3

Q ss_pred             eecccCCeEEEEEEECCC--CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           58 ELGRGEFGVTYLCIDRDT--RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      .||+|+||.||+|.....  ...+++|.+....  .....+.+.+|+.+++.+ +||||+++++.+.+....|+||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCC
Confidence            599999999999975433  3456677665432  123356889999999998 99999999999999999999999999


Q ss_pred             CCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC--
Q 015352          136 GGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--  209 (408)
Q Consensus       136 g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~--  209 (408)
                      +|+|.+++.+.    ...++..+..++.||+.||.|||+.+++||||||+|||+   +.++.+||+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence            99999998764    236677888999999999999999999999999999999   456779999999876432211  


Q ss_pred             -ceecccCCCCCcchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC-cccCCC-CC
Q 015352          210 -RFSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGL-IDFKRD-PW  277 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~-~~  277 (408)
                       ......+++.|+|||++..        .++.++|||||||++|+|++ |..||......+....+..+. .....+ ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1234467889999998742        35789999999999999997 577887777766666554432 222222 22


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+++.+.+++..|| .+|++||++.++++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            357889999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4e-39  Score=294.13  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=200.3

Q ss_pred             eEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC----
Q 015352           53 YLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----  125 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----  125 (408)
                      |.+.+.||+|+||.||+|.++   .++..+|+|++..... .....+.+.+|+.+++.+ +||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCc
Confidence            667889999999999999865   3578999999865432 333467788999999999 9999999999886532    


Q ss_pred             --eEEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          126 --AVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       126 --~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                        ..++++||+.+|+|..++...      ..++...+..++.|++.||.|||++||+||||||+||++   +.+..+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence              347899999999998887532      247889999999999999999999999999999999999   456779999


Q ss_pred             ecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCccc
Q 015352          198 DFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF  272 (408)
Q Consensus       198 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~  272 (408)
                      |||++........   .....+++.|++||.+.+ .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL-  234 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence            9999886543221   122345678999998865 58899999999999999999 89999888777666666544321 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                        ......+..+.+++.+||..+|++|||+.+++.
T Consensus       235 --~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         235 --KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-40  Score=316.99  Aligned_cols=276  Identities=26%  Similarity=0.412  Sum_probs=226.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-----e
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-----D  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~  123 (408)
                      ..+.|++.+.||.|.+|.||+++++.+|+..|+|+.....    ..-+++..|.++++.+.+|||++.++++|.     .
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            4567899999999999999999999999999999986432    223677889999999999999999999985     4


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ++.+|+|||||.|||.-++++.-  ..+.|..++.|++.++.||.+||.+.++|||||-.|||+   ..++.|||+|||.
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeee
Confidence            57899999999999999998763  568999999999999999999999999999999999999   4567799999999


Q ss_pred             ccccCCCC-ceecccCCCCCcchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          202 SIFFKPGE-RFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       202 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      +....... ...+.+|||.|||||++..      .|+..+|+||||++..||--|.+|+.+.-+...+-.|-+.. +...
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkL  248 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKL  248 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Cccc
Confidence            98875433 3456789999999999852      37789999999999999999999998876654444443332 1222


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhh
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNR  338 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (408)
                      ..+.+.+.++.+||..||.+|-.+||+..++|+|||+....      +.+++...++.....++
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~------~e~qir~~ik~~~~~~r  306 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP------NERQVRIQIKDHIDRSR  306 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc------cHHHHHHHHHHHHhhcc
Confidence            33567789999999999999999999999999999998332      44445444444444333

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=282.78  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=216.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+..||.-+..+|.|.- .|..|.+.-+++.||+|.+... +......++..+|..++..+ .|+||++++.+|-..
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQ   87 (369)
T ss_pred             cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCcc
Confidence            34567789999999999999 8999999999999999998766 44555677889999999999 999999999998543


Q ss_pred             ------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          125 ------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       125 ------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                            ...|+|||++++ +|.+.+..  .+....+..++.|++.|++|||+.||+||||||+||++   ..++.+||.|
T Consensus        88 ~~l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~d  161 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILD  161 (369)
T ss_pred             ccHHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeecc
Confidence                  468999999965 88887763  47888999999999999999999999999999999999   5677899999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc------
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID------  271 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~------  271 (408)
                      ||+|+.....-..+.++.|..|+|||++.+ +|...+||||+||++.||++|...|.+.+.-..+.++.+....      
T Consensus       162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            999987665556677889999999999875 6999999999999999999999999887665555554332211      


Q ss_pred             -------------------------cCCCCC-------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          272 -------------------------FKRDPW-------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       272 -------------------------~~~~~~-------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                                               ++...|       +.-+..+++++.+||..||++|.|++++|+|||++
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                     111111       12345689999999999999999999999999997

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.3e-38  Score=282.19  Aligned_cols=242  Identities=43%  Similarity=0.739  Sum_probs=207.5

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCchHHH
Q 015352           63 EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR  142 (408)
Q Consensus        63 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~  142 (408)
                      +||.||+|.+..+|..+|+|++........  .+.+.+|++.++.+ +|+|++++++.+......++++||+.+++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            589999999999999999999976543221  57889999999999 999999999999999999999999999999999


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcc
Q 015352          143 IVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA  222 (408)
Q Consensus       143 l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~a  222 (408)
                      +.....++...+..++.+++.++.+||+.+++|+||+|.||+++   .++.++|+|||.+.............++..|+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            98776689999999999999999999999999999999999994   457899999999988765544556678899999


Q ss_pred             hhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCC
Q 015352          223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL  300 (408)
Q Consensus       223 PE~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  300 (408)
                      ||.+. ..++.++|+||+|++++++++|..||.. .........+........ .....++..+.+++.+||..+|++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhcc
Confidence            99886 4688999999999999999999999987 555555555544443322 22222889999999999999999999


Q ss_pred             CHHHHhcCccc
Q 015352          301 TAKQVLEHPWL  311 (408)
Q Consensus       301 s~~~~l~h~~~  311 (408)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-39  Score=291.63  Aligned_cols=265  Identities=27%  Similarity=0.479  Sum_probs=205.7

Q ss_pred             cccccc-cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC----C---CCeeE
Q 015352           45 PKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK----N---SSIVS  116 (408)
Q Consensus        45 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~----h---~~i~~  116 (408)
                      .++.+. .||-+.+.||.|.|++||+|.+.++.+.||+|++.....    -.+....||.+|++++.    +   ..||+
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            466677 899999999999999999999999999999999975432    23566789999998843    2   35999


Q ss_pred             EeeEEEe----CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCC
Q 015352          117 LKEACED----DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKK  189 (408)
Q Consensus       117 ~~~~~~~----~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~  189 (408)
                      +++.|..    +.++++|+|++ |.+|..+|...  +.++...++.|++||+.||.|||.. ||||.||||+|||+...+
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence            9999974    56999999999 77999999875  4599999999999999999999965 999999999999962110


Q ss_pred             --------------------------------------------------------------------------------
Q 015352          190 --------------------------------------------------------------------------------  189 (408)
Q Consensus       190 --------------------------------------------------------------------------------  189 (408)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 015352          190 --------------------------------------------------------------------------------  189 (408)
Q Consensus       190 --------------------------------------------------------------------------------  189 (408)
                                                                                                      
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                                                                            


Q ss_pred             ---CCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC------HH
Q 015352          190 ---ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES------EQ  259 (408)
Q Consensus       190 ---~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~  259 (408)
                         ....|||+|||.|....  ..++.-+.|..|+|||++.+ .|++.+||||++|++|||.||...|...+      +.
T Consensus       386 ~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             CCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence               00126778888776642  34556678899999999887 79999999999999999999998884421      12


Q ss_pred             HHHHHHHcCCcccC-------------------------CCCCC-------------CCCHHHHHHHHHhcCCCcCCCCC
Q 015352          260 GVAQAILRGLIDFK-------------------------RDPWP-------------NVSESAKSLVRQMLEPDPKLRLT  301 (408)
Q Consensus       260 ~~~~~i~~~~~~~~-------------------------~~~~~-------------~~~~~~~~li~~~l~~dp~~R~s  301 (408)
                      ..+..|+.-....+                         ..+|+             .-..++.+|+.-||+.+|++|||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            22333322111111                         11221             12345779999999999999999


Q ss_pred             HHHHhcCccccCCcC
Q 015352          302 AKQVLEHPWLQNAKK  316 (408)
Q Consensus       302 ~~~~l~h~~~~~~~~  316 (408)
                      |.++|+|||+.....
T Consensus       544 A~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  544 AAQCLKHPWLNPVAG  558 (590)
T ss_pred             HHHHhcCccccCCCC
Confidence            999999999987543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=295.60  Aligned_cols=245  Identities=25%  Similarity=0.399  Sum_probs=205.1

Q ss_pred             ceEecceecccCCeEEEEEEECC--CCc--EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRD--TRE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~--~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...+.+.||.|.||.||+|....  .|.  -||||.-..+.  +..+.+.|..|..+|+.+ +||||+++++++.+. ..
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ce
Confidence            34556789999999999997543  233  47788765433  344578999999999999 999999999999875 58


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |||||+++-|.|..+++.+ ..++......++.||+.||.|||+.++|||||-..|||+.+   ..-|||+|||+++...
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYLE  542 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhcc
Confidence            9999999999999999876 45899999999999999999999999999999999999954   4459999999999987


Q ss_pred             CCCceecccC--CCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGERFSEIVG--SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ....+....|  ..-|||||.+. .+++.++|||-|||++||++. |..||.+-...++.-.+.+|...   +..+++|+
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl---P~P~nCPp  619 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL---PCPPNCPP  619 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC---CCCCCCCh
Confidence            6665444344  34599999987 579999999999999999776 99999998877777666666532   33468999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHh
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVL  306 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l  306 (408)
                      .+..|+.+||..+|.+||++.++.
T Consensus       620 ~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  620 ALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHHHHhccCcccCCcHHHHH
Confidence            999999999999999999987764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=299.89  Aligned_cols=259  Identities=21%  Similarity=0.286  Sum_probs=186.9

Q ss_pred             cccceEecceecccCCeEEEEEEEC----------------CCCcEEEEEEeeccccCCh-----------hcHHHHHHH
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDR----------------DTRELLACKSISKRKLRTA-----------VDIDDVRRE  101 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E  101 (408)
                      -.++|.+.+.||+|+||+||+|...                ..++.||+|.+........           ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                2456799999864321100           011223447


Q ss_pred             HHHHHhCCCCCC-----eeEEeeEEEe--------CCeEEEEEeccCCCchHHHHHhCC---------------------
Q 015352          102 VAIMKHLPKNSS-----IVSLKEACED--------DNAVHLVMELCEGGELFDRIVARG---------------------  147 (408)
Q Consensus       102 ~~~l~~l~~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~g~~L~~~l~~~~---------------------  147 (408)
                      +.++.++ +|++     +++++++|..        .+..++|+||+++++|.+++....                     
T Consensus       223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777 4443     3566666642        356899999999999999886421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceec--ccCCCCCcc
Q 015352          148 ---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPYYMA  222 (408)
Q Consensus       148 ---~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~--~~gt~~y~a  222 (408)
                         .+++..++.++.|++.+|.|||+.+|+||||||+|||++   .++.+||+|||++...........  ..+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence               234567889999999999999999999999999999994   456799999999876543332222  234789999


Q ss_pred             hhhhhcc---------------------CC--CchhHHHHHHHHHHHhhCCC-CCCCCCHH-----------HHHHHHHc
Q 015352          223 PEVLKRN---------------------YG--PEIDIWSAGVILYILLCGVP-PFWAESEQ-----------GVAQAILR  267 (408)
Q Consensus       223 PE~~~~~---------------------~~--~~~DiwslG~il~~l~~g~~-pf~~~~~~-----------~~~~~i~~  267 (408)
                      ||.+...                     |+  .+.|+||+||++|+|++|.. ||.+....           ...+.+..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            9987421                     11  24799999999999999876 66432111           11111222


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcCCCc---CCCCCHHHHhcCccccC
Q 015352          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDP---KLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~R~s~~~~l~h~~~~~  313 (408)
                      ..+.  ...+...++.+++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       459 ~~~~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        459 QKYD--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cCCC--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            2233  33467789999999999999876   68999999999999964

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=287.54  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++..+++.||+|.||.|.+|.-. .+..||+|.++...  .......|.+|+++|.+| +||||+.++++|..++.+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHH
Confidence            345678999999999999999754 36889999987543  333468899999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||++.|+|.+++.++..  ........|+.||+.|++||.+.++|||||.+.|+|+   +++.++||+|||+++....
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccccc
Confidence            9999999999999988733  3455667799999999999999999999999999999   7888999999999997766


Q ss_pred             CCcee---cccCCCCCcchhhh-hccCCCchhHHHHHHHHHHHh--hCCCCCCCCCHHHHHHHHHcCCcccCC----CCC
Q 015352          208 GERFS---EIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILL--CGVPPFWAESEQGVAQAILRGLIDFKR----DPW  277 (408)
Q Consensus       208 ~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~  277 (408)
                      ++.+.   ..+-..+|||||.+ .++++.++|+|++|+++||++  +...||...++.++.++...-......    ...
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            55432   23456789999966 478999999999999999965  578899888877776665433221111    122


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +-++..+.+++.+||..|.++|||.+++..
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            457889999999999999999999999854

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=303.17  Aligned_cols=248  Identities=24%  Similarity=0.388  Sum_probs=215.5

Q ss_pred             ceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ...|.+.||.|.||.||+|+.+..|+   .||||.+....  .......|+.|+.||-++ +||||+++.++......+.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeE
Confidence            34678899999999999999887664   59999986433  344578899999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||+|||++|+|..+|..+ +.++..+...+++.|+.|++||-+.|.|||||-..|||+   +.+..+|++|||+++....
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeeccc
Confidence            999999999999999875 679999999999999999999999999999999999999   6678899999999997744


Q ss_pred             CC--ceecccC--CCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          208 GE--RFSEIVG--SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       208 ~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..  .+++.-|  ..+|+|||.+. ..++.++||||+|++|||.++ |..|||+.+.+++++.|.++..   .++...+|
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR---LPpPmDCP  860 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR---LPPPMDCP  860 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC---CCCCCCCc
Confidence            33  2223223  35799999987 579999999999999999665 9999999999999999988753   33335789


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..+.+|+..||++|-.+||.+.||+.+
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=303.58  Aligned_cols=250  Identities=28%  Similarity=0.422  Sum_probs=200.3

Q ss_pred             eEecceecccCCe-EEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           53 YLVDRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        53 y~~~~~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      |.-.+.+|.|+.| .||+|..  .|+.||||.+-...      ..-..+|+..|+.-.+||||++++..-.+....||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            3445778999998 6899976  58899999885322      3456799999999888999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC--CCCCEEEeeccccccc
Q 015352          132 ELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLSIFF  205 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~----~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~--~~~~vkl~Dfg~~~~~  205 (408)
                      |+|.. +|.+++...+.    ......+.++.|++.||++||+.+||||||||.||||+..+  ....++|+|||+++..
T Consensus       583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            99966 99999987421    11144578899999999999999999999999999998642  3357899999999987


Q ss_pred             CCCC----ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          206 KPGE----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       206 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ..+.    ...+..||-+|+|||++.. .-+.++||+|+||++|+.++| .+||.+...  .-.+|+.+......-.. .
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~-~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEP-L  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeecc-C
Confidence            6544    2456689999999999986 456789999999999998885 999966443  33567766654332211 1


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ...++++||.+|++++|..||+|.++|.||+|=..
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            11289999999999999999999999999999553

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=294.25  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=214.1

Q ss_pred             cceEecceecccCCeEEEEEEECCC-C--cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDT-R--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ++..+.++||+|+||.|++|.++.. |  ..||||.+.......  ....|++|+.+|.+| +|||++++|++.-+ ...
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhc-cCcceeEEeeeecc-chh
Confidence            4556788999999999999998853 3  359999998665432  578999999999999 99999999999988 678


Q ss_pred             EEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|||++++|+|.+.|.+  ...+.......++.||+.|+.||.++++|||||-..|+|+..   ...|||+|||+.+.+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceecc
Confidence            899999999999999987  345888889999999999999999999999999999999954   556999999999988


Q ss_pred             CCCCceeccc----CCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          206 KPGERFSEIV----GSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       206 ~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ..++..-...    -...|+|||.++ ..++.++|+|++||++|||++ |..||.+.....++++|-.+..- +.  .+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL-pR--Pk~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL-PR--PKY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-CC--CCC
Confidence            7666543322    234599999998 479999999999999999998 89999999999998888755432 22  246


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      +|+++.+++..||..+|.+|||+..|.+.-++..
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            8999999999999999999999999976555543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=287.74  Aligned_cols=244  Identities=23%  Similarity=0.392  Sum_probs=210.5

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      ...+...||.|.||.||.|.++...-.||||.+..+    ....+.|+.|+.+|+.+ +|||+|+++++|..+-.+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEE
Confidence            344567899999999999999999999999998644    33578999999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          132 ELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||..|+|.+|+.+..  .++.-....++.||..|+.||..+++|||||-..|+|+   +++..||++|||+++.+... 
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgD-  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGD-  418 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCC-
Confidence            9999999999998754  37777778899999999999999999999999999999   78888999999999987643 


Q ss_pred             ceecccCC---CCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          210 RFSEIVGS---PYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       210 ~~~~~~gt---~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      .++...|.   .-|.|||-+. +.++.++|||+|||+|||+.| |..||.+-+..+++.-+.++. ..  +....+++..
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-RM--~~PeGCPpkV  495 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-RM--DGPEGCPPKV  495 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-cc--cCCCCCCHHH
Confidence            34444443   4599999886 579999999999999999998 999999988877776665553 22  3335899999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+|++.||+..|.+||++.|+-+
T Consensus       496 YeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  496 YELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHhcCCcccCccHHHHHH
Confidence            99999999999999999998843

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=271.12  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=208.5

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-----e
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----A  126 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~  126 (408)
                      +.+-.+.||.|+||.||.+.+..+|+.||+|.+.. -+..-...+.+.+|+.+|..+ +|.|++..+++.+...     .
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHH
Confidence            34456789999999999999999999999998853 223334457889999999999 9999999998876543     5


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+++|++.. +|...+..-..++.+.++-++.||+.||+|||+.+|.||||||.|.|+   +.+..+||||||+++...
T Consensus       132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccc
Confidence            6889999965 888888888889999999999999999999999999999999999999   667889999999998765


Q ss_pred             CCC--ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC---------
Q 015352          207 PGE--RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---------  273 (408)
Q Consensus       207 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---------  273 (408)
                      ..+  ..+..+-|.+|+|||++.+  .|+.+.||||+|||+.||+..+..|...++-+.++.|..-.....         
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            433  3444567889999999976  699999999999999999999999987776665555533221110         


Q ss_pred             ------------CCCC---------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          274 ------------RDPW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       274 ------------~~~~---------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                  .+..         ..-..+..+++..+|..||++|.+..+++.|+++...
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                        0000         1223467789999999999999999999999998764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.9e-37  Score=275.77  Aligned_cols=260  Identities=29%  Similarity=0.480  Sum_probs=205.8

Q ss_pred             cccccccceEecceecccCCeEEEEEEECC---CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....+...|.++..||.|+|++||+|.+..   .++.||+|.+.....     ..++.+|+++|..+.++.||+++.+++
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhh
Confidence            345677789999999999999999999887   788999999975432     457899999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ..+++..+|+||++..+..++...   ++...+..+++.++.||.++|.+|||||||||.|+|++.  ..+.-.|+|||+
T Consensus       105 rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgL  179 (418)
T KOG1167|consen  105 RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGL  179 (418)
T ss_pred             ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechh
Confidence            999999999999999888777643   678999999999999999999999999999999999974  455678999999


Q ss_pred             ccccC-----------------C--CC--------------------------ceecccCCCCCcchhhhhc--cCCCch
Q 015352          202 SIFFK-----------------P--GE--------------------------RFSEIVGSPYYMAPEVLKR--NYGPEI  234 (408)
Q Consensus       202 ~~~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~  234 (408)
                      |....                 +  +.                          ......||++|+|||++..  ..+++.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            87210                 0  00                          0012469999999999864  588999


Q ss_pred             hHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHH--------------HcCC---------------------------cc-
Q 015352          235 DIWSAGVILYILLCGVPPFWAESE-QGVAQAI--------------LRGL---------------------------ID-  271 (408)
Q Consensus       235 DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i--------------~~~~---------------------------~~-  271 (408)
                      ||||.|+|+..+++++.||....+ ......+              ..+.                           .. 
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            999999999999999999843211 1100000              0000                           00 


Q ss_pred             ----cCCCCC-CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          272 ----FKRDPW-PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       272 ----~~~~~~-~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                          .....| ...+..+.+|+.+||+.||.+|+|++++|+||||...
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence                001111 2245589999999999999999999999999999854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=242.44  Aligned_cols=211  Identities=23%  Similarity=0.335  Sum_probs=176.5

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      ...-+..||+|++|.|-+.+|..+|...|+|.+...- . ....+++++|+++..+-..+|.+|.+++.+-.+..++|.|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            3344677999999999999999999999999997542 2 3345678889998887778999999999999999999999


Q ss_pred             eccCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          132 ELCEGGELFDRI----VARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       132 e~~~g~~L~~~l----~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |.++- ||..+.    ++.+.++|..+-+|+..++.||.|||++ .++|||+||+|||+   +..++||+||||.+....
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeeh
Confidence            99965 665443    3457799999999999999999999986 89999999999999   678889999999998776


Q ss_pred             CCCceecccCCCCCcchhhhhc-----cCCCchhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcC
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-----NYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRG  268 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~  268 (408)
                      ..-..+-..|...|||||.+..     .|+.++||||||+++.||.+++.||.. .++.+.+.++...
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            5443344568889999998852     589999999999999999999999954 4566666666654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=290.74  Aligned_cols=261  Identities=27%  Similarity=0.453  Sum_probs=221.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .+..++|.+...+|+|.||.||+|+++.+++..|+|++....   ..+...+.+|+-+++.. +||||+.+++.|...+.
T Consensus        11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecC-CCcChHHHHhhhhhhcC
Confidence            367789999999999999999999999999999999997553   44567788999999998 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      .++.||||.||+|.+...-.+++++.++..+.+..+++|+|||+.|=+|||||-.|||++   +.+.+|+.|||.+..+.
T Consensus        87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQIT  163 (829)
T ss_pred             cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhh
Confidence            999999999999999887788999999999999999999999999999999999999994   56679999999987654


Q ss_pred             CC-CceecccCCCCCcchhhh----hccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc-ccCCCCCCCC
Q 015352          207 PG-ERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPWPNV  280 (408)
Q Consensus       207 ~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~  280 (408)
                      .. .+...++|||+|||||+-    .+.|...+|||++|++..|+---.+|..+.-+.....-.....+ +...+.....
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kw  243 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKW  243 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccc
Confidence            22 234567899999999975    35799999999999999999888888655544443333333322 2333344567


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ++.+-+|++.+|.++|++|||+..+|.|||+...
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            8999999999999999999999999999998764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.7e-36  Score=317.23  Aligned_cols=240  Identities=22%  Similarity=0.265  Sum_probs=183.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ..|...+.||+|+||.||+|++..+|..||+|.+.....       ....|+++++++ +||||+++++++.+++..|+|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEE
Confidence            456667789999999999999999999999998864321       113468899999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH---KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |||++||+|.+++..   +++..+..++.|++.||.|||   +.+|+||||||+||+++   .....++. ||.+.....
T Consensus       762 ~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        762 HEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccccccc
Confidence            999999999999853   788999999999999999999   66999999999999995   33445554 555433221


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH--HHHHH---HHHcCC-----cccCC--
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQ---AILRGL-----IDFKR--  274 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~---~i~~~~-----~~~~~--  274 (408)
                      .   ....||+.|+|||++.+ .++.++||||+||++|||+||+.||.....  .....   ......     .+...  
T Consensus       835 ~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 D---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             C---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence            1   23368899999998875 699999999999999999999999854211  11111   111000     00000  


Q ss_pred             --CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          275 --DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       275 --~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                        ........++.+++.+||+.||++|||+.|+++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              0000112356789999999999999999999874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=281.85  Aligned_cols=199  Identities=31%  Similarity=0.537  Sum_probs=176.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh-----cHHHHHHHHHHHHhCCC---CCCeeEEeeEEEe
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----DIDDVRREVAIMKHLPK---NSSIVSLKEACED  123 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~---h~~i~~~~~~~~~  123 (408)
                      .|...+.+|.|+||.|++|.++.....|+||.|.++++....     ..-.+-.||+||..| +   |+||++++++|++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFFED  640 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhheeec
Confidence            488999999999999999999999999999999887654221     222355699999999 5   9999999999999


Q ss_pred             CCeEEEEEecc-CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELC-EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~-~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      ++++|++||-- +|.+|++++..+..++|.++..|++|+..|+++||+.||||||||-+||.+   +.++-+||+|||.|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence            99999999976 456999999999899999999999999999999999999999999999999   67788999999998


Q ss_pred             cccCCCCceecccCCCCCcchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCC
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWA  255 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~  255 (408)
                      ...+. ..+..++||..|.|||++.|.  .+...|||++|++||.++....||+.
T Consensus       718 a~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            87654 467788999999999999874  57889999999999999999999863

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=255.62  Aligned_cols=261  Identities=26%  Similarity=0.379  Sum_probs=210.6

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEee-EEEe
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE-ACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~-~~~~  123 (408)
                      +.-.+.+.|.|.+.||+|.||.+-+|.|+.++..+|+|.+++..    ...+.|.+|...--.|+.|.||+.-|+ .|+.
T Consensus        18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            55678899999999999999999999999999999999998653    336789999998888888999998776 4889


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      .+.+++++||++-|+|...+... .+.|.....++.|++.||.|+|++++||||||.+|||+-..+ ..+|||||||.+.
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~  171 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTR  171 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccc
Confidence            99999999999999998887664 588999999999999999999999999999999999997643 4589999999887


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCcccC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFK  273 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~  273 (408)
                      ....  .....--+..|.+||++..      ...+.+|+|.||+++|.++||.+||+...    ..--..+...+.-.-.
T Consensus       172 k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  172 KVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             ccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence            5432  1222233456999998742      35788999999999999999999996422    1122233333333333


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCC---CCHHHHhcCccccC
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLR---LTAKQVLEHPWLQN  313 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R---~s~~~~l~h~~~~~  313 (408)
                      +..+..+++.+..+.++-|..+|++|   .++..-....|...
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            44567789999999999999999999   66666666778754

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=282.02  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=206.8

Q ss_pred             ceEecceecccCCeEEEEEEECC-------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +..+.+.||+|+||.|++|.-..       ....||+|.......  ..+.+.+..|+++|+.+..||||+.+++++...
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            33566799999999999997431       145699998865433  256788999999999998999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC
Q 015352          125 NAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK  188 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~  188 (408)
                      +.+++|+||+..|+|.+++...+                .++......++.||+.|++||++.+++||||-..|||+   
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---
Confidence            99999999999999999998766                38888999999999999999999999999999999999   


Q ss_pred             CCCCCEEEeecccccccCCCCceec--ccC--CCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCC-HHHH
Q 015352          189 KENSPLKAIDFGLSIFFKPGERFSE--IVG--SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAES-EQGV  261 (408)
Q Consensus       189 ~~~~~vkl~Dfg~~~~~~~~~~~~~--~~g--t~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~-~~~~  261 (408)
                      ..+..+||+|||+|+.......+..  ..|  ...|||||.+.. .|+.++||||+|++|||+++ |..||.+.. ..++
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            5567899999999997655544432  222  234999999986 69999999999999999998 899998855 6666


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.+..|....   .....++++.++++.||+.+|++||+..++.+
T Consensus       532 ~~~l~~G~r~~---~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 LEFLKEGNRME---QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHhcCCCCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            66666654322   22467999999999999999999999999876

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-34  Score=256.34  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=194.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhC-CCCCCeeEEeeEEEeC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL-PKNSSIVSLKEACEDD  124 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~~  124 (408)
                      ...+..+..+.+.||+|.||.||+|.++  |+.||||++...      +.+...+|.+|.+.. .+|+||+.+++.-..+
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            4567788899999999999999999986  888999999643      356777888887643 4899999998775433


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCceEeecCCCCC
Q 015352          125 ----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH--------GVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       125 ----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~ivH~dikp~NIl~~~~~~~~  192 (408)
                          .++|+|++|.+.|||+++|.+ ..++......++..++.||++||..        .|.|||||..|||+   ..++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCC
Confidence                378999999999999999987 5799999999999999999999953        49999999999999   6778


Q ss_pred             CEEEeecccccccCCCC-----ceecccCCCCCcchhhhhccCC-------CchhHHHHHHHHHHHhhC----------C
Q 015352          193 PLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVLKRNYG-------PEIDIWSAGVILYILLCG----------V  250 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il~~l~~g----------~  250 (408)
                      .+-|+|+|+|.......     .....+||.+|||||++.....       ..+||||||.++||+...          .
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            89999999998765442     2345689999999999975432       358999999999998752          4


Q ss_pred             CCCCCC-----CHHHHHHHHHcCCccc-CCCCCCCCC--HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          251 PPFWAE-----SEQGVAQAILRGLIDF-KRDPWPNVS--ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       251 ~pf~~~-----~~~~~~~~i~~~~~~~-~~~~~~~~~--~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +||.+.     +..++.+-+.-..+.. .+..|...+  ..+..+++.||..||.-|.|+--+.+
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            788553     3334433333222222 222333322  23567899999999999999876644

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=257.05  Aligned_cols=243  Identities=25%  Similarity=0.373  Sum_probs=190.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhC-CCCCCeeEEeeEEEeCC----
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL-PKNSSIVSLKEACEDDN----  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~~~----  125 (408)
                      ....+.+.||+|.||.||+|..  +++.||||+++.      .+.+.+..|-+|.+.. -.|+||++++.+-+...    
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            3456788999999999999965  468999999964      3457788888888754 26999999998876555    


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCceEeecCCCCCCEEE
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH---------GVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~---------~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      .+++|+||.+.|+|.++|+.+ .++.....+++..+++||+|||+.         .|+|||||..|||+   ..+....|
T Consensus       282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccI  357 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCI  357 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEe
Confidence            899999999999999999775 689999999999999999999963         59999999999999   56778999


Q ss_pred             eecccccccCCCC---ceecccCCCCCcchhhhhcc--CC-----CchhHHHHHHHHHHHhhCC------------CCCC
Q 015352          197 IDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKRN--YG-----PEIDIWSAGVILYILLCGV------------PPFW  254 (408)
Q Consensus       197 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~-----~~~DiwslG~il~~l~~g~------------~pf~  254 (408)
                      +|||+|..+.++.   .....+||.+|||||++.+.  +.     .+.||||+|.+|||+++.-            +||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9999999876554   33447899999999999874  33     3589999999999999742            3342


Q ss_pred             -----CCCHHHHHHHHHcCCcccC-CCCCCC--CCHHHHHHHHHhcCCCcCCCCCHHHH
Q 015352          255 -----AESEQGVAQAILRGLIDFK-RDPWPN--VSESAKSLVRQMLEPDPKLRLTAKQV  305 (408)
Q Consensus       255 -----~~~~~~~~~~i~~~~~~~~-~~~~~~--~~~~~~~li~~~l~~dp~~R~s~~~~  305 (408)
                           ..+..++...+.+...... +..|.+  ....+++.+..||..||+-|.|+.=+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                 1233444444444432211 122322  34568899999999999999998643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.6e-32  Score=238.25  Aligned_cols=211  Identities=44%  Similarity=0.714  Sum_probs=185.1

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCc
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE  138 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~  138 (408)
                      ||+|++|.||++.+..+++.+++|++.......  ....+.+|+..++.+ .|++++++++++......++++|++.|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999987553321  356789999999999 88999999999999999999999999999


Q ss_pred             hHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-ceecccC
Q 015352          139 LFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVG  216 (408)
Q Consensus       139 L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-~~~~~~g  216 (408)
                      |.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++..  ...++|+|||.+....... ......+
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence            99998776 568999999999999999999999999999999999999531  5679999999988664432 1233567


Q ss_pred             CCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          217 SPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       217 t~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      ...|++||.+..  .++.+.|+|++|++++++                                   ..+.+++.+|+..
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence            888999999875  688899999999999999                                   6788999999999


Q ss_pred             CcCCCCCHHHHhcCc
Q 015352          295 DPKLRLTAKQVLEHP  309 (408)
Q Consensus       295 dp~~R~s~~~~l~h~  309 (408)
                      +|++||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=270.45  Aligned_cols=244  Identities=24%  Similarity=0.334  Sum_probs=206.4

Q ss_pred             EecceecccCCeEEEEEEECCCCc----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      +..+.||+|+||+||+|.+-..|+    +||||++.....  .....++++|+-+|.+| +|||++++++++.... +-|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHH
Confidence            345789999999999999876654    588888765433  33357899999999999 9999999999998876 889


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      |++|+++|+|.++++.+ +.+..+....|..||++|+.|||.+.++||||-..|||+   .....+|+.|||+++...+.
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcc
Confidence            99999999999999865 568999999999999999999999999999999999999   55677999999999987655


Q ss_pred             Cc-eecccC--CCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          209 ER-FSEIVG--SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       209 ~~-~~~~~g--t~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .. +....|  .+-|||-|.+.. .|+.++||||+||++||++| |..|+.+....++...+..+..   ....+..+-+
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---LsqPpiCtiD  928 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---LSQPPICTID  928 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---CCCCCCccHH
Confidence            43 222222  345888888774 69999999999999999998 9999999998888887777654   3344678999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.-++.+||..|+..||+++++..
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHH
Confidence            999999999999999999998765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-31  Score=237.06  Aligned_cols=211  Identities=41%  Similarity=0.706  Sum_probs=181.8

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |.+.+.||.|++|.||++.+..++..+|+|.+......  ...+.+.+|++.++.+ +|+|++++++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence            56788999999999999999988999999999765432  2467889999999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC--
Q 015352          133 LCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--  209 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~--  209 (408)
                      ++++++|.+++..... +++..+..++.+++.++.+||+++++|+||+|.||+++   ....++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc
Confidence            9999999999988766 89999999999999999999999999999999999994   45789999999988765443  


Q ss_pred             ceecccCCCCCcchhhh-hc-cCCCchhHHHHHHHHHHHhhCCCCCCC--CCHHHHHHHHHcCC
Q 015352          210 RFSEIVGSPYYMAPEVL-KR-NYGPEIDIWSAGVILYILLCGVPPFWA--ESEQGVAQAILRGL  269 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~-~~-~~~~~~DiwslG~il~~l~~g~~pf~~--~~~~~~~~~i~~~~  269 (408)
                      ......++..|++||.+ .. .++.++|+|+||+++++|++|+.||..  .+...+.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            33445788899999987 43 578899999999999999999999977  33346666666654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=1e-32  Score=286.37  Aligned_cols=197  Identities=19%  Similarity=0.257  Sum_probs=147.3

Q ss_pred             CCeeEEeeEE-------EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          112 SSIVSLKEAC-------EDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       112 ~~i~~~~~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                      +||.+++++|       .....++.++|++ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5666666666       2334677888987 56999999653 4599999999999999999999999999999999999


Q ss_pred             EeecC----------------CCCCCEEEeecccccccCCC-----------------CceecccCCCCCcchhhhhc-c
Q 015352          184 LFANK----------------KENSPLKAIDFGLSIFFKPG-----------------ERFSEIVGSPYYMAPEVLKR-N  229 (408)
Q Consensus       184 l~~~~----------------~~~~~vkl~Dfg~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~-~  229 (408)
                      |++..                +....+|++|||+++.....                 ......+||+.|+|||++.+ .
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99531                23456788888887642110                 00112468999999999875 6


Q ss_pred             CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 015352          230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP  309 (408)
Q Consensus       230 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  309 (408)
                      |+.++|||||||+||||++|.+|+....  .....+.....  +. .+....+...+++.+||+++|.+|||+.|+++||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PP-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Ch-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999998875322  22222222211  11 1112345678999999999999999999999999


Q ss_pred             cccCC
Q 015352          310 WLQNA  314 (408)
Q Consensus       310 ~~~~~  314 (408)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-29  Score=223.67  Aligned_cols=249  Identities=19%  Similarity=0.254  Sum_probs=202.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCCC-----cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-e
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-D  123 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~  123 (408)
                      .+|+++...+-+|.||.||.|.+++..     +.|-+|.+...  ....+...++.|.-.+..+ .|||+..+.++.. +
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED  359 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec
Confidence            356788888999999999999877543     23445554322  2344567888999999998 8999999999875 5


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEE
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vk  195 (408)
                      ....++++.+..-|+|..++...        ..++..+...++.|+..|+.|||++|+||.||-..|+++   ++..+||
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVk  436 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVK  436 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEE
Confidence            56788999999889999998721        247778888999999999999999999999999999999   5668899


Q ss_pred             EeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCc
Q 015352          196 AIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       196 l~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      |+|=.+++..-+.+..   ...-....||+||.+.+ .|+.++|+||||++||||+| |+.|+..-++.++..-+..|..
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            9999999876554422   11123456999999875 69999999999999999998 9999999999999888887753


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      -   ....++|+++..++.-||...|++||+.+|+..
T Consensus       517 l---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 L---AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             e---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            2   233589999999999999999999999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.8e-29  Score=213.68  Aligned_cols=162  Identities=27%  Similarity=0.329  Sum_probs=128.1

Q ss_pred             CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceeccc
Q 015352          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV  215 (408)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  215 (408)
                      |+|.+++... +.+++..++.++.|++.||.|||+++      ||+|||+   +.++.+|+  ||++.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            6899999874 45999999999999999999999999      9999999   55667888  99988754322    26


Q ss_pred             CCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCcccCC---CCCCCCCH--HHHHHH
Q 015352          216 GSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKR---DPWPNVSE--SAKSLV  288 (408)
Q Consensus       216 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~~~--~~~~li  288 (408)
                      ||+.|+|||++.+ .++.++||||+||++|+|++|..||..... ......+.........   .....++.  .++++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            8999999999875 699999999999999999999999976543 2333333333222111   11122333  699999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccccC
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      .+||..+|.+|||+.++++|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-27  Score=221.26  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=195.7

Q ss_pred             ceEecceecccCCeEEEEEEECCCC-cEEEEEEeeccccCChhcHHHHHHHHHHHHhCC---CCCCeeEEeeEE-EeCCe
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLP---KNSSIVSLKEAC-EDDNA  126 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~i~~~~~~~-~~~~~  126 (408)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|+.........   ..+..|+.++..+.   ..++++.+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999988775 6789988775432211   15677999998884   246899999999 58889


Q ss_pred             EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC--CCCCEEEeecccc
Q 015352          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLS  202 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~--~~~~vkl~Dfg~~  202 (408)
                      .|+||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||+|+++....  ....+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 88999987554  5699999999999999999999999999999999999996543  1256999999999


Q ss_pred             cccC---CC-------Cc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc
Q 015352          203 IFFK---PG-------ER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       203 ~~~~---~~-------~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      +...   ..       .. .....||..|.++.+..+ ..+++.|+||++.++.+++.|..||.+.........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8321   11       11 123459999999998876 689999999999999999999999977553322333322222


Q ss_pred             ccCCC-CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          271 DFKRD-PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       271 ~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..... .....+.++..+...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22211 223456778888888888899999998877653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.8e-30  Score=253.51  Aligned_cols=261  Identities=27%  Similarity=0.464  Sum_probs=200.0

Q ss_pred             ccce-EecceecccCCeEEEEEEECCCCcEEEEEEeecc--ccCChhcH-HHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           50 EDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKR--KLRTAVDI-DDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        50 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~-~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+.| .....+|.|++|.|+.+........++.|.....  ........ ..+..|..+-..| .|||++..+..+.+..
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEID  394 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcc
Confidence            3456 4567899999998888887776666666655422  11111111 1256677778888 9999988877777666


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ..+-+||||++ +|+..+...+.++...+..+++||+.|++|+|+.||.|||+||+|+++   ...+.+||+|||.+...
T Consensus       395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVF  470 (601)
T ss_pred             cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceee
Confidence            66666999999 999999888889999999999999999999999999999999999999   45668999999998765


Q ss_pred             CCC-----CceecccCCCCCcchhhhhc-cCCC-chhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HHHHcCCc---ccC
Q 015352          206 KPG-----ERFSEIVGSPYYMAPEVLKR-NYGP-EIDIWSAGVILYILLCGVPPFWAESEQGVA--QAILRGLI---DFK  273 (408)
Q Consensus       206 ~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~---~~~  273 (408)
                      ...     ......+|+..|+|||++.+ .|.+ ..||||.|++++.|++|+.||.........  ........   .-+
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP  550 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence            322     23456789999999999876 5765 689999999999999999999654333221  11111111   111


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ...+..++.+.+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            223346788999999999999999999999999999998754

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-28  Score=204.67  Aligned_cols=252  Identities=19%  Similarity=0.239  Sum_probs=201.8

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +...+.++|++++.||+|+||.+|.|.+..+|..||||+-....     ....+..|..+.+.|++-..|+.+..+..+.
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            34456789999999999999999999999999999999865432     1235677999999997788999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      .+-.+||++. |.+|.++..- ...++...+..++-|++.-++|+|.++++||||||+|+|..-......+.|+|||+|+
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence            9999999999 8899887753 4569999999999999999999999999999999999999766666789999999998


Q ss_pred             ccCCCC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCcc
Q 015352          204 FFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLID  271 (408)
Q Consensus       204 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~  271 (408)
                      .+....        .-....||..|.+--...+ ..+...|+-|+|.+|.++.-|..||++...   .+-.+.|......
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            764322        2245679999999887665 578899999999999999999999988543   3444555554443


Q ss_pred             cCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCH
Q 015352          272 FKR-DPWPNVSESAKSLVRQMLEPDPKLRLTA  302 (408)
Q Consensus       272 ~~~-~~~~~~~~~~~~li~~~l~~dp~~R~s~  302 (408)
                      .+. ......|.++.-.+.-|-..--++-|+.
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            332 2335678888888877765555555543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=1.1e-26  Score=217.06  Aligned_cols=256  Identities=36%  Similarity=0.581  Sum_probs=209.0

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC-CeeEEeeEEEeCCeEEEEE
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~~~~~~~~~lv~  131 (408)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.++..+ .|+ +++++.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEE
Confidence            788899999999999999987   77899999876554433467899999999999 555 8999999998888899999


Q ss_pred             eccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC-CEEEeecccccccCC
Q 015352          132 ELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS-PLKAIDFGLSIFFKP  207 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~-~vkl~Dfg~~~~~~~  207 (408)
                      +++.|+++.+.+....   .+++..+..++.|++.++.|+|+.+++|||+||+||+++   ... .++++|||.+.....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCC
Confidence            9999999997777664   799999999999999999999999999999999999994   444 699999999875543


Q ss_pred             CC-------ceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCcc-
Q 015352          208 GE-------RFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLID-  271 (408)
Q Consensus       208 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~-  271 (408)
                      ..       ......|+..|+|||.+.+    .++...|+||+|++++++++|..||.....    ......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            32       2456789999999998875    578899999999999999999999877653    4444555444433 


Q ss_pred             cCCCCCCCC----CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 FKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .........    ...+.+++.+++..+|..|.+..+...++|.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            222221121    25789999999999999999999999987765543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=7.2e-28  Score=223.76  Aligned_cols=180  Identities=21%  Similarity=0.257  Sum_probs=137.3

Q ss_pred             cccccccccceEecceecccCCeEEEEEEECC-CCcEEEEEEeecccc--CChhcHHHHHHHHHHHHhCCCCCCeeE-Ee
Q 015352           43 GVPKENIEDRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKL--RTAVDIDDVRREVAIMKHLPKNSSIVS-LK  118 (408)
Q Consensus        43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~-~~  118 (408)
                      +.+...+.++|.+.+.||+|+||+||+|+++. ++..+|||++.....  ........+.+|+++|+++ +|+|++. ++
T Consensus        10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~   88 (365)
T PRK09188         10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLL   88 (365)
T ss_pred             ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEE
Confidence            34556788899999999999999999999886 677789998753211  1222356789999999999 8888874 54


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCceEeecCCCCCCEEEe
Q 015352          119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL-KPENFLFANKKENSPLKAI  197 (408)
Q Consensus       119 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~di-kp~NIl~~~~~~~~~vkl~  197 (408)
                      ++    +..|+||||++|++|.. +.   ...   ...++.|++.+|.|||++||+|||| ||+|||++   .++.+||+
T Consensus        89 ~~----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLi  154 (365)
T PRK09188         89 AT----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVI  154 (365)
T ss_pred             Ec----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEE
Confidence            32    46899999999999963 21   111   1467899999999999999999999 99999994   45679999


Q ss_pred             ecccccccCCCC---------ceecccCCCCCcchhhhhc-------cCCCchhHH
Q 015352          198 DFGLSIFFKPGE---------RFSEIVGSPYYMAPEVLKR-------NYGPEIDIW  237 (408)
Q Consensus       198 Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-------~~~~~~Diw  237 (408)
                      |||+|.......         ...+..+++.|+|||.+..       ..+...|-|
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999998654322         1245678889999999853       133456766

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.1e-27  Score=203.76  Aligned_cols=249  Identities=20%  Similarity=0.283  Sum_probs=194.7

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.-.|++++.||+|+||..+.|.+.-++++||||.-+...     +...+..|....+.|...++|+.++-+.+.+.+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            35568999999999999999999999999999999865432     2456788999999998899999999888999999


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC--CCCCCEEEeecccccc
Q 015352          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK--KENSPLKAIDFGLSIF  204 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~--~~~~~vkl~Dfg~~~~  204 (408)
                      .+|+|++ |.+|.++..- .+.++...++.++.|++.-++|+|++.+|.|||||+|+||...  .....|-++|||+|+.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999999 8899888754 3569999999999999999999999999999999999999642  2345689999999997


Q ss_pred             cCCCC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCccc
Q 015352          205 FKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDF  272 (408)
Q Consensus       205 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~  272 (408)
                      +....        ......||.+||+--...+ +.+.+.|+-|||-++++.+-|.+||.+-.   ..+-.++|-......
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            75332        2345679999999876554 68899999999999999999999998753   344445553333221


Q ss_pred             C-CCCCCCCCHHHHHHHHHhcCCCcCCCCCH
Q 015352          273 K-RDPWPNVSESAKSLVRQMLEPDPKLRLTA  302 (408)
Q Consensus       273 ~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~  302 (408)
                      + .....++|.++..-++-.-..+-.+-|+.
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            1 11223556666555555544444555553

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=233.01  Aligned_cols=241  Identities=29%  Similarity=0.464  Sum_probs=207.7

Q ss_pred             eecccCCeEEEEEEEC---CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           58 ELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      .+|.|+||.|++++..   ..|..+|+|+..+......... ....|..++.....||.+++++..++.+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            3799999999988533   4577899999887665443322 55668888888866999999999999999999999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecc
Q 015352          135 EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI  214 (408)
Q Consensus       135 ~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~  214 (408)
                      .||.|+..+.+...+.+...+.+...++-+++++|+.+|+|||+|++||++   +..|++++.|||+++..-..+..   
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence            999999999888889999999999999999999999999999999999999   67888999999999876544332   


Q ss_pred             cCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          215 VGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       215 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      +||..|||||++. ....+.|.||+|+++|+|+||..||.+    ++...|.......+.    .++..+++++..++..
T Consensus       154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR  224 (612)
T ss_pred             ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence            8999999999998 567899999999999999999999987    677778776665554    6788999999999999


Q ss_pred             CcCCCCCH-----HHHhcCccccCC
Q 015352          295 DPKLRLTA-----KQVLEHPWLQNA  314 (408)
Q Consensus       295 dp~~R~s~-----~~~l~h~~~~~~  314 (408)
                      +|..|.-.     .++++|+||+..
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheee
Confidence            99999854     789999999764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=1.2e-25  Score=200.31  Aligned_cols=234  Identities=24%  Similarity=0.376  Sum_probs=153.0

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC---------CCCeeEEeeEE-
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK---------NSSIVSLKEAC-  121 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~~i~~~~~~~-  121 (408)
                      .+...+.||.|+++.||.+.+..||+.+|+|+............+.+.+|.-....+.+         |-.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            44567899999999999999999999999999987664444556777777655444322         11222222222 


Q ss_pred             --------EeC---C-----eEEEEEeccCCCchHHHHH---hCCCC----CHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 015352          122 --------EDD---N-----AVHLVMELCEGGELFDRIV---ARGHY----TERAAAAVTRTIVEVVQLCHKHGVIHRDL  178 (408)
Q Consensus       122 --------~~~---~-----~~~lv~e~~~g~~L~~~l~---~~~~~----~~~~~~~i~~ql~~~l~~lH~~~ivH~di  178 (408)
                              +..   .     ..+++|+-+.+ +|.+.+.   .....    .......+..|++..+++||++|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                    111   1     24678888754 8877653   22222    12223455699999999999999999999


Q ss_pred             CCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc---------cCCCchhHHHHHHHHHHHhhC
Q 015352          179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR---------NYGPEIDIWSAGVILYILLCG  249 (408)
Q Consensus       179 kp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~~l~~g  249 (408)
                      +|+|+++   +.++.++|+||+.....  +........+..|.+||....         .++.+.|.|+||+++|.|+||
T Consensus       172 ~~~nfll---~~~G~v~Lg~F~~~~r~--g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLL---DQDGGVFLGDFSSLVRA--GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEET--TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEE---cCCCCEEEcChHHHeec--CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999   56788999999876553  333332345678999997632         378899999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCC
Q 015352          250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR  299 (408)
Q Consensus       250 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  299 (408)
                      ..||...........        ......++|+..+.||+.+|+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999976543221111        122334789999999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=5.5e-26  Score=224.99  Aligned_cols=224  Identities=29%  Similarity=0.525  Sum_probs=179.8

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .-....|..++.|.-|+||.||.++|+.+.+.+|+|+ .++.+        +.+-  ++... +.|.++           
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a-~npfvv-----------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFA-GNPFVV-----------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--ccccc-CCccee-----------
Confidence            3345678899999999999999999999999999954 33321        1111  34333 556555           


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                                |+-...++.-++++...        +.+++|||+.||+|||+||+|.++   ..-+++|++|||+++..-
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhh
Confidence                      34445555556666554        789999999999999999999999   456789999999986431


Q ss_pred             CC--------C--------ceecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Q 015352          207 PG--------E--------RFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       207 ~~--------~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      ..        .        .-..++|||.|+|||++. ..|+..+|.|++|+|+|+.+-|..||.+.+..+++.++....
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            10        0        013468999999999876 579999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcCCCcCCCC---CHHHHhcCccccCCc
Q 015352          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQNAK  315 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~~~  315 (408)
                      +.++.. ...++++++++|.++|+.+|..|.   .+-++.+|+||+...
T Consensus       275 i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  275 IEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             cccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence            998887 457899999999999999999995   577888999998764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=4.1e-25  Score=189.10  Aligned_cols=142  Identities=18%  Similarity=0.172  Sum_probs=110.5

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhc-----------------------HHHHHHHHHHHHhCCCCC
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-----------------------IDDVRREVAIMKHLPKNS  112 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~h~  112 (408)
                      .+.||+|++|.||+|.+. +|+.||+|++..........                       .....+|+.++.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence            568999999999999987 89999999997653211110                       12234599999998 666


Q ss_pred             CeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCceEeecCCCC
Q 015352          113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-HKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      ++.....+. ... .++||||++|+++.......+.+++..+..++.|++.+|.++ |+.||+||||||+||+++    +
T Consensus        80 ~v~~p~~~~-~~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~  153 (190)
T cd05147          80 GIPCPEPIL-LKS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D  153 (190)
T ss_pred             CCCCCcEEE-ecC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence            654333222 222 389999999987766555567899999999999999999999 799999999999999995    2


Q ss_pred             CCEEEeeccccccc
Q 015352          192 SPLKAIDFGLSIFF  205 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~  205 (408)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            56999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=3.9e-25  Score=191.28  Aligned_cols=176  Identities=19%  Similarity=0.189  Sum_probs=134.4

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHH------HHHHHHHHHhCCCCCCeeEEeeE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      +-+.++|++.+.+|.|+||.||++..  ++..+|+|++.............      +.+|+..+.++ .||+|..+.++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEe
Confidence            45778999999999999999999755  46689999997554333333333      57899999999 99999999988


Q ss_pred             EEeC--------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          121 CEDD--------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       121 ~~~~--------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      +...        +..+++|||++|.+|.+..    .+++    ....+++.+|..+|+.|++|||++|+||+++.   ++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~---~g  172 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK---NG  172 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC---CC
Confidence            6643        3588999999999997763    2333    34669999999999999999999999999953   44


Q ss_pred             CEEEeecccccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHh
Q 015352          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILL  247 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~  247 (408)
                       ++|+|||.+...........          =++...|+.++|+||||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence             99999998765432211110          022345778999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=222.00  Aligned_cols=245  Identities=24%  Similarity=0.291  Sum_probs=180.4

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeecccc-CChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .|...+.||++.|=.|.+|++++ |. |++|++-+..- -.-....+...|++ ... .++||++.+.-+.+.+...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l-~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FAL-MKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHh-hcCCcccchHHHHHhhHHHHHH
Confidence            77889999999999999998864 54 89999876541 12222333444555 333 4899999999998899999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC----
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK----  206 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~----  206 (408)
                      -+|+.. +|++++..+..+...+.+.|+.||+.||.-+|..||+|||||.+|||++   .-.-+.|+||..-+...    
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence            999966 9999998887889999999999999999999999999999999999995   45568999998655331    


Q ss_pred             CCCce----ecccCCCCCcchhhhhc-----------c-CCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC
Q 015352          207 PGERF----SEIVGSPYYMAPEVLKR-----------N-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       207 ~~~~~----~~~~gt~~y~aPE~~~~-----------~-~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      +...+    .+...-.+|.|||.+..           . .+++.||||+||+++||++ |++||.-.    .+-...++.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccC
Confidence            11122    22223356999998732           1 4678999999999999988 78888321    111111111


Q ss_pred             cccCCCCCCC-CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          270 IDFKRDPWPN-VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       270 ~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ...+...... -+..++.+|..|++.||.+|.++++.|+.
T Consensus       252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            0000000001 13468999999999999999999999984

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-24  Score=192.34  Aligned_cols=191  Identities=28%  Similarity=0.410  Sum_probs=143.0

Q ss_pred             CCCCCCeeEEeeEEEe---------------------------CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHH
Q 015352          108 LPKNSSIVSLKEACED---------------------------DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT  160 (408)
Q Consensus       108 l~~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~q  160 (408)
                      |..||||+++..+|.+                           ...+|+||..++. +|.+++..+ ..+....+-++.|
T Consensus       272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQ  349 (598)
T ss_pred             cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHH
Confidence            3579999999987632                           2368999998866 999988665 5677888999999


Q ss_pred             HHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecccccccCC-------CCceecccCCCCCcchhhhhccC--
Q 015352          161 IVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIFFKP-------GERFSEIVGSPYYMAPEVLKRNY--  230 (408)
Q Consensus       161 l~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~--  230 (408)
                      +++|+.|||++||.|||+|.+|||+.-++ .-..+.|+|||.+---..       .......-|...-||||+...-.  
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            99999999999999999999999997543 345689999998753221       11122335778899999985321  


Q ss_pred             -----CCchhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHH
Q 015352          231 -----GPEIDIWSAGVILYILLCGVPPFWAESEQGV-AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK  303 (408)
Q Consensus       231 -----~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~  303 (408)
                           -.++|.|+.|.+.||+++...||++.....+ .....+...+   .....+++.+++++..+|+.||++|++..
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP---alp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP---ALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC---CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                 2479999999999999999999987432211 1111111111   12246899999999999999999999864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=9.7e-24  Score=178.59  Aligned_cols=187  Identities=21%  Similarity=0.281  Sum_probs=140.7

Q ss_pred             ecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        55 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +...|++|+||+||.+..  .+..++.+.+.....- .......+.+|+++|++|.+++++++++++    +..|++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            467899999999998754  5677776666543321 111123578999999999777889999886    346999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCceEeecCCCCCCEEEeecccccccCCCCcee
Q 015352          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL-KPENFLFANKKENSPLKAIDFGLSIFFKPGERFS  212 (408)
Q Consensus       134 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~di-kp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~  212 (408)
                      +.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++   .++.++|+|||++....+.....
T Consensus        80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcchHH
Confidence            999998654321      1 2457889999999999999999999 79999994   45679999999998654433210


Q ss_pred             --------------cccCCCCCcchhhhh--ccCC-CchhHHHHHHHHHHHhhCCCCCCCCC
Q 015352          213 --------------EIVGSPYYMAPEVLK--RNYG-PEIDIWSAGVILYILLCGVPPFWAES  257 (408)
Q Consensus       213 --------------~~~gt~~y~aPE~~~--~~~~-~~~DiwslG~il~~l~~g~~pf~~~~  257 (408)
                                    -...++.|++|+...  ...+ ...+.++.|+-+|.++|+..|+++..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                          012578888888543  2344 56788899999999999999987754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.4e-23  Score=180.31  Aligned_cols=144  Identities=18%  Similarity=0.175  Sum_probs=112.6

Q ss_pred             ecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh------------------c-----HHHHHHHHHHHHhCCCC
Q 015352           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------------------D-----IDDVRREVAIMKHLPKN  111 (408)
Q Consensus        55 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------------------~-----~~~~~~E~~~l~~l~~h  111 (408)
                      +.+.||+|++|.||+|.+. +|+.||||++.........                  .     ...+.+|...+.++ .+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~   78 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YE   78 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-Hh
Confidence            3578999999999999987 8999999999865211000                  0     12346789999998 78


Q ss_pred             CCeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCC
Q 015352          112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKE  190 (408)
Q Consensus       112 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~  190 (408)
                      +++.....+....  .|+||||++|+++.........+++..+..++.|++.++.++|+ .||+||||||+||+++    
T Consensus        79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----  152 (190)
T cd05145          79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----  152 (190)
T ss_pred             CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----
Confidence            8774443333322  48999999998665443345678889999999999999999999 9999999999999995    


Q ss_pred             CCCEEEeecccccccC
Q 015352          191 NSPLKAIDFGLSIFFK  206 (408)
Q Consensus       191 ~~~vkl~Dfg~~~~~~  206 (408)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            4679999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.90  E-value=1e-22  Score=175.80  Aligned_cols=138  Identities=20%  Similarity=0.207  Sum_probs=109.7

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC----CCCCeeEEeeEEEeCC---eEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----KNSSIVSLKEACEDDN---AVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~---~~~  128 (408)
                      .+.||+|+||.||.  ++.++.. +||++.....   ...+.+.+|+.+++.+.    .||||++++++++++.   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46899999999995  7777665 6999875432   23467899999999983    4799999999999874   434


Q ss_pred             -EEEec--cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecccc
Q 015352          129 -LVMEL--CEGGELFDRIVARGHYTERAAAAVTRTIVEVV-QLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLS  202 (408)
Q Consensus       129 -lv~e~--~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l-~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg~~  202 (408)
                       +|+||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             78999  5579999999664 56666  35678888777 899999999999999999997543 3457999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.3e-22  Score=204.87  Aligned_cols=195  Identities=25%  Similarity=0.385  Sum_probs=160.3

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEEeCCeE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.|.|.+.||+|+||.||+|.+.+ |+.||+|+=.....      -.+.--.+++.+|.  --+-|..+...+...+..
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP------WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc------eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3578999999999999999999887 99999998643221      11222233444441  124566677777778888


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec----CCCCCCEEEeeccccc
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN----KKENSPLKAIDFGLSI  203 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~----~~~~~~vkl~Dfg~~~  203 (408)
                      ++|+||.+.|||.+++...+.+++..+..+..|++..++.||..+||||||||+|+|+..    +.+...++|+|||.+.
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            999999999999999998888999999999999999999999999999999999999964    2345569999999986


Q ss_pred             cc---CCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCC
Q 015352          204 FF---KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVP  251 (408)
Q Consensus       204 ~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~  251 (408)
                      -+   ..+..+...++|-.+-.+|+..| .|+...|.|.++.+++-|+.|+.
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            54   45557788899999999999987 69999999999999999999964

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.7e-23  Score=174.40  Aligned_cols=255  Identities=16%  Similarity=0.206  Sum_probs=192.4

Q ss_pred             ceeeccccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEE
Q 015352           38 ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL  117 (408)
Q Consensus        38 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~  117 (408)
                      ...++...+-++. ...+...|.+...|..|+|++.  |..+++|++......... .+.|..|.-.|+.+ .||||+.+
T Consensus       178 datlsr~~gid~~-~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~ri-srdfneefp~lrif-shpnilpv  252 (448)
T KOG0195|consen  178 DATLSRYTGIDVS-SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARI-SRDFNEEFPALRIF-SHPNILPV  252 (448)
T ss_pred             ccccccccCcchh-hhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhh-cchhhhhCcceeee-cCCchhhh
Confidence            3334444444332 3345667899999999999986  455778888766543322 35678898899998 99999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCC
Q 015352          118 KEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSP  193 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~  193 (408)
                      ++.+....++.+|..|++-|+|+..+.....  +...++..++..++.|+.|||+..  |.---|....++++. +-...
T Consensus       253 lgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltar  331 (448)
T KOG0195|consen  253 LGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTAR  331 (448)
T ss_pred             hhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhh
Confidence            9999999999999999999999999987644  677899999999999999999975  445568888999943 22334


Q ss_pred             EEEeecccccccCCCCceecccCCCCCcchhhhhcc----CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Q 015352          194 LKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       194 vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      +-.+|-.++....      ...-.|.|++||.++..    --.++|+|||+++++||.|...||.+-++-+.--++--.-
T Consensus       332 ismad~kfsfqe~------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg  405 (448)
T KOG0195|consen  332 ISMADTKFSFQEV------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG  405 (448)
T ss_pred             eecccceeeeecc------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc
Confidence            5555644443311      12346889999998752    2357999999999999999999998887776655554333


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 015352          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL  306 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l  306 (408)
                      +..  ...+.++..+..|+.-|+..||.+||..+.++
T Consensus       406 lrv--~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  406 LRV--HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ccc--cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            322  22368999999999999999999999887763

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=1.4e-21  Score=172.92  Aligned_cols=146  Identities=18%  Similarity=0.126  Sum_probs=114.4

Q ss_pred             ceEecceecccCCeEEEEEE-ECCCCcEEEEEEeeccccCCh-----------------h----cHHHHHHHHHHHHhCC
Q 015352           52 RYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTA-----------------V----DIDDVRREVAIMKHLP  109 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~  109 (408)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|++........                 .    ....+.+|+.+++++ 
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            47889999999999999999 777899999999975432100                 0    112457899999999 


Q ss_pred             CCC--CeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCceEee
Q 015352          110 KNS--SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG-VIHRDLKPENFLFA  186 (408)
Q Consensus       110 ~h~--~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-ivH~dikp~NIl~~  186 (408)
                      .+.  .++++++.   . ..++||||++|++|.........+....+..++.|++.+|.+||++| |+||||||+||+++
T Consensus       108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            543  34444432   2 35899999999888776545556677778899999999999999999 99999999999995


Q ss_pred             cCCCCCCEEEeecccccccC
Q 015352          187 NKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       187 ~~~~~~~vkl~Dfg~~~~~~  206 (408)
                          .+.++|+|||.+....
T Consensus       184 ----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 ----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ----CCCEEEEEChhhhccC
Confidence                4579999999887543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=6.9e-22  Score=183.72  Aligned_cols=244  Identities=25%  Similarity=0.395  Sum_probs=165.1

Q ss_pred             eEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEe------eEE--
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK------EAC--  121 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~------~~~--  121 (408)
                      +.+.+..+..+++.+....-...   ...++-+.....   .........+++-.+....+|+..+..-      ..+  
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~  322 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR  322 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence            44555566666666655543322   222222222211   1122234445555555544555433222      111  


Q ss_pred             ---EeCCeEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEE
Q 015352          122 ---EDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (408)
Q Consensus       122 ---~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vk  195 (408)
                         ....++||.|++|...+|.+++..+..   .+......++.|+..|++|   +|.+|+|+||.||++..   +..+|
T Consensus       323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~---d~q~k  396 (516)
T KOG1033|consen  323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD---DDQLK  396 (516)
T ss_pred             cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccccc---chhhh
Confidence               123468999999999999999975533   5667888999999999999   99999999999999953   44799


Q ss_pred             EeecccccccCCCC-------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 015352          196 AIDFGLSIFFKPGE-------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (408)
Q Consensus       196 l~Dfg~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~  266 (408)
                      |.|||+........       ..+..+||..||+||.+.+ .|+.++||||||+||+|++. -..+|   ........+.
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r  473 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIR  473 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhh
Confidence            99999988765444       4567789999999999986 69999999999999999997 33332   1223334444


Q ss_pred             cCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      .+.++  ...+.+. +.-..|+.+||.+.|.+||++.+.--|+|+
T Consensus       474 ~g~ip--~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  474 DGIIP--PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cCCCC--hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            44443  2222233 445799999999999999988887777775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.3e-22  Score=200.75  Aligned_cols=260  Identities=28%  Similarity=0.497  Sum_probs=209.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCC-CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ...|.+.+.||+|+|+.|-.+..... ...+|.|.+.... ........+..|..+-+.+.+|+|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            44677888899999999998876433 4446666665443 223334566678888888856999999999999999999


Q ss_pred             EEEeccCCCchHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCceEeecCCCCC-CEEEeecccccc
Q 015352          129 LVMELCEGGELFDRI-VARG-HYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKPENFLFANKKENS-PLKAIDFGLSIF  204 (408)
Q Consensus       129 lv~e~~~g~~L~~~l-~~~~-~~~~~~~~~i~~ql~~~l~~lH-~~~ivH~dikp~NIl~~~~~~~~-~vkl~Dfg~~~~  204 (408)
                      ++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++   ..+ .+++.|||+|..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcc
Confidence            999999999999988 5544 6788889999999999999999 99999999999999994   444 799999999987


Q ss_pred             cCC-CC---ceecccC-CCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHH-HHHHcCCcccCCCC
Q 015352          205 FKP-GE---RFSEIVG-SPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDP  276 (408)
Q Consensus       205 ~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~  276 (408)
                      ... ..   .....+| ++.|.|||...+  ...+..|+||+|+++..+++|..|+......... .........+....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            655 22   2344578 999999998876  4678899999999999999999998654433211 12222223334567


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      |..++....+++.+++..+|..|.+..++..++|+..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6.3e-20  Score=160.79  Aligned_cols=137  Identities=27%  Similarity=0.350  Sum_probs=112.6

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh-----hcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      +.||+|++|.||+|.+  .|..+++|+.........     .....+.+|+.++..+ .|++++....++.+.+..+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999987  677899998654332211     1224578899999998 8888877777777778889999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ||++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.||+++    .+.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            99999999998865432    7889999999999999999999999999999995    45699999998865

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=9.9e-20  Score=172.53  Aligned_cols=198  Identities=23%  Similarity=0.316  Sum_probs=156.1

Q ss_pred             HhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCC-eeccCCCCce
Q 015352          106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGV-IHRDLKPENF  183 (408)
Q Consensus       106 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i-vH~dikp~NI  183 (408)
                      +.+ .|.|+.++++.+.++...++|.+||..|+|.+.+... -.++.-....+++.|+.||.|||.-.| .|+.+++.|+
T Consensus         2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            456 8999999999999999999999999999999999873 457788888999999999999998876 9999999999


Q ss_pred             EeecCCCCCCEEEeecccccccCCC---CceecccCCCCCcchhhhhcc--------CCCchhHHHHHHHHHHHhhCCCC
Q 015352          184 LFANKKENSPLKAIDFGLSIFFKPG---ERFSEIVGSPYYMAPEVLKRN--------YGPEIDIWSAGVILYILLCGVPP  252 (408)
Q Consensus       184 l~~~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~~l~~g~~p  252 (408)
                      ++   +....+||+|||+.......   .......-...|.|||.+.+.        .+.+.|+||+|++++|+++...|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   67788999999998765321   111112234569999998652        46789999999999999999999


Q ss_pred             CCCC----CHHHHHHHHHc-CCcccCCCCC--CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          253 FWAE----SEQGVAQAILR-GLIDFKRDPW--PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       253 f~~~----~~~~~~~~i~~-~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      |...    ...++...+.. +...+.+..+  ...++++..+++.||..+|.+||++.++-.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9662    22345555555 2222222221  145668999999999999999999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=3.3e-19  Score=154.71  Aligned_cols=134  Identities=24%  Similarity=0.319  Sum_probs=105.5

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeeccccCCh-----hcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      .||+|+||.||+|.+  +|..+++|..........     .....+.+|++++..+ .++++....-++...+..++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence            489999999999984  577899998654332211     1235677899999998 66665444444556667789999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++    .+.++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            9999999888755321       8899999999999999999999999999995    467999999988763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.6e-19  Score=154.24  Aligned_cols=139  Identities=24%  Similarity=0.284  Sum_probs=106.8

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--Ch-----------------hcHHHHHHHHHHHHhCCCCCC
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TA-----------------VDIDDVRREVAIMKHLPKNSS  113 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~-----------------~~~~~~~~E~~~l~~l~~h~~  113 (408)
                      |.+.+.||+|+||.||+|.+. +|+.+|+|++......  ..                 .......+|+.++..+ .+++
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence            778899999999999999875 7999999997653210  00                 0112367789999888 6663


Q ss_pred             --eeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          114 --IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       114 --i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                        ++..++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||+|+||+++   .+
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---~~  161 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---DD  161 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---CC
Confidence              444433    234589999999999866432      145667889999999999999999999999999994   46


Q ss_pred             CCEEEeecccccccC
Q 015352          192 SPLKAIDFGLSIFFK  206 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~  206 (408)
                      +.++|+|||.+....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            789999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.7e-18  Score=172.15  Aligned_cols=142  Identities=23%  Similarity=0.316  Sum_probs=112.1

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC-----hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....|...+.||+|+||+||++.+...  .+++|+........     ....+.+.+|+++++.+ +|++++....++.+
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~  407 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEe
Confidence            344556788999999999999987543  34555432222111     12235688999999999 89998887777777


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ....++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+|||++    ++.++|+|||++.
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~  475 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGK  475 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcccc
Confidence            778899999999999998875        4577899999999999999999999999999992    3469999999987


Q ss_pred             cc
Q 015352          204 FF  205 (408)
Q Consensus       204 ~~  205 (408)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            63

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=4.5e-18  Score=146.04  Aligned_cols=139  Identities=19%  Similarity=0.238  Sum_probs=98.6

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHH---------------------HHHHHHHHHHhCCCCC--
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID---------------------DVRREVAIMKHLPKNS--  112 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h~--  112 (408)
                      .+.||+|+||+||+|.+. +|+.||+|++............                     ....|...+..+ .+.  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCC
Confidence            567999999999999986 7999999998754321111111                     113566666666 332  


Q ss_pred             CeeEEeeEEEeCCeEEEEEeccCCCchHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCC
Q 015352          113 SIVSLKEACEDDNAVHLVMELCEGGELFDR-IVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKE  190 (408)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~-l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~  190 (408)
                      .+++.+.+    ...++||||++|+++... +... .. ...+..++.+++.++.++|. .||+||||||+||+++    
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----  149 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----  149 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence            24444433    245899999999543221 1111 11 16788999999999999999 9999999999999995    


Q ss_pred             CCCEEEeecccccccC
Q 015352          191 NSPLKAIDFGLSIFFK  206 (408)
Q Consensus       191 ~~~vkl~Dfg~~~~~~  206 (408)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            5679999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=5.6e-17  Score=143.91  Aligned_cols=138  Identities=19%  Similarity=0.253  Sum_probs=103.3

Q ss_pred             ceec-ccCCeEEEEEEECCCCcEEEEEEeecccc-----C-----ChhcHHHHHHHHHHHHhCCCCCCe--eEEeeEEEe
Q 015352           57 RELG-RGEFGVTYLCIDRDTRELLACKSISKRKL-----R-----TAVDIDDVRREVAIMKHLPKNSSI--VSLKEACED  123 (408)
Q Consensus        57 ~~lg-~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~-----~~~~~~~~~~E~~~l~~l~~h~~i--~~~~~~~~~  123 (408)
                      ..|| .|+.|+||.+...  +..+++|.+....+     .     .......+.+|+.++.+| .+++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence            4677 8888899998764  77899998864321     1     112345678899999999 77664  667666433


Q ss_pred             C-Ce---EEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          124 D-NA---VHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       124 ~-~~---~~lv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      . ..   .++|||+++| .+|.+++.. ..+++..    +.+|+.+|.+||++||+||||||+|||++.   ++.++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~---~~~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDP---DGKFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcC---CCCEEEEE
Confidence            2 22   3599999998 688887754 4555543    678999999999999999999999999953   45799999


Q ss_pred             ccccccc
Q 015352          199 FGLSIFF  205 (408)
Q Consensus       199 fg~~~~~  205 (408)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2.5e-18  Score=163.04  Aligned_cols=260  Identities=21%  Similarity=0.251  Sum_probs=203.7

Q ss_pred             cccccceEecceecc--cCCeEEEEEEE--CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           47 ENIEDRYLVDRELGR--GEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      ..+...+.+...+|.  |.+|.||.+..  ..++..+|+|.-.. .........+=.+|+.-.+.+..|++.++.+..++
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccc
Confidence            345556778889999  99999999998  88899999987322 22222223344567777888878999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVE----VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~----~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      ..+..|+-+|+|. .+|..+...... ++...++..+.+...    ||.++|+.+++|-|+||.||+...+  ....+++
T Consensus       189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~--~~s~~~~  265 (524)
T KOG0601|consen  189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSD--WTSCKLT  265 (524)
T ss_pred             cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccc--cceeecC
Confidence            9999999999995 688888876544 899999999999999    9999999999999999999999532  1678999


Q ss_pred             ecccccccCCCCce------ecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc
Q 015352          198 DFGLSIFFKPGERF------SEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (408)
Q Consensus       198 Dfg~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  271 (408)
                      |||+......+...      ....|...|++||..++-++...|++++|.+..+..+|..++..... ..+.++.++.  
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~--  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGY--  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC-CCcccccccc--
Confidence            99998877655421      12257778999999999999999999999999998888766543311 1111222221  


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      .+.+.....+..+...+..|+..+|..|++++.+++|+++..
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            344445567778888999999999999999999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=2.4e-18  Score=171.35  Aligned_cols=260  Identities=26%  Similarity=0.391  Sum_probs=211.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +.+.+.+.+-+|+++.++.+.-..+|...++|+..+...-...+.+.+..+-.++-.. .+|.++...-.+......+++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchh
Confidence            4566777899999999999988888877777776655443333445555565555443 567777665556667789999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC----
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK----  206 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~----  206 (408)
                      ++|+.|++|...+...+..++..++..+..+..+++|||...+.|+|++|.|++.   ...+..++.|||......    
T Consensus       883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccC
Confidence            9999999999999988888999999999999999999999999999999999999   567788999997322110    


Q ss_pred             --CC--------------------------CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC
Q 015352          207 --PG--------------------------ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES  257 (408)
Q Consensus       207 --~~--------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~  257 (408)
                        ..                          ..-....||+.|.+||.+.+ .....+|.|++|+++++.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence              00                          00123579999999998876 68889999999999999999999999999


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHH---HHhcCccccCCc
Q 015352          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK---QVLEHPWLQNAK  315 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~---~~l~h~~~~~~~  315 (408)
                      .+.+.+++..+...++... ...++++.+++.++|..+|.+|..+.   ++-.|+||+...
T Consensus      1040 pq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             hhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            9999999999888776543 46789999999999999999999988   899999998754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.1e-16  Score=132.22  Aligned_cols=133  Identities=26%  Similarity=0.311  Sum_probs=110.3

Q ss_pred             ecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC-CCeeEEeeEEEeCCeEEEEEec
Q 015352           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        55 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +.+.||.|.++.||++....  ..+++|.......     ...+.+|+.+++.+.++ +++++++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45789999999999998754  6799998754321     45788899999999433 5899999988888899999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH---GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       134 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ++|+.+..+       +......++.+++.+|.++|..   +++|+|++|+||+++.   .+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccC
Confidence            999877543       5567778899999999999985   6999999999999953   56799999998765

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.59  E-value=3.9e-15  Score=144.97  Aligned_cols=152  Identities=21%  Similarity=0.272  Sum_probs=98.0

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC---------------------C------h----hcH
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---------------------T------A----VDI   95 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------------------~------~----~~~   95 (408)
                      +.+-..|.. +.||+|++|.||+|+.+.+|+.||||+.+.....                     .      .    .-.
T Consensus       116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~  194 (537)
T PRK04750        116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE  194 (537)
T ss_pred             HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence            344456665 7899999999999999988999999999754110                     0      0    001


Q ss_pred             HH------HHHHHHHHHhCC---CCCCeeEEeeEE-EeCCeEEEEEeccCCCchHHH--HHhCC----CCCHHHHHHHHH
Q 015352           96 DD------VRREVAIMKHLP---KNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDR--IVARG----HYTERAAAAVTR  159 (408)
Q Consensus        96 ~~------~~~E~~~l~~l~---~h~~i~~~~~~~-~~~~~~~lv~e~~~g~~L~~~--l~~~~----~~~~~~~~~i~~  159 (408)
                      +.      +.+|+..+.++.   .+...+.+-.+| +.....++||||++|+.+.+.  +...+    .+.+..+..++.
T Consensus       195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            12      333444444431   122222322333 234567799999999999764  33333    244444555555


Q ss_pred             HHHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecccccccC
Q 015352          160 TIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       160 ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg~~~~~~  206 (408)
                      |++       ..|++|+|++|.||+++.++ ..+.++++|||++....
T Consensus       275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            554       59999999999999996432 23489999999987653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=3.9e-16  Score=137.20  Aligned_cols=237  Identities=18%  Similarity=0.203  Sum_probs=159.0

Q ss_pred             EEEEEEECCCCcEEEEEEeeccccCChhc-HHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-----eEEEEEeccCCCch
Q 015352           66 VTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----AVHLVMELCEGGEL  139 (408)
Q Consensus        66 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~~~lv~e~~~g~~L  139 (408)
                      .||++-++..|.+|+.-.+.....+.... .+....=...+-++ .|.||++++.++.+..     ...+++||+..|+|
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            57777777777776654443222211111 11122222334444 6888999999986544     57899999999999


Q ss_pred             HHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeecccccccCC-----C
Q 015352          140 FDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-----G  208 (408)
Q Consensus       140 ~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-----~  208 (408)
                      ..+|++.    ..+......+|+.||+.||.|||+..  |+|+++..+.|++   ..++-||+.---.......     .
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~  236 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE  236 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence            9999763    34788888999999999999999985  9999999999999   4566666653221111100     0


Q ss_pred             CceecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhhCCCC-CCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPP-FWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      .......+-++|.+||.=. .+.+-++|||++|....+|..|..- -.+.+....-..+.+..+...       .+.-++
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~  309 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG  309 (458)
T ss_pred             hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence            1112234678899999654 3566789999999999999887653 223333333333333322211       233468


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ++.+||+..|..||++.+++.||.+-.
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeee
Confidence            899999999999999999999998654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=7.3e-14  Score=118.55  Aligned_cols=143  Identities=13%  Similarity=0.125  Sum_probs=103.3

Q ss_pred             cceecccCCeEEEEEEECC------CCcEEEEEEeecccc--C-----------------ChhcHHHHH----HHHHHHH
Q 015352           56 DRELGRGEFGVTYLCIDRD------TRELLACKSISKRKL--R-----------------TAVDIDDVR----REVAIMK  106 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~--~-----------------~~~~~~~~~----~E~~~l~  106 (408)
                      ...||.|--+.||.|....      .+..+|+|+......  +                 .......+.    +|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998653      357899999864321  0                 011122333    8999999


Q ss_pred             hCCCC-CCeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCceE
Q 015352          107 HLPKN-SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-HKHGVIHRDLKPENFL  184 (408)
Q Consensus       107 ~l~~h-~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~ivH~dikp~NIl  184 (408)
                      ++... -+++.++.+    ..-++||||+.+..+.....+...+++..+..+..+++.+|..| |+.||+||||++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            88332 356777654    45679999997754432222333466677788899999999998 8999999999999999


Q ss_pred             eecCCCCCCEEEeecccccccC
Q 015352          185 FANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       185 ~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +.    ++.+.|+|||.+....
T Consensus       158 ~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE----CCcEEEEECCCceeCC
Confidence            95    2469999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=5.5e-14  Score=135.44  Aligned_cols=143  Identities=19%  Similarity=0.233  Sum_probs=95.9

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh-----------------------hcH--------------HHH
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----------------------VDI--------------DDV   98 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------------------~~~--------------~~~   98 (408)
                      .+.||.|++|.||+|+.+ +|+.||||+....-...-                       .+.              -.+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            357999999999999875 689999999854310000                       000              023


Q ss_pred             HHHHHHHHhC----CCCCCeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 015352           99 RREVAIMKHL----PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE-VVQLCHKHG  172 (408)
Q Consensus        99 ~~E~~~l~~l----~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~-~l~~lH~~~  172 (408)
                      .+|...+.++    .+++++.-..-+.+.....++||||++|++|.+..... ....   ...++.+++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            4455555444    23454432222233345578999999999998876432 1222   2345555555 477899999


Q ss_pred             CeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       173 ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ++|+|++|.||++   ..++.++++|||++...
T Consensus       278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRL  307 (437)
T ss_pred             ceeCCCCcccEEE---CCCCcEEEEeCCCeeEC
Confidence            9999999999999   45577999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.2e-14  Score=138.35  Aligned_cols=255  Identities=21%  Similarity=0.201  Sum_probs=188.4

Q ss_pred             ccccccceEecceecccCCeEEEEEEEC-CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ......+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.......++ .-..|+.+...+..|.+++++...|...
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence            3445567888999999999999998755 6788899998866544433332 3345777777777789999988888888


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .+.|+-.|||.|+++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+++  +..++.|||....
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTR  416 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccc
Confidence            88889999999998877665555688899999999999999999999999999999999997543  6789999998764


Q ss_pred             cCCCCceecccCCCCCc-chhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          205 FKPGERFSEIVGSPYYM-APEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..-  ........-++. .+|++..  .+..+.|++|||..+.+.++|...-+..   .....+..+...    ..+...
T Consensus       417 ~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p----~~~~~~  487 (524)
T KOG0601|consen  417 LAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTP----NLPGLK  487 (524)
T ss_pred             cce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeeccccc----CCCchH
Confidence            211  111122333444 3555543  4778999999999999999986532211   122233333222    123445


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      .++..+.+.++.+++..||.+.++..|+=|.
T Consensus       488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            7888899999999999999999998876554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=8.2e-14  Score=117.50  Aligned_cols=129  Identities=19%  Similarity=0.157  Sum_probs=95.6

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      ++.|+.|.++.||++...  +..+++|+......    ....+.+|+.+++.+.+...+++++.+..  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            357899999999999864  77899999754321    12245789999998843333456655443  34579999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV-----IHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       136 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i-----vH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      |.++...        ......++.+++.+|..||+.++     +|+|++|.||+++    ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            9887543        11123567899999999999985     9999999999995    34699999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=5.5e-13  Score=128.29  Aligned_cols=184  Identities=15%  Similarity=0.148  Sum_probs=135.5

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |.+ +..+-++.+..-.|..+.++.+|.+..+..+.-   .......+-++-|+.+ +||||+++++.++.++..|+|+|
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEee
Confidence            444 444444444332566777899999988865432   3345677888999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc-
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-  210 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~-  210 (408)
                      -+.  .|..++++.+   ...+...+.||+.||.+|| +.+++|++|..+.|++   +..+..||++|.++........ 
T Consensus        90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~  161 (690)
T KOG1243|consen   90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP  161 (690)
T ss_pred             ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc
Confidence            985  5666776644   6777888999999999997 6689999999999999   6677899999988755432221 


Q ss_pred             eecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCC
Q 015352          211 FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGV  250 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~  250 (408)
                      ......--.|..|+.+... +-..|.|-|||++++++.|.
T Consensus       162 ~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  162 AKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcc
Confidence            1111112236666654321 13469999999999999993

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.47  E-value=6.3e-13  Score=108.30  Aligned_cols=148  Identities=20%  Similarity=0.221  Sum_probs=112.6

Q ss_pred             ecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-----ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        55 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      ....|-+|+-+.|+++.+  .|+...||.=.....+     ......+..+|+.+|.++ .--.|.-..-++.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence            467889999999999976  5787777754333332     223345678899999887 44455555556777777789


Q ss_pred             EEeccCC-CchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          130 VMELCEG-GELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       130 v~e~~~g-~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      +|||++| .++.+++....  .........++++|-..+.-||.++|+||||..+||++.+++....+.++|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999988 47777776542  2333334789999999999999999999999999999998777777899999998654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.42  E-value=1.6e-11  Score=114.90  Aligned_cols=290  Identities=15%  Similarity=0.160  Sum_probs=192.1

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE----eCCeEEEEEeccCC-C
Q 015352           63 EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE----DDNAVHLVMELCEG-G  137 (408)
Q Consensus        63 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----~~~~~~lv~e~~~g-~  137 (408)
                      --.+.|+|....+|..|++|++.-.+....   .....-+++|+++ .|+|+|++.++|.    .+..+++|++|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            346899999999999999999954433222   1233467899999 9999999999987    35678999999987 4


Q ss_pred             chHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          138 ELFDRIVAR---------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       138 ~L~~~l~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      +|.++.-..               ...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++   ...+++|...|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccce
Confidence            777765321               2478899999999999999999999999999999999994   4447999988877


Q ss_pred             cccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCC-CHHHH-HHHHHcCCcccCCCCCCCC
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGV-AQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~-~~~i~~~~~~~~~~~~~~~  280 (408)
                      .......           .  |.+.+  -.+-|.-.||.+++.|.||..--+.. ..++. ...|.           ..+
T Consensus       441 Dvl~~d~-----------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y  494 (655)
T KOG3741|consen  441 DVLQEDP-----------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY  494 (655)
T ss_pred             eeecCCC-----------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence            6654332           0  11111  13579999999999999996532211 11221 22222           367


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcC---ccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhh--hhhh----
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH---PWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVI--AEFL----  351 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i--~~~l----  351 (408)
                      +.+++++|.-+...++++ -++.+++.+   .||.......  ...+.....+.+-...-+|-+..++..  .+..    
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q--~~~d~mE~~Ls~emENGRLfRll~Kln~I~dR~e~~~  571 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQ--LKTDVMETELSREMENGRLFRLLLKLNFIDDRPEYVD  571 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHH--HHHHHHHHHHHHHHhcchHHHHHHHHhhhccCccccc
Confidence            899999999999999987 788888875   3443322110  001111122222222222222222221  1110    


Q ss_pred             --chhhh--HHH-----HHHHhhcCCCCCCccCHHHHHHHHHHhCC
Q 015352          352 --SVEEV--EDI-----KEMFKKIDSDNDGVVSTDELKAGLRNFGS  388 (408)
Q Consensus       352 --s~~~~--~~l-----~~~F~~~D~~~dG~i~~~el~~~l~~~g~  388 (408)
                        .+.+.  .-+     .-+|...|.|+..+++.-.+.++|.+++.
T Consensus       572 D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNKLDA  617 (655)
T KOG3741|consen  572 DPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNKLDA  617 (655)
T ss_pred             CCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhhccc
Confidence              01110  011     24667779999999999999999998863

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=3.8e-12  Score=104.32  Aligned_cols=135  Identities=24%  Similarity=0.296  Sum_probs=100.4

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh-----cHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      ..+++|+-+.+|.+...  |..+++|.=.+.......     ...+..+|+.++.++ .--.|....-+..+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence            35789999999999663  545667654443333221     234567799999887 5445555555566677788999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          132 ELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       132 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ||.+|..|.+.+...       ...+++.+-.-+.-||..||+|+||+++||++..    ..+.++|||++...
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~----~~i~~IDfGLg~~s  141 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG----GRIYFIDFGLGEFS  141 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC----CcEEEEECCccccc
Confidence            999998888888665       2567777777888999999999999999999953    33999999998764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=1.8e-11  Score=107.89  Aligned_cols=143  Identities=24%  Similarity=0.401  Sum_probs=104.9

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC-CCeeEEeeEEEeC---CeEEEEEe
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDD---NAVHLVME  132 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~---~~~~lv~e  132 (408)
                      +.|+.|.++.||++.... |..+++|+.......  .....+.+|+.+++.+.++ ..+++++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            568999999999998754 678999997654321  1245678999999998432 3467777666553   36789999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK------------------------------------------  170 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~------------------------------------------  170 (408)
                      |++|.++.+.+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765432 346777777777788888777773                                          


Q ss_pred             --------------CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          171 --------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       171 --------------~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                                    ..++|+|++|.||+++.+ ..+.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                          236999999999999542 135689999998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=3.3e-12  Score=123.46  Aligned_cols=150  Identities=19%  Similarity=0.360  Sum_probs=110.1

Q ss_pred             HHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce-----e-----cccCCCCCcchhhhhc-
Q 015352          161 IVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF-----S-----EIVGSPYYMAPEVLKR-  228 (408)
Q Consensus       161 l~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~-  228 (408)
                      +..|+.|+|.. ++||++|.|++|.+   +..+.+||+.|+++....++..+     .     -..-...|.|||.+.+ 
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             ccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            33899999976 89999999999999   66778999999998776553221     1     1123456999999876 


Q ss_pred             cCCCchhHHHHHHHHHHHh-hCCCCCCCCCHHHHHHHHHcCCcccCCC-CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 015352          229 NYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRD-PWPNVSESAKSLVRQMLEPDPKLRLTAKQVL  306 (408)
Q Consensus       229 ~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l  306 (408)
                      ..++++|++|+|+++|.+. .|+.-+...... ..........+.... .-.++|+++++=+.+++..++..||++..++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            5788999999999999999 455544433221 112222222111111 1157899999999999999999999999999


Q ss_pred             cCccccCC
Q 015352          307 EHPWLQNA  314 (408)
Q Consensus       307 ~h~~~~~~  314 (408)
                      ..|||.+.
T Consensus       264 ~~~ff~D~  271 (700)
T KOG2137|consen  264 SIPFFSDP  271 (700)
T ss_pred             cccccCCc
Confidence            99999874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.22  E-value=4.8e-10  Score=102.67  Aligned_cols=238  Identities=19%  Similarity=0.196  Sum_probs=159.7

Q ss_pred             EecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE------EeC-Ce
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC------EDD-NA  126 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~------~~~-~~  126 (408)
                      ...+.||+|+-+.+|..-.-.   ..+.|++.+.....      -.+.+..|.....||-+-.-+.|=      .+. ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchhh---chhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            346789999999999774322   24568887654321      123344455555666543312111      122 23


Q ss_pred             EEEEEeccCCCchHHHHH----hC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          127 VHLVMELCEGGELFDRIV----AR---GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~----~~---~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      +.++|..+.|..--..+.    ++   .......+....+.|+.+...||.+|.+-||++++|+|+   ++.+.|.|+|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence            778899888753222221    11   235677888999999999999999999999999999999   45667999987


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhh-c-----cCCCchhHHHHHHHHHHHhhC-CCCCCCCCH----HHHHH-HHHc
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK-R-----NYGPEIDIWSAGVILYILLCG-VPPFWAESE----QGVAQ-AILR  267 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwslG~il~~l~~g-~~pf~~~~~----~~~~~-~i~~  267 (408)
                      .......++..+...+|.+.|++||... +     .-+...|.|.||+++|+++.| ++||.+-..    ....+ .|-.
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            6555555666677778999999999865 2     346789999999999998886 999966311    11111 2222


Q ss_pred             CCcc------------cCCCCCCCCCHHHHHHHHHhcCC--CcCCCCCHH
Q 015352          268 GLID------------FKRDPWPNVSESAKSLVRQMLEP--DPKLRLTAK  303 (408)
Q Consensus       268 ~~~~------------~~~~~~~~~~~~~~~li~~~l~~--dp~~R~s~~  303 (408)
                      +.+.            ....+|.-+++.+..|..+|+..  ++.-|||++
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            2211            11234556889999999999964  356899974

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=7.9e-10  Score=99.28  Aligned_cols=137  Identities=16%  Similarity=0.094  Sum_probs=94.1

Q ss_pred             eEEEEEEECCCCcEEEEEEeeccccC----C----hhcHHHHHHHHHHHHhCCCCCC--eeEEeeEEEe-----CCeEEE
Q 015352           65 GVTYLCIDRDTRELLACKSISKRKLR----T----AVDIDDVRREVAIMKHLPKNSS--IVSLKEACED-----DNAVHL  129 (408)
Q Consensus        65 g~V~~~~~~~~~~~~aiK~~~~~~~~----~----~~~~~~~~~E~~~l~~l~~h~~--i~~~~~~~~~-----~~~~~l  129 (408)
                      ..|.++..  .|+.|.||........    .    ......+.+|...+..| ..-+  .+.+..+.+.     ....++
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEE
Confidence            34556543  4677888866322210    0    01122467788877776 2222  2334444432     235789


Q ss_pred             EEeccCCC-chHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC----CCCCCEEEeecccc
Q 015352          130 VMELCEGG-ELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK----KENSPLKAIDFGLS  202 (408)
Q Consensus       130 v~e~~~g~-~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~----~~~~~vkl~Dfg~~  202 (408)
                      |||+++|. +|.+++..  ....++.....++.+++..+.-||+.||+|+|+++.|||+..+    ++...+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999886 78888754  3456677888999999999999999999999999999999742    34567999999977


Q ss_pred             cc
Q 015352          203 IF  204 (408)
Q Consensus       203 ~~  204 (408)
                      ..
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            54

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=3.9e-10  Score=95.46  Aligned_cols=130  Identities=22%  Similarity=0.237  Sum_probs=82.0

Q ss_pred             EEEEEEECCCCcEEEEEEeeccccC-----------------------ChhcHHHHHHHHHHHHhCCCC-CCeeEEeeEE
Q 015352           66 VTYLCIDRDTRELLACKSISKRKLR-----------------------TAVDIDDVRREVAIMKHLPKN-SSIVSLKEAC  121 (408)
Q Consensus        66 ~V~~~~~~~~~~~~aiK~~~~~~~~-----------------------~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~  121 (408)
                      .||.|... .|..+|+|+.......                       .........+|.+.|.++... -++++++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999874 5779999998653111                       001124567899999999333 2467776553


Q ss_pred             EeCCeEEEEEeccC--CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          122 EDDNAVHLVMELCE--GGELFDRIVARGHYTERAAAAVTRTIVEVVQL-CHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       122 ~~~~~~~lv~e~~~--g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~-lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                          ..+|||||++  |..+.. +... .++......++.+++..+.. +|..||+||||++.||++..   + .+.++|
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~---~-~~~iID  149 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD---G-KVYIID  149 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET---T-CEEE--
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec---c-eEEEEe
Confidence                2359999998  655544 3332 12245567788888885554 68999999999999999953   2 699999


Q ss_pred             cccccccC
Q 015352          199 FGLSIFFK  206 (408)
Q Consensus       199 fg~~~~~~  206 (408)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99887643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=4.1e-09  Score=91.58  Aligned_cols=110  Identities=19%  Similarity=0.223  Sum_probs=85.0

Q ss_pred             HHHHHHHHHHHHhCC--CCCCeeEEeeEEEeC----CeEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015352           95 IDDVRREVAIMKHLP--KNSSIVSLKEACEDD----NAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVEVVQL  167 (408)
Q Consensus        95 ~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~----~~~~lv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~  167 (408)
                      .....+|...+..|.  +-| .+..+.+.+..    ...++|+|+++|. +|.+++......+......++.++...+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~-tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIP-TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCC-CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            345677777766661  222 44555555442    2468999999985 798888775557778889999999999999


Q ss_pred             HHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       168 lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ||++||+|+|+++.|||+..++....+.|+||+-+...
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999987665668999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=1.1e-08  Score=89.18  Aligned_cols=139  Identities=23%  Similarity=0.302  Sum_probs=100.9

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccc--cC---------------C--hhcHHHHHHHHHHHHhCCCC-C
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK--LR---------------T--AVDIDDVRREVAIMKHLPKN-S  112 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~---------------~--~~~~~~~~~E~~~l~~l~~h-~  112 (408)
                      +.+...||-|--|.||.|.+. .|.++|+|.=....  ++               +  ...+....+|.++|.+|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456789999999999999976 68899999753211  00               0  11234578899999999322 2


Q ss_pred             CeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      .+++.+++    +.-.+||||++|..|...     ++....+..++..|+.-+.-+-..|+||||+++-||++   ++++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg  239 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG  239 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence            46666544    455699999999777542     12355666677777777776668999999999999999   4566


Q ss_pred             CEEEeecccccc
Q 015352          193 PLKAIDFGLSIF  204 (408)
Q Consensus       193 ~vkl~Dfg~~~~  204 (408)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            799999976554

>PRK09902 hypothetical protein; Provisional

Probab=98.86  E-value=6.2e-08  Score=82.62  Aligned_cols=141  Identities=16%  Similarity=0.118  Sum_probs=100.4

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeeccc---cCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEE---e--CCeEE
Q 015352           59 LGRGEFGVTYLCIDRDTRELLACKSISKRK---LRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACE---D--DNAVH  128 (408)
Q Consensus        59 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~---~--~~~~~  128 (408)
                      -|+||-+.|++....  |..+-+|.-....   ..-......+.+|...+.+|.  +-| ++++. ++.   .  .-..+
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~  101 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRAL  101 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEE
Confidence            467888899997653  4467788764211   111334678899999988882  223 44444 332   1  12468


Q ss_pred             EEEeccCC-CchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          129 LVMELCEG-GELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       129 lv~e~~~g-~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ||+|-++| .+|.+++.+.  .+.++.....++.++..++.-||+.|+.|+|+.+.||++..++ ...++++||.-++.
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            99997765 4888877653  3467788889999999999999999999999999999996433 34599999986654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.81  E-value=3.1e-10  Score=108.96  Aligned_cols=246  Identities=17%  Similarity=0.171  Sum_probs=172.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC-eeEEeeEEEeCCe
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDNA  126 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-i~~~~~~~~~~~~  126 (408)
                      +-...|......++|+++.+++.+...+...+ .+++...        ....-++++|.++ +||| .+..++-++.+.+
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCCcccc
Confidence            34445666778999999999999887665544 6666533        3445688999999 8999 7777777888889


Q ss_pred             EEEEEeccCCC-c-hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGG-E-LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~-~-L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .+++++++.++ + ....-...-.+.+-+...+.+.-+.+++++|+.-=+|+|    ||+.+    +...+..||+....
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQ  380 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcc
Confidence            99999999887 2 211111111234445556677778899999998778998    88864    35689999999887


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC---CCCCCC
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR---DPWPNV  280 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~  280 (408)
                      +.......+..+++.++|||+..+ .+....|.|++|.-..++--|.+|-....  .....+-.+.-.+..   ..|...
T Consensus       381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~  458 (829)
T KOG0576|consen  381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPV  458 (829)
T ss_pred             cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcc
Confidence            766655667789999999997764 68899999999987777777776643311  111111111100000   111111


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                        .-+++...|+...|..|+....++.|.+|....
T Consensus       459 --~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  459 --FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             --cccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence              112578899999999999999999999998754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.74  E-value=1.4e-07  Score=96.95  Aligned_cols=207  Identities=18%  Similarity=0.194  Sum_probs=148.5

Q ss_pred             HHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe----EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015352           95 IDDVRREVAIMKHLPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK  170 (408)
Q Consensus        95 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~----~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~  170 (408)
                      +....-|+..+.++ .|+|+..++.+--....    ..+..++|.+.++...+..-+.++....+.+..+++.||.|+|+
T Consensus       226 i~~~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            44556677788887 89999999888654332    33556899999999999999999999999999999999999999


Q ss_pred             CCCeeccCCCCceEeecCCCCCCEEEe--ecccccccCCCCceecccCCCCCcchhhhhcc-C--CCchhHHHHHHHHHH
Q 015352          171 HGVIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-Y--GPEIDIWSAGVILYI  245 (408)
Q Consensus       171 ~~ivH~dikp~NIl~~~~~~~~~vkl~--Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~--~~~~DiwslG~il~~  245 (408)
                      ....|.-+...-..-...+..+.+..+  ||+.+..............+..+.+||....+ +  ....|+|.+|.....
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            966666555553333223445556666  88888776655544444556678888877653 3  334699999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       246 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +..|..+-   ........++..          .......+.+.+|+..++++|+++.+++.|+|.+...
T Consensus       385 ~~~~~~i~---~~~~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  385 LSQGEDIS---EKSAVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hhhcCccc---ccccchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            99876542   111111111111          1112678899999999999999999999999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.70  E-value=2.7e-07  Score=79.01  Aligned_cols=142  Identities=22%  Similarity=0.227  Sum_probs=88.8

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHH------HHHHHHHHHHhCC--CCCCeeEEee
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID------DVRREVAIMKHLP--KNSSIVSLKE  119 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~------~~~~E~~~l~~l~--~h~~i~~~~~  119 (408)
                      -+..+|.+.+.+-......|.+..-  .|..+++|..............      ...+++..+..+.  +......++-
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            3556788888888777776766643  5778999987543221111111      1223333333331  2222223222


Q ss_pred             E-----EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          120 A-----CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       120 ~-----~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                      +     +.-....+++|||++|..|.+..    .+++    .+...+.+++.-||+.|++|||..|.|+++++    +.+
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~----~~i  173 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN----NGI  173 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC----CcE
Confidence            2     22334567899999998886542    1333    34466778899999999999999999999963    339


Q ss_pred             EEeeccccc
Q 015352          195 KAIDFGLSI  203 (408)
Q Consensus       195 kl~Dfg~~~  203 (408)
                      +++||+...
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.68  E-value=3.7e-07  Score=80.36  Aligned_cols=73  Identities=19%  Similarity=0.208  Sum_probs=55.1

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC-eeEEeeEEEeCCeEEEEEeccC
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      ..||+|..+.||+.    .|..+++|......     ....+.+|.++++.+....- +++.+.+.++.+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            46899999999984    24567888875322     24567889999988833322 6788888888888899999999


Q ss_pred             CCc
Q 015352          136 GGE  138 (408)
Q Consensus       136 g~~  138 (408)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=2.1e-07  Score=90.65  Aligned_cols=144  Identities=19%  Similarity=0.240  Sum_probs=94.2

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccC--------------------Ch---hc----H----------HHHH
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--------------------TA---VD----I----------DDVR   99 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------~~---~~----~----------~~~~   99 (408)
                      +.|+.++-|.||+|+.+. |+.||||+.+..-..                    ..   .+    .          -.+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            679999999999999864 999999998543110                    00   00    0          1234


Q ss_pred             HHHHHHHhC----CCCCCeeEEeeEEEeCCeEEEEEeccCCCchHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 015352          100 REVAIMKHL----PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTRTIVEVVQLCHKHGV  173 (408)
Q Consensus       100 ~E~~~l~~l----~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i  173 (408)
                      +|...+.++    .+.|++.-..=+++..+.-.++|||++|..+.+..  +. ...+...+...+.++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            455555444    34555544433555566778999999999888773  34 3455333333322221  222334899


Q ss_pred             eeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       174 vH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|.|..|.||++   ..++.+.+.|||+.....+
T Consensus       287 fHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         287 FHADPHPGNILV---RSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence            999999999999   4557899999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.62  E-value=1.2e-06  Score=74.87  Aligned_cols=137  Identities=24%  Similarity=0.288  Sum_probs=98.8

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeecccc-------------CChhcHHHHHHHHHHHHhCC-----CCCCeeEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-------------RTAVDIDDVRREVAIMKHLP-----KNSSIVSL  117 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~  117 (408)
                      ...||+|+.-.||.--+   ....+||+......             ..........+|+.....+.     .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35789999999987633   33478999876650             01122456677777776662     26779999


Q ss_pred             eeEEEeCCeEEEEEeccCC------CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          118 KEACEDDNAVHLVMELCEG------GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~g------~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      +|+.+++....+|+|.+..      .||.+++.+. .+++    .+...+-.-..||-+++|+.+|++|.||++...++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998743      3788888544 4555    333444455678889999999999999999876655


Q ss_pred             C-CEEEee-cc
Q 015352          192 S-PLKAID-FG  200 (408)
Q Consensus       192 ~-~vkl~D-fg  200 (408)
                      . .+.|+| ||
T Consensus       158 ~~~lvlIDG~G  168 (199)
T PF10707_consen  158 EFRLVLIDGLG  168 (199)
T ss_pred             ceEEEEEeCCC
Confidence            5 688888 44

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.59  E-value=5e-07  Score=80.85  Aligned_cols=76  Identities=14%  Similarity=0.140  Sum_probs=55.4

Q ss_pred             eecccCC-eEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           58 ELGRGEF-GVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        58 ~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      .|-.|.+ +.||++...  +..+++|+.....      ...+.+|+++++.+..+--+++++.+...++..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 789999653  4678888875332      235678999998885555577888888877788999999999


Q ss_pred             CchHH
Q 015352          137 GELFD  141 (408)
Q Consensus       137 ~~L~~  141 (408)
                      .+|..
T Consensus        77 ~~l~~   81 (244)
T cd05150          77 VPAAA   81 (244)
T ss_pred             ccHhH
Confidence            77654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=1.1e-06  Score=77.95  Aligned_cols=79  Identities=23%  Similarity=0.214  Sum_probs=56.3

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC-CeeEEeeEE---EeCCeEEEEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEAC---EDDNAVHLVM  131 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~~---~~~~~~~lv~  131 (408)
                      ++.|+.|..+.||++....  ..+++|+....     .....+.+|..+++.|..+. .+++++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            3578999999999998765  47999997533     23567788999988884332 256666643   2334679999


Q ss_pred             eccCCCchHH
Q 015352          132 ELCEGGELFD  141 (408)
Q Consensus       132 e~~~g~~L~~  141 (408)
                      ++++|.++..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=1.2e-06  Score=75.86  Aligned_cols=140  Identities=19%  Similarity=0.162  Sum_probs=92.6

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh----------------cH-----HHHHHHHHHHHhCCC-CCCe
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV----------------DI-----DDVRREVAIMKHLPK-NSSI  114 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----------------~~-----~~~~~E~~~l~~l~~-h~~i  114 (408)
                      ..|++|--+.||+|.. ..+..+|+|++.........                ..     .-..+|..-|+++.. +=.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3667788889999975 46889999999654321100                11     123567777777611 2234


Q ss_pred             eEEeeEEEeCCeEEEEEeccCCCch-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCC
Q 015352          115 VSLKEACEDDNAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       115 ~~~~~~~~~~~~~~lv~e~~~g~~L-~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      ++.+.+.    .-.+||||+....+ .-.|+.- .+...++..+..++++.+.-|-. .++||+||+.-|||+.    .+
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~  203 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DG  203 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CC
Confidence            4554443    34599999955311 1112221 23344788888999999887766 8999999999999994    45


Q ss_pred             CEEEeecccccccC
Q 015352          193 PLKAIDFGLSIFFK  206 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~  206 (408)
                      .+.++|||-|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            68999999887654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=1.3e-06  Score=71.50  Aligned_cols=131  Identities=23%  Similarity=0.247  Sum_probs=91.1

Q ss_pred             EecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEec
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      +..+.||+|.+|.||++.++  |..+|+|+-..+     .....+..|+++|..+..-..-++++.+-++    ++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            45678999999999999875  668999986533     3467889999999998444445566655443    345999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC-C-ceEeecCCCCCCEEEeecccccccC
Q 015352          134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP-E-NFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       134 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp-~-NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ..|..|.+.....   .    +.-+..++.+---|-..||-|+.|+- . ||++.    ...+.|+||..|+.-.
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k~  157 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFKK  157 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhcc
Confidence            9998886654221   2    23334455555557778999999874 3 56652    2369999999888543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.46  E-value=1.9e-06  Score=90.30  Aligned_cols=148  Identities=19%  Similarity=0.367  Sum_probs=92.4

Q ss_pred             cceecccCCeEEEEEEECCCC--cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCe--eEEeeEEEeC---CeEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTR--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI--VSLKEACEDD---NAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i--~~~~~~~~~~---~~~~  128 (408)
                      .+.++.|.++.+|+......+  ..+++|+.......  .....+.+|+.+++.+..|+++  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            567899999999998765432  46777776543221  1235688999999998445554  7888777664   4688


Q ss_pred             EEEeccCCCchHH--------------------HHH---hCC----------C---CCHHHHHHHHHH------------
Q 015352          129 LVMELCEGGELFD--------------------RIV---ARG----------H---YTERAAAAVTRT------------  160 (408)
Q Consensus       129 lv~e~~~g~~L~~--------------------~l~---~~~----------~---~~~~~~~~i~~q------------  160 (408)
                      +||||++|..+.+                    .+.   .-.          .   +...++..+..+            
T Consensus       121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~  200 (822)
T PLN02876        121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR  200 (822)
T ss_pred             EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence            9999999864321                    111   100          0   111233322222            


Q ss_pred             ---HHHHHHHHHH-----------CCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          161 ---IVEVVQLCHK-----------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       161 ---l~~~l~~lH~-----------~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                         +...+.+|..           ..+||+|+++.||++..++ ...+-|.||+++....
T Consensus       201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~-~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTE-DRVIGILDWELSTLGN  259 (822)
T ss_pred             ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCC-CeEEEEEeeeccccCC
Confidence               2233556632           2499999999999996422 2345799999877543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.32  E-value=3.3e-05  Score=65.59  Aligned_cols=131  Identities=18%  Similarity=0.173  Sum_probs=90.8

Q ss_pred             cccceEecceecccCC-eEEEEEEECCCCcEEEEEEeeccccCC-----------h-------hcHHHHHHHHHHHHhCC
Q 015352           49 IEDRYLVDRELGRGEF-GVTYLCIDRDTRELLACKSISKRKLRT-----------A-------VDIDDVRREVAIMKHLP  109 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------~-------~~~~~~~~E~~~l~~l~  109 (408)
                      ....++.++.||.|.- |.||++..  .|+.||+|+...-....           .       .....|..|-+...+|.
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            3478999999999999 99999976  57899999932211100           0       11234667777666662


Q ss_pred             --CCCCe--eEEeeEEEeC------------------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 015352          110 --KNSSI--VSLKEACEDD------------------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL  167 (408)
Q Consensus       110 --~h~~i--~~~~~~~~~~------------------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~  167 (408)
                        ++.++  ++.++|..-.                  ....||.||++...         .++    ..-+.+|+.-+..
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHH
Confidence              34445  8888887322                  12457888887643         122    2335677778899


Q ss_pred             HHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       168 lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      +|..||+-+|+++.|..=        -||+|||.+
T Consensus       180 ~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HHHCCeeeccCccccccC--------CEEEecccC
Confidence            999999999999999872        289999964

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=98.28  E-value=2.5e-06  Score=69.12  Aligned_cols=63  Identities=32%  Similarity=0.524  Sum_probs=54.2

Q ss_pred             Hhhhhhhhh-chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          343 ALRVIAEFL-SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       343 ~l~~i~~~l-s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...+ ..+..+++..+|+.||.|++|+|+..||+.+++.+|.+++++||+.|++.+|.+
T Consensus        77 Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d  140 (160)
T COG5126          77 FLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDED  140 (160)
T ss_pred             HHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCC
Confidence            445555555 344578899999999999999999999999999999999999999999999854

>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=98.22  E-value=2.9e-06  Score=66.72  Aligned_cols=61  Identities=16%  Similarity=0.451  Sum_probs=54.7

Q ss_pred             hhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Q 015352          344 LRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS  404 (408)
Q Consensus       344 l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~  404 (408)
                      ...+...+.+.++++++++|..+|.|+||.|.+++|++.|..+|..+++++++.||.++.-
T Consensus        19 sSnvFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea~g   79 (171)
T KOG0031|consen   19 SSNVFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEAPG   79 (171)
T ss_pred             cchHHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhCCC
Confidence            3444566788999999999999999999999999999999999999999999999998753

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.17  E-value=6.3e-05  Score=71.36  Aligned_cols=81  Identities=19%  Similarity=0.227  Sum_probs=56.1

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeecccc--CC--hhcHHHHHHHHHHHHhCCCC--CCeeEEeeEEEeCCeEEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RT--AVDIDDVRREVAIMKHLPKN--SSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~--~~~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.||.|.+..||++.....++.++||.......  ..  ....++...|.+.|+.+...  .++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            3679999999999999865446899998542110  01  12456777888888886332  457777766  4456789


Q ss_pred             EEeccCCCc
Q 015352          130 VMELCEGGE  138 (408)
Q Consensus       130 v~e~~~g~~  138 (408)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.1e-05  Score=71.68  Aligned_cols=74  Identities=15%  Similarity=0.066  Sum_probs=47.1

Q ss_pred             cceecccCCe-EEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC--CeeEEeeEEEeC---CeEEE
Q 015352           56 DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS--SIVSLKEACEDD---NAVHL  129 (408)
Q Consensus        56 ~~~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--~i~~~~~~~~~~---~~~~l  129 (408)
                      ++.|+.|+.. .||+.     +..+++|+....     .....+.+|.+++..|..+-  .++.+++.....   ...++
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            3567777766 58986     234777875431     12457889999999884331  245555544332   24588


Q ss_pred             EEeccCCCch
Q 015352          130 VMELCEGGEL  139 (408)
Q Consensus       130 v~e~~~g~~L  139 (408)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            9999999766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand

Probab=98.14  E-value=2.7e-06  Score=48.00  Aligned_cols=29  Identities=31%  Similarity=0.698  Sum_probs=26.6

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      +++++|+.+|.|+||+|+.+|+..+++++
T Consensus         1 E~~~~F~~~D~d~dG~I~~~Ef~~~~~~L   29 (29)
T PF00036_consen    1 ELKEAFREFDKDGDGKIDFEEFKEMMKKL   29 (29)
T ss_dssp             HHHHHHHHHSTTSSSEEEHHHHHHHHHHT
T ss_pred             CHHHHHHHHCCCCCCcCCHHHHHHHHHhC
Confidence            47889999999999999999999999864

This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.11  E-value=2.5e-05  Score=76.21  Aligned_cols=145  Identities=17%  Similarity=0.195  Sum_probs=89.5

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh-----------------------------cHHH------HHH
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----------------------------DIDD------VRR  100 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------------------------~~~~------~~~  100 (408)
                      .+.||.-+.|.||+|+.+. |+.||||+=+.. +....                             -.+.      +.+
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            3679999999999999876 999999986432 21100                             0011      222


Q ss_pred             HHHHHHhCC---CCCC------eeEEeeEEEeCCeEEEEEeccCCCchHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 015352          101 EVAIMKHLP---KNSS------IVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTRTIVEVVQLCH  169 (408)
Q Consensus       101 E~~~l~~l~---~h~~------i~~~~~~~~~~~~~~lv~e~~~g~~L~~--~l~~~~~~~~~~~~~i~~ql~~~l~~lH  169 (408)
                      |.+-..++.   .|-+      |++++  +.....-.++|||++|..+.+  .+.+.+ ++...+...+.+...  .-+=
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf  318 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIF  318 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHH
Confidence            333222210   2333      44443  233445789999999986655  344443 555543333333222  2233


Q ss_pred             HCCCeeccCCCCceEeecC-CCCCCEEEeecccccccCC
Q 015352          170 KHGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       170 ~~~ivH~dikp~NIl~~~~-~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ..|++|+|=.|.||++..+ ..+..+.+-|||+......
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            5789999999999999753 3567899999999876543

>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13

Probab=98.11  E-value=6.3e-06  Score=60.51  Aligned_cols=51  Identities=12%  Similarity=0.188  Sum_probs=46.7

Q ss_pred             hhHHHHHHHhhcCC-CCCCccCHHHHHHHHHH-hCCCCCH-HHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDS-DNDGVVSTDELKAGLRN-FGSQLAE-SEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~-~~dG~i~~~el~~~l~~-~g~~~~~-~e~~~~~~~~d~~  405 (408)
                      .+..+.++|..+|. +++|+|+.+||+.++++ +|..++. .++++||+.+|.|
T Consensus         6 ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d   59 (89)
T cd05022           6 AIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVN   59 (89)
T ss_pred             HHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCC
Confidence            35678899999999 99999999999999999 9987888 9999999999986

S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu

>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B

Probab=98.10  E-value=1e-05  Score=59.51  Aligned_cols=51  Identities=18%  Similarity=0.266  Sum_probs=46.4

Q ss_pred             hhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKID-SDNDG-VVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+.++|+.+| .+++| .|+.+||+.+|+.     +|...++++++++|+.+|.|
T Consensus         6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n   63 (88)
T cd05027           6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSD   63 (88)
T ss_pred             HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCC
Confidence            3567899999998 79999 5999999999999     89888999999999999876

S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.09  E-value=4.3e-05  Score=67.90  Aligned_cols=76  Identities=18%  Similarity=0.226  Sum_probs=49.6

Q ss_pred             cceecccCCeEEEEEEECC-CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           56 DRELGRGEFGVTYLCIDRD-TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      ++.|..|-...+|++.... .+..|++|+...... .   .-...+|+.+++.+..+...++++.....    .+||||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-L---IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-c---eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence            3567888889999997543 356788997653211 1   11234688888888444445666554432    3799999


Q ss_pred             CCCch
Q 015352          135 EGGEL  139 (408)
Q Consensus       135 ~g~~L  139 (408)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            99765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=98.08  E-value=8.8e-06  Score=65.97  Aligned_cols=56  Identities=32%  Similarity=0.563  Sum_probs=53.2

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS  404 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~  404 (408)
                      ..++.++.++++++|..+|.|++|.|++.||..+|+.+|..+++.++.+||..+|.
T Consensus        12 ~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~   67 (160)
T COG5126          12 TQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA   67 (160)
T ss_pred             ccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC
Confidence            46788999999999999999999999999999999999999999999999999985

>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]

Probab=98.05  E-value=1.8e-05  Score=62.88  Aligned_cols=54  Identities=28%  Similarity=0.460  Sum_probs=50.6

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSVLA  407 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~~~  407 (408)
                      +..++++.+|+.+|.|++|.|+..+|+.+.+.||.+++++|+++|++++|.+.-
T Consensus       103 dt~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~d  156 (172)
T KOG0028|consen  103 DTKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGD  156 (172)
T ss_pred             CcHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhccccc
Confidence            467889999999999999999999999999999999999999999999998763

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=98.03  E-value=1e-05  Score=66.47  Aligned_cols=52  Identities=33%  Similarity=0.528  Sum_probs=48.7

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSVL  406 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~~  406 (408)
                      ...+++++|+.+|.|++|+|+.+||+.+|..+|.+.+..+++++++.+|.+.
T Consensus        83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~  134 (151)
T KOG0027|consen   83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDG  134 (151)
T ss_pred             cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCC
Confidence            4568999999999999999999999999999999999999999999999753

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=97.97  E-value=2e-05  Score=64.83  Aligned_cols=54  Identities=37%  Similarity=0.532  Sum_probs=50.6

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+..+++++|..+|.|++|+|+.+||..+++.+|..+++.++..+++++|.+
T Consensus         3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~d   56 (151)
T KOG0027|consen    3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLD   56 (151)
T ss_pred             CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            456678899999999999999999999999999999999999999999999976

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.95  E-value=7e-05  Score=67.50  Aligned_cols=134  Identities=16%  Similarity=0.090  Sum_probs=76.1

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCC
Q 015352           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG  137 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~  137 (408)
                      .+..|-.+.+|+..  .++..+++|+.......-.   -...+|..+++.+..+.-.++++....    -++|+||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG---VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc---CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            35678888999886  3466788887653321110   124679999998844433344444432    36899999986


Q ss_pred             chHH--------------HHHh---CC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCeeccC
Q 015352          138 ELFD--------------RIVA---RG----HYTE-RAAAAVTRTI---------VEVVQLCHK--------HGVIHRDL  178 (408)
Q Consensus       138 ~L~~--------------~l~~---~~----~~~~-~~~~~i~~ql---------~~~l~~lH~--------~~ivH~di  178 (408)
                      ++..              .+.+   ..    +++. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            6531              1111   10    1111 1222222222         111222222        24899999


Q ss_pred             CCCceEeecCCCCCCEEEeecccccc
Q 015352          179 KPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       179 kp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .|.||+++.   ++ +.|+||+.+..
T Consensus       154 ~~~Nil~~~---~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTP---QG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeC---CC-CEEEeccccCc
Confidence            999999953   22 78999998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.95  E-value=2.3e-06  Score=90.29  Aligned_cols=208  Identities=16%  Similarity=0.052  Sum_probs=140.3

Q ss_pred             HHHHHHHHHHHhCCCCCCeeEEeeEEEe--CCeEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH
Q 015352           96 DDVRREVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCH  169 (408)
Q Consensus        96 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH  169 (408)
                      +....|..-++.. .|+++.....-...  ...-|..++|+.+|.+++.+-++    ..+.+..+.....+.+.+..-+|
T Consensus      1274 emll~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1274 EMLLSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             Hhhhhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            3445555556665 78888776655543  34568999999999999998664    22444445555555577777777


Q ss_pred             HCC-----CeeccCCCCceEeecCCCCCCEEEeecccccccCC-CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHH
Q 015352          170 KHG-----VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVI  242 (408)
Q Consensus       170 ~~~-----ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i  242 (408)
                      +..     .+|+++|+-|.++   ..+..+|+.++|+.+...+ ........+++.|++|++... .++.++|+|..|+.
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred             hcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence            642     6899999999999   4566799999999984333 334455678889999998876 68888999999999


Q ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC-CC-CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          243 LYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-WP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       243 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~-~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      +|....|..+|.     ...+.++++..+..... .+ -.|.++-.....+|-..-..||.-...+.-+.+.
T Consensus      1430 ly~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHhcccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            999999988873     33444444443322110 01 1233444444445555566788777777766553

>PF13405 EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J_B 1OE9_B 1W7I_B 1KFU_S 1KFX_S 2BL0_B 1Y1X_B 3MSE_B

Probab=97.91  E-value=1.2e-05  Score=46.35  Aligned_cols=30  Identities=43%  Similarity=0.774  Sum_probs=26.6

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHH-HhC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLR-NFG  387 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~-~~g  387 (408)
                      +++++|..+|.|++|+|+.+||..+|+ ++|
T Consensus         1 ~l~~~F~~~D~d~dG~I~~~el~~~l~~~lG   31 (31)
T PF13405_consen    1 RLREAFKMFDKDGDGFIDFEELRAILRKSLG   31 (31)
T ss_dssp             HHHHHHHHH-TTSSSEEEHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHCCCCCCcCcHHHHHHHHHHhcC
Confidence            467899999999999999999999999 676

...

>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E

Probab=97.91  E-value=2.4e-05  Score=54.28  Aligned_cols=48  Identities=31%  Similarity=0.614  Sum_probs=40.2

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHH----HHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV----QMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~----~~~~~~~d~~  405 (408)
                      .++++|..+|.|++|+|+.+||..+++.++...++.++    +.+++.+|.|
T Consensus         1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d   52 (66)
T PF13499_consen    1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTD   52 (66)
T ss_dssp             HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTT
T ss_pred             CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCC
Confidence            36789999999999999999999999999966555444    4459988876

...

>smart00027 EH Eps15 homology domain

Probab=97.89  E-value=3.7e-05  Score=57.81  Aligned_cols=53  Identities=21%  Similarity=0.357  Sum_probs=47.7

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...++++|..+|.|++|.|+.+|++.+++..|  +++.+++++++.+|.+
T Consensus         4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~   56 (96)
T smart00027        4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADID   56 (96)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCC
Confidence            4567888999999999999999999999999999976  5889999999998865

Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.82  E-value=7.4e-05  Score=63.62  Aligned_cols=99  Identities=18%  Similarity=0.243  Sum_probs=77.4

Q ss_pred             HHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Q 015352          100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR---IVARGHYTERAAAAVTRTIVEVVQLCHK---HGV  173 (408)
Q Consensus       100 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~---l~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i  173 (408)
                      .|.-+++.+.+.+++++++|++..    +++.||...+++...   +..-...++.....|+.+++..+.+++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            488889998666799999999833    578999987665321   1122346789999999999999999997   458


Q ss_pred             eeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       174 vH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .-.|++|+|+-++   +++.+|++|.......
T Consensus        84 ~lcDv~~~nfgv~---~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVN---DDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEe---CCCcEEEEechhcchh
Confidence            8899999999995   5567999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.82  E-value=0.00015  Score=66.79  Aligned_cols=138  Identities=17%  Similarity=0.200  Sum_probs=81.1

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC-CeeEEee------EEEeCCeEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKE------ACEDDNAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~------~~~~~~~~~  128 (408)
                      .+.|..|....+|+....  +..+++|+...      .....+..|+.++..|..+. .+++++.      +...++..+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            456778888899998643  34688898753      12355677888888773221 2445443      223456678


Q ss_pred             EEEeccCCCchHH----HH----------HhC-CCCCH--------H----HH--------HHHHHHHHHHHHHHHH---
Q 015352          129 LVMELCEGGELFD----RI----------VAR-GHYTE--------R----AA--------AAVTRTIVEVVQLCHK---  170 (408)
Q Consensus       129 lv~e~~~g~~L~~----~l----------~~~-~~~~~--------~----~~--------~~i~~ql~~~l~~lH~---  170 (408)
                      +|+++++|..+..    ..          ... ..+..        .    ..        ......+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999866421    01          000 00000        0    00        0011122334445443   


Q ss_pred             ----CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          171 ----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       171 ----~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                          .+++|+|+.|.||+++   ++..+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence                4799999999999995   344468999997654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6

Probab=97.78  E-value=7.2e-05  Score=54.97  Aligned_cols=51  Identities=24%  Similarity=0.412  Sum_probs=45.2

Q ss_pred             hhHHHHHHHhhcCC-CC-CCccCHHHHHHHHHH---hCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDS-DN-DGVVSTDELKAGLRN---FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~-~~-dG~i~~~el~~~l~~---~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+..+|..+|. |+ +|+|+.+||+.++++   +|.+++++|++++|+.+|.+
T Consensus         8 ~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d   63 (88)
T cd05029           8 AIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRN   63 (88)
T ss_pred             HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC
Confidence            35668899999998 77 899999999999973   69999999999999999876

S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.75  E-value=0.00021  Score=66.08  Aligned_cols=76  Identities=13%  Similarity=0.100  Sum_probs=49.6

Q ss_pred             ceecccCCeEEEEEEECC------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           57 RELGRGEFGVTYLCIDRD------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +.+..|-...||++....      .++.+++|+..... .   ......+|..+++.+......++++.++..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-E---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-c---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            456677778999987543      25789999965432 1   123456788888888444444566665542    358


Q ss_pred             EeccCCCchH
Q 015352          131 MELCEGGELF  140 (408)
Q Consensus       131 ~e~~~g~~L~  140 (408)
                      +||++|.++.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999987653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.70  E-value=0.0004  Score=63.85  Aligned_cols=145  Identities=18%  Similarity=0.184  Sum_probs=98.2

Q ss_pred             EecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-------------------ChhcHH----HHHHHHHHHHhCCC
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-------------------TAVDID----DVRREVAIMKHLPK  110 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------------------~~~~~~----~~~~E~~~l~~l~~  110 (408)
                      .+...|..|--+.||.|.. ..|..+|||++..+-+.                   ..+.++    ....|+.-|+++ +
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N  224 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence            4567788999999999975 46888999998543211                   111122    245688888888 5


Q ss_pred             CCCeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCCceEeecCC
Q 015352          111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-HKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       111 h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~ivH~dikp~NIl~~~~~  189 (408)
                      ...|+..--+. -. .-.+||+++.+.....-..+.-.++...+..+-.|++.-+.-| |..++||.||+--|+|+    
T Consensus       225 ~aGIP~PePIl-Lk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----  298 (520)
T KOG2270|consen  225 NAGIPCPEPIL-LK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----  298 (520)
T ss_pred             hcCCCCCCcee-ee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----
Confidence            44443221111 11 3469999996543322222344678888999989988888776 56799999999999999    


Q ss_pred             CCCCEEEeecccccccC
Q 015352          190 ENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~  206 (408)
                      ..+.+.++|.+-+....
T Consensus       299 hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             ECCEEEEEEccccccCC
Confidence            35679999998776543

>cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10

Probab=97.70  E-value=9.9e-05  Score=55.20  Aligned_cols=50  Identities=18%  Similarity=0.260  Sum_probs=44.1

Q ss_pred             hHHHHHHHhhcCC-CC-CCccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDS-DN-DGVVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~-~~-dG~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+.++|..+|. |+ +|.|+.+||+.+|+.     +|..+++++++.+++.+|.+
T Consensus         7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~   63 (94)
T cd05031           7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQN   63 (94)
T ss_pred             HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCC
Confidence            5678999999997 97 799999999999986     56688999999999999865

S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.70  E-value=0.00066  Score=63.16  Aligned_cols=77  Identities=16%  Similarity=0.161  Sum_probs=50.3

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeeccc--c--CChhcHHHHHHHHHHHHhCCC-CC-CeeEEeeEEEeCCeEEEEE
Q 015352           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRK--L--RTAVDIDDVRREVAIMKHLPK-NS-SIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~--~~~~~~~~~~~E~~~l~~l~~-h~-~i~~~~~~~~~~~~~~lv~  131 (408)
                      .||.|....||++.....++.++||.-...-  .  .-....++..-|...|+.... .| .+++++  +-+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            5899999999999976444679998764211  1  113345666778888877633 23 455554  33445566999


Q ss_pred             eccCC
Q 015352          132 ELCEG  136 (408)
Q Consensus       132 e~~~g  136 (408)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99855

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif

Probab=97.61  E-value=0.00014  Score=53.60  Aligned_cols=52  Identities=21%  Similarity=0.324  Sum_probs=45.0

Q ss_pred             hhhHHHHHHHhhcCC--CCCCccCHHHHHHHHHH-hCCCC----CHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDS--DNDGVVSTDELKAGLRN-FGSQL----AESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~--~~dG~i~~~el~~~l~~-~g~~~----~~~e~~~~~~~~d~~  405 (408)
                      +++..++++|..+|.  |++|.|+.+|+..+++. +|..+    +..+++.++..+|.+
T Consensus         5 ~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~   63 (88)
T cd00213           5 KAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVN   63 (88)
T ss_pred             HHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccC
Confidence            456789999999999  89999999999999986 56444    589999999999875

Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th

>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=97.60  E-value=0.00029  Score=55.71  Aligned_cols=63  Identities=24%  Similarity=0.376  Sum_probs=53.4

Q ss_pred             Hhhhhhhhhc-hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          343 ALRVIAEFLS-VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       343 ~l~~i~~~ls-~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+.+.++ .+-.+.+..+|..||.+++|.|..+.|+++|...|.+++++||++|++..-.+
T Consensus        86 FLTmfGekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d  149 (171)
T KOG0031|consen   86 FLTMFGEKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPID  149 (171)
T ss_pred             HHHHHHHHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcc
Confidence            4555556553 34466789999999999999999999999999999999999999999987664

>cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1

Probab=97.60  E-value=0.00018  Score=53.58  Aligned_cols=50  Identities=20%  Similarity=0.303  Sum_probs=43.0

Q ss_pred             hHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH-hCC----CCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKID-SDNDG-VVSTDELKAGLRN-FGS----QLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~-~g~----~~~~~e~~~~~~~~d~~  405 (408)
                      ...+.++|..+| .+++| .|+.+||+.+|+. +|.    .+++.+++++|+.+|.+
T Consensus         8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d   64 (92)
T cd05025           8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDEN   64 (92)
T ss_pred             HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCC
Confidence            466899999997 99999 5999999999986 553    56899999999999865

S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.58  E-value=0.0011  Score=61.50  Aligned_cols=139  Identities=21%  Similarity=0.243  Sum_probs=79.1

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC-CeeEEeeE------EEeCCeEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEA------CEDDNAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~------~~~~~~~~  128 (408)
                      .+.++.|....+|++.. .+| .+++|+.....     ..+.+..|++++..|.++- .+++++..      ....+..+
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            55678888889999864 234 57889875421     1344566777777772211 14444432      12346788


Q ss_pred             EEEeccCCCchH----H-------H---HHh-CCCCCH-------HHHH----------------HHHHHHHHHHHHHHH
Q 015352          129 LVMELCEGGELF----D-------R---IVA-RGHYTE-------RAAA----------------AVTRTIVEVVQLCHK  170 (408)
Q Consensus       129 lv~e~~~g~~L~----~-------~---l~~-~~~~~~-------~~~~----------------~i~~ql~~~l~~lH~  170 (408)
                      ++++|++|.++.    .       .   +.. ...++.       ...+                .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999985431    1       1   111 001100       0000                001123334555542


Q ss_pred             -------CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          171 -------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       171 -------~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                             .+++|+|+++.||+++.   ++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~---~~~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDG---DSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEEC---CceEEEeecccccC
Confidence                   58999999999999953   34468999997653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=97.55  E-value=0.00013  Score=56.64  Aligned_cols=54  Identities=24%  Similarity=0.402  Sum_probs=48.8

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+++.+++++|..||..+||.|+..+..++||.+|.+++++||.+-+.+.+..
T Consensus         6 ~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~   59 (152)
T KOG0030|consen    6 TPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRR   59 (152)
T ss_pred             CcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccc
Confidence            456678999999999999999999999999999999999999999988776654

>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z

Probab=97.53  E-value=0.00024  Score=52.96  Aligned_cols=50  Identities=22%  Similarity=0.302  Sum_probs=42.4

Q ss_pred             hHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH-h----CCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKID-SDNDG-VVSTDELKAGLRN-F----GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~-~----g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+.++|..+| .|++| +|+.+||+.++.. +    +...++.+++++|+++|.|
T Consensus         9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n   65 (93)
T cd05026           9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSN   65 (93)
T ss_pred             HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCC
Confidence            567889999999 78998 5999999999976 3    3445788999999999976

S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac

>PLN02236 choline kinase

Probab=97.52  E-value=0.0011  Score=62.42  Aligned_cols=139  Identities=12%  Similarity=0.097  Sum_probs=81.3

Q ss_pred             cceecccCCeEEEEEEECC----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           56 DRELGRGEFGVTYLCIDRD----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      ...|-.|-...+|++....    .++.|++|+.....   ...++ -.+|..+++.+..+.--+++++.+..+    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            3456668888999986432    24678999876532   11222 267899998885554456677666443    589


Q ss_pred             eccCCCchHHH----------H----H---hCC----C-C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 015352          132 ELCEGGELFDR----------I----V---ARG----H-Y-TERAAAAVTRTI-----------------VEVVQLC---  168 (408)
Q Consensus       132 e~~~g~~L~~~----------l----~---~~~----~-~-~~~~~~~i~~ql-----------------~~~l~~l---  168 (408)
                      +|++|.+|...          +    .   ...    . . ....+..+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99988665321          1    1   000    0 1 112222332221                 1111122   


Q ss_pred             -H----HCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          169 -H----KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       169 -H----~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                       .    ...++|+|+++.||+++.  .+..+.++||..+..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~--~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDE--ETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeC--CCCcEEEEeehhccc
Confidence             1    225899999999999963  235699999987754

>cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

Probab=97.52  E-value=0.00023  Score=49.28  Aligned_cols=44  Identities=25%  Similarity=0.452  Sum_probs=39.8

Q ss_pred             HHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       360 ~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +++|..+|.|++|.|+.+|+..+++.+|.  +..+++++++.+|.+
T Consensus         2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~--~~~~~~~i~~~~d~~   45 (67)
T cd00052           2 DQIFRSLDPDGDGLISGDEARPFLGKSGL--PRSVLAQIWDLADTD   45 (67)
T ss_pred             hHHHHHhCCCCCCcCcHHHHHHHHHHcCC--CHHHHHHHHHHhcCC
Confidence            56899999999999999999999999874  888999999998865

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs.

>PF13202 EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ_B 1UHI_A 1UHH_B 1EJ3_B 1UHK_A 2ZFD_A 1UHN_A

Probab=97.49  E-value=0.00011  Score=39.85  Aligned_cols=25  Identities=32%  Similarity=0.662  Sum_probs=22.2

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHH
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGL  383 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l  383 (408)
                      ++++|..+|.|+||.|+.+|+.+.+
T Consensus         1 l~~~F~~~D~d~DG~is~~E~~~~~   25 (25)
T PF13202_consen    1 LKDAFQQFDTDGDGKISFEEFQRLV   25 (25)
T ss_dssp             HHHHHHHHTTTSSSEEEHHHHHHHH
T ss_pred             CHHHHHHHcCCCCCcCCHHHHHHHC
Confidence            4678999999999999999998753

...

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	408
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-67
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-65
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-65
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-64
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-63
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-63
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-62
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-62
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-62
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-59
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-59
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-58
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-57
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-57
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-57
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-55
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-55
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-55
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-55
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-55
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-55
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-54
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-54
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-54
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-54
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-53
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-53
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-53
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-53
3soa_A	444	Full-Length Human Camkii Length = 444		1e-51
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-51
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-49
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-47
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-46
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-46
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-46
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-45
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-45
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-45
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-45
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-45
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-45
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-45
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-45
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-45
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-45
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-45
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-45
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-45
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-45
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-44
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-44
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-44
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-43
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-43
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-43
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-43
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-43
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-43
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-43
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-43
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-43
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-43
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-43
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-43
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-43
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-43
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-43
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-43
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-43
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-43
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-43
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-43
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-43
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-42
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-42
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-42
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-42
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-42
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-42
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-42
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-42
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-42
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-42
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-41
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-41
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-40
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-40
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-39
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-39
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-39
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-38
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-38
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-38
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-38
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-38
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-37
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-37
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-37
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-37
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-37
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-37
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-37
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-37
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-37
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-37
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-37
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-36
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-36
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-36
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-36
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-35
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-35
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-35
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-35
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-35
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-35
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-35
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-35
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-35
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-35
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-35
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-35
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-35
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-35
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-35
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-35
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-35
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-35
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-35
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-35
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-35
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-34
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-34
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-34
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-34
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-34
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-34
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-34
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-34
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-34
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-34
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-34
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-34
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-34
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-34
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-34
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-34
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-34
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-33
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-33
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-32
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-32
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-32
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-32
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-31
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-31
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-30
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-30
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-30
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-30
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-29
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-29
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-28
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-28
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-28
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-28
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-28
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-28
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-28
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-27
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-27
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-27
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-27
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-27
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-27
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-27
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-27
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-27
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-27
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-27
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-27
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-27
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-26
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-26
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-26
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-26
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-26
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-26
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-26
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-26
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-26
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-26
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-26
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-26
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-26
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-26
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-26
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-26
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-26
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-26
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-26
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-26
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-26
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-26
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-26
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-26
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-26
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-26
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-26
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-25
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-25
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-25
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-25
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-25
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-25
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-25
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-25
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-25
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-25
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-25
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-25
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-25
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-25
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-25
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-25
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-25
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-25
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-25
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-25
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-25
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-25
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-25
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-25
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-25
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-25
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-25
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-25
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-25
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-25
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-25
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-25
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-25
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-25
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-25
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-25
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-25
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-25
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-25
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-25
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-25
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-25
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-25
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-25
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-25
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-25
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-25
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-25
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-25
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-25
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-25
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-25
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-25
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-25
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-25
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-25
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-25
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-25
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-25
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-25
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-25
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-25
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-24
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-24
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-24
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-24
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-24
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-24
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-24
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-24
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-24
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-24
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-24
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-24
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-24
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-24
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-24
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-23
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-23
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-23
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-23
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-23
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-23
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-23
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-23
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-23
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-23
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-22
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-22
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-22
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-21
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-21
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-21
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-21
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-21
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-21
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-21
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-21
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-20
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-20
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-20
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-20
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-20
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-20
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-20
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-20
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-20
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-19
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-19
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-19
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-19
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-19
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-19
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-19
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-19
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-19
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-18
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-17
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-17
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-16
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-16
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-16
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-15
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-15
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-15
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-15
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-15
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-15
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		9e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-14
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-14
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-14
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-14
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-14
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-14
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-14
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-13
2aao_A	166	Regulatory Apparatus Of Calcium Dependent Protein K		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-13
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-10
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-10
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-10
1s6j_A	87	N-Terminal Region Of The Ca2+-Saturated Calcium Reg		8e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-09
1s6i_A	188	Ca2+-Regulatory Region (Cld) From Soybean Calcium-D		4e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-07
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		5e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-07
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		5e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-05
3pm8_A	197	Cad Domain Of Pff0520w, Calcium Dependent Protein K		3e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-04
1f70_A	76	Refined Solution Structure Of Calmodulin N-Terminal		6e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-04
3b32_A	75	Crystal Structure Of Calcium-Saturated Calmodulin N		6e-04
1ak8_A	76	Nmr Solution Structure Of Cerium-Loaded Calmodulin		6e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-04
3uct_A	79	Structure Of Mn2+-Bound N-Terminal Domain Of Calmod		6e-04
1sw8_A	79	Solution Structure Of The N-Terminal Domain Of Huma		7e-04
2lqc_A	77	Nmr Solution Structure Of A Ca2+-Calmodulin With A		7e-04
2llo_A	80	Solution Nmr-Derived Structure Of Calmodulin N-Lobe		7e-04
2ro8_A	79	Solution Structure Of Calcium Bound Soybean Calmodu		7e-04

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  253 bits (645), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 130/341 (38%), Positives = 204/341 (59%), Gaps = 7/341 (2%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++K L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD- 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +   HK
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           H ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK L+R+
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 291 MLEPDPKLRLTAKQVLEHPWLQN-AKKAPNV---PLGDVVRSRLKQFSMMNRFKRKALRV 346
           ML   P LR+TA Q LEHPW+Q  + + P +   P  +   + ++QF    +  + AL  
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLY 319
Query: 347 IAEFL-SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
           +A  L +++E + + E+F+K+D++NDG++  DEL  G   F
Sbjct: 320 MASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEF 360

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  244 bits (622), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 127/338 (37%), Positives = 200/338 (59%), Gaps = 5/338 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 107
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 227
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 228 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 287
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
           ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL  +
Sbjct: 288 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYM 347
Query: 348 -AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
            ++  S +E +++  +F K+D + DG +   EL  G +
Sbjct: 348 GSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYK 385

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  244 bits (622), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 127/338 (37%), Positives = 200/338 (59%), Gaps = 5/338 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 108
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 228
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 229 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 288
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
           ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL  +
Sbjct: 289 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYM 348
Query: 348 -AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
            ++  S +E +++  +F K+D + DG +   EL  G +
Sbjct: 349 GSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYK 386

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  243 bits (621), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 127/338 (37%), Positives = 200/338 (59%), Gaps = 5/338 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 84
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 204
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
           ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL  +
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYM 324
Query: 348 -AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
            ++  S +E +++  +F K+D + DG +   EL  G +
Sbjct: 325 GSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYK 362

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 120/272 (44%), Positives = 167/272 (61%), Gaps = 4/272 (1%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
             G  K +I   Y ++  +GRG +G   + + + TR   A K I K  +    D+D  ++
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQ 72
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E+ IMK L  + +I+ L E  ED+  ++LVMELC GGELF+R+V +  + E  AA + + 
Sbjct: 73  EIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 131
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  V  CHK  V HRDLKPENFLF     +SPLK IDFGL+  FKPG+     VG+PYY
Sbjct: 132 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY 191
Query: 221 MAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           ++P+VL+  YGPE D WSAGV++Y+LLCG PPF A ++  V   I  G   F    W NV
Sbjct: 192 VSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 251
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           S  A+SL+R++L   PK R+T+ Q LEH W +
Sbjct: 252 SPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 120/270 (44%), Positives = 167/270 (61%), Gaps = 4/270 (1%)
Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G  K +I   Y ++  +GRG +G   + + + TR   A K I K  +    D+D  ++E+
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEI 57
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            IMK L  + +I+ L E  ED+  ++LVMELC GGELF+R+V +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             V  CHK  V HRDLKPENFLF     +SPLK IDFGL+  FKPG+     VG+PYY++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 223 PEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           P+VL+  YGPE D WSAGV++Y+LLCG PPF A ++  V   I  G   F    W NVS 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            A+SL+R++L   PK R+T+ Q LEH W +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 121/344 (35%), Positives = 198/344 (57%), Gaps = 6/344 (1%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            + DRY   ++LG G +G   LC D+ T    A K I K  + T  +   +  EVA++K 
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + +I+ L E  ED    +LVME+  GGELFD I+ R  ++E  AA + + ++     
Sbjct: 61  LD-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
            HKH ++HRDLKPEN L  +K  ++ +K +DFGLS  F+ G +  E +G+ YY+APEVL+
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLR 179
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y  + D+WS GVILYILLCG PPF  +++Q + + + +G   F    W  VS+ AK L
Sbjct: 180 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS----RLKQFSMMNRFKRKA 343
           V+ ML  +P  R++A++ L HPW+       +  +G    +     +K+F    +  + A
Sbjct: 240 VKLMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKLAQAA 299
Query: 344 LRVI-AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
           +  + ++  ++EE +++ ++F+++D++ DG +   EL  G R  
Sbjct: 300 MLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKL 343

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  236 bits (601), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 126/338 (37%), Positives = 195/338 (57%), Gaps = 5/338 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 84
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I  L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTY 204
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
            L   P  R++A+  L+H W+Q   K   + +VP  D     ++QF    +  + AL   
Sbjct: 265 XLTYVPSXRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYX 324
Query: 348 -AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
            ++  S +E +++  +F K D + DG +   EL  G +
Sbjct: 325 GSKLTSQDETKELTAIFHKXDKNGDGQLDRAELIEGYK 362

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  236 bits (601), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 133/370 (35%), Positives = 217/370 (58%), Gaps = 15/370 (4%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K ++ + Y   ++LG G +G   LC D+ T    A K I K  + T+ +   +  EVA++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVL 90
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K L  + +I+ L +  ED    +LVME  +GGELFD I+ R  + E  AA + + ++  V
Sbjct: 91  K-LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              HKH ++HRDLKPEN L  +K++++ +K +DFGLS  F+  ++  E +G+ YY+APEV
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209
Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           L++ Y  + D+WS GVIL+ILL G PPF  +++Q + + + +G   F    W NVSE AK
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN--AKKAPNVPLGDVVRS--RLKQFSMMNRFKR 341
            L++QML+ D + R++A+Q LEHPW++   +KK   + L  +  +   +++F    +  +
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQ 329
Query: 342 KALRVIAEFL-SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-GSQLA-------E 392
            AL  +A  L S EE +++ ++F+ ID + DG +   EL  G     G ++A       E
Sbjct: 330 AALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIE 389
Query: 393 SEVQMLIEAS 402
           SEV  ++ A+
Sbjct: 390 SEVDAILGAA 399

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  225 bits (574), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 125/363 (34%), Positives = 201/363 (55%), Gaps = 22/363 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD----------V 98
           I + Y   R+LG G +G   LC +++     A K I K +       DD          +
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E++++K L  + +I+ L +  ED    +LV E  EGGELF++I+ R  + E  AA + 
Sbjct: 94  YNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
           + I+  +   HKH ++HRD+KPEN L  NK     +K +DFGLS FF    +  + +G+ 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 219 YYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           YY+APEVLK+ Y  + D+WS GVI+YILLCG PPF  +++Q + + + +G   F  + W 
Sbjct: 213 YYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDV-----VRSRLKQF 333
           N+S+ AK L++ ML  D   R TA++ L   W++  K A N+   D        S +++F
Sbjct: 273 NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK--KYANNINKSDQKTLCGALSNMRKF 330
Query: 334 SMMNRFKRKALRVI-AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAG---LRNFGSQ 389
               +  + A+  I ++  ++EE +++ ++FKK+D + DG +   EL  G   LRNF ++
Sbjct: 331 EGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNE 390
Query: 390 LAE 392
           L E
Sbjct: 391 LGE 393

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  224 bits (572), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 110/266 (41%), Positives = 165/266 (62%), Gaps = 1/266 (0%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV ++K L  
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 90
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  +   HK
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           + ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APEVL   Y
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 210
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESAK L+R+
Sbjct: 211 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 270
Query: 291 MLEPDPKLRLTAKQVLEHPWLQNAKK 316
           ML   P +R++A+  L+H W+Q   K
Sbjct: 271 MLTYVPSMRISARDALDHEWIQTYTK 296

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  222 bits (566), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 129/340 (37%), Positives = 188/340 (55%), Gaps = 10/340 (2%)
Query: 11  VAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLC 70
           +  E++     S   A    G     P   + G  ++ + D + V+ ELGRG   + Y C
Sbjct: 13  LGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRC 72
Query: 71  IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV 130
             + T++  A K + K      VD   VR E+ ++  L  + +I+ LKE  E    + LV
Sbjct: 73  KQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLV 126
Query: 131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           +EL  GGELFDRIV +G+Y+ER AA   + I+E V   H++G++HRDLKPEN L+A    
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAP 186
Query: 191 NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCG 249
           ++PLK  DFGLS   +       + G+P Y APE+L+   YGPE+D+WS G+I YILLCG
Sbjct: 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 250 VPPFWAE-SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             PF+ E  +Q + + IL     F    W  VS +AK LVR+++  DPK RLT  Q L+H
Sbjct: 247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 309 PWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIA 348
           PW+    KA N    D  + +L++F+   + K     V+A
Sbjct: 307 PWVTG--KAANFVHMDTAQKKLQEFNARRKLKAAVKAVVA 344

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  220 bits (561), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 161/262 (61%), Gaps = 2/262 (0%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++K L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD- 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +   HK
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           H ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK L+R+
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML   P LR+TA Q LEHPW+Q
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQ 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  220 bits (560), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 109/262 (41%), Positives = 161/262 (61%), Gaps = 2/262 (0%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++K L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD- 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +   HK
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY 230
           H ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEVL+  Y
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
             + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK L+R+
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML   P LR+TA Q LEHPW+Q
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQ 281

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  218 bits (556), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 107/265 (40%), Positives = 161/265 (60%), Gaps = 1/265 (0%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + DRY   ++LG G +G   LC D+ T    A K I K  + T  +   +  EVA++K
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            L  + +I+ L E  ED    +LVME+  GGELFD I+ R  ++E  AA + + ++    
Sbjct: 77  QLD-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             HKH ++HRDLKPEN L  +K  ++ +K +DFGLS  F+ G +  E +G+ YY+APEVL
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
           ++ Y  + D+WS GVILYILLCG PPF  +++Q + + + +G   F    W  VS+ AK 
Sbjct: 196 RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQ 255
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           LV+ ML  +P  R++A++ L HPW+
Sbjct: 256 LVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  213 bits (542), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 163/266 (61%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K+ L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K  L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  212 bits (540), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K  L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  212 bits (539), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K  L        +  E+A++ 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAVL- 70
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H  K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 131 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 190
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP+ R T +Q L+HPW+
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  211 bits (537), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 105/266 (39%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I+  +     LG G F    L  ++ T +L A K I K+ L+       +  E+A+++
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES--SIENEIAVLR 75
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            + K+ +IV+L++  E  N ++LVM+L  GGELFDRIV +G YTE+ A+ + R +++ V 
Sbjct: 76  KI-KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVY 134
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H+ G++HRDLKPEN L+ ++ E S +   DFGLS     G+  S   G+P Y+APEVL
Sbjct: 135 YLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVL 194
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            ++ Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAK 254
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +R ++E DP  R T +Q   HPW+
Sbjct: 255 DFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  211 bits (536), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 117/301 (38%), Positives = 175/301 (58%), Gaps = 5/301 (1%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 85
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  C
Sbjct: 86  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK+
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRFKRKALRV 346
           +  ML  +PK R+TA Q L+ PW+ N ++ A  +   D V   LK+F+   + K   L  
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC-LKKFNARRKLKGAILTT 323
Query: 347 I 347
           +
Sbjct: 324 M 324

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  208 bits (529), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 109/267 (40%), Positives = 162/267 (60%), Gaps = 3/267 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L +
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-Q 62
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  CH 
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
           +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK++ 
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL+ 
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 242
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKK 316
            ML  +PK R+TA Q L+ PW+ N ++
Sbjct: 243 SMLTVNPKKRITADQALKVPWICNRER 269

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 109/267 (40%), Positives = 162/267 (60%), Gaps = 3/267 (1%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L +
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-Q 63
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  CH 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
           +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK++ 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL+ 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKK 316
            ML  +PK R+TA Q L+ PW+ N ++
Sbjct: 244 SMLTVNPKKRITADQALKVPWICNRER 270

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  208 bits (529), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 109/266 (40%), Positives = 160/266 (60%), Gaps = 3/266 (1%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL 62
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E +  C
Sbjct: 63  -QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVLK+
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AKSL
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQN 313
           +  ML  +PK R+TA Q L+ PW+ N
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICN 267

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  207 bits (528), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 118/332 (35%), Positives = 186/332 (56%), Gaps = 7/332 (2%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y +  ELG+G F V   C+   T +  A K I+ +KL +A D   + RE  I + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICR- 58
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L K+ +IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+   + I+E V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVL 226
           CH +G++HRDLKPEN L A+K + + +K  DFGL+I  +  ++ +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           +++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALR 345
            L+ +ML  +P  R+TA + L+HPW+       ++         LK+F+   + K     
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGA--- 295
Query: 346 VIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTD 377
           ++   L+       K + KK D   +   S++
Sbjct: 296 ILTTMLATRNFSAAKSLLKKPDGVKESTESSN 327

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 109/265 (41%), Positives = 158/265 (59%), Gaps = 6/265 (2%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           NI   ++    LG G F   +L   R T +L A K I K     A     +  E+A++K 
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKK 62
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           + K+ +IV+L++  E     +LVM+L  GGELFDRI+ RG YTE+ A+ V + ++  V+ 
Sbjct: 63  I-KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
            H++G++HRDLKPEN L+   +ENS +   DFGLS   + G   S   G+P Y+APEVL 
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLA 180
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
           ++ Y   +D WS GVI YILLCG PPF+ E+E  + + I  G  +F+   W ++SESAK 
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
            +  +LE DP  R T ++ L HPW+
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 117/296 (39%), Positives = 177/296 (59%), Gaps = 6/296 (2%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y +  ++G+G F V   C+   T    A K I+ +KL +A D   + RE  I + 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL-SARDHQKLEREARICR- 58
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L K+S+IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+   + I+E V  
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVL 226
           CH+ GV+HRDLKPEN L A+K + + +K  DFGL+I  +  ++ +    G+P Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           ++  YG  +DIW+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL-QNAKKAPNVPLGDVVRSRLKQFSMMNRFK 340
           +L+ QML  +P  R+TA + L+HPW+ Q +  A  +   + V   LK+F+   + K
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVEC-LKKFNARRKLK 293

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 111/264 (42%), Positives = 162/264 (61%), Gaps = 6/264 (2%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y +  ELG+G F V   C+ +   +  A K I+ +KL +A D   + RE  I + L K
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL-SARDHQKLEREARICR-LLK 88
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+     I+E V   H+
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVLKR 228
           H ++HRDLKPEN L A+K + + +K  DFGL+I  + GE+  +    G+P Y++PEVL++
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ-GEQQAWFGFAGTPGYLSPEVLRK 207
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + YG  +DIW+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK+L
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWL 311
           + QML  +P  R+TA Q L+HPW+
Sbjct: 268 INQMLTINPAKRITADQALKHPWV 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 108/266 (40%), Positives = 164/266 (61%), Gaps = 4/266 (1%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y +  ELG+G F V   C+   T +  A K I+ +KL +A D   + RE  I + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICR- 58
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L K+ +IV L ++  ++   +LV +L  GGELF+ IVAR +Y+E  A+   + I+E V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVL 226
           CH +G++HRDLKPEN L A+K + + +K  DFGL+I  +  ++ +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           +++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W  V+  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWL 311
            L+ +ML  +P  R+TA + L+HPW+
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWI 264

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 120/337 (35%), Positives = 189/337 (56%), Gaps = 8/337 (2%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           +A +      + Y +  ELG+G F V   C+     +  A   I+ +KL +A D   + R
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLER 59
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  I + L K+ +IV L ++  ++   +L+ +L  GGELF+ IVAR +Y+E  A+   + 
Sbjct: 60  EARICR-LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSP 218
           I+E V  CH+ GV+HR+LKPEN L A+K + + +K  DFGL+I  + GE+  +    G+P
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTP 177
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PEVL+++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMN 337
             V+  AK L+ +ML  +P  R+TA + L+HPW+ +     +          LK+F+   
Sbjct: 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARR 297
Query: 338 RFKRKALRVI--AEFLSVEEVEDIKEMFKKIDSDNDG 372
           + K   L V+      SV + E IK   + I++ ++G
Sbjct: 298 KLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNG 334

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  200 bits (508), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 113/301 (37%), Positives = 172/301 (57%), Gaps = 6/301 (1%)
Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G      +  Y +  ELG+G F V   C+     +  A K I+ +KL +A D   + RE 
Sbjct: 14  GTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL-SARDHQKLEREA 72
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            I + L K+ +IV L ++  ++   +L+ +L  GGELF+ IVAR +Y+E  A+   + I+
Sbjct: 73  RICR-LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYY 220
           E V  CH+ GV+HRDLKPEN L A+K + + +K  DFGL+I  + GE+  +    G+P Y
Sbjct: 132 EAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGY 190
Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           ++PEVL+++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W  
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 250
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
           V+  AK L+ +ML  +P  R+TA + L+HPW+ +     +          LK+F+   + 
Sbjct: 251 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 310
Query: 340 K 340
           K
Sbjct: 311 K 311

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  192 bits (487), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 112/309 (36%), Positives = 178/309 (57%), Gaps = 12/309 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMK 106
            ED Y +   +G+G F V   CI+R+T +  A K +   K  ++  +  +D++RE +I  
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 80
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           H+ K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYM 221
           E ++ CH + +IHRD+KPEN L A+K+ ++P+K  DFG++I   + G      VG+P++M
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+KR  YG  +D+W  GVIL+ILL G  PF+   E+ + + I++G        W ++
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRF 339
           SESAK LVR+ML  DP  R+T  + L HPWL+   + A  + L + V  +L++F+   + 
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETV-EQLRKFNARRKL 318
Query: 340 KRKALRVIA 348
           K   L  ++
Sbjct: 319 KGAVLAAVS 327

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 175/309 (56%), Gaps = 12/309 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMK 106
            ED Y +   +G+G F V   CI+R+T +  A K +   K  ++  +  +D++RE +I  
Sbjct: 24  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 82
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           H+ K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I+
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYM 221
           E ++ CH + +IHRD+KP   L A+K+ ++P+K   FG++I   + G      VG+P++M
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 202
Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+KR  YG  +D+W  GVIL+ILL G  PF+   E+ + + I++G        W ++
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 261
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRF 339
           SESAK LVR+ML  DP  R+T  + L HPWL+   + A  + L + V  +L++F+   + 
Sbjct: 262 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKL 320
Query: 340 KRKALRVIA 348
           K   L  ++
Sbjct: 321 KGAVLAAVS 329

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 175/309 (56%), Gaps = 12/309 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMK 106
            ED Y +   +G+G F V   CI+R+T +  A K +   K  ++  +  +D++RE +I  
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 80
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           H+ K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I+
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYM 221
           E ++ CH + +IHRD+KP   L A+K+ ++P+K   FG++I   + G      VG+P++M
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+KR  YG  +D+W  GVIL+ILL G  PF+   E+ + + I++G        W ++
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK-APNVPLGDVVRSRLKQFSMMNRF 339
           SESAK LVR+ML  DP  R+T  + L HPWL+   + A  + L + V  +L++F+   + 
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE-QLRKFNARRKL 318
Query: 340 KRKALRVIA 348
           K   L  ++
Sbjct: 319 KGAVLAAVS 327

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/274 (37%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREV 102
           +E++ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  +++ REV
Sbjct: 7   QEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            I++ + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 67  NILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K   +P +K IDFG++   + G  F  I G+P ++
Sbjct: 126 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  E++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N SE AK  +R++L  DPK R+   Q LEH W++
Sbjct: 244 NTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 155/275 (56%), Gaps = 10/275 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREVAIM 105
           +ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  +++ REV I+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A    + I++ V
Sbjct: 63  REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
              H   + H DLKPEN +  +K   +P +K IDFG++   + G  F  I G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 225 VLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           ++  NY P   E D+WS GVI YILL G  PF  E++Q     I     DF  + + N S
Sbjct: 182 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           E AK  +R++L  DPK R+T  Q LEH W++  ++
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 154/275 (56%), Gaps = 10/275 (3%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREVAIM 105
           +ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  +++ REV I+
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A    + I++ V
Sbjct: 84  REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
              H   + H DLKPEN +  +K   +P +K IDFG++   + G  F  I G+P ++APE
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 225 VLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           ++  NY P   E D+WS GVI YILL G  PF  E++Q     I     DF  + + N S
Sbjct: 203 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 260
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           E AK  +R++L  DPK R+   Q LEH W++  ++
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRR 295

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 166/298 (55%), Gaps = 12/298 (4%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL--QNAKKAPNVPLGDVVRSRLKQFS 334
           N S  AK  +R++L  DPK R+T +  L+HPW+  ++ ++A +     V   + K+F+
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFA 300

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 102/271 (37%), Positives = 156/271 (57%), Gaps = 8/271 (2%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            I+D ++  R+LG G FG  +L  +R +      K+I+K   R+ V ++ +  E+ ++K 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKS 76
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV---ARGH-YTERAAAAVTRTIVE 163
           L  + +I+ + E  ED + +++VME CEGGEL +RIV   ARG   +E   A + + ++ 
Sbjct: 77  L-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H   V+H+DLKPEN LF +   +SP+K IDFGL+  FK  E  +   G+  YMAP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           EV KR+   + DIWSAGV++Y LL G  PF   S + V Q       ++  +  P ++  
Sbjct: 196 EVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQ 254
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           A  L++QML  DP+ R +A QVL H W + A
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 65  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 184 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 65  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 184 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  178 bits (452), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  178 bits (451), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 155/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 154/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L+ EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 91/266 (34%), Positives = 150/266 (56%), Gaps = 15/266 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-IDDVR----REVAIMKHLPKNSS 113
           +GRG   V   C+ R T    A K +     R + + +++VR    RE  I++ +  +  
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           I++L ++ E  + + LV +L   GELFD +  +   +E+   ++ R+++E V   H + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK------ 227
           +HRDLKPEN L     +N  ++  DFG S   +PGE+  E+ G+P Y+APE+LK      
Sbjct: 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              YG E+D+W+ GVIL+ LL G PPFW   +  + + I+ G   F    W + S + K 
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           L+ ++L+ DP+ RLTA+Q L+HP+ +
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 154/274 (56%), Gaps = 10/274 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           +EN++D Y    ELG G F V   C ++ T    A K I KR+ +++   V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     +     +F+ + + 
Sbjct: 185 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           N S  AK  +R++L  DPK R+T +  L+HPW++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/287 (36%), Positives = 152/287 (52%), Gaps = 12/287 (4%)
Query: 37  PITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RT 91
           P+     V  + + D Y++ + LG G  G   L  +R T + +A K ISKRK      R 
Sbjct: 2   PLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 92  AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTE 151
           A    +V  E+ I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E
Sbjct: 62  ADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKE 119
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
                    ++  VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S         
Sbjct: 120 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 179
Query: 212 SEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAIL 266
             + G+P Y+APEVL       Y   +D WS GVIL+I L G PPF     Q  +   I 
Sbjct: 180 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 239
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            G  +F  + W  VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 240 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 101/285 (35%), Positives = 147/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 65
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +E   +PYY+A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVA 185
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 106/313 (33%), Positives = 159/313 (50%), Gaps = 25/313 (7%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D  L D+ LG G F +   C+ + + +  A K ISKR         + ++E+  +K    
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA------NTQKEITALKLCEG 64
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L E   D     LVMEL  GGELF+RI  + H++E  A+ + R +V  V   H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPYYMAPEVLKRN 229
            GV+HRDLKPEN LF ++ +N  +K IDFG +    P  +       + +Y APE+L +N
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAE-------SEQGVAQAILRGLIDFKRDPWPNVS 281
            Y    D+WS GVILY +L G  PF +        S   + + I +G   F+ + W NVS
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL---------GDVVRSRLK- 331
           + AK L++ +L  DP  RL    +  + WLQ+  +  + PL         G  V + +K 
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
Query: 332 QFSMMNRFKRKAL 344
            F   N++KR+  
Sbjct: 305 TFHAFNKYKREGF 317

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 67  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 102/275 (37%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E+ 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 117
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 118 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 237
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 238 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 297
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 298 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 342

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 111
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 67
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 73
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 74  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 193
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 194 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 253
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 254 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 298

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 71
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 72  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 191
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 192 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 251
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 252 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 296

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 67
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 147/291 (50%), Gaps = 25/291 (8%)
Query: 46  KENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           K  + D Y + ++ LG G  G    C  R T +  A        L+   D    R+EV  
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA--------LKLLYDSPKARQEVDH 74
Query: 105 MKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 158
                    IV + +  E+       + ++ME  EGGELF RI  RG   +TER AA + 
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVG 216
           R I   +Q  H H + HRD+KPEN L+ +K++++ LK  DFG   F K   +        
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---FAKETTQNALQTPCY 191
Query: 217 SPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR----GLID 271
           +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++ + Q ++  + R    G   
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           F    W  VSE AK L+R +L+ DP  RLT  Q + HPW+  +   P  PL
Sbjct: 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 81
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 82  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 201
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 202 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 261
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 262 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 66
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 67  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 186
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 187 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 246
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 247 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 65
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 185
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/285 (35%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 72
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 73  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 192
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W
Sbjct: 193 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 252
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 253 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 106/291 (36%), Positives = 147/291 (50%), Gaps = 25/291 (8%)
Query: 46  KENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           K  + D Y + ++ LG G  G    C  R T +  A        L+   D    R+EV  
Sbjct: 4   KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA--------LKLLYDSPKARQEVDH 55
Query: 105 MKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 158
                    IV + +  E+       + ++ME  EGGELF RI  RG   +TER AA + 
Sbjct: 56  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 115
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVG 216
           R I   +Q  H H + HRD+KPEN L+ +K++++ LK  DFG   F K   +        
Sbjct: 116 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---FAKETTQNALQTPCY 172
Query: 217 SPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR----GLID 271
           +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++ + Q ++  + R    G   
Sbjct: 173 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 232
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           F    W  VSE AK L+R +L+ DP  RLT  Q + HPW+  +   P  PL
Sbjct: 233 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 283

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A + ISKRK      R A    +V  E+ 
Sbjct: 147 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 206
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 207 ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 324
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 384
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 148/275 (53%), Gaps = 12/275 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRREVA 103
           + D Y++ + LG G  G   L  +R T + +A + ISKRK      R A    +V  E+ 
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         ++ 
Sbjct: 193 ILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 224 EVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWP 278
           EVL       Y   +D WS GVIL+I L G PPF     Q  +   I  G  +F  + W 
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 154/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 154/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 153/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 154/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 104/283 (36%), Positives = 149/283 (52%), Gaps = 19/283 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y+V   +G G +     C+ + T    A K I K K        D   E+ I+   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I++LK+  +D   V+LV EL  GGEL D+I+ +  ++ER A+ V  TI + V+  
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYL 137
Query: 169 HKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYY----MAP 223
           H  GV+HRDLKP N L+ ++  N   L+  DFG   F K     + ++ +P Y    +AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAP 194
Query: 224 EVLKR-NYGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPN 279
           EVLKR  Y    DIWS G++LY +L G  PF    +++ + +   I  G        W  
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           VSE+AK LV +ML  DP  RLTAKQVL+HPW+    K P   L
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQL 297

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 104/283 (36%), Positives = 149/283 (52%), Gaps = 19/283 (6%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
             D Y+V   +G G +     C+ + T    A K I K K        D   E+ I+   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I++LK+  +D   V+LV EL  GGEL D+I+ +  ++ER A+ V  TI + V+  
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYL 137
Query: 169 HKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYY----MAP 223
           H  GV+HRDLKP N L+ ++  N   L+  DFG   F K     + ++ +P Y    +AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAP 194
Query: 224 EVLKR-NYGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPN 279
           EVLKR  Y    DIWS G++LY +L G  PF    +++ + +   I  G        W  
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT 254
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           VSE+AK LV +ML  DP  RLTAKQVL+HPW+    K P   L
Sbjct: 255 VSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQL 297

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 153/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 96/273 (35%), Positives = 153/273 (56%), Gaps = 10/273 (3%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R +   V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + +I++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 222 APEVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  NY P   E D+WS GVI YILL G  PF  +++Q     I     DF  + + 
Sbjct: 186 APEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             SE AK  +R++L  + + RLT ++ L HPW+
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 146/268 (54%), Gaps = 16/268 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
           LGRG   V   CI + T +  A K   ++     +A ++ ++R    +EV I++ +  + 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV+   HK  
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK----- 227
           ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P Y+APE+++     
Sbjct: 145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 228 --RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
               YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W + S++ K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            LV + L   P+ R TA++ L HP+ Q 
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 146/268 (54%), Gaps = 16/268 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
           LGRG   V   CI + T +  A K   ++     +A ++ ++R    +EV I++ +  + 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV+   HK  
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK----- 227
           ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P Y+APE+++     
Sbjct: 132 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 228 --RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
               YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W + S++ K
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            LV + L   P+ R TA++ L HP+ Q 
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 90/268 (33%), Positives = 145/268 (54%), Gaps = 16/268 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACK--SISKRKLRTAVDIDDVR----REVAIMKHLPKNS 112
           LGRG   V   CI + T +  A K   ++     +A ++ ++R    +EV I++ +  + 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV+   HK  
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK----- 227
           ++HRDLKPEN L     ++  +K  DFG S    PGE+   + G+P Y+APE+++     
Sbjct: 145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMND 201
Query: 228 --RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
               YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W + S++ K
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            LV + L   P+ R TA++ L HP+ Q 
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 107/326 (32%), Positives = 159/326 (48%), Gaps = 24/326 (7%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQ--------DCPKARREVELHWRA 111
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +V E  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    +PYY+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 223 PEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPW 277
           PEVL    Y    D WS GVI YILLCG PPF++        G    I  G  +F    W
Sbjct: 232 PEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEW 291
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL--GDVVRSRLKQFSM 335
             VSE  K L+R +L+ +P  R T  +   HPW+  + K P  PL    V++   +++  
Sbjct: 292 SEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTSRVLKEDKERWED 351
Query: 336 MNRFKRKAL---RVIAEFLSVEEVED 358
           +      AL   RV  E + ++++ED
Sbjct: 352 VKEEXTSALATMRVDYEQIKIKKIED 377

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 150/281 (53%), Gaps = 19/281 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y V  ++G G + V   CI + T    A K I K K        D   E+ I+    +
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I++LK+  +D   V++V EL +GGEL D+I+ +  ++ER A+AV  TI + V+  H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 171 HGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSIFFKPGERFSEIVGSPYY----MAPEV 225
            GV+HRDLKP N L+ ++  N   ++  DFG   F K     + ++ +P Y    +APEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGLIDFKRDPWPNVS 281
           L+R  Y    DIWS GV+LY +L G  PF     ++ + +   I  G        W +VS
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           ++AK LV +ML  DP  RLTA  VL HPW+ +  + P   L
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 95/279 (34%), Positives = 150/279 (53%), Gaps = 11/279 (3%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           QP+ V  G    ++ D Y +  ELG G FGV + C+++ T  +   K I+       +D 
Sbjct: 40  QPVEVKQG----SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDK 92
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAA 154
             V+ E++IM  L  +  +++L +A ED   + L++E   GGELFDRI A  +  +E   
Sbjct: 93  YTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
               R   E ++  H+H ++H D+KPEN +   KK +S +K IDFGL+    P E     
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVT 210
Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
             +  + APE++ R   G   D+W+ GV+ Y+LL G+ PF  E +    Q + R   +F 
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            D + +VS  AK  ++ +L+ +P+ RLT    LEHPWL+
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 148/259 (57%), Gaps = 7/259 (2%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG  + C +  T   LA K I  R ++   D ++V+ E+++M  L  +++++ L 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQL-DHANLIQLY 152
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
           +A E  N + LVME  +GGELFDRI+   +  TE       + I E ++  H+  ++H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNY-GPEIDI 236
           LKPEN L  N+ +   +K IDFGL+  +KP E+     G+P ++APEV+  ++     D+
Sbjct: 213 LKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GVI Y+LL G+ PF  +++      IL    D + + + ++SE AK  + ++L  + 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 297 KLRLTAKQVLEHPWLQNAK 315
             R++A + L+HPWL + K
Sbjct: 332 SWRISASEALKHPWLSDHK 350

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 148/281 (52%), Gaps = 19/281 (6%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y V  ++G G + V   CI + T    A K I K K        D   E+ I+    +
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I++LK+  +D   V++V EL +GGEL D+I+ +  ++ER A+AV  TI + V+  H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 171 HGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSIFFKPGERFSEIVGSPYY----MAPEV 225
            GV+HRDLKP N L+ ++  N   ++  DFG   F K     + ++ +P Y    +APEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 226 LKR-NYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGLIDFKRDPWPNVS 281
           L+R  Y    DIWS GV+LY  L G  PF     ++ + +   I  G        W +VS
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           ++AK LV + L  DP  RLTA  VL HPW+ +  + P   L
Sbjct: 252 DTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 142/263 (53%), Gaps = 10/263 (3%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y++   LG G FG   +     T   +A K ++++K+R+   +  +RRE+  +K L ++ 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +     + + +VME   GGELFD I   G   E+ +  + + I+  V  CH+H 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY- 230
           V+HRDLKPEN L  +   N+  K  DFGLS     GE      GSP Y APEV+  R Y 
Sbjct: 137 VVHRDLKPENVLL-DAHMNA--KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+DIWS+GVILY LLCG  PF  +    + + I  G+  F    + N   S  SL++ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQYLN--PSVISLLKH 249
Query: 291 MLEPDPKLRLTAKQVLEHPWLQN 313
           ML+ DP  R T K + EH W + 
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQ 272

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 148/265 (55%), Gaps = 8/265 (3%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y++  +LGRGEFG+ + C++  +++    K +  +      D   V++E++I+ ++ +
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISIL-NIAR 59
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCH 169
           + +I+ L E+ E    + ++ E   G ++F+RI  +     ER   +    + E +Q  H
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN 229
            H + H D++PEN ++  ++ +S +K I+FG +   KPG+ F  +  +P Y APEV + +
Sbjct: 120 SHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 230 Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
                 D+WS G ++Y+LL G+ PF AE+ Q + + I+     F  + +  +S  A   V
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++L  + K R+TA + L+HPWL+ 
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 141/270 (52%), Gaps = 7/270 (2%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++ D Y +  ELG G FGV +   +R T    A K +         D + VR+E+ 
Sbjct: 44  IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQ 100
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIV 162
            M  L ++ ++V+L +A EDDN + ++ E   GGELF+++       +E  A    R + 
Sbjct: 101 TMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 159
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           + +   H++  +H DLKPEN +F  K+ N  LK IDFGL+    P +      G+  + A
Sbjct: 160 KGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 218
Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV + +  G   D+WS GV+ YILL G+ PF  E++    + +     +     +  +S
Sbjct: 219 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 278
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           E  K  +R++L  DP  R+T  Q LEHPWL
Sbjct: 279 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 141/270 (52%), Gaps = 7/270 (2%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++ D Y +  ELG G FGV +   +R T    A K +         D + VR+E+ 
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQ 206
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIV 162
            M  L ++ ++V+L +A EDDN + ++ E   GGELF+++       +E  A    R + 
Sbjct: 207 TMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           + +   H++  +H DLKPEN +F  K+ N  LK IDFGL+    P +      G+  + A
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324
Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV + +  G   D+WS GV+ YILL G+ PF  E++    + +     +     +  +S
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           E  K  +R++L  DP  R+T  Q LEHPWL
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 136/284 (47%), Gaps = 38/284 (13%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I+D  +  + LG G  G      ++ T+E  A K +         D    RREV +    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRA 67
Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIV 162
            +   IV + +  E+  A    + +VME  +GGELF RI  RG   +TER A+ + ++I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG                     A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------A 167
Query: 223 PEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPWP 278
            E     Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F    W 
Sbjct: 168 KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 146/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A + I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +  E  GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 138/264 (52%), Gaps = 10/264 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +   + T   +A K ++++K+R+   +  ++RE+  +K L ++
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRH 70
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +         +VME   GGELFD I   G   E  A  + + I+  V  CH+H
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            V+HRDLKPEN L  +   N+  K  DFGLS     GE   +  GSP Y APEV+  R Y
Sbjct: 131 MVVHRDLKPENVLL-DAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS GVILY LLCG  PF  E    + + I  G+          ++ S  +L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQN 313
            ML+ DP  R T K + EH W + 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 150/276 (54%), Gaps = 11/276 (3%)
Query: 39  TVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           T LA +PK     D + + R LG+G+FG  YL  ++  + ++A K + K +L        
Sbjct: 2   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 61
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +RRE+ I  HL ++ +I+ +     D   ++L++E    GEL+  +   G + E+ +A  
Sbjct: 62  LRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 120
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
              + + +  CH+  VIHRD+KPEN L   K E   LK  DFG S+   P  R   + G+
Sbjct: 121 MEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGT 176
Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
             Y+ PE+++ + +  ++D+W AGV+ Y  L G+PPF + S     + I+   +D K  P
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPP 234
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +  +S+ +K L+ ++L   P  RL  K V+EHPW++
Sbjct: 235 F--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 137/264 (51%), Gaps = 10/264 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +   + T   +A K ++++K+R+   +  ++RE+  +K L ++
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRH 70
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +         +VME   GGELFD I   G   E  A  + + I+  V  CH+H
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            V+HRDLKPEN L  +   N+  K  DFGLS     GE      GSP Y APEV+  R Y
Sbjct: 131 MVVHRDLKPENVLL-DAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS GVILY LLCG  PF  E    + + I  G+          ++ S  +L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQN 313
            ML+ DP  R T K + EH W + 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 150/276 (54%), Gaps = 11/276 (3%)
Query: 39  TVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           T LA +PK     D + + R LG+G+FG  YL  ++  + ++A K + K +L        
Sbjct: 1   TALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +RRE+ I  HL ++ +I+ +     D   ++L++E    GEL+  +   G + E+ +A  
Sbjct: 61  LRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 119
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
              + + +  CH+  VIHRD+KPEN L   K E   LK  DFG S+   P  R   + G+
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGT 175
Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
             Y+ PE+++ + +  ++D+W AGV+ Y  L G+PPF + S     + I+   +D K  P
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPP 233
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +  +S+ +K L+ ++L   P  RL  K V+EHPW++
Sbjct: 234 F--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A + I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 145/262 (55%), Gaps = 11/262 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 127 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 239
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
            L  +P  R T +Q+++  W+ 
Sbjct: 240 FLILNPSKRGTLEQIMKDRWMN 261

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 95/261 (36%), Positives = 145/261 (55%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV IMK L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM 267

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 13/274 (4%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +ED + + R LG+G+FG  YL  +R ++ +LA K + K +L  A     +RREV I  H
Sbjct: 10  TLED-FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  
Sbjct: 69  L-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
           CH   VIHRD+KPEN L  +   N  LK  DFG S+   P  R + + G+  Y+ PE+++
Sbjct: 128 CHSKRVIHRDIKPENLLLGS---NGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIE 183
Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAK 285
            R +  ++D+WS GV+ Y  L G+PPF A + Q   + I R  ++F    +P+ V+E A+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFT---FPDFVTEGAR 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
            L+ ++L+ +   RLT  +VLEHPW++     P+
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 155/313 (49%), Gaps = 52/313 (16%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMK 106
           ++ +Y +   +G+G +GV  + I+  TR + A K ++K K+R     D++ ++ EV +MK
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI--------------VARGHYT-- 150
            L  + +I  L E  ED+  + LVMELC GG L D++              V +      
Sbjct: 84  KL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 151 ------------------------ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA 186
                                   E+  + + R I   +   H  G+ HRD+KPENFLF+
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 187 NKKENSPLKAIDFGLSI-FFK--PGERFSEIV--GSPYYMAPEVLK---RNYGPEIDIWS 238
             K +  +K +DFGLS  F+K   GE +      G+PY++APEVL     +YGP+ D WS
Sbjct: 203 TNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 239 AGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKL 298
           AGV+L++LL G  PF   ++      +L   + F+   +  +S  A+ L+  +L  +   
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 299 RLTAKQVLEHPWL 311
           R  A + L+HPW+
Sbjct: 322 RFDAMRALQHPWI 334

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 95/280 (33%), Positives = 146/280 (52%), Gaps = 24/280 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y++   LG G FG   L     T++ +A K IS++ L+ +     V RE++ +K L ++ 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHP 69
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +       + +V+E   GGELFD IV +   TE       + I+  ++ CH+H 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLKPEN L     +N  +K  DFGLS     G       GSP Y APEV+  K   
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI---LRGLIDFKRDPWPNVSESAKSL 287
           GPE+D+WS G++LY++L G  PF  E    + + +   +  + DF       +S  A+SL
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPGAQSL 238
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
           +R+M+  DP  R+T +++   PW        NV L D +R
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWF-------NVNLPDYLR 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 13/274 (4%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +ED + + R LG+G+FG  YL  +R ++ +LA K + K +L  A     +RREV I  H
Sbjct: 10  TLED-FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  
Sbjct: 69  L-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
           CH   VIHRD+KPEN L  +   N  LK  DFG S+   P  R   + G+  Y+ PE+++
Sbjct: 128 CHSKRVIHRDIKPENLLLGS---NGELKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIE 183
Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAK 285
            R +  ++D+WS GV+ Y  L G+PPF A + Q   + I R  ++F    +P+ V+E A+
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISR--VEFT---FPDFVTEGAR 238
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
            L+ ++L+ +   RLT  +VLEHPW++     P+
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 142/261 (54%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  + 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 71
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++L+ME   GGE+FD +VA G   E+ A +  R IV  VQ CH+  
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 132 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKR 244
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWI 265

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    GE++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 152/278 (54%), Gaps = 13/278 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I
Sbjct: 2   PRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
             HL ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   
Sbjct: 62  QSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +  CH   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +E+ G+  Y+ PE
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTELCGTLDYLPPE 176
Query: 225 VLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
           +++ R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTE 231
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
            A+ L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 98/295 (33%), Positives = 138/295 (46%), Gaps = 33/295 (11%)
Query: 49  IEDRYLVDREL-GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            ED Y +  EL G G +      +     +  A K I K+   +      V REV  +  
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSR---SRVFREVETLYQ 66
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              N +I+ L E  EDD   +LV E  +GG +   I  + H+ ER A+ V R +   +  
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV--------GSPY 219
            H  G+ HRDLKPEN L  + ++ SP+K  DF L    K     + I         GS  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 220 YMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPF---------WAESE------ 258
           YMAPEV++        Y    D+WS GV+LYI+L G PPF         W   E      
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 246
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             + ++I  G  +F    W ++S  AK L+ ++L  D K RL+A QVL+HPW+Q 
Sbjct: 247 NKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    GE++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLXGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 142/261 (54%), Gaps = 11/261 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  + 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++L+ME   GGE+FD +VA G   E+ A +  R IV  VQ CH+  
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+   K+  
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+  +S   ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLKR 247
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
            L  +P  R T +Q+++  W+
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWI 268

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 149/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  +++++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 8   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 67  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 236
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 33  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 92  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 206
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 261
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 151/278 (54%), Gaps = 13/278 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I
Sbjct: 2   PRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
             HL ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   
Sbjct: 62  QSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +  CH   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPE 176
Query: 225 VLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
           +++ R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTE 231
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
            A+ L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 33  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 92  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R  ++ G+  Y+ PE+++ 
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEG 206
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 261
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 151/274 (55%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R +++ G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 24  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 83  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 141
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 197
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 198 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 252
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 253 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 286

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 145/275 (52%), Gaps = 16/275 (5%)
Query: 45  PKENIED-----RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           PK ++ D      Y + + LG G FG   L     T + +A K I+K+ L  +     + 
Sbjct: 3   PKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE 62
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           RE++ ++ L ++  I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    +
Sbjct: 63  REISYLR-LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQ 120
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  V+ CH+H ++HRDLKPEN L     E+  +K  DFGLS     G       GSP 
Sbjct: 121 QIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPN 177
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APEV+  K   GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +   
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--- 234
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +S  A  L+++ML  +P  R++  ++++  W +
Sbjct: 235 -FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 145/275 (52%), Gaps = 16/275 (5%)
Query: 45  PKENIED-----RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           PK ++ D      Y + + LG G FG   L     T + +A K I+K+ L  +     + 
Sbjct: 2   PKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE 61
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           RE++ ++ L ++  I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    +
Sbjct: 62  REISYLR-LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQ 119
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  V+ CH+H ++HRDLKPEN L     E+  +K  DFGLS     G       GSP 
Sbjct: 120 QIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPN 176
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APEV+  K   GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +   
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--- 233
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +S  A  L+++ML  +P  R++  ++++  W +
Sbjct: 234 -FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 11  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 70  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 128
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 239
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 240 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 272

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 6   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 65  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 123
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 179
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 180 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 234
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 235 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 267

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 12  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 71  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE ++ 
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEXIEG 185
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 186 RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 240
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 241 LISRLLKHNPSQRPXLREVLEHPWITANSSKPSN 274

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTXLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 148/273 (54%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R  ++ G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 8   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 67  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIEG 181
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 236
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 9   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 68  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEG 182
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 237
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/282 (34%), Positives = 134/282 (47%), Gaps = 37/282 (13%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  + 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LVME   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     GSP Y APE+   K+  
Sbjct: 135 IVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG---------------------- 268
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG                      
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVL 251
Query: 269 -------LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK 303
                  L    +D W NV    + L +   EPDP    T +
Sbjct: 252 NPIKRGSLEQIMKDRWMNVGHEEEEL-KPYTEPDPDFNDTKR 292

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 143/272 (52%), Gaps = 9/272 (3%)
Query: 47  ENIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           EN  + Y L  +ELGRG+F V   CI + T +  A K + KR+ R      ++  E+A++
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVL 82
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVE 163
           +       +++L E  E+ + + L++E   GGE+F   +       +E     + + I+E
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            V   H++ ++H DLKP+N L ++      +K +DFG+S          EI+G+P Y+AP
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 224 EVLKRNYGP---EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           E+L  NY P     D+W+ G+I Y+LL    PF  E  Q     I +  +D+  + + +V
Sbjct: 203 EIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           S+ A   ++ +L  +P+ R TA+  L H WLQ
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 149/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 8   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 67  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S    P  R + + G+  Y+ PE+++ 
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSC-HAPSSRRTTLSGTLDYLPPEMIEG 181
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 236
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 140/262 (53%), Gaps = 11/262 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + LG G FG   L     T + +A K I+K+ L  +     + RE++ ++ L ++ 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 64
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH+H 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLKPEN L     E+  +K  DFGLS     G       GSP Y APEV+  K   
Sbjct: 124 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +     +S  A  L+++
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKR 236
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML  +P  R++  ++++  W +
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFK 258

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/260 (35%), Positives = 140/260 (53%), Gaps = 11/260 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + +G+G F    L     T + +A K I K +L ++  +  + REV I K L  + 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIXKVL-NHP 73
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           +IV L E  E +  ++LV E   GGE+FD +VA G   E+ A A  R IV  VQ CH+  
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+   K+  
Sbjct: 134 IVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG     R P+   S   ++L+++
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YXSTDCENLLKK 246
Query: 291 MLEPDPKLRLTAKQVLEHPW 310
            L  +P  R T +Q+ +  W
Sbjct: 247 FLILNPSKRGTLEQIXKDRW 266

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 140/262 (53%), Gaps = 11/262 (4%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + + LG G FG   L     T + +A K I+K+ L  +     + RE++ ++ L ++ 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHP 68
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I+ L +  +  + + +V+E   G ELFD IV R   +E+ A    + I+  V+ CH+H 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNY 230
           ++HRDLKPEN L     E+  +K  DFGLS     G       GSP Y APEV+  K   
Sbjct: 128 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 231 GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQ 290
           GPE+D+WS GVILY++LC   PF  ES   + + I  G+    +     +S  A  L+++
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKR 240
Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           ML  +P  R++  ++++  W +
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFK 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 9   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 68  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  +FG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 182
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 237
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 147/273 (53%), Gaps = 13/273 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 7   LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 66  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEG 180
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 235
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+      P+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 146/265 (55%), Gaps = 13/265 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ ++L+ +P  R   ++VLEHPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 150/274 (54%), Gaps = 14/274 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  +FG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ-NAKKAPN 319
           L+ ++L+ +P  R   ++VLEHPW+  N+ K  N
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 145/265 (54%), Gaps = 13/265 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL
Sbjct: 10  LED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 69  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R   + G+  Y+ PE+++ 
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEG 183
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 238
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ ++L+ +P  R   ++VLEHPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 145/265 (54%), Gaps = 13/265 (4%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +ED + + R LG+G+FG  YL  ++  + +LA K + K +L  A     +RREV I  HL
Sbjct: 4   LED-FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            ++ +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  C
Sbjct: 63  -RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ 
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 177
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKS 286
           R +  ++D+WS GV+ Y  L G PPF A + Q   + I R  ++F    +P+ V+E A+ 
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFT---FPDFVTEGARD 232
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWL 311
           L+ ++L+ +P  R   ++VLEHPW+
Sbjct: 233 LISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 102/305 (33%), Positives = 145/305 (47%), Gaps = 37/305 (12%)
Query: 49  IEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKR--KLRTAVDIDDVRREVAIM 105
            ED Y +  + LG G       CI+  T +  A K I K+   +R+ V      REV ++
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-----FREVEML 64
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                + +++ L E  E+++  +LV E   GG +   I  R H+ E  A+ V + +   +
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
              H  G+ HRDLKPEN L  +  + SP+K  DFGL    K     S I         GS
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 218 PYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPF---------WAESEQGVA 262
             YMAPEV++        Y    D+WS GVILYILL G PPF         W   E   A
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 263 ------QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                 ++I  G  +F    W ++S +AK L+ ++L  D K RL+A QVL+HPW+Q    
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
Query: 317 APNVP 321
              +P
Sbjct: 305 ENTLP 309

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 141/274 (51%), Gaps = 12/274 (4%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           LA    E IED + V   LG+G F   Y      T   +A K I K+ +  A  +  V+ 
Sbjct: 2   LATCIGEKIED-FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTR 159
           EV I   L K+ SI+ L    ED N V+LV+E+C  GE+   +  R   ++E  A     
Sbjct: 61  EVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSP 218
            I+  +   H HG++HRDL   N L      N  +K  DFGL+   K P E+   + G+P
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE+  R+ +G E D+WS G + Y LL G PPF  ++ +     ++  L D++   +
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSF 234
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             +S  AK L+ Q+L  +P  RL+   VL+HP++
Sbjct: 235 --LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 97/273 (35%), Positives = 140/273 (51%), Gaps = 12/273 (4%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 101
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVL-KR 228
            VIHRDLK  N LF N  ++  +K  DFGL+  I F  GER  ++ G+P Y+APEVL K+
Sbjct: 162 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVLCKK 217
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALI 273
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           R+ML  DP LR +  ++L   +  +      +P
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 139/272 (51%), Gaps = 10/272 (3%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 85
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 145
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRN 229
            VIHRDLK  N LF N  ++  +K  DFGL+   +  GER  ++ G+P Y+APEVL K+ 
Sbjct: 146 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+R
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIR 258
Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           +ML  DP LR +  ++L   +  +      +P
Sbjct: 259 RMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 290

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 101/305 (33%), Positives = 144/305 (47%), Gaps = 37/305 (12%)
Query: 49  IEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKR--KLRTAVDIDDVRREVAIM 105
            ED Y +  + LG G       CI+  T +  A K I K+   +R+ V      REV ++
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-----FREVEML 64
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                + +++ L E  E+++  +LV E   GG +   I  R H+ E  A+ V + +   +
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
              H  G+ HRDLKPEN L  +  + SP+K  DF L    K     S I         GS
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 218 PYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPF---------WAESEQGVA 262
             YMAPEV++        Y    D+WS GVILYILL G PPF         W   E   A
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 263 ------QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                 ++I  G  +F    W ++S +AK L+ ++L  D K RL+A QVL+HPW+Q    
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
Query: 317 APNVP 321
              +P
Sbjct: 305 ENTLP 309

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 97/273 (35%), Positives = 139/273 (50%), Gaps = 12/273 (4%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 101
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVL-KR 228
            VIHRDLK  N LF N  ++  +K  DFGL+  I F  GER   + G+P Y+APEVL K+
Sbjct: 162 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFD-GERKKTLCGTPNYIAPEVLCKK 217
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALI 273
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           R+ML  DP LR +  ++L   +  +      +P
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 97/273 (35%), Positives = 139/273 (50%), Gaps = 12/273 (4%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY+  R LG+G F   Y   D DT+E+ A K + K  L      + +  E+AI K L  N
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-DN 101
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             +V      EDD+ V++V+E+C    L +    R   TE  A    R  ++ VQ  H +
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVL-KR 228
            VIHRDLK  N LF N  ++  +K  DFGL+  I F  GER   + G+P Y+APEVL K+
Sbjct: 162 RVIHRDLKLGN-LFLN--DDMDVKIGDFGLATKIEFD-GERKKXLCGTPNYIAPEVLCKK 217
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +  E+DIWS G ILY LL G PPF     +     I +      R    +++  A +L+
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALI 273
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           R+ML  DP LR +  ++L   +  +      +P
Sbjct: 274 RRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 144/277 (51%), Gaps = 16/277 (5%)
Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +    +D ++V+RE
Sbjct: 9   ADLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKRE 64
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           +   + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + +
Sbjct: 65  IINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 123
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSP 218
           +  V  CH   V HRDLK EN L     + SP   LK  DFG S       +    VG+P
Sbjct: 124 ISGVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 179
Query: 219 YYMAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKR 274
            Y+APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +  
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAI 239
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
             + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 240 PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 141/275 (51%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +   A    +V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA----NVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   V HRDLK EN L     + SP   LK  DFG S       +    VG+P Y
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 143/275 (52%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +    +D ++V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   V HRDLK EN L     + SP   LK   FG S       +  + VG+P Y
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 142/275 (51%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+ + EL+A K I + +    +D ++V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE---KID-ENVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   V HRDLK EN L     + SP   LK   FG S       +    VG+P Y
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 146/294 (49%), Gaps = 27/294 (9%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       DT +L A K + K  + + A   +  R E  +++H+ ++  +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + +  +HL+++   GGELF  +  R  +TE         IV  ++  HK G+I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFF--KPGERFSEIVGSPYYMAPEVLK---RN 229
           +RD+K EN L  +   N  +   DFGLS  F     ER  +  G+  YMAP++++     
Sbjct: 182 YRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSESAKSLV 288
           +   +D WS GV++Y LL G  PF  + E+     I R ++     P+P  +S  AK L+
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDLI 297
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN-------AKKAPNVPLGDVVRSRL 330
           +++L  DPK RL      A ++ EH + Q        AKK P  P   V+R  L
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP-APFKPVIRDEL 350

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 141/275 (51%), Gaps = 16/275 (5%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY + +++G G FGV  L  D+   EL+A K I + +    +D ++V+RE+ 
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE---KID-ENVKREII 67
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + +VME   GGELF+RI   G ++E  A    + ++ 
Sbjct: 68  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V   H   V HRDLK EN L     + SP   LK  DFG S       +    VG+P Y
Sbjct: 127 GVSYAHAMQVAHRDLKLENTLL----DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAY 182
Query: 221 MAPEV-LKRNY-GPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGL-IDFKRDP 276
           +APEV LK+ Y G   D+WS GV LY++L G  PF   E  +   + I R L + +    
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPD 242
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + ++S   + L+ ++   DP  R++  ++  H W 
Sbjct: 243 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 141/276 (51%), Gaps = 18/276 (6%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY   +++G G FGV  L  D+ T+EL+A K I +     A+D ++V+RE+ 
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG---AAID-ENVQREII 68
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + ++ME   GGEL++RI   G ++E  A    + ++ 
Sbjct: 69  NHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSP---LKAIDFGLSIFFKPGERFSEIVGSPYY 220
            V  CH   + HRDLK EN L     + SP   LK  DFG S       +    VG+P Y
Sbjct: 128 GVSYCHSMQICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 183
Query: 221 MAPEVLKRN-YGPEI-DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           +APEVL R  Y  +I D+WS GV LY++L G  PF    E    +  ++ ++  K    P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS-IP 242
Query: 279 N---VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           +   +S     L+ ++   DP  R++  ++  H W 
Sbjct: 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 35/289 (12%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV + C +RDT +++A K   + +    +      RE+ ++K L K+ ++V+L
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQL-KHPNLVNL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
            E       +HLV E C+   L +    +    E    ++T   ++ V  CHKH  IHRD
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRD 127
Query: 178 LKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEI 234
           +KPEN L     ++S +K  DFG + +   P + + + V + +Y +PE+L     YGP +
Sbjct: 128 VKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF------------------KRDP 276
           D+W+ G +   LL GVP +  +S+      I + L D                     DP
Sbjct: 185 DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244
Query: 277 ---------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                    +PN+S  A  L++  L  DP  RLT +Q+L HP+ +N ++
Sbjct: 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + R LG+G+FG  YL  ++ +  ++A K + K ++        +RRE+ I  HL  
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL-H 81
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L     D   ++L++E    GEL+  +     + E+  A +   + + +  CH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RN 229
             VIHRD+KPEN           LK  DFG S+   P  R   + G+  Y+ PE+++ R 
Sbjct: 142 KKVIHRDIKPEN---LLLGLKGELKIADFGWSV-HAPSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLV 288
           +  ++D+W  GV+ Y LL G PPF + S     + I++  +D K   +P +V   A+ L+
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVK--VDLK---FPASVPTGAQDLI 252
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQ 312
            ++L  +P  RL   QV  HPW++
Sbjct: 253 SKLLRHNPSERLPLAQVSAHPWVR 276

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 93
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 153 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 269 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 303

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 86
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 146 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 203 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 262 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 296

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 91
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 151 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 208 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 267 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 301

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 82
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 292

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 136
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 196 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 253 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 311
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 312 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 346

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 146/275 (53%), Gaps = 12/275 (4%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G  G+  +   R + +L+A K +  RK +     + +  EV IM+   ++ ++V +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDY-QHENVVEM 213
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +    + + +VME  EGG L D IV      E   AAV   +++ + + H  GVIHRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 178 LKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEID 235
           +K ++ L  +   +  +K  DFG  +   K   R   +VG+PY+MAPE++ R  YGPE+D
Sbjct: 273 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           IWS G+++  ++ G PP++ E     A  ++R  +  +      VS S K  + ++L  D
Sbjct: 330 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 388
Query: 296 PKLRLTAKQVLEHPWLQNA-KKAPNVPLGDVVRSR 329
           P  R TA ++L+HP+L  A   A  VPL    R+R
Sbjct: 389 PAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR 423

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 83
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 144 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 83
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 144 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 256
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 87
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 148 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 260
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 261 TARPTINELLNDEFFTSGYIPARLPI 286

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 285

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 144/295 (48%), Gaps = 29/295 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNVPLGDVVRS 328
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V  G V  S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 105
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 166 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 278
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 279 TARPTINELLNDEFFTSGYIPARLPI 304

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 107
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 168 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 280
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPI 306

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 10/266 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  +  +V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFH 81
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H++ VIHRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           K  N LF N  E+  +K  DFGL+   +  GER   + G+P Y+APEVL K+ +  E+D+
Sbjct: 142 KLGN-LFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS G I+Y LL G PPF     +     I +      +    +++  A SL+++ML+ DP
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 254
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPL 322
             R T  ++L   +  +      +P+
Sbjct: 255 TARPTINELLNDEFFTSGYIPARLPI 280

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 74
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 75  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 135 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 191
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 192 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 247
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 248 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 280

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 76
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 77  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 137 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 193
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 194 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 249
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 250 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 282

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 21/279 (7%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244
Query: 297 KLRL-----TAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           K RL      AK+V+EH +        ++   DVV+ +L
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL------SINWQDVVQKKL 277

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 37/291 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--------------------- 89
           ++Y +  E+G+G +GV  L  + +     A K +SK+KL                     
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 90  --RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM--ELCEGGELFDRIVA 145
             +    I+ V +E+AI+K L  + ++V L E  +D N  HL M  EL   G + + +  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
               +E  A    + +++ ++  H   +IHRD+KP N L     E+  +K  DFG+S  F
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEF 187
Query: 206 KPGERF-SEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
           K  +   S  VG+P +MAPE L        G  +D+W+ GV LY  + G  PF  E    
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           +   I    ++F   P  +++E  K L+ +ML+ +P+ R+   ++  HPW+
Sbjct: 248 LHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 142/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P+   S+     +      D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS------DWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 19  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 77
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 137
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 138 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 196
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 197 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 254 DIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 304 WMQDV 308

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEIXINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 4   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 59
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 60  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 119 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 229
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 276

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 22  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 81
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 82  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 141
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 198
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 199 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 255 ---IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEIXINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 24  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 82
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 83  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 142
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 143 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 201
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 202 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 259 DIPFEHDEE------IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 308
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 309 WMQDV 313

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 122
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 123 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 179
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 180 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 236 ---IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 61
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 62  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 121
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 122 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 178
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 179 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 234
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 235 ---IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 147/305 (48%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 19  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 77
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 137
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 138 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 196
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 197 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 254 DIPFEHDEE------IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 304 WMQDV 308

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 61
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 62  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 121
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 122 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 178
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 179 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 234
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 235 ---IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 122
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 123 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 179
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 180 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 236 ---IIRGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 142/293 (48%), Gaps = 22/293 (7%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL 89
           A  N      +  G  KE +E +Y V   LG G FG  Y  I       +A K + K ++
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 90  RTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIV 144
               ++ +  R   EV ++K +    S ++ L +  E  ++  L++E  E   +LFD I 
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 122
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSI 203
            RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG   
Sbjct: 123 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGA 179
Query: 204 FFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG  PF  + E   
Sbjct: 180 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 235
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
              I+RG + F++     VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 236 ---IIRGQVFFRQ----RVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDV 281

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 25/279 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 25/279 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 25/279 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 25/279 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEIXINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 25/279 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 137/279 (49%), Gaps = 25/279 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
             +  +  +L+ ++L  +P  R+T   + +  W
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 263

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQ 122
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 178
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 229
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 230 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 179
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 231 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIXNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 179
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 231 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 122
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 178
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 229
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 230 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 140/287 (48%), Gaps = 29/287 (10%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G  G   L ++R T E +A K +    ++ AVD  +++++E+ I K 
Sbjct: 5   VEDWDLV-QTLGEGAAGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKM 60
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 61  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 120 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW----LQNAKKAPNV 320
             +  +  +L+ ++L  +P  R+T   + +  W    L+   K P V
Sbjct: 231 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRV 277

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 179
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 230
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 231 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+    +I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   +K  DFGL+   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 26  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 85
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 86  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 145
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 146 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 201
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 252
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 253 -RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + SE+VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTP 180
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + L+ D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGXEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPDPKLRL-----TAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D   R          +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 91/338 (26%), Positives = 149/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   R 
Sbjct: 1   MGNAAAAKKGXEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIRT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I + +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++V+E   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPDPKLRL-----TAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D   R          +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 21  MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 69
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 128
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 189 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLT 299
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 300 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 337

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 138/277 (49%), Gaps = 22/277 (7%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EV 102
           KE +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV
Sbjct: 2   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 61
Query: 103 AIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRT 160
            ++K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 121
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           ++E V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  
Sbjct: 122 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRV 177
Query: 220 YMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y  PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++   
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ--- 228
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             VS   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 229 -RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWESPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   ++T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIGGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 4   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 62
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 63  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 122
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 123 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 181
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 182 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 239 DIPFEHDEE------IIGGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 289 WMQDV 293

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--E 58
           MGN   +     +E VK           E  A  K+        P +N       DR   
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G FG  Y  I      
Sbjct: 5   SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 63
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 64  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 123
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 124 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 182
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 183 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+ G + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 240 DIPFEHDEE------IIGGQVFFRQ----RVSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 290 WMQDV 294

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 139/277 (50%), Gaps = 20/277 (7%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 134
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 308
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQNAKKA 317
           AK+L+   L  D ++RL    V E   H + +N + A
Sbjct: 309 AKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWA 344

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 139/277 (50%), Gaps = 20/277 (7%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 129
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 303
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQNAKKA 317
           AK+L+   L  D ++RL    V E   H + +N + A
Sbjct: 304 AKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWA 339

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 138/284 (48%), Gaps = 22/284 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-----VRREVAIMK 106
           +Y     LG G FG  +  +D++  + +  K I K K+     I+D     V  E+AI+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVEVV 165
            + ++++I+ + +  E+     LVME    G +LF  I       E  A+ + R +V  V
Sbjct: 85  RV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
                  +IHRD+K EN + A   E+  +K IDFG + + + G+ F    G+  Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 226 LKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           L  N   GPE+++WS GV LY L+    PF  E E+ V  AI          P   VS+ 
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAI---------HPPYLVSKE 250
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
             SLV  +L+P P+ R T ++++  PW+       +    +V R
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 139/277 (50%), Gaps = 20/277 (7%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + TR++ A K +SK ++    D      E  IM     + 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 134
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGE-RFSEIVGSPYYMAPEVLKRN- 229
            IHRD+KP+N L     ++  LK  DFG  +   K G  R    VG+P Y++PEVLK   
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVSES 283
               YG E D WS GV LY +L G  PF+A+S  G    I+  +  + F  D   ++S+ 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 308
Query: 284 AKSLVRQMLEPDPKLRLTAKQVLE---HPWLQNAKKA 317
           AK+L+   L  D ++RL    V E   H + +N + A
Sbjct: 309 AKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWA 344

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 143/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTP 180
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + LE D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 25/279 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI-DDVRREVAIMKH 107
           +ED  LV + LG G +G   L ++R T E +A K +    ++ AVD  +++++E+ I   
Sbjct: 6   VEDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINAM 61
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  + ++V       + N  +L +E C GGELFDRI       E  A      ++  V  
Sbjct: 62  L-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
            H  G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 225 VLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-----DPW 277
           +LKR   +   +D+WS G++L  +L G  P W +      +       D+K      +PW
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQE-----YSDWKEKKTYLNPW 231
Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  +  +L+ ++L  +P  R+T   + +  W     K
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 141/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 3   KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 62
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 63  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 121
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G ++E  A      IV   +  H   +I+RDLKPEN L     E   ++  DFG +   
Sbjct: 122 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DEQGYIQVTDFGFAKRV 178
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 179 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 236
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 237 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 292
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 293 YQRKVEAPFIP 303

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 136/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+    +I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   ++  DFGL+   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGLAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 27/318 (8%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
            A K + K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           +F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++  D
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTD 184
Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+ 
Sbjct: 185 FGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWL- 311
              + + I+ G + F      + S   K L+R +L+ D   R          +  H W  
Sbjct: 243 PIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIKNHKWFA 298
Query: 312 --------QNAKKAPNVP 321
                   Q   +AP +P
Sbjct: 299 TTDWIAIYQRKVEAPFIP 316

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKAFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 207
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 263
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 309

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 147/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--E 58
           MGN   +     +E VK           E  A  K+        P +N       DR   
Sbjct: 21  MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT 69
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 128
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H   +I+RDL
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 189 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 300 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 337

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 150/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--E 58
           MGN   +     +E VK           E  A  K+        P +N       DR   
Sbjct: 21  MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT 69
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 128
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 188
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K G  ++ + G+P Y+APE +L + Y   +D W
Sbjct: 189 KPENLLI---DQQGYIQVTDFGFAKRVK-GATWT-LCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 299
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 300 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 337

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 143/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 14  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 66
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 67  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 124
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 125 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTP 181
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 234
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + LE D + R +AK++++H +L+ AK
Sbjct: 235 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAK 278

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 141/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 141/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 16/261 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 75
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 76  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 178 LKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 136 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 192
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 193 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 248
Query: 296 PKLRL-----TAKQVLEHPWL 311
           PK RL      AK++++H + 
Sbjct: 249 PKQRLGGGSEDAKEIMQHRFF 269

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 149/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 16/261 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 74
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 75  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 178 LKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 135 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 191
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 192 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 247
Query: 296 PKLRL-----TAKQVLEHPWL 311
           PK RL      AK++++H + 
Sbjct: 248 PKQRLGGGSEDAKEIMQHRFF 268

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 149/338 (44%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 16/258 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 217
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 277
Query: 178 LKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 278 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 334
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 335 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLKKD 390
Query: 296 PKLRL-----TAKQVLEH 308
           PK RL      AK++++H
Sbjct: 391 PKQRLGGGSEDAKEIMQH 408

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 27/318 (8%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
            A K + K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           +F  +   G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  D
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTD 184
Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+ 
Sbjct: 185 FGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL- 311
              + + I+ G + F      + S   K L+R +L+ D       L+     +  H W  
Sbjct: 243 PIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 312 --------QNAKKAPNVP 321
                   Q   +AP +P
Sbjct: 299 TTDWIAIYQRKVEAPFIP 316

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 129/258 (50%), Gaps = 16/258 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 214
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 178 LKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 275 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLKKD 387
Query: 296 PKLRL-----TAKQVLEH 308
           PK RL      AK++++H
Sbjct: 388 PKQRLGGGSEDAKEIMQH 405

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 16/261 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 76
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRD 177
            + +  + +  VME   GGELF  +     ++E  A      IV  +   H +  V++RD
Sbjct: 77  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 178 LKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           LK EN +     ++  +K  DFGL     K G       G+P Y+APEVL+ N YG  +D
Sbjct: 137 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 193
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W  GV++Y ++CG  PF+ +  + + + IL   I F R   P     AKSL+  +L+ D
Sbjct: 194 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE----AKSLLSGLLKKD 249
Query: 296 PKLRL-----TAKQVLEHPWL 311
           PK RL      AK++++H + 
Sbjct: 250 PKQRLGGGSEDAKEIMQHRFF 270

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 136/294 (46%), Gaps = 23/294 (7%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D +   R LG+G FG   L   ++T +L A K + K  +    D++    E  I+  L +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-LAR 81
Query: 111 NSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           N   ++    C +  + +  VME   GG+L   I     + E  A      I+  +   H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKR 228
             G+I+RDLK +N L  ++      K  DFG+       G   +   G+P Y+APE+L+ 
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             YGP +D W+ GV+LY +LCG  PF AE+E  + +AIL   + +    W  + E A  +
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LHEDATGI 254
Query: 288 VRQMLEPDPKLRLTA------KQVLEHP------WLQNAKKAPNVPLGDVVRSR 329
           ++  +  +P +RL +        +L HP      W Q   +    P    ++SR
Sbjct: 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSR 308

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/318 (27%), Positives = 142/318 (44%), Gaps = 27/318 (8%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
            A K + K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 139 LFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           +F  +   G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  D
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTD 184
Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG +   K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+ 
Sbjct: 185 FGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL- 311
              + + I+ G + F      + S   K L+R +L+ D       L+     +  H W  
Sbjct: 243 PIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 312 --------QNAKKAPNVP 321
                   Q   +AP +P
Sbjct: 299 TTDWIAIYQRKVEAPFIP 316

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPDPKLRL-----TAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D   R          +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 143/284 (50%), Gaps = 27/284 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR 99
           V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + + 
Sbjct: 13  VSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELII 65
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R
Sbjct: 66  NEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCR 123
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSP 218
             ++ ++  H + VIHRD+K +N L      +  +K  DFG      P + + S +VG+P
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233
Query: 278 PNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           P +    K        + + L+ D + R +AK++L+H +L+ AK
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L   ++T    A K + K+K+     I+    E  I++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 207
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 263
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 309

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 144/286 (50%), Gaps = 27/286 (9%)
Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           I V  G PK+    +Y    ++G+G  G  Y  +D  T + +A   I +  L+     + 
Sbjct: 12  IIVSVGDPKK----KYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKEL 64
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +  E+ +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV
Sbjct: 65  IINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAV 122
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVG 216
            R  ++ ++  H + VIHR++K +N L      +  +K  DFG      P + + S +VG
Sbjct: 123 CRECLQALEFLHSNQVIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 217 SPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +PY+MAPEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATN 232
Query: 276 PWPNVSESAK------SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
             P +    K        + + LE D + R +AK++++H +L+ AK
Sbjct: 233 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAK 278

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPDPKLRL-----TAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D   R          +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + +G G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKR---KLRTAVDIDDVRRE 101
           PK +++D + + R LG G FG  +L   R      A K + K    +L+     +D R  
Sbjct: 1   PKYSLQD-FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           ++I+ H      I+ +    +D   + ++M+  EGGELF  +     +    A      +
Sbjct: 60  LSIVTH----PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
              ++  H   +I+RDLKPEN L     +N  +K  DFG + +  P   +  + G+P Y+
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV-PDVTYX-LCGTPDYI 170
Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+  + Y   ID WS G+++Y +L G  PF+  +     + IL   + F     P  
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFF 226
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQ-----VLEHPWLQ 312
           +E  K L+ +++  D   RL   Q     V  HPW +
Sbjct: 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 140/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 136/274 (49%), Gaps = 22/274 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 106 KHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  Y  
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 223 PEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++     V
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RV 227
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           S   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 228 SXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 140/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 135 IGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 192 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 250 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 306 YQRKVEAPFIP 316

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGXEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +  L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 85
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 146 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEYLAPEIILSKG 200
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 201 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 256
Query: 290 QMLEPDPKLRL-----TAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D   R          +  H W          Q   +AP +P
Sbjct: 257 NLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 302

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 90/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +V L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 148/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +  L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN +     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 140/311 (45%), Gaps = 27/311 (8%)
Query: 28  KEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSIS 85
           KE  A  K+        P +N       DR   LG G FG   L   +++    A K + 
Sbjct: 11  KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 70
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           K+K+     I+    E  I++ +     +V L+ + +D++ +++VME   GGE+F  +  
Sbjct: 71  KQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 129
Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
            G + E  A      IV   +  H   +I+RDLKPEN L     +   ++  DFG +   
Sbjct: 130 IGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 186
Query: 206 KPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
           K   R   + G+P Y+APE +L + Y   +D W+ GV++Y +  G PPF+A+    + + 
Sbjct: 187 KG--RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 244
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPWL-------- 311
           I+ G + F      + S   K L+R +L+ D       L+     +  H W         
Sbjct: 245 IVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 300
Query: 312 -QNAKKAPNVP 321
            Q   +AP +P
Sbjct: 301 YQRKVEAPFIP 311

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + LG G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   ++  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/320 (26%), Positives = 144/320 (45%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN +     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLII---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+APE ++ + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 136/274 (49%), Gaps = 22/274 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 106 KHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  Y  
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 223 PEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE ++  R +G    +WS G++LY ++CG  PF  + E      I+RG + F++     V
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RV 227
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           S   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 143/320 (44%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P Y+AP  +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 147/338 (43%), Gaps = 38/338 (11%)
Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIE--DRYLVDRE 58
           MGN   +     +E VK           E  A  K+        P +N    D++   + 
Sbjct: 1   MGNAAAAKKGSEQESVK-----------EFLAKAKEDFLKKWENPAQNTAHLDQFERIKT 49
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG   L    +T    A K + K+K+     I+    E  I++ +     +  L+
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTKLE 108
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +D++ +++VME   GGE+F  +   G + E  A      IV   +  H   +I+RDL
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIW 237
           KPEN +     +   +K  DFG +   K   R   + G+P Y+APE +L + Y   +D W
Sbjct: 169 KPENLMI---DQQGYIKVTDFGFAKRVKG--RTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 238 SAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-- 295
           + GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D  
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLT 279
Query: 296 ---PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
                L+     +  H W          Q   +AP +P
Sbjct: 280 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 317

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + +G G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GG++F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D++   + +G G FG   L    +T    A K + K+K+     I+    E  I++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              +V L+ + +D++ +++VME   GG++F  +   G ++E  A      IV   +  H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRN 229
             +I+RDLKPEN L     +   +K  DFG +   K   R   + G+P Y+APE +L + 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKG--RTWXLCGTPEYLAPEIILSKG 214
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           Y   +D W+ GV++Y +  G PPF+A+    + + I+ G + F      + S   K L+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270
Query: 290 QMLEPD-----PKLRLTAKQVLEHPWL---------QNAKKAPNVP 321
            +L+ D       L+     +  H W          Q   +AP +P
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/224 (34%), Positives = 122/224 (54%), Gaps = 20/224 (8%)
Query: 101 EVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAA 154
           EV +++ L K+ +IV   +   D  +  +++VME CEGG+L   I      R +  E   
Sbjct: 55  EVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 155 AAVTRTIVEVVQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             V   +   ++ CH+     H V+HRDLKP N +F + K+N  +K  DFGL+      E
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDE 170
Query: 210 RFS-EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            F+ E VG+PYYM+PE + R +Y  + DIWS G +LY L   +PPF A S++ +A  I  
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           G   F+R P+   S+    ++ +ML      R + +++LE+P +
Sbjct: 231 G--KFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 120/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F  T L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 270 DATKRLGCEEM 280

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 141/279 (50%), Gaps = 15/279 (5%)
Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           + V  G P+E + +      ++G G  G+  +  ++ T + +A K +  RK +     + 
Sbjct: 36  LVVSPGDPREYLANFI----KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---EL 88
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +  EV IM+    + ++V +  +    + + +VME  EGG L D IV      E   A V
Sbjct: 89  LFNEVVIMRDY-HHDNVVDMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATV 146
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVG 216
             +++  +   H  GVIHRD+K ++ L  +   +  +K  DFG  +   K   +   +VG
Sbjct: 147 CLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKXLVG 203
Query: 217 SPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +PY+MAPEV+ R  YG E+DIWS G+++  ++ G PP++ E      + I   L    +D
Sbjct: 204 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD 263
Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
               VS   +  +  ML  +P  R TA+++L HP+L+ A
Sbjct: 264 -LHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKLA 301

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 143/320 (44%), Gaps = 31/320 (9%)
Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDR--ELGRGEFGVTYLCIDRDTREL 78
            S   + KE  A  K+        P +N       DR   LG G FG   L   +++   
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMK--HLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
            A K + K+K+     I+    E  I++  + P    +V L+ + +D++ +++VME   G
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP---FLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
           GE+F  +   G ++E  A      IV   +  H   +I+RDLKPEN L     +   ++ 
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQV 182
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWA 255
            DFG +   K   R   + G+P  +APE +L + Y   +D W+ GV++Y +  G PPF+A
Sbjct: 183 TDFGFAKRVKG--RTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD-----PKLRLTAKQVLEHPW 310
           +    + + I+ G + F      + S   K L+R +L+ D       L+     +  H W
Sbjct: 241 DQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 311 L---------QNAKKAPNVP 321
                     Q   +AP +P
Sbjct: 297 FATTDWIAIYQRKVEAPFIP 316

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 150/289 (51%), Gaps = 26/289 (8%)
Query: 52  RYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           R L+D   ++G G  G+  L  ++ +   +A K +  RK +     + +  EV IM+   
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDY- 99
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           ++ ++V + ++      + ++ME  +GG L D IV++    E   A V   +++ +   H
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGL-SIFFKPGERFSEIVGSPYYMAPEVLKR 228
             GVIHRD+K ++ L      +  +K  DFG  +   K   +   +VG+PY+MAPEV+ R
Sbjct: 159 AQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISR 215
Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-- 285
           + Y  E+DIWS G+++  ++ G PP++++S     QA+ R     +  P P +  S K  
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNSHKVS 268
Query: 286 ----SLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKAPNVPLGDVVRSR 329
                 + +ML  DP+ R TA+++L+HP+ LQ       VPL  + R +
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQ 317

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 2   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 62  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 121 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 236
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 237 ---ARDLVEKLLVLDATKRLGCEEM 258

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 1   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 60
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 61  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 119
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 120 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 235
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 236 ---ARDLVEKLLVLDATKRLGCEEM 257

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 135/274 (49%), Gaps = 22/274 (8%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +  R   EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 106 KHLPKN-SSIVSLKEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V+ CH  GV+HRD+K EN L   N+ E   LK IDFG     K    +++  G+  Y  
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 223 PEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           PE ++  R +G    +WS G++LY ++CG  PF  + E      I+ G + F++     V
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ----RV 227
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           S   + L+R  L   P  R T +++  HPW+Q+ 
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 3   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 62
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 63  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 121
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 122 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 237
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 238 ---ARDLVEKLLVLDATKRLGCEEM 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 4   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 63
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 64  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 122
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 123 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 222 APEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L +++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P  
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK- 238
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQV 305
              A+ LV ++L  D   RL  +++
Sbjct: 239 ---ARDLVEKLLVLDATKRLGCEEM 260

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 80
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 140
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 141 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 197
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 198 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 253
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 254 DATKRLGCEEM 264

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 139/275 (50%), Gaps = 24/275 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V + +GRG FG   L   + ++++ A K +SK ++    D      E  IM     + 
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 135
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            +V L  A +DD  +++VME   GG+L + +++     E+ A   T  +V  +   H  G
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----RFSEIVGSPYYMAPEVLKR 228
           +IHRD+KP+N L     ++  LK  DFG  +  K  E         VG+P Y++PEVLK 
Sbjct: 195 LIHRDVKPDNMLL---DKHGHLKLADFGTCM--KMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 229 N-----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--RGLIDFKRDPWPNVS 281
                 YG E D WS GV L+ +L G  PF+A+S  G    I+  +  + F  D    +S
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED--AEIS 307
Query: 282 ESAKSLVRQMLEPDPKLRL---TAKQVLEHPWLQN 313
           + AK+L+   L  D ++RL     +++ +HP+ +N
Sbjct: 308 KHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 341

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 99
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 160 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 216
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 217 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 272
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 273 DATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 95
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 155
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 156 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 212
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 213 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 268
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 269 DATKRLGCEEM 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 96
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 157 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 213
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 214 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 269
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 99
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 159
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 160 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 216
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 217 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 272
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 273 DATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 131/292 (44%), Gaps = 38/292 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y     +  E  A K I   K    +    +R E++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-K 58
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
           +S+IV L +       + LV E  +    +L D  V  G      A +    ++  +  C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL- 226
           H   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  V + +Y AP+VL 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLM 173
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---- 281
             + Y   IDIWS G I   ++ G P F   SE      I R L       WPNV+    
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 282 ---------------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 12/251 (4%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 95
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 155
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 156 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 212
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 213 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 268
Query: 295 DPKLRLTAKQV 305
           D   RL  +++
Sbjct: 269 DATKRLGCEEM 279

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 131/292 (44%), Gaps = 38/292 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y     +  E  A K I   K    +    +R E++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-K 58
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
           +S+IV L +       + LV E  +    +L D  V  G      A +    ++  +  C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL- 226
           H   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  V + +Y AP+VL 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLM 173
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---- 281
             + Y   IDIWS G I   ++ G P F   SE      I R L       WPNV+    
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 282 ---------------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 103
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 163
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 164 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 220
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 221 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 276
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 277 DATKRLGCEEMEGYGPLKAHPFFES 301

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 131/292 (44%), Gaps = 38/292 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y     +  E  A K I   K    +    +R E++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKEL-K 58
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
           +S+IV L +       + LV E  +    +L D  V  G      A +    ++  +  C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL- 226
           H   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  + + +Y AP+VL 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---- 281
             + Y   IDIWS G I   ++ G P F   SE      I R L       WPNV+    
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 282 ---------------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 57  RELGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNS 112
           R LG+G +G  +        +T ++ A K + K  + R A D    + E  I++ + K+ 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHP 81
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV L  A +    ++L++E   GGELF ++   G + E  A      I   +   H+ G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           +I+RDLKPEN +  ++     +K  DFGL   SI    G       G+  YMAPE+L R+
Sbjct: 142 IIYRDLKPENIMLNHQGH---VKLTDFGLCKESI--HDGTVTHTFCGTIEYMAPEILMRS 196
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +   +D WS G ++Y +L G PPF  E+ +     IL+  ++      P +++ A+ L+
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDLL 252
Query: 289 RQMLEPDPKLRLT-----AKQVLEHPWLQN 313
           +++L+ +   RL      A +V  HP+ ++
Sbjct: 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 57  RELGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNS 112
           R LG+G +G  +        +T ++ A K + K  + R A D    + E  I++ + K+ 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHP 81
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV L  A +    ++L++E   GGELF ++   G + E  A      I   +   H+ G
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN 229
           +I+RDLKPEN +  ++     +K  DFGL   SI    G       G+  YMAPE+L R+
Sbjct: 142 IIYRDLKPENIMLNHQGH---VKLTDFGLCKESI--HDGTVTHXFCGTIEYMAPEILMRS 196
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +   +D WS G ++Y +L G PPF  E+ +     IL+  ++      P +++ A+ L+
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDLL 252
Query: 289 RQMLEPDPKLRLT-----AKQVLEHPWLQN 313
           +++L+ +   RL      A +V  HP+ ++
Sbjct: 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 18/279 (6%)
Query: 45  PKENIEDRYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           P  N++   L D      LG+G FG   L   + T EL A K + K  +    D++    
Sbjct: 9   PSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  ++  L K   +  L    +  + ++ VME   GG+L   I   G + E  A      
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPY 219
           I   +   HK G+I+RDLK +N +  ++     +K  DFG+       G    E  G+P 
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMMDGVTTREFCGTPD 185
Query: 220 YMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y+APE++  + YG  +D W+ GV+LY +L G PPF  E E  + Q+I+   + + +    
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK---- 241
Query: 279 NVSESAKSLVRQMLEPDPKLRLTA-----KQVLEHPWLQ 312
           ++S+ A S+ + ++   P  RL       + V EH + +
Sbjct: 242 SLSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFR 280

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 133/309 (43%), Gaps = 34/309 (11%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           ++  P     DRY    +LG G +G  Y  ID  T E +A K I        V    +R 
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR- 82
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           EV+++K L ++ +I+ LK     ++ +HL+ E  E  +L   +      + R   +    
Sbjct: 83  EVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLF--ANKKENSPLKAIDFGLS-IFFKPGERFSEIVGS 217
           ++  V  CH    +HRDLKP+N L   ++  E   LK  DFGL+  F  P  +F+  + +
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
            +Y  PE+L   R+Y   +DIWS   I   +L   P F  +SE      I   L      
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 276 PWPNVSE-----------SAKSLVR---------------QMLEPDPKLRLTAKQVLEHP 309
            WP V+              K+L R                MLE DP  R++AK  LEHP
Sbjct: 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320
Query: 310 WLQNAKKAP 318
           +  +    P
Sbjct: 321 YFSHNDFDP 329

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 101
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 161
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 162 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 218
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 219 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPK----ARDLVEKLLVL 274
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 275 DATKRLGCEEMEGYGPLKAHPFFES 299

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 121/224 (54%), Gaps = 20/224 (8%)
Query: 101 EVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAA 154
           EV +++ L K+ +IV   +   D  +  +++VME CEGG+L   I      R +  E   
Sbjct: 55  EVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 155 AAVTRTIVEVVQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             V   +   ++ CH+     H V+HRDLKP N +F + K+N  +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDT 170
Query: 210 RFSE-IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            F++  VG+PYYM+PE + R +Y  + DIWS G +LY L   +PPF A S++ +A  I  
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           G   F+R P+   S+    ++ +ML      R + +++LE+P +
Sbjct: 231 G--KFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 121/224 (54%), Gaps = 20/224 (8%)
Query: 101 EVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAA 154
           EV +++ L K+ +IV   +   D  +  +++VME CEGG+L   I      R +  E   
Sbjct: 55  EVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 155 AAVTRTIVEVVQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             V   +   ++ CH+     H V+HRDLKP N +F + K+N  +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDT 170
Query: 210 RFSE-IVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR 267
            F++  VG+PYYM+PE + R +Y  + DIWS G +LY L   +PPF A S++ +A  I  
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           G   F+R P+   S+    ++ +ML      R + +++LE+P +
Sbjct: 231 G--KFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  +   I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + G L   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 18/265 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G F    L  +  T    A K + KR +     +  V RE  +M  L  +   V L 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLY 98
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +DD  ++  +   + GEL   I   G + E      T  IV  ++  H  G+IHRDL
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL-KRNYGPEI 234
           KPEN L     E+  ++  DFG +    P     R +  VG+  Y++PE+L +++     
Sbjct: 159 KPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS 215
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D+W+ G I+Y L+ G+PPF A +E  +   I++   DF    +P     A+ LV ++L  
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPK----ARDLVEKLLVL 271
Query: 295 DPKLRLTAKQ------VLEHPWLQN 313
           D   RL  ++      +  HP+ ++
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 136/289 (47%), Gaps = 32/289 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y +   +G G   V         +E +A K I+  K +T+  +D++ +E+  M     
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQC-H 71
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFD---RIVARGHYT-----ERAAAAVTRTIV 162
           + +IVS   +    + + LVM+L  GG + D    IVA+G +      E   A + R ++
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVG 216
           E ++  HK+G IHRD+K  N L     E+  ++  DFG+S F   G   +        VG
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 217 SPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------- 267
           +P +MAPEV++  R Y  + DIWS G+    L  G  P+       V    L+       
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 268 -GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
            G+ D  ++      +S + ++   L+ DP+ R TA ++L H + Q AK
Sbjct: 249 TGVQD--KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 136/289 (47%), Gaps = 32/289 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D Y +   +G G   V         +E +A K I+  K +T+  +D++ +E+  M     
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQC-H 66
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFD---RIVARGHYT-----ERAAAAVTRTIV 162
           + +IVS   +    + + LVM+L  GG + D    IVA+G +      E   A + R ++
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVG 216
           E ++  HK+G IHRD+K  N L     E+  ++  DFG+S F   G   +        VG
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 217 SPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------- 267
           +P +MAPEV++  R Y  + DIWS G+    L  G  P+       V    L+       
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 268 -GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
            G+ D  ++      +S + ++   L+ DP+ R TA ++L H + Q AK
Sbjct: 244 TGVQD--KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 290

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 95/362 (26%), Positives = 152/362 (41%), Gaps = 88/362 (24%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           +Y + ++LG+G +G+ +  IDR T E++A K I     + + D     RE+ I+  L  +
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGH 68
Query: 112 SSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERA-AAAVTRTIVEVVQLC 168
            +IV+L      DN   V+LV +  E        V R +  E      V   +++V++  
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDL---HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER------------------ 210
           H  G++HRD+KP N L         +K  DFGLS  F    R                  
Sbjct: 126 HSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 211 ----FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA 264
                ++ V + +Y APE+L     Y   ID+WS G IL  +LCG P F   S     + 
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 265 ILRGLIDF-------------------------------KRD---PWPNV---------- 280
           I+ G+IDF                               KRD    W N+          
Sbjct: 243 II-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL---QNAKKAPN------VPLGDVVRSRLK 331
           +E A  L+ ++L+ +P  R++A   L+HP++    N  + PN      +P+ D V+  + 
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSID 361
Query: 332 QF 333
            +
Sbjct: 362 DY 363

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 146/305 (47%), Gaps = 23/305 (7%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S  +S  H R  A  N      +  G  KE +E +Y V   LG G  G  Y  I      
Sbjct: 19  SKINSLAHLRA-APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNL 77
Query: 78  LLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMEL 133
            +A K + K ++    ++ +  R   EV ++K +    S ++ L +  E  ++  L++E 
Sbjct: 78  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 137
Query: 134 CEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF-ANKKEN 191
            E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN L   N+ E 
Sbjct: 138 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE- 196
Query: 192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG 249
             LK IDFG     K    +++  G+  Y  PE ++  R +G    +WS G++LY ++CG
Sbjct: 197 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
             PF  + E      I+RG + F++     VS   + L+R  L   P  R T +++  HP
Sbjct: 254 DIPFEHDEE------IIRGQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 310 WLQNA 314
           W+Q+ 
Sbjct: 304 WMQDV 308

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 116/247 (46%), Gaps = 9/247 (3%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +      A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 179 KPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDI 236
           KPEN L  ++     +   DFGL     +     S   G+P Y+APEVL K+ Y   +D 
Sbjct: 166 KPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++ +   +   IL   +  K    PN++ SA+ L+  +L+ D 
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 278
Query: 297 KLRLTAK 303
             RL AK
Sbjct: 279 TKRLGAK 285

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 143/274 (52%), Gaps = 30/274 (10%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y+  +++G G FG   L    +       K I+  ++ ++ + ++ RREVA++ ++ K
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-K 81
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLC- 168
           + +IV  +E+ E++ ++++VM+ CEGG+LF RI A     ++        I++  VQ+C 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-----QKGVLFQEDQILDWFVQICL 136
Query: 169 -----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMA 222
                H   ++HRD+K +N       ++  ++  DFG++ +     E     +G+PYY++
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV- 280
           PE+ + + Y  + DIW+ G +LY L      F A S + +   I+ G        +P V 
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-------SFPPVS 246
Query: 281 ---SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              S   +SLV Q+ + +P+ R +   +LE  ++
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 145
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 146 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 202
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 203 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SMSVKAA 258
Query: 286 SLVRQMLEPDPKLRLTA------KQVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 259 SVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNV 293

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKN 111
           LG+G FG  +L       D R+L A K + K  L+     D VR    R++ +  + P  
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHP-- 87
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  
Sbjct: 88  -FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRN 229
           G+I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R 
Sbjct: 147 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---GLIDFKRDPWPNVSESAKS 286
           +    D WS GV+++ +L G  PF  +  +     IL+   G+  F       +S  A+S
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-------LSPEAQS 256
Query: 287 LVRQMLEPDPKLRLTA 302
           L+R + + +P  RL A
Sbjct: 257 LLRMLFKRNPANRLGA 272

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 130
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 131 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 187
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 243
Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 244 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D   +  +A K I +R  R +     +  E+A+ KHL K+ +IV   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHL-KHKNIVQYL 85
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHY-----TERAAAAVTRTIVEVVQLCHKHGV 173
            +  ++  + + ME   GG L    + R  +      E+     T+ I+E ++  H + +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK---RN 229
           +HRD+K +N L      +  LK  DFG S         +E   G+  YMAPE++    R 
Sbjct: 144 VHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSL 287
           YG   DIWS G  +  +  G PPF+   E G  QA +  +  FK  P    ++S  AK+ 
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           + +  EPDP  R  A  +L   +L+ + K
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKN 111
           LG+G FG  +L       D R+L A K + K  L+     D VR    R++ +  + P  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHP-- 86
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  
Sbjct: 87  -FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRN 229
           G+I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R 
Sbjct: 146 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---GLIDFKRDPWPNVSESAKS 286
           +    D WS GV+++ +L G  PF  +  +     IL+   G+  F       +S  A+S
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-------LSPEAQS 255
Query: 287 LVRQMLEPDPKLRLTA 302
           L+R + + +P  RL A
Sbjct: 256 LLRMLFKRNPANRLGA 271

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 123/256 (48%), Gaps = 28/256 (10%)
Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMKHLPKN 111
           LG+G FG  +L       D R+L A K + K  L+     D VR    R++ +  + P  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHP-- 86
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H  
Sbjct: 87  -FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSPYYMAPEVL-KRN 229
           G+I+RDLKPEN L     E   +K  DFGLS      E+ +    G+  YMAPEV+ +R 
Sbjct: 146 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---GLIDFKRDPWPNVSESAKS 286
           +    D WS GV+++ +L G  PF  +  +     IL+   G+  F       +S  A+S
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-------LSPEAQS 255
Query: 287 LVRQMLEPDPKLRLTA 302
           L+R + + +P  RL A
Sbjct: 256 LLRMLFKRNPANRLGA 271

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 75  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 133 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 135 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 191
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 247
Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR-REVAIMKHLPKNSSIVS 116
           +LG G +   Y  +++ T   +A K +   KL +         RE+++MK L K+ +IV 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKEL-KHENIVR 67
Query: 117 LKEACEDDNAVHLVMELCEGG---ELFDRIVARGHYTERA-----AAAVTRTIVEVVQLC 168
           L +    +N + LV E  +      +  R V     T R             +++ +  C
Sbjct: 68  LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFC 124
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL- 226
           H++ ++HRDLKP+N L   + +   LK  DFGL+  F  P   FS  V + +Y AP+VL 
Sbjct: 125 HENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
             R Y   IDIWS G IL  ++ G P F   +++   + I   +       WP+V++  K
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 286 SL----------VRQMLEP--------------------DPKLRLTAKQVLEHPWL 311
                       +RQ+L+P                    +P +RL+AKQ L HPW 
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 126/258 (48%), Gaps = 15/258 (5%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + R +G+G FG   +    DT+++ A K ++K+K     ++ +V +E+ IM+ L +
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +V+L  + +D+  + +V++L  GG+L   +    H+ E         +V  +     
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
             +IHRD+KP+N L     E+  +   DF ++       + + + G+  YMAPE+     
Sbjct: 134 QRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 229 --NYGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPNVSES 283
              Y   +D WS GV  Y LL G  P+    + S + +       ++ +    W   S+ 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP-SAW---SQE 246
Query: 284 AKSLVRQMLEPDPKLRLT 301
             SL++++LEP+P  R +
Sbjct: 247 MVSLLKKLLEPNPDQRFS 264

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +GRG +    L   + T  + A + + K  +    DID V+ E  + +    +  +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L    + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           DLK +N L  ++     +K  D+G+     +PG+  S   G+P Y+APE+L+  +YG  +
Sbjct: 178 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 234
Query: 235 DIWSAGVILYILLCGVPPF---------WAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           D W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A 
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 290
Query: 286 SLVRQMLEPDPKLRLTAK------QVLEHPWLQNA 314
           S+++  L  DPK RL          +  HP+ +N 
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +L D + A    T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 71
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 72  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 130 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 75  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 132
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 133 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 299

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E         + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E         + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKPEN L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPENLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 22/265 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D   +  +A K I +R  R +     +  E+A+ KHL K+ +IV   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHL-KHKNIVQYL 71
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHY-----TERAAAAVTRTIVEVVQLCHKHGV 173
            +  ++  + + ME   GG L    + R  +      E+     T+ I+E ++  H + +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK---RN 229
           +HRD+K +N L      +  LK  DFG S         +E   G+  YMAPE++    R 
Sbjct: 130 VHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSL 287
           YG   DIWS G  +  +  G PPF+   E G  QA +  +  FK  P    ++S  AK+ 
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQ 312
           + +  EPDP  R  A  +L   +L+
Sbjct: 245 ILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 24/286 (8%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRREV 102
           +E  E  Y +   LG+G FG  +       R  +A K I + ++     + D      EV
Sbjct: 26  REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 103 AIMKHLPK---NSSIVSLKEACEDDNAVHLVME-LCEGGELFDRIVARGHYTERAAAAVT 158
           A++  +     +  ++ L +  E      LV+E      +LFD I  +G   E  +    
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
             +V  +Q CH  GV+HRD+K EN L   ++  +  K IDFG        E +++  G+ 
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSGALLH-DEPYTDFDGTR 202
Query: 219 YYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
            Y  PE + R+  +     +WS G++LY ++CG  PF  E +Q + +A L     F    
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILEAELH----FPA-- 254
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             +VS    +L+R+ L P P  R + +++L  PW+Q    A +VPL
Sbjct: 255 --HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT--PAEDVPL 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 71
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 72  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 129
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 130 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 296

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 68
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 69  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 127 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +L D + A    T      +   + +++Q    CH H V+
Sbjct: 70  LDVIHTENKLYLVFEFL-SMDLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVL 127
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 128 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +L D + A    T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLSM-DLKDFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E  +  +   + +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEHVD--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +     +     T      +   + +++Q    CH H V+
Sbjct: 71  LDVIHTENKLYLVFEFLH--QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 128
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 129 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 295

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A   I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 292

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A   I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 15/258 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I +RY +  +LG G     YL  D      +A K+I          +    REV     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             + +IVS+ +  E+D+  +LVME  EG  L + I + G  +   A   T  I++ ++  
Sbjct: 69  -SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVL 226
           H   ++HRD+KP+N L  +   N  LK  DFG++         + + ++G+  Y +PE  
Sbjct: 128 HDMRIVHRDIKPQNILIDS---NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 227 KRNYGPE-IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           K     E  DI+S G++LY +L G PPF  E+   +A       I   +D  PNV+   +
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-------IKHIQDSVPNVTTDVR 237
Query: 286 SLVRQMLEPDPKLRLTAK 303
             + Q L  +  LR T K
Sbjct: 238 KDIPQSL-SNVILRATEK 254

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 67
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +   + +     T      +   + +++Q    CH H V+
Sbjct: 68  LDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   +   V + +Y APE+L   + Y 
Sbjct: 126 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                          E  +SL+ QML  DP  R++AK  L HP+ Q+
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 38/290 (13%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G G +GV Y   ++ T E++A K I        V    +R E++++K L  + +IV L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL-NHPNIVKL 66
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ---LCHKHGVI 174
            +    +N ++LV E     +     +     T      +   + +++Q    CH H V+
Sbjct: 67  LDVIHTENKLYLVFEHVH--QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK--RNYG 231
           HRDLKP+N L   +     +K  DFGL+  F  P   ++  V + +Y APE+L   + Y 
Sbjct: 125 HRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS---------- 281
             +DIWS G I   ++     F  +SE      I R L       WP V+          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 282 ---------------ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          E  +SL+ QML  DP  R++AK  L HP+ Q+  K
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 139/288 (48%), Gaps = 30/288 (10%)
Query: 34  KKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV 93
           ++QP+T       +N   +Y   R LG+G FG    C  R T ++ ACK + K++++   
Sbjct: 177 ERQPVT-------KNTFRQY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
                  E  I++ +  +  +VSL  A E  +A+ LV+ L  GG+L   I   G    +A
Sbjct: 227 GEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG----QA 281
Query: 154 AAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                R +    ++C      H+  +++RDLKPEN L     ++  ++  D GL++    
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPE 338
Query: 208 GERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           G+     VG+  YMAPEV+K   Y    D W+ G +LY ++ G  PF    ++   + + 
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHP 309
           R + +   +     S  A+SL  Q+L  DP  RL     +A++V EHP
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 127/284 (44%), Gaps = 35/284 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G G +G+   C ++DT  ++A K   +      V      RE+ ++K L ++ ++V+L 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQL-RHENLVNLL 90
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
           E C+     +LV E  +   L D  +       +        I+  +  CH H +IHRD+
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN--YGPEID 235
           KPEN L +   ++  +K  DFG +     PGE + + V + +Y APE+L  +  YG  +D
Sbjct: 151 KPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVD 207
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------FKRDP----------- 276
           +W+ G ++  +  G P F  +S+      I+  L +        F ++P           
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267
Query: 277 --------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                   +P +SE    L ++ L  DP  R    ++L H + Q
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 139/288 (48%), Gaps = 30/288 (10%)
Query: 34  KKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV 93
           ++QP+T       +N   +Y   R LG+G FG    C  R T ++ ACK + K++++   
Sbjct: 177 ERQPVT-------KNTFRQY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
                  E  I++ +  +  +VSL  A E  +A+ LV+ L  GG+L   I   G    +A
Sbjct: 227 GEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG----QA 281
Query: 154 AAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                R +    ++C      H+  +++RDLKPEN L     ++  ++  D GL++    
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPE 338
Query: 208 GERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           G+     VG+  YMAPEV+K   Y    D W+ G +LY ++ G  PF    ++   + + 
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHP 309
           R + +   +     S  A+SL  Q+L  DP  RL     +A++V EHP
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           E+ + V  +LG G +G  Y  I ++T +++A K +         D+ ++ +E++IM+   
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIMQQC- 81
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLC 168
            +  +V    +   +  + +VME C  G + D I  R    TE   A + ++ ++ ++  
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLK 227
           H    IHRD+K  N L   +      K  DFG++        + + ++G+P++MAPEV++
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHA---KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ 198
Query: 228 R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV------ 280
              Y    DIWS G+    +  G PP+            +R +     +P P        
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPY-------ADIHPMRAIFMIPTNPPPTFRKPELW 251
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
           S++    V+Q L   P+ R TA Q+L+HP++++AK
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 145/309 (46%), Gaps = 21/309 (6%)
Query: 29  EAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK 88
           E   NK++P   +    K  IED + + + LG+G FG  +L   + T +  A K++ K  
Sbjct: 1   EPELNKERPSLQI----KLKIED-FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV 55
Query: 89  LRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH 148
           +    D++    E  ++    ++  +  +    +    +  VME   GG+L   I +   
Sbjct: 56  VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK 115
Query: 149 YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
           +    A      I+  +Q  H  G+++RDLK +N L     ++  +K  DFG+      G
Sbjct: 116 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG 172
Query: 209 E-RFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           + + +E  G+P Y+APE+L  + Y   +D WS GV+LY +L G  PF  + E+ +  +I 
Sbjct: 173 DAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 232
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK-QVLEHP------WLQNAKKAPN 319
                + R  W  + + AK L+ ++   +P+ RL  +  + +HP      W +  +K  +
Sbjct: 233 MDNPFYPR--W--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 288
Query: 320 VPLGDVVRS 328
            P    V+S
Sbjct: 289 PPFRPKVKS 297

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/337 (26%), Positives = 142/337 (42%), Gaps = 64/337 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRREV 102
           NI   + +   LG G +GV      + T E++A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 103 AIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
            I+KH  K+ +I+++      ++ E+ N V+++ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---------KPG 208
               +  V++ H   VIHRDLKP N L      N  LK  DFGL+              G
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 209 ER--FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES------- 257
           ++   +E V + +Y APEV+     Y   +D+WS G IL  L    P F           
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 258 -----------------EQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDP 296
                            E   A+  ++ L  +   P    +P V+     L+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
             R+TAK+ LEHP+LQ      + P G+ +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 89/337 (26%), Positives = 142/337 (42%), Gaps = 64/337 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRREV 102
           NI   + +   LG G +GV      + T E++A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 103 AIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
            I+KH  K+ +I+++      ++ E+ N V+++ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---------KPG 208
               +  V++ H   VIHRDLKP N L      N  LK  DFGL+              G
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 209 ER--FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES------- 257
           ++   +E V + +Y APEV+     Y   +D+WS G IL  L    P F           
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 258 -----------------EQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDP 296
                            E   A+  ++ L  +   P    +P V+     L+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
             R+TAK+ LEHP+LQ      + P G+ +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 122/247 (49%), Gaps = 20/247 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   +   ++  ++ A K ++K ++    +    R E  ++ +   +  I +L 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLH 140
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
            A +DDN ++LVM+   GG+L   +        E  A      +V  +   H+   +HRD
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 178 LKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFSEIVGSPYYMAPEVL------KRN 229
           +KP+N L      N  ++  DFG  L +      + S  VG+P Y++PE+L      K  
Sbjct: 201 IKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP----NVSESAK 285
           YGPE D WS GV +Y +L G  PF+AES       I+     F+   +P    +VSE+AK
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPTQVTDVSENAK 314
Query: 286 SLVRQML 292
            L+R+++
Sbjct: 315 DLIRRLI 321

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 138/292 (47%), Gaps = 17/292 (5%)
Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K  IED +++ + LG+G FG  +L   + T +  A K++ K  +    D++    E  ++
Sbjct: 13  KLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
               ++  +  +    +    +  VME   GG+L   I +   +    A      I+  +
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPE 224
           Q  H  G+++RDLK +N L     ++  +K  DFG+      G+ + +   G+P Y+APE
Sbjct: 132 QFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPE 188
Query: 225 VL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           +L  + Y   +D WS GV+LY +L G  PF  + E+ +  +I      + R  W  + + 
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKE 244
Query: 284 AKSLVRQMLEPDPKLRLTAK-QVLEHP------WLQNAKKAPNVPLGDVVRS 328
           AK L+ ++   +P+ RL  +  + +HP      W +  +K  + P    V+S
Sbjct: 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKS 296

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 50/293 (17%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKN 111
           ++G G +G  +   +R+T E++A K       R  +D DD        RE+ ++K L K+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALK-------RVRLDDDDEGVPSSALREICLLKEL-KH 60
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +IV L +    D  + LV E C+    + FD     G        +    +++ +  CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL-- 226
              V+HRDLKP+N L      N  LK  DFGL+  F  P   +S  V + +Y  P+VL  
Sbjct: 119 SRNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPWPNVSE--- 282
            + Y   ID+WSAG I   L     P +  ++     + I R L     + WP++++   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 283 ----------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                                 + + L++ +L+ +P  R++A++ L+HP+  +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 90/337 (26%), Positives = 142/337 (42%), Gaps = 64/337 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRK-----LRTAVDIDDVRREV 102
           NI   + +   LG G +GV      + T E++A K I         LRT        RE+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------REI 60
Query: 103 AIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
            I+KH  K+ +I+++      ++ E+ N V+++ EL +      R+++    ++      
Sbjct: 61  KILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYF 117
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF--------KPGE 209
               +  V++ H   VIHRDLKP N L      N  LK  DFGL+           +P  
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 210 RFS---EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES------- 257
           + S   E V + +Y APEV+     Y   +D+WS G IL  L    P F           
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 258 -----------------EQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDP 296
                            E   A+  ++ L  +   P    +P V+     L+++ML  DP
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294
Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
             R+TAK+ LEHP+LQ      + P G+ +     +F
Sbjct: 295 AKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF 331

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 50/293 (17%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAIMKHLPKN 111
           ++G G +G  +   +R+T E++A K       R  +D DD        RE+ ++K L K+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALK-------RVRLDDDDEGVPSSALREICLLKEL-KH 60
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +IV L +    D  + LV E C+    + FD     G        +    +++ +  CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL-- 226
              V+HRDLKP+N L      N  LK  +FGL+  F  P   +S  V + +Y  P+VL  
Sbjct: 119 SRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 227 KRNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE--- 282
            + Y   ID+WSAG I   L   G P F         + I R L     + WP++++   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 283 ----------------------SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                                 + + L++ +L+ +P  R++A++ L+HP+  +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  ++ +
Sbjct: 91  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 149 NYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 205
Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-- 276
           V+       R Y  + D+WS G+ L  +    PP    +   V   I +        P  
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 265
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           W   S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 266 W---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 34/275 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G  Y      T +L A K +      T  + +++++E+ ++K    + +I +  
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIVARGHYT--ERAAAAVTRTIVEVVQLCHK 170
                K     D+ + LVME C  G + D I      T  E   A + R I+  +   H+
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKRN 229
           H VIHRD+K +N L     EN+ +K +DFG+S    +   R +  +G+PY+MAPEV+  +
Sbjct: 148 HKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 230 YGPEI------DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV--- 280
             P+       D+WS G+    +  G PP             +R L    R+P P +   
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHPMRALFLIPRNPAPRLKSK 257
Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             S+  +S +   L  +   R   +Q+++HP++++
Sbjct: 258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  ++ +
Sbjct: 91  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 149 NYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205
Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-- 276
           V+       R Y  + D+WS G+ L  +    PP    +   V   I +        P  
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 265
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           W   S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 266 W---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/285 (30%), Positives = 135/285 (47%), Gaps = 27/285 (9%)
Query: 28  KEAGANKKQPIT--VLAGVPKENIEDRYLVDRELGRGEFGVTYLC--IDR-DTRELLACK 82
           K+ G  K+  IT  V AG  K +     L+ + LG+G FG  +L   + R D+  L A K
Sbjct: 4   KDEGVLKEISITHHVKAGSEKADPSHFELL-KVLGQGSFGKVFLVRKVTRPDSGHLYAMK 62
Query: 83  SISKR--KLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            + K   K+R  V     R  +A + H      +V L  A + +  ++L+++   GG+LF
Sbjct: 63  VLKKATLKVRDRVRTKMERDILADVNH----PFVVKLHYAFQTEGKLYLILDFLRGGDLF 118
Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
            R+     +TE         +   +   H  G+I+RDLKPEN L     E   +K  DFG
Sbjct: 119 TRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFG 175
Query: 201 LSIFFKPGERFS-EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
           LS      E+ +    G+  YMAPEV+ R  +    D WS GV+++ +L G  PF  +  
Sbjct: 176 LSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDR 235
Query: 259 QGVAQAILR---GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           +     IL+   G+  F       +S  A+SL+R + + +P  RL
Sbjct: 236 KETMTLILKAKLGMPQF-------LSTEAQSLLRALFKRNPANRL 273

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVV 165
              + +IV L +A   +N + +++E C GG + D ++       TE     V +  ++ +
Sbjct: 91  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDAL 148
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPE 224
              H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPE
Sbjct: 149 NYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205
Query: 225 VL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-- 276
           V+       R Y  + D+WS G+ L  +    PP    +   V   I +        P  
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 265
Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           W   S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 266 W---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 304

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 16/273 (5%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           QP   L      N    + +++++GRG+F   Y          +A K +    L  A   
Sbjct: 17  QPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR 76
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            D  +E+ ++K L  + +++    +  +DN +++V+EL + G+L  R++   H+ ++   
Sbjct: 77  ADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDL-SRMIK--HFKKQKRL 132
Query: 156 AVTRTIVE-VVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
              RT+ +  VQLC      H   V+HRD+KP N           +K  D GL  FF   
Sbjct: 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSK 189
Query: 209 ERFSE-IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
              +  +VG+PYYM+PE +  N Y  + DIWS G +LY +     PF+ +     +    
Sbjct: 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLR 299
               D+   P  + SE  + LV   + PDP+ R
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 16/278 (5%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  ++ L ++ + + 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            +     ++   LVME C G       V +    E   AAVT   ++ +   H H +IHR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----KRNYGP 232
           D+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-FKRDPWPNVSESAKSLVRQM 291
           ++D+WS G+    L    PP +  +       I +      +   W   SE  ++ V   
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 292 LEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
           L+  P+ R T++ +L+H ++   ++ P V +  + R++
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLR-ERPPTVIMDLIQRTK 287

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 94/346 (27%), Positives = 142/346 (41%), Gaps = 77/346 (22%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRRE 101
           VP +++  RY V + +G+G FG      D    + +A K +   KR  R A +      E
Sbjct: 90  VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------E 143
Query: 102 VAIMKHLPKNS-----SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAA 154
           + I++HL K       +++ + E     N + +  EL      EL  +   +G ++    
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLV 202
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                +I++ +   HK+ +IH DLKPEN L   ++  S +K IDFG S +    +R    
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY--EHQRVYTX 259
Query: 215 VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVP--PFWAESEQGVAQAILRGLID 271
           + S +Y APEV L   YG  ID+WS G IL  LL G P  P   E +Q      L G+  
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 272 FK-------------------------------------------RDP-----WPNVSES 283
            K                                           R P     W N  + 
Sbjct: 320 QKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 284 AKS-----LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
                    ++Q LE DP +R+T  Q L HPWL+  ++ P  P G+
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR--RRLPKPPTGE 423

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 16/278 (5%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  ++ L ++ + + 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 118
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            +     ++   LVME C G       V +    E   AAVT   ++ +   H H +IHR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----KRNYGP 232
           D+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  
Sbjct: 179 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 232
Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG-LIDFKRDPWPNVSESAKSLVRQM 291
           ++D+WS G+    L    PP +  +       I +      +   W   SE  ++ V   
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 289
Query: 292 LEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
           L+  P+ R T++ +L+H ++   ++ P V +  + R++
Sbjct: 290 LQKIPQDRPTSEVLLKHRFVLR-ERPPTVIMDLIQRTK 326

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 141/288 (48%), Gaps = 22/288 (7%)
Query: 40  VLAGVP-----KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD 94
           V +G+P     K + E+ +    ++G+G FG  +  ID  T++++A K I   +    ++
Sbjct: 6   VQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
              +++E+ ++     +  +     +   D  + ++ME   GG   D ++  G   E   
Sbjct: 66  D--IQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSE 213
           A + R I++ +   H    IHRD+K  N L +   E+  +K  DFG++      + + + 
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNX 178
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
            VG+P++MAPEV+K++ Y  + DIWS G+    L  G PP    SE    + +   LI  
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLF--LIPK 233
Query: 273 KRDPW--PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKA 317
              P    N S+  K  V   L  +P  R TAK++L+H + L+NAKK 
Sbjct: 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 115
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 175 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 286
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 94/346 (27%), Positives = 142/346 (41%), Gaps = 77/346 (22%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRRE 101
           VP +++  RY V + +G+G FG      D    + +A K +   KR  R A +      E
Sbjct: 90  VPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------E 143
Query: 102 VAIMKHLPKNS-----SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAA 154
           + I++HL K       +++ + E     N + +  EL      EL  +   +G ++    
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLV 202
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                +I++ +   HK+ +IH DLKPEN L   ++  S +K IDFG S +    +R    
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY--EHQRVYXX 259
Query: 215 VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVP--PFWAESEQGVAQAILRGLID 271
           + S +Y APEV L   YG  ID+WS G IL  LL G P  P   E +Q      L G+  
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPX 319
Query: 272 FK-------------------------------------------RDP-----WPNVSES 283
            K                                           R P     W N  + 
Sbjct: 320 QKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 284 AKS-----LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
                    ++Q LE DP +R+T  Q L HPWL+  ++ P  P G+
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR--RRLPKPPTGE 423

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 115
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 175 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 286
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 68
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 128 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 239
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 115
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 175 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 286
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 87
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 147 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 258
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 140/305 (45%), Gaps = 49/305 (16%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y + R+LGRG++   +  I+    E +  K +        V  + ++RE+ I+++L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKNKIKREIKILENLR 89
Query: 110 KNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +I++L +  +D       LV E     + F ++      T+         I++ +  
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF------K 273
             + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+      +
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 274 RDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            DP  N                      VS  A   + ++L  D + RLTA++ +EHP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 312 QNAKK 316
               K
Sbjct: 325 YTVVK 329

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 115/246 (46%), Gaps = 13/246 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +      G+I+RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEI 234
           K +N +  ++     +K  DFG+   +I+   G       G+P Y+APE++    YG  +
Sbjct: 148 KLDNVMLDSEGH---IKIADFGMCKENIW--DGVTTKXFCGTPDYIAPEIIAYQPYGKSV 202
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G  PF  E E  + Q+I+   + + +    ++S+ A ++ + ++  
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTK 258
Query: 295 DPKLRL 300
            P  RL
Sbjct: 259 HPGKRL 264

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 87
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 147 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 258
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 13/246 (5%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   + T EL A K + K  +    D++    E  ++    K   +  L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + ++ VME   GG+L   I   G + E  A      I   +      G+I+RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 179 KPENFLFANKKENSPLKAIDFGL---SIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEI 234
           K +N +  ++     +K  DFG+   +I+   G       G+P Y+APE++  + YG  +
Sbjct: 469 KLDNVMLDSEGH---IKIADFGMCKENIW--DGVTTKXFCGTPDYIAPEIIAYQPYGKSV 523
Query: 235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP 294
           D W+ GV+LY +L G  PF  E E  + Q+I+   + + +    ++S+ A ++ + ++  
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTK 579
Query: 295 DPKLRL 300
            P  RL
Sbjct: 580 HPGKRL 585

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 132/265 (49%), Gaps = 17/265 (6%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +  ID  T++++A K I   +    ++  D+++E+ ++     +  +   
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEITVLSQC-DSPYVTKY 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +   D  + ++ME   GG   D ++  G   E   A + R I++ +   H    IHRD
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K++ Y  + D
Sbjct: 130 IKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSLVRQMLE 293
           IWS G+    L  G PP    SE    + +   LI     P    N S+  K  V   L 
Sbjct: 187 IWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPLKEFVEACLN 241
Query: 294 PDPKLRLTAKQVLEHPW-LQNAKKA 317
            +P  R TAK++L+H + L+NAKK 
Sbjct: 242 KEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 131/265 (49%), Gaps = 17/265 (6%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +  ID  T++++A K I   +    ++   +++E+ ++     +  +   
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQC-DSPYVTKY 90
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +   D  + ++ME   GG   D ++  G   E   A + R I++ +   H    IHRD
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 149
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K++ Y  + D
Sbjct: 150 IKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 206
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSLVRQMLE 293
           IWS G+    L  G PP    SE    + +   LI     P    N S+  K  V   L 
Sbjct: 207 IWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPLKEFVEACLN 261
Query: 294 PDPKLRLTAKQVLEHPW-LQNAKKA 317
            +P  R TAK++L+H + L+NAKK 
Sbjct: 262 KEPSFRPTAKELLKHKFILRNAKKT 286

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 132/265 (49%), Gaps = 17/265 (6%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +  ID  T++++A K I   +    ++  D+++E+ ++     +  +   
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEITVLSQC-DSPYVTKY 70
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
             +   D  + ++ME   GG   D ++  G   E   A + R I++ +   H    IHRD
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGPEID 235
           +K  N L +   E+  +K  DFG++      + + +  VG+P++MAPEV+K++ Y  + D
Sbjct: 130 IKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--PNVSESAKSLVRQMLE 293
           IWS G+    L  G PP    SE    + +   LI     P    N S+  K  V   L 
Sbjct: 187 IWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGNYSKPLKEFVEACLN 241
Query: 294 PDPKLRLTAKQVLEHPW-LQNAKKA 317
            +P  R TAK++L+H + L+NAKK 
Sbjct: 242 KEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+ +     G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+ +     G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+ +     G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 14  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 71
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 131 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 242
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 243 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 128/258 (49%), Gaps = 12/258 (4%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           ED +L  R LGRG FG  + C  + T +L ACK ++K++L+          E  I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV- 242
Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVV 165
            +  IVSL  A E    + LVM +  GG++   I         + E  A   T  IV  +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPE 224
           +  H+  +I+RDLKPEN L     ++  ++  D GL++  K G+ +     G+P +MAPE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 225 -VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-VSE 282
            +L   Y   +D ++ GV LY ++    PF A  E+ V    L+  +  +   +P+  S 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSP 418
Query: 283 SAKSLVRQMLEPDPKLRL 300
           ++K     +L+ DP+ RL
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y + +++G G     +  ++ + +++ A K ++  +      +D  R E+A +  L ++S
Sbjct: 10  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHS 67
Query: 113 S-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+H
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLK- 227
           G++H DLKP NFL      +  LK IDFG++   +P          VG+  YM PE +K 
Sbjct: 127 GIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 228 ----RNYG-------PEIDIWSAGVILYILLCGVPPFWAESEQGVAQ-AILRGLIDFKRD 275
               R  G       P+ D+WS G ILY +  G  PF    +Q + Q + L  +ID   +
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----QQIINQISKLHAIIDPNHE 238
Query: 276 -PWPNVSE-SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +P++ E   + +++  L+ DPK R++  ++L HP++Q
Sbjct: 239 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           +P T L    + + ED  ++ + +GRG FG   +   ++T  + A K ++K ++    + 
Sbjct: 76  KPFTQLVKEMQLHREDFEII-KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 134
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAA 154
              R E  ++ +      I +L  A +D+N ++LVM+   GG+L   +        E  A
Sbjct: 135 ACFREERDVLVN-GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 193
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFS 212
                 +V  +   H+   +HRD+KP+N L      N  ++  DFG  L +      + S
Sbjct: 194 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSS 250
Query: 213 EIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
             VG+P Y++PE+L+        YGPE D WS GV +Y +L G  PF+AES   + +   
Sbjct: 251 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYG 307
Query: 267 RGLIDFKRDPWP----NVSESAKSLVRQML 292
           + +   +R  +P    +VSE AK L+++++
Sbjct: 308 KIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           +P T L    + + ED  ++ + +GRG FG   +   ++T  + A K ++K ++    + 
Sbjct: 60  KPFTQLVKEMQLHREDFEII-KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 118
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAA 154
              R E  ++ +      I +L  A +D+N ++LVM+   GG+L   +        E  A
Sbjct: 119 ACFREERDVLVN-GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMA 177
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFS 212
                 +V  +   H+   +HRD+KP+N L      N  ++  DFG  L +      + S
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSS 234
Query: 213 EIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
             VG+P Y++PE+L+        YGPE D WS GV +Y +L G  PF+AES   + +   
Sbjct: 235 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYG 291
Query: 267 RGLIDFKRDPWP----NVSESAKSLVRQML 292
           + +   +R  +P    +VSE AK L+++++
Sbjct: 292 KIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 91/334 (27%), Positives = 136/334 (40%), Gaps = 75/334 (22%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI--SKRKLRTAVDIDDVRRE 101
           VP +++  RY V + +G+G FG      D    + +A K +   KR  R A +      E
Sbjct: 90  VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------E 143
Query: 102 VAIMKHLPKNS-----SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAA 154
           + I++HL K       +++ + E     N + +  EL      EL  +   +G ++    
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLV 202
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                +I++ +   HK+ +IH DLKPEN L   ++  S +K IDFG S +    +R    
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSSCY--EHQRVYTX 259
Query: 215 VGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVP--PFWAESEQGVAQAILRGLID 271
           + S +Y APEV L   YG  ID+WS G IL  LL G P  P   E +Q      L G+  
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 272 FK-------------------------------------------RDP-----WPNVSES 283
            K                                           R P     W N  + 
Sbjct: 320 QKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 284 AKS-----LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                    ++Q LE DP +R+T  Q L HPWL+
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 132/304 (43%), Gaps = 51/304 (16%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRR 100
           + + ++Y    ++G G +GV Y   D   R ++A K       R  +D +D        R
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALK-------RIRLDAEDEGIPSTAIR 68
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVT 158
           E++++K L  + +IVSL +    +  + LV E  E    ++ D    +    +       
Sbjct: 69  EISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGS 217
             ++  V  CH+H ++HRDLKP+N L  +   +  LK  DFGL+  F  P   ++  V +
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--------- 266
            +Y AP+VL   + Y   +DIWS G I   ++ G P F   ++      I          
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 267 -------------RGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                        R    F++ PW    P   +    L+  ML  DP  R++A+  + HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 310 WLQN 313
           + ++
Sbjct: 303 YFKD 306

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 132/304 (43%), Gaps = 51/304 (16%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRR 100
           + + ++Y    ++G G +GV Y   D   R ++A K       R  +D +D        R
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALK-------RIRLDAEDEGIPSTAIR 68
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVT 158
           E++++K L  + +IVSL +    +  + LV E  E    ++ D    +    +       
Sbjct: 69  EISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGS 217
             ++  V  CH+H ++HRDLKP+N L  +   +  LK  DFGL+  F  P   ++  V +
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL--------- 266
            +Y AP+VL   + Y   +DIWS G I   ++ G P F   ++      I          
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 267 -------------RGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                        R    F++ PW    P   +    L+  ML  DP  R++A+  + HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302
Query: 310 WLQN 313
           + ++
Sbjct: 303 YFKD 306

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 132/271 (48%), Gaps = 30/271 (11%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y   +++T  L A K I   + ++  +++D   E+ I+     +  IV L
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATC-DHPYIVKL 81
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             A   D  + +++E C GG + D I+    RG  TE     V R ++E +   H   +I
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVL------K 227
           HRDLK  N L   + +   ++  DFG+S    K  ++    +G+PY+MAPEV+       
Sbjct: 140 HRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             Y  + DIWS G+ L  +    PP     E    + +L+     K DP   ++ S  S+
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIA---KSDPPTLLTPSKWSV 250
Query: 288 -----VRQMLEPDPKLRLTAKQVLEHPWLQN 313
                ++  L+ +P+ R +A Q+LEHP++ +
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 150/315 (47%), Gaps = 36/315 (11%)
Query: 37  PITVLAGVPKENI---EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV 93
           P+ V     + NI   E+ +     +G+G FG  +  ID  T++++A K I   +    +
Sbjct: 6   PVAVQVPGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI 65
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
           +   +++E+ ++     +S +     +    + + ++ME   GG   D + A G + E  
Sbjct: 66  ED--IQQEITVLSQC-DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQ 121
Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFS 212
            A + + I++ +   H    IHRD+K  N L +   E   +K  DFG++      + + +
Sbjct: 122 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN 178
Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
             VG+P++MAPEV++++ Y  + DIWS G+    L  G PP             +R L  
Sbjct: 179 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP-------NSDMHPMRVLFL 231
Query: 272 FKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL-QNAKKAPNVPLGDVV 326
             ++  P +    ++S K  +   L  DP  R TAK++L+H ++ +N+KK          
Sbjct: 232 IPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKT--------- 282
Query: 327 RSRLKQFSMMNRFKR 341
            S L +  +++RFKR
Sbjct: 283 -SYLTE--LIDRFKR 294

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 131/271 (48%), Gaps = 30/271 (11%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G FG  Y   +++T  L A K I  +   +  +++D   E+ I+     +  IV L
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATC-DHPYIVKL 73
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
             A   D  + +++E C GG + D I+    RG  TE     V R ++E +   H   +I
Sbjct: 74  LGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVL------K 227
           HRDLK  N L   + +   ++  DFG+S    K  ++    +G+PY+MAPEV+       
Sbjct: 132 HRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
             Y  + DIWS G+ L  +    PP     E    + +L+     K DP   ++ S  S+
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVLLKIA---KSDPPTLLTPSKWSV 242
Query: 288 -----VRQMLEPDPKLRLTAKQVLEHPWLQN 313
                ++  L+ +P+ R +A Q+LEHP++ +
Sbjct: 243 EFRDFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +DR +G+G FG  Y  ID  T+E++A K I   +    ++   +++E+ ++     +  I
Sbjct: 24  LDR-IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIED--IQQEITVLSQC-DSPYI 79
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
                +      + ++ME   GG   D ++  G   E   A + R I++ +   H    I
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKI 138
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN-YGP 232
           HRD+K  N L +   E   +K  DFG++      + + +  VG+P++MAPEV+K++ Y  
Sbjct: 139 HRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF 195
Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SESAKSLV 288
           + DIWS G+    L  G PP             +R L    ++  P +    S+  K  V
Sbjct: 196 KADIWSLGITAIELAKGEPP-------NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFV 248
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
              L  DP+ R TAK++L+H ++    K
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFITRYTK 276

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 140/284 (49%), Gaps = 24/284 (8%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID-DVRREVAIMKHLPK 110
           +YL+   LG G +G     +D +T    A K + K+KLR   + + +V++E+ +++ L +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 111 NSSIVSLKEAC--EDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +++ L +    E+   +++VME C  G  E+ D +  +     +A     + +++ ++
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ-LIDGLE 123
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H  G++H+D+KP N L         LK    G++    P       R S+  GSP + 
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQ 178
Query: 222 APEV---LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
            PE+   L    G ++DIWSAGV LY +  G+ PF  ++   + + I +G      D  P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            +S+    L++ MLE +P  R + +Q+ +H W +        P+
Sbjct: 239 PLSD----LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD--VRREVAIMKHLPKNSSIVS 116
           LG G+F   Y   D++T +++A K I       A D  +    RE+ +++ L  + +I+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 76
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTRTIVEVVQLCHKHGVI 174
           L +A    + + LV +  E     + I+       T     A     ++ ++  H+H ++
Sbjct: 77  LLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYG 231
           HRDLKP N L     EN  LK  DFGL+  F  P   +   V + +Y APE+L   R YG
Sbjct: 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----------- 280
             +D+W+ G IL  LL  VP    +S+      I   L     + WP++           
Sbjct: 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251
Query: 281 -------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                         +    L++ +   +P  R+TA Q L+  +  N
Sbjct: 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 142/344 (41%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 21  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 81  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 133 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 189
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 246 LLCGVPPFWAESEQGVAQAI-------------LRGL---------IDFKRDPW-----P 278
           LL G P F  +S  GV Q +             +R +            K  PW     P
Sbjct: 250 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 350

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 142/344 (41%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 21  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 81  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 133 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 189
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 190 DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 246 LLCGVPPFWAESEQGVAQAI-------------LRGL---------IDFKRDPW-----P 278
           LL G P F  +S  GV Q +             +R +            K  PW     P
Sbjct: 250 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 350

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 142/344 (41%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 15  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 74
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 75  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 126
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 127 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 183
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 184 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 243
Query: 246 LLCGVPPFWAESEQGVAQAI-------------LRGL---------IDFKRDPW-----P 278
           LL G P F  +S  GV Q +             +R +            K  PW     P
Sbjct: 244 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 301
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 344

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 142/344 (41%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 23  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 82
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 83  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 134
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 135 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 191
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 192 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 251
Query: 246 LLCGVPPFWAESEQGVAQAI-------------LRGL---------IDFKRDPW-----P 278
           LL G P F  +S  GV Q +             +R +            K  PW     P
Sbjct: 252 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 309
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 352

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 142/344 (41%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 25  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 84
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 85  LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 136
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 137 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 193
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 194 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 253
Query: 246 LLCGVPPFWAESEQGVAQAI-------------LRGL---------IDFKRDPW-----P 278
           LL G P F  +S  GV Q +             +R +            K  PW     P
Sbjct: 254 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 311
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 312 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 354

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 96/344 (27%), Positives = 142/344 (41%), Gaps = 53/344 (15%)
Query: 18  SNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           S + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ E
Sbjct: 66  SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 125
Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMEL 133
           L+A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L
Sbjct: 126 LVAIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 177
Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFAN 187
               E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L   
Sbjct: 178 DYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-- 234
Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
             + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  
Sbjct: 235 DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 294
Query: 246 LLCGVPPFWAESEQGVAQAI-------------LRGL---------IDFKRDPW-----P 278
           LL G P F  +S  GV Q +             +R +            K  PW     P
Sbjct: 295 LLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 352
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 395

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 116/271 (42%), Gaps = 13/271 (4%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+   +  +     LG G +G  +    ++   L A K  S    R   D      EV  
Sbjct: 51  PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGS 109
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVE 163
            + + ++   V L++A E+   ++L  ELC G  L     A G    E       R  + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H  G++H D+KP N     +      K  DFGL +            G P YMAP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVP-PFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           E+L+ +YG   D++S G+ +  + C +  P   E  Q + Q  L    +F       +S 
Sbjct: 226 ELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFTA----GLSS 279
Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             +S++  MLEPDPKLR TA+ +L  P L+ 
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 95/335 (28%), Positives = 139/335 (41%), Gaps = 57/335 (17%)
Query: 31  GANKKQPITVLAGVPKENI----EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           GA     +T +   P +      E  Y   + +G G FGV Y     D+ EL+A K + +
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 60
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDR 142
            K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   R
Sbjct: 61  DKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR 112
Query: 143 IVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKA 196
            VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK 
Sbjct: 113 -VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKL 169
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFW 254
            DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F 
Sbjct: 170 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 229
Query: 255 AESEQGVAQAI-------------LRGL---------IDFKRDPW-----PNVSESAKSL 287
            +S  GV Q +             +R +            K  PW     P     A +L
Sbjct: 230 GDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 287
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
             ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 288 CSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 321

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 95/342 (27%), Positives = 141/342 (41%), Gaps = 53/342 (15%)
Query: 20  YSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELL 79
           + S   +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+
Sbjct: 1   FGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELV 60
Query: 80  ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCE 135
           A K + + K           RE+ IM+ L  + +IV L+     + E  + V+L + L  
Sbjct: 61  AIKKVLQDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 112
Query: 136 GGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKK 189
             E   R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     
Sbjct: 113 VPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DP 169
Query: 190 ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILL 247
           + + LK  DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229
Query: 248 CGVPPFWAESEQGVAQAI-------------LRGL---------IDFKRDPW-----PNV 280
            G P F  +S  GV Q +             +R +            K  PW     P  
Sbjct: 230 LGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 287
Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
              A +L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 288 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 328

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 133/319 (41%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LR---------GLIDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R              K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 301 CAHSFFDELRD-PNVKLPN 318

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG     I +DT E +A K    R+  +  + +    E+ IMK L  + ++VS +
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHPNVVSAR 79
Query: 119 EACED------DNAVHLVMELCEGGEL---FDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           E  +       ++   L ME CEGG+L    ++        E     +   I   ++  H
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KR 228
           ++ +IHRDLKPEN +     +    K ID G +     GE  +E VG+  Y+APE+L ++
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 199
Query: 229 NYGPEIDIWSAGVILYILLCGVPPF 253
            Y   +D WS G + +  + G  PF
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG G FG     I +DT E +A K    R+  +  + +    E+ IMK L  + ++VS +
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHPNVVSAR 78
Query: 119 EACED------DNAVHLVMELCEGGEL---FDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           E  +       ++   L ME CEGG+L    ++        E     +   I   ++  H
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KR 228
           ++ +IHRDLKPEN +     +    K ID G +     GE  +E VG+  Y+APE+L ++
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198
Query: 229 NYGPEIDIWSAGVILYILLCGVPPF 253
            Y   +D WS G + +  + G  PF
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 94/336 (27%), Positives = 139/336 (41%), Gaps = 53/336 (15%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 7   SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 67  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 118
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 119 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 175
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 176 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235
Query: 254 WAESEQGVAQAI-------------LRGL---------IDFKRDPW-----PNVSESAKS 286
             +S  GV Q +             +R +            K  PW     P     A +
Sbjct: 236 PGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 293
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 294 LCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 328

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 94/336 (27%), Positives = 139/336 (41%), Gaps = 53/336 (15%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 14  SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 74  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 125
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 126 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 182
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 183 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242
Query: 254 WAESEQGVAQAI-------------LRGL---------IDFKRDPW-----PNVSESAKS 286
             +S  GV Q +             +R +            K  PW     P     A +
Sbjct: 243 PGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 300
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 301 LCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 335

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 134/319 (42%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LRGL---------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R +            K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 301 CAHSFFDELRD-PNVKLPN 318

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 100
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V+LV  L  G +L+ +++   H +          I+  ++
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLY-KLLKTQHLSNDHICYFLYQILRGLK 158
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 336 YYDPSDEPIAE 346

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 94/336 (27%), Positives = 139/336 (41%), Gaps = 53/336 (15%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 8   SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 68  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 119
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 120 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 176
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 177 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236
Query: 254 WAESEQGVAQAI-------------LRGL---------IDFKRDPW-----PNVSESAKS 286
             +S  GV Q +             +R +            K  PW     P     A +
Sbjct: 237 PGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 294
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 295 LCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 329

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 94/336 (27%), Positives = 139/336 (41%), Gaps = 53/336 (15%)
Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           +R + G+     +      P    E  Y   + +G G FGV Y     D+ EL+A K + 
Sbjct: 3   SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFD 141
           + K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   
Sbjct: 63  QDKRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 114
Query: 142 RIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLK 195
           R VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK
Sbjct: 115 R-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLK 171
Query: 196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF 253
             DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F
Sbjct: 172 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231
Query: 254 WAESEQGVAQAI-------------LRGL---------IDFKRDPW-----PNVSESAKS 286
             +S  GV Q +             +R +            K  PW     P     A +
Sbjct: 232 PGDS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 289
Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           L  ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 290 LCSRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 324

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 97/334 (29%), Positives = 140/334 (41%), Gaps = 56/334 (16%)
Query: 31  GANKKQPITVLAGV---PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKR 87
           GA   +  TV+A     P    E  Y   + +G G FGV Y     D+ EL+A K + + 
Sbjct: 1   GAMGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 60
Query: 88  KLRTAVDIDDVRREVAIMKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRI 143
           K           RE+ IM+ L  + +IV L+     + E  + V+L + L    E   R 
Sbjct: 61  KRFK-------NRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR- 111
Query: 144 VARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAI 197
           VAR +   +    V    + + QL       H  G+ HRD+KP+N L     + + LK  
Sbjct: 112 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLC 169
Query: 198 DFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA 255
           DFG +     GE     + S YY APE++    +Y   ID+WSAG +L  LL G P F  
Sbjct: 170 DFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 229
Query: 256 ESEQGVAQAI-------------LRGL---------IDFKRDPW-----PNVSESAKSLV 288
           +S  GV Q +             +R +            K  PW     P     A +L 
Sbjct: 230 DS--GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 287
Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            ++LE  P  RLT  +   H +    +  PNV L
Sbjct: 288 SRLLEYTPTARLTPLEACAHSFFDELRD-PNVKL 320

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 134/319 (42%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LRGL---------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R +            K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 301 CAHSFFDELRD-PNVKLPN 318

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 134/319 (42%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LRGL---------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R +            K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 301 CAHSFFDELRD-PNVKLPN 318

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 134/319 (42%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LRGL---------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R +            K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 301 CAHSFFDELRD-PNVKLPN 318

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 134/319 (42%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LRGL---------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R +            K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 301 CAHSFFDELRD-PNVKLPN 318

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 92/319 (28%), Positives = 134/319 (42%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 15  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQI 67
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L    E   R VAR +   +    V   
Sbjct: 68  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYV 125
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 126 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 183
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 184 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 241
Query: 266 ------LRGL---------IDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R +            K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 242 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 301
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 302 CAHSFFDELRD-PNVKLPN 319

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 133/308 (43%), Gaps = 54/308 (17%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----DDVRREVA 103
           ++ D Y +   +G G +GV         R  L  + ++ +K+  A D+        RE+ 
Sbjct: 51  DVGDEYEIIETIGNGAYGVV-----SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 105
Query: 104 IMKHLPKNSSIVSLKEACE------DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           I+KH  K+ +I+++K+         +  +V++V++L E  +L   I +    T       
Sbjct: 106 ILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYF 163
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGER---FS 212
              ++  ++  H   VIHRDLKP N L     EN  LK  DFG++  +   P E     +
Sbjct: 164 LYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMT 220
Query: 213 EIVGSPYYMAPEVLK--RNYGPEIDIWSAGVI---------------------LYILLCG 249
           E V + +Y APE++     Y   ID+WS G I                     L +++ G
Sbjct: 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280
Query: 250 VPPFWAESEQGV--AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAK 303
            P        G    +A ++ L   +  PW    P     A SL+ +ML  +P  R++A 
Sbjct: 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340
Query: 304 QVLEHPWL 311
             L HP+L
Sbjct: 341 AALRHPFL 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 27/259 (10%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KHL K+ +++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHL-KHENVIG 91
Query: 117 LKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           L +      + ED + V+LV  L   G   + IV     ++     +   ++  ++  H 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
            G+IHRDLKP N       E+S L+ +DFGL+   +  E  +  V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNVAV---NEDSELRILDFGLA--RQADEEMTGYVATRWYRAPEIMLNWM 204
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-----SES 283
           +Y   +DIWS G I+  LL G   F       + Q  L+ +++    P P V     SE 
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQ--LKRIMEVVGTPSPEVLAKISSEH 260
Query: 284 AKSLVRQMLEPDPKLRLTA 302
           A++ + Q L P P+  L++
Sbjct: 261 ARTYI-QSLPPMPQKDLSS 278

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 38/285 (13%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           D + + + +GRG F    +   + T ++ A K ++K  +    ++   R E  ++ +  +
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR----TIVEVVQ 166
              I  L  A +D+N ++LVME   GG+L   +   G   ER  A + R     IV  + 
Sbjct: 121 RW-ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAID 176
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV--GSPYYMAPE 224
             H+ G +HRD+KP+N L         ++  DFG  +  +       +V  G+P Y++PE
Sbjct: 177 SVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 225 VLK--------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------GL 269
           +L+         +YGPE D W+ GV  Y +  G  PF+A+S       I+         L
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293
Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRL---TAKQVLEHPWL 311
           +D        V E A+  ++++L P P+ RL    A     HP+ 
Sbjct: 294 VD------EGVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPFF 331

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+S LK +DFGL       +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLC--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 40/239 (16%)
Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
             G+   ++ D Y++   +GRG +G  YL  D++T + +A K ++ R     +D   + R
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILR 74
Query: 101 EVAIMKHLPKNSSIVSLKEACEDD-----NAVHLVMELCEGG--ELFDRIVARGHYTERA 153
           E+ I+  L K+  I+ L +    D     + +++V+E+ +    +LF   +     TE  
Sbjct: 75  EITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEEH 130
Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-------- 205
              +   ++      H+ G+IHRDLKP N L     ++  +K  DFGL+           
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNI 187
Query: 206 --------KPG-------ERFSEIVGSPYYMAPE--VLKRNYGPEIDIWSAGVILYILL 247
                   +PG       ++ +  V + +Y APE  +L+ NY   IDIWS G I   LL
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 91/319 (28%), Positives = 132/319 (41%), Gaps = 53/319 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQI 66
Query: 105 MKHLPKNSSIVSLK----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           M+ L  + +IV L+     + E  + V+L + L        R VAR +   +    V   
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYR-VARHYSRAKQTLPVIYV 124
Query: 161 IVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
            + + QL       H  G+ HRD+KP+N L     + + LK  DFG +     GE     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 215 VGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI------- 265
           + S YY APE++    +Y   ID+WSAG +L  LL G P F  +S  GV Q +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG 240
Query: 266 ------LR---------GLIDFKRDPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                 +R              K  PW     P     A +L  ++LE  P  RLT  + 
Sbjct: 241 TPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
Query: 306 LEHPWLQNAKKAPNVPLGD 324
             H +    +  PNV L +
Sbjct: 301 CAHSFFDELRD-PNVKLPN 318

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 310 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 365
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 424
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 425 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 454

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 127/309 (41%), Gaps = 52/309 (16%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  RY+  + LG G  G+ +  +D D  + +A K I    L     +    RE+ I++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRR 64
Query: 108 L-------------PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           L             P  S +     +  + N+V++V E  E       ++ +G   E  A
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHA 122
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----R 210
                 ++  ++  H   V+HRDLKP N LF N  E+  LK  DFGL+    P       
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 211 FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG 268
            SE + + +Y +P +L    NY   ID+W+AG I   +L G   F    E    Q IL  
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
Query: 269 L----------------IDFKRDP----------WPNVSESAKSLVRQMLEPDPKLRLTA 302
           +                +  + D            P +S  A   + Q+L   P  RLTA
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 303 KQVLEHPWL 311
           ++ L HP++
Sbjct: 301 EEALSHPYM 309

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 123/270 (45%), Gaps = 14/270 (5%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 113 S--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H 
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             V++RDLKP N L     E+  ++  D GL+  F   +  +  VG+  YMAPEVL++  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y    D +S G +L+ LL G  PF     +     I R  +    +   + S   +SL+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ D   RL      A++V E P+ ++
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 130/323 (40%), Gaps = 69/323 (21%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMK- 106
           DR+ V+R  G+G FG   L  ++ T   +A K +          I D R   RE+ IM+ 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQIMQD 72
Query: 107 ----HLPK----NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
               H P      S   +L E    D  +++VME     +   R   R +Y  + A    
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHR-CCRNYYRRQVAPPPI 129
Query: 159 RTIVEVVQLCHKHG--------VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
              V + QL    G        V HRD+KP N L    + +  LK  DFG +    P E 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEP 187
Query: 211 FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR- 267
               + S YY APE++   ++Y   +DIWS G I   ++ G P F  ++  G    I+R 
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 268 -------------------GLIDFKRDPWPNV--------SESAKSLVRQMLEPDPKLRL 300
                               L + K  PW NV        ++ A  L+  +L+  P+ R+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 301 TAKQVLEHPWLQN----AKKAPN 319
              + L HP+       A K PN
Sbjct: 308 KPYEALCHPYFDELHDPATKLPN 330

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 133/308 (43%), Gaps = 54/308 (17%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----DDVRREVA 103
           ++ D Y +   +G G +GV         R  L  + ++ +K+  A D+        RE+ 
Sbjct: 52  DVGDEYEIIETIGNGAYGVV-----SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 106
Query: 104 IMKHLPKNSSIVSLKEACE------DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           I+KH  K+ +I+++K+         +  +V++V++L E  +L   I +    T       
Sbjct: 107 ILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYF 164
Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGER---FS 212
              ++  ++  H   VIHRDLKP N L     EN  LK  DFG++  +   P E     +
Sbjct: 165 LYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMT 221
Query: 213 EIVGSPYYMAPEVLK--RNYGPEIDIWSAGVI---------------------LYILLCG 249
           E V + +Y APE++     Y   ID+WS G I                     L +++ G
Sbjct: 222 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 281
Query: 250 VPPFWAESEQGV--AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAK 303
            P        G    +A ++ L   +  PW    P     A SL+ +ML  +P  R++A 
Sbjct: 282 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 341
Query: 304 QVLEHPWL 311
             L HP+L
Sbjct: 342 AALRHPFL 349

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 132/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 84
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 85  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 141
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+S LK +DFGL+      +  +  V + +Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLA--RHTDDEMTGYVATRWYRA 196
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 317 YHDPDDEPVAD 327

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 132/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+S LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 88
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 89  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 146
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 147 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 263
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 264 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 324 YYDPSDEPIAE 334

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 82
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 318 YYDPSDEPIAE 328

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 80
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 316 YYDPSDEPIAE 326

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 100
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 158
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 336 YYDPSDEPIAE 346

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 27/259 (10%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KHL K+ +++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHL-KHENVIG 91
Query: 117 LKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           L +      + ED + V+LV  L   G   + IV     ++     +   ++  ++  H 
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
            G+IHRDLKP N       E+S L+ +DFGL+   +  E  +  V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNVAV---NEDSELRILDFGLA--RQADEEMTGYVATRWYRAPEIMLNWM 204
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-----SES 283
           +Y   +DIWS G I+  LL G   F       + Q  L+ +++    P P V     SE 
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQ--LKRIMEVVGTPSPEVLAKISSEH 260
Query: 284 AKSLVRQMLEPDPKLRLTA 302
           A++ + Q L P P+  L++
Sbjct: 261 ARTYI-QSLPPMPQKDLSS 278

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMAGFVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 78
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 136
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 253
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 314 YYDPSDEPIAE 324

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLAF-RH 82
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L       S LK  DFGL+    P        +E V + +Y A
Sbjct: 141 YIHSANVLHRDLKPSNLLL---NTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----------------WAESEQGV--- 261
           PE++   + Y   IDIWS G IL  +L   P F                 + S++ +   
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 262 ----AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
               A+  L  L    + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L  
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 318 YYDPSDEPIAE 328

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 85
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 143
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 321 YYDPSDEPIAE 331

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 86
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 87  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 144
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 145 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 261
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 262 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 322 YYDPSDEPIAE 332

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 77
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 78  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 135
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 136 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 252
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 253 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 313 YYDPSDEPIAE 323

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 122/300 (40%), Gaps = 38/300 (12%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-- 109
           RY    E+G G +G  Y   D  +   +A KS+        + I  VR EVA+++ L   
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAF 63
Query: 110 KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIV 162
           ++ ++V L + C          V LV E  +       D+    G   E     + R  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFL 122
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             +   H + ++HRDLKPEN L  +      +K  DFGL+  +      + +V + +Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 223 PEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---- 277
           PEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W    
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 278 -------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                              P + ES   L+ +ML  +P  R++A + L+H +L   +  P
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCAKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMAGFVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 82
Query: 118 KEACEDD--------NAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C            +++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 280 V 280
           V
Sbjct: 257 V 257

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/337 (24%), Positives = 141/337 (41%), Gaps = 49/337 (14%)
Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H+++     +++    +  VP     +RY     +G G +G      D  T   +A K
Sbjct: 5   HHHSQERPTFYRQELNKTIWEVP-----ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK 59
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE------ACEDDNAVHLVMELCEG 136
            +S R  ++ +      RE+ ++KH+ K+ +++ L +      + E+ N V+LV  L  G
Sbjct: 60  KLS-RPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
            +L + IV     T+     +   I+  ++  H   +IHRDLKP N       E+  LK 
Sbjct: 117 ADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKI 172
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW 254
           +DFGL+      +  +  V + +Y APE++    +Y   +DIWS G I+  LL G   F 
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 255 AESEQGVAQAILR-----------------------GLIDFKRDPWPNV----SESAKSL 287
                   + ILR                        L    +  + NV    +  A  L
Sbjct: 231 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDL 290
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
           + +ML  D   R+TA Q L H +        + P+ D
Sbjct: 291 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 327

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMAGFVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y+    +G G +G     ID+ + E +A K +S R  ++ +      RE+ ++KH+ ++ 
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHM-QHE 101
Query: 113 SIVSLKEACEDDNAV------HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           +++ L +     +++      +LVM   +      +I+    ++E     +   +++ ++
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLK 158
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  GV+HRDLKP N L  N  E+  LK +DFGL+         +  V + +Y APEV+
Sbjct: 159 YIHSAGVVHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 213
Query: 227 KR--NYGPEIDIWSAGVILYILLCG---------------------VP--PFWAESEQGV 261
               +Y   +DIWS G I+  +L G                     VP   F  +     
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273
Query: 262 AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           A++ ++ L    R  +    P  S  A  L+ +MLE D   RLTA Q L HP+ +
Sbjct: 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 98
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 99  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 210
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 331 YHDPDDEPVAD 341

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 97
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 98  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 209
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 270 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 330 YHDPDDEPVAD 340

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTADEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTADEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 130/293 (44%), Gaps = 39/293 (13%)
Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 76
Query: 115 VSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 135
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-------- 278
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                          ++ E  K L+ + L  +P  R++A   L HP+ Q+ ++
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 78
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 136
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI-----------LRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +        I           L  +
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCI 253
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 314 YYDPSDEPIAE 324

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS----EIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P    +    E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 82/321 (25%), Positives = 142/321 (44%), Gaps = 49/321 (15%)
Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A VP    +D Y + R+LGRG++   +  I+    E +  K +   K +         RE
Sbjct: 29  AHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIK------RE 82
Query: 102 VAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           V I+++L   ++I+ L +  +D       LV E     + F ++      T+        
Sbjct: 83  VKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMY 139
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            +++ +  CH  G++HRD+KP N +  ++++   L+ ID+GL+ F+ P + ++  V S Y
Sbjct: 140 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPAQEYNVRVASRY 197
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG------ 268
           +  PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G      
Sbjct: 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 257
Query: 269 ----------------LIDFKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAK 303
                           L    R  W N         VS  A  L+ ++L  D + RLTAK
Sbjct: 258 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 317
Query: 304 QVLEHPWLQNAKKAPNVPLGD 324
           + +EHP+     K  + P  D
Sbjct: 318 EAMEHPYFYPVVKEQSQPSAD 338

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 38/300 (12%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-- 109
           RY    E+G G +G  Y   D  +   +A KS+        + I  VR EVA+++ L   
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAF 63
Query: 110 KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIV 162
           ++ ++V L + C          V LV E  +       D+    G   E     + R  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFL 122
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             +   H + ++HRDLKPEN L  +      +K  DFGL+  +        +V + +Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 223 PEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---- 277
           PEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W    
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 278 -------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                              P + ES   L+ +ML  +P  R++A + L+H +L   +  P
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 85
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 143
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS----EIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P    +    E V + +Y A
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 321 YYDPSDEPIAE 331

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKCQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTADEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/337 (24%), Positives = 141/337 (41%), Gaps = 49/337 (14%)
Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H+++     +++    +  VP     +RY     +G G +G      D  T   +A K
Sbjct: 5   HHHSQERPTFYRQELNKTIWEVP-----ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 59
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE------ACEDDNAVHLVMELCEG 136
            +S R  ++ +      RE+ ++KH+ K+ +++ L +      + E+ N V+LV  L  G
Sbjct: 60  KLS-RPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
            +L + IV     T+     +   I+  ++  H   +IHRDLKP N       E+  LK 
Sbjct: 117 ADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKI 172
Query: 197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFW 254
           +DFGL+      +  +  V + +Y APE++    +Y   +DIWS G I+  LL G   F 
Sbjct: 173 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 230
Query: 255 AESEQGVAQAILR-----------------------GLIDFKRDPWPNV----SESAKSL 287
                   + ILR                        L    +  + NV    +  A  L
Sbjct: 231 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 290
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
           + +ML  D   R+TA Q L H +        + P+ D
Sbjct: 291 LEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 327

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 30  VPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 88
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 89  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 145
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 146 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 200
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 260
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 320
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 321 YHDPDDEPVAD 331

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 81
Query: 118 KEACEDD--------NAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C            +++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 138
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 139 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 280 V 280
           V
Sbjct: 256 V 256

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 130/294 (44%), Gaps = 39/294 (13%)
Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 76
Query: 115 VSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 135
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-------- 278
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
                          ++ E  K L+ + L  +P  R++A   L HP+ Q+ ++ 
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 82
Query: 118 KEACEDD--------NAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C            +++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 280 V 280
           V
Sbjct: 257 V 257

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 131/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+    ++
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLAF-RH 82
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L  
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 318 YYDPSDEPIAE 328

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 46/311 (14%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY     +G G +G+     D   +  +A + IS  + +T        RE+ I+    ++
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQ--RTLREIKILLRF-RH 84
Query: 112 SSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +I+ + +       E    V++V +L E  +L+ +++   H +          I+  ++
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLK 142
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYMA 222
             H   V+HRDLKP N L     +   LK  DFGL+    P        +E V + +Y A
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 223 PEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------QGV----AQAILRGL 269
           PE++   + Y   IDIWS G IL  +L   P F  +          G+    +Q  L  +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 270 IDFK------------RDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           I+ K            + PW    PN    A  L+ +ML  +P  R+  +Q L HP+L+ 
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 314 AKKAPNVPLGD 324
                + P+ +
Sbjct: 320 YYDPSDEPIAE 330

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y+    +G G +G     ID+ + E +A K +S R  ++ +      RE+ ++KH+ ++ 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHM-QHE 83
Query: 113 SIVSLKEACEDDNAV------HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           +++ L +     +++      +LVM   +      +I+    ++E     +   +++ ++
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLK 140
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  GV+HRDLKP N L  N  E+  LK +DFGL+         +  V + +Y APEV+
Sbjct: 141 YIHSAGVVHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 195
Query: 227 KR--NYGPEIDIWSAGVILYILLCG---------------------VP--PFWAESEQGV 261
               +Y   +DIWS G I+  +L G                     VP   F  +     
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 262 AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           A++ ++ L    R  +    P  S  A  L+ +MLE D   RLTA Q L HP+ +
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 89
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 90  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 201
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 322 YHDPDDEPVAD 332

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E   DRY +D  +G+G FG      DR  +E +A K I  +K      ++  + EV +++
Sbjct: 31  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLE 86
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
            + K+ +     IV LK      N + LV E+     L+D  + R       +  +TR  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYD--LLRNTNFRGVSLNLTRKF 143
Query: 162 VEVVQLCH--------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +  Q+C         +  +IH DLKPEN L  N K  S +K +DFG S   + G+R  +
Sbjct: 144 AQ--QMCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSSC--QLGQRIYQ 198
Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E
Sbjct: 199 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 84
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 85  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 141
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 196
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 317 YHDPDDEPVAD 327

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 89
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 90  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 201
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 322 YHDPDDEPVAD 332

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 85
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 86  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 142
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 197
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 318 YHDPDDEPVAD 328

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E   DRY +D  +G+G FG      DR  +E +A K I  +K      ++  + EV +++
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLE 105
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
            + K+ +     IV LK      N + LV E+     L+D  + R       +  +TR  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYD--LLRNTNFRGVSLNLTRKF 162
Query: 162 VEVVQLCH--------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +  Q+C         +  +IH DLKPEN L  N K  S +K +DFG S   + G+R  +
Sbjct: 163 AQ--QMCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSSC--QLGQRIYQ 217
Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E
Sbjct: 218 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 19  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 77
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 78  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 134
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 135 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 189
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 249
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 309
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 310 YHDPDDEPVAD 320

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 98
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 99  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 210
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 271 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 331 YHDPDDEPVAD 341

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 38/300 (12%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-- 109
           RY    E+G G +G  Y   D  +   +A KS+        + I  VR EVA+++ L   
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAF 63
Query: 110 KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIV 162
           ++ ++V L + C          V LV E  +       D+    G   E     + R  +
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFL 122
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             +   H + ++HRDLKPEN L  +      +K  DFGL+  +        +V + +Y A
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 223 PEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---- 277
           PEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W    
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 239
Query: 278 -------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                              P + ES   L+ +ML  +P  R++A + L+H +L   +  P
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 299

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G+G FG  +    R T + +A K +     +    I  +R E+ I++ L K+ ++V+L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLL-KHENVVNL 82
Query: 118 KEACEDDNA--------VHLVMELCE---GGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            E C    +        ++LV + CE    G L + +V    +T      V + ++  + 
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLY 139
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYM 221
             H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R+   V + +Y 
Sbjct: 140 YIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
            PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       + WPN
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 280 V 280
           V
Sbjct: 257 V 257

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 80
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 81  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 192
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 313 YHDPDDEPVAD 323

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 83
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 84  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 140
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 195
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 316 YHDPDDEPVAD 326

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 90
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 91  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 202
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 323 YHDPDDEPVAD 333

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 90
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 91  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 202
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 323 YHDPDDEPVAD 333

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 97
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 98  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 209
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 270 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 330 YHDPDDEPVAD 340

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 101
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 102 -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 213
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 334 YHDPDDEPVAD 344

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 18  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 76
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 77  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 133
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 134 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 188
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 248
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 308
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 309 YHDPDDEPVAD 319

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 75
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 76  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 132
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 187
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 308 YHDPDDEPVAD 318

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 38/200 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKKAPNVPLGD 324
            +EHP+     K  + P  D
Sbjct: 318 AMEHPYFYPVVKEQSQPCAD 337

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 74
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 75  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 131
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 186
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 307 YHDPDDEPVAD 317

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 75
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 76  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 132
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 187
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 308 YHDPDDEPVAD 318

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 129/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +SK   ++ +      RE+ ++KH+
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELRLLKHM 90
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 91  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGYVATRWYRA 202
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 323 YHDPDDEPVAD 333

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 112/241 (46%), Gaps = 21/241 (8%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++ DRY +   LG G     +L  D RD R++ A K +     R        RRE     
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 107 HLPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     
Sbjct: 68  AL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSP 218
           + +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR------EDPI 237
Query: 278 P 278
           P
Sbjct: 238 P 238

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMTGXVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 98
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 99  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +     V + +Y A
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMXGXVATRWYRA 210
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 331 YHDPDDEPVAD 341

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 101
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 102 -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +     V + +Y A
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA--RHTDDEMXGYVATRWYRA 213
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 334 YHDPDDEPVAD 344

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 27/259 (10%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G G +G      D   R+ +A K +S R  ++ +      RE+ ++KHL K+ +++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHL-KHENVIG 83
Query: 117 LKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           L +      + ED + V+LV  L   G   + IV     ++     +   ++  ++  H 
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-- 228
            G+IHRDLKP N       E+  L+ +DFGL+   +  E  +  V + +Y APE++    
Sbjct: 142 AGIIHRDLKPSNVAV---NEDCELRILDFGLA--RQADEEMTGYVATRWYRAPEIMLNWM 196
Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-----SES 283
           +Y   +DIWS G I+  LL G   F       + Q  L+ +++    P P V     SE 
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQ--LKRIMEVVGTPSPEVLAKISSEH 252
Query: 284 AKSLVRQMLEPDPKLRLTA 302
           A++ + Q L P P+  L++
Sbjct: 253 ARTYI-QSLPPMPQKDLSS 270

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 21/241 (8%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++ DRY +   LG G     +L  D RD R++ A K +     R        RRE     
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 107 HLPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     
Sbjct: 68  AL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG----ERFSEIVGSP 218
           + +   H++G+IHRD+KP N L +     + +K +DFG++           + + ++G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANILIS---ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPI 237
Query: 278 P 278
           P
Sbjct: 238 P 238

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMK 106
           RY  D E    LG+G FG          R  L  +  + +K+R T   +  +  EV ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVV-----KARNALDSRYYAIKKIRHTEEKLSTILSEVMLLA 57
Query: 107 HLPKNS------------SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            L                + V    A +  + + + ME CE G L+D I +     +R  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 155 A-AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------- 206
              + R I+E +   H  G+IHRDLKP N +F ++  N  +K  DFGL+           
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMN-IFIDESRN--VKIGDFGLAKNVHRSLDILK 174
Query: 207 ------PG--ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE 256
                 PG  +  +  +G+  Y+A EVL    +Y  +ID++S G+I + ++    PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 257 SEQGVAQAILRGL-IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            E+      LR + I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 39/289 (13%)
Query: 58  ELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSI 114
           E+G G +G  +   D ++    +A K +  +     + +  +R EVA+++HL   ++ ++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 76
Query: 115 VSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           V L + C     + +  + LV E  +       D++   G  TE     + + ++  +  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 135
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-L 226
            H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V + +Y APEV L
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-------- 278
           + +Y   +D+WS G I   +    P F   S+      IL  +     + WP        
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 252
Query: 279 ---------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                          ++ E  K L+ + L  +P  R++A   L HP+ Q
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E   DRY +D  +G+G FG      DR  +E +A K I  +K      ++  + EV +++
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLE 105
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
            + K+ +     IV LK      N + LV E+     L+D  + R       +  +TR  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYD--LLRNTNFRGVSLNLTRKF 162
Query: 162 VEVVQLCH--------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            +  Q+C         +  +IH DLKPEN L  N K  + +K +DFG S   + G+R  +
Sbjct: 163 AQ--QMCTALLFLATPELSIIHCDLKPENILLCNPKRXA-IKIVDFGSSC--QLGQRIYQ 217
Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE 258
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E
Sbjct: 218 XIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 139/305 (45%), Gaps = 49/305 (16%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y + R+LGRG++   +  I+    E +A K +   K +         RE+ I+++L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIK------REIKILENLR 89
Query: 110 KNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +I++L +  +D       LV E     + F ++      T+         I++ +  
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N L  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 147 CHSMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF------K 273
             + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+      +
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 274 RDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            DP  N                      VS  A   + ++L  D + RLTA++ +EHP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 312 QNAKK 316
               K
Sbjct: 325 YTVVK 329

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 112/241 (46%), Gaps = 21/241 (8%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           ++ DRY +   LG G     +L  D RD R++ A K +     R        RRE     
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 107 HLPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     
Sbjct: 68  AL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSP 218
           + +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP 
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPI 237
Query: 278 P 278
           P
Sbjct: 238 P 238

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 131/311 (42%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D+GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDYGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 25/271 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----SEIVGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+      +  VG+  YM+PE L+  +Y 
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 232 PEIDIWSAGVILYILLCG---VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL- 287
            + DIWS G+ L  +  G   +PP  A+ +     AI   L     +P P +     SL 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 241
Query: 288 ----VRQMLEPDPKLRLTAKQVLEHPWLQNA 314
               V + L  +P  R   KQ++ H +++ +
Sbjct: 242 FQDFVNKCLIKNPAERADLKQLMVHAFIKRS 272

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 41/303 (13%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHL 108
           RY    E+G G +G  Y   D  +   +A KS+   +       + I  VR EVA+++ L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRL 68
Query: 109 P--KNSSIVSLKEACEDDNA-----VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTR 159
              ++ ++V L + C          V LV E  +       D+    G   E     + R
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMR 127
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
             +  +   H + ++HRDLKPEN L  +      +K  DFGL+  +      + +V + +
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 220 YMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW- 277
           Y APEV L+  Y   +D+WS G I   +    P F   SE      I   +     D W 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 278 ----------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                                 P + ES   L+ +ML  +P  R++A + L+H +L   +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304
Query: 316 KAP 318
             P
Sbjct: 305 GNP 307

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DF L+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFYLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 138/308 (44%), Gaps = 49/308 (15%)
Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A VP    +D Y + R+LGRG++   +  I+    E +  K +   K +         RE
Sbjct: 34  AHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIK------RE 87
Query: 102 VAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           V I+++L   ++I+ L +  +D       LV E     + F ++      T+        
Sbjct: 88  VKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMY 144
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            +++ +  CH  G++HRD+KP N +  ++++   L+ ID+GL+ F+ P + ++  V S Y
Sbjct: 145 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQKK--LRLIDWGLAEFYHPAQEYNVRVASRY 202
Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG------ 268
           +  PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G      
Sbjct: 203 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYG 262
Query: 269 ----------------LIDFKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAK 303
                           L    R  W N         VS  A  L+ ++L  D + RLTAK
Sbjct: 263 YLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAK 322
Query: 304 QVLEHPWL 311
           + +EHP+ 
Sbjct: 323 EAMEHPYF 330

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 317 AMEHPYFYTVVK 328

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 133/315 (42%), Gaps = 56/315 (17%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           RYL D E    LGRG FGV +   ++      A K I  R     +  + V REV  +  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAK 59
Query: 108 LPKNSSIVSLKEACEDDNA------------VHLVMELCEGGELFDRIVARGHYTERAAA 155
           L ++  IV    A  + N             +++ M+LC    L D +  R    ER  +
Sbjct: 60  L-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 156 A---VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--- 209
               +   I E V+  H  G++HRDLKP N  F     +  +K  DFGL       E   
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQ 175
Query: 210 ----------RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
                     R +  VG+  YM+PE +  N Y  ++DI+S G+IL+ LL    PF  + E
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKS----LVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           +      +R L D +   +P +          +V+ ML P P  R  A  ++E+   ++ 
Sbjct: 233 R------VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286
Query: 315 KKAPNVPLGDVVRSR 329
               + P   V+R R
Sbjct: 287 ----DFPGKTVLRQR 297

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 317 AMEHPYFYTVVK 328

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 318 AMEHPYFYTVVK 329

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 316 AMEHPYFYTVVK 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 38/192 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 145 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 202
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRG---LIDF 272
             PE+L   + Y   +D+WS G +L  ++    PF+      +Q V  A + G   L D+
Sbjct: 203 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 262
Query: 273 ------KRDPWPN----------------------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                 + DP  N                      VS  A   + ++L  D + RLTA++
Sbjct: 263 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 322
Query: 305 VLEHPWLQNAKK 316
            +EHP+     K
Sbjct: 323 AMEHPYFYTVVK 334

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 19/240 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 69  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSPY 219
            +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIP 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK + FGL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILGFGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 31  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 84
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 85  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 141
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 142 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 200 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 259
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 260 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 319
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 320 QQVRAAEN 327

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 26  HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 85
Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 86  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 144
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSPY 219
            +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+  
Sbjct: 145 ALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP P
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIP 255
Query: 279 ------NVSESAKSLVRQMLEPDPKLR 299
                  +S    ++V + L  +P+ R
Sbjct: 256 PSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 32/299 (10%)
Query: 27  RKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           R EA   +KQ +  L        +D +    ELG G  GV +    + +  ++A K I  
Sbjct: 8   RLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-H 59
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
            +++ A+  + + RE+ ++ H   +  IV    A   D  + + ME  +GG L   +   
Sbjct: 60  LEIKPAIR-NQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 117
Query: 147 GHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           G   E+    V+  +++ +  L  KH ++HRD+KP N L  ++ E   +K  DFG+S   
Sbjct: 118 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS--- 171
Query: 206 KPGERF----SEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
             G+      +  VG+  YM+PE L+  +Y  + DIWS G+ L  +  G  P  + S   
Sbjct: 172 --GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSG-- 227
Query: 261 VAQAILRGLIDFKRDPWPNVSESAKSL-----VRQMLEPDPKLRLTAKQVLEHPWLQNA 314
            + AI   L     +P P +     SL     V + L  +P  R   KQ++ H +++ +
Sbjct: 228 -SMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 285

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 51  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLX 104
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 105 GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 161
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 162 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 220 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIE 279
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 280 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 339
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 340 QQVRAAEN 347

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLM 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 38/195 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           +++ +  CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 136 LLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 193
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI-------- 265
             PE+L   ++Y   +D+WS G +   ++    PF+   +       +A+ +        
Sbjct: 194 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVY 253
Query: 266 -----------LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                      L  L+    R PW           VS  A   + ++L  D + RLTA +
Sbjct: 254 LNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALE 313
Query: 305 VLEHPWLQNAKKAPN 319
            + HP+ Q  + A N
Sbjct: 314 AMTHPYFQQVRAAEN 328

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 38/195 (19%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           +++ +  CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+
Sbjct: 135 LLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 192
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI-------- 265
             PE+L   ++Y   +D+WS G +   ++    PF+   +       +A+ +        
Sbjct: 193 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVY 252
Query: 266 -----------LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQ 304
                      L  L+    R PW           VS  A   + ++L  D + RLTA +
Sbjct: 253 LNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALE 312
Query: 305 VLEHPWLQNAKKAPN 319
            + HP+ Q  + A N
Sbjct: 313 AMTHPYFQQVRAAEN 327

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 130/308 (42%), Gaps = 44/308 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  +   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 49  VPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRLLKHM 107
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 108 -KHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 164
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y A
Sbjct: 165 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRA 219
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         Q I+R             
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRM 279
Query: 268 -------GLIDFKRDPWPNVSES-------AKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                   +    + P  N ++        A  L+ +ML  D   R+TA + L HP+   
Sbjct: 280 PSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339
Query: 314 AKKAPNVP 321
                + P
Sbjct: 340 YHDPDDEP 347

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V+  +GRG FGV  +C  +   + +A K I     R A  ++   R+++ + H     +I
Sbjct: 13  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE--LRQLSRVNH----PNI 64
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCH 169
           V L  AC   N V LVME  EGG L++  V  G     +YT   A +      + V   H
Sbjct: 65  VKLYGACL--NPVCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 170 K---HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
                 +IHRDLKP N L       + LK  DFG +   +     +   GS  +MAPEV 
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVF 176
Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-PNVSESA 284
           +  NY  + D++S G+IL+ ++    PF  +   G A  I+  + +  R P   N+ +  
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 234
Query: 285 KSLVRQMLEPDPKLRLTAKQVLE 307
           +SL+ +    DP  R + +++++
Sbjct: 235 ESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLC 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKAPN 319
           Q  + A N
Sbjct: 319 QQVRAAEN 326

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 133/316 (42%), Gaps = 57/316 (18%)
Query: 38  ITVLA--GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           I VLA  G   E  E  Y   + +G G FGV +     ++ E+   K +  ++ +     
Sbjct: 25  IKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN---- 80
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEAC------EDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ IM+ + K+ ++V LK         +D+  ++LV+E     E   R  A  HY
Sbjct: 81  ----RELQIMR-IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYR--ASRHY 131
Query: 150 TERAAAAVTRTI-VEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            +         I + + QL       H  G+ HRD+KP+N L      +  LK IDFG +
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSA 189
Query: 203 IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG 260
                GE     + S YY APE++    NY   IDIWS G ++  L+ G P F  ES   
Sbjct: 190 KILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
Query: 261 VAQAILRGLIDFKRD--------------------PW-----PNVSESAKSLVRQMLEPD 295
               I++ L    R+                    P+     P     A  L+ ++LE  
Sbjct: 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT 309
Query: 296 PKLRLTAKQVLEHPWL 311
           P  RLTA + L HP+ 
Sbjct: 310 PSARLTAIEALCHPFF 325

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V+  +GRG FGV  +C  +   + +A K I     R A  ++   R+++ + H     +I
Sbjct: 12  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE--LRQLSRVNH----PNI 63
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARG-----HYTERAAAAVTRTIVEVVQLCH 169
           V L  AC   N V LVME  EGG L++  V  G     +YT   A +      + V   H
Sbjct: 64  VKLYGACL--NPVCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 170 K---HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
                 +IHRDLKP N L       + LK  DFG +   +     +   GS  +MAPEV 
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVF 175
Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-PNVSESA 284
           +  NY  + D++S G+IL+ ++    PF  +   G A  I+  + +  R P   N+ +  
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 285 KSLVRQMLEPDPKLRLTAKQVLE 307
           +SL+ +    DP  R + +++++
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 19/240 (7%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++    E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 69  L-NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSE---IVGSPY 219
            +   H++G+IHRD+KP N + +     + +K +DFG++      G   ++   ++G+  
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R       DP P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPIP 238

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDAGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 57/301 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMK 106
           + Y+   +LG G +   Y    + T  L+A K I          TA+      REV+++K
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI------REVSLLK 55
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRI--VARGHYTERAAAAVTRTIV 162
            L K+++IV+L +    + ++ LV E  +    +  D    +   H  +     + R + 
Sbjct: 56  DL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL----SIFFKPGERFSEIVGSP 218
                CH+  V+HRDLKP+N L   + E   LK  DFGL    SI   P + +   V + 
Sbjct: 115 ----YCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSI---PTKTYDNEVVTL 164
Query: 219 YYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
           +Y  P++L    +Y  +ID+W  G I Y +  G P F   + +     I R L     + 
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224
Query: 277 WPNV--SESAKS------------------------LVRQMLEPDPKLRLTAKQVLEHPW 310
           WP +  +E  K+                        L+ ++L+ + + R++A+  ++HP+
Sbjct: 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 311 L 311
Sbjct: 285 F 285

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L   G   + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDGGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +V + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS GVI+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH+
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHM 78
Query: 109 PKNSSIVSLKE------ACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            K+ +++ L +      + E+ N V+LV  L  G +L + IV     T+     +   I+
Sbjct: 79  -KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQIL 135
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             ++  H   +IHRDLKP N       E+  LK +D GL+      +  +  V + +Y A
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDRGLA--RHTDDEMTGYVATRWYRA 190
Query: 223 PEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------------- 267
           PE++    +Y   +DIWS G I+  LL G   F         + ILR             
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 268 ----------GLIDFKRDPWPNV----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                      L    +  + NV    +  A  L+ +ML  D   R+TA Q L H +   
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 314 AKKAPNVPLGD 324
                + P+ D
Sbjct: 311 YHDPDDEPVAD 321

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 87/362 (24%), Positives = 149/362 (41%), Gaps = 68/362 (18%)
Query: 43  GVPKE---------NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV 93
           GVP E         ++  RY   + +G G +G+     D   +  +A K IS  + +T  
Sbjct: 26  GVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYC 85
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKE-----ACEDDNAVHLVMELCEGGELFDRIVARGH 148
                 RE+ I+    ++ +++ +++       E    V++V +L E  +L+ +++    
Sbjct: 86  Q--RTLREIQILLRF-RHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLY-KLLKSQQ 140
Query: 149 YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            +          I+  ++  H   V+HRDLKP N L     +   LK  DFGL+    P 
Sbjct: 141 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPE 197
Query: 209 ER----FSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF--------- 253
                  +E V + +Y APE++   + Y   IDIWS G IL  +L   P F         
Sbjct: 198 HDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257
Query: 254 -------WAESEQGV-------AQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPD 295
                   + S++ +       A+  L+ L    +  W    P     A  L+ +ML  +
Sbjct: 258 NHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFN 317
Query: 296 PKLRLTAKQVLEHPWLQNAKKAPNVP-----------LGDVVRSRLKQ--FSMMNRFKRK 342
           P  R+T ++ L HP+L+      + P           L D+ + RLK+  F    RF+  
Sbjct: 318 PNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPG 377
Query: 343 AL 344
            L
Sbjct: 378 VL 379

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 132/301 (43%), Gaps = 50/301 (16%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL- 117
           +G G +G     +D  T   +A K +  R  ++ +      RE+ ++KH+ ++ +++ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHM-RHENVIGLL 90
Query: 118 -----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
                 E  +D    +LVM     G    +++      E     +   +++ ++  H  G
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG---SPYYMAPEVLKR- 228
           +IHRDLKP N       E+  LK +DFGL+      +  SE+ G   + +Y APEV+   
Sbjct: 149 IIHRDLKPGNLAV---NEDCELKILDFGLA-----RQADSEMXGXVVTRWYRAPEVILNW 200
Query: 229 -NYGPEIDIWSAGVILYILLCG---------------------VPP--FWAESEQGVAQA 264
             Y   +DIWS G I+  ++ G                      PP  F    +   A+ 
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260
Query: 265 ILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV 320
            ++GL + ++  +     N S  A +L+ +ML  D + R+TA + L HP+ ++     + 
Sbjct: 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 320
Query: 321 P 321
           P
Sbjct: 321 P 321

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMK 106
           RY  D E    LG+G FG          R  L  +  + +K+R T   +  +  EV ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVV-----KARNALDSRYYAIKKIRHTEEKLSTILSEVMLLA 57
Query: 107 HLP------------KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            L             +  + V    A +  + + + ME CE   L+D I +     +R  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 155 A-AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------- 206
              + R I+E +   H  G+IHRDLKP N +F ++  N  +K  DFGL+           
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMN-IFIDESRN--VKIGDFGLAKNVHRSLDILK 174
Query: 207 ------PG--ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE 256
                 PG  +  +  +G+  Y+A EVL    +Y  +ID++S G+I + ++    PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 257 SEQGVAQAILRGL-IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            E+      LR + I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +V + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS GVI+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 125/267 (46%), Gaps = 27/267 (10%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 72
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 73  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 132
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEID 235
           D+KP N L  ++ E   +K  DFG+S      E  +E VG+  YM+PE L+  +Y  + D
Sbjct: 133 DVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRSYMSPERLQGTHYSVQSD 188
Query: 236 IWSAGVILYILLCG---VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL----- 287
           IWS G+ L  +  G    PP           AI   L     +P P +  +  SL     
Sbjct: 189 IWSMGLSLVEMAVGRYPRPPM----------AIFELLDYIVNEPPPKLPSAVFSLEFQDF 238
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           V + L  +P  R   KQ++ H +++ +
Sbjct: 239 VNKCLIKNPAERADLKQLMVHAFIKRS 265

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/359 (23%), Positives = 145/359 (40%), Gaps = 100/359 (27%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + D Y +   +GRG +G  YL  D++  + +A K ++ R     +D   + RE+ I+  L
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-RMFEDLIDCKRILREITILNRL 84
Query: 109 PKNSSIVSLKEAC--ED---DNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTI 161
            K+  I+ L +    ED    + +++V+E+ +    +LF   +     TE+    +   +
Sbjct: 85  -KSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPI---FLTEQHVKTILYNL 140
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------------- 202
           +   +  H+ G+IHRDLKP N L     ++  +K  DFGL+                   
Sbjct: 141 LLGEKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDIHIVNDLEEKE 197
Query: 203 IFFKPG-------ERFSEIVGSPYYMAPE--VLKRNYGPEIDIWSAGVILYILL------ 247
              +PG       ++ +  V + +Y APE  +L+ NY   IDIWS G I   LL      
Sbjct: 198 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSH 257
Query: 248 -------------------------------------------CGVPP---FWAESEQGV 261
                                                       G PP       ++Q V
Sbjct: 258 INNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEV 317
Query: 262 AQAI----LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
            + I     R  ID  +  + ++S+    L+  ML  + + R+T  + L HP+L++ +K
Sbjct: 318 IKYIKLFPTRDGIDLSKK-YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRK 375

>pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/72 (52%), Positives = 51/72 (70%)
Query: 331 KQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
           KQFS  N+FK+ ALRVIAE LS EE+  +KE F  ID+D  G ++ +ELKAGL+  G+ L
Sbjct: 1   KQFSAXNKFKKXALRVIAESLSEEEIAGLKEXFNXIDADKSGQITFEELKAGLKRVGANL 60
Query: 391 AESEVQMLIEAS 402
            ESE+  L +A+
Sbjct: 61  KESEILDLXQAA 72

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 16/224 (7%)
Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
           I++VR+E  +   L K+ +I++L+  C  +  + LVME   GG L +R+++         
Sbjct: 50  IENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDIL 107
Query: 155 AAVTRTIVEVVQLCHKHGV---IHRDLKPENFLFANKKENSP-----LKAIDFGLSIFFK 206
                 I   +   H   +   IHRDLK  N L   K EN       LK  DFGL+  + 
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167
Query: 207 PGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI 265
              + S   G+  +MAPEV++ + +    D+WS GV+L+ LL G  PF       VA  +
Sbjct: 168 RTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226
Query: 266 LRGLIDFKRDPWPNVS-ESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               +     P P+   E    L+     PDP  R +   +L+ 
Sbjct: 227 AMNKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 135/306 (44%), Gaps = 49/306 (16%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D Y V R++GRG++   +  I+ +  E   C     + ++       ++RE+ I+++L 
Sbjct: 30  QDDYEVVRKVGRGKYSEVFEGINVNNNE--KCIIKILKPVKKKK----IKREIKILQNLC 83
Query: 110 KNSSIVSLKEACEDDNAV--HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
              +IV L +   D ++    L+ E        D  V     T+         +++ +  
Sbjct: 84  GGPNIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDY 140
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
           CH  G++HRD+KP N +  +  E   L+ ID+GL+ F+ PG+ ++  V S Y+  PE+L 
Sbjct: 141 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 227 -KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAI--------------- 265
             ++Y   +D+WS G +   ++    PF+   +       +A+ +               
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIE 258
Query: 266 ----LRGLID-FKRDPWPN---------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L  L+    R PW           VS  A   + ++L  D + RLTA + + HP+ 
Sbjct: 259 LDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYF 318
Query: 312 QNAKKA 317
           Q  + A
Sbjct: 319 QQVRAA 324

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 123/330 (37%), Gaps = 70/330 (21%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK- 110
           RY +   LG G FG    CID           I K   R     +  R E+ +++HL   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC---EAARSEIQVLEHLNTT 71
Query: 111 --NSSI--VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER--AAAAVTRTIVEV 164
             NS+   V + E  E    + +V EL  G   +D I   G    R      +   I + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKE----------------NSPLKAIDFGLSIFFKPG 208
           V   H + + H DLKPEN LF                     N  +K +DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 209 ERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL---YILLCGVPPFWAESEQGVAQA 264
           E  S +V + +Y APEV L   +    D+WS G IL   Y+     P   ++    + + 
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 265 IL-------------RGLIDFKRDPWPNVSESAK------------------------SL 287
           IL             R      R  W   S + +                         L
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
           +++MLE DP  R+T ++ L+HP+    KK+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           E R  V R L  G F   Y   D  + RE    + +S  + +    I    +EV  MK L
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII----QEVCFMKKL 82
Query: 109 PKNSSIVSL-------KEACEDDNAVHLVM-ELCEGG--ELFDRIVARGHYTERAAAAVT 158
             + +IV         KE  +   A  L++ ELC+G   E   ++ +RG  +      + 
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 159 RTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFG--LSIFFKPGERFS-- 212
                 VQ  H+    +IHRDLK EN L +N+     +K  DFG   +I   P   +S  
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 213 -------EIV--GSPYYMAPEV--LKRNY--GPEIDIWSAGVILYILLCGVPPFWAESEQ 259
                  EI    +P Y  PE+  L  N+  G + DIW+ G ILY+L     PF    E 
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----ED 255
Query: 260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           G    I+ G   +   P         SL+R ML+ +P+ RL+  +V+    LQ    A N
Sbjct: 256 GAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ--LQEIAAARN 311
Query: 320 V 320
           V
Sbjct: 312 V 312

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKXV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 307 EHPWL 311
           +HP++
Sbjct: 317 QHPYI 321

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 16/230 (6%)
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           REV +++   ++ +++      +D    ++ +ELC         V +  +       +T 
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHLGLEPITL 123
Query: 160 TIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPG----ERF 211
                  L H H   ++HRDLKP N L +    +  +KA+  DFGL      G     R 
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 212 SEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL 266
           S + G+  ++APE+L    K N    +DI+SAG + Y ++  G  PF  +S Q  A  +L
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILL 242
Query: 267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                    P  +    A+ L+ +M+  DP+ R +AK VL+HP+  + +K
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 120
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 179 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 307 EHPWL 311
           +HP++
Sbjct: 355 QHPYI 359

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           Q  +V  G     +  RY   + +G G  G+     D      +A K +S R  +     
Sbjct: 9   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHA 67
Query: 96  DDVRREVAIMKHLPKNSSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHY 149
               RE+ +MK +  + +I+SL      ++  E+   V+LVMEL +      +++     
Sbjct: 68  KRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELD 124
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
            ER +  + + +  +  L H  G+IHRDLKP N +    K +  LK +DFGL+       
Sbjct: 125 HERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSF 180
Query: 210 RFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL------YILLCG------------- 249
             +  V + YY APEV L   Y   +DIWS G I+       IL  G             
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240
Query: 250 ----VPPFWAESEQGVAQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQ 290
                P F  + +  V   +       GL   K  P   +P  SE        A+ L+ +
Sbjct: 241 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 300
Query: 291 MLEPDPKLRLTAKQVLEHPWL 311
           ML  DP  R++    L+HP++
Sbjct: 301 MLVIDPAKRISVDDALQHPYI 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 131/306 (42%), Gaps = 55/306 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ ++K +  +
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPF--------WAES-EQ---------GVAQAIL 266
            L   Y   +DIWS G I+  L+ G   F        W +  EQ            Q  +
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 267 RGLIDFKRDPWPNV------------SES---------AKSLVRQMLEPDPKLRLTAKQV 305
           R  ++  R  +P +            SES         A+ L+ +ML  DP  R++  + 
Sbjct: 257 RNYVE-NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 306 LEHPWL 311
           L HP++
Sbjct: 316 LRHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +V + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCG 249
            L   Y   +DIWS G I+  ++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 307 EHPWL 311
           +HP++
Sbjct: 317 QHPYI 321

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 122/330 (36%), Gaps = 70/330 (21%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK- 110
           RY +   LG G FG    CID           I K   R     +  R E+ +++HL   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC---EAARSEIQVLEHLNTT 71
Query: 111 --NSSI--VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER--AAAAVTRTIVEV 164
             NS+   V + E  E    + +V EL  G   +D I   G    R      +   I + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKE----------------NSPLKAIDFGLSIFFKPG 208
           V   H + + H DLKPEN LF                     N  +K +DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 209 ERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVIL---YILLCGVPPFWAESEQGVAQA 264
           E  S +V   +Y APEV L   +    D+WS G IL   Y+     P   ++    + + 
Sbjct: 189 EHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 265 IL-------------RGLIDFKRDPWPNVSESAK------------------------SL 287
           IL             R      R  W   S + +                         L
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
           +++MLE DP  R+T ++ L+HP+    KK+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 120
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 179 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 234
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 307 EHPWL 311
           +HP++
Sbjct: 355 QHPYI 359

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 75
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIK 133
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 134 HL-HSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 307 EHPWL 311
           +HP++
Sbjct: 310 QHPYI 314

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 81
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 139
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 140 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 195
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 196 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 255
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 256 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 315
Query: 307 EHPWL 311
           +HP++
Sbjct: 316 QHPYI 320

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 83
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 142 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 307 EHPWL 311
           +HP++
Sbjct: 318 QHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 307 EHPWL 311
           +HP++
Sbjct: 317 QHPYI 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 131/306 (42%), Gaps = 55/306 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ ++K +  +
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCV-NH 80
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIK 138
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 139 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEV 194
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPF--------WAES-EQ---------GVAQAIL 266
            L   Y   +DIWS G I+  L+ G   F        W +  EQ            Q  +
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 267 RGLIDFKRDPWPNV------------SES---------AKSLVRQMLEPDPKLRLTAKQV 305
           R  ++  R  +P +            SES         A+ L+ +ML  DP  R++  + 
Sbjct: 255 RNYVE-NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 306 LEHPWL 311
           L HP++
Sbjct: 314 LRHPYI 319

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 307 EHPWL 311
           +HP++
Sbjct: 317 QHPYI 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 83
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 142 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 307 EHPWL 311
           +HP++
Sbjct: 318 QHPYI 322

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 76
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 135 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 307 EHPWL 311
           +HP++
Sbjct: 311 QHPYI 315

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 76
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 135 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 307 EHPWL 311
           +HP++
Sbjct: 311 QHPYI 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 53/305 (17%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 75
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+SL      ++  E+   V+LVMEL +      +++      ER +  + + +  + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 134 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 226 -LKRNYGPEIDIWSAGVIL------YILLCG-----------------VPPFWAESEQGV 261
            L   Y   +DIWS G I+       IL  G                  P F  + +  V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 262 AQAI-----LRGLIDFKRDP---WPNVSE-------SAKSLVRQMLEPDPKLRLTAKQVL 306
              +       GL   K  P   +P  SE        A+ L+ +ML  DP  R++    L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 307 EHPWL 311
           +HP++
Sbjct: 310 QHPYI 314

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +L+   LG+G     +    + T +L A K  +       VD+    RE  ++K L  + 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHK 67
Query: 113 SIVSLKEACEDDNAVH--LVMELCEGGELFDRI----VARGHYTERAAAAVTRTIVEVVQ 166
           +IV L    E+    H  L+ME C  G L+  +     A G   E     V R +V  + 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 167 LCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 226 LKR---------NYGPEIDIWSAGVILYILLCGVPPF 253
            +R          YG  +D+WS GV  Y    G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +L+   LG+G     +    + T +L A K  +       VD+    RE  ++K L  + 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHK 67
Query: 113 SIVSLKEACEDDNAVH--LVMELCEGGELFDRI----VARGHYTERAAAAVTRTIVEVVQ 166
           +IV L    E+    H  L+ME C  G L+  +     A G   E     V R +V  + 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMN 126
Query: 167 LCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 226 LKR---------NYGPEIDIWSAGVILYILLCGVPPF 253
            +R          YG  +D+WS GV  Y    G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-VVNH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 135 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 192
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 193 RFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI----- 246
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 247 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 132
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 133 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 190
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 191 RFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQWHEIRQGRLPRI----- 244
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 245 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 284

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 135 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 192
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 193 RFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI----- 246
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 247 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV     L ++S +V  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGV 173
             A  +D+ + +  E C GG L D I        ++ E     +   +   ++  H   +
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFG-------LSIFFKPGE-----RFSEIV---GSP 218
           +H D+KP N   +  + + P  A + G         + FK G+     R S      G  
Sbjct: 137 VHMDIKPSNIFIS--RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 194
Query: 219 YYMAPEVLKRNYG--PEIDIWSAGVILYILLCGVPPF------WAESEQGVAQAILRGLI 270
            ++A EVL+ NY   P+ DI++  + + +   G  P       W E  QG    I     
Sbjct: 195 RFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRI----- 248
Query: 271 DFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 249 -------PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K ++ LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 52  RYLVDRE----LGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMK 106
           RY  D E    LG+G FG          R  L  +  + +K+R T   +  +  EV ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVV-----KARNALDSRYYAIKKIRHTEEKLSTILSEVXLLA 57
Query: 107 HLP------------KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            L             +  + V    A +  + + +  E CE   L+D I +     +R  
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 155 A-AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK------- 206
              + R I+E +   H  G+IHR+LKP N +F ++  N  +K  DFGL+           
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRNLKPXN-IFIDESRN--VKIGDFGLAKNVHRSLDILK 174
Query: 207 ------PG--ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAE 256
                 PG  +  +  +G+  Y+A EVL    +Y  +ID +S G+I +     + PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTG 231
Query: 257 SEQGVAQAILRGL-IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            E+      LR + I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL
Sbjct: 232 XERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            +           +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 27/235 (11%)
Query: 27  RKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           R EA   +KQ +  L        +D +    ELG G  GV +    + +  ++A K I  
Sbjct: 51  RLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-H 102
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
            +++ A+  + + RE+ ++ H   +  IV    A   D  + + ME  +GG L   +   
Sbjct: 103 LEIKPAIR-NQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 160
Query: 147 GHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           G   E+    V+  +++ +  L  KH ++HRD+KP N L  ++ E   +K  DFG+S   
Sbjct: 161 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS--- 214
Query: 206 KPGERFSEI----VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG---VPP 252
             G+    +    VG+  YM+PE L+  +Y  + DIWS G+ L  +  G   +PP
Sbjct: 215 --GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I+ L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 87
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 145
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 146 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 201
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +D+WS G I+  ++C
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMVC 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINNID 198
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 258
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 259 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 112/235 (47%), Gaps = 27/235 (11%)
Query: 27  RKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
           R EA   +KQ +  L        +D +    ELG G  GV +    + +  ++A K I  
Sbjct: 16  RLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-H 67
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
            +++ A+  + + RE+ ++ H   +  IV    A   D  + + ME  +GG L   +   
Sbjct: 68  LEIKPAIR-NQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125
Query: 147 GHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           G   E+    V+  +++ +  L  KH ++HRD+KP N L  ++ E   +K  DFG+S   
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS--- 179
Query: 206 KPGERFSEI----VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCG---VPP 252
             G+    +    VG+  YM+PE L+  +Y  + DIWS G+ L  +  G   +PP
Sbjct: 180 --GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 200
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 260
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 261 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 76
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 134
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 135 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 190
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +D+WS G I+  ++C
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVC 214

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 83
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 142 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 253
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 254 QPTVRTYVENRPK 266

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ ++  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 58  ELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +M    ++ +
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVMAKC-QHEN 91
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHK 170
           +V L     D + + LV      G L DR+         +      + +     +   H+
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF------SEIVGSPYYMAPE 224
           +  IHRD+K  N L     E    K  DFGL+   +  E+F      S IVG+  YMAPE
Sbjct: 152 NHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQTVMXSRIVGTTAYMAPE 205
Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVP 251
            L+    P+ DI+S GV+L  ++ G+P
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 203
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 263
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 264 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 80/343 (23%), Positives = 135/343 (39%), Gaps = 70/343 (20%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAI 104
           +++RY +   LG G FG    C+D         L   K++ K K    ++I+ + +   I
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEK---I 87
Query: 105 MKHLPKNSSI-VSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTI 161
            +  P N ++ V + +  +    + +  EL  G   FD +    +  Y       +   +
Sbjct: 88  NEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQL 146
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSIFF 205
            + V+  H + + H DLKPEN LF N                  +++ ++ +DFG + F 
Sbjct: 147 CQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF- 205
Query: 206 KPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ---GV 261
              E  S IV + +Y APEV L+  +    D+WS G I++    G   F     +    +
Sbjct: 206 -DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 262 AQAIL------------------RGLIDFKRDPWPN--VSESAK---------------- 285
            + IL                  RG +D+  +      V E+ K                
Sbjct: 265 MERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQL 324
Query: 286 -SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
             L+  MLE +P  RLT  + L+HP+    +  P   L D  R
Sbjct: 325 FDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+PE L+  +Y 
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  +  G   +PP
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 58  ELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +M    ++ +
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVMAKC-QHEN 91
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHK 170
           +V L     D + + LV      G L DR+         +      + +     +   H+
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVGSPYYMAPE 224
           +  IHRD+K  N L     E    K  DFGL+   +  E+F++      IVG+  YMAPE
Sbjct: 152 NHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQTVMXXRIVGTTAYMAPE 205
Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVP 251
            L+    P+ DI+S GV+L  ++ G+P
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 58  ELGRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +M    ++ +
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVMAKC-QHEN 85
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHK 170
           +V L     D + + LV      G L DR+         +      + +     +   H+
Sbjct: 86  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVGSPYYMAPE 224
           +  IHRD+K  N L     E    K  DFGL+   +  E+F++      IVG+  YMAPE
Sbjct: 146 NHHIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQXVMXXRIVGTTAYMAPE 199
Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVP 251
            L+    P+ DI+S GV+L  ++ G+P
Sbjct: 200 ALRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPSPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----SEIVGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+      +  VG+  YM+PE L+  +Y 
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  +  G   +PP
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 257
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 318 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----SEIVGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+      +  VG+  YM+PE L+  +Y 
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  +  G   +PP
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV +    + +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 69
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +   G   E+    V+  +++ +  L  KH ++HR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----SEIVGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+      +  VG+  YM+PE L+  +Y 
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  +  G   +PP
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+            V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +DIWS G I+  ++C
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMVC 220

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 84
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 142
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+            V + YY APEV
Sbjct: 143 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEV 198
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 254
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 255 QPTVRTYVENRPK 267

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
              +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++E    G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
              +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTE--- 151
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 152 --RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTERAA 154
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 155 A-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           +     +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTERAA 154
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 155 A-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           +     +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 193
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 253
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 254 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTERAA 154
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 155 A-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           +     +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 196
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 256
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 257 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTE--- 151
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 152 --RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 197
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 257
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 258 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++     G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 126 AVHLVMELCEGGELFDRIVAR-GHYTERAAA-AVTRTIVEVVQLCHKHGVIHRDLKPENF 183
            + + ME C+ G L   I  R G   ++  A  +   I + V   H   +IHRDLKP N 
Sbjct: 108 CLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNI 167
Query: 184 LFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVI 242
              + K+   +K  DFGL    K   + +   G+  YM+PE +  ++YG E+D+++ G+I
Sbjct: 168 FLVDTKQ---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 224
Query: 243 LYILL--CG----VPPFWAESEQGV--------AQAILRGLIDFKRDPWPNVSESAKSLV 288
           L  LL  C        F+ +   G+         + +L+ L+  K +  PN SE  ++L 
Sbjct: 225 LAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 284
Query: 289 RQMLEPDPKLRLTA 302
                P+   R T 
Sbjct: 285 VWKKSPEKNERHTC 298

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTE--- 151
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 152 --RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 245
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 306 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTE--- 151
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 152 --RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 189
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 250 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTE--- 151
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 152 --RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 133/311 (42%), Gaps = 53/311 (17%)
Query: 50  EDRYLVD----RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI---------- 95
           +D+Y+ D    R L +G+F    LC ++D +   A K   K  L    D           
Sbjct: 26  KDKYINDYRIIRTLNQGKFNKIILC-EKDNK-FYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 96  ----DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDR--IVARG 147
               DD + E+ I+  + KN   ++ +    + + V+++ E  E   +  FD    V   
Sbjct: 84  KSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 148 HYTERAAAAVTRTIVEVV-----QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           +YT      V + I++ V      + ++  + HRD+KP N L     +N  +K  DFG S
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGES 199
Query: 203 IFFKPGERFSEIVGSPYYMAPEVL--KRNY-GPEIDIWSAGVILYILLCGVPPFWAE-SE 258
            +    ++     G+  +M PE    + +Y G ++DIWS G+ LY++   V PF  + S 
Sbjct: 200 EYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 259 QGVAQAILRGLIDFKRD------PWPN---------VSESAKSLVRQMLEPDPKLRLTAK 303
             +   I    I++  D      P  N         +S      ++  L  +P  R+T++
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 304 QVLEHPWLQNA 314
             L+H WL + 
Sbjct: 319 DALKHEWLADT 329

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 110/253 (43%), Gaps = 19/253 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            L   Y   +DIWS G I+  ++ G   F           ++  L      P P   +  
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL----GTPCPEFMKKL 252
Query: 285 KSLVRQMLEPDPK 297
           +  VR  +E  PK
Sbjct: 253 QPTVRTYVENRPK 265

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
           ++++G+G FG+ +       + ++A KS+    S+ +        + +REV IM +L  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NH 82
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLC 168
            +IV L       N   +VME    G+L+ R++ + H  + +     R ++++   ++  
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIALGIEYM 138
Query: 169 HKHG--VIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
                 ++HRDL+  N    +  EN+P+  K  DFGLS   +     S ++G+  +MAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 225 VL---KRNYGPEIDIWSAGVILYILLCGVPPF 253
            +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIM 105
           D+  + + LG G FG   +     ID+D  +E +       +   T  D+ D+  E+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----------------GHY 149
           K + K+ +I++L  AC  D  +++++     G L + + AR                   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 150 TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T +   + T  +   ++       IHRDL   N L     EN+ +K  DFGL+      +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNID 211
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            + +         +MAPE L  R Y  + D+WS GV+++ I   G  P+     + + + 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 272 LKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY   + +G G  G+     D      +A K +S R  +         RE+ +MK +  +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NH 82
Query: 112 SSIVSL------KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
            +I+ L      +++ E+   V++VMEL +      +++      ER +  + + +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
            L H  G+IHRDLKP N +    K +  LK +DFGL+            V + YY APEV
Sbjct: 141 HL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEV 196
Query: 226 -LKRNYGPEIDIWSAGVILYILLC 248
            L   Y   +D+WS G I+  ++C
Sbjct: 197 ILGMGYKENVDLWSVGCIMGEMVC 220

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 35/287 (12%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG       R+T E++  K + +    T        +EV +M+ L ++ +++   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCL-EHPNVLKFI 73
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
                D  ++ + E  +GG L   I +    Y      +  + I   +   H   +IHRD
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFF--------------KPG--ERFSEIVGSPYYM 221
           L   N L    +EN  +   DFGL+                 KP   +R++ +VG+PY+M
Sbjct: 134 LNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT-VVGNPYWM 189
Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGV--PPFWAESEQGVAQAILRGLIDFKRDPWP 278
           APE++  R+Y  ++D++S G++L  ++  V   P +          + RG +D  R   P
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLD--RYCPP 246
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK--APNVPLG 323
           N   S   +  +  + DP+ R +  + LEH WL+  +   A ++PLG
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSFVK-LEH-WLETLRMHLAGHLPLG 291

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIM 105
           DR ++ + LG G FG   L     +D+D    +   ++   K   T  D+ D+  E+ +M
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYTE--- 151
           K + K+ +I++L  AC  D  +++++E    G L + + AR            H  E   
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 152 --RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
             +   +    +   ++       IHRDL   N L     E++ +K  DFGL+      +
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 204
Query: 210 RFSEIVGSPY---YMAPEVL-KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
              +         +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + 
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           +  G    + D   N +     ++R      P  R T KQ++E
Sbjct: 265 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 136/311 (43%), Gaps = 47/311 (15%)
Query: 39  TVLAGVPKENIEDRYLVDRELGRGEFGVTYL------CIDRDTRELLACKSISKRKLRTA 92
           T +  + + NI    ++ RELG G FG  +L      C ++D + L+A K+     L+ A
Sbjct: 5   TFVQHIKRHNI----VLKRELGEGAFGKVFLAECYNLCPEQD-KILVAVKT-----LKDA 54
Query: 93  VDI--DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--- 147
            D    D  RE  ++ +L ++  IV     C + + + +V E  + G+L   + A G   
Sbjct: 55  SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDA 113
Query: 148 ----------HYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKA 196
                       T+     + + I   +V L  +H  +HRDL   N L     EN  +K 
Sbjct: 114 VLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVG---ENLLVKI 169
Query: 197 IDFGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVP 251
            DFG+S  ++     R       P  +M PE ++ R +  E D+WS GV+L+ I   G  
Sbjct: 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229
Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           P++  S   V + I +G +  +    P   +    L+    + +P +R   K +  H  L
Sbjct: 230 PWYQLSNNEVIECITQGRVLQRPRTCP---QEVYELMLGCWQREPHMRKNIKGI--HTLL 284
Query: 312 QNAKKAPNVPL 322
           QN  KA  V L
Sbjct: 285 QNLAKASPVYL 295

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           +   V   H  G+ HRD+KP+N L  N K+N+ LK  DFG +    P E     + S +Y
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQN-LLVNSKDNT-LKLCDFGSAKKLIPSEPSVAXICSRFY 207
Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES--EQGVAQAILRG-------- 268
            APE++     Y P ID+WS G +   L+ G P F  E+  +Q V    + G        
Sbjct: 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMI 267
Query: 269 ----------LIDFKRDPW----PNVSES-AKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                         K   W    P  + S A  L+ Q+L  +P LR+   + + HP+  +
Sbjct: 268 RMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
Query: 314 AKKA 317
            + +
Sbjct: 328 LRNS 331

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKK---------VRLEVFRAEELMACAGLTSPRIVPLY 132
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   +  +G   E  A       +E ++  H   ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV------GSPYYMAPE-VLKRNYG 231
           K +N L ++   ++ L   DFG ++  +P     +++      G+  +MAPE VL R+  
Sbjct: 193 KADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++D+WS+  ++  +L G  P+
Sbjct: 251 AKVDVWSSCCMMLHMLNGCHPW 272

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKK---------VRLEVFRAEELMACAGLTSPRIVPLY 151
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   +  +G   E  A       +E ++  H   ++H D+
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++   ++ L   DFG ++  +P   G+       I G+  +MAPE VL R+  
Sbjct: 212 KADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++D+WS+  ++  +L G  P+
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHPW 291

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
           ++++G+G FG+ +       + ++A KS+    S+ +        + +REV IM +L  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NH 82
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLC 168
            +IV L       N   +VME    G+L+ R++ + H  + +     R ++++   ++  
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIALGIEYM 138
Query: 169 HKHG--VIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
                 ++HRDL+  N    +  EN+P+  K  DFG S   +     S ++G+  +MAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 225 VL---KRNYGPEIDIWSAGVILYILLCGVPPF 253
            +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 52  RYLVD-RELGRGEFG-VTYLCID---RDTRELLACKSI---SKRKLRTAVDIDDVRREVA 103
           RYL   R+LG G FG V+  C D     T E++A K++   +  + R+       ++E+ 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW-----KQEID 85
Query: 104 IMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I++ L  +  I+  K  CED  A  + LVME    G L D       Y  R +  + + +
Sbjct: 86  ILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLL 137
Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFS 212
           +   Q+C      H    IHRDL   N L  N +    +K  DFGL+     G    R  
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEXYRVR 194
Query: 213 EIVGSP-YYMAPEVLKR-NYGPEIDIWSAGVILYILL 247
           E   SP ++ APE LK   +    D+WS GV LY LL
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 131 MELCEGGELFDRIVAR-GHYTERAAA-AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK 188
           ME C+ G L   I  R G   ++  A  +   I + V   H   +I+RDLKP N    + 
Sbjct: 99  MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158
Query: 189 KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILL 247
           K+   +K  DFGL    K   +     G+  YM+PE +  ++YG E+D+++ G+IL  LL
Sbjct: 159 KQ---VKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
Query: 248 --CG----VPPFWAESEQGV--------AQAILRGLIDFKRDPWPNVSESAKSLVRQMLE 293
             C        F+ +   G+         + +L+ L+  K +  PN SE  ++L      
Sbjct: 216 HVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
Query: 294 PDPKLRLTA 302
           P+   R TA
Sbjct: 276 PEKNERHTA 284

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +  +      DD   E  +M  L  +  +
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDK---VAIKTIKEGSMSE----DDFIEEAEVMMKL-SHPKL 84
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 85  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 144
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 145 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 200
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 245

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSI----SKRKLRTAVDIDDVRREVAIMKHLPKN 111
           ++++G+G FG+ +       + ++A KS+    S+ +        + +REV IM +L  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NH 82
Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV---VQLC 168
            +IV L       N   +VME    G+L+ R++ + H  + +     R ++++   ++  
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIALGIEYM 138
Query: 169 HKHG--VIHRDLKPENFLFANKKENSPL--KAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
                 ++HRDL+  N    +  EN+P+  K  DF LS   +     S ++G+  +MAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPE 196
Query: 225 VL---KRNYGPEIDIWSAGVILYILLCGVPPF 253
            +   + +Y  + D +S  +ILY +L G  PF
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I DRY +   +G G +G      D+  + ++A K I  R     +D   + RE+AI+  L
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRL 109
Query: 109 PKNSSI----VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVE 163
             +  +    + + +  E  + +++V+E+ +    F ++     Y TE     +   ++ 
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------IFFKPGERF 211
            V+  H  G++HRDLKP N L     ++  +K  DFGL+            +   P E  
Sbjct: 168 GVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 212 SEIVGSP----------------YYMAPE--VLKRNYGPEIDIWSAGVILYILL 247
             +V  P                +Y APE  +L+ NY   ID+WS G I   LL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 64
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASV 124
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 125 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 225

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELG G  GV      R +  ++A K I   +++ A+  + + RE+ ++ H   +  IV  
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNSPYIVGF 79
Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHR 176
             A   D  + + ME  +GG L   +       E     V+  ++  +  L  KH ++HR
Sbjct: 80  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 139
Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----SEIVGSPYYMAPEVLK-RNYG 231
           D+KP N L  ++ E   +K  DFG+S     G+      +  VG+  YMAPE L+  +Y 
Sbjct: 140 DVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMAPERLQGTHYS 191
Query: 232 PEIDIWSAGVILYILLCG---VPP 252
            + DIWS G+ L  L  G   +PP
Sbjct: 192 VQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 39/275 (14%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELGRG +GV        + +++A K I     S+ + R  +D+D   R V          
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC-------P 110
Query: 113 SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYT-ERAAAAVTRTIVEVVQLCH 169
             V+   A   +  V + MEL +    + + +++ +G    E     +  +IV+ ++  H
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 170 -KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-- 226
            K  VIHRD+KP N L     +   +K  DFG+S +       +   G   YMAPE +  
Sbjct: 171 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINP 227
Query: 227 ---KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNVS 281
              ++ Y  + DIWS G+ +  L     P+  W    Q + Q +         +P P + 
Sbjct: 228 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--------EEPSPQLP 279
Query: 282 ESAKS-----LVRQMLEPDPKLRLTAKQVLEHPWL 311
               S        Q L+ + K R T  ++++HP+ 
Sbjct: 280 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + A    +  +    + R     +   H   +IHRDLK  N     
Sbjct: 84  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-- 141
Query: 188 KKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAG 240
             E++ +K  DFGL+     +    +F ++ GS  +MAPEV++      Y  + D+++ G
Sbjct: 142 -HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 200
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 201 IVLYELMTGQLPY 213

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + A    +  +    + R     +   H   +IHRDLK  N     
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-- 153
Query: 188 KKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAG 240
             E++ +K  DFGL+     +    +F ++ GS  +MAPEV++      Y  + D+++ G
Sbjct: 154 -HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 213 IVLYELMTGQLPY 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 64
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 124
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 125 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 225

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 68  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 127
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 128 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 183
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 228

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + A    +  +    + R     +   H   +IHRDLK  N     
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-- 153
Query: 188 KKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAG 240
             E++ +K  DFGL+     +    +F ++ GS  +MAPEV++      Y  + D+++ G
Sbjct: 154 -HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 213 IVLYELMTGQLPY 225

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 62
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 123 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 57  RELGRGEFGVTYL--CIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +E+G G+FG+ +L   +++D    +A K+I +     A+  +D   E  +M  L  +  +
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDK---VAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 65
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           V L   C +   + LV E  E G L D +   RG +       +   + E +    +  V
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKRN- 229
           IHRDL   N L     EN  +K  DFG++ F    ++++   G+ +   + +PEV   + 
Sbjct: 126 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 230 YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK 273
           Y  + D+WS GV+++ +   G  P+   S   V + I  G   +K
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G G FG  Y         +   K +      T       R EVA+++     + 
Sbjct: 39  MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDP----TPEQFQAFRNEVAVLRKTRHVNI 94
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHG 172
           ++ +    +D+ A+  V + CEG  L+  + V    +       + R   + +   H   
Sbjct: 95  LLFMGYMTKDNLAI--VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN 152
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVLKRN 229
           +IHRD+K  N       E   +K  DFGL+     +   ++  +  GS  +MAPEV++  
Sbjct: 153 IIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 230 ----YGPEIDIWSAGVILYILLCGVPPF 253
               +  + D++S G++LY L+ G  P+
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D + A     +       T  
Sbjct: 67  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 58/127 (45%), Gaps = 33/127 (25%)
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGL--------------------------- 201
           H+ G++HRD+KP NFL+  + +   L  +DFGL                           
Sbjct: 134 HQFGIVHRDVKPSNFLYNRRLKKYAL--VDFGLAQGTHDTKIELLKFVQSEAQQERCSQN 191
Query: 202 --SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAES 257
             SI     ++ +   G+P + APEVL +  N    ID+WSAGVI   LL G  PF+  S
Sbjct: 192 KCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251
Query: 258 EQGVAQA 264
           +   A A
Sbjct: 252 DDLTALA 258

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 39/275 (14%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSI-----SKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELGRG +GV        + +++A K I     S+ + R  +D+D   R V          
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC-------P 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYT-ERAAAAVTRTIVEVVQLCH 169
             V+   A   +  V + MEL +    + + +++ +G    E     +  +IV+ ++  H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 170 -KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-- 226
            K  VIHRD+KP N L     +   +K  DFG+S +           G   YMAPE +  
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 227 ---KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV- 280
              ++ Y  + DIWS G+ +  L     P+  W    Q + Q +         +P P + 
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--------EEPSPQLP 235
Query: 281 ----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
               S        Q L+ + K R T  ++++HP+ 
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 17  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 73  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 14  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 70  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 127
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 128 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRT---IVEVVQLCHKHGVIHRDLKPENF 183
           +++ M+LC    L D +  R    +R           I E V+  H  G++HRDLKP N 
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 184 LFANKKENSPLKAIDFGLSIFFKPGERFSEI-------------VGSPYYMAPEVLK-RN 229
            F     +  +K  DFGL       E    +             VG+  YM+PE +   N
Sbjct: 196 FFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNN 252
Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV----SESAK 285
           Y  ++DI+S G+IL+ LL     F  + E+      +R + D +   +P +         
Sbjct: 253 YSHKVDIFSLGLILFELLYS---FSTQMER------VRIITDVRNLKFPLLFTQKYPQEH 303
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            +V+ ML P P  R  A  ++E+   +N
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 17  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 73  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 130
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 131 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 12  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 68  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/331 (23%), Positives = 134/331 (40%), Gaps = 73/331 (22%)
Query: 46  KENIEDRYLVDR-ELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTAVDIDDVRREV 102
           +E +ED +  +  ++GRG +G  Y    +D ++    A K I    +  +       RE+
Sbjct: 15  RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREI 69
Query: 103 AIMKHLPKNSSIVSLKEA--CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR- 159
           A+++ L K+ +++SL++      D  V L+ +  E          R     +    + R 
Sbjct: 70  ALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 160 -------TIVEVVQLCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFF----KP 207
                   I++ +   H + V+HRDLKP N L      E   +K  D G +  F    KP
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 208 GERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------------ 253
                 +V + +Y APE+L   R+Y   IDIW+ G I   LL   P F            
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 254 --------------------WAESEQGVAQAILRGLIDFKRDPWPNVS------------ 281
                               W + ++    + L  + DF+R+ + N S            
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL--MKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 282 -ESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              A  L++++L  DP  R+T++Q ++ P+ 
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 109/265 (41%), Gaps = 26/265 (9%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDT--RELLACKSISKRKLRTAVDIDDVRREV 102
           P + +  +Y V   +  G  G  YL +DR+   R ++    +              R+ +
Sbjct: 74  PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 103 AIMKHLPKNSSIVSLKEACE--DDNAVHLVMELCEGGELFDRIVARGHYTERA-AAAVTR 159
           A + H P    I +  E  +   D   ++VME   GG+   R  ++G     A A A   
Sbjct: 134 AEVVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR--SKGQKLPVAEAIAYLL 189
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  +   H  G+++ DLKPEN +   ++    LK ID G          F  + G+P 
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAVSRIN---SFGYLYGTPG 242
Query: 220 YMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           + APE+++       DI++ G  L  L   +P        G+ +           DP   
Sbjct: 243 FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDPVLK 292
Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQ 304
             +S   L+R+ ++PDP+ R T  +
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAE 317

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 40  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 96  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 154 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 129 LVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +V + CEG  L+  + +    +       + R   + +   H   +IHRDLK  N     
Sbjct: 107 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL-- 164
Query: 188 KKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAG 240
             E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    K  Y  + D+++ G
Sbjct: 165 -HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 223
Query: 241 VILYILLCGVPPF 253
           ++LY L+ G  P+
Sbjct: 224 IVLYELMTGQLPY 236

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 43  GVPKENIEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDD 97
           G      E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA 155
             RE+ I+K L ++ +IV  K  C       + L+ME    G L D +       +    
Sbjct: 58  FEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 156 -AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-------FFK- 206
              T  I + ++       IHRDL   N L  N+     +K  DFGL+        FFK 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEFFKV 173
Query: 207 --PGERFSEIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
             PGE       SP ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 174 KEPGE-------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPRIVPLY 130
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   I   G   E  A       +E ++  H   ++H D+
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++    + L   DFG ++  +P   G+       I G+  +MAPE V+ +   
Sbjct: 191 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQG 260
            ++DIWS+  ++  +L G  P W +  +G
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHP-WTQYFRG 276

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------ENSPLKAIDFG 200
           E    ++ R I   V   H   +IHRDLKP+N L +             EN  +   DFG
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 201 LSIFFKPGE-----RFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLC-GV 250
           L      G+       +   G+  + APE+L    KR     IDI+S G + Y +L  G 
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 251 PPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQMLEPDPKLRLTAKQV 305
            PF  +  +     I+RG+  F  D    + +      A  L+ QM++ DP  R TA +V
Sbjct: 252 HPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307
Query: 306 LEHP--WLQNAK 315
           L HP  W ++ K
Sbjct: 308 LRHPLFWPKSKK 319

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 12  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  +     A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 68  LFMGYSTAPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIF---FKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 84/192 (43%), Gaps = 31/192 (16%)
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------ENSPLKAIDFG 200
           E    ++ R I   V   H   +IHRDLKP+N L +             EN  +   DFG
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 201 LSIFFKPGE-----RFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLC-GV 250
           L      G+       +   G+  + APE+L    KR     IDI+S G + Y +L  G 
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 251 PPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQMLEPDPKLRLTAKQV 305
            PF  +  +     I+RG+  F  D    + +      A  L+ QM++ DP  R TA +V
Sbjct: 252 HPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307
Query: 306 LEHP--WLQNAK 315
           L HP  W ++ K
Sbjct: 308 LRHPLFWPKSKK 319

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 60  GRGEFGVTYLCIDRDT----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIV 115
           G G FGV Y     +T    ++L A   I+  +L+   D     +E+ +     ++ ++V
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFD-----QEIKVXAKC-QHENLV 84
Query: 116 SLKEACEDDNAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHG 172
            L     D + + LV      G L DR+         +      + +     +   H++ 
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENH 144
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF------SEIVGSPYYMAPEVL 226
            IHRD+K  N L     E    K  DFGL+   +  E+F      S IVG+  Y APE L
Sbjct: 145 HIHRDIKSANILL---DEAFTAKISDFGLA---RASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 227 KRNYGPEIDIWSAGVILYILLCGVP 251
           +    P+ DI+S GV+L  ++ G+P
Sbjct: 199 RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 12  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 68  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 126 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 29/56 (51%), Positives = 43/56 (76%)
Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           +AE LS EE+  +KE+FK ID+DN G ++ DELK GL+  GS+L ESE++ L++A+
Sbjct: 13  MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 32  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 88  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 145
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 146 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V + +G G FG  Y          +A K ++     T   +   + EV +++     + +
Sbjct: 40  VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           + +  + +   A+  V + CEG  L+  + +    +       + R   + +   H   +
Sbjct: 96  LFMGYSTKPQLAI--VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 153
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSI---FFKPGERFSEIVGSPYYMAPEVL---- 226
           IHRDLK  N       E+  +K  DFGL+     +    +F ++ GS  +MAPEV+    
Sbjct: 154 IHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 227 KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  Y  + D+++ G++LY L+ G  P+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 42/277 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISK-----RKLRTAVDIDDVRREVAIMKHLPKNS 112
           E+G G  G  +    R T  ++A K + +        R  +D+D     V +  H     
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-----VVLKSH--DCP 84
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQ-LCH 169
            IV        +  V + MEL   G   +++  R  G   ER    +T  IV+ +  L  
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--- 226
           KHGVIHRD+KP N L     E   +K  DFG+S      +      G   YMAPE +   
Sbjct: 143 KHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 227 ---KRNYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILR-------GLIDFKRD 275
              K +Y    D+WS G+ L  L  G  P+   +++  V   +L+       G + F  D
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                    +S V+  L  D + R    ++LEH +++
Sbjct: 260 --------FQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPRIVPLY 132
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   I   G   E  A       +E ++  H   ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++    + L   DFG ++  +P   G+       I G+  +MAPE V+ +   
Sbjct: 193 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++DIWS+  ++  +L G  P+
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPW 272

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   R+LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L + +       +       T  
Sbjct: 67  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG  +   D+ T    A K          V ++  R E  +      +  IV L 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPRIVPLY 116
Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A  +   V++ MEL EGG L   I   G   E  A       +E ++  H   ++H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKP---GERF---SEIVGSPYYMAPE-VLKRNYG 231
           K +N L ++    + L   DFG ++  +P   G+       I G+  +MAPE V+ +   
Sbjct: 177 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 232 PEIDIWSAGVILYILLCGVPPF 253
            ++DIWS+  ++  +L G  P+
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 43  GVPKENIEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDD 97
           G      E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRD 57
Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA 155
             RE+ I+K L ++ +IV  K  C       + L+ME    G L D +       +    
Sbjct: 58  FEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 156 -AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERF 211
              T  I + ++       IHRDL   N L  N+     +K  DFGL+      K   + 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKV 173
Query: 212 SEIVGSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
            E   SP ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 94
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 95  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 210
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 62
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 63  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 121
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 122 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 179 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 213

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 67
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 68  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 126
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 127 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 184 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 69
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 70  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 128
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 129 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 185
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 186 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 220

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 81
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 82  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 140
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 141 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 61
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 62  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 120
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 121 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 178 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 66
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 67  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 70
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 71  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 129
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 130 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 186
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 187 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 221

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 63
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 64  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 68
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 69  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 127
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 128 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 184
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 185 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 219

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 84/196 (42%), Gaps = 35/196 (17%)
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------ENSPLKAIDFG 200
           E    ++ R I   V   H   +IHRDLKP+N L +             EN  +   DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 201 LSIFFKPGE-----RFSEIVGSPYYMAPEVL--------KRNYGPEIDIWSAGVILYILL 247
           L      G+       +   G+  + APE+L        KR     IDI+S G + Y +L
Sbjct: 174 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 248 C-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQMLEPDPKLRLT 301
             G  PF  +  +     I+RG+  F  D    + +      A  L+ QM++ DP  R T
Sbjct: 234 SKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289
Query: 302 AKQVLEHP--WLQNAK 315
           A +VL HP  W ++ K
Sbjct: 290 AMKVLRHPLFWPKSKK 305

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 81
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 82  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 140
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF---KPGERFSEIVGS 217
           I + ++       IHRDL   N L  N+     +K  DFGL+      K   +  E   S
Sbjct: 141 ICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 84/196 (42%), Gaps = 35/196 (17%)
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------ENSPLKAIDFG 200
           E    ++ R I   V   H   +IHRDLKP+N L +             EN  +   DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 201 LSIFFKPGE-----RFSEIVGSPYYMAPEVL--------KRNYGPEIDIWSAGVILYILL 247
           L      G+       +   G+  + APE+L        KR     IDI+S G + Y +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 248 C-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE-----SAKSLVRQMLEPDPKLRLT 301
             G  PF  +  +     I+RG+  F  D    + +      A  L+ QM++ DP  R T
Sbjct: 234 SKGKHPFGDKYSR--ESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289
Query: 302 AKQVLEHP--WLQNAK 315
           A +VL HP  W ++ K
Sbjct: 290 AMKVLRHPLFWPKSKK 305

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 52  RYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           R+L  D E+GRG F   Y  +D +T   +A   +  RKL T  +    + E   +K L +
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEXLKGL-Q 83
Query: 111 NSSIVSLKEACEDD----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +IV   ++ E        + LV EL   G L   +        +   +  R I++ +Q
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQ 143
Query: 167 LCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
             H     +IHRDLK +N           +K  D GL+   K       ++G+P + APE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATL-KRASFAKAVIGTPEFXAPE 200
Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI------DFKRDPWP 278
             +  Y   +D+++ G           P+   SE   A  I R +        F +   P
Sbjct: 201 XYEEKYDESVDVYAFGXCXLEXATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            V E  +  +RQ    +   R + K +L H + Q
Sbjct: 258 EVKEIIEGCIRQ----NKDERYSIKDLLNHAFFQ 287

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 135/311 (43%), Gaps = 54/311 (17%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVD-RELGRGEFGVTYLCI----DRDTRELLACKSISK 86
            ++K+P T    V   + E R+L   R+LG G FG   LC       +T E +A KS+  
Sbjct: 4   VSEKKPATE---VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIV 144
                   I D+++E+ I+++L  + +IV  K  C +D  N + L+ME    G L + + 
Sbjct: 61  ES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP 117
Query: 145 ARGHYTERAAAAVTRTIVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAID 198
                  +    + + +   VQ+C           +HRDL   N L  ++ +   +K  D
Sbjct: 118 KN-----KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGD 169
Query: 199 FGLSIFFKPGERFSEIV---GSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPF 253
           FGL+   +  +    +     SP ++ APE L ++ +    D+WS GV L+ LL      
Sbjct: 170 FGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT----- 224
Query: 254 WAESE----------------QGVAQAILRGLIDFKRDPW-PNVSESAKSLVRQMLEPDP 296
           + +S+                Q     ++  L + KR P  PN  +    L+R+  E  P
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP 284
Query: 297 KLRLTAKQVLE 307
             R + + ++E
Sbjct: 285 SNRTSFQNLIE 295

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 51/295 (17%)
Query: 48  NIEDRYLVD-RELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           + E R+L   R+LG G FG   LC       +T E +A KS+          I D+++E+
Sbjct: 5   HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEI 62
Query: 103 AIMKHLPKNSSIVSLKEACEDD--NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+++L  + +IV  K  C +D  N + L+ME    G L + +        +    + + 
Sbjct: 63  EILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQ 116
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           +   VQ+C           +HRDL   N L  ++ +   +K  DFGL+   +  +    +
Sbjct: 117 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTV 173
Query: 215 V---GSP-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE----------- 258
                SP ++ APE L ++ +    D+WS GV L+ LL      + +S+           
Sbjct: 174 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSPMALFLKMI 228
Query: 259 -----QGVAQAILRGLIDFKRDPW-PNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                Q     ++  L + KR P  PN  +    L+R+  E  P  R + + ++E
Sbjct: 229 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/55 (52%), Positives = 42/55 (76%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           AE LS EE+  +KE+FK ID+DN G ++ DELK GL+  GS+L ESE++ L++A+
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 55

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/329 (22%), Positives = 129/329 (39%), Gaps = 74/329 (22%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------------DIDDVR 99
           RY++ R+LG G F   +L  D      +A K +   K+ T              D D+ +
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA-----A 154
            +     H+ K     + K      N VH+VM     GE    ++ +  Y  R       
Sbjct: 80  EDSMGANHILKLLDHFNHKGP----NGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYV 133
Query: 155 AAVTRTIVEVVQLCHKH-GVIHRDLKPENFLF--ANKKEN-SPLKAIDFGLSIFFKPGER 210
             +++ ++  +   H+  G+IH D+KPEN L    +  EN   +K  D G + ++   E 
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EH 191
Query: 211 FSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPF-------WAESEQGVA 262
           ++  + +  Y +PEV L   +G   DIWS   +++ L+ G   F       + + +  +A
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 263 QAI--------------------------LRGLIDFKRDPWPNV-----------SESAK 285
           Q I                          LR +   K  P  +V           ++   
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             +  ML+ DP+ R  A  ++ HPWL++ 
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/329 (22%), Positives = 129/329 (39%), Gaps = 74/329 (22%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV------------DIDDVR 99
           RY++ R+LG G F   +L  D      +A K +   K+ T              D D+ +
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA-----A 154
            +     H+ K     + K      N VH+VM     GE    ++ +  Y  R       
Sbjct: 80  EDSMGANHILKLLDHFNHKGP----NGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYV 133
Query: 155 AAVTRTIVEVVQLCHKH-GVIHRDLKPENFLF--ANKKEN-SPLKAIDFGLSIFFKPGER 210
             +++ ++  +   H+  G+IH D+KPEN L    +  EN   +K  D G + ++   E 
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EH 191
Query: 211 FSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPF-------WAESEQGVA 262
           ++  + +  Y +PEV L   +G   DIWS   +++ L+ G   F       + + +  +A
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 263 QAI--------------------------LRGLIDFKRDPWPNV-----------SESAK 285
           Q I                          LR +   K  P  +V           ++   
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             +  ML+ DP+ R  A  ++ HPWL++ 
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 131/313 (41%), Gaps = 54/313 (17%)
Query: 33  NKKQPITVLAGV------PKE----NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           + +QP+T  +GV      PK+    N ED  ++  ++GRG FG  +    R    L+A K
Sbjct: 87  STQQPLTKKSGVVLHRAVPKDKWVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
Query: 83  SISKRKLRTAVDID---DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL 139
           S      R  +  D      +E  I+K    + +IV L   C     +++VMEL +GG+ 
Sbjct: 146 SC-----RETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 140 FDRIVARGHYTERAAAAVTRTIVEVV-------QLCHKHGVIHRDLKPENFLFANKKENS 192
              +   G      A    +T++++V       +       IHRDL   N L     E +
Sbjct: 200 LTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKN 250
Query: 193 PLKAIDFGLS------IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY- 244
            LK  DFG+S      ++   G      V    + APE L    Y  E D+WS G++L+ 
Sbjct: 251 VLKISDFGMSREEADGVYAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-SLVRQMLEPDPKLRLTAK 303
               G  P+   S Q   + + +G     R P P +   A   L+ Q    +P  R +  
Sbjct: 308 TFSLGASPYPNLSNQQTREFVEKG----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFS 363
Query: 304 QVLEHPWLQNAKK 316
            + +   LQ+ +K
Sbjct: 364 TIYQE--LQSIRK 374

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L   ++LG+G FG   +C    +  +T E++A K +      T   + D  RE+ 
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIE 64
Query: 104 IMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAA-AVTRT 160
           I+K L ++ +IV  K  C       + L+ME    G L D +       +       T  
Sbjct: 65  ILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 123
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG---S 217
           I + ++       IHR+L   N L  N+     +K  DFGL+      + + ++     S
Sbjct: 124 ICKGMEYLGTKRYIHRNLATRNILVENENR---VKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 218 P-YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
           P ++ APE L  + +    D+WS GV+LY L   +
Sbjct: 181 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 215

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +  ++G G FG  +      +   +A K + ++    A  +++  REVAIMK L ++ +I
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFH-AERVNEFLREVAIMKRL-RHPNI 96
Query: 115 VSLKEACEDDNAVHLVMELCEGGELF---DRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
           V    A      + +V E    G L+    +  AR    ER   ++   + + +   H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 172 G--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV-GSPYYMAPEVLKR 228
              ++HRDLK  N L   K     +K  DFGLS         S+   G+P +MAPEVL+ 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 229 NYGPE-IDIWSAGVILYIL 246
               E  D++S GVIL+ L
Sbjct: 214 EPSNEKSDVYSFGVILWEL 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS---I 114
           E+GRG +G     + + + +++A K     ++R+ VD  + ++ +  +  + ++S    I
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVK-----RIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT------ERAAAAVTRTIVEVV-QL 167
           V    A   +    + MEL      FD+     +        E     +T   V+ +  L
Sbjct: 84  VQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL- 226
                +IHRD+KP N L      +  +K  DFG+S         +   G   YMAPE + 
Sbjct: 142 KENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 227 ----KRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNV 280
               ++ Y    D+WS G+ LY L  G  P+  W      + Q +       K DP P +
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-------KGDP-PQL 250
Query: 281 SESAK--------SLVRQMLEPDPKLRLTAKQVLEHPWL 311
           S S +        + V   L  D   R   K++L+HP++
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 131/310 (42%), Gaps = 48/310 (15%)
Query: 33  NKKQPITVLAGV------PKE----NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           + +QP+T  +GV      PK+    N ED  ++  ++GRG FG  +    R    L+A K
Sbjct: 87  STQQPLTKKSGVVLHRAVPKDKWVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
Query: 83  SISKRKLRTAVDID---DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL 139
           S      R  +  D      +E  I+K    + +IV L   C     +++VMEL +GG+ 
Sbjct: 146 SC-----RETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 140 FDRIVARGHYTERAAAAVTRTIVEVV-------QLCHKHGVIHRDLKPENFLFANKKENS 192
              +   G      A    +T++++V       +       IHRDL   N L     E +
Sbjct: 200 LTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKN 250
Query: 193 PLKAIDFGLSIFFKPGERFSE--IVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILL 247
            LK  DFG+S     G   +   +   P  + APE L    Y  E D+WS G++L+    
Sbjct: 251 VLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK-SLVRQMLEPDPKLRLTAKQVL 306
            G  P+   S Q   + + +G     R P P +   A   L+ Q    +P  R +   + 
Sbjct: 311 LGASPYPNLSNQQTREFVEKG----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366
Query: 307 EHPWLQNAKK 316
           +   LQ+ +K
Sbjct: 367 QE--LQSIRK 374

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           +  ++G G FG  +      +   +A K + ++    A  +++  REVAIMK L ++ +I
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFH-AERVNEFLREVAIMKRL-RHPNI 96
Query: 115 VSLKEACEDDNAVHLVMELCEGGELF---DRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
           V    A      + +V E    G L+    +  AR    ER   ++   + + +   H  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 172 G--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPYYMAPEVLK 227
              ++HR+LK  N L   K     +K  DFGLS   K     S     G+P +MAPEVL+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYT---VKVCDFGLS-RLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 228 RNYGPE-IDIWSAGVILYIL 246
                E  D++S GVIL+ L
Sbjct: 213 DEPSNEKSDVYSFGVILWEL 232

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGFVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGAVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 20  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 71  MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 128
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 129 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 237

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 20  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 71  MGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 128
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 129 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 237

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 36/255 (14%)
Query: 42  AGVPKENIEDRYLV-DRELGRGEFGVTYL--CID---RDTRELLACKSISKRKLRTAVDI 95
           +G+  ++I+ R +V  RELG G FG  +L  C +      + L+A K++    L      
Sbjct: 5   SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--- 61
Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF--------DRIV--- 144
            D +RE  ++ +L ++  IV     C D + + +V E  + G+L         D ++   
Sbjct: 62  KDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 145 -----ARGHYTERAAAAVTRTIVE-VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
                A+G         +   I   +V L  +H  +HRDL   N L      N  +K  D
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVG---ANLLVKIGD 176
Query: 199 FGLS--IFFKPGERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
           FG+S  ++     R       P  +M PE ++ R +  E D+WS GVIL+ I   G  P+
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 254 WAESEQGVAQAILRG 268
           +  S   V + I +G
Sbjct: 237 FQLSNTEVIECITQG 251

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 37  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 88  MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 145
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 146 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 254

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 47  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 98  MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 155
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 156 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 264

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGLS   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 84  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 143
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 144 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 200
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 201 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 255
Query: 297 KLR 299
             R
Sbjct: 256 SRR 258

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 85  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 144
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 145 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 201
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 202 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 256
Query: 297 KLR 299
             R
Sbjct: 257 SRR 259

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 87  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 146
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 147 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 203
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 204 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 258
Query: 297 KLR 299
             R
Sbjct: 259 SRR 261

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 141
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 142 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 198
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 199 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 253
Query: 297 KLR 299
             R
Sbjct: 254 SRR 256

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 141
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 142 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 198
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 199 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 253
Query: 297 KLR 299
             R
Sbjct: 254 SRR 256

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 79  ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 138
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 139 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 195
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 196 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 250
Query: 297 KLR 299
             R
Sbjct: 251 SRR 253

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R +  + A+  +    +   +        +HRD+   N
Sbjct: 110 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 169
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 170 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 226
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 227 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 281
Query: 297 KLR 299
             R
Sbjct: 282 SRR 284

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGL+   +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R    + A+  +    +   +        +HRD+   N
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 522 VLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 297 KLR 299
             R
Sbjct: 634 SRR 636

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 32/232 (13%)
Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI----------DDVRREVAI 104
           +D+ +G GEFG   +C  R        K  SK+++  A+             D   E +I
Sbjct: 49  IDKVVGAGEFG--EVCSGR-------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIV 162
           M     + +I+ L+        V +V E  E G L D  + +    +T      + R I 
Sbjct: 100 MGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFSEIVGS-PY 219
             ++     G +HRDL   N L      N   K  DFGL    +  P   ++   G  P 
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 220 -YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + +PE +  R +    D+WS G++L+ ++  G  P+W  S Q V +A+  G
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 62
Query: 103 AIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +         ++ LVME    G L D +        RA    +R 
Sbjct: 63  QILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----RHRARLDASRL 116
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 117 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYV 172
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 75
Query: 103 AIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +         ++ LVME    G L D +        RA    +R 
Sbjct: 76  QILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----RHRARLDASRL 129
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYV 185
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 63
Query: 103 AIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +         ++ LVME    G L D +        RA    +R 
Sbjct: 64  QILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----RHRARLDASRL 117
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 118 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDYYV 173
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 120/329 (36%), Gaps = 74/329 (22%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSISK-RKLRTAVDIDDVRREVAIMK 106
           +++RY +   LG G FG    C+D    +  +A K I    K R A      R E+ ++K
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 103
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTR 159
            + +         V + +       + +  EL  G   F+ +       Y       +  
Sbjct: 104 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 162
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSI 203
            +   ++  H++ + H DLKPEN LF N +                +N+ ++  DFG + 
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 222
Query: 204 FFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE---- 258
           F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F         
Sbjct: 223 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 280
Query: 259 ---QGVAQAILRGLIDFKRDP---------WPNVSESAK--------------------- 285
              + +   I   +I   R           W   S   +                     
Sbjct: 281 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 340
Query: 286 ---SLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L+R+MLE DP  R+T  + L HP+ 
Sbjct: 341 QLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 49  IEDRYL-VDRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDID-DVRREV 102
            E+R+L    +LG+G FG   LC    +  +T  L+A K +      +  D   D +RE+
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ----HSGPDQQRDFQREI 59
Query: 103 AIMKHLPKNSSIVSLKEACEDDN--AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
            I+K L  +  IV  +          + LVME    G L D +        RA    +R 
Sbjct: 60  QILKAL-HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-----QRHRARLDASRL 113
Query: 161 IVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
           ++   Q+C           +HRDL   N L  ++     +K  DFGL+    P ++   +
Sbjct: 114 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLL-PLDKDXXV 169
Query: 215 VGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           V  P     ++ APE L  N +  + D+WS GV+LY L 
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 75/329 (22%), Positives = 122/329 (37%), Gaps = 74/329 (22%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSISK-RKLRTAVDIDDVRREVAIMK 106
           +++RY +   LG G FG    C+D    +  +A K I    K R A      R E+ ++K
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 80
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTR 159
            + +         V + +       + +  EL  G   F+ +       Y       +  
Sbjct: 81  KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 139
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSI 203
            +   ++  H++ + H DLKPEN LF N +                +N+ ++  DFG + 
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 199
Query: 204 FFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE---- 258
           F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F         
Sbjct: 200 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 257
Query: 259 ---QGVAQAILRGLIDFKRDP---------WPN-------VSESAK-------------- 285
              + +   I   +I   R           W         V E+ K              
Sbjct: 258 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 317
Query: 286 ---SLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L+R+MLE DP  R+T  + L HP+ 
Sbjct: 318 QLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGL------SIFFKPGERFSEI 214
                   +    +HRDL   N + A+   +  +K  DFG+      + +++ G +    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDF 272
           V    +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G    
Sbjct: 196 V---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + D   N  E    L+R   + +PK+R T  +++
Sbjct: 253 QPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 120/329 (36%), Gaps = 74/329 (22%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSISK-RKLRTAVDIDDVRREVAIMK 106
           +++RY +   LG G FG    C+D    +  +A K I    K R A      R E+ ++K
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 71
Query: 107 HLPKNSS-----IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTR 159
            + +         V + +       + +  EL  G   F+ +       Y       +  
Sbjct: 72  KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAIDFGLSI 203
            +   ++  H++ + H DLKPEN LF N +                +N+ ++  DFG + 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 204 FFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE---- 258
           F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F         
Sbjct: 191 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 259 ---QGVAQAILRGLIDFKRDP---------WPNVSESAK--------------------- 285
              + +   I   +I   R           W   S   +                     
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 286 ---SLVRQMLEPDPKLRLTAKQVLEHPWL 311
               L+R+MLE DP  R+T  + L HP+ 
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 22  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 78
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 79  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++        + K G+    
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 195 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 250
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +PK+R T  +++
Sbjct: 251 DQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++        + K G+    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 196 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +PK+R T  +++
Sbjct: 252 DQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIV 162
           +  + ++V+L  AC      + +++E C+ G L   + ++ +    Y E         + 
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 163 EVVQLCHKHGV------------IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
               +C+   V            IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 149 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 205
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 203
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 183
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 240
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 360 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 419
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 420 EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 477
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 534
Query: 218 PY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
           P  + APE +    +  + D+WS GV+++
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMW 563

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 127/335 (37%), Gaps = 78/335 (23%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS--KRKLRTAVDIDDVRREVAIMK 106
           + + +LV R++G G FG   LC   D ++  A K +   K+  R+A    D+ +++    
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
               N      K    D    H+ +     G     I+ R +Y       +    +E+++
Sbjct: 93  INNNNIVKYHGKFMYYD----HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 167 ---LCHKHGVIHRDLKPENFLFAN----------------------KKENSPLKAIDFGL 201
                 K  + H DLKPEN L  +                      + +++ +K IDFG 
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 202 SIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEI--DIWSAGVILYILLCGVPPFWAESE- 258
           + F    +    I+ +  Y APEV+  N G ++  D+WS G +L  L  G   F      
Sbjct: 209 ATF--KSDYHGSIINTRQYRAPEVI-LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 259 ------QGVAQAILRGLI--------------DFKRDPWPNVSESAKSL----------- 287
                 + + Q I + ++              D  +  WP  + S  S+           
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 288 ----------VRQMLEPDPKLRLTAKQVLEHPWLQ 312
                     +  +L+ DP LR +  ++L+H +L+
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 33/179 (18%)
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           + + H+ GV+HRDL P N L A   +N+ +   DF L+         +  V   +Y APE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTHRWYRAPE 203
Query: 225 VLK--RNYGPEIDIWSAGVILYIL-----LCGVPPFWAESEQGV---------------- 261
           ++   + +   +D+WSAG ++  +     L     F+ +  + V                
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 262 --AQAILRG-LIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             A+  LR  L +     W    P     A  L+ +MLE +P+ R++ +Q L HP+ ++
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R    + A+  +    +   +        +HRD+   N
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 141
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L ++   N  +K  DFGLS + +         G  P  +MAPE +  R +    D+W  
Sbjct: 142 VLVSS---NDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMF 198
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 199 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 253
Query: 297 KLR 299
             R
Sbjct: 254 SRR 256

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 361 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 420
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 421 EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 478
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 479 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 535
Query: 218 PY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
           P  + APE +    +  + D+WS GV+++
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMW 564

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 42/196 (21%)
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           R  A+++   ++ ++V L      D  + ++   C  G+L + +V R  +++  +    R
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136
Query: 160 TI---VEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
           T+   +E     H              H V+H+DL   N L  +K     +K  D GL  
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGL-- 191
Query: 204 FFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCG 249
                  F E+  + YY            MAPE ++   +  + DIWS GV+L+ +   G
Sbjct: 192 -------FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 244
Query: 250 VPPFWAESEQGVAQAI 265
           + P+   S Q V + I
Sbjct: 245 LQPYCGYSNQDVVEMI 260

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + ++ E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 33/179 (18%)
Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           + + H+ GV+HRDL P N L A   +N+ +   DF L+         +  V   +Y APE
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTHRWYRAPE 203
Query: 225 VLK--RNYGPEIDIWSAGVILYIL-----LCGVPPFWAESEQGV---------------- 261
           ++   + +   +D+WSAG ++  +     L     F+ +  + V                
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS 263
Query: 262 --AQAILRG-LIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             A+  LR  L +     W    P     A  L+ +MLE +P+ R++ +Q L HP+ ++
Sbjct: 264 PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 203
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + ++ E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 31/232 (13%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTRT 160
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +    E   A A+  +
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 161 IVEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
            +    L H                 IHRD+   N L  N       K  DFGL+     
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMN 216
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
              +  + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 DSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 42/196 (21%)
Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           R  A+++   ++ ++V L      D  + ++   C  G+L + +V R  +++  +    R
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 160 TI---VEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
           T+   +E     H              H V+H+DL   N L  +K     +K  D GL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGL-- 174
Query: 204 FFKPGERFSEIVGSPYY------------MAPE-VLKRNYGPEIDIWSAGVILY-ILLCG 249
                  F E+  + YY            MAPE ++   +  + DIWS GV+L+ +   G
Sbjct: 175 -------FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 227
Query: 250 VPPFWAESEQGVAQAI 265
           + P+   S Q V + I
Sbjct: 228 LQPYCGYSNQDVVEMI 243

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 35/273 (12%)
Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR---EVAIMKHLPKNSSI 114
           ELGRG +GV         R + + +  + +++R  V+  + +R   ++ I          
Sbjct: 41  ELGRGAYGVV-----EKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFT 95
Query: 115 VSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYT-ERAAAAVTRTIVEVVQLCH-K 170
           V+   A   +  V +  EL +    + + +++ +G    E     +  +IV+ ++  H K
Sbjct: 96  VTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 155
Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-----KPGERFSEIVGSPYYMAPEV 225
             VIHRD+KP N L     +   +K  DFG+S +      K  +   +   +P  + PE+
Sbjct: 156 LSVIHRDVKPSNVLINALGQ---VKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPEL 212
Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFKRDPWPNVSES 283
            ++ Y  + DIWS G+    L     P+  W    Q + Q +         +P P +   
Sbjct: 213 NQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV--------EEPSPQLPAD 264
Query: 284 AKS-----LVRQMLEPDPKLRLTAKQVLEHPWL 311
             S        Q L+ + K R T  ++ +HP+ 
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 31/232 (13%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTRT 160
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +    E   A A+  +
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 161 IVEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                 L H                 IHRD+   N L  N       K  DFGL+     
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMN 216
Query: 208 GERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
              +  + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 DSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 2   PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 61
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 62  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 176
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMW 205

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 8   PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 67
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 68  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 182
Query: 218 -PYYMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMW 211

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 16  PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 75
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 76  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 133
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 134 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 190
Query: 218 PY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
           P  + APE +    +  + D+WS GV+++
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMW 219

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K    +     + I     E  I K +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-----ESKIYKMM 61
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
                I +++    + +   +VMEL      +LF+    +  ++ +    +   ++  ++
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIE 119
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
             H    IHRD+KP+NFL    K+ + +  IDFGL+
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 18  PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 77
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 78  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 192
Query: 218 PY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
           P  + APE +    +  + D+WS GV+++
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 18  PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 77
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 78  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS- 217
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E +  ++  G  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKW 192
Query: 218 PY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
           P  + APE +    +  + D+WS GV+++
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMW 221

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K    +     + I     E  I K +
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-----ESKIYKMM 59
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
                I +++    + +   +VMEL      +LF+    +  ++ +    +   ++  ++
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIE 117
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
             H    IHRD+KP+NFL    K+ + +  IDFGL+
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V R +G G FGV +   +    + +A K   +R      D   +R E    K L   +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKH 171
            I ++    ++     LV++L  G  L D +   G  ++ +  A   + ++  VQ  H+ 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 172 GVIHRDLKPENFLFA--NKKENSPLKAIDFGLSIFFK--------PGERFSEIVGSPYYM 221
            +++RD+KP+NFL    N K  + +  +DFG+  F++        P      + G+  YM
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 222 APEV-LKRNYGPEIDIWSAGVILYILLCGVPPF 253
           +    L R      D+ + G +    L G  P+
Sbjct: 186 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R    + A+  +    +   +        +HRD+   N
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L +       +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 522 VLVS---ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 297 KLR 299
             R
Sbjct: 634 SRR 636

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 53  YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           Y V R +G G FGV +   +    + +A K   +R      D   +R E    K L   +
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 65
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKH 171
            I ++    ++     LV++L  G  L D +   G  ++ +  A   + ++  VQ  H+ 
Sbjct: 66  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 124
Query: 172 GVIHRDLKPENFLFA--NKKENSPLKAIDFGLSIFFK--------PGERFSEIVGSPYYM 221
            +++RD+KP+NFL    N K  + +  +DFG+  F++        P      + G+  YM
Sbjct: 125 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 184
Query: 222 APEV-LKRNYGPEIDIWSAGVILYILLCGVPPF 253
           +    L R      D+ + G +    L G  P+
Sbjct: 185 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G+GEFG   L   R  +  + C       ++          E ++M  L  ++ +  
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVI 174
           L    E+   +++V E    G L D + +RG         +  +  + E ++    +  +
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLK-RNYGP 232
           HRDL   N L +   E++  K  DFGL+   K      +    P  + APE L+ + +  
Sbjct: 140 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 233 EIDIWSAGVILY 244
           + D+WS G++L+
Sbjct: 194 KSDVWSFGILLW 205

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAV-TRTIVEVVQLCHKHGVIHRDLKPEN 182
           +N V ++MELC  GEL   +  R    + A+  +    +   +        +HRD+   N
Sbjct: 82  ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 141
Query: 183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS-PY-YMAPEVLK-RNYGPEIDIWSA 239
            L +       +K  DFGLS + +    +    G  P  +MAPE +  R +    D+W  
Sbjct: 142 VLVS---ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 198
Query: 240 GVILY-ILLCGVPPFWAESEQGVAQAILRGLI-DFKRDPW-PNVSESAKSLVRQMLEPDP 296
           GV ++ IL+ GV PF     QGV    + G I + +R P  PN   +  SL+ +    DP
Sbjct: 199 GVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 253
Query: 297 KLR 299
             R
Sbjct: 254 SRR 256

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + +++E C+ G L   +                + +   T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 203
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI---------------VARGHYTE 151
           +  + ++V+L  AC      + +++E C+ G L   +               + +   T 
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGE 209
                 +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P  
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDX 204
Query: 210 RFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                   P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI----------------VARGHYT 150
           +  + ++V+L  AC      + ++ E C+ G L   +                + +   T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPG 208
                  +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 194
Query: 209 ERFSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                    P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G+GEFG   L   R  +  + C       ++          E ++M  L  ++ +  
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVI 174
           L    E+   +++V E    G L D + +RG         +  +  + E ++    +  +
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLK-RNYGP 232
           HRDL   N L +   E++  K  DFGL+   K      +    P  + APE L+ + +  
Sbjct: 125 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 233 EIDIWSAGVILY 244
           + D+WS G++L+
Sbjct: 179 KSDVWSFGILLW 190

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++          K G+    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 196 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +PK+R T  +++
Sbjct: 252 DQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 20  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 76
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 77  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++          K G+    
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 193 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 248
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +PK+R T  +++
Sbjct: 249 DQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 43/284 (15%)
Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G +G  +  +     E +A K  S R  ++     ++   V +++H      I S  
Sbjct: 16  VGKGRYGEVWRGLWHG--ESVAVKIFSSRDEQSWFRETEIYNTV-LLRHDNILGFIASDM 72
Query: 119 EACEDDNAVHLVMELCEGGELFD---RIVARGHYTER----AAAAVTRTIVEVVQLCHKH 171
            +      + L+    E G L+D   R     H   R    AA  +    VE+     K 
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKP 132
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVL 226
            + HRD K  N L    K N      D GL++    G  + +I     VG+  YMAPEVL
Sbjct: 133 AIAHRDFKSRNVLV---KSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 227 KRNYGPE-------IDIWSAGVILY-----ILLCGV-----PPFWAESEQGVAQAILRGL 269
                 +        DIW+ G++L+      ++ G+     PPF+       +   ++ +
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKV 249
Query: 270 --IDFKRDPWPN------VSESAKSLVRQMLEPDPKLRLTAKQV 305
             +D +    PN      V      ++R+   P+P  RLTA ++
Sbjct: 250 VCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRI 293

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 20  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 70
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 71  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 128
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 129 AEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNE-YTAREGAKFPI 184
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 185 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 242
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 243 D---NCPEELYQLMRLCWKERPEDRPT 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 16  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 66
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 67  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 125 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 180
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 181 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 238
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 239 D---NCPEELYQLMRLCWKERPEDRPT 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 15  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 65
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 66  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 123
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 124 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 179
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 180 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 237
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 238 D---NCPEELYQLMRLCWKERPEDRPT 261

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 14/209 (6%)
Query: 45  PKENIEDRYLV---DRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           PKE   DR L+   D+ELG G FG V                 I K +       D++  
Sbjct: 2   PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 61
Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  +M+ L  N  IV +   CE ++ + LVME+ E G L   +    H  ++    +   
Sbjct: 62  EANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-FSEIVGSPY 219
           +   ++   +   +HRDL   N L   +      K  DFGLS   +  E  +       +
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENXYKAQTHGKW 176
Query: 220 ---YMAPEVLK-RNYGPEIDIWSAGVILY 244
              + APE +    +  + D+WS GV+++
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMW 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 25/234 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+I+   LV R LG G+FG  ++    ++ ++ A K++    +     ++    E  
Sbjct: 10  IPRESIK---LVKR-LGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTI 161
           +MK L ++  +V L      +  ++++ E    G L D + +   G          +  I
Sbjct: 61  LMKTL-QHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI 119
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L +   E+   K  DFGL+   +  E ++   G+ +  
Sbjct: 120 AEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPI 175
Query: 220 -YMAPEVLKRNYG---PEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            + APE +  N+G    + D+WS G++LY I+  G  P+   +   V  A+ +G
Sbjct: 176 KWTAPEAI--NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG 227

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           + +G+GEFG   L   R  +  + C       ++          E ++M  L  ++ +  
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRTIVEVVQLCHKHGVI 174
           L    E+   +++V E    G L D + +RG         +  +  + E ++    +  +
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-YMAPEVLK-RNYGP 232
           HRDL   N L +   E++  K  DFGL+   K      +    P  + APE L+ + +  
Sbjct: 312 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 233 EIDIWSAGVILY 244
           + D+WS G++L+
Sbjct: 366 KSDVWSFGILLW 377

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 65/144 (45%), Gaps = 9/144 (6%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY V R+LG G F   +LC D   +  +A K +   +  T   +D+++    + +  P +
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 112 SSIVSLKEACED-----DNAVHLVMELCEGGELFDRIVARGHYTE---RAAAAVTRTIVE 163
            +   + +  +D      N +H+ M     G    + + + +Y     R   ++ R +++
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQ 151
Query: 164 VVQLCH-KHGVIHRDLKPENFLFA 186
            +   H K  +IH D+KPEN L  
Sbjct: 152 GLDYLHSKCKIIHTDIKPENILMC 175

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           +V + +  E D  +++   L  G +L   +  +G      A A+ R I   +   H  G 
Sbjct: 96  VVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVLKRNY 230
            HRD+KPEN L +    +     +DFG++      E+ +++   VG+ YY APE    ++
Sbjct: 156 THRDVKPENILVS---ADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYXAPERFSESH 211
Query: 231 GP-EIDIWSAGVILYILLCGVPPFWAE 256
                DI++   +LY  L G PP+  +
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGD 238

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 5   VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 55
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 56  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 113
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E ++   G+ +  
Sbjct: 114 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNE-YTAREGAKFPI 169
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 170 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 227
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 228 D---NCPEELYQLMRLCWKERPEDRPT 251

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +    ++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI------------VARGHYTERAA 154
           +  + ++V+L  AC      + +++E C+ G L   +            + +   T    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFS 212
              +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P     
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 213 EIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 18  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 68
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 69  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 126
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 127 AEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAR-EGAKFPI 182
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 183 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 240
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 241 D---NCPEELYQLMRLCWKERPEDRPT 264

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++   K  +     D +RE  ++  L ++ 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML-QHQ 103
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA----------------AA 156
            IV     C +   + +V E    G+L   + + G   +  A                A 
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEI 214
            ++    +V L   H  +HRDL   N L     +   +K  DFG+S  I+     R    
Sbjct: 164 ASQVAAGMVYLAGLH-FVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 215 VGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL-I 270
              P  +M PE +L R +  E D+WS GV+L+ I   G  P++  S       I +G  +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  R   P V     +++R   + +P+ R + K V  H  LQ   +AP V L
Sbjct: 280 ERPRACPPEV----YAIMRGCWQREPQQRHSIKDV--HARLQALAQAPPVYL 325

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 24  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 80
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 81  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HR+L   N + A+   +  +K  DFG++        + K G+    
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 197 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 252
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +P +R T  +++
Sbjct: 253 DQPD---NCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 119/275 (43%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HR+L   N + A+   +  +K  DFG++        + K G+    
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 196 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +P +R T  +++
Sbjct: 252 DQPD---NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + ++Y + R++G G FG  YL  +  + E +A K    +     + I     E    K +
Sbjct: 7   VGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHI-----ESKFYKMM 61
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
                I S+K    + +   +VMEL      +LF+    +  ++ +    +   ++  ++
Sbjct: 62  QGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIE 119
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
             H    IHRD+KP+NFL    K+ + +  IDFGL+
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 16  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 66
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 67  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 125 AEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAR-EGAKFPI 180
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 181 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 238
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 239 D---NCPEELYQLMRLCWKERPEDRPT 262

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +    ++++ + L+      + R    E+ I+ H
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI------------VARGHYTERAA 154
           +  + ++V+L  AC      + +++E C+ G L   +            + +   T    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFS 212
              +  + + ++       IHRDL   N L +   E + +K  DFGL+  I+  P     
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRK 203
Query: 213 EIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++   K  +     D +RE  ++  L ++ 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML-QHQ 80
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA----------------AA 156
            IV     C +   + +V E    G+L   + + G   +  A                A 
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEI 214
            ++    +V L   H  +HRDL   N L     +   +K  DFG+S  I+     R    
Sbjct: 141 ASQVAAGMVYLAGLH-FVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 215 VGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL-I 270
              P  +M PE +L R +  E D+WS GV+L+ I   G  P++  S       I +G  +
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 256
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  R   P V     +++R   + +P+ R + K V  H  LQ   +AP V L
Sbjct: 257 ERPRACPPEVY----AIMRGCWQREPQQRHSIKDV--HARLQALAQAPPVYL 302

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 58  ELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           ELG G FG  +L      +    + L+A K++   K  +     D +RE  ++  L ++ 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTML-QHQ 74
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA----------------AA 156
            IV     C +   + +V E    G+L   + + G   +  A                A 
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEI 214
            ++    +V L   H  +HRDL   N L     +   +K  DFG+S  I+     R    
Sbjct: 135 ASQVAAGMVYLAGLH-FVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 215 VGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL-I 270
              P  +M PE +L R +  E D+WS GV+L+ I   G  P++  S       I +G  +
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 250
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  R   P V     +++R   + +P+ R + K V  H  LQ   +AP V L
Sbjct: 251 ERPRACPPEVY----AIMRGCWQREPQQRHSIKDV--HARLQALAQAPPVYL 296

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 19  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 69
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 70  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 127
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 128 AEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAR-EGAKFPI 183
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 184 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 241
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 242 D---NCPEELYQLMRLCWKERPEDRPT 265

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 118/275 (42%), Gaps = 39/275 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR------REVAIMKHLPK 110
           RELG+G FG+ Y   + + R+++  ++ ++  ++T  +   +R       E ++MK    
Sbjct: 23  RELGQGSFGMVY---EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 79
Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC-- 168
           +  +V L           +VMEL   G+L   + +     E        T+ E++Q+   
Sbjct: 80  H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 169 --------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFFKPGERFSE 213
                   +    +HRDL   N + A+   +  +K  DFG++          K G+    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLID 271
           +     +MAPE LK   +    D+WS GV+L+ I      P+   S + V + ++ G   
Sbjct: 196 V----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            + D   N  E    L+R   + +P +R T  +++
Sbjct: 252 DQPD---NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAR-EGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +     ++  D    E  
Sbjct: 11  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEAN 61
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 62  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 119
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 120 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 175
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 176 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 233
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 234 D---NCPEELYQLMRLCWKERPEDRPT 257

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +ELG G+FGV  L   +   + +A K I +  +      D+  +E   M  L  +  +V 
Sbjct: 14  KELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSE----DEFFQEAQTMMKL-SHPKLVK 67
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA-VTRTIVEVVQLCHKHGVIH 175
               C  +  +++V E    G L + + + G   E +    +   + E +     H  IH
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY---YMAPEVLKR-NYG 231
           RDL   N L      +  +K  DFG++ +    +  S  VG+ +   + APEV     Y 
Sbjct: 128 RDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVFHYFKYS 183
Query: 232 PEIDIWSAGVILY-ILLCGVPPF 253
            + D+W+ G++++ +   G  P+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 12  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 62
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 63  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 120
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 121 AEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEXTAR-EGAKFPI 176
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 177 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 234
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 235 D---NCPEELYQLMRLCWKERPEDRPT 258

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+FG  ++    +    +A KS+ +  +      D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEXTAR-EGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 11/197 (5%)
Query: 54  LVDRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           L D+ELG G FG V                 I K +       D++  E  +M+ L  N 
Sbjct: 8   LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP 66
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV +   CE ++ + LVME+ E G L   +    H  ++    +   +   ++   +  
Sbjct: 67  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS--PYYMAPEVLK- 227
            +HRDL   N L   +      K  DFGLS   +  E +  ++  G     + APE +  
Sbjct: 126 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 228 RNYGPEIDIWSAGVILY 244
             +  + D+WS GV+++
Sbjct: 183 YKFSSKSDVWSFGVLMW 199

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 9/144 (6%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY V R+LG G F   +L  D   ++ +A K +   +  T   +D++R   ++    P +
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 112 SSIVSLKEACEDD-----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +   + +  +D      N  H+ M     G    + + + +Y       V + I +V+Q
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 141
Query: 167 ----LCHKHGVIHRDLKPENFLFA 186
               L  K  +IH D+KPEN L +
Sbjct: 142 GLDYLHTKCRIIHTDIKPENILLS 165

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 9/144 (6%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           RY V R+LG G F   +L  D   ++ +A K +   +  T   +D++R   ++    P +
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 112 SSIVSLKEACEDD-----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            +   + +  +D      N  H+ M     G    + + + +Y       V + I +V+Q
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 167 ----LCHKHGVIHRDLKPENFLFA 186
               L  K  +IH D+KPEN L +
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLS 181

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 36  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 91
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR---------GHYTE- 151
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +         G   E 
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           R     +  + + +        IHRD+   N L  N       K  DFGL+        +
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMNDSNY 208
Query: 212 SEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
             + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 209 I-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 11/197 (5%)
Query: 54  LVDRELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           L D+ELG G FG V                 I K +       D++  E  +M+ L  N 
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP 68
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            IV +   CE ++ + LVME+ E G L   +    H  ++    +   +   ++   +  
Sbjct: 69  YIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGS--PYYMAPEVLK- 227
            +HRDL   N L   +      K  DFGLS   +  E +  ++  G     + APE +  
Sbjct: 128 FVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 228 RNYGPEIDIWSAGVILY 244
             +  + D+WS GV+++
Sbjct: 185 YKFSSKSDVWSFGVLMW 201

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 27/228 (11%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR---------GHYTE- 151
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +         G   E 
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           R     +  + + +        IHRD+   N L  N       K  DFGL+        +
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDIMNDSNY 216
Query: 212 SEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
             + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 I-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 16/90 (17%)
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPGERFSEI---VGSPYYMAP 223
           HK  + HRD K +N L       S L A+  DFGL++ F+PG+   +    VG+  YMAP
Sbjct: 140 HKPSIAHRDFKSKNVLL-----KSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 224 EVL------KRNYGPEIDIWSAGVILYILL 247
           EVL      +R+    ID+++ G++L+ L+
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 13/180 (7%)
Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAA 154
           D   E +IM     + +I+ L+          +V E  E G L  F R    G +T    
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQL 153
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFS 212
             + R +   ++     G +HRDL   N L      N   K  DFGLS   +  P   ++
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 213 EIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
              G  P  + APE +  R +    D+WS GV+++ +L  G  P+W  + + V  ++  G
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 96/239 (40%), Gaps = 40/239 (16%)
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER- 152
           D  D   E+ ++  L  + +I++L  ACE    ++L +E    G L D  + +    E  
Sbjct: 68  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETD 126
Query: 153 ---AAAAVTRTIVEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKA 196
              A A  T + +   QL H             +   IHRDL   N L     EN   K 
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKI 183
Query: 197 IDFGLSIFFKPGERFSEIVGSPY-------YMAPEVLKRN-YGPEIDIWSAGVILY-ILL 247
            DFGLS       R  E+            +MA E L  + Y    D+WS GV+L+ I+ 
Sbjct: 184 ADFGLS-------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G  P+   +   + + + +G   ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 237 LGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 40/241 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+EN+E      + LG G FG           +      ++ + L+   D  +   +  E
Sbjct: 43  PRENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRT 160
           + +M  L  + +IV+L  AC     ++L+ E C  G+L + + + R  ++E       + 
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 161 IVEVVQ----------LCHKHGV------------IHRDLKPENFLFANKKENSPLKAID 198
            +E  +          LC  + V            +HRDL   N L  + K    +K  D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICD 215
Query: 199 FGLSIFFKPGERFSEIVGSP----YYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPP 252
           FGL+        +  + G+      +MAPE L    Y  + D+WS G++L+ I   GV P
Sbjct: 216 FGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 253 F 253
           +
Sbjct: 275 Y 275

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 96/239 (40%), Gaps = 40/239 (16%)
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER- 152
           D  D   E+ ++  L  + +I++L  ACE    ++L +E    G L D  + +    E  
Sbjct: 58  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETD 116
Query: 153 ---AAAAVTRTIVEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKA 196
              A A  T + +   QL H             +   IHRDL   N L     EN   K 
Sbjct: 117 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKI 173
Query: 197 IDFGLSIFFKPGERFSEIVGSPY-------YMAPEVLKRN-YGPEIDIWSAGVILY-ILL 247
            DFGLS       R  E+            +MA E L  + Y    D+WS GV+L+ I+ 
Sbjct: 174 ADFGLS-------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            G  P+   +   + + + +G   ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 227 LGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 72
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 73  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 188
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 189 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D   N  +    L+R   + +PK+R +  +++
Sbjct: 245 FVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 67  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 182
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 183 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 239 FVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 278

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 16  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 70
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 71  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 130 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 186
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 187 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 243 FVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 282

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 73
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 74  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 189
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 190 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 246 FVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 285

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 53/288 (18%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 47  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 101
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 102 SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 161 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 208
Query: 213 EIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
           +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+   S 
Sbjct: 209 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 268
Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           + V + ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 269 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 313

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 79
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 195
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 196 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D   N  +    L+R   + +PK+R +  +++
Sbjct: 252 FVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 12/87 (13%)
Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEV 225
           HK  + HRD+K +N L  N   N      DFGL++ F+ G+   +    VG+  YMAPEV
Sbjct: 148 HKPAISHRDIKSKNVLLKN---NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 226 L------KRNYGPEIDIWSAGVILYIL 246
           L      +R+    ID+++ G++L+ L
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 18  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 72
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 73  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 188
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 189 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 245 FVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 284

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +    ++++ + L+      + R    E+ I+ H
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 108 LPKNSSIVSLKEACEDDNA-VHLVMELCEGGELFDRI--------------VARGHYTER 152
           +  + ++V+L  AC      + +++E C+ G L   +              + +   T  
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 153 AAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGER 210
                +  + + ++       IHRDL   N L +   E + +K  DFGL+  I   P   
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXV 205
Query: 211 FSEIVGSPY-YMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
                  P  +MAPE +  R Y  + D+WS GV+L+ I   G  P+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 39/237 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 44  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-----------GHYT 150
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +  +            H  
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNP 159
Query: 151 ERAAAA-----VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL---- 201
           E   ++      +  + + +        IHRD+   N L  N       K  DFGL    
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLARDI 216
Query: 202 ---SIFFKPGERFSEIVGSPYYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPPF 253
              S +   G     +     +MAPE +    Y  + D+WS G++L+ I   G+ P+
Sbjct: 217 MNDSNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 109/265 (41%), Gaps = 49/265 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N + ++L+    G G FG  Y  + RD       K   KR+   +    +          
Sbjct: 40  NFDHKFLI----GHGVFGKVYKGVLRD-----GAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
             ++  +VSL   C++ N + L+ +  E G L      + H        ++ +  + +++
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNL------KRHLYGSDLPTMSMSWEQRLEI 144
Query: 168 C----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---- 213
           C          H   +IHRD+K  N L     EN   K  DFG+S   K G    +    
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGIS---KKGTELGQTHLX 198
Query: 214 --IVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
             + G+  Y+ PE  +K     + D++S GV+L+ +LC        +   + Q++ R ++
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC--------ARSAIVQSLPREMV 250
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPD 295
           +     W   S +   L  Q+++P+
Sbjct: 251 NLAE--WAVESHNNGQL-EQIVDPN 272

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/265 (22%), Positives = 109/265 (41%), Gaps = 49/265 (18%)
Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N + ++L+    G G FG  Y  + RD       K   KR+   +    +          
Sbjct: 40  NFDHKFLI----GHGVFGKVYKGVLRD-----GAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
             ++  +VSL   C++ N + L+ +  E G L      + H        ++ +  + +++
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNL------KRHLYGSDLPTMSMSWEQRLEI 144
Query: 168 C----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---- 213
           C          H   +IHRD+K  N L     EN   K  DFG+S   K G    +    
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGIS---KKGTELDQTHLX 198
Query: 214 --IVGSPYYMAPE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI 270
             + G+  Y+ PE  +K     + D++S GV+L+ +LC        +   + Q++ R ++
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC--------ARSAIVQSLPREMV 250
Query: 271 DFKRDPWPNVSESAKSLVRQMLEPD 295
           +     W   S +   L  Q+++P+
Sbjct: 251 NLAE--WAVESHNNGQL-EQIVDPN 272

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 102/267 (38%), Gaps = 58/267 (21%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDID---DVRRE 101
           P+ NIE  Y+  R++G G FG  +               ++ + L+     D   D +RE
Sbjct: 45  PRNNIE--YV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT----------- 150
            A+M     N +IV L   C     + L+ E    G+L + + +   +T           
Sbjct: 101 AALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 151 -ERAAAAVTRTIVEVVQLCHKHGV------------IHRDLKPENFLFANKKENSPLKAI 197
             R ++     +    QLC    V            +HRDL   N L     EN  +K  
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIA 216
Query: 198 DFGLSIFFKPGERFSEIVGSPYY------------MAPEVLKRN-YGPEIDIWSAGVILY 244
           DFGLS           I  + YY            M PE +  N Y  E D+W+ GV+L+
Sbjct: 217 DFGLS---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 245 -ILLCGVPPFWAESEQGVAQAILRGLI 270
            I   G+ P++  + + V   +  G I
Sbjct: 268 EIFSYGLQPYYGMAHEEVIYYVRDGNI 294

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTER- 152
           D  D   E+ ++  L  + +I++L  ACE    ++L +E    G L D  + +    E  
Sbjct: 65  DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETD 123
Query: 153 ---AAAAVTRTIVEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKA 196
              A A  T + +   QL H             +   IHR+L   N L     EN   K 
Sbjct: 124 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVG---ENYVAKI 180
Query: 197 IDFGLS----IFFKPGERFSEIVGS--PYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLC 248
            DFGLS    ++ K      + +G     +MA E L  + Y    D+WS GV+L+ I+  
Sbjct: 181 ADFGLSRGQEVYVK------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 234
Query: 249 GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
           G  P+   +   + + + +G   ++ +   N  +    L+RQ     P  R +  Q+L
Sbjct: 235 GGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 124/283 (43%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 10  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 64
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 65  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 124 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 180
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 181 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D   N  +    L+R   + +PK+R +  +++
Sbjct: 237 FVMEGGLLDKPD---NCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 13/180 (7%)
Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIVARGHYTERAA 154
           D   E +IM     + +I+ L+          +V E  E G L  F R    G +T    
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQL 153
Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK--PGERFS 212
             + R +   ++     G +HRDL   N L      N   K  DFGLS   +  P    +
Sbjct: 154 VGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 213 EIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
              G  P  + APE +  R +    D+WS GV+++ +L  G  P+W  + + V  ++  G
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 124/283 (43%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 12  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 66
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 67  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N   A   E+  +K  DFG++        + 
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMTRDIYETDYYR 182
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 183 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D   N  +    L+R   + +PK+R +  +++
Sbjct: 239 FVMEGGLLDKPD---NCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++       ++ ++    E 
Sbjct: 185 IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKP----GSMSVEAFLAEA 234
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 235 NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY- 219
           I E +    +   IHRDL+  N L +    +   K  DFGL+   +  E ++   G+ + 
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFP 348
Query: 220 --YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFK 273
             + APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG     
Sbjct: 349 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---- 402
Query: 274 RDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQV 305
           R P P N  E   +++ +  +  P+ R T + +
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYI 435

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 112/235 (47%), Gaps = 28/235 (11%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++       ++ ++    E 
Sbjct: 12  IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKP----GSMSVEAFLAEA 61
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 62  NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 119
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY- 219
           I E +    +   IHRDL+  N L +    +   K  DFGL+   +  E ++   G+ + 
Sbjct: 120 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFP 175
Query: 220 --YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
             + APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG
Sbjct: 176 IKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 40/241 (16%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRRE 101
           P+ N++      + LG G FG           +  A   ++ + L++    D+   +  E
Sbjct: 29  PRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 84
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-----------VARGHYT 150
           + IM HL ++ +IV+L  AC     V ++ E C  G+L + +           +A G   
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 151 E------------RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
           E            R     +  + + +        IHRD+   N L  N       K  D
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGD 201
Query: 199 FGLSIFFKPGERFSEIVGSP----YYMAPE-VLKRNYGPEIDIWSAGVILY-ILLCGVPP 252
           FGL+        +  + G+      +MAPE +    Y  + D+WS G++L+ I   G+ P
Sbjct: 202 FGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 260
Query: 253 F 253
           +
Sbjct: 261 Y 261

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 79/315 (25%), Positives = 129/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 63
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+  L  + +IV             +++EL  GG+
Sbjct: 64  VAVKTLPE--VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 121 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 179
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 180 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 240 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 296
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 297 LER--IEYCTQDPDV 309

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 19  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 73
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +     E        ++ 
Sbjct: 74  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++          
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 189
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 190 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D  P++      L+R   + +PK+R +  +++
Sbjct: 246 FVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 285

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/283 (21%), Positives = 124/283 (43%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 79
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +              ++ 
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 195
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 196 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D   N  +    L+R   + +PK+R +  +++
Sbjct: 252 FVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +++ + R++G G FG  YL  +  T E +A K +   K +       +  E  I + L
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHP----QLLYESKIYRIL 59
Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTRTIVEVVQ 166
              + I +++    + +   LVM+L  G  L D     +R   + +    +   ++  V+
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVE 117
Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
             H    +HRD+KP+NFL    +  + +  IDFGL+
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 115/267 (43%), Gaps = 29/267 (10%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++   LV+R LG G+ G  ++    +    +A KS+ +  +      D    E  
Sbjct: 10  VPRETLK---LVER-LGAGQAGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEAN 60
Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTI 161
           +MK L ++  +V L  A      ++++ E  E G L D +        T      +   I
Sbjct: 61  LMKQL-QHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY-- 219
            E +    +   IHRDL+  N L ++       K  DFGL+   +  E  +   G+ +  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDAEXTAR-EGAKFPI 174
Query: 220 -YMAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
            + APE +  NYG    + D+WS G++L  I+  G  P+   +   V Q + RG    + 
Sbjct: 175 KWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLT 301
           D   N  E    L+R   +  P+ R T
Sbjct: 233 D---NCPEELYQLMRLCWKERPEDRPT 256

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 42/232 (18%)
Query: 42  AGVP---KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV 98
           +G+P   +  I    ++   +G+G FG  +    R   E +A K  S R+ R+     ++
Sbjct: 17  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEI 74
Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAA 154
            + V +     ++ +I+    A   DN     + LV +  E G LFD +     YT    
Sbjct: 75  YQTVML-----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVE 126
Query: 155 AAVTRTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
             +   +     L H H           + HRDLK +N L    K+N      D GL++ 
Sbjct: 127 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVR 183
Query: 205 FKPGERFSEI-----VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
                   +I     VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 184 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 42/232 (18%)
Query: 42  AGVP---KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV 98
           +G+P   +  I    ++   +G+G FG  +    R   E +A K  S R+ R+     ++
Sbjct: 30  SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEI 87
Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAA 154
            + V +     ++ +I+    A   DN     + LV +  E G LFD +     YT    
Sbjct: 88  YQTVML-----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVE 139
Query: 155 AAVTRTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
             +   +     L H H           + HRDLK +N L    K+N      D GL++ 
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVR 196
Query: 205 FKPGERFSEI-----VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
                   +I     VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 126/304 (41%), Gaps = 37/304 (12%)
Query: 46  KENIED------RYLVDRELGRGEFGVT--YLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           KE +ED      ++ + R LG+GEFG          D   +     + K  +  + DI++
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71
Query: 98  VRREVAIMKHL--PKNSSI--VSLKEACEDDNAVHLV-MELCEGGELFDRIVAR---GHY 149
             RE A MK    P  + +  VSL+   +    + +V +   + G+L   ++A     + 
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 150 TERAAAAVTRTIVEV---VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
                  + R +V++   ++       IHRDL   N + A   E+  +   DFGLS    
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIY 188
Query: 207 PGERFSEIVGSPY---YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGV 261
            G+ + +   S     ++A E L  N Y    D+W+ GV ++ I+  G  P+       +
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPK-------LRLTAKQVLEHPWLQNA 314
              ++ G  +  + P P   E    L+ Q    DPK       LR+  + +L H  + + 
Sbjct: 249 YNYLIGG--NRLKQP-PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305
Query: 315 KKAP 318
            + P
Sbjct: 306 SQDP 309

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G     I    ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V
Sbjct: 1   GAMGSTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTV 58
Query: 103 AIMKHLPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
            +     ++ +I+    A   DN     + LV +  E G LFD +     YT      + 
Sbjct: 59  ML-----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIK 110
Query: 159 RTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +     L H H           + HRDLK +N L    K+N      D GL++     
Sbjct: 111 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSA 167
Query: 209 ERFSEI-----VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
               +I     VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 168 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/71 (33%), Positives = 39/71 (54%)
Query: 319 NVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDE 378
           +V L   +   LK F   N  K+ AL +IA+ L   E+ +++ +F  +D DN G +S+ E
Sbjct: 19  HVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQE 78
Query: 379 LKAGLRNFGSQ 389
           +  GL+  G Q
Sbjct: 79  ILDGLKKIGYQ 89

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/283 (21%), Positives = 124/283 (43%), Gaps = 43/283 (15%)
Query: 51  DRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISK-RKLRTAVDIDDVRREV 102
           ++  + RELG+G FG+ Y  + +       +TR  +A K++++   +R  ++  +   E 
Sbjct: 15  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETR--VAIKTVNEAASMRERIEFLN---EA 69
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           ++MK       +V L           ++MEL   G+L   + +              ++ 
Sbjct: 70  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 163 EVVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------IFF 205
           +++Q+           + +  +HRDL   N + A   E+  +K  DFG++        + 
Sbjct: 129 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 185
Query: 206 KPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
           K G+    +     +M+PE LK   +    D+WS GV+L+ I      P+   S + V +
Sbjct: 186 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
            ++ G +  K D   N  +    L+R   + +PK+R +  +++
Sbjct: 242 FVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 26/268 (9%)
Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            YL  ++LG G F    L          A K I   + +   D ++ +RE A M  L  +
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQRE-ADMHRLFNH 85
Query: 112 SSIVSLKEAC-EDDNAVH---LVMELCEGGELFD---RIVARGHY-TERAAAAVTRTIVE 163
            +I+ L   C  +  A H   L++   + G L++   R+  +G++ TE     +   I  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER-------FSEIVG 216
            ++  H  G  HRDLKP N L  ++ +   +       +     G R       ++    
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 217 SPYYMAPEVLKRNYGPEI----DIWSAGVILYILLCGVPPFWAESEQGVAQAI-LRGLID 271
           +  Y APE+        I    D+WS G +LY ++ G  P+    ++G + A+ ++  + 
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLR 299
             +   P  S +   L+  M+  DP  R
Sbjct: 266 IPQS--PRHSSALWQLLNSMMTVDPHQR 291

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 31/307 (10%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 30  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 85
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIV 144
             + +  D  D   E  I+     + +IV             ++MEL  GG+L  F R  
Sbjct: 86  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR-E 141
Query: 145 ARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
            R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  D
Sbjct: 142 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 199 FGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
           FG++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 262 PSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 316
Query: 314 AKKAPNV 320
             + P+V
Sbjct: 317 CTQDPDV 323

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-DRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++    ++++LG G+FG  ++   ++ T+  +A K++       ++ ++    E 
Sbjct: 179 IPRESLK----LEKKLGAGQFGEVWMATYNKHTK--VAVKTMKP----GSMSVEAFLAEA 228
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TRT 160
            +MK L ++  +V L  A      ++++ E    G L D + +     +     +  +  
Sbjct: 229 NVMKTL-QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 286
Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           I E +    +   IHRDL+  N L +    +   K  DFGL+   + G +F        +
Sbjct: 287 IAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLA---RVGAKF-----PIKW 335
Query: 221 MAPEVLKRNYGP---EIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
            APE +  N+G    + D+WS G++L  I+  G  P+   S   V +A+ RG
Sbjct: 336 TAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 385

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 93
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 153
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 154 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 251

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 96
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 156
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 157 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 254

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 154
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 215 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 31/307 (10%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 15  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIV 144
             + +  D  D   E  I+     + +IV             ++MEL  GG+L  F R  
Sbjct: 71  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR-E 126
Query: 145 ARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
            R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  D
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 199 FGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
           FG++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 247 PSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 301
Query: 314 AKKAPNV 320
             + P+V
Sbjct: 302 CTQDPDV 308

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 126/307 (41%), Gaps = 31/307 (10%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 30  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 85
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIV 144
             + +  D  D   E  I+  L  + +IV             +++EL  GG+L  F R  
Sbjct: 86  --VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-E 141
Query: 145 ARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
            R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  D
Sbjct: 142 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 199 FGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
           FG++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 262 PSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 316
Query: 314 AKKAPNV 320
             + P+V
Sbjct: 317 CTQDPDV 323

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 100
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 160
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K  +      G+     +MA E L+ +
Sbjct: 161 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 218 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 258

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 114/269 (42%), Gaps = 39/269 (14%)
Query: 56  DRELGRGEFGVTYL--CIDR-DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           DR +G+G FGV Y    ID+   R   A KS+S  ++     ++   RE  +M+ L   +
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNHPN 83
Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKH 171
            +  +      +   H+++     G+L   I + + + T +   +    +   ++   + 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY----------- 220
             +HRDL   N +     E+  +K  DFGL+          +I+   YY           
Sbjct: 144 KFVHRDLAARNCML---DESFTVKVADFGLA---------RDILDREYYSVQQHRHARLP 191
Query: 221 ---MAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRD 275
               A E L+   +  + D+WS GV+L+ LL  G PP+       +   + +G    +R 
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG----RRL 247
Query: 276 PWPNVS-ESAKSLVRQMLEPDPKLRLTAK 303
           P P    +S   +++Q  E DP +R T +
Sbjct: 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFR 276

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V +     ++ +
Sbjct: 6   VLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVML-----RHEN 58
Query: 114 IVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           I+    A   DN     + LV +  E G LFD +     YT      +   +     L H
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAH 115
Query: 170 KH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----- 214
            H           + HRDLK +N L    K+N      D GL++         +I     
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 215 VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
           VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 14  DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 69
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 70  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 126
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 127 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 185
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 186 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 246 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 302
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 303 LER--IEYCTQDPDV 315

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V +     ++ +
Sbjct: 9   VLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVML-----RHEN 61
Query: 114 IVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           I+    A   DN     + LV +  E G LFD +     YT      +   +     L H
Sbjct: 62  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAH 118
Query: 170 KH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----- 214
            H           + HRDLK +N L    K+N      D GL++         +I     
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHR 175
Query: 215 VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
           VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)
Query: 54  LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS 113
           ++   +G+G FG  +    R   E +A K  S R+ R+     ++ + V +     ++ +
Sbjct: 7   VLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVML-----RHEN 59
Query: 114 IVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           I+    A   DN     + LV +  E G LFD +     YT      +   +     L H
Sbjct: 60  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAH 116
Query: 170 KH----------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----- 214
            H           + HRDLK +N L    K+N      D GL++         +I     
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHR 173
Query: 215 VGSPYYMAPEVLKRNYG-------PEIDIWSAGVILY 244
           VG+  YMAPEVL  +            DI++ G++ +
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 34  DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 89
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 90  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 146
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 147 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 205
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 206 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 266 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 322
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 323 LER--IEYCTQDPDV 335

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 63
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 64  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 121 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 179
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 180 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 240 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 296
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 297 LER--IEYCTQDPDV 309

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+    + A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 63
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 64  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 121 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 179
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 180 GRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 240 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 296
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 297 LER--IEYCTQDPDV 309

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 125/307 (40%), Gaps = 31/307 (10%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 30  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 85
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIV 144
             + +  D  D   E  I+     + +IV             +++EL  GG+L  F R  
Sbjct: 86  --VYSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-E 141
Query: 145 ARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
            R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  D
Sbjct: 142 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 199 FGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
           FG++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 262 PSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 316
Query: 314 AKKAPNV 320
             + P+V
Sbjct: 317 CTQDPDV 323

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 103/246 (41%), Gaps = 46/246 (18%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRRE 101
           P++N+    ++ + LG GEFG          +      +++ + L+   +  ++ D+  E
Sbjct: 21  PRKNL----VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF-----DRIVARG--------- 147
             ++K +  +  ++ L  AC  D  + L++E  + G L       R V  G         
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 148 -----HYTERAAA-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                H  ERA       +    I + +Q   +  ++HRDL   N L A   E   +K  
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKIS 192
Query: 198 DFGLSIFFKPGERF---SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC----- 248
           DFGLS      + +   S+      +MA E L  + Y  + D+WS GV+L+ ++      
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 249 --GVPP 252
             G+PP
Sbjct: 253 YPGIPP 258

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 54/250 (21%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRRE 101
           P++N+    ++ + LG GEFG          +      +++ + L+   +  ++ D+  E
Sbjct: 21  PRKNL----VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF-----DRIVARG--------- 147
             ++K +  +  ++ L  AC  D  + L++E  + G L       R V  G         
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 148 -----HYTERAAA-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                H  ERA       +    I + +Q   +  ++HRDL   N L A   E   +K  
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKIS 192
Query: 198 DFGLS--IFFKPGERFSEIVGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILLC- 248
           DFGLS  ++    E  S +  S       +MA E L  + Y  + D+WS GV+L+ ++  
Sbjct: 193 DFGLSRDVY----EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 249 ------GVPP 252
                 G+PP
Sbjct: 249 GGNPYPGIPP 258

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 94
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  ++ K         G+     +MA E L+ +
Sbjct: 155 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 252

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+      A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 24  DYNPNYCFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 79
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 80  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 137 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 195
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 196 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 256 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 312
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 313 LER--IEYCTQDPDV 325

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 62/259 (23%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTY------------LCIDRDTRELLACKSISKRKLRT 91
           +P E +E    +   +G+G FG  Y            + I+RD  + L            
Sbjct: 30  IPFEQLE----IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKA---------- 75
Query: 92  AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-----RIVAR 146
                  +REV   +   ++ ++V    AC     + ++  LC+G  L+      +IV  
Sbjct: 76  ------FKREVMAYRQ-TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128
Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL---SI 203
            + T + A    + IV+ +   H  G++H+DLK +N  + N K    +   DFGL   S 
Sbjct: 129 VNKTRQIA----QEIVKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISG 180
Query: 204 FFKPGERFSEIV---GSPYYMAPEVLKR----------NYGPEIDIWSAGVILYILLCGV 250
             + G R  ++    G   ++APE++++           +    D+++ G I Y L    
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 251 PPFWAESEQGVAQAILRGL 269
            PF  +  + +   +  G+
Sbjct: 241 WPFKTQPAEAIIWQMGTGM 259

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +++G+G +G  ++   R   E +A K     +  +     ++ + V +M+H      I +
Sbjct: 43  KQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWFRETEIYQTV-LMRHENILGFIAA 99
Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH----- 171
             +       ++L+ +  E G L+D + +    T  A + +      V  LCH H     
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 172 -----GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYM 221
                 + HRDLK +N L    K+N      D GL++ F       +I     VG+  YM
Sbjct: 157 TQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 222 APEV----LKRNYGPEI---DIWSAGVILY 244
            PEV    L RN+       D++S G+IL+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 96
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 156
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+  +  K  +      G+     +MA E L+ +
Sbjct: 157 HRDLAARNCML---DEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 254

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 113
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 173
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 174 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 231 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 271

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 114
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 174
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 175 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 232 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 272

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+      A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 25  DYNPNYCFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 80
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 81  VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 138 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 196
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 197 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 257 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 313
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 314 LER--IEYCTQDPDV 326

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 54/250 (21%)
Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRRE 101
           P++N+    ++ + LG GEFG          +      +++ + L+   +  ++ D+  E
Sbjct: 21  PRKNL----VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF-----DRIVARG--------- 147
             ++K +  +  ++ L  AC  D  + L++E  + G L       R V  G         
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 148 -----HYTERAAA-----AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                H  ERA       +    I + +Q   +  ++HRDL   N L A   E   +K  
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKIS 192
Query: 198 DFGLS--IFFKPGERFSEIVGSP-----YYMAPEVLKRN-YGPEIDIWSAGVILYILLC- 248
           DFGLS  ++    E  S +  S       +MA E L  + Y  + D+WS GV+L+ ++  
Sbjct: 193 DFGLSRDVY----EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 249 ------GVPP 252
                 G+PP
Sbjct: 249 GGNPYPGIPP 258

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 22/225 (9%)
Query: 40  VLAGVPKENIEDRYLVDRELGRGEFGVTYLCI---DRDTRELLAC-KSISKRKLRTAVD- 94
           VLA + KE  E R L  + LG G FG  +  +   + ++ ++  C K I  +  R +   
Sbjct: 23  VLARIFKET-ELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 79
Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERA 153
           + D    +  + H    + IV L   C   +++ LV +    G L D +   RG    + 
Sbjct: 80  VTDHMLAIGSLDH----AHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQL 134
Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--- 210
                  I + +    +HG++HR+L   N L    K  S ++  DFG++    P ++   
Sbjct: 135 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLL 191
Query: 211 FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPF 253
           +SE      +MA E +    Y  + D+WS GV ++ L+  G  P+
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 236

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 31/315 (9%)
Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL- 78
           D+      A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L 
Sbjct: 48  DYNPNYCFAGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 103
Query: 79  LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGE 138
           +A K++ +  + +  D  D   E  I+     + +IV             +++EL  GG+
Sbjct: 104 VAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 139 L--FDRIVARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           L  F R   R   ++ ++ A      V R I    Q   ++  IHRD+   N L      
Sbjct: 161 LKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219
Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-I 245
               K  DFG++  I+     R       P  +M PE      +  + D WS GV+L+ I
Sbjct: 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
Query: 246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
              G  P+ ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +
Sbjct: 280 FSLGYMPYPSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAII 336
Query: 306 LEHPWLQNAKKAPNV 320
           LE   ++   + P+V
Sbjct: 337 LER--IEYCTQDPDV 349

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 94
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 155 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 252

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 125/307 (40%), Gaps = 31/307 (10%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 15  AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIV 144
             + +  D  D   E  I+     + +IV             +++EL  GG+L  F R  
Sbjct: 71  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-E 126
Query: 145 ARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
            R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  D
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 199 FGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
           FG++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 247 PSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 301
Query: 314 AKKAPNV 320
             + P+V
Sbjct: 302 CTQDPDV 308

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 22/227 (9%)
Query: 38  ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCI---DRDTRELLAC-KSISKRKLRTAV 93
           + VLA + KE  E R L  + LG G FG  +  +   + ++ ++  C K I  +  R + 
Sbjct: 3   MKVLARIFKET-ELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 94  D-IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTE 151
             + D    +  + H    + IV L   C   +++ LV +    G L D +   RG    
Sbjct: 60  QAVTDHMLAIGSLDH----AHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP 114
Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER- 210
           +        I + +    +HG++HR+L   N L    K  S ++  DFG++    P ++ 
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQ 171
Query: 211 --FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPF 253
             +SE      +MA E +    Y  + D+WS GV ++ L+  G  P+
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 95
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 156 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 253

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 125/307 (40%), Gaps = 31/307 (10%)
Query: 32  ANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTY----LCIDRDTREL-LACKSISK 86
           A K   I+ L  VP++NI     + R LG G FG  Y      +  D   L +A K++ +
Sbjct: 7   AGKTSSISDLKEVPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 62
Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL--FDRIV 144
             + +  D  D   E  I+     + +IV             +++EL  GG+L  F R  
Sbjct: 63  --VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-E 118
Query: 145 ARGHYTERAAAA------VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID 198
            R   ++ ++ A      V R I    Q   ++  IHRD+   N L          K  D
Sbjct: 119 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 178
Query: 199 FGLS--IFFKPGERFSEIVGSPY-YMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPF 253
           FG++  I+     R       P  +M PE      +  + D WS GV+L+ I   G  P+
Sbjct: 179 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 238
Query: 254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            ++S Q V + +  G    + DP  N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 239 PSKSNQEVLEFVTSG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 293
Query: 314 AKKAPNV 320
             + P+V
Sbjct: 294 CTQDPDV 300

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 92
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 152
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 153 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 87
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 147
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 148 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 245

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 90
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 151 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 59  LGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           +GRG FG  Y    +D D +++  C   S  ++    ++     E  IMK    + +++S
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKI-HCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLS 93
Query: 117 LKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEVVQLCHKHGVI 174
           L   C   + +  +V+   + G+L + I    H  T +        + + ++       +
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 153
Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS--EIVGSPY---YMAPEVLK-R 228
           HRDL   N +     E   +K  DFGL+      E +S     G+     +MA E L+ +
Sbjct: 154 HRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 229 NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG 268
            +  + D+WS GV+L+ L+  G PP+   +   +   +L+G
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 251

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ-LCHKH----------GVIHRD 177
           L+    E G L+D +      T     +  R ++ +   L H H           + HRD
Sbjct: 83  LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVLKRNYGP 232
           LK +N L    K+N      D GL++         ++     VG+  YMAPEVL      
Sbjct: 139 LKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 233 E-------IDIWSAGVILY-----ILLCGV-----PPFWAESEQGVAQAILRGL--IDFK 273
           +       +DIW+ G++L+     ++  G+     PPF+       +   +R +  +D +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 274 RDPWPN------VSESAKSLVRQMLEPDPKLRLTAKQV 305
           R   PN         S   L+++    +P  RLTA ++
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 33/182 (18%)
Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           A+ +    +E+     K  + HRDLK +N L    K+N      D GL++         +
Sbjct: 144 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLD 200
Query: 214 I-----VGSPYYMAPEVLKRNYGPE-------IDIWSAGVILY-----ILLCGV-----P 251
           +     VG+  YMAPEVL      +       +DIW+ G++L+     ++  G+     P
Sbjct: 201 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 260
Query: 252 PFWAESEQGVAQAILRGL--IDFKRDPWPN------VSESAKSLVRQMLEPDPKLRLTAK 303
           PF+       +   +R +  +D +R   PN         S   L+++    +P  RLTA 
Sbjct: 261 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 320
Query: 304 QV 305
           ++
Sbjct: 321 RI 322

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ-LCHKH----------GVIHRD 177
           L+    E G L+D +      T     +  R ++ +   L H H           + HRD
Sbjct: 83  LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVLKRNYGP 232
           LK +N L    K+N      D GL++         ++     VG+  YMAPEVL      
Sbjct: 139 LKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 233 E-------IDIWSAGVILY-----ILLCGV-----PPFWAESEQGVAQAILRGL--IDFK 273
           +       +DIW+ G++L+     ++  G+     PPF+       +   +R +  +D +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 274 RDPWPN------VSESAKSLVRQMLEPDPKLRLTAKQV 305
           R   PN         S   L+++    +P  RLTA ++
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 28/228 (12%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTREL-------LACK 82
           AG    Q +T L G      +D  L+++ LG G FGV    + R   +        +A K
Sbjct: 3   AGEGPLQSLTCLIGE-----KDLRLLEK-LGDGSFGV----VRRGEWDAPSGKTVSVAVK 52
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR 142
            +    L     +DD  REV  M  L  + +++ L         + +V EL   G L DR
Sbjct: 53  CLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDR 110
Query: 143 IVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
           +   +GH+     +     + E +        IHRDL   N L A +     +K  DFGL
Sbjct: 111 LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGL 167
Query: 202 SIFFKPGER---FSEIVGSPY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
                  +      E    P+ + APE LK R +    D W  GV L+
Sbjct: 168 MRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 28/228 (12%)
Query: 30  AGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTREL-------LACK 82
           AG    Q +T L G      +D  L+++ LG G FGV    + R   +        +A K
Sbjct: 3   AGEGPLQSLTCLIGE-----KDLRLLEK-LGDGSFGV----VRRGEWDAPSGKTVSVAVK 52
Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDR 142
            +    L     +DD  REV  M  L  + +++ L         + +V EL   G L DR
Sbjct: 53  CLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDR 110
Query: 143 IVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
           +   +GH+     +     + E +        IHRDL   N L A +     +K  DFGL
Sbjct: 111 LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGL 167
Query: 202 SIFFKPGER---FSEIVGSPY-YMAPEVLK-RNYGPEIDIWSAGVILY 244
                  +      E    P+ + APE LK R +    D W  GV L+
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215

>pdb|1F70|A Chain A, Refined Solution Structure Of Calmodulin N-Terminal Domain Length = 76

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 52

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 8/85 (9%)
Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGE-RFSEIVGSPYYMAPE-VLKRN 229
           IHRDL   N L +   EN+ +K  DFGL+  I+  P   R  +      +MAPE +  + 
Sbjct: 221 IHRDLAARNILLS---ENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKI 277
Query: 230 YGPEIDIWSAGVILY-ILLCGVPPF 253
           Y  + D+WS GV+L+ I   G  P+
Sbjct: 278 YSTKSDVWSYGVLLWEIFSLGGSPY 302

>pdb|3B32|A Chain A, Crystal Structure Of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-75 Length = 75

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 52

>pdb|1AK8|A Chain A, Nmr Solution Structure Of Cerium-Loaded Calmodulin Amino- Terminal Domain (Ce2-Tr1c), 23 Structures Length = 76

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 53

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 39/272 (14%)
Query: 44  VPKENIEDRYLVDRELGRGEFGVTYL-CIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           +P+E+++   L+ R LG G+FG  ++   + +T+  +A K++    +      +    E 
Sbjct: 6   IPRESLQ---LIKR-LGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSP----ESFLEEA 55
Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-------RIVARGHYTERAAA 155
            IMK L K+  +V L  A   +  +++V E    G L D       R +   +  + AA 
Sbjct: 56  QIMKKL-KHDKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA- 112
Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
                +   +    +   IHRDL+  N L  N       K  DFGL+   +  E  +   
Sbjct: 113 ----QVAAGMAYIERMNYIHRDLRSANILVGN---GLICKIADFGLARLIEDNEXTAR-Q 164
Query: 216 GSPY---YMAPE-VLKRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI 270
           G+ +   + APE  L   +  + D+WS G++L  L+  G  P+   + + V + + RG  
Sbjct: 165 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY- 223
Query: 271 DFKRDPWP-NVSESAKSLVRQMLEPDPKLRLT 301
              R P P +   S   L+    + DP+ R T
Sbjct: 224 ---RMPCPQDCPISLHELMIHCWKKDPEERPT 252

>pdb|3UCT|A Chain A, Structure Of Mn2+-Bound N-Terminal Domain Of Calmodulin In The Presence Of Zn2+ Length = 79

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 52

>pdb|1SW8|A Chain A, Solution Structure Of The N-Terminal Domain Of Human N60d Calmodulin Refined With Paramagnetism Based Strategy Length = 79

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 52

>pdb|2LQC|A Chain A, Nmr Solution Structure Of A Ca2+-Calmodulin With A Binding Motif (Nscate) Peptide From The N-Terminal Cytoplasmic Domain Of The L-Type Voltage-Cated Calcium Channel Alpha1c Subunit Length = 77

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 52

>pdb|2LLO|A Chain A, Solution Nmr-Derived Structure Of Calmodulin N-Lobe Bound With Er Alpha Peptide Length = 80

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMI 52

>pdb|2RO8|A Chain A, Solution Structure Of Calcium Bound Soybean Calmodulin Isoform 1 N-Terminal Domain Length = 79

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I
Sbjct: 1   ADQLTDEQISEFKEAFSLFDKDGDGCITTKELGTVMRSLGQNPTEAELQDMI 52

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	408
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	0.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	0.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	0.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	0.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	0.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-179
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-177
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-173
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-172
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-171
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-171
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-169
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-169
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-169
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-169
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-169
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-168
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-167
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-165
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-164
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-164
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-161
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-159
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-158
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-158
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-157
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-157
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-152
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-149
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-147
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-147
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-104
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-101
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-90
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-88
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-88
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-88
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-87
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-86
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-85
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-85
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-85
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-83
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-83
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-83
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-82
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-82
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-82
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-81
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-81
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-81
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-80
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-80
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-80
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-80
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-80
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-78
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-76
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-74
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-74
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-72
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-68
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-68
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-68
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-65
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-64
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-63
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-63
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-60
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-55
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-53
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-52
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-50
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-50
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-50
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-49
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-49
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-49
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-48
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-48
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-48
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-48
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-47
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-47
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-47
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-47
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-47
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-47
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-47
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-46
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-46
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-46
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-45
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-45
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-45
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-45
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-44
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-44
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-44
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-44
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-44
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-44
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-44
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-44
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-44
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-44
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-44
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	1e-43
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	2e-04
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-43
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-43
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-43
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-43
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-42
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-42
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	4e-42
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	4e-05
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-41
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-39
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-38
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-37
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-37
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-37
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-37
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-36
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-35
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-34
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-33
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-33
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-33
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-32
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-32
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-31
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-30
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	1e-29
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	4e-05
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-29
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-29
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-28
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-28
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	4e-28
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	2e-07
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	3e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-27
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-27
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-27
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-27
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	9e-27
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	5e-05
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	1e-26
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	2e-04
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-26
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-23
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	2e-23
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	4e-04
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-23
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	3e-22
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	6e-07
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	2e-21
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	1e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-20
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-17
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	1e-17
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	6e-05
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	1e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-17
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	2e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-16
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-15
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-15
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-15
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-15
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-15
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-15
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-15
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	8e-15
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	1e-07
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-14
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-14
3fwb_A	161	Cell division control protein 31; gene gating, com	8e-14
3fwb_A	161	Cell division control protein 31; gene gating, com	1e-06
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	1e-13
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	1e-06
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-13
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	2e-13
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	6e-07
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	3e-13
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	3e-13
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	1e-04
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	4e-13
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	5e-07
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	5e-13
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	2e-06
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	9e-13
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	1e-06
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-12
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	1e-12
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	1e-12
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	3e-04
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	2e-12
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	2e-12
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	3e-07
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	4e-12
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	1e-05
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	6e-12
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	6e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-12
1y1x_A	191	Leishmania major homolog of programmed cell death	1e-11
1y1x_A	191	Leishmania major homolog of programmed cell death	3e-08
3li6_A	66	Calcium-binding protein; calcium signaling protein	1e-11
3li6_A	66	Calcium-binding protein; calcium signaling protein	3e-04
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	1e-11
2jnf_A	158	Troponin C; stretch activated muscle contraction,	1e-11
2jnf_A	158	Troponin C; stretch activated muscle contraction,	1e-06
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	2e-11
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	1e-06
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	3e-11
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	1e-06
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	1e-10
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	1e-10
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	2e-10
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	3e-10
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	4e-10
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	6e-10
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	6e-10
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	7e-10
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	2e-06
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	1e-09
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	3e-06
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	2e-09
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	2e-09
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	2e-07
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	2e-09
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	8e-08
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	2e-04
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	2e-09
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	4e-09
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	1e-05
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	5e-05
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	6e-09
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	3e-06
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	8e-09
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	1e-08
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	1e-08
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	4e-07
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	2e-08
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	2e-08
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	4e-05
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	3e-08
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	6e-08
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	6e-08
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	2e-04
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	3e-04
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	6e-08
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	1e-07
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	7e-08
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	8e-08
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	2e-06
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	9e-08
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	1e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-04
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	1e-07
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	3e-05
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	5e-05
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	1e-07
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	2e-06
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	1e-07
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	1e-06
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	1e-07
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	7e-05
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	2e-07
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	2e-07
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	8e-07
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	2e-07
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	4e-07
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	6e-07
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	5e-06
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	6e-07
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	8e-07
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	9e-07
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	2e-06
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	1e-06
2hps_A	186	Coelenterazine-binding protein with bound coelent;	1e-06
2hps_A	186	Coelenterazine-binding protein with bound coelent;	7e-06
2hps_A	186	Coelenterazine-binding protein with bound coelent;	7e-05
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	1e-06
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	1e-06
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	1e-06
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	2e-06
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	7e-06
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	2e-06
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	7e-04
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	3e-06
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	7e-05
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	3e-04
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	3e-06
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	2e-05
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	2e-05
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	4e-06
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	5e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-06
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	1e-05
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	2e-05
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-05
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	4e-05
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	5e-05
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	7e-05
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	1e-04
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	1e-04
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	1e-04
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	2e-04
1c07_A	95	Protein (epidermal growth factor receptor pathway	6e-04
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	9e-04

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  560 bits (1445), Expect = 0.0
 Identities = 131/375 (34%), Positives = 208/375 (55%), Gaps = 21/375 (5%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +    +RY +   LG+G FG    C DR T++  A K I+K   +   D   + REV ++
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELL 75

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           K L  + +I+ L E  ED ++ ++V EL  GGELFD I+ R  ++E  AA + + +   +
Sbjct: 76  KKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              HKH ++HRDLKPEN L  +K+++  +K IDFGLS  F+   +  + +G+ YY+APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           L+  Y  + D+WSAGVILYILL G PPF+ ++E  + + +  G   F    W  +S+ AK
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN----AKKAPNVPLGDVVRSRLKQFSMMNRFKR 341
            L+R+ML   P LR+TA Q LEHPW+Q          ++P  +   + ++QF    +  +
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQ 314

Query: 342 KALRVIAEFLS-VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-------------- 386
            AL  +A  L+ ++E + + E+F+K+D++NDG++  DEL  G   F              
Sbjct: 315 AALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQN 374

Query: 387 GSQLAESEVQMLIEA 401
                E ++  L+  
Sbjct: 375 EGSTIEDQIDSLMPL 389

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  557 bits (1438), Expect = 0.0
 Identities = 132/372 (35%), Positives = 207/372 (55%), Gaps = 16/372 (4%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
                 DRY   R LG+G FG   LC D+ T +  A K ISKR+++   D + + REV +
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           +K L  + +I+ L E  ED    +LV E+  GGELFD I++R  ++E  AA + R ++  
Sbjct: 80  LKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +   HK+ ++HRDLKPEN L  +K +++ ++ IDFGLS  F+  ++  + +G+ YY+APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           VL   Y  + D+WS GVILYILL G PPF   +E  + + + +G   F+   W  VSESA
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKR 341
           K L+R+ML   P +R++A+  L+H W+Q   K   + +VP  D     ++QF    +  +
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318

Query: 342 KALRVIAEFL-SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-----------GSQ 389
            AL  +   L S +E +++  +F K+D + DG +   EL  G +              + 
Sbjct: 319 AALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDAS 378

Query: 390 LAESEVQMLIEA 401
             E EV  +++A
Sbjct: 379 AVEHEVDQVLDA 390

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  554 bits (1429), Expect = 0.0
 Identities = 120/406 (29%), Positives = 203/406 (50%), Gaps = 30/406 (7%)

Query: 25  HARKEAGANKKQPITVLAGVP-------KENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
           H    +   +      +A  P       +  I + Y   R+LG G +G   LC +++   
Sbjct: 3   HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62

Query: 78  LLACKSISKRKLRTAV----------DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV 127
             A K I K +                 +++  E++++K L  + +I+ L +  ED    
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYF 121

Query: 128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN 187
           +LV E  EGGELF++I+ R  + E  AA + + I+  +   HKH ++HRD+KPEN L  N
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILL 247
           K     +K +DFGLS FF    +  + +G+ YY+APEVLK+ Y  + D+WS GVI+YILL
Sbjct: 182 KNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILL 241

Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           CG PPF  +++Q + + + +G   F  + W N+S+ AK L++ ML  D   R TA++ L 
Sbjct: 242 CGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301

Query: 308 HPWLQNAKK---APNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLS-VEEVEDIKEMF 363
             W++         +        S +++F    +  + A+  I   L+ +EE +++ ++F
Sbjct: 302 SRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIF 361

Query: 364 KKIDSDNDGVVSTDELKAGLRNFGS--------QLAESEVQMLIEA 401
           KK+D + DG +   EL  G     +        +  E EV  +++ 
Sbjct: 362 KKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKE 407

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  548 bits (1414), Expect = 0.0
 Identities = 129/370 (34%), Positives = 207/370 (55%), Gaps = 15/370 (4%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
            K ++ + Y   ++LG G +G   LC D+ T    A K I K  + T+     +  EVA+
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAV 89

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           +K L  + +I+ L +  ED    +LVME  +GGELFD I+ R  + E  AA + + ++  
Sbjct: 90  LKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           V   HKH ++HRDLKPEN L  +K++++ +K +DFGLS  F+  ++  E +G+ YY+APE
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
           VL++ Y  + D+WS GVIL+ILL G PPF  +++Q + + + +G   F    W NVSE A
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP----NVPLGDVVRSRLKQFSMMNRFK 340
           K L++QML+ D + R++A+Q LEHPW++           +P        +++F    +  
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328

Query: 341 RKALRVIAEFL-SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ--------LA 391
           + AL  +A  L S EE +++ ++F+ ID + DG +   EL  G      +          
Sbjct: 329 QAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQI 388

Query: 392 ESEVQMLIEA 401
           ESEV  ++ A
Sbjct: 389 ESEVDAILGA 398

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  536 bits (1384), Expect = 0.0
 Identities = 120/365 (32%), Positives = 193/365 (52%), Gaps = 8/365 (2%)

Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           +A +      + Y +  ELG+G F V   C+     +  A   I+ +KL +A D   + R
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLER 59

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E  I + L K+ +IV L ++  ++   +L+ +L  GGELF+ IVAR +Y+E  A+   + 
Sbjct: 60  EARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPY 219
           I+E V  CH+ GV+HR+LKPEN L A+K + + +K  DFGL+I  +   + +    G+P 
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178

Query: 220 YMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP 278
           Y++PEVL+++ YG  +D+W+ GVILYILL G PPFW E +  + Q I  G  DF    W 
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNR 338
            V+  AK L+ +ML  +P  R+TA + L+HPW+ +     +          LK+F+   +
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRK 298

Query: 339 FKRKALRVIA--EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQ 396
            K   L V+      SV + E IK   + I++ ++G    +          +      + 
Sbjct: 299 LKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNG--DFESYTKMCDPGMTAFEPEALG 356

Query: 397 MLIEA 401
            L+E 
Sbjct: 357 NLVEG 361

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  528 bits (1362), Expect = 0.0
 Identities = 117/365 (32%), Positives = 182/365 (49%), Gaps = 7/365 (1%)

Query: 25  HARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI 84
           H     G  +    +           D Y V  ELG+G F V   C+ + T    A K I
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 85  SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV 144
           + +KL +A D   + RE  I + L ++ +IV L ++ ++++  +LV +L  GGELF+ IV
Sbjct: 63  NTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
           AR  Y+E  A+   + I+E +  CH +G++HR+LKPEN L A+K + + +K  DFGL+I 
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 205 FKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
               E +    G+P Y++PEVLK++ Y   +DIW+ GVILYILL G PPFW E +  +  
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 240

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLG 323
            I  G  D+    W  V+  AKSL+  ML  +PK R+TA Q L+ PW+ N ++  +    
Sbjct: 241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 300

Query: 324 DVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGL 383
                 LK+F+   + K   L  +    +   + ++                  E     
Sbjct: 301 QDTVDCLKKFNARRKLKGAILTTMI---ATRNLSNLGRNLLNKKEQGPPST-IKESSESS 356

Query: 384 RNFGS 388
           +    
Sbjct: 357 QTIDD 361

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  507 bits (1308), Expect = 0.0
 Identities = 108/330 (32%), Positives = 170/330 (51%), Gaps = 10/330 (3%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--RTAVDIDDVRREVAIM 105
             ED Y +   +G+G F V   CI+R+T +  A K +   K      +  +D++RE +I 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTI 161
             L K+  IV L E    D  +++V E  +G +L   IV R      Y+E  A+   R I
Sbjct: 81  HML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYY 220
           +E ++ CH + +IHRD+KP   L A+K+ ++P+K   FG++I   + G      VG+P++
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           MAPEV+KR  YG  +D+W  GVIL+ILL G  PF+   ++ + + I++G        W +
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRF 339
           +SESAK LVR+ML  DP  R+T  + L HPWL+   +            +L++F+   + 
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKL 318

Query: 340 KRKALRVIAEFLSVEEVEDIKEMFKKIDSD 369
           K   L  ++         D  E       D
Sbjct: 319 KGAVLAAVSSHKFNSFYGDPPEELPDFSED 348

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  500 bits (1290), Expect = e-179
 Identities = 129/345 (37%), Positives = 188/345 (54%), Gaps = 10/345 (2%)

Query: 7   SPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGV 66
           S   +  E++     S   A    G     P   + G  ++ + D + V+ ELGRG   +
Sbjct: 9   SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68

Query: 67  TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA 126
            Y C  + T++  A K + K       D   VR E+ ++  L  + +I+ LKE  E    
Sbjct: 69  VYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTE 122

Query: 127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA 186
           + LV+EL  GGELFDRIV +G+Y+ER AA   + I+E V   H++G++HRDLKPEN L+A
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182

Query: 187 NKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYI 245
               ++PLK  DFGLS   +       + G+P Y APE+L+   YGPE+D+WS G+I YI
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242

Query: 246 LLCGVPPFWAE-SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQ 304
           LLCG  PF+ E  +Q + + IL     F    W  VS +AK LVR+++  DPK RLT  Q
Sbjct: 243 LLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302

Query: 305 VLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAE 349
            L+HPW+    KA N    D  + +L++F+   + K     V+A 
Sbjct: 303 ALQHPWVTG--KAANFVHMDTAQKKLQEFNARRKLKAAVKAVVAS 345

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  496 bits (1280), Expect = e-177
 Identities = 107/330 (32%), Positives = 168/330 (50%), Gaps = 16/330 (4%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+    R  V  +D+ REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 66  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 124

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     +     +F+ + + N 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFK 340
           S  AK  +R++L  DPK R+T +  L+HPW++               SR      M +FK
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ-------ALSRKASAVNMEKFK 297

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDN 370
           + A R  +   S      + ++F+    + 
Sbjct: 298 KFAARKKSNNGSGGG---LNDIFEAQKIEW 324

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  482 bits (1244), Expect = e-173
 Identities = 121/280 (43%), Positives = 169/280 (60%), Gaps = 4/280 (1%)

Query: 43  GVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           G  K +I   Y ++  +GRG +G   + + + TR   A K I K  +    D+D  ++E+
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEI 57

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
            IMK L  + +I+ L E  ED+  ++LVMELC GGELF+R+V +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
             V  CHK  V HRDLKPENFLF     +SPLK IDFGL+  FKPG+     VG+PYY++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 223 PEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           P+VL+  YGPE D WSAGV++Y+LLCG PPF A ++  V   I  G   F    W NVS 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            A+SL+R++L   PK R+T+ Q LEH W +    +    L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  482 bits (1244), Expect = e-172
 Identities = 88/326 (26%), Positives = 155/326 (47%), Gaps = 8/326 (2%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLAC 81
           H H    +G +       L     EN  + Y L  +ELGRG+F V   CI + T +  A 
Sbjct: 2   HHHHHHSSGVDLGT--ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAA 59

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD 141
           K + KR+        ++  E+A+++       +++L E  E+ + + L++E   GGE+F 
Sbjct: 60  KFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS 118

Query: 142 RIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF 199
             +       +E     + + I+E V   H++ ++H DLKP+N L ++      +K +DF
Sbjct: 119 LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178

Query: 200 GLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
           G+S          EI+G+P Y+APE+L  +      D+W+ G+I Y+LL    PF  E  
Sbjct: 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           Q     I +  +D+  + + +VS+ A   ++ +L  +P+ R TA+  L H WLQ      
Sbjct: 239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298

Query: 319 NV-PLGDVVRSRLKQFSMMNRFKRKA 343
              P      S+ +  S+ +   + +
Sbjct: 299 LFHPEETSSSSQTQDHSVRSSEDKTS 324

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  479 bits (1235), Expect = e-171
 Identities = 112/282 (39%), Positives = 165/282 (58%), Gaps = 4/282 (1%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
               D Y V  ELG+G F V   C+ + T    A K I+ +KL +A D   + RE  I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            L ++ +IV L ++ ++++  +LV +L  GGELF+ IVAR  Y+E  A+   + I+E + 
Sbjct: 61  KL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
            CH +G++HR+LKPEN L A+K + + +K  DFGL+I     E +    G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           K++ Y   +DIW+ GVILYILL G PPFW E +  +   I  G  D+    W  V+  AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQN-AKKAPNVPLGDVV 326
           SL+  ML  +PK R+TA Q L+ PW+ N  + A  +   D V
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  480 bits (1237), Expect = e-171
 Identities = 83/318 (26%), Positives = 160/318 (50%), Gaps = 12/318 (3%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + ++Y++  +LGRGEFG+ + C++  +++    K +  +      D   V++E++I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVV 165
              ++ +I+ L E+ E    + ++ E   G ++F+RI        ER   +    + E +
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
           Q  H H + H D++PEN ++  +  +S +K I+FG +   KPG+ F  +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            + +      D+WS G ++Y+LL G+ PF AE+ Q + + I+     F  + +  +S  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
              V ++L  + K R+TA + L+HPWL+   +  +      V   LK     +   +K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVST----KVIRTLKHRRYYHTLIKKDL 290

Query: 345 RVIAEFLSVEEVEDIKEM 362
            ++     +     I+  
Sbjct: 291 NMVVSAARISCGGAIRSQ 308

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  475 bits (1224), Expect = e-169
 Identities = 112/292 (38%), Positives = 165/292 (56%), Gaps = 11/292 (3%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
            H H       N            +    +RY +   LG+G FG    C DR T++  A 
Sbjct: 2   HHHHHHSSGRENLYF---------QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAV 52

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD 141
           K I+K   +   D   + REV ++K L  + +I+ L E  ED ++ ++V EL  GGELFD
Sbjct: 53  KVINKASAKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 142 RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
            I+ R  ++E  AA + + +   +   HKH ++HRDLKPEN L  +K+++  +K IDFGL
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170

Query: 202 SIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
           S  F+   +  + +G+ YY+APEVL+  Y  + D+WSAGVILYILL G PPF+ ++E  +
Sbjct: 171 STCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            + +  G   F    W  +S+ AK L+R+ML   P LR+TA Q LEHPW+Q 
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  477 bits (1229), Expect = e-169
 Identities = 100/348 (28%), Positives = 167/348 (47%), Gaps = 10/348 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R     V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + +I++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     I     DF  + +   
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS--RLKQFSMMNR 338
           SE AK  +R++L  + + RLT ++ L HPW+        +   + V +    K+  +  R
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRR 305

Query: 339 FKRKALRVIA--EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
           +K     V            +      + + +           +  L 
Sbjct: 306 WKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALH 353

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  474 bits (1222), Expect = e-169
 Identities = 104/325 (32%), Positives = 158/325 (48%), Gaps = 28/325 (8%)

Query: 46  KENIEDRY---LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
                  Y   L D+ LG G F +   C+ + + +  A K ISKR         + ++E+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEI 56

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
             +K    + +IV L E   D     LVMEL  GGELF+RI  + H++E  A+ + R +V
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV 116

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIVGSPYYM 221
             V   H  GV+HRDLKPEN LF ++ +N  +K IDFG +    P  +       + +Y 
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQ-------GVAQAILRGLIDFK 273
           APE+L +N Y    D+WS GVILY +L G  PF +            + + I +G   F+
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDV-------- 325
            + W NVS+ AK L++ +L  DP  RL    +  + WLQ+  +  + PL           
Sbjct: 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGA 296

Query: 326 -VRSRLK-QFSMMNRFKRKALRVIA 348
            V + +K  F   N++KR+   +  
Sbjct: 297 AVHTCVKATFHAFNKYKREGFCLQN 321

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  477 bits (1229), Expect = e-169
 Identities = 105/389 (26%), Positives = 170/389 (43%), Gaps = 23/389 (5%)

Query: 7   SPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGV 66
           +P          +  +           +    + L       I+D  +  + LG G  G 
Sbjct: 18  APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGK 77

Query: 67  TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--- 123
                ++ T+E  A K +              RREV +     +   IV + +  E+   
Sbjct: 78  VLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 124 -DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
               + +VME  +GGELF RI  RG   +TER A+ + ++I E +Q  H   + HRD+KP
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSA 239
           EN L+ +K+ N+ LK  DFG +         +    +PYY+APEVL    Y    D+WS 
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249

Query: 240 GVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
           GVI+YILLCG PPF++        G+   I  G  +F    W  VSE  K L+R +L+ +
Sbjct: 250 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 309

Query: 296 PKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEE 355
           P  R+T  + + HPW+  + K P  PL      +  +    +  +     +    +  E+
Sbjct: 310 PTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQ 369

Query: 356 VEDIKEMFKKIDSDNDGVVSTDELKAGLR 384
           +    ++ K  D+ N  ++   +    L 
Sbjct: 370 I----KIKKIEDASNPLLLKRRKKARALE 394

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  472 bits (1218), Expect = e-168
 Identities = 96/310 (30%), Positives = 164/310 (52%), Gaps = 9/310 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREV 102
           ++ +ED Y +  ELG G+F +   C ++ T    A K I KR+ R     V  +++ REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I++ +  + ++++L +  E+   V L++EL  GGELFD +  +   +E  A +  + I+
Sbjct: 67  SILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           + V   H   + H DLKPEN +  +K    P +K IDFGL+   + G  F  I G+P ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     I     DF  + + + 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD--VVRSRLKQFSMMNR 338
           SE AK  +R++L  + + RLT ++ L HPW+        +   +  V     ++  +  R
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRR 305

Query: 339 FKRKALRVIA 348
           +K  +  +++
Sbjct: 306 WK-LSFSIVS 314

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  472 bits (1216), Expect = e-167
 Identities = 103/326 (31%), Positives = 157/326 (48%), Gaps = 19/326 (5%)

Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
             I            D Y V  ++G G + V   CI + T    A K I K K       
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------ 60

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            D   E+ I+    ++ +I++LK+  +D   V++V EL +GGEL D+I+ +  ++ER A+
Sbjct: 61  -DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN-SPLKAIDFGLSIFFKPGER-FSE 213
           AV  TI + V+  H  GV+HRDLKP N L+ ++  N   ++  DFG +   +        
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179

Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGL 269
              +  ++APEVL+R  Y    DIWS GV+LY +L G  PF     ++ + +   I  G 
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239

Query: 270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
                  W +VS++AK LV +ML  DP  RLTA  VL HPW+ +  + P   L       
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPH 299

Query: 330 LKQ------FSMMNRFKRKALRVIAE 349
           L +      +S +NR +   L  +  
Sbjct: 300 LVKGAMAATYSALNRNQSPVLEPVGR 325

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  463 bits (1193), Expect = e-165
 Identities = 98/273 (35%), Positives = 155/273 (56%), Gaps = 8/273 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +  I+D ++  R+LG G FG  +L  +R +      K+I+K + +  V ++ +  E+ ++
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVL 74

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTI 161
           K L  + +I+ + E  ED + +++VME CEGGEL +RIV+        +E   A + + +
Sbjct: 75  KSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  +   H   V+H+DLKPEN LF +   +SP+K IDFGL+  FK  E  +   G+  YM
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193

Query: 222 APEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           APEV KR+   + DIWSAGV++Y LL G  PF   S + V Q       ++  +  P ++
Sbjct: 194 APEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LT 252

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
             A  L++QML  DP+ R +A QVL H W + A
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  465 bits (1199), Expect = e-164
 Identities = 96/326 (29%), Positives = 161/326 (49%), Gaps = 19/326 (5%)

Query: 3   NCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPK----ENIEDRYLVDRE 58
              R   + +   +      +D   K       Q +     +P     +    +Y     
Sbjct: 42  RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV 101

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD-----IDDVRREVAIMKHLPKNSS 113
           +GRG   V   C+ R T    A K +     R + +      +  RRE  I++ +  +  
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           I++L ++ E  + + LV +L   GELFD +  +   +E+   ++ R+++E V   H + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK------ 227
           +HRDLKPEN L     +N  ++  DFG S   +PGE+  E+ G+P Y+APE+LK      
Sbjct: 222 VHRDLKPENILLD---DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278

Query: 228 -RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              YG E+D+W+ GVIL+ LL G PPFW   +  + + I+ G   F    W + S + K 
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338

Query: 287 LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           L+ ++L+ DP+ RLTA+Q L+HP+ +
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFE 364

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  462 bits (1190), Expect = e-164
 Identities = 100/280 (35%), Positives = 152/280 (54%), Gaps = 6/280 (2%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREVAI 104
            +ED Y +  ELG G+F +   C  + T +  A K I KR+L   R  V  +++ REV I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           ++ + ++ +I++L +  E+   V L++EL  GGELFD +  +   TE  A    + I++ 
Sbjct: 62  LREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 165 VQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
           V   H   + H DLKPEN +  +K   N  +K IDFG++   + G  F  I G+P ++AP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           E++     G E D+WS GVI YILL G  PF  E++Q     I     DF  + + N SE
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
            AK  +R++L  DPK R+T  Q LEH W++  ++      
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  455 bits (1172), Expect = e-161
 Identities = 93/289 (32%), Positives = 147/289 (50%), Gaps = 16/289 (5%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVR---- 99
                + Y     LGRG   V   CI + T +  A K I        +A ++ ++R    
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 71

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           +EV I++ +  + +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            ++EV+   HK  ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P 
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPS 188

Query: 220 YMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           Y+APE+++         YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
               W + S++ K LV + L   P+ R TA++ L HP+ Q         
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  450 bits (1159), Expect = e-159
 Identities = 104/321 (32%), Positives = 156/321 (48%), Gaps = 18/321 (5%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRRE 101
           + + D Y++ + LG G  G   L  +R T + +A K ISKRK      R A    +V  E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           + I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         +
Sbjct: 66  IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 222 APEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDP 276
           APEVL       Y   +D WS GVIL+I L G PPF     +  +   I  G  +F  + 
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243

Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMM 336
           W  VSE A  LV+++L  DPK R T ++ L HPWLQ+                L + +  
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ------DLLSEENES 297

Query: 337 NRFKRKALRVIAEFLSVEEVE 357
               +   +         E E
Sbjct: 298 TALPQVLAQPSTSRKRPREGE 318

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  457 bits (1178), Expect = e-158
 Identities = 100/394 (25%), Positives = 168/394 (42%), Gaps = 11/394 (2%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
                   + V+   +   +         KQ       +  +++ D Y +  ELG G FG
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFG 171

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN 125
           V +   +R T    A K +         D + VR+E+  M  L ++ ++V+L +A EDDN
Sbjct: 172 VVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVL-RHPTLVNLHDAFEDDN 227

Query: 126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL 184
            + ++ E   GGELF+++       +E  A    R + + +   H++  +H DLKPEN +
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287

Query: 185 FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVIL 243
           F  K+ N  LK IDFGL+    P +      G+  + APEV + +  G   D+WS GV+ 
Sbjct: 288 FTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

Query: 244 YILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAK 303
           YILL G+ PF  E++    + +     +     +  +SE  K  +R++L  DP  R+T  
Sbjct: 347 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH 406

Query: 304 QVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMF 363
           Q LEHPWL             +  SR  +     + K  A         +  + +   + 
Sbjct: 407 QALEHPWLTPGNAPGRD--SQIPSSRYTKIRDSIKTKYDA--WPEPLPPLGRISNYSSLR 462

Query: 364 KKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
           K    +     +  +       F  +   +EV  
Sbjct: 463 KHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGE 496

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  450 bits (1159), Expect = e-158
 Identities = 97/355 (27%), Positives = 166/355 (46%), Gaps = 28/355 (7%)

Query: 24  DHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKS 83
           +   K      K+ +     V + ++ D Y +  ELG G FGV + C+++ T  +   K 
Sbjct: 24  NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83

Query: 84  ISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI 143
           I+       +D   V+ E++IM  L  +  +++L +A ED   + L++E   GGELFDRI
Sbjct: 84  INTPYP---LDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 139

Query: 144 VARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            A  +  +E       R   E ++  H+H ++H D+KPEN +   K + S +K IDFGL+
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLA 198

Query: 203 IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
               P E       +  + APE++ R   G   D+W+ GV+ Y+LL G+ PF  E +   
Sbjct: 199 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 258

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
            Q + R   +F  D + +VS  AK  ++ +L+ +P+ RLT    LEHPWL+         
Sbjct: 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318

Query: 322 LGDVVRS---------------------RLKQFSMMNRFKRKALRVIAEFLSVEE 355
           +     +                     R+  FS + + + +  ++   +   +E
Sbjct: 319 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 373

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  445 bits (1147), Expect = e-157
 Identities = 99/307 (32%), Positives = 141/307 (45%), Gaps = 35/307 (11%)

Query: 46  KENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
               ED Y +  + LG G       CI+  T +  A K I K+          V REV +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEM 63

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           +     + +++ L E  E+++  +LV E   GG +   I  R H+ E  A+ V + +   
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VG 216
           +   H  G+ HRDLKPEN L  +  + SP+K  DF L    K     S I         G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 217 SPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAE-------------- 256
           S  YMAPEV++        Y    D+WS GVILYILL G PPF                 
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243

Query: 257 -SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
             +  + ++I  G  +F    W ++S +AK L+ ++L  D K RL+A QVL+HPW+Q   
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG-- 301

Query: 316 KAPNVPL 322
            AP   L
Sbjct: 302 CAPENTL 308

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  444 bits (1145), Expect = e-157
 Identities = 111/348 (31%), Positives = 162/348 (46%), Gaps = 26/348 (7%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRE-LGRGEFGVTYLCIDRDTRELLA 80
           +H H    +G    + +       K  + D Y + ++ LG G  G    C  R T +  A
Sbjct: 2   AHHHHHHSSGL---EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA 58

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----DNAVHLVMELCEG 136
            K +              R+EV           IV + +  E+       + ++ME  EG
Sbjct: 59  LKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110

Query: 137 GELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL 194
           GELF RI  RG   +TER AA + R I   +Q  H H + HRD+KPEN L+ +K++++ L
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170

Query: 195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPF 253
           K  DFG +              +PYY+APEVL    Y    D+WS GVI+YILLCG PPF
Sbjct: 171 KLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

Query: 254 WAESEQ----GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           ++ + Q    G+ + I  G   F    W  VSE AK L+R +L+ DP  RLT  Q + HP
Sbjct: 230 YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289

Query: 310 WLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEF-LSVEEV 356
           W+  +   P  PL    R   +     +  K +    +A   +  ++V
Sbjct: 290 WINQSMVVPQTPL-HTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV 336

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  433 bits (1116), Expect = e-152
 Identities = 101/361 (27%), Positives = 174/361 (48%), Gaps = 30/361 (8%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLA-------------GVPKE 47
           M N     +     + K  +S+ D   +    +K+     +                 + 
Sbjct: 24  MKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQG 83

Query: 48  NIEDRYLVDR--ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
            +   Y V +   LG G FG  + C +  T   LA K I  R ++   D ++V+ E+++M
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVM 140

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEV 164
             L  +++++ L +A E  N + LVME  +GGELFDRI+   +  TE       + I E 
Sbjct: 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           ++  H+  ++H DLKPEN L  N+ +   +K IDFGL+  +KP E+     G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES 283
           V+  +      D+WS GVI Y+LL G+ PF  +++      IL    D + + + ++SE 
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMN--RFKR 341
           AK  + ++L  +   R++A + L+HPWL + K          + ++ K+    +   F  
Sbjct: 319 AKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR------LSAQKKKNRGSDAQDFVT 372

Query: 342 K 342
           K
Sbjct: 373 K 373

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  424 bits (1093), Expect = e-149
 Identities = 94/314 (29%), Positives = 140/314 (44%), Gaps = 39/314 (12%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
               I+D  +  + LG G  G      ++ T+E  A K +              RREV +
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVEL 63

Query: 105 MKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 158
                +   IV + +  E+       + +VME  +GGELF RI  RG   +TER A+ + 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSP 218
           ++I E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG                  
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166

Query: 219 YYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKR 274
              A E     Y    D+WS GVI+YILLCG PPF++        G+   I  G  +F  
Sbjct: 167 ---AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFS 334
             W  VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL      +  +  
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE- 282

Query: 335 MMNRFKRKALRVIA 348
                K +    +A
Sbjct: 283 RWEDVKEEMTSALA 296

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  424 bits (1091), Expect = e-147
 Identities = 100/278 (35%), Positives = 149/278 (53%), Gaps = 12/278 (4%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----RTAVDIDDVRR 100
            + + D Y++ + LG G  G   L  +R T + +A + ISKRK      R A    +V  
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E+ I+K L  +  I+ +K   + ++  ++V+EL EGGELFD++V      E         
Sbjct: 190 EIEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  VQ  H++G+IHRDLKPEN L ++++E+  +K  DFG S           + G+P Y
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307

Query: 221 MAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRD 275
           +APEVL       Y   +D WS GVIL+I L G PPF     +  +   I  G  +F  +
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            W  VSE A  LV+++L  DPK R T ++ L HPWLQ+
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  420 bits (1080), Expect = e-147
 Identities = 97/349 (27%), Positives = 161/349 (46%), Gaps = 57/349 (16%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H    +G   ++ +    G     ++ +Y +   +G+G +GV  + I+  TR + A K
Sbjct: 2   HHHHHHSSG---RENLYFQ-GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57

Query: 83  SISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            ++K K+R     D++ ++ EV +MK L  + +I  L E  ED+  + LVMELC GG L 
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLL 116

Query: 141 DRIVARGH----------------------------------------YTERAAAAVTRT 160
           D++                                               E+  + + R 
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-----GERFSEIV 215
           I   +   H  G+ HRD+KPENFLF+   ++  +K +DFGLS  F           +   
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 216 GSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF 272
           G+PY++APEVL     +YGP+ D WSAGV+L++LL G  PF   ++      +L   + F
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL-QNAKKAPNV 320
           +   +  +S  A+ L+  +L  +   R  A + L+HPW+ Q + K   +
Sbjct: 296 ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  313 bits (803), Expect = e-104
 Identities = 77/341 (22%), Positives = 134/341 (39%), Gaps = 50/341 (14%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           ++++++  + ++ LG G  G             +A K +           D    E+ ++
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLL 62

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-------TERAAAAVT 158
                + +++    +   D  +++ +ELC    L D + ++           E    ++ 
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------ENSPLKAIDFGLSIFFKPG 208
           R I   V   H   +IHRDLKP+N L +             EN  +   DFGL      G
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 209 E-----RFSEIVGSPYYMAPEVL--------KRNYGPEIDIWSAGVILYILLC-GVPPFW 254
           +       +   G+  + APE+L        KR     IDI+S G + Y +L  G  PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 255 AESEQGVAQAILRG---LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            +  +     I+RG   L + K     ++   A  L+ QM++ DP  R TA +VL HP  
Sbjct: 242 DKYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

Query: 312 QNAKKAPNVPLGDV-----VRSRLKQFSMMNRFKRKALRVI 347
               K     L  V     + +R    +++ +F   +  VI
Sbjct: 300 WPKSKKLEFLL-KVSDRLEIENRDPPSALLMKFDAGSDFVI 339

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  305 bits (784), Expect = e-101
 Identities = 72/339 (21%), Positives = 140/339 (41%), Gaps = 28/339 (8%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +  +     LG G  G T +         +A K I               REV +++   
Sbjct: 23  KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLC 168
           ++ +++      +D    ++ +ELC    L + +  +   +       + +     +   
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAI--DFGLSIFFKPGE----RFSEIVGSPYYMA 222
           H   ++HRDLKP N L +    +  +KA+  DFGL      G     R S + G+  ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 223 PEVL----KRNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           PE+L    K N    +DI+SAG + Y ++  G  PF    ++     +    +D    P 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP--LGDVVRSRLKQFSM 335
            +    A+ L+ +M+  DP+ R +AK VL+HP+  + +K       + D +        +
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPI 313

Query: 336 MNRFKRKALRVIA----EFLSVEEVEDIKEMFKKIDSDN 370
           + + +R    V+     E ++V    D+++ F+     +
Sbjct: 314 VKQLERGGRAVVKMDWRENITVPLQTDLRK-FRTYKGGS 351

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  287 bits (735), Expect = 4e-95
 Identities = 66/315 (20%), Positives = 117/315 (37%), Gaps = 43/315 (13%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +      +L+   LG+G     +    + T +L A K  +         +D   RE  ++
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61

Query: 106 KHLPKNSSIVSLKEACEDDNAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTRT 160
           K L  + +IV L    E+    H  L+ME C  G L+  +    +     E     V R 
Sbjct: 62  KKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 161 IVEVVQLCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           +V  +    ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 220 YMAPEVLKR---------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--- 267
           Y+ P++ +R          YG  +D+WS GV  Y    G  PF         + ++    
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 268 ----------------GLIDFKRD--PWPNVSESAKSLV----RQMLEPDPKLRLTAKQV 305
                           G ID+  D     ++S   + L+      +LE D +      Q 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 306 LEHPWLQNAKKAPNV 320
                    +   + 
Sbjct: 301 FAETSDILHRGNSHH 315

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  277 bits (711), Expect = 1e-90
 Identities = 67/315 (21%), Positives = 118/315 (37%), Gaps = 43/315 (13%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +      +L+   LG+G     +    + T +L A K  +         +D   RE  ++
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61

Query: 106 KHLPKNSSIVSLKEACEDDNAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTRT 160
           K L  + +IV L    E+    H  L+ME C  G L+  +    +     E     V R 
Sbjct: 62  KKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 161 IVEVVQLCHKHGVIHRDLKPENFL-FANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
           +V  +    ++G++HR++KP N +    +   S  K  DFG +   +  E+F  + G+  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 220 YMAPEVLKRN---------YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR--- 267
           Y+ P++ +R          YG  +D+WS GV  Y    G  PF         + ++    
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 268 ----------------GLIDFKRD--PWPNVSESAKSLV----RQMLEPDPKLRLTAKQV 305
                           G ID+  D     ++S   + L+      +LE D +      Q 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 306 LEHPWLQNAKKAPNV 320
                    +   +V
Sbjct: 301 FAETSDILHRMVIHV 315

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  273 bits (699), Expect = 1e-89
 Identities = 71/308 (23%), Positives = 133/308 (43%), Gaps = 28/308 (9%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           H H    +G +          +  +     Y + +++G G     +  ++ + +++ A K
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSVKGR--IYSILKQIGSGGSSKVFQVLN-EKKQIYAIK 58

Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLP-KNSSIVSLKEACEDDNAVHLVMELCEGGELFD 141
            ++  +      +D  R E+A +  L   +  I+ L +    D  +++VME C   +L  
Sbjct: 59  YVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNS 116

Query: 142 RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
            +  +         +  + ++E V   H+HG++H DLKP NFL  +      LK IDFG+
Sbjct: 117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGI 172

Query: 202 SIFFKPGERFSE---IVGSPYYMAPEVLKRN------------YGPEIDIWSAGVILYIL 246
           +   +P          VG+  YM PE +K                P+ D+WS G ILY +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

Query: 247 LCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
             G  PF     Q     AI+    + + +      +  + +++  L+ DPK R++  ++
Sbjct: 233 TYGKTPFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

Query: 306 LEHPWLQN 313
           L HP++Q 
Sbjct: 291 LAHPYVQI 298

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  271 bits (694), Expect = 1e-88
 Identities = 73/327 (22%), Positives = 135/327 (41%), Gaps = 32/327 (9%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-K 110
            Y + +++G G     +  ++   +++ A K ++  +      +D  R E+A +  L   
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  I+ L +    D  +++VME C   +L   +  +         +  + ++E V   H+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---IVGSPYYMAPEVLK 227
           HG++H DLKP NFL  +      LK IDFG++   +P          VG+  YM PE +K
Sbjct: 127 HGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 228 R------------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKR 274
                           P+ D+WS G ILY +  G  PF     Q     AI+    + + 
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEI 240

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS------ 328
           +      +  + +++  L+ DPK R++  ++L HP++Q      N               
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300

Query: 329 RLKQFSMMNRFKRKALRVIAEFLSVEE 355
           +L   +  N   + A  +   +   E 
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGES 327

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  269 bits (690), Expect = 1e-88
 Identities = 67/299 (22%), Positives = 115/299 (38%), Gaps = 41/299 (13%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
               +     LG+G FG      +       A K I   +      +  +  EV ++  L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59

Query: 109 PKNSSIVSLKEACEDDNAVH-------------LVMELCEGGELFDRIVARGHYTERAAA 155
             +  +V    A  +                  + ME CE G L+D I +     +R   
Sbjct: 60  -NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 156 A-VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------ 202
             + R I+E +   H  G+IHRDLKP N       E+  +K  DFGL+            
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 203 ---IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
                    +  +  +G+  Y+A EVL    +Y  +ID++S G+I + ++   P      
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
              + + +    I+F  D   N  +  K ++R +++ DP  R  A+ +L   WL    +
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  267 bits (685), Expect = 6e-88
 Identities = 86/273 (31%), Positives = 133/273 (48%), Gaps = 10/273 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            RY+  R LG+G F   +   D DT+E+ A K + K  L      + +  E++I + L  
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 73

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +V      ED++ V +V+ELC    L +    R   TE  A    R IV   Q  H+
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMAPEVLKRN 229
           + VIHRDLK  N    N+     +K  DFGL+   +  GER   + G+P Y+APEVL + 
Sbjct: 134 NRVIHRDLKLGNLFL-NEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +  E+D+WS G I+Y LL G PPF     +     I +   ++       ++  A SL+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 246

Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           ++ML+ DP  R T  ++L   +  +      +P
Sbjct: 247 QKMLQTDPTARPTINELLNDEFFTSGYIPARLP 279

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  268 bits (686), Expect = 2e-87
 Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 10/294 (3%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
                A   A A       +   +       RY+  R LG+G F   +   D DT+E+ A
Sbjct: 11  GVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA 70

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            K + K  L      + +  E++I + L  +  +V      ED++ V +V+ELC    L 
Sbjct: 71  GKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLL 129

Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
           +    R   TE  A    R IV   Q  H++ VIHRDLK  N    N+     +K  DFG
Sbjct: 130 ELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-NEDLE--VKIGDFG 186

Query: 201 LSIFFK-PGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
           L+   +  GER   + G+P Y+APEVL +  +  E+D+WS G I+Y LL G PPF     
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +     I +   ++       ++  A SL+++ML+ DP  R T  ++L   +  
Sbjct: 247 KETYLRIKKN--EYSIPKH--INPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  269 bits (689), Expect = 3e-87
 Identities = 76/373 (20%), Positives = 146/373 (39%), Gaps = 32/373 (8%)

Query: 5   CRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEF 64
                +  +E   + +        + G +     +  A          Y + +++G G  
Sbjct: 10  LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGS 69

Query: 65  GVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSSIVSLKEACED 123
              +  ++ + +++ A K ++  +      +D  R E+A +  L   +  I+ L +    
Sbjct: 70  SKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127

Query: 124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF 183
           D  +++VME C   +L   +  +         +  + ++E V   H+HG++H DLKP NF
Sbjct: 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186

Query: 184 LFANKKENSPLKAIDFGLSIFFKPGERFSE---IVGSPYYMAPEVLKR------------ 228
           L  +      LK IDFG++   +P          VG+  YM PE +K             
Sbjct: 187 LIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESAKSL 287
              P+ D+WS G ILY +  G  PF     Q     AI+    + + +      +  + +
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQDV 300

Query: 288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS------RLKQFSMMNRFKR 341
           ++  L+ DPK R++  ++L HP++Q      N               +L   +  N   +
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILK 360

Query: 342 KALRVIAEFLSVE 354
            A  +   +   E
Sbjct: 361 AAKTLYEHYSGGE 373

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  264 bits (677), Expect = 3e-86
 Identities = 91/272 (33%), Positives = 145/272 (53%), Gaps = 11/272 (4%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y + + +G+G F    L     T   +A K I K +L     +  + REV IMK L  +
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NH 73

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +IV L E  E +  ++L+ME   GGE+FD +VA G   E+ A +  R IV  VQ CH+ 
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            ++HRDLK EN L      +  +K  DFG S  F  G +     G+P Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+D+WS GVILY L+ G  PF  ++ + + + +LRG   ++   +  +S   ++L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLK 246

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
           + L  +P  R T +Q+++  W+    +   + 
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  264 bits (676), Expect = 1e-85
 Identities = 53/341 (15%), Positives = 100/341 (29%), Gaps = 46/341 (13%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
           ++   A       +    TV + + +   E +  +   L  G+  V +L  D +  E  A
Sbjct: 34  AAMVEAVTATVWPQNAETTVDSLLSQG--ERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-----------------------SIVSL 117
            K  +     +  +++ +         L   S                           L
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 118 KEACEDDNAVH--LVMELCEG------GELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
               +D    +  L+M             L    V RG     A   +T  ++ +     
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN 229
             G++H    P+N        +  L   D      +K G R         Y   E L  +
Sbjct: 212 SKGLVHGHFTPDNLFI---MPDGRLMLGDVSAL--WKVGTRGPASSVPVTYAPREFLNAS 266

Query: 230 ---YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-----PNVS 281
              +   ++ W  G+ +Y + C   PF   +           L     D         + 
Sbjct: 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP 326

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
           +  K+L+ + L  D + RL   + +E P     +   +  L
Sbjct: 327 DFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSL 367

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  263 bits (674), Expect = 2e-85
 Identities = 53/363 (14%), Positives = 112/363 (30%), Gaps = 62/363 (17%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
           R P A  R   +   S+ D     +  N  QP  V + + +       +    LG+ +  
Sbjct: 30  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--PRTLVRGTVLGQEDPY 87

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS------------ 113
                 D++T E          +   +  I  ++ EV  ++ L    +            
Sbjct: 88  AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147

Query: 114 ------------IVSLKEACEDDNA--VHLVMELCE------GGELFDRIVARGHYTERA 153
                       ++ ++    D        +    +      G  L             A
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
              +T  ++ ++   H +G++H  L+P + +     +   +    F              
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHL---VRDGARVV 261

Query: 214 IVGSPYYMAPEVLKRN------------YGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
              S  +  PE+  R                  D W+ G+++Y + C   P   ++  G 
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK--APN 319
           ++ I R           N+ +  ++L+   L    + RL   Q +E P  +  +   +  
Sbjct: 322 SEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 373

Query: 320 VPL 322
           +PL
Sbjct: 374 LPL 376

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  260 bits (666), Expect = 3e-85
 Identities = 92/286 (32%), Positives = 141/286 (49%), Gaps = 12/286 (4%)

Query: 41  LAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           LA    E IED + V   LG+G F   Y      T   +A K I K+ +  A  +  V+ 
Sbjct: 2   LATCIGEKIED-FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTR 159
           EV I   L K+ SI+ L    ED N V+LV+E+C  GE+   +  R   ++E  A     
Sbjct: 61  EVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSP 218
            I+  +   H HG++HRDL   N L         +K  DFGL+   K P E+   + G+P
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTP 176

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
            Y++PE+  R+ +G E D+WS G + Y LL G PPF  ++ +     ++    D++   +
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF 234

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLG 323
             +S  AK L+ Q+L  +P  RL+   VL+HP++       +   G
Sbjct: 235 --LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  255 bits (653), Expect = 2e-83
 Identities = 97/272 (35%), Positives = 137/272 (50%), Gaps = 10/272 (3%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +   + T   +A K ++++K+R+   +  ++RE+  +K   ++
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RH 70

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +         +VME   GGELFD I   G   E  A  + + I+  V  CH+H
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNY 230
            V+HRDLKPEN L      +   K  DFGLS     GE      GSP Y APEV+  R Y
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS GVILY LLCG  PF  E    + + I  G   F    +  ++ S  +L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLM 243

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
            ML+ DP  R T K + EH W +    +   P
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  256 bits (656), Expect = 3e-83
 Identities = 91/312 (29%), Positives = 141/312 (45%), Gaps = 34/312 (10%)

Query: 21  SSHDHARKEAGA----------NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLC 70
           SSH H    +G           N      +  G  KE +E +Y V   LG G FG  Y  
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 71  IDRDTRELLACKSISKRKLRTAVDIDD---VRREVAIMK---HLPKNSSIVSLKEACEDD 124
           I       +A K + K ++    ++ +   V  EV ++K          ++ L +  E  
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG--VIRLLDWFERP 120

Query: 125 NAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF 183
           ++  L++E  E   +LFD I  RG   E  A +    ++E V+ CH  GV+HRD+K EN 
Sbjct: 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180

Query: 184 LFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY-GPEIDIWSAGV 241
           L    +    LK IDFG     K    +++  G+  Y  PE ++   Y G    +WS G+
Sbjct: 181 LIDLNRGE--LKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237

Query: 242 ILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT 301
           +LY ++CG  PF  + E      I+RG + F+      VS   + L+R  L   P  R T
Sbjct: 238 LLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPT 287

Query: 302 AKQVLEHPWLQN 313
            +++  HPW+Q+
Sbjct: 288 FEEIQNHPWMQD 299

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  254 bits (650), Expect = 9e-83
 Identities = 91/293 (31%), Positives = 154/293 (52%), Gaps = 11/293 (3%)

Query: 39  TVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD 97
           T LA +PK     D + + R LG+G+FG  YL  ++  + ++A K + K +L        
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60

Query: 98  VRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           +RRE+ I  HL ++ +I+ +     D   ++L++E    GEL+  +   G + E+ +A  
Sbjct: 61  LRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 119

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
              + + +  CH+  VIHRD+KPEN L   K E   LK  DFG S+   P  R   + G+
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGT 175

Query: 218 PYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
             Y+ PE++  + +  ++D+W AGV+ Y  L G+PPF + S     + I+    D K  P
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPP 233

Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
           +  +S+ +K L+ ++L   P  RL  K V+EHPW++   +    P+    +S+
Sbjct: 234 F--LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  253 bits (648), Expect = 1e-82
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 10/269 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  CH 
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             VIHRD+KPEN L         LK  DFG S+   P  R +++ G+  Y+ PE+++   
Sbjct: 128 KRVIHRDIKPENLLLG---SAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRM 183

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  ++D+WS GV+ Y  L G PPF A + Q   + I R   +F    +  V+E A+ L+ 
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLIS 239

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
           ++L+ +P  R   ++VLEHPW+      P
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKP 268

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  254 bits (651), Expect = 3e-82
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 22/290 (7%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-----VRR 100
           +     +Y     LG G FG  +  +D++  + +  K I K K+     I+D     V  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTR 159
           E+AI+  + ++++I+ + +  E+     LVME    G +LF  I       E  A+ + R
Sbjct: 79  EIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            +V  V       +IHRD+K EN + A   E+  +K IDFG + + + G+ F    G+  
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194

Query: 220 YMAPEVLKRN-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APEVL  N Y GPE+++WS GV LY L+    PF    E       +           
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA--AIHPPYL 246

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVR 327
             VS+   SLV  +L+P P+ R T ++++  PW+       +    +V R
Sbjct: 247 --VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  253 bits (648), Expect = 4e-82
 Identities = 79/320 (24%), Positives = 128/320 (40%), Gaps = 22/320 (6%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
           S      +   A    P     G  +E  E  Y +   LG+G FG  +       R  +A
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60

Query: 81  CKSISKRKLRTAVDIDD---VRREVAIMKHLPKNSS---IVSLKEACEDDNAVHLVMEL- 133
            K I + ++     + D      EVA++  +        ++ L +  E      LV+E  
Sbjct: 61  IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120

Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP 193
               +LFD I  +G   E  +      +V  +Q CH  GV+HRD+K EN L   ++    
Sbjct: 121 LPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-- 178

Query: 194 LKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY-GPEIDIWSAGVILYILLCGVP 251
            K IDFG          +++  G+  Y  PE +    Y      +WS G++LY ++CG  
Sbjct: 179 AKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237

Query: 252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           PF  + E      IL    +        VS    +L+R+ L P P  R + +++L  PW+
Sbjct: 238 PFERDQE------ILEA--ELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

Query: 312 QNAKKAPNVPLGDVVRSRLK 331
           Q   +   +       + L 
Sbjct: 288 QTPAEDVPLNPSKGGPAPLA 307

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  261 bits (668), Expect = 4e-81
 Identities = 77/339 (22%), Positives = 133/339 (39%), Gaps = 33/339 (9%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
                  + +   LG G FG     I +DT E +A K   +    +  + +    E+ IM
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIM 66

Query: 106 KHLPKNSSIVSLKEACEDDNAVH------LVMELCEGGELFDRIVARGH---YTERAAAA 156
           K L  + ++VS +E  +    +       L ME CEGG+L   +    +     E     
Sbjct: 67  KKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           +   I   ++  H++ +IHRDLKPEN +     +    K ID G +     GE  +E VG
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------- 267
           +  Y+APE+L+ + Y   +D WS G + +  + G  PF    +       +R        
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 268 ------GLIDFKRD-PWPN-----VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
                 G + F    P PN     ++   +  ++ ML    + R T  Q       Q   
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305

Query: 316 KAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVE 354
              ++ L  V+     +       + + L+ +  +L  +
Sbjct: 306 SILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQD 344

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  252 bits (645), Expect = 5e-81
 Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 16/292 (5%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P  +  DRY   +++G G FGV  L  D+ T+EL+A K I +         ++V+RE+ 
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREII 68

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             + L ++ +IV  KE       + ++ME   GGEL++RI   G ++E  A    + ++ 
Sbjct: 69  NHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127

Query: 164 VVQLCHKHGVIHRDLKPENFLF-ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
            V  CH   + HRDLK EN L   +      LK  DFG S       +    VG+P Y+A
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIA 185

Query: 223 PEVL-KRNY-GPEIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRDP 276
           PEVL ++ Y G   D+WS GV LY++L G  PF    E    +   Q IL     +    
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV--KYSIPD 243

Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRS 328
              +S     L+ ++   DP  R++  ++  H W      A  +   +    
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  249 bits (638), Expect = 5e-81
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 14/268 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + + LG G +G   L ++R T E +A K +  ++     +  ++++E+ I K L  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKML-N 63

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V       + N  +L +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVL- 226
            G+ HRD+KPEN L     E   LK  DFGL+  F+   R   +    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 227 KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESA 284
           +R +    +D+WS G++L  +L G  P+   S+                 +PW  +  + 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            +L+ ++L  +P  R+T   + +  W  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  250 bits (640), Expect = 1e-80
 Identities = 91/281 (32%), Positives = 144/281 (51%), Gaps = 11/281 (3%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   L     T++ +A K IS++ L+ +     V RE++ +K L ++
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +       + +V+E   GGELFD IV +   TE       + I+  ++ CH+H
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNY 230
            ++HRDLKPEN L     +N  +K  DFGLS     G       GSP Y APEV+  + Y
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+D+WS G++LY++L G  PF  E    + + +      +    +  +S  A+SL+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIR 240

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRL 330
           +M+  DP  R+T +++   PW          P+ +V  S  
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYA 281

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  248 bits (636), Expect = 3e-80
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 14/268 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + + LG G +G   L ++R T E +A K +  ++     +  ++++E+ I K L  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKML-N 63

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V       + N  +L +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVL- 226
            G+ HRD+KPEN L     E   LK  DFGL+  F+   R   +    G+  Y+APE+L 
Sbjct: 124 IGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 227 KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWPNVSESA 284
           +R +    +D+WS G++L  +L G  P+   S+                 +PW  +  + 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            +L+ ++L  +P  R+T   + +  W  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  253 bits (649), Expect = 3e-80
 Identities = 97/272 (35%), Positives = 140/272 (51%), Gaps = 10/272 (3%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            Y++   LG G FG   +     T   +A K ++++K+R+   +  +RRE+  +K   ++
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RH 75

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
             I+ L +     + + +VME   GGELFD I   G   E+ +  + + I+  V  CH+H
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL-KRNY 230
            V+HRDLKPEN L      +   K  DFGLS     GE      GSP Y APEV+  R Y
Sbjct: 136 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192

Query: 231 -GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
            GPE+DIWS+GVILY LLCG  PF  +    + + I  G   F    +  ++ S  SL++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLK 248

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
            ML+ DP  R T K + EH W +        P
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFP 280

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  247 bits (633), Expect = 6e-80
 Identities = 82/291 (28%), Positives = 138/291 (47%), Gaps = 37/291 (12%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD----------------- 94
           +Y +  E+G+G +GV  L  + +     A K +SK+KL                      
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 95  ------IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL--VMELCEGGELFDRIVAR 146
                 I+ V +E+AI+K L  + ++V L E  +D N  HL  V EL   G + + +   
Sbjct: 74  IQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131

Query: 147 GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
              +E  A    + +++ ++  H   +IHRD+KP N L     E+  +K  DFG+S  FK
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFK 188

Query: 207 PGERF-SEIVGSPYYMAPEVL---KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
             +   S  VG+P +MAPE L   ++ + G  +D+W+ GV LY  + G  PF  E    +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
              I       +    P+++E  K L+ +ML+ +P+ R+   ++  HPW+ 
Sbjct: 249 HSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  244 bits (624), Expect = 2e-78
 Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 13/270 (4%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P+   +  +     LG G +G  +    ++   L A K  S    R   D      EV  
Sbjct: 51  PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGS 109

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVE 163
            + + ++   V L++A E+   ++L  ELC G  L     A G    E       R  + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            +   H  G++H D+KP N            K  DFGL +            G P YMAP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

Query: 224 EVLKRNYGPEIDIWSAGVILYILLCGVP-PFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
           E+L+ +YG   D++S G+ +  + C +  P   E  Q + Q  L             +S 
Sbjct: 226 ELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSS 279

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
             +S++  MLEPDPKLR TA+ +L  P L+
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  236 bits (604), Expect = 7e-76
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 25/278 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + Y V   +G G +G       +   ++L  K +    + T  +   +  EV +++ L K
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 63

Query: 111 NSSIVSLKEA--CEDDNAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEV 164
           + +IV   +      +  +++VME CEGG+L   I      R +  E     V   +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 165 VQLCHK-----HGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGS 217
           ++ CH+     H V+HRDLKP N FL   +     +K  DFGL+        F++  VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFAKTFVGT 179

Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP 276
           PYYM+PE +   +Y  + DIWS G +LY L   +PPF A S++ +A  I  G    K   
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KFRR 235

Query: 277 WPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            P   S+    ++ +ML      R + +++LE+P +  
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  235 bits (602), Expect = 1e-74
 Identities = 78/301 (25%), Positives = 146/301 (48%), Gaps = 16/301 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y+  +++G G FG   L    +       K I+  ++ ++ + ++ RREVA++ ++ K
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-K 81

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLC 168
           + +IV  +E+ E++ ++++VM+ CEGG+LF RI A+    + E         I   ++  
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 169 HKHGVIHRDLKPEN-FLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVL 226
           H   ++HRD+K +N FL  +      ++  DFG++         +   +G+PYY++PE+ 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
           +   Y  + DIW+ G +LY L      F A S + +   I+ G       P   + S   
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPPVSLHYSYDL 253

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           +SLV Q+ + +P+ R +   +LE  ++    +    P        LK FS        A 
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAK 313

Query: 345 R 345
           R
Sbjct: 314 R 314

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  235 bits (601), Expect = 1e-74
 Identities = 66/360 (18%), Positives = 127/360 (35%), Gaps = 59/360 (16%)

Query: 16  VKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDT 75
           +K   S++ +        K++   +          + Y + R L +G+F    LC     
Sbjct: 6   MKDILSNYSNLIYLNKYVKEKDKYI----------NDYRIIRTLNQGKFNKIILC--EKD 53

Query: 76  RELLACKSISKRKLRTAVDI--------------DDVRREVAIMKHLPKNSSIVSLKEAC 121
            +  A K   K  L    D               DD + E+ I+  + KN   ++ +   
Sbjct: 54  NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGII 112

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGH--------YTERAAAAVTRTIVEVVQLCHKH-G 172
            + + V+++ E  E   +                    +    + ++++      H    
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN 172

Query: 173 VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--- 229
           + HRD+KP N L     +N  +K  DFG S +    ++     G+  +M PE        
Sbjct: 173 ICHRDVKPSNILM---DKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSY 228

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGLIDF---------------K 273
            G ++DIWS G+ LY++   V PF  + S   +   I    I++                
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKS 288

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQF 333
                 +S      ++  L  +P  R+T++  L+H WL +            +  + K+ 
Sbjct: 289 TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  229 bits (585), Expect = 1e-72
 Identities = 69/282 (24%), Positives = 131/282 (46%), Gaps = 20/282 (7%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD-VRREVAIMKHLPK 110
           +YL+   LG G +G     +D +T    A K + K+KLR   + +  V++E+ +++ L +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64

Query: 111 NSSIVSLKE--ACEDDNAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +++ L +    E+   +++VME C  G  E+ D +     +    A      +++ ++
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLE 123

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---IFFKPGERFSEIVGSPYYMAP 223
             H  G++H+D+KP N L         LK    G++     F   +      GSP +  P
Sbjct: 124 YLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 224 EVL--KRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           E+      + G ++DIWSAGV LY +  G+ PF  ++   + + I +G   +        
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--C 236

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL 322
                 L++ MLE +P  R + +Q+ +H W +        P+
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  218 bits (557), Expect = 2e-68
 Identities = 76/310 (24%), Positives = 132/310 (42%), Gaps = 16/310 (5%)

Query: 21  SSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLA 80
                  +     + QP   L      N    + +++++GRG+F   Y          +A
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 81  CKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELF 140
            K +    L  A    D  +E+ ++K L  + +++    +  +DN +++V+EL + G+L 
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLS 120

Query: 141 DRIVARG----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN-FLFANKKENSPLK 195
             I           ER        +   ++  H   V+HRD+KP N F+ A       +K
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----VK 176

Query: 196 AIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPF 253
             D GL  FF      +  +VG+PYYM+PE +  N Y  + DIWS G +LY +     PF
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

Query: 254 WAESE--QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
           + +      + + I +   D+   P  + SE  + LV   + PDP+ R     V +    
Sbjct: 237 YGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294

Query: 312 QNAKKAPNVP 321
            +A  A ++ 
Sbjct: 295 MHACTASSLE 304

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  216 bits (553), Expect = 3e-68
 Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 38/294 (12%)

Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           A    +     +     +G G FG  +    R   +    K +           +   RE
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAERE 54

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNA----------------VHLVMELCEGGELFDRIVA 145
           V  +  L  + +IV      +  +                 + + ME C+ G L   I  
Sbjct: 55  VKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113

Query: 146 R--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
           R      +  A  +   I + V   H   +I+RDLKP N    + K+   +K  DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVT 170

Query: 204 FFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
             K   + +   G+  YM+PE +  ++YG E+D+++ G+IL  LL               
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFF 228

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             +  G+I           +  K+L++++L   P+ R    ++L    +     
Sbjct: 229 TDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  216 bits (553), Expect = 7e-68
 Identities = 64/300 (21%), Positives = 105/300 (35%), Gaps = 37/300 (12%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            YL  ++LG G F    L          A K I   + +   D ++ +RE  + +    +
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLF-NH 85

Query: 112 SSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVE 163
            +I+ L   C  +        L++   + G L++ I          TE     +   I  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---------- 213
            ++  H  G  HRDLKP N L  ++ +      +D G           S           
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 214 IVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQG--VAQAILR 267
              +  Y APE+             D+WS G +LY ++ G  P+    ++G  VA A+  
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW-LQNAKKAPNVPLGDVV 326
                     P  S +   L+  M+  DP  R     +L     LQ    AP      ++
Sbjct: 263 Q---LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP--APGQHTTQIL 317

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  208 bits (531), Expect = 6e-65
 Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 34/295 (11%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
            K      +    ++G GEFG  + C+ R    + A K  SK+ L  +VD  +  REV  
Sbjct: 5   MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYA 63

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRT 160
              L ++S +V    A  +D+ + +  E C GG L D I        ++ E     +   
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 161 IVEVVQLCHKHGVIHRDLKPEN-FLFANKKENSPLKAI---------------DFGLSIF 204
           +   ++  H   ++H D+KP N F+      N+  +                 D G    
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182

Query: 205 FKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
            +      E  G   ++A EVL+ N  + P+ DI++  + +       P      +    
Sbjct: 183 -RISSPQVE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237

Query: 263 QAILRGLIDFKRDPWPNV-SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
             I +G    +    P V S+    L++ M+ PDP+ R +A  +++H  L +A +
Sbjct: 238 HEIRQG----RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  207 bits (529), Expect = 5e-64
 Identities = 74/299 (24%), Positives = 110/299 (36%), Gaps = 41/299 (13%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
           R  V R L  G F   Y   D  +    A K +   +         + +EV  MK L  +
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGH 85

Query: 112 SSIVSLKEACEDDNA--------VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTRTI 161
            +IV    A                L+ ELC+G   E   ++ +RG  +      +    
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 162 VEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS------- 212
              VQ  H+    +IHRDLK EN L +       +K  DFG +        +S       
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 213 ------EIVGSPYYMAPEVL----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
                     +P Y  PE++        G + DIW+ G ILY+L     PF    E G  
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAK 258

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
             I+ G   +   P         SL+R ML+ +P+ RL+  +V+       A +  N  
Sbjct: 259 LRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  208 bits (530), Expect = 2e-63
 Identities = 52/351 (14%), Positives = 104/351 (29%), Gaps = 59/351 (16%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITV---LAGVPKENIEDRYLVDRELGRG 62
           R P A  R   +   S+ D     +  N  QP  V   L   P+       +    LG+ 
Sbjct: 35  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR-----TLVRGTVLGQE 89

Query: 63  EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP------------- 109
           +        D++T E          +   +  I  ++ EV  ++ L              
Sbjct: 90  DPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149

Query: 110 --------KNSSIVSLKEACEDDN-----AVHLVMELCEG------GELFDRIVARGHYT 150
                   K+     +     D+      +   +    +         L           
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
             A   +T  ++ ++   H +G++H  L+P + +     +   +    F   +       
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGASAV 266

Query: 211 FS--EIVGSPYYMAPEVL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA 262
                    P   A  +L              D W+ G+ +Y + C   P   ++  G +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           + I R           N+ +  ++L+   L    + RL   Q +E P  + 
Sbjct: 327 EWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  204 bits (521), Expect = 2e-63
 Identities = 79/310 (25%), Positives = 121/310 (39%), Gaps = 44/310 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
             +   + LGRG FGV +   ++      A K I  R     +  + V REV  +  L +
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKL-E 61

Query: 111 NSSIVSLKEACEDDNA------------VHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           +  IV    A  + N             +++ M+LC    L D +  R    ER  +   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 159 RT---IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS------------- 202
                I E V+  H  G++HRDLKP N  F        +K  DFGL              
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVL 178

Query: 203 IFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
                  R +  VG+  YM+PE +   +Y  ++DI+S G+IL+ LL    PF  + E+  
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235

Query: 262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
               +R L  F              +V+ ML P P  R  A  ++E+   ++        
Sbjct: 236 TLTDVRNLK-FPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

Query: 322 LGDVVRSRLK 331
           L    R R +
Sbjct: 294 L----RQRSR 299

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  198 bits (505), Expect = 3e-60
 Identities = 54/293 (18%), Positives = 92/293 (31%), Gaps = 39/293 (13%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRRE 101
           +       V   LG G F   Y     D      ++    K           +     + 
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA-----AAA 156
           +  +K        +    A    N   LV EL   G L + I    +  E+        +
Sbjct: 118 MERLKPS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANK--------KENSPLKAIDFGLSI---FF 205
               ++ +++  H   +IH D+KP+NF+  N           ++ L  ID G SI    F
Sbjct: 177 FAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 206 KPGERFSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQ 263
             G  F+    +  +   E+L  + +  +ID +     +Y +L G       E  +   +
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP---WLQN 313
            + R L     D W             ML       L +  +L        Q 
Sbjct: 297 GLFRRL--PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  182 bits (465), Expect = 7e-55
 Identities = 83/298 (27%), Positives = 124/298 (41%), Gaps = 25/298 (8%)

Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
           A    GA   Q         K+  ED +   + LG G F    L  +  T    A K + 
Sbjct: 6   AEPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKILE 64

Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
           KR +     +  V RE  +M  L  +   V L    +DD  ++  +   + GEL   I  
Sbjct: 65  KRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK 123

Query: 146 RGHYTERAA---AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
            G + E       A    IV  ++  H  G+IHRDLKPEN L     E+  ++  DFG +
Sbjct: 124 IGSFDETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTA 177

Query: 203 ---IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
                     R +  VG+  Y++PE+L         D+W+ G I+Y L+ G+PPF A +E
Sbjct: 178 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

Query: 259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT------AKQVLEHPW 310
             + Q I++   DF           A+ LV ++L  D   RL          +  HP+
Sbjct: 238 YLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  179 bits (455), Expect = 1e-53
 Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 15/270 (5%)

Query: 52  RYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           R+L  D E+GRG F   Y  +D +T   +A   +  RKL T  +    + E  ++K L +
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-Q 83

Query: 111 NSSIV----SLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           + +IV    S +   +    + LV EL   G L   +        +   +  R I++ +Q
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 167 LCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
             H     +IHRDLK +N           +K  D GL+   +     + ++G+P +MAPE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPE 200

Query: 225 VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-SES 283
           + +  Y   +D+++ G+ +  +     P ++E  Q  AQ   R     K   +  V    
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEYP-YSE-CQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            K ++   +  +   R + K +L H + Q 
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  177 bits (451), Expect = 6e-53
 Identities = 71/268 (26%), Positives = 122/268 (45%), Gaps = 20/268 (7%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G +G+ Y   D   +  +A K I     R +     +  E+A+ KHL K+ +IV   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHL-KHKNIVQYL 85

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIH 175
            +  ++  + + ME   GG L   + ++       E+     T+ I+E ++  H + ++H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145

Query: 176 RDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN---YG 231
           RD+K +N L      +  LK  DFG S              G+  YMAPE++ +    YG
Sbjct: 146 RDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---NVSESAKSLV 288
              DIWS G  +  +  G PP + E  +  A A+ +  +   +       ++S  AK+ +
Sbjct: 204 KAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFK--VGMFKVHPEIPESMSAEAKAFI 259

Query: 289 RQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
            +  EPDP  R  A  +L   +L+ + K
Sbjct: 260 LKCFEPDPDKRACANDLLVDEFLKVSSK 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  176 bits (448), Expect = 4e-52
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 28/304 (9%)

Query: 26  ARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS 85
                G    + +  +    +E +         +GRG FG  +   D+ T    A K + 
Sbjct: 34  TEDNEGVLLTEKLKPVDYEYREEVHW-MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 92

Query: 86  KRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA 145
               R          E+     L  +  IV L  A  +   V++ MEL EGG L   I  
Sbjct: 93  LEVFR--------VEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143

Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--- 202
            G   E  A       +E ++  H   ++H D+K +N L ++    S     DFG +   
Sbjct: 144 MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD--GSRAALCDFGHALCL 201

Query: 203 ---IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESE 258
                 K       I G+  +MAPEV+       ++DIWS+  ++  +L G  P W +  
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-WTQYF 260

Query: 259 QGVAQAILRGLIDFKRDPWP----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
           +      L+  I  +  P      + +      +++ L  +P  R +A ++         
Sbjct: 261 R--GPLCLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316

Query: 315 KKAP 318
           +   
Sbjct: 317 EVGG 320

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  171 bits (437), Expect = 1e-50
 Identities = 84/307 (27%), Positives = 142/307 (46%), Gaps = 47/307 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y    ++G G +GV + C +RDT +++A K     K   + D   ++    RE+ ++K
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLK 57

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEV 164
            L K+ ++V+L E       +HLV E C+       DR   +    E    ++T   ++ 
Sbjct: 58  QL-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQA 114

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           V  CHKH  IHRD+KPEN L         +K  DFG + +   P + + + V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-------------- 267
           E+L     YGP +D+W+ G +   LL GVP +  +S+      I +              
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231

Query: 268 GLIDFK-------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
               F                 +PN+S  A  L++  L  DP  RLT +Q+L HP+ +N 
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291

Query: 315 KKAPNVP 321
           ++  ++ 
Sbjct: 292 REIEDLA 298

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  173 bits (440), Expect = 1e-50
 Identities = 77/315 (24%), Positives = 137/315 (43%), Gaps = 25/315 (7%)

Query: 2   GNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGR 61
           GN   +     +E VK   +       +      Q            ++  +   + LG 
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQN--------TAQLDQ-FDRIKTLGT 51

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+ + 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF 110

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE 181
           +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDLKPE
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAG 240
           N L     +   ++  DFG +   +   R   + G+P  +APE++    Y   +D W+ G
Sbjct: 171 NLLID---QQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           V++Y +  G PPF+A+    + + I+ G + F   P  + S   K L+R +L+ D   R 
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKRF 281

Query: 301 -----TAKQVLEHPW 310
                    +  H W
Sbjct: 282 GNLKNGVNDIKNHKW 296

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  173 bits (440), Expect = 2e-50
 Identities = 67/271 (24%), Positives = 126/271 (46%), Gaps = 28/271 (10%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS 116
           R +G+G FG   +    DT+++ A K ++K+K     ++ +V +E+ IM+ L ++  +V+
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVN 79

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA---AAVTRTIVEVV---QLCHK 170
           L  + +D+  + +V++L  GG+L   +    H+ E              E+V        
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC------ELVMALDYLQN 133

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN- 229
             +IHRD+KP+N L     E+  +   DF ++       + + + G+  YMAPE+     
Sbjct: 134 QRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190

Query: 230 ---YGPEIDIWSAGVILYILLCGVPPFW---AESEQGVAQAILRGLIDFKRDPWPNVSES 283
              Y   +D WS GV  Y LL G  P+    + S + +       ++ +        S+ 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQE 246

Query: 284 AKSLVRQMLEPDPKLRL-TAKQVLEHPWLQN 313
             SL++++LEP+P  R      V   P++ +
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  171 bits (436), Expect = 1e-49
 Identities = 82/262 (31%), Positives = 125/262 (47%), Gaps = 16/262 (6%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG FG   L   + TR++ A K +SK ++    D      E  IM     +  +V L 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLF 135

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +DD  +++VME   GG+L   +++     E+ A   T  +V  +   H  G IHRD+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194

Query: 179 KPENFLFANKKENSPLKAIDFGLSIFFKPGERF--SEIVGSPYYMAPEVLKR-----NYG 231
           KP+N L     ++  LK  DFG  +             VG+P Y++PEVLK       YG
Sbjct: 195 KPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251

Query: 232 PEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQM 291
            E D WS GV LY +L G  PF+A+S  G    I+            ++S+ AK+L+   
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311

Query: 292 LEPDPKLRLT---AKQVLEHPW 310
           L  D ++RL     +++  H +
Sbjct: 312 LT-DREVRLGRNGVEEIKRHLF 332

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  168 bits (428), Expect = 3e-49
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 23/275 (8%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           PK +++D  ++ R LG G FG  +L   R      A K + K  +     ++    E  +
Sbjct: 1   PKYSLQDFQIL-RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA---AAVTRTI 161
           +  +  +  I+ +    +D   + ++M+  EGGELF  +     +    A   AA    +
Sbjct: 60  LSIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EV 115

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
              ++  H   +I+RDLKPEN L     +N  +K  DFG +      +    + G+P Y+
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAK--YVPDVTYTLCGTPDYI 170

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APEV+    Y   ID WS G+++Y +L G  PF+  +     + IL   + F     P  
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFF 226

Query: 281 SESAKSLVRQMLEPDPKLRL-----TAKQVLEHPW 310
           +E  K L+ +++  D   RL       + V  HPW
Sbjct: 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  167 bits (425), Expect = 8e-49
 Identities = 79/315 (25%), Positives = 148/315 (46%), Gaps = 26/315 (8%)

Query: 12  AREDVKSNYSSHDHARKEAGANKKQPITVL-AGVPKENIEDRYLVDRELGRGEFGVTYLC 70
                  +  + +   +      +Q    L   V + +         ++G G  G+  L 
Sbjct: 5   HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64

Query: 71  IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV 130
            ++ +   +A K +    LR     + +  EV IM+   ++ ++V + ++      + ++
Sbjct: 65  REKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL 120

Query: 131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE 190
           ME  +GG L D IV++    E   A V   +++ +   H  GVIHRD+K ++ L      
Sbjct: 121 MEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---L 176

Query: 191 NSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILL 247
           +  +K  DFG    I     +R S +VG+PY+MAPEV+ R+ Y  E+DIWS G+++  ++
Sbjct: 177 DGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235

Query: 248 CGVPPFWAESEQGVAQAILRGLIDFKRDPWP------NVSESAKSLVRQMLEPDPKLRLT 301
            G PP++++S        ++ +   +  P P       VS   +  + +ML  DP+ R T
Sbjct: 236 DGEPPYFSDSP-------VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288

Query: 302 AKQVLEHPWLQNAKK 316
           A+++L+HP+L     
Sbjct: 289 AQELLDHPFLLQTGL 303

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  165 bits (421), Expect = 2e-48
 Identities = 82/282 (29%), Positives = 143/282 (50%), Gaps = 25/282 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           V   + + +Y    ++G+G  G  Y  +D  T + +A + +    L+     + +  E+ 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEIL 69

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R  ++
Sbjct: 70  VMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ 127

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYM 221
            ++  H + VIHRD+K +N L      +  +K  DFG    I  +  +R + +VG+PY+M
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWM 183

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-- 278
           APEV+ R  YGP++DIWS G++   ++ G PP+  E+        LR L     +  P  
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPEL 236

Query: 279 ----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                +S   +  + + LE D + R +AK++L+H +L+ AK 
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  169 bits (429), Expect = 2e-48
 Identities = 80/291 (27%), Positives = 136/291 (46%), Gaps = 19/291 (6%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA 92
              +P T      + + ED  ++ + +GRG FG   +   ++  ++ A K ++K ++   
Sbjct: 57  EWAKPFTSKVKQMRLHREDFEIL-KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115

Query: 93  VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTE 151
            +    R E  ++ +   +  I +L  A +DDN ++LVM+   GG+L   +        E
Sbjct: 116 AETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE 174

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-- 209
             A      +V  +   H+   +HRD+KP+N L      N  ++  DFG  +        
Sbjct: 175 EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTV 231

Query: 210 RFSEIVGSPYYMAPEVL------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
           + S  VG+P Y++PE+L      K  YGPE D WS GV +Y +L G  PF+AES      
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291

Query: 264 AILRGLIDFKRDPW-PNVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPW 310
            I+     F+      +VSE+AK L+R+++      RL     +   +HP+
Sbjct: 292 KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH-RLGQNGIEDFKKHPF 341

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  166 bits (422), Expect = 2e-48
 Identities = 69/338 (20%), Positives = 112/338 (33%), Gaps = 85/338 (25%)

Query: 52  RYLVD----RELGRGEFGVTYLCIDRDTRELLACKSI-------SKRKLRTAVDIDDVRR 100
           RYL D    + +GRG FGV +   ++      A K I       ++ K+   V       
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 101 EVAIMKHLP-----------------------------------------------KNSS 113
              I+++                                                    +
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR---TIVEVVQLCHK 170
            V   +       +++ M+LC    L D +  R    +R           I E V+  H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-------------IFFKPGERFSEIVGS 217
            G++HRDLKP N  F        +K  DFGL                       +  VG+
Sbjct: 183 KGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 218 PYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-VAQAILRGLIDFKRD 275
             YM+PE +   NY  ++DI+S G+IL+ LL     F  + E+  +   +          
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFP---L 293

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
            +         +V+ ML P P  R  A  ++E+   +N
Sbjct: 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  165 bits (421), Expect = 4e-48
 Identities = 70/304 (23%), Positives = 124/304 (40%), Gaps = 57/304 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
           ++Y     +G G +G+   C ++DT  ++A K     K   + D   V+    RE+ ++K
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLK 79

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEV 164
            L ++ ++V+L E C+     +LV E  +    +  +          +        I+  
Sbjct: 80  QL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIING 136

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAP 223
           +  CH H +IHRD+KPEN L +       +K  DFG +     PGE + + V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE-------------------QGVA 262
           E+L     YG  +D+W+ G ++  +  G P F  +S+                   +   
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 263 QAILRGLIDFK-------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
           +        F                 +P +SE    L ++ L  DP  R    ++L H 
Sbjct: 254 K-----NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308

Query: 310 WLQN 313
           + Q 
Sbjct: 309 FFQM 312

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  165 bits (420), Expect = 1e-47
 Identities = 74/263 (28%), Positives = 120/263 (45%), Gaps = 15/263 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L   ++T +L A K + K  +    D++    E  I+     +  +  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +  + +  VME   GG+L   I     + E  A      I+  +   H  G+I+RDL
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L          K  DFG+       G   +   G+P Y+APE+L+   YGP +D 
Sbjct: 151 KLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W+ GV+LY +LCG  PF AE+E  + +AIL   + +       + E A  +++  +  +P
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNP 263

Query: 297 KLRL------TAKQVLEHPWLQN 313
            +RL          +L HP+ + 
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKE 286

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  164 bits (417), Expect = 2e-47
 Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 10/258 (3%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG  +L   + T +  A K++ K  +    D++    E  ++    ++  +  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              +    +  VME   GG+L   I +   +    A      I+  +Q  H  G+++RDL
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L     ++  +K  DFG+         + +   G+P Y+APE+L    Y   +D 
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           WS GV+LY +L G  PF  + E+ +  +I      + R     + + AK L+ ++   +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREP 257

Query: 297 KLRLTAKQ-VLEHPWLQN 313
           + RL  +  + +HP  + 
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  168 bits (428), Expect = 5e-47
 Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 12/260 (4%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG    C  R T ++ ACK + K++++          E  I++ +  +  +VSL 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLA 250

Query: 119 EACEDDNAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
            A E  +A+ LV+ L  GG+L   I  + +  + E  A      I   ++  H+  +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEID 235
           DLKPEN L     ++  ++  D GL++    G+     VG+  YMAPEV+K   Y    D
Sbjct: 311 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367

Query: 236 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPD 295
            W+ G +LY ++ G  PF    ++   + + R + +   +     S  A+SL  Q+L  D
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 296 PKLRL-----TAKQVLEHPW 310
           P  RL     +A++V EHP 
Sbjct: 428 PAERLGCRGGSAREVKEHPL 447

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  170 bits (431), Expect = 5e-47
 Identities = 74/308 (24%), Positives = 129/308 (41%), Gaps = 17/308 (5%)

Query: 14  EDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIED-RYLVDRELGRGEFGVTYLCID 72
           +  ++       A +E  AN            +  + D  +L    LG+G FG   L   
Sbjct: 305 KFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVMLSER 362

Query: 73  RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME 132
           + T EL A K + K  +    D++    E  ++    K   +  L    +  + ++ VME
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422

Query: 133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS 192
              GG+L   I   G + E  A      I   +      G+I+RDLK +N +        
Sbjct: 423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEG 479

Query: 193 PLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGV 250
            +K  DFG+       G       G+P Y+APE++    YG  +D W+ GV+LY +L G 
Sbjct: 480 HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

Query: 251 PPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQV 305
            PF  E E  + Q+I+   + + +    ++S+ A ++ + ++   P  RL       + +
Sbjct: 540 APFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDI 595

Query: 306 LEHPWLQN 313
            EH + + 
Sbjct: 596 KEHAFFRY 603

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  164 bits (418), Expect = 6e-47
 Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 21/293 (7%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA 92
              +PI V     +   +D + + + +GRG F    +   + T ++ A K ++K  +   
Sbjct: 44  QWAEPIVVRLKEVRLQRDD-FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102

Query: 93  VDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTE 151
            ++   R E  ++ +      I  L  A +D+N ++LVME   GG+L   +   G     
Sbjct: 103 GEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA 161

Query: 152 RAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-- 209
             A      IV  +   H+ G +HRD+KP+N L         ++  DFG  +  +     
Sbjct: 162 EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTV 218

Query: 210 RFSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
           R    VG+P Y++PE+L+         +YGPE D W+ GV  Y +  G  PF+A+S    
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

Query: 262 AQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLT---AKQVLEHPW 310
              I+              V E A+  ++++L   P+ RL    A     HP+
Sbjct: 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  169 bits (430), Expect = 8e-47
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 20/266 (7%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--I 114
           R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +       I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V +  A    + +  +++L  GG+L   +   G ++E         I+  ++  H   V+
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGP 232
           +RDLKP N L     E+  ++  D GL+  F   ++    VG+  YMAPEVL++   Y  
Sbjct: 315 YRDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDS 370

Query: 233 EIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
             D +S G +L+ LL G  PF          + +  L   ++       + S   +SL+ 
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLE 426

Query: 290 QMLEPDPKLRL-----TAKQVLEHPW 310
            +L+ D   RL      A++V E P+
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPF 452

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  162 bits (412), Expect = 1e-46
 Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 17/290 (5%)

Query: 32  ANKKQPITVLAGVPKENIED-RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
            N            +  + D  +L    LG+G FG   L   + T EL A K + K  + 
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 59

Query: 91  TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYT 150
              D++    E  ++    K   +  L    +  + ++ VME   GG+L   I   G + 
Sbjct: 60  QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 119

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGE 209
           E  A      I   +      G+I+RDLK +N +         +K  DFG+       G 
Sbjct: 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV 176

Query: 210 RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG 268
                 G+P Y+APE++    YG  +D W+ GV+LY +L G  PF  E E  + Q+I+  
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

Query: 269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
            + + +    ++S+ A ++ + ++   P  RL       + + EH + + 
Sbjct: 237 NVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  161 bits (410), Expect = 2e-46
 Identities = 81/262 (30%), Positives = 131/262 (50%), Gaps = 15/262 (5%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  ++  + +LK
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 71

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            A +  + +  VME   GGELF  +     +TE  A      IV  ++  H   V++RD+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N YG  +D 
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  GV++Y ++CG  PF+ +  + + + IL   I F R     +S  AKSL+  +L+ DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 244

Query: 297 KLRL-----TAKQVLEHPWLQN 313
           K RL      AK+V+EH +  +
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLS 266

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  160 bits (407), Expect = 4e-46
 Identities = 75/268 (27%), Positives = 125/268 (46%), Gaps = 29/268 (10%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDV------RREVAIMKHLP 109
           LG+G +G  +        +T ++ A K + K  +    +  D       R  +  +KH P
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI--VRNAKDTAHTKAERNILEEVKH-P 81

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
               IV L  A +    ++L++E   GGELF ++   G + E  A      I   +   H
Sbjct: 82  ---FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKR 228
           + G+I+RDLKPEN +         +K  DFGL       G       G+  YMAPE+L R
Sbjct: 139 QKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR 195

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + +   +D WS G ++Y +L G PPF  E+ +     IL+  ++      P +++ A+ L
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARDL 251

Query: 288 VRQMLEPDPKLRL-----TAKQVLEHPW 310
           ++++L+ +   RL      A +V  HP+
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  158 bits (403), Expect = 2e-45
 Identities = 88/333 (26%), Positives = 134/333 (40%), Gaps = 44/333 (13%)

Query: 22  SHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
            H H        +      ++  P     DRY    +LG G +G  Y  ID  T E +A 
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 82  KSISKRKLR-----TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG 136
           K I           TA+      REV+++K L ++ +I+ LK     ++ +HL+ E  E 
Sbjct: 65  KRIRLEHEEEGVPGTAI------REVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP--L 194
            +L   +      + R   +    ++  V  CH    +HRDLKP+N L +    +    L
Sbjct: 118 -DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 195 KAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVP 251
           K  DFGL+  F  P  +F+  + + +Y  PE+L   R+Y   +DIWS   I   +L   P
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

Query: 252 PFWAESEQGVAQAILRGL--------------------------IDFKRDPWPNVSESAK 285
            F  +SE      I   L                             KR     + +   
Sbjct: 237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGL 296

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            L+  MLE DP  R++AK  LEHP+  +    P
Sbjct: 297 DLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  158 bits (403), Expect = 3e-45
 Identities = 72/272 (26%), Positives = 123/272 (45%), Gaps = 24/272 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG +    L   + T  + A K + K  +    DID V+ E  + +    +  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+RDL
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L         +K  D+G+     +PG+  S   G+P Y+APE+L+   YG  +D 
Sbjct: 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193

Query: 237 WSAGVILYILLCGVPPFW---------AESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A S+
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 249

Query: 288 VRQMLEPDPKLRL------TAKQVLEHPWLQN 313
           ++  L  DPK RL          +  HP+ +N
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  158 bits (401), Expect = 3e-45
 Identities = 76/267 (28%), Positives = 120/267 (44%), Gaps = 29/267 (10%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKLRTAVDIDDV-----RREVAIMKHLPK 110
           LG+G FG  +L       D R+L A K + K  L      D V     R  +  + H P 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVEVNH-P- 86

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
              IV L  A + +  ++L+++   GG+LF R+     +TE         +   +   H 
Sbjct: 87  --FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN 229
            G+I+RDLKPEN L     E   +K  DFGLS       ++     G+  YMAPEV+ R 
Sbjct: 145 LGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +    D WS GV+++ +L G  PF  +  +     IL+  +         +S  A+SL+
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLL 257

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPW 310
           R + + +P  RL       +++  H +
Sbjct: 258 RMLFKRNPANRLGAGPDGVEEIKRHSF 284

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  156 bits (397), Expect = 5e-45
 Identities = 85/301 (28%), Positives = 128/301 (42%), Gaps = 54/301 (17%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--------RTAVDIDDVRREV 102
           ++Y    ++G G +GV Y   +    E  A K I   +L         T +      RE+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---RLEKEDEGIPSTTI------REI 51

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRT 160
           +I+K L K+S+IV L +       + LV E  +    +L D     G      A +    
Sbjct: 52  SILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQ 108

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPY 219
           ++  +  CH   V+HRDLKP+N L   + E   LK  DFGL+  F  P  +++  + + +
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLW 165

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR---------- 267
           Y AP+VL   + Y   IDIWS G I   ++ G P F   SE      I R          
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

Query: 268 ----GLIDFK-----------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                L  +                  + ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

Query: 313 N 313
            
Sbjct: 286 E 286

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  155 bits (394), Expect = 1e-44
 Identities = 78/302 (25%), Positives = 134/302 (44%), Gaps = 54/302 (17%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL--------RTAVDIDDVRREV 102
            +Y    ++G G +G  +   +R+T E++A K +   +L         +A+      RE+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSAL------REI 52

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRT 160
            ++K L K+ +IV L +    D  + LV E C+    + FD     G        +    
Sbjct: 53  CLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQ 109

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPY 219
           +++ +  CH   V+HRDLKP+N L     E   LK  +FGL+  F  P   +S  V + +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILR--------- 267
           Y  P+VL   + Y   ID+WSAG I   +   G P F         + I R         
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 268 -----GLIDFKRDP-----------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                 L D+K  P            P ++ + + L++ +L+ +P  R++A++ L+HP+ 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 312 QN 313
            +
Sbjct: 287 SD 288

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  155 bits (395), Expect = 2e-44
 Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 53/301 (17%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-------RTAVDIDDVRREVA 103
           + Y+   +LG G +   Y    + T  L+A K I   +L        TA+      REV+
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI------REVS 52

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTI 161
           ++K L K+++IV+L +    + ++ LV E  +    +  D                   +
Sbjct: 53  LLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQL 109

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYY 220
           +  +  CH+  V+HRDLKP+N L   + E   LK  DFGL+     P + +   V + +Y
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWY 166

Query: 221 MAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL--------- 269
             P++L    +Y  +ID+W  G I Y +  G P F   + +     I R L         
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 270 ----------IDFKRDP-------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                      ++ +          P +      L+ ++L+ + + R++A+  ++HP+  
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

Query: 313 N 313
           +
Sbjct: 287 S 287

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  156 bits (396), Expect = 3e-44
 Identities = 80/351 (22%), Positives = 148/351 (42%), Gaps = 25/351 (7%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
                +   +      + D       A   +   V     K++ E  +   RE+G G FG
Sbjct: 9   HHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFG 68

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN 125
             Y   D    E++A K +S    ++     D+ +EV  ++ L ++ + +  +     ++
Sbjct: 69  AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREH 127

Query: 126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF 185
              LVME C G       V +    E   AAVT   ++ +   H H +IHRD+K  N L 
Sbjct: 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 187

Query: 186 ANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----KRNYGPEIDIWSAGV 241
           +   E   +K  DFG +    P   F   VG+PY+MAPEV+    +  Y  ++D+WS G+
Sbjct: 188 S---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

Query: 242 ILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-----NVSESAKSLVRQMLEPDP 296
               L    PP +  +        +  L    ++  P     + SE  ++ V   L+  P
Sbjct: 242 TCIELAERKPPLFNMN-------AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 294

Query: 297 KLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVI 347
           + R T++ +L+H ++   +  P   + D+++        ++  + + ++ I
Sbjct: 295 QDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQYRKMKKI 343

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  157 bits (398), Expect = 3e-44
 Identities = 67/261 (25%), Positives = 115/261 (44%), Gaps = 13/261 (4%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG   L   +      A K + K+ +    +   +  E  ++    K+  +V L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
            + +  + ++ V++   GGELF  +     + E  A      I   +   H   +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           KPEN L         +   DFGL     +     S   G+P Y+APEVL +  Y   +D 
Sbjct: 166 KPENILLD---SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222

Query: 237 WSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDP 296
           W  G +LY +L G+PPF++ +   +   IL   +  K    PN++ SA+ L+  +L+ D 
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 278

Query: 297 KLRL----TAKQVLEHPWLQN 313
             RL       ++  H +   
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSL 299

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  158 bits (402), Expect = 3e-44
 Identities = 80/292 (27%), Positives = 142/292 (48%), Gaps = 19/292 (6%)

Query: 28  KEAGANKKQPITVLAGVPKENIED-RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK 86
            +    ++  +++     +  + +  YL  + LG+G FG   L  ++ T    A K + K
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYL--KLLGKGTFGKVILVKEKATGRYYAMKILKK 183

Query: 87  RKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR 146
             +    ++     E  ++++  ++  + +LK + +  + +  VME   GGELF  +   
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE 242

Query: 147 GHYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IF 204
             ++E  A      IV  +   H +  V++RDLK EN +     ++  +K  DFGL    
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEG 299

Query: 205 FKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ 263
            K G       G+P Y+APEVL+ N YG  +D W  GV++Y ++CG  PF+ +  + + +
Sbjct: 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

Query: 264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPW 310
            IL   I F R     +   AKSL+  +L+ DPK RL      AK++++H +
Sbjct: 360 LILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  155 bits (394), Expect = 3e-44
 Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 58/317 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-------RTAVDIDDVRREVA 103
            ++    +LG G +   Y  +++ T   +A K +   KL        TA+      RE++
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REIS 55

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGG-----ELFDRIVARGHYTERAAAAVT 158
           +MK L K+ +IV L +    +N + LV E  +       +                    
Sbjct: 56  LMKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGS 217
             +++ +  CH++ ++HRDLKP+N L   + +   LK  DFGL+  F  P   FS  V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVT 171

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL------ 269
            +Y AP+VL   R Y   IDIWS G IL  ++ G P F   +++   + I   +      
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 270 ------------------------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQV 305
                                      +      +  +    +  +L+ +P +RL+AKQ 
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 306 LEHPWLQNAKKAPNVPL 322
           L HPW        ++  
Sbjct: 292 LHHPWFAEYYHHASMGG 308

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  157 bits (398), Expect = 3e-44
 Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 24/272 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +GRG +    L   + T  + A + + K  +    DID V+ E  + +    +  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDL 178
              + ++ +  V+E   GG+L   +  +    E  A   +  I   +   H+ G+I+RDL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 179 KPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN-YGPEIDI 236
           K +N L         +K  D+G+     +PG+  S   G+P Y+APE+L+   YG  +D 
Sbjct: 180 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236

Query: 237 WSAGVILYILLCGVPPFW---------AESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           W+ GV+++ ++ G  PF            +E  + Q IL   I   R    ++S  A S+
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 292

Query: 288 VRQMLEPDPKLRL------TAKQVLEHPWLQN 313
           ++  L  DPK RL          +  HP+ +N
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  154 bits (392), Expect = 4e-44
 Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 28/285 (9%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
             +  + + +  ELG G FG  Y   +++T  L A K I     ++  +++D   E+ I+
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEIL 70

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIVEV 164
                +  IV L  A   D  + +++E C GG +   ++      TE     V R ++E 
Sbjct: 71  ATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GERFSEIVGSPYYMAP 223
           +   H   +IHRDLK  N L         ++  DFG+S       ++    +G+PY+MAP
Sbjct: 130 LNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 224 EVLKRN------YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           EV+         Y  + DIWS G+ L  +    PP    +        +R L+   +   
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSDP 239

Query: 278 P------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           P        S   +  ++  L+ +P+ R +A Q+LEHP++ +   
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  154 bits (392), Expect = 4e-44
 Identities = 73/283 (25%), Positives = 134/283 (47%), Gaps = 27/283 (9%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
              +  E+ + V  +LG G +G  Y  I ++T +++A K +         D+ ++ +E++
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEIS 76

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTRTIV 162
           IM+    +  +V    +   +  + +VME C  G + D I  R    TE   A + ++ +
Sbjct: 77  IMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYY 220
           + ++  H    IHRD+K  N L          K  DFG++  +     +R + ++G+P++
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFW 191

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP- 278
           MAPEV++   Y    DIWS G+    +  G PP+            +R +     +P P 
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-------PMRAIFMIPTNPPPT 244

Query: 279 -----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                  S++    V+Q L   P+ R TA Q+L+HP++++AK 
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  154 bits (391), Expect = 7e-44
 Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 49/309 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----TAVDIDDV 98
           +  + + ++Y    ++G G +GV Y   D     ++A K I           TA+     
Sbjct: 14  LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI----- 67

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAA 156
            RE++++K L  + +IVSL +    +  + LV E  E    ++ D    +    +     
Sbjct: 68  -REISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKI 123

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIV 215
               ++  V  CH+H ++HRDLKP+N L  +      LK  DFGL+  F  P   ++  V
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEV 180

Query: 216 GSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR------ 267
            + +Y AP+VL   + Y   +DIWS G I   ++ G P F   ++      I        
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240

Query: 268 --------GLIDFK------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                    L  +K                P   +    L+  ML  DP  R++A+  + 
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300

Query: 308 HPWLQNAKK 316
           HP+ ++   
Sbjct: 301 HPYFKDLDP 309

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  156 bits (397), Expect = 8e-44
 Identities = 83/343 (24%), Positives = 129/343 (37%), Gaps = 58/343 (16%)

Query: 12  AREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCI 71
                 S + S   +R + G+     +      P    E  Y   + +G G FGV Y   
Sbjct: 15  KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74

Query: 72  DRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA------CE 122
             D+ EL+A K +    + K R          E+ IM+ L  + +IV L+         +
Sbjct: 75  LCDSGELVAIKKVLQDKRFKNR----------ELQIMRKL-DHCNIVRLRYFFYSSGEKK 123

Query: 123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHR 176
           D+  ++LV++      ++          +       +  +   QL       H  G+ HR
Sbjct: 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM--YQLFRSLAYIHSFGICHR 180

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEI 234
           D+KP+N L  +  + + LK  DFG +     GE     + S YY APE++    +Y   I
Sbjct: 181 DIKPQNLL-LD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 238

Query: 235 DIWSAGVILYILLCGVPPFWAESE--QGV------------------AQAILRGLIDFKR 274
           D+WSAG +L  LL G P F  +S   Q V                             K 
Sbjct: 239 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKA 298

Query: 275 DPW-----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            PW     P     A +L  ++LE  P  RLT  +   H +  
Sbjct: 299 HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score =  150 bits (380), Expect = 1e-43
 Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 1/99 (1%)

Query: 304 QVLEHPWL-QNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEM 362
               H    +N     +V L   +   LK F   N  K+ AL +IA+ L   E+ +++ +
Sbjct: 3   HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62

Query: 363 FKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           F  +D DN G +S+ E+  GL+  G Q    ++  ++  
Sbjct: 63  FIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRD 101

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 10/63 (15%)

Query: 349 EFLSV-------EEVEDIKEMFKKIDSDNDGVVSTDELKA--GLRNFGSQLAESEVQ-ML 398
           +FL+         + E     FK  D D +G +S +ELK   G  +  + L +  +  +L
Sbjct: 114 DFLAATIDKQTYLKKEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLL 173

Query: 399 IEA 401
            E 
Sbjct: 174 QEV 176

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  153 bits (388), Expect = 1e-43
 Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 22/282 (7%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K + E+ +    ++G+G FG  +  ID  T++++A K I   +     +I+D+++E+ ++
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVL 74

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                +  +     +   D  + ++ME   GG   D ++  G   E   A + R I++ +
Sbjct: 75  SQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 132

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAP 223
              H    IHRD+K  N L +   E+  +K  DFG++  +     +R +  VG+P++MAP
Sbjct: 133 DYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAP 188

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP---- 278
           EV+K++ Y  + DIWS G+    L  G PP        V   I       K +P P    
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP------KNNP-PTLEG 241

Query: 279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV 320
           N S+  K  V   L  +P  R TAK++L+H ++    K  + 
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  158 bits (402), Expect = 1e-43
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 23/267 (8%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           LGRG FG  + C  + T +L ACK ++K++L+          E  I+  +  +  IVSL 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLA 251

Query: 119 EACEDDNAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTRTIVEVVQLCHKHGVI 174
            A E    + LVM +  GG++   I         + E  A   T  IV  ++  H+  +I
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGERFSEIVGSPYYMAPEVLKRN-YGP 232
           +RDLKPEN L     ++  ++  D GL++       +     G+P +MAPE+L    Y  
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368

Query: 233 EIDIWSAGVILYILLCGVPPFWAESEQG----VAQAILRGLIDFKRDPWPNVSESAKSLV 288
            +D ++ GV LY ++    PF A  E+     + Q +L   + +        S ++K   
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----KFSPASKDFC 424

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPW 310
             +L+ DP+ RL     +   +  HP 
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPL 451

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  152 bits (385), Expect = 4e-43
 Identities = 78/297 (26%), Positives = 130/297 (43%), Gaps = 28/297 (9%)

Query: 42  AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           + +P     D Y +   +G G   V         +E +A K I+  K +T   +D++ +E
Sbjct: 6   SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKE 63

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--------RIVARGHYTERA 153
           +  M     + +IVS   +    + + LVM+L  GG + D             G   E  
Sbjct: 64  IQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 154 AAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
            A + R ++E ++  HK+G IHRD+K  N L     E+  ++  DFG+S F   G   + 
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 179

Query: 214 ------IVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI 265
                  VG+P +MAPEV+++   Y  + DIWS G+    L  G  P+       V    
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239

Query: 266 LRG------LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           L+            ++      +S + ++   L+ DP+ R TA ++L H + Q AK 
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  152 bits (386), Expect = 9e-43
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 25/270 (9%)

Query: 59  LGRGEFGVTYLC---IDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSI 114
           LG G +G  +L       DT +L A K + K  + + A   +  R E  +++H+ ++  +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVI 174
           V+L  A + +  +HL+++   GGELF  +  R  +TE         IV  ++  HK G+I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181

Query: 175 HRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIVGSPYYMAPEVLKRN--- 229
           +RD+K EN L      N  +   DFGLS        ER  +  G+  YMAP++++     
Sbjct: 182 YRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQG----VAQAILRGLIDFKRDPWPNVSESAK 285
           +   +D WS GV++Y LL G  PF  + E+     +++ IL+    +       +S  AK
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAK 294

Query: 286 SLVRQMLEPDPKLRL-----TAKQVLEHPW 310
            L++++L  DPK RL      A ++ EH +
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  151 bits (383), Expect = 2e-42
 Identities = 72/297 (24%), Positives = 125/297 (42%), Gaps = 43/297 (14%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI---SKRKLRTAVDIDDVRREVAIMKH 107
            RY     LG G+F   Y   D++T +++A K I    + + +  ++   +R E+ +++ 
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQE 68

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTRTIVEVV 165
           L  + +I+ L +A    + + LV +  E     +          T     A     ++ +
Sbjct: 69  L-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGL 125

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPE 224
           +  H+H ++HRDLKP N L         LK  DFGL+  F  P   ++  V + +Y APE
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 225 VL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-------------------GVAQ 263
           +L   R YG  +D+W+ G IL  LL  VP    +S+                     +  
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242

Query: 264 AILRGLIDFKRDP-------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             L   + FK  P       +    +    L++ +   +P  R+TA Q L+  +  N
Sbjct: 243 --LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  152 bits (385), Expect = 3e-42
 Identities = 80/322 (24%), Positives = 128/322 (39%), Gaps = 59/322 (18%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI---SKRKL 89
           NK   +    G   E  E  Y   + +G G FGV +     ++ E+ A K +    + K 
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKN 80

Query: 90  RTAVDIDDVRREVAIMKHLPKNSSIVSLKEA------CEDDNAVHLVMELCEGGELFDRI 143
           R          E+ IM+ + K+ ++V LK         +D+  ++LV+E      ++   
Sbjct: 81  R----------ELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS 128

Query: 144 VARGHYTERAAAAVTRTIVEVVQL------CHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                  +     + +  +   QL       H  G+ HRD+KP+N L  +   +  LK I
Sbjct: 129 RHYAKLKQTMPMLLIKLYM--YQLLRSLAYIHSIGICHRDIKPQNLL-LD-PPSGVLKLI 184

Query: 198 DFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWA 255
           DFG +     GE     + S YY APE++    NY   IDIWS G ++  L+ G P F  
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244

Query: 256 ESE-------------------QGV-AQAILRGLIDFKRDPW-----PNVSESAKSLVRQ 290
           ES                    + +    +       +  P+     P     A  L+ +
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304

Query: 291 MLEPDPKLRLTAKQVLEHPWLQ 312
           +LE  P  RLTA + L HP+  
Sbjct: 305 LLEYTPSARLTAIEALCHPFFD 326

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score =  145 bits (369), Expect = 4e-42
 Identities = 22/96 (22%), Positives = 47/96 (48%), Gaps = 1/96 (1%)

Query: 306 LEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKK 365
           + H    ++ +      G  V    K + ++ +F++ A+ +IA+  +  +VE +K  F  
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60

Query: 366 IDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +D D  G ++ ++LK GL   G +L      +L++ 
Sbjct: 61  LDEDGKGYITKEQLKKGLEKDGLKL-PYNFDLLLDQ 95

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 15/65 (23%), Positives = 27/65 (41%), Gaps = 12/65 (18%)

Query: 349 EFLSV------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV------Q 396
           EF++          + I   F+  D DNDG ++T EL   L N   +   ++       +
Sbjct: 108 EFIAAALDRKQLSKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKR 167

Query: 397 MLIEA 401
           M+ + 
Sbjct: 168 MIRDV 172

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  148 bits (375), Expect = 2e-41
 Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 36/296 (12%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
             +    + +   +G G +G  Y      T +L A K +    +    + +++++E+ ++
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGD-EEEEIKQEINML 74

Query: 106 KHLPKNSSIVSLKEA------CEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAV 157
           K    + +I +   A         D+ + LVME C  G + D  +        E   A +
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS--IFFKPGERFSEIV 215
            R I+  +   H+H VIHRD+K +N L     EN+ +K +DFG+S  +    G R +  +
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT-FI 190

Query: 216 GSPYYMAPEVLKRN------YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL 269
           G+PY+MAPEV+  +      Y  + D+WS G+    +  G PP             +R L
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRAL 243

Query: 270 IDFKRDPWP-----NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV 320
               R+P P       S+  +S +   L  +   R   +Q+++HP++++      V
Sbjct: 244 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  145 bits (368), Expect = 1e-40
 Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 57/312 (18%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-----------RTAVDIDDVR 99
            RY    E+G G +G  Y   D  +   +A KS+   ++            + V      
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTV------ 59

Query: 100 REVAIMKHLPKNS--SIVSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYT 150
           REVA+++ L      ++V L + C     + +  V LV E  +       D+    G   
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LP 118

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
                 + R  +  +   H + ++HRDLKPEN L  +      +K  DFGL+  +     
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMA 175

Query: 211 FSEIVGSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR-- 267
            + +V + +Y APEVL +  Y   +D+WS G I   +    P F   SE      I    
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235

Query: 268 ------------GLIDFKRDPW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVL 306
                        L      P          P + ES   L+ +ML  +P  R++A + L
Sbjct: 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295

Query: 307 EHPWLQNAKKAP 318
           +H +L   +  P
Sbjct: 296 QHSYLHKDEGNP 307

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  143 bits (362), Expect = 2e-39
 Identities = 67/307 (21%), Positives = 123/307 (40%), Gaps = 49/307 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLR-----TAVDIDDVRREVAI 104
            +Y    E+G G +G  +   D ++    +A K +  +        + +      REVA+
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------REVAV 64

Query: 105 MKHLPKNS--SIVSLKEAC-----EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAA 155
           ++HL      ++V L + C     + +  + LV E  +       D++            
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIK 123

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
            +   ++  +   H H V+HRDLKP+N L  +  +   +K  DFGL+  +      + +V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180

Query: 216 GSPYYMAPEVL-KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----- 269
            + +Y APEVL + +Y   +D+WS G I   +    P F   S+      IL  +     
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240

Query: 270 --------------IDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                               P      ++ E  K L+ + L  +P  R++A   L HP+ 
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

Query: 312 QNAKKAP 318
           Q+ ++  
Sbjct: 301 QDLERCK 307

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  139 bits (353), Expect = 2e-38
 Identities = 67/295 (22%), Positives = 115/295 (38%), Gaps = 25/295 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +      E+G G  G  +    R T  ++A K +  R+     +   +  ++ ++     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHD 82

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE-VVQLCH 169
              IV        +  V + MEL        +   +G   ER    +T  IV+ +  L  
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPE 224
           KHGVIHRD+KP N L   + +   +K  DFG+S     G    +       G   YMAPE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPE 194

Query: 225 VLKRN------YGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPW 277
            +         Y    D+WS G+ L  L  G  P+   +++  V   +L+          
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH- 253

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQ 332
              S   +S V+  L  D + R    ++LEH +++  +    V +    +  + +
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET-LEVDVASWFKDVMAK 307

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  140 bits (355), Expect = 4e-38
 Identities = 59/366 (16%), Positives = 123/366 (33%), Gaps = 62/366 (16%)

Query: 50  EDRYLVDRELGRGE--FGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
              Y +   +G+G        L   + T E +  + I+         +  ++ E+ + K 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGELHVSKL 82

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTRTIVEVV 165
              + +IV  +     DN + +V      G   D           E A A + + +++ +
Sbjct: 83  F-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI-FFKPGER-------FSEIVGS 217
              H  G +HR +K  + L +    +  +       ++     G+R           V  
Sbjct: 142 DYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 218 PYYMAPEVLKRN---YGPEIDIWSAGVILYILLCGVPPF--------------------- 253
             +++PEVL++N   Y  + DI+S G+    L  G  PF                     
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258

Query: 254 ---------------WAESEQGVAQAILRGLIDFKRDPWPNV------SESAKSLVRQML 292
                           + +  G++ ++            P+       S      V Q L
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 293 EPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLS 352
           + +P  R +A  +L H + +  K+  +  L +++R      +      +    +     +
Sbjct: 319 QRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTN 378

Query: 353 VEEVED 358
           +EE+E 
Sbjct: 379 LEELEV 384

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  139 bits (353), Expect = 5e-38
 Identities = 70/341 (20%), Positives = 121/341 (35%), Gaps = 80/341 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREV 102
                + + +LV R++G G FG   LC   D ++  A K + + +K   +  I     E 
Sbjct: 28  KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EA 82

Query: 103 AIMKHL----PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAA 156
            I+K +      N++IV         + + L+ E   G  L++ I    +  +       
Sbjct: 83  DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL 141

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFAN----------------------KKENSPL 194
               I++ +    K  + H DLKPEN L  +                      + +++ +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPF 253
           K IDFG + F    +    I+ +  Y APEV L   +    D+WS G +L  L  G   F
Sbjct: 202 KLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

Query: 254 WAESEQGVAQAILR--GLID---------------FKRDP----WPNVSESAKS------ 286
                      +      I                  +D     WP  + S  S      
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319

Query: 287 ---------------LVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                           +  +L+ DP LR +  ++L+H +L+
Sbjct: 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (349), Expect = 1e-37
 Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 37/283 (13%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           E+GRG +G     + + + +++A K I  R      +   +  ++ ++        IV  
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 118 KEACEDDNAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVE-VVQLCHK 170
             A   +    + MEL      FD+              E     +T   V+ +  L   
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEV 225
             +IHRD+KP N L         +K  DFG+S     G+    I      G   YMAPE 
Sbjct: 145 LKIIHRDIKPSNILLDRSGN---IKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 196

Query: 226 LK-----RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRG----LIDFKRD 275
           +      + Y    D+WS G+ LY L  G  P+    S       +++G    L + +  
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            +   S S  + V   L  D   R   K++L+HP++   ++  
Sbjct: 257 EF---SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  137 bits (347), Expect = 3e-37
 Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 70/317 (22%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR----REVAIMK 106
            +Y    ++G+G FG  +    R T + +A K     K+    + +       RE+ I++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ 71

Query: 107 HLPKNSSIVSLKEAC--------EDDNAVHLVMELCEG--GELFDRIVARGHYTERAAAA 156
            L K+ ++V+L E C            +++LV + CE     L   +     +T      
Sbjct: 72  LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKR 128

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           V + ++  +   H++ ++HRD+K  N L         LK  DFGL+  F   +       
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP--- 182

Query: 217 SPY--------YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
           + Y        Y  PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I 
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242

Query: 267 R--GLIDFKRDPWPNVS----------------------------ESAKSLVRQMLEPDP 296
           +  G I    + WPNV                               A  L+ ++L  DP
Sbjct: 243 QLCGSIT--PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 300

Query: 297 KLRLTAKQVLEHPWLQN 313
             R+ +   L H +  +
Sbjct: 301 AQRIDSDDALNHDFFWS 317

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  137 bits (346), Expect = 3e-37
 Identities = 77/340 (22%), Positives = 120/340 (35%), Gaps = 74/340 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSI-SKRKLRTAVDIDDVRRE 101
              + +  RY +   LG G FG    CID       +A K + +  +   A        E
Sbjct: 7   QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----E 61

Query: 102 VAIMKHLPKN-----SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAA 154
           + +++HL           V + E  E    + +V EL  G   +D I   G   +     
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI 120

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAID 198
             +   I + V   H + + H DLKPEN LF                     N  +K +D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG + +    E  S +V + +Y APEV L   +    D+WS G IL     G   F    
Sbjct: 181 FGSATY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

Query: 258 EQG----------------VAQAILRGLIDFKRDPWPNVSESAKS--------------- 286
            +                 + +   R      R  W   S + +                
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298

Query: 287 ---------LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA 317
                    L+++MLE DP  R+T ++ L+HP+    KK+
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  137 bits (347), Expect = 3e-37
 Identities = 72/352 (20%), Positives = 122/352 (34%), Gaps = 74/352 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSI-SKRKLRTAVDIDDVRRE 101
              + +++RY +   LG G FG    C+D    +  +A K I +  K R A      R E
Sbjct: 12  RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLE 66

Query: 102 VAIMKHLPKN-----SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAA 154
           + ++K + +         V + +       + +  EL  G   F+ +       Y     
Sbjct: 67  INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV 125

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK----------------ENSPLKAID 198
             +   +   ++  H++ + H DLKPEN LF N +                +N+ ++  D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 199 FGLSIFFKPGERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAES 257
           FG + F    E  + IV + +Y  PEV L+  +    D+WS G IL+    G   F    
Sbjct: 186 FGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243

Query: 258 EQG----------------VAQAILRGLIDFKRDPWPNVSESAKS--------------- 286
            +                 + +   +         W   S   +                
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303

Query: 287 ---------LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
                    L+R+MLE DP  R+T  + L HP+                 SR
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  136 bits (345), Expect = 3e-37
 Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 49/303 (16%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
             +D Y + R+LGRG++   +  I+    E +  K +        V    ++RE+ I+++
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 86

Query: 108 LPKNSSIVSLKEACEDDNAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           L    +I++L +  +D  +    LV E     +           T+         I++ +
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 143

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
             CH  G++HRD+KP N +     E+  L+ ID+GL+ F+ PG+ ++  V S Y+  PE+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201

Query: 226 L--KRNYGPEIDIWSAGVILYILLCGVPPFWA-----------------ESEQGVAQAI- 265
           L   + Y   +D+WS G +L  ++    PF+                  E          
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 266 -------LRGLIDFKRDPW---------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP 309
                     L    R  W           VS  A   + ++L  D + RLTA++ +EHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321

Query: 310 WLQ 312
           +  
Sbjct: 322 YFY 324

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  136 bits (344), Expect = 1e-36
 Identities = 70/342 (20%), Positives = 124/342 (36%), Gaps = 74/342 (21%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREVAIMKH 107
            + RY++ R+LG G F   +L  D      +A K +   +    A +      E+ +++ 
Sbjct: 17  KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-----EIKLLQR 71

Query: 108 L----------PKNSSIVSLKEA--CEDDNAVH--LVMELCEGGELFDRIVARGH--YTE 151
           +             + I+ L +    +  N VH  +V E+  G  L   I    H     
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPL 130

Query: 152 RAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKEN---SPLKAIDFGLSIFFKP 207
                +++ ++  +   H+  G+IH D+KPEN L            +K  D G + +   
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--Y 188

Query: 208 GERFSEIVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV----- 261
            E ++  + +  Y +PEV L   +G   DIWS   +++ L+ G   F  +          
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248

Query: 262 --AQAI-LRGLID-------------FKRD----------PWPNVSESAKS--------- 286
             AQ I L G +              F              WP      +          
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308

Query: 287 ----LVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
                +  ML+ DP+ R  A  ++ HPWL++      + + D
Sbjct: 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  133 bits (337), Expect = 2e-36
 Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 29/277 (10%)

Query: 58  ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL 117
           ELGRG +GV        + +++A K I  R    + +   +  ++ I          V+ 
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 118 KEACEDDNAVHLVMELCEGG--ELFDRIVAR-GHYTERAAAAVTRTIVEVVQ-LCHKHGV 173
             A   +  V + MEL +    + + +++ +     E     +  +IV+ ++ L  K  V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYMAPEVLK- 227
           IHRD+KP N L     +   +K  DFG+S     G    ++      G   YMAPE +  
Sbjct: 132 IHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 228 ----RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLI-DFKRDPWPNVS 281
               + Y  + DIWS G+ +  L     P+ +  +     + ++         D +   S
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---S 240

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
                   Q L+ + K R T  ++++HP+    +   
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  136 bits (344), Expect = 3e-36
 Identities = 86/344 (25%), Positives = 135/344 (39%), Gaps = 75/344 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREV 102
           VP +++  RY V + +G+G FG      D    + +A K + ++++            E+
Sbjct: 90  VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EI 144

Query: 103 AIMKHL----PKNSS-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAA 155
            I++HL      N+  ++ + E     N + +  EL     L++ I       ++     
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVR 203

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
               +I++ +   HK+ +IH DLKPEN L   +   S +K IDFG S +    +R    +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDFGSSCY--EHQRVYTYI 260

Query: 216 GSPYYMAPEV-LKRNYGPEIDIWSAGVILYIL---------------------LCGVPPF 253
            S +Y APEV L   YG  ID+WS G IL  L                     L G+P  
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320

Query: 254 W------------------------AESEQGVAQAILRGLIDFKRDP-----WPNVSESA 284
                                      S+  V     R      R P     W N  +  
Sbjct: 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380

Query: 285 -----KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLG 323
                   ++Q LE DP +R+T  Q L HPWL+  ++ P  P G
Sbjct: 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR--RRLPKPPTG 422

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (337), Expect = 9e-36
 Identities = 67/316 (21%), Positives = 117/316 (37%), Gaps = 59/316 (18%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I           + + RE+ ++    
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHEC- 88

Query: 110 KNSS-IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
            NS  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +   
Sbjct: 89  -NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147

Query: 169 H-KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI----VGSPYYMAP 223
             KH ++HRD+KP N L  ++ E   +K  DFG+S     G+    +    VG+  YM+P
Sbjct: 148 REKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSP 199

Query: 224 EVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV-- 280
           E L+   Y  + DIWS G+ L  +  G  P      + +       +     +  P    
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259

Query: 281 --------------------------------------SESAKSLVRQMLEPDPKLRLTA 302
                                                 S   +  V + L  +P  R   
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319

Query: 303 KQVLEHPWLQNAKKAP 318
           KQ++ H +++ +    
Sbjct: 320 KQLMVHAFIKRSDAEE 335

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  131 bits (332), Expect = 5e-35
 Identities = 78/334 (23%), Positives = 123/334 (36%), Gaps = 71/334 (21%)

Query: 31  GANKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR 90
           G+         A        DR+ V+R  G+G FG   L  ++ T   +A K + +   R
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-R 61

Query: 91  TAVDIDDVRREVAIMKHLPKNS--SIVSLK-------EACEDDNAVHLVMELCEGGELFD 141
                    RE+ IM+ L      +IV L+       E    D  +++VME      L  
Sbjct: 62  FR------NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114

Query: 142 RIVARGHYTERAAAAVTRTI-VEVVQL-----------CHK--HGVIHRDLKPENFLFAN 187
                     R            ++++            H     V HRD+KP N L  N
Sbjct: 115 CC--------RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL-VN 165

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYI 245
           +  +  LK  DFG +    P E     + S YY APE++   ++Y   +DIWS G I   
Sbjct: 166 E-ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224

Query: 246 LLCGVPPFWAESEQGVAQAILRGL-------IDF-------------KRDPW-------- 277
           ++ G P F  ++  G    I+R L       +               K  PW        
Sbjct: 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHS 284

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              ++ A  L+  +L+  P+ R+   + L HP+ 
Sbjct: 285 LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  129 bits (327), Expect = 1e-34
 Identities = 80/319 (25%), Positives = 125/319 (39%), Gaps = 70/319 (21%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS-------KRKLRTAVDIDDVRR 100
           ++  RY+  + LG G  G+ +  +D D  + +A K I        K  LR          
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR---------- 57

Query: 101 EVAIMKHL-------------PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVA 145
           E+ I++ L             P  S +     +  + N+V++V E  E     D   ++ 
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLE 113

Query: 146 RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           +G   E  A      ++  ++  H   V+HRDLKP N LF N  E+  LK  DFGL+   
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIM 171

Query: 206 KPGERFS----EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESE- 258
            P         E + + +Y +P +L    NY   ID+W+AG I   +L G   F    E 
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231

Query: 259 ---------------------QGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLE 293
                                  V    +R  +     P     P +S  A   + Q+L 
Sbjct: 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILT 291

Query: 294 PDPKLRLTAKQVLEHPWLQ 312
             P  RLTA++ L HP++ 
Sbjct: 292 FSPMDRLTAEEALSHPYMS 310

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (339), Expect = 2e-34
 Identities = 62/264 (23%), Positives = 100/264 (37%), Gaps = 42/264 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDV---RRE-- 101
           +  +Y V   +  G  G  YL +DR  + R +   K      L  + D +       E  
Sbjct: 78  VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKG-----LVHSGDAEAQAMAMAERQ 131

Query: 102 -VAIMKHLPKNSSIVSL-----KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAA 155
            +A + H     SIV +           D   ++VME   G  L              A 
Sbjct: 132 FLAEVVH----PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAI 185

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
           A    I+  +   H  G+++ DLKPEN +   ++    LK ID G          F  + 
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLY 238

Query: 216 GSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           G+P + APE+++       DI++ G  L  L   +P        G+ +           D
Sbjct: 239 GTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DD 288

Query: 276 PWPNVSESAKSLVRQMLEPDPKLR 299
           P     +S   L+R+ ++PDP+ R
Sbjct: 289 PVLKTYDSYGRLLRRAIDPDPRQR 312

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  131 bits (330), Expect = 2e-34
 Identities = 76/338 (22%), Positives = 133/338 (39%), Gaps = 77/338 (22%)

Query: 46  KENIEDRY-LVDRELGRGEFGVTYLCIDRD--TRELLACKSISKRKL-RTAVDIDDVRRE 101
           +E +ED +     ++GRG +G  Y    +D    +  A K I    +  +A       RE
Sbjct: 15  RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC------RE 68

Query: 102 VAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEG--GELFDRIVARGHYTERAAAAV 157
           +A+++ L K+ +++SL++      D  V L+ +  E     +      R     +    +
Sbjct: 69  IALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFH--RASKANKKPVQL 125

Query: 158 TRTIVE--VVQL------CHKHGVIHRDLKPENFLFANKKENS-PLKAIDFGLS-IFFKP 207
            R +V+  + Q+       H + V+HRDLKP N L   +      +K  D G + +F  P
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185

Query: 208 GERFS----EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV 261
            +  +     +V + +Y APE+L   R+Y   IDIW+ G I   LL   P F    E   
Sbjct: 186 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244

Query: 262 AQA---------ILRGL---------------------IDFKRDPWPNV----------- 280
                       I   +                      DF+R+ + N            
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304

Query: 281 --SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                A  L++++L  DP  R+T++Q ++ P+      
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  128 bits (325), Expect = 4e-34
 Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 75/315 (23%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +   Y+    +G G +G     ID+ + E +A K +S R  ++ +      RE+ ++KH
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKH 79

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           + ++ +++ L        +  +    +LVM   +     D  +I+    ++E        
Sbjct: 80  M-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLKFSE-------- 125

Query: 160 TIVEVVQ------LC-----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
              E +Q      L      H  GV+HRDLKP N       E+  LK +DFGL+      
Sbjct: 126 ---EKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA- 178

Query: 209 ERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------------- 253
              +  V + +Y APEV+    +Y   +DIWS G I+  +L G   F             
Sbjct: 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237

Query: 254 ------------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPK 297
                           +   A++ ++ L    R  +    P  S  A  L+ +MLE D  
Sbjct: 238 KVTGVPGTEFVQKLNDKA--AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 295

Query: 298 LRLTAKQVLEHPWLQ 312
            RLTA Q L HP+ +
Sbjct: 296 KRLTAAQALTHPFFE 310

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  126 bits (319), Expect = 1e-33
 Identities = 72/313 (23%), Positives = 125/313 (39%), Gaps = 30/313 (9%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSI 114
           V+  +GRG FGV      R     +A K     ++ +  +      E+  +  +  + +I
Sbjct: 12  VEEVVGRGAFGVVCKAKWRAK--DVAIK-----QIESESERKAFIVELRQLSRV-NHPNI 63

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ------LC 168
           V L  AC   N V LVME  EGG L++ +          AA      ++  Q        
Sbjct: 64  VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
               +IHRDLKP N L       + LK  DFG +   +     +   GS  +MAPEV + 
Sbjct: 122 QPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG 177

Query: 229 N-YGPEIDIWSAGVILYILLCGVPPFW--AESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
           + Y  + D++S G+IL+ ++    PF         +  A+  G     R P   N+ +  
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT----RPPLIKNLPKPI 233

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
           +SL+ +    DP  R + +++++   + +  +        +              + +  
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKI--MTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 291

Query: 345 RVIAEFLSVEEVE 357
              AEF  +  V+
Sbjct: 292 VDFAEFYRLWSVD 304

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  128 bits (323), Expect = 2e-33
 Identities = 70/338 (20%), Positives = 122/338 (36%), Gaps = 88/338 (26%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E    +Y + + LG G FG+     D ++ +  A K + +             RE+ IMK
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMK 55

Query: 107 HLPKNSSIVSLK--------------------------------------EACEDDNAVH 128
            L  + +I+ L                                            +  ++
Sbjct: 56  VL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE--VVQL------CHKHGVIHRDLKP 180
           ++ME      L   +        R+  ++   ++   + QL       H  G+ HRD+KP
Sbjct: 115 VIMEYVPD-TLHKVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKP 169

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWS 238
           +N L  N  +++ LK  DFG +    P E     + S +Y APE++     Y P ID+WS
Sbjct: 170 QNLL-VN-SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227

Query: 239 AGVILYILLCGVPPFWAESEQGVAQAILRGL-------IDF-------------KRDPWP 278
            G +   L+ G P F  E+       I++ +       +               K   W 
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287

Query: 279 NV-----SESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
            +        A  L+ Q+L  +P LR+   + + HP+ 
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (316), Expect = 2e-33
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 20/261 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV---RRE---V 102
           I +RY +  +LG G     YL  D      +A K+I    +      + +    RE    
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNS 65

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           + + H     +IVS+ +  E+D+  +LVME  EG  L + I + G  +   A   T  I+
Sbjct: 66  SQLSH-Q---NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYY 220
           + ++  H   ++HRD+KP+N L      N  LK  DFG++         + + ++G+  Y
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178

Query: 221 MAPEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVA-QAILRGLIDFKRDPWP 278
            +PE  K        DI+S G++LY +L G PPF  E+   +A + I   + +   D   
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238

Query: 279 NVSESAKSLVRQMLEPDPKLR 299
           ++ +S  +++ +  E D   R
Sbjct: 239 DIPQSLSNVILRATEKDKANR 259

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  127 bits (320), Expect = 3e-33
 Identities = 78/321 (24%), Positives = 122/321 (38%), Gaps = 82/321 (25%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS--------KRKLRTAVDIDDVR 99
           ++  RY     +G G +G+     D   +  +A K IS        +R LR         
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR--------- 74

Query: 100 REVAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFD--RIVARGHYTER 152
            E+ I+    ++ +I+ +         E    V++V +L E     D  +++   H +  
Sbjct: 75  -EIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSN- 127

Query: 153 AAAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
                      + Q+       H   V+HRDLKP N L  N      LK  DFGL+    
Sbjct: 128 -----DHICYFLYQILRGLKYIHSANVLHRDLKPSN-LLLN--TTCDLKICDFGLARVAD 179

Query: 207 PGERFS----EIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------- 253
           P    +    E V + +Y APE++   + Y   IDIWS G IL  +L   P F       
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239

Query: 254 ------------------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQM 291
                                + +  A+  L  L    + PW    PN    A  L+ +M
Sbjct: 240 QLNHILGILGSPSQEDLNCIINLK--ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297

Query: 292 LEPDPKLRLTAKQVLEHPWLQ 312
           L  +P  R+  +Q L HP+L+
Sbjct: 298 LTFNPHKRIEVEQALAHPYLE 318

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  126 bits (319), Expect = 4e-33
 Identities = 75/304 (24%), Positives = 122/304 (40%), Gaps = 52/304 (17%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            + +RY     +G G +G      D  T   +A K +S R  ++ +      RE+ ++KH
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 84

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           + K+ +++ L        + E+ N V+LV  L       D   IV     T+     +  
Sbjct: 85  M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIY 139

Query: 160 TIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPY 219
            I+  ++  H   +IHRDLKP N       E+  LK +DFGL+         +  V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRW 194

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------------------------ 253
           Y APE++    +Y   +DIWS G I+  LL G   F                        
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254

Query: 254 -WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               SE   A+  ++ L    +  +       +  A  L+ +ML  D   R+TA Q L H
Sbjct: 255 KKISSES--ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 309 PWLQ 312
            +  
Sbjct: 313 AYFA 316

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  124 bits (314), Expect = 1e-32
 Identities = 85/332 (25%), Positives = 129/332 (38%), Gaps = 96/332 (28%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSIS--------KRKLRTAVDIDDVR 99
           NI   + +   LG G +GV      + T E++A K I          R LR         
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR--------- 58

Query: 100 REVAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFD--RIVARGHYTER 152
            E+ I+KH  K+ +I+++      ++ E+ N V+++ EL +     D  R+++    ++ 
Sbjct: 59  -EIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSD- 111

Query: 153 AAAAVTRTIVEVVQ------LC-----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGL 201
                     + +Q      L      H   VIHRDLKP N L  N   N  LK  DFGL
Sbjct: 112 ----------DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN-LLIN--SNCDLKVCDFGL 158

Query: 202 SIFFKPGERFSEIVGSP-----------YYMAPEVL--KRNYGPEIDIWSAGVILYILLC 248
           +         +                 +Y APEV+     Y   +D+WS G IL  L  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

Query: 249 GVPPFWAES------------------------EQGVAQAILRGLIDFKRDPW----PNV 280
             P F                            E   A+  ++ L  +   P     P V
Sbjct: 219 RRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRV 278

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           +     L+++ML  DP  R+TAK+ LEHP+LQ
Sbjct: 279 NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  125 bits (315), Expect = 2e-32
 Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 64/310 (20%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +   Y   + +G G +G     +D  T   +A K +  R  ++ +      RE+ ++KH
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           + ++ +++ L       E  +D    +LVM         D  +++      E       R
Sbjct: 81  M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGE------DR 129

Query: 160 TIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
               V Q+       H  G+IHRDLKP N       E+  LK +DFGL+         + 
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTG 184

Query: 214 IVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF------------------ 253
            V + +Y APEV+     Y   +DIWS G I+  ++ G   F                  
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244

Query: 254 -------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDPKLRLTA 302
                    +S++  A+  ++GL + ++  +     N S  A +L+ +ML  D + R+TA
Sbjct: 245 PPAEFVQRLQSDE--AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 302

Query: 303 KQVLEHPWLQ 312
            + L HP+ +
Sbjct: 303 GEALAHPYFE 312

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  124 bits (312), Expect = 4e-32
 Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 20/227 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREV 102
              E   DRY +D  +G+G FG      DR  +E +A K I +K+           + EV
Sbjct: 47  KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIEV 101

Query: 103 AIMKHLPKN-----SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH--YTERAAA 155
            +++ + K+       IV LK      N + LV E+     L+D +        +     
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTR 160

Query: 156 AVTRTIVEVVQLCH--KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
              + +   +      +  +IH DLKPEN L  N K  S +K +DFG S     G+R  +
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQ 217

Query: 214 IVGSPYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQ 259
            + S +Y +PEV L   Y   ID+WS G IL  +  G P F   +E 
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  125 bits (315), Expect = 4e-32
 Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 55/311 (17%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +  RY   + +G G  G+     D      +A K +S R  +         RE+ +MK 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 117

Query: 108 LPKNSSIVSLK------EACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRT 160
           +  + +I+SL       +  E+   V+LVMEL +     +   V +        + +   
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQ 172

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  ++  H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 221 MAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE--------------------- 258
            APEV L   Y   +DIWS G I+  ++     F                          
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289

Query: 259 -QGVAQAILRGLIDFKRDPW----PNVSESAKS------------LVRQMLEPDPKLRLT 301
            Q   +  +     +    +    P+    A S            L+ +ML  DP  R++
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349

Query: 302 AKQVLEHPWLQ 312
               L+HP++ 
Sbjct: 350 VDDALQHPYIN 360

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  121 bits (306), Expect = 5e-32
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 33/274 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR----TAVDIDDVRREVAIMKHLPK 110
            ++++G+G FG+ +       + ++A KS+                + +REV IM +L  
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCH 169
           + +IV L       N   +VME    G+L+ R++ + H         +   I   ++   
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 170 KHG--VIHRDLKPENFLFANKKENSP--LKAIDFGLSIFFKPGERFSE-----IVGSPYY 220
                ++HRDL+  N    +  EN+P   K  DFGLS       + S      ++G+  +
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-------QQSVHSVSGLLGNFQW 192

Query: 221 MAPEVL---KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK--RD 275
           MAPE +   + +Y  + D +S  +ILY +L G  PF    E    +     +I  +  R 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF---DEYSYGKIKFINMIREEGLRP 249

Query: 276 PWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             P +     ++++      DPK R     +++ 
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (304), Expect = 2e-31
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 29/268 (10%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV-----RRE-- 101
           + DRY +   LG G     +L  D      +A K      LR  +  D       RRE  
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRREAQ 64

Query: 102 -VAIMKHLPKNSSIVSLKEACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAA 156
             A + H P   +IV++ +  E +        +VME  +G  L D +   G  T + A  
Sbjct: 65  NAAALNH-P---AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----RFS 212
           V     + +   H++G+IHRD+KP N + +     + +K +DFG++           + +
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 213 EIVGSPYYMAPEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID 271
            ++G+  Y++PE  + +      D++S G +LY +L G PPF  +S   VA   +R    
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237

Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLR 299
                   +S    ++V + L  +P+ R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR 265

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  122 bits (307), Expect = 2e-31
 Identities = 60/316 (18%), Positives = 113/316 (35%), Gaps = 64/316 (20%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD------IDDVR-- 99
            ++  Y V R +  G +G     +D      +A K +                    R  
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 100 REVAIMKHLPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFD--RIVARGHYTER 152
           RE+ ++ H   + +I+ L+           + ++LV EL       D  +++    + +R
Sbjct: 78  REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVI----HDQR 128

Query: 153 AAAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
              +       +  +       H+ GV+HRDL P N L     +N+ +   DF L+    
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDT 185

Query: 207 PGERFSEIVGSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPF----------- 253
                +  V   +Y APE++   + +   +D+WSAG ++  +      F           
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245

Query: 254 -------------WAESEQGVAQAILRGLIDFKRDPW----PNVSESAKSLVRQMLEPDP 296
                           S       +   L +     W    P     A  L+ +MLE +P
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305

Query: 297 KLRLTAKQVLEHPWLQ 312
           + R++ +Q L HP+ +
Sbjct: 306 QRRISTEQALRHPYFE 321

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  120 bits (302), Expect = 8e-31
 Identities = 67/311 (21%), Positives = 117/311 (37%), Gaps = 55/311 (17%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +  RY   + +G G  G+     D      +A K +S R  +         RE+ +MK 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 80

Query: 108 LPKNSSIVSLKEA------CEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRT 160
           +  + +I+ L          E+   V++VMEL +     +   V +        + +   
Sbjct: 81  V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  ++  H  G+IHRDLKP N +    K +  LK +DFGL+         +  V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192

Query: 221 MAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFWAESE--------------------- 258
            APEV L   Y   +DIWS G I+  ++ G   F                          
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

Query: 259 -QGVAQAILRGLIDFKRDPW----------------PNVSESAKSLVRQMLEPDPKLRLT 301
            Q   +  +     +    +                   +  A+ L+ +ML  D   R++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312

Query: 302 AKQVLEHPWLQ 312
             + L+HP++ 
Sbjct: 313 VDEALQHPYIN 323

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  118 bits (298), Expect = 1e-30
 Identities = 50/295 (16%), Positives = 108/295 (36%), Gaps = 36/295 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNS 112
           +   +G+G FG  Y          +A + I   +      +   +REV   +        
Sbjct: 37  IGELIGKGRFGQVYHGRWHGE---VAIRLIDIERD-NEDQLKAFKREVMAYRQTRHEN-- 90

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKH 171
            +V    AC     + ++  LC+G  L+  +  A+          + + IV+ +   H  
Sbjct: 91  -VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLS------IFFKPGERFSEIVGSPYYMAPEV 225
           G++H+DLK +N  + N K    +   DFGL          +  ++     G   ++APE+
Sbjct: 150 GILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 226 LKRN----------YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
           +++           +    D+++ G I Y L     PF  +  + +   +  G+   K +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---KPN 262

Query: 276 -PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSR 329
                + +    ++      + + R T  ++++   L+   K            +
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLPKRNRRLSHPGHFWK 315

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (292), Expect = 9e-30
 Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 24/259 (9%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV-----RRE---VA 103
            Y + R +GRG  G  Y   D     ++A K      +   +  D V     +RE     
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-----MSETLSSDPVFRTRMQREARTAG 89

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
            ++  P    +V + +  E D  +++ M L  G +L   +  +G      A A+ R I  
Sbjct: 90  RLQE-P---HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYM 221
            +   H  G  HRD+KPEN L +    +     +DFG++      +  +    VG+ YYM
Sbjct: 146 ALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 222 APEVLKRNY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE    ++     DI++   +LY  L G PP+  +    V  A +   I       P +
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGI 261

Query: 281 SESAKSLVRQMLEPDPKLR 299
             +  +++ + +  +P+ R
Sbjct: 262 PVAFDAVIARGMAKNPEDR 280

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166

 Score =  111 bits (281), Expect = 1e-29
 Identities = 40/71 (56%), Positives = 53/71 (74%)

Query: 331 KQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
           KQFS MN+FK+ ALRVIAE LS EE+  +KEMF  ID+D  G ++ +ELKAGL+  G+ L
Sbjct: 1   KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60

Query: 391 AESEVQMLIEA 401
            ESE+  L++A
Sbjct: 61  KESEILDLMQA 71

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166

 Score = 42.9 bits (102), Expect = 4e-05
 Identities = 12/61 (19%), Positives = 26/61 (42%), Gaps = 10/61 (16%)

Query: 349 EFLSV-------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQ-MLIE 400
           EF++        E  + +   F   D D  G ++ DEL+     FG  + +  ++ ++ +
Sbjct: 84  EFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRD 141

Query: 401 A 401
            
Sbjct: 142 V 142

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  114 bits (287), Expect = 2e-29
 Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 23/267 (8%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLP-KNS 112
           ++  +G G FG  Y          +A K+         +  I++VR+E  +   L   N 
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN- 67

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG 172
            I++L+  C  +  + LVME   GG L   +++               I   +   H   
Sbjct: 68  -IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 173 ---VIHRDLKPENFLFANKKENSP-----LKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
              +IHRDLK  N L   K EN       LK  DFGL+  +    + S   G+  +MAPE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPE 184

Query: 225 VLKRN-YGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWP-NVS 281
           V++ + +    D+WS GV+L+ LL G  PF   +         +  L      P P    
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL----ALPIPSTCP 240

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           E    L+     PDP  R +   +L+ 
Sbjct: 241 EPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  114 bits (288), Expect = 3e-29
 Identities = 63/263 (23%), Positives = 107/263 (40%), Gaps = 20/263 (7%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSS 113
           +  ++G G FG  +      +   +A K + ++    A  +++  REVAIMK L   N  
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGS--DVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPN-- 95

Query: 114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ----L-C 168
           IV    A      + +V E    G L+  +   G   +           +V +    L  
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE-IVGSPYYMAPEVLK 227
               ++HR+LK  N L     +   +K  DFGLS         S+   G+P +MAPEVL+
Sbjct: 156 RNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 228 RN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAK 285
                 + D++S GVIL+ L     P+        AQ +       KR   P N++    
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269

Query: 286 SLVRQMLEPDPKLRLTAKQVLEH 308
           +++      +P  R +   +++ 
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDL 292

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (281), Expect = 2e-28
 Identities = 33/257 (12%), Positives = 69/257 (26%), Gaps = 40/257 (15%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE---VAIM 105
              RY +    G       +  +D      +A   +  + +     + +       ++ +
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
                   +  + +         +V E   GG L +  VA    +   A    +++    
Sbjct: 89  DK----PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAA 142

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H+ GV      P     +             G             ++  P  M    
Sbjct: 143 DAAHRAGVALSIDHPSRVRVS-----------IDGDV-----------VLAYPATMPDA- 179

Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---PNVSE 282
                 P+ DI   G  LY LL    P      +       R       +P     ++  
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 283 SAKSLVRQMLEPDPKLR 299
              ++  + ++ D  +R
Sbjct: 235 QISAVAARSVQGDGGIR 251

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  112 bits (282), Expect = 2e-28
 Identities = 65/303 (21%), Positives = 116/303 (38%), Gaps = 39/303 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNS 112
               LG+G FG       R+T E++  K + +             +EV +M+ L  P   
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPN-- 68

Query: 113 SIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKH 171
            ++        D  ++ + E  +GG L   I      Y      +  + I   +   H  
Sbjct: 69  -VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE---------------IVG 216
            +IHRDL   N L    +EN  +   DFGL+      +   E               +VG
Sbjct: 128 NIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPF--WAESEQGVAQAILRGLIDFK 273
           +PY+MAPE++  R+Y  ++D++S G++L  ++  V     +          +   L    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---- 240

Query: 274 RDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN--VPLGDVVRSRL 330
               P N   S   +  +  + DP+ R +  ++    WL+  +      +PLG  +    
Sbjct: 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHLAGHLPLGPQLEQLD 298

Query: 331 KQF 333
           + F
Sbjct: 299 RGF 301

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score =  112 bits (281), Expect = 4e-28
 Identities = 22/130 (16%), Positives = 48/130 (36%), Gaps = 11/130 (8%)

Query: 277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMM 336
              +++  +    ++ E D K++       E    + A++      GD    + +  S++
Sbjct: 43  EAQIAQKEQEQKAKLAEYDQKVQN------EFDARERAEREREAARGDAAAEKQRLASLL 96

Query: 337 NRFKRKA-----LRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLA 391
              +  A     LR     LS E+   ++++F        G  S  +LK  L  +   + 
Sbjct: 97  KDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIP 156

Query: 392 ESEVQMLIEA 401
           E  ++ L   
Sbjct: 157 EGPLKKLFVM 166

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 10/54 (18%), Positives = 24/54 (44%), Gaps = 1/54 (1%)

Query: 349 EFLSV-EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             ++V  ++  +   F+KID++++G +S  E +      G      +  +   A
Sbjct: 179 TLVAVANDLAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYA 232

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 8/54 (14%), Positives = 23/54 (42%), Gaps = 2/54 (3%)

Query: 349 EFLS-VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-SQLAESEVQMLIE 400
           E++     +  ++ ++   D D  G +S +E++  L +    + A  + +    
Sbjct: 244 EYVHLGLCLLVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFS 297

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  111 bits (280), Expect = 1e-27
 Identities = 79/350 (22%), Positives = 132/350 (37%), Gaps = 107/350 (30%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  +Y + ++LG+G +G+ +  IDR T E++A K I     + + D     RE+ I+  
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTE 64

Query: 108 LPKNSSIVSLKEAC--EDDNAVHLVMELCE--------GGELFDRIVARGHYTERAAAAV 157
           L  + +IV+L      ++D  V+LV +  E           L        H         
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-----HK-------- 111

Query: 158 TRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
            + +V   QL       H  G++HRD+KP N +  N      +K  DFGLS  F    R 
Sbjct: 112 -QYVV--YQLIKVIKYLHSGGLLHRDMKPSN-ILLN--AECHVKVADFGLSRSFVNIRRV 165

Query: 212 SEIVGSP----------------------YYMAPEVL--KRNYGPEIDIWSAGVILYILL 247
           +  +                         +Y APE+L     Y   ID+WS G IL  +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

Query: 248 CGVPPF-------------------------WAESEQGVAQAILRGLIDFKRDPW----- 277
           CG P F                           +S    A+ ++  L +           
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPF--AKTMIESLKEKVEIRQSNKRD 283

Query: 278 ---------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                           + +E A  L+ ++L+ +P  R++A   L+HP++ 
Sbjct: 284 IFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  111 bits (278), Expect = 3e-27
 Identities = 68/372 (18%), Positives = 116/372 (31%), Gaps = 112/372 (30%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           +    RY V R+LG G F   +L  D   ++ +A K + K         +    E+ ++K
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVK---SAEHYTETALDEIRLLK 88

Query: 107 HLPKNSS-------IVSLKEACEDD--NAVH--LVMELCEGGELFDRIVARGH--YTERA 153
            +  +         +V L +  +    N  H  +V E+  G  L   I+   +       
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147

Query: 154 AAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFA-------------------------- 186
              + + +++ +   H    +IH D+KPEN L +                          
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 187 --------------------NKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV- 225
                                  E   +K  D G + +    + F+E + +  Y + EV 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVL 265

Query: 226 LKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG-------VAQAI------------- 265
           +   Y    DIWS   + + L  G   F   S +        +A  I             
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325

Query: 266 -------------LRGLIDFKRDPWPNVS-----------ESAKSLVRQMLEPDPKLRLT 301
                        L+ +   K      V                  +  MLE  P+ R T
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385

Query: 302 AKQVLEHPWLQN 313
           A + L HPWL +
Sbjct: 386 AAECLRHPWLNS 397

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  111 bits (279), Expect = 3e-27
 Identities = 77/362 (21%), Positives = 135/362 (37%), Gaps = 113/362 (31%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ D Y++   +GRG +G  YL  D++T + +A K ++ R     +D   + RE+ I+  
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNR 81

Query: 108 LPKNSSIVSLK-----EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           L K+  I+ L      +     + +++V+E+ +  +L          TE           
Sbjct: 82  L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTE----------- 128

Query: 163 EVVQ------LC-----HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
           E ++      L      H+ G+IHRDLKP N L  N  ++  +K  DFGL+      +  
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCL-LN--QDCSVKVCDFGLARTINSEKDT 185

Query: 212 SEIVGSP-----------------------YYMAPEVL--KRNYGPEIDIWSAGVILYIL 246
           + +                           +Y APE++  + NY   IDIWS G I   L
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 247 LC-----------------GVPPFWAESEQGVAQAILRGLID------------------ 271
           L                  G   F    ++   +   +   D                  
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305

Query: 272 ----------------FKRDPW----PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
                            K        P++S+   +L+  ML+ +P  R+T  Q L+HP+L
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

Query: 312 QN 313
           ++
Sbjct: 366 KD 367

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  106 bits (268), Expect = 9e-27
 Identities = 40/267 (14%), Positives = 95/267 (35%), Gaps = 29/267 (10%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSS 113
              +L     G  +    +     +  K +  R   +     D   E   ++     N  
Sbjct: 14  FLTKLNENHSGELWKGRWQGN--DIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPN-- 68

Query: 114 IVSLKEACEDDNAVHL--VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ----L 167
           ++ +  AC+   A H   +      G L++ +    ++    + AV +  +++ +    L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV-KFALDMARGMAFL 127

Query: 168 -CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
              +  +    L   + +     E+   +     +   F+   R    + +P ++APE L
Sbjct: 128 HTLEPLIPRHALNSRSVMID---EDMTARISMADVKFSFQSPGR----MYAPAWVAPEAL 180

Query: 227 KR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVS 281
           ++          D+WS  V+L+ L+    PF   ++    +  ++  ++  R   P  +S
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGLRPTIPPGIS 237

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                L++  +  DP  R     ++  
Sbjct: 238 PHVSKLMKICMNEDPAKRPKFDMIVPI 264

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score =  104 bits (262), Expect = 9e-27
 Identities = 17/82 (20%), Positives = 44/82 (53%), Gaps = 4/82 (4%)

Query: 322 LGDVVRSRLKQFSMMNRFKRKALRVIAEFLSV--EEVEDIKEMFKKIDSDNDGVVSTDEL 379
           +   V + +K +   +  +   + ++A  LSV    ++ I E+F K+D++++G +S  E+
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61

Query: 380 KAGLRNFGSQLAESEVQMLIEA 401
              L + G  + + ++  +++A
Sbjct: 62  YTVLASVG--IKKWDINRILQA 81

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score = 42.7 bits (101), Expect = 5e-05
 Identities = 13/58 (22%), Positives = 25/58 (43%), Gaps = 8/58 (13%)

Query: 349 EFLSV------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           EF++        E   +K  F KID D DG +S  ++ + + +    L  +++     
Sbjct: 94  EFMAGCYRWKNIESTFLKAAFNKIDKDEDGYISKSDIVSLVHDKV--LDNNDIDNFFL 149

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score =  104 bits (262), Expect = 1e-26
 Identities = 17/93 (18%), Positives = 42/93 (45%), Gaps = 12/93 (12%)

Query: 321 PLGDVVRSRLKQFSMMNRFKRKALRVIAEFLS-VEEVEDIKEMFKKIDSDNDGVVSTDEL 379
                    +K+F    +  + A+  +   L+ +EE +++ ++F+++D++ DG +   EL
Sbjct: 3   HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKEL 62

Query: 380 KAGL-----------RNFGSQLAESEVQMLIEA 401
             G             +  S   E+EV  ++++
Sbjct: 63  IEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQS 95

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score = 40.7 bits (96), Expect = 2e-04
 Identities = 13/61 (21%), Positives = 24/61 (39%), Gaps = 10/61 (16%)

Query: 349 EFLSV-------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQ-MLIE 400
           EF++V          E +   F++ DSD  G ++ +EL          + +     +L E
Sbjct: 108 EFVTVCMDKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFGVTE--VDDETWHQVLQE 165

Query: 401 A 401
            
Sbjct: 166 C 166

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  106 bits (268), Expect = 1e-26
 Identities = 54/264 (20%), Positives = 104/264 (39%), Gaps = 23/264 (8%)

Query: 57  RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--PKNSSI 114
           + +G G FG  Y          +A K ++     T   +   + EV +++         I
Sbjct: 30  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVN---I 82

Query: 115 VSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCHKHGV 173
           +           + +V + CEG  L+  +  +   +  +    + R     +   H   +
Sbjct: 83  LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 174 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---VGSPYYMAPEVLKRN- 229
           IHRDLK  N       E++ +K  DFGL+          +     GS  +MAPEV++   
Sbjct: 142 IHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 230 ---YGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
              Y  + D+++ G++LY L+ G  P+    +   + + + RG +         N  +  
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEH 308
           K L+ + L+     R +  ++L  
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAE 282

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  105 bits (264), Expect = 4e-25
 Identities = 76/401 (18%), Positives = 137/401 (34%), Gaps = 99/401 (24%)

Query: 6   RSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGRGEFG 65
            +    +      + S  +  +++   + K   ++        I DRY +   +G G +G
Sbjct: 8   AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67

Query: 66  VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK-----EA 120
                 D+  + ++A K I  R     +D   + RE+AI+  L  +  +V +      + 
Sbjct: 68  HVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKD 125

Query: 121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
            E  + +++V+E+ +  +         + TE     +   ++  V+  H  G++HRDLKP
Sbjct: 126 VEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP 184

Query: 181 ENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSP--------------------- 218
            N L  N  ++  +K  DFGL+     P    S++  SP                     
Sbjct: 185 ANCL-VN--QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241

Query: 219 ------YYMAPEVL--KRNYGPEIDIWSAGVIL-----------YILLCGVPPF------ 253
                 +Y APE++  + NY   ID+WS G I                   P F      
Sbjct: 242 GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCF 301

Query: 254 ---WAESEQGVAQAILRGLID-----FK------RDPWPNV-SESAKSLVRQM------- 291
                +      +   RG  D     F        +    +  E AK  +R         
Sbjct: 302 PLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361

Query: 292 -------------------LEPDPKLRLTAKQVLEHPWLQN 313
                              L  +P  R+T  + L HP+ + 
Sbjct: 362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  101 bits (253), Expect = 2e-24
 Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 63/296 (21%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-----MKHLPKNSS 113
           +G+G +G  +    +   E +A K  S R      D     RE  +     ++H  +N  
Sbjct: 16  VGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVMLRH--EN-- 63

Query: 114 IVSLKEACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTRTIV------- 162
           I+    +            L+    E G L+D  +        +   +  +I        
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHLH 122

Query: 163 -EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VG 216
            E+     K  + HRDLK +N L    K+N      D GL++         ++     VG
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 217 SPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGV----------PPFWAESEQ 259
           +  YMAPEVL         +    +DIW+ G++L+ +   +          PPF+     
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 260 GVAQAILRGLIDFK--RDPWPNVSESA------KSLVRQMLEPDPKLRLTAKQVLE 307
             +   +R ++     R   PN   S         L+++    +P  RLTA ++ +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  101 bits (252), Expect = 5e-24
 Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 53/291 (18%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
           +G+G FG  +    R     +A K  S R+ R+         E+     L ++ +I+   
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFR----EAEIYQTVML-RHENILGFI 102

Query: 119 EACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTRTIV--------EVVQ 166
            A   DN       LV +  E G LFD  + R   T      +  +          E+V 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI-----VGSPYYM 221
              K  + HRDLK +N L    K+N      D GL++         +I     VG+  YM
Sbjct: 162 TQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 222 APEVLKRNYGPE-------IDIWSAGVILYILLCGV----------PPFWAESEQGVAQA 264
           APEVL  +   +        DI++ G++ + +               P++       +  
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 265 ILRGLIDFK--RDPWPNVSESA------KSLVRQMLEPDPKLRLTAKQVLE 307
            +R ++  +  R   PN  +S         ++R+    +   RLTA ++ +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 65/312 (20%), Positives = 114/312 (36%), Gaps = 65/312 (20%)

Query: 56  DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-----MKHLPK 110
            +++G+G +G  ++   R   E +A K           +     RE  I     M+H  +
Sbjct: 42  VKQIGKGRYGEVWMGKWRG--EKVAVKVFFTT------EEASWFRETEIYQTVLMRH--E 91

Query: 111 NSSIVSLKEACEDDNAVH----LVMELCEGGELFDRIVARGHYTERAAAAVTRTIV---- 162
           N  I+    A            L+ +  E G L+D  +       ++   +  + V    
Sbjct: 92  N--ILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLC 148

Query: 163 ----EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI---- 214
               E+     K  + HRDLK +N L    K+N      D GL++ F       +I    
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 215 -VGSPYYMAPEVLKRNYGPE-------IDIWSAGVILYILLCGV----------PPFWAE 256
            VG+  YM PEVL  +            D++S G+IL+ +               P+   
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 257 SEQGVAQAILRGLIDFK--RDPWPNVSESA------KSLVRQMLEPDPKLRLTAKQVLEH 308
                +   +R ++  K  R  +PN   S         L+ +    +P  RLTA +V + 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 309 PWLQNAKKAPNV 320
             L    ++ ++
Sbjct: 326 --LAKMSESQDI 335

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204

 Score = 95.9 bits (239), Expect = 2e-23
 Identities = 17/86 (19%), Positives = 33/86 (38%), Gaps = 8/86 (9%)

Query: 316 KAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVS 375
             P  PLG          + M + + + L   A       ++ +   F+++D D    + 
Sbjct: 4   LVPRGPLG---SHMDAVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRSLD 55

Query: 376 TDELKAGLRNFGSQLAESEVQMLIEA 401
            DE + GL   G  L ++E + +   
Sbjct: 56  ADEFRQGLAKLGLVLDQAEAEGVCRK 81

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 15/66 (22%), Positives = 24/66 (36%), Gaps = 8/66 (12%)

Query: 344 LRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-------GSQLAESEVQ 396
           LR +   +S      I   F K+D   DGVV+ D+L+             G    +  ++
Sbjct: 96  LRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLR 155

Query: 397 -MLIEA 401
             L   
Sbjct: 156 RFLDNF 161

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 97.5 bits (243), Expect = 6e-23
 Identities = 69/302 (22%), Positives = 114/302 (37%), Gaps = 75/302 (24%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLK 118
             RG FG  +     +  E +A K    +  ++         EV  +  + K+ +I+   
Sbjct: 32  KARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSW----QNEYEVYSLPGM-KHENILQFI 84

Query: 119 EACEDDNAVH----LVMELCEGGELFD-------------RI---VARG----HYTERAA 154
            A +   +V     L+    E G L D              I   +ARG    H      
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH------ 138

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                  +  ++  HK  + HRD+K +N L    K N      DFGL++ F+ G+   + 
Sbjct: 139 -----EDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 215 ---VGSPYYMAPEVL------KRNYGPEIDIWSAGVILYILLCG-----------VPPFW 254
              VG+  YMAPEVL      +R+    ID+++ G++L+ L              + PF 
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 255 AESEQGVAQAILRGLIDFKR------DPWPNVSESAKSLVRQMLE---PDPKLRLTAKQV 305
            E  Q  +   ++ ++  K+      D W         L   + E    D + RL+A  V
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK-HAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 306 LE 307
            E
Sbjct: 310 GE 311

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score = 93.3 bits (232), Expect = 3e-22
 Identities = 14/94 (14%), Positives = 31/94 (32%)

Query: 308 HPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKID 367
            P + N       P+          + M    +      +   + +++   I + F  +D
Sbjct: 2   QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61

Query: 368 SDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
            D  G +  +EL  G    G +L+      ++  
Sbjct: 62  RDRSGTLEINELMMGQFPGGIRLSPQTALRMMRI 95

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score = 49.0 bits (117), Expect = 6e-07
 Identities = 15/95 (15%), Positives = 29/95 (30%), Gaps = 10/95 (10%)

Query: 311 LQNAKKAPNVPLG-DVVRSRLKQFSMMNRFKRKALRVI--AEFLSV-EEVEDIKEMFKKI 366
           L   +    + L             MM  F       I   EF+++ + +E    +F   
Sbjct: 73  LMMGQFPGGIRLSPQTALR------MMRIFDTDFNGHISFYEFMAMYKFMELAYNLFVMN 126

Query: 367 DSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
                G +   E+   L+  G  + +    +L   
Sbjct: 127 ARARSGTLEPHEILPALQQLGFYINQRTSLLLHRL 161

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109

 Score = 87.7 bits (218), Expect = 2e-21
 Identities = 19/87 (21%), Positives = 40/87 (45%), Gaps = 4/87 (4%)

Query: 318 PNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTD 377
            ++   + ++  +  F+  + F  K    +   L  +  +D+K++F  +D D  G +  D
Sbjct: 3   TDLLSAEDIKKAIGAFTAADSFDHKKFFQMVG-LKKKSADDVKKVFHILDKDKSGFIEED 61

Query: 378 ELKAGLRNF---GSQLAESEVQMLIEA 401
           EL + L+ F      L+  E + L+ A
Sbjct: 62  ELGSILKGFSSDARDLSAKETKTLMAA 88

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87

 Score = 84.9 bits (211), Expect = 1e-20
 Identities = 29/57 (50%), Positives = 43/57 (75%)

Query: 345 RVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           + +AE LS EE+  +KE+FK ID+DN G ++ DELK GL+  GS+L ESE++ L++A
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDA 67

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 75/324 (23%), Positives = 118/324 (36%), Gaps = 62/324 (19%)

Query: 25  HARKEAGANKKQPITVLAGVPKENIE---DRYLVDRELGRGEFGVTYLCIDRDTRELLAC 81
               +    KK  + +   VPK+      +  ++  ++GRG FG  +    R    L+A 
Sbjct: 85  LLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAV 144

Query: 82  KSISKRKLRTAVDIDDVRREVAIMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGEL 139
           KS   R+           +E  I+K    P    IV L   C     +++VMEL +GG+ 
Sbjct: 145 KSC--RETLPPDLKAKFLQEARILKQYSHPN---IVRLIGVCTQKQPIYIVMELVQGGDF 199

Query: 140 FDRIVARGHYTERAAAAVTRTIVEVVQLC----------HKHGVIHRDLKPENFLFANKK 189
              +   G             +  ++Q+                IHRDL   N L     
Sbjct: 200 LTFLRTEGARL---------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT--- 247

Query: 190 ENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLKRN-YGPEIDI 236
           E + LK  DFG+S       R  E     Y              APE L    Y  E D+
Sbjct: 248 EKNVLKISDFGMS-------R--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 237 WSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEP 294
           WS G++L+     G  P+   S Q   + + +G     R P P    ++   L+ Q    
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----RLPCPELCPDAVFRLMEQCWAY 354

Query: 295 DPKLRLTAKQVLEHPWLQNAKKAP 318
           +P  R +   + +   LQ+ +K  
Sbjct: 355 EPGQRPSFSTIYQ--ELQSIRKRH 376

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 64/306 (20%), Positives = 102/306 (33%), Gaps = 72/306 (23%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-----MKHLPKNSS 113
           +GRG +G  Y     +    +A K  S        +  +   E  I     M+H   N  
Sbjct: 21  IGRGRYGAVYKGSLDE--RPVAVKVFSFA------NRQNFINEKNIYRVPLMEH--DN-- 68

Query: 114 IVSLKEACEDDNAVH-----LVMELCEGGELFDRIVARGHYTERA---AAAVTRTIV--- 162
           I       E   A       LVME    G L   +         +   A +VTR +    
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH 128

Query: 163 --EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------- 213
                   +K  + HRDL   N L    K +      DFGLS+                 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 214 --IVGSPYYMAPEVLK--------RNYGPEIDIWSAGVILYILLCGV------------- 250
              VG+  YMAPEVL+         +   ++D+++ G+I + +                 
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 251 PPFWAESEQGVAQAILRGLIDFKR------DPWPNVSESAKSLVRQMLE---PDPKLRLT 301
             F  E         ++ L+  ++      + W   S + +SL   + +    D + RLT
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 302 AKQVLE 307
           A+   E
Sbjct: 306 AQXAEE 311

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 7/159 (4%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K +   K +       +  E  I K +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQ----LHIESKIYKMM 61

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRTIVEVVQL 167
                I +++    + +   +VMEL  G  L D        ++ +    +   ++  ++ 
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
            H    IHRD+KP+NFL    K+ + +  IDFGL+  ++
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 21/218 (9%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +++ + R++G G FG  YL  +  T E +A K  + +          +  E  I + L
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRIL 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTRTIVEVV 165
              + I +++    + +   LVM+L  G    +LF+        + +    +   ++  V
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
           +  H    +HRD+KP+NFL    +  + +  IDFGL+  ++       I         G+
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

Query: 218 PYYMAPEV-LKRNYGPEIDIWSAGVILYILLCGVPPFW 254
             Y +    L        D+ S G +L   L G  P W
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 25/221 (11%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +   Y V R +G G FGV +   +    + +A K    R+         +R E    K L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQ----LRDEYRTYKLL 62

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTRTIVEVVQL 167
              + I ++    ++     LV++L  G  L D   +    ++ +  A   + ++  VQ 
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 168 CHKHGVIHRDLKPENFLF--ANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGS 217
            H+  +++RD+KP+NFL    N K  + +  +DFG+  F++       I         G+
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 218 PYYMAPEVLKRNYGPEI----DIWSAGVILYILLCGVPPFW 254
             YM+   +  + G E     D+ + G +    L G  P W
Sbjct: 182 ARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 38/164 (23%), Positives = 65/164 (39%), Gaps = 15/164 (9%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +   + V +++G G FG   L  +  T E +A K +   K R       +  E    K L
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQL 61

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGG----ELFDRIVARGHYTERAAAAVTRTIVEV 164
                I  +           +V+EL   G    +LFD       ++ +    +   ++  
Sbjct: 62  GSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISR 117

Query: 165 VQLCHKHGVIHRDLKPENFLF--ANKKENSPLKAIDFGLSIFFK 206
           ++  H   +I+RD+KPENFL      K    +  IDF L+  + 
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 58/280 (20%), Positives = 113/280 (40%), Gaps = 39/280 (13%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + + +I     +  +LG G++G  Y  + +     +A K++ +      +++++  +E A
Sbjct: 217 MERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 268

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK + K+ ++V L   C  +   +++ E    G L D +        R       + V 
Sbjct: 269 VMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--------RECNRQEVSAVV 319

Query: 164 VVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++ +            K   IHR+L   N L     EN  +K  DFGLS         + 
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 376

Query: 214 IVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGL 269
                P  + APE L    +  + D+W+ GV+L+ I   G+ P+       V + + +  
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436

Query: 270 IDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               R   P    E    L+R   + +P  R +  ++ + 
Sbjct: 437 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 64/295 (21%), Positives = 118/295 (40%), Gaps = 53/295 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           V +E I     + RELG+G FG+ Y      + +D  E   A K++   +  +  +  + 
Sbjct: 22  VAREKIT----MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEF 75

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E ++MK       +V L           ++MEL   G+L   + +             
Sbjct: 76  LNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
            ++ +++Q+             +  +HRDL   N + A   E+  +K  DFG++      
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT------ 185

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I  + YY            M+PE LK   +    D+WS GV+L+ I      P+ 
Sbjct: 186 -R--DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             S + V + ++ G         P N  +    L+R   + +PK+R +  +++  
Sbjct: 243 GLSNEQVLRFVMEG----GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 53/240 (22%), Positives = 98/240 (40%), Gaps = 36/240 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + + +I     +  +LG G++G  Y  + +     +A K++ +      +++++  +E A
Sbjct: 10  MERTDIT----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 61

Query: 104 IMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTR 159
           +MK +  P    +V L   C  +   +++ E    G L D  R   R   +         
Sbjct: 62  VMKEIKHPN---LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AV 111

Query: 160 TIVEV-VQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS 212
            ++ +  Q+        K   IHRDL   N L     EN  +K  DFGLS         +
Sbjct: 112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTA 168

Query: 213 EIVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                 P  + APE L    +  + D+W+ GV+L+ I   G+ P+       V + + + 
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 67/307 (21%), Positives = 117/307 (38%), Gaps = 55/307 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           VP++NI     + R LG G FG  Y      +  D   L  A K++   ++ +  D  D 
Sbjct: 27  VPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDF 80

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E  I+     + +IV             ++MEL  GG+L   +        + ++   
Sbjct: 81  LMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL-- 137

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +++++ +            ++  IHRD+   N L          K  DFG++      
Sbjct: 138 -AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------ 190

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I  + YY            M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 191 -R--DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           ++S Q V + +  G     R   P N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 248 SKSNQEVLEFVTSG----GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 301

Query: 314 AKKAPNV 320
             + P+V
Sbjct: 302 CTQDPDV 308

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 69/314 (21%), Positives = 119/314 (37%), Gaps = 61/314 (19%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           + + +I     +  ELG G FG  +L     +  +  ++L A K++   K  +     D 
Sbjct: 38  IKRRDIV----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDF 90

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-----RIVARGHYTERA 153
           +RE  ++  L ++  IV     C +   + +V E    G+L          A+       
Sbjct: 91  QREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149

Query: 154 AAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
            A     + +++ +                +HRDL   N L     +   +K  DFG+S 
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS- 205

Query: 204 FFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCG 249
                 R  +I  + YY            M PE +  R +  E D+WS GV+L+ I   G
Sbjct: 206 ------R--DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257

Query: 250 VPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             P++  S       I +G    +    P        +++R   + +P+ R + K V   
Sbjct: 258 KQPWYQLSNTEAIDCITQG----RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

Query: 309 PWLQNAKKAPNVPL 322
             LQ   +AP V L
Sbjct: 314 --LQALAQAPPVYL 325

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188

 Score = 79.6 bits (197), Expect = 1e-17
 Identities = 29/54 (53%), Positives = 41/54 (75%)

Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           AE LS EE+  +KE+FK ID+DN G ++ DELK GL+  GS+L ESE++ L++A
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDA 54

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188

 Score = 42.6 bits (101), Expect = 6e-05
 Identities = 12/57 (21%), Positives = 26/57 (45%), Gaps = 2/57 (3%)

Query: 344 LRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +        +E  E++   F   D D  G ++ DE++   ++FG  L +  +  +I+
Sbjct: 69  IAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIK 123

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108

 Score = 76.9 bits (190), Expect = 1e-17
 Identities = 23/79 (29%), Positives = 40/79 (50%), Gaps = 4/79 (5%)

Query: 326 VRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN 385
           + + L++    + F+ +        LS      +K++F+ ID+D  G +  DELK  L+ 
Sbjct: 11  IAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQK 69

Query: 386 FGSQ---LAESEVQMLIEA 401
           F S    L ESE + L++A
Sbjct: 70  FQSDARELTESETKSLMDA 88

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 66/307 (21%), Positives = 117/307 (38%), Gaps = 55/307 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           VP++NI     + R LG G FG  Y      +  D   L  A K++   ++ +  D  D 
Sbjct: 68  VPRKNIT----LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDF 121

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
             E  I+     + +IV             +++EL  GG+L   +        + ++   
Sbjct: 122 LMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL-- 178

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +++++ +            ++  IHRD+   N L          K  DFG++      
Sbjct: 179 -AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------ 231

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I  + YY            M PE      +  + D WS GV+L+ I   G  P+ 
Sbjct: 232 -R--DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           ++S Q V + +  G     R   P N       ++ Q  +  P+ R     +LE   ++ 
Sbjct: 289 SKSNQEVLEFVTSG----GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 342

Query: 314 AKKAPNV 320
             + P+V
Sbjct: 343 CTQDPDV 349

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 51/248 (20%), Positives = 98/248 (39%), Gaps = 54/248 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           + +E I     + +ELG G+FGV  L   +   ++ A K I +     ++  D+  +E  
Sbjct: 5   LKREEIT----LLKELGSGQFGVVKLGKWKGQYDV-AVKMIKE----GSMSEDEFFQEAQ 55

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
            M  L  +  +V     C  +  +++V E    G L + + + G               +
Sbjct: 56  TMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL---------EPSQ 105

Query: 164 VVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++++C+           H  IHRDL   N L      +  +K  DFG++       R+  
Sbjct: 106 LLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT-------RY-- 153

Query: 214 IVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQG 260
           ++   Y             APEV     Y  + D+W+ G++++ +   G  P+   +   
Sbjct: 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

Query: 261 VAQAILRG 268
           V   + +G
Sbjct: 214 VVLKVSQG 221

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108

 Score = 76.5 bits (189), Expect = 2e-17
 Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 4/79 (5%)

Query: 326 VRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN 385
           + + L+     + F  K    I+  +S +    +KE+F+ +D+D  G +  DELK  L+ 
Sbjct: 11  IAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEEDELKYFLQR 69

Query: 386 FGSQ---LAESEVQMLIEA 401
           F S    L  SE +  + A
Sbjct: 70  FESGARVLTASETKTFLAA 88

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 62/295 (21%), Positives = 103/295 (34%), Gaps = 52/295 (17%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRR 100
           +P++       + R LG+GEFG          D   +  A K + K  +  + DI++  R
Sbjct: 20  IPEQQFT----LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLR 74

Query: 101 EVAIMKHLPKNSSIVSLKEACEDD------NAVHLVMELCEGGELFDRIVARGHYTERAA 154
           E A MK    +  +  L                 +++   + G+L   ++A         
Sbjct: 75  EAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133

Query: 155 AAVTRTIVEVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             +   +  +V +            IHRDL   N + A   E+  +   DFGLS      
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS------ 184

Query: 209 ERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFW 254
            R  +I    YY            +A E L    Y    D+W+ GV ++ I+  G  P+ 
Sbjct: 185 -R--KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241

Query: 255 AESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                 +   ++ G     R   P    E    L+ Q    DPK R +   +   
Sbjct: 242 GIENAEIYNYLIGG----NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 53/250 (21%), Positives = 94/250 (37%), Gaps = 58/250 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++       +ELG G+FGV      R   ++ A K I +     ++  D+   E  
Sbjct: 21  IDPKDLT----FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKE----GSMSEDEFIEEAK 71

Query: 104 IMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           +M +L   K   +V L   C     + ++ E    G L + +    H             
Sbjct: 72  VMMNLSHEK---LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---------RFQT 119

Query: 162 VEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
            +++++C               +HRDL   N L     +   +K  DFGLS       R+
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS-------RY 169

Query: 212 SEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESE 258
             ++   Y              PEVL    +  + DIW+ GV+++ I   G  P+   + 
Sbjct: 170 --VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227

Query: 259 QGVAQAILRG 268
              A+ I +G
Sbjct: 228 SETAEHIAQG 237

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 48/270 (17%), Positives = 98/270 (36%), Gaps = 46/270 (17%)

Query: 20  YSSHDHARKEAGANK---KQPITVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDT 75
           +  H H+       +    Q +    G   +++E +++++ +++G G FG+ YL    + 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNK 61

Query: 76  RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA----VH--- 128
            E  A   +             +  E+   + + K   I    E  + D       +   
Sbjct: 62  PEKDARHVVKVEYQENGP----LFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117

Query: 129 -----------LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRD 177
                      +VME   G +L       G + +     +   +++V++  H++  +H D
Sbjct: 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176

Query: 178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGSPYYMAPEVLKRN 229
           +K  N L   K  +  +   D+GLS  + P     +          G+  + + +  K  
Sbjct: 177 IKAANLLLGYKNPDQ-VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-- 233

Query: 230 YGPEI----DIWSAG-VILYILLCGVPPFW 254
            G  +    D+   G  +L   LCG  P W
Sbjct: 234 -GVALSRRSDVEILGYCMLR-WLCGKLP-W 260

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 57/257 (22%), Positives = 93/257 (36%), Gaps = 53/257 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI--DRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           +   +I+        +G G FG            R   A K +  ++  +  D  D   E
Sbjct: 22  LDWNDIK----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGE 75

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD------RIVARGHYTERAAA 155
           + ++  L  + +I++L  ACE    ++L +E    G L D       +     +    + 
Sbjct: 76  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135

Query: 156 AVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF 205
           A T +  +++              +   IHRDL   N L     EN   K  DFGLS   
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS--- 189

Query: 206 KPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVP 251
               R  E      Y            MA E L    Y    D+WS GV+L+ I+  G  
Sbjct: 190 ----RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240

Query: 252 PFWAESEQGVAQAILRG 268
           P+   +   + + + +G
Sbjct: 241 PYCGMTCAELYEKLPQG 257

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 60/322 (18%), Positives = 114/322 (35%), Gaps = 56/322 (17%)

Query: 21  SSHDHARKEAGANKKQPITVLAG-----VPKENIEDRYLVDRELGRGEFGVTY--LCIDR 73
           SSH H    +G   +    +        + +  +     + + LG GEFG          
Sbjct: 3   SSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLI----LGKILGEGEFGSVMEGNLKQE 58

Query: 74  DTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH---- 128
           D   L  A K++ K    +  +I++   E A MK    + +++ L   C + ++      
Sbjct: 59  DGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKP 116

Query: 129 -LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH------KHGVIHRDLKPE 181
            +++   + G+L   ++     T      +   +  +V +            +HRDL   
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-R 228
           N +     ++  +   DFGLS       +  +I    YY            +A E L  R
Sbjct: 177 NCMLR---DDMTVCVADFGLS-------K--KIYSGDYYRQGRIAKMPVKWIAIESLADR 224

Query: 229 NYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKS 286
            Y  + D+W+ GV ++ I   G+ P+       +   +L G     R   P +  +    
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG----HRLKQPEDCLDELYE 280

Query: 287 LVRQMLEPDPKLRLTAKQVLEH 308
           ++      DP  R T   +   
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQ 302

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.0 bits (200), Expect = 7e-17
 Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 36/239 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E++     ++ +LG+G FG  ++     T   +A K++        +  +   +E  
Sbjct: 181 IPRESLR----LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP----GTMSPEAFLQEAQ 231

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L     ++  +++V E    G L D +        +        + +
Sbjct: 232 VMKKL-RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--------KGETGKYLRLPQ 281

Query: 164 VVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           +V +            +   +HRDL+  N L     EN   K  DFGL+   +  E  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR 338

Query: 214 IVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                P  + APE      +  + D+WS G++L  +   G  P+     + V   + RG
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 36/239 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E++     ++ +LG+G FG  ++     T   +A K++        +  +   +E  
Sbjct: 264 IPRESLR----LEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP----GTMSPEAFLQEAQ 314

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L     ++  +++V E    G L D +        +        + +
Sbjct: 315 VMKKL-RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--------KGETGKYLRLPQ 364

Query: 164 VVQLC----------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           +V +            +   +HRDL+  N L     EN   K  DFGL+   +  E  + 
Sbjct: 365 LVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR 421

Query: 214 IVGS-PY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                P  + APE      +  + D+WS G++L  +   G  P+     + V   + RG
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 39/258 (15%), Positives = 77/258 (29%), Gaps = 61/258 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------D 94
           +  E++      +  LG+G F   +  + R+             +    +          
Sbjct: 5   IRNEDLI----FNESLGQGTFTKIFKGVRREVG-----DYGQLHETEVLLKVLDKAHRNY 55

Query: 95  IDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAA 154
            +      ++M  L  +  +V     C   +   LV E  + G L   +    +      
Sbjct: 56  SESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN------ 108

Query: 155 AAVTRTIVEVVQLCH----------KHGVIHRDLKPENFL-----FANKKENSPLKAIDF 199
                 I+  +++            ++ +IH ++  +N L              +K  D 
Sbjct: 109 ---CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 200 GLSIFFKPGERFSEIVGSPYY------MAPEVLK--RNYGPEIDIWSAGVILY-ILLCGV 250
           G+SI          ++           + PE ++  +N     D WS G  L+ I   G 
Sbjct: 166 GISIT---------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216

Query: 251 PPFWAESEQGVAQAILRG 268
            P  A   Q   Q     
Sbjct: 217 KPLSALDSQRKLQFYEDR 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 54/248 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +    +       +E+G G+FG+ +L    +  ++ A K+I +     A+  +D   E  
Sbjct: 5   IDPSELT----FVQEIGSGQFGLVHLGYWLNKDKV-AIKTIRE----GAMSEEDFIEEAE 55

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +M  L  +  +V L   C +   + LV E  E G L D +  +                 
Sbjct: 56  VMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---------LFAAET 105

Query: 164 VVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++ +C           +  VIHRDL   N L     EN  +K  DFG++       RF  
Sbjct: 106 LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMT-------RF-- 153

Query: 214 IVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQG 260
           ++   Y             +PEV     Y  + D+WS GV+++ +   G  P+   S   
Sbjct: 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

Query: 261 VAQAILRG 268
           V + I  G
Sbjct: 214 VVEDISTG 221

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 56/287 (19%), Positives = 105/287 (36%), Gaps = 66/287 (22%)

Query: 2   GNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGR 61
           G C R       E   +       +                 +  + ++    + + +G+
Sbjct: 162 GLCTRLIKPKVMEGTVAAQDEFYRSGWA--------------LNMKELK----LLQTIGK 203

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           GEFG   L   R  +  +A K      ++          E ++M  L ++S++V L    
Sbjct: 204 GEFGDVMLGDYRGNK--VAVKC-----IKNDATAQAFLAEASVMTQL-RHSNLVQLLGVI 255

Query: 122 -EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH----------- 169
            E+   +++V E    G L D + +RG           R+++    L             
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRG-----------RSVLGGDCLLKFSLDVCEAMEY 304

Query: 170 --KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---IFFKPGERFSEIVGSPY-YMAP 223
              +  +HRDL   N L +   E++  K  DFGL+      +   +       P  + AP
Sbjct: 305 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAP 355

Query: 224 EVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
           E L+   +  + D+WS G++L+ I   G  P+     + V   + +G
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.5 bits (189), Expect = 7e-16
 Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 55/260 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           + + +I     + RELG G FG  +L     +     ++L A K++   K  T     D 
Sbjct: 12  IKRRDIV----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDF 64

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           +RE  ++ +L ++  IV     C D + + +V E  + G+L   + A G           
Sbjct: 65  QREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123

Query: 159 R------TIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           R       + +++ +                +HRDL   N L      N  +K  DFG+S
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS 180

Query: 203 IFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLC 248
                  R  ++  + YY            M PE +  R +  E D+WS GVIL+ I   
Sbjct: 181 -------R--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231

Query: 249 GVPPFWAESEQGVAQAILRG 268
           G  P++  S   V + I +G
Sbjct: 232 GKQPWFQLSNTEVIECITQG 251

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 52/231 (22%), Positives = 88/231 (38%), Gaps = 46/231 (19%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR---TAVDIDDVRR 100
            P+ N++      + LG G FG           +  A   ++ + L+    A + + +  
Sbjct: 43  FPRNNLQ----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD----RIVARGHYTERAAAA 156
           E+ IM HL ++ +IV+L  AC     V ++ E C  G+L +    +          A A 
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 157 VTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK 206
            T +  +++                  IHRD+   N L          K  DFGL+    
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA---- 211

Query: 207 PGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
              R  +I+    Y            MAPE +    Y  + D+WS G++L+
Sbjct: 212 ---R--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 60/291 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRR 100
           + +E IE    + R +G G+FG  +  + +  +   +  A K+   +   +    +   +
Sbjct: 387 IQRERIE----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQ 440

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E   M+    +  IV L     ++  V ++MELC  GEL   +  R           +  
Sbjct: 441 EALTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKF---------SLD 489

Query: 161 IVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           +  ++   +              +HRD+   N L +    N  +K  DFGLS        
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR------- 539

Query: 211 FSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
              +  S YY           MAPE +  R +    D+W  GV ++ IL+ GV PF    
Sbjct: 540 --YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

Query: 258 EQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
              V   I  G    +R P P N   +  SL+ +    DP  R    ++  
Sbjct: 598 NNDVIGRIENG----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 69/250 (27%), Positives = 98/250 (39%), Gaps = 54/250 (21%)

Query: 23  HDHARKEAGANKKQPITVLAGVPKEN--IEDRYLV-DRELGRGEFGVTYLCI----DRDT 75
           H H     GA     + VL   P +      RYL   R+LG G FG   L      +  T
Sbjct: 5   HHHHHHHHGA-----LEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGT 59

Query: 76  RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA--VHLVMEL 133
            E++A K++  +           ++E+ I++ L  +  I+  K  CED  A  + LVME 
Sbjct: 60  GEMVAVKAL--KADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEY 116

Query: 134 CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC------HKHGVIHRDLKPENFLFAN 187
              G L D       Y  R +  + + ++   Q+C      H    IHRDL   N L   
Sbjct: 117 VPLGSLRD-------YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD- 168

Query: 188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEI 234
              +  +K  DFGL+       +     G  YY             APE LK   +    
Sbjct: 169 --NDRLVKIGDFGLA-------KAVP-EGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS 218

Query: 235 DIWSAGVILY 244
           D+WS GV LY
Sbjct: 219 DVWSFGVTLY 228

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 58/258 (22%), Positives = 91/258 (35%), Gaps = 66/258 (25%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
           +   NI     +D+ +G GEFG                K  SK+++  A+          
Sbjct: 42  LDATNIS----IDKVVGAGEFGEVCSGR---------LKLPSKKEISVAIKTLKVGYTEK 88

Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
              D   E +IM     + +I+ L+        V +V E  E G L   +          
Sbjct: 89  QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----- 142

Query: 154 AAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
                 T++++V +              G +HRDL   N L      N   K  DFGL  
Sbjct: 143 ----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLG- 194

Query: 204 FFKPGERFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGV 250
                 R  E      Y            +PE +  R +    D+WS G++L+ ++  G 
Sbjct: 195 ------RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

Query: 251 PPFWAESEQGVAQAILRG 268
            P+W  S Q V +A+  G
Sbjct: 249 RPYWEMSNQDVIKAVDEG 266

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 60/258 (23%), Positives = 92/258 (35%), Gaps = 52/258 (20%)

Query: 19  NYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRE-------LGRGEFGVTYLC- 70
           +Y  H H         +      A        D    +         LG+G FG   +C 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCR 61

Query: 71  ---IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA- 126
              +  +T E++A K +   +  T   + D  RE+ I+K L ++ +IV  K  C      
Sbjct: 62  YDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 117

Query: 127 -VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC------HKHGVIHRDLK 179
            + L+ME    G L D +  + H   +      + +    Q+C           IHRDL 
Sbjct: 118 NLKLIMEYLPYGSLRDYL--QKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172

Query: 180 PENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK 227
             N L       + +K  DFGL+       +        YY             APE L 
Sbjct: 173 TRNILVE---NENRVKIGDFGLT-------KVLP-QDKEYYKVKEPGESPIFWYAPESLT 221

Query: 228 -RNYGPEIDIWSAGVILY 244
              +    D+WS GV+LY
Sbjct: 222 ESKFSVASDVWSFGVVLY 239

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 54/252 (21%), Positives = 90/252 (35%), Gaps = 53/252 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY---LCIDRDTRELL-ACKSISKRKLRTAVDIDDVR 99
           +    +       + +G GEFG  Y   L      +E+  A K++  +   T     D  
Sbjct: 41  IHPSCVT----RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFL 94

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
            E  IM     + +I+ L+        + ++ E  E G L   +  +             
Sbjct: 95  GEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---------EF 144

Query: 160 TIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           +++++V +                +HRDL   N L      N   K  DFGLS       
Sbjct: 145 SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLS------- 194

Query: 210 RFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAE 256
           R  E      Y            APE +  R +    D+WS G++++ ++  G  P+W  
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

Query: 257 SEQGVAQAILRG 268
           S   V +AI  G
Sbjct: 255 SNHEVMKAINDG 266

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 53/244 (21%), Positives = 105/244 (43%), Gaps = 46/244 (18%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +P+E+++    ++++LG G+FG  ++       ++ A K++       ++ ++    E  
Sbjct: 185 IPRESLK----LEKKLGAGQFGEVWMATYNKHTKV-AVKTMKP----GSMSVEAFLAEAN 235

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L      +  ++++ E    G L D + +     E +   + + I  
Sbjct: 236 VMKTL-QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDF 289

Query: 164 VVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
             Q+        +   IHRDL+  N L +    +   K  DFGL+       R   I  +
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLA-------RV--IEDN 337

Query: 218 PYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQA 264
            Y             APE +   ++  + D+WS G++L  I+  G  P+   S   V +A
Sbjct: 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397

Query: 265 ILRG 268
           + RG
Sbjct: 398 LERG 401

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 64/305 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-------DRDTRELLACKSISKRKLRTAVDID 96
            P++ +     + + LG G FG   +                +A K +  +   T  D+ 
Sbjct: 32  FPRDKLT----LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLS 85

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D+  E+ +MK + K+ +I++L  AC  D  +++++E    G L + +  R         +
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYS 143

Query: 157 VTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLKAID 198
                V   Q+  K                     IHRDL   N L     EN+ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIAD 200

Query: 199 FGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY- 244
           FGL+       R  +I    YY            MAPE L  R Y  + D+WS GV+++ 
Sbjct: 201 FGLA-------R--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251

Query: 245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAK 303
           I   G  P+     + + + +  G     R   P N +     ++R      P  R T K
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKEG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 307

Query: 304 QVLEH 308
           Q++E 
Sbjct: 308 QLVED 312

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 55/248 (22%), Positives = 101/248 (40%), Gaps = 54/248 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           VP+E ++    +   LG G+FG  ++       + +A KS+ +     ++  D    E  
Sbjct: 10  VPRETLK----LVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ----GSMSPDAFLAEAN 60

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +MK L ++  +V L      +  ++++ E  E G L D +        +  + +  TI +
Sbjct: 61  LMKQL-QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFL--------KTPSGIKLTINK 110

Query: 164 VVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
           ++ +            +   IHRDL+  N L +   +    K  DFGL+       R   
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-------RL-- 158

Query: 214 IVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQG 260
           I  + Y             APE +    +  + D+WS G++L  I+  G  P+   +   
Sbjct: 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

Query: 261 VAQAILRG 268
           V Q + RG
Sbjct: 219 VIQNLERG 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 53/243 (21%), Positives = 99/243 (40%), Gaps = 54/243 (22%)

Query: 56  DRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +  +GRG FG  Y    +D D +++  A KS+   ++    ++     E  IMK    + 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF-SHP 86

Query: 113 SIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-- 169
           +++SL   C   + +  +V+   + G+L + I    H           T+ +++      
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQV 137

Query: 170 --------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY- 220
                       +HRDL   N +     E   +K  DFGL+       R  ++    YY 
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA-------R--DMYDKEYYS 185

Query: 221 -------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAI 265
                        MA E L+ + +  + D+WS GV+L+ ++  G PP+   +   +   +
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

Query: 266 LRG 268
           L+G
Sbjct: 246 LQG 248

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 46/246 (18%), Positives = 82/246 (33%), Gaps = 51/246 (20%)

Query: 50  EDRYLVDRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           E  +   + LG G FG      ++      +  +A K +  R+  +     ++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
             +  N  +  L   C     V L+ +L   G L D +                    ++
Sbjct: 72  ASV-DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLL 120

Query: 166 QLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
             C              ++HRDL   N L         +K  DFGL+       +     
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLA-------KLLG-A 169

Query: 216 GSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
               Y           MA E +  R Y  + D+WS GV ++ ++  G  P+       ++
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

Query: 263 QAILRG 268
             + +G
Sbjct: 230 SILEKG 235

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 61/245 (24%), Positives = 92/245 (37%), Gaps = 50/245 (20%)

Query: 50  EDRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  + D ELG G FG     +   R  +  +A K +  ++     D +++ RE  IM  
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQ 392

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           L  N  IV L   C+ + A+ LVME+  GG L   +V +              +  V +L
Sbjct: 393 L-DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI---------PVSNVAEL 441

Query: 168 CH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGS 217
            H          +   +HR+L   N L          K  DFGLS      +        
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADD-------- 490

Query: 218 PYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQ 263
            YY             APE +  R +    D+WS GV ++  L  G  P+       V  
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550

Query: 264 AILRG 268
            I +G
Sbjct: 551 FIEQG 555

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 61/249 (24%), Positives = 93/249 (37%), Gaps = 47/249 (18%)

Query: 49  IEDRYLV-DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E+R+L    +LG+G FG   LC       +T  L+A K +   +        D +RE+ 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQ 76

Query: 104 IMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I+K L  +  IV  +          + LVME    G L D +  + H   RA    +R +
Sbjct: 77  ILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRH---RARLDASRLL 130

Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
           +   Q+C           +HRDL   N L       + +K  DFGL+      +      
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKD----- 182

Query: 216 GSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGV 261
              YY             APE L    +  + D+WS GV+LY +           +E   
Sbjct: 183 ---YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239

Query: 262 AQAILRGLI 270
                R + 
Sbjct: 240 MMGCERDVP 248

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 63/251 (25%), Positives = 95/251 (37%), Gaps = 53/251 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           + ++N+    + D ELG G FG     +   R  +  +A K +  ++     D +++ RE
Sbjct: 6   LKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMRE 60

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
             IM  L  N  IV L   C+ + A+ LVME+  GG L   +V +              +
Sbjct: 61  AQIMHQL-DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI---------PV 109

Query: 162 VEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             V +L H          +   +HRDL   N L          K  DFGLS      +  
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADD-- 164

Query: 212 SEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
                  YY             APE +  R +    D+WS GV ++  L  G  P+    
Sbjct: 165 ------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

Query: 258 EQGVAQAILRG 268
              V   I +G
Sbjct: 219 GPEVMAFIEQG 229

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 52/258 (20%), Positives = 86/258 (33%), Gaps = 66/258 (25%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
           +    I     +++ +G G+ G                +   +R +  A+          
Sbjct: 46  IEASRIH----IEKIIGSGDSGEVCYGR---------LRVPGQRDVPVAIKALKAGYTER 92

Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERA 153
              D   E +IM     + +I+ L+          +V E  E G L   +          
Sbjct: 93  QRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----- 146

Query: 154 AAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI 203
                 TI+++V +              G +HRDL   N L      N   K  DFGLS 
Sbjct: 147 ----QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLS- 198

Query: 204 FFKPGERFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGV 250
                 R  E      Y            APE +  R +    D+WS GV+++ +L  G 
Sbjct: 199 ------RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252

Query: 251 PPFWAESEQGVAQAILRG 268
            P+W  + + V  ++  G
Sbjct: 253 RPYWNMTNRDVISSVEEG 270

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 56/251 (22%), Positives = 91/251 (36%), Gaps = 53/251 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           + ++ +    L D+ELG G FG         +   + +A K + K +       D++  E
Sbjct: 13  LDRKLLT---LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE 68

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
             +M+ L  N  IV +   CE + +  LVME+ E G L   +    H             
Sbjct: 69  ANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHV----------KD 116

Query: 162 VEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
             +++L H          +   +HRDL   N L          K  DFGLS       + 
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLS-------KA 166

Query: 212 SEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
                  YY             APE +    +  + D+WS GV+++     G  P+    
Sbjct: 167 LR-ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

Query: 258 EQGVAQAILRG 268
              V   + +G
Sbjct: 226 GSEVTAMLEKG 236

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 45/222 (20%)

Query: 49  IEDRYLV-DRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
            E R+L   R+LG G FG   LC       +T E +A KS+  +       I D+++E+ 
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIE 75

Query: 104 IMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           I+++L  + +IV  K  C +D    + L+ME    G L + +    +   +    + + +
Sbjct: 76  ILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKN---KNKINLKQQL 129

Query: 162 VEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
              VQ+C           +HRDL   N L         +K  DFGL+       +  E  
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLT-------KAIE-T 178

Query: 216 GSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
              YY             APE L    +    D+WS GV L+
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 55/260 (21%), Positives = 95/260 (36%), Gaps = 54/260 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
           +    +        ELG   FG  Y           +    A K++  +        ++ 
Sbjct: 6   ISLSAVR----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEF 59

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           R E  +   L ++ ++V L      D  + ++   C  G+L + +V R  +++  +    
Sbjct: 60  RHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 159 RTI---VEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS 202
           RT+   +E     H              H V+H+DL   N L     +   +K  D GL 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF 175

Query: 203 IFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLC 248
                  R  E+  + YY            MAPE +    +  + DIWS GV+L+ +   
Sbjct: 176 -------R--EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226

Query: 249 GVPPFWAESEQGVAQAILRG 268
           G+ P+   S Q V + I   
Sbjct: 227 GLQPYCGYSNQDVVEMIRNR 246

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 71/306 (23%), Positives = 116/306 (37%), Gaps = 66/306 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
           +P++ +     + + LG G FG   L            K    R  + AV          
Sbjct: 66  LPRDRLV----LGKPLGEGAFGQVVLAEAIGLD-----KDKPNRVTKVAVKMLKSDATEK 116

Query: 94  DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD------RIVARG 147
           D+ D+  E+ +MK + K+ +I++L  AC  D  +++++E    G L +            
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176

Query: 148 HYTERAAAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAI 197
            Y          +  ++V   +              IHRDL   N L     E++ +K  
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 233

Query: 198 DFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
           DFGL+       R  +I    YY            MAPE L  R Y  + D+WS GV+L+
Sbjct: 234 DFGLA-------R--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284

Query: 245 -ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTA 302
            I   G  P+     + + + +  G     R   P N +     ++R      P  R T 
Sbjct: 285 EIFTLGGSPYPGVPVEELFKLLKEG----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340

Query: 303 KQVLEH 308
           KQ++E 
Sbjct: 341 KQLVED 346

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 64/305 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL---ACKSISKRKLRTAVDID 96
            P++ +     + + LG G FG   +     ID+D  +     A K +  +   T  D+ 
Sbjct: 78  FPRDKLT----LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLS 131

Query: 97  DVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAA 156
           D+  E+ +MK + K+ +I++L  AC  D  +++++E    G L + +  R         +
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYS 189

Query: 157 VTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLKAID 198
                V   Q+  K                     IHRDL   N L     EN+ +K  D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIAD 246

Query: 199 FGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY- 244
           FGL+       R  +I    YY            MAPE L  R Y  + D+WS GV+++ 
Sbjct: 247 FGLA-------R--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297

Query: 245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAK 303
           I   G  P+     + + + +  G     R   P N +     ++R      P  R T K
Sbjct: 298 IFTLGGSPYPGIPVEELFKLLKEG----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 353

Query: 304 QVLEH 308
           Q++E 
Sbjct: 354 QLVED 358

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 47/226 (20%)

Query: 45  PKENIEDRYLV-DRELGRGEFGVTYLC----IDRDTRELLACKSISKRKLRTAVDIDDVR 99
           P +  E+R+L   ++LG+G FG   +C    +  +T E++A K +   +  T   + D  
Sbjct: 4   PTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFE 59

Query: 100 REVAIMKHLPKNSSIVSLKEACEDDNA--VHLVMELCEGGELFDRIVARGHYTERAAAAV 157
           RE+ I+K L ++ +IV  K  C       + L+ME    G L D +  + H   +     
Sbjct: 60  REIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKH---KERIDH 113

Query: 158 TRTIVEVVQLC------HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF 211
            + +    Q+C           IHRDL   N L       + +K  DFGL+       + 
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLT-------KV 163

Query: 212 SEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
                  ++             APE L    +    D+WS GV+LY
Sbjct: 164 LP-QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 59/253 (23%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRR 100
           + +E++     ++R LG G FG  Y  +  +    ++  A K+   +K  T  + +    
Sbjct: 9   IAREDVV----LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMS 62

Query: 101 EVAIMKHL--PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 158
           E  IMK+L  P    IV L    E++    ++MEL   GEL   +    +         +
Sbjct: 63  EAVIMKNLDHPH---IVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKN---------S 109

Query: 159 RTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG 208
             ++ +V                  +HRD+   N L A       +K  DFGLS      
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS------ 160

Query: 209 ERFSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWA 255
            R+  I    YY           M+PE +  R +    D+W   V ++ IL  G  PF+ 
Sbjct: 161 -RY--IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

Query: 256 ESEQGVAQAILRG 268
              + V   + +G
Sbjct: 218 LENKDVIGVLEKG 230

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 52/242 (21%), Positives = 86/242 (35%), Gaps = 59/242 (24%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDV 98
            P+EN+E      + LG G FG                  +A K +  ++   + + + +
Sbjct: 42  FPRENLE----FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREAL 95

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD-----RIVARGHYTERA 153
             E+ +M  L  + +IV+L  AC     ++L+ E C  G+L +     R        E  
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155

Query: 154 AAAVTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLK 195
                    ++  L  +                     +HRDL   N L         +K
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVK 212

Query: 196 AIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVI 242
             DFGL+       R  +I+    Y            MAPE L    Y  + D+WS G++
Sbjct: 213 ICDFGLA-------R--DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263

Query: 243 LY 244
           L+
Sbjct: 264 LW 265

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 51/238 (21%), Positives = 99/238 (41%), Gaps = 38/238 (15%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  + ++    + + +G+GEFG   L   R  +  +A K      ++          E +
Sbjct: 18  LNMKELK----LLQTIGKGEFGDVMLGDYRGNK--VAVKC-----IKNDATAQAFLAEAS 66

Query: 104 IMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +M  L ++S++V L     E+   +++V E    G L D +  R     R+       + 
Sbjct: 67  VMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSR--GRSVLGGDCLLK 121

Query: 163 EVVQLCH------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLS---IFFKPGERFSE 213
             + +C        +  +HRDL   N L +   E++  K  DFGL+      +   +   
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL-- 176

Query: 214 IVGSPY-YMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
               P  + APE L+ + +  + D+WS G++L+ I   G  P+     + V   + +G
Sbjct: 177 ----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.8 bits (182), Expect = 7e-15
 Identities = 48/237 (20%), Positives = 82/237 (34%), Gaps = 54/237 (22%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDV 98
            P+  +       + LG G FG          I  D    +A K +  +      + + +
Sbjct: 20  FPRNRLS----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREAL 73

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFD--------RIVARGHYT 150
             E+ ++ +L  + +IV+L  AC       ++ E C  G+L +         I ++    
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 151 ERAAAAVTRTIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
                 +   + +++   +              IHRDL   N L          K  DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFG 190

Query: 201 LSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY 244
           L+       R  +I     Y            MAPE +    Y  E D+WS G+ L+
Sbjct: 191 LA-------R--DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score = 71.7 bits (176), Expect = 8e-15
 Identities = 9/67 (13%), Positives = 29/67 (43%), Gaps = 5/67 (7%)

Query: 340 KRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAG-----LRNFGSQLAESE 394
            + A+++  +F +   ++  K MF  +D + +G ++ DE+ +           +   +++
Sbjct: 3   SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62

Query: 395 VQMLIEA 401
              +   
Sbjct: 63  RHQVCVE 69

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 12/67 (17%), Positives = 22/67 (32%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
               +     L+  A        E    +F   D D  G ++ DE KA  +  G   ++ 
Sbjct: 90  DGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQE 149

Query: 394 EVQMLIE 400
           + +    
Sbjct: 150 DCEATFR 156

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 58/251 (23%), Positives = 96/251 (38%), Gaps = 55/251 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY---LCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           + +E IE    + R +G G+FG  +        +    +A K+   +   +    +   +
Sbjct: 12  IQRERIE----LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQ 65

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           E   M+    +  IV L     ++  V ++MELC  GEL   +  R +         +  
Sbjct: 66  EALTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY---------SLD 114

Query: 161 IVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           +  ++   +              +HRD+   N L +    N  +K  DFGLS       R
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS-------R 164

Query: 211 FSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
           +  +  S YY           MAPE +  R +    D+W  GV ++ IL+ GV PF    
Sbjct: 165 Y--MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

Query: 258 EQGVAQAILRG 268
              V   I  G
Sbjct: 223 NNDVIGRIENG 233

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 53/255 (20%), Positives = 99/255 (38%), Gaps = 56/255 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRR 100
           +P E +      DR +G+G FGV Y     D  +     A KS+   ++     ++   R
Sbjct: 16  IPHERVVTH--SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLR 71

Query: 101 EVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTR 159
           E  +M+ L  + ++++L       +   H+++     G+L   I +              
Sbjct: 72  EGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---------NP 121

Query: 160 TIVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE 209
           T+ +++              +   +HRDL   N +     E+  +K  DFGL+       
Sbjct: 122 TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA------- 171

Query: 210 RFSEIVGSPYY--------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPF 253
           R  +I+   YY               A E L+   +  + D+WS GV+L+ +L  G PP+
Sbjct: 172 R--DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

Query: 254 WAESEQGVAQAILRG 268
                  +   + +G
Sbjct: 230 RHIDPFDLTHFLAQG 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 51/243 (20%), Positives = 98/243 (40%), Gaps = 54/243 (22%)

Query: 56  DRELGRGEFGVTY--LCIDRDTRELL-ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS 112
           +  +GRG FG  Y    +D D +++  A KS+   ++    ++     E  IMK    + 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF-SHP 150

Query: 113 SIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-- 169
           +++SL   C   + +  +V+   + G+L + I    H           T+ +++      
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQV 201

Query: 170 --------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY- 220
                       +HRDL   N +     E   +K  DFGL+       R  ++    +  
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA-------R--DMYDKEFDS 249

Query: 221 -------------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAI 265
                        MA E L+ + +  + D+WS GV+L+ ++  G PP+   +   +   +
Sbjct: 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

Query: 266 LRG 268
           L+G
Sbjct: 310 LQG 312

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 64/305 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
            P++ ++    + + LGRG FG         ID+       A K +  ++  T  +   +
Sbjct: 24  FPRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRAL 77

Query: 99  RREVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAV 157
             E+ I+ H+  + ++V+L  AC +    + +++E C+ G L   +  R    E     V
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKV 135

Query: 158 TRTIVEVVQLCHK------------------HGVIHRDLKPENFLFANKKENSPLKAIDF 199
               +    L  +                     IHRDL   N L +   E + +K  DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDF 192

Query: 200 GLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGVILY-I 245
           GL+       R  +I   P Y            MAPE +  R Y  + D+WS GV+L+ I
Sbjct: 193 GLA-------R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 246 LLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAK 303
              G  P+   + ++   + +  G     R   P   +      +      +P  R T  
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299

Query: 304 QVLEH 308
           +++EH
Sbjct: 300 ELVEH 304

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 40/265 (15%), Positives = 91/265 (34%), Gaps = 46/265 (17%)

Query: 25  HARKEAGANKKQPITVLAGVPKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKS 83
            A +++ A +        G    ++    + V   +G+G FG  YL  D ++ E +   +
Sbjct: 8   QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDA 66

Query: 84  ISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA----VH----------- 128
               K+    D   +  E+   +   K   I       +                     
Sbjct: 67  PCVVKV-EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS 125

Query: 129 ---LVMELCEGG----ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE 181
              ++M+    G    ++++       ++ +    ++  I+++++  H+H  +H D+K  
Sbjct: 126 YRFMIMDRF--GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS 181

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKPGERFSEI--------VGSPYYMAPEVLKRNYGPE 233
           N L   K  +  +  +D+GL+  + P                G+  + +   +  + G  
Sbjct: 182 NLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---IDAHNGVA 237

Query: 234 I----DIWSAGVILYILLCGVPPFW 254
                D+   G  +   L G  P W
Sbjct: 238 PSRRGDLEILGYCMIQWLTGHLP-W 261

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 69/324 (21%), Positives = 111/324 (34%), Gaps = 69/324 (21%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLC----IDRDTRELL-ACKSISKRKLRTAVDIDDV 98
            P+ NIE      R++G G FG  +      +       + A K +  ++  +A    D 
Sbjct: 44  YPRNNIE----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADF 97

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGEL-----------FDRIVARG 147
           +RE A+M     N +IV L   C     + L+ E    G+L              +    
Sbjct: 98  QREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 148 HYTERAAAAVTRTIVEVVQLCH-------------KHGVIHRDLKPENFLFANKKENSPL 194
             T    ++     +   +                +   +HRDL   N L     EN  +
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVV 213

Query: 195 KAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPEIDIWSAGV 241
           K  DFGLS       R   I  + YY            M PE +    Y  E D+W+ GV
Sbjct: 214 KIADFGLS-------R--NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264

Query: 242 ILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLR 299
           +L+ I   G+ P++  + + V   +  G         P N      +L+R      P  R
Sbjct: 265 VLWEIFSYGLQPYYGMAHEEVIYYVRDG----NILACPENCPLELYNLMRLCWSKLPADR 320

Query: 300 LTAKQVLEHPWLQNAKKAPNVPLG 323
            +   +     LQ   +     +G
Sbjct: 321 PSFCSIHRI--LQRMCERAEGTVG 342

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 53/250 (21%), Positives = 81/250 (32%), Gaps = 51/250 (20%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTY---LCIDRDTRELLACKSISKRKLRTAVDIDDVRR 100
           + ++++     +  +LG G FGV               +A K +    L     +DD  R
Sbjct: 15  IGEKDLR----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70

Query: 101 EVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRT 160
           EV  M  L  + +++ L         + +V EL   G L DR+                 
Sbjct: 71  EVNAMHSL-DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG---------HFL 119

Query: 161 IVEVVQLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER 210
           +  + +                 IHRDL   N L A       +K  DFGL        R
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLM-------R 169

Query: 211 FSEIVGSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAES 257
                   Y             APE LK R +    D W  GV L+ +   G  P+   +
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

Query: 258 EQGVAQAILR 267
              +   I +
Sbjct: 230 GSQILHKIDK 239

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 47/246 (19%), Positives = 82/246 (33%), Gaps = 51/246 (20%)

Query: 50  EDRYLVDRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           E  +   + LG G FG      ++      +  +A K +  R+  +     ++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
             +  N  +  L   C     V L+ +L   G L D +                    ++
Sbjct: 72  ASV-DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLL 120

Query: 166 QLCH----------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
             C              ++HRDL   N L         +K  DFGL+      E      
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE------ 171

Query: 216 GSPYY-----------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVA 262
               Y           MA E +  R Y  + D+WS GV ++ ++  G  P+       ++
Sbjct: 172 --KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

Query: 263 QAILRG 268
             + +G
Sbjct: 230 SILEKG 235

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161

 Score = 68.0 bits (167), Expect = 8e-14
 Identities = 18/67 (26%), Positives = 30/67 (44%)

Query: 335 MMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE 394
           M           +   L  E+ ++I E F   D +NDG +   ELK  ++  G +L + E
Sbjct: 1   MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60

Query: 395 VQMLIEA 401
           +  LI+ 
Sbjct: 61  ILDLIDE 67

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161

 Score = 46.8 bits (112), Expect = 1e-06
 Identities = 15/60 (25%), Positives = 29/60 (48%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +F  V        + +++IK  F+  D D+ G +S   L+   +  G  L + E++ +IE
Sbjct: 80  DFYIVMGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIE 139

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161

 Score = 67.2 bits (165), Expect = 1e-13
 Identities = 17/67 (25%), Positives = 27/67 (40%), Gaps = 5/67 (7%)

Query: 336 MNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSD-NDGVVSTDELKAGLRNFGSQLAESE 394
           M+   +       E L+ E+  + K  F        DG +ST EL   +R  G      E
Sbjct: 1   MDDIYK----AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56

Query: 395 VQMLIEA 401
           +Q +I+ 
Sbjct: 57  LQEMIDE 63

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161

 Score = 47.2 bits (113), Expect = 1e-06
 Identities = 13/56 (23%), Positives = 31/56 (55%)

Query: 345 RVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           R + +    +  E++ ++F+  D + DG +  +ELK  L+  G  + E +++ L++
Sbjct: 83  RSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMK 138

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 46/238 (19%), Positives = 81/238 (34%), Gaps = 47/238 (19%)

Query: 56  DRELGRGEFGV----TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN 111
            + LG G FG      ++      +  +  K I             V   +  +  L  +
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSL-DH 74

Query: 112 SSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVE-VVQLCH 169
           + IV L   C    ++ LV +    G L D +   RG           + ++   VQ+  
Sbjct: 75  AHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALG-------PQLLLNWGVQIAK 126

Query: 170 ------KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY--- 220
                 +HG++HR+L   N L       S ++  DFG++                     
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVA-------DLLP-PDDKQLLYS 175

Query: 221 --------MAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRG 268
                   MA E +    Y  + D+WS GV ++ ++  G  P+       V   + +G
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179

 Score = 66.8 bits (164), Expect = 2e-13
 Identities = 19/55 (34%), Positives = 32/55 (58%)

Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +A+ L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I  
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINE 55

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179

 Score = 48.3 bits (116), Expect = 6e-07
 Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           EFL++        +  E+I+E F+  D D +G +S  EL+  + N G +L + EV  +I 
Sbjct: 68  EFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIR 127

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77

 Score = 63.7 bits (156), Expect = 3e-13
 Identities = 16/51 (31%), Positives = 27/51 (52%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           LS E+ ++IKE F   D++  G +   ELK  +R  G  + + E+  L+  
Sbjct: 1   LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNE 51

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153

 Score = 66.0 bits (162), Expect = 3e-13
 Identities = 16/55 (29%), Positives = 29/55 (52%)

Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +   L  EE+E+++E F++ D D DG ++  +L   +R  G    E E+  L + 
Sbjct: 1   MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQ 55

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 15/63 (23%), Positives = 35/63 (55%), Gaps = 6/63 (9%)

Query: 344 LRVIAEFLSVEE-----VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-GSQLAESEVQM 397
           + ++   L  E      V+++++ F++ D++ DG +ST EL+  +R   G Q+   +++ 
Sbjct: 70  VELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEE 129

Query: 398 LIE 400
           +I 
Sbjct: 130 IIR 132

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147

 Score = 65.2 bits (160), Expect = 4e-13
 Identities = 18/55 (32%), Positives = 31/55 (56%)

Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +++ L+ E++ + KE F   D DN G +S  EL   +R+ G   +E+EV  L+  
Sbjct: 1   MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNE 55

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147

 Score = 47.8 bits (115), Expect = 5e-07
 Identities = 18/60 (30%), Positives = 33/60 (55%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           EFL++        +  +++ E FK  D + DG++S  ELK  L + G +L ++EV  ++ 
Sbjct: 68  EFLALMSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLR 127

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156

 Score = 65.2 bits (160), Expect = 5e-13
 Identities = 17/60 (28%), Positives = 32/60 (53%)

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            KA   +   L  ++++++KE F  ID D DG VS +++KA     G    + E+  +++
Sbjct: 2   DKAASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK 61

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156

 Score = 46.7 bits (112), Expect = 2e-06
 Identities = 13/60 (21%), Positives = 24/60 (40%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            FLS+        +  E I+  F   D      ++ + +K  L N G    + E++M  +
Sbjct: 71  MFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFK 130

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169

 Score = 64.9 bits (159), Expect = 9e-13
 Identities = 18/74 (24%), Positives = 34/74 (45%), Gaps = 4/74 (5%)

Query: 328 SRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG 387
            + K      R ++K        L+ E+ ++I+E F   D+D  G +   ELK  +R  G
Sbjct: 3   YKAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALG 58

Query: 388 SQLAESEVQMLIEA 401
            +  + E++ +I  
Sbjct: 59  FEPKKEEIKKMISE 72

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169

 Score = 47.2 bits (113), Expect = 1e-06
 Identities = 17/60 (28%), Positives = 30/60 (50%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           EFL++        +  E+I + F+  D DN G ++  +L+   +  G  L E E+Q +I 
Sbjct: 85  EFLTMMTAKMGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIA 144

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 63/317 (19%), Positives = 108/317 (34%), Gaps = 83/317 (26%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---------- 93
            P++N+     + + LG GEFG                  +  R   T V          
Sbjct: 20  FPRKNLV----LGKTLGEGEFGKVVKAT---------AFHLKGRAGYTTVAVKMLKENAS 66

Query: 94  --DIDDVRREVAIMKHLP-KNSSIVSLKEACEDDNAVHLVMELCEGGELFD------RIV 144
             ++ D+  E  ++K +   +  ++ L  AC  D  + L++E  + G L        ++ 
Sbjct: 67  PSELRDLLSEFNVLKQVNHPH--VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124

Query: 145 ARGHYTERAAAAVTRTIVEVVQLCHK------------------HGVIHRDLKPENFLFA 186
                +  +  + +    +   L                       ++HRDL   N L A
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184

Query: 187 NKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY------------MAPEVLK-RNYGPE 233
              E   +K  DFGLS       R  ++     Y            MA E L    Y  +
Sbjct: 185 ---EGRKMKISDFGLS-------R--DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232

Query: 234 IDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESAKSLVRQM 291
            D+WS GV+L+ I+  G  P+     + +   +  G     R   P N SE    L+ Q 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG----HRMERPDNCSEEMYRLMLQC 288

Query: 292 LEPDPKLRLTAKQVLEH 308
            + +P  R     + + 
Sbjct: 289 WKQEPDKRPVFADISKD 305

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91

 Score = 62.4 bits (152), Expect = 1e-12
 Identities = 9/69 (13%), Positives = 26/69 (37%), Gaps = 2/69 (2%)

Query: 333 FSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAE 392
               +   R+ L         EE+  ++ +F   D++  G +  +E +A        +  
Sbjct: 3   HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRP 60

Query: 393 SEVQMLIEA 401
           ++ + + + 
Sbjct: 61  ADAEAVFQR 69

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134

 Score = 63.7 bits (156), Expect = 1e-12
 Identities = 13/42 (30%), Positives = 26/42 (61%)

Query: 360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           + +FK+ID + DG VS +E+KA +    +   E  +Q++ ++
Sbjct: 3   EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKS 44

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134

 Score = 39.4 bits (93), Expect = 3e-04
 Identities = 11/62 (17%), Positives = 25/62 (40%), Gaps = 14/62 (22%)

Query: 349 EFLSV----------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQML 398
           EF             ++   +K ++K +D D DG ++ +E+ +  +  G      +V   
Sbjct: 57  EFAKFYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHG----IEKVAEQ 112

Query: 399 IE 400
           + 
Sbjct: 113 VM 114

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107

 Score = 62.4 bits (152), Expect = 2e-12
 Identities = 14/75 (18%), Positives = 32/75 (42%), Gaps = 3/75 (4%)

Query: 329 RLKQFSMMNRFKRKAL---RVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN 385
           + +Q   ++   ++ L   +  ++     ++E  KE + + D + +G +    LK  L  
Sbjct: 1   KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60

Query: 386 FGSQLAESEVQMLIE 400
            G      E++ LI 
Sbjct: 61  LGVPKTHLELKKLIG 75

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162

 Score = 63.7 bits (156), Expect = 2e-12
 Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 4/68 (5%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
           + M   + +A      FLS E + + K  F   D+D  G +ST EL   +R  G    + 
Sbjct: 1   ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56

Query: 394 EVQMLIEA 401
           E+  +IE 
Sbjct: 57  ELDAIIEE 64

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162

 Score = 48.7 bits (117), Expect = 3e-07
 Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 7/67 (10%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
            MM R        + E    +  E++   F+  D + DG +  +EL   LR  G  + E 
Sbjct: 80  VMMVRQ-------MKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEE 132

Query: 394 EVQMLIE 400
           +++ L++
Sbjct: 133 DIEDLMK 139

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219

 Score = 64.1 bits (156), Expect = 4e-12
 Identities = 14/69 (20%), Positives = 29/69 (42%), Gaps = 5/69 (7%)

Query: 338 RFKRKALRVIAEFLSV----EEVEDIKEMFKKIDSDNDGVVSTDELKAGL-RNFGSQLAE 392
           + +++A   I + +      E  +   E+FKK D +  G +  DE+ +G           
Sbjct: 25  KDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFT 84

Query: 393 SEVQMLIEA 401
           S V+ + + 
Sbjct: 85  SRVRDITKR 93

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 13/62 (20%), Positives = 26/62 (41%), Gaps = 9/62 (14%)

Query: 349 EFLS-------VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV--QMLI 399
           EFL        + +  ++  MF +ID+  + +V  +E K  +    +  A+ E    +  
Sbjct: 115 EFLEFRLMLCYIYDFFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFK 174

Query: 400 EA 401
           E 
Sbjct: 175 EL 176

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148

 Score = 62.1 bits (152), Expect = 6e-12
 Identities = 20/54 (37%), Positives = 31/54 (57%)

Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           AE L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I  
Sbjct: 1   AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINE 54

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148

 Score = 47.5 bits (114), Expect = 6e-07
 Identities = 20/60 (33%), Positives = 32/60 (53%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           EFLS+        +  E++ E FK  D D +G++S  EL+  + N G +L + EV  +I 
Sbjct: 67  EFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIR 126

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 26/208 (12%), Positives = 64/208 (30%), Gaps = 26/208 (12%)

Query: 21  SSHDHARKEAGANKKQPI---TVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE 77
              ++   ++     + +   TVL          ++ +     R   G+ Y      T  
Sbjct: 13  LGTENLYFQSMTTSLEALPTGTVLTDKSGR----QWKLKSFQTRDNQGILYEAAPTSTLT 68

Query: 78  LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA---------------CE 122
             +     K  L+       +  E    +   K   +   K+                  
Sbjct: 69  CDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH 128

Query: 123 DDNAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP 180
            D    LV+    G  L     +  +   +ER+   V   +++ ++  H++  +H ++  
Sbjct: 129 QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTA 187

Query: 181 ENFLFANKKENSPLKAIDFGLSIFFKPG 208
           EN     + ++  +    +G +  + P 
Sbjct: 188 ENIFVDPEDQSQ-VTLAGYGFAFRYCPS 214

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 12/50 (24%), Positives = 26/50 (52%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
             + + +++ E F+ +D+D  G +S  EL A L + G   + +  + L+ 
Sbjct: 21  RHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLH 70

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 22/88 (25%), Positives = 42/88 (47%), Gaps = 9/88 (10%)

Query: 322 LGDVVRSRLKQFS------MMNRFKRKALRVI--AEFLSV-EEVEDIKEMFKKIDSDNDG 372
           L   + S    FS      +++ + +     I   EF  +   +  ++E F+K DS  DG
Sbjct: 49  LNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFILSMREGFRKRDSSGDG 108

Query: 373 VVSTDELKAGLRNFGSQLAESEVQMLIE 400
            + ++E++A L + G Q++E   Q L+ 
Sbjct: 109 RLDSNEVRAALLSSGYQVSEQTFQALMR 136

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 58.7 bits (143), Expect = 1e-11
 Identities = 13/43 (30%), Positives = 26/43 (60%)

Query: 359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
            + +FK+ID + DG VS +E+KA +    +   E  +Q++ ++
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKS 44

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 37.9 bits (89), Expect = 3e-04
 Identities = 7/45 (15%), Positives = 19/45 (42%), Gaps = 3/45 (6%)

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN 385
           +  +       + +    ++ +FK ID+D +G +  +E      +
Sbjct: 23  KAFVSKKRAIKNEQL---LQLIFKSIDADGNGEIDQNEFAKFYGS 64

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86

 Score = 59.6 bits (145), Expect = 1e-11
 Identities = 14/54 (25%), Positives = 31/54 (57%), Gaps = 1/54 (1%)

Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +A   + +++ D + +FK+ D++ DG +S+ EL   L+  G  +   EV+ ++ 
Sbjct: 1   MAAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMA 53

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158

 Score = 61.4 bits (150), Expect = 1e-11
 Identities = 15/55 (27%), Positives = 28/55 (50%), Gaps = 1/55 (1%)

Query: 348 AEFLSVEEVEDIKEMFKKID-SDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
              LS  +V+ ++  F+  +  +  G VSTD++   L   G Q  +S ++ LI+ 
Sbjct: 4   VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDE 58

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158

 Score = 47.2 bits (113), Expect = 1e-06
 Identities = 13/67 (19%), Positives = 31/67 (46%), Gaps = 6/67 (8%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
            +  RF      +  E    +  ++++E F+  D + +G +STD ++  L      L+  
Sbjct: 74  IIGARF------LGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSE 127

Query: 394 EVQMLIE 400
           ++  +I+
Sbjct: 128 DLDAMID 134

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143

 Score = 60.2 bits (147), Expect = 2e-11
 Identities = 14/48 (29%), Positives = 26/48 (54%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           E+ ++I+E F   D+D  G +   ELK  +R  G +  + E++ +I  
Sbjct: 3   EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISE 50

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143

 Score = 47.1 bits (113), Expect = 1e-06
 Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +FL+V        +  E+I + FK  D D  G +S   LK   +  G  L + E+Q +I+
Sbjct: 63  DFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMID 122

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142

 Score = 59.8 bits (146), Expect = 3e-11
 Identities = 11/48 (22%), Positives = 25/48 (52%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           ++V + KE F+  DS+  G ++ + L+  L+ FG ++  +    +   
Sbjct: 3   DQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNE 50

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142

 Score = 46.7 bits (112), Expect = 1e-06
 Identities = 12/58 (20%), Positives = 24/58 (41%), Gaps = 1/58 (1%)

Query: 344 LRVIAEFLSVEEVED-IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           L ++   +     ED +++ F+  D +  G +    L+  L N G +L   E    + 
Sbjct: 65  LSMMGRRMKQTTSEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLG 122

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67

 Score = 56.0 bits (136), Expect = 1e-10
 Identities = 11/43 (25%), Positives = 19/43 (44%)

Query: 358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
             K +F+K D + DG +S DE +     F     + ++    E
Sbjct: 2   SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFE 44

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105

 Score = 57.1 bits (138), Expect = 1e-10
 Identities = 8/48 (16%), Positives = 16/48 (33%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
                I + F+  D+     +S +E +A        L + +   L   
Sbjct: 21  SHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNE 68

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90

 Score = 55.7 bits (135), Expect = 2e-10
 Identities = 20/67 (29%), Positives = 31/67 (46%), Gaps = 4/67 (5%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
           + M   + +A      FLS E + + K  F   D+D  G +ST EL   +R  G    + 
Sbjct: 1   ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56

Query: 394 EVQMLIE 400
           E+  +IE
Sbjct: 57  ELDAIIE 63

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229

 Score = 58.7 bits (142), Expect = 3e-10
 Identities = 15/79 (18%), Positives = 28/79 (35%), Gaps = 2/79 (2%)

Query: 316 KAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVS 375
                 L D V   L+  ++ +R +   L       + +E++ +   FK       GVV+
Sbjct: 26  GLIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNE--CPSGVVN 83

Query: 376 TDELKAGLRNFGSQLAESE 394
            +  K     F  Q   + 
Sbjct: 84  EETFKEIYSQFFPQGDSTT 102

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150

 Score = 56.8 bits (137), Expect = 4e-10
 Identities = 15/81 (18%), Positives = 30/81 (37%), Gaps = 11/81 (13%)

Query: 331 KQFSMMNRFKRKALRVIAEF-----------LSVEEVEDIKEMFKKIDSDNDGVVSTDEL 379
           K F ++   + + L  I                 E++   KE + + D +N+G +    L
Sbjct: 13  KAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSL 72

Query: 380 KAGLRNFGSQLAESEVQMLIE 400
           K  +   G      E++ +I 
Sbjct: 73  KRMMEKLGVPKTHLEMKKMIS 93

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207

 Score = 57.5 bits (139), Expect = 6e-10
 Identities = 18/78 (23%), Positives = 35/78 (44%), Gaps = 5/78 (6%)

Query: 328 SRLKQFSMMNRFKRKALRVIAE--FLSVEEVEDIKEMFKKIDSD--NDGVVSTDELKAGL 383
           S+ K+ + M     +   ++A     +VEEVE + E+FKK+ S   +DG++  +E +  L
Sbjct: 6   SKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLAL 65

Query: 384 RNFGSQLAESEVQMLIEA 401
                         + + 
Sbjct: 66  F-RNRNRRNLFADRIFDV 82

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166

 Score = 56.4 bits (137), Expect = 7e-10
 Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 5/71 (7%)

Query: 340 KRKALRV---IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV- 395
           KR+A      +       E+ED KE F  ID + DG++  D+L+      G    ++E  
Sbjct: 5   KRRAAEGSSNVFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEEL 64

Query: 396 -QMLIEASSSV 405
             M+ EAS  +
Sbjct: 65  DAMIKEASGPI 75

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166

 Score = 46.4 bits (111), Expect = 2e-06
 Identities = 12/60 (20%), Positives = 23/60 (38%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            FL++        +  + I   FK +D D  G +    L+  L   G +    E++ +  
Sbjct: 79  VFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWA 138

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143

 Score = 55.2 bits (134), Expect = 1e-09
 Identities = 13/56 (23%), Positives = 27/56 (48%), Gaps = 1/56 (1%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQ-MLIEASSSV 405
               ++++ KE F  ID + DG +  ++L   L + G    +  ++ M+ EA   +
Sbjct: 1   FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSEAPGPI 56

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143

 Score = 45.6 bits (109), Expect = 3e-06
 Identities = 10/44 (22%), Positives = 18/44 (40%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           + I+  F   D +  G +  D L+  L   G +  + EV  +  
Sbjct: 76  DVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYR 119

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 2/63 (3%)

Query: 329 RLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSD--NDGVVSTDELKAGLRNF 386
            L  +          L       SV E+E + E+FKKI S   +DG+++ +E +  L   
Sbjct: 20  DLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKT 79

Query: 387 GSQ 389
             +
Sbjct: 80  NKK 82

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 12/51 (23%), Positives = 24/51 (47%), Gaps = 1/51 (1%)

Query: 352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEA 401
           ++ +   +  +F+++D D  GV+S  EL+  L N          V+ +I  
Sbjct: 2   ALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISM 52

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score = 49.5 bits (119), Expect = 2e-07
 Identities = 18/52 (34%), Positives = 30/52 (57%), Gaps = 1/52 (1%)

Query: 349 EFLSV-EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           EF  V + + D + +F+  D DN G++  +ELK  L  FG +L++    +LI
Sbjct: 65  EFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILI 116

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 11/63 (17%), Positives = 28/63 (44%), Gaps = 5/63 (7%)

Query: 343 ALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDEL-----KAGLRNFGSQLAESEVQM 397
             ++ ++F +   +   K MF  +D +++G +S DE+        + N G+   +++   
Sbjct: 2   NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61

Query: 398 LIE 400
              
Sbjct: 62  DAV 64

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score = 51.0 bits (122), Expect = 8e-08
 Identities = 11/66 (16%), Positives = 22/66 (33%)

Query: 335 MMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE 394
              +     L   A+            +F  +D D +G ++ DE KA  +  G   +  +
Sbjct: 87  GWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSED 146

Query: 395 VQMLIE 400
            +    
Sbjct: 147 CEETFR 152

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 11/46 (23%), Positives = 17/46 (36%), Gaps = 3/46 (6%)

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
           +   +      S E+ E   E F+  D D  G +  DE+      F
Sbjct: 132 KAYTKAAGIIQSSEDCE---ETFRVCDIDESGQLDVDEMTRQHLGF 174

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147

 Score = 54.9 bits (132), Expect = 2e-09
 Identities = 14/89 (15%), Positives = 32/89 (35%)

Query: 312 QNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDND 371
           Q+         G +   + ++   +N+      +   +     ++E  K  + + D + +
Sbjct: 3   QSRDLQGGKAFGLLKAQQEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGN 62

Query: 372 GVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           G +    LK  L   G      E++ LI 
Sbjct: 63  GDIDIMSLKRMLEKLGVPKTHLELKRLIR 91

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score = 55.2 bits (133), Expect = 4e-09
 Identities = 12/70 (17%), Positives = 26/70 (37%), Gaps = 2/70 (2%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLA-- 391
               R      +   E L  + +  + + F   D D+DG +  DE+          +   
Sbjct: 13  YRYLRSVGNQWQFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNAT 72

Query: 392 ESEVQMLIEA 401
           + +V+ + +A
Sbjct: 73  DEQVEKMRDA 82

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 12/68 (17%), Positives = 18/68 (26%), Gaps = 2/68 (2%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
                F                       +  +D D DG V  DELK  ++ F   + + 
Sbjct: 105 EANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQE 162

Query: 394 EVQMLIEA 401
                 E 
Sbjct: 163 AAYTFFEK 170

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score = 43.3 bits (102), Expect = 5e-05
 Identities = 12/52 (23%), Positives = 22/52 (42%), Gaps = 1/52 (1%)

Query: 344 LRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV 395
           L+ + +   V + E     F+K D+D  G +   EL    R F  +  + + 
Sbjct: 150 LKTMMKAFDVPQ-EAAYTFFEKADTDKSGKLERTELVHLFRKFWMEPYDPQW 200

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211

 Score = 54.4 bits (131), Expect = 8e-09
 Identities = 11/68 (16%), Positives = 20/68 (29%), Gaps = 6/68 (8%)

Query: 335 MMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAES 393
           M N    K++    + +  +E       F        G+ +  E K  L   G    A  
Sbjct: 3   MGNG---KSIAGDQKAVPTQETHVWYRTFMME--YPSGLQTLHEFKTLLGLQGLNQKANK 57

Query: 394 EVQMLIEA 401
            +  +   
Sbjct: 58  HIDQVYNT 65

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92

 Score = 51.4 bits (124), Expect = 1e-08
 Identities = 17/51 (33%), Positives = 30/51 (58%)

Query: 350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            +  +  E++KE FK  D D +G +S  EL+  + N G +L + EV+ +I+
Sbjct: 2   HMDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIK 52

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146

 Score = 52.6 bits (127), Expect = 1e-08
 Identities = 8/50 (16%), Positives = 18/50 (36%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
              E+V++        +  + G +S D      R  G   +  + + + E
Sbjct: 9   QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKE 58

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146

 Score = 48.0 bits (115), Expect = 4e-07
 Identities = 12/59 (20%), Positives = 27/59 (45%), Gaps = 8/59 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           ++L          + VE++ +MF   D++  G ++  ++K  L  +G  L + E    +
Sbjct: 68  QYLEYLSICVHDKDNVEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDAL 126

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81

 Score = 50.2 bits (121), Expect = 2e-08
 Identities = 15/52 (28%), Positives = 30/52 (57%), Gaps = 1/52 (1%)

Query: 350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-SQLAESEVQMLIE 400
           ++  ++ E+I   FK  D++ DGV+  DE K  ++  G   L ++EV+  ++
Sbjct: 1   WVRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMK 52

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 21/93 (22%), Positives = 40/93 (43%), Gaps = 1/93 (1%)

Query: 314 AKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGV 373
            KKA              +     R  +++   +    +  +V++ KE F+ ID D DG 
Sbjct: 14  KKKAEEEGGDAPAAPPAPKPPSQKRRAQRSGSNVFAMFTQHQVQEFKEAFQLIDQDKDGF 73

Query: 374 VSTDELKAGLRNFGSQLAESEVQ-MLIEASSSV 405
           +S ++++A   + G    E E+  M+ EA   +
Sbjct: 74  ISKNDIRATFDSLGRLCTEQELDSMVAEAPGPI 106

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 11/44 (25%), Positives = 19/44 (43%), Gaps = 1/44 (2%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           + I   F   D + DG    + LK  L  +G + ++ EV   + 
Sbjct: 126 DVIVNAFNLFD-EGDGKCKEETLKRSLTTWGEKFSQDEVDQALS 168

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204

 Score = 52.5 bits (126), Expect = 3e-08
 Identities = 13/72 (18%), Positives = 28/72 (38%), Gaps = 8/72 (11%)

Query: 331 KQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKK-IDSDNDGVVSTDELKAGLRNFGSQ 389
           +QFS     +  A+          +   ++E +KK ++    G +   E K   +   ++
Sbjct: 3   QQFSWEEAEENGAV-------GAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNE 55

Query: 390 LAESEVQMLIEA 401
            A   V+ +  A
Sbjct: 56  EATQYVEAMFRA 67

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71

 Score = 48.6 bits (117), Expect = 6e-08
 Identities = 14/49 (28%), Positives = 26/49 (53%)

Query: 352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +   +ED++  F+  D D DG ++ DEL+  +   G  L + E+  +I 
Sbjct: 1   ARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIR 49

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 12/52 (23%), Positives = 27/52 (51%), Gaps = 2/52 (3%)

Query: 352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG--SQLAESEVQMLIEA 401
           S   V+ +K  F +ID D DG ++  + ++    F   S++     ++L+++
Sbjct: 1   SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDS 52

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 10/45 (22%), Positives = 20/45 (44%), Gaps = 1/45 (2%)

Query: 344 LRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS 388
             +    L +++       F  ID++NDG++S +E      +F  
Sbjct: 116 YGIFFGMLGLDK-TMAPASFDAIDTNNDGLLSLEEFVIAGSDFFM 159

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 9/45 (20%), Positives = 18/45 (40%), Gaps = 2/45 (4%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             +   F+ +D++ D  +S DE        G  L ++      +A
Sbjct: 94  GPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDA 136

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151

 Score = 50.7 bits (122), Expect = 6e-08
 Identities = 14/45 (31%), Positives = 23/45 (51%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           ED  E F+  D + +G V   EL+  L   G ++ E EV+ ++  
Sbjct: 87  EDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG 131

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151

 Score = 49.5 bits (119), Expect = 1e-07
 Identities = 11/50 (22%), Positives = 23/50 (46%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            + +++E+ KE F+  D   DG +   +    +R  G     +EV  ++ 
Sbjct: 4   FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLG 53

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110

 Score = 49.5 bits (119), Expect = 7e-08
 Identities = 23/93 (24%), Positives = 43/93 (46%), Gaps = 14/93 (15%)

Query: 317 APNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSV-----EEVEDIKEMFKKIDSDND 371
           A ++   D ++  L        F  K      +F ++         D+K++FK ID+D  
Sbjct: 3   AKDLLKADDIKKALDAVKAEGSFNHK------KFFALVGLKAMSANDVKKVFKAIDADAS 56

Query: 372 GVVSTDELKAGLRNF---GSQLAESEVQMLIEA 401
           G +  +ELK  L++F   G  L ++E +  ++A
Sbjct: 57  GFIEEEELKFVLKSFAADGRDLTDAETKAFLKA 89

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145

 Score = 50.2 bits (121), Expect = 8e-08
 Identities = 16/47 (34%), Positives = 25/47 (53%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
              + I+E F+  D DNDG VS +EL + LR+ G     +E+  +  
Sbjct: 2   ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKG 48

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145

 Score = 46.0 bits (110), Expect = 2e-06
 Identities = 13/44 (29%), Positives = 26/44 (59%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +++ + F+ +D + +G +   EL+  L N G  L  SEV+ L++
Sbjct: 76  KEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMK 119

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272

 Score = 52.0 bits (124), Expect = 9e-08
 Identities = 7/47 (14%), Positives = 20/47 (42%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
            +  +     ++++  D+D++G +   EL    R+   +L   +   
Sbjct: 5   FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKIT 51

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 12/67 (17%), Positives = 31/67 (46%)

Query: 334 SMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
           +M+   +   L +      ++   +  ++++K D+D+ G +S  ELK  L++   Q  + 
Sbjct: 81  NMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKK 140

Query: 394 EVQMLIE 400
                ++
Sbjct: 141 IPPNKLD 147

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 23/104 (22%), Positives = 49/104 (47%), Gaps = 12/104 (11%)

Query: 44  VPKENIEDRYLVDRELGRGEFGV----TYLCIDRDTREL-LACKSISKRKLRTAVDIDDV 98
            P++ ++    + + LGRG FG         ID+      +A K +  ++  T  +   +
Sbjct: 19  FPRDRLK----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRAL 72

Query: 99  RREVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFD 141
             E+ I+ H+  + ++V+L  AC +    + +++E C+ G L  
Sbjct: 73  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 31/95 (32%), Positives = 41/95 (43%), Gaps = 26/95 (27%)

Query: 172 GVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY----------- 220
             IHRDL   N L +   E + +K  DFGL+       R  +I   P Y           
Sbjct: 213 KCIHRDLAARNILLS---EKNVVKICDFGLA-------R--DIYKDPDYVRKGDARLPLK 260

Query: 221 -MAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPP 252
            MAPE +    Y  + D+WS GV+L+ I   G  P
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 8/50 (16%), Positives = 21/50 (42%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            S+       E++   D+D  G +   EL+  ++       ++ +++  E
Sbjct: 10  SSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPE 59

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score = 44.1 bits (104), Expect = 3e-05
 Identities = 10/47 (21%), Positives = 25/47 (53%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +  E+  + ++K D+D+ G + T+ELK  L++   +  ++     + 
Sbjct: 100 KSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLA 146

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score = 43.7 bits (103), Expect = 5e-05
 Identities = 10/75 (13%), Positives = 31/75 (41%), Gaps = 4/75 (5%)

Query: 335 MMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL-AES 393
           ++     +   ++         ++  + F+  D D +G +  +EL A L++   +   E 
Sbjct: 172 LL---PVQENFLLKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQEL 228

Query: 394 EVQMLIEASSSVLAT 408
           ++  +     +++A 
Sbjct: 229 DINNISTYKKNIMAL 243

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156

 Score = 49.8 bits (120), Expect = 1e-07
 Identities = 14/52 (26%), Positives = 24/52 (46%), Gaps = 2/52 (3%)

Query: 351 LSVEEVEDIKEMFKKIDS--DNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           LS +E++D+K++F+  D     DG V   +L    R  G      +V  +  
Sbjct: 3   LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG 54

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156

 Score = 46.8 bits (112), Expect = 2e-06
 Identities = 16/59 (27%), Positives = 27/59 (45%), Gaps = 2/59 (3%)

Query: 344 LRVIAEFLSVEE--VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           L      +  E+    D  E FK  D +  G +S  EL+  L   G +L++ +V  +I+
Sbjct: 69  LPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIK 127

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 19/60 (31%), Positives = 31/60 (51%)

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            K      + L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I 
Sbjct: 296 HKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMIN 355

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 19/60 (31%), Positives = 32/60 (53%), Gaps = 8/60 (13%)

Query: 349 EFLSV--------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           EFL++        +  E+I+E F+  D D +G +S  EL+  + N G +L + EV  +I 
Sbjct: 369 EFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIR 428

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155

 Score = 49.5 bits (119), Expect = 1e-07
 Identities = 13/48 (27%), Positives = 24/48 (50%), Gaps = 4/48 (8%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +E++ + + FKK+D DN G +S +E  +             VQ +I+ 
Sbjct: 3   DEIKRLGKRFKKLDLDNSGSLSVEEFMSLP----ELQQNPLVQRVIDI 46

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155

 Score = 41.8 bits (99), Expect = 7e-05
 Identities = 14/59 (23%), Positives = 32/59 (54%), Gaps = 2/59 (3%)

Query: 344 LRVIAEFLSVEEVED-IKEMFKKIDSDNDGVVSTDELKAGLRNF-GSQLAESEVQMLIE 400
           +  +++F    + E  ++  F+  D D DG +S  EL   L+   G+ L ++++Q +++
Sbjct: 61  IEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD 119

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 15/71 (21%), Positives = 27/71 (38%), Gaps = 3/71 (4%)

Query: 334 SMMNRFKRKALRVI--AEFLSV-EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
           SM+          +   EF  +   ++  + ++K+ D D  G + + EL       G  L
Sbjct: 51  SMVAVMDSDTTGKLGFEEFKYLWNNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHL 110

Query: 391 AESEVQMLIEA 401
            E    M+I  
Sbjct: 111 NEHLYSMIIRR 121

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173

 Score = 43.2 bits (102), Expect = 3e-05
 Identities = 11/45 (24%), Positives = 19/45 (42%), Gaps = 1/45 (2%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQML 398
           EEV   + +F ++  D D  VS  EL   L    ++  + +    
Sbjct: 1   EEVRQFRRLFAQLAGD-DMEVSATELMNILNKVVTRHPDLKTDGF 44

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.4 bits (122), Expect = 2e-07
 Identities = 44/319 (13%), Positives = 96/319 (30%), Gaps = 68/319 (21%)

Query: 33  NKKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKL 89
           ++K P+     +P E ++       ++G G FG  +  I   T     ++A +       
Sbjct: 6   SQKGPVPFSHCLPTEKLQR----CEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG 61

Query: 90  RTAVDIDDVRREVAIMKHLP----------------KNSSIV------SLKEACED---- 123
                 +++  E+ I K L                  +   V       L +A +     
Sbjct: 62  SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121

Query: 124 ------------DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH 171
                       D+ + +V+E   GG   +++  +      A + + +    +       
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL 181

Query: 172 GVIHRDLKPENFLFAN---------------KKENSPLKA--IDFGLSIFFKPGERFSEI 214
              HRDL   N L                     +  L+   ID+ LS   + G     +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IV 237

Query: 215 VGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
           V     M  ++   +   + DI+   ++          +   S       +   ++    
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYR--LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 275 DPWPNVSESAKSLVRQMLE 293
                 + + K + R++ E
Sbjct: 296 FKTKCNTPAMKQIKRKIQE 314

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149

 Score = 49.1 bits (118), Expect = 2e-07
 Identities = 10/50 (20%), Positives = 19/50 (38%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
            S    +D KE F   D   D  ++  ++    R  G     +E+  ++ 
Sbjct: 2   FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILG 51

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149

 Score = 47.1 bits (113), Expect = 8e-07
 Identities = 14/45 (31%), Positives = 23/45 (51%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           ED  E  +  D + +G V   EL+  L   G ++ E EV+ L++ 
Sbjct: 85  EDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG 129

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78

 Score = 46.8 bits (112), Expect = 2e-07
 Identities = 17/44 (38%), Positives = 28/44 (63%), Gaps = 1/44 (2%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +D++ +FK+ D++ DG +S  EL   LR  GS  A+ EVQ ++ 
Sbjct: 3   DDMERIFKRFDTNGDGKISLSELTDALRTLGSTSAD-EVQRMMA 45

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94

 Score = 47.3 bits (113), Expect = 3e-07
 Identities = 16/44 (36%), Positives = 26/44 (59%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           E+I+E F+  D D +G +S  EL+  + N G +L + EV  +I 
Sbjct: 29  EEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIR 72

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 3e-07
 Identities = 60/460 (13%), Positives = 132/460 (28%), Gaps = 108/460 (23%)

Query: 1   MGNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELG 60
                +   +V  +    N+   D          K+ I  +            L    L 
Sbjct: 14  HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73

Query: 61  RGEFGVTYLC--IDRDTRELLA------CKSISKRKLRTAVDIDDVRREVAIMK--HLPK 110
           + E  V      + R   + L        +  S          D +  +  +    ++ +
Sbjct: 74  KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133

Query: 111 NSSIVSLKEA-CEDDNA----VH---------LVMELCEGGELFDRIVARGHYTERAAAA 156
               + L++A  E   A    +          + +++C   ++  ++  +  +       
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193

Query: 157 VTRTIVEVVQ-LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
              T++E++Q L ++       + P     ++   N  L+                  ++
Sbjct: 194 SPETVLEMLQKLLYQ-------IDPNWTSRSDHSSNIKLRIHSIQ--------AELRRLL 238

Query: 216 GSPYYMAPE---VLKRNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAIL----- 266
            S  Y       VL        ++ +A       L C                IL     
Sbjct: 239 KSKPY--ENCLLVLL-------NVQNAKAWNAFNLSC---------------KILLTTRF 274

Query: 267 RGLIDFKRDPWPNVSESAKSLV--RQMLEPDPKLRLTAKQVLEHPWL-QNAKKAPNV--- 320
           + + DF        + +  SL      L PD    L  K      +L    +  P     
Sbjct: 275 KQVTDFL----SAATTTHISLDHHSMTLTPDEVKSLLLK------YLDCRPQDLPREVLT 324

Query: 321 --PL-----GDVVR---SRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDN 370
             P       + +R   +    +  +N  K     +I   L+V E  + ++MF ++    
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDKLT--TIIESSLNVLEPAEYRKMFDRLSVFP 382

Query: 371 DGV-VSTDELKAGLRNFGSQLAESEVQMLIE--ASSSVLA 407
               + T  L          + +S+V +++      S++ 
Sbjct: 383 PSAHIPTILLSL----IWFDVIKSDVMVVVNKLHKYSLVE 418

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165

 Score = 48.5 bits (116), Expect = 4e-07
 Identities = 14/69 (20%), Positives = 26/69 (37%), Gaps = 3/69 (4%)

Query: 334 SMMNRFKRKALRVI--AEFLSV-EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
            M+    R     +    F  +   +   KE F  +D D  G V   EL+  +   G +L
Sbjct: 44  IMIAMLDRDHTGKMGFNAFKELWAALNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRL 103

Query: 391 AESEVQMLI 399
           +   +  ++
Sbjct: 104 SPQTLTTIV 112

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83

 Score = 46.1 bits (110), Expect = 6e-07
 Identities = 11/44 (25%), Positives = 25/44 (56%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE 394
           ++ +   +++  FKK+D++ DG V+  EL+  +    +  A S+
Sbjct: 1   MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSK 44

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256

 Score = 48.9 bits (116), Expect = 8e-07
 Identities = 18/141 (12%), Positives = 39/141 (27%), Gaps = 15/141 (10%)

Query: 254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
             E+ +        G +       P     +    R        +R          W+ +
Sbjct: 4   TKEAVKASD-----GNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCL-----IKWILS 53

Query: 314 AKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGV 373
           +         D   S L+  ++ ++ +           + +E++ +   FK       G+
Sbjct: 54  SAAPQGSDSSD---SELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKNE--CPTGL 108

Query: 374 VSTDELKAGLRNFGSQLAESE 394
           V  D  K     F  Q   + 
Sbjct: 109 VDEDTFKLIYSQFFPQGDATT 129

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148

 Score = 47.2 bits (113), Expect = 9e-07
 Identities = 14/66 (21%), Positives = 33/66 (50%), Gaps = 5/66 (7%)

Query: 335 MMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE 394
           ++   +++      +  +  + ED  + F+  D ++ G VS  +L+  L   G +L ++E
Sbjct: 66  LIEVNEKEL-----DATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAE 120

Query: 395 VQMLIE 400
           V  L++
Sbjct: 121 VDELLK 126

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148

 Score = 46.1 bits (110), Expect = 2e-06
 Identities = 13/47 (27%), Positives = 18/47 (38%)

Query: 355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
                K++F   D    G ++ D L   LR  G       VQ +I A
Sbjct: 2   ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINA 48

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 8/59 (13%), Positives = 22/59 (37%), Gaps = 2/59 (3%)

Query: 336 MNRFKRKALRVIAE--FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAE 392
               + + L  I +    S  ++  +   F  +D   +G +S ++ +       + L +
Sbjct: 6   STLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIPELAINPLGD 64

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 8/57 (14%), Positives = 22/57 (38%), Gaps = 2/57 (3%)

Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS--QLAESEVQMLIEA 401
           I E      +  +K   +++D   DG +S ++ +          +L+  + +   + 
Sbjct: 4   ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQE 60

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score = 45.5 bits (108), Expect = 7e-06
 Identities = 15/48 (31%), Positives = 20/48 (41%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             V     M+  ID+D DG VS  E KA L+  G  L + +       
Sbjct: 99  MAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNT 146

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score = 42.4 bits (100), Expect = 7e-05
 Identities = 9/46 (19%), Positives = 21/46 (45%), Gaps = 3/46 (6%)

Query: 341 RKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
           +  L+ +   L+ ++       F  +D + +G +S DE    + +F
Sbjct: 125 KAFLQAVGPDLTDDKAI---TCFNTLDFNKNGQISRDEFLVTVNDF 167

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 15/69 (21%), Positives = 27/69 (39%), Gaps = 3/69 (4%)

Query: 334 SMMNRFKRKALRVI--AEFLSV-EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
            M++   R     +   EF  +   +   ++ F   D+D  G V   EL+  L   G +L
Sbjct: 77  LMVSMLDRDMSGTMGFNEFKELWAVLNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRL 136

Query: 391 AESEVQMLI 399
           +   V  + 
Sbjct: 137 SPQAVNSIA 145

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109

 Score = 45.7 bits (109), Expect = 1e-06
 Identities = 17/54 (31%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ---LAESEVQMLIEA 401
           LS +  + IK++F  +D D  G +  +EL+  L+NF S    L  +E +  + A
Sbjct: 36  LSSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAA 89

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109

 Score = 45.7 bits (109), Expect = 1e-06
 Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 8/61 (13%)

Query: 349 EFLSV-----EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ---LAESEVQMLIE 400
            F +      +  +DIK+ F  ID D  G +  DELK  L+ F +    L ++E +  ++
Sbjct: 29  AFFAKVGLTAKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLK 88

Query: 401 A 401
           A
Sbjct: 89  A 89

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140

 Score = 46.3 bits (111), Expect = 2e-06
 Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 10/62 (16%)

Query: 349 EFLSV----------EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQML 398
           +FL V           + E+  + F+  D D  G++   EL+  L + G +L+  E+  L
Sbjct: 58  QFLQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDEL 117

Query: 399 IE 400
           ++
Sbjct: 118 LK 119

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140

 Score = 44.4 bits (106), Expect = 7e-06
 Identities = 8/43 (18%), Positives = 14/43 (32%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQ 396
            +    K+ F   D    G +    +   LR  G     +E+ 
Sbjct: 2   TDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEIT 44

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167

 Score = 46.2 bits (110), Expect = 2e-06
 Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 3/69 (4%)

Query: 334 SMMNRFKRKALRVI--AEFLSV-EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQL 390
            M++   R     +   EF  +   +   ++ F   DSD  G V   EL+  L   G +L
Sbjct: 46  LMVSMLDRDMSGTMGFNEFKELWAVLNGWRQHFISFDSDRSGTVDPQELQKALTTMGFRL 105

Query: 391 AESEVQMLI 399
               V  + 
Sbjct: 106 NPQTVNSIA 114

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167

 Score = 39.3 bits (92), Expect = 7e-04
 Identities = 8/49 (16%), Positives = 19/49 (38%), Gaps = 6/49 (12%)

Query: 356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES-----EVQMLI 399
           ++ +   F  + +  DG +  DEL+  L   G             ++++
Sbjct: 1   MDPLYGYFASV-AGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMV 48

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 6/41 (14%), Positives = 13/41 (31%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE 394
           E    I   F   D D +G +   +     +   ++   + 
Sbjct: 1   EYERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAA 41

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score = 42.0 bits (99), Expect = 7e-05
 Identities = 10/45 (22%), Positives = 16/45 (35%), Gaps = 2/45 (4%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             +       D+D DG V+  +    L  FG  + E   +    A
Sbjct: 98  PFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAA 140

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 6/30 (20%), Positives = 13/30 (43%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
           +  ++    +D+D DG V   E+      +
Sbjct: 132 DLARQAAAALDTDGDGKVGETEIVPAFARY 161

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 12/54 (22%), Positives = 24/54 (44%), Gaps = 4/54 (7%)

Query: 352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN----FGSQLAESEVQMLIEA 401
           +    + +K+ F + D D +G +   + +   ++    FG     +EVQ L  A
Sbjct: 2   TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNA 55

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 11/38 (28%), Positives = 21/38 (55%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE 394
            +  E F ++D++ +G +S DEL   +R+F     + E
Sbjct: 136 AEAAEAFNQVDTNGNGELSLDELLTAVRDFHFGRLDVE 173

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 10/45 (22%), Positives = 19/45 (42%), Gaps = 2/45 (4%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             +K +    D + DG ++ DE  A L   G  ++++E       
Sbjct: 102 PVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQ 144

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108

 Score = 44.5 bits (106), Expect = 4e-06
 Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 8/61 (13%)

Query: 349 EFLSV-----EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ---LAESEVQMLIE 400
           EF +      + ++D+K+ F  ID D  G +  DELK  L+NF      L ++E +  + 
Sbjct: 28  EFFAKVGLASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLA 87

Query: 401 A 401
            
Sbjct: 88  D 88

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193

 Score = 46.0 bits (109), Expect = 5e-06
 Identities = 10/68 (14%), Positives = 28/68 (41%), Gaps = 5/68 (7%)

Query: 337 NRFKRKALRVIAE--FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE 394
           ++ + + ++ + E    +  E+++  + F +      G +S +E K    NF      S+
Sbjct: 6   SKLRPEVMQDLLESTDFTEHEIQEWYKGFLRDC--PSGHLSMEEFKKIYGNFFPYGDASK 63

Query: 395 -VQMLIEA 401
             + +   
Sbjct: 64  FAEHVFRT 71

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 46.8 bits (112), Expect = 6e-06
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 7/88 (7%)

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEV 225
           H   +IHRD+K  N L     EN   K  DFG+S      ++    + + G+  Y+ PE 
Sbjct: 156 HTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212

Query: 226 LKRNYGPE-IDIWSAGVILYILLCGVPP 252
             +    E  D++S GV+L+ +LC    
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 8/61 (13%), Positives = 21/61 (34%), Gaps = 4/61 (6%)

Query: 336 MNRFKRKALRVIAE--FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
            ++  +  L+ +        +E++   + F K      G ++  E +   + F      S
Sbjct: 5   QSKLSQDQLQDLVRSTRFDKKELQQWYKGFFKD--CPSGHLNKSEFQKIYKQFFPFGDPS 62

Query: 394 E 394
            
Sbjct: 63  A 63

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109

 Score = 42.2 bits (100), Expect = 2e-05
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 8/61 (13%)

Query: 349 EFLSV-----EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIE 400
            F  +     +    +KE+F+ +D D  G +  +ELK  L+ F   G  L ++E + L+ 
Sbjct: 28  RFFHLVGLKGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLA 87

Query: 401 A 401
           A
Sbjct: 88  A 88

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 43/170 (25%), Positives = 66/170 (38%), Gaps = 49/170 (28%)

Query: 169 HKHGVIHRDLKPENFLFANKKENSPL------KAIDFGLSIFFKPGERF---SEIVGSPY 219
           H++  IHRD+K  N L         L      K  DFGL+   +   +    S IVG+  
Sbjct: 150 HENHHIHRDIKSANIL---------LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200

Query: 220 YMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPF-----------WAE---SEQGVAQAI 265
           YMAPE L+    P+ DI+S GV+L  ++ G+P               E    E+      
Sbjct: 201 YMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT---- 256

Query: 266 LRGLIDFKRDPWPNVSESAKSLVRQM-------LEPDPKLRLTAKQVLEH 308
           +   ID        ++++  + V  M       L      R   K+V + 
Sbjct: 257 IEDYID------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 6/46 (13%), Positives = 16/46 (34%), Gaps = 1/46 (2%)

Query: 350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV 395
             S   +  +   F+ +D +  G +S  +L+  +           +
Sbjct: 22  GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQ-IGALAVNPLGDRI 66

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 9/52 (17%), Positives = 17/52 (32%), Gaps = 3/52 (5%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE-VQMLIEA 401
           LS  E     + F        G ++  E K          + ++ V+ + E 
Sbjct: 11  LSATECHQWYKKFMTEC--PSGQLTLYEFKQFFGLKNLSPSANKYVEQMFET 60

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191

 Score = 42.5 bits (100), Expect = 7e-05
 Identities = 8/68 (11%), Positives = 23/68 (33%), Gaps = 7/68 (10%)

Query: 339 FKRKALRVIAEFLSVEEVED-----IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
           + +     +      E + +     +  MF   D+  D ++   E      ++G  + +S
Sbjct: 86  WLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKS 143

Query: 394 EVQMLIEA 401
           +     + 
Sbjct: 144 DCDAAFDT 151

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 3/30 (10%), Positives = 8/30 (26%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF 386
            D    F  +      +V+ +        +
Sbjct: 143 SDCDAAFDTLSDGGKTMVTREIFARLWTEY 172

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135

 Score = 40.8 bits (96), Expect = 1e-04
 Identities = 12/59 (20%), Positives = 30/59 (50%), Gaps = 2/59 (3%)

Query: 344 LRVIAEFLSVEE-VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIE 400
           L V+AE + VEE V ++ + F  +      +++ + L+      G + +++ + Q ++ 
Sbjct: 26  LPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVR 84

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 13/80 (16%), Positives = 25/80 (31%), Gaps = 2/80 (2%)

Query: 315 KKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVV 374
           +     P  D +   L+   + +R +           +  E++ +   FK       GVV
Sbjct: 12  QTKQRRPSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNE--CPSGVV 69

Query: 375 STDELKAGLRNFGSQLAESE 394
           + +  K     F      S 
Sbjct: 70  NEETFKQIYAQFFPHGDAST 89

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 16/68 (23%), Positives = 29/68 (42%), Gaps = 7/68 (10%)

Query: 339 FKRKALRVIAEFLSVEEVED-----IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAES 393
           +     + IA   SV ++       I  +FK +D   DG+V  +E +   +NF   L  +
Sbjct: 82  YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCA 139

Query: 394 EVQMLIEA 401
           +V  +   
Sbjct: 140 DVPAVYNV 147

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95

 Score = 37.8 bits (88), Expect = 6e-04
 Identities = 13/52 (25%), Positives = 21/52 (40%), Gaps = 2/52 (3%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           +S  E     E+F K D D DG VS  E++       + L  + +  +    
Sbjct: 4   VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK--TGLPSTLLAHIWSLC 53

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92

 Score = 37.4 bits (87), Expect = 9e-04
 Identities = 12/52 (23%), Positives = 21/52 (40%), Gaps = 2/52 (3%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS 402
           ++ E+ +     FK I  D +G +     K       S+L   E+  + E S
Sbjct: 3   ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELS 52

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	408
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.02
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	98.98
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.89
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.84
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	98.75
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.59
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.57
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	98.53
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	98.46
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	98.46
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	98.44
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	98.44
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	98.43
1j7q_A	86	CAVP, calcium vector protein; EF-hand family, calc	98.39
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	98.38
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	98.32
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	98.31
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	98.29
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	98.28
1c07_A	95	Protein (epidermal growth factor receptor pathway	98.26
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	98.26
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	98.23
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	98.23
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	98.22
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	98.22
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	98.21
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	98.21
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	98.19
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	98.18
3n22_A	98	Protein S100-A2; EF-hand, calcium-binding, zinc-bi	98.16
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	98.11
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	98.11
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	98.11
2y5i_A	99	S100Z, S100 calcium binding protein Z; metal-bindi	98.09
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	98.07
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	98.07
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.07
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	98.06
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	98.05
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	98.05
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	98.05
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	98.05
1j55_A	95	S-100P protein; metal binding protein; 2.00A {Homo	98.03
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.03
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	98.03
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	98.03
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	98.03
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	98.02
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	98.02
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	98.01
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	98.0
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	97.99
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	97.98
2wcb_A	95	Protein S100-A12; calcium signalling, HOST-parasit	97.98
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	97.97
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	97.94
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	97.94
3li6_A	66	Calcium-binding protein; calcium signaling protein	97.93
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	97.92
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	97.92
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	97.91
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	97.91
1k2h_A	93	S100A1, S-100 protein, alpha chain; non-covalent h	97.91
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	97.91
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	97.91
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	97.89
4drw_A	121	Protein S100-A10/annexin A2 chimeric protein; atyp	97.89
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	97.88
2jq6_A	139	EH domain-containing protein 1; metal binding prot	97.87
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	97.86
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	97.86
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	97.86
2kax_A	92	Protein S100-A5; EF-hand, calcium binding protien,	97.85
3fwb_A	161	Cell division control protein 31; gene gating, com	97.85
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	97.84
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	97.84
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	97.84
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	97.83
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	97.83
1xk4_C	113	Calgranulin B; S100 family, heterotetramer, metal	97.82
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.82
2h2k_A	106	Protein S100-A13; calcium binding protein, metal b	97.82
2jnf_A	158	Troponin C; stretch activated muscle contraction,	97.81
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	97.81
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	97.81
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	97.8
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	97.8
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.8
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	97.8
3fwb_A	161	Cell division control protein 31; gene gating, com	97.79
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	97.79
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	97.78
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	97.77
3nxa_A	100	Protein S100-A16; S100 family, calcium binding pro	97.76
1xk4_A	93	Calgranulin A; S100 family, heterotetramer, metal	97.75
1k8u_A	90	S100A6, calcyclin, CACY; calcium regulatory protei	97.75
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	97.74
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.73
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	97.73
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	97.73
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	97.7
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	97.67
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	97.67
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	97.67
1psr_A	100	Psoriasin, S100A7; EF-hand protein, MAD phasing, p	97.67
1cb1_A	78	Calbindin D9K; calcium-binding protein; NMR {Sus s	97.67
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	97.64
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	97.64
2jnf_A	158	Troponin C; stretch activated muscle contraction,	97.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.63
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	97.63
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	97.63
1a4p_A	96	S100A10; S100 family, EF-hand protein, ligand of a	97.62
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	97.61
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	97.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.59
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	97.58
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	97.58
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	97.57
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	97.55
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	97.55
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	97.54
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	97.53
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	97.53
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.52
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	97.52
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	97.51
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	97.5
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	97.49
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	97.49
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	97.48
1qls_A	99	S100C protein, calgizzarin; metal-binding protein/	97.46
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	97.45
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	97.45
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	97.44
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	97.44
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	97.44
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	97.43
1y1x_A	191	Leishmania major homolog of programmed cell death	97.4
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.4
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	97.39
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	97.39
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	97.38
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	97.38
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.37
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	97.37
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	97.37
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	97.36
1h8b_A	75	ACT-EF34, alpha-actinin 2, skeletal muscle isoform	97.35
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.35
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	97.34
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	97.34
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	97.32
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	97.31
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	97.3
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	97.29
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.28
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	97.27
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	97.25
2hps_A	186	Coelenterazine-binding protein with bound coelent;	97.24
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	97.21
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	97.19
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	97.19
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	97.18
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	97.17
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	97.17
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	97.17
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	97.16
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	97.16
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	97.16
1snl_A	103	Nucleobindin 1, calnuc; EF-hand, calcium-binding,	97.14
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	97.14
3fia_A	121	Intersectin-1; EH 1 domain, NESG, structural genom	97.14
1y1x_A	191	Leishmania major homolog of programmed cell death	97.13
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	97.12
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	97.09
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	97.08
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	97.08
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.07
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	97.07
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	97.06
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	97.04
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	97.02
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	96.98
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	96.98
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	96.93
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	96.91
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	96.88
2hps_A	186	Coelenterazine-binding protein with bound coelent;	96.86
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	96.84
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	96.82
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	96.81
2lvv_A	226	Flagellar calcium-binding protein TB-24; EF-hand,	96.8
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	96.78
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	96.77
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	96.72
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	96.66
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	96.66
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.64
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	96.62
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	96.61
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	96.59
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	96.58
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	96.57
2lvv_A	226	Flagellar calcium-binding protein TB-24; EF-hand,	96.54
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	96.52
2kld_A	123	Polycystin-2; PC2, PKD2, calcium binding domain, E	96.48
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	96.46
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	96.46
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	96.43
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	96.42
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	96.42
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	96.41
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	96.39
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	96.35
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	96.29
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	96.28
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	96.27
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.22
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	96.21
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	96.21
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	96.18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	96.16
1djx_A	624	PLC-D1, phosphoinositide-specific phospholipase C,	96.14
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	96.11
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	96.08
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	96.05
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	96.02
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	96.01
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	95.99
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	95.95
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	95.89
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	95.79
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	95.64

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-68  Score=487.57  Aligned_cols=258  Identities=29%  Similarity=0.508  Sum_probs=236.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.| +||||++++++|++++.+|+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEE
Confidence            36799999999999999999999999999999999877655555678899999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+..... 
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCC
Confidence            99999999999999999999999999999999999999999999999999999999   56678999999999876433 


Q ss_pred             --CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          209 --ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       209 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                        ....+.+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..++..++.++.+.++    ..+|++++
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  262 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKAR  262 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHH
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHH
Confidence              23456799999999999986 699999999999999999999999999999999999998877654    46899999


Q ss_pred             HHHHHhcCCCcCCCCCHHH------HhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQ------VLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~------~l~h~~~~~~~  315 (408)
                      +||.+||++||++|||+.|      +++||||++..
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            9999999999999999988      58899998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-67  Score=474.40  Aligned_cols=254  Identities=35%  Similarity=0.637  Sum_probs=215.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++++.+ +||||+++++++++++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEE
Confidence            6899999999999999999999999999999999887766666677899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |||| +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            9999 67999999999999999999999999999999999999999999999999   5567899999999988776666


Q ss_pred             eecccCCCCCcchhhhhc-cC-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ..+.+||+.|+|||++.+ .| +.++||||+||++|+|+||+.||.+.+...+.+.+..+...++    ..+|+++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            677899999999999986 34 6899999999999999999999999999999999988876554    46899999999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccccC
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      .+||++||++|||+.|+++||||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.4e-67  Score=484.44  Aligned_cols=259  Identities=31%  Similarity=0.531  Sum_probs=232.2

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      +..+.|++.+.||+|+||+||+|+++.+|+.||||++.+....   ..+.+.+|+.+|+.+ +|||||+++++|++++.+
T Consensus        71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~  146 (346)
T 4fih_A           71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDEL  146 (346)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred             ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence            4567899999999999999999999999999999999865432   345688999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |||||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus       147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCC
Confidence            999999999999998876 579999999999999999999999999999999999999   5667899999999987654


Q ss_pred             C-CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 G-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      . ....+.+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+..... ...+.+..+|++++
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~  301 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK  301 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHH
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHH
Confidence            3 44567899999999999975 699999999999999999999999999998888888876542 33344567999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +||.+||++||++|||+.|+|+||||++..
T Consensus       302 dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          302 GFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.2e-66  Score=508.73  Aligned_cols=361  Identities=33%  Similarity=0.596  Sum_probs=320.2

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh----------hcHHHHHHHHHHHHhCCCCCC
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA----------VDIDDVRREVAIMKHLPKNSS  113 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~~  113 (408)
                      .....+.++|.+++.||+|+||+||+|+++.++..||+|++.+......          ...+.+.+|+.+++.+ +|||
T Consensus        29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  107 (504)
T 3q5i_A           29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPN  107 (504)
T ss_dssp             EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTT
T ss_pred             ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCC
Confidence            3556788999999999999999999999999999999999987553321          3356789999999999 9999


Q ss_pred             eeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCC
Q 015352          114 IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP  193 (408)
Q Consensus       114 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~  193 (408)
                      |+++++++.+.+.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999999999999988889999999999999999999999999999999999999976555567


Q ss_pred             EEEeecccccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          194 LKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       194 vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      +||+|||++.............||+.|+|||++.+.|+.++||||+||++|+|++|..||.+.+..+....+..+...++
T Consensus       188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999999988776666677789999999999988899999999999999999999999999999999999999988887


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCC---CCchHHHhhhhhhhhhhhhHHHHhhhhhhh
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV---PLGDVVRSRLKQFSMMNRFKRKALRVIAEF  350 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~  350 (408)
                      .+.|..+|+++++||.+||+.||.+|||+.|+|+||||+........   ......+.++++|...+++++.++.++...
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~  347 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSK  347 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            77778999999999999999999999999999999999876533221   112345678889999999999999999887


Q ss_pred             h-chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh--------CCCCCHHHHHHHHHHhCCC
Q 015352          351 L-SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF--------GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 l-s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~--------g~~~~~~e~~~~~~~~d~~  405 (408)
                      + +.++..+++++|..+|.|+||.|+.+||..+++.+        |...++.+++.+|+.+|.+
T Consensus       348 ~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d  411 (504)
T 3q5i_A          348 LTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFD  411 (504)
T ss_dssp             TSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTT
T ss_pred             CCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCC
Confidence            6 78889999999999999999999999999999988        5578899999999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.7e-66  Score=509.11  Aligned_cols=360  Identities=37%  Similarity=0.647  Sum_probs=323.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+..+.++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+.
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~   98 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDK   98 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC
Confidence            4567889999999999999999999999999999999999877665556678899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +.+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999999999999988999999999999999999999999999999999999997666778899999999988


Q ss_pred             cCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ...........||+.|+|||++.+.|+.++||||+||++|+|++|.+||.+.+..+....+..+...+..+.|..+|+.+
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            77666666778999999999999899999999999999999999999999999999999999999888888888999999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC---CCCCCchHHHhhhhhhhhhhhhHHHHhhhhhhhh-chhhhHHHH
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA---PNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFL-SVEEVEDIK  360 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~l-s~~~~~~l~  360 (408)
                      ++||.+||+.||.+|||+.|+|+||||+.....   ...+.......++++|...+++++.++..++..+ +.++..+++
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~  338 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT  338 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHH
Confidence            999999999999999999999999999875431   2334445667789999999999999999998866 778889999


Q ss_pred             HHHhhcCCCCCCccCHHHHH----HHHHHhCCCCC-------HHHHHHHHHHhCCC
Q 015352          361 EMFKKIDSDNDGVVSTDELK----AGLRNFGSQLA-------ESEVQMLIEASSSV  405 (408)
Q Consensus       361 ~~F~~~D~~~dG~i~~~el~----~~l~~~g~~~~-------~~e~~~~~~~~d~~  405 (408)
                      ++|..+|.|+||.|+.+|+.    ..++.+|..++       +.+++++|+.+|.+
T Consensus       339 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d  394 (484)
T 3nyv_A          339 AIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFD  394 (484)
T ss_dssp             HHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCC
Confidence            99999999999999999994    45555677777       89999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1e-65  Score=505.95  Aligned_cols=359  Identities=37%  Similarity=0.668  Sum_probs=318.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|++.+.||+|+||+||+|+++.+|+.||+|++.+..... .....+.+|+.+++++ +||||+++++++.+.
T Consensus        16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKL-DHPNIMKLFEILEDS   93 (486)
T ss_dssp             TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred             ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcC
Confidence            44678899999999999999999999999999999999997654322 3467889999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +.+|+|||||.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++..
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999999999998888999999999999999999999999999999999999998766778899999999988


Q ss_pred             cCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ..........+||+.|+|||++.+.|+.++||||+||++|+|++|..||.+.+..+....+..+...+..+.|..+|+++
T Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             BCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             CCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            77666667778999999999999899999999999999999999999999999999999999998888888888999999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCC----CCchHHHhhhhhhhhhhhhHHHHhhhhhhhh-chhhhHHH
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNV----PLGDVVRSRLKQFSMMNRFKRKALRVIAEFL-SVEEVEDI  359 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~l-s~~~~~~l  359 (408)
                      ++||.+||+.||.+|||+.++|+||||+........    +.......++++|....++++.++.++...+ +.++..++
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l  333 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQL  333 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHH
Confidence            999999999999999999999999999876543221    1123456678889999999999999998876 77889999


Q ss_pred             HHHHhhcCCCCCCccCHHHHHHHH----HHhCCCCC----------HHHHHHHHHHhCCC
Q 015352          360 KEMFKKIDSDNDGVVSTDELKAGL----RNFGSQLA----------ESEVQMLIEASSSV  405 (408)
Q Consensus       360 ~~~F~~~D~~~dG~i~~~el~~~l----~~~g~~~~----------~~e~~~~~~~~d~~  405 (408)
                      +++|..+|.|+||.|+.+||..++    +.+|..++          +++++.+|+.+|.|
T Consensus       334 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d  393 (486)
T 3mwu_A          334 TEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMD  393 (486)
T ss_dssp             HHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCC
Confidence            999999999999999999995554    44576555          88999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-66  Score=481.96  Aligned_cols=257  Identities=26%  Similarity=0.505  Sum_probs=225.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|++| +||||++++++|++++.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence            6899999999999999999999999999999999876543 34567899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||||+||+|.+++...  ..+++..++.|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence            9999999999999765  347999999999999999999999999999999999999   55678999999999876533


Q ss_pred             C-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          209 E-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       209 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      . ...+.+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++..++..+...   +.+..+|+++++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence            2 2345689999999999986 6999999999999999999999999999999999999887653   234578999999


Q ss_pred             HHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          287 LVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ||.+||++||++|||+.|+|+||||+...
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999999997643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.9e-66  Score=507.22  Aligned_cols=359  Identities=36%  Similarity=0.635  Sum_probs=318.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|++.+.||+|+||+||+|+++.++..||+|++.+...... ....+.+|+.+++.+ +||||+++++++.+.
T Consensus        31 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  108 (494)
T 3lij_A           31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL-DHPNIMKLYDFFEDK  108 (494)
T ss_dssp             CBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred             CCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC
Confidence            556788899999999999999999999999999999999987654322 356788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +.+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++..
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999999999998888999999999999999999999999999999999999997766677899999999988


Q ss_pred             cCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ..........+||+.|+|||++.+.|+.++||||+||++|+|++|..||.+.+..+....+..+...+..+.|..+|+.+
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             CCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence            77666666778999999999998889999999999999999999999999999999999999999988888889999999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCcC----CCCCCCchHHHhhhhhhhhhhhhHHHHhhhhhhhh-chhhhHHH
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK----APNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFL-SVEEVEDI  359 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~l-s~~~~~~l  359 (408)
                      ++||.+||+.||.+|||+.++|+||||+....    ....+.......++++|...+++++.++..++..+ +.++..++
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l  348 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKEL  348 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHH
Confidence            99999999999999999999999999986421    12233445567789999999999999999998876 77888999


Q ss_pred             HHHHhhcCCCCCCccCHHHHHHHHHHhCC--------CCCHHHHHHHHHHhCCC
Q 015352          360 KEMFKKIDSDNDGVVSTDELKAGLRNFGS--------QLAESEVQMLIEASSSV  405 (408)
Q Consensus       360 ~~~F~~~D~~~dG~i~~~el~~~l~~~g~--------~~~~~e~~~~~~~~d~~  405 (408)
                      +++|..+|.|+||.|+.+||..+++.+|.        ..++.+++++|+.+|.+
T Consensus       349 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d  402 (494)
T 3lij_A          349 TDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFD  402 (494)
T ss_dssp             HHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCC
Confidence            99999999999999999999999999864        44589999999999976

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-65  Score=463.90  Aligned_cols=258  Identities=23%  Similarity=0.390  Sum_probs=223.3

Q ss_pred             cccce-EecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe----
Q 015352           49 IEDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----  123 (408)
Q Consensus        49 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----  123 (408)
                      ..++| ++.+.||+|+||+||+|+++.++..||+|++..... .....+.+.+|+.++++| +|||||+++++|++    
T Consensus        23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~  100 (290)
T 3fpq_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETT
T ss_pred             CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCC
Confidence            34566 778889999999999999999999999999986654 334467899999999999 99999999999975    


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ++.+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++  +.++.+||+|||+
T Consensus       101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGl  178 (290)
T 3fpq_A          101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTG
T ss_pred             CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcC
Confidence            4568999999999999999999899999999999999999999999999  99999999999995  2356899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCcccCCCCCCCC
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      |+... .....+.+||+.|||||++.+.|+.++|||||||++|+|+||..||.+.. ...+...+..+..+.  ......
T Consensus       179 a~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~  255 (290)
T 3fpq_A          179 ATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVA  255 (290)
T ss_dssp             GGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCC
T ss_pred             CEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC--CCCccC
Confidence            98643 34456789999999999998899999999999999999999999997654 445555555553322  223467


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ++++++||.+||++||++|||+.|+|+||||++
T Consensus       256 ~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            899999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.2e-65  Score=481.26  Aligned_cols=260  Identities=30%  Similarity=0.528  Sum_probs=232.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .+..+.|++.+.||+|+||.||+|+++.+|+.||||++......   ..+.+.+|+.+|+.+ +|||||+++++|++++.
T Consensus       147 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          147 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDE  222 (423)
T ss_dssp             SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             CChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhC-CCCCCCceEEEEEECCE
Confidence            34567899999999999999999999999999999999865432   345688999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|||||||+||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|....
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECC
Confidence            9999999999999998865 569999999999999999999999999999999999999   566789999999998765


Q ss_pred             CC-CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 PG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      .. ....+.+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+..... .....+..+|+++
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~  377 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSL  377 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHH
T ss_pred             CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHH
Confidence            43 44567899999999999975 699999999999999999999999999999888888876543 3344567899999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++||.+||++||++|||+.|+|+||||+...
T Consensus       378 ~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          378 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            9999999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-65  Score=468.08  Aligned_cols=255  Identities=29%  Similarity=0.493  Sum_probs=222.7

Q ss_pred             cceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++.+...... ....+.+|+++++++ +||||++++++|++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCC-CCTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEE
Confidence            68999999999999999999984   4688999999987654322 234678899999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence            9999999999999999999999999999999999999999999999999999999999   5667899999999986543


Q ss_pred             -CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 -GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                       .....+.+||+.|+|||++.+ .|+.++||||+||++|+|+||..||.+.+..++...+.++...++    ..+|++++
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence             334566789999999999975 699999999999999999999999999999999999988876543    46899999


Q ss_pred             HHHHHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      +||.+||++||++|||     ++|+++||||+..
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999998     5799999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.4e-64  Score=463.55  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=223.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +.|.+.+.||+|+||+||+|+++.+|+.||||++.++...        .+|+.+++.| +|||||++++++++++.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l-~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGL-SSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence            5689999999999999999999999999999999865432        3699999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC-CEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS-PLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~-~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++   .++ .+||+|||+|+......
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCC
Confidence            99999999999999989999999999999999999999999999999999999995   333 69999999998765432


Q ss_pred             c------eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          210 R------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       210 ~------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .      ....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+..++...+......+. ..++.+|+
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCH
Confidence            1      234579999999999986 699999999999999999999999998887777788877765432 33468999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHH-------------hcCccccCCcCC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQV-------------LEHPWLQNAKKA  317 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~-------------l~h~~~~~~~~~  317 (408)
                      ++++||.+||++||.+|||+.|+             |+|||+.....+
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            99999999999999999999997             579999876543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-62  Score=464.09  Aligned_cols=263  Identities=29%  Similarity=0.408  Sum_probs=227.6

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe---
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED---  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---  123 (408)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.| +||||+++++++..   
T Consensus        50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSC
T ss_pred             CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccc
Confidence            3467899999999999999999999999999999999975432 334456788999999999 99999999998764   


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          124 ---DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       124 ---~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                         .+.+|||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFG  203 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFG  203 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecc
Confidence               468999999996 5899999988999999999999999999999999999999999999999   566789999999


Q ss_pred             cccccCC-----CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          201 LSIFFKP-----GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       201 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      +|+....     .....+.+||+.|+|||++.+  .|+.++||||+||++|+|++|.+||.+.+..+....|......++
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9986532     223456799999999999875  479999999999999999999999999999888888866543322


Q ss_pred             CC---------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          274 RD---------------------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       274 ~~---------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..                           .++.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            11                           1245789999999999999999999999999999998754

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-60  Score=475.29  Aligned_cols=267  Identities=33%  Similarity=0.606  Sum_probs=245.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ..+.+.++|++.+.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+.+|+.| +||||++++++|+++
T Consensus       151 ~~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD  226 (573)
T ss_dssp             BSSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECS
T ss_pred             CCCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC
Confidence            34556789999999999999999999999999999999997643   33457789999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|.
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~  305 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTA  305 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCE
T ss_pred             CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeecccee
Confidence            999999999999999999965 4679999999999999999999999999999999999999642 34689999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ...+.......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+....+.++...+..+|+
T Consensus       306 ~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  385 (573)
T 3uto_A          306 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  385 (573)
T ss_dssp             ECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred             EccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            9887777788899999999999986 699999999999999999999999999999999999999988888888889999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ++++||.+||+.||.+|||+.|+|+||||+....
T Consensus       386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            9999999999999999999999999999987543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-60  Score=447.21  Aligned_cols=257  Identities=24%  Similarity=0.461  Sum_probs=212.4

Q ss_pred             ccccceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+.++|++.+.||+|+||+||+|+++   .+++.||+|.+.+..     ....+.+|+++|+.+.+||||++++++|++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            46789999999999999999999875   467899999986432     3467889999999987899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +++|+|||||+||+|.+++   +.+++.+++.++.||+.||+|||++||+||||||+|||++.  +.+.+||+|||+|+.
T Consensus        93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQG  167 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCEE
T ss_pred             CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCcc
Confidence            9999999999999999988   35999999999999999999999999999999999999963  336799999999975


Q ss_pred             cCCC-----------------------------CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCC
Q 015352          205 FKPG-----------------------------ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPF  253 (408)
Q Consensus       205 ~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf  253 (408)
                      ....                             ....+.+||+.|+|||++.+  .|+.++||||+||++|+|++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            4321                             12345689999999999875  4899999999999999999999999


Q ss_pred             CCC-CHHHHHHHHHcCC--------------------------------------------------cccCCCCCCCCCH
Q 015352          254 WAE-SEQGVAQAILRGL--------------------------------------------------IDFKRDPWPNVSE  282 (408)
Q Consensus       254 ~~~-~~~~~~~~i~~~~--------------------------------------------------~~~~~~~~~~~~~  282 (408)
                      ... +..+....|....                                                  .....+.|..+|+
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            654 4444443332200                                                  0011234567899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ++++||.+||+.||++|||+.|+|+||||++.
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-60  Score=435.43  Aligned_cols=253  Identities=28%  Similarity=0.440  Sum_probs=201.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-----
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-----  125 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----  125 (408)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+.+|++| +||||++++++|.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence            46999999999999999999999999999999997543  334457889999999999 9999999999997654     


Q ss_pred             -------eEEEEEeccCCCchHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEE
Q 015352          126 -------AVHLVMELCEGGELFDRIVARGHY---TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLK  195 (408)
Q Consensus       126 -------~~~lv~e~~~g~~L~~~l~~~~~~---~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vk  195 (408)
                             ++|+|||||+||+|.+++...+.+   ++..++.++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence                   479999999999999999877653   456788999999999999999999999999999999   4567899


Q ss_pred             EeecccccccCCCC-------------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-H
Q 015352          196 AIDFGLSIFFKPGE-------------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-G  260 (408)
Q Consensus       196 l~Dfg~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~  260 (408)
                      |+|||+|+......             ...+.+||+.|||||++.+ .|+.++|||||||++|+|++   ||.+.... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            99999998764332             1234579999999999986 69999999999999999996   88654322 2


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ....+.....+   +.+...++.+.+||.+||++||++|||+.|+++||||+...
T Consensus       236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            23333333221   12234567889999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-59  Score=463.78  Aligned_cols=255  Identities=27%  Similarity=0.464  Sum_probs=222.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHH---HHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE---VAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+..+........+.+|   +.+++.+ +||||++++++|++.+.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence            679999999999999999999999999999999987654433334444444   5566666 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|.....
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCC
Confidence            9999999999999999999999999999999999999999999999999999999999   5678899999999987654


Q ss_pred             CCceecccCCCCCcchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          208 GERFSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAE---SEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      . ...+.+||+.|+|||++. + .|+.++|+|||||++|+|++|.+||.+.   +..++...+......+    +..+|+
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~----p~~~S~  419 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----PDSFSP  419 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC----CTTSCH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC----CccCCH
Confidence            3 345679999999999985 4 5999999999999999999999999764   3345555666555443    357899


Q ss_pred             HHHHHHHHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          283 SAKSLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      ++++||.+||++||.+|++     +.|+++||||+..
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999998     7999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-59  Score=430.14  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=217.8

Q ss_pred             ccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .++|.+.+.||+|+||+||+|++.     .++..||||++...   .....+.+.+|+++|++| +|||||++++++.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC
Confidence            367999999999999999999875     35788999999643   334467899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          125 NAVHLVMELCEGGELFDRIVARG-------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      +.+|+|||||+||+|.+++.+.+             .+++..+..++.||+.||.|||+++|+||||||+|||+   +.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence            99999999999999999997643             59999999999999999999999999999999999999   556


Q ss_pred             CCEEEeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 015352          192 SPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~  266 (408)
                      +.+||+|||+|+........   ....||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+.+..++...+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            78999999999865443322   23468999999999875 79999999999999999998 999999999999999888


Q ss_pred             cCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .+...   +.+..+|+++.+|+.+||+.||++|||+.+++  +|++..
T Consensus       245 ~~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          245 QGRVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             cCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence            87643   22357899999999999999999999999994  577653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.5e-59  Score=449.43  Aligned_cols=302  Identities=36%  Similarity=0.661  Sum_probs=267.5

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +...+.++|++.+.||+|+||.||+|.++.+|+.+|+|++...... ....+.+.+|+.+++.+ +||||+++++++.++
T Consensus         5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~   82 (444)
T 3soa_A            5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLL-KHPNIVRLHDSISEE   82 (444)
T ss_dssp             --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECS
T ss_pred             ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEEC
Confidence            4567889999999999999999999999999999999999876542 33456789999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..|+|||||+||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++..
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999999999999999999999999999999999999999999999999999998765678899999999987


Q ss_pred             cCCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ..... ......||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+....+..+...++.+.|+.+++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            65433 3456789999999999976 699999999999999999999999999999999999999999999988999999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhh
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIA  348 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  348 (408)
                      ++++||.+||+.||.+|||+.|+|+||||+.................+++|...++++..++..+.
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~  308 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVML  308 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEEC
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999998654333333445667888999999999988887764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.6e-58  Score=433.69  Aligned_cols=302  Identities=38%  Similarity=0.694  Sum_probs=266.9

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|.+.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.++
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~  100 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEE  100 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC
Confidence            455678899999999999999999999999999999999986554 334467889999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++..
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999999999998888899999999999999999999999999999999999998766667899999999988


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ...........||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+..+...++.+.|..++++
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            766666667789999999999876 6999999999999999999999999999999999999999888888888899999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhh
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIA  348 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  348 (408)
                      +++||.+||+.||.+|||+.++|+||||..................+++|...++++..++..+.
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  325 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI  325 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998643322223334566778888888888777666553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.7e-58  Score=425.47  Aligned_cols=249  Identities=22%  Similarity=0.350  Sum_probs=210.4

Q ss_pred             ccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .++|.+.+.||+|+||+||+|+++     .++..||||++...   .....+.+.+|+++|++| +|||||++++++.++
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTML-QHQHIVRFFGVCTEG  115 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence            357889999999999999999875     36889999999643   334567899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC
Q 015352          125 NAVHLVMELCEGGELFDRIVAR---------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~  189 (408)
                      +.+|||||||+||+|.+++.+.               +++++.++..++.||+.||.|||+++|+||||||+|||+   +
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence            9999999999999999999754               358999999999999999999999999999999999999   4


Q ss_pred             CCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 015352          190 ENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQA  264 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~  264 (408)
                      .++.+||+|||+|+......   ......||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+.+..++...
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  272 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC  272 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            56789999999998654332   2244679999999999875 69999999999999999999 9999999999998888


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +..+...   +....+|+++.+|+.+||+.||++|||+.|++++
T Consensus       273 i~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            8876422   2235789999999999999999999999999873

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-58  Score=421.52  Aligned_cols=252  Identities=22%  Similarity=0.372  Sum_probs=206.5

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .-.+++.+.+.||+|+||+||+|+++.   .||||++.... ......+.+.+|+.+++++ +||||+++++++.+ +.+
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSC
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeE
Confidence            345678899999999999999998653   49999986443 2344567899999999999 99999999998765 568


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |||||||+||+|.+++... +.+++..+..++.||+.||.|||+++||||||||+|||++   .++.+||+|||+|+...
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC--
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecc
Confidence            9999999999999999765 5799999999999999999999999999999999999994   56789999999998654


Q ss_pred             CC---CceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH-HHcCCcccC-CCCC
Q 015352          207 PG---ERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA-ILRGLIDFK-RDPW  277 (408)
Q Consensus       207 ~~---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~~-~~~~  277 (408)
                      ..   ......+||+.|||||++.+    .|+.++|||||||++|||+||+.||.+.+....... +..+..... ...+
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence            32   23456689999999999863    489999999999999999999999988665544444 444433222 2345


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..+|+.+.+|+.+||+.||++|||+.|++++
T Consensus       264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6789999999999999999999999988654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-57  Score=418.43  Aligned_cols=250  Identities=21%  Similarity=0.317  Sum_probs=216.2

Q ss_pred             ccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+.+++.+.||+|+||+||+|+..     .+++.||||++....  .....+.+.+|+.++++| +||||+++++++.++
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEEC
Confidence            356888999999999999999864     467899999986442  233467899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC
Q 015352          125 NAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK  188 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~  188 (408)
                      +.+|+|||||++|+|.+++...                ..+++..+..++.||+.||.|||+++||||||||+|||+   
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence            9999999999999999999753                358999999999999999999999999999999999999   


Q ss_pred             CCCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHH
Q 015352          189 KENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQ  263 (408)
Q Consensus       189 ~~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~  263 (408)
                      ++++.+||+|||+|+......   ......||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+.+..++..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            556789999999998654322   2345679999999999874 79999999999999999998 899999999999988


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          264 AILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+..+...   +....+|+.+.+|+.+||+.||++|||+.|++++
T Consensus       259 ~i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            88876542   2235789999999999999999999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-56  Score=423.66  Aligned_cols=269  Identities=35%  Similarity=0.629  Sum_probs=244.4

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....+.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.....   ....+.+.+|+.+++.+ +||||+++++++
T Consensus         6 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~   84 (361)
T 2yab_A            6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVY   84 (361)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred             cCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEE
Confidence            45678899999999999999999999999999999999998765432   12457899999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC-CCCEEEeecc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDFG  200 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~-~~~vkl~Dfg  200 (408)
                      ++.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++. ...+||+|||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999999999988888999999999999999999999999999999999999964321 2379999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++...|..
T Consensus       165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            9988776666677789999999999875 699999999999999999999999999999999999999888887777788


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +++.+++||.+||..||.+|||+.|+++||||+..
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            99999999999999999999999999999999854

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-56  Score=419.77  Aligned_cols=253  Identities=22%  Similarity=0.333  Sum_probs=212.5

Q ss_pred             ccccceEecceecccCCeEEEEEEECCC-----CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      --.++|++.+.||+|+||+||+|.+..+     ++.||+|.+....  .....+.+.+|+.+|+++.+|||||+++++|.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            4457899999999999999999998654     3679999986543  23345789999999999966799999999986


Q ss_pred             e-CCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEe
Q 015352          123 D-DNAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (408)
Q Consensus       123 ~-~~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~  185 (408)
                      . ++.+|||||||+||+|.+++.+.                ..+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            5 46789999999999999999763                348999999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCH-H
Q 015352          186 ANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESE-Q  259 (408)
Q Consensus       186 ~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~-~  259 (408)
                         +.++.+||+|||+|+.......   ..+..||+.|||||++.+ .|+.++|||||||++|||+| |..||.+.+. .
T Consensus       219 ---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          219 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             ---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence               4567899999999987644332   234579999999999875 69999999999999999998 9999988654 4


Q ss_pred             HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+...+..+.. +  +....+|+++.+|+.+||+.||++|||+.|+++|
T Consensus       296 ~~~~~i~~g~~-~--~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTR-M--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCC-C--CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            44455555432 2  2234689999999999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-55  Score=410.50  Aligned_cols=260  Identities=35%  Similarity=0.610  Sum_probs=236.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|++.+.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCE
Confidence            3456789999999999999999999999999999999986544 334567789999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGS
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecC
Confidence            99999999999999999988899999999999999999999999999999999999999   566789999999998877


Q ss_pred             CCCceecccCCCCCcchhhhhc-cC-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ........+||+.|+|||++.+ .+ ++++||||+||++|+|++|..||.+.+..+....+..+...++    ..+++++
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  241 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDC  241 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence            7777777899999999999876 44 4799999999999999999999999999999999988876544    3579999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||.+||+.||.+|||+.|+++||||+...
T Consensus       242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999998654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-56  Score=417.60  Aligned_cols=262  Identities=29%  Similarity=0.617  Sum_probs=239.7

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.+|+|++...    ......+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIA-RHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEE
Confidence            4678999999999999999999999999999999998643    23456788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence            9999999999999999765 369999999999999999999999999999999999999642 25789999999999887


Q ss_pred             CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++...++.+|+++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            7777777889999999999876 489999999999999999999999999999999999999888877777788999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +||.+||..||.+|||+.|+|+||||+...
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            999999999999999999999999998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-55  Score=414.34  Aligned_cols=297  Identities=40%  Similarity=0.697  Sum_probs=239.8

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      .....+.++|.+.+.||+|+||.||+|++..+++.||+|++....     ..+.+.+|+.+++.+ +||||+++++++.+
T Consensus        46 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  119 (349)
T 2w4o_A           46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFET  119 (349)
T ss_dssp             SBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHC-CCTTBCCEEEEEEC
T ss_pred             cccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhC-CCCCCcceeeeEec
Confidence            345667889999999999999999999999999999999997542     245678899999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      .+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            99999999999999999999888889999999999999999999999999999999999999765567889999999998


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCCCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .....+......+..+.+..++
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  279 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS  279 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred             ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence            7665555566789999999999876 6999999999999999999999999776544 4677777777777777778899


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhh
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIA  348 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  348 (408)
                      .++.+||.+||..||++|||+.|+++||||......  ..........+++|....++++.....++
T Consensus       280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (349)
T 2w4o_A          280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN--FVHMDTAQKKLQEFNARRKLKAAVKAVVA  344 (349)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC--CSCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc--hhhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999876532  22335556677788877777776665543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.6e-56  Score=420.93  Aligned_cols=301  Identities=35%  Similarity=0.622  Sum_probs=245.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC--hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT--AVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ...+.++|++.+.||+|+||+||+|.++.+|+.||+|++.......  ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS   97 (351)
T ss_dssp             -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE
T ss_pred             CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence            3456789999999999999999999999999999999997644321  22467899999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      ++.+|+|||||+|++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence            99999999999999998887643    35899999999999999999999999999999999999977666677999999


Q ss_pred             ccccccCCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          200 GLSIFFKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       200 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      |++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. .......+..+...+....|
T Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH
T ss_pred             cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc
Confidence            9998765433 2345689999999999875 5899999999999999999999999875 45667777777776666666


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhh
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIA  348 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~  348 (408)
                      ..+++++++||.+||+.||.+|||+.++++||||+.................+++|...++++..++..+.
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  327 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVS  327 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----------
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999999999999999998754211111223345667777777777766666554

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-55  Score=408.56  Aligned_cols=269  Identities=36%  Similarity=0.651  Sum_probs=241.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.+.....   ....+.+.+|+.+++.+ +||||+++++++
T Consensus         5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   83 (326)
T 2y0a_A            5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY   83 (326)
T ss_dssp             BCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEE
Confidence            44668889999999999999999999999999999999998754432   22467899999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFG  200 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg  200 (408)
                      .+.+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999999999998888899999999999999999999999999999999999996433 23479999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......++...+..
T Consensus       164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            9988765555667789999999999875 699999999999999999999999999998888888888777666656678


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +++.+++||.+||+.||.+|||+.++|+||||+..
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            89999999999999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-55  Score=413.72  Aligned_cols=259  Identities=29%  Similarity=0.520  Sum_probs=228.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            34789999999999999999999999999999999987654444556788899999999878999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-C
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-P  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~  207 (408)
                      +||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .
T Consensus       101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC-
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccC
Confidence            999999999999999988899999999999999999999999999999999999999   566789999999998643 3


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+..+...++    ..+++.+.+
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  253 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATG  253 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            334456789999999999875 699999999999999999999999999999999999998876654    358999999


Q ss_pred             HHHHhcCCCcCCCCCH------HHHhcCccccCC
Q 015352          287 LVRQMLEPDPKLRLTA------KQVLEHPWLQNA  314 (408)
Q Consensus       287 li~~~l~~dp~~R~s~------~~~l~h~~~~~~  314 (408)
                      ||.+||+.||.+||++      .++++||||+..
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            9999999999999999      899999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.1e-55  Score=413.35  Aligned_cols=262  Identities=33%  Similarity=0.533  Sum_probs=212.6

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +.....++|++.+.||+|+||+||+|+++.+|+.||+|++.....    ..+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSL-RHPNIVRFKEVILTP   88 (361)
T ss_dssp             CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred             cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhC-CCCCCCcEEEEEeeC
Confidence            445567899999999999999999999999999999999975432    235688999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKS  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC--
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCcccc
Confidence            999999999999999999988888999999999999999999999999999999999999953 2234599999999986


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCC-chhHHHHHHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCcccCCCCCC
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGP-EIDIWSAGVILYILLCGVPPFWAESE----QGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ...........||+.|+|||++.+ .++. ++|||||||++|+|++|..||.+...    ......+......++  ...
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  245 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDI  245 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--TTS
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--CcC
Confidence            554444556689999999999875 4554 48999999999999999999987543    344455555444333  234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .+++.+++||.+||+.||.+|||+.|+++||||...
T Consensus       246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            689999999999999999999999999999999664

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-54  Score=406.57  Aligned_cols=257  Identities=31%  Similarity=0.538  Sum_probs=232.0

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEE
Confidence            36899999999999999999999999999999999865443344567889999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~  208 (408)
                      ||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ..
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCC
Confidence            99999999999999988899999999999999999999999999999999999999   556789999999998643 33


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ......+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+.......+......++    ..+++++++|
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  235 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSL  235 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            44566789999999999875 699999999999999999999999999998888888887766544    3689999999


Q ss_pred             HHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          288 VRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       288 i~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      |.+||+.||.+||     ++.++++||||...
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999999999     99999999999764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.7e-54  Score=394.34  Aligned_cols=267  Identities=41%  Similarity=0.761  Sum_probs=245.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      +.+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE
Confidence            4578999999999999999999999999999999999976554 334467788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      .|+||||++|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999999999999888889999999999999999999999999999999999999776666779999999998776


Q ss_pred             CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++.+.+..+++++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            6666666789999999999876 589999999999999999999999999999999999999988888888889999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +||.+||+.||++|||+.|+++||||+...
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            999999999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.2e-55  Score=396.96  Aligned_cols=267  Identities=45%  Similarity=0.817  Sum_probs=243.7

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|++.+.||+|+||.||+|.+..++..+|+|++.....   ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   78 (277)
T 3f3z_A            3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSL-DHPNIIRLYETFEDN   78 (277)
T ss_dssp             ---CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred             chhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence            345688899999999999999999999999999999999976543   2367889999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++..++.++.+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999999999999998888899999999999999999999999999999999999997666778899999999988


Q ss_pred             cCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ...........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+..+...++...+..+++.+
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          159 FKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             CCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             ccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence            77666667778999999999998889999999999999999999999999999999999998888777766667899999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||.+||+.||.+|||+.++++||||++..
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            9999999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-54  Score=409.35  Aligned_cols=267  Identities=34%  Similarity=0.623  Sum_probs=240.9

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|.+.+.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.+++.+ +||||+++++++.+.
T Consensus        45 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~  120 (387)
T 1kob_A           45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK  120 (387)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS
T ss_pred             cCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeC
Confidence            44567789999999999999999999999999999999997542   23356788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++.
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT  199 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccce
Confidence            99999999999999999987654 6999999999999999999999999999999999999954 234679999999998


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++...+..+++
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  279 (387)
T 1kob_A          200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP  279 (387)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence            8766666666789999999999875 589999999999999999999999999998888899988888888778889999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ++++||.+||+.||.+|||+.|+|+||||+....
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            9999999999999999999999999999987643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-54  Score=405.90  Aligned_cols=263  Identities=35%  Similarity=0.621  Sum_probs=233.2

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ...+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.+....       ..+|++++.++.+||||+++++++++++
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            456788999999999999999999999999999999999765422       3468888888778999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg~~~~  204 (408)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999999999999888999999999999999999999999999999999999986432 234699999999987


Q ss_pred             cCCC-CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCC---CCHHHHHHHHHcCCcccCCCCCCC
Q 015352          205 FKPG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWA---ESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       205 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      .... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+   ....++...+..+...+....|..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6433 34456789999999999876 589999999999999999999999986   456778888888888888888889


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +|+++++||.+||..||.+|||+.++++||||....
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            999999999999999999999999999999997643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.6e-54  Score=410.41  Aligned_cols=259  Identities=27%  Similarity=0.501  Sum_probs=226.3

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..++.++.+||||+++++++.+.+.+|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            34689999999999999999999999999999999987766555555678899999988768999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc-cCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF-FKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~-~~~  207 (408)
                      +||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.. ...
T Consensus       130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence            999999999999999988899999999999999999999999999999999999999   5667899999999986 334


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC---------CHHHHHHHHHcCCcccCCCCC
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---------SEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      .....+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...         ....+.+.+......++    
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  282 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  282 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----
Confidence            455667789999999999876 6999999999999999999999999642         23345566666655443    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCH------HHHhcCccccCC
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTA------KQVLEHPWLQNA  314 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~------~~~l~h~~~~~~  314 (408)
                      ..+++++++||.+||+.||.+||++      .|+++||||+..
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            4689999999999999999999985      899999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-54  Score=405.08  Aligned_cols=259  Identities=24%  Similarity=0.440  Sum_probs=231.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+++.+.+||||+++++++++.+.+|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            45789999999999999999999999999999999987543333456778899999987668999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-  207 (408)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... 
T Consensus        95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccC
Confidence            999999999999999988889999999999999999999999999999999999999   5567899999999986432 


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      .......+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..++...+......++    ..+++++++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  247 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKD  247 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHH
Confidence            334556789999999999875 699999999999999999999999999999888888887765543    358999999


Q ss_pred             HHHHhcCCCcCCCCCHH-HHhcCccccCC
Q 015352          287 LVRQMLEPDPKLRLTAK-QVLEHPWLQNA  314 (408)
Q Consensus       287 li~~~l~~dp~~R~s~~-~~l~h~~~~~~  314 (408)
                      ||.+||+.||.+||++. ++++||||+..
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            99999999999999998 99999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-54  Score=398.06  Aligned_cols=255  Identities=27%  Similarity=0.525  Sum_probs=231.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEE
Confidence            46899999999999999999999999999999999865443334567888999999998 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....  
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC--
Confidence            99999999999999998899999999999999999999999999999999999999   5667899999999987543  


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ...+.+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+.......+......++    ..+++++++||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  234 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLL  234 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHH
Confidence            2345689999999999875 689999999999999999999999999998888888888766544    36899999999


Q ss_pred             HHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          289 RQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       289 ~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      .+||..||.+||     ++.++++||||+..
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            999999999999     99999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-53  Score=391.23  Aligned_cols=265  Identities=36%  Similarity=0.630  Sum_probs=229.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|.+.+.||+|+||.||+|.++.++..+|+|++.....  ....+.+.+|+++++.+ +||||+++++++.+.
T Consensus        16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDY   92 (285)
T ss_dssp             ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred             CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhC-CCchHHhHHHheecC
Confidence            345788999999999999999999999999999999999986542  33467899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          125 NAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      +..|+||||++|++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++..+.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            999999999999999998854    3679999999999999999999999999999999999999766667889999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ++.............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+..+....+......+... ...+
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  251 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPL  251 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred             cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcC
Confidence            998766655556678999999999998889999999999999999999999999988888777776655444332 2457


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-53  Score=400.77  Aligned_cols=258  Identities=28%  Similarity=0.504  Sum_probs=228.4

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++++.+||||+++++++.+.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999887666666677889999999987789999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc-CCC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~-~~~  208 (408)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++... ...
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCC
Confidence            99999999999999988889999999999999999999999999999999999999   55678999999999863 234


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCC---------CCHHHHHHHHHcCCcccCCCCCC
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWA---------ESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||..         .......+.+......++    .
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~  240 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R  240 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----T
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----C
Confidence            44566789999999999875 689999999999999999999999965         233445566666655443    4


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCH------HHHhcCccccCC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTA------KQVLEHPWLQNA  314 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~------~~~l~h~~~~~~  314 (408)
                      .+++++++||.+||+.||.+||++      .++++||||+..
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            689999999999999999999995      899999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.3e-54  Score=404.31  Aligned_cols=259  Identities=26%  Similarity=0.439  Sum_probs=232.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..++..+.+||+|+++++++++.+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34689999999999999999999999999999999987644334456788899999998878999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-C
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-P  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~  207 (408)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccC
Confidence            999999999999999988889999999999999999999999999999999999999   566789999999998643 3


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      .......+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..++...+......++    ..+++++++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  250 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVA  250 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence            334556789999999999875 699999999999999999999999999999999999988776554    368999999


Q ss_pred             HHHHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          287 LVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       287 li~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      ||.+||..||.+||+     +.++++||||+..
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            999999999999994     6999999999763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-54  Score=413.01  Aligned_cols=262  Identities=32%  Similarity=0.471  Sum_probs=231.1

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence            457899999999999999999999999999999999764332222344578899999998 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence            99999999999998876 469999999999999999999999999999999999999   56778999999999876544


Q ss_pred             Cc--eecccCCCCCcchhhhhc-c----CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          209 ER--FSEIVGSPYYMAPEVLKR-N----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       209 ~~--~~~~~gt~~y~aPE~~~~-~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..  ..+.+||+.|+|||++.+ .    |+.++|||||||++|+|++|..||.+.+..+....+......+..+.+..+|
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            32  346789999999999864 2    7899999999999999999999999999999999998776545555556899


Q ss_pred             HHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCCc
Q 015352          282 ESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~~  315 (408)
                      +++++||.+||+.+|.+  ||++.|+++||||+...
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            99999999999999998  99999999999998753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.7e-54  Score=399.71  Aligned_cols=269  Identities=36%  Similarity=0.641  Sum_probs=215.7

Q ss_pred             ccccceEec---ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           48 NIEDRYLVD---RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        48 ~~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+.++|.+.   +.||+|+||.||+|.++.+|+.||+|++.+.      ....+.+|+.+++.+.+||||+++++++.++
T Consensus         5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            345678875   7899999999999999999999999999743      2467789999999996699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999999999998999999999999999999999999999999999999997655556899999999986


Q ss_pred             cCCC-CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCcccCCC
Q 015352          205 FKPG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES-------EQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       205 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~  275 (408)
                      .... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..       ..+....+..+...+..+
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            5433 23455678999999999875 69999999999999999999999997643       356777888887777766


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCC
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPL  322 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~  322 (408)
                      .|..+++++++||.+||+.||.+|||+.++++||||+.....+..++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~  285 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL  285 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCC
Confidence            67789999999999999999999999999999999998765444433

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-53  Score=401.43  Aligned_cols=257  Identities=28%  Similarity=0.508  Sum_probs=233.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEE
Confidence            3457999999999999999999999999999999999876544444567889999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence            9999999999999999988889999999999999999999999999999999999999   5667899999999987643


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS  286 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  286 (408)
                      .  ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++    ..+++++.+
T Consensus       194 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  267 (350)
T 1rdq_E          194 R--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKD  267 (350)
T ss_dssp             C--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHH
T ss_pred             C--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            2  345689999999999875 689999999999999999999999999999999999988876554    368999999


Q ss_pred             HHHHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          287 LVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       287 li~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      ||.+||+.||.+||+     +.++++||||+..
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            999999999999998     9999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-54  Score=406.01  Aligned_cols=258  Identities=34%  Similarity=0.605  Sum_probs=224.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEE
Confidence            4557899999999999999999999999999999999865443333446789999999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTT
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccC
Confidence            9999999 77999999888899999999999999999999999999999999999999   5567899999999988776


Q ss_pred             CCceecccCCCCCcchhhhhcc-C-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLKRN-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .......+||+.|+|||++.+. + ++++|||||||++|+|++|..||.+.........+..+..    .....+|+.+.
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~----~~p~~~s~~~~  236 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY----VMPDFLSPGAQ  236 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCC----CCCTTSCHHHH
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC----CCcccCCHHHH
Confidence            6666777899999999998763 3 7899999999999999999999987654443333222222    22346899999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +||.+||+.||.+|||+.|+++||||+..
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            99999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.5e-53  Score=388.59  Aligned_cols=261  Identities=29%  Similarity=0.493  Sum_probs=226.9

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .....++|++.+.||+|+||+||+|.+..+|+.||+|++.....   ...+.+.+|+.+++.+ +||||+++++++.+++
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGD   90 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETT
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECC
Confidence            34567899999999999999999999999999999999976543   2356789999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|+||||++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceec
Confidence            999999999999999998765 69999999999999999999999999999999999999   55677999999998876


Q ss_pred             CCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          206 KPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       206 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+...... .......+++.
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAI  245 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHH
T ss_pred             CCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHH
Confidence            5433 3455689999999999875 6999999999999999999999999988877666555443322 12223568999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +.+||.+||+.||.+|||+.|+++||||+...
T Consensus       246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            99999999999999999999999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-53  Score=402.53  Aligned_cols=260  Identities=26%  Similarity=0.510  Sum_probs=230.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|.+.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+ +||||++++++|.+.+.
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence            44457999999999999999999999999999999999876544445577899999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeecc
Confidence            99999999999999999988899999999999999999999999999999999999999   566789999999999877


Q ss_pred             CCCceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHHcCCcccCCCCCCC
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAE---SEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ........+||+.|+|||++.+    .|+.++|||||||++|+|++|..||...   ........+......++    ..
T Consensus       167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~  242 (384)
T 4fr4_A          167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SA  242 (384)
T ss_dssp             TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TT
T ss_pred             CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----Cc
Confidence            6666777899999999999853    4899999999999999999999999753   34455555555544433    46


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCC-HHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLT-AKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s-~~~~l~h~~~~~~  314 (408)
                      +++.+.+||.+||+.||.+||+ +.++++||||+..
T Consensus       243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            8999999999999999999998 9999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-53  Score=407.61  Aligned_cols=266  Identities=37%  Similarity=0.673  Sum_probs=222.9

Q ss_pred             cccccccceEec-ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....+.++|.+. +.||+|+||+||+|+++.+|+.||+|++...        ..+.+|+.++.++.+||||++++++|..
T Consensus        55 ~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            344566778876 7899999999999999999999999998632        4567899988665699999999999876


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          124 ----DNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       124 ----~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                          .+++|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence                678999999999999999998754  59999999999999999999999999999999999999765557889999


Q ss_pred             ecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCccc
Q 015352          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLIDF  272 (408)
Q Consensus       198 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~  272 (408)
                      |||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....    .....+..+...+
T Consensus       207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            9999987765555667789999999999875 6999999999999999999999999875432    2556677777777


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCC
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  318 (408)
                      +...|..+++++++||.+||+.||.+|||+.++++||||......+
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  332 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  332 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence            7777889999999999999999999999999999999998765433

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-53  Score=394.81  Aligned_cols=266  Identities=35%  Similarity=0.583  Sum_probs=224.6

Q ss_pred             cccccceEec-ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           47 ENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        47 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ..+.++|.+. +.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++++.+||||+++++++.+++
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            4577899995 78999999999999999999999999997653   2346788999999999658999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999998888999999999999999999999999999999999999976555566999999998765


Q ss_pred             CCCC--------ceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCC--------------
Q 015352          206 KPGE--------RFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAES--------------  257 (408)
Q Consensus       206 ~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------------  257 (408)
                      ....        ......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+..              
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3211        223456999999999986      348999999999999999999999997754              


Q ss_pred             -HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          258 -EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       258 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                       .......+..+...++...+..+++.+++||.+||+.||.+|||+.|+++||||+...
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence             2445667777766666555567899999999999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.1e-53  Score=395.24  Aligned_cols=269  Identities=34%  Similarity=0.632  Sum_probs=239.6

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....+.++|++.+.||+|+||.||+|++..+|+.||+|++.......   ....+.+.+|+.+++.+ +||||+++++++
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   84 (321)
T 2a2a_A            6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVY   84 (321)
T ss_dssp             BCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             cchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence            34567889999999999999999999999999999999998654332   12467899999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC-CCCEEEeecc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE-NSPLKAIDFG  200 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~-~~~vkl~Dfg  200 (408)
                      .+.+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999999999998888999999999999999999999999999999999999964321 1279999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......++...+..
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence            9988766655666789999999999875 689999999999999999999999999998888888888776665555567


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +++.+.+||.+||..||.+|||+.++++||||+..
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            89999999999999999999999999999999764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-53  Score=413.82  Aligned_cols=263  Identities=35%  Similarity=0.603  Sum_probs=236.6

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+....++|.+.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP   88 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence            4455668999999999999999999999999999999999865443334467889999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM  165 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhh
Confidence            9999999999999999999888889999999999999999999999999999999999999   5567899999999998


Q ss_pred             cCCCCceecccCCCCCcchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ........+.+||+.|+|||++.+.  .+.++|||||||++|+|++|..||.+.........+..+....+    ..+++
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~  241 (476)
T 2y94_A          166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNP  241 (476)
T ss_dssp             CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCH
T ss_pred             ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCH
Confidence            7766666777899999999998863  47899999999999999999999999888888888888765433    36799


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++.+||.+||+.||.+|||+.++++||||+...
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            999999999999999999999999999998643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.5e-53  Score=400.10  Aligned_cols=259  Identities=27%  Similarity=0.489  Sum_probs=222.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHH-HhCCCCCCeeEEeeEEEeCCe
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM-KHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++ +.+ +||||+++++++.+.+.
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCE
Confidence            3457899999999999999999999999999999999887665555556677788774 556 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence            99999999999999999988889999999999999999999999999999999999999   566789999999998643


Q ss_pred             -CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 -PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                       ........+||+.|+|||++.+ .|+.++|+|||||++|+|++|..||.+.+..++...+......++    +.+++.+
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  266 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSA  266 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHH
Confidence             3344566789999999999876 699999999999999999999999999999999999988765543    4689999


Q ss_pred             HHHHHHhcCCCcCCCCCH----HHHhcCccccCC
Q 015352          285 KSLVRQMLEPDPKLRLTA----KQVLEHPWLQNA  314 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~----~~~l~h~~~~~~  314 (408)
                      ++||.+||+.||.+||++    .++++||||+..
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999999987    699999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.6e-53  Score=411.10  Aligned_cols=264  Identities=28%  Similarity=0.462  Sum_probs=229.2

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+++.+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEE
Confidence            3457899999999999999999999999999999999764332222334578899999998 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence            999999999999999987 4679999999999999999999999999999999999999   566789999999997665


Q ss_pred             CCCc--eecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC-CC
Q 015352          207 PGER--FSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-PW  277 (408)
Q Consensus       207 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~  277 (408)
                      ....  ....+||+.|+|||++.      +.|+.++|||||||++|+|++|..||.+.+..+....+......+..+ .+
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  306 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV  306 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence            4332  23468999999999985      358999999999999999999999999999988888887654332222 23


Q ss_pred             CCCCHHHHHHHHHhcCCCcCC--CCCHHHHhcCccccCCc
Q 015352          278 PNVSESAKSLVRQMLEPDPKL--RLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~--R~s~~~~l~h~~~~~~~  315 (408)
                      ..+|+++++||++||..+|++  |+++.|+++||||+...
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            568999999999999999988  99999999999998653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.5e-53  Score=394.50  Aligned_cols=270  Identities=30%  Similarity=0.540  Sum_probs=238.2

Q ss_pred             cccccccceEec-ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....+.++|.+. +.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.+.+||||+++++++.+
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            567788999998 899999999999999999999999999976543 334467889999999999778999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      .+.+|+||||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.....+.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999999988553  6699999999999999999999999999999999999997544467899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++.+.+..+
T Consensus       181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  260 (327)
T 3lm5_A          181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV  260 (327)
T ss_dssp             CEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred             ccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence            988766555566789999999999875 6899999999999999999999999999998888888888888888888899


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            99999999999999999999999999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-52  Score=388.63  Aligned_cols=265  Identities=41%  Similarity=0.738  Sum_probs=236.1

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ...+.++|.+.+.||+|+||.||+|++..+|+.||+|++.....   .....+.+|+.+++.+ +||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKI-KHENIVTLEDIYESTT   79 (304)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhC-CCCCeeehhhhcccCC
Confidence            45688899999999999999999999999999999999975432   2245688999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++...+.++.+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999999999999988888999999999999999999999999999999999999966566788999999998764


Q ss_pred             CCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++.+.+..+++.+
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            432 2344579999999999875 58999999999999999999999999999888889999888887777778899999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||.+||..||.+|||+.++++||||+...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.3e-52  Score=384.14  Aligned_cols=258  Identities=28%  Similarity=0.496  Sum_probs=217.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.+++++ +||||+++++++.+++.+|+|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence            5899999999999999999999999999999999865532 33356788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-C
Q 015352          131 MELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-G  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~  208 (408)
                      |||++| +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence            999987 55555544 6779999999999999999999999999999999999999   5567899999999987643 2


Q ss_pred             CceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCC-CCCCCHHHHHHHHHcCCcccCCC----------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPP-FWAESEQGVAQAILRGLIDFKRD----------  275 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~----------  275 (408)
                      .......||+.|+|||++.+ . ++.++||||+||++|+|++|..| |.+.+..+....+.+........          
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            33455678999999999865 3 89999999999999999988777 55666666666665432222111          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          276 ---------------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       276 ---------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                     ..+.+++.+++||.+||+.||++|||+.|+++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                           123578999999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-52  Score=388.54  Aligned_cols=266  Identities=27%  Similarity=0.444  Sum_probs=219.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--ChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLP--KNSSIVSLKEAC  121 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~  121 (408)
                      +..+.++|++.+.||+|+||+||+|++..+|+.||+|++......  .......+.+|+.+++.+.  +||||+++++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            456778999999999999999999999999999999999754321  1112345677888887762  499999999999


Q ss_pred             EeCC-----eEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          122 EDDN-----AVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       122 ~~~~-----~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                      ....     .+++||||+.| +|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||+   +.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~  159 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTV  159 (308)
T ss_dssp             EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCE
T ss_pred             eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCE
Confidence            8765     58999999975 99999987654  9999999999999999999999999999999999999   556789


Q ss_pred             EEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       195 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      ||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999999987766666667789999999999865 699999999999999999999999999988888777765433222


Q ss_pred             CCCC-----------------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          274 RDPW-----------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       274 ~~~~-----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ...|                       +.+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            2221                       35789999999999999999999999999999998754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=398.69  Aligned_cols=262  Identities=35%  Similarity=0.624  Sum_probs=230.1

Q ss_pred             ccccceEe--cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           48 NIEDRYLV--DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        48 ~~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+.+.|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        84 ~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  159 (373)
T 2x4f_A           84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKN  159 (373)
T ss_dssp             CGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred             ccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECC
Confidence            34556666  568999999999999999999999999997643   23457889999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .+|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++..
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARR  238 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCcee
Confidence            999999999999999988765 46999999999999999999999999999999999999964 3456799999999998


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++...+..++++
T Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  318 (373)
T 2x4f_A          239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE  318 (373)
T ss_dssp             CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred             cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence            776666666789999999999875 6899999999999999999999999999999999999988877777777889999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +++||.+||+.||.+|||+.|+++||||+..
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.4e-53  Score=390.01  Aligned_cols=247  Identities=22%  Similarity=0.281  Sum_probs=191.4

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC----
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----  125 (408)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||++.....    .......|+..+.++ +||||+++++++.+++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCce
Confidence            46799999999999999999987  589999999864321    112233455566677 8999999999998654    


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCceEeecCCCCCCEEEe
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH--------GVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      .+|||||||+||+|.+++... .+++..+..++.|++.||.|||++        +|+||||||+|||+   +.++.+||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence            689999999999999999764 689999999999999999999987        99999999999999   567789999


Q ss_pred             ecccccccCCCCc-----eecccCCCCCcchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCC---------
Q 015352          198 DFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAE---------  256 (408)
Q Consensus       198 Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~l~~g~~pf~~~---------  256 (408)
                      |||+|+.......     ....+||+.|+|||++.+       .|+.++|||||||++|||+||.+||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999987654332     234579999999999864       3677999999999999999997765321         


Q ss_pred             ------CHHHHHHHHHcCCcccCCCC-C--CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          257 ------SEQGVAQAILRGLIDFKRDP-W--PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       257 ------~~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                            ........+.........+. +  ...++.+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                  22333334433333221111 0  112356889999999999999999999976

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-52  Score=388.59  Aligned_cols=264  Identities=27%  Similarity=0.453  Sum_probs=219.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+..+.++|++.+.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.+ +||||+++++++.++
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSE   91 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCS
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccC
Confidence            45678899999999999999999999986 589999999975432 222346788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+||||++| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCce
Confidence            999999999986 888887765 459999999999999999999999999999999999999   456779999999998


Q ss_pred             ccCC-CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC----
Q 015352          204 FFKP-GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP----  276 (408)
Q Consensus       204 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----  276 (408)
                      .... ........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+...........    
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            7643 233455678999999999864  589999999999999999999999988777666666544222111111    


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          277 ----------------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       277 ----------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                            .+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                  134788999999999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-53  Score=404.98  Aligned_cols=263  Identities=26%  Similarity=0.435  Sum_probs=226.8

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.++..+ +||||+++++++++.+.+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999999764433333345678899999998 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence            9999999999999999875 479999999999999999999999999999999999999   566789999999998765


Q ss_pred             CCCce--ecccCCCCCcchhhhh--------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC-
Q 015352          207 PGERF--SEIVGSPYYMAPEVLK--------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD-  275 (408)
Q Consensus       207 ~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  275 (408)
                      .....  ...+||+.|+|||++.        +.|+.++|||||||++|+|++|..||.+.+..+....+......+..+ 
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  293 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL  293 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence            44332  3468999999999986        258999999999999999999999999999888888887643222222 


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCC---CCHHHHhcCccccCCc
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLR---LTAKQVLEHPWLQNAK  315 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R---~s~~~~l~h~~~~~~~  315 (408)
                      ....+|+++++||++||. +|.+|   |++.|+++||||+...
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            124789999999999999 99998   5999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.2e-53  Score=385.78  Aligned_cols=268  Identities=41%  Similarity=0.748  Sum_probs=243.1

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++++ +||||+++++++.+.+
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   94 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSS   94 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCC
Confidence            456778999999999999999999999999999999999765432 33567899999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999999999999988888999999999999999999999999999999999999976666678999999999877


Q ss_pred             CCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ..........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+.......+..+...++.+.+..+++++.
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          175 QQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             cCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            65555555678999999999988899999999999999999999999999998888888888887777666778999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +||.+||..||.+|||+.++++||||+...
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999997643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-52  Score=392.12  Aligned_cols=268  Identities=31%  Similarity=0.485  Sum_probs=217.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +.....++|++.+.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.+++.+ +||||+++++++.++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHN  105 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGC-CCTTBCCEEEEEEET
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHc-CCCCcceEEEEEecC
Confidence            456677899999999999999999999999999999999975533 222345678999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC--CCCCEEEeecccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLS  202 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~--~~~~vkl~Dfg~~  202 (408)
                      +.+|+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ....+||+|||++
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999999999975 9999999988999999999999999999999999999999999999996432  3456999999999


Q ss_pred             cccCCC-CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC-
Q 015352          203 IFFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-  278 (408)
Q Consensus       203 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-  278 (408)
                      ...... .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+...........|+ 
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            876432 33455678999999999875  48999999999999999999999999988887777766543222221111 


Q ss_pred             -------------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          279 -------------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       279 -------------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                               .+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                                     1678999999999999999999999999999998764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-52  Score=388.95  Aligned_cols=261  Identities=29%  Similarity=0.504  Sum_probs=219.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      .....++|++.+.||+|+||.||+|++.   .+|+.||+|++.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   90 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAF   90 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEE
Confidence            3445679999999999999999999985   68999999999865432 223445678899999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      .+++.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~  167 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL  167 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence            9999999999999999999999988889999999999999999999999999999999999999   4567899999999


Q ss_pred             ccccCC-CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          202 SIFFKP-GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       202 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      +..... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    +.
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~  243 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PY  243 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TT
T ss_pred             ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CC
Confidence            876432 233455689999999999875 689999999999999999999999999998888888888765543    46


Q ss_pred             CCHHHHHHHHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +++++++||.+||..||.+||     ++.++++||||+..
T Consensus       244 ~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            899999999999999999999     89999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-52  Score=397.29  Aligned_cols=264  Identities=34%  Similarity=0.684  Sum_probs=236.5

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC-----hhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ..+.++|.+.+.||+|+||.||+|+++.+|+.||||++.......     ....+.+.+|+.+++.+.+||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            345678999999999999999999999999999999997653211     112456789999999987799999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ...+..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||+
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~  246 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGF  246 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCc
Confidence            9999999999999999999999888889999999999999999999999999999999999999   5567899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      +.............||+.|+|||++.+       .++.++|||||||++|+|++|..||.+.........+..+...+..
T Consensus       247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS  326 (365)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            988776666677889999999998853       4788999999999999999999999999888888888888777766


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      +.|..+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            666789999999999999999999999999999999963

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.2e-52  Score=384.13  Aligned_cols=268  Identities=34%  Similarity=0.636  Sum_probs=237.9

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC------hhcHHHHHHHHHHHHhCCCCCCeeEEe
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT------AVDIDDVRREVAIMKHLPKNSSIVSLK  118 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~i~~~~  118 (408)
                      ....+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.......      ....+.+.+|+.+++++.+||||++++
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             ----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            34567889999999999999999999999999999999997653211      122456789999999995699999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          119 EACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       119 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      +++.+++..|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~d  167 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTD  167 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECC
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEec
Confidence            9999999999999999999999999988889999999999999999999999999999999999999   5567799999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhh-------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLK-------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID  271 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  271 (408)
                      ||++.............||+.|+|||++.       ..++.++||||||+++|+|++|..||.+.+.......+..+...
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            99998876666666778999999999875       24788999999999999999999999999988888888888877


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +..+.+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            77777778999999999999999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-52  Score=408.89  Aligned_cols=258  Identities=29%  Similarity=0.530  Sum_probs=221.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEE
Confidence            457899999999999999999999999999999999865544444556788999999998 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccC-
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-  206 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-  206 (408)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||++.... 
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence            999999999999999988899999999999999999999998 999999999999999   456789999999998643 


Q ss_pred             CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  377 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAK  377 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence            3334556789999999999875 699999999999999999999999999999888888887766544    36899999


Q ss_pred             HHHHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +||.+||+.||.+||     |+.|+++||||+..
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999999     99999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.9e-53  Score=408.24  Aligned_cols=266  Identities=37%  Similarity=0.658  Sum_probs=222.0

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC-----hhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-----AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ..+.++|.+.+.||+|+||.||+|.++.+++.||+|++.+.....     ......+.+|+.+++++ +||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence            345689999999999999999999999999999999998764321     11223578999999999 999999999998


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      .. +.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            65 45899999999999999998888899999999999999999999999999999999999997766667899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCcccCCCC
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDP  276 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~  276 (408)
                      +.............||+.|+|||++.    ..|+.++|||||||++|+|++|..||.+... ......+..+...+....
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            98876655566778999999999874    3578899999999999999999999976543 345566666666666556


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            67899999999999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.8e-53  Score=415.53  Aligned_cols=259  Identities=31%  Similarity=0.507  Sum_probs=228.6

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++++.+.+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEE
Confidence            3456899999999999999999999999999999999876544444567789999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |+||||++||+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceec
Confidence            999999999999999987544  9999999999999999999999999999999999999   56678999999999887


Q ss_pred             CCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCcccCCCCCCCC
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+..    ...+...+......+    ...+
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~----p~~~  412 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY----SERF  412 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC----CTTS
T ss_pred             ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC----CccC
Confidence            76666677799999999999876 69999999999999999999999998753    344555555544333    3578


Q ss_pred             CHHHHHHHHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      |+++++||.+||+.||.+||     ++.|+++||||+..
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999999999999     89999999999873

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.6e-52  Score=381.30  Aligned_cols=257  Identities=32%  Similarity=0.481  Sum_probs=214.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|++ .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence            5899999999999999999998 67899999999755432 22346788999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      |||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence            999986 998888764 679999999999999999999999999999999999999   55678999999999865432 


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC------------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------------  274 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------  274 (408)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.+.......            
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            23445678999999999864  4899999999999999999999999998877776666542211110            


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          275 -------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       275 -------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                   .....+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         1123578999999999999999999999999999999763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.8e-52  Score=380.77  Aligned_cols=266  Identities=37%  Similarity=0.677  Sum_probs=232.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      +.++|++.+.||+|+||.||+|++..+|+.||+|++.......   ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCC
Confidence            5678999999999999999999999999999999998764432   22467899999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg~~~~  204 (408)
                      ..++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999999998888899999999999999999999999999999999999996533 234799999999987


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ...........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......++...+..+++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            765555566789999999999875 6899999999999999999999999999888888888777666555555678999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +.+||.+||..||.+|||+.++++||||+...
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            99999999999999999999999999997653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.5e-52  Score=379.02  Aligned_cols=259  Identities=32%  Similarity=0.576  Sum_probs=227.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEE
Confidence            457899999999999999999999999999999999765544444467789999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC---
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc
Confidence            999999999999999988889999999999999999999999999999999999999   55678999999998654332


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++    ..+++.+.+|
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  237 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence             2345679999999999876 588999999999999999999999999988888888877655443    3578999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      |.+||+.||.+|||+.|+++||||+....
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999999987654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5e-52  Score=405.65  Aligned_cols=265  Identities=26%  Similarity=0.435  Sum_probs=203.4

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE--
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--  122 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--  122 (408)
                      ....+.++|++.+.||+|+||+||+|+++.+|+.||||++.+. .......+.+.+|+.+++.+ +||||+++++++.  
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPK  124 (458)
T ss_dssp             SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCS
T ss_pred             CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecC
Confidence            3446778999999999999999999999999999999999653 33444567889999999999 9999999999984  


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          123 ---DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       123 ---~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                         ....+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DF  200 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDF  200 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCC
T ss_pred             CcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeeccc
Confidence               336799999998 56999999888889999999999999999999999999999999999999   56678999999


Q ss_pred             ccccccCCC----------------------------CceecccCCCCCcchhhhh--ccCCCchhHHHHHHHHHHHhh-
Q 015352          200 GLSIFFKPG----------------------------ERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLC-  248 (408)
Q Consensus       200 g~~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~l~~-  248 (408)
                      |+++.....                            ......+||+.|+|||++.  ..|+.++|||||||++|+|++ 
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            999865322                            1234567899999999864  359999999999999999999 


Q ss_pred             ----------CCCCCCCCCH--------------------HHHHHHHHcCC-----------------------cc----
Q 015352          249 ----------GVPPFWAESE--------------------QGVAQAILRGL-----------------------ID----  271 (408)
Q Consensus       249 ----------g~~pf~~~~~--------------------~~~~~~i~~~~-----------------------~~----  271 (408)
                                |.++|.+.+.                    ......+....                       ..    
T Consensus       281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (458)
T 3rp9_A          281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT  360 (458)
T ss_dssp             STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred             ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence                      6777766441                    11222221100                       00    


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .....++..++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            00122456799999999999999999999999999999998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.4e-52  Score=385.61  Aligned_cols=260  Identities=27%  Similarity=0.467  Sum_probs=208.3

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.....  ......+.+|+.+++.+ +||||+++++++.+++.+|+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEE
Confidence            4689999999999999999999999999999999976542  22346788999999999 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          130 VMELCEGGELFDRIVAR------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ||||++| +|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCE
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccce
Confidence            9999985 999988754      358999999999999999999999999999999999999   556789999999998


Q ss_pred             ccCCC-CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC------
Q 015352          204 FFKPG-ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------  274 (408)
Q Consensus       204 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------  274 (408)
                      ..... .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.........      
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            75432 33455689999999999865  5899999999999999999999999998888777776543211110      


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          275 ------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       275 ------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                              .....+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                    011257889999999999999999999999999999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-52  Score=389.02  Aligned_cols=260  Identities=28%  Similarity=0.511  Sum_probs=219.3

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|++......  ...+.+.+|+.+++.+ +||||+++++++.+++..
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~   80 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQ   80 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence            3568999999999999999999999999999999999754432  2235688999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEE
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceecc
Confidence            9999999999999999888789999999999999999999999999999999999999   5567899999999976532


Q ss_pred             CC---ceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCCCCCCCCC
Q 015352          208 GE---RFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       208 ~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..   ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||...... ...........  ....+..++
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKID  235 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSC
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCC
Confidence            22   2345689999999999875 3 477899999999999999999999876543 22223332222  223356789


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       236 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.5e-52  Score=383.30  Aligned_cols=258  Identities=31%  Similarity=0.578  Sum_probs=218.5

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh-----------------------hcHHHHHHHHHHH
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----------------------VDIDDVRREVAIM  105 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------------------~~~~~~~~E~~~l  105 (408)
                      ..++|.+.+.||+|+||.||+|++..+|+.||+|++........                       ...+.+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            45799999999999999999999999999999999976543211                       1235688999999


Q ss_pred             HhCCCCCCeeEEeeEEEe--CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          106 KHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       106 ~~l~~h~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                      +.+ +||||+++++++.+  .+.+|+||||+++++|.+++ ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        91 ~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           91 KKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999 99999999999987  67899999999999998754 345799999999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEeecccccccCCCC-ceecccCCCCCcchhhhhcc----CCCchhHHHHHHHHHHHhhCCCCCCCCCH
Q 015352          184 LFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESE  258 (408)
Q Consensus       184 l~~~~~~~~~vkl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~  258 (408)
                      |+   +.++.+||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|..||.+...
T Consensus       169 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          169 LV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99   456789999999998765433 34556899999999998753    37789999999999999999999999888


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ......+......++.  ...+++.+.+||.+||+.||++|||+.|+++||||++
T Consensus       246 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            7777777766554433  3578999999999999999999999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-52  Score=399.62  Aligned_cols=264  Identities=30%  Similarity=0.512  Sum_probs=213.2

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      +..+.++|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.+.+||||+++++++..++
T Consensus         4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            345778999999999999999999999999999999998643 3344556778899999999955999999999997544


Q ss_pred             --eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          126 --AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       126 --~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                        .+|+||||++| +|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        83 ~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           83 DRDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR  157 (388)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence              79999999975 89888876 579999999999999999999999999999999999999   566789999999997


Q ss_pred             ccCC----------------------CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH
Q 015352          204 FFKP----------------------GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ  259 (408)
Q Consensus       204 ~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  259 (408)
                      ....                      .......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            6432                      112345689999999999865  5899999999999999999999999999888


Q ss_pred             HHHHHHHcCCcccC-------------------------------------------CCCCCCCCHHHHHHHHHhcCCCc
Q 015352          260 GVAQAILRGLIDFK-------------------------------------------RDPWPNVSESAKSLVRQMLEPDP  296 (408)
Q Consensus       260 ~~~~~i~~~~~~~~-------------------------------------------~~~~~~~~~~~~~li~~~l~~dp  296 (408)
                      .....+........                                           ......+++++.+||.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            77777653221110                                           01123678999999999999999


Q ss_pred             CCCCCHHHHhcCccccCCc
Q 015352          297 KLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       297 ~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+|||+.|+|+||||+...
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTC
T ss_pred             ccCCCHHHHhCCHHHHHhc
Confidence            9999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-51  Score=384.82  Aligned_cols=262  Identities=32%  Similarity=0.506  Sum_probs=234.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCe
Confidence            45667999999999999999999999999999999999876655556677899999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence            99999999999999999888889999999999999999999999999999999999999   456779999999998764


Q ss_pred             C-CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 P-GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      . ........||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++    ..+++.+
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~  268 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVA  268 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHH
Confidence            2 233445679999999999875 589999999999999999999999999888887777777655433    3678999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      .+||.+||+.||++|||+.|+++||||.....
T Consensus       269 ~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          269 ASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            99999999999999999999999999987654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.1e-52  Score=398.90  Aligned_cols=325  Identities=26%  Similarity=0.375  Sum_probs=228.2

Q ss_pred             ccccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           42 AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      .+..+.....+|.+.+.||+|+||+||+|++..++. +|+|.+......       ..+|+.+++.+ +||||+++++++
T Consensus        31 ~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l-~h~niv~l~~~~  101 (394)
T 4e7w_A           31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIV-KHPNVVDLKAFF  101 (394)
T ss_dssp             ESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             CCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhC-CCCCcceEEEEE
Confidence            344566777899999999999999999999987776 888887654321       13699999999 999999999999


Q ss_pred             EeCC------eEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          122 EDDN------AVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       122 ~~~~------~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      ...+      .+|+||||++++ +...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++  ..+
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~  178 (394)
T 4e7w_A          102 YSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPS  178 (394)
T ss_dssp             EEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTT
T ss_pred             EecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCC
Confidence            5543      388999999875 433332    256799999999999999999999999999999999999995  246


Q ss_pred             CCEEEeecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Q 015352          192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      +.+||+|||++.............||+.|+|||++.+  .|+.++||||+||++|+|++|..||.+.+..+....+.+..
T Consensus       179 ~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~  258 (394)
T 4e7w_A          179 GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL  258 (394)
T ss_dssp             TEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             CcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            6799999999988766666667789999999999865  58999999999999999999999999988777666665421


Q ss_pred             cc-----------------cCC--------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCch
Q 015352          270 ID-----------------FKR--------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD  324 (408)
Q Consensus       270 ~~-----------------~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~  324 (408)
                      ..                 ++.        ...+.+++++.+||.+||+.||.+|||+.|+++||||+............
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  338 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNG  338 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTS
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCC
Confidence            10                 000        01234889999999999999999999999999999998765432211100


Q ss_pred             HHHhhhhhhhhhhhhHHHHhhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHH
Q 015352          325 VVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAG  382 (408)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~  382 (408)
                      .....+.+|.... +. .....+...+......++.+  ..+|.|++|.++.+|+...
T Consensus       339 ~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  392 (394)
T 4e7w_A          339 RELPPLFNWTKEE-LS-VRPDLISRLVPQHAEAELLS--RGIDVHNFQPIPLESLKVT  392 (394)
T ss_dssp             SCCCCSCCCCHHH-HH-TCGGGHHHHSCGGGCSSSST--TSCCCC-------------
T ss_pred             CCCCCcCCCCHHH-hh-cCHHHHHhhccHhhhhhhhc--cCcccccCCCCCHHHhccc
Confidence            0011111221110 00 00011111111111111111  6789999999999988643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.1e-52  Score=406.43  Aligned_cols=260  Identities=26%  Similarity=0.382  Sum_probs=213.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--  124 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--  124 (408)
                      ..+.++|++.+.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.+++.+ +||||+++++++...  
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCS
T ss_pred             eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCc
Confidence            356789999999999999999999999999999999997642 3344567889999999999 999999999999654  


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          125 ----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       125 ----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                          ..+|+||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus       136 ~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG  209 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  209 (464)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCC
T ss_pred             cccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEE
Confidence                467999999977 5666663  359999999999999999999999999999999999999   556789999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC----
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD----  275 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  275 (408)
                      ++............+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+..........    
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9988766656677889999999999876 69999999999999999999999999988877777665432211000    


Q ss_pred             -------------CCCC---------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          276 -------------PWPN---------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       276 -------------~~~~---------------------~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                   .+..                     .++++++||.+||+.||++|||+.|+|+||||+..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                         0000                     15679999999999999999999999999999853

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.7e-52  Score=390.38  Aligned_cols=267  Identities=38%  Similarity=0.667  Sum_probs=225.2

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-----ChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----TAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      +..+.++|.+.+.||+|+||.||+|++..+++.||+|++......     .......+.+|+.+++.+ +||||++++++
T Consensus         5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   83 (322)
T 2ycf_A            5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNF   83 (322)
T ss_dssp             CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeE
Confidence            345778999999999999999999999999999999999765431     122234578999999999 99999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      +..++ +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||
T Consensus        84 ~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           84 FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             EESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             EcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            98765 89999999999999999888889999999999999999999999999999999999999766566679999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRD  275 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~  275 (408)
                      ++.............||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+...+...
T Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (322)
T 2ycf_A          163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE  242 (322)
T ss_dssp             TCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred             cceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence            998765544445567999999999874    35899999999999999999999999765432 3445556665554444


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus       243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            456789999999999999999999999999999999763

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.1e-51  Score=376.08  Aligned_cols=264  Identities=32%  Similarity=0.503  Sum_probs=234.8

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .....++|.+.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDND   88 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCC
Confidence            345678999999999999999999999999999999999876655555677899999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceec
Confidence            999999999999999999888889999999999999999999999999999999999999   45678999999999875


Q ss_pred             CC-CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          206 KP-GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       206 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .. ........||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+    ..+++.
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  241 (294)
T 2rku_A          166 EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPV  241 (294)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHH
T ss_pred             ccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHH
Confidence            42 233445679999999999875 589999999999999999999999999888887777776654433    467899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                      +.++|.+||+.||++|||+.++++||||.....+
T Consensus       242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          242 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence            9999999999999999999999999999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7e-52  Score=420.65  Aligned_cols=258  Identities=26%  Similarity=0.444  Sum_probs=233.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+..|..++..+.+||+|+.+++++++.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999865443344567788999999988789999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC-CC
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~-~~  208 (408)
                      ||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ..
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence            99999999999999988899999999999999999999999999999999999999   566789999999998643 33


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      ....+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+......++    ..+++++++|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence            44566789999999999875 699999999999999999999999999999999999998876655    3689999999


Q ss_pred             HHHhcCCCcCCCCCH-----HHHhcCccccCC
Q 015352          288 VRQMLEPDPKLRLTA-----KQVLEHPWLQNA  314 (408)
Q Consensus       288 i~~~l~~dp~~R~s~-----~~~l~h~~~~~~  314 (408)
                      |.+||+.||.+||++     .|+++||||+..
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            999999999999997     999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-52  Score=394.51  Aligned_cols=269  Identities=34%  Similarity=0.645  Sum_probs=230.6

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--TAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      ....+.++|++.+.||+|+||.||+|++..+++.||+|++.+....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~   98 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYE   98 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhc
Confidence            4456788999999999999999999999999999999999765432  233467899999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHH
Q 015352          123 DDNAVHLVMELCEGGELFDRIVA----------------------------------------RGHYTERAAAAVTRTIV  162 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~ql~  162 (408)
                      +.+..|+||||++||+|.+++..                                        ...+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            99999999999999999998742                                        11246788899999999


Q ss_pred             HHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-----ceecccCCCCCcchhhhh---ccCCCch
Q 015352          163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVLK---RNYGPEI  234 (408)
Q Consensus       163 ~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~  234 (408)
                      .||.|||++||+||||||+||+++. +....+||+|||++.......     ......||+.|+|||++.   ..++.++
T Consensus       179 ~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          179 SALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999999999999999999954 223479999999998653211     234567999999999986   3589999


Q ss_pred             hHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          235 DIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       235 DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      |||||||++|+|++|..||.+....+....+......+..+.+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            99999999999999999999999999989998888777777677799999999999999999999999999999999875


Q ss_pred             c
Q 015352          315 K  315 (408)
Q Consensus       315 ~  315 (408)
                      .
T Consensus       338 ~  338 (345)
T 3hko_A          338 S  338 (345)
T ss_dssp             S
T ss_pred             h
Confidence            4

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-51  Score=394.18  Aligned_cols=263  Identities=20%  Similarity=0.281  Sum_probs=217.6

Q ss_pred             cccceEecceeccc--CCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           49 IEDRYLVDRELGRG--EFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        49 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      -.++|++.+.||+|  +||.||+|+++.+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCE
Confidence            45689999999999  999999999999999999999986543 334467788999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +|+||||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||.+..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEccccccee
Confidence            99999999999999999876  679999999999999999999999999999999999999   5567899999998764


Q ss_pred             cCCCC--------ceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc-
Q 015352          205 FKPGE--------RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-  272 (408)
Q Consensus       205 ~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-  272 (408)
                      .....        ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.+.+.......+..+.... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            32211        1223478999999999875   58999999999999999999999998766554444333322110 


Q ss_pred             -----------------------------------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          273 -----------------------------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       273 -----------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                                                               ..+.+..+++.+.+||.+||+.||.+|||+.|+|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence                                                     111234578999999999999999999999999999999


Q ss_pred             cCCcC
Q 015352          312 QNAKK  316 (408)
Q Consensus       312 ~~~~~  316 (408)
                      +....
T Consensus       338 ~~~~~  342 (389)
T 3gni_B          338 KQIKR  342 (389)
T ss_dssp             GGC--
T ss_pred             HHHhh
Confidence            87653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-52  Score=388.13  Aligned_cols=259  Identities=26%  Similarity=0.472  Sum_probs=213.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|.+.+.||+|+||+||+|++..+++.||+|++.......  ....+.+|+.+++.+ +||||+++++++.+++.+++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEE
Confidence            68999999999999999999999999999999996543211  112345799999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-C
Q 015352          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-G  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~  208 (408)
                      |||++| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence            999975 8989887754 59999999999999999999999999999999999999   4567899999999976542 2


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC---------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW---------  277 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------  277 (408)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.+.........|         
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            23445678999999999865  5899999999999999999999999999888877777654333222222         


Q ss_pred             -----------------CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          278 -----------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       278 -----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                       +.+++++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                             356889999999999999999999999999999988654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9e-52  Score=391.49  Aligned_cols=272  Identities=24%  Similarity=0.397  Sum_probs=226.4

Q ss_pred             CCCcceeeccccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC----
Q 015352           34 KKQPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----  109 (408)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----  109 (408)
                      ...........++..+.++|.+.+.||+|+||+||+|++..+++.||+|++...    ......+..|+.+++.+.    
T Consensus        18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~   93 (360)
T 3llt_A           18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDI   93 (360)
T ss_dssp             --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCST
T ss_pred             cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCC
Confidence            334444555567888999999999999999999999999999999999998642    233466788999999984    


Q ss_pred             CCCCeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec
Q 015352          110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN  187 (408)
Q Consensus       110 ~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~  187 (408)
                      +||||+++++++...+..|+||||+ |++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  172 (360)
T 3llt_A           94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD  172 (360)
T ss_dssp             TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred             CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence            3999999999999999999999999 889999998764  4999999999999999999999999999999999999953


Q ss_pred             C----------------------CCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHH
Q 015352          188 K----------------------KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILY  244 (408)
Q Consensus       188 ~----------------------~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~  244 (408)
                      .                      ...+.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             ccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence            1                      1267899999999986443  2345689999999999875 6999999999999999


Q ss_pred             HHhhCCCCCCCCCHHHHHHHHHcCCcccCCC---------------------CCC---------------------CCCH
Q 015352          245 ILLCGVPPFWAESEQGVAQAILRGLIDFKRD---------------------PWP---------------------NVSE  282 (408)
Q Consensus       245 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~~~  282 (408)
                      +|++|..||.+.+..+....+......++..                     .|+                     ..++
T Consensus       251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            9999999999988777766665433222110                     000                     1236


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      .+.+||.+||+.||.+|||+.|+|+||||+
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            788999999999999999999999999995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=380.76  Aligned_cols=262  Identities=32%  Similarity=0.572  Sum_probs=217.6

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEE
Confidence            4789999999999999999999999999999999865432 233356788999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-  208 (408)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence            99999999999988888889999999999999999999999999999999999999   55678999999999876532 


Q ss_pred             CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc---------------
Q 015352          209 ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID---------------  271 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------------  271 (408)
                      .......||+.|+|||++.+  .++.++||||+|+++|+|++|..||.+....+....+......               
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            33455679999999999864  5899999999999999999999999998877665554332111               


Q ss_pred             ----cCCC--------CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          272 ----FKRD--------PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       272 ----~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                          .+..        .++.+++.+.+||.+||+.||.+|||+.|+++||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                0000        12468899999999999999999999999999999988653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-52  Score=383.52  Aligned_cols=260  Identities=26%  Similarity=0.382  Sum_probs=214.7

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      .+++.+.++|++.+.||+|+||+||+|++..+|+.||+|++..... ..........|+..+..+.+||||+++++++.+
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            3556677899999999999999999999999999999999865432 233344556666666665589999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      ++.+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLL  204 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceee
Confidence            99999999999 66898888764 459999999999999999999999999999999999999   45667999999999


Q ss_pred             cccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .............||+.|+|||++.+.++.++|||||||++|+|++|..||.+..   ....+..+...  ......+++
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~  279 (311)
T 3p1a_A          205 VELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLP--PEFTAGLSS  279 (311)
T ss_dssp             EECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCC--HHHHTTSCH
T ss_pred             eecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCC--cccccCCCH
Confidence            8776555555667999999999998899999999999999999999977775532   23344433321  122346899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ++.+||.+||+.||++|||+.++++||||++
T Consensus       280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-51  Score=375.05  Aligned_cols=262  Identities=36%  Similarity=0.611  Sum_probs=222.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+....++|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP   83 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC
Confidence            4455668999999999999999999999999999999999765443334567889999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM  160 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   4567799999999987


Q ss_pred             cCCCCceecccCCCCCcchhhhhcc-C-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKRN-Y-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ...........||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+..+....+    ..+++
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  236 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNR  236 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCH
Confidence            7655555566799999999998764 3 6899999999999999999999999888888877776654432    35789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .+.++|.+||+.||.+|||+.++++||||+..
T Consensus       237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            99999999999999999999999999999764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-51  Score=375.56  Aligned_cols=259  Identities=31%  Similarity=0.608  Sum_probs=229.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|.+.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEE
Confidence            447899999999999999999999999999999999765433333457789999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc
Confidence            999999999999999988889999999999999999999999999999999999999   45667999999998765432


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                       ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++    ..+++.+++|
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  242 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDL  242 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHH
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHH
Confidence             2345679999999999875 589999999999999999999999999888888777777654433    4689999999


Q ss_pred             HHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          288 VRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      |.+||..||.+|||+.++++||||+....
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            99999999999999999999999987543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.2e-51  Score=384.43  Aligned_cols=264  Identities=27%  Similarity=0.448  Sum_probs=223.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe---
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED---  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---  123 (408)
                      ....++|++.+.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++..   
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKAS   90 (351)
T ss_dssp             SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--
T ss_pred             cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhc-cCCCcccHhheeecccc
Confidence            345689999999999999999999999999999999997654332 2345678899999999 89999999999987   


Q ss_pred             -----CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          124 -----DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       124 -----~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                           .+.+|+||||++| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEEC
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEc
Confidence                 4578999999976 777777654 569999999999999999999999999999999999999   556789999


Q ss_pred             ecccccccCC-----CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc
Q 015352          198 DFGLSIFFKP-----GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       198 Dfg~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      |||++.....     ........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999976542     223345678999999998864  489999999999999999999999999988888777766555


Q ss_pred             ccCCCCCCCC----------------------------CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          271 DFKRDPWPNV----------------------------SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       271 ~~~~~~~~~~----------------------------~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      .++...|+..                            ++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            5444444332                            678999999999999999999999999999987653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.4e-52  Score=387.50  Aligned_cols=267  Identities=24%  Similarity=0.376  Sum_probs=226.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~   84 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAE   84 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeecc
Confidence            4466889999999999999999999999999999999999876555555567889999999999 999999999998765


Q ss_pred             C----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          125 N----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       125 ~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      .    ..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg  161 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFG  161 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCS
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeecc
Confidence            4    3599999999999999999888999999999999999999999999999999999999995   45679999999


Q ss_pred             cccccCCCC----ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC
Q 015352          201 LSIFFKPGE----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       201 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (408)
                      ++.......    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.......+..
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  241 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence            997654322    2234569999999999876 68999999999999999999999999998888777777665544444


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+..+++++.+||.+||+.||.+||++.+++.|+|++...
T Consensus       242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            4567899999999999999999999999999999997543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.6e-51  Score=403.03  Aligned_cols=259  Identities=31%  Similarity=0.514  Sum_probs=227.3

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .-.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++++.+.+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999999876544444567889999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          128 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      |+||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence            9999999999999999764    369999999999999999999999999999999999999   566789999999998


Q ss_pred             ccCCCCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHHcCCcccCCCCC
Q 015352          204 FFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE----SEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       204 ~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      ....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.    ....+...+......++    
T Consensus       338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----  413 (543)
T 3c4z_A          338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----  413 (543)
T ss_dssp             ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----
T ss_pred             eccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----
Confidence            7654433 344689999999999876 6999999999999999999999999875    34566667766655443    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      ..+|+.+++||.+||+.||.+||+     +.++++||||+..
T Consensus       414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            478999999999999999999996     5899999999873

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.5e-51  Score=374.33  Aligned_cols=265  Identities=27%  Similarity=0.409  Sum_probs=224.7

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+..+.++|++.+.||+|+||.||+|++..++..||+|++...........+.+.+|+.+++.+ +||||+++++++.++
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEED   83 (294)
T ss_dssp             CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECS
T ss_pred             hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeC
Confidence            5677889999999999999999999999999999999999776555555667899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTT
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccc
Confidence            9999999999999999999988899999999999999999999999999999999999999   5567899999999986


Q ss_pred             cCCCC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc-cCCCCCCCC
Q 015352          205 FKPGE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID-FKRDPWPNV  280 (408)
Q Consensus       205 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~  280 (408)
                      .....  ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.............. ......+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T 4eqm_A          161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI  240 (294)
T ss_dssp             C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred             cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence            54332  2334579999999999876 5899999999999999999999999998877766555554432 222334678


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      |+.+.++|.+||+.||.+||+..+.+.+.|..-
T Consensus       241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            999999999999999999996666666666543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-51  Score=385.78  Aligned_cols=262  Identities=25%  Similarity=0.408  Sum_probs=217.6

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC-
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD-  124 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-  124 (408)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++... 
T Consensus        20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDE   97 (367)
T ss_dssp             EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCS
T ss_pred             eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCC
Confidence            3457789999999999999999999999999999999986542 2344467789999999999 899999999999866 


Q ss_pred             -----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          125 -----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       125 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                           ..+|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Df  172 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF  172 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEee
Confidence                 3569999999 8899998876 579999999999999999999999999999999999999   55678999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc-----
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF-----  272 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-----  272 (408)
                      |++.....  .....+||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.+..+....+.......     
T Consensus       173 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99987543  3455689999999998865  69999999999999999999999999988777766665422111     


Q ss_pred             ------------------C----CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          273 ------------------K----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       273 ------------------~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                        .    ...++..++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                              0    1123567999999999999999999999999999999987643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=386.35  Aligned_cols=256  Identities=31%  Similarity=0.535  Sum_probs=221.5

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh-----hcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA-----VDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      ...+.++|++.+.||+|+||.||+|+++.+|+.||+|++........     .....+.+|+.+++.+ +||||++++++
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~   97 (335)
T 3dls_A           19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDI   97 (335)
T ss_dssp             TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEE
T ss_pred             CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence            34577899999999999999999999999999999999987653221     1234567899999999 99999999999


Q ss_pred             EEeCCeEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          121 CEDDNAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      +.+.+.+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Df  174 (335)
T 3dls_A           98 FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDF  174 (335)
T ss_dssp             EECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCC
T ss_pred             EeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeec
Confidence            99999999999999776 999999988889999999999999999999999999999999999999   45678999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhhc-cC-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKR-NY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      |++.............||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.....      ....    .....
T Consensus       175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~----~~~~~  244 (335)
T 3dls_A          175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA----AIHPP  244 (335)
T ss_dssp             TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT----CCCCS
T ss_pred             ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh----ccCCC
Confidence            99988776666667789999999999875 34 7899999999999999999999976321      1111    12223


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            45899999999999999999999999999999998643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-50  Score=392.82  Aligned_cols=267  Identities=29%  Similarity=0.536  Sum_probs=215.5

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      .....+.++|.+.+.||+|+||.||+|+++.+|+.||||++... .......+.+.+|+.+++.+ +||||+++++++..
T Consensus        19 ~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~   96 (432)
T 3n9x_A           19 IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KSDYIIRLYDLIIP   96 (432)
T ss_dssp             GGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCC
T ss_pred             CCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEec
Confidence            35567889999999999999999999999999999999999753 33444567889999999999 89999999999987


Q ss_pred             C-----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          124 D-----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       124 ~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      .     +.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus        97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~D  172 (432)
T 3n9x_A           97 DDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCD  172 (432)
T ss_dssp             SCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred             CCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEcc
Confidence            6     67999999996 4999999888889999999999999999999999999999999999999   5667899999


Q ss_pred             cccccccCCCC-----------------------ceecccCCCCCcchhhhh--ccCCCchhHHHHHHHHHHHhhC----
Q 015352          199 FGLSIFFKPGE-----------------------RFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCG----  249 (408)
Q Consensus       199 fg~~~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~l~~g----  249 (408)
                      ||++.......                       .....+||+.|+|||++.  ..|+.++|||||||++|+|++|    
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            99998764322                       235678999999999864  3599999999999999999984    


Q ss_pred             -------CCCCCCCC-----------------HHHHHHHHHcCC-----------------------cccCC----CCCC
Q 015352          250 -------VPPFWAES-----------------EQGVAQAILRGL-----------------------IDFKR----DPWP  278 (408)
Q Consensus       250 -------~~pf~~~~-----------------~~~~~~~i~~~~-----------------------~~~~~----~~~~  278 (408)
                             .++|.+.+                 .......+....                       .....    ..++
T Consensus       253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (432)
T 3n9x_A          253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP  332 (432)
T ss_dssp             CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred             ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence                   44444432                 111122221100                       00000    1125


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      .+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            68999999999999999999999999999999988654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.7e-51  Score=388.58  Aligned_cols=257  Identities=26%  Similarity=0.471  Sum_probs=215.8

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC-CCCeeEEeeEEEeCCeEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-NSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~~~~  128 (408)
                      ..+|.+.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.+.+ ||||+++++++..++.+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            4569999999999999999999865 89999999976543 33456788999999999954 699999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++......
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCC
Confidence            9999 56889999999988999999999999999999999999999999999999993    357999999999876433


Q ss_pred             C---ceecccCCCCCcchhhhhc------------cCCCchhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCccc
Q 015352          209 E---RFSEIVGSPYYMAPEVLKR------------NYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDF  272 (408)
Q Consensus       209 ~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~  272 (408)
                      .   .....+||+.|+|||++.+            .++.++|||||||++|+|++|..||.... .......+......+
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            2   2345679999999999864            58899999999999999999999998753 334455555544433


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..+  ...++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            322  34578999999999999999999999999999998654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-50  Score=381.31  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=224.4

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|.+.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  128 (348)
T 1u5q_A           50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHT  128 (348)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCe
Confidence            45567899999999999999999999999999999999865444444457789999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .|+||||+.| +|.+++. ..+.+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus       129 ~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          129 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSS
T ss_pred             EEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCceec
Confidence            9999999975 7878775 456799999999999999999999999999999999999995   5567999999999765


Q ss_pred             CCCCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ...   ....||+.|+|||++.    +.++.++|||||||++|+|++|..||.+.+.......+.......  .....++
T Consensus       205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  279 (348)
T 1u5q_A          205 APA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWS  279 (348)
T ss_dssp             SSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSC
T ss_pred             CCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCC
Confidence            432   3467999999999884    368999999999999999999999999888777766666654322  2234689


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +.+++||.+||+.||++|||+.++++||||....
T Consensus       280 ~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-51  Score=372.95  Aligned_cols=259  Identities=32%  Similarity=0.521  Sum_probs=199.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEE
Confidence            346899999999999999999999999999999999765433333457889999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC-
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccC
Confidence            999999999999999875 569999999999999999999999999999999999999   4567799999999987543


Q ss_pred             C-CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 G-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      . .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.....    .....++.++.
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  240 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY----EMPSFLSIEAK  240 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC----CCCTTSCHHHH
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc----CCccccCHHHH
Confidence            2 23344679999999998875 589999999999999999999999987665544444333222    22246899999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +||.+||+.||++|||+.++++||||....
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.9e-50  Score=368.15  Aligned_cols=260  Identities=23%  Similarity=0.370  Sum_probs=221.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe----
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----  123 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----  123 (408)
                      .-...|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.+ +||||+++++++..    
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSS
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCC
Confidence            344568999999999999999999999999999999986544 334567889999999999 99999999999875    


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ...+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+||+++  +.++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGL  178 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTG
T ss_pred             CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCC
Confidence            4678999999999999999998888999999999999999999999999  99999999999995  2556899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCcccCCCCCCCC
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      +...... ......||+.|+|||++.+.++.++|||||||++|+|++|..||.+... ......+..+....  ......
T Consensus       179 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  255 (290)
T 1t4h_A          179 ATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVA  255 (290)
T ss_dssp             GGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCC
T ss_pred             ccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc--ccCCCC
Confidence            9764433 3445679999999999988899999999999999999999999987444 44444444433221  122356


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            7899999999999999999999999999999763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-50  Score=373.78  Aligned_cols=256  Identities=27%  Similarity=0.474  Sum_probs=222.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ..|...+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEE
Confidence            35888889999999999999999999999999997543   23467789999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      |||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... .
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc
Confidence            999999999998754 579999999999999999999999999999999999999   45678999999998875433 2


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+....... ......+++.+.+||
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li  275 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFL  275 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHH
Confidence            3345689999999999875 58999999999999999999999999988877777776554321 122346789999999


Q ss_pred             HHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          289 RQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||+.||++|||+.++++||||....
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999999998653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-50  Score=381.90  Aligned_cols=265  Identities=28%  Similarity=0.409  Sum_probs=216.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh--hcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA--VDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....++|.+.+.||+|+||.||+|++..+|+.||+|++........  .....+.+|+.+++.+ +||||+++++++.+.
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHK   84 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeC
Confidence            3456799999999999999999999999999999999975432211  1124678999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +..++||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAK  160 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGS
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccce
Confidence            999999999986 888888665 358999999999999999999999999999999999999   556789999999998


Q ss_pred             ccCC-CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC----
Q 015352          204 FFKP-GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP----  276 (408)
Q Consensus       204 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----  276 (408)
                      .... ........||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+...........    
T Consensus       161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            7643 334455689999999999864  489999999999999999999999999988887777765432222111    


Q ss_pred             --------------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          277 --------------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       277 --------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                          +..+++++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence                                1456789999999999999999999999999999987643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-50  Score=388.88  Aligned_cols=259  Identities=29%  Similarity=0.439  Sum_probs=214.1

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe---
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED---  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---  123 (408)
                      .....+|.+.+.||+|+||.||+|++..+|+.||||++.....       ...+|+++++.+ +||||++++++|..   
T Consensus        50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l-~hpniv~l~~~~~~~~~  121 (420)
T 1j1b_A           50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSGE  121 (420)
T ss_dssp             CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEEEEET
T ss_pred             CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHc-CCCCccceeeEEeccCC
Confidence            3455689999999999999999999999999999999875432       123699999999 99999999998853   


Q ss_pred             ---CCeEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          124 ---DNAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       124 ---~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                         ..++++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.  +.+.+||
T Consensus       122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl  198 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKL  198 (420)
T ss_dssp             TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEE
T ss_pred             CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEe
Confidence               2247799999986 6666554    3467999999999999999999999999999999999999953  3456899


Q ss_pred             eecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----
Q 015352          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL-----  269 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-----  269 (408)
                      +|||+++............||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+.+..+....+.+..     
T Consensus       199 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             CCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999987766655666789999999999864  59999999999999999999999999988776666554421     


Q ss_pred             ------------cccCC---C-----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          270 ------------IDFKR---D-----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       270 ------------~~~~~---~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                  +.++.   .     ..+.+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                        01110   0     11356899999999999999999999999999999987543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.9e-51  Score=381.19  Aligned_cols=265  Identities=38%  Similarity=0.683  Sum_probs=196.8

Q ss_pred             cccccccceEecc-eecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHH-HHhCCCCCCeeEEeeEEE
Q 015352           45 PKENIEDRYLVDR-ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI-MKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        45 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~i~~~~~~~~  122 (408)
                      ....+.++|.+.+ .||+|+||.||+|+++.+|+.||+|++...        ....+|+.. ++.+ +||||+++++++.
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~-~h~~i~~~~~~~~   92 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQAS-GGPHIVCILDVYE   92 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHT-TSTTBCCEEEEEE
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhc-CCCChHHHHHHHh
Confidence            4456889999965 699999999999999999999999998643        122334443 4454 9999999999998


Q ss_pred             e----CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          123 D----DNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       123 ~----~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      .    ...+++||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence            6    556899999999999999998764  5999999999999999999999999999999999999987666778999


Q ss_pred             eecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCcc
Q 015352          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGV----AQAILRGLID  271 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~  271 (408)
                      +|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......    ...+......
T Consensus       173 ~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          173 TDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             CCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             eccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            999999865432 3345678999999999864 688999999999999999999999977655433    3344445555


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCC
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~  319 (408)
                      ++.+.+..+++++.+||.+||+.||.+|||+.|+++||||+.....+.
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  299 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ  299 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence            666667789999999999999999999999999999999988654443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.8e-50  Score=383.97  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=208.7

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC--
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--  125 (408)
                      .+.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+  
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCST
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccc
Confidence            46689999999999999999999999999999999997543 2344457788999999999 9999999999998665  


Q ss_pred             ----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          126 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       126 ----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                          .+|+||||++| +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  173 (371)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred             ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence                78999999976 7888875  358999999999999999999999999999999999999   4567899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC------
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------  274 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------  274 (408)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.........      
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            987655545556789999999999875 6999999999999999999999999998887777777654321100      


Q ss_pred             -----------CCCC---------------------CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          275 -----------DPWP---------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       275 -----------~~~~---------------------~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                 +.+.                     ..++.+++||.+||+.||.+|||+.|+|+||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                       0000                     015678999999999999999999999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.1e-50  Score=377.65  Aligned_cols=262  Identities=26%  Similarity=0.472  Sum_probs=218.5

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   99 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRW   99 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEE
Confidence            345799999999999999999999999999999999875432 333456678999999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-----
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecC
Confidence            9999999999998887777889999999999999999999999999999999999999   5567899999999976543


Q ss_pred             -CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc------------
Q 015352          208 -GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF------------  272 (408)
Q Consensus       208 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------  272 (408)
                       ........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......            
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence             233455679999999999875  58999999999999999999999999988776665554321110            


Q ss_pred             -------C--------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          273 -------K--------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       273 -------~--------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                             +        ...++.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                   0        00123678999999999999999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-50  Score=384.40  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=205.5

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPA  100 (367)
T ss_dssp             EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSC
T ss_pred             cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecC
Confidence            34457789999999999999999999999999999999986532 3344567888999999999 899999999999754


Q ss_pred             ------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          125 ------NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       125 ------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                            ..+|+|+|++ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~D  175 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILD  175 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEee
Confidence                  6689999999 7799888865 579999999999999999999999999999999999999   5567899999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc----
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF----  272 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----  272 (408)
                      ||++.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+.+.....    
T Consensus       176 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          176 FGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999986543  2445689999999999865  58999999999999999999999999988877766665422111    


Q ss_pred             -------------------CC----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          273 -------------------KR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       273 -------------------~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                         +.    ..++..++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                               00    012457899999999999999999999999999999987543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-51  Score=386.22  Aligned_cols=259  Identities=31%  Similarity=0.528  Sum_probs=217.7

Q ss_pred             cccceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      -.++|.+.+.||+|+||.||+|++.   .+|+.||+|++.+.... .....+.+.+|+.+++.+.+||||+++++++..+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3479999999999999999999984   58999999998754321 1122345677999999986799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence            9999999999999999999988889999999999999999999999999999999999999   5567899999999976


Q ss_pred             cCCC--CceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCcccCCC
Q 015352          205 FKPG--ERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       205 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~  275 (408)
                      ....  .......||+.|+|||++.+   .++.++|||||||++|+|++|..||....    ...+...+.....    .
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----~  284 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----P  284 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC----C
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC----C
Confidence            5322  22334679999999999874   37899999999999999999999997543    3344444444333    2


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      ....+++.+.+||.+||..||.+||     |+.++++||||+..
T Consensus       285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            3357899999999999999999999     99999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-50  Score=383.89  Aligned_cols=257  Identities=25%  Similarity=0.439  Sum_probs=214.8

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe----
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED----  123 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----  123 (408)
                      ...++|.+.+.||+|+||+||+|++..+|+.||+|++......       ..+|+.+++.+ +||||+++++++..    
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l-~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVL-DHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTC-CCTTBCCEEEEEEEC---
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHc-CCCCccchhheeeecCcc
Confidence            3467999999999999999999999999999999998754321       23699999999 99999999999843    


Q ss_pred             ----------------------------------CCeEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHH
Q 015352          124 ----------------------------------DNAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVV  165 (408)
Q Consensus       124 ----------------------------------~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~l  165 (408)
                                                        ..++++||||++| +|.+.+.    ..+.+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              4458999999985 7766654    356799999999999999999


Q ss_pred             HHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHH
Q 015352          166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVIL  243 (408)
Q Consensus       166 ~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il  243 (408)
                      .|||++||+||||||+|||++.  .++.+||+|||++.............||+.|+|||++.+  .++.++||||+||++
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            9999999999999999999952  456799999999998766666667789999999998865  489999999999999


Q ss_pred             HHHhhCCCCCCCCCHHHHHHHHHcCCcc-----------------cCC---C-----CCCCCCHHHHHHHHHhcCCCcCC
Q 015352          244 YILLCGVPPFWAESEQGVAQAILRGLID-----------------FKR---D-----PWPNVSESAKSLVRQMLEPDPKL  298 (408)
Q Consensus       244 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------------~~~---~-----~~~~~~~~~~~li~~~l~~dp~~  298 (408)
                      |+|++|..||.+.+..+....+......                 ++.   .     ....+++++.+||.+||+.||.+
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            9999999999998887777766542111                 100   0     12357899999999999999999


Q ss_pred             CCCHHHHhcCccccCCc
Q 015352          299 RLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       299 R~s~~~~l~h~~~~~~~  315 (408)
                      |||+.|+++||||+...
T Consensus       313 R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             SCCHHHHHTSGGGHHHH
T ss_pred             CCCHHHHhcCHHHHHHH
Confidence            99999999999997643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.6e-50  Score=365.43  Aligned_cols=258  Identities=23%  Similarity=0.332  Sum_probs=216.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++..+.+||||+++++++.+++.
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            34668999999999999999999999999999999999865433 33456788999999998789999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC-------------
Q 015352          127 VHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-------------  189 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-------------  189 (408)
                      .++||||++|++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+||+++.++             
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999999764    6799999999999999999999999999999999999996543             


Q ss_pred             ---CCCCEEEeecccccccCCCCceecccCCCCCcchhhhhcc--CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH
Q 015352          190 ---ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA  264 (408)
Q Consensus       190 ---~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  264 (408)
                         ....+||+|||.+.......   ...||+.|+|||++.+.  +++++|||||||++|+|++|.+|+....   ....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH
T ss_pred             ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH
Confidence               45679999999998765432   34699999999998753  5679999999999999999998775443   3344


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          265 ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       265 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +..+...   .....+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       240 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          240 IRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            4444332   2224689999999999999999999999999999999865

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.4e-50  Score=378.73  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=208.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC--
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--  125 (408)
                      .+.++|++.+.||+|+||.||+|+++.+|+.||+|++....  .....+.+.+|+.+++++ +||||+++++++.+..  
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSC
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccc
Confidence            35578999999999999999999999999999999997654  233457899999999999 9999999999986543  


Q ss_pred             -------------------------------------------------------eEEEEEeccCCCchHHHHHhCCC--
Q 015352          126 -------------------------------------------------------AVHLVMELCEGGELFDRIVARGH--  148 (408)
Q Consensus       126 -------------------------------------------------------~~~lv~e~~~g~~L~~~l~~~~~--  148 (408)
                                                                             ..|+|||||+|++|.+++.....  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                   38999999999999999987644  


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-------------ceecc
Q 015352          149 -YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-------------RFSEI  214 (408)
Q Consensus       149 -~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-------------~~~~~  214 (408)
                       .++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......             .....
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence             5666789999999999999999999999999999999   456689999999998765432             22345


Q ss_pred             cCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcC
Q 015352          215 VGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLE  293 (408)
Q Consensus       215 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  293 (408)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..|+..  .......+......   ..+...++.+.+||.+||+
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~  311 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP---LLFTQKYPQEHMMVQDMLS  311 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHHC
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC---cccccCChhHHHHHHHHcc
Confidence            79999999999876 699999999999999999999777521  22233333333221   1123457888999999999


Q ss_pred             CCcCCCCCHHHHhcCccccC
Q 015352          294 PDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       294 ~dp~~R~s~~~~l~h~~~~~  313 (408)
                      .||.+|||+.|+++||||++
T Consensus       312 ~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          312 PSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SSGGGSCCHHHHHHSTTCCC
T ss_pred             CCCCcCCCHHHHhhchhhhc
Confidence            99999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.1e-50  Score=373.17  Aligned_cols=256  Identities=27%  Similarity=0.505  Sum_probs=214.5

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--CCe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNA  126 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~  126 (408)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...      ..+.+.+|+.+++.+.+||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            457899999999999999999999999999999998632      256789999999999669999999999998  678


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      .++||||+.+++|.+++.   .+++..++.++.||+.||.|||++||+||||||+|||++.  +...+||+|||++....
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEECC
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEcC
Confidence            999999999999988874   4899999999999999999999999999999999999953  23379999999998877


Q ss_pred             CCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHc-------------CCc
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILR-------------GLI  270 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~-------------~~~  270 (408)
                      .........||+.|+|||++.+  .++.++|||||||++|+|++|..||... ...+....+..             ...
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            6666667789999999999865  5899999999999999999999999543 33222222211             111


Q ss_pred             cc--------------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          271 DF--------------------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       271 ~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..                    .......+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            10                    0111123799999999999999999999999999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.3e-50  Score=388.02  Aligned_cols=266  Identities=29%  Similarity=0.449  Sum_probs=219.2

Q ss_pred             ccccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC-----CCCCeeE
Q 015352           42 AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-----KNSSIVS  116 (408)
Q Consensus        42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~  116 (408)
                      ...+.+.+..+|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.+.     +|+||++
T Consensus        88 ~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           88 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             CCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            3446778889999999999999999999999999999999999643    223456778888888772     5779999


Q ss_pred             EeeEEEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          117 LKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       117 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                      +++++...+.+++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+
T Consensus       164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~v  241 (429)
T 3kvw_A          164 MLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGI  241 (429)
T ss_dssp             EEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCE
T ss_pred             EEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-Ccce
Confidence            9999999999999999996 58999988764  499999999999999999999999999999999999995321 2349


Q ss_pred             EEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       195 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      ||+|||++....  ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+.......+
T Consensus       242 kL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          242 KVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             EECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999997643  23445689999999999875 699999999999999999999999999888777666553211000


Q ss_pred             C--------------------------------------------------C-----CCCCCCHHHHHHHHHhcCCCcCC
Q 015352          274 R--------------------------------------------------D-----PWPNVSESAKSLVRQMLEPDPKL  298 (408)
Q Consensus       274 ~--------------------------------------------------~-----~~~~~~~~~~~li~~~l~~dp~~  298 (408)
                      .                                                  .     .....++.+.+||.+||+.||.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence            0                                                  0     00124788999999999999999


Q ss_pred             CCCHHHHhcCccccCCc
Q 015352          299 RLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       299 R~s~~~~l~h~~~~~~~  315 (408)
                      |||+.|+|+||||+...
T Consensus       400 Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          400 RMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             SCCHHHHHTSTTTC---
T ss_pred             CCCHHHHhCChhhccCC
Confidence            99999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=374.92  Aligned_cols=262  Identities=23%  Similarity=0.382  Sum_probs=217.7

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ...+.++|.+.+.||+|+||+||+|++..+|+.||+|++......  ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   80 (319)
T 4euu_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETT   80 (319)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTT
T ss_pred             ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCCcceEEEEeecCC
Confidence            456778999999999999999999999999999999999754432  2357788999999999 8999999999998765


Q ss_pred             --eEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec-CCCCCCEEEeec
Q 015352          126 --AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN-KKENSPLKAIDF  199 (408)
Q Consensus       126 --~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~-~~~~~~vkl~Df  199 (408)
                        ..|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+.. ++..+.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence              88999999999999999976533   999999999999999999999999999999999999743 234567999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhh---------ccCCCchhHHHHHHHHHHHhhCCCCCCCCC----HHHHHHHHH
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK---------RNYGPEIDIWSAGVILYILLCGVPPFWAES----EQGVAQAIL  266 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~  266 (408)
                      |++.............||+.|+|||++.         ..++.++|||||||++|+|++|..||....    ..+....+.
T Consensus       161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            9998877666666778999999999885         458899999999999999999999996432    234455554


Q ss_pred             cCCccc-------------------C--CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          267 RGLIDF-------------------K--RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       267 ~~~~~~-------------------~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      .+....                   +  ......+++.+.+||.+||+.||++|||+.|+|+||=
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            433210                   0  0111234567899999999999999999999999873

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.5e-50  Score=365.02  Aligned_cols=259  Identities=28%  Similarity=0.513  Sum_probs=221.1

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.+ +||||+++++++.+++..|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEE
Confidence            457899999999999999999999999999999999755432  2357889999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence            999999999999999877789999999999999999999999999999999999999   45677999999998765322


Q ss_pred             C---ceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCCCCCCCCCH
Q 015352          209 E---RFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       209 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .   ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||...... .....+......  ...+..+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence            2   2345679999999999875 3 477899999999999999999999876543 223333332221  223457899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999999999998754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.1e-50  Score=378.60  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=218.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|++....  .....+.+.+|+.+++.+ +||||+++++++...   
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCcc
Confidence            45579999999999999999999999999999999997432  334457789999999999 899999999999765   


Q ss_pred             --CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          125 --NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       125 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                        ...|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       101 ~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          101 QMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  175 (364)
T ss_dssp             TCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcce
Confidence              479999999975 99988866 469999999999999999999999999999999999999   55677999999999


Q ss_pred             cccCCCC----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC--
Q 015352          203 IFFKPGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR--  274 (408)
Q Consensus       203 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--  274 (408)
                      .......    ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.........  
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            8654322    1244589999999998753  4899999999999999999999999988777666665432111100  


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          275 -------------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       275 -------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                               ..++.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                                     01246789999999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=372.79  Aligned_cols=258  Identities=26%  Similarity=0.464  Sum_probs=211.5

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC-CCeeEEeeEEEeCCeE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDDNAV  127 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~~~~  127 (408)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.+.+| |||+++++++.+++.+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4568999999999999999999884 688999999976543 334457889999999999433 9999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++.....
T Consensus        85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred             EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence            99999 45789999999998999999999999999999999999999999999999995    35699999999987643


Q ss_pred             CCc---eecccCCCCCcchhhhh------------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCcc
Q 015352          208 GER---FSEIVGSPYYMAPEVLK------------RNYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGLID  271 (408)
Q Consensus       208 ~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~  271 (408)
                      ...   .....||+.|+|||++.            ..++.++|||||||++|+|++|..||..... ......+......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  239 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  239 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence            322   23567999999999985            3588899999999999999999999977433 2333444433322


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .  ......++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       240 ~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          240 I--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             C--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             c--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            2  22235678999999999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-50  Score=385.69  Aligned_cols=265  Identities=26%  Similarity=0.445  Sum_probs=202.0

Q ss_pred             cccccccceEe-cceecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           45 PKENIEDRYLV-DRELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        45 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....+.+.|.+ .+.||+|+||+||+|+++  .+++.||+|++.....     ...+.+|+.+++.+ +||||+++++++
T Consensus        14 ~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l-~hpniv~~~~~~   87 (405)
T 3rgf_A           14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVF   87 (405)
T ss_dssp             HCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHC-CCTTBCCCCEEE
T ss_pred             hhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhc-CCCCeeeEeeEE
Confidence            34567788988 457999999999999976  5688999999975432     24678999999999 899999999999


Q ss_pred             E--eCCeEEEEEeccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC-C
Q 015352          122 E--DDNAVHLVMELCEGGELFDRIVAR---------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK-K  189 (408)
Q Consensus       122 ~--~~~~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~-~  189 (408)
                      .  .+..+|+||||+.| +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           88 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             EETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSST
T ss_pred             ecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCC
Confidence            5  47789999999975 888877532         249999999999999999999999999999999999999654 4


Q ss_pred             CCCCEEEeecccccccCCC----CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH----
Q 015352          190 ENSPLKAIDFGLSIFFKPG----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQ----  259 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----  259 (408)
                      ..+.+||+|||++......    ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....    
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            5678999999999875432    23345689999999999875  4899999999999999999999999765542    


Q ss_pred             -----HHHHHHHcCCcccCCCCCC----------------------------------CCCHHHHHHHHHhcCCCcCCCC
Q 015352          260 -----GVAQAILRGLIDFKRDPWP----------------------------------NVSESAKSLVRQMLEPDPKLRL  300 (408)
Q Consensus       260 -----~~~~~i~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~l~~dp~~R~  300 (408)
                           +....+...........|.                                  ..++.+.+||.+||+.||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                 3344443322222222221                                  2378899999999999999999


Q ss_pred             CHHHHhcCccccCCcC
Q 015352          301 TAKQVLEHPWLQNAKK  316 (408)
Q Consensus       301 s~~~~l~h~~~~~~~~  316 (408)
                      |+.|+|+||||.....
T Consensus       327 ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             CHHHHHTSGGGTSSSC
T ss_pred             CHHHHhcChhhccCCC
Confidence            9999999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-51  Score=390.38  Aligned_cols=251  Identities=17%  Similarity=0.228  Sum_probs=205.8

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEe-------e
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLK-------E  119 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~-------~  119 (408)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.+.  +||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            4578999999999999999999999999999999998765555556788999995554443  799999988       7


Q ss_pred             EEEeCCe-----------------EEEEEeccCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCCee
Q 015352          120 ACEDDNA-----------------VHLVMELCEGGELFDRIVARGHYTE-------RAAAAVTRTIVEVVQLCHKHGVIH  175 (408)
Q Consensus       120 ~~~~~~~-----------------~~lv~e~~~g~~L~~~l~~~~~~~~-------~~~~~i~~ql~~~l~~lH~~~ivH  175 (408)
                      ++++.+.                 .|+||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            7776643                 89999999 6799999987655555       788889999999999999999999


Q ss_pred             ccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc------------cCCCchhHHHHHHHH
Q 015352          176 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR------------NYGPEIDIWSAGVIL  243 (408)
Q Consensus       176 ~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il  243 (408)
                      |||||+|||+   +.++.+||+|||++...  ........| +.|+|||++.+            .++.++|||||||++
T Consensus       230 rDikp~NIll---~~~~~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVL---DQRGGVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEE---CTTCCEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEE---cCCCCEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            9999999999   45578999999999863  334556678 99999999864            599999999999999


Q ss_pred             HHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          244 YILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       244 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      |+|++|..||.+.........+        ...+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHSSCCC------CCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhh--------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            9999999999765543322222        22335789999999999999999999999999999999764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.5e-49  Score=363.44  Aligned_cols=259  Identities=27%  Similarity=0.467  Sum_probs=226.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|.+.+.||+|+||.||+|++..+++.||+|++.....  ....+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCe
Confidence            4566789999999999999999999999999999999976543  23467899999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECB
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecC
Confidence            9999999999999998854 579999999999999999999999999999999999999   456789999999997754


Q ss_pred             CCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 PGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......   .....++..+
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  247 (303)
T 3a7i_A          171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPL  247 (303)
T ss_dssp             TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHH
T ss_pred             ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHH
Confidence            332 2345679999999999875 6899999999999999999999999988877766666554322   2234789999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||.+||..||.+|||+.++++||||....
T Consensus       248 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          248 KEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            9999999999999999999999999997654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.4e-50  Score=378.37  Aligned_cols=262  Identities=24%  Similarity=0.357  Sum_probs=221.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+....++|++.+.||+|+||.||+|.+..+|..||+|++....  .....+.+.+|+.+++.+ +||||+++++++.++
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  103 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD  103 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC
Confidence            34566789999999999999999999999999999999997642  334457889999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+||++   +.++.+||+|||++.
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSG  180 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCH
T ss_pred             CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCc
Confidence            99999999999999999999888899999999999999999999996 99999999999999   456779999999987


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH-----------------
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI-----------------  265 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i-----------------  265 (408)
                      ..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+                 
T Consensus       181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          181 QLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             ccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            54322 2234579999999999875 6899999999999999999999999877655432221                 


Q ss_pred             -------------------------HcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          266 -------------------------LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       266 -------------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                               .....  +......+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                     11111  1111235789999999999999999999999999999998754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-49  Score=379.24  Aligned_cols=263  Identities=29%  Similarity=0.435  Sum_probs=218.5

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC-----eeEEe
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-----IVSLK  118 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-----i~~~~  118 (408)
                      ..+..+.++|++.+.||+|+||+||+|++..+++.||+|++...    ......+.+|+.+++.+.+|++     |++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            45677889999999999999999999999999999999999643    2334667789999988844654     99999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCceEeecCCCCCCE
Q 015352          119 EACEDDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCH--KHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       119 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH--~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                      +++...+.+|+||||+.| +|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++. +..+.+
T Consensus       123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCE
T ss_pred             eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcE
Confidence            999999999999999965 999999875  45999999999999999999999  579999999999999954 345679


Q ss_pred             EEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       195 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      ||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus       201 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          201 KIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             EECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999999987643  3345689999999999876 699999999999999999999999999888777776654321110


Q ss_pred             C------------------CCC-----------------CC-------------------------CCHHHHHHHHHhcC
Q 015352          274 R------------------DPW-----------------PN-------------------------VSESAKSLVRQMLE  293 (408)
Q Consensus       274 ~------------------~~~-----------------~~-------------------------~~~~~~~li~~~l~  293 (408)
                      .                  ..|                 ..                         .++++.+||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence            0                  000                 00                         01378999999999


Q ss_pred             CCcCCCCCHHHHhcCccccCC
Q 015352          294 PDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       294 ~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .||++|||+.|+|+||||+..
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC-
T ss_pred             CChhhCCCHHHHhcCcccccC
Confidence            999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.8e-49  Score=362.96  Aligned_cols=260  Identities=23%  Similarity=0.281  Sum_probs=200.7

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.++...++.+ +||||+++++++.+++..
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCE
Confidence            345799999999999999999999999999999999975432 122223344444456666 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          128 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      |+||||++| +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+||++   +.++.+||+|||++
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC---
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCc
Confidence            999999975 88776653    46799999999999999999999998 99999999999999   45678999999999


Q ss_pred             cccCCCCceecccCCCCCcchhhh----h-ccCCCchhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCcccCCCC
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVL----K-RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDP  276 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~----~-~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~  276 (408)
                      .............||+.|+|||++    . ..++.++||||+||++|+|++|..||.. ................  ...
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~  235 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QLP  235 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CCC
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Ccc
Confidence            876655555556799999999996    2 3588999999999999999999999976 3333444444433222  222


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ...+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            346899999999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-49  Score=365.59  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=218.0

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--  123 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--  123 (408)
                      .....++|++.+.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+++++.+||||+++++++..  
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3456789999999999999999999999999999999997543    2346788999999998789999999999987  


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          124 ----DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       124 ----~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                          .+.+|+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~  171 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLV  171 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEe
Confidence                56899999999999999999875  569999999999999999999999999999999999999   456779999


Q ss_pred             ecccccccCCC-CceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc
Q 015352          198 DFGLSIFFKPG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       198 Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      |||++...... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            99998765432 2234557999999999985      3588999999999999999999999998887766666655433


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .  ......+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       252 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          252 P--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             C--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             c--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            2  222356899999999999999999999999999999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.2e-49  Score=364.02  Aligned_cols=262  Identities=27%  Similarity=0.432  Sum_probs=220.0

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++.+ +||||+++++++.+++
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATC-DHPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCC
Confidence            4567789999999999999999999999999999999987542   33467889999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||++   +.++.+||+|||++..
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcc
Confidence            99999999999999998876 4669999999999999999999999999999999999999   4566799999998754


Q ss_pred             cCC-CCceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          205 FKP-GERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       205 ~~~-~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      ... ........||+.|+|||++.      ..++.++||||||+++|+|++|..||...+.......+........ ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  245 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTP  245 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSG
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCc
Confidence            321 11223457899999999873      3588999999999999999999999999888777766666543211 122


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..++..+.++|.+||..||.+|||+.++++||||+...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            46789999999999999999999999999999998754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.5e-49  Score=370.02  Aligned_cols=265  Identities=30%  Similarity=0.454  Sum_probs=219.2

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++...  ........+.+|+.+++.+ +||||+++++++..+
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   81 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHF-KHENIITIFNIQRPD   81 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCS
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeeccc
Confidence            4556889999999999999999999999999999999999643  2333456788999999999 899999999988754


Q ss_pred             -----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          125 -----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       125 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                           ...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        82 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Df  156 (353)
T 2b9h_A           82 SFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDF  156 (353)
T ss_dssp             CSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCC
T ss_pred             ccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEec
Confidence                 78999999997 489888876 579999999999999999999999999999999999999   55678999999


Q ss_pred             ccccccCCCC-----------ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 015352          200 GLSIFFKPGE-----------RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL  266 (408)
Q Consensus       200 g~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  266 (408)
                      |++.......           ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9998654221           1233578999999998753  58999999999999999999999999887766555443


Q ss_pred             cCCccc------------------------CC----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          267 RGLIDF------------------------KR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       267 ~~~~~~------------------------~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                      ......                        +.    ..++.+++++.+||.+||+.||.+|||+.++++||||+.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence            211100                        00    0124689999999999999999999999999999999876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=368.67  Aligned_cols=265  Identities=29%  Similarity=0.450  Sum_probs=215.8

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-  122 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-  122 (408)
                      .++..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.+ +||||+++++++. 
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   79 (320)
T 2i6l_A            4 IHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRL-DHDNIVKVFEILGP   79 (320)
T ss_dssp             --CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECT
T ss_pred             cccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccc
Confidence            35678889999999999999999999999999999999998754   334467889999999999 9999999999874 


Q ss_pred             -------------eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC
Q 015352          123 -------------DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       123 -------------~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~  189 (408)
                                   +.+..|+||||+. |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--  155 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--  155 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--
Confidence                         4478999999997 59988885 467999999999999999999999999999999999999953  


Q ss_pred             CCCCEEEeecccccccCCC----CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHH
Q 015352          190 ENSPLKAIDFGLSIFFKPG----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ  263 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  263 (408)
                      .++.+||+|||++......    .......+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+...
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  235 (320)
T 2i6l_A          156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ  235 (320)
T ss_dssp             TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            3467999999999865422    22344567999999998753  58999999999999999999999999988777666


Q ss_pred             HHHcCCcccC----------------------C----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          264 AILRGLIDFK----------------------R----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       264 ~i~~~~~~~~----------------------~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      .+........                      .    ..++.+++++++||.+||+.||.+|||+.++++||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            6654321110                      0    112468999999999999999999999999999999987543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.6e-49  Score=363.77  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=212.4

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ..+...++|++.+.||+|+||+||+|++  +|..||+|++..... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQP  106 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECST
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC
Confidence            3445567999999999999999999987  588899999976543 334457789999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeec
Q 015352          125 NAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      +.+++||||++||+|.+++...+.   +++..++.++.||+.||.|||++|  |+||||||+|||+   +.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCC
Confidence            999999999999999999987654   999999999999999999999999  9999999999999   55678999999


Q ss_pred             ccccccCCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          200 GLSIFFKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       200 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      |++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......  ...
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~  261 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIP  261 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCC
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCC
Confidence            9997644322 2345679999999999876 58999999999999999999999999988877776665443322  223


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc--CccccCC
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE--HPWLQNA  314 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~~  314 (408)
                      ..+++.+.+||.+||+.||.+|||+.++++  .+|++..
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            578999999999999999999999999988  4555543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-49  Score=367.26  Aligned_cols=265  Identities=29%  Similarity=0.464  Sum_probs=199.7

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +.....++|.+.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.+ +||||+++++++...
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK   85 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCC-CCTTBCCEEEEEESS
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec
Confidence            455567899999999999999999999999999999999865432  22356788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          125 NAVHLVMELCEGGELFDRIVA--------RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~--------~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      +..|+||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl  162 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQI  162 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEE
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEE
Confidence            999999999999999999874        4569999999999999999999999999999999999999   45678999


Q ss_pred             eecccccccCCCC------ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Q 015352          197 IDFGLSIFFKPGE------RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       197 ~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  268 (408)
                      +|||++.......      ......||+.|+|||++.+  .++.++||||||+++|+|++|..||...............
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            9999987654322      1234579999999999864  5899999999999999999999999887766555544443


Q ss_pred             CcccC------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          269 LIDFK------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       269 ~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .....      ......+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            32211      122356889999999999999999999999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=365.40  Aligned_cols=259  Identities=25%  Similarity=0.502  Sum_probs=220.0

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE--EeCC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEAC--EDDN  125 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--~~~~  125 (408)
                      +.++|.+.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.+ +||||+++++++  .+.+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence            567999999999999999999999999999999999765432 123457789999999999 899999999998  4566


Q ss_pred             eEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          126 AVHLVMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ..|+||||++++ |.+++..  .+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence            899999999876 7777765  3569999999999999999999999999999999999999   456789999999998


Q ss_pred             ccCC---CCceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          204 FFKP---GERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       204 ~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      ....   ........||+.|+|||++.+   .++.++||||||+++|+|++|..||.+.+..+....+..+...++    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence            7542   223345679999999999875   247799999999999999999999999988888888877755433    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ..+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            467999999999999999999999999999999987643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.5e-50  Score=378.74  Aligned_cols=263  Identities=24%  Similarity=0.451  Sum_probs=225.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhc--------------HHHHHHHHHHHHhCCCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD--------------IDDVRREVAIMKHLPKN  111 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~~h  111 (408)
                      +....++|.+.+.||+|+||.||+|.+  +|+.||+|++..........              .+.+.+|+.+++.+ +|
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  102 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KN  102 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CC
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CC
Confidence            345568999999999999999999998  89999999997654332211              27889999999999 89


Q ss_pred             CCeeEEeeEEEeCCeEEEEEeccCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCc
Q 015352          112 SSIVSLKEACEDDNAVHLVMELCEGGELFDR------IVA--RGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPEN  182 (408)
Q Consensus       112 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~------l~~--~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~N  182 (408)
                      |||+++++++.+.+.+|+||||++|++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999998      655  5679999999999999999999999 999999999999


Q ss_pred             eEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhcc--CCC-chhHHHHHHHHHHHhhCCCCCCCCCH-
Q 015352          183 FLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKRN--YGP-EIDIWSAGVILYILLCGVPPFWAESE-  258 (408)
Q Consensus       183 Il~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwslG~il~~l~~g~~pf~~~~~-  258 (408)
                      |++   +.++.+||+|||++...... ......||+.|+|||++.+.  ++. ++|||||||++|+|++|..||..... 
T Consensus       183 il~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            999   55678999999999875443 44566899999999998753  555 99999999999999999999988776 


Q ss_pred             HHHHHHHHcCCcccCCCC---------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          259 QGVAQAILRGLIDFKRDP---------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+....+..+...++...               ...+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            677777777655544211               146899999999999999999999999999999998753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=363.07  Aligned_cols=260  Identities=27%  Similarity=0.449  Sum_probs=216.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .....++|.+.+.||+|+||.||+|.+..+|+.||+|++....     ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETT
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCC
Confidence            3456789999999999999999999999999999999997542     346788999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .+|+||||++|++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||++   +.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchh
Confidence            9999999999999999987 45679999999999999999999999999999999999999   4567799999999976


Q ss_pred             cCCC-CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......+++
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  253 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSD  253 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCH
T ss_pred             hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCH
Confidence            5433 22345579999999999875 6899999999999999999999999887776655554443321 1112235789


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+.+||.+||..||.+|||+.++++||||+...
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.5e-49  Score=369.42  Aligned_cols=264  Identities=28%  Similarity=0.458  Sum_probs=219.2

Q ss_pred             ccccccccceEecceecccCCeEEEEEEE-CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC------CeeE
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS------SIVS  116 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------~i~~  116 (408)
                      .+++.+.++|++.+.||+|+||.||+|.+ ..+|+.||+|++...    ....+.+.+|+.+++.+ +|+      ++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~   81 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHL-NTTDPNSTFRCVQ   81 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHH-HHHCTTCTTCBCC
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHh-hhcCCCCceeeEe
Confidence            36677889999999999999999999998 567899999998643    23356788999999888 544      5999


Q ss_pred             EeeEEEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC----
Q 015352          117 LKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE----  190 (408)
Q Consensus       117 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~----  190 (408)
                      +++++.+.+.+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++..+.    
T Consensus        82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence            999999999999999999 889999998775  5899999999999999999999999999999999999964321    


Q ss_pred             ------------CCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC
Q 015352          191 ------------NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES  257 (408)
Q Consensus       191 ------------~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~  257 (408)
                                  ++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                        56799999999986443  2345689999999999875 69999999999999999999999999888


Q ss_pred             HHHHHHHHHcCCcccCC----------------CCC------------------------CCCCHHHHHHHHHhcCCCcC
Q 015352          258 EQGVAQAILRGLIDFKR----------------DPW------------------------PNVSESAKSLVRQMLEPDPK  297 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~~l~~dp~  297 (408)
                      ..+....+......++.                ..|                        ...++.+.+||.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            76655544332211110                001                        12356788999999999999


Q ss_pred             CCCCHHHHhcCccccCCc
Q 015352          298 LRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       298 ~R~s~~~~l~h~~~~~~~  315 (408)
                      +|||+.|+++||||+...
T Consensus       319 ~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          319 KRITLREALKHPFFDLLK  336 (339)
T ss_dssp             TSCCHHHHTTSGGGGGGG
T ss_pred             cccCHHHHhcCHHHHHHh
Confidence            999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.1e-49  Score=372.50  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=217.3

Q ss_pred             cccccceEecceecccCCeEEEEEEEC-------CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEee
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKE  119 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~  119 (408)
                      ....++|.+.+.||+|+||.||+|++.       .++..||+|++....  .....+.+.+|+.+++.+.+||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            344579999999999999999999874       345679999997542  33446789999999999978999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          120 ACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       120 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                      ++.+.+.+|+||||++||+|.+++...+                .+++..+..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998753                478999999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCH
Q 015352          184 LFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESE  258 (408)
Q Consensus       184 l~~~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  258 (408)
                      |+   +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus       235 ll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          235 LV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             EE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99   556789999999998654332   2233457889999998875 69999999999999999999 9999999888


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+....+..+...   .....+++.+.++|.+||+.||.+|||+.|++++
T Consensus       312 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          312 EELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8877777665432   2234789999999999999999999999999873

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-48  Score=365.05  Aligned_cols=264  Identities=25%  Similarity=0.424  Sum_probs=218.8

Q ss_pred             ccccceEecceecccCCeEEEEEEEC-CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEE--
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDR-DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACE--  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~--  122 (408)
                      ...++|++.+.||+|+||.||+|++. .+|+.||+|++........ ....+.+|+.+++.+.  +||||+++++++.  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            35579999999999999999999995 6789999999975443221 1234556777776553  7999999999987  


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          123 ---DDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       123 ---~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                         ....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEe
Confidence               5678999999997 59999998753  49999999999999999999999999999999999999   456789999


Q ss_pred             ecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC---
Q 015352          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK---  273 (408)
Q Consensus       198 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---  273 (408)
                      |||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+........   
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            9999987654444556789999999999875 689999999999999999999999999888777776654211100   


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          274 --------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       274 --------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                          ...+..+++.+++||.+||..||.+|||+.++++||||+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                                1123468899999999999999999999999999999987653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.3e-49  Score=358.23  Aligned_cols=259  Identities=28%  Similarity=0.478  Sum_probs=222.3

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE--eCCe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--DDNA  126 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~  126 (408)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.  ..+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCce
Confidence            34789999999999999999999999999999999986543 334467889999999999 9999999999874  4678


Q ss_pred             EEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCceEeecCCCCCCEEEe
Q 015352          127 VHLVMELCEGGELFDRIVAR----GHYTERAAAAVTRTIVEVVQLCHKHG-----VIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~-----ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      +|+||||++|++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+||++   +.++.+||+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~  158 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLG  158 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEe
Confidence            99999999999999998753    34999999999999999999999999     9999999999999   456789999


Q ss_pred             ecccccccCCCCc-eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC
Q 015352          198 DFGLSIFFKPGER-FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       198 Dfg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (408)
                      |||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+..+....   
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---  235 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---  235 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---
Confidence            9999987644332 234578999999999875 68999999999999999999999999988888888887765432   


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ....+++++.++|.+||+.||.+|||+.|+++|+|+....
T Consensus       236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            2246899999999999999999999999999999997654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.6e-49  Score=373.68  Aligned_cols=261  Identities=28%  Similarity=0.464  Sum_probs=216.7

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus        36 ~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  113 (371)
T 4exu_A           36 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPA  113 (371)
T ss_dssp             EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSC
T ss_pred             ceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc-CCCCchhhhhheecc
Confidence            33457789999999999999999999999999999999997543 2334457888999999999 899999999999877


Q ss_pred             CeE------EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          125 NAV------HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       125 ~~~------~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      +..      |+||||+. ++|.+.+  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~D  187 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILD  187 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECS
T ss_pred             CCcccceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEe
Confidence            654      99999997 4887776  3459999999999999999999999999999999999999   5567899999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc----
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF----  272 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----  272 (408)
                      ||++.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......    
T Consensus       188 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          188 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             TTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            999986533  3345678999999999875  68999999999999999999999999988777666664421110    


Q ss_pred             -------------------CC----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          273 -------------------KR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       273 -------------------~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                         ..    ..++.+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                               00    01246789999999999999999999999999999998653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=372.63  Aligned_cols=260  Identities=22%  Similarity=0.247  Sum_probs=222.1

Q ss_pred             cccccceEecceecccCCeEEEEEE-----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....++|.+.+.||+|+||.||+|.     +..++..||+|++...  ........+.+|+.+++.+ +||||+++++++
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  143 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVS  143 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhC-CCCCCCeEEEEE
Confidence            4456789999999999999999999     4557889999998643  2334456788999999999 999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                      .+.+..|+||||++||+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.++....+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999999999999997653       48999999999999999999999999999999999999766666779


Q ss_pred             EEeecccccccCC---CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC
Q 015352          195 KAIDFGLSIFFKP---GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       195 kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      ||+|||++.....   ........||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+.
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999975421   223344568999999998864 69999999999999999998 999999999888888887765


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      ...   ....+++.+.+||.+||+.||.+|||+.+++++.|..
T Consensus       304 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          304 RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            322   2347899999999999999999999999999987754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=363.53  Aligned_cols=254  Identities=22%  Similarity=0.315  Sum_probs=216.8

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ......++|.+.+.||+|+||.||+|.+..++.   .||+|++....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  119 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQF-DHPNIIRLEGVV  119 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEE
Confidence            345567899999999999999999999986655   49999997432  334457789999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                      .+++..|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg  196 (325)
T 3kul_A          120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFG  196 (325)
T ss_dssp             CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCS
T ss_pred             EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCC
Confidence            9999999999999999999999765 579999999999999999999999999999999999999   556789999999


Q ss_pred             cccccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          201 LSIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       201 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      ++........    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---  273 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL---  273 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC---
Confidence            9987643321    122346778999999875 69999999999999999999 99999999988888888766322   


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +....+++.+.+||.+||..||.+|||+.++++
T Consensus       274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            223578999999999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-48  Score=370.06  Aligned_cols=262  Identities=25%  Similarity=0.347  Sum_probs=206.6

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe-
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA-  126 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~-  126 (408)
                      ...++|.+.+.||+|+||.||+|++..+|+.||+|++......    .....+|+..++.+ +||||+++++++...+. 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVL-HHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSS
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhc-CCCCcccHHHhhhccccc
Confidence            3457999999999999999999999999999999998654322    23556788888888 99999999999976443 


Q ss_pred             ------EEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCceEeecCCCCCCE
Q 015352          127 ------VHLVMELCEGGELFDRIV----ARGHYTERAAAAVTRTIVEVVQLCH--KHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       127 ------~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~l~~lH--~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                            +++||||++| +|...+.    ....+++..++.++.||+.||.|||  ++||+||||||+|||++.  .++.+
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcE
Confidence                  8999999987 4444333    4567999999999999999999999  999999999999999952  35679


Q ss_pred             EEeecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc
Q 015352          195 KAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF  272 (408)
Q Consensus       195 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  272 (408)
                      ||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+.+.....
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  251 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP  251 (360)
T ss_dssp             EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence            9999999988776666667789999999999864  48999999999999999999999999988877777765422111


Q ss_pred             C----------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCC
Q 015352          273 K----------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKA  317 (408)
Q Consensus       273 ~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  317 (408)
                      +                            .......++++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence            0                            01112357889999999999999999999999999999986543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8e-50  Score=379.59  Aligned_cols=259  Identities=16%  Similarity=0.204  Sum_probs=198.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC-CCCCeeEEe-------eEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-KNSSIVSLK-------EAC  121 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~i~~~~-------~~~  121 (408)
                      ...|.+.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.|. +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            446999999999999999999999999999999998766544555677888977666663 599988755       555


Q ss_pred             EeC-----------------CeEEEEEeccCCCchHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHCCCeecc
Q 015352          122 EDD-----------------NAVHLVMELCEGGELFDRIVAR-GHYTERAA------AAVTRTIVEVVQLCHKHGVIHRD  177 (408)
Q Consensus       122 ~~~-----------------~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~------~~i~~ql~~~l~~lH~~~ivH~d  177 (408)
                      ...                 ..+|+||||++ |+|.+++... ..+++...      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            443                 34899999998 7999999864 33444444      57779999999999999999999


Q ss_pred             CCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCC
Q 015352          178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFW  254 (408)
Q Consensus       178 ikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~  254 (408)
                      |||+|||+   +.++.+||+|||++....  .......+|+.|+|||++.+   .++.++|||||||++|+|++|..||.
T Consensus       220 ikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFI---MPDGRLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEE---CTTSCEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEE---CCCCCEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999   556789999999998653  22325567799999999874   59999999999999999999999998


Q ss_pred             CCCHHHHH--HH---HHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          255 AESEQGVA--QA---ILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       255 ~~~~~~~~--~~---i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +.......  ..   .......+..+.+..+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            76432100  00   01111222333445789999999999999999999999999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.2e-49  Score=372.82  Aligned_cols=264  Identities=22%  Similarity=0.353  Sum_probs=210.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC--------ChhcHHHHHHHHHHHHhCCCCCCeeEE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR--------TAVDIDDVRREVAIMKHLPKNSSIVSL  117 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~i~~~  117 (408)
                      ...+.++|.+.+.||+|+||.||+|.+.. |..||+|++......        .....+.+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~   94 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGL   94 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCC
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccce
Confidence            34577899999999999999999999865 999999999654322        122247889999999999 89999999


Q ss_pred             eeEEEe-----CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          118 KEACED-----DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       118 ~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      ++++..     ...+|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||++   +.+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~  170 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADN  170 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred             eeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCC
Confidence            999843     3478999999974 888887765 369999999999999999999999999999999999999   456


Q ss_pred             CCEEEeecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Q 015352          192 SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      +.+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (362)
T 3pg1_A          171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV  250 (362)
T ss_dssp             CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            7799999999986655555566789999999998864  58999999999999999999999999988777766664321


Q ss_pred             ccc------------------------CCC----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          270 IDF------------------------KRD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       270 ~~~------------------------~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ...                        +..    ..+..++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            110                        110    1235688999999999999999999999999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.3e-49  Score=377.19  Aligned_cols=263  Identities=24%  Similarity=0.397  Sum_probs=210.7

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC-------CCCCeeE
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP-------KNSSIVS  116 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~~i~~  116 (408)
                      ..++.+.++|++.+.||+|+||+||+|++..+++.||+|++...    ....+.+.+|+.+++.+.       +||||++
T Consensus        30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            35677889999999999999999999999999999999999643    234567889999999883       1788999


Q ss_pred             EeeEEE----eCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCC
Q 015352          117 LKEACE----DDNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKK  189 (408)
Q Consensus       117 ~~~~~~----~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~  189 (408)
                      +++++.    +...+|+||||+ +++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999998    566899999999 55777776654  4699999999999999999999998 999999999999996432


Q ss_pred             ----------------------------------------------CCCCEEEeecccccccCCCCceecccCCCCCcch
Q 015352          190 ----------------------------------------------ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP  223 (408)
Q Consensus       190 ----------------------------------------------~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aP  223 (408)
                                                                    ....+||+|||++......  .....||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP  262 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence                                                          1237999999999875432  3456799999999


Q ss_pred             hhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC------HHHHHHHHHcCCcccCC----------------------
Q 015352          224 EVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES------EQGVAQAILRGLIDFKR----------------------  274 (408)
Q Consensus       224 E~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~----------------------  274 (408)
                      |++.+ .++.++|||||||++|+|++|..||.+.+      .......+.......+.                      
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            99876 59999999999999999999999997654      22222222211100000                      


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          275 ----------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       275 ----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                                      ......++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                            001123467889999999999999999999999999963

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.1e-48  Score=359.09  Aligned_cols=255  Identities=26%  Similarity=0.457  Sum_probs=211.7

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----  123 (408)
                      +.++|++.+.||+|+||.||+|++..+|+.||+|++...    ....+.+.+|+.+++.+ +||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence            567899999999999999999999999999999999643    23457789999999999 99999999998865     


Q ss_pred             --------CCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          124 --------DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       124 --------~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                              .+..|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence                    467899999999999999998654 58899999999999999999999999999999999999   556779


Q ss_pred             EEeecccccccCCC---------------CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCC-C
Q 015352          195 KAIDFGLSIFFKPG---------------ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWA-E  256 (408)
Q Consensus       195 kl~Dfg~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~-~  256 (408)
                      ||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||.. .
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999998765321               22344579999999999874  58999999999999999998   5543 2


Q ss_pred             CHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ........+......++.......++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            3345556666665566655556788899999999999999999999999999999754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-48  Score=366.58  Aligned_cols=266  Identities=25%  Similarity=0.414  Sum_probs=218.1

Q ss_pred             ccccccccccceEecceecccCCeEEEEEEECCCC-cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC------e
Q 015352           42 AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTR-ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS------I  114 (408)
Q Consensus        42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~------i  114 (408)
                      ....++.+.++|++.+.||+|+||.||+|.+..++ ..||+|++...    ....+.+.+|+.+++.+ .|++      +
T Consensus        10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~~~~~~~~   84 (355)
T 2eu9_A           10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKI-KEKDKENKFLC   84 (355)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHHCTTSCSCB
T ss_pred             ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHH-hhcCCCCceeE
Confidence            34467788999999999999999999999998877 68999998643    23356788899999988 5544      9


Q ss_pred             eEEeeEEEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC----
Q 015352          115 VSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK----  188 (408)
Q Consensus       115 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~----  188 (408)
                      +.+++++...+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+...    
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred             EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence            99999999999999999999 567777777653  69999999999999999999999999999999999999543    


Q ss_pred             ------------CCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCC
Q 015352          189 ------------KENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWA  255 (408)
Q Consensus       189 ------------~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~  255 (408)
                                  +..+.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                        2467899999999986433  2345689999999999875 699999999999999999999999998


Q ss_pred             CCHHHHHHHHHcCCcccCC----------------CCC------------------------CCCCHHHHHHHHHhcCCC
Q 015352          256 ESEQGVAQAILRGLIDFKR----------------DPW------------------------PNVSESAKSLVRQMLEPD  295 (408)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~~l~~d  295 (408)
                      ....+....+.......+.                ..|                        ...++++.+||.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            8776655544332211110                001                        112457889999999999


Q ss_pred             cCCCCCHHHHhcCccccCCc
Q 015352          296 PKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       296 p~~R~s~~~~l~h~~~~~~~  315 (408)
                      |.+|||+.|+++||||+...
T Consensus       322 P~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          322 PAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             TTTSCCHHHHTTSGGGGGCC
T ss_pred             hhhCcCHHHHhcChhhcCCC
Confidence            99999999999999998753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=365.33  Aligned_cols=259  Identities=27%  Similarity=0.463  Sum_probs=214.8

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..+.++|.+.+.||+|+||.||+|+++.+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+.
T Consensus        20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred             cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccc
Confidence            346789999999999999999999999999999999997543 2333456788999999999 89999999999987654


Q ss_pred             ------EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          127 ------VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       127 ------~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                            +|+||||+. ++|.+++.  ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg  171 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFG  171 (353)
T ss_dssp             GGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTT
T ss_pred             cccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecc
Confidence                  599999997 48887763  359999999999999999999999999999999999999   556789999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc--------
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI--------  270 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--------  270 (408)
                      ++.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.....        
T Consensus       172 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          172 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             CTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             cccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9986543  2345678999999998865  589999999999999999999999998887766655543210        


Q ss_pred             ---------------ccC----CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          271 ---------------DFK----RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       271 ---------------~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                     ..+    ...++.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                           001    122346799999999999999999999999999999998653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1e-48  Score=364.50  Aligned_cols=261  Identities=32%  Similarity=0.541  Sum_probs=217.6

Q ss_pred             ccccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh---hcHHHHHHHHHHHHhCC-CCCCeeEE
Q 015352           42 AGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREVAIMKHLP-KNSSIVSL  117 (408)
Q Consensus        42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~~i~~~  117 (408)
                      .......+.++|++.+.||+|+||.||+|++..+|+.||+|++........   .....+.+|+.+++.+. .||||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            344667789999999999999999999999999999999999987644321   11245667999999984 26999999


Q ss_pred             eeEEEeCCeEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          118 KEACEDDNAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      ++++...+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.  ..+.+||
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL  191 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKL  191 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEE
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEE
Confidence            9999999999999999986 899999998889999999999999999999999999999999999999952  4567999


Q ss_pred             eecccccccCCCCceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      +|||++...... ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||....      .+......+  
T Consensus       192 ~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~--  262 (320)
T 3a99_A          192 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF--  262 (320)
T ss_dssp             CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC--
T ss_pred             eeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc--
Confidence            999999876533 3345679999999998875 3 4688999999999999999999996532      223333222  


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                        ...+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       263 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          263 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             --SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence              246899999999999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.7e-48  Score=354.65  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=208.4

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      |.....||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEE
Confidence            333458999999999999999999999999997543   23357789999999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          133 LCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |++|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++.  .++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCCC
Confidence            999999999998752   4678999999999999999999999999999999999953  25679999999998754322


Q ss_pred             -ceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCcccCCCCCCCCCHHH
Q 015352          210 -RFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGV-AQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       210 -~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                       ......||+.|+|||++.+   .++.++||||||+++|+|++|..||........ ......  ..........+++++
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKVHPEIPESMSAEA  255 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCCCCCCCTTSCHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--ccccccccccCCHHH
Confidence             2345579999999999864   388999999999999999999999976433221 111111  112223335789999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      .+||.+||+.||++|||+.++++||||+...
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.9e-48  Score=361.03  Aligned_cols=262  Identities=22%  Similarity=0.313  Sum_probs=199.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....++|.+.+.||+|+||.||+|.+..++.   .||+|++...... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~   96 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEF-DHPHVAKLVGVSLR   96 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEEC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHC-CCCceehhhceeec
Confidence            3455789999999999999999999887765   8999999755432 33467899999999999 99999999999987


Q ss_pred             CCeE------EEEEeccCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC
Q 015352          124 DNAV------HLVMELCEGGELFDRIVARG------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       124 ~~~~------~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      ....      ++||||++||+|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||+   +.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCC
Confidence            7655      99999999999999986542      59999999999999999999999999999999999999   456


Q ss_pred             CCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 015352          192 SPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAIL  266 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~  266 (408)
                      +.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+.
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            7899999999987544332   223456788999999875 58999999999999999999 999999988888877777


Q ss_pred             cCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCC-------HHHHhcCccccCCcC
Q 015352          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLT-------AKQVLEHPWLQNAKK  316 (408)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s-------~~~~l~h~~~~~~~~  316 (408)
                      .+...   .....+++.+.+||.+||+.||.+|||       +.+++.|||+.....
T Consensus       254 ~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          254 GGNRL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             TTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             cCCCC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            65432   223578999999999999999999999       778889999987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.5e-48  Score=356.50  Aligned_cols=256  Identities=24%  Similarity=0.366  Sum_probs=208.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCe
Confidence            34557999999999999999999999999999999999765544444457889999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-----
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccc
Confidence            99999999999999999988889999999999999999999999999999999999999   456689999999987654


Q ss_pred             CCC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          207 PGE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       207 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ...  ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+ ...........+.+|+.
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTH
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHH
Confidence            332  2335579999999999875 6899999999999999999999999887665444333 33333333445678999


Q ss_pred             HHHHHHHhcCCCcCCCC-CHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRL-TAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~-s~~~~l~  307 (408)
                      +.++|.+||+.||++|| |+.++++
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999999 7888765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-47  Score=347.68  Aligned_cols=248  Identities=24%  Similarity=0.377  Sum_probs=214.7

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|++.+.||+|+||.||+|++. ++..||+|++.....    ..+.+.+|+.+++++ +||||+++++++.+++..|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceE
Confidence            3468999999999999999999987 477799999975432    346789999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCC
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccccc
Confidence            999999999999999764 458999999999999999999999999999999999999   4456799999999986543


Q ss_pred             CC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ..  ......+|+.|+|||++.+ .++.++||||+|+++|+|++ |..||.+....+....+..+....   .....++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  235 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTH  235 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHH
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCHH
Confidence            22  1223456778999999874 69999999999999999999 999999999888888887764322   22467999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +.+++.+||+.||.+|||+.++++|
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          236 VYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999885

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-47  Score=346.39  Aligned_cols=248  Identities=21%  Similarity=0.346  Sum_probs=215.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||.||+|.++ ++..||+|++.....    ..+.+.+|+.+++.+ +||||+++++++.+++..|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceE
Confidence            4578999999999999999999876 567799999975432    346789999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||++|++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecch
Confidence            9999999999999997754 49999999999999999999999999999999999999   5567899999999987654


Q ss_pred             CCce--ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ....  ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+......   ...++.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDT  233 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHH
Confidence            4322  22346678999999876 68999999999999999999 99999998888887777766543322   457899


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +.++|.+||+.||.+|||+.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-47  Score=353.62  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=206.0

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      +....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++..++
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDN  105 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETT
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCC
Confidence            445667899999999999999999999999999999999865555555667899999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          126 AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ..++||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGL  182 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC--
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccc
Confidence            99999999999999998864    4569999999999999999999999999999999999999   4567899999999


Q ss_pred             ccccCCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCcccCCCCC
Q 015352          202 SIFFKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES--EQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       202 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~  277 (408)
                      +....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+..  .......+.....  +....
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  260 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPS  260 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS--CCCCT
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC--CCCcc
Confidence            87654332 2334578999999999875 68999999999999999999999997643  3344455544432  22233


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+++++.+||.+||..||.+|||+.++++
T Consensus       261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          261 DHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            578999999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-47  Score=347.90  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=204.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC-hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      .++|++.+.||+|+||.||+|.+.  |..||+|++....... ....+.+.+|+.+++.+ +||||+++++++.+++..|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceE
Confidence            468999999999999999999974  8899999987643322 23457889999999999 8999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCceEeecCC-----CCCCEEEeecc
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG---VIHRDLKPENFLFANKK-----ENSPLKAIDFG  200 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---ivH~dikp~NIl~~~~~-----~~~~vkl~Dfg  200 (408)
                      +||||++|++|.+++. .+.+++..++.++.|++.||.|||++|   |+||||||+||+++...     ..+.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999988874 557999999999999999999999999   89999999999996432     26779999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ++........ ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+.......+.  ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  238 (271)
T 3dtc_A          162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PST  238 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTT
T ss_pred             cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Ccc
Confidence            9986543332 34579999999999875 5899999999999999999999999998887777777666544332  357


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +++.+.++|.+||+.||.+|||+.|++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            89999999999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.4e-48  Score=366.79  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=211.3

Q ss_pred             cccccceEecceecccCCeEEEEEE-----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....++|.+.+.||+|+||.||+|+     +..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            4456899999999999999999999     55677899999997542  2334567899999999998899999999999


Q ss_pred             EeCC-eEEEEEeccCCCchHHHHHhCCC----------------------------------------------------
Q 015352          122 EDDN-AVHLVMELCEGGELFDRIVARGH----------------------------------------------------  148 (408)
Q Consensus       122 ~~~~-~~~lv~e~~~g~~L~~~l~~~~~----------------------------------------------------  148 (408)
                      .+.+ .+++||||++||+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8755 48999999999999999976543                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC---ce
Q 015352          149 --------------YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RF  211 (408)
Q Consensus       149 --------------~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~---~~  211 (408)
                                    +++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchhc
Confidence                          89999999999999999999999999999999999994   55679999999998654332   22


Q ss_pred             ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          212 SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       212 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.................  .....+++++.++|.
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTML  330 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC--CCCCCCCHHHHHHHH
Confidence            34568899999998875 68999999999999999998 999998866444333333322222  222468999999999


Q ss_pred             HhcCCCcCCCCCHHHHhcC
Q 015352          290 QMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~h  308 (408)
                      +||+.||.+|||+.++++|
T Consensus       331 ~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHH
Confidence            9999999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=359.50  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=209.0

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|+.+++.+ +||||+++++++.+++..++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEE
Confidence            47899999999999999999999999999999998542   344567899999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence            9999999999999987 4679999999999999999999999999999999999999   55677999999999865432


Q ss_pred             Cce---------------ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHHc
Q 015352          209 ERF---------------SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG-----VAQAILR  267 (408)
Q Consensus       209 ~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~  267 (408)
                      ...               ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.......     .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            211               14579999999999876 68999999999999999999999986532210     0111111


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      .      .....+++.+.++|.+||+.||++|||+.++++  |++
T Consensus       242 ~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~  278 (310)
T 3s95_A          242 R------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE  278 (310)
T ss_dssp             H------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred             c------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence            1      112468899999999999999999999999987  544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=363.86  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=220.1

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCC-------CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDT-------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL  117 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~  117 (408)
                      ......++|.+.+.||+|+||.||+|++..+       +..||+|++....  .......+.+|+++++.+.+||||+++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            3455668999999999999999999997543       3579999987542  344457889999999998789999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 015352          118 KEACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE  181 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~  181 (408)
                      ++++.+++..|+||||++||+|.+++....                .+++..++.++.||+.||.|||++||+||||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            999999999999999999999999998754                4899999999999999999999999999999999


Q ss_pred             ceEeecCCCCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCC
Q 015352          182 NFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAE  256 (408)
Q Consensus       182 NIl~~~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~  256 (408)
                      |||+   +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.
T Consensus       221 NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          221 NVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999   456789999999998664332   2234457889999999875 58999999999999999999 99999999


Q ss_pred             CHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ...+....+..+...   .....+++++.+||.+||+.||++|||+.+++++
T Consensus       298 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            888888777766432   2235789999999999999999999999999984

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.6e-48  Score=360.59  Aligned_cols=253  Identities=19%  Similarity=0.212  Sum_probs=210.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.++|++.+.||+|+||.||+|++..+|+.||+|++.....     .+.+.+|+.+++.+.+||||+++++++.+++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            456799999999999999999999999999999999875432     235788999999998899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC--CCCEEEeecccccc
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE--NSPLKAIDFGLSIF  204 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~--~~~vkl~Dfg~~~~  204 (408)
                      |+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.  ...+||+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 99999999874 67999999999999999999999999999999999999954322  12399999999986


Q ss_pred             cCCCCc--------eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHHcCCccc
Q 015352          205 FKPGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---SEQGVAQAILRGLIDF  272 (408)
Q Consensus       205 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~  272 (408)
                      ......        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.   ...+....+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            543321        245689999999999876 5899999999999999999999999874   3344445554433332


Q ss_pred             CCCC-CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          273 KRDP-WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       273 ~~~~-~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +... ....| ++.++|.+||..||.+||++.++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            2221 12344 9999999999999999999998876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.5e-47  Score=347.87  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=213.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..-.++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCC
Confidence            445679999999999999999999886 577899999975432    346789999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      +|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccc
Confidence            9999999999999999977 4679999999999999999999999999999999999999   55678999999999865


Q ss_pred             CCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .....  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+.....   ....+
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  247 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLAS  247 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCC
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCC
Confidence            43221  123356788999999874 69999999999999999998 9999999888888888877643322   24678


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +.+.++|.+||+.||.+|||+.++++|
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=353.53  Aligned_cols=262  Identities=24%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..-.++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.++..+++.+ +||||+++++++.+++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCc
Confidence            33457899999999999999999999999999999999765321 12223344445567776 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +|+||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+||++   +.++.+||+|||++..
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--
T ss_pred             EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchh
Confidence            99999999 5566555543 46799999999999999999999995 99999999999999   4567899999999987


Q ss_pred             cCCCCceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCcccCCCCC
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWA-ESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      ...........||+.|+|||++.      ..++.++|||||||++|+|++|..||.. ....+....+....... .+..
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  253 (318)
T 2dyl_A          175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-LPGH  253 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-CCSS
T ss_pred             ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-CCcc
Confidence            65555555667999999999984      3588999999999999999999999987 44556666666554332 2223


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            46899999999999999999999999999999997643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-47  Score=358.35  Aligned_cols=261  Identities=23%  Similarity=0.268  Sum_probs=219.3

Q ss_pred             ccccccceEecceecccCCeEEEEEE-----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCI-----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      .....++|.+.+.||+|+||.||+|+     +..++..||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  101 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIGV  101 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCCCCeEEEE
Confidence            34566899999999999999999999     56678899999996432  334456788999999999 99999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCC
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSP  193 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~  193 (408)
                      +.+.+..|+||||++|++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++....
T Consensus       102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence            999999999999999999999998753       4899999999999999999999999999999999999976556678


Q ss_pred             EEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcC
Q 015352          194 LKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       194 vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~  268 (408)
                      +||+|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            9999999987543222   2234568899999998864 68999999999999999998 99999998888887777766


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      ...   .....+++.+.++|.+||+.||.+|||+.++++|.|..
T Consensus       262 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 GRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            432   22357899999999999999999999999999998864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.2e-47  Score=348.87  Aligned_cols=255  Identities=22%  Similarity=0.344  Sum_probs=211.0

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhc----HHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD----IDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      +....++|++.+.||+|+||.||+|++..+++.||+|++..........    .+.+.+|+.+++.+ +||||+++++++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~   92 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLM   92 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheee
Confidence            3455689999999999999999999999999999999997654332221    26789999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCC--CCCEEE
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKE--NSPLKA  196 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~--~~~vkl  196 (408)
                      .+..  ++||||++|++|.+++... ..+++..++.++.|++.||.|||++|  |+||||||+||+++.++.  ...+||
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            7766  6999999999999988765 46999999999999999999999999  999999999999964321  224999


Q ss_pred             eecccccccCCCCceecccCCCCCcchhhhh---ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHHHcCCcc
Q 015352          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV--AQAILRGLID  271 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~  271 (408)
                      +|||++....  .......||+.|+|||++.   ..++.++|||||||++|+|++|..||........  ...+..... 
T Consensus       171 ~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-  247 (287)
T 4f0f_A          171 ADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL-  247 (287)
T ss_dssp             CCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-
T ss_pred             CCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-
Confidence            9999997543  2345678999999999984   2578999999999999999999999977554333  333333332 


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                       .......+++.+.++|.+||+.||.+|||+.++++
T Consensus       248 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 -RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             22333578999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-47  Score=354.23  Aligned_cols=260  Identities=26%  Similarity=0.456  Sum_probs=212.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC-CCCeeEEeeEEEeCC
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK-NSSIVSLKEACEDDN  125 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~  125 (408)
                      ....++|.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++++.+ ||||+++++++.+++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            445578999999999999999999985 588999999976543 33456788999999999943 699999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      ..|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++    ++.+||+|||++...
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC-
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccc
Confidence            9999999 55789999999988999999999999999999999999999999999999994    257999999999876


Q ss_pred             CCCCc---eecccCCCCCcchhhhhc------------cCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCC
Q 015352          206 KPGER---FSEIVGSPYYMAPEVLKR------------NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRGL  269 (408)
Q Consensus       206 ~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~  269 (408)
                      .....   .....||+.|+|||++.+            .++.++||||||+++|+|++|..||..... ......+....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  256 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  256 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence            43321   234579999999999864            578899999999999999999999977533 33344444433


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ....  .....++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       257 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          257 HEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             SCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             cccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            2222  2235688999999999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-47  Score=351.68  Aligned_cols=257  Identities=19%  Similarity=0.258  Sum_probs=214.3

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .+..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|+.+++.+.+|||++++++++.++
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            345678899999999999999999999999999999999865432     235778999999998899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC--CCCCEEEeeccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGL  201 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~--~~~~vkl~Dfg~  201 (408)
                      ...++||||+ |++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++  ....+||+|||+
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999999999 999999998754 599999999999999999999999999999999999996532  234599999999


Q ss_pred             ccccCCCC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC---CHHHHHHHHHcCC
Q 015352          202 SIFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE---SEQGVAQAILRGL  269 (408)
Q Consensus       202 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~  269 (408)
                      +.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.   ........+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            98764332        2345679999999999875 5899999999999999999999999874   3344444443332


Q ss_pred             cccC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          270 IDFK-RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       270 ~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...+ ......+|+++.++|.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            2221 1123468999999999999999999999999977

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-47  Score=359.34  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=218.0

Q ss_pred             ccccccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      .....++|.+.+.||+|+||.||+|++.     .+++.||+|++....  .....+.+.+|+.+++.+ +||||++++++
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~  118 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGV  118 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEE
Confidence            3556689999999999999999999987     455889999997543  233457789999999999 99999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHR  176 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~  176 (408)
                      +.+++.+|+||||++|++|.+++...                        ..+++..++.++.||+.||.|||++||+||
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~  198 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  198 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            99999999999999999999999774                        568999999999999999999999999999


Q ss_pred             cCCCCceEeecCCCCCCEEEeecccccccCCC---CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCC
Q 015352          177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPG---ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVP  251 (408)
Q Consensus       177 dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~  251 (408)
                      ||||+||++   +.++.+||+|||++......   .......||+.|+|||++.+ .++.++||||||+++|+|++ |..
T Consensus       199 Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          199 DLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            999999999   45667999999998765322   12234568899999998875 69999999999999999999 999


Q ss_pred             CCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          252 PFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       252 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ||.+....+....+..+....   ....+++.+.+||.+||+.||.+|||+.++++
T Consensus       276 p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          276 PYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            999999888888887765432   22478999999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.3e-48  Score=366.33  Aligned_cols=261  Identities=23%  Similarity=0.412  Sum_probs=209.2

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC----------CCCCeeEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----------KNSSIVSLK  118 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~~i~~~~  118 (408)
                      ..++|.+.+.||+|+||.||+|++..+|+.||+|++...    ......+.+|+.+++++.          .||||++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            356999999999999999999999999999999999743    233567888999999872          179999999


Q ss_pred             eEEEeCC----eEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCC--
Q 015352          119 EACEDDN----AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKK--  189 (408)
Q Consensus       119 ~~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~--  189 (408)
                      +++...+    .+++||||+ |++|.+++...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++  
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            9998654    899999999 88999999874  4599999999999999999999998 999999999999996432  


Q ss_pred             -CCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC------HHHH
Q 015352          190 -ENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES------EQGV  261 (408)
Q Consensus       190 -~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~  261 (408)
                       ....+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..      ....
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence             334799999999986543  2345579999999999876 58999999999999999999999997654      2222


Q ss_pred             HHHHHcCCcccC--------------------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHH
Q 015352          262 AQAILRGLIDFK--------------------------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAK  303 (408)
Q Consensus       262 ~~~i~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~  303 (408)
                      ...+.......+                                      .......++++.+||.+||+.||.+|||+.
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            222222111000                                      001123457889999999999999999999


Q ss_pred             HHhcCccccCCcC
Q 015352          304 QVLEHPWLQNAKK  316 (408)
Q Consensus       304 ~~l~h~~~~~~~~  316 (408)
                      |+|+||||+....
T Consensus       330 ell~hp~f~~~~~  342 (373)
T 1q8y_A          330 GLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHTCGGGTTCTT
T ss_pred             HHhhChhhhcccC
Confidence            9999999998654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.5e-47  Score=353.96  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=217.0

Q ss_pred             cccccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....++|.+.+.||+|+||.||+|.+.     .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~   95 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQV-NHPHVIKLYGAC   95 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCceeeEEEEE
Confidence            445679999999999999999999983     456889999987442  344467889999999999 999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGH------------------------YTERAAAAVTRTIVEVVQLCHKHGVIHRD  177 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~------------------------~~~~~~~~i~~ql~~~l~~lH~~~ivH~d  177 (408)
                      .+++..|+||||++|++|.+++.....                        +++..++.++.||+.||.|||++||+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            999999999999999999999987543                        89999999999999999999999999999


Q ss_pred             CCCCceEeecCCCCCCEEEeecccccccCCCCce---ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCC
Q 015352          178 LKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPP  252 (408)
Q Consensus       178 ikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~p  252 (408)
                      |||+||+++   .++.+||+|||++.........   ....+|+.|+|||++.+ .++.++|||||||++|+|++ |..|
T Consensus       176 ikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          176 LAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999995   4567999999999866443322   23457788999998875 58999999999999999999 9999


Q ss_pred             CCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          253 FWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       253 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      |.+.........+..+...   .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             STTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9998887777777665422   2335789999999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-47  Score=357.57  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=212.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEE--EEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELL--ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ++|.+.+.||+|+||.||+|++..+|..+  |+|.+....  .....+.+.+|+.+++++.+||||+++++++.+.+.+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            68999999999999999999999888865  899886432  23345678899999999978999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          129 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      +||||++|++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+||++   +.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence            9999999999999997754                69999999999999999999999999999999999999   4556


Q ss_pred             CEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCc
Q 015352          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~  270 (408)
                      .+||+|||++.............+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            799999999875433333334467889999999875 58999999999999999998 9999999888887777665532


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                         ......+++.+.+||.+||..||.+|||+.+++++
T Consensus       260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               22234789999999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-47  Score=357.36  Aligned_cols=262  Identities=22%  Similarity=0.320  Sum_probs=193.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHH-HHHhCCCCCCeeEEeeEEEeCC
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA-IMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ..-.++|.+.+.||+|+||.||+|.++.+|+.||+|++....  .......+.+|+. +++.+ +||||+++++++.+++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREG   94 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSS
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCC
Confidence            344579999999999999999999999999999999997543  2233455666776 55555 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          126 AVHLVMELCEGGELFDRIVA-----RGHYTERAAAAVTRTIVEVVQLCHKH-GVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~-~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      ..|+||||++| +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+||+++   .++.+||+||
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Df  170 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDF  170 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCC
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccC
Confidence            99999999986 88777763     56799999999999999999999999 999999999999994   5567999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhh-----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCC-ccc
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK-----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGL-IDF  272 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~-~~~  272 (408)
                      |++.............||+.|+|||++.     ..++.++|||||||++|+|++|..||.+.... +....+..+. ..+
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            9998765544445557999999999983     35899999999999999999999999764321 2222222211 112


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ....+..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            2223346899999999999999999999999999999997643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.7e-47  Score=348.46  Aligned_cols=249  Identities=36%  Similarity=0.669  Sum_probs=202.7

Q ss_pred             cccccccceEec-ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVD-RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....+.++|.+. +.||+|+||.||+|.+..+++.||+|++...        ..+.+|+.++.++.+||||+++++++..
T Consensus        11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            445677788887 7899999999999999999999999998632        4567899998555599999999999987


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          124 ----DNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       124 ----~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                          ...+|+||||++|++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+||+++..+.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence                778999999999999999998764  69999999999999999999999999999999999999765557889999


Q ss_pred             ecccccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc----CCcccC
Q 015352          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILR----GLIDFK  273 (408)
Q Consensus       198 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~----~~~~~~  273 (408)
                      |||++.....                    ..++.++|||||||++|+|++|..||.+.........+..    ....++
T Consensus       163 Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  222 (299)
T 3m2w_A          163 DFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  222 (299)
T ss_dssp             CCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred             cccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence            9998865331                    2467899999999999999999999987654433221111    111222


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCC
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP  321 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~  321 (408)
                      ...+..+++++.+||.+||+.||.+|||+.|+++||||+.....+..+
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~  270 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  270 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence            222256899999999999999999999999999999998876554443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.1e-47  Score=354.67  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=217.9

Q ss_pred             cccccccceEecceecccCCeEEEEEEEC-------CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDR-------DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSL  117 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~  117 (408)
                      ......++|.+.+.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++.+.+||||+++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            34455689999999999999999999986       457789999987542  334467789999999998789999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 015352          118 KEACEDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE  181 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~  181 (408)
                      ++++.+.+.+|+||||++|++|.+++....                .+++..++.++.||+.||.|||++||+||||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999999998654                3899999999999999999999999999999999


Q ss_pred             ceEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCC
Q 015352          182 NFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAE  256 (408)
Q Consensus       182 NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~  256 (408)
                      ||++   +.++.+||+|||++........   .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.
T Consensus       187 NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          187 NVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            9999   5567899999999987654332   223457788999998865 68999999999999999999 99999998


Q ss_pred             CHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          257 SEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ...+....+..+...   .....+++.+.++|.+||..||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          264 PVEELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CHHHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            888887777665432   2235789999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-47  Score=364.37  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=213.7

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|.+.+.||+|+||.||+|.++.+++.||+|++....  .....+.+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcE
Confidence            4578999999999999999999999999999999986432  223345688999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTT
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCC
Confidence            9999999999999997654 59999999999999999999999999999999999999   5567899999999986433


Q ss_pred             CCcee---cccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          208 GERFS---EIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       208 ~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .....   ...+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   +....+|+
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  342 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL---PCPELCPD  342 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            22111   1234667999999874 68999999999999999998 99999998888777777655322   22346899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.+||.+||+.||++|||+.++++
T Consensus       343 ~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999999976

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.4e-48  Score=368.67  Aligned_cols=260  Identities=23%  Similarity=0.391  Sum_probs=214.6

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      +....++|.+.+.||+|+||.||+|++..+|+.||+|++.....  ....+.+.+|+++++++ +||||+++++++...+
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETT   80 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTT
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCC
Confidence            45677899999999999999999999999999999999975443  22357788999999999 8999999999998765


Q ss_pred             --eEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec-CCCCCCEEEeec
Q 015352          126 --AVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN-KKENSPLKAIDF  199 (408)
Q Consensus       126 --~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~-~~~~~~vkl~Df  199 (408)
                        ..|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+.. ++..+.+||+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence              7899999999999999987643   3999999999999999999999999999999999999843 234556999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhh---------ccCCCchhHHHHHHHHHHHhhCCCCCCC----CCHHHHHHHHH
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLK---------RNYGPEIDIWSAGVILYILLCGVPPFWA----ESEQGVAQAIL  266 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~l~~g~~pf~~----~~~~~~~~~i~  266 (408)
                      |++.............||+.|+|||++.         ..++.++|||||||++|+|++|..||..    ....+....+.
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            9998876666666678999999999875         3578899999999999999999999964    23345555555


Q ss_pred             cCCcccC-----------------CC----CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          267 RGLIDFK-----------------RD----PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       267 ~~~~~~~-----------------~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+.....                 .+    ....+++.+.++|.+||+.||++|||+.+++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            5432110                 00    011245678899999999999999999998663

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-48  Score=358.41  Aligned_cols=259  Identities=29%  Similarity=0.515  Sum_probs=205.4

Q ss_pred             ccccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh---hcHHHHHHHHHHHHhCC---CCCCeeEE
Q 015352           44 VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---VDIDDVRREVAIMKHLP---KNSSIVSL  117 (408)
Q Consensus        44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~~i~~~  117 (408)
                      .....+.++|++.+.||+|+||.||+|++..+|+.||+|++........   .....+.+|+.+++++.   +||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            4567788999999999999999999999999999999999976543221   12234567888888874   69999999


Q ss_pred             eeEEEeCCeEEEEEec-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEE
Q 015352          118 KEACEDDNAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~-~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      ++++.+.+..++|+|+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.  .++.+||
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl  181 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKL  181 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEE
Confidence            9999999999999999 789999999998888999999999999999999999999999999999999952  4567999


Q ss_pred             eecccccccCCCCceecccCCCCCcchhhhhc-cC-CCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC
Q 015352          197 IDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NY-GPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR  274 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  274 (408)
                      +|||++...... ......||+.|+|||++.+ .+ +.++||||||+++|+|++|..||....      .+......+  
T Consensus       182 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~--  252 (312)
T 2iwi_A          182 IDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF--  252 (312)
T ss_dssp             CCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC--
T ss_pred             EEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC--
Confidence            999999876543 3455679999999998875 33 458999999999999999999996532      223333222  


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                        ...+++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus       253 --~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          253 --PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             --cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence              246899999999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-47  Score=352.75  Aligned_cols=255  Identities=21%  Similarity=0.312  Sum_probs=214.6

Q ss_pred             cccccceEecceecccCCeEEEEEEE-----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....++|.+.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            44567999999999999999999985     4578899999997543  2334578899999999997899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                      .+++..++||||++||+|.+++...+                  .+++..++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999998754                  389999999999999999999999999999999999


Q ss_pred             EeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCH
Q 015352          184 LFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESE  258 (408)
Q Consensus       184 l~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~  258 (408)
                      +++   .++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+...
T Consensus       177 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          177 LLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEc---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            994   456799999999987654432   223457788999998865 68999999999999999999 9999988765


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          259 QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..............  .....+++.+.++|.+||..||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            54444444333222  2235689999999999999999999999999873

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.6e-47  Score=346.80  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=203.6

Q ss_pred             cccccceEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.+++.+ +||||+++++++. 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-
Confidence            44567999999999999999999998754   4569999886432  334456789999999999 9999999999985 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      ++..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~  163 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLS  163 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE---TTEEEECC----
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC---CCCEEECccccc
Confidence            457899999999999999998754 6999999999999999999999999999999999999954   467999999999


Q ss_pred             cccCCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          203 IFFKPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       203 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ........  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+...   +...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~  240 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPP  240 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred             cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCC
Confidence            87644332  233456788999999874 68999999999999999996 99999988887777777765432   2335


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+++.+.++|.+||..||.+|||+.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            789999999999999999999999999873

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=357.32  Aligned_cols=256  Identities=20%  Similarity=0.294  Sum_probs=212.4

Q ss_pred             cccccceEecceecccCCeEEEEEEE-----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      +...++|.+.+.||+|+||.||+|.+     ..++..||+|++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34557999999999999999999997     3457789999997543  2233568899999999997899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDL  178 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~di  178 (408)
                      ...+..|+||||++||+|.+++....                       .+++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999997653                       2789999999999999999999999999999


Q ss_pred             CCCceEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCC
Q 015352          179 KPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPF  253 (408)
Q Consensus       179 kp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf  253 (408)
                      ||+||+++   .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||
T Consensus       199 kp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          199 AARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             SGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ChhhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999995   456799999999986543322   233457889999998864 69999999999999999998 99999


Q ss_pred             CCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 015352          254 WAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP  309 (408)
Q Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  309 (408)
                      .+.........+........  ....+++.+.+||.+||..||.+|||+.++++|.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            88765555555544433322  2346899999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.1e-47  Score=345.93  Aligned_cols=252  Identities=21%  Similarity=0.341  Sum_probs=218.4

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ......++|++.+.||+|+||.||+|.+..++..||+|++...    ....+.+.+|+.+++.+ +||||+++++++.++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE   81 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC
Confidence            3445678999999999999999999999999999999999643    23467889999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      +.+|+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS  158 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence            9999999999999999999874  349999999999999999999999999999999999999   45567999999999


Q ss_pred             cccCCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          203 IFFKPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       203 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ........  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.......+.....   .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~  235 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPE  235 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred             eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCC
Confidence            87654332  223457888999999874 68999999999999999999 9999998887777666665432   22335


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+++.+.+||.+||..||.+|||+.++++
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            78999999999999999999999999976

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.4e-47  Score=348.77  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=203.7

Q ss_pred             cccccccceEecceecccCCeEEEEEE----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      +.....++|++.+.||+|+||+||+|+    +..+++.||+|++...   .....+.+.+|+.+++.+ +||||++++++
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   79 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGV   79 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence            445567899999999999999999998    5678999999998643   334457889999999999 89999999999


Q ss_pred             EEe--CCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          121 CED--DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       121 ~~~--~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      +..  ...+++||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus        80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~  156 (295)
T 3ugc_A           80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIG  156 (295)
T ss_dssp             ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEEC
T ss_pred             EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEc
Confidence            854  456899999999999999998764 499999999999999999999999999999999999995   45679999


Q ss_pred             ecccccccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-------------
Q 015352          198 DFGLSIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-------------  259 (408)
Q Consensus       198 Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------------  259 (408)
                      |||++........    .....+++.|+|||++.+ .++.++||||||+++|+|++|..||......             
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            9999987643321    223456778999999875 6999999999999999999999998653221             


Q ss_pred             ---HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          260 ---GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       260 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                         .....+....   ..+....+++++.+||.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IVFHLIELLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhccC---cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               1112222211   12233578999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.7e-47  Score=359.18  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=205.5

Q ss_pred             ccccccceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      .....++|.+.+.||+|+||.||+|+++   .++..||+|++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  116 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVT  116 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence            3445568999999999999999999887   467789999986542  334457899999999999 9999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      +.+.+|+||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~  193 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGL  193 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcc
Confidence            9999999999999999999998754 69999999999999999999999999999999999999   5567899999999


Q ss_pred             ccccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCC
Q 015352          202 SIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       202 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (408)
                      +........    .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+...   +
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---~  270 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---P  270 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC---C
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---C
Confidence            987643321    112245678999999875 69999999999999999998 99999999888887777665322   2


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ....++..+.++|.+||+.||.+|||+.++++
T Consensus       271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            23468899999999999999999999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-47  Score=354.91  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=208.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcE----EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTREL----LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      -.++|++.+.||+|+||.||+|++..++..    ||+|.+.....  ......+.+|+.+++.+ +||||+++++++. +
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-B
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-C
Confidence            457899999999999999999999988876    66666643321  12234567899999999 9999999999987 4


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVAD  163 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccc
Confidence            5689999999999999999775 579999999999999999999999999999999999999   456779999999998


Q ss_pred             ccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          204 FFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       204 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+.....   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  240 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQ  240 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CT
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CC
Confidence            764432   2344567889999999874 69999999999999999999 9999998887777777766543222   23


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+++++.++|.+||..||.+|||+.+++++
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          241 ICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            578899999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.6e-47  Score=347.04  Aligned_cols=249  Identities=23%  Similarity=0.386  Sum_probs=213.1

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--  123 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--  123 (408)
                      +..+..+|++.+.||+|+||.||+|.+..+|+.||+|++....       ..+.+|+.+++.+ +||||+++++++..  
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEE
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhC-CCCCEEEEeeeEeccc
Confidence            3456789999999999999999999999999999999997542       3467899999999 99999999999865  


Q ss_pred             --------------CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec
Q 015352          124 --------------DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN  187 (408)
Q Consensus       124 --------------~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~  187 (408)
                                    ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++ 
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-  156 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-  156 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc-
Confidence                          45689999999999999999764  5799999999999999999999999999999999999995 


Q ss_pred             CCCCCCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 015352          188 KKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL  266 (408)
Q Consensus       188 ~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  266 (408)
                        .++.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...  ......+.
T Consensus       157 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~  232 (284)
T 2a19_B          157 --DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR  232 (284)
T ss_dssp             --ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred             --CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence              455799999999988766555556689999999999875 5899999999999999999999987432  23333343


Q ss_pred             cCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          267 RGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ....      ...+++.+.++|.+||..||.+|||+.++++|.|.-.
T Consensus       233 ~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          233 DGII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TTCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            3322      2467899999999999999999999999999987644

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1e-46  Score=346.98  Aligned_cols=255  Identities=19%  Similarity=0.248  Sum_probs=208.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..+.++|++.+.||+|+||.||+|++..+|+.||+|++.....     ...+.+|+.+++.+.+++++..+..++...+.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            3567899999999999999999999999999999999875432     23578999999999545556666666678889


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 8899999974 457999999999999999999999999999999999999964446678999999999876


Q ss_pred             CCCCc--------eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCcccC
Q 015352          206 KPGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES---EQGVAQAILRGLIDFK  273 (408)
Q Consensus       206 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~  273 (408)
                      .....        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..   .......+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            54322        245679999999999876 68999999999999999999999997632   2223333333322222


Q ss_pred             C-CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          274 R-DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       274 ~-~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      . .....+|+.+.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1 112468999999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.6e-47  Score=348.08  Aligned_cols=248  Identities=17%  Similarity=0.263  Sum_probs=206.3

Q ss_pred             cccceEecceecccCCeEEEEEEECCCC-------cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTR-------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ..++|.+.+.||+|+||+||+|++..++       ..||+|++....   ....+.+.+|+.+++.+ +||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~   81 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKL-SHKHLVLNYGVC   81 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTS-CCTTBCCEEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhC-CCCCEeEEEEEE
Confidence            4578999999999999999999998877       469999986542   33457899999999999 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC-----CCEE
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN-----SPLK  195 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~-----~~vk  195 (408)
                      .+++..|+||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++..     ..+|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 9999999999999999999999999999999999999654321     2299


Q ss_pred             EeecccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCC-CCCCCCCHHHHHHHHHcCCccc
Q 015352          196 AIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGV-PPFWAESEQGVAQAILRGLIDF  272 (408)
Q Consensus       196 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~i~~~~~~~  272 (408)
                      |+|||++......   ....||+.|+|||++.+  .++.++|||||||++|+|++|. +||......... .........
T Consensus       162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~~  237 (289)
T 4fvq_A          162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQL  237 (289)
T ss_dssp             ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCC
T ss_pred             eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCCC
Confidence            9999998764332   33468899999999874  5899999999999999999954 555554444433 333332222


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                          ....++++.+||.+||+.||.+|||+.++++|
T Consensus       238 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          238 ----PAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                23568889999999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.7e-47  Score=352.18  Aligned_cols=250  Identities=20%  Similarity=0.277  Sum_probs=204.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEE----EEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELL----ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ..++|++.+.||+|+||+||+|++..+|+.+    |+|.+....  .....+.+.+|+.+++++ +||||+++++++.++
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC
Confidence            4578999999999999999999998887765    666664322  233457899999999999 999999999999876


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      . .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHH
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCccee
Confidence            5 78999999999999999874 5699999999999999999999999999999999999995   45679999999998


Q ss_pred             ccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          204 FFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       204 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+...   ....
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  242 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPP  242 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---CCCc
Confidence            7644332   223456889999998875 69999999999999999999 99999988877776666655422   2234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..+..+.+++.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            688999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-46  Score=350.58  Aligned_cols=254  Identities=21%  Similarity=0.321  Sum_probs=217.9

Q ss_pred             ccccccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      .....++|.+.+.||+|+||.||+|++.     .+++.||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   96 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGV   96 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhc-CCCCEeeeEEE
Confidence            3456689999999999999999999877     457889999987432  233456788999999999 99999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCC
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKE  190 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~  190 (408)
                      +.+.+..|+||||++||+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+||++   +.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cC
Confidence            99999999999999999999998753          357999999999999999999999999999999999999   45


Q ss_pred             CCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 015352          191 NSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAI  265 (408)
Q Consensus       191 ~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i  265 (408)
                      ++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.......+
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence            67899999999876543321   223457889999999875 68999999999999999999 89999998888888877


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..+....   ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          254 MEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7665422   235789999999999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-46  Score=339.65  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=214.1

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+ +||||+++++++.+++..|+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEE
Confidence            468999999999999999999987 577899999975432    346789999999999 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          130 VMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccc
Confidence            99999999999999875 568999999999999999999999999999999999999   45567999999999865432


Q ss_pred             C--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          209 E--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       209 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      .  ......+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+....   .....++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHH
Confidence            1  1123456788999999874 68999999999999999999 999999988888888877664322   224678999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+++.+||+.||.+|||+.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-46  Score=362.86  Aligned_cols=258  Identities=26%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++....      .+.+.+|+.+++.+.+||||+++++++.+++.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            4566788889999999999998754 4579999999986432      35678899999876589999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecC----------C
Q 015352          127 VHLVMELCEGGELFDRIVARGHYT-------ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANK----------K  189 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~-------~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~----------~  189 (408)
                      +|+|||||. |+|.+++...+...       +..++.++.||+.||.|||++||+||||||+|||++.+          +
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence            999999996 59999998764332       23457899999999999999999999999999999753          2


Q ss_pred             CCCCEEEeecccccccCCCCc-----eecccCCCCCcchhhhhc--------cCCCchhHHHHHHHHHHHhh-CCCCCCC
Q 015352          190 ENSPLKAIDFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLC-GVPPFWA  255 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~l~~-g~~pf~~  255 (408)
                      ....+||+|||++........     .....||+.|+|||++.+        .++.++|||||||++|+|++ |..||.+
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            456799999999987654321     234579999999999853        48899999999999999999 9999976


Q ss_pred             CCHHHHHHHHHcCCcccCCCC---CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          256 ESEQGVAQAILRGLIDFKRDP---WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      .....  ..+..+....+...   ...+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            55433  34555544433221   12346889999999999999999999999999999653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.7e-46  Score=345.17  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=206.3

Q ss_pred             cccccccceEecceecccCCeEEEEEE----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      +......+|++.+.||+|+||.||+|+    +..+++.||+|++....  .....+.+.+|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~   91 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGI   91 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCeeeeeeE
Confidence            444456779999999999999999999    56789999999997543  233467899999999999 89999999999


Q ss_pred             EEeC--CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          121 CEDD--NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       121 ~~~~--~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      +.+.  ..+++||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+
T Consensus        92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~  168 (302)
T 4e5w_A           92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKIG  168 (302)
T ss_dssp             EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEEC
T ss_pred             EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC---CCCEEEC
Confidence            9876  679999999999999999954 466999999999999999999999999999999999999954   5579999


Q ss_pred             ecccccccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC--------------CH
Q 015352          198 DFGLSIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE--------------SE  258 (408)
Q Consensus       198 Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~--------------~~  258 (408)
                      |||++........    .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...              ..
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (302)
T 4e5w_A          169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT  248 (302)
T ss_dssp             CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred             cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence            9999987654432    234567888999998875 6889999999999999999999876322              11


Q ss_pred             -HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          259 -QGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       259 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                       ......+..+.   ..+....+++.+.+||.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          249 VTRLVNTLKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhccC---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence             12222222222   22233578999999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.2e-46  Score=342.96  Aligned_cols=249  Identities=21%  Similarity=0.312  Sum_probs=210.8

Q ss_pred             ccceEecc-eecccCCeEEEEEEE--CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           50 EDRYLVDR-ELGRGEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        50 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .++|.+.+ .||+|+||.||+|.+  ..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCC
Confidence            46899988 999999999999954  56788999999975532 223357899999999999 999999999999 5667


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      .|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC---CCcEEEccCCcceeec
Confidence            8999999999999999999888999999999999999999999999999999999999954   4579999999998765


Q ss_pred             CCCce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          207 PGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       207 ~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .....    ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+...   .....+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  245 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGC  245 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence            44322    22346788999999875 68899999999999999999 99999998888877777665432   223578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++.+.++|.+||+.||.+|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999976

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.8e-47  Score=360.21  Aligned_cols=257  Identities=14%  Similarity=0.167  Sum_probs=198.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECCC-----CcEEEEEEeeccccCChh--------cHHHHHHHHHHHHhCCCCCCe
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDT-----RELLACKSISKRKLRTAV--------DIDDVRREVAIMKHLPKNSSI  114 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~~i  114 (408)
                      ...++|++.+.||+|+||.||+|.+..+     ++.||+|++.........        ....+.+|+..++.+ +||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCC
Confidence            3445999999999999999999999765     578999998754311000        011233455556666 79999


Q ss_pred             eEEeeEEEeC----CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC
Q 015352          115 VSLKEACEDD----NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK  189 (408)
Q Consensus       115 ~~~~~~~~~~----~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~  189 (408)
                      +++++++...    .+.|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~  188 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K  188 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence            9999998765    5689999999 99999999876 67999999999999999999999999999999999999963 2


Q ss_pred             CCCCEEEeecccccccCCCC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHH
Q 015352          190 ENSPLKAIDFGLSIFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQG  260 (408)
Q Consensus       190 ~~~~vkl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  260 (408)
                      .++.+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            46789999999997654221        1134459999999999876 59999999999999999999999998643222


Q ss_pred             HHHHHHc-----CCcccCC--CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          261 VAQAILR-----GLIDFKR--DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       261 ~~~~i~~-----~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .......     ....+..  .....+|+++.+++..||..||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1111111     0000000  011467999999999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-46  Score=347.64  Aligned_cols=255  Identities=22%  Similarity=0.315  Sum_probs=210.8

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCC----cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      ..+....+|.+.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  114 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGV  114 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEE
Confidence            34556678999999999999999999987653    459999986432  233456789999999999 99999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      +.+.+..++||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+||
T Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Df  191 (333)
T 1mqb_A          115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDF  191 (333)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC
T ss_pred             EecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCC
Confidence            99999999999999999999999765 569999999999999999999999999999999999999   45678999999


Q ss_pred             ccccccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          200 GLSIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       200 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      |++........    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...  
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--  269 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--  269 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC--
Confidence            99987543221    122346788999999875 68999999999999999999 99999998888888777765321  


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       274 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                       +....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       270 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 -PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             2234789999999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=350.00  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=204.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEE----EEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELL----ACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ..++|++.+.||+|+||.||+|.+..+++.+    |+|.+....  .......+.+|+.+++.+ +||||+++++++..+
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS   89 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC
Confidence            4578999999999999999999999888766    555553222  233567899999999999 999999999999876


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      . .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC--
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCccee
Confidence            5 78999999999999999874 5699999999999999999999999999999999999995   45569999999998


Q ss_pred             ccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          204 FFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       204 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      .......   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   +...
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  242 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPP  242 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCc
Confidence            7543322   223456788999999875 68999999999999999999 99999998887777766665422   2234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+++++.++|.+||..||.+|||+.++++
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68999999999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-47  Score=355.59  Aligned_cols=256  Identities=20%  Similarity=0.288  Sum_probs=207.3

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      -....++|.+.+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFC-RHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTT
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCC
Confidence            3456789999999999999999999964 68999999886542   23467889999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          126 AVHLVMELCEGGELFDRIVARG----HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ..|+||||++||+|.+++....    .+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccc
Confidence            9999999999999999886543    48999999999999999999999999999999999999   5667899999999


Q ss_pred             ccccCCC---CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCc
Q 015352          202 SIFFKPG---ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA-------QAILRGLI  270 (408)
Q Consensus       202 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~  270 (408)
                      +......   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+..       .....+..
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            9764322   12234568999999998864 6999999999999999999999999765432211       11111111


Q ss_pred             cc------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCc
Q 015352          271 DF------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHP  309 (408)
Q Consensus       271 ~~------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  309 (408)
                      ..      .....+..+..+.+++.+||+.||++|||+.+++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            10      0011123456789999999999999999999999853

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-46  Score=349.65  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=211.1

Q ss_pred             cccccceEecceecccCCeEEEEEEE-----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCID-----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ....++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            34567999999999999999999985     3567899999997543  2334567899999999997899999999998


Q ss_pred             EeCC-eEEEEEeccCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceE
Q 015352          122 EDDN-AVHLVMELCEGGELFDRIVARGH----------------YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFL  184 (408)
Q Consensus       122 ~~~~-~~~lv~e~~~g~~L~~~l~~~~~----------------~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl  184 (408)
                      ...+ .+++||||++|++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||+
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7754 59999999999999999987654                899999999999999999999999999999999999


Q ss_pred             eecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHH
Q 015352          185 FANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQ  259 (408)
Q Consensus       185 ~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~  259 (408)
                      ++   .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....
T Consensus       181 ~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          181 LS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EC---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EC---CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            94   556799999999986543322   233467889999998875 68999999999999999998 99999876543


Q ss_pred             -HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          260 -GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       260 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                       .....+..+.. .  .....+++.+.++|.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTR-M--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCcc-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             33344444322 1  2224689999999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-47  Score=365.17  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=199.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      .+|.+.+.||+|+||+|+. ....+|+.||||++.....      ..+.+|+.+++.+.+||||+++++++.+.+..|+|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            4699999999999999764 3446789999999865432      22467999999987899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC--CCCCEEEeecccccccCC
Q 015352          131 MELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~--~~~~vkl~Dfg~~~~~~~  207 (408)
                      ||||.| +|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.++  ....+||+|||++.....
T Consensus        97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            999964 9999997754 356667789999999999999999999999999999996432  334688999999987653


Q ss_pred             CC----ceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          208 GE----RFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       208 ~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ..    ......||+.|+|||++.    ..++.++|||||||++|+|++ |..||........ ..+.............
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  254 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCLHPEK  254 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTSCTTC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCccccCccc
Confidence            32    234567999999999986    357889999999999999999 9999966544333 2222221111111122


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ..+..+++||.+||+.||.+|||+.++++||||...
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            345668999999999999999999999999999764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-46  Score=351.25  Aligned_cols=255  Identities=21%  Similarity=0.307  Sum_probs=213.4

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCc-----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRE-----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      .....++|.+.+.||+|+||.||+|.+..++.     .||+|++....  .....+.+.+|+.+++.+.+||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34456789999999999999999999987664     79999986543  233457789999999999789999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEee
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVAR--------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA  186 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~--------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~  186 (408)
                      +.+.+.+|+||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998753              3579999999999999999999999999999999999995


Q ss_pred             cCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHH
Q 015352          187 NKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGV  261 (408)
Q Consensus       187 ~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~  261 (408)
                         .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+......
T Consensus       199 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          199 ---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             ---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             ---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence               456799999999986543322   223457788999998875 68999999999999999998 9999988765555


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          262 AQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...+........  .....++.+.++|.+||+.||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            444444433222  23467899999999999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.9e-46  Score=338.40  Aligned_cols=247  Identities=15%  Similarity=0.208  Sum_probs=211.6

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC--C
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD--N  125 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~  125 (408)
                      .-.++|.+.+.||+|+||.||+|++.  |..||+|++..... .....+.+.+|+.+++++ +||||+++++++.+.  +
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCC
Confidence            34578999999999999999999985  88899999976533 334456799999999999 999999999999887  7


Q ss_pred             eEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          126 AVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      .+++||||++||+|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+||++   +.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~  159 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADV  159 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGS
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccc
Confidence            8999999999999999998765  4899999999999999999999999  9999999999999   4567799998887


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhcc----CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      +.....    ....||+.|+|||++.+.    ++.++|||||||++|+|++|..||.+.+.......+........  ..
T Consensus       160 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  233 (271)
T 3kmu_A          160 KFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IP  233 (271)
T ss_dssp             CCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CC
T ss_pred             eeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CC
Confidence            755332    234789999999998752    33489999999999999999999999888877776665544332  33


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+++.+.++|.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            578999999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-46  Score=341.20  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=213.2

Q ss_pred             cccceEecc-eecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           49 IEDRYLVDR-ELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        49 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      ..++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++ ..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESS
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCC
Confidence            346787777 9999999999999864  468889999997542  344567899999999999 999999999999 456


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..++||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKA  159 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceee
Confidence            699999999999999998654 4599999999999999999999999999999999999995   456799999999987


Q ss_pred             cCCCCce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          205 FKPGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       205 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      .......    ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+...   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~  236 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP  236 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCC
Confidence            6433321    23356889999999874 68999999999999999998 99999988888877777765432   2235


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      .+++.+.++|.+||..||.+|||+.+++++.+
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            78999999999999999999999999998644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7e-46  Score=360.91  Aligned_cols=244  Identities=23%  Similarity=0.328  Sum_probs=209.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-e
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-A  126 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~  126 (408)
                      .-.++|.+.+.||+|+||.||+|.+.  |+.||||++....     ..+.+.+|+.+++++ +||||+++++++...+ .
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSC
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCc
Confidence            34578999999999999999999885  7799999997532     346789999999999 9999999999987654 7


Q ss_pred             EEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +|+||||++||+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccc
Confidence            9999999999999999987644  7999999999999999999999999999999999999   5567899999999986


Q ss_pred             cCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          205 FKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ....  .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+..+..   .+....+|+
T Consensus       339 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~  413 (450)
T 1k9a_A          339 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPP  413 (450)
T ss_dssp             CC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCH
T ss_pred             cccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCH
Confidence            4332  223467889999999875 69999999999999999998 9999998887777777776532   223357899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+.+||.+||+.||.+|||+.++++
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999976

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-46  Score=344.93  Aligned_cols=255  Identities=19%  Similarity=0.248  Sum_probs=202.7

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ..+.++|++.+.||+|+||.||+|++..+++.||+|++......     ..+.+|+.+++.+.+++++..+..++...+.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            35678999999999999999999999999999999987654322     3477899999999555556666666688899


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            99999999 8899999875 457999999999999999999999999999999999999965456678999999999876


Q ss_pred             CCCCc--------eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCcccC
Q 015352          206 KPGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---GVAQAILRGLIDFK  273 (408)
Q Consensus       206 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~  273 (408)
                      .....        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....   .....+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            44322        235679999999999876 6899999999999999999999999764321   22223322222221


Q ss_pred             C-CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          274 R-DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       274 ~-~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      . .....+|+.+.+||.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            1 112467899999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5e-46  Score=345.21  Aligned_cols=252  Identities=19%  Similarity=0.280  Sum_probs=204.0

Q ss_pred             cccceEecceecccCCeEEEEEEECC---CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      -.++|.+.+.||+|+||.||+|.+..   ++..||+|++..... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC--
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecc
Confidence            45789999999999999999998765   566899999875432 334457789999999999 8999999999998755


Q ss_pred             -----eEEEEEeccCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCE
Q 015352          126 -----AVHLVMELCEGGELFDRIVA------RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       126 -----~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~v  194 (408)
                           ..++||||+++++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcE
Confidence                 45999999999999999853      3569999999999999999999999999999999999999   456789


Q ss_pred             EEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCC
Q 015352          195 KAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGL  269 (408)
Q Consensus       195 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~  269 (408)
                      ||+|||++.......   ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+.........+..+.
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            999999998654332   1223457889999999875 58999999999999999999 999999888887777777664


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          270 IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..   .....+++.+.++|.+||..||.+|||+.+++++
T Consensus       267 ~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 RL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32   2235789999999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.8e-46  Score=341.43  Aligned_cols=254  Identities=23%  Similarity=0.410  Sum_probs=201.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      +++...++|++.+.||+|+||.||+|++..   .+|+|++..... .....+.+.+|+.+++.+ +||||++++++. ..
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TA   91 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CS
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cC
Confidence            456677899999999999999999998643   499999875432 344567899999999999 999999999955 55


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ...++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT  168 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC---
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceecc
Confidence            6789999999999999998654 5699999999999999999999999999999999999995   45679999999987


Q ss_pred             ccCC---CCceecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCcccCC-
Q 015352          204 FFKP---GERFSEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ-GVAQAILRGLIDFKR-  274 (408)
Q Consensus       204 ~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~-  274 (408)
                      ....   ........||+.|+|||++.    ..++.++||||||+++|+|++|..||.+.... .....+..+...... 
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence            6542   22334567999999999985    25788999999999999999999999875444 444455454443322 


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .....+|+.+.+||.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            223578999999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-46  Score=350.40  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=197.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC----e
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN----A  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----~  126 (408)
                      ++|++.+.||+|+||+||+|++.  ++.||+|++....    .......+|+.+++.+ +||||+++++++.+..    .
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCce
Confidence            68999999999999999999875  7899999996432    2234566799999999 8999999999998754    4


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeccCCCCceEeecCCCCCCEEE
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH----------GVIHRDLKPENFLFANKKENSPLKA  196 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~----------~ivH~dikp~NIl~~~~~~~~~vkl  196 (408)
                      +|+||||+++|+|.+++... .+++..++.++.||+.||.|||+.          ||+||||||+|||+   +.++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEE
Confidence            79999999999999999764 599999999999999999999999          99999999999999   55678999


Q ss_pred             eecccccccCCCCc---eecccCCCCCcchhhhhc------cCCCchhHHHHHHHHHHHhhCCCCCCCCC----------
Q 015352          197 IDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR------NYGPEIDIWSAGVILYILLCGVPPFWAES----------  257 (408)
Q Consensus       197 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~----------  257 (408)
                      +|||++........   .....||+.|+|||++.+      .++.++|||||||++|+|++|..||.+..          
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999976643322   234579999999999874      45678999999999999999999996542          


Q ss_pred             ------HHHHHHHHHcCCcccCCCC-C--CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          258 ------EQGVAQAILRGLIDFKRDP-W--PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       258 ------~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                            .......+........... +  ...++.+.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  2222222222222111110 0  112345999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.2e-46  Score=366.43  Aligned_cols=249  Identities=21%  Similarity=0.339  Sum_probs=215.9

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .-.++|.+.+.||+|+||.||+|.++.++..||+|++....    ...+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcE
Confidence            34568999999999999999999999999999999987542    2467899999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |+||||++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceec
Confidence            9999999999999999874  458999999999999999999999999999999999999   45678999999999876


Q ss_pred             CCCCce--ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ......  ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..++...+..+..   ......++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  445 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCP  445 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCC
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            433221  22345678999999874 69999999999999999999 9999999887777776655432   22335789


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+.+||.+||+.||.+|||+.++++
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.1e-46  Score=339.30  Aligned_cols=252  Identities=22%  Similarity=0.287  Sum_probs=209.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECC---CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....++|.+.+.||+|+||.||+|++..   ++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC
Confidence            3455789999999999999999998654   34569999987542  234467889999999999 99999999999876


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      + ..|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.   ++.+||+|||++
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~  160 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS---PECVKLGDFGLS  160 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE---TTEEEECCCCGG
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC---CCcEEeCccCCC
Confidence            5 468999999999999999765 45999999999999999999999999999999999999954   557999999999


Q ss_pred             cccCCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          203 IFFKPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       203 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ........  .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+...   +...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  237 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---PKPD  237 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---CCCT
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---CCCC
Confidence            87643322  233457889999999875 68999999999999999998 99999887777776666655322   2234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+++.+.++|.+||..||.+|||+.+++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            689999999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-45  Score=359.77  Aligned_cols=248  Identities=21%  Similarity=0.342  Sum_probs=212.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|.+.+.||+|+||.||+|.+. ++..||||++....    ...+.+.+|+.+++.+ +||||+++++++. .+.
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSS
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCc
Confidence            445678999999999999999999986 46789999997543    3467899999999999 9999999999987 567


Q ss_pred             EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARV  333 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGG
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceE
Confidence            89999999999999999754  368999999999999999999999999999999999999   5567899999999987


Q ss_pred             cCCCCc--eecccCCCCCcchhhhh-ccCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          205 FKPGER--FSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       205 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ......  .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..+....+..+...   +....+
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~  410 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENC  410 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTS
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence            543211  12234677899999987 469999999999999999999 99999999888888887765322   223578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++++.+||.+||..||++|||+.++++
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-45  Score=335.35  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=212.2

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|++....    ...+.+.+|+.+++.+ +||||+++++++.+ +.
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CC
Confidence            445679999999999999999999976 56789999986543    2357889999999999 99999999999874 45


Q ss_pred             EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .++||||++|++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARL  158 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCccccc
Confidence            899999999999999986543  69999999999999999999999999999999999999   4567899999999987


Q ss_pred             cCCCCce--ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          205 FKPGERF--SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       205 ~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .......  ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+...   .....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNC  235 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTC
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCcccc
Confidence            6543321  23456788999999874 68999999999999999999 99999998888887777665322   223578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++.+.++|.+||..||++|||+.++++
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=356.41  Aligned_cols=257  Identities=17%  Similarity=0.205  Sum_probs=200.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECC---CCcEEEEEEeeccccCCh--------hcHHHHHHHHHHHHhCCCCCCeeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTA--------VDIDDVRREVAIMKHLPKNSSIVS  116 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~i~~  116 (408)
                      ...++|.+.+.||+|+||.||+|.+..   ++..+|+|++........        .....+.+|+.+++.+ +||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcce
Confidence            345789999999999999999999987   788999999976532110        1123466788999998 9999999


Q ss_pred             EeeEEEe----CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          117 LKEACED----DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       117 ~~~~~~~----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      +++++.+    ....|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CC
Confidence            9999988    78999999999 999999998777899999999999999999999999999999999999996532 24


Q ss_pred             CEEEeecccccccCCCC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC--CHHHH
Q 015352          193 PLKAIDFGLSIFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE--SEQGV  261 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~  261 (408)
                      .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.  .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            89999999997653221        1244579999999999886 5899999999999999999999999653  22222


Q ss_pred             HHHHHcCCcccCC-----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          262 AQAILRGLIDFKR-----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       262 ~~~i~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...........+.     .....+++++.++|.+||..||++|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1111111111110     011268999999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-46  Score=342.17  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=205.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECC-CCc--EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRD-TRE--LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....++|++.+.||+|+||+||+|.+.. ++.  .||+|++...........+.+.+|+.+++.+ +||||+++++++.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   92 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT   92 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcc
Confidence            3345799999999999999999998653 333  6899998765544445567899999999999 89999999999987


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      +. .++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~  168 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLM  168 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccc
Confidence            65 88999999999999998764 5699999999999999999999999999999999999995   4557999999999


Q ss_pred             cccCCCCce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCC
Q 015352          203 IFFKPGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDP  276 (408)
Q Consensus       203 ~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (408)
                      .........    ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+....+......++  .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~  246 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--R  246 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--C
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--C
Confidence            876543321    23457788999999875 58899999999999999999 9999999988888888776654433  2


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ...+++.+.++|.+||..||.+|||+.++++
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            3578999999999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-47  Score=381.08  Aligned_cols=262  Identities=27%  Similarity=0.391  Sum_probs=212.5

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----  123 (408)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....  .....+.+.+|+.+++.+ +||||+++++++..     
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCceeeeeccccccc
Confidence            4489999999999999999999999999999999986532  344467789999999999 99999999998765     


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          124 -DNAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                       ++..|+||||++||+|.+++...+   .+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             778899999999999999998754   5899999999999999999999999999999999999986555566999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH--------------
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA--------------  264 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~--------------  264 (408)
                      |++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........              
T Consensus       169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            99988776666667789999999999875 699999999999999999999999976543221100              


Q ss_pred             HHcCCcccCC------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          265 ILRGLIDFKR------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       265 i~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      ...+...+..      .....+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            0111111111      112235788999999999999999999999999999965

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.1e-46  Score=345.99  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=207.0

Q ss_pred             ccceEecceecccCCeEEEEEE----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE--e
Q 015352           50 EDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE--D  123 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~  123 (408)
                      .++|++.+.||+|+||.||+|+    +..+++.||+|++...   .....+.+.+|+.+++.+ +||||+++++++.  +
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Confidence            3689999999999999999999    4678999999998754   234456789999999999 9999999999886  5


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      .+.+|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence            6779999999999999999977 35699999999999999999999999999999999999995   4567999999999


Q ss_pred             cccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH---------------HHH
Q 015352          203 IFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---------------GVA  262 (408)
Q Consensus       203 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------------~~~  262 (408)
                      ........    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......               ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87654332    123457888999999875 5899999999999999999999998654322               122


Q ss_pred             HHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..+..+.   .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus       255 ~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          255 ELLEEGQ---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhccc---CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2222222   122335789999999999999999999999999764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=345.95  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=203.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE----eCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE----DDN  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----~~~  125 (408)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.+ +||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCc
Confidence            46899999999999999999999999999999998653   334567889999999999 9999999999987    345


Q ss_pred             eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          126 AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                      ..|+||||+++++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCc
Confidence            78999999999999999876    4679999999999999999999999999999999999999   4567799999998


Q ss_pred             ccccCCCC----------ceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHHH
Q 015352          202 SIFFKPGE----------RFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESE--QGVAQAI  265 (408)
Q Consensus       202 ~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i  265 (408)
                      +.......          ......||+.|+|||++.+    .++.++||||||+++|+|++|..||.....  ......+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            87543111          1123457999999999863    378999999999999999999999953111  1112222


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      . ....  .+....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       261 ~-~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          261 Q-NQLS--IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             H-CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             h-ccCC--CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            2 2222  22335789999999999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-45  Score=359.31  Aligned_cols=254  Identities=19%  Similarity=0.254  Sum_probs=211.2

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++......     ..+.+|+.+++.|.+++++..+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4678999999999999999999999999999999998754322     34778999999996678888888888899999


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8899999975 4679999999999999999999999999999999999999654567789999999998765


Q ss_pred             CCCc--------eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCcccCC
Q 015352          207 PGER--------FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDFKR  274 (408)
Q Consensus       207 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~  274 (408)
                      ....        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...   ......+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4322        225679999999999876 699999999999999999999999987432   3333333332221111


Q ss_pred             -CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          275 -DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       275 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                       .....+++++.+||.+||..||++||++.++++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             112467899999999999999999999998875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-45  Score=338.74  Aligned_cols=249  Identities=21%  Similarity=0.323  Sum_probs=206.9

Q ss_pred             ccceEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE-EeCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC-EDDN  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~~~  125 (408)
                      ..+|.+.+.||+|+||.||+|.+..+   +..+|+|.+...  ......+.+.+|+.+++++ +||||+++++++ ..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCC
Confidence            35799999999999999999997644   345889988643  2344567889999999999 899999999985 5667


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence            889999999999999999764 458999999999999999999999999999999999999   5667899999999976


Q ss_pred             cCCCC-----ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          205 FKPGE-----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       205 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      .....     ......||+.|+|||.+.+ .++.++||||||+++|+|++ |.+||.+....+....+..+.....   .
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---C
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---C
Confidence            54322     2234467889999999875 68999999999999999999 6777877777777777766654332   2


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+++.+.++|.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            467899999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-45  Score=336.04  Aligned_cols=243  Identities=22%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-CCeE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DNAV  127 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~  127 (408)
                      -.++|++.+.||+|+||.||+|.+.  |+.||+|++....     ..+.+.+|+.+++.+ +||||+++++++.. .+.+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCce
Confidence            3578999999999999999999874  8899999986432     357789999999999 89999999998754 4579


Q ss_pred             EEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |+||||++|++|.+++...+.  +++..++.++.|++.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccc
Confidence            999999999999999976543  8999999999999999999999999999999999999   45678999999998765


Q ss_pred             CCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ...  .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+..   ......+++.
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  242 (278)
T 1byg_A          168 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPA  242 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHH
T ss_pred             ccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHH
Confidence            432  223467889999999875 68999999999999999998 9999998887777776655432   2233578999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.++|.+||..||.+|||+.++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          243 VYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCChhhCCCHHHHHH
Confidence            999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=347.42  Aligned_cols=250  Identities=28%  Similarity=0.410  Sum_probs=189.3

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-----
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-----  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----  122 (408)
                      ....+|++.+.||+|+||.||+|++..+|+.||+|++...   .......+.+|+.+++++.+||||+++++++.     
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            3456899999999999999999999999999999998544   23445678899999999956999999999984     


Q ss_pred             ---eCCeEEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCE
Q 015352          123 ---DDNAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPL  194 (408)
Q Consensus       123 ---~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~v  194 (408)
                         ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||+   +.++.+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~  177 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTI  177 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCE
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCE
Confidence               4456899999996 589888865   467999999999999999999999999  9999999999999   456689


Q ss_pred             EEeecccccccCCCCce-------------ecccCCCCCcchhhhh----ccCCCchhHHHHHHHHHHHhhCCCCCCCCC
Q 015352          195 KAIDFGLSIFFKPGERF-------------SEIVGSPYYMAPEVLK----RNYGPEIDIWSAGVILYILLCGVPPFWAES  257 (408)
Q Consensus       195 kl~Dfg~~~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~  257 (408)
                      ||+|||++.........             ....||+.|+|||++.    ..++.++|||||||++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            99999999876433221             1456899999999983    258889999999999999999999997655


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcc
Q 015352          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW  310 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  310 (408)
                      .....    .....  .......++.+.+||.+||+.||.+|||+.++++|.+
T Consensus       258 ~~~~~----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          258 KLRIV----NGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhh----cCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            43322    22222  2223567889999999999999999999999999744

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.6e-46  Score=341.26  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=197.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHh--CCCCCCeeEEeeEEEe-
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH--LPKNSSIVSLKEACED-  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~i~~~~~~~~~-  123 (408)
                      ..+.++|++.+.||+|+||+||+|++  +|+.||+|++...      ....+.+|.+++..  + +||||+++++++.. 
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence            55778999999999999999999987  6889999998643      24566678888777  5 89999999998654 


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCceEeecCCCCC
Q 015352          124 ---DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH--------KHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       124 ---~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                         ...+|+||||+++|+|.+++. ...+++..+..++.||+.||.|||        ++||+||||||+|||+   +.++
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~  150 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNG  150 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTS
T ss_pred             cCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCC
Confidence               356899999999999999984 457999999999999999999999        9999999999999999   4567


Q ss_pred             CEEEeecccccccCCCCce-----ecccCCCCCcchhhhhcc-------CCCchhHHHHHHHHHHHhhC----------C
Q 015352          193 PLKAIDFGLSIFFKPGERF-----SEIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCG----------V  250 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~~l~~g----------~  250 (408)
                      .+||+|||++.........     ....||+.|+|||++.+.       ++.++|||||||++|+|++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            8999999999765443322     234799999999998753       44689999999999999999          8


Q ss_pred             CCCCCCC----HHHHHHHHHcCCcccCCCC----CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          251 PPFWAES----EQGVAQAILRGLIDFKRDP----WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       251 ~pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .||....    ...............+..+    ....++.+.+||.+||+.||.+|||+.++++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            8886532    1222222222211111110    0124577999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.8e-46  Score=345.92  Aligned_cols=260  Identities=20%  Similarity=0.247  Sum_probs=206.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ......++|.+.+.||+|+||.||+|.+. +|+.||+|++........  ...+.+|+.+++.+ +||||+++++++.+.
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMA-VHRNLLRLRGFCMTP   99 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTC-CCTTBCCCCEEECCS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhc-cCCCccceEEEEecC
Confidence            34556789999999999999999999854 688999999976543222  23688999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCceEeecCCCCCCEEEe
Q 015352          125 NAVHLVMELCEGGELFDRIVARG----HYTERAAAAVTRTIVEVVQLCHKH---GVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~ql~~~l~~lH~~---~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      +..++||||++||+|.+++....    .+++..+..++.|++.||.|||++   ||+||||||+|||+   +.++.+||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~  176 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVG  176 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEEC
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEec
Confidence            99999999999999999997653    399999999999999999999999   99999999999999   556789999


Q ss_pred             ecccccccCCC--CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHHcCCc
Q 015352          198 DFGLSIFFKPG--ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE----SEQGVAQAILRGLI  270 (408)
Q Consensus       198 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~  270 (408)
                      |||++......  .......||+.|+|||++.+ .++.++|||||||++|+|++|..||...    ..............
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99999876432  23344569999999999864 6899999999999999999999999521    11111111111111


Q ss_pred             ccC-----------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          271 DFK-----------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       271 ~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      ...           .......++.+.+++.+||+.||.+|||+.++++|-+-
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            100           00111234679999999999999999999999997653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-45  Score=342.94  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=205.2

Q ss_pred             cccccce-EecceecccCCeEEEEEEE----CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           47 ENIEDRY-LVDRELGRGEFGVTYLCID----RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        47 ~~~~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ..+.++| ++.+.||+|+||+||+|..    ..+|+.||+|++....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  102 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTL-YHEHIIKYKGCC  102 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCcchhhEEEEE
Confidence            3466677 9999999999999988754    4578999999997542  334467789999999999 899999999999


Q ss_pred             Ee--CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          122 ED--DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       122 ~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                      .+  ...+++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+||
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Df  178 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDF  178 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCG
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCc
Confidence            87  46899999999999999998665 59999999999999999999999999999999999999   55678999999


Q ss_pred             ccccccCCCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH---------------
Q 015352          200 GLSIFFKPGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ---------------  259 (408)
Q Consensus       200 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------------  259 (408)
                      |++........    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......               
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL  258 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence            99987654432    233467888999999875 6889999999999999999999998654221               


Q ss_pred             HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .....+..+.   ..+....+++.+.+||.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          259 RLTELLERGE---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccc---CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1112222221   12233578999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-45  Score=335.77  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=206.1

Q ss_pred             ceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE-
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV-  127 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~-  127 (408)
                      .|.+.+.||+|+||+||+|.+..++.   .+|+|++...  ......+.+.+|+.+++.+ +||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCc
Confidence            67788999999999999999765544   7999998643  2344567889999999999 999999999999876655 


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccccc
Confidence            9999999999999999773 568999999999999999999999999999999999999   556789999999997543


Q ss_pred             CC-----CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          207 PG-----ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       207 ~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      ..     .......+++.|+|||.+.+ .++.++||||||+++|+|++ |.+||...+.......+..+...   .....
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  252 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---PQPEY  252 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC---CCCTT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC---CCCcc
Confidence            22     22234567889999999876 68999999999999999999 55556666666666666655422   22346


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +++.+.++|.+||+.||.+|||+.++++
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=350.84  Aligned_cols=245  Identities=14%  Similarity=0.191  Sum_probs=200.7

Q ss_pred             ccceEecceecccCCeEEEEEEECCC--------CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeE-----
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDT--------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVS-----  116 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~-----  116 (408)
                      .++|.+.+.||+|+||.||+|++..+        ++.||+|++...        ..+.+|+.+++++ +||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRA-AKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHh-cccchhhhhhhh
Confidence            57999999999999999999999874        889999998753        3577899999999 8988877     


Q ss_pred             ----------EeeEEEe-CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCce
Q 015352          117 ----------LKEACED-DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENF  183 (408)
Q Consensus       117 ----------~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NI  183 (408)
                                +++++.. ++.+|+||||+ |++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777766 78899999999 99999999886  7799999999999999999999999999999999999


Q ss_pred             EeecCCCCC--CEEEeecccccccCCCC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCC
Q 015352          184 LFANKKENS--PLKAIDFGLSIFFKPGE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPP  252 (408)
Q Consensus       184 l~~~~~~~~--~vkl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~p  252 (408)
                      |++.   ++  .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus       191 l~~~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVDP---EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEET---TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEcC---CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9953   33  79999999997654221        1234579999999999876 689999999999999999999999


Q ss_pred             CCCCC--HHHHHHHH---HcCCcccC--CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          253 FWAES--EQGVAQAI---LRGLIDFK--RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       253 f~~~~--~~~~~~~i---~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      |.+..  ........   ......+.  ...+..+++.+.+||.+||..||.+|||+.++++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            98753  22222222   22211111  1223467999999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.4e-45  Score=354.82  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=207.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|++.+.||+|+||.||+|.+.. +..||+|++....    ...+.+.+|+.+++++ +||||+++++++.+ +.
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-Cc
Confidence            3455789999999999999999999875 4669999987543    2356789999999999 99999999999876 67


Q ss_pred             EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCcccee
Confidence            89999999999999999643  569999999999999999999999999999999999999   4566799999999987


Q ss_pred             cCCCC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          205 FKPGE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       205 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .....  ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   +....+
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~  406 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPEC  406 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTS
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence            54322  1223456788999998874 69999999999999999999 99999999888888887765422   223578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      |+.+.+||.+||+.||++|||+.++++
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=349.86  Aligned_cols=249  Identities=21%  Similarity=0.315  Sum_probs=199.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCC---cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-eCCe
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-DDNA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~~~~  126 (408)
                      ..|.+.+.||+|+||.||+|.+..++   ..||+|.+...  ......+.+.+|+.+++++ +||||+++++++. .++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence            35888999999999999999876432   45899988642  2334567899999999999 9999999999864 5568


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence            89999999999999999765 458999999999999999999999999999999999999   55678999999999865


Q ss_pred             CCCC-----ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          206 KPGE-----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       206 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ....     ......+|+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+.+..+....+..+....   ...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~---~p~  319 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPE  319 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC---CCT
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence            3322     1233457788999999875 69999999999999999999 788888777666666666654322   224


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+++.+.+++.+||+.||.+|||+.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            689999999999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-45  Score=341.05  Aligned_cols=250  Identities=25%  Similarity=0.343  Sum_probs=203.2

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeecccc-CChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEE
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-RTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVM  131 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  131 (408)
                      |...+.||+|+||.||+|.+  ++..||+|++..... ......+.+.+|+.+++.+ +||||+++++++.+.+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEE
Confidence            44568999999999999986  588999999875432 2233457889999999999 9999999999999999999999


Q ss_pred             eccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          132 ELCEGGELFDRIVA---RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       132 e~~~g~~L~~~l~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      ||++|++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence            99999999999874   3459999999999999999999999999999999999999   55678999999998865432


Q ss_pred             Cc---eecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCccc-------CC
Q 015352          209 ER---FSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQG----VAQAILRGLIDF-------KR  274 (408)
Q Consensus       209 ~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~-------~~  274 (408)
                      ..   .....||+.|+|||++.+.++.++||||||+++|+|++|..||.......    ....+......+       ..
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            21   23457999999999998889999999999999999999999997654322    222222211110       01


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ......++.+.+++.+||+.||.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1112345678999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.5e-45  Score=366.28  Aligned_cols=242  Identities=22%  Similarity=0.319  Sum_probs=205.5

Q ss_pred             ceecccCCeEEEEEEE--CCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           57 RELGRGEFGVTYLCID--RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      +.||+|+||.||+|.+  +.+++.||||++.... ......+.+.+|+.+++++ +||||+++++++..+ .+++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CEEEEEEcc
Confidence            4799999999999955  4567899999997543 2334467899999999999 899999999999754 588999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc----
Q 015352          135 EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----  210 (408)
Q Consensus       135 ~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~----  210 (408)
                      +||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........    
T Consensus       452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-------
T ss_pred             CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCcccccc
Confidence            9999999999888899999999999999999999999999999999999995   455799999999987644322    


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..++...+..+...   .....+++++.+||
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li  605 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM  605 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence            223356788999999875 69999999999999999998 99999999988888888776532   22347899999999


Q ss_pred             HHhcCCCcCCCCCHHHHhc
Q 015352          289 RQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+||+.||++|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999976

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=347.59  Aligned_cols=246  Identities=21%  Similarity=0.252  Sum_probs=198.5

Q ss_pred             ccccceEecceecccCCeEEEEE-----EECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC---CCCeeEEee
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK---NSSIVSLKE  119 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---h~~i~~~~~  119 (408)
                      ...++|.+.+.||+|+||+||+|     .+..+++.||+|++...      ....+.+|+.+++.+ +   |+||+++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l-~~~~~~~iv~~~~  134 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERL-KPSMQHMFMKFYS  134 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHS-CGGGGGGBCCEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHh-hhhhhhhhhhhhe
Confidence            34578999999999999999999     46778999999998643      245778899999988 5   899999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeec-------
Q 015352          120 ACEDDNAVHLVMELCEGGELFDRIVA-----RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFAN-------  187 (408)
Q Consensus       120 ~~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~-------  187 (408)
                      ++...+..|+||||++||+|.+++..     .+.+++..++.++.||+.||.|||++||+||||||+|||++.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     456999999999999999999999999999999999999964       


Q ss_pred             -CCCCCCEEEeecccccccC---CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHH
Q 015352          188 -KKENSPLKAIDFGLSIFFK---PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVA  262 (408)
Q Consensus       188 -~~~~~~vkl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  262 (408)
                       ++..+.+||+|||+|....   ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence             2226789999999996543   3344566789999999999876 58999999999999999999999996543210  


Q ss_pred             HHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                         ......+..   ...++.+.+++..||+.+|.+|++..+.+.+
T Consensus       293 ---~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 ---CKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ---EEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ---eeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence               000001111   1346789999999999999999765555443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=334.93  Aligned_cols=242  Identities=29%  Similarity=0.418  Sum_probs=195.4

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++...     ...+.+.+|+.+++++ +||||+++++++.+  ..|+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEE
Confidence            368999999999999999999875  788999998532     2357789999999999 99999999998874  4789


Q ss_pred             EEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHH---CCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          130 VMELCEGGELFDRIVARGH---YTERAAAAVTRTIVEVVQLCHK---HGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~ql~~~l~~lH~---~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      ||||++|++|.+++...+.   +++..+..++.|++.||.|||+   +||+||||||+||+++.+  ...+||+|||++.
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~~kl~Dfg~~~  154 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTAC  154 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETT--TTEEEECCCCC--
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCC--CCEEEEccccccc
Confidence            9999999999999987653   7899999999999999999999   899999999999999532  2237999999987


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCcccCCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAES--EQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .....  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....  .......+..+..   ......+
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  229 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNL  229 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTC
T ss_pred             ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCccccc
Confidence            65322  234569999999999876 68999999999999999999999997543  2233333333322   2233578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=337.44  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=205.3

Q ss_pred             cccccccceEecceecccCCeEEEEEE----ECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCI----DRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      +.....++|++.+.||+|+||.||+|+    +..+|+.||+|++...   .....+.+.+|+.+++.+ +||||++++++
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  110 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGV  110 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Confidence            445566789999999999999999998    4568999999998753   234467889999999999 89999999999


Q ss_pred             EEeCC--eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          121 CEDDN--AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       121 ~~~~~--~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      +...+  .+++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+
T Consensus       111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~  187 (326)
T 2w1i_A          111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIG  187 (326)
T ss_dssp             ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEEC
T ss_pred             EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEe
Confidence            87654  789999999999999999876 4599999999999999999999999999999999999995   45679999


Q ss_pred             ecccccccCCCCce----ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH-------------
Q 015352          198 DFGLSIFFKPGERF----SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ-------------  259 (408)
Q Consensus       198 Dfg~~~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------------  259 (408)
                      |||++.........    ....+++.|+|||++.+ .++.++||||||+++|+|++|..||......             
T Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  267 (326)
T ss_dssp             CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred             cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence            99999876544321    22356778999999875 5899999999999999999999998543110             


Q ss_pred             ---HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          260 ---GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       260 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                         .....+..+. .  .+....+++++.++|.+||..||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 IVFHLIELLKNNG-R--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHTTC-C--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHhhcCC-C--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               1111222211 1  1223578999999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=361.38  Aligned_cols=247  Identities=25%  Similarity=0.341  Sum_probs=205.5

Q ss_pred             cceEecc-eecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDR-ELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      +++.+.+ .||+|+||.||+|.++  .++..||||++....  .....+.+.+|+.+++.+ +||||+++++++.. +.+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCe
Confidence            4455555 7999999999999876  356679999997542  233567899999999999 99999999999986 569


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCccccc
Confidence            9999999999999998754 4599999999999999999999999999999999999995   45679999999998764


Q ss_pred             CCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          207 PGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       207 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ....    .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..++...+..+...   .....+
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~  564 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPEC  564 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTTC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence            3321    122345688999999874 69999999999999999998 99999998888888888776432   223468


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++++.+||.+||..||.+|||+.++++
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999854

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=357.39  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=211.8

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ....++|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.+|+++ +||||+++++++.+ +.
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-cc
Confidence            3456789999999999999999999875 4669999997543    2356789999999999 99999999999876 67


Q ss_pred             EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      +|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL  412 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTT
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEccccccee
Confidence            89999999999999999643  569999999999999999999999999999999999999   4566799999999986


Q ss_pred             cCCCC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          205 FKPGE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       205 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .....  ......++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+..+...   +....+
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~  489 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPEC  489 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTC
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence            54321  1122346788999998874 69999999999999999999 99999999888888887765321   223578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++.+.+||.+||+.||++|||+.++++
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=338.83  Aligned_cols=251  Identities=18%  Similarity=0.313  Sum_probs=209.4

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .....++|++.+.||+|+||.||+|.+..   .+|+|++...... ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQT-RHENVVLFMGACMSPP  102 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSS
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCC
Confidence            34456789999999999999999999864   3999998765332 22335567899999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++    ++.+||+|||++..
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSI  178 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC-
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccc
Confidence            9999999999999999997754 699999999999999999999999999999999999994    45799999999765


Q ss_pred             cCC------CCceecccCCCCCcchhhhhc----------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Q 015352          205 FKP------GERFSEIVGSPYYMAPEVLKR----------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRG  268 (408)
Q Consensus       205 ~~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~  268 (408)
                      ...      ........||+.|+|||++.+          .++.++||||||+++|+|++|..||...........+..+
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  258 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG  258 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence            421      122334568999999999853          3788999999999999999999999998888877777666


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          269 LIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .....  ....+++++.++|.+||..||.+|||+.++++
T Consensus       259 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          259 MKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            43322  22368899999999999999999999999988

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-44  Score=339.85  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=204.7

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhC-CCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL-PKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~  123 (408)
                      .+..+.++|.+.+.||+|+||.||+|.+  +|+.||+|++...      ....+.+|+++++.+ .+||||+++++++..
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            4466778999999999999999999988  4899999998643      246678899999883 289999999999988


Q ss_pred             CC----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCceEeecCCCC
Q 015352          124 DN----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH--------KHGVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       124 ~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~ivH~dikp~NIl~~~~~~~  191 (408)
                      ..    .+|+||||+++|+|.+++.+. .+++..++.++.||+.||.|||        ++||+||||||+|||+   +.+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~  183 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKN  183 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTT
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCC
Confidence            76    899999999999999999764 6999999999999999999999        8999999999999999   456


Q ss_pred             CCEEEeecccccccCCCCc-----eecccCCCCCcchhhhhcc-------CCCchhHHHHHHHHHHHhhC----------
Q 015352          192 SPLKAIDFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCG----------  249 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~~l~~g----------  249 (408)
                      +.+||+|||++........     .....||+.|+|||++.+.       ++.++|||||||++|+|++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            6899999999987654432     2445799999999998753       23689999999999999999          


Q ss_pred             CCCCCCC-----CHHHHHHHHHcCCcccCCCC---CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          250 VPPFWAE-----SEQGVAQAILRGLIDFKRDP---WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       250 ~~pf~~~-----~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..||...     ........+.........+.   ....++.+.+||.+||+.||.+|||+.++++|
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            7898764     22344444433322211110   01234678999999999999999999999884

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-44  Score=335.25  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=197.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhC-CCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL-PKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~  123 (408)
                      ....+.++|++.+.||+|+||.||+|++.  |+.||+|++....      .....+|.+++..+ .+||||+++++++..
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            45677889999999999999999999885  8899999986432      34445566666543 289999999999988


Q ss_pred             C----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCceEeecCCCC
Q 015352          124 D----NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH--------GVIHRDLKPENFLFANKKEN  191 (408)
Q Consensus       124 ~----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~ivH~dikp~NIl~~~~~~~  191 (408)
                      .    ..+|+||||++||+|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||+   +.+
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~  178 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKN  178 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCC
Confidence            7    7899999999999999999664 699999999999999999999999        99999999999999   456


Q ss_pred             CCEEEeecccccccCCCCc-----eecccCCCCCcchhhhhcc-CCCc------hhHHHHHHHHHHHhhC----------
Q 015352          192 SPLKAIDFGLSIFFKPGER-----FSEIVGSPYYMAPEVLKRN-YGPE------IDIWSAGVILYILLCG----------  249 (408)
Q Consensus       192 ~~vkl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~------~DiwslG~il~~l~~g----------  249 (408)
                      +.+||+|||++........     .....||+.|+|||++.+. ++..      +|||||||++|+|++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            7899999999976543322     1245799999999998753 4443      8999999999999999          


Q ss_pred             CCCCCCCC-----HHHHHHHHHcCCcccCCCC---CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          250 VPPFWAES-----EQGVAQAILRGLIDFKRDP---WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       250 ~~pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ..||....     .......+.........+.   ...+++.+.+||.+||+.||.+|||+.++++|
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            77775431     1222222222211111110   11456779999999999999999999999885

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.6e-47  Score=355.77  Aligned_cols=252  Identities=17%  Similarity=0.227  Sum_probs=198.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-----ChhcHHHHHHHHHHHHhCC--------CCCCee
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----TAVDIDDVRREVAIMKHLP--------KNSSIV  115 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~~i~  115 (408)
                      ..++|++.+.||+|+||+||+|++  +|+.||+|++......     .....+.+.+|+.+++.+.        .||||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999998  6899999999876432     2334578899999999884        377777


Q ss_pred             EEeeEEE------------------------------eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 015352          116 SLKEACE------------------------------DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV  165 (408)
Q Consensus       116 ~~~~~~~------------------------------~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l  165 (408)
                      ++.+++.                              +.+.+|+|||||++|++.+.+.+ +.+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            7776642                              27899999999999987777644 5689999999999999999


Q ss_pred             HHHH-HCCCeeccCCCCceEeecCCC-----------------CCCEEEeecccccccCCCCceecccCCCCCcchhhhh
Q 015352          166 QLCH-KHGVIHRDLKPENFLFANKKE-----------------NSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK  227 (408)
Q Consensus       166 ~~lH-~~~ivH~dikp~NIl~~~~~~-----------------~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  227 (408)
                      .||| ++||+||||||+|||++.++.                 ...+||+|||+|+.....    ..+||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 999999999999999976431                 227999999999876543    347999999999998


Q ss_pred             ccCCCchhHHHHHHH-HHHHhhCCCCCCCCCH-HHHHHHHHcCCcc---cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCH
Q 015352          228 RNYGPEIDIWSAGVI-LYILLCGVPPFWAESE-QGVAQAILRGLID---FKRDPWPNVSESAKSLVRQMLEPDPKLRLTA  302 (408)
Q Consensus       228 ~~~~~~~DiwslG~i-l~~l~~g~~pf~~~~~-~~~~~~i~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~  302 (408)
                      +..+.++||||+|++ .+++++|..||.+... ......+......   .....++.+|+++++||.+||+.|     |+
T Consensus       251 g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa  325 (336)
T 2vuw_A          251 GDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA  325 (336)
T ss_dssp             CCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred             CCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence            877899999998777 7789999999843211 1222333322111   111112357889999999999977     99


Q ss_pred             HHHh-cCcccc
Q 015352          303 KQVL-EHPWLQ  312 (408)
Q Consensus       303 ~~~l-~h~~~~  312 (408)
                      .|+| +||||+
T Consensus       326 ~e~l~~Hp~f~  336 (336)
T 2vuw_A          326 TDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHCGGGC
T ss_pred             HHHHhcCCCcC
Confidence            9999 999995

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=341.98  Aligned_cols=254  Identities=22%  Similarity=0.317  Sum_probs=190.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHH--HhCCCCCCeeEEeeEEEe---
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM--KHLPKNSSIVSLKEACED---  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l--~~l~~h~~i~~~~~~~~~---  123 (408)
                      -.++|++.+.||+|+||.||+|++  +++.||+|++....      ...+..|.+++  ..+ +||||+++++.+..   
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTA   81 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECT
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheeccccccc
Confidence            457999999999999999999976  68999999997432      33444455554  346 89999999986542   


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCceEeecCCCCC
Q 015352          124 --DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH---------GVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       124 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~---------~ivH~dikp~NIl~~~~~~~~  192 (408)
                        ...+|+||||++||+|.+++... ..++..++.++.||+.||.|||++         ||+||||||+|||+   +.++
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~  157 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDG  157 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTS
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCC
Confidence              33679999999999999999765 458999999999999999999999         99999999999999   4567


Q ss_pred             CEEEeecccccccCCCC---------ceecccCCCCCcchhhhhc--------cCCCchhHHHHHHHHHHHhhCCCCCCC
Q 015352          193 PLKAIDFGLSIFFKPGE---------RFSEIVGSPYYMAPEVLKR--------NYGPEIDIWSAGVILYILLCGVPPFWA  255 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~l~~g~~pf~~  255 (408)
                      .+||+|||++.......         ......||+.|+|||++.+        .++.++|||||||++|+|++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            89999999998654321         2234579999999999864        466789999999999999999776643


Q ss_pred             CCH------------------HHHHHHHHcCCcccC-CCCC---CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc------
Q 015352          256 ESE------------------QGVAQAILRGLIDFK-RDPW---PNVSESAKSLVRQMLEPDPKLRLTAKQVLE------  307 (408)
Q Consensus       256 ~~~------------------~~~~~~i~~~~~~~~-~~~~---~~~~~~~~~li~~~l~~dp~~R~s~~~~l~------  307 (408)
                      ...                  ......+........ ...+   ...++.+.+||.+||+.||++|||+.|+++      
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            211                  111111111111111 1111   124457999999999999999999999954      


Q ss_pred             CccccCCc
Q 015352          308 HPWLQNAK  315 (408)
Q Consensus       308 h~~~~~~~  315 (408)
                      ++|-++..
T Consensus       318 ~~~~~~~~  325 (336)
T 3g2f_A          318 MIWERNKS  325 (336)
T ss_dssp             HCCCC---
T ss_pred             HHHHhccc
Confidence            67766554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-45  Score=351.28  Aligned_cols=248  Identities=15%  Similarity=0.193  Sum_probs=193.2

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC-CCe---------------
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSI---------------  114 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~i---------------  114 (408)
                      ..|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+ .| ++.               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence            4588899999999999999999999999999998755444444567899999999998 44 321               


Q ss_pred             ------eEEeeEEEe-----CCeEEEEEeccCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 015352          115 ------VSLKEACED-----DNAVHLVMELCEGGELFDRIVA-------RGHYTERAAAAVTRTIVEVVQLCHKHGVIHR  176 (408)
Q Consensus       115 ------~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~  176 (408)
                            ..+..++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111111222     23567888877 5699888842       2347788899999999999999999999999


Q ss_pred             cCCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcchhhh----------hc-cCCCchhHHHHHHHHHH
Q 015352          177 DLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL----------KR-NYGPEIDIWSAGVILYI  245 (408)
Q Consensus       177 dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DiwslG~il~~  245 (408)
                      ||||+|||+   +.++.+||+|||++.....  .....+| +.|+|||++          .+ .++.++|||||||++|+
T Consensus       236 DiKp~NILl---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVL---DQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEE---ecCCeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999   5566799999999876432  2455678 999999998          32 47889999999999999


Q ss_pred             HhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          246 LLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       246 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      |++|+.||.+.+.......+        ...+..+|+.+.+||.+||+.||++|||+.++++||||+..
T Consensus       310 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            99999999876544322222        22335789999999999999999999999999999999754

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-44  Score=330.83  Aligned_cols=232  Identities=14%  Similarity=0.116  Sum_probs=191.8

Q ss_pred             cccc-ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           44 VPKE-NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        44 ~~~~-~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      .++. .+.++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.
T Consensus        23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~  101 (286)
T 3uqc_A           23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVH  101 (286)
T ss_dssp             CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred             CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEE
Confidence            3555 6778999999999999999999999999999999999876554455567899999999999 9999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      +++..|+||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++   .++.+||+++|  
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~--  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA--  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC--
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc--
Confidence            99999999999999999999854 3 46667889999999999999999999999999999995   45678888543  


Q ss_pred             cccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HHHcCCcccCCCCCCC
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQ---AILRGLIDFKRDPWPN  279 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~  279 (408)
                                       |++|      ++.++|||||||++|+|++|..||.+.+......   ....+...........
T Consensus       175 -----------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 -----------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD  231 (286)
T ss_dssp             -----------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred             -----------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence                             3333      6789999999999999999999998765432110   0111111111122357


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +++.+.+||.+||+.||.+| |+.++++
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            89999999999999999999 9999988

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-43  Score=359.38  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=210.3

Q ss_pred             cccccceEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ....++|.+.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.+++.+ +||||+++++++. 
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-
Confidence            34557899999999999999999998654   4579999876432  333457889999999999 9999999999985 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          124 DNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      ++..|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a  538 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS  538 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCC
Confidence            456899999999999999998654 689999999999999999999999999999999999995   4567999999999


Q ss_pred             cccCCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          203 IFFKPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       203 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ........  .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   +..+
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~  615 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPP  615 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---CCCT
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCc
Confidence            87644332  223456789999999875 69999999999999999997 99999999888888887766432   2235


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+++.+.+||.+||..||.+|||+.++++
T Consensus       616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          616 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            78999999999999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-44  Score=368.40  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=204.7

Q ss_pred             cccccccceEecceecccCCeEEEEEEECC-CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRD-TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      +++.+.++|++.+.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.+++.+ +||||+++++++..
T Consensus        74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEH  150 (681)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE
T ss_pred             CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEee
Confidence            556778999999999999999999999986 78999999986432  233456788999999999 89999999999987


Q ss_pred             CCe-----EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEee
Q 015352          124 DNA-----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       124 ~~~-----~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      .+.     .|+||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.    ..+||+|
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~D  224 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLID  224 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEECC
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEEe
Confidence            765     7999999999999887654  7999999999999999999999999999999999999953    3799999


Q ss_pred             cccccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          199 FGLSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       199 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      ||++......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+....        . .. ......
T Consensus       225 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~-~~-~~~~~~  291 (681)
T 2pzi_A          225 LGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------G-LP-EDDPVL  291 (681)
T ss_dssp             CTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------S-CC-TTCHHH
T ss_pred             cccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc--------c-cc-cccccc
Confidence            9999876443   456799999999999887899999999999999999999988653211        0 00 001111


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      ..++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus       292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            2467899999999999999999999999988874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.6e-36  Score=300.26  Aligned_cols=232  Identities=16%  Similarity=0.101  Sum_probs=160.3

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeeccccCC-------hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           58 ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT-------AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        58 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ..+.|+.|.+..++....|+.+++|++.+.....       ....+.+.+|+++|+++.+|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4678888888888888889999999998754321       233467999999999998899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-C
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-E  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~  209 (408)
                      |||++|++|.+++.+.+++++.   .|+.||+.||.|+|++|||||||||+|||+   +.++.+||+|||+|+..... .
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---C
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCc
Confidence            9999999999999999888875   478999999999999999999999999999   55678999999999876433 3


Q ss_pred             ceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ...+.+||+.|+|||++.+.+..++|+||+|++++.+.++..|+        ...+....    .     ....+..+..
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~~----~-----~~~~~~~l~~  457 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQEP----V-----ERWNFVLLLA  457 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTSC----G-----GGCSHHHHHH
T ss_pred             cccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcCC----C-----CCCcHHHHHH
Confidence            44567899999999999998889999999999998887765443        11111110    0     0112455666


Q ss_pred             HhcCCCcCCCCCHHHHhcCcccc
Q 015352          290 QMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      .+...+|..|+.......++|..
T Consensus       458 ~l~~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          458 LFEKKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             HHHTGGGSCCGGGSSCCHHHHHH
T ss_pred             HHhCCCCCCCCChhhhccchhHH
Confidence            66777777777666666666653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=5.4e-30  Score=253.43  Aligned_cols=184  Identities=22%  Similarity=0.211  Sum_probs=144.4

Q ss_pred             EecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh-----cHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           54 LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV-----DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        54 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ...+.||+|+||.||+|.  ..+..+++|...........     ..+.+.+|+++++++ +||||+++..++...+..|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence            446689999999999994  45788999987654433221     234579999999999 9999996555666777789


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +||||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++   .  .+||+|||+++.....
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence            99999999999998865        678999999999999999999999999999995   3  7999999999887543


Q ss_pred             Cc--------eecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCC
Q 015352          209 ER--------FSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPF  253 (408)
Q Consensus       209 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf  253 (408)
                      ..        .....||+.|+|||++..   .|+..+|+||..+-..+-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            22        135689999999999874   5888899999998888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=8.6e-27  Score=211.90  Aligned_cols=146  Identities=20%  Similarity=0.262  Sum_probs=115.3

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh---------------hcHHHHHHHHHHHHhCCCCCCeeEE
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA---------------VDIDDVRREVAIMKHLPKNSSIVSL  117 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~~i~~~  117 (408)
                      |.+.+.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+++.+ +  | +++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v  166 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAV  166 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSS
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCc
Confidence            34449999999999999999 8899999999965322111               1346788999999999 4  4 555


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      .+++.. +..|+||||++|++|.+ +      ....+..++.|++.||.|||++||+||||||+|||++    ++.+||+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl~  234 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII  234 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEEE
Confidence            555554 45699999999999987 3      1234557999999999999999999999999999995    5679999


Q ss_pred             ecccccccCCCCceecccCCCCCcchhhhh
Q 015352          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLK  227 (408)
Q Consensus       198 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  227 (408)
                      |||+|..            +..+.|||.+.
T Consensus       235 DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             CCTTCEE------------TTSTTHHHHHH
T ss_pred             ECCCCeE------------CCCCCHHHHHH
Confidence            9999864            34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1e-22  Score=182.80  Aligned_cols=141  Identities=14%  Similarity=0.110  Sum_probs=107.5

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcE--EEEEEeeccccCCh---------------------hcHHHHHHHHHHHHhC
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTA---------------------VDIDDVRREVAIMKHL  108 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l  108 (408)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++........                     .....+.+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999999778999  99999754321100                     1123678999999998


Q ss_pred             CCCCCe--eEEeeEEEeCCeEEEEEeccCC-C----chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCC
Q 015352          109 PKNSSI--VSLKEACEDDNAVHLVMELCEG-G----ELFDRIVARGHYTERAAAAVTRTIVEVVQLCH-KHGVIHRDLKP  180 (408)
Q Consensus       109 ~~h~~i--~~~~~~~~~~~~~~lv~e~~~g-~----~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~ivH~dikp  180 (408)
                       .|+++  +.+++.    +..++||||+.+ |    +|.+....   .++..+..++.||+.||.||| ++||+||||||
T Consensus       128 -~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 -KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             -HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             -HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence             66653  334332    356899999942 3    66655322   235578899999999999999 99999999999


Q ss_pred             CceEeecCCCCCCEEEeeccccccc
Q 015352          181 ENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       181 ~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      +|||++   .  .++|+|||+|...
T Consensus       200 ~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEES---S--SEEECCCTTCEET
T ss_pred             HHEEEc---C--cEEEEECcccccC
Confidence            999994   3  7999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=4.4e-20  Score=172.16  Aligned_cols=144  Identities=19%  Similarity=0.214  Sum_probs=101.8

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-----------ChhcH--------HHHHHHHHHHHhCCCCC
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----------TAVDI--------DDVRREVAIMKHLPKNS  112 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~--------~~~~~E~~~l~~l~~h~  112 (408)
                      -|.+.+.||+|++|.||+|.+. +|+.||||++......           .....        ....+|...|.++ .++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hhc
Confidence            3899999999999999999975 6999999998643211           00011        1124577777777 544


Q ss_pred             CeeEEeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCC-
Q 015352          113 SIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKEN-  191 (408)
Q Consensus       113 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~-  191 (408)
                      ++... ..+.... .++||||++|++|....      ....+..++.||+.+|.+||++|||||||||.|||++.+++. 
T Consensus       174 gv~vp-~p~~~~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVP-EPIAQSR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCC-CEEEEET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCC-eeeeccC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            44221 1222222 36999999999886532      223456789999999999999999999999999999764321 


Q ss_pred             ------CCEEEeeccccccc
Q 015352          192 ------SPLKAIDFGLSIFF  205 (408)
Q Consensus       192 ------~~vkl~Dfg~~~~~  205 (408)
                            ..+.|+||+-+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                  13789999977653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=1e-13  Score=124.34  Aligned_cols=141  Identities=21%  Similarity=0.188  Sum_probs=111.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      +.|.+...++.|+.+.||++...  +..+++|+........   ...+.+|+.+++.|..+..++++++++.+.+..|+|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            46888889999999999999743  6789999986432111   235788999999996577788999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK----------------------------------------  170 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~----------------------------------------  170 (408)
                      |||++|.+|.+.+     .+......++.++..+|..||+                                        
T Consensus        89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            9999999987652     1223345788999999999998                                        


Q ss_pred             -------------------CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          171 -------------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       171 -------------------~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                                         ..++|||++|.||+++   ++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence                               4589999999999994   234457999997754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=1.3e-12  Score=116.76  Aligned_cols=136  Identities=15%  Similarity=0.141  Sum_probs=98.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC-eeEEeeEEEeCCeEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS-IVSLKEACEDDNAVHL  129 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-i~~~~~~~~~~~~~~l  129 (408)
                      ..|.+....+.|..+.||++.. .+|..+++|+....      ....+.+|+.+++.+..++. +++++.+...++..++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            3455544445666799999964 45778999997543      12356789999998844422 6778888888888999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG-------------------------------------  172 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-------------------------------------  172 (408)
                      ||||++|.+|.  .   ...+   ...++.++...|..||+..                                     
T Consensus        93 v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999998883  1   1122   2356677777778887643                                     


Q ss_pred             ---------------------CeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          173 ---------------------VIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       173 ---------------------ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                                           ++|||++|.||+++   ++..+.|+|||.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                 99999999999995   234456999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.26  E-value=7.6e-12  Score=114.63  Aligned_cols=185  Identities=17%  Similarity=0.220  Sum_probs=125.4

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCC--eeEEeeEEEeCC---eEEEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSS--IVSLKEACEDDN---AVHLV  130 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~--i~~~~~~~~~~~---~~~lv  130 (408)
                      .+.++.|....||++.     ..+++|+....     .....+.+|..+++.+..+..  +++++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            3568999999999873     45889986422     235678899999988744333  445544443333   35899


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK----------------------------------------  170 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~----------------------------------------  170 (408)
                      |++++|.+|.....  ..++..+...++.++...|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999998875433  247788888899999999999986                                        


Q ss_pred             ------------------CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecccCCCCCcchhhhh---cc
Q 015352          171 ------------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK---RN  229 (408)
Q Consensus       171 ------------------~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~  229 (408)
                                        ..++|+|++|.||+++.+ ....+.|+||+.+....+............-.+|+...   ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                              136999999999999642 14457899999887654332221111110003344321   12


Q ss_pred             CCC------------chhHHHHHHHHHHHhhCCCCC
Q 015352          230 YGP------------EIDIWSAGVILYILLCGVPPF  253 (408)
Q Consensus       230 ~~~------------~~DiwslG~il~~l~~g~~pf  253 (408)
                      |..            -.+.|++|.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            221            258999999999999998876

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=1.6e-11  Score=115.17  Aligned_cols=142  Identities=20%  Similarity=0.364  Sum_probs=104.1

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEee--ccccCChhcHHHHHHHHHHHHhCCC-CCCeeEEeeEEEeC---CeEEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSIS--KRKLRTAVDIDDVRREVAIMKHLPK-NSSIVSLKEACEDD---NAVHL  129 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~---~~~~l  129 (408)
                      .+.|+.|.++.||++...  +..+++|+..  .....  .....+.+|+.+++.|.. +..+++++.++.+.   +..|+
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            567899999999999754  4678888875  32211  123467889999999843 34578888888776   45899


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK---------------------------------------  170 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~---------------------------------------  170 (408)
                      ||||++|.++.+..  ...+++.....++.++..+|..||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999998775421  2346788889999999999999997                                       


Q ss_pred             -------------------CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          171 -------------------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       171 -------------------~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                                         ..++|||++|.||+++.++. ..+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence                               35899999999999964221 3368999998765

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=99.08  E-value=1.7e-10  Score=98.60  Aligned_cols=98  Identities=26%  Similarity=0.395  Sum_probs=77.2

Q ss_pred             cCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          307 EHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       307 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .|||.+... ..++++...++.++++|...+.+++.++..++..++.++...+.++|..+|.|++|.|+.+|+..+++.+
T Consensus         8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~   86 (197)
T 3pm8_A            8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI   86 (197)
T ss_dssp             ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred             cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence            489998766 4577888899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHhCCC
Q 015352          387 GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       387 g~~~~~~e~~~~~~~~d~~  405 (408)
                      |..++..+++.+|+.+|.+
T Consensus        87 g~~~~~~~~~~l~~~~D~d  105 (197)
T 3pm8_A           87 GYQKIPPDIHQVLRDIDSN  105 (197)
T ss_dssp             C----CHHHHHHHHC----
T ss_pred             CCCCCHHHHHHHHHHhCCC
Confidence            9999999999999998865

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=98.98  E-value=6.1e-10  Score=94.53  Aligned_cols=97  Identities=24%  Similarity=0.390  Sum_probs=80.5

Q ss_pred             cCccccCCcCCCCCCCchHHHhhhhhhhhhhhhHHHHhhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          307 EHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       307 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .|||+-... +...++...++.++++|...+++++.++..++..++.++...++++|..+|.|++|.|+.+|+..+++.+
T Consensus         3 ~~~~~~~~~-~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~   81 (191)
T 3k21_A            3 HHHHHSSGR-ENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD   81 (191)
T ss_dssp             ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred             CCccccCCc-cccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence            467765543 3345677788999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHhCCC
Q 015352          387 GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       387 g~~~~~~e~~~~~~~~d~~  405 (408)
                      |..++ .+++.+++.+|.+
T Consensus        82 g~~~~-~~~~~l~~~~D~d   99 (191)
T 3k21_A           82 GLKLP-YNFDLLLDQIDSD   99 (191)
T ss_dssp             TCCCC-TTHHHHHHHHCTT
T ss_pred             CCCcH-HHHHHHHHHhCCC
Confidence            98888 8999999999876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.89  E-value=2.6e-08  Score=91.08  Aligned_cols=139  Identities=19%  Similarity=0.228  Sum_probs=96.6

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC-C-CeeEEeeEEE-eCCeEEEEEe
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-S-SIVSLKEACE-DDNAVHLVME  132 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~-~i~~~~~~~~-~~~~~~lv~e  132 (408)
                      .+.++.|....||+.     |..+++|+...     ......+.+|..+|+.|..+ + .+++++.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            345788999999998     56688888531     22356789999999998543 2 2566666664 4567889999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH-----------------------------------------  171 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~-----------------------------------------  171 (408)
                      +++|.++.....  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988866322  2345555566666666666666642                                         


Q ss_pred             -------------------CCeeccCCCCceEeecCCCCCCE-EEeecccccccC
Q 015352          172 -------------------GVIHRDLKPENFLFANKKENSPL-KAIDFGLSIFFK  206 (408)
Q Consensus       172 -------------------~ivH~dikp~NIl~~~~~~~~~v-kl~Dfg~~~~~~  206 (408)
                                         .++|+|++|.||+++.++.++.+ .|+||+.+....
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                               35999999999999642223454 899999876543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.84  E-value=3.6e-08  Score=88.34  Aligned_cols=134  Identities=17%  Similarity=0.209  Sum_probs=97.5

Q ss_pred             eecccCCe-EEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccCC
Q 015352           58 ELGRGEFG-VTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEG  136 (408)
Q Consensus        58 ~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~g  136 (408)
                      .+..|..| .||+......+..+++|+-...      ....+.+|..+|+.|..+--+++++.++.+++..|+|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            34455555 6999887777788999986532      2456888999999885554478899999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 015352          137 GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKH---------------------------------------------  171 (408)
Q Consensus       137 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~---------------------------------------------  171 (408)
                      .++.+.....    ......+..++...|.-||+.                                             
T Consensus       105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            8887665432    122334555666666666621                                             


Q ss_pred             -------------CCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          172 -------------GVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       172 -------------~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                                   .++|+|+.+.||+++   +.+.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence                         268999999999995   334467999998765

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=98.75  E-value=1.1e-08  Score=76.67  Aligned_cols=56  Identities=30%  Similarity=0.522  Sum_probs=52.5

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++..+++++|+.+|.|++|+|+.+||+.+|+.+|..++++|++++|+.+|.|
T Consensus        29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d   84 (100)
T 2lv7_A           29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMD   84 (100)
T ss_dssp             CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSS
T ss_pred             cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCC
Confidence            35677888999999999999999999999999999999999999999999999986

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.57  E-value=1.8e-07  Score=88.73  Aligned_cols=81  Identities=17%  Similarity=0.167  Sum_probs=51.0

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeecccc-CC---hhcHHHHHHHHHHHHhCCCC-C-CeeEEeeEEEeCCeEEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKL-RT---AVDIDDVRREVAIMKHLPKN-S-SIVSLKEACEDDNAVHL  129 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~~h-~-~i~~~~~~~~~~~~~~l  129 (408)
                      .+.||.|.++.||++....++..+++|....... ..   ......+..|.++++.+... | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4579999999999997665678899998653211 00   11234567899998877332 3 34555543  3445689


Q ss_pred             EEeccCCCc
Q 015352          130 VMELCEGGE  138 (408)
Q Consensus       130 v~e~~~g~~  138 (408)
                      |||+++|..
T Consensus       113 vmE~l~g~~  121 (397)
T 2olc_A          113 VMEDLSHLK  121 (397)
T ss_dssp             EECCCTTSE
T ss_pred             EEEeCCCcc
Confidence            999998743

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=98.53  E-value=3.2e-07  Score=76.75  Aligned_cols=81  Identities=20%  Similarity=0.347  Sum_probs=74.0

Q ss_pred             chHHHhhhhhhhhhhhhHHHHhhhhhhhhc--hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 015352          323 GDVVRSRLKQFSMMNRFKRKALRVIAEFLS--VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE  400 (408)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~l~~i~~~ls--~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~  400 (408)
                      ...++.++++|...+.+++.++..+...++  .++...++++|..+|.|++|.|+.+|+..+++.+|.  +..+++.+|+
T Consensus         3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~--~~~~~~~~~~   80 (180)
T 3mse_B            3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGI--KKWDINRILQ   80 (180)
T ss_dssp             CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC--CHHHHHHHHH
Confidence            456788999999999999999999999887  788899999999999999999999999999999985  4789999999


Q ss_pred             HhCCC
Q 015352          401 ASSSV  405 (408)
Q Consensus       401 ~~d~~  405 (408)
                      .+|.+
T Consensus        81 ~~D~d   85 (180)
T 3mse_B           81 ALDIN   85 (180)
T ss_dssp             HHCTT
T ss_pred             HhCCC
Confidence            99875

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=98.46  E-value=1.1e-07  Score=80.18  Aligned_cols=85  Identities=21%  Similarity=0.405  Sum_probs=77.0

Q ss_pred             CCchHHHhhhhhhhhhhhhHHHHhhhhhhhh-chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh-----------CC
Q 015352          321 PLGDVVRSRLKQFSMMNRFKRKALRVIAEFL-SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-----------GS  388 (408)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~l-s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~-----------g~  388 (408)
                      ++...++.++++|...+.+++.++..+...+ +.++...+.++|..+|.|++|.|+.+|+..+++.+           |.
T Consensus         3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~   82 (191)
T 3khe_A            3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS   82 (191)
T ss_dssp             CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence            3456678899999999999999999999888 78889999999999999999999999999999988           76


Q ss_pred             CCCHHHHHHHHHHhCCC
Q 015352          389 QLAESEVQMLIEASSSV  405 (408)
Q Consensus       389 ~~~~~e~~~~~~~~d~~  405 (408)
                      .++..++..+++.+|.+
T Consensus        83 ~~~~~~~~~~~~~~D~d   99 (191)
T 3khe_A           83 SQIEAEVDHILQSVDFD   99 (191)
T ss_dssp             HHHHHHHHHHHHHTCTT
T ss_pred             hhhHHHHHHHHHHhCCC
Confidence            77889999999999875

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=98.46  E-value=4e-07  Score=74.77  Aligned_cols=75  Identities=53%  Similarity=0.775  Sum_probs=66.6

Q ss_pred             hhhhhhhhhHHHHhhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          331 KQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       331 ~~~~~~~~~~~~~l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++|...+.+++.++..+...++.++...+.++|..+|.|++|.|+.+|+..+++.+|..++..++..+++.+|.+
T Consensus         1 ~~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~   75 (166)
T 2aao_A            1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVD   75 (166)
T ss_dssp             -----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTT
T ss_pred             CchhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            357778889999999999999999999999999999999999999999999999999999999999999999875

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A

Probab=98.44  E-value=5.1e-07  Score=66.02  Aligned_cols=59  Identities=31%  Similarity=0.464  Sum_probs=53.9

Q ss_pred             hhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       347 i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +...++.++...+..+|..+|.|++|.|+.+|+..+++.+|..+++.+++.+++.+|.+
T Consensus        10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~   68 (90)
T 1avs_A           10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDED   68 (90)
T ss_dssp             HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            34456778888999999999999999999999999999999999999999999999875

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A

Probab=98.44  E-value=3.2e-07  Score=66.44  Aligned_cols=57  Identities=25%  Similarity=0.482  Sum_probs=50.3

Q ss_pred             hhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       348 ~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..++.++...++.+|..+|.|++|.|+.+|+..+++.+| .++..+++.+++.+|.+
T Consensus         2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~   58 (86)
T 2opo_A            2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTD   58 (86)
T ss_dssp             ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTT
T ss_pred             CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCC
Confidence            3456777888999999999999999999999999999999 99999999999999876

>1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A

Probab=98.39  E-value=3.7e-07  Score=66.15  Aligned_cols=57  Identities=14%  Similarity=0.257  Sum_probs=52.0

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHH---HHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE---VQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e---~~~~~~~~d~~  405 (408)
                      ..++.++..+++++|..+|.|++|.|+.+||..+|+.+|..++..+   ++.++..+|.+
T Consensus         6 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~   65 (86)
T 1j7q_A            6 RALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGD   65 (86)
T ss_dssp             CCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCS
T ss_pred             ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCC
Confidence            3456777889999999999999999999999999999999999999   99999998865

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus}

Probab=98.38  E-value=4.8e-07  Score=63.89  Aligned_cols=54  Identities=28%  Similarity=0.476  Sum_probs=50.1

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.++...++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~   55 (77)
T 2joj_A            2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDRE   55 (77)
T ss_dssp             CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCS
T ss_pred             CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCC
Confidence            456678899999999999999999999999999999999999999999999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=2.6e-07  Score=86.23  Aligned_cols=86  Identities=9%  Similarity=0.103  Sum_probs=56.1

Q ss_pred             eccee-cccCCeEEEEEEEC--C----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC--CCeeEEeeEEEeC-
Q 015352           55 VDREL-GRGEFGVTYLCIDR--D----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN--SSIVSLKEACEDD-  124 (408)
Q Consensus        55 ~~~~l-g~G~~g~V~~~~~~--~----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~-  124 (408)
                      ..+.| +.|..+.+|+....  .    ++..+++|+..............+.+|+.+++.|..+  -.+++++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34667 88989999988653  1    1567889986543200000013467788888887443  2477788777655 


Q ss_pred             --CeEEEEEeccCCCchH
Q 015352          125 --NAVHLVMELCEGGELF  140 (408)
Q Consensus       125 --~~~~lv~e~~~g~~L~  140 (408)
                        +..|+|||+++|.++.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              4578999999986653

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=98.32  E-value=3.6e-08  Score=90.66  Aligned_cols=122  Identities=16%  Similarity=0.182  Sum_probs=82.2

Q ss_pred             CCCHHHHHHHHHhc---CCCcCCCCCHHHHhcC------ccccCCcC--------------------CCC---CCCchHH
Q 015352          279 NVSESAKSLVRQML---EPDPKLRLTAKQVLEH------PWLQNAKK--------------------APN---VPLGDVV  326 (408)
Q Consensus       279 ~~~~~~~~li~~~l---~~dp~~R~s~~~~l~h------~~~~~~~~--------------------~~~---~~~~~~~  326 (408)
                      .+..++.+|.+++.   ..+|+.|.+..+.+.|      +|+.....                    ...   ......+
T Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~v   95 (323)
T 1ij5_A           16 KVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASL   95 (323)
T ss_dssp             HHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHH
Confidence            45677889999888   8999999999999988      88765410                    000   0011234


Q ss_pred             Hhhhh-hhhhhhhhHHHHhhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          327 RSRLK-QFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       327 ~~~~~-~~~~~~~~~~~~l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.+++ +|...+.+++     ++..++.++...+..+|..+|.|++|.|+.+||..+|+.+|..++..++..++..+|.+
T Consensus        96 l~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D~d  170 (323)
T 1ij5_A           96 LKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVEND  170 (323)
T ss_dssp             HHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCC
Confidence            45555 5666666655     34567788899999999999999999999999999999999999999999999988764

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=98.31  E-value=6e-07  Score=74.79  Aligned_cols=57  Identities=32%  Similarity=0.485  Sum_probs=53.5

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.++.+++.+++++|..+|.|++|.|+.+||..+|+.+|..+++.++.+++..+|.+
T Consensus         3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d   59 (176)
T 2lhi_A            3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVD   59 (176)
T ss_dssp             CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSS
T ss_pred             CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcC
Confidence            457888999999999999999999999999999999999999999999999998875

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus}

Probab=98.29  E-value=1.8e-06  Score=63.66  Aligned_cols=52  Identities=31%  Similarity=0.551  Sum_probs=48.3

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+++++|..+|.|++|.|+.+||..+++.+|..+++.+++++++.+|.+
T Consensus        26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d   77 (94)
T 2kz2_A           26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADID   77 (94)
T ss_dssp             SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            4566789999999999999999999999999999999999999999999875

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=98.28  E-value=1.4e-06  Score=64.06  Aligned_cols=52  Identities=21%  Similarity=0.176  Sum_probs=47.5

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.++..+++++|..+|.|++|+|+.+|++.+++.+|  +++.+++++++.+|.+
T Consensus         4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d   55 (92)
T 1fi6_A            4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFD   55 (92)
T ss_dssp             CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCC
Confidence            456778899999999999999999999999999997  5799999999999875

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=98.26  E-value=1.5e-06  Score=64.34  Aligned_cols=52  Identities=27%  Similarity=0.309  Sum_probs=47.4

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.++..+++++|..+|.|++|+|+.+|++.+++.+|  +++.+++++++.+|.+
T Consensus         5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d   56 (95)
T 1c07_A            5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTK   56 (95)
T ss_dssp             CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCCC
Confidence            456788899999999999999999999999999987  5799999999999875

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max}

Probab=98.26  E-value=1.9e-06  Score=63.17  Aligned_cols=54  Identities=31%  Similarity=0.561  Sum_probs=49.7

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+....+..+|..+|.|++|.|+.+||..+++.+|..++..+++.++..+|.+
T Consensus         4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~   57 (92)
T 2kn2_A            4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLD   57 (92)
T ss_dssp             CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSS
T ss_pred             CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            345677899999999999999999999999999999999999999999999865

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5

Probab=98.23  E-value=1.7e-06  Score=59.02  Aligned_cols=48  Identities=23%  Similarity=0.406  Sum_probs=45.3

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~   49 (67)
T 1tiz_A            2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVD   49 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCC
Confidence            467899999999999999999999999999999999999999999875

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A

Probab=98.23  E-value=1.2e-06  Score=65.35  Aligned_cols=52  Identities=17%  Similarity=0.197  Sum_probs=45.9

Q ss_pred             hhhHHHHHHHhhcC-CCCC-CccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDND-GVVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~d-G~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.++|..+| .|++ |+|+.+||+.+|+.     +|..+++.+++++|+.+|.|
T Consensus         7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~d   65 (101)
T 3nso_A            7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTN   65 (101)
T ss_dssp             HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCC
Confidence            34678899999997 8887 99999999999996     46788999999999999876

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens}

Probab=98.22  E-value=2.2e-06  Score=62.79  Aligned_cols=55  Identities=13%  Similarity=0.244  Sum_probs=49.7

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.++...++++|..+|.|++|.|+.+|+..+++.+|  ++..+++.+++.+|.+
T Consensus        19 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~d   73 (91)
T 2pmy_A           19 ADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDAD   73 (91)
T ss_dssp             CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTT
T ss_pred             ccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCCC
Confidence            345667788899999999999999999999999999998  6899999999999875

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens}

Probab=98.22  E-value=1.6e-06  Score=59.95  Aligned_cols=51  Identities=27%  Similarity=0.576  Sum_probs=47.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~   54 (71)
T 2b1u_A            4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVD   54 (71)
T ss_dssp             THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSS
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            456788999999999999999999999999999999999999999999865

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A

Probab=98.21  E-value=2.1e-06  Score=65.34  Aligned_cols=53  Identities=23%  Similarity=0.318  Sum_probs=47.3

Q ss_pred             hhhhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKID-SDNDG-VVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+++++|..|| .|++| +|+.+||+.+|+.     +|..+++++++++|+.+|.|
T Consensus        18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~d   77 (113)
T 2lnk_A           18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSN   77 (113)
T ss_dssp             HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSS
T ss_pred             hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCC
Confidence            345678999999999 89997 9999999999987     77788999999999999976

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=98.21  E-value=1.6e-06  Score=80.60  Aligned_cols=59  Identities=31%  Similarity=0.513  Sum_probs=55.4

Q ss_pred             hhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       347 i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      -.+.++.+++.+++++|..+|.|++|.|+.+||+.+|+.+|..++++|+++||+.+|.+
T Consensus       292 s~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~D  350 (440)
T 3u0k_A          292 TRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD  350 (440)
T ss_dssp             BCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSS
T ss_pred             hHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            34567889999999999999999999999999999999999999999999999999976

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=98.20  E-value=7.4e-07  Score=64.61  Aligned_cols=56  Identities=48%  Similarity=0.728  Sum_probs=50.5

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++...++++|..+|.|++|.|+.+|++.+++.+|..++..+++.+++.+|.+
T Consensus        16 ~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~   71 (87)
T 1s6j_A           16 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADID   71 (87)
T ss_dssp             SSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTT
T ss_pred             HCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            44555667788999999999999999999999999999999999999999999865

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=1.7e-05  Score=73.27  Aligned_cols=74  Identities=9%  Similarity=0.128  Sum_probs=43.0

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC-CCeeEEee------EEEeCCeEEE
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKE------ACEDDNAVHL  129 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~------~~~~~~~~~l  129 (408)
                      +.|+.|..+.||++...  +..+++|+....       ...+..|..+++.|..+ -.+++++.      +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            45677788999999763  335899998642       23344566666555211 12344433      2245678899


Q ss_pred             EEeccCCCch
Q 015352          130 VMELCEGGEL  139 (408)
Q Consensus       130 v~e~~~g~~L  139 (408)
                      +|+|++|.++
T Consensus       109 l~~~i~G~~~  118 (346)
T 2q83_A          109 VYDWIEGRPF  118 (346)
T ss_dssp             EEECCCCBCC
T ss_pred             EEEeecCccC
Confidence            9999998654

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=98.19  E-value=2.3e-06  Score=69.47  Aligned_cols=51  Identities=22%  Similarity=0.423  Sum_probs=47.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++++|+.+|.|++|+|+.+||+.+|..+|..++++++++|++.+|.+
T Consensus        83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~  133 (153)
T 3i5g_B           83 PEDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK  133 (153)
T ss_dssp             CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE
T ss_pred             cHHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC
Confidence            356799999999999999999999999999999999999999999998854

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=98.18  E-value=2.6e-06  Score=69.06  Aligned_cols=56  Identities=25%  Similarity=0.498  Sum_probs=51.7

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.+++.+++++|..+|.|++|.|+.+||..+|+.+|..+++.++..++...+..
T Consensus         9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~~~~   64 (153)
T 3i5g_B            9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLKECPGQ   64 (153)
T ss_dssp             TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHHTSSSC
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHHhccCC
Confidence            46888999999999999999999999999999999999999999999998876654

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=98.11  E-value=4.7e-06  Score=68.06  Aligned_cols=50  Identities=20%  Similarity=0.468  Sum_probs=46.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS  404 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~  404 (408)
                      ...+++++|+.+|.|++|+|+.+||+.+|..+|..++++|+++|++.+|.
T Consensus        83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~  132 (159)
T 3i5g_C           83 AADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDI  132 (159)
T ss_dssp             CHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCc
Confidence            35678999999999999999999999999999999999999999999985

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens}

Probab=98.11  E-value=5.1e-06  Score=63.26  Aligned_cols=53  Identities=13%  Similarity=0.184  Sum_probs=47.5

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++..+++++|..+|.|++|+|+.+||+.+++  |..++..+++++++.+|.+
T Consensus         8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~d   60 (111)
T 2kgr_A            8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDID   60 (111)
T ss_dssp             SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCSS
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCCC
Confidence            3556778899999999999999999999999998  6678999999999999876

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens}

Probab=98.11  E-value=6.5e-06  Score=62.21  Aligned_cols=53  Identities=26%  Similarity=0.341  Sum_probs=49.6

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+....+..+|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus        28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~d   80 (107)
T 2d58_A           28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSSG   80 (107)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            46678899999999999999999999999999999999999999999999875

>2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio}

Probab=98.09  E-value=5.1e-06  Score=61.82  Aligned_cols=52  Identities=23%  Similarity=0.256  Sum_probs=46.4

Q ss_pred             hhhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDNDG-VVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|..+| .|++| +|+.+||+.+|+.     +|..+++.+++++|+.+|.|
T Consensus         7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d   65 (99)
T 2y5i_A            7 GAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSN   65 (99)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCC
Confidence            34678999999997 89998 9999999999997     67788999999999999976

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A

Probab=98.07  E-value=1.3e-05  Score=64.38  Aligned_cols=53  Identities=25%  Similarity=0.310  Sum_probs=49.6

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++..+++.+|..+|.|++|.|+.+||..+++.+|..+++.+++++++.+|.+
T Consensus        44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d   96 (147)
T 1wy9_A           44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSG   96 (147)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            46678899999999999999999999999999999999999999999999875

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10

Probab=98.07  E-value=4.6e-06  Score=58.91  Aligned_cols=48  Identities=31%  Similarity=0.609  Sum_probs=44.8

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++++.+|..+|.|++|.|+.+|+..+++.+| .+++.+++.+++.+|.+
T Consensus         3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~   50 (78)
T 1k9u_A            3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDTD   50 (78)
T ss_dssp             CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCCC
Confidence            4578899999999999999999999999999 99999999999999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.07  E-value=1.8e-05  Score=75.48  Aligned_cols=77  Identities=8%  Similarity=0.043  Sum_probs=45.1

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccc--cCC----hhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRK--LRT----AVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.||.|..+.||++..  ++..+++|......  ...    ......+..|+..+..-.....+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            46789999999999953  46789999533211  011    012233444443332211223466666554  566789


Q ss_pred             EEecc-CC
Q 015352          130 VMELC-EG  136 (408)
Q Consensus       130 v~e~~-~g  136 (408)
                      ||||+ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=98.06  E-value=2.4e-06  Score=68.81  Aligned_cols=56  Identities=29%  Similarity=0.479  Sum_probs=52.3

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.+++.+++++|..+|.|++|.|+.+||..+++.+|..+++.++..++..+|.+
T Consensus         3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~   58 (148)
T 2lmt_A            3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENN   58 (148)
T ss_dssp             SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccC
Confidence            36778899999999999999999999999999999999999999999999998875

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=98.05  E-value=4.8e-06  Score=66.52  Aligned_cols=53  Identities=26%  Similarity=0.499  Sum_probs=49.2

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++..+++++|..+|.|++|.|+.+||..+|+.+|..++..+++.+++.+|.+
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~   54 (143)
T 2obh_A            2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKE   54 (143)
T ss_dssp             HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            35677899999999999999999999999999999999999999999999875

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=98.05  E-value=8.8e-06  Score=65.41  Aligned_cols=50  Identities=30%  Similarity=0.540  Sum_probs=47.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+.+.++|+.+|.|++|+|+.+||+.++..+|..++..+++++|+.+|.|
T Consensus        82 ~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d  131 (148)
T 2lmt_A           82 EEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFD  131 (148)
T ss_dssp             HHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCC
Confidence            45688999999999999999999999999999999999999999999976

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7

Probab=98.05  E-value=9e-06  Score=61.11  Aligned_cols=52  Identities=15%  Similarity=0.195  Sum_probs=47.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....+..+|..+|.|++|.|+.+||+.+++.+|..+++.+++++++.+|.+
T Consensus        21 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~   72 (105)
T 1wlz_A           21 SHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVN   72 (105)
T ss_dssp             HTHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBC
T ss_pred             chHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCC
Confidence            3456789999999999999999999999999999999999999999998864

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A

Probab=98.05  E-value=8.7e-06  Score=61.28  Aligned_cols=52  Identities=21%  Similarity=0.243  Sum_probs=47.2

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++..+++++|..+|. ++|+|+.+|++.+|+.+|  +++.++++|++.+|.+
T Consensus         9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d   60 (106)
T 1eh2_A            9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDID   60 (106)
T ss_dssp             SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCSS
T ss_pred             CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCC
Confidence            356778889999999999 999999999999999987  6899999999999976

>1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A

Probab=98.03  E-value=5.3e-06  Score=61.24  Aligned_cols=52  Identities=17%  Similarity=0.266  Sum_probs=40.7

Q ss_pred             hhhHHHHHHHhhcC-CCC-CCccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDN-DGVVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~-dG~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|..+| .|+ +|+|+.+||+.+|+.     +|..+++.+++++|+.+|.+
T Consensus         6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d   64 (95)
T 1j55_A            6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDAN   64 (95)
T ss_dssp             HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCC
Confidence            34678999999999 788 589999999999997     56677899999999999976

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.03  E-value=2.6e-05  Score=71.00  Aligned_cols=76  Identities=16%  Similarity=0.132  Sum_probs=60.1

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCC--CCCeeEEeeEEEeCCeEEEEEec
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK--NSSIVSLKEACEDDNAVHLVMEL  133 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~~~~~lv~e~  133 (408)
                      .+.|+.|....+|+...  .+..+++|+....      ....+..|...|+.|..  ...+++++.+....+..|+||||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            45689999999999974  4677889987632      25678889999988733  25588888888888899999999


Q ss_pred             cCCCch
Q 015352          134 CEGGEL  139 (408)
Q Consensus       134 ~~g~~L  139 (408)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=98.03  E-value=1.6e-05  Score=63.42  Aligned_cols=51  Identities=29%  Similarity=0.478  Sum_probs=47.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|+|+.+||+.+++.+|..+++.+++++++.+|.+
T Consensus        77 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d  127 (143)
T 2obh_A           77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRD  127 (143)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            346788999999999999999999999999999999999999999999876

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6

Probab=98.03  E-value=5e-06  Score=61.86  Aligned_cols=50  Identities=14%  Similarity=0.214  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|..+|.|++|+|+.+|++.+++.+|  ++++++++|++.+|.+
T Consensus         8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~d   57 (99)
T 1qjt_A            8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTD   57 (99)
T ss_dssp             TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCS
T ss_pred             hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCCC
Confidence            4567789999999999999999999999999987  5899999999999875

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ...

Probab=98.03  E-value=8.9e-06  Score=59.62  Aligned_cols=51  Identities=20%  Similarity=0.311  Sum_probs=46.0

Q ss_pred             hhhHHHHHHHhhcCCCCCC---ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDG---VVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG---~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+.++|..+| ++||   +|+.+||+.+|+.     +|..+++.+++++|+.+|.|
T Consensus         6 ~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d   64 (92)
T 3rm1_A            6 KAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSN   64 (92)
T ss_dssp             HHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCC
Confidence            34677899999999 7777   9999999999999     89999999999999999976

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=98.02  E-value=6.3e-06  Score=68.53  Aligned_cols=50  Identities=32%  Similarity=0.573  Sum_probs=46.5

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ...+++.++|+.+|.|++|+|+.+||+.+|..+|..++++|+++|++.+|
T Consensus        81 ~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d  130 (176)
T 2lhi_A           81 DSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS  130 (176)
T ss_dssp             HHHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc
Confidence            34567899999999999999999999999999999999999999999987

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens}

Probab=98.02  E-value=9.4e-06  Score=60.83  Aligned_cols=52  Identities=21%  Similarity=0.257  Sum_probs=44.5

Q ss_pred             hhhHHHHHHHhhcC-CCCC-CccCHHHHHHHHHH-hC----CCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDND-GVVSTDELKAGLRN-FG----SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~d-G~i~~~el~~~l~~-~g----~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.++|..+| .|++ |+|+.+||+.+|+. +|    ..+++.+++++|+.+|.|
T Consensus        10 ~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d   68 (104)
T 3zwh_A           10 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSN   68 (104)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCC
Confidence            34678999999997 6775 89999999999996 55    456899999999999986

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A

Probab=98.01  E-value=2.3e-06  Score=61.29  Aligned_cols=53  Identities=25%  Similarity=0.420  Sum_probs=47.7

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC--CCCCHHHHHH----HHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG--SQLAESEVQM----LIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g--~~~~~~e~~~----~~~~~d~~  405 (408)
                      .+....+..+|..+|.|++|+|+.+|+..+++.+|  ..++..+++.    +++.+|.+
T Consensus         3 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~~   61 (83)
T 1yx7_A            3 CKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKN   61 (83)
T ss_dssp             SCSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCSS
T ss_pred             ccHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCCC
Confidence            34567789999999999999999999999999999  8889999999    99988865

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A

Probab=98.00  E-value=4e-06  Score=59.69  Aligned_cols=51  Identities=29%  Similarity=0.511  Sum_probs=46.6

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC-CCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g-~~~~~~e~~~~~~~~d~~  405 (408)
                      .....+. +|..+|.|++|.|+.+|+..+++.+| ..+++.+++.+++.+|.+
T Consensus         6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~   57 (81)
T 1c7v_A            6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADED   57 (81)
T ss_dssp             -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSS
T ss_pred             cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCC
Confidence            4456788 99999999999999999999999999 999999999999999865

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=97.99  E-value=1.1e-05  Score=64.78  Aligned_cols=56  Identities=32%  Similarity=0.529  Sum_probs=51.4

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++..+++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~   58 (148)
T 1exr_A            3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD   58 (148)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTT
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCC
Confidence            35667788899999999999999999999999999999999999999999999875

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A*

Probab=97.98  E-value=1.1e-05  Score=59.21  Aligned_cols=52  Identities=21%  Similarity=0.257  Sum_probs=43.3

Q ss_pred             hhhHHHHHHHhhcC-CCCC-CccCHHHHHHHHHH-hC----CCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDND-GVVSTDELKAGLRN-FG----SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~d-G~i~~~el~~~l~~-~g----~~~~~~e~~~~~~~~d~~  405 (408)
                      .....++++|+.+| .|++ |+|+.+||+.+++. +|    ...++.+++++|+.+|.|
T Consensus         7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d   65 (93)
T 4eto_A            7 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSN   65 (93)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCC
Confidence            34678899999997 6775 89999999999996 65    345899999999999986

>2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A

Probab=97.98  E-value=3.5e-06  Score=62.25  Aligned_cols=52  Identities=17%  Similarity=0.240  Sum_probs=46.1

Q ss_pred             hhhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDNDG-VVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|+.+| .|++| +|+.+||+.+++.     +|..+++.+++++++.+|.+
T Consensus         9 ~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d   67 (95)
T 2wcb_A            9 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDAN   67 (95)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSS
T ss_pred             HHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCC
Confidence            44678999999999 89998 9999999999987     67778999999999999876

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=97.97  E-value=1.7e-06  Score=65.72  Aligned_cols=53  Identities=19%  Similarity=0.211  Sum_probs=47.1

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++..+++++|..+|.|++|+|+.+|++.+|+.+|  ++++++++|++.+|.+
T Consensus        16 ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d   68 (110)
T 1iq3_A           16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDAD   68 (110)
T ss_dssp             CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSS
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCC
Confidence            3556778899999999999999999999999999887  5788999999999875

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=97.94  E-value=1.4e-05  Score=63.68  Aligned_cols=58  Identities=31%  Similarity=0.472  Sum_probs=52.6

Q ss_pred             hhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       348 ~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..++.++...+.++|..+|.|++|.|+.+|+..+++.+|..++..++..+++.+|.+
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~   59 (147)
T 4ds7_A            2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVD   59 (147)
T ss_dssp             --CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             CCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccC
Confidence            4556788899999999999999999999999999999999999999999999999875

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A

Probab=97.94  E-value=1.8e-05  Score=63.88  Aligned_cols=53  Identities=21%  Similarity=0.337  Sum_probs=49.0

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++...++++|..+|.|++|.|+.+||..+|+.+|..+++.+++++++.+|.+
T Consensus        46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d   98 (150)
T 2jjz_A           46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGG   98 (150)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCC
Confidence            35567899999999999999999999999999999999999999999999865

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica}

Probab=97.93  E-value=2.4e-06  Score=58.17  Aligned_cols=47  Identities=28%  Similarity=0.389  Sum_probs=42.9

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~   48 (66)
T 3li6_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDAD   48 (66)
T ss_dssp             CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCC
Confidence            35789999999999999999999999999888899999999999876

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=97.92  E-value=1.8e-05  Score=64.24  Aligned_cols=58  Identities=28%  Similarity=0.365  Sum_probs=53.3

Q ss_pred             hhhhchhhhHHHHHHHhhcCCCC-CCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          348 AEFLSVEEVEDIKEMFKKIDSDN-DGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       348 ~~~ls~~~~~~l~~~F~~~D~~~-dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...++.++...+.++|..+|.|+ +|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         9 ~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~   67 (161)
T 1dtl_A            9 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDED   67 (161)
T ss_dssp             GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             HhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            34567788899999999999999 99999999999999999999999999999999875

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=97.92  E-value=1.7e-05  Score=65.77  Aligned_cols=57  Identities=32%  Similarity=0.538  Sum_probs=51.1

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.++...++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~   59 (179)
T 2f2o_A            3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD   59 (179)
T ss_dssp             ---CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccC
Confidence            456777888999999999999999999999999999999999999999999999875

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=97.91  E-value=1.3e-05  Score=74.57  Aligned_cols=51  Identities=31%  Similarity=0.568  Sum_probs=47.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++++++|+.+|.|++|+|+.+||+.+|.++|..++++|+++||+.+|.|
T Consensus       373 ~eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~D  423 (440)
T 3u0k_A          373 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADID  423 (440)
T ss_dssp             -CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTT
T ss_pred             hHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            456789999999999999999999999999999999999999999999976

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4

Probab=97.91  E-value=1.5e-05  Score=60.22  Aligned_cols=51  Identities=33%  Similarity=0.606  Sum_probs=47.3

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.+|+.+|.|++|+|+.+|+..+++.+   |..+++.+++.+++.+|.+
T Consensus        39 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~   92 (109)
T 5pal_A           39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSD   92 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            45678899999999999999999999999999   9999999999999999876

>1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A

Probab=97.91  E-value=9.7e-06  Score=59.38  Aligned_cols=52  Identities=19%  Similarity=0.279  Sum_probs=47.2

Q ss_pred             hhhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDNDG-VVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....++.+|..+| .|++| .|+.+|++.+++.     +|..+++.+++++++.+|.+
T Consensus         6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d   64 (93)
T 1k2h_A            6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDEN   64 (93)
T ss_dssp             HHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            34677899999999 79999 9999999999998     99999999999999998854

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4

Probab=97.91  E-value=1.6e-05  Score=60.16  Aligned_cols=52  Identities=35%  Similarity=0.541  Sum_probs=47.6

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....++.+|..+|.|++|+|+.+|+..+++.+   |..+++.+++.+++.+|.+
T Consensus        39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~   93 (109)
T 1bu3_A           39 KSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSD   93 (109)
T ss_dssp             SCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCTT
T ss_pred             hhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCCC
Confidence            345678899999999999999999999999999   7889999999999999875

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A

Probab=97.91  E-value=1.8e-05  Score=59.83  Aligned_cols=52  Identities=29%  Similarity=0.557  Sum_probs=47.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....++.+|..+|.|++|+|+.+|+..+++.+   |..+++.+++.+++.+|.+
T Consensus        38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~   92 (109)
T 1rwy_A           38 KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKD   92 (109)
T ss_dssp             SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTT
T ss_pred             chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCCC
Confidence            346678999999999999999999999999999   7889999999999999875

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A

Probab=97.89  E-value=5.8e-06  Score=57.93  Aligned_cols=51  Identities=27%  Similarity=0.432  Sum_probs=46.8

Q ss_pred             hhHHHHHHHhhc-CCCCC-CccCHHHHHHHHHHhCCCC--CHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKI-DSDND-GVVSTDELKAGLRNFGSQL--AESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~-D~~~d-G~i~~~el~~~l~~~g~~~--~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+ |.|++ |.|+.+|+..+++.+|..+  +..+++.+++.+|.+
T Consensus         3 ~~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~   57 (76)
T 1qx2_A            3 SPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKN   57 (76)
T ss_dssp             CHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTT
T ss_pred             hHHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCC
Confidence            346788999999 99999 9999999999999999888  999999999999875

>4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens}

Probab=97.89  E-value=9.1e-06  Score=62.55  Aligned_cols=50  Identities=16%  Similarity=0.315  Sum_probs=45.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.+..+|..+|.| +|+|+.+||+.+|++     +|...++.++++||+.+|.|
T Consensus        13 ~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d   67 (121)
T 4drw_A           13 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQC   67 (121)
T ss_dssp             HHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCC
Confidence            467899999999988 899999999999987     78889999999999999987

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=97.88  E-value=2.1e-05  Score=62.40  Aligned_cols=53  Identities=21%  Similarity=0.492  Sum_probs=48.1

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +++..+++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~   54 (142)
T 2bl0_C            2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADAT   54 (142)
T ss_dssp             CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcC
Confidence            45677899999999999999999999999999999999999999999998875

>2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A

Probab=97.87  E-value=2.4e-05  Score=61.68  Aligned_cols=50  Identities=10%  Similarity=0.151  Sum_probs=45.6

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++..+++++|+.+| |++|+|+.+|++.+|+.+|  +++.++++|++.+|.+
T Consensus        47 ~~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g--l~~~el~~I~~~~D~d   96 (139)
T 2jq6_A           47 GKDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK--LPNTVLGKIWKLADVD   96 (139)
T ss_dssp             GGTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCSS
T ss_pred             hHHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC--cCHHHHHHHHHHhCCC
Confidence            356778999999999 9999999999999999977  6899999999999976

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A

Probab=97.86  E-value=1.4e-05  Score=60.35  Aligned_cols=52  Identities=31%  Similarity=0.554  Sum_probs=47.5

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....++.+|..+|.|++|+|+.+||..+++.+   |..+++.+++.+++.+|.+
T Consensus        38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~   92 (108)
T 2pvb_A           38 KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKD   92 (108)
T ss_dssp             SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTT
T ss_pred             hHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCCC
Confidence            345678899999999999999999999999999   7889999999999999875

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=97.86  E-value=2e-05  Score=68.07  Aligned_cols=74  Identities=15%  Similarity=0.213  Sum_probs=64.1

Q ss_pred             hhhhhhhhHHHHhhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          332 QFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       332 ~~~~~~~~~~~~l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+.....+++.....+...++.++...++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus        26 ~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d   99 (220)
T 3sjs_A           26 IYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTD   99 (220)
T ss_dssp             HHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTT
T ss_pred             ccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            34445556666666677788999999999999999999999999999999999999999999999999999865

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=97.86  E-value=4.9e-05  Score=60.80  Aligned_cols=51  Identities=31%  Similarity=0.551  Sum_probs=47.3

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|.|+.+||+.++..+|..+++.+++++++.+|.+
T Consensus        81 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d  131 (148)
T 1exr_A           81 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADID  131 (148)
T ss_dssp             HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSS
T ss_pred             cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            346688999999999999999999999999999999999999999999875

>2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A

Probab=97.85  E-value=1e-05  Score=59.32  Aligned_cols=51  Identities=20%  Similarity=0.369  Sum_probs=44.9

Q ss_pred             hhhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH---hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDNDG-VVSTDELKAGLRN---FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~---~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++...++++|..+| .|++| +|+.+||+.+++.   +|. +++.+++++|+.+|.|
T Consensus         7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d   62 (92)
T 2kax_A            7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKN   62 (92)
T ss_dssp             HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTT
T ss_pred             HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCC
Confidence            34678999999999 99999 9999999999997   334 7889999999999976

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=97.85  E-value=2.4e-05  Score=63.40  Aligned_cols=57  Identities=32%  Similarity=0.455  Sum_probs=52.8

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.++...+.++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus        15 ~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~   71 (161)
T 3fwb_A           15 SELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSE   71 (161)
T ss_dssp             TTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcC
Confidence            356778889999999999999999999999999999999999999999999999875

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana}

Probab=97.84  E-value=2.2e-05  Score=62.00  Aligned_cols=51  Identities=10%  Similarity=0.227  Sum_probs=47.1

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC-CCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g-~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.+|..+|.|++|+|+.+||+.+++.+| ..+++.+++.+++.+|.+
T Consensus        38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~d   89 (135)
T 3h4s_E           38 FVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDLD   89 (135)
T ss_dssp             HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCSS
T ss_pred             hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCC
Confidence            456788999999999999999999999999999 599999999999999875

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A

Probab=97.84  E-value=1.6e-05  Score=60.24  Aligned_cols=52  Identities=33%  Similarity=0.624  Sum_probs=47.6

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....++.+|..+|.|++|+|+.+|+..+++.+   |..+++.+++.+++.+|.+
T Consensus        39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~~   93 (110)
T 1pva_A           39 MSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKD   93 (110)
T ss_dssp             SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTT
T ss_pred             chHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCCC
Confidence            346678999999999999999999999999999   7889999999999999875

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B

Probab=97.84  E-value=2.7e-05  Score=63.68  Aligned_cols=55  Identities=29%  Similarity=0.613  Sum_probs=50.4

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC-CCCHHHHHHHHHHhCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS-QLAESEVQMLIEASSS  404 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~-~~~~~e~~~~~~~~d~  404 (408)
                      .++.++...++++|..+|.|++|.|+.+|+..+|+.+|. .++..++..++...|-
T Consensus        18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~dg   73 (166)
T 2mys_B           18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEASG   73 (166)
T ss_pred             hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHCCC
Confidence            567788899999999999999999999999999999999 9999999999987653

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=97.83  E-value=1e-05  Score=64.92  Aligned_cols=57  Identities=28%  Similarity=0.457  Sum_probs=52.8

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.++...+.++|..+|.|++|.|+.+|+..+++.+|..++..++..+++.+|.+
T Consensus         3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~   59 (153)
T 3ox6_A            3 RSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMN   59 (153)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTT
T ss_pred             ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            456778889999999999999999999999999999999999999999999998865

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A

Probab=97.83  E-value=1.6e-05  Score=60.17  Aligned_cols=51  Identities=27%  Similarity=0.509  Sum_probs=47.2

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.+|+.+|.|++|+|+.+|+..+++.+   |..+++.+++.+++.+|.+
T Consensus        40 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~~   93 (109)
T 3fs7_A           40 TPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTD   93 (109)
T ss_dssp             CHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCCC
Confidence            45678899999999999999999999999999   8899999999999999876

>1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A*

Probab=97.82  E-value=2.8e-05  Score=59.32  Aligned_cols=52  Identities=15%  Similarity=0.243  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHhhcCC-CCCC-ccCHHHHHHHHH-HhCCC-----CCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDS-DNDG-VVSTDELKAGLR-NFGSQ-----LAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~-~~dG-~i~~~el~~~l~-~~g~~-----~~~~e~~~~~~~~d~~  405 (408)
                      ++...++++|..+|. |++| +|+.+||+.+|+ .+|..     +++.+++++|+.+|.|
T Consensus         9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d   68 (113)
T 1xk4_C            9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTN   68 (113)
T ss_dssp             HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCC
Confidence            346788999999995 9999 999999999999 78852     5899999999999876

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.82  E-value=3.6e-05  Score=71.99  Aligned_cols=141  Identities=13%  Similarity=0.123  Sum_probs=83.9

Q ss_pred             cceecccCCeEEEEEEECC-------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           56 DRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      .+.|..|-...+|++....       .+..+++|+.... .   .....+.+|..+++.|..+.-.++++.++.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            4568888889999998642       3578999986321 1   2345667899999888545445677766654    2


Q ss_pred             EEEeccCCCchHH--------------HHH---hC----C-CC--CHHHHHHHHHHHHH-------------------HH
Q 015352          129 LVMELCEGGELFD--------------RIV---AR----G-HY--TERAAAAVTRTIVE-------------------VV  165 (408)
Q Consensus       129 lv~e~~~g~~L~~--------------~l~---~~----~-~~--~~~~~~~i~~ql~~-------------------~l  165 (408)
                      +||||++|.+|..              .+.   ..    + ..  -..++..+..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999999865421              111   11    1 11  13455556554422                   23


Q ss_pred             HHHH----H----CCCeeccCCCCceEeecC-CCCCCEEEeecccccc
Q 015352          166 QLCH----K----HGVIHRDLKPENFLFANK-KENSPLKAIDFGLSIF  204 (408)
Q Consensus       166 ~~lH----~----~~ivH~dikp~NIl~~~~-~~~~~vkl~Dfg~~~~  204 (408)
                      ..|.    .    ..++|+|+.+.||++..+ +..+.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3333    2    258999999999999753 1235799999997754

>2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A

Probab=97.82  E-value=1.3e-05  Score=60.40  Aligned_cols=52  Identities=13%  Similarity=0.196  Sum_probs=43.9

Q ss_pred             hhhHHHHHHHhhcC-CCCC-CccCHHHHHHHHHH-hCCCC-CHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDND-GVVSTDELKAGLRN-FGSQL-AESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~d-G~i~~~el~~~l~~-~g~~~-~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|..|| .|++ |+|+.+||+.+|+. +|... ++.+++++|+.+|.|
T Consensus        19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d   74 (106)
T 2h2k_A           19 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVN   74 (106)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCC
Confidence            44678999999999 7987 79999999999986 77544 357899999999976

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=97.81  E-value=3.3e-05  Score=62.50  Aligned_cols=56  Identities=27%  Similarity=0.407  Sum_probs=51.8

Q ss_pred             hhchhhhHHHHHHHhhcC-CCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKID-SDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D-~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++...++++|..+| .|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~   62 (158)
T 2jnf_A            6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPF   62 (158)
T ss_dssp             TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTT
T ss_pred             hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            356778889999999999 99999999999999999999999999999999999875

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=97.81  E-value=3.7e-05  Score=62.98  Aligned_cols=56  Identities=27%  Similarity=0.477  Sum_probs=51.9

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++...+.++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus        21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~   76 (169)
T 3qrx_A           21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKD   76 (169)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSS
T ss_pred             CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCC
Confidence            35667888999999999999999999999999999999999999999999999875

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=97.81  E-value=3.5e-05  Score=62.53  Aligned_cols=59  Identities=31%  Similarity=0.464  Sum_probs=54.4

Q ss_pred             hhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       347 i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +...++.++...+.++|..+|.|++|.|+.+|+..+++.+|..++..++..+++.+|.+
T Consensus        10 ~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~   68 (162)
T 1top_A           10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDED   68 (162)
T ss_dssp             HHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             hhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCC
Confidence            44567888899999999999999999999999999999999999999999999999875

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=97.80  E-value=4.9e-06  Score=67.92  Aligned_cols=51  Identities=27%  Similarity=0.408  Sum_probs=46.5

Q ss_pred             hhchhhhHHHHHHHhhcCC--CCCCccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 015352          350 FLSVEEVEDIKEMFKKIDS--DNDGVVSTDELKAGLRNFGSQLAESEVQMLIE  400 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~--~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~  400 (408)
                      +++.+++.+++++|..+|.  |++|+|+.+||..+|+.+|..+++.++++++.
T Consensus         2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~   54 (159)
T 3i5g_C            2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGG   54 (159)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTC
T ss_pred             CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHc
Confidence            4678889999999999995  89999999999999999999999999988764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.80  E-value=4.2e-05  Score=69.37  Aligned_cols=72  Identities=11%  Similarity=0.032  Sum_probs=44.8

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc-
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC-  134 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-  134 (408)
                      .+.|+.|....+|++      ..+++|+...... ...   ...+|+.+++.+..+.-.++++.+  +.+.-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~---~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYI---NRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CC---CHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc-cee---CHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            678999999999999      4488898764311 111   124577777766333222455544  333457899999 


Q ss_pred             CCCch
Q 015352          135 EGGEL  139 (408)
Q Consensus       135 ~g~~L  139 (408)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            76555

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B

Probab=97.80  E-value=5.8e-05  Score=61.64  Aligned_cols=51  Identities=22%  Similarity=0.271  Sum_probs=47.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+||..++..+|..+++.+++.+|+.+|.|
T Consensus        93 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d  143 (166)
T 2mys_B           93 PEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPD  143 (166)
T ss_pred             cHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCC
Confidence            346788999999999999999999999999999999999999999999875

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=97.79  E-value=7.3e-05  Score=60.51  Aligned_cols=52  Identities=25%  Similarity=0.492  Sum_probs=48.0

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+
T Consensus        93 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~  144 (161)
T 3fwb_A           93 DPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLD  144 (161)
T ss_dssp             CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSS
T ss_pred             CcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            3456788999999999999999999999999999999999999999999865

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=97.79  E-value=5.1e-05  Score=62.08  Aligned_cols=51  Identities=27%  Similarity=0.515  Sum_probs=47.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|.|+.+|+..++..+|..+++++++.+++.+|.+
T Consensus        99 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~  149 (169)
T 3qrx_A           99 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRN  149 (169)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            356788999999999999999999999999999999999999999999876

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=97.78  E-value=4.1e-05  Score=61.06  Aligned_cols=55  Identities=18%  Similarity=0.323  Sum_probs=50.5

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh---CCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS---SSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~---d~~  405 (408)
                      ++.++..++.++|..+|.|++|.|+.+|+..+++.+|..++..++..+++.+   |.+
T Consensus         2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~   59 (149)
T 2mys_C            2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMN   59 (149)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhcccc
Confidence            4567788899999999999999999999999999999999999999999998   764

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A

Probab=97.77  E-value=2e-05  Score=59.46  Aligned_cols=52  Identities=35%  Similarity=0.566  Sum_probs=47.0

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....++.+|+.+|.|++|+|+.+|+..+++.+   |..+++.+++.+++.+|.+
T Consensus        38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~   92 (108)
T 1rro_A           38 MSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADND   92 (108)
T ss_dssp             SCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCS
T ss_pred             ccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCC
Confidence            345678899999999999999999999999998   6789999999999999875

>3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A

Probab=97.76  E-value=6.7e-05  Score=55.73  Aligned_cols=52  Identities=19%  Similarity=0.146  Sum_probs=43.2

Q ss_pred             hhhHHHHHHHhhcCCCC---CCccCHHHHHHHHHHhC-CCCC----HHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDN---DGVVSTDELKAGLRNFG-SQLA----ESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~---dG~i~~~el~~~l~~~g-~~~~----~~e~~~~~~~~d~~  405 (408)
                      ....+++++|..||.++   +|+|+.+||+.+|+.++ ..++    +.+++++|+.+|.|
T Consensus         8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d   67 (100)
T 3nxa_A            8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDAN   67 (100)
T ss_dssp             HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCC
T ss_pred             HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCC
Confidence            34678999999999964   79999999999998753 3333    78999999999976

>1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A

Probab=97.75  E-value=7.9e-06  Score=60.02  Aligned_cols=52  Identities=13%  Similarity=0.171  Sum_probs=45.4

Q ss_pred             hhhHHHHHHHhhcCC-CCCC-ccCHHHHHHHH-HHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDS-DNDG-VVSTDELKAGL-RNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~-~~dG-~i~~~el~~~l-~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +....+..+|..+|. |++| .|+.+||+.++ +.+|..++..+++.+++.+|.|
T Consensus         7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~d   61 (93)
T 1xk4_A            7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDIN   61 (93)
T ss_dssp             HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCCC
Confidence            345678999999999 9999 99999999999 7888666678899999999876

>1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A

Probab=97.75  E-value=1.4e-05  Score=58.10  Aligned_cols=51  Identities=25%  Similarity=0.423  Sum_probs=46.2

Q ss_pred             hhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHHH---hCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKID-SDNDG-VVSTDELKAGLRN---FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~~---~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+| .|++| .|+.+||+.+++.   +|..+++.+++++++.+|.+
T Consensus         8 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~   63 (90)
T 1k8u_A            8 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRN   63 (90)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhCCC
Confidence            4567899999999 59999 9999999999998   99889999999999999865

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=97.74  E-value=1.9e-05  Score=66.30  Aligned_cols=56  Identities=48%  Similarity=0.728  Sum_probs=51.0

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++...++++|..+|.|++|.|+.+|+..+|+.+|..++..+++.+++.+|.+
T Consensus         3 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d   58 (188)
T 1s6i_A            3 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADID   58 (188)
T ss_dssp             SSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTT
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCC
Confidence            35667788899999999999999999999999999999999999999999999875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.73  E-value=0.00031  Score=59.29  Aligned_cols=122  Identities=16%  Similarity=0.043  Sum_probs=77.8

Q ss_pred             CchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCceecc
Q 015352          137 GELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI  214 (408)
Q Consensus       137 ~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~~~~  214 (408)
                      .+|.+.|... .+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++.   .+|.|-+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence            3788888764 679999999999999999877622 1212333456788884   445554442 1110           


Q ss_pred             cCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCC
Q 015352          215 VGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEP  294 (408)
Q Consensus       215 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (408)
                      .....+.|||......+.+.=|||||+++|..+--..|-                     ..-..+|+.+..||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHHHHHHHHHHhc
Confidence            122346788876545667889999999999988643331                     11136899999999999765

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=97.73  E-value=4.2e-05  Score=61.05  Aligned_cols=51  Identities=27%  Similarity=0.474  Sum_probs=47.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|.|+.+|++.+++.+|..+++.+++.+++.+|.+
T Consensus        81 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d  131 (148)
T 1m45_A           81 KTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVD  131 (148)
T ss_dssp             CTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCC
T ss_pred             cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            356788999999999999999999999999999999999999999999875

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus}

Probab=97.73  E-value=4e-05  Score=60.78  Aligned_cols=51  Identities=20%  Similarity=0.387  Sum_probs=47.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|++.++..+|..+++.+++.+++.+|.+
T Consensus        74 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d  124 (143)
T 3j04_B           74 PEDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPID  124 (143)
T ss_dssp             CHHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCC
T ss_pred             cHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCC
Confidence            346788999999999999999999999999999999999999999999875

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=97.67  E-value=8.3e-05  Score=59.92  Aligned_cols=52  Identities=27%  Similarity=0.452  Sum_probs=47.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHH--hCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA--SSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~--~d~~  405 (408)
                      .....+..+|..+|.|++|.|+.+|++.+++.+|..+++.+++.+++.  +|.+
T Consensus        81 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d  134 (156)
T 1wdc_C           81 GTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQED  134 (156)
T ss_dssp             CCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCC
T ss_pred             ChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCC
Confidence            345678899999999999999999999999999999999999999999  8865

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ...

Probab=97.67  E-value=5.7e-05  Score=60.97  Aligned_cols=56  Identities=27%  Similarity=0.492  Sum_probs=48.5

Q ss_pred             hhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       348 ~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ...++.++...++++|..+|.|++|.|+.+|+..+|+.+|..++..++..+++..|
T Consensus         9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~   64 (156)
T 1wdc_B            9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEAP   64 (156)
T ss_dssp             ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTTSS
T ss_pred             hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHhCC
Confidence            34567788899999999999999999999999999999999999999999986543

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group}

Probab=97.67  E-value=5.3e-05  Score=63.04  Aligned_cols=52  Identities=17%  Similarity=0.359  Sum_probs=46.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHH-HhCCC-C------CHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLR-NFGSQ-L------AESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~-~~g~~-~------~~~e~~~~~~~~d~~  405 (408)
                      .....++.+|+.+|.|++|+|+.+||+.+++ .+|.. +      ++.+++.+|+.+|.+
T Consensus        95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d  154 (179)
T 3a8r_A           95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPT  154 (179)
T ss_dssp             CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTT
T ss_pred             CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCC
Confidence            3456799999999999999999999999999 88876 6      889999999999976

>1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A

Probab=97.67  E-value=1.3e-05  Score=59.75  Aligned_cols=51  Identities=12%  Similarity=0.227  Sum_probs=44.4

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHH-----hCC--CCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN-----FGS--QLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~-----~g~--~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|..+|.+ +|+|+.+||+.+|+.     +|.  .+++.+++++|+.+|.|
T Consensus         7 ~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d   64 (100)
T 1psr_A            7 RSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKN   64 (100)
T ss_dssp             HHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTT
T ss_pred             HHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCC
Confidence            4567899999999976 799999999999987     565  67888999999999976

>1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1

Probab=97.67  E-value=1.1e-05  Score=56.71  Aligned_cols=51  Identities=24%  Similarity=0.363  Sum_probs=45.7

Q ss_pred             hhHHHHHHHhhcCC-CCCC-ccCHHHHHHHHHH-hCCCC-CHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDS-DNDG-VVSTDELKAGLRN-FGSQL-AESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~-~~dG-~i~~~el~~~l~~-~g~~~-~~~e~~~~~~~~d~~  405 (408)
                      +...++.+|..+|. |++| .|+.+|+..+++. +|..+ +..+++.+++.+|.+
T Consensus         5 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~   59 (78)
T 1cb1_A            5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKN   59 (78)
T ss_dssp             CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCC
Confidence            45678999999999 9999 9999999999986 88777 888999999999875

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=97.64  E-value=0.00013  Score=60.22  Aligned_cols=51  Identities=31%  Similarity=0.568  Sum_probs=45.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|+..++..+|..+++++++.+|+.+|.+
T Consensus        82 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~  132 (179)
T 2f2o_A           82 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADID  132 (179)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCC
Confidence            346688999999999999999999999999999999999999999999875

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=97.64  E-value=0.00018  Score=58.24  Aligned_cols=51  Identities=25%  Similarity=0.487  Sum_probs=47.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|.|+.+|++.++..+|..+++++++.+++.+|.+
T Consensus        94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~  144 (162)
T 1top_A           94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKN  144 (162)
T ss_dssp             HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            456788999999999999999999999999999999999999999999875

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=97.63  E-value=8.7e-05  Score=59.92  Aligned_cols=51  Identities=20%  Similarity=0.436  Sum_probs=47.3

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|++.+++.+|..+++.+++.+++.+|.+
T Consensus        89 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d  139 (158)
T 2jnf_A           89 MQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDAD  139 (158)
T ss_dssp             TSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCC
Confidence            345688999999999999999999999999999999999999999999875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.63  E-value=0.00011  Score=70.05  Aligned_cols=75  Identities=13%  Similarity=0.075  Sum_probs=51.1

Q ss_pred             cceecccCCeEEEEEEECC-------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           56 DRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      .+.|+.|....||++....       .+..+++|+....  ..   ...+.+|..+++.|..+...+++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            4568889999999998653       2577999987421  11   24556799999888444444667666543    2


Q ss_pred             EEEeccCCCch
Q 015352          129 LVMELCEGGEL  139 (408)
Q Consensus       129 lv~e~~~g~~L  139 (408)
                      +|+||++|.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999987443

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ...

Probab=97.63  E-value=6e-05  Score=60.81  Aligned_cols=50  Identities=20%  Similarity=0.359  Sum_probs=46.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+||+.++..+|..+++++++.+++.+|.+
T Consensus        86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~  135 (156)
T 1wdc_B           86 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE  135 (156)
T ss_dssp             HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE
T ss_pred             HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC
Confidence            46788999999999999999999999999999999999999999999865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=6e-05  Score=68.94  Aligned_cols=139  Identities=19%  Similarity=0.179  Sum_probs=76.9

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC-CeeEEeeE------EEeCCeEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEA------CEDDNAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~------~~~~~~~~  128 (408)
                      .+.|+.|....+|++... .| .+++|+.....     ....+..|+.+++.|..+. .+++++..      ....+..+
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            456788888999999764 33 58899886421     1234566888877763221 13343321      23356789


Q ss_pred             EEEeccCCCchHH--------------HHHhC-CCC--------CHHHHHH---------------HHHHHHHHHHHHHH
Q 015352          129 LVMELCEGGELFD--------------RIVAR-GHY--------TERAAAA---------------VTRTIVEVVQLCHK  170 (408)
Q Consensus       129 lv~e~~~g~~L~~--------------~l~~~-~~~--------~~~~~~~---------------i~~ql~~~l~~lH~  170 (408)
                      ++++|++|..+..              .+... ..+        .......               +-..+...+..++.
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            9999999864310              11110 011        1110000               00113344555553


Q ss_pred             -------CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          171 -------HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       171 -------~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                             .+++|+|+++.||+++.   +..+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~---~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLG---DELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEET---TEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEeC---CceEEEecchhccC
Confidence                   36899999999999953   33357999997654

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=97.63  E-value=8.9e-05  Score=58.63  Aligned_cols=50  Identities=18%  Similarity=0.419  Sum_probs=46.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|++.+++.+|..+++.+++.+++.+| +
T Consensus        77 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~  126 (142)
T 2bl0_C           77 SEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-T  126 (142)
T ss_dssp             CHHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-C
T ss_pred             hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-C
Confidence            3557889999999999999999999999999999999999999999998 5

>1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A

Probab=97.62  E-value=2.7e-05  Score=57.50  Aligned_cols=51  Identities=14%  Similarity=0.296  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|..+|. ++|+|+.+||+.+|+.     +|..+++.+++++|+.+|.|
T Consensus         6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d   61 (96)
T 1a4p_A            6 HAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQC   61 (96)
T ss_dssp             HHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCC
Confidence            446789999999994 6779999999999987     56678899999999999976

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=97.61  E-value=6.4e-05  Score=59.65  Aligned_cols=52  Identities=29%  Similarity=0.533  Sum_probs=47.5

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....+..+|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+|.+
T Consensus        73 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~  124 (145)
T 2bl0_B           73 EQSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVS  124 (145)
T ss_dssp             GGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCC
T ss_pred             ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCC
Confidence            3456788999999999999999999999999999999999999999998865

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5

Probab=97.61  E-value=8.2e-05  Score=58.74  Aligned_cols=50  Identities=24%  Similarity=0.468  Sum_probs=46.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS  404 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~  404 (408)
                      ....+..+|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+|.
T Consensus        74 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~  123 (140)
T 1ggw_A           74 DPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV  123 (140)
T ss_dssp             CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC
T ss_pred             cHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC
Confidence            34678899999999999999999999999999999999999999999885

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.59  E-value=0.0001  Score=67.84  Aligned_cols=140  Identities=14%  Similarity=0.072  Sum_probs=70.4

Q ss_pred             ceecccCCeE-EEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC-CeeEEeeEEEeCCeEEEEEecc
Q 015352           57 RELGRGEFGV-TYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        57 ~~lg~G~~g~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      +.|+.|+... +|+... .+|..+++|.......      ..+..|+.+++.|..+. .+++++.+....+  +++||++
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence            3465555544 667643 2356677776543210      22345777777663322 2556665533333  7899999


Q ss_pred             CCCchHHHHHhC--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 015352          135 EGGELFDRIVAR--------------------------GHYTERAAA-------A-VT------------RTIVEVVQLC  168 (408)
Q Consensus       135 ~g~~L~~~l~~~--------------------------~~~~~~~~~-------~-i~------------~ql~~~l~~l  168 (408)
                      .|.++.+.+...                          ..+......       . +.            ..+...+..+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            776665443221                          012221110       0 00            0111222233


Q ss_pred             ------HHCCCeeccCCCCceEeecCCC-CCCEEEeeccccccc
Q 015352          169 ------HKHGVIHRDLKPENFLFANKKE-NSPLKAIDFGLSIFF  205 (408)
Q Consensus       169 ------H~~~ivH~dikp~NIl~~~~~~-~~~vkl~Dfg~~~~~  205 (408)
                            +...++|||+.+.||++..+.. ...+.|+||+.+...
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence                  1246999999999999954211 246899999987653

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=97.58  E-value=0.00013  Score=58.28  Aligned_cols=50  Identities=26%  Similarity=0.617  Sum_probs=46.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN-FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~-~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..+++. +|..+++.+++.+++.+|.+
T Consensus        87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~  137 (153)
T 3ox6_A           87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLN  137 (153)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCC
Confidence            466889999999999999999999999999 89999999999999999875

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=97.57  E-value=0.00022  Score=56.53  Aligned_cols=49  Identities=33%  Similarity=0.573  Sum_probs=45.8

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ....+..+|..+|.|++|.|+.+|+..++..+|..+++.+++.+++.+|
T Consensus        82 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d  130 (147)
T 4ds7_A           82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS  130 (147)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS
T ss_pred             cHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence            3457888999999999999999999999999999999999999999998

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A

Probab=97.55  E-value=3e-05  Score=61.83  Aligned_cols=54  Identities=17%  Similarity=0.190  Sum_probs=49.1

Q ss_pred             chhhhHHHHHHHhhcCCCC-CCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDN-DGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~-dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++..+++++|..+|.|+ +|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         9 ~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~   63 (146)
T 2qac_A            9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN   63 (146)
T ss_dssp             HHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE
T ss_pred             HHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            3455677899999999999 99999999999999999999999999999998865

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A*

Probab=97.55  E-value=5.1e-05  Score=63.71  Aligned_cols=60  Identities=15%  Similarity=0.240  Sum_probs=51.4

Q ss_pred             hhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHH-----HHHHHhCCCCCHH-----HHHHHHHHhCCC
Q 015352          346 VIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELK-----AGLRNFGSQLAES-----EVQMLIEASSSV  405 (408)
Q Consensus       346 ~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~-----~~l~~~g~~~~~~-----e~~~~~~~~d~~  405 (408)
                      .+...++.++...+.++|..+|.|++|.|+.+|+.     .+++.+|..++..     +++.+++.+|.+
T Consensus         9 ~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d   78 (195)
T 1qv0_A            9 LKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGME   78 (195)
T ss_dssp             CSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCC
T ss_pred             cCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCC
Confidence            34445678889999999999999999999999999     7888999877766     688899999865

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus}

Probab=97.54  E-value=6.7e-05  Score=59.48  Aligned_cols=50  Identities=20%  Similarity=0.480  Sum_probs=45.6

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHH
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA  401 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~  401 (408)
                      +.++...++++|..+|.|++|.|+.+|+..+|+.+|..++..++..++..
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~   51 (143)
T 3j04_B            2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE   51 (143)
T ss_dssp             CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT
T ss_pred             CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh
Confidence            46778899999999999999999999999999999999999999887754

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia}

Probab=97.53  E-value=9.8e-05  Score=62.29  Aligned_cols=50  Identities=14%  Similarity=0.213  Sum_probs=46.2

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|+|+.+||+.+| .+|..+++.+++.+|+.+|.|
T Consensus       124 ~~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d  173 (196)
T 3dtp_E          124 EEDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPID  173 (196)
T ss_dssp             CHHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEE
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCC
Confidence            35678899999999999999999999999 999999999999999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.52  E-value=0.0004  Score=63.58  Aligned_cols=77  Identities=13%  Similarity=0.137  Sum_probs=49.2

Q ss_pred             ceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC-CeeEEeeE-----EEeCCeEEEE
Q 015352           57 RELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS-SIVSLKEA-----CEDDNAVHLV  130 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~-----~~~~~~~~lv  130 (408)
                      ..++ |....||++.. .+|+.+++|+......    ....+..|..+++.|..+. .+++++..     ...++..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3466 88889998854 3466799999863211    2456777888888773221 14444432     2345677899


Q ss_pred             EeccCCCch
Q 015352          131 MELCEGGEL  139 (408)
Q Consensus       131 ~e~~~g~~L  139 (408)
                      |++++|.++
T Consensus       106 ~~~i~G~~~  114 (328)
T 1zyl_A          106 FPSVGGRQF  114 (328)
T ss_dssp             EECCCCEEC
T ss_pred             EEecCCCCC
Confidence            999988543

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=97.52  E-value=0.00029  Score=60.65  Aligned_cols=47  Identities=15%  Similarity=0.210  Sum_probs=45.1

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ..+..+|+.+|.|++|+|+.+|++.+++.+|..+++++++.+++.+|
T Consensus       117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d  163 (220)
T 3sjs_A          117 ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA  163 (220)
T ss_dssp             HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc
Confidence            66889999999999999999999999999999999999999999998

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=97.51  E-value=0.00058  Score=54.64  Aligned_cols=52  Identities=23%  Similarity=0.453  Sum_probs=47.0

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHH-hCCCCCHHHHHHHHHH----hCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN-FGSQLAESEVQMLIEA----SSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~-~g~~~~~~e~~~~~~~----~d~~  405 (408)
                      .....+..+|..+|.|++|.|+.+|+..++.. +|..+++.+++++++.    +|.+
T Consensus        72 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~  128 (155)
T 3ll8_B           72 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKD  128 (155)
T ss_dssp             CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCC
Confidence            34567899999999999999999999999999 6999999999999998    8865

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=97.50  E-value=0.00015  Score=57.75  Aligned_cols=51  Identities=27%  Similarity=0.447  Sum_probs=46.6

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .....+..+|..+|.|++|.|+.+|++.++..+|..+++++++.+++. |.+
T Consensus        82 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~  132 (149)
T 2mys_C           82 GTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QED  132 (149)
T ss_pred             chHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCC
Confidence            345678899999999999999999999999999999999999999998 865

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=97.49  E-value=1.9e-05  Score=63.41  Aligned_cols=55  Identities=22%  Similarity=0.358  Sum_probs=45.0

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~   58 (151)
T 1w7j_B            4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSD   58 (151)
T ss_dssp             -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcC
Confidence            4567788899999999999999999999999999999999999999999877653

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=97.49  E-value=5.6e-05  Score=60.54  Aligned_cols=48  Identities=29%  Similarity=0.489  Sum_probs=43.9

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ...+..+|..+|.|++|.|+.+|++.+++.+|..+++++++.+++.+|
T Consensus        86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d  133 (151)
T 1w7j_B           86 YEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE  133 (151)
T ss_dssp             --CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc
Confidence            456778999999999999999999999999999999999999999887

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=97.48  E-value=0.00029  Score=59.53  Aligned_cols=52  Identities=23%  Similarity=0.367  Sum_probs=47.5

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh-CCCCCHHHHHHHHHH----hCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-GSQLAESEVQMLIEA----SSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~-g~~~~~~e~~~~~~~----~d~~  405 (408)
                      .....+..+|+.+|.|++|.|+.+||..++..+ |..+++++++.+++.    +|.|
T Consensus       111 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d  167 (202)
T 2bec_A          111 SRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADED  167 (202)
T ss_dssp             SHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSS
T ss_pred             cHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCC
Confidence            445678899999999999999999999999999 999999999999998    8865

>1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A

Probab=97.46  E-value=7.5e-05  Score=55.24  Aligned_cols=52  Identities=13%  Similarity=0.206  Sum_probs=45.1

Q ss_pred             hhhHHHHHHHhhcC-CCCCC-ccCHHHHHHHHH-HhC----CCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKID-SDNDG-VVSTDELKAGLR-NFG----SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D-~~~dG-~i~~~el~~~l~-~~g----~~~~~~e~~~~~~~~d~~  405 (408)
                      +....+..+|..+| .|++| .|+.+||+.+++ .+|    ..+++.+++.+++.+|.+
T Consensus        10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~~   68 (99)
T 1qls_A           10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLD   68 (99)
T ss_dssp             HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCCC
Confidence            34567899999998 99999 999999999998 453    678899999999999876

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=97.45  E-value=0.00013  Score=61.78  Aligned_cols=54  Identities=19%  Similarity=0.413  Sum_probs=44.3

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+...++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus        32 ~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d   85 (204)
T 3e3r_A           32 GASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRN   85 (204)
T ss_dssp             --------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTT
T ss_pred             CchhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccC
Confidence            345677899999999999999999999999999999999999999999999875

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=97.45  E-value=0.00044  Score=57.71  Aligned_cols=48  Identities=17%  Similarity=0.322  Sum_probs=44.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..+++.+|  +++.+++.+|+.+|.|
T Consensus       108 ~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~d  155 (191)
T 2ccm_A          108 TKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSDG  155 (191)
T ss_dssp             HHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCCC
Confidence            35688999999999999999999999999998  7899999999999976

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A*

Probab=97.44  E-value=0.00023  Score=59.67  Aligned_cols=45  Identities=20%  Similarity=0.257  Sum_probs=39.4

Q ss_pred             HHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          361 EMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       361 ~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+|+.+|.|++|.|+.+|++.+++.+|..+++++++++|+.+|.|
T Consensus       117 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d  161 (195)
T 1qv0_A          117 AVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLD  161 (195)
T ss_dssp             HHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCC
T ss_pred             HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            899999999999999999999999999999999999999999875

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia}

Probab=97.44  E-value=0.00014  Score=61.36  Aligned_cols=54  Identities=26%  Similarity=0.581  Sum_probs=49.4

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~  402 (408)
                      ..++.++...++++|..+|.|++|.|+.+||..+|+.+|..++..++..++..+
T Consensus        49 ~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~  102 (196)
T 3dtp_E           49 AMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA  102 (196)
T ss_dssp             CSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS
T ss_pred             hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc
Confidence            346778889999999999999999999999999999999999999999998765

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A

Probab=97.44  E-value=0.00017  Score=60.15  Aligned_cols=46  Identities=20%  Similarity=0.317  Sum_probs=43.7

Q ss_pred             HHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       360 ~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+|+.+|.|++|.|+.+|++.+++.+|..+++++++.+|+.+|.|
T Consensus       112 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d  157 (191)
T 1uhk_A          112 DALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDID  157 (191)
T ss_dssp             HHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCC
T ss_pred             HHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            3899999999999999999999999999999999999999999875

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens}

Probab=97.43  E-value=0.00011  Score=60.75  Aligned_cols=46  Identities=17%  Similarity=0.326  Sum_probs=43.5

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHh----CCCCCHHHHHHHHHHhC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF----GSQLAESEVQMLIEASS  403 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g~~~~~~e~~~~~~~~d  403 (408)
                      ..++++|+.+| |++|+|+.+||+.+++.+    |..+++++++++++.+|
T Consensus        76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d  125 (174)
T 2i7a_A           76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS  125 (174)
T ss_dssp             HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS
T ss_pred             HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc
Confidence            46889999999 999999999999999999    99999999999999988

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=97.40  E-value=0.00024  Score=59.61  Aligned_cols=49  Identities=31%  Similarity=0.451  Sum_probs=45.6

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.++|+.+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.+
T Consensus        93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d  141 (191)
T 1y1x_A           93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQ  141 (191)
T ss_dssp             HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            5678899999999999999999999999999999999999999999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.40  E-value=0.00091  Score=64.16  Aligned_cols=76  Identities=13%  Similarity=0.069  Sum_probs=49.8

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEeccC
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      .+.|+.|-...+|++.....+..+++|+..... ....+   ..+|..+++.|..+.-.+++++++.  +  .+|+||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIIN---REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            456888999999999876545788999875321 11111   2579999999855544567777763  2  25999999


Q ss_pred             CCch
Q 015352          136 GGEL  139 (408)
Q Consensus       136 g~~L  139 (408)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            8544

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A

Probab=97.39  E-value=0.00026  Score=60.19  Aligned_cols=51  Identities=24%  Similarity=0.388  Sum_probs=46.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh-CCCCCHHHHHHH----HHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-GSQLAESEVQML----IEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~-g~~~~~~e~~~~----~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|.|+.+||..++..+ |..+++++++.+    |+.+|.|
T Consensus       111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d  166 (208)
T 2ct9_A          111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQD  166 (208)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCC
Confidence            45678899999999999999999999999997 999999999988    9999875

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A

Probab=97.39  E-value=0.00027  Score=61.23  Aligned_cols=50  Identities=14%  Similarity=0.277  Sum_probs=42.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh------------CCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF------------GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~------------g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+|+..+++.+            +...++.+++.+|+.+|.|
T Consensus       137 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d  198 (229)
T 3dd4_A          137 QEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKN  198 (229)
T ss_dssp             HHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCC
Confidence            4578899999999999999999999999987            5667889999999999876

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=97.38  E-value=0.00028  Score=57.88  Aligned_cols=50  Identities=30%  Similarity=0.565  Sum_probs=46.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..+|..+++.+++.+++.+|.+
T Consensus        73 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~  122 (172)
T 2znd_A           73 ITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQ  122 (172)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            35688999999999999999999999999999999999999999999875

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A

Probab=97.38  E-value=0.00024  Score=56.44  Aligned_cols=48  Identities=25%  Similarity=0.463  Sum_probs=44.7

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~  402 (408)
                      ....+..+|+.+|.|++|.|+.+|++.++..+|..+++.+++.+++.+
T Consensus        82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~  129 (146)
T 2qac_A           82 NVEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF  129 (146)
T ss_dssp             CHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc
Confidence            356788999999999999999999999999999999999999999887

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.37  E-value=0.0013  Score=59.04  Aligned_cols=79  Identities=16%  Similarity=0.041  Sum_probs=54.3

Q ss_pred             ceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCC--CeeEEeeEEEeCCeEEE
Q 015352           52 RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNS--SIVSLKEACEDDNAVHL  129 (408)
Q Consensus        52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--~i~~~~~~~~~~~~~~l  129 (408)
                      +..-++.+|.|..+.||+.... +|+.|++|+......   .....+..|...|+.|....  -+++++.+  +.  .++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            3455678999999999999864 688999998654322   12245788999999884332  24555543  22  368


Q ss_pred             EEeccCCCc
Q 015352          130 VMELCEGGE  138 (408)
Q Consensus       130 v~e~~~g~~  138 (408)
                      ||||++++.
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            999998764

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=97.37  E-value=0.00011  Score=62.51  Aligned_cols=57  Identities=18%  Similarity=0.194  Sum_probs=46.2

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC--CCCHHHHHHHH-------HHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS--QLAESEVQMLI-------EASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~--~~~~~e~~~~~-------~~~d~~  405 (408)
                      ..++.++...+.++|..+|.|++|.|+.+|+..+++.+|.  .++..+++.++       +.+|.+
T Consensus        28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d   93 (208)
T 2hpk_A           28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVE   93 (208)
T ss_dssp             --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCC
Confidence            3456677889999999999999999999999999999997  89999999999       888865

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=97.37  E-value=0.00019  Score=59.98  Aligned_cols=56  Identities=16%  Similarity=0.229  Sum_probs=50.2

Q ss_pred             hhchhhhHHHHHHHhhc-CCCCCCccCHHHHHHHHHHh----CCCCCHHHHHHHH-----------HHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKI-DSDNDGVVSTDELKAGLRNF----GSQLAESEVQMLI-----------EASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~-D~~~dG~i~~~el~~~l~~~----g~~~~~~e~~~~~-----------~~~d~~  405 (408)
                      .++..+...++++|..+ |.|++|.|+.+|+..+++.+    |..++..+++.++           +.+|.+
T Consensus         5 ~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d   76 (191)
T 2ccm_A            5 QLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADEN   76 (191)
T ss_dssp             CCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred             hccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            45667788899999999 99999999999999999998    9888999999999           888865

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=97.36  E-value=0.00016  Score=58.47  Aligned_cols=51  Identities=24%  Similarity=0.522  Sum_probs=45.3

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|++.++..+|..+++.+++.+|+.+|.+
T Consensus        93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d  143 (161)
T 1dtl_A           93 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKN  143 (161)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            455688999999999999999999999999999999999999999999865

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.35  E-value=0.00029  Score=65.74  Aligned_cols=76  Identities=13%  Similarity=0.102  Sum_probs=44.7

Q ss_pred             cceecccCCeEEEEEEECC--------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           56 DRELGRGEFGVTYLCIDRD--------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.|+.|....+|++....        .+..+++|+......    .......|..+++.|..+...++++...  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4567888889999997653        136788888754211    1112356888888774333345666544  22  


Q ss_pred             EEEEeccCCCch
Q 015352          128 HLVMELCEGGEL  139 (408)
Q Consensus       128 ~lv~e~~~g~~L  139 (408)
                      ++||||++|.++
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999998543

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=97.34  E-value=3.3e-05  Score=61.69  Aligned_cols=50  Identities=28%  Similarity=0.375  Sum_probs=44.1

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh-CCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS-SSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~-d~~  405 (408)
                      +.+++++|..+|.|++|.|+.+|+..+|+.+|..++..+++.+++.+ |.+
T Consensus         3 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~   53 (148)
T 1m45_A            3 TRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLR   53 (148)
T ss_dssp             CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC-
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCC
Confidence            44567889999999999999999999999999999999999999988 765

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=97.34  E-value=0.00018  Score=55.99  Aligned_cols=47  Identities=28%  Similarity=0.389  Sum_probs=31.1

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++++|..+|.|++|.|+.+|+..+++.+|..++..+++.+++.+|.+
T Consensus         2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~   48 (134)
T 1jfj_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDAD   48 (134)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCC
Confidence            45566666666667777777766666666666666666666666654

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A

Probab=97.32  E-value=0.00018  Score=60.00  Aligned_cols=55  Identities=20%  Similarity=0.319  Sum_probs=48.8

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHH-----HHHHHhCCCCCHH-----HHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELK-----AGLRNFGSQLAES-----EVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~-----~~l~~~g~~~~~~-----e~~~~~~~~d~~  405 (408)
                      .+.++..+++++|..+|.|++|.|+.+|+.     .+++.+|..++..     +++.+++.+|.+
T Consensus        10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d   74 (191)
T 1uhk_A           10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMK   74 (191)
T ss_dssp             TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcC
Confidence            356778899999999999999999999999     8899999887777     689999999875

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=97.31  E-value=0.00029  Score=66.78  Aligned_cols=51  Identities=31%  Similarity=0.568  Sum_probs=47.3

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.++.+|+.+|.|++|+|+.+||+.+|+.+|..+++++++.+++.+|.+
T Consensus       383 ~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D  433 (450)
T 3sg6_A          383 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADID  433 (450)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTT
T ss_pred             hhhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            345688999999999999999999999999999999999999999999865

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A

Probab=97.30  E-value=2.2e-05  Score=59.19  Aligned_cols=51  Identities=31%  Similarity=0.529  Sum_probs=46.3

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.+|+.+|.|++|+|+.+|+..+++.+   |..+++.+++.+++.+|.+
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~d   92 (108)
T 2kyc_A           39 SSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADHD   92 (108)
T ss_dssp             CSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCCS
T ss_pred             cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCC
Confidence            34568899999999999999999999999999   7889999999999999865

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=97.29  E-value=7.5e-05  Score=60.20  Aligned_cols=54  Identities=26%  Similarity=0.418  Sum_probs=44.5

Q ss_pred             hchhhhHHHHHHHhhcCC--CCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDS--DNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~--~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++..+++++|..+|.  |++|.|+.+|+..+|+.+|..++..++..+ +.+|.+
T Consensus         3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~   58 (156)
T 1wdc_C            3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKM   58 (156)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSST
T ss_pred             CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCC
Confidence            456677888888999998  899999999999999888888888888887 666654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.28  E-value=0.0018  Score=59.53  Aligned_cols=69  Identities=9%  Similarity=-0.015  Sum_probs=43.4

Q ss_pred             cccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeE------EEeCCeEEEEE
Q 015352           60 GRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEA------CEDDNAVHLVM  131 (408)
Q Consensus        60 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~------~~~~~~~~lv~  131 (408)
                      |.|....||++... +| .+++|+......         ..|+.+++.|.  .-|.+++++..      ....+..+++|
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            44446899999743 45 899998765431         24666665552  22334444432      34467889999


Q ss_pred             eccCCCch
Q 015352          132 ELCEGGEL  139 (408)
Q Consensus       132 e~~~g~~L  139 (408)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99998765

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A

Probab=97.27  E-value=0.00042  Score=56.16  Aligned_cols=48  Identities=21%  Similarity=0.285  Sum_probs=44.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+|+..++..+|  +++++++.+++.+|.+
T Consensus        97 ~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~d  144 (166)
T 3akb_A           97 RPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTD  144 (166)
T ss_dssp             HHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCC
Confidence            34588999999999999999999999999998  8999999999999875

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=97.25  E-value=0.00016  Score=61.02  Aligned_cols=50  Identities=24%  Similarity=0.244  Sum_probs=44.0

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh--CCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF--GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~--g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+||..++..+  |..+++++++++|+.+|.+
T Consensus       128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~d  179 (197)
T 3pm8_A          128 KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLN  179 (197)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcCC
Confidence            4578899999999999999999999999998  7778899999999999876

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A

Probab=97.24  E-value=7e-05  Score=62.36  Aligned_cols=52  Identities=17%  Similarity=0.271  Sum_probs=45.7

Q ss_pred             hhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh------CCCCCHHHHHHHH
Q 015352          348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF------GSQLAESEVQMLI  399 (408)
Q Consensus       348 ~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~------g~~~~~~e~~~~~  399 (408)
                      ...++.++...++++|..+|.|++|.|+.+|+..+++.+      |..++..+++.++
T Consensus         5 ~~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~   62 (186)
T 2hps_A            5 TESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFL   62 (186)
T ss_dssp             CHHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHH
T ss_pred             cccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHH
Confidence            345667788899999999999999999999999999877      8888889998885

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A

Probab=97.21  E-value=0.00061  Score=55.74  Aligned_cols=48  Identities=19%  Similarity=0.290  Sum_probs=44.1

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+|++.++..+|  +++++++.+|+.+|.|
T Consensus        93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d  140 (174)
T 1q80_A           93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDTN  140 (174)
T ss_dssp             HTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCCC
Confidence            46788999999999999999999999999997  6889999999999875

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=97.19  E-value=0.00024  Score=58.31  Aligned_cols=51  Identities=24%  Similarity=0.368  Sum_probs=44.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC-CCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g-~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+++++|..+|.|++|.|+.+|+..+++.+| ..++..+++.+++.+|.+
T Consensus         5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~   56 (172)
T 2znd_A            5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRE   56 (172)
T ss_dssp             -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSS
T ss_pred             chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCC
Confidence            456788999999999999999999999999888 678999999999998875

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A

Probab=97.19  E-value=0.00068  Score=55.08  Aligned_cols=46  Identities=24%  Similarity=0.441  Sum_probs=43.5

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~  402 (408)
                      ..+..+|+.+|.|++|.|+.+|+..+++.+|..+++.+++.+++.+
T Consensus        70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~  115 (165)
T 1k94_A           70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY  115 (165)
T ss_dssp             HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence            5688999999999999999999999999999999999999999887

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi}

Probab=97.18  E-value=0.00022  Score=61.30  Aligned_cols=50  Identities=16%  Similarity=0.278  Sum_probs=45.9

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS-QLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~-~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|+|+.+||+.++..+|. .+++++++.+|+.+|.|
T Consensus       129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d  179 (219)
T 3cs1_A          129 FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKN  179 (219)
T ss_dssp             HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCC
Confidence            457889999999999999999999999999987 78889999999999875

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=97.17  E-value=0.00014  Score=60.89  Aligned_cols=48  Identities=23%  Similarity=0.484  Sum_probs=43.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|++.++..+|  +++.+++.+|+.+|.+
T Consensus        81 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d  128 (188)
T 1s6i_A           81 EENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQD  128 (188)
T ss_dssp             CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCC
Confidence            35678999999999999999999999999988  5788999999999876

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=97.17  E-value=0.00045  Score=58.32  Aligned_cols=51  Identities=24%  Similarity=0.375  Sum_probs=45.0

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHH-------HhCCCCCHHHHHHHHHHhCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLR-------NFGSQLAESEVQMLIEASSS  404 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~-------~~g~~~~~~e~~~~~~~~d~  404 (408)
                      .....+..+|..+|.|++|.|+.+|+..++.       ..|...++++++.+|+.+|.
T Consensus       106 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~  163 (204)
T 3e3r_A          106 AREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDS  163 (204)
T ss_dssp             HHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSC
T ss_pred             hHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhc
Confidence            4456789999999999999999999999998       45677788899999999996

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5

Probab=97.17  E-value=0.00057  Score=55.98  Aligned_cols=48  Identities=21%  Similarity=0.323  Sum_probs=44.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..+|  +++++++.+|+.+|.+
T Consensus       101 ~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d  148 (176)
T 1nya_A          101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTN  148 (176)
T ss_dssp             HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCC
Confidence            35678999999999999999999999999998  8999999999999876

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=97.16  E-value=0.00039  Score=59.04  Aligned_cols=45  Identities=24%  Similarity=0.477  Sum_probs=42.6

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+|+.+|.|++|.|+.+|+..+++.+|  +++++++.+|+.+|.|
T Consensus       130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d  174 (208)
T 2hpk_A          130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADTD  174 (208)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCTT
T ss_pred             HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCCC
Confidence            78899999999999999999999999999  7899999999999875

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=97.16  E-value=0.00025  Score=57.63  Aligned_cols=49  Identities=20%  Similarity=0.441  Sum_probs=37.2

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|+..+++.+|  +++++++.+++.+|.+
T Consensus        97 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~~~~~~~~~~~~d~~  145 (166)
T 2aao_A           97 REDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDVDQD  145 (166)
T ss_dssp             TTHHHHHHHHHHCTTCSSSBCHHHHHHHTCC----------CCHHHHHCTT
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHhCCC
Confidence            346788999999999999999999999999887  5688899999999875

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=97.16  E-value=0.0005  Score=65.18  Aligned_cols=56  Identities=32%  Similarity=0.532  Sum_probs=51.2

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++..+++++|..+|.|++|.|+.+||..+|+.+|..++..+++.+++.+|.+
T Consensus       305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~D  360 (450)
T 3sg6_A          305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD  360 (450)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTT
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccC
Confidence            45667778999999999999999999999999999999999999999999999875

>1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7

Probab=97.14  E-value=0.00054  Score=51.02  Aligned_cols=48  Identities=21%  Similarity=0.321  Sum_probs=40.1

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHH-----hCCCCCH-----------HHHHHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRN-----FGSQLAE-----------SEVQMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~-----~g~~~~~-----------~e~~~~~~~~d~~  405 (408)
                      .+..+|..+|.|++|+|+.+||..+++.     +|...+.           ..++.+|+.+|.|
T Consensus        21 ~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~d   84 (103)
T 1snl_A           21 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTN   84 (103)
T ss_dssp             CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCCC
Confidence            4788999999999999999999999996     4755443           3488899999876

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C

Probab=97.14  E-value=0.00029  Score=56.07  Aligned_cols=50  Identities=20%  Similarity=0.239  Sum_probs=39.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC--------CCCCHHHHHHHH----HHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG--------SQLAESEVQMLI----EASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g--------~~~~~~e~~~~~----~~~d~~  405 (408)
                      .+.+..+|+.+|.|++|+|+.+|+..+++.++        ..++.+++++++    +.+|.|
T Consensus        67 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D~d  128 (143)
T 3a4u_B           67 QELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKN  128 (143)
T ss_dssp             HHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcCCC
Confidence            35677899999999999999999999998874        578999997766    888865

>3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A

Probab=97.14  E-value=0.00073  Score=51.51  Aligned_cols=52  Identities=15%  Similarity=0.260  Sum_probs=46.3

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...+.++|+.+|. ++|+|+.+|++.++.+.|  ++..++.+|++.+|.+
T Consensus        27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg--Lp~~~L~~Iw~laD~d   78 (121)
T 3fia_A           27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG--LPQPVLAQIWALADMN   78 (121)
T ss_dssp             CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC--CCHHHHHHHHHHHCTT
T ss_pred             CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC--CCHHHHHHHHHHHcCC
Confidence            466788889999999998 899999999999999875  5799999999999976

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=97.13  E-value=0.00033  Score=58.66  Aligned_cols=50  Identities=24%  Similarity=0.437  Sum_probs=40.4

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+++++|..+|.|++|.|+.+|+..++..+|..+++.+++.+++.+|.+
T Consensus        26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d   75 (191)
T 1y1x_A           26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKN   75 (191)
T ss_dssp             TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            34577788888888888888888888887777777888888888888765

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A

Probab=97.12  E-value=0.00047  Score=56.59  Aligned_cols=47  Identities=26%  Similarity=0.451  Sum_probs=44.3

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ..+..+|..+|.|++|.|+.+|+..+++.+|..+++.+++.+++.+|
T Consensus        77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d  123 (173)
T 1alv_A           77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS  123 (173)
T ss_dssp             HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence            56888999999999999999999999999999999999999999887

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5

Probab=97.09  E-value=0.00036  Score=54.95  Aligned_cols=45  Identities=18%  Similarity=0.250  Sum_probs=41.4

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE  400 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~  400 (408)
                      ..+++++|..+|.|++|.|+.+|+..+++.+|..++..++..+++
T Consensus         4 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~   48 (140)
T 1ggw_A            4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES   48 (140)
T ss_dssp             CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh
Confidence            456789999999999999999999999999999999999999886

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=97.08  E-value=0.00063  Score=56.65  Aligned_cols=48  Identities=17%  Similarity=0.325  Sum_probs=44.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++.  |..+++++++.+++.+|.+
T Consensus       122 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~~~~~~D~~  169 (191)
T 3khe_A          122 RERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQECDKN  169 (191)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHHHHHHhCCC
Confidence            45688999999999999999999999998  8889999999999999875

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=97.08  E-value=0.00094  Score=56.18  Aligned_cols=46  Identities=24%  Similarity=0.437  Sum_probs=43.7

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~  402 (408)
                      ..+.++|+.+|.|++|.|+.+|++.+++.+|..+++++++.+++.+
T Consensus       103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~  148 (198)
T 1juo_A          103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY  148 (198)
T ss_dssp             HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence            5788999999999999999999999999999999999999999887

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8

Probab=97.08  E-value=0.00082  Score=54.76  Aligned_cols=46  Identities=26%  Similarity=0.431  Sum_probs=43.5

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~  402 (408)
                      ..+..+|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+
T Consensus        72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~  117 (167)
T 1gjy_A           72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY  117 (167)
T ss_dssp             HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh
Confidence            5688999999999999999999999999999999999999999887

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=97.07  E-value=0.0005  Score=54.30  Aligned_cols=43  Identities=37%  Similarity=0.611  Sum_probs=41.1

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHH
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA  401 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~  401 (408)
                      ++++|..+|.|++|.|+.+|+..+++.+|..++..++..+++.
T Consensus         7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~   49 (145)
T 2bl0_B            7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ   49 (145)
T ss_dssp             HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Confidence            8899999999999999999999999999999999999999876

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=97.06  E-value=0.00027  Score=59.60  Aligned_cols=53  Identities=13%  Similarity=0.217  Sum_probs=47.2

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC-----CCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS-----QLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~-----~~~~~e~~~~~~~~d~~  405 (408)
                      ..++..++++ |..+|.|++|.|+.+||..+++.+|.     .++..+++.+++.+|.+
T Consensus        28 ~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d   85 (198)
T 1juo_A           28 PGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRD   85 (198)
T ss_dssp             TTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTT
T ss_pred             CccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCC
Confidence            3456677888 99999999999999999999999986     67999999999999876

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi}

Probab=97.04  E-value=0.00038  Score=59.77  Aligned_cols=53  Identities=23%  Similarity=0.273  Sum_probs=45.2

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHH-hCCCCCHHHHHHHHHH
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN-FGSQLAESEVQMLIEA  401 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~-~g~~~~~~e~~~~~~~  401 (408)
                      ..++.++...++++|..+|.|++|.|+.+||..+|+. +|..++..+++.++..
T Consensus        40 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~   93 (219)
T 3cs1_A           40 REKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKR   93 (219)
T ss_dssp             CSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHH
Confidence            3456788899999999999999999999999999998 7987777777776543

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=97.02  E-value=0.00056  Score=56.64  Aligned_cols=47  Identities=23%  Similarity=0.421  Sum_probs=43.3

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+|..+|.|++|.|+.+|++.+++  +..+++.+++++++.+|.+
T Consensus       108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~d~~  154 (180)
T 3mse_B          108 TFLKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSVHSI  154 (180)
T ss_dssp             CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TSSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHc--CCCCCHHHHHHHHHHhhhc
Confidence            5688999999999999999999999998  6678999999999999875

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=96.98  E-value=0.0013  Score=54.93  Aligned_cols=50  Identities=28%  Similarity=0.332  Sum_probs=43.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH--hCCCCCH---HHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN--FGSQLAE---SEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~--~g~~~~~---~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..  .|..+++   ++++++|+.+|.|
T Consensus       121 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~d  175 (191)
T 3k21_A          121 KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKN  175 (191)
T ss_dssp             HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcCC
Confidence            467889999999999999999999999998  5566776   4689999999876

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=96.98  E-value=0.0021  Score=54.61  Aligned_cols=50  Identities=20%  Similarity=0.317  Sum_probs=43.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC-----CCCCHHH-HHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-----SQLAESE-VQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g-----~~~~~~e-~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+|+..++..++     ...+..+ ++.+|+.+|.+
T Consensus        92 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d  147 (211)
T 2ggz_A           92 EQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDIN  147 (211)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCC
Confidence            45688999999999999999999999999986     5666654 89999999875

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A

Probab=96.93  E-value=0.00056  Score=58.49  Aligned_cols=50  Identities=22%  Similarity=0.330  Sum_probs=43.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC-----CCCHHHHHH----HHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS-----QLAESEVQM----LIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~-----~~~~~e~~~----~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|+|+.+||..++..+|.     .+++++++.    +|+.+|.|
T Consensus       128 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d  186 (214)
T 2l4h_A          128 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDID  186 (214)
T ss_dssp             HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCC
Confidence            457889999999999999999999999999875     678888875    89998875

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=96.91  E-value=0.00091  Score=56.51  Aligned_cols=50  Identities=16%  Similarity=0.202  Sum_probs=36.9

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        58 ~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d  107 (204)
T 1jba_A           58 TQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKD  107 (204)
T ss_dssp             HHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhCCC
Confidence            34566777777888888888888877777777666777777777777764

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A*

Probab=96.88  E-value=0.00054  Score=56.80  Aligned_cols=50  Identities=22%  Similarity=0.330  Sum_probs=44.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC-----CCCHHHHHH----HHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS-----QLAESEVQM----LIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~-----~~~~~e~~~----~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+||+.++..+|.     .+++++++.    +|+.+|.+
T Consensus        97 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d  155 (183)
T 1dgu_A           97 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDID  155 (183)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCC
Confidence            357889999999999999999999999999976     678888886    89998875

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A

Probab=96.86  E-value=0.0015  Score=54.05  Aligned_cols=49  Identities=29%  Similarity=0.369  Sum_probs=42.7

Q ss_pred             HHHHHHH--hhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMF--KKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F--~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++...|  ..+|.|++|.|+.+|+..++..+|..+++++++.+|+.+|.+
T Consensus       100 ~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d  150 (186)
T 2hps_A          100 AVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFN  150 (186)
T ss_dssp             TTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCC
Confidence            3444545  667999999999999999999999989999999999999975

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5

Probab=96.84  E-value=0.0025  Score=54.75  Aligned_cols=51  Identities=18%  Similarity=0.339  Sum_probs=42.8

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----CCC----C----CHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----GSQ----L----AESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g~~----~----~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|.|+.+|+..++..+    |..    +    +.++++++|+.+|.|
T Consensus       123 ~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d  185 (224)
T 1s1e_A          123 VHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKN  185 (224)
T ss_dssp             HHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCC
Confidence            34578899999999999999999999999886    632    2    348899999999876

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=96.82  E-value=0.00045  Score=60.80  Aligned_cols=56  Identities=14%  Similarity=0.237  Sum_probs=47.9

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCH------HHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAE------SEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~------~e~~~~~~~~d~~  405 (408)
                      .++..+..+++++|..+|.|++|.|+.+|+..+++.+|..++.      .+++.++..+|.+
T Consensus         9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~~   70 (263)
T 2f33_A            9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQR   70 (263)
T ss_dssp             TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTTG
T ss_pred             hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCCC
Confidence            3556677889999999999999999999999999998755544      7889999998865

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=96.81  E-value=0.003  Score=52.93  Aligned_cols=50  Identities=18%  Similarity=0.313  Sum_probs=42.7

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC------CCCCHHH-HHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG------SQLAESE-VQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g------~~~~~~e-~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..++      ...+..+ ++.+|+.+|.+
T Consensus        87 ~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d  143 (198)
T 2r2i_A           87 DQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDIN  143 (198)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCC
Confidence            45678899999999999999999999999886      4556555 89999999875

>2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei}

Probab=96.80  E-value=0.00033  Score=60.48  Aligned_cols=55  Identities=13%  Similarity=0.154  Sum_probs=46.7

Q ss_pred             hhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHH-HHHHhCCCCCHHHHHHHHHHh
Q 015352          348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKA-GLRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       348 ~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~-~l~~~g~~~~~~e~~~~~~~~  402 (408)
                      ...++.++..+++++|..+|.|++|.|+.+||.. +++.+|..++..++..+++.+
T Consensus        42 ~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~   97 (226)
T 2lvv_A           42 PRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRA   97 (226)
T ss_dssp             CSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHH
T ss_pred             chhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHH
Confidence            3456778889999999999999999999999998 566678888888888887766

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=96.78  E-value=0.0025  Score=52.56  Aligned_cols=50  Identities=18%  Similarity=0.353  Sum_probs=41.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----CCC----CC----HHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----GSQ----LA----ESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g~~----~~----~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+|+..++..+    |..    ++    .++++++|+.+|.+
T Consensus        91 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d  152 (183)
T 1s6c_A           91 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKN  152 (183)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCC
Confidence            4578899999999999999999999999887    642    33    48899999999875

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=96.77  E-value=0.0034  Score=52.91  Aligned_cols=51  Identities=20%  Similarity=0.202  Sum_probs=42.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----C------------C-CCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----G------------S-QLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g------------~-~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|+..++..+    |            . ..++++++.+|+.+|.+
T Consensus        93 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d  160 (204)
T 1jba_A           93 LEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDEN  160 (204)
T ss_dssp             CTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCC
Confidence            34568899999999999999999999999887    3            1 14567899999999875

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5

Probab=96.72  E-value=0.00056  Score=56.53  Aligned_cols=48  Identities=25%  Similarity=0.398  Sum_probs=43.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..+++.+|  +++++++++|+.+|.|
T Consensus       104 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~~~~~~~~~D~d  151 (185)
T 2sas_A          104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDG  151 (185)
T ss_dssp             HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHHHHHHHHHhcCC
Confidence            35688999999999999999999999999888  5788999999999876

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=96.66  E-value=0.0011  Score=52.95  Aligned_cols=48  Identities=17%  Similarity=0.299  Sum_probs=34.1

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHhCCC-CCHHHHHHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~-~~~~e~~~~~~~~d~~  405 (408)
                      .+.++|..+|.|++|.|+.+|+..++..+... ....++..+|+.+|.+
T Consensus        39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d   87 (155)
T 3ll8_B           39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMD   87 (155)
T ss_dssp             THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCC
Confidence            56677777788888888888888777765433 3456677777777765

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=96.66  E-value=0.0027  Score=52.72  Aligned_cols=50  Identities=24%  Similarity=0.348  Sum_probs=42.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----C--------CCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----G--------SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g--------~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..+    |        ...++++++++|+.+|.+
T Consensus        98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d  159 (190)
T 1g8i_A           98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKN  159 (190)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCC
Confidence            4567889999999999999999999999883    3        356788999999999876

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.64  E-value=0.0023  Score=60.59  Aligned_cols=76  Identities=11%  Similarity=0.111  Sum_probs=49.3

Q ss_pred             cceecccCCeEEEEEEECCC-------CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           56 DRELGRGEFGVTYLCIDRDT-------RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      .+.+..|-...+|++.....       +..+++++..... ....   ...+|..+++.|..+.-.+++++.+  .+  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~i---dR~~E~~~l~~L~~~gi~P~l~~~~--~~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFY---DSKVELDVFRYLSNINIAPNIIADF--PE--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCC---CHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhc---CHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence            45677888899999987531       5779999865321 1111   2356888888874444456666533  22  6


Q ss_pred             EEEeccCCCch
Q 015352          129 LVMELCEGGEL  139 (408)
Q Consensus       129 lv~e~~~g~~L  139 (408)
                      .|+||++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999999653

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus}

Probab=96.62  E-value=0.0041  Score=54.63  Aligned_cols=50  Identities=20%  Similarity=0.343  Sum_probs=43.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----C--------CCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----G--------SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g--------~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+|+..++..+    |        ...++++++++|+.+|.+
T Consensus       164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d  225 (256)
T 2jul_A          164 HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRN  225 (256)
T ss_dssp             HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCS
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCC
Confidence            4578899999999999999999999999887    5        345788999999999876

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=96.61  E-value=0.0037  Score=60.45  Aligned_cols=49  Identities=22%  Similarity=0.333  Sum_probs=44.0

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.+..+|+.+|.|+||+|+.+||..++..  ..+++++++++|+.+|.|
T Consensus       416 ~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~~~D~d  464 (484)
T 3nyv_A          416 SRERLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLSEVDKN  464 (484)
T ss_dssp             HHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhcCC
Confidence            3467889999999999999999999999987  467899999999999976

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=96.59  E-value=0.001  Score=56.12  Aligned_cols=52  Identities=15%  Similarity=0.163  Sum_probs=45.2

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++...+.++|..+|.|++|.|+.+|+..+ +.+|..++   ++.+++.+|.+
T Consensus        22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d   73 (202)
T 2bec_A           22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPD   73 (202)
T ss_dssp             CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCS
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCC
Confidence            456778889999999999999999999999999 88886655   88899988865

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=96.58  E-value=0.004  Score=54.57  Aligned_cols=51  Identities=22%  Similarity=0.457  Sum_probs=45.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----CCCCCHHHHHH----HHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----GSQLAESEVQM----LIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g~~~~~~e~~~----~~~~~d~~  405 (408)
                      ...++..+|..+|.|++|.|+.+|+..+++.+    |..++..+++.    +++.+|.+
T Consensus       101 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~  159 (263)
T 2f33_A          101 SCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSN  159 (263)
T ss_dssp             CHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCC
Confidence            35668899999999999999999999999988    88999999987    99988865

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=96.57  E-value=0.0054  Score=50.86  Aligned_cols=50  Identities=22%  Similarity=0.322  Sum_probs=43.1

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----C--------CCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----G--------SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g--------~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..+    |        ...+..+++.+|+.+|.+
T Consensus        98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d  159 (190)
T 2l2e_A           98 NDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKN  159 (190)
T ss_dssp             HHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCC
Confidence            4567889999999999999999999999873    2        356889999999999875

>2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei}

Probab=96.54  E-value=0.0031  Score=54.26  Aligned_cols=48  Identities=17%  Similarity=0.388  Sum_probs=41.7

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|+|+.+||+.+++.+   |....  +++.+|+.+|.+
T Consensus       132 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~--e~~~~~~~~D~d  182 (226)
T 2lvv_A          132 IFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDIT--DATTVFNEIDTN  182 (226)
T ss_dssp             HHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCC--SCHHHHHHHCCS
T ss_pred             HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHH--HHHHHHHHhCCC
Confidence            3578899999999999999999999999987   65444  589999999876

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=96.52  E-value=0.0039  Score=53.56  Aligned_cols=51  Identities=18%  Similarity=0.298  Sum_probs=43.3

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHH----HhCCCCCHHHHHHHHH----HhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLR----NFGSQLAESEVQMLIE----ASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~----~~g~~~~~~e~~~~~~----~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|+..++.    .+|..+++.+++++++    .+|.|
T Consensus       120 ~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d  178 (226)
T 2zfd_A          120 IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTK  178 (226)
T ss_dssp             HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCC
Confidence            345688999999999999999999999996    6788899999877664    77765

>2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A

Probab=96.48  E-value=0.00049  Score=53.18  Aligned_cols=46  Identities=24%  Similarity=0.447  Sum_probs=38.0

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++..+++++|+.+|    |+|+.+||+.+|+.+|.  ++.+++++++.+|.+
T Consensus        47 ~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~--t~~ei~~~~~~~D~d   92 (123)
T 2kld_A           47 NTVDDISESLRQGG----GKLNFDELRQDLKGKGH--TDAEIEAIFTKYDQD   92 (123)
T ss_dssp             ----CCSCSSTTTT----TCEEHHHHHHHTTTCCS--SHHHHHHHHHHHSSS
T ss_pred             hHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC--CHHHHHHHHHHHcCC
Confidence            33456778899998    99999999999999997  899999999999875

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=96.46  E-value=0.0042  Score=51.48  Aligned_cols=49  Identities=18%  Similarity=0.243  Sum_probs=43.7

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d  111 (190)
T 1fpw_A           63 DFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLN  111 (190)
T ss_dssp             HHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcCC
Confidence            3578899999999999999999999999998888889999999999875

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=96.46  E-value=0.0023  Score=56.53  Aligned_cols=50  Identities=12%  Similarity=0.295  Sum_probs=44.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC----CCCHHHHHH----HHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS----QLAESEVQM----LIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~----~~~~~e~~~----~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..+++.+|.    .+++.+++.    +|+.+|.|
T Consensus       195 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d  252 (272)
T 2be4_A          195 KRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMN  252 (272)
T ss_dssp             HHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCC
Confidence            456889999999999999999999999998876    789999987    99999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=96.43  E-value=0.00043  Score=67.22  Aligned_cols=50  Identities=28%  Similarity=0.369  Sum_probs=27.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|+||.|+.+||..++..+|..+++++++++|+.+|.|
T Consensus       416 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d  465 (486)
T 3mwu_A          416 RERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNN  465 (486)
T ss_dssp             HHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSS
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            46788999999999999999999999999999999999999999999876

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=96.42  E-value=0.0051  Score=51.85  Aligned_cols=50  Identities=22%  Similarity=0.299  Sum_probs=42.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHH----HhCCCCCHHHHHHHH----HHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLR----NFGSQLAESEVQMLI----EASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~----~~g~~~~~~e~~~~~----~~~d~~  405 (408)
                      ...+..+|+.+|.|++|.|+.+|+..+++    .+|..+++++++.++    +.+|.+
T Consensus       110 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d  167 (207)
T 2ehb_A          110 HEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRK  167 (207)
T ss_dssp             HHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCC
Confidence            45688999999999999999999999995    568889999987666    478765

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=96.42  E-value=0.0015  Score=59.64  Aligned_cols=48  Identities=15%  Similarity=0.176  Sum_probs=45.2

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHH-HHhCCCCCHHHHHHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGL-RNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l-~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+|..+|.|++|+|+.+||..++ ..+|..+++.+++.+|..+|.|
T Consensus       254 ~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~d  302 (323)
T 1ij5_A          254 VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVD  302 (323)
T ss_dssp             HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTT
T ss_pred             HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCCC
Confidence            68899999999999999999999999 9999889999999999999875

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1

Probab=96.41  E-value=0.0017  Score=67.67  Aligned_cols=55  Identities=18%  Similarity=0.447  Sum_probs=50.6

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...+..+|..+|.|++|.|+.+||..+|+.+|..+++.+++.+|+.+|.+
T Consensus       719 l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d  773 (863)
T 1sjj_A          719 ISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPN  773 (863)
T ss_dssp             SSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTT
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            3456678899999999999999999999999999999999999999999999875

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=96.39  E-value=0.0037  Score=52.74  Aligned_cols=50  Identities=16%  Similarity=0.201  Sum_probs=42.4

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----C----CCCC------HHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----G----SQLA------ESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g----~~~~------~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..+    |    ..++      +++++.+|+.+|.+
T Consensus       106 ~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d  169 (207)
T 2d8n_A          106 NQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKN  169 (207)
T ss_dssp             STTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCC
Confidence            3567889999999999999999999999986    7    4444      36799999999876

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=96.35  E-value=0.0026  Score=56.12  Aligned_cols=49  Identities=16%  Similarity=0.400  Sum_probs=43.2

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHH----HhCC--CCCHHHHHHHHH
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR----NFGS--QLAESEVQMLIE  400 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~----~~g~--~~~~~e~~~~~~  400 (408)
                      +..+..+++++|..+|.|++|.|+.+||..+|+    .+|.  .++..+++.+++
T Consensus         6 ~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~   60 (272)
T 2be4_A            6 ANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKK   60 (272)
T ss_dssp             CCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHH
T ss_pred             HhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            445567899999999999999999999999999    8998  899999988663

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=96.29  E-value=0.0063  Score=50.38  Aligned_cols=50  Identities=22%  Similarity=0.318  Sum_probs=42.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH----hCC--------CCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN----FGS--------QLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~----~g~--------~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..    +|.        ..+..+++++|+.+|.+
T Consensus        98 ~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d  159 (190)
T 1fpw_A           98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKN  159 (190)
T ss_dssp             THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCC
Confidence            356788999999999999999999999988    342        36788999999999875

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=96.28  E-value=0.0059  Score=51.10  Aligned_cols=50  Identities=16%  Similarity=0.201  Sum_probs=45.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        51 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d  100 (198)
T 2r2i_A           51 NKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVD  100 (198)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcCC
Confidence            45588899999999999999999999999998888899999999999875

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=96.27  E-value=0.0057  Score=51.57  Aligned_cols=53  Identities=26%  Similarity=0.427  Sum_probs=27.2

Q ss_pred             chhhhHHHHHHHhhcCCC--CCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSD--NDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~--~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.++...+.++|..+|.|  ++|.|+.+|+..+|+. .....+..++++|+.+|.+
T Consensus        32 s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d   86 (207)
T 2ehb_A           32 TVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVK   86 (207)
T ss_dssp             CHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCC
Confidence            444555555556555555  5566666666555554 2222333444555555543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.22  E-value=0.011  Score=55.66  Aligned_cols=32  Identities=31%  Similarity=0.459  Sum_probs=26.1

Q ss_pred             CeeccCCCCceEeecC---CCCCCEEEeecccccc
Q 015352          173 VIHRDLKPENFLFANK---KENSPLKAIDFGLSIF  204 (408)
Q Consensus       173 ivH~dikp~NIl~~~~---~~~~~vkl~Dfg~~~~  204 (408)
                      ++|+|+.+.||++..+   ++...+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999642   3456799999998765

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=96.21  E-value=0.0053  Score=52.72  Aligned_cols=54  Identities=26%  Similarity=0.429  Sum_probs=27.9

Q ss_pred             hchhhhHHHHHHHhhcCCC--CCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSD--NDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~--~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...+.++|..+|.|  ++|.|+.+|+..+|+. +....+..++++|+.+|.+
T Consensus        42 ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d   97 (226)
T 2zfd_A           42 FSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTK   97 (226)
T ss_dssp             CCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSS
T ss_pred             CCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCC
Confidence            3445555555566666655  5666666666555554 2222333444555555543

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=96.21  E-value=0.0055  Score=50.82  Aligned_cols=50  Identities=12%  Similarity=0.111  Sum_probs=45.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        62 ~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d  111 (190)
T 2l2e_A           62 SAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLD  111 (190)
T ss_dssp             HHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCC
Confidence            34678899999999999999999999999999888999999999999875

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=96.18  E-value=0.0035  Score=48.33  Aligned_cols=45  Identities=20%  Similarity=0.368  Sum_probs=39.3

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++..+|..+|.|++|.|+.+|+..++..+|...    +..+|+.+|.+
T Consensus        75 ~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~----~~~~~~~~D~~  119 (134)
T 1jfj_A           75 IGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK----VAEQVMKADAN  119 (134)
T ss_dssp             HHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHH----HHHHHHHHHCS
T ss_pred             HHHHHHHHHHCCCCCCccCHHHHHHHHHHhCHHH----HHHHHHHhCCC
Confidence            3488999999999999999999999999888543    88899998865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=96.16  E-value=0.0041  Score=60.57  Aligned_cols=48  Identities=17%  Similarity=0.295  Sum_probs=43.0

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+.+..+|+.+|.|++|+|+.+||+.++...  .+++++++++|+.+|.|
T Consensus       434 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~--~~~~~~~~~~~~~~D~d  481 (504)
T 3q5i_A          434 EERLRRAFNLFDTDKSGKITKEELANLFGLT--SISEKTWNDVLGEADQN  481 (504)
T ss_dssp             HHHHHHHHHHHCTTCCSEECHHHHHHHTTCS--CCCHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHhhC--CCCHHHHHHHHHHhCCC
Confidence            4578899999999999999999999998763  47899999999999976

>1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A

Probab=96.14  E-value=0.00087  Score=66.70  Aligned_cols=49  Identities=18%  Similarity=0.274  Sum_probs=0.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++++|..+|.|++|.|+.+||..+|+.+|..+++++++++|+.+|.+
T Consensus        11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d   59 (624)
T 1djx_A           11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHS   59 (624)
T ss_dssp             -------------------------------------------------
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            3567778888888888888888888888887777777888888777754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=96.11  E-value=0.0036  Score=60.77  Aligned_cols=48  Identities=25%  Similarity=0.396  Sum_probs=42.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+.+..+|+.+|.|++|+|+.+||+.++..  ..+++++++++|+.+|.|
T Consensus       425 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~d  472 (494)
T 3lij_A          425 KDKLESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDSN  472 (494)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHC-C--CSCCCHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhCCC
Confidence            456889999999999999999999999976  567889999999999876

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=96.08  E-value=0.0054  Score=62.29  Aligned_cols=47  Identities=19%  Similarity=0.418  Sum_probs=44.9

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ..++.+|+.+|.|++|.|+.+||+.+|+.+|..+++++++.+++.+|
T Consensus       605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D  651 (714)
T 3bow_A          605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA  651 (714)
T ss_dssp             HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS
T ss_pred             HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence            66889999999999999999999999999999999999999999998

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=96.05  E-value=0.0078  Score=50.71  Aligned_cols=50  Identities=14%  Similarity=0.166  Sum_probs=45.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        70 ~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d  119 (207)
T 2d8n_A           70 KAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVD  119 (207)
T ss_dssp             HHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCC
Confidence            45688999999999999999999999999998888889999999999875

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=96.02  E-value=0.011  Score=49.12  Aligned_cols=50  Identities=16%  Similarity=0.275  Sum_probs=41.0

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh----C--CCCC------HHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF----G--SQLA------ESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~----g--~~~~------~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..+    |  ..++      ..++.++|+.+|.+
T Consensus        98 ~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d  159 (193)
T 1bjf_A           98 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTN  159 (193)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTT
T ss_pred             HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCC
Confidence            4567889999999999999999999999874    5  2333      35589999999875

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=96.01  E-value=0.0078  Score=49.96  Aligned_cols=49  Identities=14%  Similarity=0.202  Sum_probs=44.5

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d  111 (193)
T 1bjf_A           63 KFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLD  111 (193)
T ss_dssp             HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcCCC
Confidence            4567899999999999999999999999998888889999999999875

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=95.99  E-value=0.0072  Score=49.72  Aligned_cols=51  Identities=10%  Similarity=0.128  Sum_probs=43.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        54 ~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d  104 (183)
T 1s6c_A           54 ASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDIN  104 (183)
T ss_dssp             CHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTT
T ss_pred             hHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHHhCCC
Confidence            345678889999999999999999999998887777888899999998865

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=95.95  E-value=0.0099  Score=50.36  Aligned_cols=51  Identities=16%  Similarity=0.261  Sum_probs=45.7

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+.++|..+|.|++|.|+.+|+..++..++......++..+|+.+|.+
T Consensus        55 ~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~d  105 (211)
T 2ggz_A           55 ANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDAD  105 (211)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHCTT
T ss_pred             hHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhcCC
Confidence            345688999999999999999999999999988777889999999999975

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group}

Probab=95.89  E-value=0.0081  Score=49.58  Aligned_cols=57  Identities=12%  Similarity=0.269  Sum_probs=45.2

Q ss_pred             HHhhhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          342 KALRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       342 ~~l~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ..+.+++......+..++.+.|..+|  ++|.|+.+||..++   |..++..+++++++.+|
T Consensus        13 ~~l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~~~~~~~~~~i~~~~d   69 (179)
T 3a8r_A           13 KGLQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GMDGSDEFAVQMFDSLA   69 (179)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TCCSCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CCCCcHHHHHHHHHHHH
Confidence            44556666655566788999999999  89999999999864   77778888888888776

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=95.79  E-value=0.0076  Score=61.18  Aligned_cols=54  Identities=15%  Similarity=0.305  Sum_probs=49.0

Q ss_pred             hchhh-hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh--------CCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEE-VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF--------GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~-~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~--------g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++ ..+++++|..+| |++|.|+.+||..+|+.+        |..++.++++.|++.+|.+
T Consensus       525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d  587 (714)
T 3bow_A          525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDED  587 (714)
T ss_dssp             CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCS
T ss_pred             CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCC
Confidence            45566 788999999999 999999999999999997        7889999999999999976

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=95.64  E-value=0.0084  Score=49.62  Aligned_cols=49  Identities=12%  Similarity=0.133  Sum_probs=43.9

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+|..+|.|++|.|+.+|+..++..++...+..++..+|+.+|.+
T Consensus        63 ~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d  111 (190)
T 1g8i_A           63 KFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLD  111 (190)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHhhcCC
Confidence            4478899999999999999999999999887777888999999999875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	408
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-92
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-90
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-86
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-86
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-86
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-85
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-83
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-81
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-81
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-80
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-79
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-79
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-79
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-74
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-72
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-72
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-71
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-70
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-69
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-68
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-66
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-65
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-64
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-64
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-63
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-63
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-63
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-63
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-62
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-62
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-61
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-61
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-60
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-60
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-55
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-49
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-48
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-43
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	3e-12
d1s6ja_	87	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	5e-11
d1s6ia_	182	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	2e-09
d1f54a_	77	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	3e-08
d1y1xa_	182	a.39.1.8 (A:) Programmed cell death 6 protein-like	2e-07
d2pq3a1	73	a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T	2e-07
d1lkja_	146	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	2e-07
d1lkja_	146	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	4e-04
d1avsa_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	3e-07
d1c7va_	68	a.39.1.5 (A:) Calcium vector protein {Amphioxus (B	4e-07
d1wrka1	82	a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens)	4e-07
d1qv0a_	189	a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr	6e-07
d1oqpa_	77	a.39.1.5 (A:) Caltractin (centrin 2) {Green algae	6e-07
d1m45a_	146	a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye	9e-07
d1jbaa_	189	a.39.1.5 (A:) Guanylate cyclase activating protein	1e-06
d1wdcb_	142	a.39.1.5 (B:) Myosin Essential Chain {Bay scallop	1e-06
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	2e-06
d1w7jb1	139	a.39.1.5 (B:11-149) Myosin Essential Chain {Human	2e-06
d1uhka1	187	a.39.1.5 (A:3-189) Calcium-regulated photoprotein	2e-06
d1dtla_	156	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	4e-06
d1dtla_	156	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	0.001
d1alva_	173	a.39.1.8 (A:) Calpain small (regulatory) subunit (	4e-06
d2scpa_	174	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	5e-06
d2zfda1	183	a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {	5e-06
d1jfja_	134	a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly	5e-06
d1topa_	162	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	8e-06
d1topa_	162	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	2e-04
d1exra_	146	a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr	9e-06
d1exra_	146	a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr	0.002
d2fcea1	61	a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [	2e-05
d1auib_	165	a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch	2e-05
d1rroa_	108	a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus)	2e-05
d1wdcc_	152	a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop	2e-05
d1snla_	99	a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo	2e-05
d2hf5a1	33	a.39.1.5 (A:81-113) Troponin C {Human (Homo sapien	2e-05
d1pvaa_	109	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	3e-05
d2obha1	141	a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien	3e-05
d2obha1	141	a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien	0.004
d1nyaa_	176	a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth	3e-05
d1nyaa_	176	a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth	2e-04
d1jc2a_	75	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	3e-05
d5pala_	109	a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis	4e-05
d1fw4a_	65	a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId:	4e-05
d1juoa_	172	a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId:	5e-05
d1fi5a_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus),	5e-05
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	5e-05
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	8e-05
d1df0a1	186	a.39.1.8 (A:515-700) Calpain large subunit, C-term	1e-04
d1tiza_	67	a.39.1.5 (A:) Calmodulin-related protein T21P5.17	1e-04
d1hqva_	181	a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous	1e-04
d2pvba_	107	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	1e-04
d1rwya_	109	a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta	2e-04
d1qx2a_	76	a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax	4e-04
d1bjfa_	181	a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId	5e-04
d1g8ia_	187	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	0.001
d1s6ca_	178	a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera	0.001
d1qxpa2	188	a.39.1.8 (A:515-702) Calpain large subunit, C-term	0.001
d1qxpa2	188	a.39.1.8 (A:515-702) Calpain large subunit, C-term	0.003
d1ggwa_	140	a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo	0.002
d1wlza1	83	a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H	0.002
d1cb1a_	78	a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax	0.003

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  279 bits (714), Expect = 1e-92
 Identities = 114/304 (37%), Positives = 178/304 (58%), Gaps = 7/304 (2%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E+I D Y     LG G F    L  D+ T++L+A K I+K+ L        +  E+A++ 
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLH 62

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
            + K+ +IV+L +  E    ++L+M+L  GGELFDRIV +G YTER A+ +   +++ V+
Sbjct: 63  KI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVL 226
             H  G++HRDLKPEN L+ +  E+S +   DFGLS    PG   S   G+P Y+APEVL
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 227 K-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
             + Y   +D WS GVI YILLCG PPF+ E++  + + IL+   +F    W ++S+SAK
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKR--KA 343
             +R ++E DP+ R T +Q L+HPW+     A +  +   V  ++K+    +++K+   A
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQAFNA 300

Query: 344 LRVI 347
             V+
Sbjct: 301 TAVV 304

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  275 bits (704), Expect = 1e-90
 Identities = 100/343 (29%), Positives = 166/343 (48%), Gaps = 32/343 (9%)

Query: 36  QPITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDI 95
           QP+ V  G    ++ D Y +  ELG G FGV + C+++ T  +   K I+       +D 
Sbjct: 18  QPVEVKQG----SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDK 70

Query: 96  DDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAA 154
             V+ E++IM  L  +  +++L +A ED   + L++E   GGELFDRI A  +  +E   
Sbjct: 71  YTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 129

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
               R   E ++  H+H ++H D+KPEN +    K+ S +K IDFGL+    P E     
Sbjct: 130 INYMRQACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT 188

Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK 273
             +  + APE++ R   G   D+W+ GV+ Y+LL G+ PF  E +    Q + R   +F 
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 248

Query: 274 RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN-------------------- 313
            D + +VS  AK  ++ +L+ +P+ RLT    LEHPWL+                     
Sbjct: 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308

Query: 314 -AKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEE 355
             +K  + P       R+  FS + + + +  ++   +   +E
Sbjct: 309 IKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  265 bits (678), Expect = 1e-86
 Identities = 88/271 (32%), Positives = 141/271 (52%), Gaps = 7/271 (2%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           +  +++ D Y +  ELG G FGV +   +R T    A K +         D + VR+E+ 
Sbjct: 19  IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQ 75

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIV 162
            M  L ++ ++V+L +A EDDN + ++ E   GGELF+++       +E  A    R + 
Sbjct: 76  TMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMA 222
           + +   H++  +H DLKPEN +F  K  ++ LK IDFGL+    P +      G+  + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193

Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV + +  G   D+WS GV+ YILL G+ PF  E++    + +     +     +  +S
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
           E  K  +R++L  DP  R+T  Q LEHPWL 
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  263 bits (674), Expect = 2e-86
 Identities = 81/305 (26%), Positives = 157/305 (51%), Gaps = 12/305 (3%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           + + ++Y++  +LGRGEFG+ + C++  +++    K +  +      D   V++E++I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVV 165
              ++ +I+ L E+ E    + ++ E   G ++F+RI        ER   +    + E +
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
           Q  H H + H D++PEN ++  +  +S +K I+FG +   KPG+ F  +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 226 LKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
            + +      D+WS G ++Y+LL G+ PF AE+ Q + + I+     F  + +  +S  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKAL 344
              V ++L  + K R+TA + L+HPWL+   +  +  +       LK     +   +K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV----IRTLKHRRYYHTLIKKDL 290

Query: 345 RVIAE 349
            ++  
Sbjct: 291 NMVVS 295

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  261 bits (667), Expect = 7e-86
 Identities = 98/273 (35%), Positives = 151/273 (55%), Gaps = 6/273 (2%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKL---RTAVDIDDVRREV 102
           +EN++D Y    ELG G+F V   C ++ T    A K I KR+    R  V  +D+ REV
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 103 AIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           +I+K + ++ ++++L E  E+   V L++EL  GGELFD +  +   TE  A    + I+
Sbjct: 65  SILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSP-LKAIDFGLSIFFKPGERFSEIVGSPYYM 221
             V   H   + H DLKPEN +  ++    P +K IDFGL+     G  F  I G+P ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           APE++     G E D+WS GVI YILL G  PF  +++Q     +     +F+ + + N 
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
           S  AK  +R++L  DPK R+T +  L+HPW++ 
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  258 bits (661), Expect = 4e-85
 Identities = 91/275 (33%), Positives = 141/275 (51%), Gaps = 16/275 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD------VRREVAI 104
           + Y     LGRG   V   CI + T +  A K I      +    +         +EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           ++ +  + +I+ LK+  E +    LV +L + GELFD +  +   +E+    + R ++EV
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           +   HK  ++HRDLKPEN L     ++  +K  DFG S    PGE+  E+ G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 225 VL-------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           ++          YG E+D+WS GVI+Y LL G PPFW   +  + + I+ G   F    W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
            + S++ K LV + L   P+ R TA++ L HP+ Q
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (649), Expect = 2e-83
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 10/263 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + R LG+G+FG  YL  ++ ++ +LA K + K +L  A     +RREV I  HL +
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 64

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +I+ L     D   V+L++E    G ++  +     + E+  A     +   +  CH 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RN 229
             VIHRD+KPEN L  +  E   LK  DFG S+   P  R + + G+  Y+ PE+++ R 
Sbjct: 125 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 230 YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR 289
           +  ++D+WS GV+ Y  L G PPF A + Q   + I R    F       V+E A+ L+ 
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLIS 236

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQ 312
           ++L+ +P  R   ++VLEHPW+ 
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWIT 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  251 bits (641), Expect = 1e-81
 Identities = 75/304 (24%), Positives = 138/304 (45%), Gaps = 15/304 (4%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           K++ E  +   RE+G G FG  Y   D    E++A K +S    ++     D+ +EV  +
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L ++ + +  +     ++   LVME C G       V +    E   AAVT   ++ +
Sbjct: 70  QKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEV 225
              H H +IHRD+K  N L +   E   +K  DFG +    P   F   VG+PY+MAPEV
Sbjct: 129 AYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEV 182

Query: 226 L----KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           +    +  Y  ++D+WS G+    L    PP +  +       I +   +       + S
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWS 240

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKR 341
           E  ++ V   L+  P+ R T++ +L+H ++   +  P   + D+++        ++  + 
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQY 298

Query: 342 KALR 345
           + ++
Sbjct: 299 RKMK 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 5e-81
 Identities = 106/336 (31%), Positives = 158/336 (47%), Gaps = 21/336 (6%)

Query: 44  VPKENIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREV 102
           + K  I D Y +  + LG G  G      ++ T+E  A K +              RREV
Sbjct: 4   IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREV 55

Query: 103 AIMKHLPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGH--YTERAAAA 156
            +     +   IV + +  E+       + +VME  +GGELF RI  RG   +TER A+ 
Sbjct: 56  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVG 216
           + ++I E +Q  H   + HRD+KPEN L+ +K+ N+ LK  DFG +         +    
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQ----GVAQAILRGLID 271
           +PYY+APEVL    Y    D+WS GVI+YILLCG PPF++        G+   I  G  +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 272 FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK 331
           F    W  VSE  K L+R +L+ +P  R+T  + + HPW+  + K P  PL    R   +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKE 294

Query: 332 QFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFKKID 367
                   K +    +A      E   IK++    +
Sbjct: 295 DKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 2e-80
 Identities = 79/294 (26%), Positives = 130/294 (44%), Gaps = 25/294 (8%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P++   + +   + LG G F    L  +  T    A K + KR +     +  V RE  +
Sbjct: 2   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
           M  L  +   V L    +DD  ++  +   + GEL   I   G + E      T  IV  
Sbjct: 62  MSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYM 221
           ++  H  G+IHRDLKPEN L     E+  ++  DFG +    P     R +  VG+  Y+
Sbjct: 121 LEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNV 280
           +PE+L  ++     D+W+ G I+Y L+ G+PPF A +E  + Q I++   DF        
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKF 233

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQ------VLEHPWLQN-------AKKAPNVP 321
              A+ LV ++L  D   RL  ++      +  HP+ ++        +  P + 
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (625), Expect = 2e-79
 Identities = 77/280 (27%), Positives = 142/280 (50%), Gaps = 11/280 (3%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVA 103
           V   + + +Y    ++G+G  G  Y  +D  T + +A + ++ ++       + +  E+ 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEIL 69

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           +M+   KN +IV+  ++    + + +VME   GG L D +V      E   AAV R  ++
Sbjct: 70  VMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ 127

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK-PGERFSEIVGSPYYMA 222
            ++  H + VIHRD+K +N L      +  +K  DFG          + S +VG+PY+MA
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 223 PEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PEV+ R  YGP++DIWS G++   ++ G PP+  E+       I        ++P   +S
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLS 243

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVP 321
              +  + + L+ D + R +AK++L+H +L+ AK   ++ 
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (622), Expect = 5e-79
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 16/279 (5%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           N ED + +  ELG G FG  Y   +++T  L A K I  +      +++D   E+ I+  
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILAS 65

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQ 166
              + +IV L +A   +N + +++E C GG +   ++      TE     V +  ++ + 
Sbjct: 66  C-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEV 225
             H + +IHRDLK  N LF     +  +K  DFG+S    +  +R    +G+PY+MAPEV
Sbjct: 125 YLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

Query: 226 L------KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           +       R Y  + D+WS G+ L  +    PP    +   V   I +        P   
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP 318
            S + K  +++ LE +   R T  Q+L+HP++      P
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 7e-79
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 12/271 (4%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + + + LG G +G   L ++R T E +A K +  ++     +  ++++E+ I K L  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKML-N 61

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + ++V       + N  +L +E C GGELFDRI       E  A      ++  V   H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLK 227
            G+ HRD+KPEN L     E   LK  DFGL+  F+   R    +++ G+  Y+APE+LK
Sbjct: 122 IGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 228 RN--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
           R   +   +D+WS G++L  +L G  P+   S+     +  +    +  +PW  +  +  
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPL 237

Query: 286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
           +L+ ++L  +P  R+T   + +  W     K
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 1e-74
 Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 15/272 (5%)

Query: 49  IEDRYL-VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            + R+L  D E+GRG F   Y  +D +T   +A   +  RKL T  +    + E  ++K 
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKG 64

Query: 108 LPKNSSIVSLKEACED----DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L ++ +IV   ++ E        + LV EL   G L   +        +   +  R I++
Sbjct: 65  L-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 164 VVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
            +Q  H     +IHRDLK +N           +K  D GL+   K       ++G+P +M
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL-KRASFAKAVIGTPEFM 180

Query: 222 APEVLKRNYGPEIDIWSAGVILYILLCGVPPFW-AESEQGVAQAILRGLIDFKRDPWPNV 280
           APE+ +  Y   +D+++ G+ +  +     P+   ++   + + +  G+           
Sbjct: 181 APEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVA 238

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
               K ++   +  +   R + K +L H + Q
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (581), Expect = 2e-72
 Identities = 64/266 (24%), Positives = 125/266 (46%), Gaps = 10/266 (3%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + +++ + LG+G FG  +L   + T +  A K++ K  +    D++    E  ++    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  +  +    +    +  VME   GG+L   I +   +    A      I+  +Q  H 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-RFSEIVGSPYYMAPEVLK-R 228
            G+++RDLK +N L     ++  +K  DFG+      G+ + +   G+P Y+APE+L  +
Sbjct: 122 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 229 NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            Y   +D WS GV+LY +L G  PF  + E+ +  +I      +       + + AK L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLL 234

Query: 289 RQMLEPDPKLRLTAK-QVLEHPWLQN 313
            ++   +P+ RL  +  + +HP  + 
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFRE 260

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 5e-72
 Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 21/274 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + Y V   +G G +G       +   ++L  K +    + T  +   +  EV +++ L K
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 61

Query: 111 NSSIVSLKEACED--DNAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEV 164
           + +IV   +   D  +  +++VME CEGG+L   I      R +  E     V   +   
Sbjct: 62  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 165 VQLCHK-----HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFS-EIVGSP 218
           ++ CH+     H V+HRDLKP N           +K  DFGL+        F+   VG+P
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 219 YYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           YYM+PE + R  Y  + DIWS G +LY L   +PPF A S++ +A  I  G     R   
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIP 235

Query: 278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL 311
              S+    ++ +ML      R + +++LE+P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 7e-72
 Identities = 66/324 (20%), Positives = 119/324 (36%), Gaps = 50/324 (15%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP 109
           +D +    ELG G  GV +    + +  ++A K I           + + RE+ ++    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC- 61

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
            +  IV    A   D  + + ME  +GG L   +   G   E+    V+  +++ +    
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 170 -KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
            KH ++HRD+KP N L  ++ E   +K  DFG+S         +  VG+  YM+PE L+ 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQG 177

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI----------------- 270
            +Y  + DIWS G+ L  +  G  P      + +       +                  
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 271 -----------------------DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                                     + P    S   +  V + L  +P  R   KQ++ 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 308 HPWLQNAKKAPNVPLGDVVRSRLK 331
           H +++ +     V     + S + 
Sbjct: 298 HAFIKRSDAEE-VDFAGWLCSTIG 320

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 3e-71
 Identities = 83/272 (30%), Positives = 132/272 (48%), Gaps = 20/272 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDD---VRREVAIM 105
           +E +Y V   LG G FG  Y  I       +A K + K ++    ++ +   V  EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 106 KHL-PKNSSIVSLKEACEDDNAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTRTIVE 163
           K +    S ++ L +  E  ++  L++E  E   +LFD I  RG   E  A +    ++E
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            V+ CH  GV+HRD+K EN L    +    LK IDFG     K    +++  G+  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           E +   R +G    +WS G++LY ++CG  PF  + E      I+RG + F+      VS
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVS 228

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
              + L+R  L   P  R T +++  HPW+Q+
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  221 bits (564), Expect = 1e-70
 Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 7/271 (2%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++ DRY +   LG G     +L  D      +A K +     R        RRE      
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 108 LPKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           L  + +IV++ +  E +       ++VME  +G  L D +   G  T + A  V     +
Sbjct: 64  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG-LSIFFKPGERFSEIVGSPYYMA 222
            +   H++G+IHRD+KP N + +       +       ++       + + ++G+  Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 223 PEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           PE  +  +     D++S G +LY +L G PPF  +S   VA   +R            +S
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
               ++V + L  +P+ R      +    ++
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  221 bits (563), Expect = 3e-69
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 14/272 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + + V R +GRG FG  Y C   DT ++ A K + K++++          E  ++  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 111 NSS--IVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
                IV +  A    + +  +++L  GG+L   +   G ++E         I+  ++  
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR 228
           H   V++RDLKP N L     E+  ++  D GL+  F   +     VG+  YMAPEVL++
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQK 179

Query: 229 N--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKS 286
              Y    D +S G +L+ LL G  PF     +   + I R  +    +   + S   +S
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRS 238

Query: 287 LVRQMLEPDPKLRLT-----AKQVLEHPWLQN 313
           L+  +L+ D   RL      A++V E P+ ++
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  216 bits (552), Expect = 3e-68
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 17/271 (6%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           ++D + + R LG G FG  +L   R      A K + K  +     ++    E  ++  +
Sbjct: 3   LQD-FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
             +  I+ +    +D   + ++M+  EGGELF  +     +    A      +   ++  
Sbjct: 62  -THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK- 227
           H   +I+RDLKPEN L     +N  +K  DFG + +    +    + G+P Y+APEV+  
Sbjct: 121 HSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL 287
           + Y   ID WS G+++Y +L G  PF+  +     + IL   + F     P  +E  K L
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDL 231

Query: 288 VRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
           + +++  D   RL       + V  HPW + 
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 4e-66
 Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 15/270 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + +   + LG+G FG   L  ++ T    A K + K  +    ++     E  ++++  +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-R 63

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +  + +LK A +  + +  VME   GGELF  +     +TE  A      IV  ++  H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVLKRN 229
             V++RD+K EN +     ++  +K  DFGL       G       G+P Y+APEVL+ N
Sbjct: 124 RDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 230 -YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV 288
            YG  +D W  GV++Y ++CG  PF+ +  + + + IL   I F       +S  AKSL+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236

Query: 289 RQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             +L+ DPK RL      AK+V+EH +  +
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 8e-65
 Identities = 76/354 (21%), Positives = 131/354 (37%), Gaps = 51/354 (14%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
           ++  RY     +G G +G+     D   +  +A K IS  + +T        RE+ I+  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLR 62

Query: 108 LPKNSSIVSLKEACEDDNAVHL----VMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
             ++ +I+ + +         +    ++    G +L+  +    H +          I+ 
Sbjct: 63  F-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----RFSEIVGSPY 219
            ++  H   V+HRDLKP N L         LK  DFGL+    P        +E V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 220 YMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW 277
           Y APE++   + Y   IDIWS G IL  +L   P F  +        IL  L    ++  
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 278 ---------------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPW 310
                                      PN    A  L+ +ML  +P  R+  +Q L HP+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

Query: 311 LQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAEFLSVEEVEDIKEMFK 364
           L+      + P+ +       +   + + K K L         EE    +  ++
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELI-------FEETARFQPGYR 344

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 2e-64
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 33/284 (11%)

Query: 59  LGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD--IDDVRREVAIMKHLPKNSSIVS 116
           LG G+F   Y   D++T +++A K I       A D       RE+ +++ L  + +I+ 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 64

Query: 117 LKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHR 176
           L +A    + + LV +  E              T     A     ++ ++  H+H ++HR
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

Query: 177 DLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLK--RNYGPE 233
           DLKP N L     EN  LK  DFGL+  F  P   ++  V + +Y APE+L   R YG  
Sbjct: 125 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 234 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP--------------- 278
           +D+W+ G IL  LL  VP    +S+      I   L     + WP               
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 279 ---------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                       +    L++ +   +P  R+TA Q L+  +  N
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 5e-64
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 48/306 (15%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +Y    ++G+G FG  +    R T + +A K +     +    I    RE+ I++ L K
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLL-K 67

Query: 111 NSSIVSLKEACED--------DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIV 162
           + ++V+L E C            +++LV + CE             +T      V + ++
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127

Query: 163 EVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFSEIVGS 217
             +   H++ ++HRD+K  N L      +  LK  DFGL+  F   +     R++  V +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 218 PYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
            +Y  PE+L  +R+YGP ID+W AG I+  +    P     +EQ     I +       +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 276 PWPNV----------------------------SESAKSLVRQMLEPDPKLRLTAKQVLE 307
            WPNV                               A  L+ ++L  DP  R+ +   L 
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

Query: 308 HPWLQN 313
           H +  +
Sbjct: 305 HDFFWS 310

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 2e-63
 Identities = 82/277 (29%), Positives = 138/277 (49%), Gaps = 17/277 (6%)

Query: 51  DRYLVDRELGRGEFGVTYLCID---RDTRELLACKSISKRKL-RTAVDIDDVRREVAIMK 106
           + + + + LG G +G  +L       DT +L A K + K  + + A   +  R E  +++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQ 166
           H+ ++  +V+L  A + +  +HL+++   GGELF  +  R  +TE         IV  ++
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 167 LCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP--GERFSEIVGSPYYMAPE 224
             HK G+I+RD+K EN L      N  +   DFGLS  F     ER  +  G+  YMAP+
Sbjct: 144 HLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 225 VLK---RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS 281
           +++     +   +D WS GV++Y LL G  PF  + E+     I R ++  +      +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 282 ESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQN 313
             AK L++++L  DPK RL      A ++ EH + Q 
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 75/332 (22%), Positives = 136/332 (40%), Gaps = 52/332 (15%)

Query: 26  ARKEAGANKKQP---ITVLAGVPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACK 82
           AR     N  +P       + V +   +D Y + R+LGRG++   +  I+    E +  K
Sbjct: 7   ARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66

Query: 83  SISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAVHLVMELCEGGELF 140
            +   K +       ++RE+ I+++L    +I++L +  +D       LV E     +  
Sbjct: 67  ILKPVKKK------KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 120

Query: 141 DRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG 200
                    T+         I++ +  CH  G++HRD+KP N +  +  E+  L+ ID+G
Sbjct: 121 QLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWG 175

Query: 201 LSIFFKPGERFSEIVGSPYYMAPEVLK--RNYGPEIDIWSAGVILYILLCGVPPFWA-ES 257
           L+ F+ PG+ ++  V S Y+  PE+L   + Y   +D+WS G +L  ++    PF+    
Sbjct: 176 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235

Query: 258 EQGVAQAILRGL---------------------------------IDFKRDPWPNVSESA 284
                  I + L                                      +    VS  A
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
              + ++L  D + RLTA++ +EHP+     K
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (513), Expect = 8e-63
 Identities = 84/290 (28%), Positives = 123/290 (42%), Gaps = 34/290 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           ++Y    ++G G +GV Y   +       A K I   K    +      RE++I+K L K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGI-PSTTIREISILKEL-K 58

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           +S+IV L +       + LV E  +        V  G      A +    ++  +  CH 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVL--K 227
             V+HRDLKP+N L         LK  DFGL+  F  P  +++  + + +Y AP+VL   
Sbjct: 119 RRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 228 RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN-------- 279
           + Y   IDIWS G I   ++ G P F   SE      I R L       WPN        
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 280 -----------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                            + ES   L+ +ML+ DP  R+TAKQ LEH + +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 8e-63
 Identities = 79/314 (25%), Positives = 122/314 (38%), Gaps = 47/314 (14%)

Query: 45  PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAI 104
           P    E  Y   + +G G FGV Y     D+ EL+A K + + K           RE+ I
Sbjct: 14  PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQI 66

Query: 105 MKHLPKNSSIVSLKEAC------EDDNAVHLVMELCEGG---ELFDRIVARGHYTERAAA 155
           M+ L  + +IV L+         +D+  ++LV++               A+         
Sbjct: 67  MRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIV 215
                +   +   H  G+ HRD+KP+N L     + + LK  DFG +     GE     +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 216 GSPYYMAPEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL---- 269
            S YY APE++    +Y   ID+WSAG +L  LL G P F  +S       I++ L    
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 270 ---------------------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                                  + +   P     A +L  ++LE  P  RLT  +   H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 309 PWLQNAKKAPNVPL 322
            +    +  PNV L
Sbjct: 304 SFFDELRD-PNVKL 316

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (513), Expect = 1e-62
 Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 37/300 (12%)

Query: 50  EDRYLVDRELGRGEFGVTYLCID-RDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +Y    E+G G +G  +   D ++    +A K +  +     + +    REVA+++HL
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS-TIREVAVLRHL 64

Query: 109 PKNS--SIVSLKEAC-----EDDNAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTRT 160
                 ++V L + C     + +  + LV E  +     +   V            +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYY 220
           ++  +   H H V+HRDLKP+N L  +  +    K  DFGL+  +      + +V + +Y
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWY 181

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP- 278
            APEVL ++ Y   +D+WS G I   +    P F   S+      IL  +     + WP 
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 279 ----------------------NVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK 316
                                 ++ E  K L+ + L  +P  R++A   L HP+ Q+ ++
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-62
 Identities = 55/268 (20%), Positives = 108/268 (40%), Gaps = 19/268 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +  V + +G G FG  Y          +A K ++     T   +   + EV +++   +
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-R 62

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTRTIVEVVQLCH 169
           + +I+           + +V + CEG  L+  + +    +       + R   + +   H
Sbjct: 63  HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVL 226
              +IHRDLK  N       E+  +K  DFGL+          +F ++ GS  +MAPEV+
Sbjct: 122 AKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 227 KRN----YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP--WPNV 280
           +      Y  + D+++ G++LY L+ G  P+   + +     ++              N 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 281 SESAKSLVRQMLEPDPKLRLTAKQVLEH 308
            ++ K L+ + L+     R    Q+L  
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (505), Expect = 1e-61
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 34/292 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
            +Y    ++G G +G  +   +R+T E++A K +        V      RE+ ++K L K
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-K 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK 170
           + +IV L +    D  + LV E C+           G        +    +++ +  CH 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLS-IFFKPGERFSEIVGSPYYMAPEVL--K 227
             V+HRDLKP+N L     E    K  +FGL+  F  P   +S  V + +Y  P+VL   
Sbjct: 120 RNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 228 RNYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPW--------- 277
           + Y   ID+WSAG I   L     P F         + I R L     + W         
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236

Query: 278 ----------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN 313
                           P ++ + + L++ +L+ +P  R++A++ L+HP+  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (504), Expect = 9e-61
 Identities = 79/318 (24%), Positives = 137/318 (43%), Gaps = 25/318 (7%)

Query: 2   GNCCRSPAAVAREDVKSNYSSHDHARKEAGANKKQPITVLAGVPKENIEDRYLVDRELGR 61
           GN   +     +E VK   +       +      Q    L         D++   + LG 
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL---------DQFDRIKTLGT 51

Query: 62  GEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC 121
           G FG   L   +++    A K + K+K+     I+    E  I++ +     +V L+ + 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSF 110

Query: 122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPE 181
           +D++ +++VME   GGE+F  +   G ++E  A      IV   +  H   +I+RDLKPE
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170

Query: 182 NFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAG 240
           N L         ++  DFG +   K   R   + G+P  +APE++  + Y   +D W+ G
Sbjct: 171 NLLIDQ---QGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225

Query: 241 VILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRL 300
           V++Y +  G PPF+A+    + + I+ G + F      + S   K L+R +L+ D   R 
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRNLLQVDLTKRF 281

Query: 301 -----TAKQVLEHPWLQN 313
                    +  H W   
Sbjct: 282 GNLKNGVNDIKNHKWFAT 299

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 82/302 (27%), Positives = 129/302 (42%), Gaps = 35/302 (11%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           + +    ++G G +GV Y   ++ T E++A K I        V      RE++++K L  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV-PSTAIREISLLKEL-N 59

Query: 111 NSSIVSLKEACEDDNAVHLVMELCE-GGELFDRIVARGHYTERAAAAVTRTIVEVVQLCH 169
           + +IV L +    +N ++LV E      + F    A          +    +++ +  CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF-KPGERFSEIVGSPYYMAPEVLKR 228
            H V+HRDLKP+N L         +K  DFGL+  F  P   ++  V + +Y APE+L  
Sbjct: 120 SHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 229 N--YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW--------- 277
              Y   +DIWS G I   ++     F  +SE      I R L       W         
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 278 ----------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA-KKAPNV 320
                           P + E  +SL+ QML  DP  R++AK  L HP+ Q+  K  P++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296

Query: 321 PL 322
            L
Sbjct: 297 RL 298

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-60
 Identities = 72/337 (21%), Positives = 133/337 (39%), Gaps = 47/337 (13%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +   Y   + +G G +G     +D  T   +A K +  R  ++ +      RE+ ++KH
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKH 73

Query: 108 LPKNSSIVSLKEACEDDNA------VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           + ++ +++ L +    D         +LVM     G    +++      E     +   +
Sbjct: 74  M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           ++ ++  H  G+IHRDLKP N       E+  LK +DFGL+         +  V + +Y 
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTRWYR 185

Query: 222 APEVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW-- 277
           APEV+     Y   +DIWS G I+  ++ G   F         + I++       +    
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245

Query: 278 -------------------------PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ 312
                                     N S  A +L+ +ML  D + R+TA + L HP+ +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

Query: 313 NAKKAPNVPLGDVVRSRLKQFSMMNRFKRKALRVIAE 349
           +     + P    V+     F  ++R   +  RV  +
Sbjct: 306 SLHDTEDEP---QVQKYDDSFDDVDRTLDEWKRVTYK 339

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (494), Expect = 7e-60
 Identities = 49/281 (17%), Positives = 94/281 (33%), Gaps = 21/281 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           + +RY + R++G G FG  YL  D    E +A K    +          +  E  I K +
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM 59

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
                I +++    + +   +VMEL               ++ +    +   ++  ++  
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--------RFSEIVGSPYY 220
           H    IHRD+KP+NFL    K+ + +  IDFGL+  ++               + G+  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 221 MAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP--- 276
            +             D+ S G +L     G  P+         Q   R        P   
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 277 -WPNVSESAKSLVRQMLEPDPKLRLTA---KQVLEHPWLQN 313
                     + +          +      +Q+  + + + 
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 7e-59
 Identities = 71/337 (21%), Positives = 130/337 (38%), Gaps = 41/337 (12%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            + +RY     +G G +G      D  T   +A K +S+   ++ +      RE+ ++KH
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 73

Query: 108 LPKNSSIVSLKEACEDDNAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVE 163
           + K+ +++ L +      ++     + +     G   + IV     T+     +   I+ 
Sbjct: 74  M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAP 223
            ++  H   +IHRDLKP N       E+  LK +DFGL+      +  +  V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187

Query: 224 EVL--KRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK-------- 273
           E++    +Y   +DIWS G I+  LL G   F         + ILR +            
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 274 -------------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA 314
                               + +   +  A  L+ +ML  D   R+TA Q L H +    
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 315 KKAPNVPLGDVVRSRLKQFSM-MNRFKRKALRVIAEF 350
               + P+ D      +   + ++ +K      +  F
Sbjct: 308 HDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISF 344

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-58
 Identities = 60/280 (21%), Positives = 105/280 (37%), Gaps = 23/280 (8%)

Query: 51  DRYLV---DRELGRGEFGVTYLCIDRDTR--ELLACKSISKRKLRTAVDIDDVRREVAIM 105
           DR L+   D+ELG G FG       +  +  + +A K +       A+  D++  E  +M
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-KDELLAEANVM 62

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
           + L  N  IV +   CE ++   LVME+ E G L   +    H  ++    +   +   +
Sbjct: 63  QQL-DNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF----SEIVGSPYYM 221
           +   +   +HRDL   N L          K  DFGLS   +  E +    +       + 
Sbjct: 121 KYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 222 APEVLKRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE +    +  + D+WS GV+++     G  P+       V   + +G    +      
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAG 234

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQV---LEHPWLQNAKK 316
                  L+      D + R     V   L + +     +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 65/285 (22%), Positives = 108/285 (37%), Gaps = 25/285 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRDTRE--LLACKSISKRKLRTAVDIDDVRRE 101
           + ++N+    + D ELG G FG     + R  ++   +A K + +   +   D +++ RE
Sbjct: 5   LKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMRE 59

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRT 160
             IM  L  N  IV L   C+ +  + LVME+  GG L   +V  R        A +   
Sbjct: 60  AQIMHQL-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117

Query: 161 IVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE----IVG 216
           +   ++   +   +HRDL   N L          K  DFGLS      + +         
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 217 SPYYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKR 274
              + APE +  R +    D+WS GV ++  L  G  P+       V   I +G    + 
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RM 231

Query: 275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQV---LEHPWLQNAKK 316
           +  P       +L+        + R     V   +   +   A K
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 4e-57
 Identities = 56/263 (21%), Positives = 107/263 (40%), Gaps = 21/263 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
               + + +G+GEFG   L   R  +  +A K I                E ++M  L +
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDA-----TAQAFLAEASVMTQL-R 58

Query: 111 NSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTRTIVEVVQL 167
           +S++V L     E+   +++V E    G L D + +RG            +  + E ++ 
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLK 227
              +  +HRDL   N L +   E++  K  DFGL+      +          + APE L+
Sbjct: 119 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALR 173

Query: 228 -RNYGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            + +  + D+WS G++L+ +   G  P+     + V   + +G   +K D       +  
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVY 230

Query: 286 SLVRQMLEPDPKLRLTAKQVLEH 308
            +++     D  +R +  Q+ E 
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQ 253

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 5e-56
 Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 26/292 (8%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +       +G G FG       +     +       ++  +  D  D   E+ ++  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRI----------------VARGHYTERAA 154
           + +I++L  ACE    ++L +E    G L D +                      + +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 155 AAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEI 214
                 +   +    +   IHRDL   N L     EN   K  DFGLS   +   + +  
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILL-CGVPPFWAESEQGVAQAILRGLIDF 272
                +MA E L  + Y    D+WS GV+L+ ++  G  P+   +   + + + +G   +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y 243

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH--PWLQNAKKAPNVPL 322
           + +   N  +    L+RQ     P  R +  Q+L      L+  K   N  L
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL 295

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 7e-56
 Identities = 53/289 (18%), Positives = 100/289 (34%), Gaps = 36/289 (12%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVD---IDDVRREVAIMKH 107
           +     + LG G FG           +      ++ + L+   D    + +  E+ +M  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH------------------- 148
           L  + +IV+L  AC     ++L+ E C  G+L + + ++                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 149 ----YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF 204
                T          + + ++       +HRDL   N L         +K  DFGL+  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213

Query: 205 FKPGERFS---EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQ 259
                 +           +MAPE L    Y  + D+WS G++L+ I   GV P+      
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 260 GVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
                +++    FK D     +E    +++     D + R +   +   
Sbjct: 274 ANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (466), Expect = 1e-55
 Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 19/284 (6%)

Query: 46  KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK-RKLRTAVDIDDVRREVAI 104
           KE       +++ +G GEFG       +   +     +I   +   T     D   E +I
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80

Query: 105 MKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVE 163
           M     + +++ L+        V ++ E  E G L   +    G +T      + R I  
Sbjct: 81  MGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 164 VVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE------IVGS 217
            ++       +HRDL   N L      N   K  DFGLS F +                 
Sbjct: 140 GMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 218 PYYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRD 275
             + APE ++ R +    D+WS G++++ ++  G  P+W  + Q V  AI +   D++  
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLP 253

Query: 276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
           P  +   +   L+    + D   R    Q++    L    + PN
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIRNPN 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 1e-55
 Identities = 59/283 (20%), Positives = 111/283 (39%), Gaps = 24/283 (8%)

Query: 42  AGVPKENIE---DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDV 98
            G+ K+  E   +   ++ +LG+G FG  ++     T  + A K++    +      +  
Sbjct: 5   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAF 59

Query: 99  RREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAA 156
            +E  +MK L ++  +V L     ++  +++V E    G L D +      +        
Sbjct: 60  LQEAQVMKKL-RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117

Query: 157 VTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--I 214
           +   I   +    +   +HRDL+  N L     EN   K  DFGL+   +  E  +    
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGA 174

Query: 215 VGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDF 272
                + APE      +  + D+WS G++L  L   G  P+     + V   + RG   +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---Y 231

Query: 273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE--HPWLQN 313
           +    P   ES   L+ Q    +P+ R T + +      +  +
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-55
 Identities = 60/264 (22%), Positives = 104/264 (39%), Gaps = 19/264 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
                 +ELG G+FGV      R   ++ A K I +  +      D+   E  +M +L  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNL-S 57

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTRTIVEVVQLCH 169
           +  +V L   C     + ++ E    G L + +   R  +  +    + + + E ++   
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVLK 227
               +HRDL   N L     +   +K  DFGLS +    E            +  PEVL 
Sbjct: 118 SKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 228 RN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWP-NVSESA 284
            + +  + DIW+ GV+++ I   G  P+   +    A+ I +GL    R   P   SE  
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----RLYRPHLASEKV 230

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEH 308
            +++          R T K +L +
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 5e-55
 Identities = 61/276 (22%), Positives = 98/276 (35%), Gaps = 19/276 (6%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMK 106
           E    +  +LG G FGV               +A K +    L     +DD  REV  M 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVV 165
            L  + +++ L         + +V EL   G L DR+    GH+     +     + E +
Sbjct: 67  SL-DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE----RFSEIVGSPYYM 221
                   IHRDL   N L A       +K  DFGL       +              + 
Sbjct: 125 GYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE LK R +    D W  GV L+ +   G  P+   +   +   I +     +     +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPED 239

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK 315
             +   +++ Q     P+ R T   + +  +L  A+
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-54
 Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 53/320 (16%)

Query: 48  NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKH 107
            +  RY   + +G G  G+     D      +A K +S+   +         RE+ +MK 
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72

Query: 108 LPKNSSIVSLKEAC------EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTI 161
           +  + +I+SL          E+   V+LVMEL +          +        + +   +
Sbjct: 73  V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQM 128

Query: 162 VEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYM 221
           +  ++  H  G+IHRDLKP N      K +  LK +DFGL+         +  V + YY 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185

Query: 222 APE-VLKRNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGL----------- 269
           APE +L   Y   +DIWS G I+  ++     F           ++  L           
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 270 -----------IDFKRDPWPN----------------VSESAKSLVRQMLEPDPKLRLTA 302
                        +    +P                  +  A+ L+ +ML  DP  R++ 
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 303 KQVLEHPWLQNAKKAPNVPL 322
              L+HP++        V  
Sbjct: 306 DDALQHPYINVWYDPAEVEA 325

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 17/263 (6%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
                 +E+G G+FG+ +L    +  ++ A K+I +  +      +D   E  +M  L  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKL-S 58

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTRTIVEVVQLCH 169
           +  +V L   C +   + LV E  E G L D +  +   +       +   + E +    
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 170 KHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER--FSEIVGSPYYMAPEVLK 227
           +  VIHRDL   N L     EN  +K  DFG++ F    +    +       + +PEV  
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 228 RN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
            + Y  + D+WS GV+++ +   G  P+   S   V + I  G   F+       S    
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVY 232

Query: 286 SLVRQMLEPDPKLRLTAKQVLEH 308
            ++    +  P+ R    ++L  
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 5e-54
 Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 19/263 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
           +   +   LG G+FG  ++       ++ A KS+ +  +      D    E  +MK L +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQL-Q 66

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLC 168
           +  +V L      +  ++++ E  E G L D +        T      +   I E +   
Sbjct: 67  HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE--IVGSPYYMAPEVL 226
            +   IHRDL+  N L ++       K  DFGL+   +  E  +         + APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 227 KRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
               +  + D+WS G++L  ++  G  P+   +   V Q + RG   ++     N  E  
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEEL 239

Query: 285 KSLVRQMLEPDPKLRLTAKQVLE 307
             L+R   +  P+ R T   +  
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRS 262

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  178 bits (451), Expect = 1e-53
 Identities = 49/274 (17%), Positives = 93/274 (33%), Gaps = 20/274 (7%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           +   Y V R +G G FGV +   +    + +A K   +R      D   +R E    K L
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 57

Query: 109 PKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLC 168
              + I ++    ++     LV++L          +    ++ +  A   + ++  VQ  
Sbjct: 58  AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 169 HKHGVIHRDLKPENFLFANK--KENSPLKAIDFGLSIFFKPGE--------RFSEIVGSP 218
           H+  +++RD+KP+NFL      K  + +  +DFG+  F++               + G+ 
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 219 YYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP- 276
            YM+      R      D+ + G +    L G  P+         Q   R     +  P 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 277 ---WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                   E     +                +  
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 4e-52
 Identities = 59/264 (22%), Positives = 102/264 (38%), Gaps = 14/264 (5%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSI-SKRKLRTAVDIDDVRREVAIMKHLP 109
           +R  + R +G G+FG  +  I           +I + +   +    +   +E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65

Query: 110 KNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLC 168
            +  IV L     ++  V ++MELC  GEL   +  R       +       +   +   
Sbjct: 66  DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVL 226
                +HRD+   N L ++      +K  DFGLS + +     + S+      +MAPE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 227 K-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA 284
             R +    D+W  GV ++ IL+ GV PF       V   I  G    +    PN   + 
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTL 238

Query: 285 KSLVRQMLEPDPKLRLTAKQVLEH 308
            SL+ +    DP  R    ++   
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (440), Expect = 5e-52
 Identities = 55/277 (19%), Positives = 110/277 (39%), Gaps = 17/277 (6%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPK 110
               +  +LG G++G  Y  + +     +A K++ +  +    ++++  +E A+MK + K
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-K 71

Query: 111 NSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTRTIVEVVQLC 168
           + ++V L   C  +   +++ E    G L D +        +      +   I   ++  
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 169 HKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE--RFSEIVGSPYYMAPEVL 226
            K   IHRDL   N L     EN  +K  DFGLS           +       + APE L
Sbjct: 132 EKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 227 KRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK 285
             N +  + D+W+ GV+L+ +       +   +      +L    D++ +      E   
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCPEKVY 246

Query: 286 SLVRQMLEPDPKLRLTAKQVLE--HPWLQNAKKAPNV 320
            L+R   + +P  R +  ++ +      Q +  +  V
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 9e-50
 Identities = 57/283 (20%), Positives = 104/283 (36%), Gaps = 30/283 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRE-------LLACKSISKRKLRTAVDIDDVRREVA 103
           DR ++ + LG G FG   L       +        +A K +         D+ D+  E+ 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70

Query: 104 IMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRI----------------VARG 147
           +MK + K+ +I++L  AC  D  +++++E    G L + +                    
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 148 HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
             + +   +    +   ++       IHRDL   N L                       
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 208 GERFSEIVGSPYYMAPEVLK-RNYGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAI 265
            ++ +       +MAPE L  R Y  + D+WS GV+L+ I   G  P+     + + + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 266 LRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
             G    + D   N +     ++R      P  R T KQ++E 
Sbjct: 251 KEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-49
 Identities = 54/320 (16%), Positives = 107/320 (33%), Gaps = 22/320 (6%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISK--RKLRTAVDIDDVRREVAIMKH 107
           E  +   + LG G FG  Y  +     E +      K  R+  +     ++  E  +M  
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 108 LPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQL 167
           +  N  +  L   C       +   +  G  L      + +   +        I + +  
Sbjct: 68  V-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 168 CHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPE 224
                ++HRDL   N L    K    +K  DFGL+      E+            +MA E
Sbjct: 127 LEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 225 VLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE 282
            +  R Y  + D+WS GV ++ L+  G  P+       ++  + +G    +    P  + 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTI 240

Query: 283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRFKRK 342
               ++ +    D   R   ++++         + P   L      R+   S  +     
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIE--FSKMARDPQRYLVIQGDERMHLPSPTDS---- 294

Query: 343 ALRVIAEFLSVEEVEDIKEM 362
                   +  E+++D+ + 
Sbjct: 295 --NFYRALMDEEDMDDVVDA 312

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 35/285 (12%)

Query: 51  DRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRREVAIM 105
           +R    + LG G FG          I  D    +A K +      T  + + +  E+ ++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----------------- 148
            +L  + +IV+L  AC       ++ E C  G+L + +  +                   
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 149 -YTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP 207
                   + +  + + +        IHRDL   N L          K  DFGL+   K 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKN 197

Query: 208 GERF---SEIVGSPYYMAPEVLKRNY-GPEIDIWSAGVILYILLC-GVPPFWAESEQGVA 262
              +           +MAPE +       E D+WS G+ L+ L   G  P+         
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 263 QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
             +++    F+     +       +++   + DP  R T KQ+++
Sbjct: 258 YKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 8e-47
 Identities = 59/295 (20%), Positives = 106/295 (35%), Gaps = 43/295 (14%)

Query: 47  ENIEDRYLVDRELGRGEFGVTYLC-----IDRDTRELLACKSISKRKLRTAVDIDDVRRE 101
           E   +     R++G G FG  +       +  +   ++A K + +    +A    D +RE
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 66

Query: 102 VAIMKHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHY------------ 149
            A+M     N +IV L   C     + L+ E    G+L + + +   +            
Sbjct: 67  AALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 150 ------------TERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI 197
                       +      + R +   +    +   +HRDL   N L     EN  +K  
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIA 182

Query: 198 DFGLSIFFKPGERF---SEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC-GVPP 252
           DFGLS      + +           +M PE +  N Y  E D+W+ GV+L+ +   G+ P
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 253 FWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
           ++  + + V   +  G I        N      +L+R      P  R +   +  
Sbjct: 243 YYGMAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 56/278 (20%), Positives = 112/278 (40%), Gaps = 25/278 (8%)

Query: 44  VPKENIEDRYLVDRELGRGEFGVTYLCIDRD---TRELLACKSISKRKLRTAVDIDDVRR 100
           +   ++   +  +  +GRG FG  Y     D    +   A KS+   ++    ++     
Sbjct: 22  IGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLT 77

Query: 101 EVAIMKHLPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGH-YTERAAAAVT 158
           E  IMK    + +++SL   C   + +  +V+   + G+L + I    H  T +      
Sbjct: 78  EGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 136

Query: 159 RTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE----- 213
             + + ++       +HRDL   N +     E   +K  DFGL+      E  S      
Sbjct: 137 LQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTG 193

Query: 214 IVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLID 271
                 +MA E L+   +  + D+WS GV+L+ L+  G PP+   +   +   +L+G   
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--- 250

Query: 272 FKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
            +R   P    +    ++ +   P  ++R +  +++  
Sbjct: 251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 7e-45
 Identities = 58/280 (20%), Positives = 105/280 (37%), Gaps = 22/280 (7%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMK 106
                 + +G GEFG  Y  + + +       +A K++      T     D   E  IM 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMG 64

Query: 107 HLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVV 165
               + +I+ L+        + ++ E  E G L   +  + G ++      + R I   +
Sbjct: 65  QF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER----FSEIVGSPYYM 221
           +       +HRDL   N L  +       K  DFGLS   +         S       + 
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 222 APEVLK-RNYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPN 279
           APE +  R +    D+WS G++++ ++  G  P+W  S   V +AI  G   F+     +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMD 237

Query: 280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN 319
              +   L+ Q  + +   R     ++    L    +AP+
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSI--LDKLIRAPD 275

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 1e-44
 Identities = 55/278 (19%), Positives = 114/278 (41%), Gaps = 29/278 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTR-----ELLACKSISKRKLRTAVDIDDVRREVAIM 105
           ++  + RELG+G FG+ Y  + +          +A K++++       +  +   E ++M
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGH----------YTERAAA 155
           K       +V L           ++MEL   G+L   + +              +     
Sbjct: 78  KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 156 AVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE---RFS 212
            +   I + +   + +  +HRDL   N + A   E+  +K  DFG++      +   +  
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 213 EIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILY-ILLCGVPPFWAESEQGVAQAILRGLI 270
           + +    +M+PE LK   +    D+WS GV+L+ I      P+   S + V + ++ G +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
               D   N  +    L+R   + +PK+R +  +++  
Sbjct: 254 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-43
 Identities = 60/300 (20%), Positives = 108/300 (36%), Gaps = 51/300 (17%)

Query: 49  IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL 108
           I    ++   +G+G FG  +    +   E +A K  S R+ R+         E+     L
Sbjct: 1   IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWF----REAEIYQTVML 54

Query: 109 PKNSSIVSLKEACEDDNA----VHLVMELCEGGELFDRIVARGHYTERA-------AAAV 157
            ++ +I+    A   DN     + LV +  E G LFD +       E         A+ +
Sbjct: 55  -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113

Query: 158 TRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-----RFS 212
               +E+V    K  + HRDLK +N L    K+N      D GL++             +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 213 EIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCGVPPFWAESEQG----- 260
             VG+  YMAPEVL  +            DI++ G++ + +           +       
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 261 ------VAQAILRGLIDFKRDP-------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLE 307
                   + + + + + K  P                 ++R+    +   RLTA ++ +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (383), Expect = 5e-43
 Identities = 63/335 (18%), Positives = 118/335 (35%), Gaps = 66/335 (19%)

Query: 52  RYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHL--- 108
           RY++ R+LG G F   +L  D      +A K +   K+ T    +    E+ +++ +   
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69

Query: 109 -------PKNSSIVSLKEACED--DNAVHLVMELCEGG---ELFDRIVARGHYTERAAAA 156
                     + I+ L +       N VH+VM     G       +              
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 157 VTRTIVEVVQ-LCHKHGVIHRDLKPENFLFANKKENSPLKAI-DFGLSIFFKPGERFSEI 214
           +++ ++  +  +  + G+IH D+KPEN L         L  I    L       E ++  
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 215 VGSPYYMAPEVLK-RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGV------------ 261
           + +  Y +PEVL    +G   DIWS   +++ L+ G   F  +                 
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 262 ---------------------AQAILRGLIDFKRDPW-----------PNVSESAKSLVR 289
                                ++ +LR +   K  P             + ++     + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 290 QMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGD 324
            ML+ DP+ R  A  ++ HPWL++      + + D
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 9e-43
 Identities = 57/283 (20%), Positives = 111/283 (39%), Gaps = 30/283 (10%)

Query: 51  DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVR---REVAIMKH 107
           DR  + + LGRG FG           +   C++++ + L+      + R    E+ I+ H
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 108 LPKNSSIVSLKEAC-EDDNAVHLVMELCEGGELFDRIVARGHY----------------T 150
           +  + ++V+L  AC +    + +++E C+ G L   + ++ +                 T
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 151 ERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE- 209
                  +  + + ++       IHRDL   N L     E + +K  DFGL+        
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPD 189

Query: 210 --RFSEIVGSPYYMAPEVLKRN-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL 266
             R  +      +MAPE +    Y  + D+WS GV+L+ +       +   +  + +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--IDEEFC 247

Query: 267 RGLIDFKRDPWP-NVSESAKSLVRQMLEPDPKLRLTAKQVLEH 308
           R L +  R   P   +      +      +P  R T  +++EH
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 1e-18
 Identities = 42/202 (20%), Positives = 69/202 (34%), Gaps = 25/202 (12%)

Query: 55  VDRELGRGEFGVTYLCIDRDTRELLACK-----SISKRKLRTAVDIDDVR-REVAIMKHL 108
           + + +G G+    + C      E    K       S +K++   D  D+    +AI    
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 109 PKNSSIVSLKEACE----DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEV 164
            +  ++  L+              ++MEL +  E                  V   I+E 
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115

Query: 165 VQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPE 224
           V   +  G++H DL   N L + +     +  IDF  S+     E + EI+         
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-EGWREILERDVRNIIT 170

Query: 225 VLKRNYGPEIDIWSAGVILYIL 246
              R Y  E DI S   I  IL
Sbjct: 171 YFSRTYRTEKDINS--AIDRIL 190

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 64.7 bits (156), Expect = 3e-12
 Identities = 18/95 (18%), Positives = 36/95 (37%), Gaps = 5/95 (5%)

Query: 312 QNAKKAPNVPLGDVVRSRLKQFSMMNRFKRKA-----LRVIAEFLSVEEVEDIKEMFKKI 366
           + A++      GD    + +  S++   +  A     LR     LS E+   ++++F   
Sbjct: 72  ERAEREREAARGDAAAEKQRLASLLKDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSS 131

Query: 367 DSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
                G  S  +LK  L  +   + E  ++ L   
Sbjct: 132 AVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVM 166

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 56.5 bits (136), Expect = 5e-11
 Identities = 28/54 (51%), Positives = 40/54 (74%)

Query: 345 RVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQML 398
           + +AE LS EE+  +KE+FK ID+DN G ++ DELK GL+  GS+L ESE++ L
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDL 64

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 54.7 bits (130), Expect = 2e-09
 Identities = 22/40 (55%), Positives = 29/40 (72%)

Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG 387
           AE LS EE+  +KE+FK ID+DN G ++ DELK GL+  G
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG 40

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 48.5 bits (115), Expect = 3e-08
 Identities = 18/51 (35%), Positives = 30/51 (58%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           L+ E++ + KE F   D DN+G +S+ EL   +R+ G   +E+EV  L+  
Sbjct: 4   LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNE 54

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

 Score = 48.5 bits (114), Expect = 2e-07
 Identities = 11/46 (23%), Positives = 24/46 (52%)

Query: 352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
            + + +++ E F+ +D+D  G +S  EL A L + G   + +  + 
Sbjct: 13  HMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEK 58

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

 Score = 45.7 bits (108), Expect = 2e-07
 Identities = 18/50 (36%), Positives = 29/50 (58%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q +I 
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMIN 51

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 47.5 bits (112), Expect = 2e-07
 Identities = 17/47 (36%), Positives = 28/47 (59%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
           L+ E++ + KE F   D DN+G +S+ EL   +R+ G   +E+EV  
Sbjct: 4   LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVND 50

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 38.3 bits (88), Expect = 4e-04
 Identities = 15/44 (34%), Positives = 27/44 (61%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +++ E FK  D + DG++S  ELK  L + G +L ++EV  ++ 
Sbjct: 83  QELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLR 126

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 45.4 bits (107), Expect = 3e-07
 Identities = 18/53 (33%), Positives = 26/53 (49%)

Query: 349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
            FLS E + + K  F   D+D  G +ST EL   +R  G    + E+  +IE 
Sbjct: 6   AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEE 58

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 44.8 bits (106), Expect = 4e-07
 Identities = 15/46 (32%), Positives = 27/46 (58%), Gaps = 1/46 (2%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEA 401
           E+I   FK  D++ DGV+  DE K  ++  G + L ++EV+  ++ 
Sbjct: 2   EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKE 47

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 45.4 bits (107), Expect = 4e-07
 Identities = 16/57 (28%), Positives = 25/57 (43%), Gaps = 1/57 (1%)

Query: 345 RVIAEFLSVEEVEDIKEMFKKIDSDN-DGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +   E L+ E+  + K  F        DG +ST EL   +R  G      E+Q +I+
Sbjct: 3   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMID 59

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

 Score = 47.3 bits (111), Expect = 6e-07
 Identities = 8/61 (13%), Positives = 27/61 (44%), Gaps = 5/61 (8%)

Query: 344 LRVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAG-----LRNFGSQLAESEVQML 398
           +++  +F +   ++  K MF  +D + +G ++ DE+ +           +   +++   +
Sbjct: 1   VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQV 60

Query: 399 I 399
            
Sbjct: 61  C 61

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 44.5 bits (105), Expect = 6e-07
 Identities = 14/48 (29%), Positives = 25/48 (52%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +  E+I + F+  D DN G ++  +L+   +  G  L E E+Q +I  
Sbjct: 6   DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAE 53

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 45.8 bits (107), Expect = 9e-07
 Identities = 11/39 (28%), Positives = 15/39 (38%)

Query: 359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
            K++F   D    G ++ D L   LR  G       VQ 
Sbjct: 4   NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQD 42

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.4 bits (109), Expect = 1e-06
 Identities = 9/52 (17%), Positives = 21/52 (40%), Gaps = 1/52 (1%)

Query: 351 LSVEEVEDIKEMFKKIDSD-NDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +   +   ++E +KK   +   G +   E K   +   ++ A   V+ +  A
Sbjct: 15  VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRA 66

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 45.4 bits (106), Expect = 1e-06
 Identities = 15/49 (30%), Positives = 28/49 (57%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           L  ++++++KE F  ID D DG VS +++KA     G    + E+  ++
Sbjct: 1   LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAML 49

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 43.4 bits (102), Expect = 2e-06
 Identities = 14/48 (29%), Positives = 28/48 (58%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           +++ D + +FK+ D++ DG +S+ EL   L+  GS   +   +M+ E 
Sbjct: 3   QDIADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEI 50

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (104), Expect = 2e-06
 Identities = 10/42 (23%), Positives = 18/42 (42%)

Query: 358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLI 399
           + KE F+  D   DG +   +    +R  G     +EV  ++
Sbjct: 1   EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVL 42

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

 Score = 45.7 bits (107), Expect = 2e-06
 Identities = 9/38 (23%), Positives = 20/38 (52%)

Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRN 385
           ++F +   +   K MF  +D +++G +S DE+     +
Sbjct: 3   SDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASD 40

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 44.6 bits (104), Expect = 4e-06
 Identities = 15/54 (27%), Positives = 22/54 (40%), Gaps = 1/54 (1%)

Query: 345 RVIAEFLSVEEVEDIKEMFKKIDSD-NDGVVSTDELKAGLRNFGSQLAESEVQM 397
           +   E L+ E+  + K  F        DG +ST EL   +R  G      E+Q 
Sbjct: 2   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQE 55

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 36.9 bits (84), Expect = 0.001
 Identities = 12/44 (27%), Positives = 27/44 (61%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           E++ ++F+  D + DG +  +ELK  L+  G  + E +++ L++
Sbjct: 91  EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMK 134

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 44.5 bits (104), Expect = 4e-06
 Identities = 10/47 (21%), Positives = 19/47 (40%), Gaps = 1/47 (2%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           EEV   + +F ++   +D  VS  EL   L    ++  + +      
Sbjct: 1   EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGI 46

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

 Score = 44.3 bits (103), Expect = 5e-06
 Identities = 10/46 (21%), Positives = 19/46 (41%)

Query: 352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
           S   V+ +K  F +ID D DG ++  + ++    F  +        
Sbjct: 1   SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHA 46

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 44.5 bits (104), Expect = 5e-06
 Identities = 14/51 (27%), Positives = 27/51 (52%), Gaps = 2/51 (3%)

Query: 350 FLSVEEVEDIKEMFKKIDSD--NDGVVSTDELKAGLRNFGSQLAESEVQML 398
             SV E+E + E+FKKI S   +DG+++ +E +  L     + +    ++ 
Sbjct: 10  VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESLFADRVF 60

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

 Score = 43.6 bits (101), Expect = 5e-06
 Identities = 13/37 (35%), Positives = 22/37 (59%)

Query: 361 EMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
            +FK+ID + DG VS +E+KA +    +   E  +Q+
Sbjct: 4   ALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQL 40

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 43.4 bits (101), Expect = 8e-06
 Identities = 16/49 (32%), Positives = 23/49 (46%)

Query: 349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
            FLS E + + K  F   D+D  G +ST EL   +R  G    + E+  
Sbjct: 12  AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDA 60

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 39.5 bits (91), Expect = 2e-04
 Identities = 12/44 (27%), Positives = 24/44 (54%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           E++   F+  D + DG +  +EL   LR  G  + E +++ L++
Sbjct: 96  EELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMK 139

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

 Score = 43.0 bits (100), Expect = 9e-06
 Identities = 18/49 (36%), Positives = 28/49 (57%)

Query: 349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
           E L+ E++ + KE F   D D DG ++T EL   +R+ G    E+E+Q 
Sbjct: 1   EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQD 49

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

 Score = 36.4 bits (83), Expect = 0.002
 Identities = 16/44 (36%), Positives = 26/44 (59%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           E++ E FK  D D +G++S  EL+  + N G +L + EV  +I 
Sbjct: 82  EELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIR 125

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.0 bits (93), Expect = 2e-05
 Identities = 14/45 (31%), Positives = 25/45 (55%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           ED  + F+  D ++ G VS  +L+  L   G +L ++EV  L++ 
Sbjct: 1   EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKG 45

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 2e-05
 Identities = 11/52 (21%), Positives = 25/52 (48%)

Query: 347 IAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQML 398
           +      +E++ + + FKK+D DN G +S +E  +      + L +  + + 
Sbjct: 6   MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIF 57

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.5 bits (97), Expect = 2e-05
 Identities = 20/54 (37%), Positives = 31/54 (57%), Gaps = 3/54 (5%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEA 401
           LS      +K++F+ ID+D  G +  DELK  L+ F     +L ESE + L++A
Sbjct: 35  LSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDA 88

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 42.3 bits (98), Expect = 2e-05
 Identities = 14/50 (28%), Positives = 24/50 (48%), Gaps = 2/50 (4%)

Query: 351 LSVEEVEDIKEMFKKIDS--DNDGVVSTDELKAGLRNFGSQLAESEVQML 398
           LS +E++D+K++F+  D     DG V   +L    R  G      +V  +
Sbjct: 1   LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV 50

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.8 bits (95), Expect = 2e-05
 Identities = 9/44 (20%), Positives = 19/44 (43%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
               + K  F   D ++DGV+   EL+A       ++ + + + 
Sbjct: 13  PNRFNPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEE 56

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 33

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 39.1 bits (92), Expect = 2e-05
 Identities = 12/31 (38%), Positives = 19/31 (61%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFG 387
           E+I+E F+  D D +G +S  EL+  + N G
Sbjct: 3   EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 40.7 bits (95), Expect = 3e-05
 Identities = 18/54 (33%), Positives = 31/54 (57%), Gaps = 3/54 (5%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEA 401
           L      D+K++FK ID+D  G +  +ELK  L++F   G  L ++E +  ++A
Sbjct: 35  LKAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKA 88

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (96), Expect = 3e-05
 Identities = 13/44 (29%), Positives = 24/44 (54%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
           E+ ++I+E F   D+D  G +   ELK  +R  G +  + E++ 
Sbjct: 3   EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKK 46

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.3 bits (80), Expect = 0.004
 Identities = 15/44 (34%), Positives = 23/44 (52%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           E+I + FK  D D  G +S   LK   +  G  L + E+Q +I+
Sbjct: 79  EEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMID 122

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

 Score = 41.9 bits (97), Expect = 3e-05
 Identities = 5/47 (10%), Positives = 18/47 (38%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
              + +K+ F + D D +G +   + +   ++      +      ++
Sbjct: 4   IASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQ 50

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

 Score = 40.0 bits (92), Expect = 2e-04
 Identities = 11/39 (28%), Positives = 22/39 (56%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV 395
            +  E F ++D++ +G +S DEL   +R+F     + E+
Sbjct: 136 AEAAEAFNQVDTNGNGELSLDELLTAVRDFHFGRLDVEL 174

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 39.5 bits (92), Expect = 3e-05
 Identities = 12/45 (26%), Positives = 24/45 (53%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           E++   F+  D + DG +  +EL   LR  G  + E +++ L++ 
Sbjct: 9   EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKD 53

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

 Score = 40.3 bits (94), Expect = 4e-05
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 8/61 (13%)

Query: 349 EFLSV-----EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIE 400
            F  +     +    +KE+F+ +D D  G +  +ELK  L+ F   G  L ++E + L+ 
Sbjct: 28  RFFHLVGLKGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLA 87

Query: 401 A 401
           A
Sbjct: 88  A 88

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 39.2 bits (91), Expect = 4e-05
 Identities = 16/45 (35%), Positives = 26/45 (57%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           E+I+E F+  D D +G +S  EL+  + N G +L + EV  +I  
Sbjct: 3   EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 47

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 5e-05
 Identities = 8/55 (14%), Positives = 18/55 (32%), Gaps = 6/55 (10%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-----SQLAESEVQMLIE 400
              +  + +   F  +    DG +  DEL+  L   G             ++++ 
Sbjct: 1   FPGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVS 54

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

 Score = 39.2 bits (91), Expect = 5e-05
 Identities = 12/45 (26%), Positives = 27/45 (60%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
           E++ ++F+  D + DG +  +ELK  L+  G  + E +++ L++ 
Sbjct: 15  EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKD 59

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 41.5 bits (96), Expect = 5e-05
 Identities = 8/45 (17%), Positives = 19/45 (42%), Gaps = 1/45 (2%)

Query: 351 LSVEEVEDIKEMFKKI-DSDNDGVVSTDELKAGLRNFGSQLAESE 394
           L+  + + IK  F    D ++DG +  ++ +  +  +      S 
Sbjct: 2   LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSL 46

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 42.1 bits (98), Expect = 8e-05
 Identities = 23/168 (13%), Positives = 50/168 (29%), Gaps = 4/168 (2%)

Query: 50  EDRYLVDRELGRGEFGVTYLCIDRDTRELLACK----SISKRKLRTAVDIDDVRREVAIM 105
               L  +E+G G     +   D++    L  K              + ID  R E + +
Sbjct: 25  SKSTLTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSAL 84

Query: 106 KHLPKNSSIVSLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVV 165
               ++   +  +    D      VME     ++  + +  G      +  +   + + +
Sbjct: 85  IRQGEHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTL 144

Query: 166 QLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERFSE 213
                + +  +  K     F N +     + + F    F      F E
Sbjct: 145 FYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEE 192

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 1e-04
 Identities = 7/47 (14%), Positives = 19/47 (40%), Gaps = 1/47 (2%)

Query: 354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           +  +  + +F ++    D  +S  EL+  LR   ++  + +      
Sbjct: 15  DIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSI 60

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 37.6 bits (87), Expect = 1e-04
 Identities = 11/44 (25%), Positives = 19/44 (43%)

Query: 358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
             K +F+K D + DG +S DE +     F     + ++    E 
Sbjct: 2   SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEE 45

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 40.1 bits (92), Expect = 1e-04
 Identities = 12/52 (23%), Positives = 26/52 (50%), Gaps = 1/52 (1%)

Query: 348 AEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG-SQLAESEVQML 398
           A   ++ +   +  +F+++D D  GV+S +EL+  L N   +      V+ +
Sbjct: 10  AAGAALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSI 61

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 38.8 bits (90), Expect = 1e-04
 Identities = 15/39 (38%), Positives = 23/39 (58%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ 389
           L+ + ++D+K+ F  ID D  G +  DELK  L+NF   
Sbjct: 34  LASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPS 72

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

 Score = 38.8 bits (90), Expect = 2e-04
 Identities = 13/39 (33%), Positives = 22/39 (56%)

Query: 351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ 389
           L  +  +D+K++F  +D D  G +  DEL + L+ F S 
Sbjct: 35  LKKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSD 73

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 36.4 bits (84), Expect = 4e-04
 Identities = 11/50 (22%), Positives = 22/50 (44%), Gaps = 4/50 (8%)

Query: 354 EEVEDIKEMFKKIDSD--NDGVVSTDELKAGLRNFGSQ--LAESEVQMLI 399
           +  E+IK  F+   +   +   +S +ELK  ++  G       S +  +I
Sbjct: 2   KSPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMI 51

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.3 bits (88), Expect = 5e-04
 Identities = 10/64 (15%), Positives = 26/64 (40%), Gaps = 4/64 (6%)

Query: 338 RFKRKALRVIAE--FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV 395
           + + + ++ + E    +  E+++  + F +      G +S +E K    NF      S+ 
Sbjct: 3   KLRPEVMQDLLESTDFTEHEIQEWYKGFLRDC--PSGHLSMEEFKKIYGNFFPYGDASKF 60

Query: 396 QMLI 399
              +
Sbjct: 61  AEHV 64

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.001
 Identities = 7/64 (10%), Positives = 22/64 (34%), Gaps = 4/64 (6%)

Query: 338 RFKRKALRVIAE--FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEV 395
           + K + +  +    + + +EV+   + F K      G +     +   + F      ++ 
Sbjct: 4   KLKPEVVEELTRKTYFTEKEVQQWYKGFIKD--CPSGQLDAAGFQKIYKQFFPFGDPTKF 61

Query: 396 QMLI 399
              +
Sbjct: 62  ATFV 65

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.1 bits (85), Expect = 0.001
 Identities = 11/53 (20%), Positives = 17/53 (32%), Gaps = 3/53 (5%)

Query: 350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESE-VQMLIEA 401
             +  E++ +   FK       GVV+ +  K     F      S     L  A
Sbjct: 9   NFTKRELQVLYRGFKNE--CPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNA 59

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

 Score = 37.4 bits (86), Expect = 0.001
 Identities = 10/43 (23%), Positives = 20/43 (46%)

Query: 359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA 401
              +F+K D D  G +S  E++  +   G +L     Q+++  
Sbjct: 95  YLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR 137

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.003
 Identities = 15/53 (28%), Positives = 24/53 (45%), Gaps = 2/53 (3%)

Query: 349 EFLSVEEVED-IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIE 400
           + LS EE++D  K +F K+  D D  +S  EL+  L    S+  +        
Sbjct: 11  KVLSEEEIDDNFKTLFSKLAGD-DMEISVKELQTILNRIISKHKDLRTNGFSL 62

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 36.5 bits (83), Expect = 0.002
 Identities = 9/46 (19%), Positives = 16/46 (34%), Gaps = 1/46 (2%)

Query: 352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQM 397
           S ++    K+ F   D    G +    +   LR  G     +E+  
Sbjct: 1   STDDSP-YKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITE 45

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.1 bits (80), Expect = 0.002
 Identities = 7/36 (19%), Positives = 14/36 (38%)

Query: 357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAE 392
             I + F+  D+     +S +E +A        L +
Sbjct: 20  HAITQEFENFDTMKTNTISREEFRAICNRRVQILTD 55

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 34.0 bits (78), Expect = 0.003
 Identities = 9/53 (16%), Positives = 24/53 (45%), Gaps = 4/53 (7%)

Query: 352 SVEEVEDIKEMFKKIDS--DNDGVVSTDELKAGLRNFGSQLAES--EVQMLIE 400
           + +   ++K +F+K  +   +   +S +ELK  ++     L +    +  L +
Sbjct: 2   AQKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQ 54

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	408
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.86
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	98.86
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	98.85
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	98.78
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	98.76
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	98.74
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.7
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	98.7
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	98.66
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.65
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	98.59
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	98.57
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	98.54
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	98.49
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	98.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.45
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	98.3
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	98.29
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	98.2
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	98.17
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.07
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	98.05
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.04
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	98.03
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	98.03
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.01
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	98.0
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	97.98
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	97.96
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	97.94
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	97.94
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	97.93
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	97.9
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	97.89
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	97.89
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	97.88
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	97.87
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	97.87
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	97.86
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	97.77
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	97.74
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	97.74
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	97.72
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.71
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	97.66
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	97.65
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	97.64
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	97.64
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	97.64
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	97.63
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	97.62
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	97.59
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	97.54
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	97.54
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	97.53
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	97.52
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	97.51
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	97.5
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	97.45
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	97.42
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	97.42
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	97.38
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	97.34
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	97.31
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	97.26
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	97.25
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	97.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.18
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	97.18
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	97.15
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	97.14
d1juoa_	172	Sorcin {Human (Homo sapiens) [TaxId: 9606]}	97.13
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	97.11
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	97.1
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	97.04
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	96.97
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	96.91
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	96.86
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	96.85
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	96.78
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	96.76
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	96.71
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	96.69
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	96.68
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	96.53
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	96.52
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	96.48
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	96.46
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	96.44
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	96.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.05
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	96.03
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	96.0
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	95.7
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	95.52
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	95.46
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	95.42
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	95.3
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	95.28
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	95.27
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	95.24
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	95.11
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	95.08
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	94.97
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	94.83
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	94.62
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	94.43
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	94.24
d1j7qa_	86	Calcium vector protein {Amphioxus (Branchiostoma l	94.15
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	93.65
d2zkmx1	170	Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI	93.55
d1qlsa_	95	Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1	93.47
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	93.32
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	93.24
d1j55a_	94	Calcyclin (S100) {Human (Homo sapiens), s100p [Tax	93.2
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	93.0
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	92.75
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	92.58
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	92.56
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	92.42
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	92.39
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	92.28
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	91.99
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	91.98
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	91.23
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	91.19
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	91.0
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	90.43
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	90.41
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	90.4
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	90.25
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	90.19
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	89.98
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	89.95
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	89.95
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	89.77
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	89.73
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	89.61
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	89.61
d1qlsa_	95	Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1	89.43
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	89.38
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	89.01
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	88.94
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	88.91
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	88.61
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	87.87
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	86.91
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	86.83
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	86.6
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	86.32
d1j55a_	94	Calcyclin (S100) {Human (Homo sapiens), s100p [Tax	86.3
d1xk4c1	83	Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr	85.9
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	85.73
d1xk4c1	83	Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr	85.6
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	85.52
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	85.06
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	84.87
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	84.82
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	84.77
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	83.49
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	82.14

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.3e-67  Score=479.65  Aligned_cols=290  Identities=38%  Similarity=0.709  Sum_probs=236.6

Q ss_pred             ccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+++.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.....  ....+.+|+.+|+++ +||||+++++++++++
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKI-KHPNIVALDDIYESGG   80 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence            4678899999999999999999999999999999999998765432  235688999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          126 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+...++++.+||+|||+|...
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999999999999889999999999999999999999999999999999999987667789999999999987


Q ss_pred             CCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          206 KPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      .......+.+||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+....+....+.++...++.+.++.+|+++
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            76666677889999999999986 59999999999999999999999999999999999999999888888888999999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhhhhhhhhhh
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLKQFSMMNRF  339 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (408)
                      ++||.+||++||++|||+.|+++||||++.... ...+...+...+++....+++
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  294 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKNFAKSKW  294 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC-CCCCHHHHHHHHHHHSCCCTT
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc-ccccchhHHHHHHHHHHHhhh
Confidence            999999999999999999999999999865422 223334444444444333333

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-65  Score=457.79  Aligned_cols=255  Identities=32%  Similarity=0.586  Sum_probs=233.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++++.+ +||||+++++++.+++.+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence            6899999999999999999999999999999999876554455567899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|...... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC-c
Confidence            9999999999999988899999999999999999999999999999999999999   45678999999999876543 3


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.+....++    ..+|+++++||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence            456789999999999986 589999999999999999999999999999999999888776543    468999999999


Q ss_pred             HhcCCCcCCCCCHHHHhcCccccCC
Q 015352          290 QMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +||++||++|||+.|+|+||||+..
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-64  Score=460.51  Aligned_cols=270  Identities=36%  Similarity=0.649  Sum_probs=245.0

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCC---hhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRT---AVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      ...++.++|++.+.||+|+||+||+|+++.+|+.||||++.+.....   ....+.+.+|+.+|+++ +||||++++++|
T Consensus         4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~   82 (293)
T d1jksa_           4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVY   82 (293)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             cCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEE
Confidence            34668899999999999999999999999999999999998765432   23467899999999999 999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC-CCCCEEEeecc
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK-ENSPLKAIDFG  200 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~-~~~~vkl~Dfg  200 (408)
                      ++++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ....+||+|||
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999999999999888999999999999999999999999999999999999996543 23469999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      +|..........+..||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......++...++.
T Consensus       163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence            9998877777777889999999999986 599999999999999999999999999999999999999888777666678


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +|+++++||.+||+.||++|||++|+|+||||+...
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999999998643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.4e-64  Score=466.87  Aligned_cols=267  Identities=34%  Similarity=0.623  Sum_probs=243.8

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ....+.++|++++.||+|+||.||+|+++.+|+.||+|++.+..   ..+...+.+|+.+|+++ +||||++++++|+++
T Consensus        23 ~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~   98 (352)
T d1koba_          23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK   98 (352)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS
T ss_pred             CCCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence            34457789999999999999999999999999999999997643   23456788999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ...+.+||+|||+|.
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~  177 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT  177 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccce
Confidence            99999999999999999876654 6999999999999999999999999999999999999954 245789999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ............||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+..+....+.++...++...+..+|+
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  257 (352)
T d1koba_         178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP  257 (352)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             ecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            8887777777899999999999976 599999999999999999999999999999999999999998888888889999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                      ++++||.+||++||.+|||+.|+|+||||+....
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            9999999999999999999999999999987543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.3e-64  Score=466.54  Aligned_cols=266  Identities=33%  Similarity=0.609  Sum_probs=242.8

Q ss_pred             cccccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           45 PKENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      ..+.+.++|++.+.||+|+||.||+|+++.+|+.||||++.+..   ....+.+.+|+.+|+++ +||||++++++++++
T Consensus        20 ~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~   95 (350)
T d1koaa2          20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD   95 (350)
T ss_dssp             BCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEET
T ss_pred             CCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence            34567789999999999999999999999999999999997543   33467889999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++. +.++.+||+|||+|.
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTA  174 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhe
Confidence            999999999999999999854 467999999999999999999999999999999999999964 235789999999999


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .........+..||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+......++...+..+|+
T Consensus       175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  254 (350)
T d1koaa2         175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  254 (350)
T ss_dssp             ECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred             ecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            8877777777899999999999886 589999999999999999999999999999999999999888877777778999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++++||.+||+.||++|||++|+|+||||+...
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-64  Score=454.83  Aligned_cols=259  Identities=28%  Similarity=0.520  Sum_probs=219.7

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      +.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.....  ..+.+.+|+.+++++ +||||+++++++.+++.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML-NHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeE
Confidence            4578999999999999999999999999999999998654322  245688999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence            999999999999999888889999999999999999999999999999999999999   45567999999999876433


Q ss_pred             C---ceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          209 E---RFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       209 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      .   .....+||+.|+|||++.+ . ++.++||||+||++|+|++|..||................. .....+..+|++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~  235 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSA  235 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TTSTTGGGSCHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCCHH
Confidence            2   2355689999999999875 4 46789999999999999999999977654333222222222 223345678999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +++||.+||+.||++|||+.|+|+||||++.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-64  Score=455.68  Aligned_cols=258  Identities=30%  Similarity=0.508  Sum_probs=230.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++++++ +||||+++++++++++.+|
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEE
Confidence            346899999999999999999999999999999999876554455678899999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      +|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.....
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence            999999999999999998999999999999999999999999999999999999999   55678999999999876432


Q ss_pred             C---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          209 E---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       209 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      .   ...+.+||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+..++..++.++.+.++    ..+|+++
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  237 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA  237 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHH
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHH
Confidence            2   3345689999999999976 699999999999999999999999999999999999988876554    4689999


Q ss_pred             HHHHHHhcCCCcCCCCCHHH------HhcCccccCC
Q 015352          285 KSLVRQMLEPDPKLRLTAKQ------VLEHPWLQNA  314 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~------~l~h~~~~~~  314 (408)
                      ++||.+||++||++|||++|      +++||||+..
T Consensus       238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            99999999999999999988      5788998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-63  Score=452.03  Aligned_cols=259  Identities=29%  Similarity=0.491  Sum_probs=227.9

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .+..++|++.+.||+|+||+||+|+++.+|+.||+|++.+...   ...+.+.+|+.+++++ +||||++++++|.+++.
T Consensus        16 ~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~   91 (293)
T d1yhwa1          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDE   91 (293)
T ss_dssp             SCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             CCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCE
Confidence            4456799999999999999999999999999999999986543   2357899999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|....
T Consensus        92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeec
Confidence            9999999999999987765 479999999999999999999999999999999999999   456789999999998765


Q ss_pred             CC-CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 PG-ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      .. ......+||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+.......+...... ....+..+|+++
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~  246 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIF  246 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHH
T ss_pred             cccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHH
Confidence            43 34456789999999999986 5999999999999999999999999998877766666554321 223345789999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ++||.+||++||.+|||+.|+|+||||+..
T Consensus       247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.7e-63  Score=445.43  Aligned_cols=262  Identities=35%  Similarity=0.650  Sum_probs=239.7

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCCh------hcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTA------VDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.+......      ...+.+.+|+.+++++..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            46899999999999999999999999999999999987654321      123468899999999956999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          123 DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                      +++++|+|||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhe
Confidence            999999999999999999999999999999999999999999999999999999999999999   56778999999999


Q ss_pred             cccCCCCceecccCCCCCcchhhhhc-------cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCC
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLKR-------NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (408)
                      .............||+.|+|||.+.+       .++.++||||+||++|+|++|..||.+.+.......+..+...++.+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98776666677889999999998853       36889999999999999999999999999999999999998887777


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                      .+..+|+++++||.+||++||.+|||++|+|+||||+.
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            77899999999999999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-62  Score=442.52  Aligned_cols=258  Identities=23%  Similarity=0.390  Sum_probs=222.6

Q ss_pred             ccccce-EecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe---
Q 015352           48 NIEDRY-LVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED---  123 (408)
Q Consensus        48 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---  123 (408)
                      ...++| ++.+.||+|+||+||+|+++.+++.||+|.+..... .....+.+.+|+++|+++ +||||+++++++++   
T Consensus         5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_           5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVK   82 (270)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESS
T ss_pred             CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccc
Confidence            344566 678889999999999999999999999999986654 334467899999999999 89999999999875   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          124 -DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHG--VIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                       +..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++  ++++.+||+|||
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFG  160 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLG  160 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecC
Confidence             4568999999999999999999889999999999999999999999999  99999999999995  345679999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhccCCCchhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCcccCCCCCCC
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKRNYGPEIDIWSAGVILYILLCGVPPFWAES-EQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      +|..... ....+.+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.. ...+.+.+..+..+.  .....
T Consensus       161 la~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~  237 (270)
T d1t4ha_         161 LATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKV  237 (270)
T ss_dssp             GGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGC
T ss_pred             cceeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--ccCcc
Confidence            9986443 3445678999999999999899999999999999999999999997654 445556665543322  22346


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      .++++++||.+||++||++|||+.|+|+||||+
T Consensus       238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            789999999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-63  Score=452.65  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=231.8

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ++..++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++++ +||||+++++++.+++.
T Consensus        11 ~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHT   89 (309)
T ss_dssp             SCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTE
T ss_pred             cCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCE
Confidence            34556799999999999999999999999999999999877665555667899999999999 99999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|+|||||.||+|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|....
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSS
T ss_pred             EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccccC
Confidence            999999999999988888888899999999999999999999999999999999999994   56779999999998754


Q ss_pred             CCCceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .   .....||+.|+|||++.+    .|+.++|||||||++|+|++|..||.+.+..+....+..+......  ...+|+
T Consensus       167 ~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~  241 (309)
T d1u5ra_         167 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSE  241 (309)
T ss_dssp             S---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCH
T ss_pred             C---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCH
Confidence            3   345689999999999853    4899999999999999999999999998888888777776543322  346899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      ++++||.+||+.||.+|||++|+|+||||....
T Consensus       242 ~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            999999999999999999999999999998653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-62  Score=455.47  Aligned_cols=256  Identities=31%  Similarity=0.543  Sum_probs=235.0

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.+ +||||++++++|++++.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence            5799999999999999999999999999999999876654455678899999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-CC
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-GE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~~  209 (408)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   5567899999999987543 44


Q ss_pred             ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          210 RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..++.+.+..+.+.++    ..+|+++++||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            5566789999999999975 699999999999999999999999999999999999988876654    47899999999


Q ss_pred             HHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          289 RQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       289 ~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      .+||++||.+|++     +.|+++||||+..
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999994     9999999999764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-63  Score=456.12  Aligned_cols=262  Identities=29%  Similarity=0.622  Sum_probs=240.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.++|.+.+.||+|+||+||+|+++.+|+.||+|++.+..    .+...+.+|+++|+.+ +||||++++++|++++.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence            46789999999999999999999999999999999997543    2345688999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+|||||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++. +....+||+|||++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccc
Confidence            99999999999999998765 6999999999999999999999999999999999999964 245689999999999887


Q ss_pred             CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .........||+.|+|||.+.+ .|+.++||||+||++|+|++|..||.+.+..+....+.++...++...++.+|++++
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            7777777889999999999875 699999999999999999999999999999999999999988888777788999999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                      +||.+||++||++|||+.|+++||||+...
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            999999999999999999999999997643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-63  Score=448.06  Aligned_cols=259  Identities=29%  Similarity=0.466  Sum_probs=226.8

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      +..+.|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+++|+++ +||||+++++++.+++.+
T Consensus         9 ~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~   84 (288)
T d2jfla1           9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNL   84 (288)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred             CcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeE
Confidence            34568999999999999999999999999999999997643   23456788999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|....
T Consensus        85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECH
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccC
Confidence            999999999999998765 4569999999999999999999999999999999999999   456789999999987643


Q ss_pred             CC-CceecccCCCCCcchhhhh------ccCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCC
Q 015352          207 PG-ERFSEIVGSPYYMAPEVLK------RNYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPN  279 (408)
Q Consensus       207 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  279 (408)
                      .. ....+..||+.|+|||++.      ..|+.++|||||||++|+|++|..||.+.+..+...++..+.... ...+..
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~  240 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSR  240 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGG
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCcccc
Confidence            22 2234568999999999983      248999999999999999999999999998888888888775432 222357


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          280 VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       280 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +|+++++||.+||++||++|||+.|+|+||||+..
T Consensus       241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            89999999999999999999999999999999753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-62  Score=440.44  Aligned_cols=254  Identities=30%  Similarity=0.502  Sum_probs=214.3

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--CCeE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAV  127 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~  127 (408)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+++++++ +||||+++++++.+  ++.+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEE
Confidence            3689999999999999999999999999999999987654 344567899999999999 99999999999864  5678


Q ss_pred             EEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCceEeecCCCCCCEEEee
Q 015352          128 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTRTIVEVVQLCHKHG-----VIHRDLKPENFLFANKKENSPLKAID  198 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~-----ivH~dikp~NIl~~~~~~~~~vkl~D  198 (408)
                      |+|||||+||+|.+++.+    .+.+++..++.++.||+.||.|||++|     |+||||||+|||+   +.++.+||+|
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~D  157 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  157 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEee
Confidence            999999999999998864    467999999999999999999999976     9999999999999   4567899999


Q ss_pred             cccccccCCCC-ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC
Q 015352          199 FGLSIFFKPGE-RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP  276 (408)
Q Consensus       199 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  276 (408)
                      ||+|....... ......||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+..++...+..+....   .
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~  234 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---I  234 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---C
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence            99998765443 3456789999999999975 69999999999999999999999999999998888888776542   2


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccc
Q 015352          277 WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWL  311 (408)
Q Consensus       277 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  311 (408)
                      +..+|+++++||.+||+.||.+|||+.|+++|||+
T Consensus       235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            34789999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-61  Score=445.98  Aligned_cols=254  Identities=27%  Similarity=0.530  Sum_probs=232.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence            5799999999999999999999999999999999876554445578899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      ||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....  .
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~--~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--V  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--C
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecc--c
Confidence            9999999999999999999999999999999999999999999999999999999   5667899999999987643  3


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ..+.+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+..+...++    +.+|++++++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            345789999999999986 599999999999999999999999999999999999988866543    468999999999


Q ss_pred             HhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          290 QMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +||++||.+|+     |++++++||||++.
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999996     99999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-62  Score=451.58  Aligned_cols=267  Identities=36%  Similarity=0.657  Sum_probs=227.9

Q ss_pred             cccccccceEecc-eecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           45 PKENIEDRYLVDR-ELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        45 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      +...+.++|.+.+ .||+|+||+||+|+++.+|+.||||++...        ..+.+|+.++.++.+||||++++++|++
T Consensus         5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1           5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            4456778999875 699999999999999999999999998642        4577899997665589999999999976


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          124 ----DNAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       124 ----~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                          +.++|+|||||+||+|.+++.+.  ..+++.+++.++.||+.||+|||++||+||||||+|||++..+..+.+||+
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence                46799999999999999999875  369999999999999999999999999999999999999876677889999


Q ss_pred             ecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH----HHcCCccc
Q 015352          198 DFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQA----ILRGLIDF  272 (408)
Q Consensus       198 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~----i~~~~~~~  272 (408)
                      |||+|+............||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.+.......    +..+...+
T Consensus       157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~  236 (335)
T d2ozaa1         157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  236 (335)
T ss_dssp             CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred             ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            9999998777666777899999999999876 699999999999999999999999987665444333    33344445


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCC
Q 015352          273 KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPN  319 (408)
Q Consensus       273 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~  319 (408)
                      +.+.+..+|+++++||.+||+.||++|||+.|+++||||......+.
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  283 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  283 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence            55555578999999999999999999999999999999977654433

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-62  Score=450.04  Aligned_cols=260  Identities=24%  Similarity=0.363  Sum_probs=217.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.+..  .....+.+.+|+.+|+++ +||||++++++|.+++++|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence            4678999999999999999999999999999999997653  223357889999999999 9999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence            999999999999999988899999999999999999999997 599999999999999   5567899999999987543


Q ss_pred             CCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH---cCC--------------
Q 015352          208 GERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAIL---RGL--------------  269 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~--------------  269 (408)
                      . ...+.+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+......   .+.              
T Consensus       158 ~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             H-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             C-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence            2 2345789999999999986 69999999999999999999999998765332211000   000              


Q ss_pred             -----------------------cccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          270 -----------------------IDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       270 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                             ...+......+|.++++||.+||+.||.+|||+.|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                                   0000111124688999999999999999999999999999998644

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-61  Score=448.87  Aligned_cols=254  Identities=28%  Similarity=0.520  Sum_probs=232.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+ +||||+++++++.+.+.+|+|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence            7999999999999999999999999999999999876554455677899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCc
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGER  210 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~  210 (408)
                      |||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+.....  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence            9999999999999998899999999999999999999999999999999999999   45678999999999876533  


Q ss_pred             eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 015352          211 FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVR  289 (408)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  289 (408)
                      ..+..||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+.......+..+...++    ..+|+++.+||+
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence            345689999999999886 599999999999999999999999999999999999988866543    478999999999


Q ss_pred             HhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          290 QMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       290 ~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +||++||.+|+     |++++++||||+..
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999995     99999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=440.61  Aligned_cols=256  Identities=25%  Similarity=0.460  Sum_probs=229.9

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHH-hCCCCCCeeEEeeEEEeCCeEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMK-HLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      ++|.+++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..++. .+ +||||+++++++.+++.+|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence            67999999999999999999999999999999998765444445677778888776 56 99999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC-C
Q 015352          130 VMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP-G  208 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~-~  208 (408)
                      |||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++..... .
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence            99999999999999998999999999999999999999999999999999999999   5667899999999986543 3


Q ss_pred             CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 015352          209 ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSL  287 (408)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  287 (408)
                      .......||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+..++...+..+...++    ..+|+++++|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  233 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL  233 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence            34455689999999999986 699999999999999999999999999999999999887765443    4689999999


Q ss_pred             HHHhcCCCcCCCCCHH-HHhcCccccCC
Q 015352          288 VRQMLEPDPKLRLTAK-QVLEHPWLQNA  314 (408)
Q Consensus       288 i~~~l~~dp~~R~s~~-~~l~h~~~~~~  314 (408)
                      |.+||++||.+|||+. ++++||||+..
T Consensus       234 i~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         234 LVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999999995 89999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-60  Score=445.72  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=220.3

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHH---HHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRRE---VAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|   +.+++.+ +||||+++++++++++.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            579999999999999999999999999999999986554333333444444   6666676 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+|.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            9999999999999999998999999999999999999999999999999999999999   5667899999999987654


Q ss_pred             CCceecccCCCCCcchhhhh-c-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          208 GERFSEIVGSPYYMAPEVLK-R-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      . ......||+.|+|||++. + .|+.++|||||||++|+|+||..||.+.+..... .+.+.........+..+|++++
T Consensus       160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSSSCHHHH
T ss_pred             C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCCHHHH
Confidence            3 344568999999999986 3 4899999999999999999999999876543322 2333333334444567999999


Q ss_pred             HHHHHhcCCCcCCCCC-----HHHHhcCccccCC
Q 015352          286 SLVRQMLEPDPKLRLT-----AKQVLEHPWLQNA  314 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s-----~~~~l~h~~~~~~  314 (408)
                      +||.+||++||.+|||     ++|+++||||++.
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999     7999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-59  Score=431.83  Aligned_cols=258  Identities=27%  Similarity=0.385  Sum_probs=216.6

Q ss_pred             ecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh--cHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEe
Q 015352           55 VDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV--DIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVME  132 (408)
Q Consensus        55 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  132 (408)
                      .++.||+|+||+||+|+++.+|+.||||++.........  ..+.+.+|+.+++++ +||||+++++++.+++++|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999765432211  134688999999999 99999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC-Cce
Q 015352          133 LCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG-ERF  211 (408)
Q Consensus       133 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~-~~~  211 (408)
                      |+.|+++..+...++.+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+|...... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence            99998887766666779999999999999999999999999999999999999   56678999999999876433 334


Q ss_pred             ecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC-------------
Q 015352          212 SEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP-------------  276 (408)
Q Consensus       212 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------  276 (408)
                      ...+||+.|+|||++.+  .|+.++||||+||++|+|++|.+||.+.+..+....+.+.........             
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            55689999999998863  489999999999999999999999999998888887765432221111             


Q ss_pred             -----------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          277 -----------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       277 -----------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                 ++.+++++++||.+||+.||++|||+.|+|+||||++...
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence                       1356899999999999999999999999999999987653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.5e-59  Score=423.47  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=224.1

Q ss_pred             cccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC-
Q 015352           47 ENIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN-  125 (408)
Q Consensus        47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-  125 (408)
                      ..+.++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.+ +||||+++++++...+ 
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence            45788999999999999999999999999999999999877666666667899999999999 9999999999998654 


Q ss_pred             ---eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          126 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       126 ---~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                         .+|+|||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.++|+|||.+
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~  158 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIA  158 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTTC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhhh
Confidence               4899999999999999999989999999999999999999999999999999999999994   5567999999988


Q ss_pred             cccCCC----CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCC
Q 015352          203 IFFKPG----ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPW  277 (408)
Q Consensus       203 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  277 (408)
                      ......    ......+||+.|+|||++.+ .|++++||||+||++|+|+||.+||.+.+..+....+.+....++...+
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence            754322    23445689999999999886 5999999999999999999999999999988888888887776666667


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCcccc
Q 015352          278 PNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQ  312 (408)
Q Consensus       278 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  312 (408)
                      +.+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            78999999999999999999999555555566653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-59  Score=422.52  Aligned_cols=253  Identities=32%  Similarity=0.554  Sum_probs=217.6

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChh---cHHHHHHHHHHHHhCC-CCCCeeEEeeEEEeC
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAV---DIDDVRREVAIMKHLP-KNSSIVSLKEACEDD  124 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~~i~~~~~~~~~~  124 (408)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.+.......   ....+.+|+.+++++. .||||++++++++++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            567999999999999999999999999999999999876543322   1234668999999983 389999999999999


Q ss_pred             CeEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+||||+.+ +++.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.  +.+.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECccccce
Confidence            999999999986 588888888889999999999999999999999999999999999999963  34679999999998


Q ss_pred             ccCCCCceecccCCCCCcchhhhhc-c-CCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          204 FFKPGERFSEIVGSPYYMAPEVLKR-N-YGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .... ....+..||+.|+|||++.+ . ++.++||||+||++|+|++|..||.+.      ..+.++...++    ..+|
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~s  228 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVS  228 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCCC
T ss_pred             eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCCC
Confidence            6543 34456789999999999875 3 567899999999999999999999753      23455544433    4689


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      +++++||.+||+.||++|||++|+|+||||++.
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=422.01  Aligned_cols=260  Identities=29%  Similarity=0.446  Sum_probs=217.6

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++...... ....+.+.+|+++++++ +||||+++++++.+++++|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence            6899999999999999999999999999999999765432 23356889999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCC
Q 015352          131 MELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPG  208 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~  208 (408)
                      |||+.|+.+ .++..  .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        80 ~e~~~~~~~-~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSEEHH-HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred             EeecCCchh-hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence            999976544 44433  3569999999999999999999999999999999999999   45678999999999876543


Q ss_pred             -CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCC---------
Q 015352          209 -ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDP---------  276 (408)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------  276 (408)
                       .......||+.|+|||++..  .++.++||||+||++|+|++|+.||.+.+..+....+...........         
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             33445689999999998764  368999999999999999999999999888777776654322211111         


Q ss_pred             ----------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          277 ----------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       277 ----------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                      .+.+|+++++||.+||+.||++|||+.|+|+||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                            2356889999999999999999999999999999987654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=418.51  Aligned_cols=262  Identities=25%  Similarity=0.400  Sum_probs=217.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCC-CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC--CCCCeeEEeeEEEe---
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDT-RELLACKSISKRKLRTAVDIDDVRREVAIMKHLP--KNSSIVSLKEACED---  123 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~---  123 (408)
                      .++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+++.|.  +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47999999999999999999999766 66799999976543322 2234567887776652  79999999999853   


Q ss_pred             --CCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          124 --DNAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       124 --~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                        ...+|++|||+.|+.+...... ...+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence              4578999999998877544433 3569999999999999999999999999999999999999   566789999999


Q ss_pred             cccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC------
Q 015352          201 LSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK------  273 (408)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~------  273 (408)
                      ++.............||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+....+........      
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            9987665666677889999999999875 699999999999999999999999999988887777654321110      


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          274 -----------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       274 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                       ...+..+++.+++||.+||+.||++|||+.|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                             112346789999999999999999999999999999998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-57  Score=413.64  Aligned_cols=257  Identities=32%  Similarity=0.459  Sum_probs=217.5

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+|+++ +||||+++++++.+++..|++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence            69999999999999999999986 7899999999765432 33457899999999999 899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      |||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||.|....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence            9999887777776667889999999999999999999999999999999999999   556789999999998765332 


Q ss_pred             ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC-------------
Q 015352          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR-------------  274 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------  274 (408)
                      ......|++.|+|||.+.+  .++.++||||+||++|+|++|+.||.+.+..+...++.........             
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            3345579999999999864  4799999999999999999999999998887777766543221111             


Q ss_pred             ------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccC
Q 015352          275 ------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQN  313 (408)
Q Consensus       275 ------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  313 (408)
                                  .....+++.+++||++||++||++|||+.|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                        112457889999999999999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=416.65  Aligned_cols=258  Identities=29%  Similarity=0.414  Sum_probs=215.2

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----  123 (408)
                      ...+|...+.||+|+||+||+|+++.+|+.||||++.+....       ..+|+++|+++ +||||++++++|..     
T Consensus        18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKL-DHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHC-CCTTBCCEEEEEEEC--CC
T ss_pred             ccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhc-CCCCCCcEEEEEEecCccC
Confidence            344799999999999999999999999999999999765321       23799999999 99999999999853     


Q ss_pred             -CCeEEEEEeccCCCchHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeec
Q 015352          124 -DNAVHLVMELCEGGELFDR---IVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDF  199 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~---l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Df  199 (408)
                       ..++|+|||||+++.+...   ......+++..++.++.||+.||+|||++||+||||||+|||++.  +...+||+||
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DF  167 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDF  167 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCC
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecc
Confidence             3468999999987643332   234567999999999999999999999999999999999999953  3347999999


Q ss_pred             ccccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCc-------
Q 015352          200 GLSIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLI-------  270 (408)
Q Consensus       200 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-------  270 (408)
                      |++..........+.+||+.|+|||.+.+  .|+.++||||+||++|+|++|..||...+..+....+.+...       
T Consensus       168 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             TTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence            99998777776777899999999998754  589999999999999999999999998887777666643210       


Q ss_pred             ----------cc--------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          271 ----------DF--------KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       271 ----------~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                .+        .....+.+++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                      00        01123457899999999999999999999999999999987643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-56  Score=405.98  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=213.1

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      --.++|++.+.||+|+||+||+|+++.+|+.||||++....    ...+.+.+|+++|+++ +||||+++++++.+++.+
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhC-CCCCEecCCccEeeCCee
Confidence            34578999999999999999999999999999999987543    3467899999999999 999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          128 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      |+|||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeec
Confidence            9999999999999999765  568999999999999999999999999999999999999   45678999999999876


Q ss_pred             CCCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCC-CCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPF-WAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      .....  .....|++.|+|||++.+ .|+.++||||+||++|+|++|..|| .+.+...+.+.+..+.   ..+.+..+|
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---~~~~~~~~~  242 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCP  242 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---CCCCCTTCC
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC---CCCCCccch
Confidence            54332  223458899999998874 7999999999999999999966554 4555555555554442   223345789


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +++++||.+||+.||++|||+.|+++
T Consensus       243 ~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=417.21  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=214.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC--
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--  125 (408)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+++ +||||++++++|...+  
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence            478999999999999999999999999999999999975433 444567889999999999 9999999999998655  


Q ss_pred             ----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          126 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       126 ----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                          ++|+||||| |.+|...+ +.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL  167 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccc
Confidence                579999999 66776655 45679999999999999999999999999999999999999   5677899999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcc--------
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLID--------  271 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------  271 (408)
                      |.....  ......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.+.......+......        
T Consensus       168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            987543  3456789999999999864  4789999999999999999999999988776665554332211        


Q ss_pred             ---------------cCC----CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 ---------------FKR----DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 ---------------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                     ...    .....+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                           111    12346789999999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-56  Score=409.34  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=217.5

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-----
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-----  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----  123 (408)
                      -.++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.+|+++ +||||+++++++..     
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-----
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHh-cCCCccceEeeeecccccc
Confidence            3589999999999999999999999999999999997665433 3456788999999999 89999999998854     


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecc
Q 015352          124 ---DNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFG  200 (408)
Q Consensus       124 ---~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg  200 (408)
                         ++++|+||||+.++.+.........+++..++.+++||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg  162 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFG  162 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCT
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecc
Confidence               45789999999887776555556779999999999999999999999999999999999999   556789999999


Q ss_pred             cccccCCC-----CceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccC
Q 015352          201 LSIFFKPG-----ERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFK  273 (408)
Q Consensus       201 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  273 (408)
                      ++......     ......+||+.|+|||++.+  .|++++||||+||++|+|++|+.||.+.+.......+.+....+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99765422     22344579999999999864  589999999999999999999999999888887777766554443


Q ss_pred             CCCCCC----------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          274 RDPWPN----------------------------VSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       274 ~~~~~~----------------------------~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                      ...+..                            .++++++||.+||+.||++|||+.|+|+||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            332221                            26788999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=403.93  Aligned_cols=251  Identities=22%  Similarity=0.389  Sum_probs=206.4

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      -.++|.+.+.||+|+||+||+|+++   ..||||++...... ....+.+.+|+.+++++ +||||+++++++. ++.+|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEE
Confidence            3578999999999999999999754   35999999765433 34567899999999999 9999999999865 45689


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|.....
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC---
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeeccc
Confidence            999999999999999765 5699999999999999999999999999999999999994   567899999999977543


Q ss_pred             C---CceecccCCCCCcchhhhhc----cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCcccC-CCCCC
Q 015352          208 G---ERFSEIVGSPYYMAPEVLKR----NYGPEIDIWSAGVILYILLCGVPPFWAESEQGV-AQAILRGLIDFK-RDPWP  278 (408)
Q Consensus       208 ~---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~-~~~~~  278 (408)
                      .   ....+..||+.|+|||++.+    .|+.++|||||||++|||+||..||.+.+.... ...+.++..... .....
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence            2   23455689999999999853    489999999999999999999999988665544 344444433222 23345


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+|+++.+||.+||+.||++|||+.|++++
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            789999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.5e-56  Score=404.76  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=206.5

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCc---EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRE---LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~  124 (408)
                      .-.++|++.+.||+|+||+||+|+++.+|+   .||||.+....  .....+.+.+|+.+|+++ +||||+++++++.++
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKS   99 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC
Confidence            345789999999999999999999987765   58888876432  334467899999999999 999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccc
Q 015352          125 NAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSI  203 (408)
Q Consensus       125 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~  203 (408)
                      +.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC----
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccce
Confidence            9999999999999999988774 569999999999999999999999999999999999999   567789999999998


Q ss_pred             ccCCCCce------ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCC
Q 015352          204 FFKPGERF------SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRD  275 (408)
Q Consensus       204 ~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  275 (408)
                      ........      ....||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+.+..++...+..+..   .+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~  253 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---LP  253 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CC
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CC
Confidence            76543221      22457899999999875 69999999999999999998 8999999999888888877643   22


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          276 PWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       276 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ....+|+.+.+||.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            335789999999999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=413.17  Aligned_cols=253  Identities=19%  Similarity=0.296  Sum_probs=212.9

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCc-----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRE-----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      -.++|++.+.||+|+||+||+|++..+++     .||+|.+.....  ......+.+|+.+++++.+||||+++++++.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            34789999999999999999999876543     689998865432  23356789999999998789999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 015352          124 DNAVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKP  180 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp  180 (408)
                      .+.+|+|||||+||+|.+++....                       .+++..++.++.||+.||.|||++||+||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence            999999999999999999997642                       488999999999999999999999999999999


Q ss_pred             CceEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCC
Q 015352          181 ENFLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWA  255 (408)
Q Consensus       181 ~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~  255 (408)
                      +|||++   .++.+||+|||+|+.......   ..+..||+.|+|||++.+ .|+.++|||||||++|+|+| |..||.+
T Consensus       193 ~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         193 RNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             GGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hccccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999994   567899999999987654332   234568999999998874 79999999999999999998 8999988


Q ss_pred             CCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          256 ESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      .+.......+......++  .+..+|+++++||.+||+.||++|||++|+++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            766666666665544433  335789999999999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=414.16  Aligned_cols=261  Identities=31%  Similarity=0.536  Sum_probs=222.9

Q ss_pred             cceEecceecccCCeEEEEEEEC---CCCcEEEEEEeeccccC-ChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDR---DTRELLACKSISKRKLR-TAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ++|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .....+.+.+|+++++++.+||||+++++++++...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            78999999999999999999974   47899999999765432 222345678899999999556899999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          127 VHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++++|||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999   456789999999997654


Q ss_pred             CC--CceecccCCCCCcchhhhhc---cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          207 PG--ERFSEIVGSPYYMAPEVLKR---NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       207 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ..  .......|++.|+|||.+.+   .++.++|||||||++|+|++|..||.+.+.......+.+.......+....+|
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            32  23345679999999999864   47889999999999999999999998876655555555554444444456799


Q ss_pred             HHHHHHHHHhcCCCcCCCC-----CHHHHhcCccccCC
Q 015352          282 ESAKSLVRQMLEPDPKLRL-----TAKQVLEHPWLQNA  314 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~-----s~~~~l~h~~~~~~  314 (408)
                      +++.+||.+||++||.+||     |++|+++||||+..
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            9999999999999999999     58999999999764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-55  Score=410.30  Aligned_cols=255  Identities=27%  Similarity=0.510  Sum_probs=213.8

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe--CCeE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED--DNAV  127 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~  127 (408)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.      ..+.+.+|+++|+.+.+||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            47899999999999999999999999999999998643      256788999999999679999999999984  4679


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          128 HLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      ++|||||.+++|...   .+.+++..++.++.||+.||.|||++||+||||||+|||++.  ++..+||+|||+|.....
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceeccC
Confidence            999999999999765   356999999999999999999999999999999999999963  334699999999998877


Q ss_pred             CCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcC-------------Ccc
Q 015352          208 GERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESE-QGVAQAILRG-------------LID  271 (408)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~-------------~~~  271 (408)
                      .......+||+.|+|||.+.+  .++.++||||+||++|+|++|..||..... ......+...             ...
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            777777889999999999865  489999999999999999999999976542 2222222110             000


Q ss_pred             --------------------cCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCc
Q 015352          272 --------------------FKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAK  315 (408)
Q Consensus       272 --------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  315 (408)
                                          ........+++++++||++||+.||.+|||++|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                01112234789999999999999999999999999999998753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=396.53  Aligned_cols=246  Identities=24%  Similarity=0.384  Sum_probs=204.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|+++ ++..||||++....    ...+.+.+|+++++++ +||||+++++++.+++.+|+|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEE
Confidence            57999999999999999999986 56789999987543    2356799999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence            9999999999998765 558999999999999999999999999999999999999   456789999999998765433


Q ss_pred             c--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          210 R--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       210 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .  .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||...+..++...+..+....   .....++++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---CCTTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHH
Confidence            2  234578999999999875 69999999999999999999 577777778888888887764322   2246789999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +||.+||+.||++|||++|+++|
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999885

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-56  Score=400.86  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             ceecccCCeEEEEEEEC--CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEEEecc
Q 015352           57 RELGRGEFGVTYLCIDR--DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLVMELC  134 (408)
Q Consensus        57 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~  134 (408)
                      +.||+|+||+||+|.++  .+++.||||++..... .....+.+.+|+.+|+++ +||||++++++++++ ..|+|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcC
Confidence            46999999999999865  4567899999965433 333457899999999999 999999999999765 578999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCCce---
Q 015352          135 EGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGERF---  211 (408)
Q Consensus       135 ~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~~~---  211 (408)
                      +||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++........   
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccccc
Confidence            9999999999988999999999999999999999999999999999999995   4567999999999876543322   


Q ss_pred             -ecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 015352          212 -SEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAKSLV  288 (408)
Q Consensus       212 -~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  288 (408)
                       ....||+.|+|||++.+ .++.++|||||||++|||+| |..||.+.+..++...+.++...   +....+|+++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHH
Confidence             23468999999999875 69999999999999999998 89999999988888888776432   22357899999999


Q ss_pred             HHhcCCCcCCCCCHHHHh---cCccc
Q 015352          289 RQMLEPDPKLRLTAKQVL---EHPWL  311 (408)
Q Consensus       289 ~~~l~~dp~~R~s~~~~l---~h~~~  311 (408)
                      .+||+.||++|||+++++   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999984   55554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=391.49  Aligned_cols=246  Identities=23%  Similarity=0.337  Sum_probs=217.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+...    ..+.+.+|+.+++++ +||||+++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Confidence            57889999999999999999985 688899999986543    346799999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence            9999999999987654 569999999999999999999999999999999999999   566789999999998654433


Q ss_pred             c--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 015352          210 R--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESAK  285 (408)
Q Consensus       210 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  285 (408)
                      .  .....||+.|+|||++.+ .|+.++|||||||++|||+| |+.||.+.+..++...+..+...   ..+...++++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---CCcccccHHHH
Confidence            2  234568999999999875 69999999999999999998 89999999999988888876432   23357889999


Q ss_pred             HHHHHhcCCCcCCCCCHHHHhcC
Q 015352          286 SLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       286 ~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +||.+||+.||++|||+.++++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=399.63  Aligned_cols=252  Identities=25%  Similarity=0.333  Sum_probs=214.1

Q ss_pred             cceEecce-ecccCCeEEEEEEECC--CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRE-LGRGEFGVTYLCIDRD--TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||++....  .....+.+.+|+++|+++ +||||+++++++.++ .+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~-~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE-AL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC-eE
Confidence            56778875 9999999999998764  45579999987542  344567899999999999 999999999999764 58


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      |+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+...
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhccc
Confidence            9999999999999987654 5799999999999999999999999999999999999995   45679999999998765


Q ss_pred             CCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          207 PGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       207 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ....    .....||+.|+|||++.+ .++.++|||||||++|||+| |..||.+.+..++...+..+...   +..+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~  237 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPEC  237 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence            4332    234568999999999874 69999999999999999998 99999998888888888776532   233578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHH---hcCcccc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQV---LEHPWLQ  312 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~---l~h~~~~  312 (408)
                      |+++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999888   5677764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-55  Score=398.27  Aligned_cols=259  Identities=27%  Similarity=0.453  Sum_probs=220.7

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHLV  130 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  130 (408)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+++.+ +||||+++++++.+...+++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence            689999999999999999999999999999999976543 334467899999999999 999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC-
Q 015352          131 MELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE-  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~-  209 (408)
                      +|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+   +..+.+||+|||.+....... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            9999999999888888899999999999999999999999999999999999999   456679999999998765433 


Q ss_pred             ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCC-CCCCHHHHHHHHHcCCcccC-------------
Q 015352          210 RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPF-WAESEQGVAQAILRGLIDFK-------------  273 (408)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~-------------  273 (408)
                      ......+++.|+|||++.+  .++.++||||+||++|+|++|..|| .+.+..+....+........             
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            3344567889999998864  3799999999999999999999886 44555555555433221111             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          274 ------------RDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       274 ------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                  ......+++.+++||.+||+.||.+|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                        11224578899999999999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=411.17  Aligned_cols=261  Identities=28%  Similarity=0.444  Sum_probs=213.2

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC--
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN--  125 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--  125 (408)
                      ++.++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|+++ +||||+++++++..+.  
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeecccc
Confidence            46689999999999999999999999999999999997543  334456789999999999 9999999999997653  


Q ss_pred             ---eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          126 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       126 ---~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                         .+|++ +|+.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        82 ~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a  156 (345)
T d1pmea_          82 QMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  156 (345)
T ss_dssp             TCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCce
Confidence               34555 556689999998664 79999999999999999999999999999999999999   45678999999999


Q ss_pred             cccCCCC----ceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc----
Q 015352          203 IFFKPGE----RFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF----  272 (408)
Q Consensus       203 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----  272 (408)
                      .......    .....+||+.|+|||++..  .++.++||||+||++|+|++|..||.+.+..............+    
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            7654322    2345679999999998853  47899999999999999999999998887665554443211110    


Q ss_pred             ----------------CC-------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcC
Q 015352          273 ----------------KR-------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKK  316 (408)
Q Consensus       273 ----------------~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  316 (408)
                                      +.       ..++.+++++++||.+||+.||.+|||+.|+|+||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                            00       113567899999999999999999999999999999986543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=397.14  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=214.2

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ..++|++.+.||+|+||.||+|+++ ++..||||++....    ...+.+.+|+.+++++ +||||+++++++.+ +.+|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeE
Confidence            4578999999999999999999986 57889999997543    2357899999999999 99999999998765 5678


Q ss_pred             EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          129 LVMELCEGGELFDRIVAR--GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +|||||++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEcc
Confidence            999999999999876443  359999999999999999999999999999999999999   566789999999998775


Q ss_pred             CCCc--eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          207 PGER--FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       207 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      ....  .....||+.|+|||++.+ .++.++|||||||++|+|+| |.+||...+..+....+..+....   ....+|+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~  237 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPE  237 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccChH
Confidence            4432  234578999999999874 69999999999999999999 566677777778888877664322   2357899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhc--Ccccc
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLE--HPWLQ  312 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~  312 (408)
                      ++.+||.+||+.||++|||+.++++  |+||.
T Consensus       238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999999988  67774

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-55  Score=409.58  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=217.7

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeC---
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDD---  124 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---  124 (408)
                      .+.++|++.+.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+++ +||||+++++++...   
T Consensus        15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL   92 (348)
T ss_dssp             EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSST
T ss_pred             cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccc
Confidence            467899999999999999999999999999999999976532 334456789999999999 999999999999643   


Q ss_pred             --CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccc
Q 015352          125 --NAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLS  202 (408)
Q Consensus       125 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~  202 (408)
                        ...+++++|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||++
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA  168 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC---
T ss_pred             ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchh
Confidence              334566777789999998854 579999999999999999999999999999999999999   55678999999998


Q ss_pred             cccCCCCceecccCCCCCcchhhhhc--cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCcccCC------
Q 015352          203 IFFKPGERFSEIVGSPYYMAPEVLKR--NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDFKR------  274 (408)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------  274 (408)
                      ....  ....+..||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.+.......+.........      
T Consensus       169 ~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         169 RHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             -CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            7643  33455679999999998765  4789999999999999999999999998887777776554322111      


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCC
Q 015352          275 ---------------------DPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAP  318 (408)
Q Consensus       275 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  318 (408)
                                           ..+..+++++++||.+||+.||.+|||+.|+|+||||+......
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence                                 01246789999999999999999999999999999998765433

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=407.12  Aligned_cols=259  Identities=25%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-----
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-----  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----  122 (408)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+++++ +||||++++++|.     
T Consensus        14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeccccc
Confidence            466899999999999999999999999999999999986543 344566789999999999 9999999999996     


Q ss_pred             -eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccc
Q 015352          123 -DDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGL  201 (408)
Q Consensus       123 -~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~  201 (408)
                       +.+++|+|||||.|+.+ +.+  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+|++|||+
T Consensus        92 ~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~  165 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_dssp             TTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred             ccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhh
Confidence             34789999999977544 444  3569999999999999999999999999999999999999   4567799999999


Q ss_pred             ccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCccc--------
Q 015352          202 SIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGLIDF--------  272 (408)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  272 (408)
                      +.............||+.|+|||++.+ .+++++||||+||++|+|++|++||.+.+.......+.......        
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            988776666777789999999999876 69999999999999999999999999888776666554322110        


Q ss_pred             --------------CCCC----------------CCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcCccccCC
Q 015352          273 --------------KRDP----------------WPNVSESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNA  314 (408)
Q Consensus       273 --------------~~~~----------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  314 (408)
                                    ....                ....++++++||++||..||++|||++|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                          0000                01135678999999999999999999999999999863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=388.25  Aligned_cols=249  Identities=24%  Similarity=0.324  Sum_probs=204.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCC---CcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDT---RELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      .++|++.+.||+|+||.||+|++..+   +..||+|.+...  ......+.+.+|+.+++++ +||||+++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCe
Confidence            47899999999999999999998755   346888887533  2344467899999999999 9999999999996 467


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      +|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheec
Confidence            89999999999999987654 5699999999999999999999999999999999999995   4567999999999876


Q ss_pred             CCCC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCC
Q 015352          206 KPGE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVS  281 (408)
Q Consensus       206 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  281 (408)
                      ....  ......||+.|+|||++.+ .|+.++|||||||++|+|++ |.+||.+.+..++...+..+...   +.++.+|
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            4332  2344568999999999875 79999999999999999998 89999999988888888876532   3346899


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      +.+.+||.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=385.01  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=204.7

Q ss_pred             ccceEecceecccCCeEEEEEEECCCC----cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCC
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTR----ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDN  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  125 (408)
                      .+.|.+.+.||+|+||.||+|.++.++    ..||||++....  .......+.+|+.+++++ +||||+++++++.+.+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCC
Confidence            357999999999999999999987654    469999986433  333456789999999999 9999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          126 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       126 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      ..++|||||.++++.+.+... +.+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+|+.
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhc
Confidence            999999999999999988765 569999999999999999999999999999999999999   5667899999999987


Q ss_pred             cCCCC----ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHcCCcccCCCCCC
Q 015352          205 FKPGE----RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPWP  278 (408)
Q Consensus       205 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  278 (408)
                      .....    ......||+.|+|||++.+ .++.++|||||||++|||++| .+||...+..++...+..+..   .+...
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---~~~~~  236 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LPTPM  236 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCCT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC---CCCch
Confidence            64332    1223468999999999875 699999999999999999995 555666677777777766532   22335


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          279 NVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       279 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      .+++.+.+||.+||+.||++|||+.|+++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            68999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=395.44  Aligned_cols=250  Identities=22%  Similarity=0.281  Sum_probs=211.8

Q ss_pred             cceEecceecccCCeEEEEEEECCCCcE--EEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTREL--LACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ++|++.+.||+|+||.||+|+++.+|..  ||||.+....  .....+.+.+|+++|+++.+||||+++++++.+++.+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            6899999999999999999999988875  5667665332  23345679999999999867999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          129 LVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      +||||++||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||+   +..+
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999999754                568999999999999999999999999999999999999   4566


Q ss_pred             CEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCC-CCCCCCCHHHHHHHHHcCCc
Q 015352          193 PLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGV-PPFWAESEQGVAQAILRGLI  270 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~i~~~~~  270 (408)
                      .+||+|||++.............||+.|+|||.+.+ .|+.++|||||||++|+|++|. +||.+.+..++...+.++..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            799999999987654444445679999999999875 6999999999999999999965 67888888888888776532


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          271 DFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       271 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                         .+.+..+++++++||.+||+.||++|||+.++++|
T Consensus       245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence               23345789999999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=384.77  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=209.3

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .++|++.+.||+|+||.||+|+++.+ ..||||++....    ...+.+.+|+.+++++ +||||+++++++.+ +.+|+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEE
Confidence            47899999999999999999999765 569999996543    2357899999999999 99999999999865 55789


Q ss_pred             EEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          130 VMELCEGGELFDRIVA--RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       130 v~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      |||||++|+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccC
Confidence            9999999999988754  3569999999999999999999999999999999999999   4557799999999987643


Q ss_pred             CC--ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 015352          208 GE--RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILRGLIDFKRDPWPNVSES  283 (408)
Q Consensus       208 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  283 (408)
                      ..  ......||+.|+|||++.. .++.++||||+||++|+|++| .+||.+....+....+.++..   .+....+|++
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~  242 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPES  242 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHH
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHH
Confidence            33  2234578999999999875 799999999999999999995 555666777777777776542   2234578999


Q ss_pred             HHHHHHHhcCCCcCCCCCHHHHhc--CccccCCc
Q 015352          284 AKSLVRQMLEPDPKLRLTAKQVLE--HPWLQNAK  315 (408)
Q Consensus       284 ~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~~~  315 (408)
                      +++||.+||+.||++|||++++++  ++||....
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            999999999999999999999988  88887653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=386.12  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=204.1

Q ss_pred             cceEecceecccCCeEEEEEEECC-CC--cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRD-TR--ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      ++|++.+.||+|+||.||+|++.. ++  ..||||++.+.........+.+.+|+.+++++ +||||+++++++.++ .+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec-ch
Confidence            579999999999999999998653 33  36899999876665555567899999999999 999999999999764 67


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          128 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      ++|||||++|++.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhcc
Confidence            8999999999999877654 56999999999999999999999999999999999999964   4579999999998765


Q ss_pred             CCCc----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          207 PGER----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       207 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      ....    .....|++.|+|||++.+ .++.++|||||||++|||+| |..||.+.+..+....+.+....++  ..+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence            4432    223457889999999875 68999999999999999998 8999999999999888887765443  34678


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      |+.+++||.+||..||++|||+.++++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999964

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-53  Score=390.08  Aligned_cols=248  Identities=20%  Similarity=0.277  Sum_probs=206.1

Q ss_pred             cceEecceecccCCeEEEEEEECCCCc----EEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCe
Q 015352           51 DRYLVDRELGRGEFGVTYLCIDRDTRE----LLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNA  126 (408)
Q Consensus        51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  126 (408)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.+....  .....+.+.+|+.+++++ +||||+++++++.++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-C
Confidence            469999999999999999999998876    47777765332  233467899999999999 999999999999875 4


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeeccccccc
Q 015352          127 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFF  205 (408)
Q Consensus       127 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~  205 (408)
                      .++++||+.+|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|...
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceec
Confidence            67888999999999988765 5699999999999999999999999999999999999995   4567999999999876


Q ss_pred             CCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCC
Q 015352          206 KPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNV  280 (408)
Q Consensus       206 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  280 (408)
                      .....   .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||.+.+..++...+..+...   +..+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~  238 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPIC  238 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTTB
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccc
Confidence            54332   233468999999998875 69999999999999999998 89999988888887777766432   223578


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          281 SESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       281 ~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      |+++.+||.+||+.||.+|||+.|+++|
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=388.44  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             cccceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      -.++|++.+.||+|+||.||+|++..     +++.||+|++....  .....+.+.+|..++.++.+||||+.+++++..
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            34789999999999999999999754     45689999986433  233456788888888888789999999998765


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEee
Q 015352          124 -DNAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFA  186 (408)
Q Consensus       124 -~~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~  186 (408)
                       ++.+++|||||+||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||+ 
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-  167 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-  167 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE-
Confidence             45789999999999999999754                248899999999999999999999999999999999999 


Q ss_pred             cCCCCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhC-CCCCCCCCHHHH
Q 015352          187 NKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCG-VPPFWAESEQGV  261 (408)
Q Consensus       187 ~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~  261 (408)
                        +.++.+||+|||+|+......   ......||+.|+|||++.+ .++.++||||+||++|+|+|| .+||.+....+.
T Consensus       168 --~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             --CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             --CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence              456789999999998654332   2234679999999999875 699999999999999999986 567877654443


Q ss_pred             H-HHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          262 A-QAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       262 ~-~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      . ..+..+. .+  +....+++++++||.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGT-RM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCC-CC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3 4444433 22  2335689999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=378.62  Aligned_cols=242  Identities=22%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE-eCCeEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE-DDNAVH  128 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~~~~~~  128 (408)
                      .++|++.+.||+|+||.||+|+++  |..||||++....     ..+.+.+|+++++++ +||||+++++++. ..+.+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEE
Confidence            357999999999999999999984  7789999996432     357789999999999 9999999999885 456789


Q ss_pred             EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccC
Q 015352          129 LVMELCEGGELFDRIVARG--HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFK  206 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~  206 (408)
                      +||||+++|+|.+++.+.+  .+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||++....
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecC
Confidence            9999999999999997653  48999999999999999999999999999999999999   566789999999998754


Q ss_pred             CCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 015352          207 PGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQGVAQAILRGLIDFKRDPWPNVSESA  284 (408)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  284 (408)
                      ..  .....+|+.|+|||++.+ .+++++|||||||++|||+| |++||...+..++...+.++...   +....+++++
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~  229 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAV  229 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHH
T ss_pred             CC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHH
Confidence            33  334578999999998864 79999999999999999998 79999988888888888765332   2335689999


Q ss_pred             HHHHHHhcCCCcCCCCCHHHHhc
Q 015352          285 KSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       285 ~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ++||.+||..||.+|||+.++++
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcccCHhHCcCHHHHHH
Confidence            99999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-52  Score=384.22  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=215.1

Q ss_pred             cccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED  123 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~  123 (408)
                      ..++|++.+.||+|+||+||+|+++     .++..||||++....  .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCAV   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhc-CCCCcccceeeecc
Confidence            4578999999999999999999875     356789999986543  233457899999999999 99999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q 015352          124 DNAVHLVMELCEGGELFDRIVARG------------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLK  179 (408)
Q Consensus       124 ~~~~~lv~e~~~g~~L~~~l~~~~------------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dik  179 (408)
                      .+..++||||+++|+|.+++....                        .+++..+..++.||+.||+|||++||+|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            999999999999999999997532                        38899999999999999999999999999999


Q ss_pred             CCceEeecCCCCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCC-CCCC
Q 015352          180 PENFLFANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGV-PPFW  254 (408)
Q Consensus       180 p~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~-~pf~  254 (408)
                      |+|||+   +.++.+||+|||+|.......   ...+..||+.|+|||.+.+ .|+.++|||||||++|||++|. +||.
T Consensus       168 p~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         168 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999   456789999999998654332   2345678999999999875 6999999999999999999985 7899


Q ss_pred             CCCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          255 AESEQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +.+..++...+..+...   +....+|+++.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         245 GMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999998888877642   223578999999999999999999999999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=381.87  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=211.3

Q ss_pred             cccceEecceecccCCeEEEEEEECCCC-------cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTR-------ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEAC  121 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~  121 (408)
                      -.++|.+.+.||+|+||.||+|++..++       ..||+|++.+..  .......+.+|...+.++.+||||+++++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            4579999999999999999999976554       479999987543  3344577889999998887899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEe
Q 015352          122 EDDNAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLF  185 (408)
Q Consensus       122 ~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~  185 (408)
                      .+++..|+|||||++|+|.+++....                .+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            99999999999999999999997543                48999999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecccccccCCCC---ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCCHHH
Q 015352          186 ANKKENSPLKAIDFGLSIFFKPGE---RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAESEQG  260 (408)
Q Consensus       186 ~~~~~~~~vkl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~  260 (408)
                         +.++.+||+|||++.......   ......||+.|+|||.+.+ .|++++|||||||++|+|++ |.+||.+.+...
T Consensus       169 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         169 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             ---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence               556789999999998764332   2334578999999998874 79999999999999999998 799999988888


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          261 VAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +...+..+...   +....+|+++.+||.+||+.||++|||+.|+++
T Consensus       246 ~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            88777765422   223578999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-52  Score=381.75  Aligned_cols=259  Identities=19%  Similarity=0.247  Sum_probs=208.1

Q ss_pred             cccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           49 IEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      +.++|++.+.||+|+||.||+|++..+|+.||||++......     ..+.+|+++++.+.+|++|+.+..++.+.+.++
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            567999999999999999999999999999999998754321     346789999999966667778888889999999


Q ss_pred             EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCC
Q 015352          129 LVMELCEGGELFDRIVA-RGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKP  207 (408)
Q Consensus       129 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~  207 (408)
                      +||||+.+ +|...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+.+..+||+|||+|.....
T Consensus        80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999955 66565544 56799999999999999999999999999999999999997666677899999999987643


Q ss_pred             CC--------ceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH---HcCCcccC-C
Q 015352          208 GE--------RFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQGVAQAI---LRGLIDFK-R  274 (408)
Q Consensus       208 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~-~  274 (408)
                      ..        ......||+.|+|||++.+ .+++++|||||||++|+|++|..||...........+   .......+ .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            32        2345689999999999886 5999999999999999999999999876544333222   11111111 1


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHHH---HhcCccccC
Q 015352          275 DPWPNVSESAKSLVRQMLEPDPKLRLTAKQ---VLEHPWLQN  313 (408)
Q Consensus       275 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~---~l~h~~~~~  313 (408)
                      .....+|+++.+||.+||+.||++||++.+   +|+|+|.+.
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            123578999999999999999999999874   567776544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=377.42  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=214.0

Q ss_pred             ccccccceEecceecccCCeEEEEEEEC-----CCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeE
Q 015352           46 KENIEDRYLVDRELGRGEFGVTYLCIDR-----DTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEA  120 (408)
Q Consensus        46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~  120 (408)
                      .+.-.++|++.+.||+|+||.||+|++.     .+++.||||++....  .......+.+|+.+++++.+||||++++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3344589999999999999999999863     467789999997543  344566789999999999779999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 015352          121 CEDDNAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPEN  182 (408)
Q Consensus       121 ~~~~~~~~lv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~N  182 (408)
                      +.+.+.+|+|||||+||+|.+++....                  .+++..+..++.||+.||+|||++|++||||||+|
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            999999999999999999999997643                  58999999999999999999999999999999999


Q ss_pred             eEeecCCCCCCEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhh-CCCCCCCCC
Q 015352          183 FLFANKKENSPLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLC-GVPPFWAES  257 (408)
Q Consensus       183 Il~~~~~~~~~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~  257 (408)
                      |+++   ..+.+|++|||.++.......   .....||+.|+|||++.+ .++.++|||||||++|+|+| |.+||.+.+
T Consensus       176 Il~~---~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         176 ILLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             EEEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccc---ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            9994   556799999999987654332   234578999999998874 68999999999999999998 666676666


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          258 EQGVAQAILRGLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      ..+....+........  .....|+.+.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         253 VDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6555555544433322  22468999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=375.35  Aligned_cols=251  Identities=21%  Similarity=0.327  Sum_probs=216.0

Q ss_pred             ccccceEecceecccCCeEEEEEEECC-----CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRD-----TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACE  122 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~  122 (408)
                      .-.++|.+.+.||+|+||.||+|.++.     ++..||||++....  .......+.+|+.+++++ +||||+++++++.
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~   93 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVS   93 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEe
Confidence            345899999999999999999998853     35789999987442  334456789999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCC
Q 015352          123 DDNAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENS  192 (408)
Q Consensus       123 ~~~~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~  192 (408)
                      .++..++|||||++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||+   +.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCc
Confidence            999999999999999999988643          247889999999999999999999999999999999999   5677


Q ss_pred             CEEEeecccccccCCCCc---eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhC-CCCCCCCCHHHHHHHHHc
Q 015352          193 PLKAIDFGLSIFFKPGER---FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCG-VPPFWAESEQGVAQAILR  267 (408)
Q Consensus       193 ~vkl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~  267 (408)
                      .+||+|||+|+.......   .....||+.|+|||.+.+ .++.++|||||||++|+|+|| .+||.+.+..+....+.+
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            899999999986543322   233468999999999875 689999999999999999998 588999999998888887


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          268 GLIDFKRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                      +...   +....+|+.+.++|.+||+.||++|||+.++++
T Consensus       251 ~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         251 GGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6542   223578999999999999999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=367.79  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=201.0

Q ss_pred             ecceecccCCeEEEEEEECCCC---cEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEe-CCeEEEE
Q 015352           55 VDRELGRGEFGVTYLCIDRDTR---ELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACED-DNAVHLV  130 (408)
Q Consensus        55 ~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv  130 (408)
                      +.+.||+|+||+||+|++..++   ..||||++.+.  ......+.+.+|+++|+++ +||||+++++++.+ ++.+++|
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEE
Confidence            3578999999999999987653   36899998642  3455568899999999999 89999999999765 5689999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEeecccccccCCCC
Q 015352          131 MELCEGGELFDRIVAR-GHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGE  209 (408)
Q Consensus       131 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~~~~~~  209 (408)
                      ||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+   ++++.+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccccc
Confidence            9999999999988755 357888999999999999999999999999999999999   566789999999998764332


Q ss_pred             c-----eecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCcccCCCCCCCCCH
Q 015352          210 R-----FSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAE-SEQGVAQAILRGLIDFKRDPWPNVSE  282 (408)
Q Consensus       210 ~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~  282 (408)
                      .     .....||+.|+|||.+.. .++.++||||||+++|||+||..||... +..+....+..+....   ....+++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---~p~~~~~  261 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPEYCPD  261 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC---CCTTCCH
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CcccCcH
Confidence            2     223568999999998874 7999999999999999999977776553 4445556666664322   2246889


Q ss_pred             HHHHHHHHhcCCCcCCCCCHHHHhcC
Q 015352          283 SAKSLVRQMLEPDPKLRLTAKQVLEH  308 (408)
Q Consensus       283 ~~~~li~~~l~~dp~~R~s~~~~l~h  308 (408)
                      ++.+||.+||+.||++|||+.|+++|
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.5e-50  Score=365.24  Aligned_cols=254  Identities=19%  Similarity=0.257  Sum_probs=209.4

Q ss_pred             ccccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeE
Q 015352           48 NIEDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAV  127 (408)
Q Consensus        48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  127 (408)
                      .+.++|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.+.+|+|++.+++++..+...
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            356899999999999999999999999999999999865432     234678999999997779999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCC--CCCCEEEeecccccc
Q 015352          128 HLVMELCEGGELFDRIVARG-HYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKK--ENSPLKAIDFGLSIF  204 (408)
Q Consensus       128 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~--~~~~vkl~Dfg~~~~  204 (408)
                      |+||||+ |++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++...  ..+.+||+|||+|+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 679999887654 699999999999999999999999999999999999996532  356799999999987


Q ss_pred             cCCC--------CceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCccc
Q 015352          205 FKPG--------ERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESE---QGVAQAILRGLIDF  272 (408)
Q Consensus       205 ~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~  272 (408)
                      ....        .......||+.|+|||++.+ .+++++|||||||++|+|++|..||.+...   ......+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            5422        12345679999999999886 599999999999999999999999976432   23333333222111


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          273 -KRDPWPNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       273 -~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                       ..+..+.+|+++.+++..|+..+|++||+++.+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             11223568999999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-49  Score=358.52  Aligned_cols=245  Identities=23%  Similarity=0.299  Sum_probs=190.2

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHH--HHHHHHhCCCCCCeeEEeeEEEeCC--
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRR--EVAIMKHLPKNSSIVSLKEACEDDN--  125 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~--E~~~l~~l~~h~~i~~~~~~~~~~~--  125 (408)
                      ..+|.+.+.||+|+||.||+|++  +|+.||||++..+.      .....+  |+..++.+ +||||+++++++.+++  
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVML-RHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCc
Confidence            46789999999999999999986  58899999986432      233444  44455566 8999999999997654  


Q ss_pred             --eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeccCCCCceEeecCCCCCCEE
Q 015352          126 --AVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHK--------HGVIHRDLKPENFLFANKKENSPLK  195 (408)
Q Consensus       126 --~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~--------~~ivH~dikp~NIl~~~~~~~~~vk  195 (408)
                        .+|+|||||++|+|.+++.+. .+++..+..++.|++.||.|||+        +||+||||||+|||+   +.++.+|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred             ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeE
Confidence              689999999999999999765 68999999999999999999996        599999999999999   5667899


Q ss_pred             EeecccccccCCCC-----ceecccCCCCCcchhhhhcc-------CCCchhHHHHHHHHHHHhhCCCCCCCC-------
Q 015352          196 AIDFGLSIFFKPGE-----RFSEIVGSPYYMAPEVLKRN-------YGPEIDIWSAGVILYILLCGVPPFWAE-------  256 (408)
Q Consensus       196 l~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~~l~~g~~pf~~~-------  256 (408)
                      |+|||++.......     ......||+.|+|||++.+.       ++.++|||||||++|||+||..||...       
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998765433     22356799999999998642       567899999999999999998876321       


Q ss_pred             --------CHHHHHHHHHcCCcccCCC-CC--CCCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 015352          257 --------SEQGVAQAILRGLIDFKRD-PW--PNVSESAKSLVRQMLEPDPKLRLTAKQVLE  307 (408)
Q Consensus       257 --------~~~~~~~~i~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  307 (408)
                              ........+.........+ .+  ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                    2223333333322211111 00  112345889999999999999999999977

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-47  Score=357.86  Aligned_cols=265  Identities=24%  Similarity=0.406  Sum_probs=199.9

Q ss_pred             cccccc-cceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCC----------CCCC
Q 015352           45 PKENIE-DRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLP----------KNSS  113 (408)
Q Consensus        45 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~~  113 (408)
                      .|+.+. +||++++.||+|+||+||+|+++.+|+.||||++.+..    ...+.+.+|+.+++.+.          .|||
T Consensus         6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~   81 (362)
T d1q8ya_           6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   81 (362)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence            466665 57999999999999999999999999999999997543    22456788999988872          2578


Q ss_pred             eeEEeeEEEe--CCeEEEEEeccCCCchHHHH-H--hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCceEeec
Q 015352          114 IVSLKEACED--DNAVHLVMELCEGGELFDRI-V--ARGHYTERAAAAVTRTIVEVVQLCHK-HGVIHRDLKPENFLFAN  187 (408)
Q Consensus       114 i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l-~--~~~~~~~~~~~~i~~ql~~~l~~lH~-~~ivH~dikp~NIl~~~  187 (408)
                      |+++++++..  ....+++++++.++...... .  ....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence            9999998764  45667777776655433322 2  23568999999999999999999998 89999999999999975


Q ss_pred             CCCC---CCEEEeecccccccCCCCceecccCCCCCcchhhhhc-cCCCchhHHHHHHHHHHHhhCCCCCCCCCHH----
Q 015352          188 KKEN---SPLKAIDFGLSIFFKPGERFSEIVGSPYYMAPEVLKR-NYGPEIDIWSAGVILYILLCGVPPFWAESEQ----  259 (408)
Q Consensus       188 ~~~~---~~vkl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----  259 (408)
                      ++..   ..++++|||.+.....  .....+||+.|+|||++.+ .|+.++||||+||++++|++|+.||......    
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             cCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence            4332   2489999999876543  2345689999999998875 6999999999999999999999999754321    


Q ss_pred             --HHHHHHHcCCc------------------------cc--------------CCCCCCCCCHHHHHHHHHhcCCCcCCC
Q 015352          260 --GVAQAILRGLI------------------------DF--------------KRDPWPNVSESAKSLVRQMLEPDPKLR  299 (408)
Q Consensus       260 --~~~~~i~~~~~------------------------~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~R  299 (408)
                        ...........                        ..              ....+...++++++||.+||..||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence              11111110000                        00              000112346789999999999999999


Q ss_pred             CCHHHHhcCccccCCc
Q 015352          300 LTAKQVLEHPWLQNAK  315 (408)
Q Consensus       300 ~s~~~~l~h~~~~~~~  315 (408)
                      ||++|+|+||||++..
T Consensus       320 pta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         320 ADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             BCHHHHHTCGGGTTCT
T ss_pred             cCHHHHhcCcccCCCC
Confidence            9999999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.9e-27  Score=200.64  Aligned_cols=166  Identities=20%  Similarity=0.225  Sum_probs=122.5

Q ss_pred             eEecceecccCCeEEEEEEECCCCcEEEEEEeeccccC-----C----------hhcHHHHHHHHHHHHhCCCCCCeeEE
Q 015352           53 YLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLR-----T----------AVDIDDVRREVAIMKHLPKNSSIVSL  117 (408)
Q Consensus        53 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~----------~~~~~~~~~E~~~l~~l~~h~~i~~~  117 (408)
                      |.+.+.||+|+||+||+|++. +|+.||||++......     .          ........+|...+.++ .|++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            457899999999999999985 6899999987532111     0          01123456788999998 88899887


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCceEeecCCCCCCEEEe
Q 015352          118 KEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTRTIVEVVQLCHKHGVIHRDLKPENFLFANKKENSPLKAI  197 (408)
Q Consensus       118 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~l~~lH~~~ivH~dikp~NIl~~~~~~~~~vkl~  197 (408)
                      +++..    .+++|||+++..+.+       +++..+..++.|++.+|.|||++||+||||||+|||++.    ..++|+
T Consensus        80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----~~~~li  144 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----EGIWII  144 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----TEEEEC
T ss_pred             EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----CCEEEE
Confidence            76532    269999999876532       556667889999999999999999999999999999963    238999


Q ss_pred             ecccccccCCCCceecccCCCCCcc------hhhhhccCCCchhHHHHHHH
Q 015352          198 DFGLSIFFKPGERFSEIVGSPYYMA------PEVLKRNYGPEIDIWSAGVI  242 (408)
Q Consensus       198 Dfg~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwslG~i  242 (408)
                      |||.|........       ..|..      .+.+...|+.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            9999876543221       11222      12344578999999997543

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.86  E-value=2.8e-09  Score=74.72  Aligned_cols=56  Identities=32%  Similarity=0.497  Sum_probs=53.2

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.+++.+++++|..+|.|++|.|+.+||+.+|+.+|..+++.+++++|..+|.+
T Consensus         7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d   62 (81)
T d1avsa_           7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDED   62 (81)
T ss_dssp             HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            46788899999999999999999999999999999999999999999999999976

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=98.86  E-value=2.8e-09  Score=74.78  Aligned_cols=60  Identities=27%  Similarity=0.349  Sum_probs=55.6

Q ss_pred             hhhhhhchhhhHHHHHHHhhcCCCC-CCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          346 VIAEFLSVEEVEDIKEMFKKIDSDN-DGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       346 ~i~~~ls~~~~~~l~~~F~~~D~~~-dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+.++.++..+++++|..+|.++ +|.|+..||+.+|+++|..+++.+++++++.+|.+
T Consensus         4 ~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d   64 (82)
T d1wrka1           4 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDED   64 (82)
T ss_dssp             HHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTT
T ss_pred             HHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            4456788999999999999999996 79999999999999999999999999999999976

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.85  E-value=1.7e-09  Score=75.22  Aligned_cols=57  Identities=32%  Similarity=0.485  Sum_probs=53.6

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.+++.+++++|..+|.|++|+|+.+||+.+|+.+|..+++.+++++++.+|.+
T Consensus         2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~   58 (77)
T d1f54a_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVD   58 (77)
T ss_dssp             CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCS
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            356788899999999999999999999999999999999999999999999999976

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=98.78  E-value=1.3e-09  Score=77.53  Aligned_cols=61  Identities=48%  Similarity=0.719  Sum_probs=56.1

Q ss_pred             hhhhhhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          345 RVIAEFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       345 ~~i~~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..|+..++.+++..++++|..+|.|++|.|+.+||+.+|+.+|..+++.+++++++.+|.+
T Consensus        11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d   71 (87)
T d1s6ja_          11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADID   71 (87)
T ss_dssp             HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTT
T ss_pred             HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCC
Confidence            3455677888888899999999999999999999999999999999999999999999986

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=98.76  E-value=4.1e-09  Score=72.27  Aligned_cols=55  Identities=33%  Similarity=0.557  Sum_probs=52.5

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.+++.+++++|+.+|.|++|.|+.+||+.+++.+|..++++++..+++.+|.+
T Consensus         2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d   56 (73)
T d2pq3a1           2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD   56 (73)
T ss_dssp             CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            5778899999999999999999999999999999999999999999999999986

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=98.74  E-value=6.9e-09  Score=72.65  Aligned_cols=53  Identities=25%  Similarity=0.552  Sum_probs=49.4

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +++++.+++++|..+|.|++|.|+.+||+.+|+.+| .++..+++++|+.+|.+
T Consensus         1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d   53 (81)
T d2opoa1           1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTD   53 (81)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCC
Confidence            357788999999999999999999999999999999 68999999999999986

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.70  E-value=3.6e-08  Score=85.68  Aligned_cols=88  Identities=19%  Similarity=0.143  Sum_probs=63.7

Q ss_pred             ccceEecceecccCCeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEEE
Q 015352           50 EDRYLVDRELGRGEFGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.|+..+..+.++.+.||+..  ..+..+++|+........   ...+.+|...+..|..+--+++++.+..+++..|+
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            3567777665556667899885  356668889876543222   23467799998887555447888888889999999


Q ss_pred             EEeccCCCchHHH
Q 015352          130 VMELCEGGELFDR  142 (408)
Q Consensus       130 v~e~~~g~~L~~~  142 (408)
                      ||++++|.++.+.
T Consensus        88 v~~~l~G~~~~~~  100 (263)
T d1j7la_          88 LMSEADGVLCSEE  100 (263)
T ss_dssp             EEECCSSEEHHHH
T ss_pred             EEEeccccccccc
Confidence            9999999877554

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.70  E-value=8.7e-09  Score=67.82  Aligned_cols=49  Identities=29%  Similarity=0.485  Sum_probs=46.6

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++++++|+.+|++++|+|+.+||+.+|+.+|..+++.+++.|++.+|.+
T Consensus         1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d   49 (61)
T d2fcea1           1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVD   49 (61)
T ss_dssp             HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCC
T ss_pred             ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCC
Confidence            4688999999999999999999999999999999999999999999876

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.66  E-value=1.9e-08  Score=67.13  Aligned_cols=49  Identities=33%  Similarity=0.603  Sum_probs=46.9

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++++++|+.+|.|++|+|+.+||+.+++.+|..+++.+++.+++.+|.+
T Consensus         3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d   51 (65)
T d1fw4a_           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADID   51 (65)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTT
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCC
Confidence            5689999999999999999999999999999999999999999999986

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.65  E-value=2.1e-08  Score=68.89  Aligned_cols=50  Identities=26%  Similarity=0.486  Sum_probs=47.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++++++|..+|.|++|+|+.+||+.+|+.+|..+++.+++++++.+|.+
T Consensus         8 eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d   57 (75)
T d1jc2a_           8 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKN   57 (75)
T ss_dssp             HHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCC
Confidence            35789999999999999999999999999999999999999999999976

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=98.59  E-value=1.6e-08  Score=70.69  Aligned_cols=50  Identities=24%  Similarity=0.531  Sum_probs=47.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++++++|..+|.|++|+|+.+||+.+++.+|..+++.+++++|..+|.+
T Consensus        14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d   63 (81)
T d1fi5a_          14 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKN   63 (81)
T ss_dssp             HHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCC
Confidence            35789999999999999999999999999999999999999999999986

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.57  E-value=5.4e-08  Score=67.32  Aligned_cols=52  Identities=27%  Similarity=0.523  Sum_probs=48.6

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..++++++|..+|.|++|+|+.+||+.+|+++|..++..++.++++.+|.+
T Consensus         6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d   57 (77)
T d1oqpa_           6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRN   57 (77)
T ss_dssp             SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Confidence            3456799999999999999999999999999999999999999999999976

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=98.54  E-value=6.8e-08  Score=64.75  Aligned_cols=48  Identities=23%  Similarity=0.406  Sum_probs=45.6

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++++|..+|.|++|+|+.+||+.+++.+|..+++++++++|+.+|.+
T Consensus         2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d   49 (67)
T d1tiza_           2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVD   49 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCS
T ss_pred             hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCC
Confidence            367899999999999999999999999999999999999999999976

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=98.49  E-value=2.9e-08  Score=54.97  Aligned_cols=31  Identities=39%  Similarity=0.745  Sum_probs=29.1

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFG  387 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g  387 (408)
                      ++++++|+.||.|++|+|+.+||+.+|+.+|
T Consensus         3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG   33 (33)
T d2hf5a1           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG   33 (33)
T ss_dssp             HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence            5789999999999999999999999999876

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=98.46  E-value=5.5e-08  Score=65.34  Aligned_cols=49  Identities=31%  Similarity=0.537  Sum_probs=45.8

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCC-CCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~-~~~~e~~~~~~~~d~~  405 (408)
                      ++++++|+.+|.+++|+|+.+||+.+|+.+|.. +++.+++.+|+.+|.|
T Consensus         2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d   51 (68)
T d1c7va_           2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADED   51 (68)
T ss_dssp             HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCC
Confidence            468899999999999999999999999999975 7999999999999986

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.45  E-value=2.4e-07  Score=85.30  Aligned_cols=82  Identities=17%  Similarity=0.184  Sum_probs=51.5

Q ss_pred             cceecccCCeEEEEEEECCCCcEEEEEEeeccc-c-C--ChhcHHHHHHHHHHHHhCCCC--CCeeEEeeEEEeCCeEEE
Q 015352           56 DRELGRGEFGVTYLCIDRDTRELLACKSISKRK-L-R--TAVDIDDVRREVAIMKHLPKN--SSIVSLKEACEDDNAVHL  129 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~-~--~~~~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~~~~l  129 (408)
                      .+.||.|....||++.+..+++.+++|...... . .  ......+...|...|+.+..+  ..+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456899999999999887778889999764311 1 0  112234566788888776332  335666543  4455678


Q ss_pred             EEeccCCCch
Q 015352          130 VMELCEGGEL  139 (408)
Q Consensus       130 v~e~~~g~~L  139 (408)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987654

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=98.30  E-value=4.3e-07  Score=67.02  Aligned_cols=51  Identities=33%  Similarity=0.606  Sum_probs=46.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++++++|+.+|.|++|+|+.+||+.+|+.+   |..+++++++++|+.+|.|
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d   92 (109)
T d5pala_          39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSD   92 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCC
Confidence            34678999999999999999999999999887   6789999999999999976

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=5.2e-07  Score=63.18  Aligned_cols=51  Identities=16%  Similarity=0.197  Sum_probs=47.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+.++|..+|.+++|.|+.+||+.+|..+|..+++.|++.++..+|.+
T Consensus        18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~   68 (83)
T d1wlza1          18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVN   68 (83)
T ss_dssp             THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBC
T ss_pred             HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccC
Confidence            456789999999999999999999999999999999999999999999876

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.20  E-value=3.6e-06  Score=65.33  Aligned_cols=51  Identities=20%  Similarity=0.353  Sum_probs=47.4

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.+.++|+.+|.|++|+|+.+||+.++..+|..+++.|++++|+.+|.+
T Consensus        74 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~  124 (142)
T d1wdcb_          74 SEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE  124 (142)
T ss_dssp             CHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE
T ss_pred             hhhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCC
Confidence            356789999999999999999999999999999999999999999998864

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=98.17  E-value=8.5e-07  Score=65.39  Aligned_cols=50  Identities=34%  Similarity=0.660  Sum_probs=45.7

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh---CCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF---GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~---g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...++++|+.+|.|++|+|+.+||+.+++.+   |..+++++++++|+.+|.|
T Consensus        40 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d   92 (109)
T d1pvaa_          40 ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKD   92 (109)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCC
Confidence            4567899999999999999999999999887   6688999999999999976

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.07  E-value=7.9e-06  Score=69.97  Aligned_cols=75  Identities=13%  Similarity=0.184  Sum_probs=51.8

Q ss_pred             eecccCC-eEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC-CCeeEEeeEEEeCCeEEEEEeccC
Q 015352           58 ELGRGEF-GVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN-SSIVSLKEACEDDNAVHLVMELCE  135 (408)
Q Consensus        58 ~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~~~~~lv~e~~~  135 (408)
                      .+..|.. +.||+... ..+..+++|......      ...+..|...++.|..+ -.+++++.+..+++..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            3445554 67898874 456668889865332      22456788877766332 226778888888889999999999


Q ss_pred             CCch
Q 015352          136 GGEL  139 (408)
Q Consensus       136 g~~L  139 (408)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8665

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=98.05  E-value=2.1e-06  Score=63.00  Aligned_cols=52  Identities=31%  Similarity=0.553  Sum_probs=46.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC---CCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG---SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g---~~~~~~e~~~~~~~~d~~  405 (408)
                      ...++++++|+.+|.|++|+|+.+|++..+++++   ..+++++++++|+.+|.|
T Consensus        37 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d   91 (107)
T d2pvba_          37 KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKD   91 (107)
T ss_dssp             SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTT
T ss_pred             CCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCC
Confidence            4456789999999999999999999999999985   568999999999999976

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.04  E-value=3.6e-06  Score=44.21  Aligned_cols=32  Identities=31%  Similarity=0.553  Sum_probs=28.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG  387 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g  387 (408)
                      .+++.+.|+.||+|.||+|+.+||...++.-|
T Consensus         3 EeELae~FRifDkNaDGyiD~eEl~~ilr~tG   34 (34)
T d1ctda_           3 EEELANAFRIFDKNADGYIDIEELGEILRATG   34 (34)
T ss_dssp             HHHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence            45788999999999999999999999998654

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.03  E-value=3.1e-06  Score=65.79  Aligned_cols=54  Identities=28%  Similarity=0.541  Sum_probs=49.2

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS  404 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~  404 (408)
                      ++++++.+++++|..+|.|++|.|+.+|+..+|+.+|..+++.++..+++..+.
T Consensus         1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~~~~~   54 (142)
T d1wdcb_           1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEAPG   54 (142)
T ss_dssp             CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTTSSS
T ss_pred             CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHHhccC
Confidence            356788999999999999999999999999999999999999999999876553

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.03  E-value=1.8e-06  Score=63.53  Aligned_cols=53  Identities=34%  Similarity=0.535  Sum_probs=47.0

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC---CCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG---SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g---~~~~~~e~~~~~~~~d~~  405 (408)
                      .....+++++|+.+|.|++|+|+.+||+.+++.++   ..+++++++.+++.+|.|
T Consensus        37 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d   92 (108)
T d1rroa_          37 KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADND   92 (108)
T ss_dssp             GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCS
T ss_pred             cCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCC
Confidence            34556789999999999999999999999999874   568999999999999986

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.01  E-value=4.9e-06  Score=59.56  Aligned_cols=53  Identities=26%  Similarity=0.314  Sum_probs=48.1

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...+.++|+.+|.|++|.|+.+|++.++...|  ++..+++++++.+|.+
T Consensus         4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d   56 (95)
T d1c07a_           4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTK   56 (95)
T ss_dssp             SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTT
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCC
Confidence            4667788899999999999999999999999999876  5899999999999976

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=98.00  E-value=4.7e-06  Score=61.32  Aligned_cols=51  Identities=29%  Similarity=0.560  Sum_probs=45.8

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC---CCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG---SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g---~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++++|+.+|.|++|+|+.+||+.+|+.++   ..+++.+++.|++.+|.|
T Consensus        39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d   92 (109)
T d1rwya_          39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKD   92 (109)
T ss_dssp             CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTT
T ss_pred             CHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCC
Confidence            455788999999999999999999999999885   468999999999999976

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.98  E-value=4.2e-06  Score=64.79  Aligned_cols=51  Identities=24%  Similarity=0.448  Sum_probs=47.6

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...++.++|+.+|.+++|+|+.+||+.+|..+|..++++|++++++.+|.+
T Consensus        74 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~  124 (140)
T d1ggwa_          74 DPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK  124 (140)
T ss_dssp             CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS
T ss_pred             HHHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC
Confidence            356789999999999999999999999999999999999999999999865

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.96  E-value=7.4e-06  Score=58.20  Aligned_cols=53  Identities=21%  Similarity=0.190  Sum_probs=48.6

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...++++|..+|.|++|.|+.+|++.++.+.|  ++..++.+|++.+|.|
T Consensus         3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d   55 (92)
T d1fi6a_           3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFD   55 (92)
T ss_dssp             CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTT
T ss_pred             CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCC
Confidence            4677888899999999999999999999999999986  5889999999999987

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.94  E-value=8.4e-06  Score=64.26  Aligned_cols=58  Identities=28%  Similarity=0.365  Sum_probs=53.1

Q ss_pred             hhhhchhhhHHHHHHHhhcCCCC-CCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          348 AEFLSVEEVEDIKEMFKKIDSDN-DGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       348 ~~~ls~~~~~~l~~~F~~~D~~~-dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+.++.++..+++++|..+|.++ +|.|+.+|++.+|+.+|..++..++.+++..++.+
T Consensus         5 ~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~   63 (156)
T d1dtla_           5 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDED   63 (156)
T ss_dssp             GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             HHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhcc
Confidence            45678888999999999999995 89999999999999999999999999999988765

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=97.94  E-value=8.6e-06  Score=63.93  Aligned_cols=52  Identities=27%  Similarity=0.471  Sum_probs=47.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.++|+.+|.+++|+|+.+||+.+|..+|..++++|++.+++.+|.+
T Consensus        79 ~~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~  130 (152)
T d1wdcc_          79 GTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQ  130 (152)
T ss_dssp             CCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCC
T ss_pred             hHHHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccC
Confidence            3356789999999999999999999999999999999999999999998854

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.93  E-value=8.9e-06  Score=64.71  Aligned_cols=50  Identities=24%  Similarity=0.418  Sum_probs=46.4

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...++.+|+.+|.|++|+|+.+||+.+|+.+|.++++++++.|+...|.+
T Consensus        69 ~~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~~  118 (165)
T d1k94a_          69 LNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSKN  118 (165)
T ss_dssp             HHHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCBT
T ss_pred             cchhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCCC
Confidence            35678899999999999999999999999999999999999999998865

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=97.90  E-value=9.2e-06  Score=63.19  Aligned_cols=56  Identities=32%  Similarity=0.529  Sum_probs=52.0

Q ss_pred             hhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          350 FLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       350 ~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++.++..+++++|..+|.|++|.|+.+|+..++..+|..++..++..+++.+|.+
T Consensus         2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~   57 (146)
T d1exra_           2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDAD   57 (146)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTT
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCC
Confidence            35677888999999999999999999999999999999999999999999999875

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=97.89  E-value=2e-05  Score=61.19  Aligned_cols=51  Identities=31%  Similarity=0.551  Sum_probs=47.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|.|+.+|++..+..+|..+++++++++++.+|.|
T Consensus        80 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d  130 (146)
T d1exra_          80 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADID  130 (146)
T ss_dssp             HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSS
T ss_pred             hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCC
Confidence            456789999999999999999999999999999999999999999999975

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.89  E-value=7.9e-06  Score=63.64  Aligned_cols=57  Identities=32%  Similarity=0.485  Sum_probs=52.1

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.++.++..+++++|..+|.|++|.|+.+|++.++...|..+++.++..++...+.+
T Consensus         2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~   58 (146)
T d1lkja_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVD   58 (146)
T ss_dssp             CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSS
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccC
Confidence            356788899999999999999999999999999999999999999999998887754

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.88  E-value=7.4e-06  Score=65.00  Aligned_cols=57  Identities=32%  Similarity=0.489  Sum_probs=52.9

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.++..+++++|..+|.|++|+|+.+|++.+++.++..+++.++..++..+|.+
T Consensus        12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~   68 (162)
T d1topa_          12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDED   68 (162)
T ss_dssp             HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccC
Confidence            356788889999999999999999999999999999999999999999999999865

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.87  E-value=5.4e-06  Score=64.52  Aligned_cols=50  Identities=20%  Similarity=0.364  Sum_probs=46.1

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++++++|..+|.|++|.|+.+||..+|+.+|..++..++..++...+.+
T Consensus         3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d   52 (145)
T d2mysc_           3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKE   52 (145)
T ss_pred             HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhc
Confidence            56789999999999999999999999999999999999999999887654

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=97.87  E-value=4.1e-06  Score=68.04  Aligned_cols=57  Identities=49%  Similarity=0.736  Sum_probs=53.0

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +.++.++..+++++|..+|.|++|.|+.+|+..+++.+|..++..+++.++...|.+
T Consensus         2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~   58 (182)
T d1s6ia_           2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADID   58 (182)
T ss_dssp             CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTT
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhcc
Confidence            456778888999999999999999999999999999999999999999999999875

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.86  E-value=4.3e-06  Score=57.12  Aligned_cols=50  Identities=26%  Similarity=0.393  Sum_probs=41.8

Q ss_pred             hHHHHHHHhhcCC--CCCCccCHHHHHHHHHHhCCCCC--HHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDS--DNDGVVSTDELKAGLRNFGSQLA--ESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~--~~dG~i~~~el~~~l~~~g~~~~--~~e~~~~~~~~d~~  405 (408)
                      .++++++|..||.  +++|+|+.+||+.+|+.+|..++  +.+++++|+.+|.|
T Consensus         4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d   57 (76)
T d1qx2a_           4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKN   57 (76)
T ss_dssp             HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcC
Confidence            4568889999854  35799999999999999997665  45799999999986

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.77  E-value=1.6e-05  Score=61.72  Aligned_cols=50  Identities=22%  Similarity=0.280  Sum_probs=47.0

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+.++|+.+|.+++|+|+.+|++.+|+.+|..++++|++++++.+|.+
T Consensus        76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d  125 (145)
T d2mysb_          76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPD  125 (145)
T ss_pred             HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC
Confidence            45688999999999999999999999999999999999999999999876

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.74  E-value=1.3e-05  Score=62.38  Aligned_cols=51  Identities=27%  Similarity=0.474  Sum_probs=47.6

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.+.++|..+|.+++|.|+.+||+.+|+.+|..+++++++.++..+|.+
T Consensus        79 ~~~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d  129 (146)
T d1m45a_          79 KTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVD  129 (146)
T ss_dssp             CTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCC
T ss_pred             hHHHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCC
Confidence            346789999999999999999999999999999999999999999999876

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.74  E-value=3.3e-05  Score=59.92  Aligned_cols=48  Identities=33%  Similarity=0.576  Sum_probs=45.7

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      .+.+.++|+.+|.+++|+|+.+||+.++..+|..+++.+++++++.+|
T Consensus        82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d  129 (146)
T d1lkja_          82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS  129 (146)
T ss_dssp             HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc
Confidence            467889999999999999999999999999999999999999999987

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.72  E-value=1.9e-05  Score=60.86  Aligned_cols=54  Identities=26%  Similarity=0.463  Sum_probs=49.6

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSVL  406 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~~  406 (408)
                      .++..+++++|..+|.|++|.|+.+||..+++.+|..++..++..++...|.+-
T Consensus         2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~   55 (141)
T d2obha1           2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEG   55 (141)
T ss_dssp             HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCC
Confidence            456788999999999999999999999999999999999999999999988653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.71  E-value=5.1e-05  Score=69.43  Aligned_cols=75  Identities=12%  Similarity=0.068  Sum_probs=53.0

Q ss_pred             cceecccCCeEEEEEEECC-------CCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCCCCeeEEeeEEEeCCeEE
Q 015352           56 DRELGRGEFGVTYLCIDRD-------TRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKNSSIVSLKEACEDDNAVH  128 (408)
Q Consensus        56 ~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  128 (408)
                      ++.|+.|-.-.+|++....       ....|++++.....     ..-...+|..+++.+..+.-.++++.++.+    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            4678999999999998753       24567777765221     123456899999988556556678877753    5


Q ss_pred             EEEeccCCCch
Q 015352          129 LVMELCEGGEL  139 (408)
Q Consensus       129 lv~e~~~g~~L  139 (408)
                      +|+||++|.+|
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999988544

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.66  E-value=1.7e-05  Score=62.34  Aligned_cols=51  Identities=24%  Similarity=0.522  Sum_probs=45.6

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.+++|+|+.+|++.++..+|..+++++++.+++.+|.+
T Consensus        89 ~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d  139 (156)
T d1dtla_          89 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKN  139 (156)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCC
Confidence            346688999999999999999999999999999999999999999999876

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=97.65  E-value=1.5e-05  Score=64.64  Aligned_cols=52  Identities=23%  Similarity=0.443  Sum_probs=47.9

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++++++|..+|.|++|+|+.+|+..+|+.+|..+++.+++.+++.+|.+
T Consensus        15 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d   66 (182)
T d1y1xa_          15 NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKN   66 (182)
T ss_dssp             CTTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTT
T ss_pred             CcHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhcccccc
Confidence            3446799999999999999999999999999999999999999999999876

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.64  E-value=3e-05  Score=55.22  Aligned_cols=52  Identities=21%  Similarity=0.236  Sum_probs=46.7

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...+.++|..+| +++|.|+.+|++..|.+.|  ++..++++|++.+|.+
T Consensus         4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~   55 (95)
T d2jxca1           4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDID   55 (95)
T ss_dssp             SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTT
T ss_pred             CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCC
Confidence            46778888999999999 8999999999999998876  5789999999999976

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.64  E-value=3.8e-05  Score=59.47  Aligned_cols=48  Identities=29%  Similarity=0.492  Sum_probs=44.1

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHH
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA  401 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~  401 (408)
                      .....+.++|+.+|.+++|+|+.+||+.+|..+|..+++.+++.+++.
T Consensus        78 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~  125 (145)
T d2mysc_          78 GTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG  125 (145)
T ss_pred             chHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh
Confidence            345678899999999999999999999999999999999999999975

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.64  E-value=8.3e-05  Score=58.64  Aligned_cols=51  Identities=25%  Similarity=0.487  Sum_probs=47.0

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|+.+|.|++|+|+.+|++.++..+|...++++++.+|+.+|.+
T Consensus        94 ~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d  144 (162)
T d1topa_          94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKN  144 (162)
T ss_dssp             HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCC
Confidence            345678899999999999999999999999999999999999999999875

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=97.63  E-value=6.9e-05  Score=60.60  Aligned_cols=50  Identities=18%  Similarity=0.196  Sum_probs=46.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|++.+|+.+|..+++++++.+|+.+|.+
T Consensus       104 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d  153 (187)
T d1uhka1         104 RIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDID  153 (187)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCC
T ss_pred             HHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCC
Confidence            34578899999999999999999999999999999999999999999976

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=97.62  E-value=4.7e-05  Score=53.97  Aligned_cols=51  Identities=20%  Similarity=0.196  Sum_probs=44.0

Q ss_pred             hhHHHHHHHhhc-CCCCC-CccCHHHHHHHHHHhC-----CCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKI-DSDND-GVVSTDELKAGLRNFG-----SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~-D~~~d-G~i~~~el~~~l~~~g-----~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+.++|..+ |.+|+ |+|+.+||+.+|++++     ...++.+++++|+.+|.|
T Consensus         7 ~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d   64 (93)
T d1zfsa1           7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDEN   64 (93)
T ss_dssp             HHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCC
Confidence            357788999988 88875 9999999999999875     356899999999999987

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=97.59  E-value=7.3e-05  Score=60.61  Aligned_cols=49  Identities=20%  Similarity=0.199  Sum_probs=42.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+|..+|.|++|+|+.+|+..++..+|..+++++++.+|+.+|.|
T Consensus       107 ~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d  155 (189)
T d1qv0a_         107 EWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLD  155 (189)
T ss_dssp             HHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCC
T ss_pred             HHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCC
Confidence            4567899999999999999999999999999999999999999999976

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=97.54  E-value=1.1e-05  Score=55.24  Aligned_cols=52  Identities=15%  Similarity=0.214  Sum_probs=43.3

Q ss_pred             hhhHHHHHHHhhcCC--CCCCccCHHHHHHHHHHh--CCCCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDS--DNDGVVSTDELKAGLRNF--GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~--~~dG~i~~~el~~~l~~~--g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+++..+|..+|.  ++.|+|+.+||+.+|+.+  +...++++++++|+.+|.|
T Consensus         4 ~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d   59 (78)
T d1cb1a_           4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKN   59 (78)
T ss_dssp             CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCC
T ss_pred             hhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCC
Confidence            346788999999965  345899999999999997  4556778899999999987

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.54  E-value=2.4e-05  Score=60.29  Aligned_cols=47  Identities=17%  Similarity=0.252  Sum_probs=42.3

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ..++++|..+|.|++|.|+.+||..+|+.+|..++..++..+....+
T Consensus         5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~~~~~~   51 (140)
T d1ggwa_           5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTLP   51 (140)
T ss_dssp             TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHTTSC
T ss_pred             HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhhhcccc
Confidence            56789999999999999999999999999999999999988765443

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.53  E-value=0.00017  Score=55.25  Aligned_cols=51  Identities=29%  Similarity=0.478  Sum_probs=47.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....+..+|..+|.+++|.|+.++|..++..+|..+++.+++.+|+.+|.|
T Consensus        77 ~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d  127 (141)
T d2obha1          77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRD  127 (141)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTT
T ss_pred             cHHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCC
Confidence            456789999999999999999999999999999999999999999999975

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=97.52  E-value=1.9e-05  Score=61.83  Aligned_cols=49  Identities=29%  Similarity=0.434  Sum_probs=43.7

Q ss_pred             hchhhhHHHHHHHhhcC--CCCCCccCHHHHHHHHHHhCCCCCHHHHHHHH
Q 015352          351 LSVEEVEDIKEMFKKID--SDNDGVVSTDELKAGLRNFGSQLAESEVQMLI  399 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D--~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~  399 (408)
                      ++.+++.+++++|..+|  .|++|.|+.+||+.+|+.+|..+++.++..++
T Consensus         1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~   51 (152)
T d1wdcc_           1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG   51 (152)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhh
Confidence            35678889999999999  48999999999999999999999999998764

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=97.51  E-value=4.3e-05  Score=58.09  Aligned_cols=46  Identities=28%  Similarity=0.403  Sum_probs=42.2

Q ss_pred             HHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          360 KEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       360 ~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .++|+.+|.|++|.|+.+|+..++..+|..+++.+++.+++.+|.+
T Consensus         3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~   48 (134)
T d1jfja_           3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDAD   48 (134)
T ss_dssp             HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSS
T ss_pred             HHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhc
Confidence            5789999999999999999999999999999999999999999876

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.50  E-value=1.2e-05  Score=61.88  Aligned_cols=46  Identities=22%  Similarity=0.354  Sum_probs=42.2

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      +++++|..+|.+++|.|+.+||..+|+.+|..+++.++..++...+
T Consensus         1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~   46 (139)
T d1w7jb1           1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPK   46 (139)
T ss_dssp             CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCC
T ss_pred             CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHh
Confidence            4789999999999999999999999999999999999999886554

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=97.45  E-value=0.00014  Score=51.23  Aligned_cols=51  Identities=24%  Similarity=0.332  Sum_probs=43.2

Q ss_pred             hhHHHHHHHhhc-CCCCCC-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKI-DSDNDG-VVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~-D~~~dG-~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+.++|..+ |.+++| +|+.+||+++|+.     ++...+++++++||+.+|.|
T Consensus         7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n   64 (93)
T d3c1va1           7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSN   64 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCC
Confidence            456788999998 666655 7999999999987     45678999999999999986

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=97.42  E-value=7.4e-05  Score=53.36  Aligned_cols=52  Identities=12%  Similarity=0.114  Sum_probs=43.0

Q ss_pred             hhhHHHHHHHhhc-CCCCC-CccCHHHHHHHHHHhCC--CCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKI-DSDND-GVVSTDELKAGLRNFGS--QLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~-D~~~d-G~i~~~el~~~l~~~g~--~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+..+|..+ |.+++ |+|+.+||+.+|++.+.  ..+..+++++|+.+|.|
T Consensus        11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d   66 (98)
T d1yuta1          11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVN   66 (98)
T ss_dssp             HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCC
Confidence            3456788999998 77775 99999999999998653  44677899999999987

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=97.42  E-value=3.4e-05  Score=54.50  Aligned_cols=50  Identities=16%  Similarity=0.276  Sum_probs=42.8

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh-----CCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-----GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~-----g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+..+|..+|.+ +|+|+.+||..+|+..     +...++.+++++|+.+|.|
T Consensus         7 ~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n   61 (92)
T d1a4pa_           7 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQC   61 (92)
T ss_dssp             HHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCC
Confidence            467789999999977 8999999999999873     3455788899999999987

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.38  E-value=5.7e-05  Score=57.93  Aligned_cols=49  Identities=29%  Similarity=0.479  Sum_probs=42.5

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSS  404 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~  404 (408)
                      ...++..+|+.+|.+++|+|+.+||+.+|.++|..+++.+++.|++. |.
T Consensus        75 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~  123 (139)
T d1w7jb1          75 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HE  123 (139)
T ss_dssp             ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CC
T ss_pred             HHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CC
Confidence            34567899999999999999999999999999999999999999864 44

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=97.34  E-value=0.00017  Score=58.04  Aligned_cols=49  Identities=31%  Similarity=0.451  Sum_probs=45.6

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.+.|..+|.+++|.|+.+||+.++..+|..+++++++.+++.+|.|
T Consensus        84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~  132 (182)
T d1y1xa_          84 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQ  132 (182)
T ss_dssp             HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTT
T ss_pred             cccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccC
Confidence            4567889999999999999999999999999999999999999999876

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.31  E-value=2.4e-05  Score=60.73  Aligned_cols=45  Identities=31%  Similarity=0.446  Sum_probs=40.4

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASS  403 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d  403 (408)
                      ++++|..+|.|++|+|+.+||..+|+.+|..++.++++.++...+
T Consensus         4 ~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~   48 (146)
T d1m45a_           4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADS   48 (146)
T ss_dssp             CTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--
T ss_pred             HHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhcccc
Confidence            567899999999999999999999999999999999999986443

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.26  E-value=3.3e-05  Score=56.56  Aligned_cols=53  Identities=19%  Similarity=0.211  Sum_probs=45.9

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...+.++|..+|.|++|+|+.+|++.+|.+.|  ++..++++|++.+|.+
T Consensus        16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d   68 (110)
T d1iq3a_          16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDAD   68 (110)
T ss_dssp             CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSS
T ss_pred             cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccC
Confidence            4667788889999999999999999999999997765  5677899999999876

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=97.25  E-value=0.00021  Score=50.22  Aligned_cols=51  Identities=18%  Similarity=0.182  Sum_probs=43.4

Q ss_pred             hhHHHHHHHhhc-CCCCCC-ccCHHHHHHHHHHhC-----CCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKI-DSDNDG-VVSTDELKAGLRNFG-----SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~-D~~~dG-~i~~~el~~~l~~~g-----~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+..+|.++ |.+|+| +|+.+||+++|++..     ...++.+++++|+.+|.|
T Consensus         7 ~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n   64 (93)
T d1ksoa_           7 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTN   64 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCC
Confidence            456788899987 999999 599999999998753     456799999999999976

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.23  E-value=0.00023  Score=54.88  Aligned_cols=51  Identities=29%  Similarity=0.578  Sum_probs=41.3

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCC-HHHHHHHHHHh
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLA-ESEVQMLIEAS  402 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~-~~e~~~~~~~~  402 (408)
                      +.+++.+++++|..+|.+++|.|+.+|+..+|+.+|..++ .+.++.++...
T Consensus         2 ~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~   53 (145)
T d2mysb_           2 DETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA   53 (145)
T ss_pred             CHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHHhc
Confidence            4577889999999999999999999999999999996544 44455555443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.18  E-value=0.00072  Score=59.70  Aligned_cols=68  Identities=13%  Similarity=0.124  Sum_probs=45.1

Q ss_pred             CeEEEEEEECCCCcEEEEEEeeccccCChhcHHHHHHHHHHHHhCCCC--CCeeEEe-----eEEEeCCeEEEEEeccCC
Q 015352           64 FGVTYLCIDRDTRELLACKSISKRKLRTAVDIDDVRREVAIMKHLPKN--SSIVSLK-----EACEDDNAVHLVMELCEG  136 (408)
Q Consensus        64 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~i~~~~-----~~~~~~~~~~lv~e~~~g  136 (408)
                      --.||++.. .+|..|++|+.....    ...+.+..|...+..|..+  | ++...     ..+..++..+.++++++|
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gip-v~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVP-VAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCS-BCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCC-CCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            358999975 468889999986432    2346678899888877222  2 11111     134567788999999987


Q ss_pred             C
Q 015352          137 G  137 (408)
Q Consensus       137 ~  137 (408)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=97.18  E-value=0.00014  Score=50.80  Aligned_cols=51  Identities=25%  Similarity=0.421  Sum_probs=43.6

Q ss_pred             hhHHHHHHHhhc-CCCCCC-ccCHHHHHHHHHH---hCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKI-DSDNDG-VVSTDELKAGLRN---FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~-D~~~dG-~i~~~el~~~l~~---~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+..+|.++ |++++| +|++.||+.+++.   +|...++.+++++|+.+|.|
T Consensus         7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d   62 (89)
T d1k8ua_           7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRN   62 (89)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCC
Confidence            456788899888 999999 6999999999987   56677889999999999876

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=97.15  E-value=0.00011  Score=64.88  Aligned_cols=55  Identities=20%  Similarity=0.315  Sum_probs=50.4

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ++.++...++++|..+|.|++|.|+.+|++.+|+.+|..++..++..+|..+|.+
T Consensus       116 l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~  170 (321)
T d1ij5a_         116 LSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVEND  170 (321)
T ss_dssp             CCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhc
Confidence            4566778899999999999999999999999999999999999999999998865

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=97.14  E-value=0.00039  Score=55.12  Aligned_cols=48  Identities=21%  Similarity=0.323  Sum_probs=43.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|++.+++.+|  +++.+++.+|+.+|.+
T Consensus       101 ~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~d  148 (176)
T d1nyaa_         101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTN  148 (176)
T ss_dssp             HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCCC
Confidence            44578899999999999999999999999987  5899999999999976

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.13  E-value=0.00045  Score=54.86  Aligned_cols=49  Identities=24%  Similarity=0.420  Sum_probs=45.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++|+.+|.+++|.|+.+|++.+|..+|..++.++++.++++.|.+
T Consensus        77 ~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d~~  125 (172)
T d1juoa_          77 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTN  125 (172)
T ss_dssp             HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCSS
T ss_pred             hhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHHhc
Confidence            4467789999999999999999999999999999999999999998865

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.11  E-value=0.00021  Score=51.12  Aligned_cols=47  Identities=19%  Similarity=0.167  Sum_probs=37.9

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCC----------------CCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ----------------LAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~----------------~~~~e~~~~~~~~d~~  405 (408)
                      ++.+|..+|.|++|+|+.+||..+++.++..                ..+..++.+|+.+|.|
T Consensus        18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d   80 (99)
T d1snla_          18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTN   80 (99)
T ss_dssp             HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCC
Confidence            6789999999999999999999999865311                1234577899999986

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=97.10  E-value=0.00036  Score=56.34  Aligned_cols=46  Identities=22%  Similarity=0.408  Sum_probs=41.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA  401 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~  401 (408)
                      ...++.+|+.+|.|++|+|+.+||+.+|..+|..++++.++.|++.
T Consensus        92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~  137 (188)
T d1qxpa2          92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR  137 (188)
T ss_dssp             HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH
Confidence            4567889999999999999999999999999999998887777765

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.04  E-value=0.00024  Score=57.12  Aligned_cols=52  Identities=23%  Similarity=0.342  Sum_probs=45.5

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCC-CCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~-~~~~e~~~~~~~~d~~  405 (408)
                      .+.+.+.++|..+|.|++|+|+.+|++.+|+.++.. .+..+++.+++.+|.+
T Consensus        16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d   68 (181)
T d1hqva_          16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRE   68 (181)
T ss_dssp             SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCS
T ss_pred             ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccc
Confidence            455778999999999999999999999999988754 6889999999998765

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=96.97  E-value=0.00045  Score=49.24  Aligned_cols=47  Identities=15%  Similarity=0.247  Sum_probs=41.5

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++|+.+|.+++|+|+.+|++.+++..|  ++..++.+|++.+|.+
T Consensus        11 ~~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d   57 (99)
T d1qjta_          11 PVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTD   57 (99)
T ss_dssp             THHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCC
Confidence            3456889999999999999999999999776  5899999999999976

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=96.91  E-value=0.00019  Score=49.88  Aligned_cols=51  Identities=14%  Similarity=0.126  Sum_probs=39.7

Q ss_pred             hhHHHHHHHhhc-CCCCCCc-cCHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKI-DSDNDGV-VSTDELKAGLRN-FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~-D~~~dG~-i~~~el~~~l~~-~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+..+|.++ |.+|+|. ++.+||+.++.+ +|..++..+++++|+++|.|
T Consensus         8 ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n   61 (87)
T d1xk4a1           8 ALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDIN   61 (87)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCC
Confidence            345677888887 8888885 488999988875 67666777888899988876

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=96.86  E-value=0.00075  Score=53.92  Aligned_cols=53  Identities=15%  Similarity=0.177  Sum_probs=43.9

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC------------CCCCHHHHHHHHHHhCCC
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG------------SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g------------~~~~~~e~~~~~~~~d~~  405 (408)
                      ......++.+|+.+|.|++|.|+.+|+..++..+.            ....+..++.+|+++|.|
T Consensus        91 ~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d  155 (181)
T d1bjfa_          91 GKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTN  155 (181)
T ss_dssp             SCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTT
T ss_pred             hchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCC
Confidence            33456788999999999999999999999998652            245667889999999976

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=96.85  E-value=0.0015  Score=45.01  Aligned_cols=51  Identities=16%  Similarity=0.167  Sum_probs=41.3

Q ss_pred             hhHHHHHHHhhc-CCCCCC-ccCHHHHHHHHHHh-----CCCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKI-DSDNDG-VVSTDELKAGLRNF-----GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~-D~~~dG-~i~~~el~~~l~~~-----g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+..+..+|.++ +.++++ +|+++||++++++.     +...++..++++|+.+|.|
T Consensus         6 ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n   63 (87)
T d1e8aa_           6 HLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDAN   63 (87)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCC
Confidence            456788999988 556555 69999999999873     3455789999999999987

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=96.78  E-value=0.0013  Score=52.57  Aligned_cols=49  Identities=31%  Similarity=0.555  Sum_probs=45.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.+|+.+|.+++|.|+.+||+.++...|..+++++++++++.+|.+
T Consensus        86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~  134 (181)
T d1hqva_          86 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQ  134 (181)
T ss_dssp             HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSS
T ss_pred             cccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCC
Confidence            4567899999999999999999999999999999999999999998864

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=96.76  E-value=0.00029  Score=56.57  Aligned_cols=48  Identities=25%  Similarity=0.398  Sum_probs=42.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|+|+.+|++.+++.+|  ++.++++.+|+.+|.|
T Consensus       104 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~d  151 (185)
T d2sasa_         104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDG  151 (185)
T ss_dssp             HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCCC
Confidence            34578899999999999999999999999887  4778899999999976

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=96.71  E-value=0.0009  Score=52.95  Aligned_cols=48  Identities=17%  Similarity=0.248  Sum_probs=42.7

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|..+|.|++|.|+.+|+..+++.+|.  +.+++..+|+.+|.|
T Consensus        93 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~~~~~~~~f~~~D~d  140 (174)
T d2scpa_          93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--DKTMAPASFDAIDTN  140 (174)
T ss_dssp             HTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CGGGHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--hhHHHHHHHhhcCCC
Confidence            445788999999999999999999999998874  678899999999976

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=96.69  E-value=0.002  Score=51.74  Aligned_cols=118  Identities=14%  Similarity=0.122  Sum_probs=65.8

Q ss_pred             HHHHHHHHHhcCCCcCCCCCHHHHhcCccccCCcCCCCCCCchHHHhhhh-hhhhhhh--h-HHHHhhhhhhhhchhhhH
Q 015352          282 ESAKSLVRQMLEPDPKLRLTAKQVLEHPWLQNAKKAPNVPLGDVVRSRLK-QFSMMNR--F-KRKALRVIAEFLSVEEVE  357 (408)
Q Consensus       282 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~-~~~~l~~i~~~ls~~~~~  357 (408)
                      .+++++.++....+|+-+.|..+..+  ++....    .+........+- .+.....  + -..++..+..........
T Consensus        21 ~ei~~~~~~F~~~~~~G~i~~~Ef~~--~l~~~~----~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~   94 (189)
T d1jbaa_          21 AQLQEWYKKFLEECPSGTLFMHEFKR--FFKVPD----NEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEH   94 (189)
T ss_dssp             HHHHHHHHHHHSSSTTCCEEHHHHHH--HHHCCS----SSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTH
T ss_pred             HHHHHHHHHhcccCCCCeeeHHHHHH--HHHHcC----CCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHH
Confidence            45677777777777888888887644  332221    111122222221 1111100  0 011122222222222345


Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHhC----------------CCCC-HHHHHHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFG----------------SQLA-ESEVQMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~g----------------~~~~-~~e~~~~~~~~d~~  405 (408)
                      .++.+|+.+|.|++|.|+.+|+..++..+.                ...+ ++.++++|+.+|.|
T Consensus        95 ~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d  159 (189)
T d1jbaa_          95 KLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDEN  159 (189)
T ss_dssp             HHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCS
T ss_pred             HHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCC
Confidence            678899999999999999999998876431                1122 45568899999876

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=96.68  E-value=0.0003  Score=50.32  Aligned_cols=51  Identities=12%  Similarity=0.156  Sum_probs=41.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC-------CCCHHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS-------QLAESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~-------~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+..+|..++ +++|.|+.+||+.+|+..+.       ..++.+|+++|+.+|.|
T Consensus         7 ~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n   64 (100)
T d1psra_           7 RSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKN   64 (100)
T ss_dssp             HHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTT
T ss_pred             HHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCC
Confidence            44667888999997 68899999999999998652       23556789999999987

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=96.53  E-value=0.00045  Score=55.48  Aligned_cols=48  Identities=23%  Similarity=0.484  Sum_probs=43.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      .+.+..+|..+|.+++|+|+.++|+.++.++|  +++.+++.+|+.+|.|
T Consensus        81 ~e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~d  128 (182)
T d1s6ia_          81 EENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQD  128 (182)
T ss_dssp             CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhcC
Confidence            34678899999999999999999999999887  5889999999999976

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.52  E-value=0.00079  Score=52.94  Aligned_cols=53  Identities=25%  Similarity=0.337  Sum_probs=32.0

Q ss_pred             hhhchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          349 EFLSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       349 ~~ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++.+++..+.++|..+|.|++|+|+.+||..++.... .   ..++++++.+|.+
T Consensus         8 t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~-~---~~~~~l~~~~d~~   60 (165)
T d1auib_           8 SHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQ-N---PLVQRVIDIFDTD   60 (165)
T ss_dssp             CSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHT-C---TTHHHHHHHHCTT
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccC-C---HHHHHHHHHHccc
Confidence            445666677777777777777777777777766554322 2   1244556555543

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.48  E-value=0.0019  Score=51.84  Aligned_cols=50  Identities=22%  Similarity=0.278  Sum_probs=40.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC------------CCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG------------SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g------------~~~~~~e~~~~~~~~d~~  405 (408)
                      .+.+..+|+.+|.|++|.|+.+|+..+++.+.            ....++.++.+|+++|.|
T Consensus        95 ~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d  156 (187)
T d1g8ia_          95 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKN  156 (187)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSS
T ss_pred             hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCC
Confidence            45688899999999999999999999987542            123356788999999976

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.46  E-value=0.002  Score=51.35  Aligned_cols=50  Identities=22%  Similarity=0.333  Sum_probs=38.9

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh-----CCCCCHHHH----HHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-----GSQLAESEV----QMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~-----g~~~~~~e~----~~~~~~~d~~  405 (408)
                      .+.++.+|+.+|.|++|+|+.+||..+++.+     +..+++.++    +.+++++|.+
T Consensus        94 ~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d  152 (180)
T d1xo5a_          94 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDID  152 (180)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTT
T ss_pred             HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCC
Confidence            4568889999999999999999999999886     344555554    4577888865

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=96.44  E-value=0.0099  Score=46.68  Aligned_cols=45  Identities=24%  Similarity=0.468  Sum_probs=35.2

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEA  401 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~  401 (408)
                      ..++.+|+.+|.|++|.|+.+|++.+|+..|..+++++++.++..
T Consensus        77 ~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~~  121 (173)
T d1alva_          77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRR  121 (173)
T ss_dssp             HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhcc
Confidence            345678888888888888888888888888888888777666543

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=96.38  E-value=0.0012  Score=53.11  Aligned_cols=49  Identities=22%  Similarity=0.397  Sum_probs=40.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+..+|+.+|.|++|+|+.+||+.+|+.+|..++.+.++ ++...|.|
T Consensus        90 ~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~-~~~~~d~d  138 (186)
T d1df0a1          90 IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQ-VIVARFAD  138 (186)
T ss_dssp             HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHH-HHHHHHCC
T ss_pred             HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHH-HHHHHHcC
Confidence            45678999999999999999999999999999888876554 44456654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.05  E-value=0.004  Score=54.33  Aligned_cols=31  Identities=35%  Similarity=0.471  Sum_probs=24.8

Q ss_pred             CCCeeccCCCCceEeecCCCCCCEEEeecccccc
Q 015352          171 HGVIHRDLKPENFLFANKKENSPLKAIDFGLSIF  204 (408)
Q Consensus       171 ~~ivH~dikp~NIl~~~~~~~~~vkl~Dfg~~~~  204 (408)
                      .|+||+|+.++||+++   ++...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcc---cccceeEeccccccc
Confidence            4799999999999995   333457999997754

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=96.03  E-value=0.0038  Score=50.09  Aligned_cols=50  Identities=18%  Similarity=0.223  Sum_probs=40.9

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC------------CCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS------------QLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~------------~~~~~e~~~~~~~~d~~  405 (408)
                      .+.++.+|+.+|.|++|.|+.+|+..+++..+.            ...+..++++|+++|.|
T Consensus        98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d  159 (190)
T d1fpwa_          98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKN  159 (190)
T ss_dssp             THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCC
Confidence            456788999999999999999999999986532            12256789999999976

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.00  E-value=0.013  Score=45.61  Aligned_cols=52  Identities=25%  Similarity=0.362  Sum_probs=41.9

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh-CCCCC----HHHHHHHHHHhCCC
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF-GSQLA----ESEVQMLIEASSSV  405 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~-g~~~~----~~e~~~~~~~~d~~  405 (408)
                      .....+..+|..+|.|++|.|+.+|+...++.. |..+.    +..++.+|+++|.|
T Consensus        82 ~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~  138 (165)
T d1auib_          82 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKD  138 (165)
T ss_dssp             CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTT
T ss_pred             hhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCC
Confidence            345678999999999999999999999999874 55444    55567788888875

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=95.70  E-value=0.0057  Score=48.91  Aligned_cols=49  Identities=16%  Similarity=0.206  Sum_probs=41.4

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.++|..+|.|++|.|+.+|+..++..+.....+..+..+|+.+|.|
T Consensus        58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~d  106 (189)
T d1jbaa_          58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKD  106 (189)
T ss_dssp             HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSS
T ss_pred             HHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhccC
Confidence            4577889999999999999999999998877666778888899888876

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=95.52  E-value=0.0068  Score=48.31  Aligned_cols=51  Identities=14%  Similarity=0.253  Sum_probs=40.3

Q ss_pred             chhhhHHHHHHHhhcCCCCCCccCHHHHHHH-----HHHhCCCCCHHHHHHHHHHh
Q 015352          352 SVEEVEDIKEMFKKIDSDNDGVVSTDELKAG-----LRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       352 s~~~~~~l~~~F~~~D~~~dG~i~~~el~~~-----l~~~g~~~~~~e~~~~~~~~  402 (408)
                      .++.+..++++|..+|.|++|.|+.+|+...     ++.+|..++..++..++..+
T Consensus         9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~   64 (189)
T d1qv0a_           9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEA   64 (189)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHH
Confidence            3456678999999999999999999999874     45678777777776665554

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=95.46  E-value=0.013  Score=47.17  Aligned_cols=50  Identities=14%  Similarity=0.174  Sum_probs=39.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCC--------------HHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLA--------------ESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~--------------~~e~~~~~~~~d~~  405 (408)
                      ...++.+|+.+|.|++|.|+.+|+...++.++....              +..++.+|+.+|.|
T Consensus        98 ~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d  161 (201)
T d1omra_          98 NQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKK  161 (201)
T ss_dssp             GGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCC
Confidence            345788999999999999999999999987643222              34567899999876

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=95.42  E-value=0.0063  Score=45.35  Aligned_cols=46  Identities=20%  Similarity=0.361  Sum_probs=38.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...++.+|+.+|.+++|.|+.+|++..+..+|.    +++.++|+++|.|
T Consensus        74 ~~~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~----~~~~~~~~~~D~d  119 (134)
T d1jfja_          74 KIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI----EKVAEQVMKADAN  119 (134)
T ss_dssp             HHHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC----HHHHHHHHHHHCS
T ss_pred             cccccccccccccccCCcccHHHHHHHHHhcCc----HHHHHHHHHHCCC
Confidence            345678999999999999999999999987764    6788888888865

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=95.30  E-value=0.0044  Score=49.52  Aligned_cols=49  Identities=14%  Similarity=0.272  Sum_probs=42.1

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC--------CCCHHHHHHHHHHhCCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS--------QLAESEVQMLIEASSSVL  406 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~--------~~~~~e~~~~~~~~d~~~  406 (408)
                      +.++++|..+| |+||.|+.+||..+|+.+|.        .++.+++..++..+|.+-
T Consensus        18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~   74 (186)
T d1df0a1          18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDG   74 (186)
T ss_dssp             HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCC
Confidence            45899999998 99999999999999988763        356788999999999864

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=95.28  E-value=0.03  Score=38.40  Aligned_cols=50  Identities=20%  Similarity=0.278  Sum_probs=39.7

Q ss_pred             hHHHHHHHhhc-CCCCC-CccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKI-DSDND-GVVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~-D~~~d-G~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+..+|.++ ..+|+ ++++++||++++++     ++...++..++++|+.+|.|
T Consensus         8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n   64 (90)
T d3cr5x1           8 VVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSD   64 (90)
T ss_dssp             HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCC
Confidence            45678899887 45555 57999999999987     34445678899999999987

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=95.27  E-value=0.012  Score=46.99  Aligned_cols=47  Identities=19%  Similarity=0.266  Sum_probs=43.3

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+|..+|.+++|.|+.+|+..++..++....++.++.+|+.+|.|
T Consensus        65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d  111 (190)
T d1fpwa_          65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLN  111 (190)
T ss_dssp             HHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSS
T ss_pred             HHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhccC
Confidence            46799999999999999999999999998778899999999999976

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=95.24  E-value=0.0057  Score=53.21  Aligned_cols=49  Identities=14%  Similarity=0.166  Sum_probs=44.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGS-QLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~-~~~~~e~~~~~~~~d~~  405 (408)
                      ..+..+|..+|.|++|+|+.+||+.++..+|. .++..++..+|+.+|.+
T Consensus       253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d  302 (321)
T d1ij5a_         253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVD  302 (321)
T ss_dssp             HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTT
T ss_pred             hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCC
Confidence            34567899999999999999999999999996 47889999999999976

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=95.11  E-value=0.0079  Score=47.76  Aligned_cols=49  Identities=20%  Similarity=0.264  Sum_probs=37.2

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHH-----HhCCCCCHHHHHHHHHH
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLR-----NFGSQLAESEVQMLIEA  401 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~-----~~g~~~~~~e~~~~~~~  401 (408)
                      +.....++++|..+|.|++|.|+.+|+..++.     .+|..++..++...+..
T Consensus         8 p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~   61 (187)
T d1uhka1           8 PRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVE   61 (187)
T ss_dssp             HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHH
Confidence            44567889999999999999999999977654     35666666666555443

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=95.08  E-value=0.02  Score=44.98  Aligned_cols=51  Identities=14%  Similarity=0.253  Sum_probs=38.2

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC------------CCCCHHHHHHHHHHhCCC
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG------------SQLAESEVQMLIEASSSV  405 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g------------~~~~~~e~~~~~~~~d~~  405 (408)
                      ....++.+|+.+|.|++|.|+.+|+...+..+.            ....+..++.+|+++|.|
T Consensus        85 ~~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d  147 (178)
T d1s6ca_          85 VHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKN  147 (178)
T ss_dssp             HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTT
T ss_pred             hHHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCC
Confidence            345678899999999999999999988765431            122355577899999875

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=94.97  E-value=0.021  Score=45.13  Aligned_cols=50  Identities=18%  Similarity=0.278  Sum_probs=38.7

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH----hCCCCCHHHH----HHHHHHhCCC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN----FGSQLAESEV----QMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~----~g~~~~~~e~----~~~~~~~d~~  405 (408)
                      ...++.+|+.+|.|++|.|+.+|++..+..    .|....+.++    +.+|+++|.|
T Consensus        90 ~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d  147 (183)
T d2zfda1          90 DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTK  147 (183)
T ss_dssp             HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSS
T ss_pred             HHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCC
Confidence            345778999999999999999999998754    4666666665    4567778765

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=94.83  E-value=0.023  Score=38.22  Aligned_cols=40  Identities=28%  Similarity=0.438  Sum_probs=31.4

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQML  398 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~  398 (408)
                      .++.++|..+|.|++|.|+.+|+..+++...  -...++.++
T Consensus        41 ~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~--~~~~e~~~~   80 (81)
T d2opoa1          41 DEVRRMMAEIDTDGDGFISFDEFTDFARANR--GLVKDVSKI   80 (81)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHCT--TTHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEeHHHHHHHHHHCc--cchHHHHhh
Confidence            4578899999999999999999999998643  234455544

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=94.62  E-value=0.021  Score=36.83  Aligned_cols=30  Identities=33%  Similarity=0.643  Sum_probs=26.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      ..++.++|..+|.|++|.|+.+|+..++.+
T Consensus        36 ~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~   65 (67)
T d1tiza_          36 QEDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             HHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             hHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            356788899999999999999999999875

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=94.43  E-value=0.023  Score=39.32  Aligned_cols=33  Identities=18%  Similarity=0.265  Sum_probs=28.7

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .....+.++|..+|.|+||.|+.+|+..++..+
T Consensus        49 ~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l   81 (93)
T d3c1va1          49 TDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI   81 (93)
T ss_dssp             CSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Confidence            345668899999999999999999999988765

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=94.24  E-value=0.03  Score=44.13  Aligned_cols=48  Identities=13%  Similarity=0.286  Sum_probs=37.1

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHhCCC-CCHHHHHHHHHHhCCC
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEASSSV  405 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~-~~~~e~~~~~~~~d~~  405 (408)
                      ....+|..+|.|++|.|+.+|+..++..+-.. ..++.++.+|+.+|.+
T Consensus        55 ~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d  103 (183)
T d2zfda1          55 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLK  103 (183)
T ss_dssp             HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccC
Confidence            45788899999999999999998888766433 3456678888888876

>d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=94.15  E-value=0.1  Score=32.20  Aligned_cols=52  Identities=15%  Similarity=0.374  Sum_probs=47.2

Q ss_pred             hchhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Q 015352          351 LSVEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEAS  402 (408)
Q Consensus       351 ls~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~  402 (408)
                      +.+++.++-.++|..||.|....-...+-.+.|..+|...+..|-+.+|.+.
T Consensus         8 lgpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkea   59 (86)
T d1j7qa_           8 LGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEA   59 (86)
T ss_dssp             CSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHH
T ss_pred             cCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHh
Confidence            4667788889999999999999999999999999999999999999999875

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=93.65  E-value=0.036  Score=44.42  Aligned_cols=47  Identities=13%  Similarity=0.239  Sum_probs=37.8

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+|..+|.|++|.|+.+|+..++..+.....++.++.+|+..|.+
T Consensus        65 ~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d  111 (201)
T d1omra_          65 AQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVD  111 (201)
T ss_dssp             HHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCTT
T ss_pred             HHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHccC
Confidence            46788888888888888888888888776666777788888888765

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.55  E-value=0.019  Score=44.91  Aligned_cols=49  Identities=16%  Similarity=0.235  Sum_probs=29.8

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCC----------CCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ----------LAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~----------~~~~e~~~~~~~~d~~  405 (408)
                      .++..+|..+|.|++|.|+.+||...|++.+..          ++.+.++++++....+
T Consensus        78 ~ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~  136 (170)
T d2zkmx1          78 PEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPS  136 (170)
T ss_dssp             HHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC
T ss_pred             HHHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccc
Confidence            457789999999999999999999999986543          4667788888887654

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

Probab=93.47  E-value=0.04  Score=38.07  Aligned_cols=50  Identities=14%  Similarity=0.184  Sum_probs=39.5

Q ss_pred             hHHHHHHHhhc-CCCCC-CccCHHHHHHHHHH-----hCCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKI-DSDND-GVVSTDELKAGLRN-----FGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~-D~~~d-G~i~~~el~~~l~~-----~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+..+|..+ ..+|+ +++++.||+.++++     ++..-+...++++|+.+|.|
T Consensus         8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n   64 (95)
T d1qlsa_           8 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLD   64 (95)
T ss_dssp             HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCC
Confidence            55677899887 44565 67999999999975     44445778899999999986

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=93.32  E-value=0.0044  Score=49.66  Aligned_cols=54  Identities=22%  Similarity=0.314  Sum_probs=31.6

Q ss_pred             chhhh-HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCC--------CCHHHHHHHHHHhCCCC
Q 015352          352 SVEEV-EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQ--------LAESEVQMLIEASSSVL  406 (408)
Q Consensus       352 s~~~~-~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~--------~~~~e~~~~~~~~d~~~  406 (408)
                      +.++. +.++++|..+| +++|.|+..||..+|.+.|..        ++.+.++.|+..+|.+-
T Consensus        14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~   76 (188)
T d1qxpa2          14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDG   76 (188)
T ss_dssp             -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--
T ss_pred             CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCC
Confidence            44454 35899999999 558999999999998765533        46678999999999874

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=93.24  E-value=0.05  Score=37.46  Aligned_cols=31  Identities=16%  Similarity=0.268  Sum_probs=26.9

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ...+.++|..+|.|+||.|+.+|+..++..+
T Consensus        48 ~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l   78 (92)
T d1a4pa_          48 PLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL   78 (92)
T ss_dssp             TTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence            4567889999999999999999999888654

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

Probab=93.20  E-value=0.067  Score=36.85  Aligned_cols=50  Identities=18%  Similarity=0.280  Sum_probs=35.7

Q ss_pred             hHHHHHHHhhcC-CCCC-CccCHHHHHHHHHH-h----CCCCCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKID-SDND-GVVSTDELKAGLRN-F----GSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D-~~~d-G~i~~~el~~~l~~-~----g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+..+|.++. .+++ +++++.||+.++++ +    +...+...++++|+.+|.|
T Consensus         8 i~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n   64 (94)
T d1j55a_           8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDAN   64 (94)
T ss_dssp             HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSS
T ss_pred             HHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCC
Confidence            456778998874 4444 58999999999987 3    3344567799999999987

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=93.00  E-value=0.065  Score=35.37  Aligned_cols=31  Identities=23%  Similarity=0.435  Sum_probs=27.1

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ..++.++|..+|.|++|.|+.+|+..++++-
T Consensus        44 ~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~   74 (77)
T d1oqpa_          44 EEELQEMIAEADRNDDNEIDEDEFIRIMKKT   74 (77)
T ss_dssp             HHHHHHHHHHHCCSSSSEECHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCcEeHHHHHHHHHcc
Confidence            3467788999999999999999999998764

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=92.75  E-value=0.025  Score=36.55  Aligned_cols=30  Identities=23%  Similarity=0.473  Sum_probs=26.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      ..++..+|..+|.|++|.|+.+|+..++.+
T Consensus        38 ~~e~~~~~~~~D~d~dG~i~~~EF~~~m~r   67 (68)
T d1c7va_          38 DAEVEEAMKEADEDGNGVIDIPEFMDLIKK   67 (68)
T ss_dssp             HHHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            456778899999999999999999998863

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=92.58  E-value=0.069  Score=41.66  Aligned_cols=47  Identities=11%  Similarity=0.167  Sum_probs=39.4

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+|..+|.|++|.|+.+|+..++..+-....+..++.+++.+|.+
T Consensus        53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~D~~   99 (178)
T d1s6ca_          53 AHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDIN   99 (178)
T ss_dssp             HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhhccC
Confidence            46789999999999999999999887665555677888899888875

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=92.56  E-value=0.08  Score=35.91  Aligned_cols=33  Identities=21%  Similarity=0.306  Sum_probs=28.4

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .+...+.++++.+|.|+||.|+.+|+...+..+
T Consensus        48 ~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l   80 (87)
T d1e8aa_          48 KDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA   80 (87)
T ss_dssp             TSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence            345678899999999999999999999888654

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=92.42  E-value=0.057  Score=37.25  Aligned_cols=32  Identities=19%  Similarity=0.452  Sum_probs=27.9

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ....+.++|..+|.|+||.|+.+|+..++..+
T Consensus        50 ~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l   81 (93)
T d1zfsa1          50 DADAVDKIMKELDENGDGEVDFQEFVVLVAAL   81 (93)
T ss_dssp             CHHHHHHHHHHHTTTCCSEECSHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence            34667889999999999999999999988664

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.39  E-value=0.037  Score=38.72  Aligned_cols=29  Identities=21%  Similarity=0.399  Sum_probs=25.9

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      ..+..+|..+|.|+||.|+.+|+.+++++
T Consensus        68 ~~v~~~~~~~D~d~DG~Is~~EF~~~~~~   96 (99)
T d1snla_          68 RMREHVMKNVDTNQDRLVTLEEFLASTQR   96 (99)
T ss_dssp             HHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred             HHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence            45788999999999999999999998764

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=92.28  E-value=0.047  Score=37.69  Aligned_cols=33  Identities=18%  Similarity=0.165  Sum_probs=28.5

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .....+.+++..+|.|+||.|+.+|+...+..+
T Consensus        49 ~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l   81 (93)
T d1ksoa_          49 FRECDYNKFMSVLDTNKDCEVDFVEYVRSLACL   81 (93)
T ss_dssp             TCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence            345678899999999999999999999988764

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=91.99  E-value=0.051  Score=35.86  Aligned_cols=30  Identities=27%  Similarity=0.536  Sum_probs=26.7

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .++.++|..+|.|++|.|+.+|+...+..+
T Consensus        45 ~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~   74 (76)
T d1qx2a_          45 STLDEMIEEVDKNGDGEVSFEEFLVMMKKI   74 (76)
T ss_dssp             CSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence            357889999999999999999999998764

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=91.98  E-value=0.055  Score=42.37  Aligned_cols=47  Identities=15%  Similarity=0.234  Sum_probs=36.4

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..++|..+|.+++|.|+.+|+..++..+-....++.+..+++.+|.+
T Consensus        61 ~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~d  107 (181)
T d1bjfa_          61 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLD  107 (181)
T ss_dssp             HHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhccC
Confidence            46788888888888888888888887776555667777788888765

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=91.23  E-value=0.12  Score=33.92  Aligned_cols=30  Identities=33%  Similarity=0.578  Sum_probs=26.2

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .++.++|..+|.|++|.|+.+|+..++..+
T Consensus        45 ~e~~~~~~~~D~d~dg~I~~~EF~~~m~~~   74 (75)
T d1jc2a_          45 EDIEDLMKDSDKNNDGRIDFDEFLKMMEGV   74 (75)
T ss_dssp             HHHHHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred             HHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence            457788999999999999999999998653

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.19  E-value=0.12  Score=40.58  Aligned_cols=47  Identities=13%  Similarity=0.162  Sum_probs=39.5

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ...+|..+|.+++|.|+.+|+..++..+-....++.++.+|+.+|.|
T Consensus        62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~d  108 (187)
T d1g8ia_          62 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLD  108 (187)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhcC
Confidence            45689999999999999999999988765444567788899999876

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=91.00  E-value=0.062  Score=38.25  Aligned_cols=28  Identities=25%  Similarity=0.531  Sum_probs=25.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      .++..+|..+|.|+||.|+.+|+..+++
T Consensus        80 ~~~~~~~~~~D~d~dG~I~~~EF~~~m~  107 (108)
T d1rroa_          80 SETKSLMDAADNDGDGKIGADEFQEMVH  107 (108)
T ss_dssp             HHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence            5577889999999999999999999875

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=90.43  E-value=0.095  Score=37.27  Aligned_cols=29  Identities=28%  Similarity=0.510  Sum_probs=25.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      .++.++|..+|.|+||.|+.+|+...+.+
T Consensus        80 ~ev~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d1pvaa_          80 AETKAFLKAADKDGDGKIGIDEFETLVHE  108 (109)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence            44677899999999999999999998753

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=90.41  E-value=0.098  Score=37.18  Aligned_cols=29  Identities=21%  Similarity=0.406  Sum_probs=25.4

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      .++..+|+.+|.|+||.|+.+|+.+++.+
T Consensus        80 ~e~~~~~~~~D~d~dG~i~~~EF~~~m~~  108 (109)
T d1rwya_          80 KETKTLMAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            45678899999999999999999998864

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=90.40  E-value=0.11  Score=34.70  Aligned_cols=29  Identities=34%  Similarity=0.581  Sum_probs=25.5

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      .++.++|..+|.|++|.|+.+|+...++.
T Consensus        51 ~ev~~~~~~~D~d~dg~I~~~EF~~~m~~   79 (81)
T d1fi5a_          51 DDIEELMKDGDKNNDGRIDYDEFLEFMKG   79 (81)
T ss_dssp             HHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred             HHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence            45778899999999999999999998863

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=90.25  E-value=0.11  Score=37.01  Aligned_cols=29  Identities=28%  Similarity=0.450  Sum_probs=25.7

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      .++.++|..+|.|+||.|+.+|+..++.+
T Consensus        80 ~e~~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d5pala_          80 TETKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence            45778899999999999999999998864

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=90.19  E-value=0.097  Score=35.88  Aligned_cols=28  Identities=25%  Similarity=0.482  Sum_probs=24.5

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      ..+.+++...|.|++|.|+.+|+..+++
T Consensus        43 ~~l~~i~~~~D~d~dG~l~~~EF~~a~~   70 (92)
T d1fi6a_          43 LELSHIWELSDFDKDGALTLDEFCAAFH   70 (92)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence            4678899999999999999999987654

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=89.98  E-value=0.15  Score=32.25  Aligned_cols=27  Identities=33%  Similarity=0.591  Sum_probs=23.6

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGL  383 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l  383 (408)
                      .++.++|..+|.|++|.|+.+|+.+++
T Consensus        39 ~e~~~l~~~~D~d~~g~I~~~eF~~~m   65 (65)
T d1fw4a_          39 EEVDEMIREADIDGDGQVNYEEFVQMM   65 (65)
T ss_dssp             HHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred             HHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence            567788999999999999999998753

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=89.95  E-value=0.11  Score=36.76  Aligned_cols=28  Identities=29%  Similarity=0.538  Sum_probs=25.1

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      .++..+|+.+|.|+||.|+.+|+...++
T Consensus        79 ~~~~~l~~~~D~d~dG~I~~~EF~~~m~  106 (107)
T d2pvba_          79 AETKAFLADGDKDGDGMIGVDEFAAMIK  106 (107)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence            4677889999999999999999998876

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=89.95  E-value=0.21  Score=33.73  Aligned_cols=30  Identities=23%  Similarity=0.361  Sum_probs=26.3

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ..+.+++...|.|+||.|+.+|+...+..+
T Consensus        49 ~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l   78 (87)
T d1xk4a1          49 KGADVWFKELDINTDGAVNFQEFLILVIKM   78 (87)
T ss_dssp             TCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            347788999999999999999999998764

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=89.77  E-value=0.17  Score=33.69  Aligned_cols=30  Identities=30%  Similarity=0.525  Sum_probs=26.3

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      ..++.+++..+|.|++|.|+.+|+...+..
T Consensus        51 ~~el~~~i~~~D~d~~G~I~f~eFl~im~~   80 (82)
T d1wrka1          51 PEELQEMIDEVDEDGSGTVDFDEFLVMMVR   80 (82)
T ss_dssp             HHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            456788899999999999999999988764

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=89.73  E-value=0.23  Score=33.73  Aligned_cols=34  Identities=26%  Similarity=0.405  Sum_probs=28.3

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ..+...+.++|+.+|.|+||.|+.+|+..++..+
T Consensus        48 ~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l   81 (90)
T d3cr5x1          48 IKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMI   81 (90)
T ss_dssp             CCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence            3445668899999999999999999998887654

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=89.61  E-value=0.12  Score=36.12  Aligned_cols=32  Identities=19%  Similarity=0.342  Sum_probs=27.4

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHhC
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNFG  387 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g  387 (408)
                      ...+.++|..+|.|+||.|+.+|+..++..+.
T Consensus        51 ~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~   82 (100)
T d1psra_          51 TNYLADVFEKKDKNEDKKIDFSEFLSLLGDIA   82 (100)
T ss_dssp             CCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence            34577889999999999999999999887653

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=89.61  E-value=0.23  Score=32.87  Aligned_cols=29  Identities=17%  Similarity=0.472  Sum_probs=25.4

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      .++.++|..+|.|++|.|+.+|+..++.+
T Consensus        50 ~e~~~~~~~~D~d~~g~I~~~eF~~~m~~   78 (81)
T d1avsa_          50 EELDAIIEEVDEDGSGTIDFEEFLVMMVR   78 (81)
T ss_dssp             HHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            45678899999999999999999998864

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

Probab=89.43  E-value=0.21  Score=34.33  Aligned_cols=33  Identities=24%  Similarity=0.397  Sum_probs=28.2

Q ss_pred             hhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          354 EEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       354 ~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .+...+.++++.+|.|+||.|+.+|+..++..+
T Consensus        49 ~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~l   81 (95)
T d1qlsa_          49 KDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGL   81 (95)
T ss_dssp             CCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence            445668899999999999999999998887654

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=89.38  E-value=0.11  Score=36.17  Aligned_cols=29  Identities=28%  Similarity=0.409  Sum_probs=25.6

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      ...+.++|...|.|++|.|+.+|+..+++
T Consensus        44 ~~~L~~i~~~~D~d~dG~L~~~EF~~am~   72 (99)
T d1qjta_          44 DLILGKIWDLADTDGKGVLSKQEFFVALR   72 (99)
T ss_dssp             HHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence            34577899999999999999999998886

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=89.01  E-value=0.26  Score=30.54  Aligned_cols=26  Identities=15%  Similarity=0.443  Sum_probs=22.2

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKA  381 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~  381 (408)
                      ..++..+|+.+|.|++|.|+.+|+.+
T Consensus        36 ~~ei~~l~~~~D~d~dg~I~~~eFl~   61 (61)
T d2fcea1          36 DAEVDELLKGVEVDSNGEIDYKKFIE   61 (61)
T ss_dssp             HHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence            35677889999999999999999853

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.94  E-value=0.077  Score=36.70  Aligned_cols=28  Identities=14%  Similarity=0.315  Sum_probs=24.3

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      ..+.++|..+|.|++|.|+.+|+..++.
T Consensus        44 ~~l~~i~~~~D~d~dG~l~~~EF~~am~   71 (95)
T d1c07a_          44 TLLAHIWSLCDTKDCGKLSKDQFALAFH   71 (95)
T ss_dssp             HHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence            4577899999999999999999987663

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=88.91  E-value=0.16  Score=32.97  Aligned_cols=30  Identities=17%  Similarity=0.464  Sum_probs=25.8

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      ...+..+|..+|.|++|.|+.+|+..++..
T Consensus        43 ~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~   72 (73)
T d2pq3a1          43 EAELQDMINEVDADGNGTIDFPEFLTMMAR   72 (73)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            345778899999999999999999988753

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.61  E-value=0.39  Score=36.74  Aligned_cols=43  Identities=14%  Similarity=0.146  Sum_probs=32.0

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      +..+.++..+|.|++|.|+.+|+..++..+      .++..+|+.+|.+
T Consensus        40 ~~~~~li~~~D~~~~G~i~~~EF~~l~~~~------~~~~~~F~~fD~d   82 (165)
T d1k94a_          40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENFMTVDQD   82 (165)
T ss_dssp             HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHHHCTT
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHhhcc------chhHHHHHHhCCC
Confidence            456677888899999999999998887643      4455566666543

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.87  E-value=0.18  Score=34.73  Aligned_cols=28  Identities=21%  Similarity=0.446  Sum_probs=24.4

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      ..+.+++...|.|++|+|+.+|+..++.
T Consensus        43 ~~L~~Iw~~~D~~~dG~l~~~EF~~a~~   70 (95)
T d2jxca1          43 DILGRVWELSDIDHDGMLDRDEFAVAMF   70 (95)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence            4688899999999999999999976654

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=86.91  E-value=0.27  Score=33.98  Aligned_cols=30  Identities=17%  Similarity=0.273  Sum_probs=26.4

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ..+.++|..+|.|+||.|+.+|+...+..+
T Consensus        54 ~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l   83 (98)
T d1yuta1          54 GSLDEKMKSLDVNQDSELKFNEYWRLIGEL   83 (98)
T ss_dssp             SCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence            457789999999999999999999998754

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=86.83  E-value=0.38  Score=31.34  Aligned_cols=29  Identities=17%  Similarity=0.365  Sum_probs=25.5

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      ..++.++|..+|.+++|.|+.+|+..++.
T Consensus        45 ~~e~~~~~~~~D~~~~g~I~~~eF~~~m~   73 (77)
T d1f54a_          45 EAEVNDLMNEIDVDGNHQIEFSEFLALMS   73 (77)
T ss_dssp             HHHHHHHHHTTCCSSCCEEEHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence            35678899999999999999999998874

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=86.60  E-value=0.23  Score=32.67  Aligned_cols=29  Identities=24%  Similarity=0.613  Sum_probs=25.8

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .+.+++..+|.|+||.|+.+|+...+..+
T Consensus        48 ~v~~~~~~~D~d~dG~Idf~EF~~l~~~l   76 (78)
T d1cb1a_          48 TLDDLFQELDKNGDGEVSFEEFQVLVKKI   76 (78)
T ss_dssp             CSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            46678999999999999999999998765

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=86.32  E-value=0.23  Score=38.14  Aligned_cols=30  Identities=30%  Similarity=0.491  Sum_probs=26.8

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      .++..+|..+|.|+||.|+.+|+.++++.+
T Consensus       128 ~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~f  157 (174)
T d2scpa_         128 TMAPASFDAIDTNNDGLLSLEEFVIAGSDF  157 (174)
T ss_dssp             GGHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCCCcEeHHHHHHHHHHH
Confidence            356778999999999999999999999875

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

Probab=86.30  E-value=0.36  Score=33.00  Aligned_cols=34  Identities=15%  Similarity=0.315  Sum_probs=26.6

Q ss_pred             hhhhHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          353 VEEVEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       353 ~~~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      +.+...+.++++.+|.|+||.|+.+|+...+..+
T Consensus        48 ~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~l   81 (94)
T d1j55a_          48 GKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI   81 (94)
T ss_dssp             ----CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence            3445568899999999999999999998887654

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

Probab=85.90  E-value=0.92  Score=29.99  Aligned_cols=50  Identities=16%  Similarity=0.275  Sum_probs=37.3

Q ss_pred             hHHHHHHHhhcC-CCC-CCccCHHHHHHHHHH-hCC----C-CCHHHHHHHHHHhCCC
Q 015352          356 VEDIKEMFKKID-SDN-DGVVSTDELKAGLRN-FGS----Q-LAESEVQMLIEASSSV  405 (408)
Q Consensus       356 ~~~l~~~F~~~D-~~~-dG~i~~~el~~~l~~-~g~----~-~~~~e~~~~~~~~d~~  405 (408)
                      +..+..+|.++. .+| .+++++.||+.++++ ++.    . -.+..++++|+.+|.|
T Consensus         9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n   66 (83)
T d1xk4c1           9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTN   66 (83)
T ss_dssp             HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCC
Confidence            456778898884 333 368999999999987 442    1 2456689999999987

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=85.73  E-value=0.15  Score=39.08  Aligned_cols=31  Identities=32%  Similarity=0.654  Sum_probs=27.8

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHHHHHhC
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAGLRNFG  387 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~l~~~g  387 (408)
                      .++.++|..+|.|++|.|+.+|+..+++.+.
T Consensus       136 ~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~  166 (176)
T d1nyaa_         136 AEAAEAFNQVDTNGNGELSLDELLTAVRDFH  166 (176)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHSCCS
T ss_pred             HHHHHHHHHHCCCCCCcEeHHHHHHHHHHHh
Confidence            4577899999999999999999999998754

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

Probab=85.60  E-value=0.8  Score=30.31  Aligned_cols=31  Identities=16%  Similarity=0.293  Sum_probs=26.2

Q ss_pred             hhHHHHHHHhhcCCCCCCccCHHHHHHHHHH
Q 015352          355 EVEDIKEMFKKIDSDNDGVVSTDELKAGLRN  385 (408)
Q Consensus       355 ~~~~l~~~F~~~D~~~dG~i~~~el~~~l~~  385 (408)
                      +...+.+++..+|.|+||.|+.+|+...+-.
T Consensus        52 d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~   82 (83)
T d1xk4c1          52 NEKVIEHIMEDLDTNADKQLSFEEFIMLMAR   82 (83)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence            3456788999999999999999999887654

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=85.52  E-value=0.23  Score=33.67  Aligned_cols=31  Identities=19%  Similarity=0.292  Sum_probs=27.0

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ...+.++++.+|.|+||.|+.+|+...+..+
T Consensus        49 ~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l   79 (89)
T d1k8ua_          49 DAEIARLMEDLDRNKDQEVNFQEYVTFLGAL   79 (89)
T ss_dssp             SHHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            3568889999999999999999999988654

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.06  E-value=0.61  Score=30.74  Aligned_cols=28  Identities=7%  Similarity=0.284  Sum_probs=24.1

Q ss_pred             hHHHHHHHhhcCCCCCCccCHHHHHHHH
Q 015352          356 VEDIKEMFKKIDSDNDGVVSTDELKAGL  383 (408)
Q Consensus       356 ~~~l~~~F~~~D~~~dG~i~~~el~~~l  383 (408)
                      ..++..+|..+|.|++|.|+..|+...+
T Consensus        55 ~~e~~~l~~~~d~~~~g~I~y~eFl~~f   82 (83)
T d1wlza1          55 DEQFDRLWNEMPVNAKGRLKYPDFLSRF   82 (83)
T ss_dssp             HHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred             hhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence            3457788999999999999999998765

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=84.87  E-value=0.58  Score=35.81  Aligned_cols=41  Identities=15%  Similarity=0.150  Sum_probs=30.7

Q ss_pred             HHHHHhhcCCCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSDNDGVVSTDELKAGLRNFGSQLAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~~dG~i~~~el~~~l~~~g~~~~~~e~~~~~~~~d~~  405 (408)
                      ..+.|..+|.|++|.|+.+|+..++..+      +.+.++|+..|.+
T Consensus       114 ~~~~~~~~d~d~~G~i~~~EF~~~~~~~------~~~~~~f~~~D~d  154 (173)
T d1alva_         114 LYSMIIRRYSDEGGNMDFDNFISCLVRL------DAMFRAFKSLDKD  154 (173)
T ss_dssp             HHHHHHHHHTCSSSCBCHHHHHHHHHHH------HHHHHHHHHHSSS
T ss_pred             HHHHhhccccCCCCeEeHHHHHHHHHHH------HHHHHHHHHhCCC
Confidence            3445666777899999999998888654      4677788888765

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.82  E-value=0.64  Score=35.95  Aligned_cols=47  Identities=6%  Similarity=0.069  Sum_probs=37.4

Q ss_pred             HHHHHhhcCCC-CCCccCHHHHHHHHHHhCCC-CCHHHHHHHHHHhCCC
Q 015352          359 IKEMFKKIDSD-NDGVVSTDELKAGLRNFGSQ-LAESEVQMLIEASSSV  405 (408)
Q Consensus       359 l~~~F~~~D~~-~dG~i~~~el~~~l~~~g~~-~~~~e~~~~~~~~d~~  405 (408)
                      ..++|+.+|.+ ++|.|+.+|+..++..+... ..++.+..+|+-+|.+
T Consensus        59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d  107 (180)
T d1xo5a_          59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFD  107 (180)
T ss_dssp             HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTT
T ss_pred             HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCC
Confidence            35688899987 69999999999999876433 3466788899998876

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.77  E-value=0.27  Score=34.82  Aligned_cols=27  Identities=22%  Similarity=0.446  Sum_probs=23.6

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHH
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLR  384 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~  384 (408)
                      .+.+++...|.|++|.|+.+|+..+|+
T Consensus        57 ~L~~Iw~l~D~d~dG~l~~~EF~~am~   83 (110)
T d1iq3a_          57 ELSYIWELSDADCDGALTLPEFCAAFH   83 (110)
T ss_dssp             CHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCCeECHHHHHHHHH
Confidence            467789999999999999999987764

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=83.49  E-value=0.24  Score=38.34  Aligned_cols=29  Identities=10%  Similarity=0.190  Sum_probs=26.1

Q ss_pred             HHHHHHhhcCCCCCCccCHHHHHHHHHHh
Q 015352          358 DIKEMFKKIDSDNDGVVSTDELKAGLRNF  386 (408)
Q Consensus       358 ~l~~~F~~~D~~~dG~i~~~el~~~l~~~  386 (408)
                      ++..+|..+|.|++|.|+.+|+..++.++
T Consensus       140 ~~~~~f~~~D~d~dG~i~~~EF~~~~~~f  168 (185)
T d2sasa_         140 DVPAVYNVITDGGKVTFDLNRYKELYYRL  168 (185)
T ss_dssp             SHHHHHHHHHTTTTSCCSHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCcHHHHHHHHHHH
Confidence            46789999999999999999999999774

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=82.14  E-value=0.17  Score=34.18  Aligned_cols=26  Identities=27%  Similarity=0.516  Sum_probs=22.8

Q ss_pred             HHHHHHHhhcCCCCCCccCHHHHHHH
Q 015352          357 EDIKEMFKKIDSDNDGVVSTDELKAG  382 (408)
Q Consensus       357 ~~l~~~F~~~D~~~dG~i~~~el~~~  382 (408)
                      .++.++|..+|.|++|.|+.+|+..+
T Consensus        59 ~e~~~l~~~~D~d~~g~I~~~EFl~a   84 (87)
T d1s6ja_          59 SEIKDLMDAADIDKSGTIDYGEFIAA   84 (87)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHTTC
T ss_pred             HHHHHHHHHcCCCCCCeEeHHHHHHH
Confidence            46788999999999999999998754